Citrus Sinensis ID: 013897

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430----
Protein Sequence
MAIRPFQFTIHRNNYKNTTLFSSFFAISSNTSSSRTTSVSKILFSPLSQSSRIFTPFGTLRGLASSASLSHARHQHQRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAESSRSRS
Secondary Structure (PSIPRED)
cccccccccccccccccccHHHEEEHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHccccccccccccccccccccccccccEEEEEEEEEEcccccccEEEEEEEcccccEEEEEEEcccccEEEEEEcccccHHHHHHHHHHHHHccccccEEEEcEEEEcccccccEEEEEEcccccHHHHcccccHHHHHHHHHHHHHHHHHHHHccccccccccccEEEccccccEEEEEcccccccccccccEEEEEccccccHHHHcccccccccccHHHHHHHHHHHHHcccccccccccHHHHHHHHHHcccccHHHHHHHHcccccHHHHHHcccccccccccccccccccccccHHHHHHHHHccccccccccHHHHHcccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccccEEEEcccccccccHHHHHHHcccccccccccccccEEccccccccccccccccHHHcccccccccccccccccccccccccccccccccccccccccccccccccHHHHccHHHHcHHHcccccccHHHEEEEEEEEEcccEEEEEEEEccccEEEEEEEEccccHHHHHHHHHHHHHHcccccEccEEEEEEccccccEEEEEEccccccHHHHHHHccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEEccccEEEEccccccEEcccccccccccccHHHccHHHHccccccccHHHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHHcHHHHHHHHHHccccccHHHHHHHcccccccHHHHcccccHHHccHHHHHHHHHHccccHHHcccHHHHHccHHHHHHHHHHcccccc
Coil and Loop (DISEMBL)
mairpfqftihrnnyknttLFSSFFAIssntsssrttSVSKIlfsplsqssriftpfgtlrglassaslsHARHQHQRLrqlatppdtlaQKIGKsvrrsgapskarvysdinvvrpreywdyesltvqwgeqddyEVVRKVGRGKYSEVfegvhctdnekCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRdqqsktpslifehvnntdfkvlyptlsdydVRYYIYELLKALDYchsqgimhrdvkphnvmidhEQRKLRLIDWglaefyhpgkeyNVRVASryfkgpellvDLQDYDYSLDLWSLGCMFAgmifrkepffyghdnYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVgrhsrkpwskfitvenqhlavpEAVDFLDKLLRYdhqerptakeamahpyffpirnaessrsrs
Flexible Loop (DISEMBL)
mairpfqftihrnnyknTTLFSSFFAISSNTSSSRTTSVSKILFSPLSQSSRIFTPFGTLRGLASSASLSHARHQHQrlrqlatppdtlaqkigksvrrsgapskarvysdinvvrpreywdyesltvqwgeqddYEVVRKVGRGKYSEvfegvhctdnekciikilkpvkkkkIKREIKIlqnlcggpnIVKLLDIVRDQQSKTPSlifehvnntdfkvlyPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERptakeamahpyffpirnaessrsrs
Low Complexity Region (SEG)
MAIRPFQFTIHRNNYKNTTLfssffaissntsssrttsvsKILFSPLSQSSRIFTPFGTlrglassaslsharhqhqRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEkciikilkpvkkkkikreikiLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAESSRSRS
Disordered region (IsUnstruct)
*****FQFTIHRNNYKNTTLFSSFFAI***************L*********IFTPFGTL**********************************************RVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDH**********AHPYFFP***********
Disordered Region (DISOPRED)
***RP**FTIHRNNYKNTTLFSSFF***********************************************************************************YSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI**********
Disordered Region (DISEMBL)
MAIRPFQFTIHRNNYKNTTLFSSFFAIS***********SKILFSPLSQSSRIFTPFGTLRGLA***************RQLATPPDTLAQKI*************RVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR*********
Disordered Region (DISPRO)
*AIRPFQFTIHRNNYKNTTLFSSFFAISS****SRTTSVSKILFSPLS**********************************************************RVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAES*****
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MAIRPFQFTIHRNNYKNTTLFSSFFAISSNTSSSRTTSVSKILFSPLSQSSRIFTPFGTLRGLASSASLSHARHQHQRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAESSRSRS
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	434	2.2.26 [Sep-21-2011]
O64816	432	Casein kinase II subunit	yes	no	0.861	0.865	0.871	0.0
Q08467	409	Casein kinase II subunit	no	no	0.799	0.848	0.842	1e-165
Q08466	403	Casein kinase II subunit	no	no	0.790	0.851	0.839	1e-165
P28523	332	Casein kinase II subunit	N/A	no	0.762	0.996	0.879	1e-165
O64817	333	Probable casein kinase II	no	no	0.762	0.993	0.836	1e-157
P21868	391	Casein kinase II subunit	yes	no	0.744	0.826	0.764	1e-141
O76484	353	Casein kinase II subunit	N/A	no	0.746	0.917	0.765	1e-141
P28020	392	Casein kinase II subunit	N/A	no	0.755	0.836	0.753	1e-141
Q60737	391	Casein kinase II subunit	yes	no	0.767	0.851	0.738	1e-140
P19139	391	Casein kinase II subunit	yes	no	0.767	0.851	0.738	1e-140

>sp|O64816|CSK2P_ARATH Casein kinase II subunit alpha, chloroplastic OS=Arabidopsis thaliana GN=At2g23070 PE=2 SV=1

 Score =  652 bits (1683), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 332/381 (87%), Positives = 355/381 (93%), Gaps = 7/381 (1%)

Query: 59  TLRGLASSASL--SHARHQHQRLR-----QLATPPDTLAQKIGKSVRRSGAPSKARVYSD 111
            LR  ASSASL   H R+Q Q+ +     ++    +TLAQKIGKS+RR+GAPSKARVY+D
Sbjct: 48  NLRRFASSASLYRQHLRNQQQQHQQQQQSRVKEKSETLAQKIGKSIRRAGAPSKARVYAD 107

Query: 112 INVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK 171
           +NVVRP++YWDYESL VQWG QDDYEVVRKVGRGKYSEVFEG+H TDNEKC+IKILKPVK
Sbjct: 108 VNVVRPKDYWDYESLAVQWGVQDDYEVVRKVGRGKYSEVFEGIHATDNEKCVIKILKPVK 167

Query: 172 KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVR 231
           KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN DFKVLYPTLSDYDVR
Sbjct: 168 KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNKDFKVLYPTLSDYDVR 227

Query: 232 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS 291
           YYI+ELLKALD+CHS+GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS
Sbjct: 228 YYIFELLKALDFCHSRGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS 287

Query: 292 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL 351
           RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL
Sbjct: 288 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL 347

Query: 352 NAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT 411
           NAYLNKY IELDP+L +LVGRHSRKPW+KFI  ENQHLAVPEAVDF+DKLLRYDHQERPT
Sbjct: 348 NAYLNKYRIELDPNLTSLVGRHSRKPWTKFINSENQHLAVPEAVDFVDKLLRYDHQERPT 407

Query: 412 AKEAMAHPYFFPIRNAESSRS 432
           AKEAMAHPYF+PIRNAESSR+
Sbjct: 408 AKEAMAHPYFYPIRNAESSRT 428

Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. May act as an ectokinase that phosphorylates several extracellular proteins.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q08467|CSK21_ARATH Casein kinase II subunit alpha-1 OS=Arabidopsis thaliana GN=CKA1 PE=1 SV=3

 Score =  583 bits (1502), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 294/349 (84%), Positives = 319/349 (91%), Gaps = 2/349 (0%)

Query: 86  PDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRG 145
           PD L + I  S  ++ A SKARVY+++NV+RP++YWDYESL VQWGEQDDYEVVRKVGRG
Sbjct: 62  PDFLVE-ISDS-NQTRAMSKARVYTEVNVIRPKDYWDYESLIVQWGEQDDYEVVRKVGRG 119

Query: 146 KYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205
           KYSEVFEG++    EKCIIKILKPVKKKKI+REIKILQNLCGGPNIVKLLD+VRDQ SKT
Sbjct: 120 KYSEVFEGINVNSKEKCIIKILKPVKKKKIRREIKILQNLCGGPNIVKLLDVVRDQHSKT 179

Query: 206 PSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ 265
           PSLIFE+VN+TDFKVLYPTL+DYD+RYYIYELLKALD+CHSQGIMHRDVKPHNVMIDHE 
Sbjct: 180 PSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDFCHSQGIMHRDVKPHNVMIDHEL 239

Query: 266 RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFR 325
           RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD+WSLGCMFAGMIFR
Sbjct: 240 RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFR 299

Query: 326 KEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVE 385
           KEPFFYGHDN DQLVKIAKVLGTDELNAYLNKY +ELDP L ALVGRHSRKPWSKFI  +
Sbjct: 300 KEPFFYGHDNQDQLVKIAKVLGTDELNAYLNKYQLELDPQLEALVGRHSRKPWSKFINAD 359

Query: 386 NQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAESSRSRS 434
           NQHL  PEA+DFLDKLLRYDHQ+R TAKEAMAH YF  +R AE+SR RS
Sbjct: 360 NQHLVSPEAIDFLDKLLRYDHQDRLTAKEAMAHAYFAQVRAAETSRMRS 408

Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. May act as an ectokinase that phosphorylates several extracellular proteins.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q08466|CSK22_ARATH Casein kinase II subunit alpha-2 OS=Arabidopsis thaliana GN=CKA2 PE=2 SV=3

 Score =  582 bits (1500), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 292/348 (83%), Positives = 319/348 (91%), Gaps = 5/348 (1%)

Query: 87  DTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGK 146
           D+LA+     +  S   SKARVY+D+NV+RP++YWDYESL VQWGEQDDYEVVRKVGRGK
Sbjct: 60  DSLAK-----ISLSTVMSKARVYTDVNVIRPKDYWDYESLNVQWGEQDDYEVVRKVGRGK 114

Query: 147 YSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206
           YSEVFEG++  +NEKCIIKILKPVKKKKI+REIKILQNLCGGPNIVKLLD+VRDQ SKTP
Sbjct: 115 YSEVFEGINMNNNEKCIIKILKPVKKKKIRREIKILQNLCGGPNIVKLLDVVRDQHSKTP 174

Query: 207 SLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR 266
           SLIFE+VN+TDFKVLYPTL+DYD+RYYIYELLKALD+CHSQGIMHRDVKPHNVMIDHE R
Sbjct: 175 SLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDFCHSQGIMHRDVKPHNVMIDHELR 234

Query: 267 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRK 326
           KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD+WSLGCMFAGMIFRK
Sbjct: 235 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRK 294

Query: 327 EPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVEN 386
           EPFFYGHDN DQLVKIAKVLGTDELNAYLNKY +ELD  L ALVGRHSRKPWSKFI  +N
Sbjct: 295 EPFFYGHDNQDQLVKIAKVLGTDELNAYLNKYQLELDTQLEALVGRHSRKPWSKFINADN 354

Query: 387 QHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAESSRSRS 434
           +HL  PEA+D+LDKLLRYDHQ+R TAKEAMAHPYF  +R AESSR R+
Sbjct: 355 RHLVSPEAIDYLDKLLRYDHQDRLTAKEAMAHPYFAQVRAAESSRMRT 402

Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. May act as an ectokinase that phosphorylates several extracellular proteins.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P28523|CSK2A_MAIZE Casein kinase II subunit alpha OS=Zea mays GN=ACK2 PE=1 SV=1

 Score =  582 bits (1499), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 291/331 (87%), Positives = 311/331 (93%)

Query: 104 SKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI 163
           SKARVY+D+NV+RP+EYWDYE+LTVQWGEQDDYEVVRKVGRGKYSEVFEG++  +NEKCI
Sbjct: 2   SKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI 61

Query: 164 IKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP 223
           IKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ SKTPSLIFE+VNNTDFKVLYP
Sbjct: 62  IKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP 121

Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
           TL+DYD+RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPGK
Sbjct: 122 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 181

Query: 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA 343
           EYNVRVASRYFKGPELLVDLQDYDYSLD+WSLGCMFAGMIFRKEPFFYGHDN+DQLVKIA
Sbjct: 182 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 241

Query: 344 KVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLR 403
           KVLGTD LN YLNKY IELDP L ALVGRHSRKPW KF+  +NQHL  PEA+DFLDKLLR
Sbjct: 242 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 301

Query: 404 YDHQERPTAKEAMAHPYFFPIRNAESSRSRS 434
           YDHQER TA EAM HPYF  +R AE+SR+R+
Sbjct: 302 YDHQERLTALEAMTHPYFQQVRAAENSRTRA 332

Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site.

Zea mays (taxid: 4577)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O64817|CSK23_ARATH Probable casein kinase II subunit alpha OS=Arabidopsis thaliana GN=At2g23080 PE=1 SV=1

 Score =  556 bits (1433), Expect = e-157,   Method: Compositional matrix adjust.
 Identities = 277/331 (83%), Positives = 304/331 (91%)

Query: 104 SKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI 163
           SKARVY+D+NVVRP+EYWDYESL VQWG QDDYEVVRKVGRGKYSEVFEG +   NE+C+
Sbjct: 2   SKARVYTDVNVVRPKEYWDYESLVVQWGHQDDYEVVRKVGRGKYSEVFEGKNVNTNERCV 61

Query: 164 IKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP 223
           IKILKPVKKKKIKREIKILQNLCGGPNIVKL DIVRD+ SKTPSL+FE VN+ DFKVLYP
Sbjct: 62  IKILKPVKKKKIKREIKILQNLCGGPNIVKLYDIVRDEHSKTPSLVFEFVNSVDFKVLYP 121

Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
           TL+DYD+RYYIYELLKALD+CHSQGIMHRDVKPHNVMIDH+ RKLRLIDWGLAEFYHPGK
Sbjct: 122 TLTDYDIRYYIYELLKALDFCHSQGIMHRDVKPHNVMIDHQLRKLRLIDWGLAEFYHPGK 181

Query: 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA 343
           EYNVRVASRYFKGPELLVDLQDYDYSLD+WSLGCMFAGMIFRKEPFFYGHDN+DQLVKIA
Sbjct: 182 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 241

Query: 344 KVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLR 403
           KVLGT+EL+ YLNKY ++LDP L ALVGRH  KPWSKFI  +NQHL  PEA+DFLDKLL+
Sbjct: 242 KVLGTNELDHYLNKYQLDLDPQLEALVGRHVPKPWSKFINADNQHLVSPEAIDFLDKLLQ 301

Query: 404 YDHQERPTAKEAMAHPYFFPIRNAESSRSRS 434
           YDHQ+R TA+EAM HPYF  ++ AESSR R+
Sbjct: 302 YDHQDRLTAREAMDHPYFAQVKAAESSRLRT 332

Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. May act as an ectokinase that phosphorylates several extracellular proteins.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P21868|CSK21_CHICK Casein kinase II subunit alpha OS=Gallus gallus GN=CSNK2A1 PE=2 SV=1

 Score =  502 bits (1292), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 247/323 (76%), Positives = 286/323 (88%)

Query: 102 APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEK 161
            PS+ARVY+D+N  RPREYWDYES  V+WG QDDY++VRK+GRGKYSEVFE ++ T+NEK
Sbjct: 5   VPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEK 64

Query: 162 CIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL 221
            ++KILKPVKKKKIKREIKIL+NL GGPNI+ L DIV+D  S+TP+L+FEHVNNTDFK L
Sbjct: 65  VVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL 124

Query: 222 YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281
           Y TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHP
Sbjct: 125 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 184

Query: 282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 341
           G+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFRKEPFF+GHDNYDQLV+
Sbjct: 185 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 244

Query: 342 IAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKL 401
           IAKVLGT++L  Y++KY+IELDP    ++GRHSRK W +F+  ENQHL  PEA+DFLDKL
Sbjct: 245 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKL 304

Query: 402 LRYDHQERPTAKEAMAHPYFFPI 424
           LRYDHQ R TA+EAM HPYF+PI
Sbjct: 305 LRYDHQSRLTAREAMEHPYFYPI 327

Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha and alpha' chains contain the catalytic site. Participates in Wnt signaling.

Gallus gallus (taxid: 9031)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O76484|CSK2A_SPOFR Casein kinase II subunit alpha OS=Spodoptera frugiperda PE=2 SV=1

 Score =  502 bits (1292), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 248/324 (76%), Positives = 284/324 (87%)

Query: 101 GAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNE 160
             PS+ARVY+D+N  RPREYWDYES  V WG Q+DY++VRK+GRGKYSEVFE ++ T+NE
Sbjct: 4   AVPSRARVYADVNSQRPREYWDYESYVVDWGNQEDYQLVRKLGRGKYSEVFEAINITNNE 63

Query: 161 KCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKV 220
           KC++KILKPVKKKKIKREIKIL+NL GG NI+ L  +V+D  S+TP+LIFEHVNNTDFK 
Sbjct: 64  KCVVKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQ 123

Query: 221 LYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280
           LY TLSDYD+RYY+YELLKALDYCHS GIMHRDVKPHNVMIDH+ RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLSDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHDHRKLRLIDWGLAEFYH 183

Query: 281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
           PG++YNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFRKEPFF+GHDNYDQLV
Sbjct: 184 PGQDYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243

Query: 341 KIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDK 400
           +IAKVLGT+EL  YL+KYHIELDP    ++GRHSRK W +F+  ENQHL  PEA+DFLD+
Sbjct: 244 RIAKVLGTEELFEYLDKYHIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDR 303

Query: 401 LLRYDHQERPTAKEAMAHPYFFPI 424
           LLRYDH ER TA+EAM HPYF+PI
Sbjct: 304 LLRYDHYERYTAREAMDHPYFYPI 327

Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. May participate in Wnt signaling.

Spodoptera frugiperda (taxid: 7108)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P28020|CSK21_XENLA Casein kinase II subunit alpha OS=Xenopus laevis GN=csnk2a1 PE=2 SV=2

 Score =  502 bits (1292), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 247/328 (75%), Positives = 288/328 (87%)

Query: 102 APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEK 161
            PS+ARVY+D+N  RPR+YWDYES  V+WG QDDY++VRK+GRGKYSEVFE ++ T+NEK
Sbjct: 5   VPSRARVYTDVNTHRPRDYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEK 64

Query: 162 CIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL 221
            ++KILKPVKKKKIKREIKIL+NL GGPNI+ L DIV+D  S+TP+L+FEHVNNTDFK L
Sbjct: 65  VVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL 124

Query: 222 YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281
           Y TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHP
Sbjct: 125 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 184

Query: 282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 341
           G+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFRKEPFF+GHDNYDQLV+
Sbjct: 185 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 244

Query: 342 IAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKL 401
           IAKVLGT++L  Y++KY+IELDP    ++GRHSRK W +F+  ENQHL  PEA+DFLDKL
Sbjct: 245 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKL 304

Query: 402 LRYDHQERPTAKEAMAHPYFFPIRNAES 429
           LRYDHQ R TA+EAM HPYF+PI   +S
Sbjct: 305 LRYDHQTRLTAREAMDHPYFYPIVKDQS 332

Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha and alpha' chains contain the catalytic site. Participates in Wnt signaling.

Xenopus laevis (taxid: 8355)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q60737|CSK21_MOUSE Casein kinase II subunit alpha OS=Mus musculus GN=Csnk2a1 PE=1 SV=2

 Score =  499 bits (1284), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 246/333 (73%), Positives = 289/333 (86%)

Query: 102 APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEK 161
            PS+ARVY+D+N  RPREYWDYES  V+WG QDDY++VRK+GRGKYSEVFE ++ T+NEK
Sbjct: 5   VPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEK 64

Query: 162 CIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL 221
            ++KILKPVKKKKIKREIKIL+NL GGPNI+ L DIV+D  S+TP+L+FEHVNNTDFK L
Sbjct: 65  VVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL 124

Query: 222 YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281
           Y TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHP
Sbjct: 125 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 184

Query: 282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 341
           G+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFRKEPFF+GHDNYDQLV+
Sbjct: 185 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 244

Query: 342 IAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKL 401
           IAKVLGT++L  Y++KY+IELDP    ++GRHSRK W +F+  ENQHL  PEA+DFLDKL
Sbjct: 245 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKL 304

Query: 402 LRYDHQERPTAKEAMAHPYFFPIRNAESSRSRS 434
           LRYDHQ R TA+EAM HPYF+ +   ++  S +
Sbjct: 305 LRYDHQSRLTAREAMEHPYFYTVVKDQARMSST 337

Catalytic subunit of a constitutively active serine/threonine-protein kinase complex that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine. Regulates numerous cellular processes, such as cell cycle progression, apoptosis and transcription, as well as viral infection. May act as a regulatory node which integrates and coordinates numerous signals leading to an appropriate cellular response. During mitosis, functions as a component of the p53/TP53-dependent spindle assembly checkpoint (SAC) that maintains cyclin-B-CDK1 activity and G2 arrest in response to spindle damage. Also required for p53/TP53-mediated apoptosis, phosphorylating 'Ser-392' of p53/TP53 following UV irradiation. Can also negatively regulate apoptosis. Phosphorylates the caspases CASP9 and CASP2 and the apoptotic regulator NOL3. Phosphorylation protects CASP9 from cleavage and activation by CASP8, and inhibits the dimerization of CASP2 and activation of CASP8. Regulates transcription by direct phosphorylation of RNA polymerases I, II, III and IV. Also phosphorylates and regulates numerous transcription factors including NF-kappa-B, STAT1, CREB1, IRF1, IRF2, ATF1, SRF, MAX, JUN, FOS, MYC and MYB. Phosphorylates Hsp90 and its co-chaperones FKBP4 and CDC37, which is essential for chaperone function. Regulates Wnt signaling by phosphorylating CTNNB1 and the transcription factor LEF1. Acts as an ectokinase that phosphorylates several extracellular proteins.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P19139|CSK21_RAT Casein kinase II subunit alpha OS=Rattus norvegicus GN=Csnk2a1 PE=1 SV=2

 Score =  498 bits (1283), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 246/333 (73%), Positives = 289/333 (86%)

Query: 102 APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEK 161
            PS+ARVY+D+N  RPREYWDYES  V+WG QDDY++VRK+GRGKYSEVFE ++ T+NEK
Sbjct: 5   VPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEK 64

Query: 162 CIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL 221
            ++KILKPVKKKKIKREIKIL+NL GGPNI+ L DIV+D  S+TP+L+FEHVNNTDFK L
Sbjct: 65  VVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL 124

Query: 222 YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281
           Y TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHP
Sbjct: 125 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 184

Query: 282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 341
           G+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFRKEPFF+GHDNYDQLV+
Sbjct: 185 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 244

Query: 342 IAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKL 401
           IAKVLGT++L  Y++KY+IELDP    ++GRHSRK W +F+  ENQHL  PEA+DFLDKL
Sbjct: 245 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKL 304

Query: 402 LRYDHQERPTAKEAMAHPYFFPIRNAESSRSRS 434
           LRYDHQ R TA+EAM HPYF+ +   ++  S +
Sbjct: 305 LRYDHQSRLTAREAMEHPYFYTVVKDQARMSSA 337

Catalytic subunit of a constitutively active serine/threonine-protein kinase complex that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine. Regulates numerous cellular processes, such as cell cycle progression, apoptosis and transcription, as well as viral infection. May act as a regulatory node which integrates and coordinates numerous signals leading to an appropriate cellular response. During mitosis, functions as a component of the p53/TP53-dependent spindle assembly checkpoint (SAC) that maintains cyclin-B-CDK1 activity and G2 arrest in response to spindle damage. Also required for p53/TP53-mediated apoptosis, phosphorylating 'Ser-392' of p53/TP53 following UV irradiation. Can also negatively regulate apoptosis. Phosphorylates the caspases CASP9 and CASP2 and the apoptotic regulator NOL3. Phosphorylation protects CASP9 from cleavage and activation by CASP8, and inhibits the dimerization of CASP2 and activation of CASP8. Regulates transcription by direct phosphorylation of RNA polymerases I, II, III and IV. Also phosphorylates and regulates numerous transcription factors including NF-kappa-B, STAT1, CREB1, IRF1, IRF2, ATF1, SRF, MAX, JUN, FOS, MYC and MYB. Phosphorylates Hsp90 and its co-chaperones FKBP4 and CDC37, which is essential for chaperone function. Regulates Wnt signaling by phosphorylating CTNNB1 and the transcription factor LEF1. Acts as an ectokinase that phosphorylates several extracellular proteins.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	434
224071301	448	predicted protein [Populus trichocarpa]	0.983	0.953	0.797	0.0
225438980	424	PREDICTED: casein kinase II subunit alph	0.859	0.879	0.885	0.0
147841853	392	hypothetical protein VITISV_034030 [Viti	0.824	0.913	0.927	0.0
255568569	489	casein kinase II, alpha chain, putative	0.894	0.793	0.822	0.0
297825193	432	hypothetical protein ARALYDRAFT_481178 [	0.970	0.974	0.790	0.0
15227778	432	casein kinase 2, alpha polypeptide [Arab	0.861	0.865	0.871	0.0
17977868	414	casein kinase II alpha subunit [Sinapis	0.937	0.983	0.776	0.0
449519104	441	PREDICTED: casein kinase II subunit alph	0.801	0.789	0.925	0.0
224081845	361	predicted protein [Populus trichocarpa]	0.820	0.986	0.918	0.0
449448236	423	PREDICTED: casein kinase II subunit alph	0.956	0.981	0.770	0.0

>gi|224071301|ref|XP_002303393.1| predicted protein [Populus trichocarpa] gi|222840825|gb|EEE78372.1| predicted protein [Populus trichocarpa]

 Score =  681 bits (1758), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 363/455 (79%), Positives = 385/455 (84%), Gaps = 28/455 (6%)

Query: 1   MAIRPFQF-----TI------HRNNYKNTTLFSSFFAISSNTSSSRTTSVSKILFSP-LS 48
           MAIRPF       TI       + N  N TLFSS   I       R  + +    +P L 
Sbjct: 1   MAIRPFLLQQKLTTILNRQRQKKKNNINKTLFSSLLFI-------RNNNNNNNNNNPFLF 53

Query: 49  QSSRIFTPFGTLRGLASSAS-LSHARHQHQ--------RLRQLATPPDTLAQKIGKSVRR 99
            S +  +    LR  ASS +  SH +   Q        R R L  PPDTLAQKIGKS+RR
Sbjct: 54  SSPQSSSISTLLRQFASSTTAFSHQKQGQQEIQHRLPHRFRSLVPPPDTLAQKIGKSIRR 113

Query: 100 SGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDN 159
            GAPSKARVY+DINV+RP++YWDYESLTVQWGEQDDYEVV+KVGRGKYSEVFEGVHCTDN
Sbjct: 114 PGAPSKARVYADINVIRPKDYWDYESLTVQWGEQDDYEVVKKVGRGKYSEVFEGVHCTDN 173

Query: 160 EKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK 219
           EKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE+VNNTDFK
Sbjct: 174 EKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEYVNNTDFK 233

Query: 220 VLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279
           VLYPTLSD+D+RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY
Sbjct: 234 VLYPTLSDFDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 293

Query: 280 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQL 339
           HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQL
Sbjct: 294 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQL 353

Query: 340 VKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLD 399
           VKIAKVLGTDELNAYLN+Y IELD HLAALVGRHSRKPWSKFI V+NQHLAVPEAVDFLD
Sbjct: 354 VKIAKVLGTDELNAYLNRYRIELDLHLAALVGRHSRKPWSKFINVDNQHLAVPEAVDFLD 413

Query: 400 KLLRYDHQERPTAKEAMAHPYFFPIRNAESSRSRS 434
           KLLRYDHQERPTAKEAMAHPYF+PIRNAESSR+R+
Sbjct: 414 KLLRYDHQERPTAKEAMAHPYFYPIRNAESSRTRT 448

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225438980|ref|XP_002284333.1| PREDICTED: casein kinase II subunit alpha isoform 1 [Vitis vinifera] gi|296087330|emb|CBI33704.3| unnamed protein product [Vitis vinifera]

 Score =  669 bits (1726), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 339/383 (88%), Positives = 358/383 (93%), Gaps = 10/383 (2%)

Query: 61  RGLASSASLSHAR---------HQHQRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSD 111
           R  +S A LSH +           H R   L++ P+TLAQ+IGKSVRR GAPSKARVY+D
Sbjct: 42  RLASSPAPLSHPQKSPPPPPPPPSHHRF-ALSSLPETLAQRIGKSVRRPGAPSKARVYAD 100

Query: 112 INVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK 171
           INV+RP+EYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK
Sbjct: 101 INVIRPKEYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK 160

Query: 172 KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVR 231
           KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE+VNNTDFKVLYPTLSDYD+R
Sbjct: 161 KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEYVNNTDFKVLYPTLSDYDIR 220

Query: 232 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS 291
           YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS
Sbjct: 221 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS 280

Query: 292 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL 351
           RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL
Sbjct: 281 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL 340

Query: 352 NAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT 411
           NAYLNKY +ELDPHLAALVGRHSRKPW+KF+  +NQHLAVPE++DFLDKLLRYDHQERPT
Sbjct: 341 NAYLNKYRLELDPHLAALVGRHSRKPWTKFVNADNQHLAVPESIDFLDKLLRYDHQERPT 400

Query: 412 AKEAMAHPYFFPIRNAESSRSRS 434
           AKEAMAHPYF+PIRNAESSRSR+
Sbjct: 401 AKEAMAHPYFYPIRNAESSRSRA 423

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147841853|emb|CAN71837.1| hypothetical protein VITISV_034030 [Vitis vinifera]

 Score =  667 bits (1721), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 333/359 (92%), Positives = 350/359 (97%), Gaps = 1/359 (0%)

Query: 76  HQRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDD 135
           H R   L++ P+TLAQ+IGKSVRR GAPSKARVY+DINV+RP+EYWDYESLTVQWGEQDD
Sbjct: 34  HHRF-ALSSLPETLAQRIGKSVRRPGAPSKARVYADINVIRPKEYWDYESLTVQWGEQDD 92

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLL 195
           YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLL
Sbjct: 93  YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLL 152

Query: 196 DIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVK 255
           DIVRDQQSKTPSLIFE+VNNTDFKVLYPTLSDYD+RYYIYELLKALDYCHSQGIMHRDVK
Sbjct: 153 DIVRDQQSKTPSLIFEYVNNTDFKVLYPTLSDYDIRYYIYELLKALDYCHSQGIMHRDVK 212

Query: 256 PHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSL 315
           PHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSL
Sbjct: 213 PHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSL 272

Query: 316 GCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSR 375
           GCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY +ELDPHLAALVGRHSR
Sbjct: 273 GCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYRLELDPHLAALVGRHSR 332

Query: 376 KPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAESSRSRS 434
           KPW+KF+  +NQHLAVPE++DFLDKLLRYDHQERPTAKEAMAHPYF+PIRNAESSRSR+
Sbjct: 333 KPWTKFVNADNQHLAVPESIDFLDKLLRYDHQERPTAKEAMAHPYFYPIRNAESSRSRA 391

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255568569|ref|XP_002525258.1| casein kinase II, alpha chain, putative [Ricinus communis] gi|223535416|gb|EEF37086.1| casein kinase II, alpha chain, putative [Ricinus communis]

 Score =  666 bits (1719), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 339/412 (82%), Positives = 362/412 (87%), Gaps = 24/412 (5%)

Query: 47  LSQSSRIFTPFGTLRGLASSASLSHARHQH-----------------------QRLRQ-L 82
           L   S +F+P   +  +   AS S  R QH                        RL+  +
Sbjct: 78  LPSPSPLFSPQSPITSVLRLASTSSHRKQHLPPPPPPPPPPPPLQPIAEAIRLHRLKNSV 137

Query: 83  ATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKV 142
           A   +TLAQKIGKS+RR GAPSKARVY+D+NV+RP++YWDYESLTVQWGEQDDYEVVRKV
Sbjct: 138 ALSSETLAQKIGKSIRRPGAPSKARVYADVNVIRPKDYWDYESLTVQWGEQDDYEVVRKV 197

Query: 143 GRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202
           GRGKYSEVFEGVHC DNEKC+IKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ
Sbjct: 198 GRGKYSEVFEGVHCADNEKCVIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 257

Query: 203 SKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 262
           SKTPSLIFE+VNNTDFKVLYPTLSDYD+RYYIYELLKALDYCHSQGIMHRDVKPHNVMID
Sbjct: 258 SKTPSLIFEYVNNTDFKVLYPTLSDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 317

Query: 263 HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGM 322
           HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGM
Sbjct: 318 HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGM 377

Query: 323 IFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFI 382
           IFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY IELDPHLAALVGRH+RKPW+KFI
Sbjct: 378 IFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYRIELDPHLAALVGRHNRKPWAKFI 437

Query: 383 TVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAESSRSRS 434
            ++NQHLAVPEAV+FLDKLLRYDHQERPTAKEAMAHPYF+PIRNAESSR R+
Sbjct: 438 NMDNQHLAVPEAVNFLDKLLRYDHQERPTAKEAMAHPYFYPIRNAESSRVRT 489

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297825193|ref|XP_002880479.1| hypothetical protein ARALYDRAFT_481178 [Arabidopsis lyrata subsp. lyrata] gi|297326318|gb|EFH56738.1| hypothetical protein ARALYDRAFT_481178 [Arabidopsis lyrata subsp. lyrata]

 Score =  654 bits (1686), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 347/439 (79%), Positives = 380/439 (86%), Gaps = 18/439 (4%)

Query: 1   MAIRPFQ-FTIHRNNYKNTTLFSSFFAISSNTSSSRTTSVSKILFSPLSQSSRIFTPFGT 59
           MA+RP   FTI  ++ +N +  +       + SSS + +   +LFS L            
Sbjct: 1   MALRPCTGFTI--SSLRNASAANDNLFSLLSFSSSSSPAKRNLLFSSLRDH--------- 49

Query: 60  LRGLASSASL--SHARHQHQRLR----QLATPPDTLAQKIGKSVRRSGAPSKARVYSDIN 113
           LR  ASSASL   H R+Q Q+ +    ++    +TLAQKIGKS+RR+GAPSKARVY+D+N
Sbjct: 50  LRRFASSASLYRQHLRNQQQQQQQQQSRVKEKSETLAQKIGKSIRRAGAPSKARVYADVN 109

Query: 114 VVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK 173
           VVRP++YWDYESL VQWG QDDYEVVRKVGRGKYSEVFEG+H TDNEKC+IKILKPVKKK
Sbjct: 110 VVRPKDYWDYESLAVQWGVQDDYEVVRKVGRGKYSEVFEGIHATDNEKCVIKILKPVKKK 169

Query: 174 KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYY 233
           KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN DFKVLYPTLSDYDVRYY
Sbjct: 170 KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNKDFKVLYPTLSDYDVRYY 229

Query: 234 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY 293
           I+ELLKALD+CHS+GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY
Sbjct: 230 IFELLKALDFCHSRGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY 289

Query: 294 FKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 353
           FKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA
Sbjct: 290 FKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 349

Query: 354 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK 413
           YLNKY IELDP+L +LVGRHSRKPW+KFI  ENQHLAVPEAVDF+DKLLRYDHQERPTAK
Sbjct: 350 YLNKYRIELDPNLTSLVGRHSRKPWTKFINSENQHLAVPEAVDFVDKLLRYDHQERPTAK 409

Query: 414 EAMAHPYFFPIRNAESSRS 432
           EAMAHPYF+PIRNAESSR+
Sbjct: 410 EAMAHPYFYPIRNAESSRT 428

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15227778|ref|NP_179889.1| casein kinase 2, alpha polypeptide [Arabidopsis thaliana] gi|75318502|sp|O64816.1|CSK2P_ARATH RecName: Full=Casein kinase II subunit alpha, chloroplastic; Flags: Precursor gi|3169180|gb|AAC17823.1| putative casein kinase II catalytic (alpha) subunit [Arabidopsis thaliana] gi|17065110|gb|AAL32709.1| putative casein kinase II catalytic (alpha) subunit [Arabidopsis thaliana] gi|20148299|gb|AAM10040.1| putative casein kinase II catalytic (alpha) subunit [Arabidopsis thaliana] gi|330252310|gb|AEC07404.1| casein kinase 2, alpha polypeptide [Arabidopsis thaliana]

 Score =  652 bits (1683), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 332/381 (87%), Positives = 355/381 (93%), Gaps = 7/381 (1%)

Query: 59  TLRGLASSASL--SHARHQHQRLR-----QLATPPDTLAQKIGKSVRRSGAPSKARVYSD 111
            LR  ASSASL   H R+Q Q+ +     ++    +TLAQKIGKS+RR+GAPSKARVY+D
Sbjct: 48  NLRRFASSASLYRQHLRNQQQQHQQQQQSRVKEKSETLAQKIGKSIRRAGAPSKARVYAD 107

Query: 112 INVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK 171
           +NVVRP++YWDYESL VQWG QDDYEVVRKVGRGKYSEVFEG+H TDNEKC+IKILKPVK
Sbjct: 108 VNVVRPKDYWDYESLAVQWGVQDDYEVVRKVGRGKYSEVFEGIHATDNEKCVIKILKPVK 167

Query: 172 KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVR 231
           KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN DFKVLYPTLSDYDVR
Sbjct: 168 KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNKDFKVLYPTLSDYDVR 227

Query: 232 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS 291
           YYI+ELLKALD+CHS+GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS
Sbjct: 228 YYIFELLKALDFCHSRGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS 287

Query: 292 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL 351
           RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL
Sbjct: 288 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL 347

Query: 352 NAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT 411
           NAYLNKY IELDP+L +LVGRHSRKPW+KFI  ENQHLAVPEAVDF+DKLLRYDHQERPT
Sbjct: 348 NAYLNKYRIELDPNLTSLVGRHSRKPWTKFINSENQHLAVPEAVDFVDKLLRYDHQERPT 407

Query: 412 AKEAMAHPYFFPIRNAESSRS 432
           AKEAMAHPYF+PIRNAESSR+
Sbjct: 408 AKEAMAHPYFYPIRNAESSRT 428

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|17977868|emb|CAD12663.1| casein kinase II alpha subunit [Sinapis alba]

 Score =  652 bits (1682), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 337/434 (77%), Positives = 365/434 (84%), Gaps = 27/434 (6%)

Query: 1   MAIRPFQFTIH--RNNYKNTTLFSSFFAISSNTSSSRTTSVSKILFSPLSQSSRIFTPFG 58
           MA RP  +TI   R       L  SF +I S+  + +   +S                  
Sbjct: 1   MAFRPIGYTISSLRKASAANDLRFSFLSIYSSFPAKKNLLLS------------------ 42

Query: 59  TLRGLASSASLSHARHQHQRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPR 118
            LRG +S        H+ Q+ +      +TLAQKIGKS+RR+GAPSKARVY+D+NV++P+
Sbjct: 43  FLRGFSS-------LHRRQQQQSRVNKSETLAQKIGKSIRRAGAPSKARVYADVNVIKPK 95

Query: 119 EYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKRE 178
           +YWDYESL VQWG QDDYEVVRKVGRGKYSEVFEG+H TDNEKC+IKILKPVKKKKIKRE
Sbjct: 96  DYWDYESLAVQWGAQDDYEVVRKVGRGKYSEVFEGIHATDNEKCVIKILKPVKKKKIKRE 155

Query: 179 IKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELL 238
           IKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN DFKVLYPTLSDYDVRYYIYELL
Sbjct: 156 IKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNKDFKVLYPTLSDYDVRYYIYELL 215

Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
           KALD+CHS+GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE
Sbjct: 216 KALDFCHSRGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 275

Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 358
           LLVDL DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELN YLN+Y
Sbjct: 276 LLVDLMDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNTYLNRY 335

Query: 359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
            IELDP+LA+LVGRHSRKPWSKFI  ENQHLAVPEAVDF+DKLL+YDHQERPTAKEAMAH
Sbjct: 336 RIELDPNLASLVGRHSRKPWSKFINSENQHLAVPEAVDFVDKLLKYDHQERPTAKEAMAH 395

Query: 419 PYFFPIRNAESSRS 432
           PYF PIRNAESSRS
Sbjct: 396 PYFNPIRNAESSRS 409

Source: Sinapis alba

Species: Sinapis alba

Genus: Sinapis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449519104|ref|XP_004166575.1| PREDICTED: casein kinase II subunit alpha, chloroplastic-like [Cucumis sativus]

 Score =  652 bits (1682), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 322/348 (92%), Positives = 341/348 (97%)

Query: 87  DTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGK 146
           +TLAQKIGKS+RR GAPSKARVY+D+NV+RP++YWDYESLTVQWG+QD+YEVVRKVGRGK
Sbjct: 93  ETLAQKIGKSIRRPGAPSKARVYADVNVIRPKDYWDYESLTVQWGDQDNYEVVRKVGRGK 152

Query: 147 YSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206
           YSEVFEGVHCTDNEKC+IKILKPVKKKKIKREIKILQNLCGG NIVKLLDIVRDQQSKTP
Sbjct: 153 YSEVFEGVHCTDNEKCVIKILKPVKKKKIKREIKILQNLCGGINIVKLLDIVRDQQSKTP 212

Query: 207 SLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR 266
           SLIFEHVNN DFKVLYPTLSD+D+RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR
Sbjct: 213 SLIFEHVNNIDFKVLYPTLSDFDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR 272

Query: 267 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRK 326
           KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRK
Sbjct: 273 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRK 332

Query: 327 EPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVEN 386
           EPFFYGHDNYDQLVKIAKVLGTDELN YL+KY IELDPHL+ALVGRHSRKPW+KFI V+N
Sbjct: 333 EPFFYGHDNYDQLVKIAKVLGTDELNTYLSKYRIELDPHLSALVGRHSRKPWTKFINVDN 392

Query: 387 QHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAESSRSRS 434
           QHLAVPEAVDF+DKLLRYDHQER TAKEAMAHPYFFPIRNAESSR+R+
Sbjct: 393 QHLAVPEAVDFVDKLLRYDHQERLTAKEAMAHPYFFPIRNAESSRTRN 440

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224081845|ref|XP_002306501.1| predicted protein [Populus trichocarpa] gi|222855950|gb|EEE93497.1| predicted protein [Populus trichocarpa]

 Score =  650 bits (1676), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 327/356 (91%), Positives = 339/356 (95%)

Query: 77  QRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDY 136
            R R     PDTLAQKIGKS RR GAPSKARVY+D NV+RP++YWDYESLTVQWGEQDDY
Sbjct: 6   HRFRSSVPLPDTLAQKIGKSFRRPGAPSKARVYADANVIRPKDYWDYESLTVQWGEQDDY 65

Query: 137 EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLD 196
            VV+KVGRGKYSEVFEG+HCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLD
Sbjct: 66  MVVKKVGRGKYSEVFEGMHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLD 125

Query: 197 IVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKP 256
           IVRDQQSKTPSLIFE+V NTDFKVLYPTLSD+D RYYIYELLKALDYCHSQGIMHRDVKP
Sbjct: 126 IVRDQQSKTPSLIFEYVKNTDFKVLYPTLSDFDTRYYIYELLKALDYCHSQGIMHRDVKP 185

Query: 257 HNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLG 316
           HNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLG
Sbjct: 186 HNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLG 245

Query: 317 CMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRK 376
           CMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTD+LNAYLNKY IELDPHLAALVGRHSRK
Sbjct: 246 CMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDDLNAYLNKYRIELDPHLAALVGRHSRK 305

Query: 377 PWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAESSRS 432
           PWSKF  V+NQHLAVPEAVDFLDKLLRYDH ERPTAKEAMAHPYF+PIRNAESSR+
Sbjct: 306 PWSKFTNVDNQHLAVPEAVDFLDKLLRYDHLERPTAKEAMAHPYFYPIRNAESSRT 361

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449448236|ref|XP_004141872.1| PREDICTED: casein kinase II subunit alpha, chloroplastic-like [Cucumis sativus]

 Score =  647 bits (1669), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 340/441 (77%), Positives = 368/441 (83%), Gaps = 26/441 (5%)

Query: 1   MAIRPFQFTIHRNNYKNTTLFSSFFAISSNTSSSRTTSVSKILFSPLSQSSRIFTPFGTL 60
           MAIRP  F +  N +  T            ++ S   S+                 F  L
Sbjct: 1   MAIRPLNFKVSSNFH--TLSSILSSPSLFLSAQSPPPSI-----------------FFFL 41

Query: 61  RGLASSAS-------LSHARHQHQRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDIN 113
           R +ASS +         H         +  +P +TLAQKIGKS+RR GAPSKARVY+D+N
Sbjct: 42  RRIASSTASLSPSHHHHHPPPPPPPRLRSPSPQETLAQKIGKSIRRPGAPSKARVYADVN 101

Query: 114 VVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK 173
           V+RP++YWDYESLTVQWG+QD+YEVVRKVGRGKYSEVFEGVHCTDNEKC+IKILKPVKKK
Sbjct: 102 VIRPKDYWDYESLTVQWGDQDNYEVVRKVGRGKYSEVFEGVHCTDNEKCVIKILKPVKKK 161

Query: 174 KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYY 233
           KIKREIKILQNLCGG NIVKLLDIVRDQQSKTPSLIFEHVNN DFKVLYPTLSD+D+RYY
Sbjct: 162 KIKREIKILQNLCGGINIVKLLDIVRDQQSKTPSLIFEHVNNIDFKVLYPTLSDFDIRYY 221

Query: 234 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY 293
           IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY
Sbjct: 222 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY 281

Query: 294 FKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 353
           FKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELN 
Sbjct: 282 FKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNT 341

Query: 354 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK 413
           YL+KY IELDPHL+ALVGRHSRKPW+KFI V+NQHLAVPEAVDF+DKLLRYDHQER TAK
Sbjct: 342 YLSKYRIELDPHLSALVGRHSRKPWTKFINVDNQHLAVPEAVDFVDKLLRYDHQERLTAK 401

Query: 414 EAMAHPYFFPIRNAESSRSRS 434
           EAMAHPYFFPIRNAESSR+R+
Sbjct: 402 EAMAHPYFFPIRNAESSRTRN 422

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	434
TAIR|locus:2045339	432	AT2G23070 [Arabidopsis thalian	0.797	0.800	0.867	7.6e-167
UNIPROTKB|Q9AR27	333	OSCKA2 "Casein kinase II alpha	0.760	0.990	0.830	1.5e-152
TAIR|locus:2045349	333	CKA3 "casein kinase II, alpha	0.762	0.993	0.779	2.6e-143
UNIPROTKB|P21868	391	CSNK2A1 "Casein kinase II subu	0.748	0.831	0.708	2.2e-130
UNIPROTKB|P68399	391	CSNK2A1 "Casein kinase II subu	0.748	0.831	0.702	1.9e-129
UNIPROTKB|E2RHZ1	391	CSNK2A1 "Uncharacterized prote	0.748	0.831	0.702	1.9e-129
UNIPROTKB|E7EU96	385	CSNK2A1 "Casein kinase II subu	0.748	0.844	0.702	1.9e-129
UNIPROTKB|P68400	391	CSNK2A1 "Casein kinase II subu	0.748	0.831	0.702	1.9e-129
UNIPROTKB|F2Z5I5	391	CSNK2A1 "Uncharacterized prote	0.748	0.831	0.702	1.9e-129
MGI|MGI:88543	391	Csnk2a1 "casein kinase 2, alph	0.748	0.831	0.702	1.9e-129

TAIR|locus:2045339 AT2G23070 [Arabidopsis thaliana (taxid:3702)]

 Score = 1623 (576.4 bits), Expect = 7.6e-167, P = 7.6e-167
 Identities = 300/346 (86%), Positives = 317/346 (91%)

Query:    87 DTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGK 146
             +TLAQKIGKS+RR+GAPSKARVY+D+NVVRP++YWDYESL VQWG QDDYEVVRKVGRGK
Sbjct:    83 ETLAQKIGKSIRRAGAPSKARVYADVNVVRPKDYWDYESLAVQWGVQDDYEVVRKVGRGK 142

Query:   147 YSEVFEGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTP 206
             YSEVFEG+H TDNE                     LQNLCGGPNIVKLLDIVRDQQSKTP
Sbjct:   143 YSEVFEGIHATDNEKCVIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 202

Query:   207 SLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR 266
             SLIFEHVNN DFKVLYPTLSDYDVRYYI+ELLKALD+CHS+GIMHRDVKPHNVMIDHEQR
Sbjct:   203 SLIFEHVNNKDFKVLYPTLSDYDVRYYIFELLKALDFCHSRGIMHRDVKPHNVMIDHEQR 262

Query:   267 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRK 326
             KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRK
Sbjct:   263 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRK 322

Query:   327 EPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVEN 386
             EPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY IELDP+L +LVGRHSRKPW+KFI  EN
Sbjct:   323 EPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYRIELDPNLTSLVGRHSRKPWTKFINSEN 382

Query:   387 QHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAESSRS 432
             QHLAVPEAVDF+DKLLRYDHQERPTAKEAMAHPYF+PIRNAESSR+
Sbjct:   383 QHLAVPEAVDFVDKLLRYDHQERPTAKEAMAHPYFYPIRNAESSRT 428

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

UNIPROTKB|Q9AR27 OSCKA2 "Casein kinase II alpha subunit" [Oryza sativa Indica Group (taxid:39946)]

 Score = 1488 (528.9 bits), Expect = 1.5e-152, P = 1.5e-152
 Identities = 274/330 (83%), Positives = 294/330 (89%)

Query:   104 SKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEXXX 163
             SKARVY+D+NV+RP+EYWDYE+LTVQWGEQDDYEVVRKVGRGKYSEVFEG++  +NE   
Sbjct:     2 SKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI 61

Query:   164 XXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP 223
                               LQNLCGGPNIVKLLDIVRDQ SKTPSLIFE+VNNTDFKVLYP
Sbjct:    62 IKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP 121

Query:   224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
             TL+DYD+RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPGK
Sbjct:   122 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 181

Query:   284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA 343
             EYNVRVASRYFKGPELLVDLQDYDYSLD+WSLGCMFAGMIFRKEPFFYGHDN+DQLVKIA
Sbjct:   182 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 241

Query:   344 KVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLR 403
             KVLGT+ LNAYLNKYHIELDP L ALVGRHSRKPWSKFI  +NQHL  PEAVDFLDKLLR
Sbjct:   242 KVLGTEALNAYLNKYHIELDPQLEALVGRHSRKPWSKFINADNQHLVSPEAVDFLDKLLR 301

Query:   404 YDHQERPTAKEAMAHPYFFPIRNAESSRSR 433
             YDHQ+R TA+EAMAHPYF  +R AE+SR+R
Sbjct:   302 YDHQDRLTAREAMAHPYFLQVRAAENSRAR 331

GO:0009648 "photoperiodism" evidence=IGI

GO:0010229 "inflorescence development" evidence=IMP

TAIR|locus:2045349 CKA3 "casein kinase II, alpha chain 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1401 (498.2 bits), Expect = 2.6e-143, P = 2.6e-143
 Identities = 258/331 (77%), Positives = 283/331 (85%)

Query:   104 SKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEXXX 163
             SKARVY+D+NVVRP+EYWDYESL VQWG QDDYEVVRKVGRGKYSEVFEG +   NE   
Sbjct:     2 SKARVYTDVNVVRPKEYWDYESLVVQWGHQDDYEVVRKVGRGKYSEVFEGKNVNTNERCV 61

Query:   164 XXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP 223
                               LQNLCGGPNIVKL DIVRD+ SKTPSL+FE VN+ DFKVLYP
Sbjct:    62 IKILKPVKKKKIKREIKILQNLCGGPNIVKLYDIVRDEHSKTPSLVFEFVNSVDFKVLYP 121

Query:   224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
             TL+DYD+RYYIYELLKALD+CHSQGIMHRDVKPHNVMIDH+ RKLRLIDWGLAEFYHPGK
Sbjct:   122 TLTDYDIRYYIYELLKALDFCHSQGIMHRDVKPHNVMIDHQLRKLRLIDWGLAEFYHPGK 181

Query:   284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA 343
             EYNVRVASRYFKGPELLVDLQDYDYSLD+WSLGCMFAGMIFRKEPFFYGHDN+DQLVKIA
Sbjct:   182 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 241

Query:   344 KVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLR 403
             KVLGT+EL+ YLNKY ++LDP L ALVGRH  KPWSKFI  +NQHL  PEA+DFLDKLL+
Sbjct:   242 KVLGTNELDHYLNKYQLDLDPQLEALVGRHVPKPWSKFINADNQHLVSPEAIDFLDKLLQ 301

Query:   404 YDHQERPTAKEAMAHPYFFPIRNAESSRSRS 434
             YDHQ+R TA+EAM HPYF  ++ AESSR R+
Sbjct:   302 YDHQDRLTAREAMDHPYFAQVKAAESSRLRT 332

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007623 "circadian rhythm" evidence=IGI

GO:0006281 "DNA repair" evidence=IDA

GO:0006325 "chromatin organization" evidence=IEP;IDA

GO:0010225 "response to UV-C" evidence=IMP

GO:0010332 "response to gamma radiation" evidence=IMP

GO:0051726 "regulation of cell cycle" evidence=IEP

GO:2001020 "regulation of response to DNA damage stimulus" evidence=IEP

GO:0009612 "response to mechanical stimulus" evidence=RCA

GO:0019722 "calcium-mediated signaling" evidence=RCA

UNIPROTKB|P21868 CSNK2A1 "Casein kinase II subunit alpha" [Gallus gallus (taxid:9031)]

 Score = 1279 (455.3 bits), Expect = 2.2e-130, P = 2.2e-130
 Identities = 231/326 (70%), Positives = 268/326 (82%)

Query:   100 SG-APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTD 158
             SG  PS+ARVY+D+N  RPREYWDYES  V+WG QDDY++VRK+GRGKYSEVFE ++ T+
Sbjct:     2 SGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITN 61

Query:   159 NEXXXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF 218
             NE                     L+NL GGPNI+ L DIV+D  S+TP+L+FEHVNNTDF
Sbjct:    62 NEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF 121

Query:   219 KVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278
             K LY TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEF
Sbjct:   122 KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 181

Query:   279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQ 338
             YHPG+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFRKEPFF+GHDNYDQ
Sbjct:   182 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 241

Query:   339 LVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFL 398
             LV+IAKVLGT++L  Y++KY+IELDP    ++GRHSRK W +F+  ENQHL  PEA+DFL
Sbjct:   242 LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFL 301

Query:   399 DKLLRYDHQERPTAKEAMAHPYFFPI 424
             DKLLRYDHQ R TA+EAM HPYF+PI
Sbjct:   302 DKLLRYDHQSRLTAREAMEHPYFYPI 327

GO:0005524 "ATP binding" evidence=IEA

GO:0016055 "Wnt receptor signaling pathway" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0008013 "beta-catenin binding" evidence=IEA

GO:0016580 "Sin3 complex" evidence=IEA

GO:0016581 "NuRD complex" evidence=IEA

GO:0019888 "protein phosphatase regulator activity" evidence=IEA

GO:0030177 "positive regulation of Wnt receptor signaling pathway" evidence=IEA

GO:0043154 "negative regulation of cysteine-type endopeptidase activity involved in apoptotic process" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0047485 "protein N-terminus binding" evidence=IEA

GO:0071174 "mitotic spindle checkpoint" evidence=IEA

GO:0031519 "PcG protein complex" evidence=ISS

UNIPROTKB|P68399 CSNK2A1 "Casein kinase II subunit alpha" [Bos taurus (taxid:9913)]

 Score = 1270 (452.1 bits), Expect = 1.9e-129, P = 1.9e-129
 Identities = 229/326 (70%), Positives = 267/326 (81%)

Query:   100 SG-APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTD 158
             SG  PS+ARVY+D+N  RPREYWDYES  V+WG QDDY++VRK+GRGKYSEVFE ++ T+
Sbjct:     2 SGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITN 61

Query:   159 NEXXXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF 218
             NE                     L+NL GGPNI+ L DIV+D  S+TP+L+FEHVNNTDF
Sbjct:    62 NEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF 121

Query:   219 KVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278
             K LY TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEF
Sbjct:   122 KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 181

Query:   279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQ 338
             YHPG+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFRKEPFF+GHDNYDQ
Sbjct:   182 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 241

Query:   339 LVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFL 398
             LV+IAKVLGT++L  Y++KY+IELDP    ++GRHSRK W +F+  ENQHL  PEA+DFL
Sbjct:   242 LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFL 301

Query:   399 DKLLRYDHQERPTAKEAMAHPYFFPI 424
             DKLLRYDHQ R TA+EAM HPYF+ +
Sbjct:   302 DKLLRYDHQSRLTAREAMEHPYFYTV 327

GO:0047485 "protein N-terminus binding" evidence=ISS

GO:0030177 "positive regulation of Wnt receptor signaling pathway" evidence=ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0071174 "mitotic spindle checkpoint" evidence=ISS

GO:0043154 "negative regulation of cysteine-type endopeptidase activity involved in apoptotic process" evidence=ISS

GO:0031519 "PcG protein complex" evidence=ISS

GO:0016055 "Wnt receptor signaling pathway" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006351 "transcription, DNA-dependent" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|E2RHZ1 CSNK2A1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 1270 (452.1 bits), Expect = 1.9e-129, P = 1.9e-129
 Identities = 229/326 (70%), Positives = 267/326 (81%)

Query:   100 SG-APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTD 158
             SG  PS+ARVY+D+N  RPREYWDYES  V+WG QDDY++VRK+GRGKYSEVFE ++ T+
Sbjct:     2 SGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITN 61

Query:   159 NEXXXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF 218
             NE                     L+NL GGPNI+ L DIV+D  S+TP+L+FEHVNNTDF
Sbjct:    62 NEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF 121

Query:   219 KVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278
             K LY TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEF
Sbjct:   122 KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 181

Query:   279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQ 338
             YHPG+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFRKEPFF+GHDNYDQ
Sbjct:   182 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 241

Query:   339 LVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFL 398
             LV+IAKVLGT++L  Y++KY+IELDP    ++GRHSRK W +F+  ENQHL  PEA+DFL
Sbjct:   242 LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFL 301

Query:   399 DKLLRYDHQERPTAKEAMAHPYFFPI 424
             DKLLRYDHQ R TA+EAM HPYF+ +
Sbjct:   302 DKLLRYDHQSRLTAREAMEHPYFYTV 327

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0071174 "mitotic spindle checkpoint" evidence=IEA

GO:0047485 "protein N-terminus binding" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0043154 "negative regulation of cysteine-type endopeptidase activity involved in apoptotic process" evidence=IEA

GO:0031519 "PcG protein complex" evidence=IEA

GO:0030177 "positive regulation of Wnt receptor signaling pathway" evidence=IEA

GO:0019888 "protein phosphatase regulator activity" evidence=IEA

GO:0016581 "NuRD complex" evidence=IEA

GO:0016580 "Sin3 complex" evidence=IEA

GO:0008013 "beta-catenin binding" evidence=IEA

UNIPROTKB|E7EU96 CSNK2A1 "Casein kinase II subunit alpha" [Homo sapiens (taxid:9606)]

 Score = 1270 (452.1 bits), Expect = 1.9e-129, P = 1.9e-129
 Identities = 229/326 (70%), Positives = 267/326 (81%)

Query:   100 SG-APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTD 158
             SG  PS+ARVY+D+N  RPREYWDYES  V+WG QDDY++VRK+GRGKYSEVFE ++ T+
Sbjct:     2 SGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITN 61

Query:   159 NEXXXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF 218
             NE                     L+NL GGPNI+ L DIV+D  S+TP+L+FEHVNNTDF
Sbjct:    62 NEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF 121

Query:   219 KVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278
             K LY TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEF
Sbjct:   122 KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 181

Query:   279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQ 338
             YHPG+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFRKEPFF+GHDNYDQ
Sbjct:   182 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 241

Query:   339 LVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFL 398
             LV+IAKVLGT++L  Y++KY+IELDP    ++GRHSRK W +F+  ENQHL  PEA+DFL
Sbjct:   242 LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFL 301

Query:   399 DKLLRYDHQERPTAKEAMAHPYFFPI 424
             DKLLRYDHQ R TA+EAM HPYF+ +
Sbjct:   302 DKLLRYDHQSRLTAREAMEHPYFYTV 327

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|P68400 CSNK2A1 "Casein kinase II subunit alpha" [Homo sapiens (taxid:9606)]

 Score = 1270 (452.1 bits), Expect = 1.9e-129, P = 1.9e-129
 Identities = 229/326 (70%), Positives = 267/326 (81%)

Query:   100 SG-APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTD 158
             SG  PS+ARVY+D+N  RPREYWDYES  V+WG QDDY++VRK+GRGKYSEVFE ++ T+
Sbjct:     2 SGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITN 61

Query:   159 NEXXXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF 218
             NE                     L+NL GGPNI+ L DIV+D  S+TP+L+FEHVNNTDF
Sbjct:    62 NEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF 121

Query:   219 KVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278
             K LY TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEF
Sbjct:   122 KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 181

Query:   279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQ 338
             YHPG+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFRKEPFF+GHDNYDQ
Sbjct:   182 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 241

Query:   339 LVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFL 398
             LV+IAKVLGT++L  Y++KY+IELDP    ++GRHSRK W +F+  ENQHL  PEA+DFL
Sbjct:   242 LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFL 301

Query:   399 DKLLRYDHQERPTAKEAMAHPYFFPI 424
             DKLLRYDHQ R TA+EAM HPYF+ +
Sbjct:   302 DKLLRYDHQSRLTAREAMEHPYFYTV 327

GO:0005524 "ATP binding" evidence=IEA

GO:0006351 "transcription, DNA-dependent" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0016055 "Wnt receptor signaling pathway" evidence=IEA

GO:0008013 "beta-catenin binding" evidence=IEA

GO:0019888 "protein phosphatase regulator activity" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA;TAS

GO:0047485 "protein N-terminus binding" evidence=IPI

GO:0005515 "protein binding" evidence=IPI

GO:0045732 "positive regulation of protein catabolic process" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0030307 "positive regulation of cell growth" evidence=IDA

GO:0008284 "positive regulation of cell proliferation" evidence=IDA

GO:0031519 "PcG protein complex" evidence=IDA

GO:0071174 "mitotic spindle checkpoint" evidence=IMP

GO:0043154 "negative regulation of cysteine-type endopeptidase activity involved in apoptotic process" evidence=IMP

GO:0030177 "positive regulation of Wnt receptor signaling pathway" evidence=IMP

GO:0051879 "Hsp90 protein binding" evidence=TAS

GO:0061077 "chaperone-mediated protein folding" evidence=TAS

GO:0005634 "nucleus" evidence=IDA

GO:0005886 "plasma membrane" evidence=TAS

GO:0007165 "signal transduction" evidence=TAS

GO:0005829 "cytosol" evidence=TAS

GO:0007411 "axon guidance" evidence=TAS

GO:0016581 "NuRD complex" evidence=IDA

GO:0016580 "Sin3 complex" evidence=IDA

UNIPROTKB|F2Z5I5 CSNK2A1 "Uncharacterized protein" [Sus scrofa (taxid:9823)]

 Score = 1270 (452.1 bits), Expect = 1.9e-129, P = 1.9e-129
 Identities = 229/326 (70%), Positives = 267/326 (81%)

Query:   100 SG-APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTD 158
             SG  PS+ARVY+D+N  RPREYWDYES  V+WG QDDY++VRK+GRGKYSEVFE ++ T+
Sbjct:     2 SGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITN 61

Query:   159 NEXXXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF 218
             NE                     L+NL GGPNI+ L DIV+D  S+TP+L+FEHVNNTDF
Sbjct:    62 NEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF 121

Query:   219 KVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278
             K LY TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEF
Sbjct:   122 KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 181

Query:   279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQ 338
             YHPG+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFRKEPFF+GHDNYDQ
Sbjct:   182 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 241

Query:   339 LVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFL 398
             LV+IAKVLGT++L  Y++KY+IELDP    ++GRHSRK W +F+  ENQHL  PEA+DFL
Sbjct:   242 LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFL 301

Query:   399 DKLLRYDHQERPTAKEAMAHPYFFPI 424
             DKLLRYDHQ R TA+EAM HPYF+ +
Sbjct:   302 DKLLRYDHQSRLTAREAMEHPYFYTV 327

GO:0071174 "mitotic spindle checkpoint" evidence=IEA

GO:0047485 "protein N-terminus binding" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0043154 "negative regulation of cysteine-type endopeptidase activity involved in apoptotic process" evidence=IEA

GO:0031519 "PcG protein complex" evidence=IEA

GO:0030177 "positive regulation of Wnt receptor signaling pathway" evidence=IEA

GO:0019888 "protein phosphatase regulator activity" evidence=IEA

GO:0016581 "NuRD complex" evidence=IEA

GO:0016580 "Sin3 complex" evidence=IEA

GO:0008013 "beta-catenin binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

MGI|MGI:88543 Csnk2a1 "casein kinase 2, alpha 1 polypeptide" [Mus musculus (taxid:10090)]

 Score = 1270 (452.1 bits), Expect = 1.9e-129, P = 1.9e-129
 Identities = 229/326 (70%), Positives = 267/326 (81%)

Query:   100 SG-APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTD 158
             SG  PS+ARVY+D+N  RPREYWDYES  V+WG QDDY++VRK+GRGKYSEVFE ++ T+
Sbjct:     2 SGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITN 61

Query:   159 NEXXXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF 218
             NE                     L+NL GGPNI+ L DIV+D  S+TP+L+FEHVNNTDF
Sbjct:    62 NEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF 121

Query:   219 KVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278
             K LY TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEF
Sbjct:   122 KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 181

Query:   279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQ 338
             YHPG+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFRKEPFF+GHDNYDQ
Sbjct:   182 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 241

Query:   339 LVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFL 398
             LV+IAKVLGT++L  Y++KY+IELDP    ++GRHSRK W +F+  ENQHL  PEA+DFL
Sbjct:   242 LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFL 301

Query:   399 DKLLRYDHQERPTAKEAMAHPYFFPI 424
             DKLLRYDHQ R TA+EAM HPYF+ +
Sbjct:   302 DKLLRYDHQSRLTAREAMEHPYFYTV 327

GO:0000166 "nucleotide binding" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISO

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISO

GO:0005956 "protein kinase CK2 complex" evidence=TAS

GO:0006351 "transcription, DNA-dependent" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;ISO;IDA

GO:0006915 "apoptotic process" evidence=IEA

GO:0007049 "cell cycle" evidence=IEA

GO:0008013 "beta-catenin binding" evidence=IDA

GO:0008284 "positive regulation of cell proliferation" evidence=ISO

GO:0016055 "Wnt receptor signaling pathway" evidence=IEA

GO:0016301 "kinase activity" evidence=IDA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016580 "Sin3 complex" evidence=ISO

GO:0016581 "NuRD complex" evidence=ISO

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0019888 "protein phosphatase regulator activity" evidence=IDA

GO:0030177 "positive regulation of Wnt receptor signaling pathway" evidence=ISO

GO:0030307 "positive regulation of cell growth" evidence=ISO

GO:0043154 "negative regulation of cysteine-type endopeptidase activity involved in apoptotic process" evidence=ISO

GO:0045732 "positive regulation of protein catabolic process" evidence=ISO

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0047485 "protein N-terminus binding" evidence=ISO

GO:0050790 "regulation of catalytic activity" evidence=IDA

GO:0071174 "mitotic spindle checkpoint" evidence=ISO

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
P19454	CSK22_YEAST	2, ., 7, ., 1, 1, ., 1	0.6129	0.7672	0.9823	yes	no
P21868	CSK21_CHICK	2, ., 7, ., 1, 1, ., 1	0.7647	0.7442	0.8260	yes	no
Q8TG13	CSK2A_NEUCR	2, ., 7, ., 1, 1, ., 1	0.7469	0.7534	0.9732	N/A	no
P68399	CSK21_BOVIN	2, ., 7, ., 1, 1, ., 1	0.7585	0.7442	0.8260	yes	no
P28523	CSK2A_MAIZE	2, ., 7, ., 1, 1, ., 1	0.8791	0.7626	0.9969	N/A	no
O64816	CSK2P_ARATH	2, ., 7, ., 1, 1, ., 1	0.8713	0.8617	0.8657	yes	no
P18334	CSK2A_CAEEL	2, ., 7, ., 1, 1, ., 1	0.7370	0.7534	0.9083	yes	no
P08181	CSK2A_DROME	2, ., 7, ., 1, 1, ., 1	0.7439	0.7557	0.9761	yes	no
P19139	CSK21_RAT	2, ., 7, ., 1, 1, ., 1	0.7387	0.7672	0.8516	yes	no
O76484	CSK2A_SPOFR	2, ., 7, ., 1, 1, ., 1	0.7654	0.7465	0.9178	N/A	no
P28547	CSK2A_THEPA	2, ., 7, ., 1, 1, ., 1	0.6906	0.7373	0.9195	yes	no
P68400	CSK21_HUMAN	2, ., 7, ., 1, 1, ., 1	0.7585	0.7442	0.8260	yes	no
P40231	CSK2A_SCHPO	2, ., 7, ., 1, 1, ., 1	0.7037	0.7419	0.9698	yes	no
Q02720	CSK2A_DICDI	2, ., 7, ., 1, 1, ., 1	0.7289	0.7396	0.9525	yes	no
P33674	CSK21_RABIT	2, ., 7, ., 1, 1, ., 1	0.7554	0.7442	0.8260	yes	no
P28020	CSK21_XENLA	2, ., 7, ., 1, 1, ., 1	0.7530	0.7557	0.8367	N/A	no
Q60737	CSK21_MOUSE	2, ., 7, ., 1, 1, ., 1	0.7387	0.7672	0.8516	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.991
3rd Layer	2.7.11	0.976

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	434
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-71
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-70
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-64
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-61
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-57
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-55
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	8e-55
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	7e-54
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-52
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-48
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-47
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-46
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-46
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-45
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	8e-45
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-44
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-44
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-44
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	5e-44
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	8e-44
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-42
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-42
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-42
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	9e-42
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-41
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-41
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	7e-41
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-40
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-40
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-40
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-40
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-40
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-40
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-40
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-37
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-37
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-37
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	5e-37
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-35
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	5e-35
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-34
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-34
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-34
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	8e-33
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	8e-33
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-32
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-32
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	6e-32
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-31
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	4e-31
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-30
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-30
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-29
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-29
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-29
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	6e-29
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	9e-29
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	6e-26
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	8e-26
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-25
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	6e-25
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	8e-25
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	9e-25
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	9e-25
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-23
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-23
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	7e-23
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	9e-23
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-22
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-22
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-22
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-22
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	4e-21
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	8e-21
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-20
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	4e-20
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	8e-20
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-19
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-19
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-18
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	6e-18
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	6e-18
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	3e-17
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-17
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	5e-17
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-16
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-16
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	4e-16
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	9e-16
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-15
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-15
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-15
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-15
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	5e-15
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	4e-14
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	4e-14
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	4e-14
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	5e-14
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	6e-14
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	7e-14
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-13
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-13
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-13
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-13
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-13
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-13
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-13
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-13
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	4e-13
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	5e-13
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	5e-13
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	6e-13
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	7e-13
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	7e-13
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-12
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-12
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-12
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-12
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-12
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-12
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-12
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-12
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-12
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-12
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	4e-12
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	4e-12
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	4e-12
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	6e-12
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	6e-12
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	7e-12
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	8e-12
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-11
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-11
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-11
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-11
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-11
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-11
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-11
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-11
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-11
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-11
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-11
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-11
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	4e-11
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	4e-11
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	4e-11
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	4e-11
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	6e-11
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	7e-11
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	7e-11
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	8e-11
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	9e-11
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-10
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-10
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-10
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-10
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-10
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-10
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-10
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	4e-10
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	6e-10
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	6e-10
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	7e-10
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	9e-10
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-09
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-09
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-09
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-09
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-09
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-09
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-09
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-09
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-09
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-09
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-09
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-09
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-09
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	4e-09
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	4e-09
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	5e-09
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	5e-09
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	5e-09
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	6e-09
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	6e-09
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	7e-09
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	8e-09
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-08
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-08
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-08
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-08
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-08
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-08
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	4e-08
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	4e-08
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	6e-08
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	6e-08
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-07
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-07
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-07
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-07
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	6e-07
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-06
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-06
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-06
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-06
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-06
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-06
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-06
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-06
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	6e-06
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	8e-06
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	9e-06
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-05
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	1e-05
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-05
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-05
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-05
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-05
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-05
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-05
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	3e-05
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	3e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	4e-05
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	4e-05
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	5e-05
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	5e-05
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	6e-05
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	7e-05
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	1e-04
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-04
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-04
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-04
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-04
pfam01636	238	pfam01636, APH, Phosphotransferase enzyme family	2e-04
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-04
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-04
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	6e-04
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	6e-04
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	6e-04
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	8e-04
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	8e-04
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	9e-04
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	0.001
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	0.001
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	0.002
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	0.002
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	0.003
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	0.003
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	0.003

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  224 bits (574), Expect = 3e-71
 Identities = 85/295 (28%), Positives = 137/295 (46%), Gaps = 44/295 (14%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-----REIKILQNLCGGPN 190
           YE++RK+G G +  V++  H    +   +KILK   +K  K     REI+IL+ L   PN
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRL-SHPN 59

Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFK---VLYPTLSDYDVRYYIYELLKALDYCHSQ 247
           IV+L+D   D       L+ E+    D          LS+ + +    ++L+ L+Y HS 
Sbjct: 60  IVRLIDAFED--KDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN 117

Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQDY 306
           GI+HRD+KP N+++D     +++ D+GLA+            V + ++  PE+L+    Y
Sbjct: 118 GIIHRDLKPENILLDENGV-VKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGY 176

Query: 307 DYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL 366
              +D+WSLG +   ++  K P F G +  DQL  I ++LG                   
Sbjct: 177 GPKVDVWSLGVILYELLTGKPP-FSGENILDQLQLIRRILGPP----------------- 218

Query: 367 AALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
                        K+ +         EA D + K L  D  +RPTA+E + HP+F
Sbjct: 219 -------LEFDEPKWSSGS------EEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  223 bits (571), Expect = 1e-70
 Identities = 95/293 (32%), Positives = 147/293 (50%), Gaps = 46/293 (15%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK----IKREIKILQNLCGGPNI 191
           YE++ K+G G + +V+        +   IK++K  K KK    I REIKIL+ L   PNI
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKL-KHPNI 59

Query: 192 VKLLDIVRDQQSKTPSLIFEHVNNTD-FKVL--YPTLSDYDVRYYIYELLKALDYCHSQG 248
           V+L D+  D+      L+ E+    D F +L     LS+ + R+Y+ ++L AL+Y HS+G
Sbjct: 60  VRLYDVFEDEDK--LYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG 117

Query: 249 IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 308
           I+HRD+KP N+++D E   ++L D+GLA    PG++    V +  +  PE+L+  + Y  
Sbjct: 118 IVHRDLKPENILLD-EDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLG-KGYGK 175

Query: 309 SLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAA 368
           ++D+WSLG +   ++  K P F G D   +L K               K      P    
Sbjct: 176 AVDIWSLGVILYELLTGK-PPFPGDDQLLELFKKIG------------KPKPPFPPP--- 219

Query: 369 LVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
                     S            PEA D + KLL  D ++R TA+EA+ HP+F
Sbjct: 220 ------EWDIS------------PEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  208 bits (531), Expect = 2e-64
 Identities = 100/298 (33%), Positives = 161/298 (54%), Gaps = 28/298 (9%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK-IK----REIKILQNLCGGPN 190
           YE + K+G G Y  V++       E   +K ++   +++ I     REI +L+ L   PN
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKEL-KHPN 59

Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL----YPTLSDYDVRYYIYELLKALDYCHS 246
           IVKLLD++  ++     L+FE+ +  D K         LS   ++  +Y+LL+ L YCHS
Sbjct: 60  IVKLLDVIHTERKLY--LVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS 116

Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQD 305
             I+HRD+KP N++I+ +   L+L D+GLA  F  P + Y   V + +++ PE+L+  + 
Sbjct: 117 HRILHRDLKPQNILINRDGV-LKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKH 175

Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAY--LNKYHIELD 363
           Y  ++D+WS+GC+FA MI   +P F G    DQL KI ++LGT    ++  + K      
Sbjct: 176 YSTAVDIWSVGCIFAEMI-TGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKL----- 229

Query: 364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
           P       +   K   K +   +     PE +D L K+L+Y+  +R +AKEA+ HPYF
Sbjct: 230 PDYKPTFPKFPPKDLEKVLPRLD-----PEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  201 bits (515), Expect = 2e-61
 Identities = 107/320 (33%), Positives = 169/320 (52%), Gaps = 49/320 (15%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKK----KKIKREIKILQNLCGGPN 190
           YE+++ +G G Y  V   V      K  IK I          K+I REIK+L++L    N
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHL-RHEN 60

Query: 191 IVKLLDIVRDQQSKTPSLIFEHVN------NTDF-KVLY--PTLSDYDVRYYIYELLKAL 241
           I+ LLDI+R    +     F  V        TD  KV+     L+D  ++Y++Y++L+ L
Sbjct: 61  IIGLLDILRPPSPED----FNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGL 116

Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-----EFYHPGK--EYNVRVASRYF 294
            Y HS  ++HRD+KP N++++     L++ D+GLA     +    G   EY   V +R++
Sbjct: 117 KYLHSANVIHRDLKPSNILVNSNC-DLKICDFGLARGVDPDEDEKGFLTEY---VVTRWY 172

Query: 295 KGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---DEL 351
           + PELL+    Y  ++D+WS+GC+FA ++ RK P F G D  DQL  I +VLGT   ++L
Sbjct: 173 RAPELLLSSSRYTKAIDIWSVGCIFAELLTRK-PLFPGRDYIDQLNLIVEVLGTPSEEDL 231

Query: 352 NAYLN---KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQE 408
               +   + +++  P          +KP SK     +     PEA+D L+K+L +D ++
Sbjct: 232 KFITSEKARNYLKSLPK-------KPKKPLSKLFPGAS-----PEAIDLLEKMLVFDPKK 279

Query: 409 RPTAKEAMAHPYFFPIRNAE 428
           R TA EA+AHPY   + + E
Sbjct: 280 RITADEALAHPYLAQLHDPE 299

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  189 bits (483), Expect = 3e-57
 Identities = 90/301 (29%), Positives = 158/301 (52%), Gaps = 29/301 (9%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK-----IKREIKILQNLCGGPN 190
           YE + ++G G Y +V++  +    E   +K ++   +K+       REIK+LQ L   PN
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRH-PN 59

Query: 191 IVKLLDIVRDQQSKTPSLIFEHV--------NNTDFKVLYPTLSDYDVRYYIYELLKALD 242
           IV+L +IV  +   +  ++FE++        ++ + K      ++  ++ Y+ +LL+ L 
Sbjct: 60  IVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVK-----FTESQIKCYMKQLLEGLQ 114

Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP--GKEYNVRVASRYFKGPELL 300
           Y HS GI+HRD+K  N++I+++   L+L D+GLA  Y      +Y  RV + +++ PELL
Sbjct: 115 YLHSNGILHRDIKGSNILINNDGV-LKLADFGLARPYTKRNSADYTNRVITLWYRPPELL 173

Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 360
           +    Y   +D+WS+GC+ A + F  +P F G    +QL KI ++ G+     +     +
Sbjct: 174 LGATRYGPEVDMWSVGCILAEL-FLGKPIFQGSTELEQLEKIFELCGSPTDENWPG---V 229

Query: 361 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 420
              P    L  +  +    +      +HL  P A+D LDKLL  D ++R +A +A+ H Y
Sbjct: 230 SKLPWFENL--KPKKPYKRRLREFF-KHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286

Query: 421 F 421
           F
Sbjct: 287 F 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  185 bits (471), Expect = 2e-55
 Identities = 104/302 (34%), Positives = 162/302 (53%), Gaps = 35/302 (11%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNLCGGPN 190
           Y+ + K+G G Y  V++       E   IK +K         K   REIK+L+ L   PN
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKEL-NHPN 59

Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL----YPTLSDYDVRYYIYELLKALDYCHS 246
           I+KLLD+ R +      L+FE ++   +K++       L +  ++ Y+Y+LL+ L +CHS
Sbjct: 60  IIKLLDVFRHKGDL--YLVFEFMDTDLYKLIKDRQRG-LPESLIKSYLYQLLQGLAFCHS 116

Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQD 305
            GI+HRD+KP N++I+  +  L+L D+GLA  F  P + Y   V +R+++ PELL+  + 
Sbjct: 117 HGILHRDLKPENLLIN-TEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKG 175

Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT------DELNAYLNKYH 359
           Y   +D+WS+GC+FA ++ R+ P F G    DQL KI + LGT       +  +    Y 
Sbjct: 176 YSTPVDIWSVGCIFAELLSRR-PLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234

Query: 360 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHP 419
               P  A +       P  K         A P+A+D L ++L YD  +R TA++A+AHP
Sbjct: 235 FSF-PKKAGM-------PLPKLFPN-----ASPQALDLLSQMLHYDPHKRITAEQALAHP 281

Query: 420 YF 421
           YF
Sbjct: 282 YF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  183 bits (466), Expect = 8e-55
 Identities = 95/302 (31%), Positives = 151/302 (50%), Gaps = 30/302 (9%)

Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKKKKIK----REIKILQNLCGGP 189
            Y+++ ++G G +  VF+       E   +K +     +  I     REIK LQ  C  P
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQA-CQHP 59

Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL----YPTLSDYDVRYYIYELLKALDYCH 245
            +VKLLD+          L+ E++ +   +VL     P L +  V+ Y+  LLK + Y H
Sbjct: 60  YVVKLLDVFPHGSGF--VLVMEYMPSDLSEVLRDEERP-LPEAQVKSYMRMLLKGVAYMH 116

Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDL 303
           + GIMHRD+KP N++I      L++ D+GLA  +   +   Y+ +VA+R+++ PELL   
Sbjct: 117 ANGIMHRDLKPANLLIS-ADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA 175

Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363
           + YD  +DLW++GC+FA ++    P F G ++ +QL  + + LGT     +     +   
Sbjct: 176 RKYDPGVDLWAVGCIFAELL-NGSPLFPGENDIEQLAIVFRTLGTPNEETWPG---LTSL 231

Query: 364 PHLAALVGRHS-RKPWSKFITVENQHL--AVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 420
           P    +    S   P         +    A PEA+D L  LL YD  +R +A EA+ HPY
Sbjct: 232 PDYNKITFPESKPIPL-------EEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284

Query: 421 FF 422
           F 
Sbjct: 285 FT 286

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  181 bits (461), Expect = 7e-54
 Identities = 95/304 (31%), Positives = 156/304 (51%), Gaps = 36/304 (11%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK--------REIKILQNLCG 187
           YE  +K+G G Y+ V++           IK +K  ++K+ K        REIK+LQ L  
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL-K 60

Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDY 243
            PNI+ LLD+   + +   +L+FE +  TD + +       L+  D++ Y+   L+ L+Y
Sbjct: 61  HPNIIGLLDVFGHKSNI--NLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEY 117

Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVD 302
            HS  I+HRD+KP+N++I      L+L D+GLA  +  P ++   +V +R+++ PELL  
Sbjct: 118 LHSNWILHRDLKPNNLLIA-SDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFG 176

Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELN----AYLNKY 358
            + Y   +D+WS+GC+FA ++ R  PF  G  + DQL KI + LGT              
Sbjct: 177 ARHYGVGVDMWSVGCIFAELLLRV-PFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD 235

Query: 359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
           ++E  P            P  +     +      +A+D L +LL  +  +R TA++A+ H
Sbjct: 236 YVEFKP--------FPPTPLKQIFPAASD-----DALDLLQRLLTLNPNKRITARQALEH 282

Query: 419 PYFF 422
           PYF 
Sbjct: 283 PYFS 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  177 bits (452), Expect = 1e-52
 Identities = 105/301 (34%), Positives = 152/301 (50%), Gaps = 30/301 (9%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNLCGGPN 190
           YEV+  VG G Y  V +  +    E   IK  K        KK   RE+K+L+ L    N
Sbjct: 3   YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL-RHEN 61

Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPTLSDYD-VRYYIYELLKALDYCHSQ 247
           IV L +  R  +     L+FE+V  T  ++L   P     D VR YI++LL+A+ YCHS 
Sbjct: 62  IVNLKEAFR--RKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH 119

Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH--PGKEYNVRVASRYFKGPELLVDLQD 305
            I+HRD+KP N+++  E   L+L D+G A      P       VA+R+++ PELLV   +
Sbjct: 120 NIIHRDIKPENILVS-ESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTN 178

Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL--- 362
           Y   +D+W++GC+ A ++   EP F G  + DQL  I K LG       L   H EL   
Sbjct: 179 YGKPVDVWAIGCIMAELL-DGEPLFPGDSDIDQLYLIQKCLGP------LPPSHQELFSS 231

Query: 363 DPHLAALVGRHSRKPWSKFITVENQHLAVPE--AVDFLDKLLRYDHQERPTAKEAMAHPY 420
           +P  A +    +    S+  ++E ++       A+DFL   LR D +ER T  E + HPY
Sbjct: 232 NPRFAGV----AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287

Query: 421 F 421
           F
Sbjct: 288 F 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  166 bits (422), Expect = 2e-48
 Identities = 94/296 (31%), Positives = 160/296 (54%), Gaps = 24/296 (8%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVKKKKIKREIKILQNLCGGPNI 191
           Y+++ K+G G +SEV +       +    KC+ K  K +++    REI+ L+ L   PNI
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNI 60

Query: 192 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVL----YPTLSDYDVRYYIYELLKALDYCHSQ 247
           ++L++++ D+++   +L+FE ++   ++++     P L +  V+ Y+Y+LLK+LD+ H  
Sbjct: 61  LRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRP-LPEKRVKSYMYQLLKSLDHMHRN 119

Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 307
           GI HRD+KP N++I      L+L D+G     +    Y   +++R+++ PE L+    Y 
Sbjct: 120 GIFHRDIKPENILIK--DDILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYG 177

Query: 308 YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT--DELNAYLNKYHIELDPH 365
             +D+W++GC+F  ++    P F G +  DQ+ KI  VLGT   E+     K    ++ +
Sbjct: 178 PKMDIWAVGCVFFEILSLF-PLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR-HMNYN 235

Query: 366 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
             +  G   RK             A  E +D L KLL YD  ER TAK+A+ HPYF
Sbjct: 236 FPSKKGTGLRK---------LLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  164 bits (417), Expect = 1e-47
 Identities = 99/305 (32%), Positives = 158/305 (51%), Gaps = 41/305 (13%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-------------REIKIL 182
           Y+ V K+G G Y  V++       E         V  KKI+             REI +L
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLTGEI--------VALKKIRLETEDEGVPSTAIREISLL 52

Query: 183 QNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD-----VRYYIYEL 237
           + L   PNIV+LLD+V   ++K   L+FE ++  D K    +          ++ Y+Y+L
Sbjct: 53  KEL-NHPNIVRLLDVVH-SENKL-YLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQL 108

Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKG 296
           L+ + YCHS  ++HRD+KP N++ID E   L+L D+GLA  F  P + Y   V + +++ 
Sbjct: 109 LQGIAYCHSHRVLHRDLKPQNLLIDREG-ALKLADFGLARAFGVPVRTYTHEVVTLWYRA 167

Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 356
           PE+L+  + Y   +D+WS+GC+FA M+ R+ P F G    DQL +I + LGT + + +  
Sbjct: 168 PEILLGSRQYSTPVDIWSIGCIFAEMVNRR-PLFPGDSEIDQLFRIFRTLGTPDEDVWPG 226

Query: 357 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAM 416
              +   P       + +R+  SK +   +      + +D L K+L YD  +R +AK A+
Sbjct: 227 ---VTSLPDYKPTFPKWARQDLSKVVPNLD-----EDGLDLLSKMLVYDPAKRISAKAAL 278

Query: 417 AHPYF 421
            HPYF
Sbjct: 279 QHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  161 bits (410), Expect = 1e-46
 Identities = 91/304 (29%), Positives = 152/304 (50%), Gaps = 39/304 (12%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK--------REIKILQNLCG 187
           Y+V++++G G +  V+   +    E   IK +K    KK          RE+K L+ L  
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKMK----KKFYSWEECMNLREVKSLRKLNE 56

Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL----YPTLSDYDVRYYIYELLKALDY 243
            PNIVKL ++ R+  +     +FE++    ++++        S+  +R  IY++L+ L +
Sbjct: 57  HPNIVKLKEVFRE--NDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114

Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 303
            H  G  HRD+KP N+++      +++ D+GLA        Y   V++R+++ PE+L+  
Sbjct: 115 IHKHGFFHRDLKPENLLVS-GPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRS 173

Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363
             Y   +D+W+LGC+ A + +   P F G    DQL KI  VLGT     +   Y     
Sbjct: 174 TSYSSPVDIWALGCIMAEL-YTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGY----- 227

Query: 364 PHLAALVGRHSRKPWSKFITVENQHL------AVPEAVDFLDKLLRYDHQERPTAKEAMA 417
             LA+ +G        +F       L      A PEA+D +  +LR+D ++RPTA +A+ 
Sbjct: 228 -KLASKLGF-------RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279

Query: 418 HPYF 421
           HPYF
Sbjct: 280 HPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  161 bits (408), Expect = 3e-46
 Identities = 100/317 (31%), Positives = 165/317 (52%), Gaps = 52/317 (16%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-----------REIKIL 182
           D YE + K+G G Y +V++       +      L  +KK +++           REI +L
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGK------LVALKKTRLEMDEEGIPPTALREISLL 54

Query: 183 QNLCGGPNIVKLLDIVR-DQQSKTPSL--IFEHVNNTDFKVLYPT--------LSDYDVR 231
           Q L     IV+LLD+   ++++  PSL  +FE+++ +D K    +        L    ++
Sbjct: 55  QMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLD-SDLKKFMDSNGRGPGRPLPAKTIK 113

Query: 232 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVA 290
            ++Y+LLK + +CH  G+MHRD+KP N+++D ++  L++ D GL   F  P K Y   + 
Sbjct: 114 SFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV 173

Query: 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE 350
           + +++ PE+L+    Y   +D+WS+GC+FA M  RK+P F G     QL+ I K+LGT  
Sbjct: 174 TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS-RKQPLFPGDSELQQLLHIFKLLGTPT 232

Query: 351 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAV------PEAVDFLDKLLRY 404
              +         P ++ L      + W +F   + Q L+       PE +D L K+LRY
Sbjct: 233 EQVW---------PGVSKL------RDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRY 277

Query: 405 DHQERPTAKEAMAHPYF 421
           D  +R +AK A+ HPYF
Sbjct: 278 DPAKRISAKAALTHPYF 294

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  160 bits (406), Expect = 2e-45
 Identities = 93/305 (30%), Positives = 162/305 (53%), Gaps = 29/305 (9%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL-----KPVKKKKIKREIKILQNLCGG 188
             Y+ +  +G G Y  V   +     +K  IK +      P   K+  RE+KIL++    
Sbjct: 5   SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF-KH 63

Query: 189 PNIVKLLDIVRDQQS--KTPSLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYC 244
            NI+ + DI+R   +  K   ++ + + +    +++    L++  +RY++Y+LL+ L Y 
Sbjct: 64  DNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYI 123

Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY------HPG--KEYNVRVASRYFKG 296
           HS  ++HRD+KP N++++ E  +LR+ D+G+A         H     EY   VA+R+++ 
Sbjct: 124 HSANVIHRDLKPSNLLVN-EDCELRIGDFGMARGLSSSPTEHKYFMTEY---VATRWYRA 179

Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 356
           PELL+ L +Y  ++D+WS+GC+FA M+ R++  F G +   QL  I  VLG+      LN
Sbjct: 180 PELLLSLPEYTTAIDMWSVGCIFAEMLGRRQ-LFPGKNYVHQLKLILSVLGSPS-EEVLN 237

Query: 357 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAM 416
           +   +        + R    PWSK         A PEA+D L ++L++D +ER T ++A+
Sbjct: 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPK-----ASPEALDLLSQMLQFDPEERITVEQAL 292

Query: 417 AHPYF 421
            HP+ 
Sbjct: 293 QHPFL 297

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  154 bits (392), Expect = 8e-45
 Identities = 56/190 (29%), Positives = 94/190 (49%), Gaps = 12/190 (6%)

Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK----IKREIKILQNLCGGPNIVKLLDI 197
           +G G +  V+        +K  IKI+K          + REI+IL+ L   PNIVKL  +
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKL-NHPNIVKLYGV 59

Query: 198 VRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRD 253
             D+      L+ E+      K L       LS+ ++   + ++L+ L+Y HS GI+HRD
Sbjct: 60  FEDENH--LYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117

Query: 254 VKPHNVMIDHEQRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDL 312
           +KP N+++D +  K++L D+GL++            V +  +  PE+L+    Y    D+
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDI 177

Query: 313 WSLGCMFAGM 322
           WSLG +   +
Sbjct: 178 WSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  158 bits (401), Expect = 1e-44
 Identities = 98/308 (31%), Positives = 167/308 (54%), Gaps = 39/308 (12%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK----KIKREIKILQNLCGGP 189
             Y+ +  +G G Y  V    H     K  IK + P + +    +  REIKIL+      
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRF-KHE 63

Query: 190 NIVKLLDIVR--DQQSKTPSLIFEHVNNTD-FKVLYP-TLSDYDVRYYIYELLKALDYCH 245
           NI+ +LDI+R    +S     I + +  TD +K++    LS+  ++Y++Y++L+ L Y H
Sbjct: 64  NIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIH 123

Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-----EFYHPGK--EYNVRVASRYFKGPE 298
           S  ++HRD+KP N++++     L++ D+GLA     E  H G   EY   VA+R+++ PE
Sbjct: 124 SANVLHRDLKPSNLLLN-TNCDLKICDFGLARIADPEHDHTGFLTEY---VATRWYRAPE 179

Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---DELNAYL 355
           ++++ + Y  ++D+WS+GC+ A M+  + P F G D   QL  I  VLGT   ++LN  +
Sbjct: 180 IMLNSKGYTKAIDIWSVGCILAEMLSNR-PLFPGKDYLHQLNLILGVLGTPSQEDLNCII 238

Query: 356 N---KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA 412
           +   + +I+  P          + PW+K     +     P+A+D LDK+L ++  +R T 
Sbjct: 239 SLRARNYIKSLPF-------KPKVPWNKLFPNAD-----PKALDLLDKMLTFNPHKRITV 286

Query: 413 KEAMAHPY 420
           +EA+AHPY
Sbjct: 287 EEALAHPY 294

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  155 bits (395), Expect = 2e-44
 Identities = 90/318 (28%), Positives = 153/318 (48%), Gaps = 63/318 (19%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-------------REIKIL 182
           YE + ++G G Y  V++               + V  KK++             REI +L
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTG--------RFVALKKVRVPLSEEGIPLSTLREIALL 52

Query: 183 QNL--CGGPNIVKLLDI---VRDQQSKTPSLIFEHVNN--TDF--KVLYPTLSDYDVRYY 233
           + L     PNIV+LLD+    R  +    +L+FEHV+     +  K   P L    ++  
Sbjct: 53  KQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDL 112

Query: 234 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR----V 289
           + +LL+ +D+ HS  I+HRD+KP N+++  + + +++ D+GLA  Y     + +     V
Sbjct: 113 MRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ-VKIADFGLARIY----SFEMALTSVV 167

Query: 290 ASRYFKGPELLVDLQD-YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
            + +++ PE+L  LQ  Y   +D+WS+GC+FA + FR+ P F G    DQL KI  V+G 
Sbjct: 168 VTLWYRAPEVL--LQSSYATPVDMWSVGCIFAEL-FRRRPLFRGTSEADQLDKIFDVIGL 224

Query: 349 ---DE--LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLR 403
              +E   N  L +               ++ + +  F+          E +D L K+L 
Sbjct: 225 PSEEEWPRNVSLPRSSFP----------SYTPRSFKSFVPEIC-----EEGLDLLKKMLT 269

Query: 404 YDHQERPTAKEAMAHPYF 421
           ++  +R +A EA+ HPYF
Sbjct: 270 FNPHKRISAFEALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  157 bits (399), Expect = 3e-44
 Identities = 101/322 (31%), Positives = 161/322 (50%), Gaps = 52/322 (16%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKI-------------KREIKIL 182
           YE+++K+G+G Y  V++ +     E         V  KKI              REI  L
Sbjct: 9   YEILQKLGKGAYGIVWKAIDRRTKEV--------VALKKIFDAFRNATDAQRTFREIMFL 60

Query: 183 QNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELLKA 240
           Q L   PNIVKLL++++ +  K   L+FE++  TD   +     L D   RY +Y+LLKA
Sbjct: 61  QELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRANILEDVHKRYIMYQLLKA 119

Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR------VASRYF 294
           L Y HS  ++HRD+KP N++++ + R ++L D+GLA      +E          VA+R++
Sbjct: 120 LKYIHSGNVIHRDLKPSNILLNSDCR-VKLADFGLARSLSELEENPENPVLTDYVATRWY 178

Query: 295 KGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---TDEL 351
           + PE+L+    Y   +D+WS+GC+   M+  K P F G    +QL KI +V+G    +++
Sbjct: 179 RAPEILLGSTRYTKGVDMWSVGCILGEMLLGK-PLFPGTSTLNQLEKIIEVIGPPSAEDI 237

Query: 352 NAYLNKYHIELDPHLAALVGRHS----RKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQ 407
            +        +    AA +        RKP  + +       A  +A+D L KLL ++  
Sbjct: 238 ES--------IKSPFAATMLDSLPSRPRKPLDELLPK-----ASDDALDLLKKLLVFNPN 284

Query: 408 ERPTAKEAMAHPYFFPIRNAES 429
           +R TA+EA+ HPY     N   
Sbjct: 285 KRLTAEEALEHPYVAQFHNPSD 306

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  156 bits (397), Expect = 5e-44
 Identities = 93/324 (28%), Positives = 169/324 (52%), Gaps = 51/324 (15%)

Query: 130 WGEQDDYEVVRKVGRGKYSEVFEGV-HCTDNEKCIIKILKP----VKKKKIKREIKILQN 184
           W   D Y+ +  VG G Y +V       T  +  I K+ +P    +  K+  RE+++L++
Sbjct: 11  WEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKH 70

Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN-TDFKVLYP-------------TLSDYDV 230
           +    N++ LLD+       TP+     + +  D  ++                LSD  +
Sbjct: 71  MDH-ENVIGLLDVF------TPA---SSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHI 120

Query: 231 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVA 290
           ++ +Y++L+ L Y HS GI+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA
Sbjct: 121 QFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN-EDCELKILDFGLAR--HTDDEMTGYVA 177

Query: 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT-- 348
           +R+++ PE++++   Y+ ++D+WS+GC+ A ++  K   F G D+ DQL +I  ++GT  
Sbjct: 178 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK-TLFPGSDHIDQLKRIMNLVGTPD 236

Query: 349 DELNAYLN----KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRY 404
           +EL   ++    + +I+  P       +  +K + +  +  N     P A+D L+K+L  
Sbjct: 237 EELLQKISSESARNYIQSLP-------QMPKKDFKEVFSGAN-----PLAIDLLEKMLVL 284

Query: 405 DHQERPTAKEAMAHPYFFPIRNAE 428
           D  +R TA EA+AHPY     + E
Sbjct: 285 DPDKRITAAEALAHPYLAEYHDPE 308

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  154 bits (391), Expect = 8e-44
 Identities = 102/313 (32%), Positives = 162/313 (51%), Gaps = 40/313 (12%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK------PVKKKKIKREIKILQNLCG 187
           D YE V K+G G Y  V++      NE   +K ++       V    I REI +L+ +  
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAI-REISLLKEMQH 60

Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD-----VRYYIYELLKALD 242
           G NIV+L D+V  +  K   L+FE+++  D K    +  D+      ++ Y+Y++L+ + 
Sbjct: 61  G-NIVRLQDVVHSE--KRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116

Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 301
           YCHS  ++HRD+KP N++ID     L+L D+GLA  F  P + +   V + +++ PE+L+
Sbjct: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILL 176

Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 361
             + Y   +D+WS+GC+FA M+ +K P F G    D+L KI ++LGT     +       
Sbjct: 177 GSRHYSTPVDIWSVGCIFAEMVNQK-PLFPGDSEIDELFKIFRILGTPNEETW------- 228

Query: 362 LDPHLAALVGRHSRKP-WSKFITVENQHLAV------PEAVDFLDKLLRYDHQERPTAKE 414
             P + +L    S  P W        + LA       P  VD L K+LR D  +R TA+ 
Sbjct: 229 --PGVTSLPDYKSAFPKW------PPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARA 280

Query: 415 AMAHPYFFPIRNA 427
           A+ H YF  + +A
Sbjct: 281 ALEHEYFKDLGDA 293

Length = 294

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  152 bits (386), Expect = 1e-42
 Identities = 93/302 (30%), Positives = 159/302 (52%), Gaps = 26/302 (8%)

Query: 136 YEVVRKVGRGKYSEVFEG--VHCTDNEKCIIKILKPVKKKKIK-----REIKILQNLCGG 188
           YE+++++G+G Y  V        ++ E   IK +  V  KKI      RE+K+L++  G 
Sbjct: 2   YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61

Query: 189 PNIVKL--LDIVRDQQSKTPSLIFEHVNNTDFKVLYPT---LSDYDVRYYIYELLKALDY 243
            NI  L  +DIV         L +E +   D   +  +   L+D   + +IY++L  L Y
Sbjct: 62  KNITCLYDMDIVFPGNFNELYL-YEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKY 120

Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR-----VASRYFKGPE 298
            HS  ++HRD+KP N++++ +  +L++ D+GLA  +      N       VA+R+++ PE
Sbjct: 121 IHSANVLHRDLKPGNLLVNADC-ELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPE 179

Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 358
           +++  Q Y  ++D+WS+GC+ A ++ RK P F G D  DQL +I +VLGT +    L++ 
Sbjct: 180 IMLSFQSYTKAIDVWSVGCILAELLGRK-PVFKGKDYVDQLNQILQVLGTPDEET-LSRI 237

Query: 359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
                 +    +    +KP+       N     P A+D L+KLL +D  +R + +EA+ H
Sbjct: 238 GSPKAQNYIRSLPNIPKKPFESIFPNAN-----PLALDLLEKLLAFDPTKRISVEEALEH 292

Query: 419 PY 420
           PY
Sbjct: 293 PY 294

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  151 bits (383), Expect = 2e-42
 Identities = 94/329 (28%), Positives = 153/329 (46%), Gaps = 64/329 (19%)

Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKKKKIK----REIKILQNLCG 187
             DYE++ K+G G + EV++           +K IL   +K        REIKIL+ L  
Sbjct: 7   LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL-K 65

Query: 188 GPNIVKLLDIV---RDQQSKTPSLIF------EH-----VNNTDFKVLYPTLSDYDVRYY 233
            PN+V L+D+     D+  +    ++      +H     + N   K     L++  ++ Y
Sbjct: 66  HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK-----LTESQIKCY 120

Query: 234 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY--------HPG--- 282
           + +LL+ ++Y H   I+HRD+K  N++ID+ Q  L++ D+GLA  Y          G   
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANILIDN-QGILKIADFGLARPYDGPPPNPKGGGGGG 179

Query: 283 -KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 341
            ++Y   V +R+++ PELL+  + Y  ++D+W +GC+FA M  R+ P   G  + DQL  
Sbjct: 180 TRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR-PILQGKSDIDQLHL 238

Query: 342 IAKVLGT---------DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVP 392
           I K+ GT           L      +              + R    +F  +       P
Sbjct: 239 IFKLCGTPTEETWPGWRSLPGCEGVH----------SFTNYPRTLEERFGKL------GP 282

Query: 393 EAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
           E +D L KLL  D  +R TA +A+ HPYF
Sbjct: 283 EGLDLLSKLLSLDPYKRLTASDALEHPYF 311

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  149 bits (378), Expect = 3e-42
 Identities = 82/294 (27%), Positives = 135/294 (45%), Gaps = 49/294 (16%)

Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK---IKREIKILQNLCGGPNI 191
            +E++ K+G+G + EV++  H    ++  IK++K   K+K   I  EI+IL+  C  PNI
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILK-KCKHPNI 59

Query: 192 VKLLDIVRDQQSKTPSLIFEHVNN---TD-FKVLYPTLSDYDVRYYIYELLKALDYCHSQ 247
           VK        +     ++ E  +     D  K    TL++  + Y   ELLK L+Y HS 
Sbjct: 60  VKYYGSY--LKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117

Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 307
           GI+HRD+K  N+++  +  +++LID+GL+      K  N  V + Y+  PE++   + YD
Sbjct: 118 GIIHRDIKAANILLTSDG-EVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING-KPYD 175

Query: 308 YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLA 367
           Y  D+WSLG     +   K P+                               EL P  A
Sbjct: 176 YKADIWSLGITAIELAEGKPPYS------------------------------ELPPMKA 205

Query: 368 A-LVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 420
              +  +          + N      E  DFL K L+ + ++RPTA++ + HP+
Sbjct: 206 LFKIATNG------PPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  149 bits (378), Expect = 9e-42
 Identities = 85/314 (27%), Positives = 165/314 (52%), Gaps = 36/314 (11%)

Query: 130 WGEQ--DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK-----IKREIKIL 182
           WG++  D ++++ ++G G Y +V++       E   +K ++   +K+       REIKIL
Sbjct: 1   WGKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKIL 60

Query: 183 QNLCGGPNIVKLLDIVRDQQSKTP--------SLIFEHVNNTDFKVLYPTLSDYD---VR 231
           + L    NIV L +IV D+Q             L+FE++++    +L   L  +    ++
Sbjct: 61  RQL-NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK 119

Query: 232 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG--KEYNVRV 289
            ++ +LL+ L+YCH +  +HRD+K  N++++++  +++L D+GLA  Y+    + Y  +V
Sbjct: 120 SFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKG-QIKLADFGLARLYNSEESRPYTNKV 178

Query: 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTD 349
            + +++ PELL+  + Y  ++D+WS GC+  G +F K+P F  +    QL  I+++ G+ 
Sbjct: 179 ITLWYRPPELLLGEERYGPAIDVWSCGCIL-GELFTKKPIFQANQELAQLELISRLCGSP 237

Query: 350 ELNAYLNKYHIELDPHLAALVGRHSRKP---WSKFITVENQHLAVPEAVDFLDKLLRYDH 406
               +         P +  L   ++ KP   + + +  E   +    A+D LD +L  D 
Sbjct: 238 CPAVW---------PDVIKLPYFNTMKPKKQYRRRLREEFSFIP-TPALDLLDHMLTLDP 287

Query: 407 QERPTAKEAMAHPY 420
            +R TA+EA+  P+
Sbjct: 288 SKRCTAEEALNSPW 301

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  150 bits (378), Expect = 3e-41
 Identities = 88/322 (27%), Positives = 141/322 (43%), Gaps = 55/322 (17%)

Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK------IKREIKILQNLCGG 188
            Y ++RK+G G + EV+      D +   +K+L    + K        REI+IL +L   
Sbjct: 1   SYRILRKLGEGSFGEVYLAR---DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALD 242
           PNIVKL D  +D+ S    L+ E+V+    + L         LS+ +  + + ++L AL+
Sbjct: 58  PNIVKLYDFFQDEGSLY--LVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALE 115

Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY-------HPGKEYNVRVASRYFK 295
           Y HS+GI+HRD+KP N+++D + R ++LID+GLA+               +  V +  + 
Sbjct: 116 YLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175

Query: 296 GPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPF--FYGHDNYDQLVKIAKVLGTDEL 351
            PE+L+   L     S D+WSLG     ++    PF          Q +KI   L T  L
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235

Query: 352 NAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT 411
            + L+                             N  L    A D L KLL  D + R +
Sbjct: 236 ASPLSPS---------------------------NPELISKAASDLLKKLLAKDPKNRLS 268

Query: 412 AKEAMAHPYFFPIRNAESSRSR 433
           +   ++H     ++  ES  S 
Sbjct: 269 SSSDLSHDLLAHLKLKESDLSD 290

Length = 384

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  147 bits (372), Expect = 4e-41
 Identities = 90/297 (30%), Positives = 159/297 (53%), Gaps = 25/297 (8%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK------PVKKKKIKREIKILQNLCGGP 189
           ++ V K+G G Y  V++  +    E   +K ++       V    I REI +L+ L   P
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHP 59

Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPT----LSDYDVRYYIYELLKALDYCH 245
           NIVKLLD++  +      L+FE ++    K +  +    +    ++ Y+++LL+ L +CH
Sbjct: 60  NIVKLLDVIHTE--NKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH 117

Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 304
           S  ++HRD+KP N++I+  +  ++L D+GLA  F  P + Y   V + +++ PE+L+  +
Sbjct: 118 SHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 176

Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   P
Sbjct: 177 YYSTAVDIWSLGCIFAEMVTRR-ALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL---P 232

Query: 365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
                  + +R+ +SK +   +      +  D L ++L YD  +R +AK A+AHP+F
Sbjct: 233 DYKPSFPKWARQDFSKVVPPLD-----EDGRDLLSQMLHYDPNKRISAKAALAHPFF 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  146 bits (371), Expect = 7e-41
 Identities = 94/311 (30%), Positives = 155/311 (49%), Gaps = 48/311 (15%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--------PVKKKKIKREIKILQNL 185
           + YE + K+G G Y  VF+   C + E   I  +K        PV KK   REI++L+ L
Sbjct: 1   EKYEKLSKIGEGSYGVVFK---CRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQL 57

Query: 186 CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPT-LSDYDVRYYIYELLKALD 242
              PN+V L+++ R  + +   L+FE+ ++T    L   P  + ++ ++  I++ L+A++
Sbjct: 58  -KHPNLVNLIEVFR--RKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVN 114

Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLV 301
           +CH    +HRDVKP N++I  + + ++L D+G A     PG +Y   VA+R+++ PELLV
Sbjct: 115 FCHKHNCIHRDVKPENILITKQGQ-IKLCDFGFARILTGPGDDYTDYVATRWYRAPELLV 173

Query: 302 -DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL--------- 351
            D Q Y   +D+W++GC+FA ++   +P + G  + DQL  I K LG  +L         
Sbjct: 174 GDTQ-YGPPVDVWAIGCVFAELL-TGQPLWPGKSDVDQLYLIRKTLG--DLIPRHQQIFS 229

Query: 352 -NAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP 410
            N +     I        L  +                     A+ FL   L+ D  ER 
Sbjct: 230 TNQFFKGLSIPEPETREPLESKFPNIS--------------SPALSFLKGCLQMDPTERL 275

Query: 411 TAKEAMAHPYF 421
           + +E + HPYF
Sbjct: 276 SCEELLEHPYF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  146 bits (369), Expect = 1e-40
 Identities = 89/299 (29%), Positives = 151/299 (50%), Gaps = 29/299 (9%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--------KKKIKREIKILQNLCG 187
           YE + K+G G Y  VF+  +   +E   I  LK V+             REI +L+ L  
Sbjct: 2   YEKLEKIGEGTYGTVFKAKNRETHE---IVALKRVRLDDDDEGVPSSALREICLLKEL-K 57

Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY----DVRYYIYELLKALDY 243
             NIV+L D++   +  T  L+FE+ +  D K  + + +       V+ ++++LLK L +
Sbjct: 58  HKNIVRLYDVLHSDKKLT--LVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAF 114

Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVD 302
           CHS  ++HRD+KP N++I+ +  +L+L D+GLA  +  P + Y+  V + +++ P++L  
Sbjct: 115 CHSHNVLHRDLKPQNLLIN-KNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 173

Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 362
            + Y  S+D+WS GC+FA +     P F G+D  DQL +I ++LGT    ++     +  
Sbjct: 174 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL-- 231

Query: 363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            P         +       +   N         D L  LL  +  +R +A+EA+ HPYF
Sbjct: 232 -PDYKPYPMYPATTSLVNVVPKLN-----STGRDLLQNLLVCNPVQRISAEEALQHPYF 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  145 bits (368), Expect = 2e-40
 Identities = 88/300 (29%), Positives = 155/300 (51%), Gaps = 31/300 (10%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-------KKKIKREIKILQNLCGG 188
           ++ + K+G G Y+ V++G + T  E   I  LK +             REI +++ L   
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGE---IVALKEIHLDAEEGTPSTAIREISLMKEL-KH 57

Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPT------LSDYDVRYYIYELLKALD 242
            NIV+L D++  +      L+FE+++  D K    T      L    V+ + Y+LLK + 
Sbjct: 58  ENIVRLHDVIHTENKLM--LVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIA 114

Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 301
           +CH   ++HRD+KP N++I+     L+L D+GLA  F  P   ++  V + +++ P++L+
Sbjct: 115 FCHENRVLHRDLKPQNLLINKRGE-LKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLL 173

Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 361
             + Y  S+D+WS+GC+ A MI  + P F G +N DQL+KI +++GT   + +     I 
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITGR-PLFPGTNNEDQLLKIFRIMGTPTESTWPG---IS 229

Query: 362 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
             P       R+  +   +         A P  +D L +LL+ + + R +A +A+ HP+F
Sbjct: 230 QLPEYKPTFPRYPPQDLQQLFPH-----ADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  145 bits (368), Expect = 2e-40
 Identities = 96/301 (31%), Positives = 152/301 (50%), Gaps = 32/301 (10%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL------KPVKKKKIKREIKILQNLCGGP 189
           YE +  VG G Y  V +  H    +   IK        K VKK  + REI++L+ L    
Sbjct: 3   YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAM-REIRMLKQL-RHE 60

Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPTLSDYD-VRYYIYELLKALDYCHS 246
           N+V L+++ R  + K   L+FE V++T    L  YP   D   VR Y++++L+ +++CHS
Sbjct: 61  NLVNLIEVFR--RKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHS 118

Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQD 305
             I+HRD+KP N+++  +   ++L D+G A     PG+ Y   VA+R+++ PELLV    
Sbjct: 119 HNIIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTK 177

Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL--- 362
           Y  ++D+W++GC+   M    EP F G  + DQL  I K LG       L   H E+   
Sbjct: 178 YGRAVDIWAVGCLVTEM-LTGEPLFPGDSDIDQLYHIIKCLGN------LIPRHQEIFQK 230

Query: 363 DPHLAALVGRHSRKPWSKFITVENQHLAV--PEAVDFLDKLLRYDHQERPTAKEAMAHPY 420
           +P  A +     R P  K I    +         +D   + LR D  +RP++ + + H +
Sbjct: 231 NPLFAGM-----RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285

Query: 421 F 421
           F
Sbjct: 286 F 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  146 bits (371), Expect = 2e-40
 Identities = 101/320 (31%), Positives = 167/320 (52%), Gaps = 44/320 (13%)

Query: 130 WGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL-KPVKK----KKIKREIKILQN 184
           W   + Y  +++VG G Y  V   +     EK  IK L +P +     K+  RE+ +L++
Sbjct: 11  WELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKH 70

Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN---------TDF-KVLYPTLSDYDVRYYI 234
           +    N++ LLD+       T ++  +   +         TD  K++   LS+  V+Y +
Sbjct: 71  M-QHENVIGLLDV------FTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLV 123

Query: 235 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYF 294
           Y++L  L Y HS GI+HRD+KP N+ ++ E  +L+++D+GLA   H   E    V +R++
Sbjct: 124 YQMLCGLKYIHSAGIIHRDLKPGNLAVN-EDCELKILDFGLAR--HADAEMTGYVVTRWY 180

Query: 295 KGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------T 348
           + PE++++   Y+ ++D+WS+GC+ A M+  K   F G D  DQL +I KV G       
Sbjct: 181 RAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKT-LFKGKDYLDQLTQILKVTGVPGPEFV 239

Query: 349 DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQE 408
            +L     K +I+  P       ++ RK +S          A P+AVD L+K+L  D  +
Sbjct: 240 QKLEDKAAKSYIKSLP-------KYPRKDFSTLFPK-----ASPQAVDLLEKMLELDVDK 287

Query: 409 RPTAKEAMAHPYFFPIRNAE 428
           R TA EA+ HPYF   R+A+
Sbjct: 288 RLTATEALEHPYFDSFRDAD 307

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  144 bits (366), Expect = 3e-40
 Identities = 97/308 (31%), Positives = 159/308 (51%), Gaps = 44/308 (14%)

Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-------------REIKI 181
           DY  + K+G G Y  V++G +            + V  KKI+             REI +
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTG--------QIVAMKKIRLESEEEGVPSTAIREISL 52

Query: 182 LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD------VRYYIY 235
           L+ L   PNIV L D++  Q+S+   LIFE ++  D K    +L          V+ Y+Y
Sbjct: 53  LKEL-QHPNIVCLQDVLM-QESRL-YLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLY 108

Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYF 294
           ++L+ + +CHS+ ++HRD+KP N++ID  +  ++L D+GLA  F  P + Y   V + ++
Sbjct: 109 QILQGILFCHSRRVLHRDLKPQNLLID-NKGVIKLADFGLARAFGIPVRVYTHEVVTLWY 167

Query: 295 KGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAY 354
           + PE+L+    Y   +D+WS+G +FA M  +K P F+G    DQL +I ++LGT   + +
Sbjct: 168 RAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK-PLFHGDSEIDQLFRIFRILGTPTEDVW 226

Query: 355 LNKYHIELDPHLAALVGRHSRKP-WSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK 413
                    P + +L    +  P W K            + +D L+K+L YD  +R +AK
Sbjct: 227 ---------PGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAK 277

Query: 414 EAMAHPYF 421
           +A+ HPYF
Sbjct: 278 KALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  146 bits (370), Expect = 3e-40
 Identities = 101/327 (30%), Positives = 170/327 (51%), Gaps = 37/327 (11%)

Query: 120 YWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL-KPVKK----KK 174
           Y+  E     W   D Y  +++VG G Y  V   +      K  IK L +P +     K+
Sbjct: 1   YYRQEVNKTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKR 60

Query: 175 IKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP----------- 223
             RE+++L+++    N++ LLD+       TP L  +  +  DF ++ P           
Sbjct: 61  AYRELRLLKHM-KHENVIGLLDVF------TPDLSLDRFH--DFYLVMPFMGTDLGKLMK 111

Query: 224 --TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281
              LS+  +++ +Y++LK L Y H+ GI+HRD+KP N+ ++ E  +L+++D+GLA     
Sbjct: 112 HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVN-EDCELKILDFGLAR--QT 168

Query: 282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 341
             E    V +R+++ PE++++   Y  ++D+WS+GC+ A M+  K P F GHD+ DQL++
Sbjct: 169 DSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK-PLFKGHDHLDQLME 227

Query: 342 IAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKL 401
           I KV GT     ++ K   E   +    + R  +K +   +   N     P AV+ L+K+
Sbjct: 228 IMKVTGTPS-KEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNAN-----PLAVNVLEKM 281

Query: 402 LRYDHQERPTAKEAMAHPYFFPIRNAE 428
           L  D + R TA EA+AHPYF    + E
Sbjct: 282 LVLDAESRITAAEALAHPYFEEFHDPE 308

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  145 bits (367), Expect = 3e-40
 Identities = 96/310 (30%), Positives = 159/310 (51%), Gaps = 37/310 (11%)

Query: 130 WGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK------------R 177
           +G+ + Y+ + K+G G Y+ V++G              + V  K+I+            R
Sbjct: 1   FGKLETYKKLDKLGEGSYATVYKGRSKLTG--------QLVALKEIRLEHEEGAPFTAIR 52

Query: 178 EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPT-LSDYDVRYY 233
           E  +L++L    NIV L DI+  +  KT +L+FE+++ TD K         LS ++VR +
Sbjct: 53  EASLLKDL-KHANIVTLHDIIHTK--KTLTLVFEYLD-TDLKQYMDDCGGGLSMHNVRLF 108

Query: 234 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASR 292
           +++LL+ L YCH + ++HRD+KP N++I  E+ +L+L D+GLA     P K Y+  V + 
Sbjct: 109 LFQLLRGLAYCHQRRVLHRDLKPQNLLIS-ERGELKLADFGLARAKSVPSKTYSNEVVTL 167

Query: 293 YFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH-DNYDQLVKIAKVLGTDEL 351
           +++ P++L+   +Y  SLD+W +GC+F  M     P F G  D  DQL KI +VLGT   
Sbjct: 168 WYRPPDVLLGSTEYSTSLDMWGVGCIFYEMA-TGRPLFPGSTDVEDQLHKIFRVLGTPTE 226

Query: 352 NAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT 411
             +     +  +P                 I    +   +P   +   K L+Y+ ++R +
Sbjct: 227 ETWPG---VSSNPEFKPYSFPFYPP--RPLINHAPRLDRIPHGEELALKFLQYEPKKRIS 281

Query: 412 AKEAMAHPYF 421
           A EAM HPYF
Sbjct: 282 AAEAMKHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  138 bits (350), Expect = 2e-37
 Identities = 99/299 (33%), Positives = 157/299 (52%), Gaps = 28/299 (9%)

Query: 136 YEVVRKVGRGKYSEVFEGV-HCTDNEKCIIKILKP----VKKKKIKREIKILQNLCGGPN 190
           Y  ++ VG G +  V       T     I KI+KP    V  K+  RE+K+L++L    N
Sbjct: 12  YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL-RHEN 70

Query: 191 IVKLLDIVRDQQSKTPSLIF-EHVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYCHSQ 247
           I+ L DI     S    + F   +  TD   L  +  L    ++Y++Y++L+ L Y HS 
Sbjct: 71  IISLSDIF---ISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSA 127

Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 307
           G++HRD+KP N++I+ E   L++ D+GLA    P  +    V++RY++ PE+++  Q YD
Sbjct: 128 GVVHRDLKPSNILIN-ENCDLKICDFGLARIQDP--QMTGYVSTRYYRAPEIMLTWQKYD 184

Query: 308 YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---DELNAYLNKYHIELDP 364
             +D+WS GC+FA M    +P F G D+ +Q   I  +LGT   D +N   ++  +    
Sbjct: 185 VEVDIWSAGCIFAEM-LEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF-- 241

Query: 365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP 423
            + +L  R       KF   +      P A+D L+K+L +D Q+R +A EA+AHPY  P
Sbjct: 242 -VQSLPKREPVPFSEKFKNAD------PSAIDLLEKMLVFDPQKRISAAEALAHPYLAP 293

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  137 bits (347), Expect = 2e-37
 Identities = 92/308 (29%), Positives = 154/308 (50%), Gaps = 39/308 (12%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK---IK--REIKILQNLCGG 188
           D+YE + ++  G Y  V+        E   +K LK  K+K+   I   REI IL  L   
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKL-QH 63

Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY----DVRYYIYELLKALDYC 244
           PNIV + ++V         ++ E+V + D K L  T+       +V+  + +LL  + + 
Sbjct: 64  PNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHL 122

Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDL 303
           H   I+HRD+K  N+++++    L++ D+GLA E+  P K Y   V + +++ PELL+  
Sbjct: 123 HDNWILHRDLKTSNLLLNNRGI-LKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGA 181

Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363
           ++Y  ++D+WS+GC+FA ++  K+P F G    DQL KI K+LGT     +         
Sbjct: 182 KEYSTAIDMWSVGCIFAELL-TKKPLFPGKSEIDQLNKIFKLLGTPTEKIW--------- 231

Query: 364 PHLAALVGRHSRKPWSKFITVENQHLAVPE----------AVDFLDKLLRYDHQERPTAK 413
           P  + L G        K    +  +  + +            D L++LL YD  +R +A+
Sbjct: 232 PGFSELPG------AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAE 285

Query: 414 EAMAHPYF 421
           +A+ HPYF
Sbjct: 286 DALKHPYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  137 bits (347), Expect = 4e-37
 Identities = 97/314 (30%), Positives = 162/314 (51%), Gaps = 45/314 (14%)

Query: 130 WGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL-KP----VKKKKIKREIKILQN 184
           W   + Y+ +  VG G Y  V         +K  +K L +P    +  ++  RE+++L++
Sbjct: 11  WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKH 70

Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVN-----------NTDFKVLYPTLSDYDVRYY 233
           +    N++ LLD+       TP+   E+ N           + +  V    LSD  V++ 
Sbjct: 71  M-KHENVIGLLDVF------TPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFL 123

Query: 234 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY 293
           IY+LL+ L Y HS GI+HRD+KP NV ++ E  +LR++D+GLA       E    VA+R+
Sbjct: 124 IYQLLRGLKYIHSAGIIHRDLKPSNVAVN-EDCELRILDFGLAR--QADDEMTGYVATRW 180

Query: 294 FKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 353
           ++ PE++++   Y+ ++D+WS+GC+ A ++ + +  F G+D  DQL +I +V+GT     
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELL-KGKALFPGNDYIDQLKRIMEVVGTPSPEV 239

Query: 354 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHL------AVPEAVDFLDKLLRYDHQ 407
                       L  +   H+RK       +  Q L      A P A+D L+K+L  D  
Sbjct: 240 ------------LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSD 287

Query: 408 ERPTAKEAMAHPYF 421
           +R +A EA+AHPYF
Sbjct: 288 KRISASEALAHPYF 301

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  135 bits (343), Expect = 5e-37
 Identities = 78/298 (26%), Positives = 133/298 (44%), Gaps = 49/298 (16%)

Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK--ILKPVKKKK---IKREIKILQNLCGGP 189
           ++     +GRG +  V+  +     E   +K   L    +++   ++REI+IL +L   P
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSL-QHP 59

Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKALDYCHS 246
           NIV+     RD++  T ++  E+V+    +     +  L +  +R Y  ++L+ L Y HS
Sbjct: 60  NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119

Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLA---EFYHPGKEYNVRVASRYFKGPELLVDL 303
            GI+HRD+K  N+++D +   ++L D+G A        G+       + Y+  PE++   
Sbjct: 120 NGIVHRDIKGANILVDSDGV-VKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG- 177

Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363
           ++Y  + D+WSLGC    M   K P+    +    L KI             +    E+ 
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS-----------SGEPPEIP 226

Query: 364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            HL+                         EA DFL K LR D ++RPTA E + HP+ 
Sbjct: 227 EHLS------------------------EEAKDFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  134 bits (338), Expect = 1e-35
 Identities = 97/316 (30%), Positives = 163/316 (51%), Gaps = 52/316 (16%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL-----KPVKKKKIKREIKILQNLCGGPN 190
           Y  ++ +GRG Y  V    +   NEK  IK +       +  K+  REIK+L++L    N
Sbjct: 7   YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL-DHEN 65

Query: 191 IVKLLDIVRDQQSKTPSLIFEHVN------NTDFKVLY---PTLSDYDVRYYIYELLKAL 241
           ++ + DI+     +     F  V       +TD   +     TLSD   +Y++Y+LL+ L
Sbjct: 66  VIAIKDIMPPPHREA----FNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGL 121

Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-------EFYHPGKEYNVRVASRYF 294
            Y HS  ++HRD+KP N++++     L++ D+GLA       +F     EY   V +R++
Sbjct: 122 KYIHSANVLHRDLKPSNLLLN-ANCDLKICDFGLARTTSEKGDFM---TEY---VVTRWY 174

Query: 295 KGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---DEL 351
           + PELL++  +Y  ++D+WS+GC+FA ++ RK P F G D   QL  I ++LG+   ++L
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFAELLGRK-PLFPGKDYVHQLKLITELLGSPSEEDL 233

Query: 352 NAYLN---KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQE 408
               N   + +I   P          R+ +++     N     P A+D L+K+L +D  +
Sbjct: 234 GFIRNEKARRYIRSLP-------YTPRQSFARLFPHAN-----PLAIDLLEKMLVFDPSK 281

Query: 409 RPTAKEAMAHPYFFPI 424
           R T +EA+AHPY   +
Sbjct: 282 RITVEEALAHPYLASL 297

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  132 bits (333), Expect = 5e-35
 Identities = 90/308 (29%), Positives = 155/308 (50%), Gaps = 33/308 (10%)

Query: 130 WGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL-KP----VKKKKIKREIKILQN 184
           W   + Y+ +  VG G Y  V          +  +K L +P    +  K+  RE+++L++
Sbjct: 13  WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKH 72

Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN---------TDFK--VLYPTLSDYDVRYY 233
           +    N++ LLD+       TP+   E  N+          D    V    L+D  V++ 
Sbjct: 73  M-KHENVIGLLDVF------TPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 125

Query: 234 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY 293
           IY++L+ L Y HS  I+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+R+
Sbjct: 126 IYQILRGLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRW 182

Query: 294 FKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 353
           ++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT     
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTPGAEL 241

Query: 354 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK 413
                      ++ +L         + FI       A P AVD L+K+L  D  +R TA 
Sbjct: 242 LKKISSESARNYIQSLTQMPKMNFANVFIG------ANPLAVDLLEKMLVLDSDKRITAA 295

Query: 414 EAMAHPYF 421
           +A+AH YF
Sbjct: 296 QALAHAYF 303

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  130 bits (328), Expect = 1e-34
 Identities = 88/326 (26%), Positives = 137/326 (42%), Gaps = 84/326 (25%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKK---IKREIKILQNLCG 187
           DD++  + +G G +S V        N++  IKIL     +K+KK   +K E ++L  L G
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 188 GPNIVKLLDIVRDQQSKTPSLIF--EHVNNTDFKVL---YPTLSDYDVRYYIYELLKALD 242
            P I+KL    +D+++    L F  E+  N +       Y +L +   R+Y  E+L AL+
Sbjct: 61  HPGIIKLYYTFQDEEN----LYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALE 116

Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK---------------EYNV 287
           Y HS+GI+HRD+KP N+++D +   +++ D+G A+   P                     
Sbjct: 117 YLHSKGIIHRDLKPENILLDKDMH-IKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175

Query: 288 RVASRYFKG------PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV- 340
           R     F G      PELL + +    S DLW+LGC+   M+  K PF     + + L  
Sbjct: 176 RRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPF---RGSNEYLTF 231

Query: 341 -KIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLD 399
            KI K                                     +         P+A D ++
Sbjct: 232 QKILK-------------------------------------LEYSFPPNFPPDAKDLIE 254

Query: 400 KLLRYDHQERPTAKEA----MAHPYF 421
           KLL  D Q+R    E      AHP+F
Sbjct: 255 KLLVLDPQDRLGVNEGYDELKAHPFF 280

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  128 bits (324), Expect = 3e-34
 Identities = 86/307 (28%), Positives = 155/307 (50%), Gaps = 31/307 (10%)

Query: 130 WGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK----REIKILQNL 185
           +G    Y  + K+G G Y+ V++G+   + +   +K++    ++ +     RE  +L+ L
Sbjct: 1   FGAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGL 60

Query: 186 CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPT-LSDYDVRYYIYELLKALDYC 244
               NIV L DI+  +++ T    + H +   + + +P  L  Y+VR ++++LL+ L Y 
Sbjct: 61  -KHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYI 119

Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDL 303
           H Q I+HRD+KP N++I +   +L+L D+GLA     P + Y+  V + +++ P++L+  
Sbjct: 120 HGQHILHRDLKPQNLLISY-LGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGA 178

Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN-YDQLVKIAKVLGTDELNAY-----LNK 357
            DY  +LD+W  GC+F  M  + +P F G  + ++QL KI  VLG    + +     L  
Sbjct: 179 TDYSSALDIWGAGCIFIEM-LQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN 237

Query: 358 YHIELDPHLAALVGRHSRKPWSK---FITVENQHLAVPEAVDFLDKLLRYDHQERPTAKE 414
           Y  E                  K      V  +    P+A D   ++L    ++R +A++
Sbjct: 238 YKPEW-------------FLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQD 284

Query: 415 AMAHPYF 421
           A+ HPYF
Sbjct: 285 ALLHPYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  129 bits (327), Expect = 4e-34
 Identities = 89/309 (28%), Positives = 152/309 (49%), Gaps = 35/309 (11%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK---REIKILQNLCGGPNIV 192
           Y  +R +G G    VF  V    +++  +K +     + +K   REIKI++ L    NIV
Sbjct: 7   YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRL-DHDNIV 65

Query: 193 KLLDIVRDQQSKTPSLIFE--HVN---------NTDFKVL--YPTLSDYDVRYYIYELLK 239
           K+ +++    S     +     +N          TD   +     LS+   R ++Y+LL+
Sbjct: 66  KVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLR 125

Query: 240 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY----NVRVASRYFK 295
            L Y HS  ++HRD+KP NV I+ E   L++ D+GLA    P   +    +  + +++++
Sbjct: 126 GLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYR 185

Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK---VLGTDELN 352
            P LL+   +Y  ++D+W+ GC+FA M+  K P F G    +Q+  I +   V+  ++ N
Sbjct: 186 SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK-PLFAGAHELEQMQLILESVPVVREEDRN 244

Query: 353 AYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA 412
             LN       P      G   R+P    +   N     PEA+DFL+++L ++  +R TA
Sbjct: 245 ELLNV-----IPSFVRNDGGEPRRPLRDLLPGVN-----PEALDFLEQILTFNPMDRLTA 294

Query: 413 KEAMAHPYF 421
           +EA+ HPY 
Sbjct: 295 EEALMHPYM 303

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  128 bits (322), Expect = 8e-33
 Identities = 97/314 (30%), Positives = 164/314 (52%), Gaps = 45/314 (14%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKKKKIKREIKILQNLCGGPNIVKL 194
           Y++   +G G +  V+E +    +EK  IK +L+  + K   RE+ I++NL    NI+ L
Sbjct: 68  YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN--RELLIMKNL-NHINIIFL 124

Query: 195 LD------IVRDQQSKTPSLIFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALD 242
            D        +++++   +++ E +  T  K +         L  + V+ Y Y+L +AL 
Sbjct: 125 KDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALA 184

Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
           Y HS+ I HRD+KP N++ID     L+L D+G A+    G+     + SR+++ PEL++ 
Sbjct: 185 YIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLG 244

Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---DELNAYLNKYH 359
             +Y   +DLWSLGC+ A MI    P F G  + DQLV+I +VLGT   D+L        
Sbjct: 245 ATNYTTHIDLWSLGCIIAEMIL-GYPIFSGQSSVDQLVRIIQVLGTPTEDQLK------- 296

Query: 360 IELDPHLAALVGRHSRKPWSKFITVENQHL------AVP-EAVDFLDKLLRYDHQERPTA 412
            E++P+ A +          KF  V+ + L        P +A++F+ + L+Y+  +R   
Sbjct: 297 -EMNPNYADI----------KFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNP 345

Query: 413 KEAMAHPYFFPIRN 426
            EA+A P+F  +R+
Sbjct: 346 IEALADPFFDDLRD 359

Length = 440

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  125 bits (314), Expect = 8e-33
 Identities = 92/309 (29%), Positives = 155/309 (50%), Gaps = 44/309 (14%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK--------REIKILQNLCG 187
           YE V ++G G Y +VF+     +  + +   LK V+ +  +        RE+ +L++L  
Sbjct: 3   YECVAEIGEGAYGKVFKARDLKNGGRFVA--LKRVRVQTGEEGMPLSTIREVAVLRHLET 60

Query: 188 --GPNIVKLLDIV---RDQQSKTPSLIFEHVNN--TDF--KVLYPTLSDYDVRYYIYELL 238
              PN+V+L D+    R  +    +L+FEHV+   T +  KV  P +    ++  +++LL
Sbjct: 61  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 120

Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
           + LD+ HS  ++HRD+KP N+++     +++L D+GLA  Y         V + +++ PE
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPE 179

Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 358
           +L+    Y   +DLWS+GC+FA M FR++P F G  + DQL KI  V+G      +    
Sbjct: 180 VLLQ-SSYATPVDLWSVGCIFAEM-FRRKPLFRGSSDVDQLGKILDVIGLPGEEDW---- 233

Query: 359 HIELDPHLAALVGRHSRKPWSKFITVENQHLA--VPE----AVDFLDKLLRYDHQERPTA 412
                P   AL       P   F +   Q +   V +      D L K L ++  +R +A
Sbjct: 234 -----PRDVAL-------PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA 281

Query: 413 KEAMAHPYF 421
             A++HPYF
Sbjct: 282 YSALSHPYF 290

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  124 bits (313), Expect = 2e-32
 Identities = 96/322 (29%), Positives = 168/322 (52%), Gaps = 64/322 (19%)

Query: 130 WGEQDDYEVVRKVGRGKYSEVFEG-VHCTDNEKCIIKILKPVKKKKIK-------REIKI 181
           +G+ + Y  + K+G G Y+ V++G    TDN    +  LK ++ +  +       RE+ +
Sbjct: 2   FGKLETYIKLDKLGEGTYATVYKGRSKLTDN----LVALKEIRLEHEEGAPCTAIREVSL 57

Query: 182 LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSD-------YDVRYYI 234
           L++L    NIV L DI+  ++S T  L+FE+++    K L   L D       ++V+ ++
Sbjct: 58  LKDL-KHANIVTLHDIIHTEKSLT--LVFEYLD----KDLKQYLDDCGNSINMHNVKLFL 110

Query: 235 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRY 293
           ++LL+ L+YCH + ++HRD+KP N++I+ E+ +L+L D+GLA     P K Y+  V + +
Sbjct: 111 FQLLRGLNYCHRRKVLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYSNEVVTLW 169

Query: 294 FKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT----- 348
           ++ P++L+   DY   +D+W +GC+F  M   + P F G    +QL  I ++LGT     
Sbjct: 170 YRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR-PLFPGSTVEEQLHFIFRILGTPTEET 228

Query: 349 -------DELNAY-LNKYHIE-LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLD 399
                  +E  +Y   KY  + L  H   L                       +  + L 
Sbjct: 229 WPGILSNEEFKSYNYPKYRADCLHNHAPRLDS---------------------DGAELLS 267

Query: 400 KLLRYDHQERPTAKEAMAHPYF 421
           KLL+++ ++R +A+EAM HPYF
Sbjct: 268 KLLQFEGRKRISAEEAMKHPYF 289

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  123 bits (311), Expect = 2e-32
 Identities = 93/303 (30%), Positives = 150/303 (49%), Gaps = 31/303 (10%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGG 188
           + +EV+  VG G Y  V +  H    E   IK  K  +     K+   RE+K+L+ L   
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTL-KQ 59

Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPTLSDYD-VRYYIYELLKALDYCH 245
            NIV+L +  R  +     L+FE+V     ++L   P     + VR YIY+L+KA+ +CH
Sbjct: 60  ENIVELKEAFR--RRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCH 117

Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDL 303
              I+HRD+KP N++I H    L+L D+G A     G    Y   VA+R+++ PELL+  
Sbjct: 118 KNDIVHRDIKPENLLISHND-VLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLG- 175

Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---TDELNAYLNKYHI 360
             Y  ++D+WS+GC+  G +   +P F G    DQL  I KVLG    +++  + +    
Sbjct: 176 APYGKAVDMWSVGCIL-GELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS---- 230

Query: 361 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAV--DFLDKLLRYDHQERPTAKEAMAH 418
             +P    L       P     ++E ++L +   V  D +  LL+ +  +R   ++ + H
Sbjct: 231 --NPRFHGLRFPAVNHPQ----SLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284

Query: 419 PYF 421
           P F
Sbjct: 285 PAF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  123 bits (310), Expect = 6e-32
 Identities = 84/322 (26%), Positives = 158/322 (49%), Gaps = 43/322 (13%)

Query: 136 YEVVRKVGRGKYSEVFEGV--HCTDNEKCIIKILKPVKKKKIK------REIKILQNLCG 187
           YE+   +GRG Y  V++    +  D ++  IK  K  K++         REI +L+ L  
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL-K 60

Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKA 240
             N+V L+++  +   K+  L+F++  +  ++++         ++    V+  ++++L  
Sbjct: 61  HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120

Query: 241 LDYCHSQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYH----PGKEYNVRVASRY 293
           + Y HS  ++HRD+KP N+++     E+  +++ D GLA  ++    P  + +  V + +
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIW 180

Query: 294 FKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD---------NYDQLVKIAK 344
           ++ PELL+  + Y  ++D+W++GC+FA ++   EP F G +           DQL +I +
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELL-TLEPIFKGREAKIKKSNPFQRDQLERIFE 239

Query: 345 VLG--TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAV---PEAVDFLD 399
           VLG  T++    + K      P    L+     K +      +          +  D L 
Sbjct: 240 VLGTPTEKDWPDIKKM-----PEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLR 294

Query: 400 KLLRYDHQERPTAKEAMAHPYF 421
           KLL YD  +R TA+EA+ HPYF
Sbjct: 295 KLLEYDPTKRITAEEALEHPYF 316

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  121 bits (304), Expect = 2e-31
 Identities = 89/305 (29%), Positives = 161/305 (52%), Gaps = 27/305 (8%)

Query: 130 WGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK----REIKILQNL 185
           +G+ D YE + K+G G Y+ V++G    + +   +K+++  +++       RE  +L+ L
Sbjct: 1   FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL 60

Query: 186 CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPT-LSDYDVRYYIYELLKALD 242
               NIV L DI+  +++ T  L+FE+V+    + +  +P  L   +V+ ++++LL+ L 
Sbjct: 61  -KHANIVLLHDIIHTKETLT--LVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLS 117

Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLV 301
           Y H + I+HRD+KP N++I  +  +L+L D+GLA     P   Y+  V + +++ P++L+
Sbjct: 118 YIHQRYILHRDLKPQNLLIS-DTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLL 176

Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 361
              +Y   LD+W +GC+F  MI     F    D  DQL +I  VLGT   + +   + + 
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL- 235

Query: 362 LDPH-----LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAM 416
             PH           ++ R+ W+K   V +       A D   KLL+   + R +A+ A+
Sbjct: 236 --PHFKPERFTLYSPKNLRQAWNKLSYVNH-------AEDLASKLLQCFPKNRLSAQAAL 286

Query: 417 AHPYF 421
           +H YF
Sbjct: 287 SHEYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  122 bits (307), Expect = 4e-31
 Identities = 91/308 (29%), Positives = 153/308 (49%), Gaps = 40/308 (12%)

Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGP 189
           D E  R +G G +  V+      D ++  +K +  V       K++ RE+K+L       
Sbjct: 1   DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKML-CFFKHD 59

Query: 190 NIVKLLDIVRDQQSKTPSL-IFEHVN------NTDF-KVLY--PTLSDYDVRYYIYELLK 239
           N++  LDI+     + P +  FE +        +D  K++     LS   V+ ++Y++L+
Sbjct: 60  NVLSALDIL-----QPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILR 114

Query: 240 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP--GKEYNVRVASRYFKGP 297
            L Y HS GI+HRD+KP N++++     L++ D+GLA    P   K     V ++Y++ P
Sbjct: 115 GLKYLHSAGILHRDIKPGNLLVNSNCV-LKICDFGLARVEEPDESKHMTQEVVTQYYRAP 173

Query: 298 ELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN- 356
           E+L+  + Y  ++D+WS+GC+FA ++ R+   F       QL  I  +LGT  L A  + 
Sbjct: 174 EILMGSRHYTSAVDIWSVGCIFAELLGRR-ILFQAQSPIQQLDLITDLLGTPSLEAMRSA 232

Query: 357 ----KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA 412
               + HI        L G H         T+ +Q  A  EAV  L ++L +D  +R +A
Sbjct: 233 CEGARAHI--------LRGPHKPPSLPVLYTLSSQ--ATHEAVHLLCRMLVFDPDKRISA 282

Query: 413 KEAMAHPY 420
            +A+AHPY
Sbjct: 283 ADALAHPY 290

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  119 bits (299), Expect = 2e-30
 Identities = 96/322 (29%), Positives = 163/322 (50%), Gaps = 64/322 (19%)

Query: 130 WGEQDDYEVVRKVGRGKYSEVFEG-VHCTDNEKCIIKILKPVKKKKIK-------REIKI 181
           +G+ + Y  + K+G G Y+ VF+G    T+N    +  LK ++ +  +       RE+ +
Sbjct: 2   FGKMETYIKLEKLGEGTYATVFKGRSKLTEN----LVALKEIRLEHEEGAPCTAIREVSL 57

Query: 182 LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYEL 237
           L++L    NIV L DIV   +S T  L+FE+++  D K         +S ++V+ ++Y++
Sbjct: 58  LKDL-KHANIVTLHDIVHTDKSLT--LVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQI 113

Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKG 296
           L+ L YCH + ++HRD+KP N++I+ E+ +L+L D+GLA     P K Y+  V + +++ 
Sbjct: 114 LRGLAYCHRRKVLHRDLKPQNLLIN-ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRP 172

Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT-------- 348
           P++L+   +Y   +D+W +GC+F  M   + P F G    D+L  I ++LGT        
Sbjct: 173 PDVLLGSSEYSTQIDMWGVGCIFFEMASGR-PLFPGSTVEDELHLIFRLLGTPTEETWPG 231

Query: 349 ----DELNAY-LNKYH----IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLD 399
               DE   Y   KY     I   P L                          E ++ L 
Sbjct: 232 ISSNDEFKNYNFPKYKPQPLINHAPRLDT------------------------EGIELLT 267

Query: 400 KLLRYDHQERPTAKEAMAHPYF 421
           K L+Y+ ++R +A+EAM H YF
Sbjct: 268 KFLQYESKKRISAEEAMKHAYF 289

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  118 bits (298), Expect = 2e-30
 Identities = 81/300 (27%), Positives = 147/300 (49%), Gaps = 27/300 (9%)

Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK--------REIKILQNLC 186
           ++E + ++G G Y  V+     T  E   I  LK V+    +        REI +L N  
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTTSGE---IVALKKVRMDNERDGIPISSLREITLLLN-L 63

Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDY 243
             PNIV+L ++V  +   +  L+ E+       +L       S+  V+  + +LL+ L Y
Sbjct: 64  RHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQY 123

Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVD 302
            H   I+HRD+K  N+++   +  L++ D+GLA  Y  P K    +V + +++ PELL+ 
Sbjct: 124 LHENFIIHRDLKVSNLLLTD-KGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLG 182

Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 362
              Y  ++D+W++GC+ A +    +P   G    +QL  I ++LGT   + +     +  
Sbjct: 183 CTTYTTAIDMWAVGCILAEL-LAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL-- 239

Query: 363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEA-VDFLDKLLRYDHQERPTAKEAMAHPYF 421
            P +         +P++    ++++   + EA +  L+ LL YD ++R TA+EA+   YF
Sbjct: 240 -PLVGKFTLPK--QPYN---NLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYF 293

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  116 bits (292), Expect = 1e-29
 Identities = 88/312 (28%), Positives = 149/312 (47%), Gaps = 51/312 (16%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK--------REIKILQNL-- 185
           YE V ++G G Y  V++     D        LK V+ +  +        RE+ +L+ L  
Sbjct: 2   YEPVAEIGVGAYGTVYKA---RDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEA 58

Query: 186 CGGPNIVKLLDIV----RDQQSKTPSLIFEHVNNTDF-----KVLYPTLSDYDVRYYIYE 236
              PNIV+L+D+      D+++K  +L+FEHV+  D      KV  P L    ++  + +
Sbjct: 59  FDHPNIVRLMDVCATSRTDRETKV-TLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQ 116

Query: 237 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 296
            L+ LD+ H+  I+HRD+KP N+++     +++L D+GLA  Y         V + +++ 
Sbjct: 117 FLRGLDFLHANCIVHRDLKPENILVT-SGGQVKLADFGLARIYSCQMALTPVVVTLWYRA 175

Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---TDELNA 353
           PE+L+    Y   +D+WS+GC+FA M FR++P F G+   DQL KI  ++G    D+   
Sbjct: 176 PEVLLQ-STYATPVDMWSVGCIFAEM-FRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 233

Query: 354 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPE----AVDFLDKLLRYDHQER 409
            +        P           +P             VPE        L ++L ++  +R
Sbjct: 234 DVTLPRGAFSP--------RGPRPVQSV---------VPEIEESGAQLLLEMLTFNPHKR 276

Query: 410 PTAKEAMAHPYF 421
            +A  A+ HP+F
Sbjct: 277 ISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  117 bits (294), Expect = 2e-29
 Identities = 90/313 (28%), Positives = 159/313 (50%), Gaps = 24/313 (7%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPN 190
           Y++   +G+G Y  V   +     EK  IK +  V        +I REIK+L+ L   P+
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLR-LLRHPD 60

Query: 191 IVKLLDIV---RDQQSKTPSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYCH 245
           IV++  I+     ++ K   ++FE + +   +V+     L+    ++++Y+LL+AL Y H
Sbjct: 61  IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH 120

Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV----RVASRYFKGPELLV 301
           +  + HRD+KP N++ + +  KL++ D+GLA          +     VA+R+++ PEL  
Sbjct: 121 TANVFHRDLKPKNILANADC-KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 179

Query: 302 DL-QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 360
                Y  ++D+WS+GC+FA ++  K P F G +   QL  I  +LGT          + 
Sbjct: 180 SFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKNVVHQLDLITDLLGTPSPETISRVRNE 238

Query: 361 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 420
           +   +L+++  +       KF   +      P A+  L++LL +D ++RPTA+EA+A PY
Sbjct: 239 KARRYLSSMRKKQPVPFSQKFPNAD------PLALRLLERLLAFDPKDRPTAEEALADPY 292

Query: 421 FFPIRNAESSRSR 433
           F  +   E   S 
Sbjct: 293 FKGLAKVEREPSA 305

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  115 bits (289), Expect = 2e-29
 Identities = 90/315 (28%), Positives = 163/315 (51%), Gaps = 50/315 (15%)

Query: 130 WGEQDDYEVVRKVGRGKYSEVFEG-VHCTDNEKCIIKILKPVKKKKIK-------REIKI 181
           +G+ + Y  + K+G G Y+ VF+G    T+N    +  LK ++ +  +       RE+ +
Sbjct: 1   FGKLETYVKLDKLGEGTYATVFKGRSKLTEN----LVALKEIRLEHEEGAPCTAIREVSL 56

Query: 182 LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPT----LSDYDVRYYIYEL 237
           L+NL    NIV L DI+  ++  T  L+FE++++ D K         +S ++V+ ++++L
Sbjct: 57  LKNL-KHANIVTLHDIIHTERCLT--LVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQL 112

Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKG 296
           L+ L YCH + I+HRD+KP N++I+ E+ +L+L D+GLA     P K Y+  V + +++ 
Sbjct: 113 LRGLSYCHKRKILHRDLKPQNLLIN-EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRP 171

Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 356
           P++L+   +Y   +D+W +GC+   M   + P F G    ++L  I ++LGT        
Sbjct: 172 PDVLLGSTEYSTPIDMWGVGCILYEMATGR-PMFPGSTVKEELHLIFRLLGT-------- 222

Query: 357 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVP----------EAVDFLDKLLRYDH 406
                  P      G  S + +  ++    Q+ A P          + +D L  LL Y+ 
Sbjct: 223 -------PTEETWPGITSNEEFRSYLF--PQYRAQPLINHAPRLDTDGIDLLSSLLLYET 273

Query: 407 QERPTAKEAMAHPYF 421
           + R +A+ A+ H YF
Sbjct: 274 KSRISAEAALRHSYF 288

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  113 bits (285), Expect = 6e-29
 Identities = 72/292 (24%), Positives = 120/292 (41%), Gaps = 55/292 (18%)

Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--------KKIKREIKILQNLCGGPNIVK 193
           +G G +  V+EG++  D +   +K +             K++++EI +L  L   PNIV+
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQH-PNIVQ 66

Query: 194 LLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCHSQGIM 250
            L   R+       +  E V       L   Y +  +  +R Y  ++L  L+Y H +  +
Sbjct: 67  YLGTERE--EDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTV 124

Query: 251 HRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSL 310
           HRD+K  N+++D     ++L D+G+A+             S Y+  PE++     Y  + 
Sbjct: 125 HRDIKGANILVDTNG-VVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAA 183

Query: 311 DLWSLGCMFAGMIFRKEPF--FYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAA 368
           D+WSLGC    M   K P+    G      + KI +           +K    +  HL+ 
Sbjct: 184 DIWSLGCTVLEMATGKPPWSQLEG---VAAVFKIGR-----------SKELPPIPDHLS- 228

Query: 369 LVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 420
                                   EA DF+ K L+ D   RPTA E + HP+
Sbjct: 229 -----------------------DEAKDFILKCLQRDPSLRPTAAELLEHPF 257

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  114 bits (287), Expect = 9e-29
 Identities = 94/324 (29%), Positives = 149/324 (45%), Gaps = 57/324 (17%)

Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKKKKIK----REIKILQNLC 186
           E   YE + K+G+G + EVF+  H    +   +K +L   +K+       REIKILQ L 
Sbjct: 10  EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLL- 68

Query: 187 GGPNIVKLLDIVRDQQSK------TPSLIFE---H-----VNNTDFKVLYPTLSDYDVRY 232
              N+V L++I R + +       +  L+FE   H     ++N + K    TLS+  ++ 
Sbjct: 69  KHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKF---TLSE--IKK 123

Query: 233 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-----YNV 287
            +  LL  L Y H   I+HRD+K  N++I  +   L+L D+GLA  +   K      Y  
Sbjct: 124 VMKMLLNGLYYIHRNKILHRDMKAANILITKDG-ILKLADFGLARAFSLSKNSKPNRYTN 182

Query: 288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG 347
           RV + +++ PELL+  +DY   +D+W  GC+ A M  R  P   G+    QL  I+++ G
Sbjct: 183 RVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTR-SPIMQGNTEQHQLTLISQLCG 241

Query: 348 TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPE----------AVDF 397
           +     +     +EL               + K    + Q   V E          A+D 
Sbjct: 242 SITPEVWPGVDKLEL---------------FKKMELPQGQKRKVKERLKPYVKDPHALDL 286

Query: 398 LDKLLRYDHQERPTAKEAMAHPYF 421
           +DKLL  D  +R  A  A+ H +F
Sbjct: 287 IDKLLVLDPAKRIDADTALNHDFF 310

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  105 bits (264), Expect = 6e-26
 Identities = 78/296 (26%), Positives = 131/296 (44%), Gaps = 62/296 (20%)

Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR---------EIKILQNLCGGPNIV 192
           +G+G + +V         +   +K+LK   KKKI +         E  IL  +   P IV
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLK---KKKIIKRKEVEHTLTERNILSRINH-PFIV 56

Query: 193 KLLDIVRDQQSKTPSLIFEHVNNTD-FKVLY--PTLSDYDVRYYIYELLKALDYCHSQGI 249
           KL    + ++     L+ E+    + F  L      S+   R+Y  E++ AL+Y HS GI
Sbjct: 57  KLHYAFQTEEKL--YLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGI 114

Query: 250 MHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 308
           ++RD+KP N+++D     ++L D+GLA E    G   N    +  +  PE+L   + Y  
Sbjct: 115 IYRDLKPENILLD-ADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVL-LGKGYGK 172

Query: 309 SLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAA 368
           ++D WSLG +   M+  K PF+   ++  ++ +  K+L  D L                 
Sbjct: 173 AVDWWSLGVLLYEMLTGKPPFY--AEDRKEIYE--KIL-KDPLR---------------- 211

Query: 369 LVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEA---MAHPYF 421
                    + +F++        PEA D +  LL+ D  +R  +  A    AHP+F
Sbjct: 212 ---------FPEFLS--------PEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  107 bits (268), Expect = 8e-26
 Identities = 75/283 (26%), Positives = 143/283 (50%), Gaps = 28/283 (9%)

Query: 157 TDNEKCIIKILKPVKK----KKIKREIKILQNLCGGPNIVKLLDIVRDQQS----KTPSL 208
           T     I K+ +P +     K+  RE+ +++ L    NI+ LL++   Q+S    +   L
Sbjct: 40  TGQNVAIKKLSRPFQNVTHAKRAYRELVLMK-LVNHKNIIGLLNVFTPQKSLEEFQDVYL 98

Query: 209 IFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKL 268
           + E ++    +V+   L    + Y +Y++L  + + HS GI+HRD+KP N+++  +   L
Sbjct: 99  VMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TL 157

Query: 269 RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEP 328
           +++D+GLA            V +RY++ PE+++ +  Y  ++D+WS+GC+   MI R   
Sbjct: 158 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMI-RGTV 215

Query: 329 FFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALV---GRHSRKPWSKFI--- 382
            F G D+ DQ  KI + LGT   + ++++    L P +   V    +++   + +     
Sbjct: 216 LFPGTDHIDQWNKIIEQLGTPS-DEFMSR----LQPTVRNYVENRPKYAGYSFEELFPDV 270

Query: 383 -----TVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 420
                +  +  L   +A D L K+L  D ++R +  +A+ HPY
Sbjct: 271 LFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPY 313

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  104 bits (262), Expect = 2e-25
 Identities = 80/312 (25%), Positives = 137/312 (43%), Gaps = 66/312 (21%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIK--ILKPVKKKKIKREIKILQNLCGGPNIVK 193
           Y+ + K+G G   EV++       ++  IK   L+   K+ I  EI I+++ C  PNIV 
Sbjct: 21  YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKD-CKHPNIVD 79

Query: 194 LLDIVRDQQSKTPSLIFEHVNN---TDFKVLYPT---LSDYDVRYYIYELLKALDYCHSQ 247
             D           ++ E+++    TD  ++      +++  + Y   E+L+ L+Y HSQ
Sbjct: 80  YYDSYLVG--DELWVVMEYMDGGSLTD--IITQNFVRMNEPQIAYVCREVLQGLEYLHSQ 135

Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDLQDY 306
            ++HRD+K  N+++  +   ++L D+G  A+      + N  V + Y+  PE++   +DY
Sbjct: 136 NVIHRDIKSDNILLSKDGS-VKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKR-KDY 193

Query: 307 DYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL 366
              +D+WSLG M   M    EP                         YL       +P L
Sbjct: 194 GPKVDIWSLGIMCIEMA-EGEP------------------------PYLR------EPPL 222

Query: 367 AALVGRHSRKPWSKFIT------VENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 420
            AL            IT      ++N     PE  DFL+K L  D ++RP+A+E + HP+
Sbjct: 223 RAL----------FLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPF 272

Query: 421 FFPIRNAESSRS 432
              ++ A     
Sbjct: 273 ---LKKACPKEE 281

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  102 bits (256), Expect = 6e-25
 Identities = 77/304 (25%), Positives = 137/304 (45%), Gaps = 67/304 (22%)

Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK-----IKREIKILQNLCGGP 189
           +Y++   +GRG +  V++G++    +   IK +   K K+     I +EI +L+NL   P
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNL-KHP 59

Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD------VRYYIYELLKALDY 243
           NIVK +  +    S    +I E+  N     L   +  +       V  Y+Y++L+ L Y
Sbjct: 60  NIVKYIGSIETSDSL--YIILEYAENGS---LRQIIKKFGPFPESLVAVYVYQVLQGLAY 114

Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVD 302
            H QG++HRD+K  N++   +   ++L D+G+A +     K+    V + Y+  PE +++
Sbjct: 115 LHEQGVIHRDIKAANILTTKDG-VVKLADFGVATKLNDVSKDDASVVGTPYWMAPE-VIE 172

Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 362
           +     + D+WSLGC    ++    P++                              +L
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGNPPYY------------------------------DL 202

Query: 363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAV-----DFLDKLLRYDHQERPTAKEAMA 417
           +P  AAL           F  V++ H  +PE +     DFL +  + D   RPTAK+ + 
Sbjct: 203 NPM-AAL-----------FRIVQDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250

Query: 418 HPYF 421
           HP+ 
Sbjct: 251 HPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score =  104 bits (260), Expect = 8e-25
 Identities = 77/305 (25%), Positives = 149/305 (48%), Gaps = 30/305 (9%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEK------CIIKILKPVKK----KKIKREIKILQNL 185
           Y+ ++ +G G      +G+ C   +        + K+ +P +     K+  RE+ +L+ +
Sbjct: 23  YQQLKPIGSGA-----QGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCV 77

Query: 186 CGGPNIVKLLDIVRDQQS----KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKAL 241
               NI+ LL++   Q+S    +   L+ E ++    +V++  L    + Y +Y++L  +
Sbjct: 78  -NHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGI 136

Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 301
            + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++
Sbjct: 137 KHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRAPEVIL 195

Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN----- 356
            +  Y  ++D+WS+GC+   ++ +    F G D+ DQ  K+ + LGT     ++N     
Sbjct: 196 GMG-YKENVDIWSVGCIMGELV-KGSVIFQGTDHIDQWNKVIEQLGTPSAE-FMNRLQPT 252

Query: 357 -KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEA 415
            + ++E  P    +        W      E   L   +A D L K+L  D  +R +  EA
Sbjct: 253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEA 312

Query: 416 MAHPY 420
           + HPY
Sbjct: 313 LRHPY 317

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  104 bits (260), Expect = 9e-25
 Identities = 81/322 (25%), Positives = 140/322 (43%), Gaps = 62/322 (19%)

Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-----------------REIKILQN 184
           +G G Y +V +       +   IK +K ++                      RE+KI+  
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 185 LCGGPNIVKLLD---------IVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIY 235
           +    NI+ L+D         +V D  +     +       D K+    L++  V+  + 
Sbjct: 77  I-KHENIMGLVDVYVEGDFINLVMDIMASDLKKVV------DRKIR---LTESQVKCILL 126

Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA---------------EFYH 280
           ++L  L+  H    MHRD+ P N+ I+  +   ++ D+GLA               E   
Sbjct: 127 QILNGLNVLHKWYFMHRDLSPANIFIN-SKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185

Query: 281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
             +E   +V + +++ PELL+  + Y +++D+WS+GC+FA ++  K P F G +  DQL 
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK-PLFPGENEIDQLG 244

Query: 341 KIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDK 400
           +I ++LGT   + +     + L            RKP        N   A  +A+D L  
Sbjct: 245 RIFELLGTPNEDNWPQAKKLPLYTEFTP------RKPKDLKTIFPN---ASDDAIDLLQS 295

Query: 401 LLRYDHQERPTAKEAMAHPYFF 422
           LL+ +  ER +AKEA+ H YF 
Sbjct: 296 LLKLNPLERISAKEALKHEYFK 317

Length = 335

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  102 bits (256), Expect = 9e-25
 Identities = 57/223 (25%), Positives = 107/223 (47%), Gaps = 23/223 (10%)

Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLCGGP 189
            YE+++++G+G + +V+     +D +  ++K      +   +++    E+KIL+ L   P
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKL-NHP 59

Query: 190 NIVKLLDIVRDQQSKTPSLIF-EHVNNTD-------FKVLYPTLSDYDVRYYIYELLKAL 241
           NI+K  +     + K    I  E+ +  D        K       +  +  +  +L  AL
Sbjct: 60  NIIKYYE---SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116

Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELL 300
            Y HS+ I+HRD+KP N+ +      ++L D+G+++      +     V + Y+  PEL 
Sbjct: 117 KYLHSRKILHRDIKPQNIFLTSNG-LVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELC 175

Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV-KI 342
            + + Y+Y  D+WSLGC+   +   K PF    +N  +L  KI
Sbjct: 176 QN-KPYNYKSDIWSLGCVLYELCTLKHPF--EGENLLELALKI 215

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score =  100 bits (251), Expect = 1e-23
 Identities = 86/306 (28%), Positives = 149/306 (48%), Gaps = 32/306 (10%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCT------DNEKCIIKILKPVKK----KKIKREIKILQNL 185
           Y+ ++ +G G      +G+ C       D    I K+ +P +     K+  RE+ +L   
Sbjct: 19  YQNLKPIGSGA-----QGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYREL-VLMKC 72

Query: 186 CGGPNIVKLLDIVRDQQS----KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKAL 241
               NI+ LL++   Q+S    +   L+ E ++    +V+   L    + Y +Y++L  +
Sbjct: 73  VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 132

Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 301
            + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 191

Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT------DELNAYL 355
            +  Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ + LGT       +L   +
Sbjct: 192 GM-GYKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249

Query: 356 NKYHIELDPHLAALVGRHSRKPWSKF-ITVENQHLAVPEAVDFLDKLLRYDHQERPTAKE 414
             Y +E  P  A L       P S F    E+  L   +A D L K+L  D  +R +  E
Sbjct: 250 RNY-VENRPKYAGLT-FPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDE 307

Query: 415 AMAHPY 420
           A+ HPY
Sbjct: 308 ALQHPY 313

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 98.1 bits (245), Expect = 3e-23
 Identities = 71/307 (23%), Positives = 123/307 (40%), Gaps = 58/307 (18%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNI 191
             +E+V  +G G Y +V++  H    +   IKI+  ++  +++IK E  IL+     PNI
Sbjct: 6   GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNI 65

Query: 192 VKL--LDIVRDQQSKTPSLIF-----------EHVNNTDFKVLYPTLSDYDVRYYIYELL 238
                  I ++       L             + V     +     L +  + Y + E L
Sbjct: 66  ATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGL--RKKGKRLKEEWIAYILRETL 123

Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGP 297
           + L Y H   ++HRD+K  N+++      ++L+D+G+ A+        N  + + Y+  P
Sbjct: 124 RGLAYLHENKVIHRDIKGQNILLTKNAE-VKLVDFGVSAQLDSTLGRRNTFIGTPYWMAP 182

Query: 298 E-LLVDLQD---YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 353
           E +  D Q    YD   D+WSLG     +   K P    H     L KI +         
Sbjct: 183 EVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-RALFKIPR--------- 232

Query: 354 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK 413
             N       P L       S + WSK            +  DF+ + L  ++++RP  +
Sbjct: 233 --NP-----PPTLK------SPENWSK------------KFNDFISECLIKNYEQRPFME 267

Query: 414 EAMAHPY 420
           E + HP+
Sbjct: 268 ELLEHPF 274

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 98.2 bits (245), Expect = 7e-23
 Identities = 63/205 (30%), Positives = 101/205 (49%), Gaps = 18/205 (8%)

Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGG 188
           D++++ +VG+G Y +VF        E   +K +K        + + +  E  IL      
Sbjct: 2   DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTT-TKS 60

Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCH 245
             +VKLL   +D +     L  E+V   DF+ L      LS+   R+Y+ E+ +A+D  H
Sbjct: 61  EWLVKLLYAFQDDEYLY--LAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALH 118

Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLVDLQ 304
             G +HRD+KP N +ID     ++L D+GL++       Y N  V S  +  PE+L   +
Sbjct: 119 ELGYIHRDLKPENFLIDASGH-IKLTDFGLSK---GIVTYANSVVGSPDYMAPEVLRG-K 173

Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPF 329
            YD+++D WSLGCM    +    PF
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCGFPPF 198

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 96.6 bits (241), Expect = 9e-23
 Identities = 72/298 (24%), Positives = 139/298 (46%), Gaps = 52/298 (17%)

Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--KKIKREIKILQNLCGGPN 190
           ++ ++++ K+G G Y  V++ +H    +   IK++ PV++  ++I +EI IL+  C  P 
Sbjct: 2   EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVV-PVEEDLQEIIKEISILKQ-CDSPY 59

Query: 191 IVKLLDIVRDQQSKTPSLIFEH-----VNNTDFKVLYPTLSDYDVRYYIYELLKALDYCH 245
           IVK        ++    ++ E+     V++   K+   TL++ ++   +Y+ LK L+Y H
Sbjct: 60  IVKYYGSY--FKNTDLWIVMEYCGAGSVSDI-MKITNKTLTEEEIAAILYQTLKGLEYLH 116

Query: 246 SQGIMHRDVKPHNVMIDHE-QRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDL 303
           S   +HRD+K  N++++ E Q K  L D+G++ +      + N  + + ++  PE++ + 
Sbjct: 117 SNKKIHRDIKAGNILLNEEGQAK--LADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE- 173

Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363
             Y+   D+WSLG     M   K P+                               ++ 
Sbjct: 174 IGYNNKADIWSLGITAIEMAEGKPPYS------------------------------DIH 203

Query: 364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
           P  A  +  +   P     T+ +     PE  DF+ K L  D +ERP+A + + HP+ 
Sbjct: 204 PMRAIFMIPNKPPP-----TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 97.8 bits (243), Expect = 2e-22
 Identities = 79/309 (25%), Positives = 146/309 (47%), Gaps = 38/309 (12%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCT------DNEKCIIKILKPVKK----KKIKREIKILQNL 185
           Y+ ++ +G G      +G+ C       +    I K+ +P +     K+  RE+ +L   
Sbjct: 26  YQNLKPIGSGA-----QGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYREL-VLMKC 79

Query: 186 CGGPNIVKLLDIVRDQQS----KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKAL 241
               NI+ LL++   Q+S    +   ++ E ++    +V+   L    + Y +Y++L  +
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139

Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 301
            + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198

Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 361
            +  Y  ++D+WS+GC+   MI      F G D+ DQ  K+ + LGT        ++  +
Sbjct: 199 GM-GYKENVDIWSVGCIMGEMIKGG-VLFPGTDHIDQWNKVIEQLGTP-----CPEFMKK 251

Query: 362 LDPHLAALVGRHSRKPWSKFITV----------ENQHLAVPEAVDFLDKLLRYDHQERPT 411
           L P +   V    +     F  +          E+  L   +A D L K+L  D  +R +
Sbjct: 252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS 311

Query: 412 AKEAMAHPY 420
             EA+ HPY
Sbjct: 312 VDEALQHPY 320

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 95.6 bits (238), Expect = 3e-22
 Identities = 60/227 (26%), Positives = 110/227 (48%), Gaps = 22/227 (9%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCI----IKILKPVKKK---KIKREIKILQNLC 186
            ++++ +K+G+G++S V++ + C  + + +    ++I + +  K      +EI +L+ L 
Sbjct: 2   GNFKIEKKIGKGQFSVVYKAI-CLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL- 59

Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-------FKVLYPTLSDYDVRYYIYELLK 239
             PN++K L    +       ++ E  +  D       FK     + +  +  Y  +L  
Sbjct: 60  DHPNVIKYLASFIENNELN--IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCS 117

Query: 240 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPE 298
           AL++ HS+ IMHRD+KP NV I      ++L D GL  F+       +  V + Y+  PE
Sbjct: 118 ALEHMHSKRIMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176

Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN-YDQLVKIAK 344
            + +   Y++  D+WSLGC+   M   + PF+    N Y    KI K
Sbjct: 177 RIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEK 222

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 95.4 bits (238), Expect = 3e-22
 Identities = 78/303 (25%), Positives = 126/303 (41%), Gaps = 66/303 (21%)

Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR--------EIKILQNLCGGPNIVK 193
           + +G Y  VF     +  +   IK++K  K   I++        E  IL      P +VK
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIK--KADMIRKNQVDQVLTERDILSQ-AQSPYVVK 57

Query: 194 LLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCHSQGIM 250
           L      Q  K   L+ E++   D   L     +L +   R YI E++ AL+Y HS GI+
Sbjct: 58  LYYSF--QGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGII 115

Query: 251 HRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASR---------YFKGPELLV 301
           HRD+KP N++ID     L+L D+GL++     ++ N+    +          +  PE+++
Sbjct: 116 HRDLKPDNILIDSNG-HLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL 174

Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 361
             Q +  ++D WSLGC+    +    PF   H    + +    +L          K    
Sbjct: 175 -GQGHSKTVDWWSLGCILYEFLVGIPPF---HGETPEEI-FQNILN--------GKI--- 218

Query: 362 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK---EAMAH 418
                           W + + V        EA+D + KLL  D ++R  AK   E   H
Sbjct: 219 ---------------EWPEDVEVS------DEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257

Query: 419 PYF 421
           P+F
Sbjct: 258 PFF 260

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 95.1 bits (237), Expect = 3e-22
 Identities = 79/300 (26%), Positives = 131/300 (43%), Gaps = 57/300 (19%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVKKKKIK---REIKILQNLCGG 188
           +E++R +G+G + +V         +    K + K  K V+K  ++    E +ILQ L   
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQ-KCVEKGSVRNVLNERRILQEL-NH 59

Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDY 243
           P +V L    +D+++    L+ + +   D +  Y        S+  V+++I E++ AL+Y
Sbjct: 60  PFLVNLWYSFQDEENMY--LVVDLLLGGDLR--YHLSQKVKFSEEQVKFWICEIVLALEY 115

Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 303
            HS+GI+HRD+KP N+++D EQ  + + D+ +A    P         +  +  PE+L   
Sbjct: 116 LHSKGIIHRDIKPDNILLD-EQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCR- 173

Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363
           Q Y  ++D WSLG      +  K P + GH    +    AK    D L            
Sbjct: 174 QGYSVAVDWWSLGVTAYECLRGKRP-YRGHSRTIRDQIRAKQETADVL------------ 220

Query: 364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQER--PTAKEAMAHPYF 421
                         WS             EA+D ++KLL  D Q+R     K+   HPYF
Sbjct: 221 ----------YPATWST------------EAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 93.2 bits (231), Expect = 4e-21
 Identities = 80/316 (25%), Positives = 151/316 (47%), Gaps = 41/316 (12%)

Query: 141 KVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK----REIKILQNLCGGPNIVKLLD 196
           KVGRG Y  V++     D +      LK ++   I     REI +L+ L   PN++ L  
Sbjct: 8   KVGRGTYGHVYKAKR-KDGKDDRDYALKQIEGTGISMSACREIALLREL-KHPNVISLQK 65

Query: 197 IVRDQQSKTPSLIFEHVNNTDFKVLY-----------PTLSDYDVRYYIYELLKALDYCH 245
           +      +   L+F++  +  + ++              L    V+  +Y++L  + Y H
Sbjct: 66  VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125

Query: 246 SQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYH----PGKEYNVRVASRYFKGPE 298
           +  ++HRD+KP N+++     E+ ++++ D G A  ++    P  + +  V + +++ PE
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185

Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD---------NYDQLVKIAKVLGTD 349
           LL+  + Y  ++D+W++GC+FA ++   EP F+            ++DQL +I  V+G  
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG-- 242

Query: 350 ELNAYLNKYHIELDPHLAALVGRHSRKPWSK--FITVENQHLAVPEAVDF--LDKLLRYD 405
              A  +   I+  P  + L+    R  ++    I    +H   P++  F  L KLL  D
Sbjct: 243 -FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMD 301

Query: 406 HQERPTAKEAMAHPYF 421
             +R T+++AM  PYF
Sbjct: 302 PIKRITSEQAMQDPYF 317

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 91.0 bits (226), Expect = 8e-21
 Identities = 76/296 (25%), Positives = 127/296 (42%), Gaps = 55/296 (18%)

Query: 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKI---KREIKILQNLCGGPNIV 192
           ++ + +G +  V+     +  +   IK+LK    + K ++   K E  I+      P + 
Sbjct: 1   LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60

Query: 193 KLLDIVRDQQSKTP-SLIFEHVNNTDFKVLYPT---LSDYDVRYYIYELLKALDYCHSQG 248
           KL       QSK    L+ E++N  D   L  T   L +   + YI E++  ++  H +G
Sbjct: 61  KLYYSF---QSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG 117

Query: 249 IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 308
           I+HRD+KP N++ID +   L+L D+GL+      K++   V +  +  PE ++ + D D 
Sbjct: 118 IIHRDIKPENLLID-QTGHLKLTDFGLSRNGLENKKF---VGTPDYLAPETILGVGD-DK 172

Query: 309 SLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAA 368
             D WSLGC+    +F   PF   H      V    +L                      
Sbjct: 173 MSDWWSLGCVIFEFLFGYPPF---HAETPDAV-FDNIL---------------------- 206

Query: 369 LVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK---EAMAHPYF 421
                 R  W + +    +    PEAVD +++LL  D  +R  A    E  +HP+F
Sbjct: 207 ----SRRINWPEEV----KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFF 254

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 90.9 bits (225), Expect = 2e-20
 Identities = 80/316 (25%), Positives = 148/316 (46%), Gaps = 41/316 (12%)

Query: 141 KVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK----REIKILQNLCGGPNIVKLLD 196
           KVGRG Y  V++     D +      LK ++   I     REI +L+ L   PN++ L  
Sbjct: 8   KVGRGTYGHVYKAKR-KDGKDEKEYALKQIEGTGISMSACREIALLREL-KHPNVIALQK 65

Query: 197 IVRDQQSKTPSLIFEHVNNTDFKVLY-----------PTLSDYDVRYYIYELLKALDYCH 245
           +      +   L+F++  +  + ++              L    V+  +Y++L  + Y H
Sbjct: 66  VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125

Query: 246 SQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYH----PGKEYNVRVASRYFKGPE 298
           +  ++HRD+KP N+++     E+ ++++ D G A  ++    P  + +  V + +++ PE
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185

Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD---------NYDQLVKIAKVLGTD 349
           LL+  + Y  ++D+W++GC+FA ++   EP F+            ++DQL +I  V+G  
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMG-- 242

Query: 350 ELNAYLNKYHIELDPHLAALVGRHSRKPW--SKFITVENQHLAVPEAVDF--LDKLLRYD 405
              A  +   I   P    L     R  +  S  I    +H   P++  F  L KLL  D
Sbjct: 243 -FPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMD 301

Query: 406 HQERPTAKEAMAHPYF 421
             +R T+++A+  PYF
Sbjct: 302 PTKRITSEQALQDPYF 317

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 89.3 bits (222), Expect = 4e-20
 Identities = 82/308 (26%), Positives = 126/308 (40%), Gaps = 77/308 (25%)

Query: 140 RKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVKK--KKIKREIKILQNLCGGPNIVK 193
            K+G G + +V+  V+    E    K  I+I     K  K+I  E+K+L+ L   PN+VK
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVK-EIRIQDNDPKTIKEIADEMKVLELL-KHPNLVK 63

Query: 194 L--LDIVRDQ--------QSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDY 243
              +++ R++           T   + EH    D  V         +R Y  +LL+ L Y
Sbjct: 64  YYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHV---------IRVYTLQLLEGLAY 114

Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------- 296
            HS GI+HRD+KP N+ +DH    ++L D+G A                  +        
Sbjct: 115 LHSHGIVHRDIKPANIFLDHNG-VIKLGDFGCAVKLKNNT----TTMGEEVQSLAGTPAY 169

Query: 297 --PELLV--DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELN 352
             PE++     + +  + D+WSLGC+   M   K P+       D   +I          
Sbjct: 170 MAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPW----SELDNEFQIM--------- 216

Query: 353 AYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA 412
                +H          VG   + P    I    Q    PE  DFLD+ L  D ++RPTA
Sbjct: 217 -----FH----------VGAGHKPP----IPDSLQ--LSPEGKDFLDRCLESDPKKRPTA 255

Query: 413 KEAMAHPY 420
            E + HP+
Sbjct: 256 SELLQHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 88.1 bits (219), Expect = 8e-20
 Identities = 70/301 (23%), Positives = 123/301 (40%), Gaps = 54/301 (17%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVKKKKIKREIKILQNLCGGP 189
           DD E + ++G G    V + +H    +    K I   +    +K+I RE+ IL   C  P
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHK-CNSP 59

Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYI----YELLKALDYCH 245
            IV       +      S+  E+++      +   +        +      +LK L Y H
Sbjct: 60  YIVGFYGAFYNNG--DISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH 117

Query: 246 SQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN----VRVASRYFKGPELL 300
            +  I+HRDVKP N++++  + +++L D+G++     G+  N      V +  +  PE +
Sbjct: 118 EKHKIIHRDVKPSNILVNS-RGQIKLCDFGVS-----GQLVNSLAKTFVGTSSYMAPERI 171

Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 360
               DY    D+WSLG     +   + P+   +D  D +         + L   +N    
Sbjct: 172 QGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIF--------ELLQYIVN---- 218

Query: 361 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 420
           E  P L +         +S            P+  DF++  L  D +ERP+ KE + HP+
Sbjct: 219 EPPPRLPS-------GKFS------------PDFQDFVNLCLIKDPRERPSYKELLEHPF 259

Query: 421 F 421
            
Sbjct: 260 I 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 87.2 bits (216), Expect = 2e-19
 Identities = 74/301 (24%), Positives = 129/301 (42%), Gaps = 64/301 (21%)

Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKIL-------KPVKKKK-----IKREIKILQNLCGGP 189
           +G G +  V+ G++ +  E   +K +           +K+     + REI +L+ L    
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-QHE 66

Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCHS 246
           NIV+ L    D       +  E+V       L   Y    +  VR ++ ++LK L+Y H+
Sbjct: 67  NIVQYLGSSLDADHLN--IFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124

Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASR-------YFKGPEL 299
           +GI+HRD+K  N+++D++   +++ D+G+++             +R       ++  PE 
Sbjct: 125 RGIIHRDIKGANILVDNKG-GIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE- 182

Query: 300 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 359
           +V    Y    D+WSLGC+   M+  K PF     +  QL  I K               
Sbjct: 183 VVKQTSYTRKADIWSLGCLVVEMLTGKHPF----PDCTQLQAIFK--------------- 223

Query: 360 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHP 419
                     +G ++       I+         EA+DFL+K    DH +RPTA E + HP
Sbjct: 224 ----------IGENASPEIPSNISS--------EAIDFLEKTFEIDHNKRPTAAELLKHP 265

Query: 420 Y 420
           +
Sbjct: 266 F 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 88.1 bits (219), Expect = 3e-19
 Identities = 84/342 (24%), Positives = 134/342 (39%), Gaps = 102/342 (29%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKI-----------KREIKIL 182
           DD+EV++ +GRG + EV+      D +   +  +K ++K  +           +R+I   
Sbjct: 1   DDFEVIKVIGRGAFGEVWL---VRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILAD 57

Query: 183 QNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDV------RYYIYE 236
            +    P IVKL    +D++     L+ E++   D   L   L   DV      R+YI E
Sbjct: 58  AD---SPWIVKLYYSFQDEEHLY--LVMEYMPGGDLMNL---LIRKDVFPEETARFYIAE 109

Query: 237 LLKALDYCHSQGIMHRDVKPHNVMID---HEQRKLRLIDWGLA----------------- 276
           L+ ALD  H  G +HRD+KP N++ID   H    ++L D+GL                  
Sbjct: 110 LVLALDSVHKLGFIHRDIKPDNILIDADGH----IKLADFGLCKKMNKAKDREYYLNDSH 165

Query: 277 ---------EFYHPGKEYNVR----VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI 323
                          K+  VR    V +  +  PE+L     Y    D WSLG +   M+
Sbjct: 166 NLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEML 224

Query: 324 FRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFIT 383
           +   PF+                 +D L    NK                    W + + 
Sbjct: 225 YGFPPFY-----------------SDTLQETYNKII-----------------NWKESLR 250

Query: 384 VENQHLAVPEAVDFLDKLLRYDHQER-PTAKEAMAHPYFFPI 424
                   PEA+D + +LL  D ++R  + +E  +HP+F  I
Sbjct: 251 FPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 83.9 bits (207), Expect = 3e-18
 Identities = 57/211 (27%), Positives = 106/211 (50%), Gaps = 21/211 (9%)

Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKC------IIKILKPVKKKKIKREIKILQNLCGG 188
           ++++ +K+GRG++SEV+      D +        I +++    ++   +EI +L+ L   
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NH 61

Query: 189 PNIVKLLD-IVRDQQSKTPSLIFEHVNNTD-------FKVLYPTLSDYDVRYYIYELLKA 240
           PN++K LD  + D +    +++ E  +  D       FK     + +  V  Y  +L  A
Sbjct: 62  PNVIKYLDSFIEDNEL---NIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA 118

Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVRVASRYFKGPEL 299
           +++ HS+ +MHRD+KP NV I      ++L D GL  F+       +  V + Y+  PE 
Sbjct: 119 VEHMHSRRVMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177

Query: 300 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
           + +   Y++  D+WSLGC+   M   + PF+
Sbjct: 178 IHE-NGYNFKSDIWSLGCLLYEMAALQSPFY 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 83.1 bits (206), Expect = 6e-18
 Identities = 67/256 (26%), Positives = 113/256 (44%), Gaps = 28/256 (10%)

Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-----ILKPVKKKKIKREIKILQNLCGGP 189
           DYEV+  +G+G +  V +    +D +  + K      +   +K+++  E+ IL+ L   P
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILREL-KHP 59

Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIY----ELLKALD 242
           NIV+  D + D+ ++T  ++ E+    D   L         Y    +I+    +LL AL 
Sbjct: 60  NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119

Query: 243 YCH-----SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKG 296
            CH        ++HRD+KP N+ +D     ++L D+GLA+       +    V + Y+  
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLD-ANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMS 178

Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF-YGHDNYDQLVKIAKVLG-----TDE 350
           PE L     YD   D+WSLGC+   +     PF           +K  K        + E
Sbjct: 179 PEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSE 237

Query: 351 LNAYLNKYHIELDPHL 366
           LN  + K  + +DP  
Sbjct: 238 LNEVI-KSMLNVDPDK 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 83.3 bits (206), Expect = 6e-18
 Identities = 74/300 (24%), Positives = 121/300 (40%), Gaps = 63/300 (21%)

Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR---------EIKILQNLCGGPNIV 192
           +G+G + EV          K  +   K + KK++K+         E KIL+       IV
Sbjct: 1   LGKGGFGEVC-ACQVKATGK--MYACKKLDKKRLKKRKGEQMALNEKKILE-KVSSRFIV 56

Query: 193 KLLDIVRDQQSKTP-SLIFEHVNNTDFK-----VLYPTLSDYDVRYYIYELLKALDYCHS 246
            L       ++K    L+   +N  D K     V  P   +    +Y  +++  L++ H 
Sbjct: 57  SL---AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ 113

Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 306
           + I++RD+KP NV++D +   +R+ D GLA     GK+   R  +  +  PE+L   + Y
Sbjct: 114 RRIVYRDLKPENVLLD-DHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQG-EVY 171

Query: 307 DYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL 366
           D+S+D ++LGC    MI  + PF                           K         
Sbjct: 172 DFSVDWFALGCTLYEMIAGRSPF----------------------RQRKEK--------- 200

Query: 367 AALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQER-----PTAKEAMAHPYF 421
              V +   K  +  + VE      PEA D  + LL+ D ++R      +A E   HP F
Sbjct: 201 ---VEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLF 257

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 81.6 bits (201), Expect = 3e-17
 Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 18/200 (9%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--KKIKREIKILQNLCGGPNI 191
           D +E++  +G+G Y +V++  +  D     +KIL P+    ++I+ E  ILQ+L   PN+
Sbjct: 22  DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNV 81

Query: 192 VKLLDIVRDQQSKTPS---LIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKAL 241
           VK   +             L+ E  N      L          L +  + Y +Y  L  L
Sbjct: 82  VKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGL 141

Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELL 300
            + H+  I+HRDVK +N+++  E   ++L+D+G+ A+        N  V + ++  PE++
Sbjct: 142 QHLHNNRIIHRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVI 200

Query: 301 VDLQDYDYSL----DLWSLG 316
              Q YDYS     D+WSLG
Sbjct: 201 ACEQQYDYSYDARCDVWSLG 220

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 80.7 bits (200), Expect = 3e-17
 Identities = 66/305 (21%), Positives = 128/305 (41%), Gaps = 50/305 (16%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGGP 189
            D E V+ +G+G    V++  H    +   +K +        +K++ RE+K L++ C  P
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRS-CESP 59

Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKALDYCHS 246
            +VK        +    S++ E+++     D       + +  + Y   ++LK LDY H+
Sbjct: 60  YVVKCYGAF--YKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHT 117

Query: 247 Q-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLVDLQ 304
           +  I+HRD+KP N++I+ +  ++++ D+G+++      +  N  V +  +  PE +   +
Sbjct: 118 KRHIIHRDIKPSNLLINSKG-EVKIADFGISKVLENTLDQCNTFVGTVTYMSPERI-QGE 175

Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y Y+ D+WSLG         K PF            +  +                L  
Sbjct: 176 SYSYAADIWSLGLTLLECALGKFPFLPP-GQPSFFELMQAICDGPP---------PSLPA 225

Query: 365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 424
              +                       PE  DF+   L+ D ++RP+A E + HP+   I
Sbjct: 226 EEFS-----------------------PEFRDFISACLQKDPKKRPSAAELLQHPF---I 259

Query: 425 RNAES 429
           + A++
Sbjct: 260 KKADN 264

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 80.4 bits (199), Expect = 5e-17
 Identities = 73/303 (24%), Positives = 129/303 (42%), Gaps = 57/303 (18%)

Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK---KKIKREIKILQNLCGGP 189
           Q+DYE+++++G G Y +V++       E   IK++K       + I++EI +L+  C  P
Sbjct: 2   QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKE-CRHP 60

Query: 190 NIVKLL-DIVRDQQ-------SKTPSLIFEHVNNTD-FKVLYPTLSDYDVRYYIYELLKA 240
           NIV      +R  +           SL        D ++V    LS+  + Y   E LK 
Sbjct: 61  NIVAYFGSYLRRDKLWIVMEYCGGGSL-------QDIYQVTRGPLSELQIAYVCRETLKG 113

Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPEL 299
           L Y H  G +HRD+K  N+++  E   ++L D+G+ A+      +    + + Y+  PE+
Sbjct: 114 LAYLHETGKIHRDIKGANILLT-EDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEV 172

Query: 300 LVDLQ--DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 357
               +   YD   D+W+LG     +   + P F  H          + L           
Sbjct: 173 AAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH--------PMRAL----------- 213

Query: 358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 417
                      L+ + +  P      ++++    P   DF+ K L  D ++RPTA + + 
Sbjct: 214 ----------FLISKSNFPP----PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259

Query: 418 HPY 420
           HP+
Sbjct: 260 HPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 78.9 bits (194), Expect = 2e-16
 Identities = 75/309 (24%), Positives = 129/309 (41%), Gaps = 63/309 (20%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNI 191
           D +E++  +G+G Y +VF+ ++  +  K  +KIL P+    ++I+ E  IL+ L   PN+
Sbjct: 18  DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNV 77

Query: 192 VKLLDIVRDQQSKTPS---LIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKAL 241
           VK   +   +  K      L+ E  N      L          + +  + Y ++E L  L
Sbjct: 78  VKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGL 137

Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELL 300
            + H    +HRDVK +N+++  E   ++L+D+G+ A+        N  V + ++  PE++
Sbjct: 138 QHLHVNKTIHRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVI 196

Query: 301 VDLQD----YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 356
              Q     YD   D+WSLG                                        
Sbjct: 197 ACEQQLDSTYDARCDVWSLGIT-------------------------------------- 218

Query: 357 KYHIEL---DPHLAALVGRHS--RKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT 411
              IEL   DP LA L    +  + P +   T+    L   E  DF+ K L  D+++RPT
Sbjct: 219 --AIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPT 276

Query: 412 AKEAMAHPY 420
             + + H +
Sbjct: 277 VSDLLQHVF 285

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 78.0 bits (193), Expect = 3e-16
 Identities = 65/271 (23%), Positives = 127/271 (46%), Gaps = 49/271 (18%)

Query: 161 KCIIK--ILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD- 217
           KC+ K  I++  +++ I  E +IL+  C  P IVKL    +D++     ++ E+    + 
Sbjct: 24  KCVKKRHIVETGQQEHIFSEKEILEE-CNHPFIVKLYRTFKDKKYIY--MLMEYCLGGEL 80

Query: 218 FKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL 275
           + +L       +Y  R+YI  ++ A +Y H++GI++RD+KP N+++D     ++L+D+G 
Sbjct: 81  WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGY-VKLVDFGF 139

Query: 276 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN 335
           A+    G++      +  +  PE++++ + YD+S+D WSLG +   ++  + PF  G D+
Sbjct: 140 AKKLKSGQKTWTFCGTPEYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPF--GEDD 196

Query: 336 YDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAV 395
            D +     +L             +E                +  +I           A 
Sbjct: 197 EDPMEIYNDILK--------GNGKLE----------------FPNYID--------KAAK 224

Query: 396 DFLDKLLRYDHQER-----PTAKEAMAHPYF 421
           D + +LLR + +ER        K+   H +F
Sbjct: 225 DLIKQLLRRNPEERLGNLKGGIKDIKKHKWF 255

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 77.4 bits (191), Expect = 4e-16
 Identities = 71/319 (22%), Positives = 121/319 (37%), Gaps = 83/319 (26%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGGP 189
           DDYE++  +G G  + V+  +   +NEK  IK +          ++++E++ + + C  P
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAM-SQCNHP 59

Query: 190 NIVK----------------------LLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSD 227
           N+VK                      LLDI++   S  P    +                
Sbjct: 60  NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMK---SSYPRGGLDEAI------------- 103

Query: 228 YDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPG---- 282
             +   + E+LK L+Y HS G +HRD+K  N+++  E   +++ D+G+ A     G    
Sbjct: 104 --IATVLKEVLKGLEYLHSNGQIHRDIKAGNILLG-EDGSVKIADFGVSASLADGGDRTR 160

Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKI 342
           K     V +  +  PE++  +  YD+  D+WS G     +         G   Y +    
Sbjct: 161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELA-------TGAAPYSKY-PP 212

Query: 343 AKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLL 402
            KVL    L           D            K +SK                 +   L
Sbjct: 213 MKVL-MLTLQNDPPSLETGAD-----------YKKYSK------------SFRKMISLCL 248

Query: 403 RYDHQERPTAKEAMAHPYF 421
           + D  +RPTA+E + H +F
Sbjct: 249 QKDPSKRPTAEELLKHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 76.7 bits (189), Expect = 9e-16
 Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 24/203 (11%)

Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGG--PNIVK-- 193
           +GRG Y  V+ G H        +KI+           I+RE+ +L  L     PNI K  
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 194 --LLDIVRDQQSKTPSL--IFEHVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYCHSQ 247
              L        K P L  I E+      + L     +++  +   I E+L AL Y H  
Sbjct: 69  GSYL--------KGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKV 120

Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDLQDY 306
           G++HRD+K  N+++ +    ++L D+G+ A       + +  V + Y+  PE++ + + Y
Sbjct: 121 GVIHRDIKAANILVTNTGN-VKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYY 179

Query: 307 DYSLDLWSLGCMFAGMIFRKEPF 329
           D   D+WSLG     M     P+
Sbjct: 180 DTKADIWSLGITIYEMATGNPPY 202

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 76.4 bits (188), Expect = 1e-15
 Identities = 63/260 (24%), Positives = 107/260 (41%), Gaps = 55/260 (21%)

Query: 175 IKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD----- 229
           +++EI+++  L   P+I+++L      +    +L  E +       L   LS Y      
Sbjct: 50  LRKEIRLMARL-NHPHIIRMLGAT--CEDSHFNLFVEWMAGGSVSHL---LSKYGAFKEA 103

Query: 230 -VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-----EFYHPGK 283
            +  Y  +LL+ L Y H   I+HRDVK  N++ID   ++LR+ D+G A     +    G+
Sbjct: 104 VIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE 163

Query: 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF-FYGHDNYDQLV-K 341
                + +  F  PE+L   + Y  S D+WS+GC+   M   K P+    H N+  L+ K
Sbjct: 164 FQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK 222

Query: 342 IAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKL 401
           IA       +  +L+                                   P   D   + 
Sbjct: 223 IASATTAPSIPEHLS-----------------------------------PGLRDVTLRC 247

Query: 402 LRYDHQERPTAKEAMAHPYF 421
           L    ++RP ++E + HP F
Sbjct: 248 LELQPEDRPPSRELLKHPVF 267

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 75.6 bits (186), Expect = 2e-15
 Identities = 72/305 (23%), Positives = 130/305 (42%), Gaps = 68/305 (22%)

Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKK-------------KKIKREIKILQNLCGG 188
           +G+G Y  V+  ++ T  E   +K ++                 K ++ EI+ L++L   
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL-DH 67

Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD---VRYYIYELLKALDYCH 245
            NIV+ L    +   +  S+  E+V          T   ++   VR++  ++L+ L Y H
Sbjct: 68  LNIVQYLGF--ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH 125

Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGL----AEFYHPGKEYNVRVASRYFKGPELLV 301
           S+GI+HRD+K  N+++D      ++ D+G+     + Y   +  +++  S ++  PE ++
Sbjct: 126 SKGILHRDLKADNLLVDA-DGICKISDFGISKKSDDIYDNDQNMSMQ-GSVFWMAPE-VI 182

Query: 302 DLQDYDYS--LDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 355
                 YS  +D+WSLGC    MFAG    + P+                   +E  A +
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAG----RRPW-----------------SDEEAIAAM 221

Query: 356 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEA 415
            K            +G     P    I  +      P A+DFL+     +   RPTA+E 
Sbjct: 222 FK------------LGNKRSAP---PIPPDVSMNLSPVALDFLNACFTINPDNRPTAREL 266

Query: 416 MAHPY 420
           + HP+
Sbjct: 267 LQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 59/222 (26%), Positives = 104/222 (46%), Gaps = 21/222 (9%)

Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK------ILKPVKKKKIKREIKILQNLCGG 188
           ++ + +K+GRG++SEV+      D     +K      ++    +    +EI +L+ L   
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NH 61

Query: 189 PNIVKL-LDIVRDQQSKTPSLIFEHVNNTD-------FKVLYPTLSDYDVRYYIYELLKA 240
           PN++K     + D +    +++ E  +  D       FK     + +  V  Y  +L  A
Sbjct: 62  PNVIKYYASFIEDNEL---NIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA 118

Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPEL 299
           L++ HS+ +MHRD+KP NV I      ++L D GL  F+       +  V + Y+  PE 
Sbjct: 119 LEHMHSRRVMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177

Query: 300 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 341
           + +   Y++  D+WSLGC+   M   + PF+    N   L K
Sbjct: 178 IHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK 218

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 75.5 bits (185), Expect = 3e-15
 Identities = 72/294 (24%), Positives = 129/294 (43%), Gaps = 50/294 (17%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIK---ILKPVKKKKIKREIKILQNLCGGPNIV 192
           Y    K+G+G    VF  +     ++  IK   + K  KK+ I  EI +++ L   PNIV
Sbjct: 21  YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKEL-KNPNIV 79

Query: 193 KLLD--IVRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYCHSQG 248
             LD  +V D+      ++ E++        V    + +  +     E L+AL++ H+  
Sbjct: 80  NFLDSFLVGDELF----VVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQ 135

Query: 249 IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYD 307
           ++HRD+K  NV++  +   ++L D+G      P + + +  V + Y+  PE +V  + Y 
Sbjct: 136 VIHRDIKSDNVLLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE-VVTRKAYG 193

Query: 308 YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLA 367
             +D+WSLG M   M+  + P+   ++N  + + +    GT EL                
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYL--NENPLRALYLIATNGTPEL---------------- 235

Query: 368 ALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
                            +N     P   DFL++ L  D ++R +AKE + HP+ 
Sbjct: 236 -----------------QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 74.9 bits (185), Expect = 5e-15
 Identities = 58/214 (27%), Positives = 102/214 (47%), Gaps = 32/214 (14%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL---KPVKKKK---IKREIKILQNLCG 187
           DD+E ++ +G G +  V    H    +   +KIL   K VK K+   +  E +ILQ++  
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60

Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVL--YPTLSDYDVRYYIYELLKALDYC 244
            P +V L    +D  +    L+ E+V   + F  L       +   R+Y  +++ AL+Y 
Sbjct: 61  -PFLVNLYGSFQDDSNL--YLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYL 117

Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK--------G 296
           HS  I++RD+KP N+++D     +++ D+G A           RV  R +          
Sbjct: 118 HSLDIVYRDLKPENLLLDS-DGYIKITDFGFA----------KRVKGRTYTLCGTPEYLA 166

Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
           PE+++  + Y  ++D W+LG +   M+    PFF
Sbjct: 167 PEIIL-SKGYGKAVDWWALGILIYEMLAGYPPFF 199

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 71.9 bits (177), Expect = 4e-14
 Identities = 48/193 (24%), Positives = 95/193 (49%), Gaps = 16/193 (8%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK----IKREIKILQNLCGGP 189
           + + ++  +G+G + EV++ +    N+   IK++   + +     I++EI+ L   C  P
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQ-CRSP 59

Query: 190 NIVKLLDIVRDQQSKTPSL--IFEHVNN-TDFKVLYP-TLSDYDVRYYIYELLKALDYCH 245
            I K          K   L  I E+    +   +L P  L +  + + + E+L  L+Y H
Sbjct: 60  YITKYYGSF----LKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLH 115

Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQ 304
            +G +HRD+K  N+++  E+  ++L D+G++ +      + N  V + ++  PE++    
Sbjct: 116 EEGKIHRDIKAANILLS-EEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQ-S 173

Query: 305 DYDYSLDLWSLGC 317
            YD   D+WSLG 
Sbjct: 174 GYDEKADIWSLGI 186

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 72.1 bits (177), Expect = 4e-14
 Identities = 54/196 (27%), Positives = 84/196 (42%), Gaps = 44/196 (22%)

Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR---VASRYF 294
           LKAL + H+QG++HRD+K  ++++  + R ++L D+G        KE   R   V + Y+
Sbjct: 125 LKALSFLHAQGVIHRDIKSDSILLTSDGR-VKLSDFGFCA--QVSKEVPRRKSLVGTPYW 181

Query: 295 KGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAY 354
             PE++  L  Y   +D+WSLG M   M+  + P+F                        
Sbjct: 182 MAPEVISRLP-YGTEVDIWSLGIMVIEMVDGEPPYFN----------------------- 217

Query: 355 LNKYHIELDPHLAALVG-RHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK 413
                   +P L A+   R +  P  K     N H   P    FLD++L  D  +R TA 
Sbjct: 218 --------EPPLQAMKRIRDNLPPKLK-----NLHKVSPRLRSFLDRMLVRDPAQRATAA 264

Query: 414 EAMAHPYFFPIRNAES 429
           E + HP+        S
Sbjct: 265 ELLNHPFLAKAGPPSS 280

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 72.4 bits (177), Expect = 4e-14
 Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 20/211 (9%)

Query: 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKI---------KREIKILQNLCGGPN 190
           R +GRG Y++V   V    N++  I  +K VKK+ +         + E  + +     P 
Sbjct: 1   RVIGRGSYAKVLL-VRLKKNDQ--IYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPF 57

Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQ 247
           +V L      Q +    L+ E+VN  D          L +   R+Y  E+  AL++ H +
Sbjct: 58  LVGLHSCF--QTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER 115

Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDY 306
           GI++RD+K  NV++D +   ++L D+G+  E   PG   +    +  +  PE+L   ++Y
Sbjct: 116 GIIYRDLKLDNVLLDADGH-IKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG-EEY 173

Query: 307 DYSLDLWSLGCMFAGMIFRKEPFFYGHDNYD 337
            +S+D W+LG +   M+  + PF    DN D
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIITDNPD 204

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 71.4 bits (176), Expect = 5e-14
 Identities = 38/162 (23%), Positives = 77/162 (47%), Gaps = 18/162 (11%)

Query: 140 RKVGRGKYSEVFEGV----HCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNI 191
           +K+G G + EV++G           +  +K LK        ++  RE +I++ L   PN+
Sbjct: 5   KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKL-DHPNV 63

Query: 192 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHS 246
           VKLL +  +++     ++ E++   D    Y     P LS  D+  +  ++ + ++Y  S
Sbjct: 64  VKLLGVCTEEEP--LYIVMEYMEGGDLL-SYLRKNRPKLSLSDLLSFALQIARGMEYLES 120

Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR 288
           +  +HRD+   N ++  E   +++ D+GL+   +    Y  R
Sbjct: 121 KNFIHRDLAARNCLVG-ENLVVKISDFGLSRDLYDDDYYRKR 161

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 72.2 bits (177), Expect = 6e-14
 Identities = 59/218 (27%), Positives = 95/218 (43%), Gaps = 31/218 (14%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--------VKKKKIKREIKILQNL 185
            D++V   VGRG + EV         +   +K++K         V   + +R+I  + N 
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN- 59

Query: 186 CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD-------VRYYIYELL 238
              P I +L    +D       L+ E+    D   L   L+ Y+        ++Y+ EL+
Sbjct: 60  --SPWIPQLQYAFQD--KDNLYLVMEYQPGGD---LLSLLNRYEDQFDEDMAQFYLAELV 112

Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR--VASRYFKG 296
            A+   H  G +HRD+KP NV+ID     ++L D+G A      K  N +  V +  +  
Sbjct: 113 LAIHSVHQMGYVHRDIKPENVLIDRTGH-IKLADFGSAARLTANKMVNSKLPVGTPDYIA 171

Query: 297 PELLVDLQD-----YDYSLDLWSLGCMFAGMIFRKEPF 329
           PE+L  +       Y    D WSLG +   MI+ + PF
Sbjct: 172 PEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF 209

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 70.8 bits (173), Expect = 7e-14
 Identities = 57/218 (26%), Positives = 105/218 (48%), Gaps = 21/218 (9%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGGPNI 191
           YE+++K+G G + +++     +D+E C+IK +     PVK+K+  ++  IL      PNI
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61

Query: 192 VKLLDIVRDQQSKTPSLIFEHVNNTDFK--------VLYPTLSDYDVRYYIYELLKALDY 243
           V        Q++    ++ E+ +  D          VL+   S+  +  +  ++   L +
Sbjct: 62  VTFFASF--QENGRLFIVMEYCDGGDLMKRINRQRGVLF---SEDQILSWFVQISLGLKH 116

Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLVD 302
            H + I+HRD+K  N+ +       +L D+G+A   +   E     V + Y+  PE+  +
Sbjct: 117 IHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQN 176

Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
            + Y+   D+WSLGC+   +   K PF    +N  QLV
Sbjct: 177 -RPYNNKTDIWSLGCVLYELCTLKHPF--EGNNLHQLV 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 70.9 bits (173), Expect = 1e-13
 Identities = 71/304 (23%), Positives = 125/304 (41%), Gaps = 59/304 (19%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVK 193
           +E+V  VG G Y +V++G H    +   IK++     ++++IK+EI +L+      NI  
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67

Query: 194 LLDIVRDQQSKTPS-------LIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKAL 241
                     K P        L+ E         L       TL +  + Y   E+L+ L
Sbjct: 68  YYGAF---IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 124

Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELL 300
            + H   ++HRD+K  NV++  E  +++L+D+G+ A+        N  + + Y+  PE++
Sbjct: 125 SHLHQHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 183

Query: 301 VDLQD----YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 356
              ++    YD+  DLWSLG     M     P                     +++    
Sbjct: 184 ACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC-------------------DMHPMRA 224

Query: 357 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAM 416
            + I  +P       R   K WSK            +   F++  L  +H +RPT ++ M
Sbjct: 225 LFLIPRNP-----APRLKSKKWSK------------KFQSFIESCLVKNHSQRPTTEQLM 267

Query: 417 AHPY 420
            HP+
Sbjct: 268 KHPF 271

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 70.6 bits (174), Expect = 1e-13
 Identities = 47/207 (22%), Positives = 93/207 (44%), Gaps = 41/207 (19%)

Query: 140 RKVGRGKYSEVFEG-VHCTDNEKCI--IKILK----PVKKKKIKREIKILQNLCGGPNIV 192
           +K+G G + EV++G +   D +     +K LK      ++K   +E ++++ L G PN+V
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKL-GHPNVV 59

Query: 193 KLLDIVRDQQSKTPSLIFEHVNNTDFK------------VLYPTLSDYDVRYYIYELLKA 240
           +LL +  +++     L+ E++   D                  TLS  D+  +  ++ K 
Sbjct: 60  RLLGVCTEEEP--LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117

Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG---- 296
           ++Y  S+  +HRD+   N ++  E   +++ D+GL+   +    Y  +       G    
Sbjct: 118 MEYLASKKFVHRDLAARNCLVG-EDLVVKISDFGLSRDVYDDDYYRKKT-----GGKLPI 171

Query: 297 ----PELLVDLQDYDYSL--DLWSLGC 317
               PE    L+D  ++   D+WS G 
Sbjct: 172 RWMAPES---LKDGIFTSKSDVWSFGV 195

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 72.5 bits (177), Expect = 1e-13
 Identities = 65/260 (25%), Positives = 124/260 (47%), Gaps = 44/260 (16%)

Query: 117 PREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNE----KCI-IKILKPVK 171
           P +Y D ES        ++YEV++K+G G++ EVF   H    E    K I  + LK  +
Sbjct: 2   PGKYDDGES------RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKERE 55

Query: 172 KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK-------VLYPT 224
           K ++  E+ +++ L    NIV+ +D   ++ ++   ++ E  +  D          ++  
Sbjct: 56  KSQLVIEVNVMREL-KHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGK 114

Query: 225 LSDYDVRYYIYELLKALDYCHS-------QGIMHRDVKPHNVMIDHEQRKL--------- 268
           + ++ +     +LL AL YCH+       + ++HRD+KP N+ +    R +         
Sbjct: 115 IEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANN 174

Query: 269 -------RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV-DLQDYDYSLDLWSLGCMFA 320
                  ++ D+GL++        +  V + Y+  PELL+ + + YD   D+W+LGC+  
Sbjct: 175 LNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234

Query: 321 GMIFRKEPFFYGHDNYDQLV 340
            +   K P F+  +N+ QL+
Sbjct: 235 ELCSGKTP-FHKANNFSQLI 253

Length = 1021

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 71.2 bits (174), Expect = 2e-13
 Identities = 66/216 (30%), Positives = 103/216 (47%), Gaps = 29/216 (13%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR-------EIKILQNLC 186
           +DYEVV+ +GRG + EV    H +  +   +K+L   K + IKR       E + +    
Sbjct: 43  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLS--KFEMIKRSDSAFFWEERDIMAFA 100

Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDV-----RYYIYELLKAL 241
             P +V+L    +D   +   ++ E++   D   L   +S+YDV     R+Y  E++ AL
Sbjct: 101 NSPWVVQLFYAFQD--DRYLYMVMEYMPGGD---LVNLMSNYDVPEKWARFYTAEVVLAL 155

Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKGP 297
           D  HS G +HRDVKP N+++D +   L+L D+G        KE  VR    V +  +  P
Sbjct: 156 DAIHSMGFIHRDVKPDNMLLD-KSGHLKLADFGTC--MKMNKEGMVRCDTAVGTPDYISP 212

Query: 298 ELLVDLQD---YDYSLDLWSLGCMFAGMIFRKEPFF 330
           E+L        Y    D WS+G     M+    PF+
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 53/187 (28%), Positives = 87/187 (46%), Gaps = 38/187 (20%)

Query: 237 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFK 295
           +L+AL Y HSQG++HRD+K  ++++  + R ++L D+G  A+      +    V + Y+ 
Sbjct: 126 VLQALCYLHSQGVIHRDIKSDSILLTLDGR-VKLSDFGFCAQISKDVPKRKSLVGTPYWM 184

Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 355
            PE ++    Y   +D+WSLG M   M+  + P+F      D  V+  K L         
Sbjct: 185 APE-VISRTPYGTEVDIWSLGIMVIEMVDGEPPYF-----SDSPVQAMKRL--------- 229

Query: 356 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEA 415
                           R S  P      ++N H   P   DFL+++L  + QER TA+E 
Sbjct: 230 ----------------RDSPPP-----KLKNAHKISPVLRDFLERMLTREPQERATAQEL 268

Query: 416 MAHPYFF 422
           + HP+  
Sbjct: 269 LDHPFLL 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 70.1 bits (171), Expect = 2e-13
 Identities = 75/300 (25%), Positives = 134/300 (44%), Gaps = 53/300 (17%)

Query: 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK----IKREIKILQNLCGGPNIVKL 194
           + K+G+G + EVF+G+     +   IKI+   + +     I++EI +L   C  P + K 
Sbjct: 9   LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQ-CDSPYVTKY 67

Query: 195 L-DIVRDQQSKTPSLIFEHVNN-TDFKVLYP-TLSDYDVRYYIYELLKALDYCHSQGIMH 251
               ++D +     +I E++   +   +L P  L +  +   + E+LK LDY HS+  +H
Sbjct: 68  YGSYLKDTKL---WIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIH 124

Query: 252 RDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSL 310
           RD+K  NV++  E  +++L D+G+A +      + N  V + ++  PE ++    YD   
Sbjct: 125 RDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIKQSAYDSKA 182

Query: 311 DLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALV 370
           D+WSLG + A  + + EP                              H EL P     +
Sbjct: 183 DIWSLG-ITAIELAKGEP-----------------------------PHSELHPMKVLFL 212

Query: 371 GRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAESS 430
              +  P     T+E  +       +F++  L  +   RPTAKE + H   F +R A+ +
Sbjct: 213 IPKNNPP-----TLEGNY--SKPLKEFVEACLNKEPSFRPTAKELLKHK--FIVRFAKKT 263

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 69.8 bits (170), Expect = 3e-13
 Identities = 71/294 (24%), Positives = 128/294 (43%), Gaps = 50/294 (17%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIK---ILKPVKKKKIKREIKILQNLCGGPNIV 192
           Y    K+G+G    V+  +     ++  IK   + +  KK+ I  EI +++     PNIV
Sbjct: 21  YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE-NKNPNIV 79

Query: 193 KLLD--IVRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYCHSQG 248
             LD  +V D+      ++ E++        V    + +  +     E L+ALD+ HS  
Sbjct: 80  NYLDSYLVGDELW----VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQ 135

Query: 249 IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYD 307
           ++HRD+K  N+++  +   ++L D+G      P + + +  V + Y+  PE +V  + Y 
Sbjct: 136 VIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE-VVTRKAYG 193

Query: 308 YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLA 367
             +D+WSLG M   M+  + P+   ++N  + + +    GT EL           +P   
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYL--NENPLRALYLIATNGTPELQ----------NPERL 241

Query: 368 ALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
           + V R                       DFL++ L  D   R +AKE + HP+ 
Sbjct: 242 SAVFR-----------------------DFLNRCLEMDVDRRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 69.3 bits (169), Expect = 3e-13
 Identities = 73/287 (25%), Positives = 127/287 (44%), Gaps = 49/287 (17%)

Query: 141 KVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK----IKREIKILQNLCGGPNIVKLLD 196
           ++G+G + EV++G+     E   IKI+   + +     I++EI +L   C  P I +   
Sbjct: 11  RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQ-CDSPYITRYYG 69

Query: 197 IVRDQQSKTPSLIFEHVNN-TDFKVLYP-TLSDYDVRYYIYELLKALDYCHSQGIMHRDV 254
                +     +I E++   +   +L P  L +  +   + E+LK LDY HS+  +HRD+
Sbjct: 70  SY--LKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDI 127

Query: 255 KPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLW 313
           K  NV++  EQ  ++L D+G+A +      + N  V + ++  PE ++    YD+  D+W
Sbjct: 128 KAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIKQSAYDFKADIW 185

Query: 314 SLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRH 373
           SLG + A  + + EP          L  I K                        L G++
Sbjct: 186 SLG-ITAIELAKGEPPNSDLHPMRVLFLIPK-------------------NSPPTLEGQY 225

Query: 374 SRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 420
           S KP+                 +F++  L  D + RPTAKE + H +
Sbjct: 226 S-KPFK----------------EFVEACLNKDPRFRPTAKELLKHKF 255

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 69.3 bits (169), Expect = 4e-13
 Identities = 55/189 (29%), Positives = 86/189 (45%), Gaps = 44/189 (23%)

Query: 237 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR---VASRY 293
           +LKAL   H+QG++HRD+K  ++++ H+ R ++L D+G        KE   R   V + Y
Sbjct: 125 VLKALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCA--QVSKEVPRRKSLVGTPY 181

Query: 294 FKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 353
           +  PEL+  L  Y   +D+WSLG M   M+  + P+F                       
Sbjct: 182 WMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFN---------------------- 218

Query: 354 YLNKYHIELDPHLAAL-VGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA 412
                    +P L A+ + R +  P      ++N H   P    FLD+LL  D  +R TA
Sbjct: 219 ---------EPPLKAMKMIRDNLPP-----KLKNLHKVSPSLKGFLDRLLVRDPAQRATA 264

Query: 413 KEAMAHPYF 421
            E + HP+ 
Sbjct: 265 AELLKHPFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 68.3 bits (168), Expect = 5e-13
 Identities = 39/162 (24%), Positives = 78/162 (48%), Gaps = 17/162 (10%)

Query: 140 RKVGRGKYSEVFEGV--HCTDN--EKCIIKILKPVK----KKKIKREIKILQNLCGGPNI 191
           +K+G G + EV++G      D    +  +K LK        ++  RE +I++ L   PNI
Sbjct: 5   KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKL-DHPNI 63

Query: 192 VKLLDIVRDQQSKTPSLIFEHVNNTDFK-VL----YPTLSDYDVRYYIYELLKALDYCHS 246
           VKLL +  +++     ++ E++   D    L       LS  D+  +  ++ + ++Y  S
Sbjct: 64  VKLLGVCTEEEP--LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES 121

Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR 288
           +  +HRD+   N ++  E   +++ D+GL+   +    Y V+
Sbjct: 122 KNFIHRDLAARNCLVG-ENLVVKISDFGLSRDLYDDDYYKVK 162

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 69.3 bits (169), Expect = 5e-13
 Identities = 62/214 (28%), Positives = 100/214 (46%), Gaps = 22/214 (10%)

Query: 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKI---------KREIKILQNLCGGPN 190
           R +GRG Y++V   V     E+  I  +K VKK+ +         + E  + +     P 
Sbjct: 1   RVIGRGSYAKVLL-VRLKKTER--IYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPF 57

Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQ 247
           +V L      Q       + E+VN  D          L +   R+Y  E+  AL+Y H +
Sbjct: 58  LVGLHSCF--QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 115

Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDY 306
           GI++RD+K  NV++D E   ++L D+G+  E   PG   +    +  +  PE+L   +DY
Sbjct: 116 GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-EDY 173

Query: 307 DYSLDLWSLGCMFAGMIFRKEPF--FYGHDNYDQ 338
            +S+D W+LG +   M+  + PF      DN DQ
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 207

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 68.6 bits (168), Expect = 6e-13
 Identities = 50/225 (22%), Positives = 97/225 (43%), Gaps = 25/225 (11%)

Query: 139 VRKVGRGKYSEVFEGVH--CTDN--EKCIIKILK----PVKKKKIKREIKILQNLCGGPN 190
           ++++G G + +V    +    DN  E+  +K L        +   +REI+IL+ L    N
Sbjct: 9   IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL-DHEN 67

Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVR----YYIYELLKALDYCHS 246
           IVK   +      ++  LI E++ +   +       D         +  ++ K +DY  S
Sbjct: 68  IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127

Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLVD 302
           Q  +HRD+   N++++ E   +++ D+GLA+     K+Y        +  ++  PE L  
Sbjct: 128 QRYIHRDLAARNILVESEDL-VKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRT 186

Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG 347
            +    S D+WS G     +      F YG  +     +  +++G
Sbjct: 187 SKFSSAS-DVWSFGVTLYEL------FTYGDPSQSPPAEFLRMIG 224

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 69.3 bits (169), Expect = 7e-13
 Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 25/214 (11%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR-------EIKILQNLC 186
           +DY+VV+ +GRG + EV    H +  +   +K+L   K + IKR       E + +    
Sbjct: 43  EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLS--KFEMIKRSDSAFFWEERDIMAFA 100

Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDV-----RYYIYELLKAL 241
             P +V+L    +D   K   ++ E++   D   L   +S+YDV     ++Y  E++ AL
Sbjct: 101 NSPWVVQLFCAFQDD--KYLYMVMEYMPGGD---LVNLMSNYDVPEKWAKFYTAEVVLAL 155

Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEY-NVRVASRYFKGPEL 299
           D  HS G++HRDVKP N+++D +   L+L D+G   +    G    +  V +  +  PE+
Sbjct: 156 DAIHSMGLIHRDVKPDNMLLD-KHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEV 214

Query: 300 LVDLQD---YDYSLDLWSLGCMFAGMIFRKEPFF 330
           L        Y    D WS+G     M+    PF+
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY 248

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 68.2 bits (166), Expect = 7e-13
 Identities = 64/250 (25%), Positives = 108/250 (43%), Gaps = 47/250 (18%)

Query: 178 EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK---VLYPTLSDYDVRYYI 234
           EI++L+NL     IV+    +RD+  KT ++  E++     K     Y  L++   R Y 
Sbjct: 54  EIQLLKNL-QHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYT 112

Query: 235 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG----LAEFYHPGKEYNVRVA 290
            ++L+ + Y HS  I+HRD+K  N++ D     ++L D+G    L      G        
Sbjct: 113 RQILEGMSYLHSNMIVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICMSGTGIRSVTG 171

Query: 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE 350
           + Y+  PE ++  + Y    D+WSLGC    M+  K P+      Y+ +  I K+  T  
Sbjct: 172 TPYWMSPE-VISGEGYGRKADVWSLGCTVVEMLTEKPPW----AEYEAMAAIFKI-ATQP 225

Query: 351 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP 410
            N           P L + +  H+R                    DFL  +   + + RP
Sbjct: 226 TN-----------PQLPSHISEHAR--------------------DFLGCIF-VEARHRP 253

Query: 411 TAKEAMAHPY 420
           +A+E + HP+
Sbjct: 254 SAEELLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 67.9 bits (166), Expect = 1e-12
 Identities = 74/300 (24%), Positives = 123/300 (41%), Gaps = 62/300 (20%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK------IKREIKILQNLCGGP 189
           +  +R++G G +  V+       NE   IK +    K+       I +E++ LQ     P
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQ-LRHP 75

Query: 190 NIVKLLDI-VRDQQSKTPSLIFEHV--NNTD-FKVLYPTLSDYDVRYYIYELLKALDYCH 245
           N ++     +R+    T  L+ E+   + +D  +V    L + ++    +  L+ L Y H
Sbjct: 76  NTIEYKGCYLREH---TAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLH 132

Query: 246 SQGIMHRDVKPHNVMI-DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE--LLVD 302
           S   +HRD+K  N+++ +    KL   D+G A    P    N  V + Y+  PE  L +D
Sbjct: 133 SHERIHRDIKAGNILLTEPGTVKLA--DFGSASLVSPA---NSFVGTPYWMAPEVILAMD 187

Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 362
              YD  +D+WSLG     +  RK P F                    +NA    YHI  
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLF-------------------NMNAMSALYHIAQ 228

Query: 363 D--PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 420
           +  P L       S   WS                +F+D  L+   Q+RP+++E + H +
Sbjct: 229 NDSPTL-------SSNDWSD------------YFRNFVDSCLQKIPQDRPSSEELLKHRF 269

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 67.4 bits (164), Expect = 1e-12
 Identities = 63/250 (25%), Positives = 104/250 (41%), Gaps = 47/250 (18%)

Query: 178 EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK---VLYPTLSDYDVRYYI 234
           EI++L+NL     IV+    +RD   +T S+  EH+     K     Y  L++   R Y 
Sbjct: 54  EIQLLKNLLH-ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYT 112

Query: 235 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG----LAEFYHPGKEYNVRVA 290
            ++L+ + Y HS  I+HRD+K  N++ D     ++L D+G    L      G        
Sbjct: 113 RQILEGVSYLHSNMIVHRDIKGANILRD-SVGNVKLGDFGASKRLQTICLSGTGMKSVTG 171

Query: 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE 350
           + Y+  PE ++  + Y    D+WS+GC    M+  K P+      ++ +  I K+  T  
Sbjct: 172 TPYWMSPE-VISGEGYGRKADIWSVGCTVVEMLTEKPPW----AEFEAMAAIFKI-ATQP 225

Query: 351 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP 410
            N           P L   V  H R                    DFL ++   + + RP
Sbjct: 226 TN-----------PVLPPHVSDHCR--------------------DFLKRIF-VEAKLRP 253

Query: 411 TAKEAMAHPY 420
           +A E + H +
Sbjct: 254 SADELLRHTF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 67.9 bits (166), Expect = 1e-12
 Identities = 54/203 (26%), Positives = 95/203 (46%), Gaps = 20/203 (9%)

Query: 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKK----IKREIKILQNLCGGPNIVK 193
           R +GRG Y++V             +K++K   V   +    ++ E  + +     P +V 
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60

Query: 194 LLDIVRDQQSKTPSLIF---EHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQ 247
           L         +T S +F   E V+  D          L +   R+Y  E+  AL++ H +
Sbjct: 61  LHSCF-----QTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHER 115

Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDY 306
           GI++RD+K  NV++D E   ++L D+G+  E   PG   +    +  +  PE+L   +DY
Sbjct: 116 GIIYRDLKLDNVLLDAEGH-IKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRG-EDY 173

Query: 307 DYSLDLWSLGCMFAGMIFRKEPF 329
            +S+D W+LG +   M+  + PF
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 26/214 (12%)

Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ 201
           +GRG + EV+ G    D  K  +  +K + KK+IK  +K  + L     I  +L +V   
Sbjct: 2   IGRGGFGEVY-GCRKADTGK--MYAMKCLDKKRIK--MKQGETLALNERI--MLSLVSTG 54

Query: 202 QS----------KTP---SLIFEHVNNTDFKV---LYPTLSDYDVRYYIYELLKALDYCH 245
                        TP   S I + +N  D       +   S+ ++R+Y  E++  L++ H
Sbjct: 55  DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMH 114

Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
           ++ +++RD+KP N+++D E   +R+ D GLA  +   K +   V +  +  PE+L     
Sbjct: 115 NRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPH-ASVGTHGYMAPEVLQKGVA 172

Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQL 339
           YD S D +SLGCM   ++    P F  H   D+ 
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSP-FRQHKTKDKH 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 70/298 (23%), Positives = 130/298 (43%), Gaps = 47/298 (15%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR---EIKILQNLCGGPN 190
           D +E++ ++G G + +V++  H         KI++   +++++    EI IL   C  PN
Sbjct: 5   DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSE-CKHPN 63

Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKV--LYPTLSDYDVRYYIYELLKALDYCHSQG 248
           IV L +    +      + F      D  +  L   L++  +RY   ++L+AL++ HS  
Sbjct: 64  IVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK 123

Query: 249 IMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLV----DL 303
           ++HRD+K  N+++  +   ++L D+G+ A+     ++ +  + + Y+  PE++       
Sbjct: 124 VIHRDLKAGNILLTLDG-DVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKD 182

Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363
             YDY  D+WSLG     +   + P    H   + +  + K+L ++              
Sbjct: 183 NPYDYKADIWSLGITLIELAQMEPP----HHELNPMRVLLKILKSEP------------- 225

Query: 364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
           P L         K WS                DFL   L  D  +RPTA E + HP+ 
Sbjct: 226 PTLDQ-----PSK-WSS------------SFNDFLKSCLVKDPDDRPTAAELLKHPFV 265

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 67.4 bits (164), Expect = 2e-12
 Identities = 71/295 (24%), Positives = 127/295 (43%), Gaps = 58/295 (19%)

Query: 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK------IKREIKILQNLCGGPNIV 192
           +R++G G +  V+       NE   IK +    K+       I +E+K LQ +   PN +
Sbjct: 30  LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI-KHPNSI 88

Query: 193 KLLDIVRDQQSKTPSLIFEHV--NNTDF-KVLYPTLSDYDVRYYIYELLKALDYCHSQGI 249
           +       +   T  L+ E+   + +D  +V    L + ++    +  L+ L Y HS  +
Sbjct: 89  EYKGCYLREH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 146

Query: 250 MHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD--YD 307
           +HRD+K  N+++  E  +++L D+G A    P   +   V + Y+  PE+++ + +  YD
Sbjct: 147 IHRDIKAGNILLT-EPGQVKLADFGSASIASPANSF---VGTPYWMAPEVILAMDEGQYD 202

Query: 308 YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD--PH 365
             +D+WSLG     +  RK P F                    +NA    YHI  +  P 
Sbjct: 203 GKVDVWSLGITCIELAERKPPLF-------------------NMNAMSALYHIAQNESPT 243

Query: 366 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 420
           L +         WS +              +F+D  L+   Q+RPT++E + H +
Sbjct: 244 LQS-------NEWSDYFR------------NFVDSCLQKIPQDRPTSEELLKHMF 279

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 66.9 bits (163), Expect = 2e-12
 Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 24/205 (11%)

Query: 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR---------EIKILQNLCGGPN 190
           R +G+G + EV     C       +   K ++KK+IK+         E +IL+ +    N
Sbjct: 6   RVLGKGGFGEV---CACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV----N 58

Query: 191 IVKLLDIVRDQQSKTP-SLIFEHVNNTDFKV-LY----PTLSDYDVRYYIYELLKALDYC 244
              ++++    ++K    L+   +N  D K  +Y    P   +    +Y  E+L  L+  
Sbjct: 59  SQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDL 118

Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           H +  ++RD+KP N+++D +   +R+ D GLA     G+    RV +  +  PE+L + Q
Sbjct: 119 HRENTVYRDLKPENILLD-DYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNN-Q 176

Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPF 329
            Y  S D W LGC+   MI  + PF
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 66.4 bits (162), Expect = 3e-12
 Identities = 69/300 (23%), Positives = 125/300 (41%), Gaps = 63/300 (21%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGP 189
           YE +R VGRG +  V       D +  IIK + PV      ++   + E ++L+ L   P
Sbjct: 2   YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQI-PVEQMTKDERLAAQNECQVLKLL-SHP 59

Query: 190 NIV---------KLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKA 240
           NI+         K L IV   +      + E++     K     L +  + ++  ++L A
Sbjct: 60  NIIEYYENFLEDKALMIV--MEYAPGGTLAEYIQ----KRCNSLLDEDTILHFFVQILLA 113

Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPEL 299
           L + H++ I+HRD+K  N+++D  +  +++ D+G++       K Y V V +  +  PE 
Sbjct: 114 LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTV-VGTPCYISPE- 171

Query: 300 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 359
           L + + Y+   D+W+LGC+   +   K  F                   +  N       
Sbjct: 172 LCEGKPYNQKSDIWALGCVLYELASLKRAF-------------------EAAN------- 205

Query: 360 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHP 419
                 L ALV +        F  + +++   P+    +  +L  D  +RP   + MA P
Sbjct: 206 ------LPALVLKIMS---GTFAPISDRY--SPDLRQLILSMLNLDPSKRPQLSQIMAQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 74/311 (23%), Positives = 131/311 (42%), Gaps = 53/311 (17%)

Query: 123 YESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR----- 177
           YE +       + +E++ ++G G + +V++     + E   +   K ++ K  +      
Sbjct: 1   YEHVRRDLDPNEVWEIIGELGDGAFGKVYKA---KNKETGALAAAKVIETKSEEELEDYM 57

Query: 178 -EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYI 234
            EI+IL   C  P IVKLL            + F      D  +L     L++  ++   
Sbjct: 58  VEIEILAT-CNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVIC 116

Query: 235 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRY 293
            ++L+AL Y HS  I+HRD+K  NV++  +   ++L D+G+ A+     +  +  + + Y
Sbjct: 117 RQMLEALQYLHSMKIIHRDLKAGNVLLTLDG-DIKLADFGVSAKNVKTLQRRDSFIGTPY 175

Query: 294 FKGPELLV--DLQD--YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTD 349
           +  PE+++   ++D  YDY  D+WSLG     M  + EP  +  +    L+KIAK     
Sbjct: 176 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMA-QIEPPHHELNPMRVLLKIAKS---- 230

Query: 350 ELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQER 409
                        +P             WS             E  DFL   L    + R
Sbjct: 231 -------------EPP-----TLSQPSKWS------------MEFRDFLKTALDKHPETR 260

Query: 410 PTAKEAMAHPY 420
           P+A + + HP+
Sbjct: 261 PSAAQLLEHPF 271

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 66.4 bits (162), Expect = 3e-12
 Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 26/206 (12%)

Query: 140 RKVGRGKYSEVFEGVHCTDNEKCIIKI--LKPVKKKKIKR---------EIKILQNLCGG 188
           R +G+G + EV     C    +   K+   K ++KK+IK+         E +IL+ +   
Sbjct: 6   RVLGKGGFGEV-----CACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NS 59

Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKV-LY----PTLSDYDVRYYIYELLKALDY 243
             +V L      + +    L+   +N  D K  +Y    P   +    +Y  E+   L+ 
Sbjct: 60  RFVVSLAYAYETKDALC--LVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLED 117

Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 303
            H + I++RD+KP N+++D +   +R+ D GLA     G+    RV +  +  PE +V  
Sbjct: 118 LHRERIVYRDLKPENILLD-DYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPE-VVKN 175

Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPF 329
           + Y +S D W LGC+   MI  K PF
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGKSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 66.5 bits (162), Expect = 4e-12
 Identities = 74/297 (24%), Positives = 132/297 (44%), Gaps = 56/297 (18%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIK---ILKPVKKKKIKREIKILQNLCGGPNIV 192
           Y    K+G+G    V+  +     ++  IK   + +  KK+ I  EI +++     PNIV
Sbjct: 21  YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMREN-KHPNIV 79

Query: 193 KLLD--IVRDQQSKTPSLIFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ 247
             LD  +V D+      ++ E++     TD  V    + +  +     E L+AL++ HS 
Sbjct: 80  NYLDSYLVGDELW----VVMEYLAGGSLTDV-VTETCMDEGQIAAVCRECLQALEFLHSN 134

Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELLVDLQ 304
            ++HRD+K  N+++  +   ++L D+G      P  E + R   V + Y+  PE +V  +
Sbjct: 135 QVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPE-VVTRK 190

Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y   +D+WSLG M   M+  + P  Y ++N  + + +    GT EL             
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPP--YLNENPLRALYLIATNGTPEL------------- 235

Query: 365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
                  ++  K  + F              DFL++ L  D ++R +AKE + HP+ 
Sbjct: 236 -------QNPEKLSAIF-------------RDFLNRCLEMDVEKRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 66.5 bits (162), Expect = 4e-12
 Identities = 74/307 (24%), Positives = 136/307 (44%), Gaps = 57/307 (18%)

Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKI----------KREIKILQN 184
           ++E+++ +G G Y +VF     T ++   +  +K ++K  +          + E  +L++
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYP--TLSDYDVRYYIYELLKAL 241
           +   P +V L      Q      LI ++V+  + F  LY     S+ +VR+Y  E++ AL
Sbjct: 61  VRQSPFLVTLHYAF--QTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILAL 118

Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVR-VASRYFKGPEL 299
           ++ H  GI++RD+K  N+++D E   + L D+GL+ EF    KE       +  +  PE+
Sbjct: 119 EHLHKLGIVYRDIKLENILLDSEGH-VVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEI 177

Query: 300 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 359
           +     +  ++D WSLG +   ++    PF               + G     + +++  
Sbjct: 178 IRGKGGHGKAVDWWSLGILIFELLTGASPF--------------TLEGERNTQSEVSRRI 223

Query: 360 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQER-----PTAKE 414
           ++ DP   + +G                    PEA D L KLLR D ++R       A E
Sbjct: 224 LKCDPPFPSFIG--------------------PEAQDLLHKLLRKDPKKRLGAGPQGASE 263

Query: 415 AMAHPYF 421
              HP+F
Sbjct: 264 IKEHPFF 270

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 66.2 bits (161), Expect = 4e-12
 Identities = 53/200 (26%), Positives = 95/200 (47%), Gaps = 23/200 (11%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVK 193
           +E+V  VG G Y +V++G H    +   IK++   +  +++IK EI +L+      NI  
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77

Query: 194 LLDIVRDQQSKTPS-------LIFEHVNN---TDF--KVLYPTLSDYDVRYYIYELLKAL 241
                     K+P        L+ E       TD         L +  + Y   E+L+ L
Sbjct: 78  YYGAF---IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGL 134

Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELL 300
            + H+  ++HRD+K  NV++  E  +++L+D+G+ A+        N  + + Y+  PE++
Sbjct: 135 AHLHAHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 193

Query: 301 VDLQD----YDYSLDLWSLG 316
              ++    YDY  D+WSLG
Sbjct: 194 ACDENPDATYDYRSDIWSLG 213

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 66.0 bits (161), Expect = 6e-12
 Identities = 42/118 (35%), Positives = 67/118 (56%), Gaps = 6/118 (5%)

Query: 229 DVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE--FYHPGKEYN 286
           DV++Y+ EL  ALD+ HS GI++RD+KP N+++D E+  ++L D+GL++    H  K Y+
Sbjct: 99  DVKFYLAELALALDHLHSLGIIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYS 157

Query: 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
                 Y   PE +V+ + +  S D WS G +   M+    P F G D  + +  I K
Sbjct: 158 FCGTVEYM-APE-VVNRRGHTQSADWWSFGVLMFEMLTGSLP-FQGKDRKETMTMILK 212

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 65.2 bits (159), Expect = 6e-12
 Identities = 55/210 (26%), Positives = 97/210 (46%), Gaps = 24/210 (11%)

Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR--------EIKILQNLC 186
           D+E++ K+G+G +  VF+ V   D     +  +K +   K+ R        E ++L  L 
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKR---VYAMKQIDLSKMNRREREEAIDEARVLAKL- 56

Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKA 240
               I++  +   D+     +++ E+  N D   L       P   D   R++I  LL  
Sbjct: 57  DSSYIIRYYESFLDKGKL--NIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILL-G 113

Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPEL 299
           L + HS+ I+HRD+K  N+ +D     +++ D G+A+       + N  V + Y+  PEL
Sbjct: 114 LAHLHSKKILHRDIKSLNLFLD-AYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPEL 172

Query: 300 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
             D + Y+   D+W+LG +       K PF
Sbjct: 173 CED-KPYNEKSDVWALGVVLYECCTGKHPF 201

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 66.9 bits (163), Expect = 7e-12
 Identities = 97/454 (21%), Positives = 181/454 (39%), Gaps = 86/454 (18%)

Query: 26  AISSNTSSSRTTSVSKILFSPLSQSSRIFTPFGTLRGLASSASLSHARHQHQRLRQLATP 85
            +++ + +S   + S       S+S+      G+ R   ++ S    R +     + A  
Sbjct: 23  PVNALSGNSPKANNSASTGQTTSRSTNSARRSGSKRDRETATSTDSGRTKSH---EGAAT 79

Query: 86  PDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDD-----YEVVR 140
                     +V  +  P K +V        P +  +     V  GE  D     ++++ 
Sbjct: 80  TKQATTTPTTNVEVAPPPKKKKV----TYALPNQSREEGHFYVVLGEDIDVSTQRFKILS 135

Query: 141 KVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--KKIKREIKILQN--LCGGPNIVKLLD 196
            +G G + +V E       E C +KI++ V K  +  K EI+ ++        +   L+ 
Sbjct: 136 LLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMK 195

Query: 197 IVRDQQSKT-----------PSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCH 245
           I R  Q++T           P L+       D+ + +   S   +   I++   ALDY H
Sbjct: 196 IQRYFQNETGHMCIVMPKYGPCLL-------DWIMKHGPFSHRHLAQIIFQTGVALDYFH 248

Query: 246 SQ-GIMHRDVKPHNVMIDHEQR---------------KLRLIDWGLAEFYHPGKEYNVR- 288
           ++  +MH D+KP N++++                   ++R+ D G         E + R 
Sbjct: 249 TELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC-----CDERHSRT 303

Query: 289 --VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL 346
             V++R+++ PE+++ L  + YS D+WS+GC+   + +  +  +  HDN + L  + K L
Sbjct: 304 AIVSTRHYRSPEVVLGL-GWMYSTDMWSMGCIIYEL-YTGKLLYDTHDNLEHLHLMEKTL 361

Query: 347 -----------GTDELNAYLN---KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVP 392
                      GT+E     N   +     DP   A + R   +P  + I          
Sbjct: 362 GRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIAR--ARPVREVIR-------DD 412

Query: 393 EAVDFLDKLLRYDHQERPTAKEAMAHPY---FFP 423
              D +  LL YD Q+R  A++   HPY   ++P
Sbjct: 413 LLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYYP 446

Length = 467

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 65.1 bits (159), Expect = 8e-12
 Identities = 55/234 (23%), Positives = 103/234 (44%), Gaps = 37/234 (15%)

Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI---IKILK----PVKKKKIKREIKILQNL 185
           ++D  + R +G G++ +V++GV+ +   + I   +K  K    P  ++K  +E  I++  
Sbjct: 5   REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQF 64

Query: 186 CGGPNIVKLLDIVRDQQSKTPSLI------------FEHVNNTDFKVLYPTLSDYDVRYY 233
              P+IVKL+ ++ +     P  I            +  VN     +    L       Y
Sbjct: 65  -DHPHIVKLIGVITEN----PVWIVMELAPLGELRSYLQVNKYSLDLASLIL-------Y 112

Query: 234 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY 293
            Y+L  AL Y  S+  +HRD+   NV++      ++L D+GL+ +      Y        
Sbjct: 113 SYQLSTALAYLESKRFVHRDIAARNVLVSSPD-CVKLGDFGLSRYLEDESYYKASKGKLP 171

Query: 294 FK--GPELLVDLQDYDYSLDLWSLG-CMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
            K   PE  ++ + +  + D+W  G CM+  ++   +PF  G  N D + +I  
Sbjct: 172 IKWMAPE-SINFRRFTSASDVWMFGVCMWEILMLGVKPFQ-GVKNNDVIGRIEN 223

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 33/100 (33%), Positives = 55/100 (55%), Gaps = 2/100 (2%)

Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRV 289
           V +Y  ++   + + HS  I++RD+KP NV++D +Q   RL D GLA     GK    R 
Sbjct: 97  VIHYSAQITCGILHLHSMDIVYRDMKPENVLLD-DQGNCRLSDLGLAVELKDGKTITQRA 155

Query: 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
            +  +  PE+L + + Y Y +D +++GC    M+  + PF
Sbjct: 156 GTNGYMAPEILKE-EPYSYPVDWFAMGCSIYEMVAGRTPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 53/200 (26%), Positives = 95/200 (47%), Gaps = 16/200 (8%)

Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKIL--KPVKKKKIKREIK-----ILQNLCGGPNIVKL 194
           +G+G + +V      +D     +K+L  K + KKK +  I      +L+NL   P +V L
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNL-KHPFLVGL 61

Query: 195 LDIVRDQQSKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMH 251
                 Q ++    + ++VN  +            +   R+Y  E+  A+ Y HS  I++
Sbjct: 62  H--YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIY 119

Query: 252 RDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSL 310
           RD+KP N+++D  Q  + L D+GL  E   P +  +    +  +  PE+L   + YD ++
Sbjct: 120 RDLKPENILLD-SQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRK-EPYDRTV 177

Query: 311 DLWSLGCMFAGMIFRKEPFF 330
           D W LG +   M++   PF+
Sbjct: 178 DWWCLGAVLYEMLYGLPPFY 197

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 65.1 bits (158), Expect = 1e-11
 Identities = 71/294 (24%), Positives = 127/294 (43%), Gaps = 54/294 (18%)

Query: 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK------IKREIKILQNLCGGPNIV 192
           +R++G G +  V+      ++E   IK +    K+       I +E++ LQ L   PN +
Sbjct: 20  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTI 78

Query: 193 KLLDIVRDQQSKTPSLIFEHV--NNTDF-KVLYPTLSDYDVRYYIYELLKALDYCHSQGI 249
           +       +   T  L+ E+   + +D  +V    L + ++    +  L+ L Y HS  +
Sbjct: 79  QYRGCYLREH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136

Query: 250 MHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD--YD 307
           +HRDVK  N+++  E   ++L D+G A    P   +   V + Y+  PE+++ + +  YD
Sbjct: 137 IHRDVKAGNILLS-EPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAMDEGQYD 192

Query: 308 YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLA 367
             +D+WSLG     +  RK P F                    +NA    YHI  +    
Sbjct: 193 GKVDVWSLGITCIELAERKPPLF-------------------NMNAMSALYHIAQNES-P 232

Query: 368 ALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
           AL   H    WS++              +F+D  L+   Q+RPT++  + H + 
Sbjct: 233 ALQSGH----WSEYFR------------NFVDSCLQKIPQDRPTSEVLLKHRFV 270

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 34/105 (32%), Positives = 61/105 (58%), Gaps = 2/105 (1%)

Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
            S+ ++R+Y  E++  L++ H++ +++RD+KP N+++D E   +R+ D GLA  +   K 
Sbjct: 94  FSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKP 152

Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
           +   V +  +  PE+L     YD S D +SLGCM   ++    PF
Sbjct: 153 H-ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 64.3 bits (156), Expect = 1e-11
 Identities = 72/287 (25%), Positives = 124/287 (43%), Gaps = 49/287 (17%)

Query: 141 KVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK----IKREIKILQNLCGGPNIVKLLD 196
           ++G+G + EVF+G+     +   IKI+   + +     I++EI +L   C  P + K   
Sbjct: 11  RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQ-CDSPYVTKYYG 69

Query: 197 IVRDQQSKTPSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYCHSQGIMHRDV 254
                +     +I E++       L       ++ +   + E+LK LDY HS+  +HRD+
Sbjct: 70  SY--LKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDI 127

Query: 255 KPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLW 313
           K  NV++  EQ  ++L D+G+A +      + N  V + ++  PE ++    YD   D+W
Sbjct: 128 KAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIQQSAYDSKADIW 185

Query: 314 SLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRH 373
           SLG + A  + + EP      N D  +   +VL           + I  +     L G  
Sbjct: 186 SLG-ITAIELAKGEP-----PNSD--MHPMRVL-----------FLIPKNNP-PTLTGEF 225

Query: 374 SRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 420
           S+                    +F+D  L  D   RPTAKE + H +
Sbjct: 226 SKP-----------------FKEFIDACLNKDPSFRPTAKELLKHKF 255

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 64.1 bits (157), Expect = 1e-11
 Identities = 45/201 (22%), Positives = 87/201 (43%), Gaps = 38/201 (18%)

Query: 140 RKVGRGKYSEVFEGV----HCTDNEKCIIKILKP----VKKKKIKREIKILQNLCGGPNI 191
           +K+G G + EV++G           K  +K LK      ++++   E  I++ L   PNI
Sbjct: 5   KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKL-SHPNI 63

Query: 192 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHS 246
           V+LL +    +     ++ E++   D    +       L+  D+     ++ K ++Y  S
Sbjct: 64  VRLLGVCTQGEP--LYIVTEYMPGGDLL-DFLRKHGEKLTLKDLLQMALQIAKGMEYLES 120

Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR---------VASRYFKGP 297
           +  +HRD+   N ++  E   +++ D+GL+   +    Y  R         +A      P
Sbjct: 121 KNFVHRDLAARNCLVT-ENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMA------P 173

Query: 298 ELLVDLQDYDYSL--DLWSLG 316
           E    L+D  ++   D+WS G
Sbjct: 174 ES---LKDGKFTSKSDVWSFG 191

Length = 258

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 64.1 bits (156), Expect = 2e-11
 Identities = 37/119 (31%), Positives = 65/119 (54%), Gaps = 5/119 (4%)

Query: 212 HVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLI 271
           H+ N D +   P   +    +Y  +++  L++ H + I++RD+KP NV++D++   +R+ 
Sbjct: 83  HIYNVDEE--NPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDG-NVRIS 139

Query: 272 DWGLAEFYHPGKEYNVRVA-SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
           D GLA     G+      A +  F  PELL   ++YD+S+D ++LG     MI  + PF
Sbjct: 140 DLGLAVELKDGQSKTKGYAGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPF 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 63.7 bits (155), Expect = 2e-11
 Identities = 60/256 (23%), Positives = 111/256 (43%), Gaps = 48/256 (18%)

Query: 173 KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK---VLYPTLSDYD 229
             ++ EI++L+NL     IV+    +RD +  T S+  E++     K     Y  L++  
Sbjct: 49  NALECEIQLLKNL-QHERIVQYYGCLRDDE--TLSIFMEYMPGGSVKDQLKAYGALTETV 105

Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG----LAEFYHPGKEY 285
            R Y  ++L+ ++Y HS  I+HRD+K  N++ D     ++L D+G    L      G   
Sbjct: 106 TRKYTRQILEGVEYLHSNMIVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICSSGTGM 164

Query: 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV 345
                + Y+  PE ++  + Y    D+WS+GC    M+  K P+      ++ +  I K+
Sbjct: 165 KSVTGTPYWMSPE-VISGEGYGRKADVWSVGCTVVEMLTEKPPW----AEFEAMAAIFKI 219

Query: 346 LGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYD 405
             T   N        +L  H++                        P+A +FL +    +
Sbjct: 220 -ATQPTNP-------QLPSHVS------------------------PDARNFLRRTFVEN 247

Query: 406 HQERPTAKEAMAHPYF 421
            ++RP+A+E + H + 
Sbjct: 248 AKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 64.9 bits (158), Expect = 2e-11
 Identities = 76/312 (24%), Positives = 118/312 (37%), Gaps = 53/312 (16%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVKKKKIKREIKILQNLCGGPN 190
           Y ++  +  G   EVF    CT       +K I+K +     K   REI IL+ +     
Sbjct: 94  YNILSSLTPGSEGEVFV---CTKHGDEQRKKVIVKAV--TGGKTPGREIDILKTI-SHRA 147

Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPTLSDYDVRYYIYELLKALDYCHSQG 248
           I+ L+   R +   T  ++        F  +     L           LL+AL Y H +G
Sbjct: 148 IINLIHAYRWKS--TVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG 205

Query: 249 IMHRDVKPHNVMIDHEQRKLRLIDWGLA-----EFYHPGKEYNVRVASRYFKGPELLVDL 303
           I+HRDVK  N+ +D  +  + L D+G A         P + Y     +     PELL  L
Sbjct: 206 IIHRDVKTENIFLDEPENAV-LGDFGAACKLDAHPDTP-QCYG-WSGTLETNSPELLA-L 261

Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYD--QLVKIAKVLGTDELNAYLN----- 356
             Y    D+WS G +   M  +    F         QL  I + +    L    N     
Sbjct: 262 DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNL 321

Query: 357 -----KYHIELDPHLAALVGRHSRKPWS--KFITVENQHLAVPEAVDFLDKLLRYDHQER 409
                +Y I L            R P++    I     H+ V   +    K+L +D + R
Sbjct: 322 CKHFKQYAIVL------------RPPYTIPPVIRKYGMHMDVEYLIA---KMLTFDQEFR 366

Query: 410 PTAKEAMAHPYF 421
           P+A++ ++ P F
Sbjct: 367 PSAQDILSLPLF 378

Length = 392

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 69/295 (23%), Positives = 123/295 (41%), Gaps = 58/295 (19%)

Query: 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK------KIKREIKILQNLCGGPNIV 192
           + ++G G +  V+   +   NE   +K +    K+       I +E+K LQ L   PN +
Sbjct: 26  LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-KHPNTI 84

Query: 193 KLLDIVRDQQSKTPSLIFEHV--NNTD-FKVLYPTLSDYDVRYYIYELLKALDYCHSQGI 249
           +       +   T  L+ E+   + +D  +V    L + ++    +  L+ L Y HS  +
Sbjct: 85  EYKGCYLKEH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 142

Query: 250 MHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD--YD 307
           +HRD+K  N+++  E  +++L D+G A    P   +   V + Y+  PE+++ + +  YD
Sbjct: 143 IHRDIKAGNILLT-EPGQVKLADFGSASKSSPANSF---VGTPYWMAPEVILAMDEGQYD 198

Query: 308 YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD--PH 365
             +D+WSLG     +  RK P F                    +NA    YHI  +  P 
Sbjct: 199 GKVDVWSLGITCIELAERKPPLF-------------------NMNAMSALYHIAQNDSPT 239

Query: 366 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 420
           L +         W+                 F+D  L+   QERP + E + H +
Sbjct: 240 LQS-------NEWTDSFR------------GFVDYCLQKIPQERPASAELLRHDF 275

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 63.7 bits (155), Expect = 3e-11
 Identities = 79/310 (25%), Positives = 134/310 (43%), Gaps = 64/310 (20%)

Query: 135 DYEVVRKVGRGKYSEVF----EGVHCTDNEKCIIKILKP---VKKKKI----KREIKILQ 183
           ++E++R +G G Y +VF     G H    +   +K+LK    V+K K     + E ++L+
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGH-DAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLE 59

Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYPT--LSDYDVRYYIYELLKA 240
            +   P +V L      Q      LI ++VN  + F  LY     ++ +VR YI E++ A
Sbjct: 60  AVRRCPFLVTLHYAF--QTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLA 117

Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY--NVRVASRYFKGPE 298
           LD+ H  GI++RD+K  N+++D E   + L D+GL++ +   +E        +  +  PE
Sbjct: 118 LDHLHQLGIIYRDIKLENILLDSEGH-VVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPE 176

Query: 299 LLVDLQD-YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 357
           ++      +D ++D WSLG +   ++    PF               V G          
Sbjct: 177 VIRGGSGGHDKAVDWWSLGVLTFELLTGASPF--------------TVDG---------- 212

Query: 358 YHIELDPHLAALVGRHSRKPWSKFITVEN---QHLAVPEAVDFLDKLLRYDHQER---PT 411
                         ++S+   S+ I             EA DF+ KLL  D ++R     
Sbjct: 213 -------------EQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANG 259

Query: 412 AKEAMAHPYF 421
           A E   HP+F
Sbjct: 260 ADEIKNHPFF 269

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 63.1 bits (153), Expect = 4e-11
 Identities = 51/211 (24%), Positives = 100/211 (47%), Gaps = 15/211 (7%)

Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVKKKKIKREIKILQNLCGGPN 190
           Q+D+E+++++G G Y +V++  +    E   IK++K  P +   + ++  I+   C   N
Sbjct: 8   QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSN 67

Query: 191 IVKLLD--IVRDQQSKTPSLIFEHVNNTDFKVLYPT---LSDYDVRYYIYELLKALDYCH 245
           IV      + RD+      +  E       + +Y     LS+  + Y   E L+ L Y H
Sbjct: 68  IVAYFGSYLRRDKLW----ICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLH 123

Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           S+G MHRD+K  N+++  +   ++L D+G+ A+      +    + + Y+  PE+    +
Sbjct: 124 SKGKMHRDIKGANILLT-DNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVER 182

Query: 305 D--YDYSLDLWSLGCMFAGMIFRKEPFFYGH 333
              Y+   D+W++G     +   + P F  H
Sbjct: 183 KGGYNQLCDIWAVGITAIELAELQPPMFDLH 213

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 63.2 bits (153), Expect = 4e-11
 Identities = 68/294 (23%), Positives = 129/294 (43%), Gaps = 50/294 (17%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIK---ILKPVKKKKIKREIKILQNLCGGPNIV 192
           Y    K+G+G    V+  +     ++  I+   + +  KK+ I  EI +++     PNIV
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE-NKNPNIV 80

Query: 193 KLLD--IVRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYCHSQG 248
             LD  +V D+      ++ E++        V    + +  +     E L+AL++ HS  
Sbjct: 81  NYLDSYLVGDELW----VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ 136

Query: 249 IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYD 307
           ++HRD+K  N+++  +   ++L D+G      P + + +  V + Y+  PE +V  + Y 
Sbjct: 137 VIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE-VVTRKAYG 194

Query: 308 YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLA 367
             +D+WSLG M   MI  + P+   ++N  + + +    GT EL           +P   
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYL--NENPLRALYLIATNGTPELQ----------NPEKL 242

Query: 368 ALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
           + + R                       DFL++ L  D ++R +AKE + H + 
Sbjct: 243 SAIFR-----------------------DFLNRCLDMDVEKRGSAKELLQHQFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 64.4 bits (157), Expect = 4e-11
 Identities = 52/227 (22%), Positives = 81/227 (35%), Gaps = 77/227 (33%)

Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY-- 293
           ++L ALD  HS GI+HRDVKP N++        ++ID G A         ++RV   Y  
Sbjct: 263 QILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAA--------DLRVGINYIP 314

Query: 294 --------FKGPELLV------------------------DLQDYDYSLDLWSLGCMFAG 321
                   +  PE  +                        +L D     D++S G +F  
Sbjct: 315 KEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD---RFDIYSAGLIFLQ 371

Query: 322 MIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGR-------HS 374
           M F   P      N  Q  +  K    D     L  +   ++P  +  + R         
Sbjct: 372 MAF---PNLRSDSNLIQFNRQLKRNDYD-----LVAWRKLVEPRASPDLRRGFEVLDLDG 423

Query: 375 RKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
              W                 + L  ++R+  ++R +AK A+AHPYF
Sbjct: 424 GAGW-----------------ELLKSMMRFKGRQRISAKAALAHPYF 453

Length = 566

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 63.1 bits (153), Expect = 4e-11
 Identities = 74/301 (24%), Positives = 130/301 (43%), Gaps = 53/301 (17%)

Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR------EIKILQNLC 186
           ++ +E++ ++G G + +V++     + E  ++   K +  K  +       EI IL + C
Sbjct: 4   EEFWEIIGELGDGAFGKVYKA---QNKETGVLAAAKVIDTKSEEELEDYMVEIDILAS-C 59

Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYC 244
             PNIVKLLD    + +    + F      D  +L     L++  +R    + L+AL+Y 
Sbjct: 60  DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYL 119

Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLV-- 301
           H   I+HRD+K  N++   +   ++L D+G+ A+     +  +  + + Y+  PE+++  
Sbjct: 120 HENKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCE 178

Query: 302 --DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 359
               + YDY  D+WSLG     M  + EP  +  +    L+KIAK               
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEMA-QIEPPHHELNPMRVLLKIAKS-------------- 223

Query: 360 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHP 419
              +P   A   R     WS             E  DFL K L  +   R T  + + HP
Sbjct: 224 ---EPPTLAQPSR-----WS------------SEFKDFLKKCLEKNVDARWTTTQLLQHP 263

Query: 420 Y 420
           +
Sbjct: 264 F 264

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 63.6 bits (155), Expect = 4e-11
 Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 29/216 (13%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR-------EIKILQNLC 186
           +D++V++ +GRG + EV    H +  +   +K+L   K + IKR       E + +    
Sbjct: 43  EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLS--KFEMIKRSDSAFFWEERDIMAHA 100

Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDV-----RYYIYELLKAL 241
               IV+L    +D   K   ++ E++   D   L   +S+YD+     R+Y  E++ AL
Sbjct: 101 NSEWIVQLHYAFQDD--KYLYMVMEYMPGGDLVNL---MSNYDIPEKWARFYTAEVVLAL 155

Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKGP 297
           D  HS G +HRDVKP N+++D +   L+L D+G            VR    V +  +  P
Sbjct: 156 DAIHSMGFIHRDVKPDNMLLD-KSGHLKLADFGTC--MKMDANGMVRCDTAVGTPDYISP 212

Query: 298 ELLVDLQ---DYDYSLDLWSLGCMFAGMIFRKEPFF 330
           E+L        Y    D WS+G     M+    PF+
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 62.4 bits (152), Expect = 6e-11
 Identities = 49/194 (25%), Positives = 88/194 (45%), Gaps = 40/194 (20%)

Query: 237 LLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 295
           ++KAL+Y HS+  ++HRDVKP NV+I+    +++L D+G++ +        +    + + 
Sbjct: 112 IVKALEYLHSKLSVIHRDVKPSNVLINR-NGQVKLCDFGISGYLVDSVAKTIDAGCKPYM 170

Query: 296 GPELL---VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELN 352
            PE +   ++ + YD   D+WSLG     +   + P+      + QL ++ +        
Sbjct: 171 APERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE-------- 222

Query: 353 AYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA 412
                   E  P L          P  KF          PE  DF++K L+ +++ERP  
Sbjct: 223 --------EPSPQL----------PAEKF---------SPEFQDFVNKCLKKNYKERPNY 255

Query: 413 KEAMAHPYFFPIRN 426
            E + HP+F    +
Sbjct: 256 PELLQHPFFELHLS 269

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 62.9 bits (153), Expect = 7e-11
 Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 20/202 (9%)

Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKIL--KPVKKKK----IKREIKILQNLCGGPNIVKLL 195
           +G+G + +V    H  D +   +K+L  K + KKK    I  E  +L      P +V L 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 196 DIVRDQQSKTPSLIFEHVNNTDFKVLYPTL------SDYDVRYYIYELLKALDYCHSQGI 249
                Q +     + ++VN  +   L+  L       +   R+Y  E+  AL Y HS  I
Sbjct: 63  --YSFQTADKLYFVLDYVNGGE---LFFHLQRERSFPEPRARFYAAEIASALGYLHSLNI 117

Query: 250 MHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 308
           ++RD+KP N+++D  Q  + L D+GL  E     K  +    +  +  PE+L   Q YD 
Sbjct: 118 IYRDLKPENILLDS-QGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRK-QPYDR 175

Query: 309 SLDLWSLGCMFAGMIFRKEPFF 330
           ++D W LG +   M++   PF+
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFY 197

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 62.9 bits (153), Expect = 7e-11
 Identities = 83/307 (27%), Positives = 131/307 (42%), Gaps = 72/307 (23%)

Query: 139 VRKVGRGKYSEVF--EGVHCTDNEKCIIKILKPVKKKKIKREIK----------ILQNLC 186
           ++ +G+G Y +VF    V   D  K  I  +K +KK  I R  K          IL+ + 
Sbjct: 1   LKVLGKGGYGKVFQVRKVTGADTGK--IFAMKVLKKATIVRNQKDTAHTKAERNILEAV- 57

Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDV------RYYIYELLKA 240
             P IV L  I   Q      LI E+++  +   L+  L    +       +Y+ E+  A
Sbjct: 58  KHPFIVDL--IYAFQTGGKLYLILEYLSGGE---LFMHLEREGIFMEDTACFYLSEISLA 112

Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPEL 299
           L++ H QGI++RD+KP N+++D  Q  ++L D+GL  E  H G   +    +  +  PE+
Sbjct: 113 LEHLHQQGIIYRDLKPENILLDA-QGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEI 171

Query: 300 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 359
           L+    +  ++D WSLG +   M+    PF    +N  +   I K+L          K  
Sbjct: 172 LMR-SGHGKAVDWWSLGALMYDMLTGAPPF--TAENRKK--TIDKIL----------KGK 216

Query: 360 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQER-----PTAKE 414
           + L P+L                         PEA D L KLL+ +   R       A E
Sbjct: 217 LNLPPYLT------------------------PEARDLLKKLLKRNPSSRLGAGPGDAAE 252

Query: 415 AMAHPYF 421
             +HP+F
Sbjct: 253 VQSHPFF 259

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 62.1 bits (151), Expect = 8e-11
 Identities = 65/300 (21%), Positives = 123/300 (41%), Gaps = 63/300 (21%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-----ILKPVKKKKIKREIKILQNLCGGPN 190
           Y  +R +G+G + E        D+   + K      L   +++    EI IL  L   PN
Sbjct: 2   YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLL-QHPN 60

Query: 191 IVKLLDIVRDQQSKTPSL-------IFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDY 243
           I+   +   D  +    +       +++ +     ++      +  V +Y+++++ A+ Y
Sbjct: 61  IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLF----EEEMVLWYLFQIVSAVSY 116

Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELL 300
            H  GI+HRD+K  N+ +  +   ++L D+G+++    G EY++    V + Y+  PE L
Sbjct: 117 IHKAGILHRDIKTLNIFLT-KAGLIKLGDFGISKIL--GSEYSMAETVVGTPYYMSPE-L 172

Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV-KIAKVLGTDELNAYLNKYH 359
                Y++  D+W+LGC+   ++  K  F     N   LV KI +   T  ++ Y     
Sbjct: 173 CQGVKYNFKSDIWALGCVLYELLTLKRTF--DATNPLNLVVKIVQGNYTPVVSVY----- 225

Query: 360 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHP 419
                                            E +  +  LL+ D ++RPTA E +  P
Sbjct: 226 -------------------------------SSELISLVHSLLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 62.3 bits (151), Expect = 9e-11
 Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 38/211 (18%)

Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKIL--KPVKKKKIKREIKILQNLCGGPNIVKLLDIVR 199
           +G+G + +V    H  + +   +K+L  K + KKK ++ I   +N+        LL  V 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNV--------LLKNV- 53

Query: 200 DQQSKTPSLIFEHVNNTDFKVLYPTLSDY-------------------DVRYYIYELLKA 240
               K P L+  H +      LY  L DY                     R+Y  E+  A
Sbjct: 54  ----KHPFLVGLHFSFQTADKLYFVL-DYINGGELFYHLQRERCFLEPRARFYAAEIASA 108

Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPEL 299
           L Y HS  I++RD+KP N+++D  Q  + L D+GL  E        +    +  +  PE+
Sbjct: 109 LGYLHSLNIVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEV 167

Query: 300 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
           L   Q YD ++D W LG +   M++   PF+
Sbjct: 168 L-HKQPYDRTVDWWCLGAVLYEMLYGLPPFY 197

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 62.2 bits (151), Expect = 1e-10
 Identities = 75/321 (23%), Positives = 130/321 (40%), Gaps = 69/321 (21%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLL 195
           Y V++ +  G    VF        +  ++KI    +K     E  +LQN+   P+++++ 
Sbjct: 68  YTVIKTLTPGSEGRVFVATKPGQPDPVVLKI---GQKGTTLIEAMLLQNV-NHPSVIRMK 123

Query: 196 DIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYI-------YELLKALDYCHSQG 248
           D +         ++  H ++     LY  L+       I        ++L+ L Y H+Q 
Sbjct: 124 DTL--VSGAITCMVLPHYSSD----LYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR 177

Query: 249 IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG---------PEL 299
           I+HRDVK  N+ I+    ++ + D G A+F          V +  F G         PE+
Sbjct: 178 IIHRDVKTENIFINDVD-QVCIGDLGAAQF---------PVVAPAFLGLAGTVETNAPEV 227

Query: 300 LVDLQDYDYSLDLWSLGCMFAGM------IFRKEPFF---YGHDNYDQLVKIAKVLGTDE 350
           L     Y+   D+WS G +   M      IF   P     Y    +  L+KI   L    
Sbjct: 228 LAR-DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLK--- 283

Query: 351 LNAYLNKYHIELDP---------HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFL-DK 400
               ++      DP           A+L     R+P++++     Q + +P   +FL  K
Sbjct: 284 ----VHPEEFPRDPGSRLVRGFIEYASLE----RQPYTRYPCF--QRVNLPIDGEFLVHK 333

Query: 401 LLRYDHQERPTAKEAMAHPYF 421
           +L +D   RP+A+E + +P F
Sbjct: 334 MLTFDAAMRPSAEEILNYPMF 354

Length = 357

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 33/98 (33%), Positives = 55/98 (56%), Gaps = 2/98 (2%)

Query: 232 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS 291
           +Y  E+   L+  H + I++RD+KP N+++D +   +R+ D GLA     G+    RV +
Sbjct: 106 FYAAEICCGLEDLHQERIVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVGT 164

Query: 292 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
             +  PE +V  + Y +S D W+LGC+   MI  + PF
Sbjct: 165 VGYMAPE-VVKNERYTFSPDWWALGCLLYEMIAGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 60.9 bits (148), Expect = 1e-10
 Identities = 52/209 (24%), Positives = 96/209 (45%), Gaps = 22/209 (10%)

Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR-----EIKILQNLCGGP 189
           D++V++K+G+G Y  V++    +DN+   +K +      + +R     EI+IL ++   P
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASV-NHP 59

Query: 190 NIVK----LLDIVR----DQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKAL 241
           NI+      LD  +     + +    L          + L P       R +I +LL+ L
Sbjct: 60  NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPE--QEIWRIFI-QLLRGL 116

Query: 242 DYCHSQGIMHRDVKPHNVMI-DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 300
              H Q I+HRD+K  N+++  ++  K+   D G+++           + + ++  PE+ 
Sbjct: 117 QALHEQKILHRDLKSANILLVANDLVKIG--DLGISKVLKKNMAKTQ-IGTPHYMAPEVW 173

Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
              + Y Y  D+WSLGC+   M     PF
Sbjct: 174 KG-RPYSYKSDIWSLGCLLYEMATFAPPF 201

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 61.3 bits (149), Expect = 2e-10
 Identities = 51/206 (24%), Positives = 101/206 (49%), Gaps = 16/206 (7%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK---PVKKKK---IKREIKILQNLCG 187
           DD E ++ VG G +  V             +K++     ++ K+   +  E ++L+ +  
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-S 59

Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYP--TLSDYDVRYYIYELLKALDYC 244
            P I++L     DQ+     ++ E+V   + F  L      S+    +Y  E++ AL+Y 
Sbjct: 60  HPFIIRLFWTEHDQRFLY--MLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYL 117

Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS+ I++RD+KP N+++D E   ++L D+G A+     + + +     Y   PE++   +
Sbjct: 118 HSKEIVYRDLKPENILLDKEGH-IKLTDFGFAKKLR-DRTWTLCGTPEYL-APEVIQS-K 173

Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFF 330
            ++ ++D W+LG +   M+    PFF
Sbjct: 174 GHNKAVDWWALGILIYEMLVGYPPFF 199

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 38/216 (17%)

Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR------EIKILQNLCGG 188
           D+E+   +G G +  V    H    E   IK LK  +  K+K+      E  IL  L   
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSH- 77

Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVL-----YPTLSDYDV-RYYIYELLKAL 241
           P IV ++   +D+       + E V   + F  L     +P     DV ++Y  EL+ A 
Sbjct: 78  PFIVNMMCSFQDE--NRVYFLLEFVVGGELFTHLRKAGRFPN----DVAKFYHAELVLAF 131

Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK---GPE 298
           +Y HS+ I++RD+KP N+++D  +  +++ D+G A+          +V  R F     PE
Sbjct: 132 EYLHSKDIIYRDLKPENLLLD-NKGHVKVTDFGFAK----------KVPDRTFTLCGTPE 180

Query: 299 LL----VDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
            L    +  + +  ++D W++G +    I    PFF
Sbjct: 181 YLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFF 216

Length = 329

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 61.1 bits (148), Expect = 3e-10
 Identities = 55/212 (25%), Positives = 101/212 (47%), Gaps = 37/212 (17%)

Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ 201
           +G+G + +V++ V   D  +  I  +K + KK+I  + ++   + G  NI     +VR  
Sbjct: 1   IGKGTFGQVYQ-VRKKDTRR--IYAMKVLSKKEIVAKKEVAHTI-GERNI-----LVRTL 51

Query: 202 QSKTPSLI---FEHVNNTDFKVLYPTLSDY-------------------DVRYYIYELLK 239
             ++P ++   F    ++D   LY  ++DY                     ++YI EL+ 
Sbjct: 52  LDESPFIVGLKFSFQTDSD---LY-LVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVL 107

Query: 240 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF-YHPGKEYNVRVASRYFKGPE 298
           AL++ H   I++RD+KP N+++D     + L D+GL++      K  N    +  +  PE
Sbjct: 108 ALEHLHKYDIVYRDLKPENILLDATGH-IALCDFGLSKANLTDNKTTNTFCGTTEYLAPE 166

Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
           +L+D + Y   +D WSLG +   M     PF+
Sbjct: 167 VLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFY 198

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 52/210 (24%), Positives = 100/210 (47%), Gaps = 13/210 (6%)

Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK---IKREIKILQNLCGGP 189
           Q DYE++++VG G Y +V++  +    E   +KI+K         I++EI +++  C   
Sbjct: 8   QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKE-CKHC 66

Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPT---LSDYDVRYYIYELLKALDYCHS 246
           NIV        ++     +  E+      + +Y     LS+  + Y   E L+ L Y HS
Sbjct: 67  NIVAYFGSYLSREKLW--ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHS 124

Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
           +G MHRD+K  N+++  +   ++L D+G+ A+      +    + + Y+  PE+    ++
Sbjct: 125 KGKMHRDIKGANILLT-DNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKN 183

Query: 306 --YDYSLDLWSLGCMFAGMIFRKEPFFYGH 333
             Y+   D+W++G     +   + P F  H
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPMFDLH 213

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 60.1 bits (146), Expect = 4e-10
 Identities = 78/339 (23%), Positives = 123/339 (36%), Gaps = 83/339 (24%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDN----EKCIIKILKPVKKKKIKREIKILQNLCGGP 189
           DD+E + ++G G    V + +H         K I   +KP  + +I RE+K+L   C  P
Sbjct: 1   DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHE-CNSP 59

Query: 190 NIVKL---------------------LDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY 228
            IV                       LD V  +  + P  I   ++              
Sbjct: 60  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKIS-------------- 105

Query: 229 DVRYYIYELLKALDYC---HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285
                   +L+ L Y    H   IMHRDVKP N++++  + +++L D+G++         
Sbjct: 106 ------IAVLRGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMA- 155

Query: 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV 345
           N  V +R +  PE L     Y    D+WSLG     M   + P        D   ++  +
Sbjct: 156 NSFVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPI----PPPDAK-ELEAM 209

Query: 346 LGTDELNAYLNKYHIELDPH-------------LAALVGRHSRKPWSKFITVENQHLAVP 392
            G         + H  +  H             L  +V     K  S   +         
Sbjct: 210 FGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFS--------D 261

Query: 393 EAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAESSR 431
           E  DF+DK L+ + +ER   KE   HP+   I+ AE   
Sbjct: 262 EFQDFVDKCLKKNPKERADLKELTKHPF---IKRAELEE 297

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 59.6 bits (144), Expect = 6e-10
 Identities = 54/205 (26%), Positives = 97/205 (47%), Gaps = 24/205 (11%)

Query: 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR---------EIKILQNLCGGPN 190
           R +G+G + EV     C       +   K ++KK+IK+         E +IL+ +    N
Sbjct: 6   RVLGKGGFGEV---CACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV----N 58

Query: 191 IVKLLDIVRDQQSKTP-SLIFEHVNNTDFKV-LY----PTLSDYDVRYYIYELLKALDYC 244
              ++ +    ++K    L+   +N  D K  +Y    P   +    +Y  EL   L+  
Sbjct: 59  SRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDL 118

Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
             + I++RD+KP N+++D ++  +R+ D GLA     G+    RV +  +  PE++ + +
Sbjct: 119 QRERIVYRDLKPENILLD-DRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINN-E 176

Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPF 329
            Y +S D W LGC+   MI  + PF
Sbjct: 177 KYTFSPDWWGLGCLIYEMIQGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 59.6 bits (144), Expect = 6e-10
 Identities = 35/131 (26%), Positives = 70/131 (53%), Gaps = 7/131 (5%)

Query: 208 LIFEHVNNTDFKVLYPTLSDYDV---RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 264
            + E++N  D      +   +D+    +Y  E++  L + HS+GI++RD+K  N+++D +
Sbjct: 73  FVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTD 132

Query: 265 QRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI 323
              +++ D+G+ +    G  +      +  +  PE+L+  Q Y+ S+D WS G +   M+
Sbjct: 133 GH-IKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG-QKYNTSVDWWSFGVLLYEML 190

Query: 324 FRKEPFFYGHD 334
             + P F+GHD
Sbjct: 191 IGQSP-FHGHD 200

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 60.0 bits (145), Expect = 7e-10
 Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 24/215 (11%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCII-------KILKPVKKKKIKREIKILQNLC 186
           DD+E+++ +GRG + EV   V     E+          ++LK  +    + E  +L N  
Sbjct: 1   DDFEIIKVIGRGAFGEV-AVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVN-- 57

Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY---DV-RYYIYELLKALD 242
           G    +  L     Q      L+ ++    D   L     D    D+ R+YI E++ A+ 
Sbjct: 58  GDCQWITTLHYAF-QDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIH 116

Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG--LAEFYHPGKEYNVRVASRYFKGPELL 300
             H    +HRD+KP NV++D     +RL D+G  L        + +V V +  +  PE+L
Sbjct: 117 SIHQLHYVHRDIKPDNVLLDMNGH-IRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEIL 175

Query: 301 VDLQD----YDYSLDLWSLG-CMFAGMIFRKEPFF 330
             ++D    Y    D WSLG CM+  M++ + PF+
Sbjct: 176 QAMEDGMGKYGPECDWWSLGVCMYE-MLYGETPFY 209

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 59.6 bits (144), Expect = 9e-10
 Identities = 77/295 (26%), Positives = 128/295 (43%), Gaps = 49/295 (16%)

Query: 156 CTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 215
           C DN+ C   ++K  ++     E  IL+ +   P+I++L        +K   LI      
Sbjct: 111 CIDNKTCEHVVIKAGQRGGTATEAHILRAI-NHPSIIQLKGTF--TYNKFTCLILPRYK- 166

Query: 216 TDFKVLYPTLSDY------DVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLR 269
           TD   LY  L+        D+      +L+A+ Y H   I+HRD+K  N+ I+H    + 
Sbjct: 167 TD---LYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPG-DVC 222

Query: 270 LIDWGLAEFYHPGKEYNVRV-ASRYF--------KGPELLVDLQDYDYSLDLWSLGCMFA 320
           L D+G A        + V + A++Y+          PELL     Y  ++D+WS G +  
Sbjct: 223 LGDFGAA-------CFPVDINANKYYGWAGTIATNAPELLAR-DPYGPAVDIWSAGIVLF 274

Query: 321 GM------IFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE----LDPHLAALV 370
            M      +F K+      D+  Q+  I +  GT     + N++ I+    LD     L 
Sbjct: 275 EMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGT-----HPNEFPIDAQANLDEIYIGLA 329

Query: 371 GRHSRKPWSKFITVENQHLAVPEAVDFLD-KLLRYDHQERPTAKEAMAHPYFFPI 424
            + SRKP S+ +      L  P  +++L  K+L +D   RP+A+  +    F  I
Sbjct: 330 KKSSRKPGSRPLWTNLYEL--PIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI 382

Length = 391

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 38/107 (35%), Positives = 61/107 (57%), Gaps = 9/107 (8%)

Query: 231 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG--LAEFYHPGKEYNVR 288
           R+Y+ E++ A+D  H  G +HRD+KP NV++D +   +RL D+G  L        + NV 
Sbjct: 105 RFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLD-KNGHIRLADFGSCLRLLADGTVQSNVA 163

Query: 289 VASRYFKGPELLVDLQD----YDYSLDLWSLG-CMFAGMIFRKEPFF 330
           V +  +  PE+L  ++D    Y    D WSLG CM+  M++ + PF+
Sbjct: 164 VGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYE-MLYGETPFY 209

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 59.0 bits (143), Expect = 1e-09
 Identities = 62/260 (23%), Positives = 109/260 (41%), Gaps = 39/260 (15%)

Query: 169 PVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY 228
           P  +K+I RE++I ++ C  P IVK      D+ S +  +  E+        +Y  +   
Sbjct: 40  PDLQKQILRELEINKS-CKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKR 98

Query: 229 DVRYYIYEL-------LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYH 280
             R     L       LK L Y HS+ I+HRD+KP N+++   + +++L D+G++ E  +
Sbjct: 99  GGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLT-RKGQVKLCDFGVSGELVN 157

Query: 281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
                     + ++  PE +   + Y  + D+WSLG     +   + PF    +    L 
Sbjct: 158 SLA--GTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPF--PPEGEPPLG 212

Query: 341 KIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDK 400
            I      + L+  +N  + EL       +       WS+            E  DF+ +
Sbjct: 213 PI------ELLSYIVNMPNPELKDEPGNGIK------WSE------------EFKDFIKQ 248

Query: 401 LLRYDHQERPTAKEAMAHPY 420
            L  D   RPT  + + HP+
Sbjct: 249 CLEKDPTRRPTPWDMLEHPW 268

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 54/214 (25%), Positives = 95/214 (44%), Gaps = 22/214 (10%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCII-------KILKPVKKKKIKREIKILQNLC 186
           +D+E+++ +GRG + EV   V   + +K          ++LK  +    + E  +L N  
Sbjct: 1   EDFEILKVIGRGAFGEV-AVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN-- 57

Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY----DVRYYIYELLKALD 242
           G    +  L     Q      L+ ++    D   L     D       R+Y+ E++ A+D
Sbjct: 58  GDNQWITTLHYAF-QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAID 116

Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG--LAEFYHPGKEYNVRVASRYFKGPELL 300
             H    +HRD+KP N+++D     +RL D+G  L        + +V V +  +  PE+L
Sbjct: 117 SVHQLHYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 175

Query: 301 VDLQD----YDYSLDLWSLGCMFAGMIFRKEPFF 330
             ++D    Y    D WSLG     M++ + PF+
Sbjct: 176 QAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY 209

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 58.9 bits (143), Expect = 1e-09
 Identities = 48/202 (23%), Positives = 79/202 (39%), Gaps = 44/202 (21%)

Query: 235 YELLKALDYC-HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY 293
             ++KAL Y     G++HRDVKP N+++D     ++L D+G++      K          
Sbjct: 121 VAIVKALHYLKEKHGVIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKAKTRSAGCAA 179

Query: 294 FKGPELLVDLQD----YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTD 349
           +  PE + D  D    YD   D+WSLG     +   + P+      ++ L KI       
Sbjct: 180 YMAPERI-DPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKIL------ 232

Query: 350 ELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQER 409
                      + +P         S                 P+   F+D  L  DH++R
Sbjct: 233 -----------QEEPPSLPPNEGFS-----------------PDFCSFVDLCLTKDHRKR 264

Query: 410 PTAKEAMAHPYFFPIRNAESSR 431
           P  +E + HP+   IR  E++ 
Sbjct: 265 PKYRELLQHPF---IRRYETAE 283

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 49/187 (26%), Positives = 84/187 (44%), Gaps = 40/187 (21%)

Query: 237 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFK 295
           +L+AL Y H+QG++HRD+K  ++++  + R ++L D+G  A+      +    V + Y+ 
Sbjct: 127 VLRALSYLHNQGVIHRDIKSDSILLTSDGR-IKLSDFGFCAQVSKEVPKRKSLVGTPYWM 185

Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 355
            PE++  L  Y   +D+WSLG M   MI  + P+F                         
Sbjct: 186 APEVISRLP-YGTEVDIWSLGIMVIEMIDGEPPYFN------------------------ 220

Query: 356 NKYHIELDPHLAALVG-RHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKE 414
                  +P L A+   R +  P      V++ H        FLD +L  +  +R TA+E
Sbjct: 221 -------EPPLQAMRRIRDNLPP-----RVKDSHKVSSVLRGFLDLMLVREPSQRATAQE 268

Query: 415 AMAHPYF 421
            + HP+ 
Sbjct: 269 LLQHPFL 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 58.4 bits (141), Expect = 1e-09
 Identities = 56/227 (24%), Positives = 101/227 (44%), Gaps = 23/227 (10%)

Query: 139 VRKVGRGKYSEVFEGVHCTD------NEKCIIKILK----PVKKKKIKREIKILQNLCGG 188
           +R +G G + +V   ++C D       E   +K LK           K+EI IL+ L   
Sbjct: 9   IRVLGEGHFGKV--SLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL-YH 65

Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHS 246
            NIVK      +Q  K   LI E+V     +   P   L+   +  +  ++ + + Y HS
Sbjct: 66  ENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHS 125

Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASR-----YFKGPELLV 301
           Q  +HRD+   NV++D++ R +++ D+GLA+    G EY  RV        ++   E L 
Sbjct: 126 QHYIHRDLAARNVLLDND-RLVKIGDFGLAKAVPEGHEY-YRVREDGDSPVFWYAVECLK 183

Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
           + +   Y+ D+WS G     ++   +        +++++   +   T
Sbjct: 184 ENKFS-YASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMT 229

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 58.4 bits (141), Expect = 1e-09
 Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 27/198 (13%)

Query: 139 VRKVGRGKYSEVF------EGVHCTDN--EKCIIKILKPVKKKK----IKREIKILQNLC 186
           +R +G G + +V       EG    DN  E+  +K LKP         +K+EI+IL+NL 
Sbjct: 9   IRDLGEGHFGKVELCRYDPEG----DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY 64

Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALD 242
              NIVK   I  +       LI E + +   K   P     ++      Y  ++ K +D
Sbjct: 65  H-ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMD 123

Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV----RVASRYFKGPE 298
           Y  S+  +HRD+   NV+++ E + +++ D+GL +     KEY        +  ++  PE
Sbjct: 124 YLGSRQYVHRDLAARNVLVESEHQ-VKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPE 182

Query: 299 LLVDLQDYDYSLDLWSLG 316
            L+  + Y  S D+WS G
Sbjct: 183 CLIQSKFYIAS-DVWSFG 199

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 58.8 bits (142), Expect = 2e-09
 Identities = 41/133 (30%), Positives = 67/133 (50%), Gaps = 9/133 (6%)

Query: 204 KTPSLIF---EHVNNTDFKVLYPTLSDYD---VRYYIYELLKALDYCHSQGIMHRDVKPH 257
           +TP  +F   E VN  D          +D    R+Y  E+  AL + H +GI++RD+K  
Sbjct: 66  QTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLD 125

Query: 258 NVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLG 316
           NV++DHE    +L D+G+  E    GK  +    +  +  PE+L ++  Y  S+D W++G
Sbjct: 126 NVLLDHEGH-CKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEML-YGPSVDWWAMG 183

Query: 317 CMFAGMIFRKEPF 329
            +   M+    PF
Sbjct: 184 VLLYEMLCGHAPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 71/301 (23%), Positives = 124/301 (41%), Gaps = 49/301 (16%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDN----EKCIIKILKPVKKKKIKREIKILQNLCGGP 189
           +D E +  +G G    V +  H        +K +    K   +K+I RE++I+   C  P
Sbjct: 5   EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHE-CRSP 63

Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTD--FKVLYPTLSDYDVRYYIYELLKALDYCHS- 246
            IV       ++ +    + F    + D  +K   P   +  +      +++ L Y ++ 
Sbjct: 64  YIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEI-LGKIAVAVVEGLTYLYNV 122

Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN----VRVASRYFKGPELLVD 302
             IMHRD+KP N++++  + +++L D+G++     G+  N      V +  +  PE    
Sbjct: 123 HRIMHRDIKPSNILVN-SRGQIKLCDFGVS-----GELINSIADTFVGTSTYMSPE---R 173

Query: 303 LQDYDYSL--DLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 360
           +Q   Y++  D+WSLG     +   K PF + + + D       +L  D L   +     
Sbjct: 174 IQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGIL--DLLQQIVQ---- 227

Query: 361 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 420
           E  P L          P S F           +  DF+D  L  D  ERPT ++  A P 
Sbjct: 228 EPPPRL----------PSSDF---------PEDLRDFVDACLLKDPTERPTPQQLCAMPP 268

Query: 421 F 421
           F
Sbjct: 269 F 269

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 60/250 (24%), Positives = 103/250 (41%), Gaps = 47/250 (18%)

Query: 178 EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK---VLYPTLSDYDVRYYI 234
           EI++L+NL     IV+    +RD + K  S+  E++     K     Y  L++   R Y 
Sbjct: 54  EIQLLKNL-RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYT 112

Query: 235 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE----FYHPGKEYNVRVA 290
            ++L+ + Y HS  I+HRD+K  N++ D     ++L D+G ++        G        
Sbjct: 113 RQILQGVSYLHSNMIVHRDIKGANILRD-SAGNVKLGDFGASKRIQTICMSGTGIKSVTG 171

Query: 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE 350
           + Y+  PE ++  + Y    D+WS+ C    M+  K P+      Y+ +  I K+  T  
Sbjct: 172 TPYWMSPE-VISGEGYGRKADVWSVACTVVEMLTEKPPW----AEYEAMAAIFKI-ATQP 225

Query: 351 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP 410
                        P L   V    R                    DFL ++   + + RP
Sbjct: 226 TK-----------PMLPDGVSDACR--------------------DFLKQIFVEEKR-RP 253

Query: 411 TAKEAMAHPY 420
           TA+  + HP+
Sbjct: 254 TAEFLLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 43/160 (26%), Positives = 77/160 (48%), Gaps = 21/160 (13%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKRE----IKILQNLCG-- 187
           DD+E ++ +GRG + EV             +K L+  K + +++E    ++  +++    
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLR--KSEMLEKEQVAHVRAERDILAEA 58

Query: 188 -GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDY 243
             P +VKL    +D       LI E++   D   L     T ++ + R+YI E + A+D 
Sbjct: 59  DNPWVVKLYYSFQD--ENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDS 116

Query: 244 CHSQGIMHRDVKPHNVMID---HEQRKLRLIDWGLAEFYH 280
            H  G +HRD+KP N+++D   H    ++L D+GL     
Sbjct: 117 IHKLGYIHRDIKPDNLLLDAKGH----IKLSDFGLCTGLK 152

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 57.5 bits (139), Expect = 2e-09
 Identities = 49/205 (23%), Positives = 88/205 (42%), Gaps = 26/205 (12%)

Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK----IKREIKILQNLCGGPNIVKLLDI 197
           +G+G Y  V+     +   +  IK + P +  +    +  EI +   L    NIV+ L  
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEI-PERDSRYVQPLHEEIALHSYLKHR-NIVQYLG- 72

Query: 198 VRDQQSKTPSLIFEHVNNTDFKVLYPT----LSDYD--VRYYIYELLKALDYCHSQGIMH 251
             D ++    +  E V       L  +    L D +  + +Y  ++L+ L Y H   I+H
Sbjct: 73  -SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVH 131

Query: 252 RDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------PELL-VDLQ 304
           RD+K  NV+++     +++ D+G ++     +   +   +  F G      PE++    +
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFGTSK-----RLAGINPCTETFTGTLQYMAPEVIDKGPR 186

Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPF 329
            Y    D+WSLGC    M   K PF
Sbjct: 187 GYGAPADIWSLGCTIVEMATGKPPF 211

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 57.5 bits (139), Expect = 3e-09
 Identities = 39/135 (28%), Positives = 65/135 (48%), Gaps = 8/135 (5%)

Query: 209 IFEHVNNTDFKVLYPTLSDYD---VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ 265
           + E+VN  D          +D    R+Y  E+  AL + H  G+++RD+K  N+++D E 
Sbjct: 74  VMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEG 133

Query: 266 RKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF 324
              +L D+G+  E    G        +  +  PE+L +  +Y  S+D W+LG +   M+ 
Sbjct: 134 H-CKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMA 191

Query: 325 RKEPFFYGHDNYDQL 339
            + PF    DN D L
Sbjct: 192 GQPPF--EADNEDDL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 57.7 bits (139), Expect = 4e-09
 Identities = 35/113 (30%), Positives = 58/113 (51%), Gaps = 5/113 (4%)

Query: 231 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRV 289
           R+Y  E+  AL Y HS  I++RD+KP N+++D  Q  + L D+GL  E            
Sbjct: 99  RFYAAEIASALGYLHSINIVYRDLKPENILLD-SQGHVVLTDFGLCKEGIAQSDTTTTFC 157

Query: 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFY--GHDNYDQLV 340
            +  +  PE++   Q YD ++D W LG +   M++   PF+     + YD ++
Sbjct: 158 GTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNIL 209

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 57.3 bits (138), Expect = 4e-09
 Identities = 32/101 (31%), Positives = 57/101 (56%), Gaps = 3/101 (2%)

Query: 231 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRV 289
           R+Y  E++ AL+Y HS+ +++RD+K  N+M+D +   +++ D+GL  E    G       
Sbjct: 98  RFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFC 156

Query: 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
            +  +  PE+L D  DY  ++D W LG +   M+  + PF+
Sbjct: 157 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY 196

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 57.5 bits (139), Expect = 5e-09
 Identities = 51/198 (25%), Positives = 98/198 (49%), Gaps = 28/198 (14%)

Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL----KPVKKKKIKREIKILQNLCGGPN 190
           + E V ++G G    V++ +H        +K++    +   +++I REI+IL+++   PN
Sbjct: 75  ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDV-NHPN 133

Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHS 246
           +VK  D+     +    ++ E ++    +  +      L+D        ++L  + Y H 
Sbjct: 134 VVKCHDMF--DHNGEIQVLLEFMDGGSLEGTHIADEQFLADVA-----RQILSGIAYLHR 186

Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWG----LAEFYHPGKEYNVRVASRYFKGPELL-V 301
           + I+HRD+KP N++I+   + +++ D+G    LA+   P    N  V +  +  PE +  
Sbjct: 187 RHIVHRDIKPSNLLIN-SAKNVKIADFGVSRILAQTMDP---CNSSVGTIAYMSPERINT 242

Query: 302 DLQD--YD-YSLDLWSLG 316
           DL    YD Y+ D+WSLG
Sbjct: 243 DLNHGAYDGYAGDIWSLG 260

Length = 353

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 56.5 bits (136), Expect = 5e-09
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 21/208 (10%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNLCGGPN 190
           Y  VR VG+G Y EV    H TD ++ +IK L        ++K  ++E ++L  L   PN
Sbjct: 2   YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL-KHPN 60

Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY--------DVRYYIYELLKALD 242
           IV      R+       L++  +   +   LY  L +          V  +  ++  AL 
Sbjct: 61  IV----AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQ 116

Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLV 301
           Y H + I+HRD+K  NV +      +++ D G+A       +  +  + + Y+  PEL  
Sbjct: 117 YLHEKHILHRDLKTQNVFLT-RTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFS 175

Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
           + + Y+Y  D+W+LGC    M   K  F
Sbjct: 176 N-KPYNYKSDVWALGCCVYEMATLKHAF 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 56.9 bits (137), Expect = 5e-09
 Identities = 36/119 (30%), Positives = 66/119 (55%), Gaps = 5/119 (4%)

Query: 228 YDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYN 286
           Y   +Y  E++  L + HS+GI++RD+K  NVM+D +   +++ D+G+  E        +
Sbjct: 96  YRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGH-IKIADFGMCKENVFGDNRAS 154

Query: 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV 345
               +  +  PE+L  L+ Y +S+D WS G +   M+  + P F+G D+ D+L +  +V
Sbjct: 155 TFCGTPDYIAPEILQGLK-YTFSVDWWSFGVLLYEMLIGQSP-FHG-DDEDELFESIRV 210

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 56.4 bits (136), Expect = 6e-09
 Identities = 54/220 (24%), Positives = 104/220 (47%), Gaps = 26/220 (11%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-----ILKPVKKKKIKREIKILQNLCGGPN 190
           Y  V+K+G G + +        D ++ +IK      + P ++++ ++E+ +L N+   PN
Sbjct: 2   YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNM-KHPN 60

Query: 191 IVKL---------LDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKAL 241
           IV+          L IV D        +++ +N     VL+P   +  +  +  ++  AL
Sbjct: 61  IVQYQESFEENGNLYIVMDYCEGGD--LYKKINAQR-GVLFP---EDQILDWFVQICLAL 114

Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELL 300
            + H + I+HRD+K  N+ +  +   ++L D+G+A   +   E     + + Y+  PE +
Sbjct: 115 KHVHDRKILHRDIKSQNIFLTKDG-TIKLGDFGIARVLNSTVELARTCIGTPYYLSPE-I 172

Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
            + + Y+   D+W+LGC+   M   K  F  G  N   LV
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLKHAFEAG--NMKNLV 210

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 57.0 bits (138), Expect = 6e-09
 Identities = 33/107 (30%), Positives = 57/107 (53%), Gaps = 17/107 (15%)

Query: 231 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR-- 288
           R+Y  E++  L + H +GI++RD+K  NV++D E   +++ D+G+       KE  +   
Sbjct: 99  RFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGH-IKIADFGMC------KE-GILGG 150

Query: 289 VASRYFKG------PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
           V +  F G      PE+L   Q Y  ++D W+LG +   M+  + PF
Sbjct: 151 VTTSTFCGTPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPF 196

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 56.5 bits (136), Expect = 7e-09
 Identities = 32/104 (30%), Positives = 55/104 (52%), Gaps = 3/104 (2%)

Query: 228 YDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-YN 286
              R+Y  ELL AL+  H   +++RD+KP N+++D+ Q  + L D+GL +      +  N
Sbjct: 93  SRARFYTAELLCALENLHKFNVIYRDLKPENILLDY-QGHIALCDFGLCKLNMKDDDKTN 151

Query: 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
               +  +  PELL+    Y  ++D W+LG +   M+    PF+
Sbjct: 152 TFCGTPEYLAPELLLGH-GYTKAVDWWTLGVLLYEMLTGLPPFY 194

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 56.3 bits (136), Expect = 8e-09
 Identities = 34/116 (29%), Positives = 62/116 (53%), Gaps = 7/116 (6%)

Query: 226 SDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA--EFYHPGK 283
            +   R+Y  E++  L + H +GI++RD+K  NV++D +   +++ D+G+        GK
Sbjct: 94  DEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGH-IKIADFGMCKENMNGEGK 152

Query: 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQL 339
             +    +  +  PE+L   Q Y+ S+D WS G +   M+  + P F+G D  D+L
Sbjct: 153 A-STFCGTPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSP-FHGEDE-DEL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 56.4 bits (136), Expect = 1e-08
 Identities = 33/108 (30%), Positives = 57/108 (52%), Gaps = 3/108 (2%)

Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPG 282
             S+   R+Y  E++ AL Y HS  +++RD+K  N+M+D +   +++ D+GL  E    G
Sbjct: 91  VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGH-IKITDFGLCKEGISDG 149

Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
                   +  +  PE+L D  DY  ++D W LG +   M+  + PF+
Sbjct: 150 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY 196

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 55.6 bits (134), Expect = 1e-08
 Identities = 45/167 (26%), Positives = 78/167 (46%), Gaps = 16/167 (9%)

Query: 174 KIKREIKILQNLCGGPNIVKL---------LDIVRDQQSKTPSLIFEHVNNTDFKVLYPT 224
            I  E+ I++     PNIV+          L IV D     P  + EH N+   K     
Sbjct: 54  DIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAP--LGEHFNS--LKEKKQR 109

Query: 225 LSDYDVRYYIYELLKALDYCHSQG-IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
            ++  +     +++ AL Y H +  I+HRD+ P+N+M+  E  K+ + D+GLA+   P  
Sbjct: 110 FTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLG-EDDKVTITDFGLAKQKQPES 168

Query: 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
           +    V +  +  PE++ +   Y    D+W+ GC+   M   + PF+
Sbjct: 169 KLTSVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQPPFY 214

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 55.5 bits (133), Expect = 2e-08
 Identities = 34/107 (31%), Positives = 57/107 (53%), Gaps = 3/107 (2%)

Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGK 283
            S+   R+Y  E++ ALDY HS  I++RD+K  N+M+D +   +++ D+GL  E      
Sbjct: 92  FSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGH-IKITDFGLCKEGITDAA 150

Query: 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
                  +  +  PE+L D  DY  ++D W LG +   M+  + PF+
Sbjct: 151 TMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY 196

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 62/241 (25%), Positives = 107/241 (44%), Gaps = 50/241 (20%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKK---IKREIKILQNLCG 187
           DD+E ++ +GRG + EV             +KIL+    ++K++   I+ E  IL     
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVE-AD 59

Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYC 244
           G  +VK+    +D+++    LI E +   D   L     TLS+   ++YI E + A+D  
Sbjct: 60  GAWVVKMFYSFQDKRNLY--LIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAI 117

Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL---------AEFY-----HPGKEYNVR-- 288
           H  G +HRD+KP N+++D  +  ++L D+GL          EFY     +P  +++ +  
Sbjct: 118 HQLGFIHRDIKPDNLLLD-AKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNM 176

Query: 289 --------------------VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEP 328
                               V +  +  PE+ +    Y+   D WSLG +   M+    P
Sbjct: 177 NSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPP 235

Query: 329 F 329
           F
Sbjct: 236 F 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 55.0 bits (133), Expect = 3e-08
 Identities = 42/155 (27%), Positives = 73/155 (47%), Gaps = 17/155 (10%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTD-NEKCIIKILKP---VKKKKIKR---EIKILQNLC 186
             ++ ++ +G+G    VF  V      +   +K+L     +K+ K+KR   E +IL  L 
Sbjct: 1   KHFKKIKLLGKGDVGRVFL-VRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL- 58

Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPT-----LSDYDVRYYIYELLKAL 241
             P +  L      Q      L+ ++    +   L        LS+   R+Y  E+L AL
Sbjct: 59  DHPFLPTLY--ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLAL 116

Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
           +Y H  GI++RD+KP N+++ HE   + L D+ L+
Sbjct: 117 EYLHLLGIVYRDLKPENILL-HESGHIMLSDFDLS 150

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 50/193 (25%), Positives = 85/193 (44%), Gaps = 22/193 (11%)

Query: 141 KVGRGKYSEVFEGVHCTDNEKCIIK----ILKPVKKKKIKREIKILQNLCGGPNIVKLLD 196
           ++GRG + EVF G    DN    +K     L P  K K  +E +IL+     PNIV+L+ 
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIG 60

Query: 197 IVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLK-------ALDYCHSQGI 249
           +    Q +   ++ E V   DF      L     R  + EL++        ++Y  S+  
Sbjct: 61  VC--TQKQPIYIVMELVQGGDFLTF---LRTEGPRLKVKELIQMVENAAAGMEYLESKHC 115

Query: 250 MHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG---KEYNVRVASRYFKGPELLVDLQDY 306
           +HRD+   N ++  E+  L++ D+G++     G       ++     +  PE L +   Y
Sbjct: 116 IHRDLAARNCLVT-EKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEAL-NYGRY 173

Query: 307 DYSLDLWSLGCMF 319
               D+WS G + 
Sbjct: 174 SSESDVWSFGILL 186

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 54.3 bits (130), Expect = 4e-08
 Identities = 34/108 (31%), Positives = 59/108 (54%), Gaps = 4/108 (3%)

Query: 225 LSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPG 282
            S+   R+Y  E++ ALDY HS+  +++RD+K  N+M+D +   +++ D+GL  E    G
Sbjct: 92  FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDG 150

Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
                   +  +  PE+L D  DY  ++D W LG +   M+  + PF+
Sbjct: 151 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY 197

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 53.8 bits (129), Expect = 4e-08
 Identities = 49/207 (23%), Positives = 96/207 (46%), Gaps = 19/207 (9%)

Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-PVKKKKIK--REIKILQNLCGGPNI 191
            Y V+R VG G +       H   ++K  +K ++ P     ++  R+  +L      PNI
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60

Query: 192 VKLLDIVRDQQSKTPSLIFEHVNNTDF--KV------LYPTLSDYDVRYYIYELLKALDY 243
           V   +    +      ++ E+ +  D   K+      L+P   D  +++++ ++   + +
Sbjct: 61  VAFKESF--EADGHLYIVMEYCDGGDLMQKIKLQRGKLFP--EDTILQWFV-QMCLGVQH 115

Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVD 302
            H + ++HRD+K  N+ +  +  K++L D+G A     PG      V + Y+  PE+  +
Sbjct: 116 IHEKRVLHRDIKSKNIFLT-QNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWEN 174

Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPF 329
           +  Y+   D+WSLGC+   +   K PF
Sbjct: 175 MP-YNNKSDIWSLGCILYELCTLKHPF 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 54.1 bits (130), Expect = 6e-08
 Identities = 48/159 (30%), Positives = 77/159 (48%), Gaps = 19/159 (11%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK----KK-----IKREIKILQN 184
           +D+  V+ +G+G + EV   V   D  K  I  +K + K    KK     +K E  +L  
Sbjct: 1   EDFHTVKVIGKGAFGEV-RLVQKKDTGK--IYAMKTLLKSEMFKKDQLAHVKAERDVLAE 57

Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKAL 241
               P +V L    +D Q     LI E +   D   +   Y T S+   R+Y+ E + A+
Sbjct: 58  -SDSPWVVSLYYSFQDAQYLY--LIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAI 114

Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280
           +  H  G +HRD+KP N++ID     ++L D+GL+  +H
Sbjct: 115 EAVHKLGFIHRDIKPDNILIDRGGH-IKLSDFGLSTGFH 152

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 53.5 bits (128), Expect = 6e-08
 Identities = 50/215 (23%), Positives = 105/215 (48%), Gaps = 27/215 (12%)

Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKI----------KREIKILQN 184
           ++E+++ +G G Y +VF     + ++   +  +K +KK  I          + E ++L++
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLS------DYDVRYYIYELL 238
           +   P +V L      Q      LI +++N  +   L+  LS      + +V+ Y  E++
Sbjct: 61  IRQSPFLVTLHYAF--QTDTKLHLILDYINGGE---LFTHLSQRERFKEQEVQIYSGEIV 115

Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG---KEYNVRVASRYFK 295
            AL++ H  GI++RD+K  N+++D     + L D+GL++ +H     + Y+      Y  
Sbjct: 116 LALEHLHKLGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFHEDEVERAYSFCGTIEYM- 173

Query: 296 GPELLVDLQD-YDYSLDLWSLGCMFAGMIFRKEPF 329
            P+++      +D ++D WS+G +   ++    PF
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF 208

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 53.7 bits (129), Expect = 1e-07
 Identities = 42/151 (27%), Positives = 79/151 (52%), Gaps = 11/151 (7%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQN---LCGG 188
           +++ +V+ + RG + +V+ G    +++   +K++K      K +  +++  ++   L   
Sbjct: 4   EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63

Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD---VRYYIYELLKALDYCH 245
           P IV L   +  Q +    L+ E++   D K L      +D      YI E+  ALDY H
Sbjct: 64  PFIVHLYYSL--QSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLH 121

Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
             GI+HRD+KP N++I +E   ++L D+GL+
Sbjct: 122 RHGIIHRDLKPDNMLISNEGH-IKLTDFGLS 151

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 31/99 (31%), Positives = 53/99 (53%), Gaps = 3/99 (3%)

Query: 232 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVA 290
           +Y  E+   L + HS+GI++RD+K  NVM+D E   +++ D+G+  E    GK       
Sbjct: 105 FYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGH-IKIADFGMCKENIFGGKTTRTFCG 163

Query: 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
           +  +  PE ++  Q Y  S+D W+ G +   M+  + PF
Sbjct: 164 TPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQPPF 201

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 53.3 bits (128), Expect = 2e-07
 Identities = 31/112 (27%), Positives = 54/112 (48%), Gaps = 15/112 (13%)

Query: 173 KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS----LIFEHVNNTDFKVLYPT---L 225
            + +RE  +   L   PNIV LLD       + P      +FE+V     + +      L
Sbjct: 23  ARFRRETALCARL-YHPNIVALLD-----SGEAPPGLLFAVFEYVPGRTLREVLAADGAL 76

Query: 226 SDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--QRKLRLIDWGL 275
              +    + ++L AL   H+QGI+HRD+KP N+M+     +   +++D+G+
Sbjct: 77  PAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGI 128

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 51.6 bits (123), Expect = 3e-07
 Identities = 54/212 (25%), Positives = 92/212 (43%), Gaps = 28/212 (13%)

Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDN----EKCIIKILKPVKKKKIKREIKILQNLCG 187
           + DD+E + ++G G    VF+  H         K I   +KP  + +I RE+++L   C 
Sbjct: 3   KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHE-CN 61

Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF--------KVLYPTLSDYDVRYYIYELLK 239
            P IV              S+  EH++            ++    L    +      ++K
Sbjct: 62  SPYIVGFYGAFYSDGEI--SICMEHMDGGSLDQVLKKAGRIPEQILGKVSI-----AVIK 114

Query: 240 ALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
            L Y   +  IMHRDVKP N++++  + +++L D+G++         N  V +R +  PE
Sbjct: 115 GLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMA-NSFVGTRSYMSPE 172

Query: 299 LLVDLQDYDYSL--DLWSLGCMFAGMIFRKEP 328
               LQ   YS+  D+WS+G     M   + P
Sbjct: 173 ---RLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 51.0 bits (122), Expect = 6e-07
 Identities = 49/238 (20%), Positives = 82/238 (34%), Gaps = 84/238 (35%)

Query: 231 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL---------AEFYHP 281
           R+YI EL  A++  H  G +HRD+KP N++ID +   ++L D+GL         +++Y  
Sbjct: 104 RFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH-IKLTDFGLCTGFRWTHDSKYYQK 162

Query: 282 G-------------------------KEYNVR----------VASRYFKGPELLVDLQDY 306
           G                         +    R          V +  +  PE+L+    Y
Sbjct: 163 GDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGY 221

Query: 307 DYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL 366
               D WS+G +   M+  + PF     +            T                  
Sbjct: 222 TQLCDWWSVGVILYEMLVGQPPF---LAD--------TPAET------------------ 252

Query: 367 AALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQER---PTAKEAMAHPYF 421
                +     W   + + +Q     EA D + +L     ++R     A E  AHP+F
Sbjct: 253 -----QLKVINWETTLHIPSQAKLSREASDLILRLCC-GAEDRLGKNGADEIKAHPFF 304

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 49.5 bits (118), Expect = 1e-06
 Identities = 47/201 (23%), Positives = 89/201 (44%), Gaps = 18/201 (8%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK--------REIKILQNLCG 187
           Y + +++G+G +  V+         +  +K+LK +   ++         +E ++L  L  
Sbjct: 2   YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL-D 60

Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALD 242
            P IVK      ++ +      +    + D K+        TLS+  V  +  +LL  + 
Sbjct: 61  HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120

Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLV 301
           Y H + I+HRD+K  N+ +  +   L++ D+G++       +       + Y+  PE L 
Sbjct: 121 YMHQRRILHRDLKAKNIFL--KNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALK 178

Query: 302 DLQDYDYSLDLWSLGCMFAGM 322
             Q YD   D+WSLGC+   M
Sbjct: 179 H-QGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 49.5 bits (118), Expect = 1e-06
 Identities = 63/294 (21%), Positives = 112/294 (38%), Gaps = 52/294 (17%)

Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKI-LKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRD 200
           +G+G Y  V+ G+        + ++ L        ++E + LQ        +K ++IV+ 
Sbjct: 8   LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67

Query: 201 ----QQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCHSQGIMHRD 253
                   T S+  E V       +   +  L +     Y  ++L  + Y H+  ++HRD
Sbjct: 68  LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRD 127

Query: 254 VKPHNVMIDHEQRKLRLIDWG----LAEFYHPGKEYNVRVASR---YFKGPELLVDLQDY 306
           +K +NVM+      ++LID+G    LA     G   N+  +     Y+  PE++ +   Y
Sbjct: 128 IKGNNVML-MPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE-SGY 185

Query: 307 DYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL 366
               D+WS+GC    M   K P      + D+L  +  +     L          L    
Sbjct: 186 GRKSDIWSIGCTVFEMATGKPPL----ASMDRLAAMFYIGAHRGLMP-------RLPDSF 234

Query: 367 AALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 420
           +A                         A+DF+   L  D  ERP+A + + H +
Sbjct: 235 SA------------------------AAIDFVTSCLTRDQHERPSALQLLRHDF 264

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 49.5 bits (119), Expect = 1e-06
 Identities = 51/198 (25%), Positives = 87/198 (43%), Gaps = 39/198 (19%)

Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
           LS+ +V+  I +L++AL+  H   I+H D+K  NV+ D  + ++ L D+GL +       
Sbjct: 106 LSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSC 165

Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
           Y+  +   YF  PE +    +YD S D W++G +   ++  K PF    D          
Sbjct: 166 YDGTLD--YFS-PEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE--------- 212

Query: 345 VLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRY 404
                           ELD    +L+ R  +K    FI   +++     A DF+  +L+Y
Sbjct: 213 ----------------ELDL--ESLLKRQQKKL--PFIKNVSKN-----ANDFVQSMLKY 247

Query: 405 DHQER-PTAKEAMAHPYF 421
           +   R     E + HP+ 
Sbjct: 248 NINYRLTNYNEIIKHPFL 265

Length = 267

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 49.3 bits (118), Expect = 2e-06
 Identities = 44/197 (22%), Positives = 79/197 (40%), Gaps = 46/197 (23%)

Query: 231 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRV 289
            +Y   ++  L Y H   I++RD+K  N+++D E   +++ D+GL  E    G   +   
Sbjct: 104 VFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGF-VKIADFGLCKEGMGFGDRTSTFC 162

Query: 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTD 349
            +  F  PE+L +   Y  ++D W LG +   M+  + PF                 G D
Sbjct: 163 GTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPF----------------PGDD 205

Query: 350 ELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQER 409
           E            +    ++V    R P         + L+  EA+  + +LLR + + R
Sbjct: 206 E------------EEVFDSIVNDEVRYP---------RFLSR-EAISIMRRLLRRNPERR 243

Query: 410 -----PTAKEAMAHPYF 421
                  A++    P+F
Sbjct: 244 LGSGEKDAEDVKKQPFF 260

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 53/215 (24%), Positives = 85/215 (39%), Gaps = 64/215 (29%)

Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE---------FYH 280
            R Y  E + AL+Y H+ GI+HRD+KP N++I      ++L D+GL++          Y 
Sbjct: 103 ARMYFAETVLALEYLHNYGIVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMSLTTNLY- 160

Query: 281 PGKEYNVRVASRYFK-----------GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
              E ++   +R F             PE+++  Q Y   +D W++G +    +    PF
Sbjct: 161 ---EGHIEKDTREFLDKQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPF 216

Query: 330 FYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHL 389
           F   D  ++L    +V+  D          IE                W      E    
Sbjct: 217 F--GDTPEEL--FGQVISDD----------IE----------------WP-----EGDEA 241

Query: 390 AVPEAVDFLDKLLRYDHQER---PTAKEAMAHPYF 421
              +A D + +LLR +  ER     A E   H +F
Sbjct: 242 LPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFF 276

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 34/105 (32%), Positives = 56/105 (53%), Gaps = 15/105 (14%)

Query: 232 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR-VA 290
           +Y  E+   L + H +GI++RD+K  NVM+D E   +++ D+G+       KE+ V  V 
Sbjct: 105 FYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGH-IKIADFGMC------KEHMVDGVT 157

Query: 291 SRYFKG------PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
           +R F G      PE++   Q Y  S+D W+ G +   M+  + PF
Sbjct: 158 TRTFCGTPDYIAPEIIA-YQPYGKSVDWWAYGVLLYEMLAGQPPF 201

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 49.3 bits (117), Expect = 3e-06
 Identities = 78/308 (25%), Positives = 119/308 (38%), Gaps = 68/308 (22%)

Query: 161 KCIIKILKPVKKK-----KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 215
           KC   I K VK       +++ EI  L  L    NI+K+ +I+R     + +  +     
Sbjct: 191 KCERLIAKRVKAGSRAAIQLENEILALGRL-NHENILKIEEILR-----SEANTYMITQK 244

Query: 216 TDFKVLYPTLSDYDV-----------RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 264
            DF  LY  + D              R  + +LL A++Y H + ++HRD+K  N+ ++ +
Sbjct: 245 YDFD-LYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD 303

Query: 265 QRKLRLIDWGLAEFYHPGKEYNVRVASRY-------FKGPELLVDLQDYDYSLDLWSLGC 317
             K+ L D+G A  +        R A  Y          PE+L     Y    D+WS G 
Sbjct: 304 G-KIVLGDFGTAMPFE-----KEREAFDYGWVGTVATNSPEILAG-DGYCEITDIWSCGL 356

Query: 318 MFAGMIFRKE-PFFYGHDN-YDQLVKIAKVLGT-DE--------LNAYLNKYHIELDPHL 366
           +   M+     P   G      QL+KI   L   DE        L  Y++   I+   H 
Sbjct: 357 ILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHS 416

Query: 367 AALVGRHSRKPWSKFITVENQHLAVPEAVDF-LDKLLRYDHQERPTAKEAMAHPYFFPIR 425
              + R             N  L  P   ++ L K+L +D   RP A E +A P F    
Sbjct: 417 VPPLIR-------------NLGL--PADFEYPLVKMLTFDWHLRPGAAELLALPLF---- 457

Query: 426 NAESSRSR 433
           +AE     
Sbjct: 458 SAEEEEEI 465

Length = 501

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 52/228 (22%), Positives = 108/228 (47%), Gaps = 29/228 (12%)

Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPN 190
           ++  ++V+K+G G++ EV+ G +  ++ K  +K LKP  +  +    E  +++ L     
Sbjct: 5   RESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGTMSVQAFLEEANLMKTL-QHDK 62

Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNN---TDF-------KVLYPTLSDYDVRYYIYELLKA 240
           +V+L  +V   + +   +I E++      DF       KVL P L D+       ++ + 
Sbjct: 63  LVRLYAVV--TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA-----QIAEG 115

Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGP 297
           + Y   +  +HRD++  NV++  E    ++ D+GLA       EY  R  +++   +  P
Sbjct: 116 MAYIERKNYIHRDLRAANVLVS-ESLMCKIADFGLARVIE-DNEYTAREGAKFPIKWTAP 173

Query: 298 ELLVDLQDYDYSLDLWSLGCMFAGMI-FRKEPFFYGHDNYDQLVKIAK 344
           E  ++   +    D+WS G +   ++ + K P + G  N D +  + +
Sbjct: 174 E-AINFGSFTIKSDVWSFGILLYEIVTYGKIP-YPGMSNSDVMSALQR 219

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 47.2 bits (112), Expect = 6e-06
 Identities = 63/287 (21%), Positives = 115/287 (40%), Gaps = 48/287 (16%)

Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKIL----KPVKKKKIKREIKILQNLCGGPNIVKLLD- 196
           +G G    V++  H        +K++        +K+I  E++IL   C  P I+     
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYK-CDSPYIIGFYGA 67

Query: 197 -IVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVK 255
             V ++ S    +  E ++     V Y  + ++ +      ++K L Y  S  I+HRDVK
Sbjct: 68  FFVENRIS----ICTEFMDGGSLDV-YRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVK 122

Query: 256 PHNVMIDHEQRKLRLIDWGLAE--FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLW 313
           P N++++  + +++L D+G++        K Y   V +  +  PE +   Q Y    D+W
Sbjct: 123 PSNMLVN-TRGQVKLCDFGVSTQLVNSIAKTY---VGTNAYMAPERISGEQ-YGIHSDVW 177

Query: 314 SLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRH 373
           SLG  F  +   + P+     N   L+ +       +L              L  +V   
Sbjct: 178 SLGISFMELALGRFPYPQIQKNQGSLMPL-------QL--------------LQCIV--D 214

Query: 374 SRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 420
              P      V        + V F+ + +R   +ERP  +  M HP+
Sbjct: 215 EDPP------VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPF 255

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 47.4 bits (112), Expect = 8e-06
 Identities = 43/151 (28%), Positives = 78/151 (51%), Gaps = 13/151 (8%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKK---IKREIKILQNLCG 187
           +D+E ++ +GRG + EV             +KIL+    ++K++   I+ E  IL     
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVE-AD 59

Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYC 244
              +VK+    +D+ +    LI E +   D   L     TL++ + ++YI E + A+D  
Sbjct: 60  SLWVVKMFYSFQDKLNLY--LIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSI 117

Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL 275
           H  G +HRD+KP N+++D  +  ++L D+GL
Sbjct: 118 HQLGFIHRDIKPDNLLLD-SKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 47.7 bits (113), Expect = 9e-06
 Identities = 31/106 (29%), Positives = 56/106 (52%), Gaps = 5/106 (4%)

Query: 227 DYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN 286
           +Y+V    Y+++ ALD  HS+ +MHRD+K  N+ +      ++L D+G ++ Y      +
Sbjct: 168 EYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL-MPTGIIKLGDFGFSKQYSDSVSLD 226

Query: 287 VRVA---SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
           V  +   + Y+  PEL  + + Y    D+WSLG +   ++    PF
Sbjct: 227 VASSFCGTPYYLAPELW-ERKRYSKKADMWSLGVILYELLTLHRPF 271

Length = 478

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 30/99 (30%), Positives = 52/99 (52%), Gaps = 3/99 (3%)

Query: 232 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVA 290
           +Y  E+   L + HS+GI++RD+K  NVM+D E   +++ D+G+  E    G        
Sbjct: 105 FYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENMWDGVTTKTFCG 163

Query: 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
           +  +  PE++   Q Y  S+D W+ G +   M+  + PF
Sbjct: 164 TPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQAPF 201

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 47.2 bits (112), Expect = 1e-05
 Identities = 58/207 (28%), Positives = 92/207 (44%), Gaps = 33/207 (15%)

Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF--------YHPGKEYNV 287
           +LL A+DY H +GI+HRD+K  NV+++  +  + L D+G A F        +H G    V
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPE-DICLGDFGAACFARGSWSTPFHYGIAGTV 326

Query: 288 RVASRYFKGPELLVDLQDYDYSLDLWSLG-CMFAGMIFRKEPFFYGHDN----YD-QLVK 341
                    PE+L     Y  S+D+WS G  +F   +     F     +    YD Q+++
Sbjct: 327 DT-----NAPEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILR 380

Query: 342 I---AKVLGTDELNAYLNKYHIELDPHLAALVGR--HSRKPWSKFITVENQHLAVPEAVD 396
           I   A+V   DE   +     +    H AA   R  ++R  W+++  +    L V   V 
Sbjct: 381 IIRQAQV-HVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKL---DLDVEYLV- 435

Query: 397 FLDKLLRYDHQERPTAKEAMAHPYFFP 423
              + L +D   RP+A E +  P F  
Sbjct: 436 --CRALTFDGARRPSAAELLRLPLFQS 460

Length = 461

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 54/232 (23%), Positives = 93/232 (40%), Gaps = 46/232 (19%)

Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNV------------------MIDHEQR 266
           +S+  + Y +  +LKALDY H  G +HR VK  ++                  MI+H QR
Sbjct: 98  MSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157

Query: 267 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL-VDLQDYDYSLDLWSLGCMFAGMIFR 325
            LR++        H   +Y+V+V    +  PE+L  +LQ YD   D++S+G     +   
Sbjct: 158 -LRVV--------HDFPKYSVKVLP--WLSPEVLQQNLQGYDAKSDIYSVGITACELANG 206

Query: 326 KEPFFYGHDNYDQLVKIAKVLGT------------DELNAYLNKYHIELDPHLAALVGRH 373
             PF    D     + + K+ GT            +EL    ++         +  V   
Sbjct: 207 HVPF---KDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTP 263

Query: 374 SRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR 425
                       N+  + P    F+++ L+ +   RP+A   + H +F  I+
Sbjct: 264 RPSNGESSSHPYNRTFS-PHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 314

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 55/241 (22%), Positives = 84/241 (34%), Gaps = 86/241 (35%)

Query: 231 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL---------AEFYHP 281
           R+YI EL  A++  H  G +HRD+KP N++ID +   ++L D+GL         +++Y  
Sbjct: 104 RFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGH-IKLTDFGLCTGFRWTHNSKYYQK 162

Query: 282 GKEY---------------NVRVASRY------------------------FKGPELLVD 302
           G                  N R   R                         +  PE+L+ 
Sbjct: 163 GSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR 222

Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 362
            + Y    D WS+G +   M+  + PF        QL    KV+                
Sbjct: 223 -KGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQL----KVIN--------------- 262

Query: 363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLL--RYDHQERPTAKEAMAHPY 420
                          W   + +  Q    PEAVD + KL     +   R  A +  AHP+
Sbjct: 263 ---------------WENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPF 307

Query: 421 F 421
           F
Sbjct: 308 F 308

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 45/212 (21%), Positives = 83/212 (39%), Gaps = 35/212 (16%)

Query: 141 KVGRGKYSEVFEGVHCTDNEKCI---IKILKPVKKKKIK----REIKILQNLCGGPNIVK 193
           K+G G +  V  G   T   K I   +K LK  K   I     +E  I+ +L    N+++
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSL-DHENLIR 60

Query: 194 LLDIVRDQQSKTPSLIFE-----------HVNNTDFKVLYPTLSDYDVRYYIYELLKALD 242
           L  +V         ++ E             +      L  TL DY V     ++   + 
Sbjct: 61  LYGVVLTHPLM---MVTELAPLGSLLDRLRKDALGH-FLISTLCDYAV-----QIANGMR 111

Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK----GPE 298
           Y  S+  +HRD+   N+++     K+++ D+GL       +++ V             PE
Sbjct: 112 YLESKRFIHRDLAARNILL-ASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPE 170

Query: 299 LLVDLQDYDYSLDLWSLG-CMFAGMIFRKEPF 329
            L     + ++ D+W  G  ++    + +EP+
Sbjct: 171 SLRTRT-FSHASDVWMFGVTLWEMFTYGEEPW 201

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 50/227 (22%), Positives = 95/227 (41%), Gaps = 35/227 (15%)

Query: 142 VGRGKYSEVFEGV------HCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGGPNI 191
           +G G + EV+EG         +   +  +K L+      +KK+  +E  ++ N    PNI
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNF-NHPNI 61

Query: 192 VKLLDIVRDQQSKTPSLIFEHVNNTDF----------KVLYPTLSDYDVRYYIYELLKAL 241
           VKLL +    + +   +I E +   D           +   P L+  ++     ++ K  
Sbjct: 62  VKLLGVCLLNEPQ--YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119

Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQ----RKLRLIDWGLAEFYHPGKEYNVR----VASRY 293
            Y      +HRD+   N ++  +     R +++ D+GLA   +    Y       +  R+
Sbjct: 120 VYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179

Query: 294 FKGPELLVDLQDYDYSLDLWSLGC-MFAGMIFRKEPFFYGHDNYDQL 339
              PE L+D +    S D+WS G  M+  +   ++P +   +N + L
Sbjct: 180 M-APESLLDGKFTTQS-DVWSFGVLMWEILTLGQQP-YPALNNQEVL 223

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 45.5 bits (108), Expect = 2e-05
 Identities = 51/216 (23%), Positives = 101/216 (46%), Gaps = 36/216 (16%)

Query: 137 EVVRKVGRGKYSEVFEGVHCTDNEK-CI---IKILK----PVKKKKIKREIKILQNLCGG 188
           E ++ +G G +  V++GV   + EK  I   IK+L+    P   K+I  E  ++ +    
Sbjct: 10  EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMAS-VDH 68

Query: 189 PNIVKLLDIVRDQQSKTPSLI---------FEHV-NNTDFKVLYPTLSDYDVRYYIYELL 238
           P++V+LL I     S    LI          ++V N+ D       +    +  +  ++ 
Sbjct: 69  PHVVRLLGIC---LSSQVQLITQLMPLGCLLDYVRNHKD------NIGSQYLLNWCVQIA 119

Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYNV---RVASRYF 294
           K + Y   + ++HRD+   NV++    + +++ D+GLA+      KEY+    +V  ++ 
Sbjct: 120 KGMSYLEEKRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM 178

Query: 295 KGPELLVDLQDYDYSLDLWSLGC-MFAGMIFRKEPF 329
              E ++  + Y +  D+WS G  ++  M F  +P+
Sbjct: 179 -ALESIL-HRIYTHKSDVWSYGVTVWELMTFGAKPY 212

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 45.2 bits (107), Expect = 3e-05
 Identities = 48/226 (21%), Positives = 103/226 (45%), Gaps = 30/226 (13%)

Query: 140 RKVGRGKYSEVFEGVHCTDNEK---CIIKILKPVKK----KKIKREIKILQNLCGGPNIV 192
           R +G+G +  V+ G     + +   C +K L  +      ++  +E  I+++    PN++
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDF-SHPNVL 59

Query: 193 KLLDIVRDQQSKTPSLIFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALDYCHS 246
            LL I    +  +P ++  ++ + D +         PT+ D  +  +  ++ K ++Y  S
Sbjct: 60  SLLGICLPSEG-SPLVVLPYMKHGDLRNFIRSETHNPTVKD--LIGFGLQVAKGMEYLAS 116

Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLA------EFYHPGKEYNVRVASRYFKGPELL 300
           +  +HRD+   N M+D E   +++ D+GLA      E+Y        ++  ++      L
Sbjct: 117 KKFVHRDLAARNCMLD-ESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMA----L 171

Query: 301 VDLQDYDYSL--DLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
             LQ   ++   D+WS G +   ++ R  P +   D++D  V + +
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ 217

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 46.3 bits (110), Expect = 3e-05
 Identities = 39/170 (22%), Positives = 70/170 (41%), Gaps = 38/170 (22%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK------PVKKKKIKREIKILQNLCGGP 189
           Y+++R +G+G   EV+       + +  +K ++      P+ KK+  RE KI  +L   P
Sbjct: 4   YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIH-P 62

Query: 190 NIVKLLDIVRDQQS---------------------KTPSLIFEHVNNTDFKVLYPTLSDY 228
            IV +  I  D                        +  SL  E    T            
Sbjct: 63  GIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF--- 119

Query: 229 DVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278
                 +++   ++Y HS+G++HRD+KP N+++      + ++DWG A F
Sbjct: 120 ------HKICATIEYVHSKGVLHRDLKPDNILLGLFGEVV-ILDWGAAIF 162

Length = 932

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 45.3 bits (107), Expect = 3e-05
 Identities = 18/44 (40%), Positives = 28/44 (63%), Gaps = 1/44 (2%)

Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279
           ++L  L+Y H  GI H D+KP N+M+D   R   +ID+G+A  +
Sbjct: 134 DMLTTLEYIHEHGISHGDIKPENIMVDGNNRGY-IIDYGIASHF 176

Length = 294

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 49/209 (23%), Positives = 94/209 (44%), Gaps = 21/209 (10%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDN---------EKCIIKILKPVKKKKIKREIKILQN 184
           +D+  +R +G G +  V    +  ++         EK   KI+K  +   +  E KIL N
Sbjct: 30  EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKS--KIIKQKQVDHVFSERKIL-N 86

Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY--DVR-YYIYELLKAL 241
               P  V L    +D+      L+ E V   +F         +  DV  +Y  +++   
Sbjct: 87  YINHPFCVNLYGSFKDESYLY--LVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIF 144

Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 301
           +Y  S  I++RD+KP N+++D +   +++ D+G A+     + Y +     Y   PE+L+
Sbjct: 145 EYLQSLNIVYRDLKPENLLLDKDGF-IKMTDFGFAKVVDT-RTYTLCGTPEYI-APEILL 201

Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
           ++  +  + D W+LG     ++    PF+
Sbjct: 202 NV-GHGKAADWWTLGIFIYEILVGCPPFY 229

Length = 340

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 23/58 (39%), Positives = 35/58 (60%), Gaps = 4/58 (6%)

Query: 231 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA---EFYHPGKEY 285
           R+YI EL  A++  H  G +HRD+KP N++ID +   ++L D+GL     + H  K Y
Sbjct: 104 RFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGH-IKLTDFGLCTGFRWTHDSKYY 160

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 43.2 bits (102), Expect = 4e-05
 Identities = 29/129 (22%), Positives = 53/129 (41%), Gaps = 10/129 (7%)

Query: 157 TDNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 215
           T +E  ++KI     K    +RE+ ILQ L      V  + +   +      L+ E +  
Sbjct: 19  TKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKV-LASGESDGWSYLLMEWIEG 77

Query: 216 TDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ---GIMHRDVKPHNVMIDHEQRKLRLID 272
                    +S+ +      +L + L   H      + H D+ P N+++D + + L +ID
Sbjct: 78  ET----LDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD-DGKILGIID 132

Query: 273 WGLAEFYHP 281
           W  A +  P
Sbjct: 133 WEYAGYGPP 141

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 44.8 bits (106), Expect = 4e-05
 Identities = 48/195 (24%), Positives = 83/195 (42%), Gaps = 31/195 (15%)

Query: 140 RKVGRGKYSEVFEGVHCTDNEKCIIKI------LKPVKKKKIKREIKILQNLCGGPNIVK 193
            K+G+G + +V++GV         + +      L P  K+K  +E +IL+     PNIVK
Sbjct: 1   EKIGKGNFGDVYKGVL---KGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQY-DHPNIVK 56

Query: 194 LLDIVRDQQSKTPSLI-FEHVNNTDFKVLYPTLSDYDVRYYIYELLK-------ALDYCH 245
           L+ +   +Q   P  I  E V             +   R  + +LL+        ++Y  
Sbjct: 57  LIGVCVQKQ---PIYIVMELVPGGSLLTFLRKKKN---RLTVKKLLQMSLDAAAGMEYLE 110

Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY----FKGPELLV 301
           S+  +HRD+   N ++  E   L++ D+G++     G  Y V    +     +  PE L 
Sbjct: 111 SKNCIHRDLAARNCLVG-ENNVLKISDFGMSREEEGG-IYTVSDGLKQIPIKWTAPEAL- 167

Query: 302 DLQDYDYSLDLWSLG 316
           +   Y    D+WS G
Sbjct: 168 NYGRYTSESDVWSYG 182

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 44.6 bits (106), Expect = 5e-05
 Identities = 51/234 (21%), Positives = 89/234 (38%), Gaps = 62/234 (26%)

Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNV------------------MIDHEQRKLRLI 271
           + + + ++L ALDY HS+G +HR VK  ++                  MI H +R+  + 
Sbjct: 103 IAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162

Query: 272 DWGLAEFYHPGKEYNVRVASRYFKGPELL-VDLQDYDYSLDLWSLG---CMFAGMIFRKE 327
           D+            N+   S     PE+L  +LQ Y+   D++S+G   C  A       
Sbjct: 163 DFPK------SSVKNLPWLS-----PEVLQQNLQGYNEKSDIYSVGITACELANGH---V 208

Query: 328 PFFYGHDNYDQLVKIAKVLGT-----------DELNAYLNKYHIELDPHLAALVGRHSRK 376
           PF    D     + + KV GT              ++          P+    V     +
Sbjct: 209 PFK---DMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTR 265

Query: 377 PWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAESS 430
            +S     E+ H        F++  L+ D + RP+A + + H +F   +   +S
Sbjct: 266 TFS-----EHFH-------QFVELCLQRDPESRPSASQLLNHSFFKQCKRRNTS 307

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 44.7 bits (105), Expect = 5e-05
 Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 18/207 (8%)

Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDN----EKCIIKILKPVKKKKIKREIKILQNLCG 187
           + DD+E + ++G G    V +  H         K I   +KP  + +I RE+++L   C 
Sbjct: 3   KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHE-CN 61

Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF-KVLYPT--LSDYDVRYYIYELLKALDYC 244
            P IV              S+  EH++     +VL     + +  +      +L+ L Y 
Sbjct: 62  SPYIVGFYGAFYSDGEI--SICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYL 119

Query: 245 HSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 303
             +  IMHRDVKP N++++  + +++L D+G++         N  V +R +  PE    L
Sbjct: 120 REKHQIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMA-NSFVGTRSYMSPE---RL 174

Query: 304 QDYDYSL--DLWSLGCMFAGMIFRKEP 328
           Q   YS+  D+WS+G     +   + P
Sbjct: 175 QGTHYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 44.3 bits (105), Expect = 6e-05
 Identities = 40/214 (18%), Positives = 85/214 (39%), Gaps = 40/214 (18%)

Query: 133 QDDYEVVRKVGRGKYSEVFEGV--HCTDNE---KCIIKILKPV----KKKKIKREIKILQ 183
           ++   ++R++G+G +  V+EG+       E   +  IK +       ++ +   E  +++
Sbjct: 5   REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMK 64

Query: 184 NL-CGGPNIVKLLDIVRDQQSKTPSLIF--------------EHVNNTDFKVLYPTLSDY 228
              C   ++V+LL +V   Q   P+L+                     +        +  
Sbjct: 65  EFNC--HHVVRLLGVVSTGQ---PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ 119

Query: 229 DVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA------EFYHPG 282
                  E+   + Y  ++  +HRD+   N M+  E   +++ D+G+       ++Y  G
Sbjct: 120 KFIQMAAEIADGMAYLAAKKFVHRDLAARNCMV-AEDLTVKIGDFGMTRDIYETDYYRKG 178

Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLG 316
            +  + V  R+   PE L D   +    D+WS G
Sbjct: 179 GKGLLPV--RWM-APESLKD-GVFTTKSDVWSFG 208

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 43.9 bits (104), Expect = 7e-05
 Identities = 43/194 (22%), Positives = 83/194 (42%), Gaps = 26/194 (13%)

Query: 140 RKVGRGKYSEVFEGVHCTDNEK---CIIKILKPVK----KKKIKREIKILQNLCGGPNIV 192
           +++G G +  V +GV+   + K     +K LK       KK+  RE  ++  L   P IV
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL-DHPCIV 59

Query: 193 KLLDIVRDQQSKTPS--LIFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ 247
           +L+ +      K     L+ E         +      +   D++   +++   + Y  S+
Sbjct: 60  RLIGV-----CKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK 114

Query: 248 GIMHRDVKPHNVMI-DHEQRKLRLIDWGLAEFYHPGKE-YNVRVASRY---FKGPELLVD 302
             +HRD+   NV++ +  Q K+   D+G++     G + Y    A R+   +  PE  ++
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKIS--DFGMSRALGAGSDYYRATTAGRWPLKWYAPE-CIN 171

Query: 303 LQDYDYSLDLWSLG 316
              +    D+WS G
Sbjct: 172 YGKFSSKSDVWSYG 185

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 44.1 bits (105), Expect = 1e-04
 Identities = 18/83 (21%), Positives = 40/83 (48%), Gaps = 9/83 (10%)

Query: 197 IVRDQQSKTPSLIFEHVNNTDFK-VLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVK 255
           ++ D   +  +++ E++   D K VL            + ++ + +   H  GI+H D+ 
Sbjct: 402 VIYDVDPEEKTIVMEYIGGKDLKDVLEGNPE------LVRKVGEIVAKLHKAGIVHGDLT 455

Query: 256 PHNVMIDHEQRKLRLIDWGLAEF 278
             N ++  +  +L LID+GL ++
Sbjct: 456 TSNFIVRDD--RLYLIDFGLGKY 476

Length = 535

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 11/90 (12%)

Query: 235 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA------EFYHPGKEYNVR 288
           Y++ + ++Y  SQ  +HRD+   NV++  E   +++ D+GLA      ++Y   K  N R
Sbjct: 144 YQVARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLARDVNNIDYYK--KTTNGR 200

Query: 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCM 318
           +  ++   PE L D + Y +  D+WS G +
Sbjct: 201 LPVKWM-APEALFD-RVYTHQSDVWSFGVL 228

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 29/99 (29%), Positives = 51/99 (51%), Gaps = 7/99 (7%)

Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP--- 281
           LS  D+    Y++ + ++Y  S+  +HRD+   NV++  E   +++ D+GLA   H    
Sbjct: 137 LSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT-EDNVMKIADFGLARDIHHIDY 195

Query: 282 -GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMF 319
             K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 196 YKKTTNGRLPVKWM-APEALFD-RIYTHQSDVWSFGVLL 232

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 43.2 bits (102), Expect = 1e-04
 Identities = 47/216 (21%), Positives = 93/216 (43%), Gaps = 35/216 (16%)

Query: 132 EQDDYEVVRKVGRGKYSEVFE----GVHCTDNE-KCIIKILKPVKKKK----IKREIKIL 182
            +D   + + +G G + +V +    G+   +      +K+LK    +K    +  E++++
Sbjct: 10  PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMM 69

Query: 183 QNLCGGPNIVKLLDIVRDQQSKTPSLIFE---HVNNTDF----------------KVLYP 223
           + +    NI+ LL +    Q     ++ E   H N  DF                +    
Sbjct: 70  KMIGKHKNIINLLGVC--TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEE 127

Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
           TL+  D+  + Y++ + +++  S+  +HRD+   NV++  E   +++ D+GLA   H   
Sbjct: 128 TLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT-EDHVMKIADFGLARDIHHID 186

Query: 284 EYNVRVASRY---FKGPELLVDLQDYDYSLDLWSLG 316
            Y      R    +  PE L D + Y +  D+WS G
Sbjct: 187 YYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFG 221

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 29/100 (29%), Positives = 51/100 (51%), Gaps = 7/100 (7%)

Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-- 281
            L+  D+    Y++ + ++Y  SQ  +HRD+   NV++  E   +++ D+GLA   H   
Sbjct: 130 QLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT-EDNVMKIADFGLARDVHNID 188

Query: 282 --GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMF 319
              K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 189 YYKKTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLL 226

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|216618 pfam01636, APH, Phosphotransferase enzyme family

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 13/48 (27%), Positives = 22/48 (45%)

Query: 234 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281
           +   L AL       ++H D+ P N+++D   R   +ID+  A    P
Sbjct: 152 LLAALLALLPALPLVLVHGDLHPGNLLVDPGGRVTGVIDFEDAGLGDP 199

This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881. Length = 238

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 42.5 bits (100), Expect = 2e-04
 Identities = 69/313 (22%), Positives = 118/313 (37%), Gaps = 59/313 (18%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK----ILKPVKKKKIKREIKILQNLCGGP 189
           D+ EV+ ++G+G Y  V++ +H        +K     L   K  +I  E+ IL      P
Sbjct: 1   DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHK-AVSP 59

Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD------VRYYIYELLKALDY 243
            IV               +  E+++      LY      +      +R   Y ++K L +
Sbjct: 60  YIVDFYGAF--FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKF 117

Query: 244 CHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELL- 300
              +  I+HRDVKP NV+++    +++L D+G++        + N+   S  +  PE + 
Sbjct: 118 LKEEHNIIHRDVKPTNVLVN-GNGQVKLCDFGVSGNLVASLAKTNIGCQS--YMAPERIK 174

Query: 301 ----VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 356
                    Y    D+WSLG     M   + P  Y  + Y  +                 
Sbjct: 175 SGGPNQNPTYTVQSDVWSLGLSILEMALGRYP--YPPETYANIFA--------------- 217

Query: 357 KYHIELDPHLAALV-GRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEA 415
                    L+A+V G     P S +           +A DF+ K L      RPT  + 
Sbjct: 218 --------QLSAIVDGDPPTLP-SGY---------SDDAQDFVAKCLNKIPNRRPTYAQL 259

Query: 416 MAHPYFFPIRNAE 428
           + HP+    +NA+
Sbjct: 260 LEHPWLVKYKNAD 272

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 41.9 bits (98), Expect = 3e-04
 Identities = 52/225 (23%), Positives = 99/225 (44%), Gaps = 27/225 (12%)

Query: 140 RKVGRGKYSEVFEGVHCTDNE--KCIIKILKPVKKKKIKREIKILQNLC----GGPNIVK 193
           + +G G++  V EG    D+   K  +K +K     + + E  + + +C      PN+++
Sbjct: 5   KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64

Query: 194 LLDI----VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRY-------YIYELLKA 240
           L+ +    V  +   +P +I   + + D    +LY  L D            ++ ++   
Sbjct: 65  LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124

Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV-RVASRYFK--GP 297
           ++Y  S+  +HRD+   N M++ E   + + D+GL++  + G  Y   R+A    K    
Sbjct: 125 MEYLSSKSFIHRDLAARNCMLN-ENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183

Query: 298 ELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN---YDQL 339
           E L D + Y    D+WS G     +  R +  + G +N   YD L
Sbjct: 184 ESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYL 227

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 41.5 bits (97), Expect = 6e-04
 Identities = 31/129 (24%), Positives = 62/129 (48%), Gaps = 12/129 (9%)

Query: 194 LLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRD 253
           L + +R ++   P   F+     + ++ +      D+    Y++ + ++Y  S+  +HRD
Sbjct: 105 LREFLRARRPPGPDYTFDITKVPEEQLSFK-----DLVSCAYQVARGMEYLESRRCIHRD 159

Query: 254 VKPHNVMIDHEQRKLRLIDWGLAEFYHP----GKEYNVRVASRYFKGPELLVDLQDYDYS 309
           +   NV++  E   +++ D+GLA   H      K  N R+  ++   PE L D + Y + 
Sbjct: 160 LAARNVLVT-EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWM-APEALFD-RVYTHQ 216

Query: 310 LDLWSLGCM 318
            D+WS G +
Sbjct: 217 SDVWSFGIL 225

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 41.3 bits (97), Expect = 6e-04
 Identities = 46/201 (22%), Positives = 89/201 (44%), Gaps = 21/201 (10%)

Query: 133 QDDYEVVRKVGRGKYSEVFEGV-----HCTDNEKCIIKILKPV----KKKKIKREIKILQ 183
           +++    + +G G + +V E             K  +K+LKP     +++ +  E+KI+ 
Sbjct: 34  RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMS 93

Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF-----KVLYPTLSDYDVRYYIYELL 238
           +L    NIV LL            +I E+    D      +     L+  D+  + Y++ 
Sbjct: 94  HLGNHENIVNLLGAC--TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVA 151

Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY---FK 295
           K + +  S+  +HRD+   NV++ H  + +++ D+GLA        Y V+  +R    + 
Sbjct: 152 KGMAFLASKNCIHRDLAARNVLLTH-GKIVKICDFGLARDIMNDSNYVVKGNARLPVKWM 210

Query: 296 GPELLVDLQDYDYSLDLWSLG 316
            PE + +   Y +  D+WS G
Sbjct: 211 APESIFNCV-YTFESDVWSYG 230

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 41.0 bits (96), Expect = 6e-04
 Identities = 40/199 (20%), Positives = 92/199 (46%), Gaps = 20/199 (10%)

Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGP 189
           E+ D  +  K+G G+Y EV+EGV    +    +K LK   ++ ++  +E  +++ +   P
Sbjct: 4   ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHP 62

Query: 190 NIVKLLDIVRDQ-------QSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALD 242
           N+V+LL +   +       +  T   + +++   + + +   +    + Y   ++  A++
Sbjct: 63  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVV----LLYMATQISSAME 118

Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGPEL 299
           Y   +  +HRD+   N ++  E   +++ D+GL+     G  Y     +++   +  PE 
Sbjct: 119 YLEKKNFIHRDLAARNCLVG-ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPES 176

Query: 300 LVDLQDYDYSLDLWSLGCM 318
           L     +    D+W+ G +
Sbjct: 177 LA-YNKFSIKSDVWAFGVL 194

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 40.8 bits (95), Expect = 8e-04
 Identities = 47/226 (20%), Positives = 102/226 (45%), Gaps = 26/226 (11%)

Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPN 190
           ++  ++++K+G G++ EV+ G     N K  +K LKP  +  +    E +I++ L     
Sbjct: 5   RESLQLIKKLGNGQFGEVWMGT-WNGNTKVAVKTLKPGTMSPESFLEEAQIMKKL-RHDK 62

Query: 191 IVKLLDIVRDQ--------QSKTPSLIFEHVNNTDFKVL-YPTLSDYDVRYYIYELLKAL 241
           +V+L  +V ++         SK   L F  + + + + L  P L D        ++   +
Sbjct: 63  LVQLYAVVSEEPIYIVTEYMSKGSLLDF--LKDGEGRALKLPNLVDMAA-----QVAAGM 115

Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGPE 298
            Y      +HRD++  N+++  +    ++ D+GLA       EY  R  +++   +  PE
Sbjct: 116 AYIERMNYIHRDLRSANILVG-DGLVCKIADFGLARLIE-DNEYTARQGAKFPIKWTAPE 173

Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
             +    +    D+WS G +   ++ +    + G +N + L ++ +
Sbjct: 174 AAL-YGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER 218

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 40.6 bits (95), Expect = 8e-04
 Identities = 21/81 (25%), Positives = 42/81 (51%), Gaps = 11/81 (13%)

Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY------DVRYYIYELLKALD 242
           PN+V L   +  + S     +F  + + +   L+  +S +       V+ +  E++ ALD
Sbjct: 45  PNMVCLHKYIVSEDS-----VFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALD 99

Query: 243 YCHSQGIMHRDVKPHNVMIDH 263
             H +GI+ RD+ P+N+++D 
Sbjct: 100 ALHREGIVCRDLNPNNILLDD 120

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 40.5 bits (95), Expect = 9e-04
 Identities = 43/171 (25%), Positives = 81/171 (47%), Gaps = 28/171 (16%)

Query: 164 IKILKPVKKKKI---KREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKV 220
           +K L+    + +   +REI+IL++L    NIVK   +      +   L+ E++       
Sbjct: 38  VKKLQHSTAEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRRNLRLVMEYLP------ 90

Query: 221 LYPTLSDYDVRY-----------YIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLR 269
            Y +L DY  ++           Y  ++ K ++Y  S+  +HRD+   N++++ E R ++
Sbjct: 91  -YGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENR-VK 148

Query: 270 LIDWGLAEFYHPGKE-YNVRVASR---YFKGPELLVDLQDYDYSLDLWSLG 316
           + D+GL +     KE Y VR       ++  PE L +   +  + D+WS G
Sbjct: 149 IGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTE-SKFSVASDVWSFG 198

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 40.1 bits (94), Expect = 0.001
 Identities = 45/213 (21%), Positives = 83/213 (38%), Gaps = 44/213 (20%)

Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK--REIKILQNLCGGPNIVKLLDIVR 199
           +G+G++ +V  G +    +K  +K LK           E  ++  L   PN+V+LL +V 
Sbjct: 14  IGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTL-RHPNLVQLLGVVL 70

Query: 200 DQQSKTPSLIFEHVNNTDFKVLYPTLSDY------------DVRYYIYELLKALDYCHSQ 247
                   ++ E++          +L DY                +  ++ + ++Y   +
Sbjct: 71  QGNPLY--IVTEYMAKG-------SLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK 121

Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYF----KGPELLVDL 303
             +HRD+   NV++  E    ++ D+GLA      KE +    S         PE L   
Sbjct: 122 NFVHRDLAARNVLVS-EDLVAKVSDFGLA------KEASQGQDSGKLPVKWTAPEAL-RE 173

Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNY 336
           + +    D+WS G      I   E + +G   Y
Sbjct: 174 KKFSTKSDVWSFG------ILLWEIYSFGRVPY 200

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 40.1 bits (94), Expect = 0.001
 Identities = 39/154 (25%), Positives = 76/154 (49%), Gaps = 21/154 (13%)

Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKIKREIKILQNLCGGPNI 191
           ++ + RK+G G + EV+EG+   +  +  IKILK    +K++  ++E++ L+ L    ++
Sbjct: 7   EFTLERKLGSGYFGEVWEGL-WKNRVRVAIKILKSDDLLKQQDFQKEVQALKRL-RHKHL 64

Query: 192 VKLLD---------IVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALD 242
           + L           I+ +   K   L F  + + + +VL P  S  D+   + E    + 
Sbjct: 65  ISLFAVCSVGEPVYIITELMEKGSLLAF--LRSPEGQVL-PVASLIDMACQVAE---GMA 118

Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
           Y   Q  +HRD+   N+++  E    ++ D+GLA
Sbjct: 119 YLEEQNSIHRDLAARNILVG-EDLVCKVADFGLA 151

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 39.8 bits (93), Expect = 0.002
 Identities = 44/207 (21%), Positives = 94/207 (45%), Gaps = 30/207 (14%)

Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPN 190
           ++  ++V+K+G G++ EV+ G +   + K  IK LK   +  +    E  +++ L   P 
Sbjct: 5   RETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMSPEAFLAEANLMKQL-QHPR 62

Query: 191 IVKLLDIVRDQQSKTPSLIF-EHVNN---TDF-------KVLYPTLSDYDVRYYIYELLK 239
           +V+L  +V    ++ P  I  E++ N    DF       K+    L D        ++ +
Sbjct: 63  LVRLYAVV----TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAA-----QIAE 113

Query: 240 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKG 296
            + +   +  +HRD++  N+++       ++ D+GLA       EY  R  +++   +  
Sbjct: 114 GMAFIERKNYIHRDLRAANILVSETL-CCKIADFGLARLIED-NEYTAREGAKFPIKWTA 171

Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMI 323
           PE  ++   +    D+WS G +   ++
Sbjct: 172 PE-AINYGTFTIKSDVWSFGILLTEIV 197

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 39.3 bits (92), Expect = 0.002
 Identities = 46/199 (23%), Positives = 89/199 (44%), Gaps = 25/199 (12%)

Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGP 189
           ++   +++RK+G G++ EV+EG+   +     +K LKP  +  K    E +I++ L   P
Sbjct: 4   DRTSIQLLRKLGAGQFGEVWEGL-WNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKL-RHP 61

Query: 190 NIVKLLDIVRDQQS--------KTPSLIFEHVNNTDFKVL-YPTLSDYDVRYYIYELLKA 240
            +++L  +   ++         K  SL+ E++     + L  P L D        ++   
Sbjct: 62  KLIQLYAVCTLEEPIYIVTELMKYGSLL-EYLQGGAGRALKLPQLIDMAA-----QVASG 115

Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGP 297
           + Y  +Q  +HRD+   NV++  E    ++ D+GLA        Y  R  +++   +  P
Sbjct: 116 MAYLEAQNYIHRDLAARNVLVG-ENNICKVADFGLARVIKE-DIYEAREGAKFPIKWTAP 173

Query: 298 ELLVDLQDYDYSLDLWSLG 316
           E       +    D+WS G
Sbjct: 174 E-AALYNRFSIKSDVWSFG 191

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 39.2 bits (92), Expect = 0.003
 Identities = 40/168 (23%), Positives = 77/168 (45%), Gaps = 25/168 (14%)

Query: 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNIVKLLD 196
            RK+G G++ EV+ G       K  +K LKP  +  +   +E +I++ L     +V+L  
Sbjct: 11  ERKLGAGQFGEVWMGTW-NGTTKVAVKTLKPGTMSPEAFLQEAQIMKKL-RHDKLVQLYA 68

Query: 197 IVRDQQSKTPSLIF-EHVNN---TDF-------KVLYPTLSDYDVRYYIYELLKALDYCH 245
           +  +++   P  I  E+++     DF       K+  P L D        ++ + + Y  
Sbjct: 69  VCSEEE---PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAA-----QIAEGMAYLE 120

Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY 293
           S+  +HRD+   N+++  E    ++ D+GLA       EY  R  +++
Sbjct: 121 SRNYIHRDLAARNILVG-ENLVCKIADFGLARLIED-DEYTAREGAKF 166

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 39.3 bits (92), Expect = 0.003
 Identities = 27/87 (31%), Positives = 42/87 (48%), Gaps = 8/87 (9%)

Query: 235 YELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRK--LRLIDWGLAEFYHPGKEYNVRVAS 291
              +KAL+Y   +  I+HRDVKP N+++D   R   ++L D+G++               
Sbjct: 114 VATVKALNYLKEELKIIHRDVKPSNILLD---RNGNIKLCDFGISGQLVDSIAKTRDAGC 170

Query: 292 RYFKGPELLV--DLQDYDYSLDLWSLG 316
           R +  PE +       YD   D+WSLG
Sbjct: 171 RPYMAPERIDPSARDGYDVRSDVWSLG 197

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 39.0 bits (91), Expect = 0.003
 Identities = 40/175 (22%), Positives = 77/175 (44%), Gaps = 32/175 (18%)

Query: 141 KVGRGKYSEVFEGVHCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGGPNIVKLLD 196
           KV +G+ +   E +  T      IK LK    P  +++ ++E +++ +L   PNIV LL 
Sbjct: 20  KVYKGELTGPNERLSAT---SVAIKTLKENAEPKVQQEFRQEAELMSDL-QHPNIVCLLG 75

Query: 197 IVRDQQSKTPSLIFEHVNNTD---FKVLYPTLSDY----------------DVRYYIYEL 237
           +    + +   ++FE++ + D   F V     SD                 D  +   ++
Sbjct: 76  VC--TKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQI 133

Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASR 292
              ++Y  S   +HRD+   N ++  E   +++ D+GL+   +    Y  RV S+
Sbjct: 134 AAGMEYLSSHHFVHRDLAARNCLV-GEGLTVKISDFGLSRDIYSADYY--RVQSK 185

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	434
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.94
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.93
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.92
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.91
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.9
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.9
PRK12274	218	serine/threonine protein kinase; Provisional	99.9
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.9
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.89
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.88
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.87
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.87
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.87
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.85
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.85
PRK10345	210	hypothetical protein; Provisional	99.84
smart00090	237	RIO RIO-like kinase.	99.81
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.79
PRK14879	211	serine/threonine protein kinase; Provisional	99.79
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.78
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.78
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.75
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.75
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.74
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.72
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.71
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.69
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.68
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.54
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.51
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.5
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.47
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.43
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.38
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.38
KOG1243	690	consensus Protein kinase [General function predict	99.35
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.32
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.31
KOG3087	229	consensus Serine/threonine protein kinase [General	99.25
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.22
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.21
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.14
COG4248	637	Uncharacterized protein with protein kinase and he	99.1
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.05
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.94
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.91
PRK09902	216	hypothetical protein; Provisional	98.81
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.78
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.64
PF01636	239	APH: Phosphotransferase enzyme family This family	98.59
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.57
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.5
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.5
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.44
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.43
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.42
PLN02876	822	acyl-CoA dehydrogenase	98.42
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.41
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.4
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.34
PRK10593	297	hypothetical protein; Provisional	98.15
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.14
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.07
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.05
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.96
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.94
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.86
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.82
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.67
PRK05231	319	homoserine kinase; Provisional	97.64
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.5
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.48
KOG2270	520	consensus Serine/threonine protein kinase involved	97.43
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.41
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.33
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.24
PLN02236	344	choline kinase	97.18
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	97.18
COG2334	331	Putative homoserine kinase type II (protein kinase	97.09
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.03
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.03
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.72
PTZ00384	383	choline kinase; Provisional	96.64
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.63
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.32
PLN02756	418	S-methyl-5-thioribose kinase	96.26
PRK06148	1013	hypothetical protein; Provisional	96.22
PRK12396	409	5-methylribose kinase; Reviewed	96.07
PTZ00296	442	choline kinase; Provisional	95.81
PRK11768	325	serine/threonine protein kinase; Provisional	95.79
PRK06149	972	hypothetical protein; Provisional	95.7
PF07914	414	DUF1679: Protein of unknown function (DUF1679); In	95.29
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.05
KOG4720	391	consensus Ethanolamine kinase [Lipid transport and	94.74

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=1.4e-69  Score=469.96  Aligned_cols=334  Identities=84%  Similarity=1.366  Sum_probs=325.3

Q ss_pred             CCCCCCcccccCccCCCCCcccccccccccCCCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHH
Q 013897          101 GAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIK  180 (434)
Q Consensus       101 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~E~~  180 (434)
                      ..++.++++.+++...++++|+++...+.|+.+++|++++++|+|.+++||.|....++++++||++++.+++.+.+|+.
T Consensus         5 ~v~s~ARvya~vn~~rp~eYWdYE~~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREik   84 (338)
T KOG0668|consen    5 VVPSVARVYADVNEERPREYWDYESLVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIK   84 (338)
T ss_pred             ccchhhhhhhhccccCchhhcchhheeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHH
Confidence            35678899999999999999999999999999999999999999999999999998999999999999999999999999


Q ss_pred             HHHHhcCCCCeeeEeeEEEccCCCccEEEEeecCCCchhhhcCCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceE
Q 013897          181 ILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVM  260 (434)
Q Consensus       181 ~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIl  260 (434)
                      ||++|++||||+++++++.++......||+||+.+.++..+.+.++..+++.++.++++||.|+|+.||+|||+||.|++
T Consensus        85 IL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvm  164 (338)
T KOG0668|consen   85 ILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYPTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVM  164 (338)
T ss_pred             HHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhhhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceee
Confidence            99999999999999999999998999999999999999999999999999999999999999999999999999999999


Q ss_pred             ecCCCCeEEEEecccceecCCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHH
Q 013897          261 IDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV  340 (434)
Q Consensus       261 l~~~~~~vkl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~  340 (434)
                      +|+....++|+|+|+|.+++++..++.++.+.+|..||.+.....|+...|+|||||+|..|+..+.|||.|.++.+|++
T Consensus       165 Idh~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLV  244 (338)
T KOG0668|consen  165 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV  244 (338)
T ss_pred             echhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHH
Confidence            99999999999999999999999999999999999999999988999999999999999999999999999999999999


Q ss_pred             HHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCC
Q 013897          341 KIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY  420 (434)
Q Consensus       341 ~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~  420 (434)
                      +|++++|..++..+..++.+.++|.+..+++...+.+|..++..++.+.+++++.|||.++|.+|.++|+||.|+|.|||
T Consensus       245 kIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~Hpy  324 (338)
T KOG0668|consen  245 KIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPY  324 (338)
T ss_pred             HHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCch
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccccccccccCCC
Q 013897          421 FFPIRNAESSRSRS  434 (434)
Q Consensus       421 ~~~~~~~~~~~~~~  434 (434)
                      |..+.+++.+|.++
T Consensus       325 F~~~~~~~~~~~~~  338 (338)
T KOG0668|consen  325 FAPVREAESSRMRS  338 (338)
T ss_pred             HHHHHHHhhcccCC
Confidence            99999999888764

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.6e-57  Score=422.58  Aligned_cols=257  Identities=27%  Similarity=0.458  Sum_probs=211.4

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc----------HHHHHHHHHHHHHhcCCCCeeeEeeEEEccC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ  202 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  202 (434)
                      .+.|.+.+.||+|+||.|-+|..+.+|+.||||++++..          .....+|+++|++| +|||||+++++|+.+ 
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL-~HP~IV~~~d~f~~~-  248 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKL-SHPNIVRIKDFFEVP-  248 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhc-CCCCEEEEeeeeecC-
Confidence            477899999999999999999999999999999996432          12357999999999 999999999999765 


Q ss_pred             CCccEEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC--CCeEEEEecccce
Q 013897          203 SKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--QRKLRLIDWGLAE  277 (434)
Q Consensus       203 ~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~--~~~vkl~DFGla~  277 (434)
                       .+.|+||||+.||+|.+..   +.+.+...+.+++||+.||.|||++||+||||||+|||+..+  .-.+||+|||+|+
T Consensus       249 -ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK  327 (475)
T KOG0615|consen  249 -DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK  327 (475)
T ss_pred             -CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence             4558999999999986654   458888889999999999999999999999999999999754  2379999999999


Q ss_pred             ecCCCCccceeccCCcccccccccC--CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHH
Q 013897          278 FYHPGKEYNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL  355 (434)
Q Consensus       278 ~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~  355 (434)
                      ....+.-+.+.|||+.|.|||++.+  ...+..++|+||+||+||-+++|.+||.....+.-....|.+.          
T Consensus       328 ~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G----------  397 (475)
T KOG0615|consen  328 VSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKG----------  397 (475)
T ss_pred             ccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcC----------
Confidence            9887788899999999999999975  2235568999999999999999999995444433222222110          


Q ss_pred             hhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccc
Q 013897          356 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                         ...+.                    ......+++++.+||..||.+||++|||++|+|+||||+.+.
T Consensus       398 ---~y~f~--------------------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  398 ---RYAFG--------------------PLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP  444 (475)
T ss_pred             ---ccccc--------------------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence               00000                    011123678999999999999999999999999999999654

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.1e-56  Score=425.80  Aligned_cols=279  Identities=32%  Similarity=0.609  Sum_probs=237.4

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      .+.|+.+++||+|+||.||+|++..+|+.||+|.+.-..     ..-..+||.||++| +||||++|.+.+.+.....+|
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l-~HpNIikL~eivt~~~~~siY  194 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRL-DHPNIIKLEEIVTSKLSGSIY  194 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhc-CCCcccceeeEEEecCCceEE
Confidence            477999999999999999999999999999999986443     34467999999999 999999999999887778899


Q ss_pred             EEEeecCCCchhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC-
Q 013897          208 LIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-  283 (434)
Q Consensus       208 lv~e~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~-  283 (434)
                      ||+|||++.....+..   .|++.+++.|++||+.||+|+|.+||+|||||.+|||||.+| .+||+|||||+++.... 
T Consensus       195 lVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G-~LKiaDFGLAr~y~~~~~  273 (560)
T KOG0600|consen  195 LVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNG-VLKIADFGLARFYTPSGS  273 (560)
T ss_pred             EEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCC-CEEeccccceeeccCCCC
Confidence            9999999876555543   599999999999999999999999999999999999999777 89999999999876554 


Q ss_pred             -ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          284 -EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       284 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                       .++.++.|.+|+|||.++|...|+.++|+||.||||.||++|+ |++.|.++.+|+..|.+.+|.+....|. ...+..
T Consensus       274 ~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gk-PI~~G~tEveQl~kIfklcGSP~e~~W~-~~kLP~  351 (560)
T KOG0600|consen  274 APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGK-PILQGRTEVEQLHKIFKLCGSPTEDYWP-VSKLPH  351 (560)
T ss_pred             cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCC-CCcCCccHHHHHHHHHHHhCCCChhccc-cccCCc
Confidence             5789999999999999999889999999999999999999998 6669999999999999999999887776 332221


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFF  422 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~  422 (434)
                      ...+      .+..++...+ .+....+++.+.+|+..||..||.+|.||.++|+|+||.
T Consensus       352 ~~~~------kp~~~y~r~l-~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~  404 (560)
T KOG0600|consen  352 ATIF------KPQQPYKRRL-RETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFT  404 (560)
T ss_pred             cccc------CCCCcccchH-HHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccc
Confidence            1110      0111111111 112456788999999999999999999999999999995

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=6.6e-57  Score=405.59  Aligned_cols=276  Identities=31%  Similarity=0.554  Sum_probs=230.1

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      +.|+.+.++|+|+||.||+|+++.+|+.||||.+...     -++-..+|+++|++| .|+|+|.++++|..  ...++|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqL-kH~NLVnLiEVFrr--krklhL   78 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQL-KHENLVNLIEVFRR--KRKLHL   78 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhc-ccchHHHHHHHHHh--cceeEE
Confidence            5688999999999999999999999999999998532     245678999999999 99999999999954  467789


Q ss_pred             EEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecC-CCCc
Q 013897          209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKE  284 (434)
Q Consensus       209 v~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~-~~~~  284 (434)
                      |+|||...-|..+-   ..++...++.++.|++.|+.|+|+++||||||||+|||++.++ .+||||||+|+.+. ++..
T Consensus        79 VFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~g-vvKLCDFGFAR~L~~pgd~  157 (396)
T KOG0593|consen   79 VFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNG-VVKLCDFGFARTLSAPGDN  157 (396)
T ss_pred             EeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCC-cEEeccchhhHhhcCCcch
Confidence            99999998776553   4589999999999999999999999999999999999999887 89999999999887 7788


Q ss_pred             cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCCh
Q 013897          285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP  364 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  364 (434)
                      ++.++.|.+|+|||.+.+...|+..+||||+||++.||++|. |+++|.++.+|+..|.+.+|.-....           
T Consensus       158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~-pL~PG~SDiDQLy~I~ktLG~L~prh-----------  225 (396)
T KOG0593|consen  158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGE-PLWPGRSDIDQLYLIRKTLGNLIPRH-----------  225 (396)
T ss_pred             hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCC-cCCCCcchHHHHHHHHHHHcccCHHH-----------
Confidence            899999999999999999889999999999999999999998 77799999999999999999643221           


Q ss_pred             hHHHHhcccCCC-----C-Cccccccc-cccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccccc
Q 013897          365 HLAALVGRHSRK-----P-WSKFITVE-NQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA  427 (434)
Q Consensus       365 ~~~~~~~~~~~~-----~-~~~~~~~~-~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~  427 (434)
                        .++....+..     + .......+ ....++.-+.||+++||..||.+|++.+|+|.||||.+..+.
T Consensus       226 --q~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~er  293 (396)
T KOG0593|consen  226 --QSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIER  293 (396)
T ss_pred             --HHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHHH
Confidence              1111111000     0 00000011 112356678999999999999999999999999999766443

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-56  Score=412.78  Aligned_cols=257  Identities=23%  Similarity=0.417  Sum_probs=216.8

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEec----cccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~----~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      ++.+.++.||+|..|+||+++++.+++.+|+|.+.    +..++++.+|+++++.. +|||||++||.|.++.. .+.|+
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~-~spyIV~~ygaF~~~~~-~isI~  156 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSC-QSPYIVGFYGAFYSNGE-EISIC  156 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEeEEEEeCCc-eEEee
Confidence            46778899999999999999999999999999993    44568899999999998 99999999999987654 57899


Q ss_pred             EeecCCCchhhhcC---CCChHHHHHHHHHHHHHHHHHHH-CCceeecCCCCceEecCCCCeEEEEecccceecCCCCcc
Q 013897          210 FEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY  285 (434)
Q Consensus       210 ~e~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~  285 (434)
                      ||||++|+|+.++.   .+++.....++.++++||.|||+ ++||||||||+|||++..| .|||||||.++.+... ..
T Consensus       157 mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskG-eVKicDFGVS~~lvnS-~a  234 (364)
T KOG0581|consen  157 MEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKG-EVKICDFGVSGILVNS-IA  234 (364)
T ss_pred             hhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCC-CEEeccccccHHhhhh-hc
Confidence            99999999998875   49999999999999999999996 8999999999999999877 8999999999887655 55


Q ss_pred             ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCC-CHHHHHHHHHHhCChhHHHHHhhccccCCh
Q 013897          286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD-NYDQLVKIAKVLGTDELNAYLNKYHIELDP  364 (434)
Q Consensus       286 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~-~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  364 (434)
                      ++.+||..|||||.+.+ ..|+.++||||||+.++|+.+|+.||.+... ....+..+..++..+               
T Consensus       235 ~tfvGT~~YMsPERi~g-~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~p---------------  298 (364)
T KOG0581|consen  235 NTFVGTSAYMSPERISG-ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEP---------------  298 (364)
T ss_pred             ccccccccccChhhhcC-CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCC---------------
Confidence            88899999999999998 7999999999999999999999999966422 112222222211110               


Q ss_pred             hHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccccc
Q 013897          365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA  427 (434)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~  427 (434)
                              .++.+         ...+++++++|+..||++||.+|+++.|+|+|||+++....
T Consensus       299 --------pP~lP---------~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~  344 (364)
T KOG0581|consen  299 --------PPRLP---------EGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDP  344 (364)
T ss_pred             --------CCCCC---------cccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcccc
Confidence                    00000         01478999999999999999999999999999999976543

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.6e-55  Score=390.32  Aligned_cols=277  Identities=34%  Similarity=0.659  Sum_probs=230.6

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccccH-----HHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK-----KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      ++|..+++||+|.||.||+|++..+|+.||||.++..+.     ....+||+.|+.+ +|+||+.++++|.  ....+.|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel-~h~nIi~LiD~F~--~~~~l~l   78 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQEL-KHPNIIELIDVFP--HKSNLSL   78 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHc-cCcchhhhhhhcc--CCCceEE
Confidence            468889999999999999999999999999999975433     3578999999999 8999999999995  4466779


Q ss_pred             EEeecCCCchhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC-C
Q 013897          209 IFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-K  283 (434)
Q Consensus       209 v~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~-~  283 (434)
                      |+|||+... +..++    .++..+++.++.++++||+|||++.|+||||||.|+|++.+| .+||+|||+|+.+.+. .
T Consensus        79 VfEfm~tdL-e~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g-~lKiADFGLAr~f~~p~~  156 (318)
T KOG0659|consen   79 VFEFMPTDL-EVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDG-QLKIADFGLARFFGSPNR  156 (318)
T ss_pred             EEEeccccH-HHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCC-cEEeecccchhccCCCCc
Confidence            999999654 43432    488999999999999999999999999999999999999887 8999999999987544 3


Q ss_pred             ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                      ..+..+.|.+|+|||.+.|.+.|+..+||||.|||+.||+-|. ||++|.++.+|+..|+..+|.+....|.+-..+.  
T Consensus       157 ~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~-P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp--  233 (318)
T KOG0659|consen  157 IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRV-PFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP--  233 (318)
T ss_pred             ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccC-CCCCCCchHHHHHHHHHHcCCCCcccCccccccc--
Confidence            3455589999999999999999999999999999999999775 9999999999999999999999888887533322  


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                       ++.++. ..+..+...     -...+++++.||+.+||.+||.+|+|+.|+|+|+||+...
T Consensus       234 -dY~~~~-~~P~~~~~~-----lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P  288 (318)
T KOG0659|consen  234 -DYVKIQ-QFPKPPLNN-----LFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP  288 (318)
T ss_pred             -cHHHHh-cCCCCcccc-----ccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence             222211 111111111     1223677889999999999999999999999999999643

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-56  Score=423.35  Aligned_cols=282  Identities=30%  Similarity=0.585  Sum_probs=236.7

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc--HHH--HHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKK--IKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~--~~~--~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      .++|.++++||.|+||.||+|+.+.+++.||||.++..-  .++  -.||+..|++|..|||||++.+++.+... .+++
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~-~L~f   87 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR-ILYF   87 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc-eEee
Confidence            478999999999999999999999999999999997532  233  36899999999449999999999987654 8999


Q ss_pred             EEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCcc
Q 013897          209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY  285 (434)
Q Consensus       209 v~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~  285 (434)
                      |||||.....+.+.   ..|++..++.|+.||++||+|+|.+|+.|||+||+|||+.... .|||+|||+|+.......+
T Consensus        88 VfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~-~iKiaDFGLARev~SkpPY  166 (538)
T KOG0661|consen   88 VFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGND-VIKIADFGLAREVRSKPPY  166 (538)
T ss_pred             eHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccc-eeEecccccccccccCCCc
Confidence            99999987765443   3599999999999999999999999999999999999999544 8999999999999989999


Q ss_pred             ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChh
Q 013897          286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH  365 (434)
Q Consensus       286 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~  365 (434)
                      +.++.|++|+|||++.....|+.++||||+|||++|+.+-+ |.|+|.++.+++.+|.+++|.+....|...+.      
T Consensus       167 TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLr-PLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~------  239 (538)
T KOG0661|consen  167 TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLR-PLFPGASEIDQIYKICEVLGTPDKDSWPEGYN------  239 (538)
T ss_pred             chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhc-ccCCCCcHHHHHHHHHHHhCCCccccchhHHH------
Confidence            99999999999999988789999999999999999999987 77799999999999999999988777664311      


Q ss_pred             HHHHhcccCCCCCccccc--c-ccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccccc
Q 013897          366 LAALVGRHSRKPWSKFIT--V-ENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA  427 (434)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~  427 (434)
                      +...+    ...+.+...  + .--..++.++.++|.+||.+||.+||||.|+|+||||+.-...
T Consensus       240 La~~m----nf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~  300 (538)
T KOG0661|consen  240 LASAM----NFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRAS  300 (538)
T ss_pred             HHHHh----ccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccc
Confidence            11111    111111100  0 0112378899999999999999999999999999999965544

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.2e-55  Score=399.48  Aligned_cols=288  Identities=29%  Similarity=0.483  Sum_probs=239.1

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccccHH-----HHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK-----KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      -++|+.+++|++|+||.||+|+++.+++.||+|.++....+     ...+||.+|.++ +|||||.+-++++..+-..+|
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~-~H~NIV~vkEVVvG~~~d~iy  153 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKA-RHPNIVEVKEVVVGSNMDKIY  153 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhc-CCCCeeeeEEEEeccccceee
Confidence            47799999999999999999999999999999999865533     257999999999 899999999999988778899


Q ss_pred             EEEeecCCCc---hhhhcCCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC-CC
Q 013897          208 LIFEHVNNTD---FKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GK  283 (434)
Q Consensus       208 lv~e~~~~~~---l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~-~~  283 (434)
                      ||||||+...   +..+.++|...+++.++.|+++||+|||.+.|+|||||++|+|+++.| .+||+|||+|+.+.. ..
T Consensus       154 ~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G-~lKiaDFGLAR~ygsp~k  232 (419)
T KOG0663|consen  154 IVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKG-ILKIADFGLAREYGSPLK  232 (419)
T ss_pred             eeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCC-cEEecccchhhhhcCCcc
Confidence            9999999863   233445799999999999999999999999999999999999999777 899999999987753 35


Q ss_pred             ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                      .++..+.|.+|+|||.+.+...|+..+|+||+|||+.||++++ |.++|....+|+.+|++.+|.+....|.+-.....-
T Consensus       233 ~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~k-Plf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~  311 (419)
T KOG0663|consen  233 PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQK-PLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAV  311 (419)
T ss_pred             cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcC-CCCCCCchHHHHHHHHHHhCCCccccCCCccccchh
Confidence            6788899999999999999899999999999999999999987 777999999999999999999877776643322211


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccccc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~  428 (434)
                      .     .......++..+-.......+++...||+..+|.+||.+|.||+|+|.|+||.....+.
T Consensus       312 k-----~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~  371 (419)
T KOG0663|consen  312 K-----KMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPI  371 (419)
T ss_pred             h-----ccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCC
Confidence            0     01111222222111111111668899999999999999999999999999999865443

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.2e-54  Score=401.86  Aligned_cols=284  Identities=33%  Similarity=0.590  Sum_probs=236.4

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCC---ccEEEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK---TPSLIF  210 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~---~~~lv~  210 (434)
                      -.|...+++|.|+||.||+|....+++.||||..-...+ --.+|+.+|+.+ .|||||+|.-+|......   ++.+||
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-~knrEl~im~~l-~HpNIV~L~~~f~~~~~~d~~~lnlVl  101 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-YKNRELQIMRKL-DHPNIVRLLYFFSSSTESDEVYLNLVL  101 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-cCcHHHHHHHhc-CCcCeeeEEEEEEecCCCchhHHHHHH
Confidence            358889999999999999999999999999998754432 336899999988 999999999988754433   677999


Q ss_pred             eecCCCchhhhc------CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc
Q 013897          211 EHVNNTDFKVLY------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE  284 (434)
Q Consensus       211 e~~~~~~l~~~~------~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~  284 (434)
                      |||+......+.      ..++...++-+..||++||.|||+.||+||||||.|+|+|.+.+.+||||||.|+.+..+..
T Consensus       102 eymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ep  181 (364)
T KOG0658|consen  102 EYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEP  181 (364)
T ss_pred             HhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCC
Confidence            999987655443      56888999999999999999999999999999999999999988999999999999999888


Q ss_pred             cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCCh
Q 013897          285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP  364 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  364 (434)
                      ...+..|++|+|||.+.+...|+.+.||||.||+++||+-|+ |+|+|.+..+|+.+|.+.+|.+.......-.....+-
T Consensus       182 niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~-plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~  260 (364)
T KOG0658|consen  182 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQ-PLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEF  260 (364)
T ss_pred             ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCC-cccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccc
Confidence            889999999999999999999999999999999999999998 6679999999999999999987654432211000000


Q ss_pred             hHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccccc
Q 013897          365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~  428 (434)
                          ........+|.+    ......++++.||+.++|+++|.+|.++.|+|.||||...+.+.
T Consensus       261 ----~~p~ik~~~~~~----~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~  316 (364)
T KOG0658|consen  261 ----KFPQIKAHPWHK----VFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPN  316 (364)
T ss_pred             ----cCccccccccee----ecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcC
Confidence                011111222222    13345789999999999999999999999999999999888764

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-54  Score=399.19  Aligned_cols=254  Identities=30%  Similarity=0.513  Sum_probs=216.9

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      .++|++++.||+|+||+||+++.+.+++.||+|++++..      .+....|..||..+ +||.||+++..|.  +...+
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v-~hPFiv~l~ysFQ--t~~kL  100 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKI-KHPFIVKLIYSFQ--TEEKL  100 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhC-CCCcEeeeEEecc--cCCeE
Confidence            478999999999999999999999999999999997532      35678999999998 9999999999994  55788


Q ss_pred             EEEEeecCCCchhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceec-CCC
Q 013897          207 SLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY-HPG  282 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~-~~~  282 (434)
                      |+|+||+.||.|..+++   .+++..++.|+.+|+.||.|||++|||||||||+|||+|.+| +++|+|||+|+.. ..+
T Consensus       101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~G-Hi~LtDFgL~k~~~~~~  179 (357)
T KOG0598|consen  101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQG-HIKLTDFGLCKEDLKDG  179 (357)
T ss_pred             EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCC-cEEEeccccchhcccCC
Confidence            99999999999987775   599999999999999999999999999999999999999887 9999999999854 444


Q ss_pred             CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                      ....+.|||+.|||||++.+ .+|+..+|+|||||++|||++|.+||. +.+.......|.+.-                
T Consensus       180 ~~t~tfcGT~eYmAPEil~~-~gy~~~vDWWsLGillYeML~G~pPF~-~~~~~~~~~~I~~~k----------------  241 (357)
T KOG0598|consen  180 DATRTFCGTPEYMAPEILLG-KGYDKAVDWWSLGILLYEMLTGKPPFY-AEDVKKMYDKILKGK----------------  241 (357)
T ss_pred             CccccccCCccccChHHHhc-CCCCcccchHhHHHHHHHHhhCCCCCc-CccHHHHHHHHhcCc----------------
Confidence            55667899999999999998 799999999999999999999999983 334333333332210                


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCc----cHHHHhcCCCcccccccc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP----TAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rp----t~~elL~Hp~~~~~~~~~  428 (434)
                                          ....+..++.+++|||+++|..||++|.    .++++-+||||..+++..
T Consensus       242 --------------------~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~  291 (357)
T KOG0598|consen  242 --------------------LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEK  291 (357)
T ss_pred             --------------------CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHH
Confidence                                0111223678999999999999999995    688999999999998654

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-54  Score=397.66  Aligned_cols=290  Identities=33%  Similarity=0.614  Sum_probs=237.6

Q ss_pred             ccCCCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecc-----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEEc---
Q 013897          129 QWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRD---  200 (434)
Q Consensus       129 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~---  200 (434)
                      .+.....|..++.||+|+||.|+.+.++.+|+.||||.+..     ...++..+|+++|+.+ +|+||+.+++++..   
T Consensus        17 ~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~-~HeNIi~l~di~~p~~~   95 (359)
T KOG0660|consen   17 LFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHL-RHENIIGLLDIFRPPSR   95 (359)
T ss_pred             EEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHh-cCCCcceEEeecccccc
Confidence            33445667778999999999999999999999999998852     3346788999999999 79999999999875   


Q ss_pred             cCCCccEEEEeecCCCchhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccce
Q 013897          201 QQSKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE  277 (434)
Q Consensus       201 ~~~~~~~lv~e~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~  277 (434)
                      .....+|+|+|+|+ .+|...++   .+++..++.++.||++||.|+|+.+|+||||||+|+|++.+- .+||||||+|+
T Consensus        96 ~~f~DvYiV~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c-~lKI~DFGLAR  173 (359)
T KOG0660|consen   96 DKFNDVYLVFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADC-DLKICDFGLAR  173 (359)
T ss_pred             cccceeEEehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCC-CEEecccccee
Confidence            34567899999994 55655542   389999999999999999999999999999999999999777 79999999999


Q ss_pred             ecCC---CCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHH
Q 013897          278 FYHP---GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAY  354 (434)
Q Consensus       278 ~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~  354 (434)
                      ....   ....+..+.|.+|+|||++.....|+..+||||+||||+||++|+ |.|+|.+..+|+..|.+.+|.+.....
T Consensus       174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gk-plFpG~d~v~Ql~lI~~~lGtP~~e~l  252 (359)
T KOG0660|consen  174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGK-PLFPGKDYVHQLQLILELLGTPSEEDL  252 (359)
T ss_pred             eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCC-CCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence            8753   455688899999999999998889999999999999999999998 666999999999999999998754333


Q ss_pred             HhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccccc
Q 013897          355 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~  428 (434)
                      . .........+-.-....++.++...+     +.+++.+.|||.+||+.||.+|+|++|+|+||||.+...++
T Consensus       253 ~-~i~s~~ar~yi~slp~~p~~~f~~~f-----p~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~  320 (359)
T KOG0660|consen  253 Q-KIRSEKARPYIKSLPQIPKQPFSSIF-----PNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPE  320 (359)
T ss_pred             H-HhccHHHHHHHHhCCCCCCCCHHHHc-----CCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCc
Confidence            2 21111111122222333444443332     24788999999999999999999999999999999887655

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-53  Score=416.62  Aligned_cols=246  Identities=26%  Similarity=0.506  Sum_probs=214.2

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecc------ccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      ..|+..+.||+|||+.||.+++..+|+.||+|++.+      ..++.+.+||+|.+.| +|||||+++++|+|.  .++|
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L-~HpnIV~f~~~FEDs--~nVY   94 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSL-KHPNIVQFYHFFEDS--NNVY   94 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhc-CCCcEEeeeeEeecC--CceE
Confidence            569999999999999999999999999999999854      3457789999999999 999999999999764  6888


Q ss_pred             EEEeecCCCchhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC-C
Q 013897          208 LIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-K  283 (434)
Q Consensus       208 lv~e~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~-~  283 (434)
                      ||.|.|..++|..+++   .+++.+++.+++||+.||.|||+++|+|||||..|+|++.+. +|||+|||||..+..+ .
T Consensus        95 ivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~-~VKIgDFGLAt~le~~~E  173 (592)
T KOG0575|consen   95 IVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENM-NVKIGDFGLATQLEYDGE  173 (592)
T ss_pred             EEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcC-cEEecccceeeeecCccc
Confidence            9999999999977764   699999999999999999999999999999999999999777 8999999999888744 5


Q ss_pred             ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                      ...+.|||+.|.|||++.. .+.+..+||||+||+||-||+|++|| ...+-.+.+.+|...                  
T Consensus       174 rk~TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPF-etk~vkety~~Ik~~------------------  233 (592)
T KOG0575|consen  174 RKKTLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPF-ETKTVKETYNKIKLN------------------  233 (592)
T ss_pred             ccceecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCc-ccchHHHHHHHHHhc------------------
Confidence            6678899999999999986 78999999999999999999999998 333333344433210                  


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFF  422 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~  422 (434)
                                         ....+..++.++.|||.+||+.||.+|||++++|.|+||+
T Consensus       234 -------------------~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~  273 (592)
T KOG0575|consen  234 -------------------EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFK  273 (592)
T ss_pred             -------------------CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhh
Confidence                               0112234788999999999999999999999999999994

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-53  Score=406.23  Aligned_cols=253  Identities=32%  Similarity=0.523  Sum_probs=219.7

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecc------ccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      ..||..++.||+|+|++|++|+.+.+++.||||++.+      .+.+-+.+|-.+|.+|.+||.|++|+..|.|  ...+
T Consensus        72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD--~~sL  149 (604)
T KOG0592|consen   72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQD--EESL  149 (604)
T ss_pred             hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeec--ccce
Confidence            4789999999999999999999999999999999853      3345578899999999999999999999965  4788


Q ss_pred             EEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC
Q 013897          207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~  283 (434)
                      |+|+||+++|+|..++   +.|++..++.|+.||+.||+|||++|||||||||+|||||.|+ ++||+|||.|+.+.+..
T Consensus       150 YFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dm-hikITDFGsAK~l~~~~  228 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDG-HIKITDFGSAKILSPSQ  228 (604)
T ss_pred             EEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCC-cEEEeeccccccCChhh
Confidence            9999999999987775   4689999999999999999999999999999999999999888 89999999998875422


Q ss_pred             c--------------cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCh
Q 013897          284 E--------------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTD  349 (434)
Q Consensus       284 ~--------------~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~  349 (434)
                      .              ....+||..|.+||++.. ...++.+|+|+||||||+|+.|++|| .+.++.-.+.+|.++-   
T Consensus       229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPF-ra~NeyliFqkI~~l~---  303 (604)
T KOG0592|consen  229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPF-RAANEYLIFQKIQALD---  303 (604)
T ss_pred             ccccCccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCC-ccccHHHHHHHHHHhc---
Confidence            1              145799999999999887 78999999999999999999999997 6667777777765421   


Q ss_pred             hHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccccc
Q 013897          350 ELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA  427 (434)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~  427 (434)
                                                        ...+..+++.+.||++++|+.||.+|+|+.|+.+||||.+|++.
T Consensus       304 ----------------------------------y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~  347 (604)
T KOG0592|consen  304 ----------------------------------YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWE  347 (604)
T ss_pred             ----------------------------------ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChh
Confidence                                              11223366889999999999999999999999999999999864

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.7e-52  Score=402.06  Aligned_cols=257  Identities=28%  Similarity=0.469  Sum_probs=215.7

Q ss_pred             CCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCc
Q 013897          132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT  205 (434)
Q Consensus       132 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  205 (434)
                      ..++|++++.||+|+||.||+|+.+.+|..+|+|++++.      ..+.++.|-.+|... .+|+||+|+..|.  +..+
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-ds~~vVKLyYsFQ--D~~~  215 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-DSPWVVKLYYSFQ--DKEY  215 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-CCCcEEEEEEEec--CCCe
Confidence            358999999999999999999999999999999999753      235577899999996 9999999999995  4578


Q ss_pred             cEEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC-
Q 013897          206 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-  281 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~-  281 (434)
                      +||||||++||++..++   ..|++..++.|+.+++.|++-||+.|+|||||||+|+|||..| ++||+||||+..+.. 
T Consensus       216 LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~G-HiKLSDFGLs~gl~~~  294 (550)
T KOG0605|consen  216 LYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKG-HIKLSDFGLSTGLDKK  294 (550)
T ss_pred             eEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCC-CEeeccccccchhhhh
Confidence            99999999999988776   4599999999999999999999999999999999999999887 999999999843211 


Q ss_pred             ----------------------CCc-----c--------------------ceeccCCcccccccccCCCCCCccccHHH
Q 013897          282 ----------------------GKE-----Y--------------------NVRVASRYFKGPELLVDLQDYDYSLDLWS  314 (434)
Q Consensus       282 ----------------------~~~-----~--------------------~~~~~t~~y~aPE~~~~~~~~~~~~DvwS  314 (434)
                                            ...     .                    ...+|||.|+|||++.+ .+|+..+|+||
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~-kgY~~~cDwWS  373 (550)
T KOG0605|consen  295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG-KGYGKECDWWS  373 (550)
T ss_pred             hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc-CCCCccccHHH
Confidence                                  000     0                    11379999999999998 78999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHH
Q 013897          315 LGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEA  394 (434)
Q Consensus       315 lGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (434)
                      ||||+||||.|.+|| .+.+..+...+|..         |..                        -+.......+++++
T Consensus       374 LG~ImyEmLvGyPPF-~s~tp~~T~rkI~n---------wr~------------------------~l~fP~~~~~s~eA  419 (550)
T KOG0605|consen  374 LGCIMYEMLVGYPPF-CSETPQETYRKIVN---------WRE------------------------TLKFPEEVDLSDEA  419 (550)
T ss_pred             HHHHHHHHHhCCCCC-CCCCHHHHHHHHHH---------Hhh------------------------hccCCCcCcccHHH
Confidence            999999999999998 66666677766543         111                        11222333467899


Q ss_pred             HHHHHHccccCCCCCcc---HHHHhcCCCcccccccc
Q 013897          395 VDFLDKLLRYDHQERPT---AKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       395 ~dll~~cL~~dP~~Rpt---~~elL~Hp~~~~~~~~~  428 (434)
                      .|||.+||. ||++|..   ++|+.+||||++|++--
T Consensus       420 ~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~  455 (550)
T KOG0605|consen  420 KDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDH  455 (550)
T ss_pred             HHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcch
Confidence            999999999 9999975   89999999999998654

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-51  Score=368.62  Aligned_cols=251  Identities=24%  Similarity=0.430  Sum_probs=216.9

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      .++|+.++.||.|+||.|.+++.+.+|..+|+|+++...      .+...+|..+|+.+ .||+++++++.+.+  ..++
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v-~~PFlv~l~~t~~d--~~~l  119 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAV-SHPFLVKLYGTFKD--NSNL  119 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhc-cCceeEEEEEeecc--CCeE
Confidence            478999999999999999999999999999999997543      24567899999999 89999999999965  4678


Q ss_pred             EEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC
Q 013897          207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~  283 (434)
                      ++||||++||.+-.++   +++++..++.++.||+.||+|||+++|++|||||+|||+|.+| .+||+|||.|+..... 
T Consensus       120 ymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G-~iKitDFGFAK~v~~r-  197 (355)
T KOG0616|consen  120 YMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNG-HIKITDFGFAKRVSGR-  197 (355)
T ss_pred             EEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCC-cEEEEeccceEEecCc-
Confidence            8999999999886665   4699999999999999999999999999999999999999887 8999999999987533 


Q ss_pred             ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                       .-+.|||+.|+|||++.. ++|+.++|+|||||++|||+.|.+||+.... .....+|.+.                  
T Consensus       198 -T~TlCGTPeYLAPEii~s-k~ynkavDWWalGVLIYEMlaG~pPF~~~~~-~~iY~KI~~~------------------  256 (355)
T KOG0616|consen  198 -TWTLCGTPEYLAPEIIQS-KGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-IQIYEKILEG------------------  256 (355)
T ss_pred             -EEEecCCccccChHHhhc-CCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-HHHHHHHHhC------------------
Confidence             567899999999999987 8999999999999999999999999965433 4444444321                  


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCC-----ccHHHHhcCCCcccccccc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQER-----PTAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~R-----pt~~elL~Hp~~~~~~~~~  428 (434)
                                         ....+..++++++|||+++|++|-.+|     ....++.+||||+.+++.+
T Consensus       257 -------------------~v~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~  307 (355)
T KOG0616|consen  257 -------------------KVKFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEA  307 (355)
T ss_pred             -------------------cccCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHH
Confidence                               122344578899999999999999999     4578999999999998766

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-51  Score=383.27  Aligned_cols=253  Identities=29%  Similarity=0.516  Sum_probs=212.3

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      .++|.+.+.||.|+||+||+|+++.++..||||.+...     ..+.+..|+.+|+.+ +|||||.++++++.+  .+++
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel-~H~nIV~l~d~~~~~--~~i~   85 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKEL-KHPNIVRLLDCIEDD--DFIY   85 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhc-CCcceeeEEEEEecC--CeEE
Confidence            47899999999999999999999999999999998654     345678999999999 899999999999755  5888


Q ss_pred             EEEeecCCCchhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC--C---CeEEEEecccceec
Q 013897          208 LIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--Q---RKLRLIDWGLAEFY  279 (434)
Q Consensus       208 lv~e~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~--~---~~vkl~DFGla~~~  279 (434)
                      ||||||.||+|..++.   .+++..++.++.||+.||++||+++||||||||+||||+..  .   ..+||+|||+|+.+
T Consensus        86 lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L  165 (429)
T KOG0595|consen   86 LVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL  165 (429)
T ss_pred             EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence            9999999999988763   68999999999999999999999999999999999999854  2   36999999999999


Q ss_pred             CCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcc
Q 013897          280 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH  359 (434)
Q Consensus       280 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  359 (434)
                      .++....+.||++.|||||++.. ..|+.|+|+||+|+|+|+|++|+.|| ...+..+.+..+.+  +.           
T Consensus       166 ~~~~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf-~a~t~~eL~~~~~k--~~-----------  230 (429)
T KOG0595|consen  166 QPGSMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPF-DAETPKELLLYIKK--GN-----------  230 (429)
T ss_pred             CchhHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCc-cccCHHHHHHHHhc--cc-----------
Confidence            98888889999999999999976 79999999999999999999999998 33333333332211  00           


Q ss_pred             ccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccc
Q 013897          360 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI  424 (434)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~  424 (434)
                       ..-                    ..-+...+....+++...|+.+|.+|.+..+-+.|+++..-
T Consensus       231 -~~~--------------------~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~  274 (429)
T KOG0595|consen  231 -EIV--------------------PVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAAN  274 (429)
T ss_pred             -ccc--------------------CchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccC
Confidence             000                    01111245567799999999999999999999999998754

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-50  Score=399.50  Aligned_cols=256  Identities=26%  Similarity=0.446  Sum_probs=222.7

Q ss_pred             CCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCc
Q 013897          132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT  205 (434)
Q Consensus       132 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  205 (434)
                      ..++|.+++.||+|+||+|+++..+.+++.+|||++++.      ..+....|..|+..+.+||.++.++..|  +...+
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f--QT~~~  443 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF--QTKEH  443 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc--ccCCe
Confidence            358899999999999999999999999999999999863      3466788999999887899999999999  56788


Q ss_pred             cEEEEeecCCCchhhhc--CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecC-CC
Q 013897          206 PSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PG  282 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~-~~  282 (434)
                      +++||||+.||++..+.  ..+++..++.|+.+|+.||.|||++||||||||.+|||||.+| ++||+|||+++..- .+
T Consensus       444 l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eG-h~kiADFGlcKe~m~~g  522 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEG-HVKIADFGLCKEGMGQG  522 (694)
T ss_pred             EEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccC-cEEecccccccccCCCC
Confidence            99999999999965554  4699999999999999999999999999999999999999888 89999999998654 45


Q ss_pred             CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                      ....+.|||+.|||||++.+ ..|+..+|+|||||+|||||.|..|| ++.+..+.+..|.-                  
T Consensus       523 ~~TsTfCGTpey~aPEil~e-~~Yt~aVDWW~lGVLlyeML~Gq~PF-~gddEee~FdsI~~------------------  582 (694)
T KOG0694|consen  523 DRTSTFCGTPEFLAPEVLTE-QSYTRAVDWWGLGVLLYEMLVGESPF-PGDDEEEVFDSIVN------------------  582 (694)
T ss_pred             CccccccCChhhcChhhhcc-CcccchhhHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHhc------------------
Confidence            66788999999999999998 79999999999999999999999998 66666666665431                  


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccH-----HHHhcCCCccccccccc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA-----KEAMAHPYFFPIRNAES  429 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~-----~elL~Hp~~~~~~~~~~  429 (434)
                                         .....+..++.++.++|+++|+.||++|..+     +++..||||+.+++...
T Consensus       583 -------------------d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L  635 (694)
T KOG0694|consen  583 -------------------DEVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDL  635 (694)
T ss_pred             -------------------CCCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHH
Confidence                               0112233478899999999999999999875     79999999999987653

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=3.8e-50  Score=396.96  Aligned_cols=286  Identities=29%  Similarity=0.498  Sum_probs=221.0

Q ss_pred             CeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccccH--HHHHHHHHHHHHhcCC-----CCeeeEeeEEEccCCCccE
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--KKIKREIKILQNLCGG-----PNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~E~~~l~~l~~h-----~niv~l~~~~~~~~~~~~~  207 (434)
                      +|++++.||+|+||.|.+|.+..+++.||||++++...  .+...|+.+|..|..|     -|+|+++++|..  ..++|
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f--r~Hlc  264 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF--RNHLC  264 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc--cccee
Confidence            68999999999999999999999999999999986653  6678899999999534     599999999964  46788


Q ss_pred             EEEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCC-CeEEEEecccceecCCC
Q 013897          208 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ-RKLRLIDWGLAEFYHPG  282 (434)
Q Consensus       208 lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~-~~vkl~DFGla~~~~~~  282 (434)
                      ||+|.+.....+.+.    ..++...++.++.||+.||.+||+.+|||+||||+||||.+.+ ..|||+|||.|..... 
T Consensus       265 iVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q-  343 (586)
T KOG0667|consen  265 IVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ-  343 (586)
T ss_pred             eeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCC-
Confidence            999998876544443    3588999999999999999999999999999999999996433 2799999999986542 


Q ss_pred             CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccc--
Q 013897          283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI--  360 (434)
Q Consensus       283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~--  360 (434)
                       ...+++.+.+|+|||++.| .+|+.+.||||||||++||++| .|+|+|.+..+|+..|.+++|.+...........  
T Consensus       344 -~vytYiQSRfYRAPEVILG-lpY~~~IDmWSLGCIlAEL~tG-~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~k  420 (586)
T KOG0667|consen  344 -RVYTYIQSRFYRAPEVILG-LPYDTAIDMWSLGCILAELFTG-EPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHK  420 (586)
T ss_pred             -cceeeeeccccccchhhcc-CCCCCccceeehhhhHHhHhcC-ccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccce
Confidence             3338899999999999999 7999999999999999999999 5888999999999999999997654322211100  


Q ss_pred             cCCh---hHH-----------------H---HhcccCCCC-CccccccccccCCchHHHHHHHHccccCCCCCccHHHHh
Q 013897          361 ELDP---HLA-----------------A---LVGRHSRKP-WSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAM  416 (434)
Q Consensus       361 ~~~~---~~~-----------------~---~~~~~~~~~-~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL  416 (434)
                      .++.   ...                 .   ......+.+ -...........-...+.|||++||.+||.+|+|+.|+|
T Consensus       421 ff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal  500 (586)
T KOG0667|consen  421 FFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQAL  500 (586)
T ss_pred             ehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHh
Confidence            0000   000                 0   000000111 000000001112234679999999999999999999999


Q ss_pred             cCCCcccccc
Q 013897          417 AHPYFFPIRN  426 (434)
Q Consensus       417 ~Hp~~~~~~~  426 (434)
                      +||||.+...
T Consensus       501 ~Hpfl~~~~~  510 (586)
T KOG0667|consen  501 NHPFLTGTSL  510 (586)
T ss_pred             cCcccccccc
Confidence            9999995543

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-51  Score=394.58  Aligned_cols=254  Identities=26%  Similarity=0.475  Sum_probs=218.1

Q ss_pred             CCCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecc---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       131 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      .....|....+||+|+.|.||.+....+++.||||.+..   .+++.+.+|+.+|+.+ +|+|||.+++.|...  ..++
T Consensus       270 dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~-~H~NiVnfl~Sylv~--deLW  346 (550)
T KOG0578|consen  270 DPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDL-HHPNIVNFLDSYLVG--DELW  346 (550)
T ss_pred             ChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhc-cchHHHHHHHHhccc--ceeE
Confidence            345679999999999999999999999999999999853   3456789999999999 999999999988654  5678


Q ss_pred             EEEeecCCCchhhhcC--CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC-c
Q 013897          208 LIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-E  284 (434)
Q Consensus       208 lv~e~~~~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~-~  284 (434)
                      +|||||++|+|.+...  .+++.+++.++++++.||+|||.+||+|||||.+|||++.++ .+||+|||+|..+.... .
T Consensus       347 VVMEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g-~vKltDFGFcaqi~~~~~K  425 (550)
T KOG0578|consen  347 VVMEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDG-SVKLTDFGFCAQISEEQSK  425 (550)
T ss_pred             EEEeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCC-cEEEeeeeeeeccccccCc
Confidence            9999999999988875  489999999999999999999999999999999999999888 79999999998776554 4


Q ss_pred             cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCCh
Q 013897          285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP  364 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  364 (434)
                      ..+.+||++|||||++.. ..|++++||||||++++||+-|.+||+. ++....+..|+. .|.+               
T Consensus       426 R~TmVGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYln-E~PlrAlyLIa~-ng~P---------------  487 (550)
T KOG0578|consen  426 RSTMVGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIAT-NGTP---------------  487 (550)
T ss_pred             cccccCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCccC-CChHHHHHHHhh-cCCC---------------
Confidence            567799999999999876 7999999999999999999999999976 344444444432 1211               


Q ss_pred             hHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccc
Q 013897          365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI  424 (434)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~  424 (434)
                                        .+.+...+++.++|||.+||+.|+++|++|.|||+||||+..
T Consensus       488 ------------------~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a  529 (550)
T KOG0578|consen  488 ------------------KLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMA  529 (550)
T ss_pred             ------------------CcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence                              123445688999999999999999999999999999999644

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.5e-50  Score=373.69  Aligned_cols=283  Identities=32%  Similarity=0.568  Sum_probs=228.4

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccccH-----HHHHHHHHHHHHhcCCCC-eeeEeeEEEccC----C
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK-----KKIKREIKILQNLCGGPN-IVKLLDIVRDQQ----S  203 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~E~~~l~~l~~h~n-iv~l~~~~~~~~----~  203 (434)
                      ..|+.+++||+|+||+||+|+.+.+|+.||+|.+.-...     ....+|+.+|++| +|+| ||.+++++...+    .
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L-~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRL-SHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHh-CCCcceEEEEeeeeeccccccc
Confidence            457788899999999999999999999999999875433     3468999999999 8999 999999986543    2


Q ss_pred             CccEEEEeecCCCchhhhc-------CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccc
Q 013897          204 KTPSLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA  276 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla  276 (434)
                      ..+++|+||+.-.. ..++       ..++...++.+++||+.||+|||+++|+||||||.|||++.++ .+||+|||+|
T Consensus        90 ~~l~lvfe~~d~DL-~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G-~lKlaDFGlA  167 (323)
T KOG0594|consen   90 GKLYLVFEFLDRDL-KKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSG-VLKLADFGLA  167 (323)
T ss_pred             ceEEEEEEeecccH-HHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCC-cEeeeccchH
Confidence            36789999998643 2222       2466678999999999999999999999999999999999866 8999999999


Q ss_pred             eecC-CCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHH
Q 013897          277 EFYH-PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL  355 (434)
Q Consensus       277 ~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~  355 (434)
                      +... +...++..++|.+|+|||++.+...|+..+||||+|||++||++++ |.|++..+.+++..|.+.+|.+....|.
T Consensus       168 ra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~-~LFpG~se~~ql~~If~~lGtP~e~~Wp  246 (323)
T KOG0594|consen  168 RAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRR-PLFPGDSEIDQLFRIFRLLGTPNEKDWP  246 (323)
T ss_pred             HHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCC-CCCCCCcHHHHHHHHHHHcCCCCccCCC
Confidence            8765 5566788899999999999999889999999999999999999976 7779999999999999999999887776


Q ss_pred             hhccccCChhHHHHhcccC-CCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccccc
Q 013897          356 NKYHIELDPHLAALVGRHS-RKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~  428 (434)
                      .-....-   +......+. ...+     .......+++..|++.+||+++|.+|+|++.+|.||||..+....
T Consensus       247 ~v~~~~~---~k~~f~~~~~~~~l-----~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~  312 (323)
T KOG0594|consen  247 GVSSLPD---YKAPFPKWPGPKDL-----SSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKS  312 (323)
T ss_pred             Ccccccc---ccccCcCCCCccch-----HHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccch
Confidence            4321111   000000000 0000     011122346899999999999999999999999999999886544

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-49  Score=385.62  Aligned_cols=251  Identities=31%  Similarity=0.497  Sum_probs=210.3

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc--------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK  204 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~--------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  204 (434)
                      .+.|.+.+.||+|+||+|+.|.+..++..||+|+++..        ..+.+.+|+.+++.+..||||+++++++...  .
T Consensus        16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~--~   93 (370)
T KOG0583|consen   16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP--T   93 (370)
T ss_pred             cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC--C
Confidence            46899999999999999999999999999999987653        2345678999999995599999999999655  3


Q ss_pred             ccEEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceec-C
Q 013897          205 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY-H  280 (434)
Q Consensus       205 ~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~-~  280 (434)
                      .+++||||+.+|+|...+   .++.+.+++.++.||+.|++|||++||+||||||+|||++.+...+||+|||++... .
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~  173 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPG  173 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCC
Confidence            488999999999886664   468999999999999999999999999999999999999977248999999999988 4


Q ss_pred             CCCccceeccCCcccccccccCCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcc
Q 013897          281 PGKEYNVRVASRYFKGPELLVDLQDY-DYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH  359 (434)
Q Consensus       281 ~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  359 (434)
                      .+....+.+||+.|+|||++.+...| +.++||||+||+||.|++|+.||.. .+.......|.+               
T Consensus       174 ~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d-~~~~~l~~ki~~---------------  237 (370)
T KOG0583|consen  174 EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD-SNVPNLYRKIRK---------------  237 (370)
T ss_pred             CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-ccHHHHHHHHhc---------------
Confidence            66778899999999999999884425 5899999999999999999999943 222112211110               


Q ss_pred             ccCChhHHHHhcccCCCCCccccccccccCC-chHHHHHHHHccccCCCCCccHHHHhcCCCccc
Q 013897          360 IELDPHLAALVGRHSRKPWSKFITVENQHLA-VPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP  423 (434)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~  423 (434)
                                            -....+..+ ++++.+|+.+||..||.+|+|+.++++||||+.
T Consensus       238 ----------------------~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  238 ----------------------GEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             ----------------------CCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence                                  001122335 889999999999999999999999999999997

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-49  Score=377.22  Aligned_cols=254  Identities=28%  Similarity=0.510  Sum_probs=211.1

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc-----------------HHHHHHHHHHHHHhcCCCCeeeEe
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------------KKKIKREIKILQNLCGGPNIVKLL  195 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----------------~~~~~~E~~~l~~l~~h~niv~l~  195 (434)
                      .++|++.+.||+|.||+|.+|++..+++.||||++.+..                 .+...+||.||++| +|||||+|+
T Consensus        96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl-~H~nVV~Li  174 (576)
T KOG0585|consen   96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL-HHPNVVKLI  174 (576)
T ss_pred             hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc-CCcCeeEEE
Confidence            578999999999999999999999999999999996422                 24678999999999 999999999


Q ss_pred             eEEEccCCCccEEEEeecCCCchhhhc--CC-CChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEe
Q 013897          196 DIVRDQQSKTPSLIFEHVNNTDFKVLY--PT-LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLID  272 (434)
Q Consensus       196 ~~~~~~~~~~~~lv~e~~~~~~l~~~~--~~-l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~D  272 (434)
                      ++..++....+|||+|||..|.+...-  .. +++.+++.|+++++.||+|||.+|||||||||+|+||+.++ +|||+|
T Consensus       175 EvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g-~VKIsD  253 (576)
T KOG0585|consen  175 EVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDG-TVKISD  253 (576)
T ss_pred             EeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCC-cEEeec
Confidence            999999999999999999999876543  23 88999999999999999999999999999999999999886 999999


Q ss_pred             cccceecCCC------CccceeccCCcccccccccCC---CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 013897          273 WGLAEFYHPG------KEYNVRVASRYFKGPELLVDL---QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA  343 (434)
Q Consensus       273 FGla~~~~~~------~~~~~~~~t~~y~aPE~~~~~---~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~  343 (434)
                      ||.+.....+      ......+||+.|+|||.+.+.   ...+.+.||||+||+||.|+.|+.||+. ....+.+.+|.
T Consensus       254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~-~~~~~l~~KIv  332 (576)
T KOG0585|consen  254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD-DFELELFDKIV  332 (576)
T ss_pred             cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc-chHHHHHHHHh
Confidence            9999766322      223446899999999999762   2357889999999999999999999942 22333333332


Q ss_pred             HHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccc
Q 013897          344 KVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP  423 (434)
Q Consensus       344 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~  423 (434)
                      .                                   ..+.+.....+...++|||.+||.+||++|+++.++..|||...
T Consensus       333 n-----------------------------------~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~  377 (576)
T KOG0585|consen  333 N-----------------------------------DPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR  377 (576)
T ss_pred             c-----------------------------------CcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence            1                                   01112223345678999999999999999999999999999985


Q ss_pred             c
Q 013897          424 I  424 (434)
Q Consensus       424 ~  424 (434)
                      -
T Consensus       378 ~  378 (576)
T KOG0585|consen  378 D  378 (576)
T ss_pred             C
Confidence            4

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-50  Score=377.26  Aligned_cols=257  Identities=26%  Similarity=0.432  Sum_probs=204.7

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF  210 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  210 (434)
                      .++...+.||+|+||.||++.+..+|...|||.+....   .+.+.+|+.+|.+| +|||||+++|.........+++.|
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l-~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRL-NHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhC-CCCCEEeeCCccccccCeeeEeee
Confidence            34678899999999999999998889999999986554   45689999999999 699999999974433224678999


Q ss_pred             eecCCCchhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC----C
Q 013897          211 EHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP----G  282 (434)
Q Consensus       211 e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~----~  282 (434)
                      ||+.+|+|..++.    .+++..++.+.+||++||+|||++|||||||||+|||++..++.+||+|||+++....    .
T Consensus        96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~  175 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKS  175 (313)
T ss_pred             eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccccc
Confidence            9999999987764    5899999999999999999999999999999999999997334899999999987653    1


Q ss_pred             CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                      .......||+.|||||++.+......++|||||||++.||+||+.||..-   .+....+.......             
T Consensus       176 ~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~---~~~~~~~~~ig~~~-------------  239 (313)
T KOG0198|consen  176 DSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF---FEEAEALLLIGRED-------------  239 (313)
T ss_pred             cccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh---cchHHHHHHHhccC-------------
Confidence            22345789999999999985223345999999999999999999998321   11111111111000             


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN  426 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~  426 (434)
                                         ....-+..+++++.+||.+||..||++||||+++|+|||.++...
T Consensus       240 -------------------~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  240 -------------------SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             -------------------CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence                               000122347889999999999999999999999999999987543

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.2e-49  Score=388.00  Aligned_cols=254  Identities=26%  Similarity=0.449  Sum_probs=218.2

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      .-|++++.||.|+-|.|-+|++..+|+.+|||++....      ...+++|+.+|+-+ .|||++++|+++++  ...+|
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi-~HpnVl~LydVwe~--~~~ly   88 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLI-EHPNVLRLYDVWEN--KQHLY   88 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHh-cCCCeeeeeeeecc--CceEE
Confidence            34789999999999999999999999999999996542      35689999999988 99999999999954  46788


Q ss_pred             EEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc
Q 013897          208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE  284 (434)
Q Consensus       208 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~  284 (434)
                      +|.||+.+|.|.+++   +++++.+++.+++||+.|+.|+|..+|+||||||+|+|||..+ .+||+|||+|..-.++.-
T Consensus        89 lvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~-nIKIADFGMAsLe~~gkl  167 (786)
T KOG0588|consen   89 LVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKN-NIKIADFGMASLEVPGKL  167 (786)
T ss_pred             EEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhccc-CEeeeccceeecccCCcc
Confidence            999999999876654   5799999999999999999999999999999999999999888 599999999998888888


Q ss_pred             cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCCh
Q 013897          285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP  364 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  364 (434)
                      ..+.||++.|.+||++.|....+.++||||.|||||.||||+.||.  +++...+..-++. |                 
T Consensus       168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd--DdNir~LLlKV~~-G-----------------  227 (786)
T KOG0588|consen  168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD--DDNIRVLLLKVQR-G-----------------  227 (786)
T ss_pred             ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC--CccHHHHHHHHHc-C-----------------
Confidence            8999999999999999995556789999999999999999999993  3443333321110 0                 


Q ss_pred             hHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccccccc
Q 013897          365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAES  429 (434)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~~  429 (434)
                                        .++-+..++++++|||++||.+||++|+|.+|++.|||+.+-.....
T Consensus       228 ------------------~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~  274 (786)
T KOG0588|consen  228 ------------------VFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPS  274 (786)
T ss_pred             ------------------cccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCCh
Confidence                              01223458899999999999999999999999999999998766553

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=4.5e-48  Score=372.53  Aligned_cols=287  Identities=30%  Similarity=0.507  Sum_probs=218.4

Q ss_pred             cCCCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCc
Q 013897          130 WGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT  205 (434)
Q Consensus       130 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  205 (434)
                      |+..++|++.+.||+|+||.||+|.+..+++.||+|+++...    ...+.+|+.+++.+ +||||+++++++.+.  ..
T Consensus         1 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~~   77 (303)
T cd07869           1 FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL-KHANIVLLHDIIHTK--ET   77 (303)
T ss_pred             CCccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhC-CCCCcCeEEEEEecC--Ce
Confidence            355689999999999999999999998899999999986432    24577899999999 999999999999654  56


Q ss_pred             cEEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC
Q 013897          206 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG  282 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~  282 (434)
                      .++||||+.++.+..+.   ..+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+||+|||++......
T Consensus        78 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~  156 (303)
T cd07869          78 LTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTG-ELKLADFGLARAKSVP  156 (303)
T ss_pred             EEEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEECCCCcceeccCC
Confidence            78999999865544333   3488899999999999999999999999999999999999776 8999999999754322


Q ss_pred             -CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcccc
Q 013897          283 -KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE  361 (434)
Q Consensus       283 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  361 (434)
                       .......+++.|+|||++.+...++.++|||||||++|+|++|+.||....+..+.+..+...++.+....+.......
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T cd07869         157 SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP  236 (303)
T ss_pred             CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc
Confidence             2334567889999999987656789999999999999999999999965555556666776666655433332211100


Q ss_pred             -CChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccc
Q 013897          362 -LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN  426 (434)
Q Consensus       362 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~  426 (434)
                       ..+.   .........   ..........++++.|||.+||+.||++|||+.|+|+||||+.+..
T Consensus       237 ~~~~~---~~~~~~~~~---~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~  296 (303)
T cd07869         237 HFKPE---RFTLYSPKN---LRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP  296 (303)
T ss_pred             ccccc---cccccCCcc---HHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCCh
Confidence             0000   000000000   0000011124578999999999999999999999999999998753

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.6e-51  Score=363.04  Aligned_cols=247  Identities=26%  Similarity=0.518  Sum_probs=203.4

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecc-----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      ..+|.++++||+|+||+||++.+..+|..+|.|.++-     ..+.....|+.+|++| +|||||++++.-...+...+.
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL-~HpNIVqYy~~~f~~~~evln   96 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQL-NHPNIVQYYAHSFIEDNEVLN   96 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhc-CCchHHHHHHHhhhccchhhH
Confidence            3578999999999999999999999999999998762     3456688999999999 999999999944444556678


Q ss_pred             EEEeecCCCchhhhcC-------CCChHHHHHHHHHHHHHHHHHHH--CC--ceeecCCCCceEecCCCCeEEEEecccc
Q 013897          208 LIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHS--QG--IMHRDVKPHNVMIDHEQRKLRLIDWGLA  276 (434)
Q Consensus       208 lv~e~~~~~~l~~~~~-------~l~~~~~~~~~~qi~~~L~~LH~--~~--ivHrDlKp~NIll~~~~~~vkl~DFGla  276 (434)
                      ||||+|.+|+|..+++       .+++..++.++.|++.||..+|.  .+  |+||||||.||+++.+| .|||+|||++
T Consensus        97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~g-vvKLGDfGL~  175 (375)
T KOG0591|consen   97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANG-VVKLGDFGLG  175 (375)
T ss_pred             HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCC-ceeeccchhH
Confidence            9999999999988763       48999999999999999999999  45  99999999999999777 8999999999


Q ss_pred             eecCCCCcc-ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHH-HHHHHhCChhHHHH
Q 013897          277 EFYHPGKEY-NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV-KIAKVLGTDELNAY  354 (434)
Q Consensus       277 ~~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~-~i~~~~g~~~~~~~  354 (434)
                      +.+...... ...+|||+||+||.+.+ .+|++++||||+||++|||..-..||+. . +...+. +|.+. ..+     
T Consensus       176 r~l~s~~tfA~S~VGTPyYMSPE~i~~-~~Y~~kSDiWslGCllyEMcaL~~PF~g-~-n~~~L~~KI~qg-d~~-----  246 (375)
T KOG0591|consen  176 RFLSSKTTFAHSLVGTPYYMSPERIHE-SGYNFKSDIWSLGCLLYEMCALQSPFYG-D-NLLSLCKKIEQG-DYP-----  246 (375)
T ss_pred             hHhcchhHHHHhhcCCCcccCHHHHhc-CCCCcchhHHHHHHHHHHHHhcCCCccc-c-cHHHHHHHHHcC-CCC-----
Confidence            988765443 56799999999999998 7999999999999999999999999843 3 433333 23221 000     


Q ss_pred             HhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccc
Q 013897          355 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI  424 (434)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~  424 (434)
                               |                    .....+|.++..++..|+..||+.||+.     ||+++.+
T Consensus       247 ---------~--------------------~p~~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~di  282 (375)
T KOG0591|consen  247 ---------P--------------------LPDEHYSTDLRELINMCIAVDPEQRPDT-----VPYVQDI  282 (375)
T ss_pred             ---------C--------------------CcHHHhhhHHHHHHHHHccCCcccCCCc-----chHHHHH
Confidence                     0                    0012367789999999999999999986     5555544

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=4.3e-48  Score=390.82  Aligned_cols=284  Identities=31%  Similarity=0.525  Sum_probs=220.1

Q ss_pred             CCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeEeeEEEcc------CCCc
Q 013897          132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ------QSKT  205 (434)
Q Consensus       132 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~------~~~~  205 (434)
                      ...+|.+.+.||+|+||.||+|.+..+++.||||.+.... ....+|+.+|+.+ +||||+++++++...      ...+
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-~~~~~Ei~il~~l-~h~niv~l~~~~~~~~~~~~~~~~~  141 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-QYKNRELLIMKNL-NHINIIFLKDYYYTECFKKNEKNIF  141 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-chHHHHHHHHHhc-CCCCCcceeeeEeecccccCCCceE
Confidence            3568999999999999999999998899999999885432 3456799999999 999999999876432      1235


Q ss_pred             cEEEEeecCCCchhhh------cCCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceec
Q 013897          206 PSLIFEHVNNTDFKVL------YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY  279 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~------~~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~  279 (434)
                      +++||||++++....+      ...+++..++.++.||+.||+|||+++|+||||||+|||++.++..+||+|||+|+.+
T Consensus       142 l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~  221 (440)
T PTZ00036        142 LNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL  221 (440)
T ss_pred             EEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhc
Confidence            6799999997643322      1358889999999999999999999999999999999999976657999999999877


Q ss_pred             CCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcc
Q 013897          280 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH  359 (434)
Q Consensus       280 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  359 (434)
                      .........++++.|+|||++.+...|+.++|||||||++|||++|.+|| .+....+++..+.+.+|.+....+...  
T Consensus       222 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf-~~~~~~~~~~~i~~~~~~p~~~~~~~~--  298 (440)
T PTZ00036        222 LAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIF-SGQSSVDQLVRIIQVLGTPTEDQLKEM--  298 (440)
T ss_pred             cCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCCHHHHHHh--
Confidence            65555556688999999999877567999999999999999999999887 666777888888888887654333211  


Q ss_pred             ccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccc
Q 013897          360 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN  426 (434)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~  426 (434)
                         .+.+....  ..... ........+...++++.+||.+||++||.+|||+.|+|+||||..+..
T Consensus       299 ---~~~~~~~~--~~~~~-~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~  359 (440)
T PTZ00036        299 ---NPNYADIK--FPDVK-PKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD  359 (440)
T ss_pred             ---chhhhccc--CCccC-chhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence               01110000  00000 000001112236788999999999999999999999999999987764

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-50  Score=355.10  Aligned_cols=255  Identities=28%  Similarity=0.502  Sum_probs=212.3

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecc-----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      .+.|++.+.||+|.|+.||++.+..+|+.+|+|+++.     ...+++++|+.|-+.| +|||||++.+.+.+  ..+.+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~L-qHP~IvrL~~ti~~--~~~~y   86 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQE--ESFHY   86 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhc-CCCcEeehhhhhcc--cceeE
Confidence            4789999999999999999999999999999998853     3457789999999999 99999999998854  46778


Q ss_pred             EEEeecCCCchhh-hcC--CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecC--CCCeEEEEecccceecCCC
Q 013897          208 LIFEHVNNTDFKV-LYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--EQRKLRLIDWGLAEFYHPG  282 (434)
Q Consensus       208 lv~e~~~~~~l~~-~~~--~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~--~~~~vkl~DFGla~~~~~~  282 (434)
                      ||+|+|.|++|-. +..  -+++..+-.+++||+++|.|+|.+||||||+||+|+|+..  .+.-+||+|||+|..+..+
T Consensus        87 lvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g  166 (355)
T KOG0033|consen   87 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG  166 (355)
T ss_pred             EEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCc
Confidence            9999999998743 222  2677788889999999999999999999999999999953  3447999999999988877


Q ss_pred             CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                      .....++||+.|||||++.. .+|+..+|||+.|||||-|+.|++||+ +++..+....|.+.             ...+
T Consensus       167 ~~~~G~~GtP~fmaPEvvrk-dpy~kpvDiW~cGViLfiLL~G~~PF~-~~~~~rlye~I~~g-------------~yd~  231 (355)
T KOG0033|consen  167 EAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFW-DEDQHRLYEQIKAG-------------AYDY  231 (355)
T ss_pred             cccccccCCCcccCHHHhhc-CCCCCcchhhhhhHHHHHHHhCCCCCC-CccHHHHHHHHhcc-------------ccCC
Confidence            77788899999999999986 789999999999999999999999984 44444444444321             0011


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                      +                    ..+...+++++++|+++||..||.+|+|+.|+|+|||+.+-+
T Consensus       232 ~--------------------~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~  274 (355)
T KOG0033|consen  232 P--------------------SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRE  274 (355)
T ss_pred             C--------------------CcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchH
Confidence            1                    112234788999999999999999999999999999998653

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-48  Score=365.24  Aligned_cols=264  Identities=23%  Similarity=0.380  Sum_probs=212.4

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      .++|++.+.||.|..++||+|++..+++.||||++.-.+    .+.+.+|+..|..+ +||||++++..|...  ..+++
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~-~HPNIv~~~~sFvv~--~~LWv  101 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLI-DHPNIVTYHCSFVVD--SELWV  101 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhc-CCCCcceEEEEEEec--ceeEE
Confidence            378999999999999999999999999999999997433    46789999999988 999999999999764  67889


Q ss_pred             EEeecCCCchhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC
Q 013897          209 IFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       209 v~e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~  283 (434)
                      ||.||.+|++.+++.     .+.+..+..+++++++||.|||.+|.||||||+.||||+.+| .|||+|||.+..+....
T Consensus       102 VmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG-~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  102 VMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDG-TVKLADFGVSASLFDSG  180 (516)
T ss_pred             eehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCC-cEEEcCceeeeeecccC
Confidence            999999999876653     488999999999999999999999999999999999999887 89999999876654332


Q ss_pred             c-c----ceeccCCccccccc-ccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhh
Q 013897          284 E-Y----NVRVASRYFKGPEL-LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK  357 (434)
Q Consensus       284 ~-~----~~~~~t~~y~aPE~-~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  357 (434)
                      . .    ++.+|+++|||||+ .....+|+.|+||||||++..||.+|..||..- .....+.  .+.-+.+..      
T Consensus       181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~-pPmkvLl--~tLqn~pp~------  251 (516)
T KOG0582|consen  181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKY-PPMKVLL--LTLQNDPPT------  251 (516)
T ss_pred             ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccC-ChHHHHH--HHhcCCCCC------
Confidence            1 1    45589999999999 455568999999999999999999999999321 1111111  111111100      


Q ss_pred             ccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccccc
Q 013897          358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~  428 (434)
                                         ........+..+.++..+++++..||+.||++||||+++|+|+||++....+
T Consensus       252 -------------------~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~  303 (516)
T KOG0582|consen  252 -------------------LLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKE  303 (516)
T ss_pred             -------------------cccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchh
Confidence                               0001112223334667899999999999999999999999999999876543

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.6e-48  Score=365.15  Aligned_cols=254  Identities=26%  Similarity=0.408  Sum_probs=214.5

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      ++|++++.||.|.-|+||++..+.++..+|+|++.+.      +..+...|-+||+.+ +||.++.||+.|+  ...+.|
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~l-DHPFlPTLYa~fe--t~~~~c  153 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLL-DHPFLPTLYASFE--TDKYSC  153 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhc-CCCccchhhheee--ccceeE
Confidence            5688999999999999999999999999999999753      235577899999999 9999999999995  457889


Q ss_pred             EEEeecCCCchhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC-
Q 013897          208 LIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-  281 (434)
Q Consensus       208 lv~e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~-  281 (434)
                      +|||||+||+|..+.+     .+++..++.|+.+++.||+|||..|||+|||||+||||-++| +|.|+||.|+....- 
T Consensus       154 l~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredG-HIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  154 LVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDG-HIMLSDFDLSLRCPVS  232 (459)
T ss_pred             EEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCC-cEEeeeccccccCCCC
Confidence            9999999999987764     389999999999999999999999999999999999999777 999999998732200 


Q ss_pred             --------------------------------C-C-----------------------ccceeccCCcccccccccCCCC
Q 013897          282 --------------------------------G-K-----------------------EYNVRVASRYFKGPELLVDLQD  305 (434)
Q Consensus       282 --------------------------------~-~-----------------------~~~~~~~t~~y~aPE~~~~~~~  305 (434)
                                                      . .                       .....+||..|.|||++.| .+
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G-~G  311 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG-EG  311 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec-CC
Confidence                                            0 0                       0123478999999999998 78


Q ss_pred             CCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccc
Q 013897          306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVE  385 (434)
Q Consensus       306 ~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  385 (434)
                      .+.++|+|+|||++|||+.|..|| .|.++.+.+..|..   .                                ...+.
T Consensus       312 HgsAVDWWtfGIflYEmLyG~TPF-KG~~~~~Tl~NIv~---~--------------------------------~l~Fp  355 (459)
T KOG0610|consen  312 HGSAVDWWTFGIFLYEMLYGTTPF-KGSNNKETLRNIVG---Q--------------------------------PLKFP  355 (459)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCc-CCCCchhhHHHHhc---C--------------------------------CCcCC
Confidence            899999999999999999999998 67777777766532   1                                01122


Q ss_pred             cccCCchHHHHHHHHccccCCCCCcc----HHHHhcCCCcccccccc
Q 013897          386 NQHLAVPEAVDFLDKLLRYDHQERPT----AKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       386 ~~~~~~~~~~dll~~cL~~dP~~Rpt----~~elL~Hp~~~~~~~~~  428 (434)
                      ....++-+++|||+++|.+||++|..    |.|+-+||||++|+++=
T Consensus       356 ~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaL  402 (459)
T KOG0610|consen  356 EEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWAL  402 (459)
T ss_pred             CCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhh
Confidence            22246678999999999999999999    99999999999999874

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.3e-49  Score=353.74  Aligned_cols=257  Identities=26%  Similarity=0.487  Sum_probs=213.7

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc-----------HHHHHHHHHHHHHhcCCCCeeeEeeEEEccC
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ  202 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  202 (434)
                      +.|+-.+.||.|..+.|.++.++.++..+|+|++....           .+...+|+.||+++.+||+|+++.++++.  
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes--   94 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES--   94 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC--
Confidence            56778889999999999999999999999999985211           24567899999999999999999999954  


Q ss_pred             CCccEEEEeecCCCchhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceec
Q 013897          203 SKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY  279 (434)
Q Consensus       203 ~~~~~lv~e~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~  279 (434)
                      ..++++|+|.|+.|.|-+++.   .+++.+.+.+++|+++|++|||.++||||||||+|||+|++. .+||+|||.|+.+
T Consensus        95 ~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~-~i~isDFGFa~~l  173 (411)
T KOG0599|consen   95 DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNM-NIKISDFGFACQL  173 (411)
T ss_pred             cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeecccc-ceEEeccceeecc
Confidence            467889999999999877764   489999999999999999999999999999999999999776 8999999999999


Q ss_pred             CCCCccceeccCCcccccccccC-----CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHH
Q 013897          280 HPGKEYNVRVASRYFKGPELLVD-----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAY  354 (434)
Q Consensus       280 ~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~  354 (434)
                      .++......|||+.|+|||.+..     ..+|+..+|+|++|||||-|+.|.+||+.    ..|+..+-..+.       
T Consensus       174 ~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH----RkQmlMLR~Ime-------  242 (411)
T KOG0599|consen  174 EPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH----RKQMLMLRMIME-------  242 (411)
T ss_pred             CCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH----HHHHHHHHHHHh-------
Confidence            99999999999999999999843     35799999999999999999999999943    223222111100       


Q ss_pred             HhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccccc
Q 013897          355 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA  427 (434)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~  427 (434)
                       +++.                      +..++...++...+|||.+||++||.+|+|++|+|+||||.++...
T Consensus       243 -Gkyq----------------------F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~  292 (411)
T KOG0599|consen  243 -GKYQ----------------------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQ  292 (411)
T ss_pred             -cccc----------------------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHh
Confidence             0000                      0111222367789999999999999999999999999999766443

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.4e-47  Score=364.84  Aligned_cols=277  Identities=28%  Similarity=0.563  Sum_probs=215.5

Q ss_pred             CCCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       131 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      +..++|++.+.||.|+||.||+|.+..++..||+|+++..    ....+.+|+.+++.+ +||||+++++++...  ...
T Consensus         2 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~~~   78 (288)
T cd07871           2 GKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNL-KHANIVTLHDIIHTE--RCL   78 (288)
T ss_pred             CccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhC-CCCCEeeEEEEEcCC--CeE
Confidence            3457899999999999999999999999999999998642    234677999999999 999999999998643  567


Q ss_pred             EEEEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC
Q 013897          207 SLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG  282 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~  282 (434)
                      ++||||+.+ ++..++    ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus        79 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~-~~kl~DfG~~~~~~~~  156 (288)
T cd07871          79 TLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKG-ELKLADFGLARAKSVP  156 (288)
T ss_pred             EEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEEECcCcceeeccCC
Confidence            899999986 554433    2368889999999999999999999999999999999999776 8999999999765322


Q ss_pred             -CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcccc
Q 013897          283 -KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE  361 (434)
Q Consensus       283 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  361 (434)
                       .......++..|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+.+.++.+....|..-.   
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  232 (288)
T cd07871         157 TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMF-PGSTVKEELHLIFRLLGTPTEETWPGIT---  232 (288)
T ss_pred             CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCChHHhhccc---
Confidence             22344578899999999876567899999999999999999999887 5556667777777777766554443210   


Q ss_pred             CChhHHHHh-cccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          362 LDPHLAALV-GRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       362 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                      ....+.... ......++     ......+++++.|||.+||++||.+|||++|+|+||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         233 SNEEFRSYLFPQYRAQPL-----INHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             cchhhhccccCccCCCch-----HHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence            001111100 00000000     11123467889999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=4.5e-49  Score=380.06  Aligned_cols=247  Identities=30%  Similarity=0.539  Sum_probs=207.4

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccccHHH-----HHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK-----IKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~-----~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      ++|.+.+.||+|+||.||||+.+.+.+.||+|.+.+..+.+     +.+|++|++.| +|||||.++++|+  ....+++
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~l-kHpniv~m~esfE--t~~~~~v   78 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSL-KHPNIVEMLESFE--TSAHLWV   78 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhc-CCcchhhHHHhhc--ccceEEE
Confidence            56888999999999999999999999999999997655433     88999999999 9999999999995  4578889


Q ss_pred             EEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCcc
Q 013897          209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY  285 (434)
Q Consensus       209 v~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~  285 (434)
                      |.||+.+ +|..++   ..++++.++.++.+++.||.|||+.+|+|||+||.|||++.++ .+|+||||+|+.+..+...
T Consensus        79 Vte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~-~~KlcdFg~Ar~m~~~t~v  156 (808)
T KOG0597|consen   79 VTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGG-TLKLCDFGLARAMSTNTSV  156 (808)
T ss_pred             Eehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCC-ceeechhhhhhhcccCcee
Confidence            9999998 666555   4699999999999999999999999999999999999999776 8999999999987665443


Q ss_pred             -ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCCh
Q 013897          286 -NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP  364 (434)
Q Consensus       286 -~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  364 (434)
                       +..-||+.|||||++.+ .+|+..+|+||||||+|||++|++||+...  ..++.+.  ++..+               
T Consensus       157 ltsikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a~s--i~~Lv~~--I~~d~---------------  216 (808)
T KOG0597|consen  157 LTSIKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYARS--ITQLVKS--ILKDP---------------  216 (808)
T ss_pred             eeeccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchHHH--HHHHHHH--HhcCC---------------
Confidence             44469999999999987 899999999999999999999999995321  1111111  00000               


Q ss_pred             hHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccc
Q 013897          365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI  424 (434)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~  424 (434)
                                         ...+...+..+..||..+|.+||.+|+|..+++.|||+++.
T Consensus       217 -------------------v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~  257 (808)
T KOG0597|consen  217 -------------------VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK  257 (808)
T ss_pred             -------------------CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence                               00112367889999999999999999999999999999853

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.4e-46  Score=381.56  Aligned_cols=289  Identities=21%  Similarity=0.394  Sum_probs=210.1

Q ss_pred             CCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhc-----CCCCeeeEeeEEEccCCC
Q 013897          132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLC-----GGPNIVKLLDIVRDQQSK  204 (434)
Q Consensus       132 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~E~~~l~~l~-----~h~niv~l~~~~~~~~~~  204 (434)
                      ..++|+++++||+|+||+||+|.+..+++.||||+++..  ....+..|+.+++.+.     +|.+++++++++... ..
T Consensus       127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~-~~  205 (467)
T PTZ00284        127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE-TG  205 (467)
T ss_pred             CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC-Cc
Confidence            357899999999999999999999889999999999643  2345677888888772     345689999988654 35


Q ss_pred             ccEEEEeecCCCchhhhc--CCCChHHHHHHHHHHHHHHHHHHH-CCceeecCCCCceEecCCCC---------------
Q 013897          205 TPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQR---------------  266 (434)
Q Consensus       205 ~~~lv~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlKp~NIll~~~~~---------------  266 (434)
                      +.++|||++++..+..+.  ..+++..++.++.||+.||+|||+ .|||||||||+|||++.++.               
T Consensus       206 ~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~  285 (467)
T PTZ00284        206 HMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPC  285 (467)
T ss_pred             eEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCc
Confidence            678999998665544433  358999999999999999999998 59999999999999986542               


Q ss_pred             eEEEEecccceecCCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh
Q 013897          267 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL  346 (434)
Q Consensus       267 ~vkl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~  346 (434)
                      .+||+|||++...  .......+||+.|+|||++.+ ..|+.++|||||||++|||++|+.|| .+.+..+.+..+.+.+
T Consensus       286 ~vkl~DfG~~~~~--~~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf-~~~~~~~~~~~i~~~~  361 (467)
T PTZ00284        286 RVRICDLGGCCDE--RHSRTAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLY-DTHDNLEHLHLMEKTL  361 (467)
T ss_pred             eEEECCCCccccC--ccccccccCCccccCcHHhhc-CCCCcHHHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHc
Confidence            4999999988543  223355689999999999987 68999999999999999999999887 5666677777888877


Q ss_pred             CChhHHHHHhhccccCChhHHHHhcccC-CC---CCccccc--cccccCCchHHHHHHHHccccCCCCCccHHHHhcCCC
Q 013897          347 GTDELNAYLNKYHIELDPHLAALVGRHS-RK---PWSKFIT--VENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY  420 (434)
Q Consensus       347 g~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~---~~~~~~~--~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~  420 (434)
                      |... ..|...........+........ ..   .+.....  .......++.+.|||.+||++||++|||++|+|+|||
T Consensus       362 g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~  440 (467)
T PTZ00284        362 GRLP-SEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPY  440 (467)
T ss_pred             CCCC-HHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcc
Confidence            7542 22221111000000000000000 00   0000000  0000112467889999999999999999999999999


Q ss_pred             cccccc
Q 013897          421 FFPIRN  426 (434)
Q Consensus       421 ~~~~~~  426 (434)
                      |++...
T Consensus       441 ~~~~~~  446 (467)
T PTZ00284        441 VLKYYP  446 (467)
T ss_pred             ccccCC
Confidence            997643

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=9.3e-47  Score=368.62  Aligned_cols=285  Identities=31%  Similarity=0.561  Sum_probs=214.9

Q ss_pred             CeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC---Ccc
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS---KTP  206 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~---~~~  206 (434)
                      +|++.+.||+|+||.||+|++..++..||||.++..     ....+.+|+.+++.+ +||||+++++++.....   ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~   79 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKDI   79 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhC-CCCCEeeecceEeccCCCCCceE
Confidence            488999999999999999999999999999998632     234578999999999 99999999998864322   357


Q ss_pred             EEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC
Q 013897          207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~  283 (434)
                      ++||||+.+ +|...+   ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus        80 ~lv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~  157 (338)
T cd07859          80 YVVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVAFNDT  157 (338)
T ss_pred             EEEEecCCC-CHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-cEEEccCcccccccccc
Confidence            899999975 554443   3588999999999999999999999999999999999999776 89999999997543221


Q ss_pred             ----ccceeccCCcccccccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhc
Q 013897          284 ----EYNVRVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY  358 (434)
Q Consensus       284 ----~~~~~~~t~~y~aPE~~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  358 (434)
                          .....+|+..|+|||++.+. ..++.++|||||||++|||++|+.|| .+.+...++..+...+|.+.......-.
T Consensus       158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~i~  236 (338)
T cd07859         158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF-PGKNVVHQLDLITDLLGTPSPETISRVR  236 (338)
T ss_pred             CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCC-CCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence                12345789999999997642 47899999999999999999999887 5555566666666666654433221110


Q ss_pred             cccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccccccc
Q 013897          359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAES  429 (434)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~~  429 (434)
                      .    .................+  ......+++++.+||.+||+.||++|||++|+|+||||+.+...+.
T Consensus       237 ~----~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~~  301 (338)
T cd07859         237 N----EKARRYLSSMRKKQPVPF--SQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVER  301 (338)
T ss_pred             h----hhHHHHHHhhcccCCCch--HHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCcccc
Confidence            0    000111111000000000  0111235678999999999999999999999999999998877653

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-47  Score=372.11  Aligned_cols=258  Identities=31%  Similarity=0.558  Sum_probs=216.4

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      .+.|++.+.||+|.||.||+++.+.+|+.+|+|++++..      .+.+.+|+.+|+++..|||||.++++|++.  ..+
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~--~~~  111 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP--DSV  111 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC--CeE
Confidence            467999999999999999999999999999999996543      257899999999996699999999999765  477


Q ss_pred             EEEEeecCCCchhhhcCC--CChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCC---CeEEEEecccceecCC
Q 013897          207 SLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ---RKLRLIDWGLAEFYHP  281 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~~~--l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~---~~vkl~DFGla~~~~~  281 (434)
                      ++|||++.||.|.+.+..  +++.++..++.|++.++.|||+.||+||||||+|+|+....   ..+|++|||+|.....
T Consensus       112 ~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~  191 (382)
T KOG0032|consen  112 YLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP  191 (382)
T ss_pred             EEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence            899999999988665533  99999999999999999999999999999999999996542   2799999999998887


Q ss_pred             CCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcccc
Q 013897          282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE  361 (434)
Q Consensus       282 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  361 (434)
                      +......+||++|+|||++.. ..|+..+||||+||++|.|++|..||+. .+.......+..  |..            
T Consensus       192 ~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~-~~~~~~~~~i~~--~~~------------  255 (382)
T KOG0032|consen  192 GERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWG-ETEFEIFLAILR--GDF------------  255 (382)
T ss_pred             CceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcC-CChhHHHHHHHc--CCC------------
Confidence            667788899999999999886 7899999999999999999999999843 333333333221  000            


Q ss_pred             CChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccccc
Q 013897          362 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA  427 (434)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~  427 (434)
                                         .+..+....++..+.||+++||..||.+|+|+.++|+|||++....+
T Consensus       256 -------------------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~  302 (382)
T KOG0032|consen  256 -------------------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEA  302 (382)
T ss_pred             -------------------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCccc
Confidence                               01111223467899999999999999999999999999999987433

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.7e-46  Score=370.29  Aligned_cols=283  Identities=27%  Similarity=0.494  Sum_probs=217.8

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC----
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS----  203 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~----  203 (434)
                      .++|++.+.||+|+||.||++.+..++..||+|++...     ....+.+|+.+++.+ +||||+++++++.....    
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCV-NHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhC-CCCCEeeeeeeeccCCCcccc
Confidence            47899999999999999999999899999999998632     235677899999999 99999999999864332    


Q ss_pred             CccEEEEeecCCCchhhhcCCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC
Q 013897          204 KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~  283 (434)
                      ...++||||+.++.+..+...+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus        99 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~-~~kl~Dfg~a~~~~~~~  177 (359)
T cd07876          99 QDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNF  177 (359)
T ss_pred             ceeEEEEeCCCcCHHHHHhccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEEEecCCCccccccCc
Confidence            34689999999876666666788999999999999999999999999999999999999776 89999999997654444


Q ss_pred             ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                      ......++..|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.+..+.+..+.+.++.+...-. ....    
T Consensus       178 ~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf-~~~~~~~~~~~~~~~~~~~~~~~~-~~~~----  250 (359)
T cd07876         178 MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIF-QGTDHIDQWNKVIEQLGTPSAEFM-NRLQ----  250 (359)
T ss_pred             cCCCCcccCCCCCchhccC-CCCCcchhhHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCCcHHHH-HHHH----
Confidence            4455678999999999877 68999999999999999999999998 455566677777766665432111 1000    


Q ss_pred             hhHHHHhcccCCCC----------CccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccc
Q 013897          364 PHLAALVGRHSRKP----------WSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI  424 (434)
Q Consensus       364 ~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~  424 (434)
                      .............+          |............++++.+||.+||+.||++|||+.|+|+||||+.+
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  321 (359)
T cd07876         251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVW  321 (359)
T ss_pred             HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhh
Confidence            00000000000000          00000111222356789999999999999999999999999999853

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.3e-46  Score=357.51  Aligned_cols=253  Identities=24%  Similarity=0.378  Sum_probs=205.5

Q ss_pred             eEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       136 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      |++.+.||+|+||.||+|.+..+++.||+|.+....      ...+.+|+.+++.+ +|+||+++++++.+.  ...++|
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~iv~~~~~~~~~--~~~~lv   78 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-NSRFVVSLAYAYETK--DALCLV   78 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhc-CCCcEEEEEEEEccC--CeEEEE
Confidence            778999999999999999999999999999986422      23467899999999 999999999998654  467899


Q ss_pred             EeecCCCchhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc
Q 013897          210 FEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE  284 (434)
Q Consensus       210 ~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~  284 (434)
                      |||+.+++|...+     ..+++..+..++.||+.||+|||+++|+||||||+|||++.++ .+||+|||++........
T Consensus        79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~-~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05631          79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRG-HIRISDLGLAVQIPEGET  157 (285)
T ss_pred             EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC-CEEEeeCCCcEEcCCCCe
Confidence            9999999986543     2478889999999999999999999999999999999999766 899999999987655444


Q ss_pred             cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCCh
Q 013897          285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP  364 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  364 (434)
                      .....|+..|+|||++.+ ..++.++|||||||++|+|++|+.||...... .....+.......               
T Consensus       158 ~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-~~~~~~~~~~~~~---------------  220 (285)
T cd05631         158 VRGRVGTVGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER-VKREEVDRRVKED---------------  220 (285)
T ss_pred             ecCCCCCCCccCHhhhcC-CCCCcccCchhHHHHHHHHHhCCCCCCCCCcc-hhHHHHHHHhhcc---------------
Confidence            556688999999999987 68999999999999999999999998533221 1111111100000               


Q ss_pred             hHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCcc-----HHHHhcCCCccccccc
Q 013897          365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT-----AKEAMAHPYFFPIRNA  427 (434)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt-----~~elL~Hp~~~~~~~~  427 (434)
                                        .......+++++.+|+.+||+.||++||+     ++++++||||.+++..
T Consensus       221 ------------------~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~  270 (285)
T cd05631         221 ------------------QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFK  270 (285)
T ss_pred             ------------------cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHH
Confidence                              00112236788999999999999999997     8999999999988743

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.1e-46  Score=357.79  Aligned_cols=277  Identities=32%  Similarity=0.564  Sum_probs=211.6

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      ++|++.+.||+|+||.||+|+++.+++.||+|+++..     ..+.+.+|+.+++.+ +||||+++++++.+.  ...++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~l   77 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTL-KQENIVELKEAFRRR--GKLYL   77 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhC-CCccccchhhhEecC--CEEEE
Confidence            4699999999999999999999999999999998643     235678999999999 999999999998653  57789


Q ss_pred             EEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC--
Q 013897          209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--  283 (434)
Q Consensus       209 v~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~--  283 (434)
                      ||||+.++.+..+.   ..+++..++.++.||+.||.|||+.+|+||||||+||+++.++ .+||+|||++.......  
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~  156 (287)
T cd07848          78 VFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHND-VLKLCDFGFARNLSEGSNA  156 (287)
T ss_pred             EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-cEEEeeccCcccccccccc
Confidence            99999998776553   3588899999999999999999999999999999999999776 89999999998764322  


Q ss_pred             ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                      ......|+..|+|||++.+ ..++.++|||||||++|||++|+.|| .+.+..+.+..+....+......+.....   +
T Consensus       157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~  231 (287)
T cd07848         157 NYTEYVATRWYRSPELLLG-APYGKAVDMWSVGCILGELSDGQPLF-PGESEIDQLFTIQKVLGPLPAEQMKLFYS---N  231 (287)
T ss_pred             cccccccccccCCcHHHcC-CCCCCchhHHhHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHhhCCCCHHHHHhhhc---c
Confidence            2234578999999999877 67899999999999999999999887 45555566666666555433222111000   0


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                      +.....  ..................+++++.|||.+||+.||++|||++|+|+||||
T Consensus       232 ~~~~~~--~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         232 PRFHGL--RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             chhccc--ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            000000  00000000000001112367889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.6e-48  Score=336.23  Aligned_cols=249  Identities=26%  Similarity=0.431  Sum_probs=213.3

Q ss_pred             CCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCc
Q 013897          132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT  205 (434)
Q Consensus       132 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  205 (434)
                      ..++|++.+.||+|.||.||+|+.+.++-.||+|++.+.      -..++.+|++|-.+| +||||+++|++|.+.  ..
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L-~hpnilrlY~~fhd~--~r   96 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHL-RHPNILRLYGYFHDS--KR   96 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeeccc-CCccHHhhhhheecc--ce
Confidence            358899999999999999999999999999999998543      236688999999999 999999999999654  67


Q ss_pred             cEEEEeecCCCchhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecC
Q 013897          206 PSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH  280 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~  280 (434)
                      +||++||...|.+...+     .++++.....++.|++.||.|+|.++|+||||||+|+|++.++ .+||+|||.+...+
T Consensus        97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~-~lkiAdfGwsV~~p  175 (281)
T KOG0580|consen   97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAP  175 (281)
T ss_pred             eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCC-CeeccCCCceeecC
Confidence            88999999999875444     3588899999999999999999999999999999999999888 89999999997554


Q ss_pred             CCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccc
Q 013897          281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI  360 (434)
Q Consensus       281 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  360 (434)
                       .....+.|||..|.+||...+ ..++..+|+|++|++.||++.|.+||.... ..+...+|.+.-              
T Consensus       176 -~~kR~tlcgt~dyl~pEmv~~-~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k~~--------------  238 (281)
T KOG0580|consen  176 -SNKRKTLCGTLDYLPPEMVEG-RGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRKVD--------------  238 (281)
T ss_pred             -CCCceeeecccccCCHhhcCC-CCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHHcc--------------
Confidence             556678899999999999887 789999999999999999999999984333 444444443310              


Q ss_pred             cCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccc
Q 013897          361 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI  424 (434)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~  424 (434)
                                             ...+..++.++.|+|.+||..+|.+|.+..|++.|||+.+.
T Consensus       239 -----------------------~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  239 -----------------------LKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             -----------------------ccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence                                   11123477899999999999999999999999999999865

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.4e-46  Score=372.47  Aligned_cols=284  Identities=24%  Similarity=0.328  Sum_probs=211.5

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEee
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH  212 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  212 (434)
                      ..+|++++.||+|+||.||+|.+..+++.||+|...   ...+.+|+.+++++ +||||+++++++...  ...++|+|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---~~~~~~E~~il~~l-~HpnIv~~~~~~~~~--~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---RGGTATEAHILRAI-NHPSIIQLKGTFTYN--KFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---hhhhHHHHHHHHhC-CCCCCCCEeEEEEEC--CeeEEEEec
Confidence            367999999999999999999999999999999753   34578999999999 999999999999654  567899999


Q ss_pred             cCCCchhhhc--CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC--Ccccee
Q 013897          213 VNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG--KEYNVR  288 (434)
Q Consensus       213 ~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~--~~~~~~  288 (434)
                      +.+..+..+.  ..+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+.....  ......
T Consensus       165 ~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~-~vkL~DFG~a~~~~~~~~~~~~~~  243 (391)
T PHA03212        165 YKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPG-DVCLGDFGAACFPVDINANKYYGW  243 (391)
T ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCC-CEEEEeCCcccccccccccccccc
Confidence            9754333332  3588899999999999999999999999999999999999776 8999999999653221  223345


Q ss_pred             ccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC------CCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH------DNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       289 ~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~------~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                      +||+.|+|||++.+ ..++.++|||||||++|||++|+.||+...      +...++..+...+|..... +.......+
T Consensus       244 ~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~-~~~~~~~~~  321 (391)
T PHA03212        244 AGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNE-FPIDAQANL  321 (391)
T ss_pred             cCccCCCChhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhh-cCcchhHHH
Confidence            79999999999876 689999999999999999999999987543      2334566666666643211 100000000


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN  426 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~  426 (434)
                      ...+..........+.. ...+.....++.++.+||.+||+.||++|||++|+|+||||+.+..
T Consensus       322 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~  384 (391)
T PHA03212        322 DEIYIGLAKKSSRKPGS-RPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPD  384 (391)
T ss_pred             HHHHHHHHhccCCCCCC-CCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCC
Confidence            00010111111111110 0111122235678999999999999999999999999999998754

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-46  Score=359.75  Aligned_cols=250  Identities=24%  Similarity=0.421  Sum_probs=205.2

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++...      ....+.+|+.+++.+ +||||+++++++.+.  ..++
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~--~~~~   77 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-SHPFIIRLFWTEHDQ--RFLY   77 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhC-CCCcHhhhHhhhccC--CeEE
Confidence            4689999999999999999999889999999998642      234578899999999 999999999988653  5788


Q ss_pred             EEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc
Q 013897          208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE  284 (434)
Q Consensus       208 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~  284 (434)
                      +||||+.+++|..++   ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.....  
T Consensus        78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~-~~kl~Dfg~~~~~~~~--  154 (291)
T cd05612          78 MLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEG-HIKLTDFGFAKKLRDR--  154 (291)
T ss_pred             EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC-CEEEEecCcchhccCC--
Confidence            999999999987665   3588899999999999999999999999999999999999776 8999999999765432  


Q ss_pred             cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCCh
Q 013897          285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP  364 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  364 (434)
                      ....+|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.. .+.......+..  +                 
T Consensus       155 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~-~~~~~~~~~i~~--~-----------------  213 (291)
T cd05612         155 TWTLCGTPEYLAPEVIQS-KGHNKAVDWWALGILIYEMLVGYPPFFD-DNPFGIYEKILA--G-----------------  213 (291)
T ss_pred             cccccCChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHh--C-----------------
Confidence            234578999999999876 6789999999999999999999999843 222222222110  0                 


Q ss_pred             hHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCcc-----HHHHhcCCCcccccccc
Q 013897          365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT-----AKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt-----~~elL~Hp~~~~~~~~~  428 (434)
                                .        ......+++.+.+||++||+.||.+|++     ++|+++||||+.++...
T Consensus       214 ----------~--------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~  264 (291)
T cd05612         214 ----------K--------LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDD  264 (291)
T ss_pred             ----------C--------cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHHH
Confidence                      0        0011235678999999999999999995     99999999999876543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=7.5e-46  Score=354.43  Aligned_cols=274  Identities=30%  Similarity=0.563  Sum_probs=208.8

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcC-CCeEEEEEEecccc-----HHHHHHHHHHHHHhc--CCCCeeeEeeEEEc---cC
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCT-DNEKCIIKILKPVK-----KKKIKREIKILQNLC--GGPNIVKLLDIVRD---QQ  202 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~-~~~~vaiK~~~~~~-----~~~~~~E~~~l~~l~--~h~niv~l~~~~~~---~~  202 (434)
                      ++|++++.||+|+||.||+|.+.. ++..||+|.++...     ...+.+|+.+++.+.  .||||+++++++..   ..
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            368899999999999999999854 56889999886322     235667888887763  69999999998853   23


Q ss_pred             CCccEEEEeecCCCchhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccce
Q 013897          203 SKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE  277 (434)
Q Consensus       203 ~~~~~lv~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~  277 (434)
                      ...+++||||+.+ ++..++     ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++
T Consensus        81 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~-~~kl~Dfg~~~  158 (290)
T cd07862          81 ETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-QIKLADFGLAR  158 (290)
T ss_pred             CCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCC-CEEEccccceE
Confidence            4567899999985 554443     2378889999999999999999999999999999999999776 89999999998


Q ss_pred             ecCCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhh
Q 013897          278 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK  357 (434)
Q Consensus       278 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  357 (434)
                      ............|+..|+|||.+.+ ..++.++|||||||++|||++|+.|| .+....+.+..+....+.+....+...
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~~f-~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (290)
T cd07862         159 IYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLF-RGSSDVDQLGKILDVIGLPGEEDWPRD  236 (290)
T ss_pred             eccCCcccccccccccccChHHHhC-CCCCCccchHHHHHHHHHHHcCCCCc-CCCCHHHHHHHHHHHhCCCChhhchhh
Confidence            7654444455678999999999876 67899999999999999999999877 556666777777776665443333221


Q ss_pred             ccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                      ....  ..   ........+...     ....+++.+.+|+.+||+.||++|||+.|+|+||||
T Consensus       237 ~~~~--~~---~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         237 VALP--RQ---AFHSKSAQPIEK-----FVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hccc--ch---hccCCCCCCHHH-----HccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence            1100  00   000000110000     112367789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=3e-46  Score=364.14  Aligned_cols=249  Identities=24%  Similarity=0.411  Sum_probs=205.2

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      .++|++.+.||+|+||.||+|.+..+++.||+|+++..      ..+.+.+|+.+++.+ +||||+++++++.+.  ...
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~--~~~   93 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL-SHPFIVNMMCSFQDE--NRV   93 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEcC--CEE
Confidence            37899999999999999999999999999999998643      234578999999999 999999999999654  567


Q ss_pred             EEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC
Q 013897          207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~  283 (434)
                      ++||||+.+++|...+   ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..... 
T Consensus        94 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~-  171 (329)
T PTZ00263         94 YFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKG-HVKVTDFGFAKKVPDR-  171 (329)
T ss_pred             EEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCC-CEEEeeccCceEcCCC-
Confidence            8999999999987664   3578889999999999999999999999999999999999776 8999999999866432 


Q ss_pred             ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                       ....+|++.|+|||++.+ ..++.++|||||||++|+|++|+.||... ........+..                   
T Consensus       172 -~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~-~~~~~~~~i~~-------------------  229 (329)
T PTZ00263        172 -TFTLCGTPEYLAPEVIQS-KGHGKAVDWWTMGVLLYEFIAGYPPFFDD-TPFRIYEKILA-------------------  229 (329)
T ss_pred             -cceecCChhhcCHHHHcC-CCCCCcceeechHHHHHHHHcCCCCCCCC-CHHHHHHHHhc-------------------
Confidence             234578999999999887 67899999999999999999999998432 22221111110                   


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCcc-----HHHHhcCCCcccccc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT-----AKEAMAHPYFFPIRN  426 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt-----~~elL~Hp~~~~~~~  426 (434)
                              .  .        ...+..+++.+.+||.+||+.||++|++     ++++++||||.+++.
T Consensus       230 --------~--~--------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~  279 (329)
T PTZ00263        230 --------G--R--------LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANW  279 (329)
T ss_pred             --------C--C--------cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCH
Confidence                    0  0        0011235678999999999999999997     799999999997643

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=9e-46  Score=358.64  Aligned_cols=281  Identities=25%  Similarity=0.492  Sum_probs=206.4

Q ss_pred             EeeeeecCceEEEEEEEc--CCCeEEEEEEecccc-HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeecCC
Q 013897          139 VRKVGRGKYSEVFEGVHC--TDNEKCIIKILKPVK-KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN  215 (434)
Q Consensus       139 ~~~lG~G~fg~Vy~~~~~--~~~~~vaiK~~~~~~-~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~  215 (434)
                      .++||+|+||+||+|.++  .+++.||+|.++... ...+.+|+.+++++ +||||+++++++.......+++||||+.+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLREL-KHPNVISLQKVFLSHADRKVWLLFDYAEH   84 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhc-CCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence            468999999999999875  356899999986543 35678999999999 99999999999977666778999999987


Q ss_pred             Cchhhhc-----------CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecC---CCCeEEEEecccceecCC
Q 013897          216 TDFKVLY-----------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH---EQRKLRLIDWGLAEFYHP  281 (434)
Q Consensus       216 ~~l~~~~-----------~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~---~~~~vkl~DFGla~~~~~  281 (434)
                      .....+.           ..+++..++.++.||+.||.|||++||+||||||+|||++.   ..+.+||+|||+++....
T Consensus        85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~  164 (317)
T cd07868          85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS  164 (317)
T ss_pred             CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCC
Confidence            5332221           14788899999999999999999999999999999999942   233799999999976543


Q ss_pred             CC----ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCC--------CHHHHHHHHHHhCCh
Q 013897          282 GK----EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD--------NYDQLVKIAKVLGTD  349 (434)
Q Consensus       282 ~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~--------~~~~~~~i~~~~g~~  349 (434)
                      ..    .....++|+.|+|||++.+...++.++|||||||++|+|++|+.||.....        ..+++..+...+|.+
T Consensus       165 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (317)
T cd07868         165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFP  244 (317)
T ss_pred             CCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCC
Confidence            21    234567899999999988756789999999999999999999999853322        235666777777765


Q ss_pred             hHHHHHhhccccCChhHHHHhcccCC--CCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          350 ELNAYLNKYHIELDPHLAALVGRHSR--KPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                      ....|.....................  ........ ......+.++.|||.+||+.||++|||++|+|+||||
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         245 ADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYME-KHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             ChHHhHHHhhccchhhhhhhhhccccCcccccchHH-hcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            54444332211111111110000000  00000000 0111245679999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-46  Score=361.55  Aligned_cols=243  Identities=20%  Similarity=0.345  Sum_probs=196.6

Q ss_pred             CeEEEeeeeecCceEEEEEEEcCCCeE-EEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCTDNEK-CIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~-vaiK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      +..+.+.||+|+||+||+|.++  |+. ||||++....     .+.|.+|+.+|.++ +|||||+++|+|.++.. .++|
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l-~HpNIV~f~G~~~~~~~-~~~i  117 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRL-RHPNIVQFYGACTSPPG-SLCI  117 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCC-ceEE
Confidence            3445666999999999999984  445 9999997543     45899999999999 99999999999976532 5789


Q ss_pred             EEeecCCCchhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCC-ceeecCCCCceEecCCCCeEEEEecccceecCCC
Q 013897          209 IFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQG-IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG  282 (434)
Q Consensus       209 v~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~-ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~  282 (434)
                      ||||+++|+|..++     ..++...+..++.||++||+|||+++ ||||||||+|||++.+..++||+|||+++.....
T Consensus       118 VtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~  197 (362)
T KOG0192|consen  118 VTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS  197 (362)
T ss_pred             EEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence            99999999998776     35899999999999999999999999 9999999999999977558999999999876644


Q ss_pred             -CccceeccCCcccccccccC-CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccc
Q 013897          283 -KEYNVRVASRYFKGPELLVD-LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI  360 (434)
Q Consensus       283 -~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  360 (434)
                       ...+...||..|||||++.+ ...|+.|+||||||++||||+||+.||..-.. ......+..                
T Consensus       198 ~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~v~~----------------  260 (362)
T KOG0192|consen  198 KTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASAVVV----------------  260 (362)
T ss_pred             cccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHh----------------
Confidence             34445789999999999985 26899999999999999999999999943222 111111110                


Q ss_pred             cCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          361 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                 ...+        ...+..+++.+.+|+.+||..||++||+..+++.
T Consensus       261 -----------~~~R--------p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  261 -----------GGLR--------PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             -----------cCCC--------CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence                       0111        1112236789999999999999999999988764

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.1e-45  Score=365.05  Aligned_cols=285  Identities=27%  Similarity=0.489  Sum_probs=218.6

Q ss_pred             CCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccC----
Q 013897          132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ----  202 (434)
Q Consensus       132 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----  202 (434)
                      ..++|.+.+.||+|+||.||+|.+..+++.||||++...     ....+.+|+.+++.+ +||||+++++++....    
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~~~~~~~  100 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEE  100 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhc-CCCCccccceeecccccccc
Confidence            357899999999999999999999889999999998642     235677899999998 9999999999885432    


Q ss_pred             CCccEEEEeecCCCchhhhcCCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC
Q 013897          203 SKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG  282 (434)
Q Consensus       203 ~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~  282 (434)
                      ...+++||||+.++....+...+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus       101 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~~  179 (364)
T cd07875         101 FQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTS  179 (364)
T ss_pred             cCeEEEEEeCCCCCHHHHHHhcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCC-cEEEEeCCCccccCCC
Confidence            235789999999876665556688899999999999999999999999999999999999776 8999999999866544


Q ss_pred             CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                      .......++..|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.+..+.+..+.+.++.+... +...    +
T Consensus       180 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf-~~~~~~~~~~~~~~~~~~~~~~-~~~~----~  252 (364)
T cd07875         180 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLF-PGTDHIDQWNKVIEQLGTPCPE-FMKK----L  252 (364)
T ss_pred             CcccCCcccCCcCCHHHHhC-CCCCchhhHHhHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCCCHH-HHHh----h
Confidence            44455688999999999887 68999999999999999999999998 5556667777776666654321 1111    1


Q ss_pred             ChhHHHHhcccCCCC---Cccc-------cccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccc
Q 013897          363 DPHLAALVGRHSRKP---WSKF-------ITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~---~~~~-------~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                      .+.........+...   +...       .........+.++.+||.+||+.||++|||+.|+|+||||..+.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~  325 (364)
T cd07875         253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY  325 (364)
T ss_pred             hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccccc
Confidence            111111111111000   0000       00111122456799999999999999999999999999998643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1e-45  Score=364.08  Aligned_cols=284  Identities=27%  Similarity=0.485  Sum_probs=217.0

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccC----C
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ----S  203 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----~  203 (434)
                      .++|.+.+.||+|+||.||++.+..+++.||||.+...     ....+.+|+.+++.+ +||||+++++++....    .
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHh-CCCchhceeeeeecccccccc
Confidence            57899999999999999999999889999999998642     235577899999998 9999999999886432    2


Q ss_pred             CccEEEEeecCCCchhhhcCCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC
Q 013897          204 KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~  283 (434)
                      ...++||||+.++....+...+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus        95 ~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~-~~kl~Dfg~~~~~~~~~  173 (355)
T cd07874          95 QDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSF  173 (355)
T ss_pred             ceeEEEhhhhcccHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCC-CEEEeeCcccccCCCcc
Confidence            35689999999876666656788999999999999999999999999999999999999776 89999999998665444


Q ss_pred             ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                      ......++..|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.+..+.+..+.+.++.+....+ .+    +.
T Consensus       174 ~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~-~~----~~  246 (355)
T cd07874         174 MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILF-PGRDYIDQWNKVIEQLGTPCPEFM-KK----LQ  246 (355)
T ss_pred             ccCCccccCCccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHH-Hh----hc
Confidence            4455688999999999877 67999999999999999999999998 455555666666665554322111 10    01


Q ss_pred             hhHHHHhcccCCC---CCc-----ccc--ccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccc
Q 013897          364 PHLAALVGRHSRK---PWS-----KFI--TVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       364 ~~~~~~~~~~~~~---~~~-----~~~--~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                      +............   ...     ...  ........+.++.+||.+||+.||++|||+.|+|+||||...-
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~  318 (355)
T cd07874         247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWY  318 (355)
T ss_pred             HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhccc
Confidence            1111111110000   000     000  0111223456889999999999999999999999999998653

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.4e-46  Score=362.79  Aligned_cols=244  Identities=26%  Similarity=0.422  Sum_probs=199.1

Q ss_pred             eeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeec
Q 013897          140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV  213 (434)
Q Consensus       140 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  213 (434)
                      +.||+|+||.||+|.+..+++.||+|+++..      ....+.+|+.+++.+ +||||+++++++.+.  ..+++||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~--~~~~lv~e~~   77 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT-RHPFLTALKYSFQTH--DRLCFVMEYA   77 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEcC--CEEEEEEeCC
Confidence            4699999999999999999999999998742      224567899999999 999999999998654  5778999999


Q ss_pred             CCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC-CCccceec
Q 013897          214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVRV  289 (434)
Q Consensus       214 ~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~-~~~~~~~~  289 (434)
                      .+++|...+   ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.... .......+
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~-~~kl~DfG~a~~~~~~~~~~~~~~  156 (323)
T cd05571          78 NGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDG-HIKITDFGLCKEGISDGATMKTFC  156 (323)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC-CEEEeeCCCCcccccCCCccccee
Confidence            999986654   3588999999999999999999999999999999999999776 899999999975322 23334567


Q ss_pred             cCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHH
Q 013897          290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAAL  369 (434)
Q Consensus       290 ~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~  369 (434)
                      |++.|+|||++.+ ..++.++|||||||++|||++|+.||... +.......+..                         
T Consensus       157 gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~-~~~~~~~~~~~-------------------------  209 (323)
T cd05571         157 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-DHEKLFELILM-------------------------  209 (323)
T ss_pred             cCccccChhhhcC-CCCCccccCcccchhhhhhhcCCCCCCCC-CHHHHHHHHHc-------------------------
Confidence            9999999999876 68999999999999999999999998532 11111111100                         


Q ss_pred             hcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCc-----cHHHHhcCCCcccccc
Q 013897          370 VGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-----TAKEAMAHPYFFPIRN  426 (434)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rp-----t~~elL~Hp~~~~~~~  426 (434)
                        .          ....+..+++++.+||.+||+.||++||     ++.++++||||.+++.
T Consensus       210 --~----------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~  259 (323)
T cd05571         210 --E----------EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINW  259 (323)
T ss_pred             --C----------CCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence              0          0001123678899999999999999999     8999999999998653

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1e-45  Score=365.13  Aligned_cols=255  Identities=24%  Similarity=0.410  Sum_probs=202.0

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      ++|++++.||+|+||+||+|.+..+++.||+|+++...      ...+.+|+.++..+ +|+||+++++.+.+.  ..++
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~-~~~~iv~~~~~~~~~--~~~~   77 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA-DSLWVVKMFYSFQDK--LNLY   77 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhC-CCCCcceEEEEEecC--CeEE
Confidence            47899999999999999999999999999999996422      24577899999998 999999999999654  5778


Q ss_pred             EEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC-
Q 013897          208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-  283 (434)
Q Consensus       208 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~-  283 (434)
                      +||||+.+++|..++   ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...... 
T Consensus        78 lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~-~vkL~DFGla~~~~~~~~  156 (363)
T cd05628          78 LIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKG-HVKLSDFGLCTGLKKAHR  156 (363)
T ss_pred             EEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC-CEEEeeccCccccccccc
Confidence            999999999987665   3589999999999999999999999999999999999999776 89999999987543211 


Q ss_pred             -----------------------------------ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCC
Q 013897          284 -----------------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEP  328 (434)
Q Consensus       284 -----------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~p  328 (434)
                                                         .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~P  235 (363)
T cd05628         157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPP  235 (363)
T ss_pred             ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC-CCCCCchhhhhhHHHHHHHHhCCCC
Confidence                                               0123479999999999887 6899999999999999999999999


Q ss_pred             CCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCC-
Q 013897          329 FFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQ-  407 (434)
Q Consensus       329 f~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~-  407 (434)
                      |. +.+..+....+......                                 ........+++++.+||.+|+. +|+ 
T Consensus       236 f~-~~~~~~~~~~i~~~~~~---------------------------------~~~p~~~~~s~~~~~li~~l~~-~~~~  280 (363)
T cd05628         236 FC-SETPQETYKKVMNWKET---------------------------------LIFPPEVPISEKAKDLILRFCC-EWEH  280 (363)
T ss_pred             CC-CCCHHHHHHHHHcCcCc---------------------------------ccCCCcCCCCHHHHHHHHHHcC-Chhh
Confidence            84 33322333222210000                                 0011111256789999999765 444 


Q ss_pred             --CCccHHHHhcCCCcccccccc
Q 013897          408 --ERPTAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       408 --~Rpt~~elL~Hp~~~~~~~~~  428 (434)
                        .||+++|+++||||++++...
T Consensus       281 r~~r~~~~ei~~hp~f~~~~~~~  303 (363)
T cd05628         281 RIGAPGVEEIKTNPFFEGVDWEH  303 (363)
T ss_pred             cCCCCCHHHHhCCCCCCCCCHHH
Confidence              468999999999999886543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.1e-45  Score=366.20  Aligned_cols=283  Identities=30%  Similarity=0.517  Sum_probs=217.9

Q ss_pred             CeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccC---CCcc
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ---SKTP  206 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---~~~~  206 (434)
                      +|++.+.||+|+||.||+|.+..+++.||||.+...     ..+.+.+|+.+++.+ +|+||+++++++....   ....
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~   79 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFF-KHDNVLSALDILQPPHIDPFEEI   79 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhC-CCCCcCCHhheecCCCccccceE
Confidence            467899999999999999999889999999998642     235678999999999 9999999999987543   1257


Q ss_pred             EEEEeecCCCchhhhc--CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC-
Q 013897          207 SLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-  283 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~-  283 (434)
                      ++|+||+.++.+..+.  ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...... 
T Consensus        80 ~lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~a~~~~~~~~  158 (372)
T cd07853          80 YVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNC-VLKICDFGLARVEEPDES  158 (372)
T ss_pred             EEEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCC-CEEeccccceeecccCcc
Confidence            8999999865443332  3588999999999999999999999999999999999999776 89999999997654322 


Q ss_pred             -ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          284 -EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       284 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                       .....+++..|+|||++.+...++.++|||||||++|||++|+.|| .+.+..+++..+.+.+|.+....+....    
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~i~~~~g~~~~~~~~~~~----  233 (372)
T cd07853         159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILF-QAQSPIQQLDLITDLLGTPSLEAMRSAC----  233 (372)
T ss_pred             ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCC-CCCCHHHHHHHHHHHcCCCCHHHHHHhh----
Confidence             2234567889999999887566899999999999999999999887 5666777888888888876654433211    


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                       ......+......+.............++++.+||.+||+.||++|||+.|+|+||||++..
T Consensus       234 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  295 (372)
T cd07853         234 -EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR  295 (372)
T ss_pred             -HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence             01111111111111000000111223578899999999999999999999999999999753

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2e-45  Score=355.09  Aligned_cols=283  Identities=28%  Similarity=0.541  Sum_probs=217.3

Q ss_pred             CCCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       131 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      +..++|.+.+.||+|+||.||+|.++.+++.||+|.++...    ...+.+|+.+++++ +||||+++++++...  ...
T Consensus         3 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~   79 (309)
T cd07872           3 GKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIVHTD--KSL   79 (309)
T ss_pred             CCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhC-CCCCcceEEEEEeeC--CeE
Confidence            44578999999999999999999998899999999986432    24577899999999 999999999999654  567


Q ss_pred             EEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC-
Q 013897          207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-  282 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~-  282 (434)
                      ++||||+.+..+..+.   ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...... 
T Consensus        80 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~  158 (309)
T cd07872          80 TLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERG-ELKLADFGLARAKSVPT  158 (309)
T ss_pred             EEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEECccccceecCCCc
Confidence            8999999874443332   2378888999999999999999999999999999999999776 8999999999764322 


Q ss_pred             CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                      .......++..|+|||.+.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+...++.+....|....... 
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  236 (309)
T cd07872         159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLF-PGSTVEDELHLIFRLLGTPTEETWPGISSND-  236 (309)
T ss_pred             cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCCHHHHhhhcchh-
Confidence            22334567889999999876567899999999999999999999887 4555566677777777766554443211000 


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                        .... .. ...  +...........+++++.+||.+||+.||.+|||++|+|+||||+.+.
T Consensus       237 --~~~~-~~-~~~--~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  293 (309)
T cd07872         237 --EFKN-YN-FPK--YKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG  293 (309)
T ss_pred             --hhhh-hh-cCc--cCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence              0000 00 000  000000111224678899999999999999999999999999999764

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-46  Score=365.83  Aligned_cols=254  Identities=26%  Similarity=0.456  Sum_probs=203.8

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      ++|++++.||+|+||+||+|.+..+++.||||+++...      ...+.+|+.+++.+ +||||+++++++.+.  ..++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~~--~~~~   77 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA-DNPWVVKLYYSFQDE--NYLY   77 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEcC--CeEE
Confidence            47899999999999999999999999999999996431      24467899999999 899999999999654  5778


Q ss_pred             EEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc
Q 013897          208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE  284 (434)
Q Consensus       208 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~  284 (434)
                      +||||+.+++|..++   ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.+.....
T Consensus        78 lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~  156 (364)
T cd05599          78 LIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKG-HIKLSDFGLCTGLKKSHR  156 (364)
T ss_pred             EEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC-CEEEeecccceecccccc
Confidence            999999999987665   3589999999999999999999999999999999999999777 899999999875432110


Q ss_pred             ---------------------------------------cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhC
Q 013897          285 ---------------------------------------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFR  325 (434)
Q Consensus       285 ---------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg  325 (434)
                                                             ....+||+.|+|||++.+ ..++.++|||||||++|||++|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~G  235 (364)
T cd05599         157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIMYEMLVG  235 (364)
T ss_pred             ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-CCCCCeeeeecchhHHHHhhcC
Confidence                                                   012368999999999876 6899999999999999999999


Q ss_pred             CCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccC
Q 013897          326 KEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYD  405 (434)
Q Consensus       326 ~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~d  405 (434)
                      ..||... +..+....+...                                 ...........+++++.+||.+||. +
T Consensus       236 ~~Pf~~~-~~~~~~~~i~~~---------------------------------~~~~~~~~~~~~s~~~~~li~~ll~-~  280 (364)
T cd05599         236 YPPFCSD-NPQETYRKIINW---------------------------------KETLQFPDEVPLSPEAKDLIKRLCC-E  280 (364)
T ss_pred             CCCCCCC-CHHHHHHHHHcC---------------------------------CCccCCCCCCCCCHHHHHHHHHHcc-C
Confidence            9998432 222222211100                                 0000011112367899999999997 9


Q ss_pred             CCCCcc---HHHHhcCCCccccccc
Q 013897          406 HQERPT---AKEAMAHPYFFPIRNA  427 (434)
Q Consensus       406 P~~Rpt---~~elL~Hp~~~~~~~~  427 (434)
                      |.+|++   ++|+|+||||++++..
T Consensus       281 p~~R~~~~~~~~ll~h~~~~~~~~~  305 (364)
T cd05599         281 AERRLGNNGVNEIKSHPFFKGVDWE  305 (364)
T ss_pred             HhhcCCCCCHHHHhcCCCcCCCCHH
Confidence            999998   9999999999987643

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-45  Score=359.97  Aligned_cols=256  Identities=29%  Similarity=0.474  Sum_probs=207.1

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      ++|++++.||+|+||.||+|.+..+++.||||+++..      ....+.+|+.++..+ +||||+++++++.+.  ...+
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~~--~~~~   77 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTT-KSEWLVKLLYAFQDD--EYLY   77 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhC-CCCCCccEEEEEEcC--CEEE
Confidence            3689999999999999999999889999999998643      234577899999999 899999999999654  5778


Q ss_pred             EEEeecCCCchhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc
Q 013897          208 LIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE  284 (434)
Q Consensus       208 lv~e~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~  284 (434)
                      +||||+++++|..++.   .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.....  .
T Consensus        78 lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kL~Dfg~a~~~~~--~  154 (333)
T cd05600          78 LAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASG-HIKLTDFGLSKGIVT--Y  154 (333)
T ss_pred             EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC-CEEEEeCcCCccccc--c
Confidence            9999999999987763   578999999999999999999999999999999999999776 899999999976543  3


Q ss_pred             cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCCh
Q 013897          285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP  364 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  364 (434)
                      ....+|++.|+|||++.+ ..++.++|||||||++|||++|..||. +.+..+.+..+......             +  
T Consensus       155 ~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~-~~~~~~~~~~i~~~~~~-------------~--  217 (333)
T cd05600         155 ANSVVGSPDYMAPEVLRG-KGYDFTVDYWSLGCMLYEFLCGFPPFS-GSTPNETWENLKYWKET-------------L--  217 (333)
T ss_pred             cCCcccCccccChhHhcC-CCCCCccceecchHHHhhhhhCCCCCC-CCCHHHHHHHHHhcccc-------------c--
Confidence            345678999999999887 589999999999999999999999983 33322222222110000             0  


Q ss_pred             hHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccc
Q 013897          365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN  426 (434)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~  426 (434)
                               ....     .......+++++.+||.+||..+|++||+++++++||||..++.
T Consensus       218 ---------~~~~-----~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~  265 (333)
T cd05600         218 ---------QRPV-----YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDW  265 (333)
T ss_pred             ---------cCCC-----CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCH
Confidence                     0000     00001235789999999999999999999999999999998754

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-45  Score=366.86  Aligned_cols=254  Identities=25%  Similarity=0.438  Sum_probs=201.4

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      ++|.+++.||+|+||+||++.+..+++.||||++...      ..+.+.+|+.+++.+ +||||+++++++.+.  ...+
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~~--~~~~   77 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES-DSPWVVSLYYSFQDA--QYLY   77 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcC--CeeE
Confidence            4689999999999999999999999999999998542      234578899999998 999999999999654  5678


Q ss_pred             EEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc
Q 013897          208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE  284 (434)
Q Consensus       208 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~  284 (434)
                      +||||+.+++|..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.+.....
T Consensus        78 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~-~~kl~DfGla~~~~~~~~  156 (377)
T cd05629          78 LIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGG-HIKLSDFGLSTGFHKQHD  156 (377)
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCC-CEEEeecccccccccccc
Confidence            999999999987665   3588899999999999999999999999999999999999776 899999999863321000


Q ss_pred             ------------------------------------------------cceeccCCcccccccccCCCCCCccccHHHHH
Q 013897          285 ------------------------------------------------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLG  316 (434)
Q Consensus       285 ------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlG  316 (434)
                                                                      ....+||+.|+|||++.+ ..++.++||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG  235 (377)
T cd05629         157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLG  235 (377)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-CCCCCceeeEecc
Confidence                                                            012468999999999876 6799999999999


Q ss_pred             HHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHH
Q 013897          317 CMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVD  396 (434)
Q Consensus       317 vil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  396 (434)
                      |++|||++|..||.. .+..+.+..+....                                 ..........+++++.+
T Consensus       236 vil~elltG~~Pf~~-~~~~~~~~~i~~~~---------------------------------~~~~~p~~~~~s~~~~d  281 (377)
T cd05629         236 AIMFECLIGWPPFCS-ENSHETYRKIINWR---------------------------------ETLYFPDDIHLSVEAED  281 (377)
T ss_pred             hhhhhhhcCCCCCCC-CCHHHHHHHHHccC---------------------------------CccCCCCCCCCCHHHHH
Confidence            999999999999843 22223222221100                                 00001111235788999


Q ss_pred             HHHHccccCCCCC---ccHHHHhcCCCccccccc
Q 013897          397 FLDKLLRYDHQER---PTAKEAMAHPYFFPIRNA  427 (434)
Q Consensus       397 ll~~cL~~dP~~R---pt~~elL~Hp~~~~~~~~  427 (434)
                      ||.+||. +|.+|   +++.|+|+||||++++..
T Consensus       282 li~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~~  314 (377)
T cd05629         282 LIRRLIT-NAENRLGRGGAHEIKSHPFFRGVDWD  314 (377)
T ss_pred             HHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCCHH
Confidence            9999998 77765   599999999999987643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-46  Score=357.57  Aligned_cols=253  Identities=23%  Similarity=0.438  Sum_probs=220.1

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      .-|.+.+.||+|.|+.|.+|++.-+|++||||++.+.+     ...+.+|+..|+-+ +|||||+||++..  ...-+||
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLV-QHpNiVRLYEViD--TQTKlyL   94 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLV-QHPNIVRLYEVID--TQTKLYL   94 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHh-cCcCeeeeeehhc--ccceEEE
Confidence            45889999999999999999999999999999997654     35678999999988 9999999999984  3456789


Q ss_pred             EEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc
Q 013897          209 IFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE  284 (434)
Q Consensus       209 v~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~  284 (434)
                      |+|.-.+|+|.+++    ..+.+..+++|+.||+.|+.|+|+..+|||||||+||.+-+..+.|||+|||++..+.++..
T Consensus        95 iLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k  174 (864)
T KOG4717|consen   95 ILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK  174 (864)
T ss_pred             EEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcch
Confidence            99999999987775    45899999999999999999999999999999999999877777999999999999999999


Q ss_pred             cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCCh
Q 013897          285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP  364 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  364 (434)
                      .++.||+..|-|||++.|.....+++||||||||||.|++|+.||. ..++.+.+.+|.+.                   
T Consensus       175 L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFq-eANDSETLTmImDC-------------------  234 (864)
T KOG4717|consen  175 LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQ-EANDSETLTMIMDC-------------------  234 (864)
T ss_pred             hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccc-cccchhhhhhhhcc-------------------
Confidence            9999999999999999995555678999999999999999999984 44455555554321                   


Q ss_pred             hHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccccc
Q 013897          365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA  427 (434)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~  427 (434)
                                        ....+..++.+++|||..||+.||++|.+.+|+..|+|+++++..
T Consensus       235 ------------------KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~  279 (864)
T KOG4717|consen  235 ------------------KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRG  279 (864)
T ss_pred             ------------------cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCC
Confidence                              112233467899999999999999999999999999999998754

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=3.8e-45  Score=349.09  Aligned_cols=273  Identities=27%  Similarity=0.544  Sum_probs=208.6

Q ss_pred             CeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhc--CCCCeeeEeeEEEcc---CCC
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLC--GGPNIVKLLDIVRDQ---QSK  204 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~E~~~l~~l~--~h~niv~l~~~~~~~---~~~  204 (434)
                      +|++.+.||+|+||+||+|.++.+++.||+|.++...     ...+.+|+.+++.+.  +||||+++++++...   ...
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4889999999999999999999999999999986421     234667888887763  699999999988643   234


Q ss_pred             ccEEEEeecCCCchhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceec
Q 013897          205 TPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY  279 (434)
Q Consensus       205 ~~~lv~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~  279 (434)
                      .+++||||+.+ ++..++     ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~-~~kl~dfg~~~~~  158 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG-QVKLADFGLARIY  158 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEECccCccccc
Confidence            57899999986 443332     2378999999999999999999999999999999999999776 8999999999876


Q ss_pred             CCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcc
Q 013897          280 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH  359 (434)
Q Consensus       280 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  359 (434)
                      ..........++..|+|||++.+ ..++.++|||||||++|+|++|+.|| .+....+.+.++....+.+....+.....
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~~f-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07863         159 SCQMALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLF-CGNSEADQLGKIFDLIGLPPEDDWPRDVT  236 (288)
T ss_pred             cCcccCCCccccccccCchHhhC-CCCCCcchhhhHHHHHHHHHhCCcCc-CCCCHHHHHHHHHHHhCCCChhhCccccc
Confidence            54444455678899999999876 67999999999999999999998776 55566667777776666544333322111


Q ss_pred             ccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          360 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                      .....     ........     .......++..+.+||.+||+.||++|||+.|+|.||||
T Consensus       237 ~~~~~-----~~~~~~~~-----~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         237 LPRGA-----FSPRGPRP-----VQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             ccccc-----cCCCCCCc-----hHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            00000     00000000     001112366789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.7e-45  Score=360.13  Aligned_cols=250  Identities=21%  Similarity=0.372  Sum_probs=204.3

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCC-eEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDN-EKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT  205 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~-~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  205 (434)
                      .++|++.+.||+|+||.||+|.+..++ ..||+|.+...      ..+.+.+|+.+++.+ +||||+++++++.+.  ..
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~--~~  105 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI-NHPFCVNLYGSFKDE--SY  105 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCCcceEEEEEeC--CE
Confidence            478999999999999999999876554 78999998532      234577899999999 999999999999654  56


Q ss_pred             cEEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC
Q 013897          206 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG  282 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~  282 (434)
                      .++||||+.+++|..++   ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.... 
T Consensus       106 ~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~-~ikL~DFG~a~~~~~-  183 (340)
T PTZ00426        106 LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDG-FIKMTDFGFAKVVDT-  183 (340)
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC-CEEEecCCCCeecCC-
Confidence            78999999999987665   3588899999999999999999999999999999999999766 899999999986542 


Q ss_pred             CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                       .....+||+.|+|||++.+ ..++.++|||||||++|||++|..||... +.......+..                  
T Consensus       184 -~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~-~~~~~~~~i~~------------------  242 (340)
T PTZ00426        184 -RTYTLCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCPPFYAN-EPLLIYQKILE------------------  242 (340)
T ss_pred             -CcceecCChhhcCHHHHhC-CCCCccccccchhhHHHHHhcCCCCCCCC-CHHHHHHHHhc------------------
Confidence             2345678999999999877 67899999999999999999999998532 22222222110                  


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCc-----cHHHHhcCCCccccccc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-----TAKEAMAHPYFFPIRNA  427 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rp-----t~~elL~Hp~~~~~~~~  427 (434)
                               ..          ...+..+++.+.++|++||+.||++|+     +++++++||||.++++.
T Consensus       243 ---------~~----------~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~  293 (340)
T PTZ00426        243 ---------GI----------IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWV  293 (340)
T ss_pred             ---------CC----------CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence                     00          001123567899999999999999995     89999999999987643

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.2e-45  Score=365.15  Aligned_cols=253  Identities=25%  Similarity=0.430  Sum_probs=200.2

Q ss_pred             CeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      .|++++.||+|+||+||+|.+..+++.||||++...      ....+.+|+.+++.+ +||||+++++++.+.  ..+++
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~--~~~~l   78 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEA-DNEWVVKLYYSFQDK--DNLYF   78 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhc-CCCCeeeeEEEEecC--CEEEE
Confidence            588999999999999999999999999999998642      234578899999998 999999999999754  56889


Q ss_pred             EEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC--
Q 013897          209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--  283 (434)
Q Consensus       209 v~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~--  283 (434)
                      ||||+++++|..++   ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..+....  
T Consensus        79 v~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~-~~kL~DFGl~~~~~~~~~~  157 (381)
T cd05626          79 VMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDG-HIKLTDFGLCTGFRWTHNS  157 (381)
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCC-CEEEeeCcCCccccccccc
Confidence            99999999987665   3588899999999999999999999999999999999999776 89999999975331000  


Q ss_pred             ----------------------------------------------ccceeccCCcccccccccCCCCCCccccHHHHHH
Q 013897          284 ----------------------------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGC  317 (434)
Q Consensus       284 ----------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv  317 (434)
                                                                    .....+||..|+|||++.+ ..++.++|||||||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlG~  236 (381)
T cd05626         158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCDWWSVGV  236 (381)
T ss_pred             ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC-CCCCCccceeehhh
Confidence                                                          0123478999999999876 67999999999999


Q ss_pred             HHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHH
Q 013897          318 MFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDF  397 (434)
Q Consensus       318 il~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl  397 (434)
                      ++|||++|+.||..... .+....+...                                 ...........+++++.+|
T Consensus       237 il~elltG~~Pf~~~~~-~~~~~~i~~~---------------------------------~~~~~~~~~~~~s~~~~dl  282 (381)
T cd05626         237 ILFEMLVGQPPFLAPTP-TETQLKVINW---------------------------------ENTLHIPPQVKLSPEAVDL  282 (381)
T ss_pred             HHHHHHhCCCCCcCCCH-HHHHHHHHcc---------------------------------ccccCCCCCCCCCHHHHHH
Confidence            99999999999954322 2211111100                                 0000111122367899999


Q ss_pred             HHHccc--cCCCCCccHHHHhcCCCcccccc
Q 013897          398 LDKLLR--YDHQERPTAKEAMAHPYFFPIRN  426 (434)
Q Consensus       398 l~~cL~--~dP~~Rpt~~elL~Hp~~~~~~~  426 (434)
                      |.+|+.  .+|..|++++|+++||||++++.
T Consensus       283 i~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~  313 (381)
T cd05626         283 ITKLCCSAEERLGRNGADDIKAHPFFSEVDF  313 (381)
T ss_pred             HHHHccCcccccCCCCHHHHhcCcccCCCCh
Confidence            999554  45556999999999999998764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.1e-46  Score=340.58  Aligned_cols=289  Identities=28%  Similarity=0.538  Sum_probs=226.4

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCe----EEEEEEeccccH-----HHHHHHHHHHHHhcCCCCeeeEeeEEEccCCC
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVKK-----KKIKREIKILQNLCGGPNIVKLLDIVRDQQSK  204 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~----~vaiK~~~~~~~-----~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  204 (434)
                      ..|++++.||+|+||.||+|..+.++.    .+|||.++..+.     ...-+|+..++.| +|||++.+..++... ..
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl-~h~nvi~Lv~Vfl~~-d~  101 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLREL-KHPNVISLVKVFLSH-DK  101 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHh-cCCcchhHHHHHhcc-Cc
Confidence            568999999999999999997655443    689999976532     4567999999999 999999999998754 57


Q ss_pred             ccEEEEeecCCCchhhhc-------CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCC---CeEEEEecc
Q 013897          205 TPSLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ---RKLRLIDWG  274 (434)
Q Consensus       205 ~~~lv~e~~~~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~---~~vkl~DFG  274 (434)
                      .+++++||.+...+..+.       ..++...++.++.||+.|++|||++-|+||||||.|||+..++   +.|||+|||
T Consensus       102 ~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG  181 (438)
T KOG0666|consen  102 KVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLG  181 (438)
T ss_pred             eEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence            889999999988765432       3488889999999999999999999999999999999997661   389999999


Q ss_pred             cceecCCCC----ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCC--------CHHHHHHH
Q 013897          275 LAEFYHPGK----EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD--------NYDQLVKI  342 (434)
Q Consensus       275 la~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~--------~~~~~~~i  342 (434)
                      +|+.+...-    .....+.|.+|+|||.+.|...|+.+.|||+.|||+.||+|-++.|...+.        ..+++.+|
T Consensus       182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rI  261 (438)
T KOG0666|consen  182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRI  261 (438)
T ss_pred             HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHH
Confidence            998875432    234567899999999999999999999999999999999998866643221        24688899


Q ss_pred             HHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccc--ccc-ccccCCchHHHHHHHHccccCCCCCccHHHHhcCC
Q 013897          343 AKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKF--ITV-ENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHP  419 (434)
Q Consensus       343 ~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~-~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp  419 (434)
                      .+++|.+....|..-...   |++...+...++..+...  ..+ .....-++.+.+||.+||.+||.+|+|++++|+|+
T Consensus       262 f~vLG~Pt~~~Wp~lkk~---Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~  338 (438)
T KOG0666|consen  262 FEVLGTPTDKDWPDLKKM---PEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP  338 (438)
T ss_pred             HHHcCCCccccchhhhhC---cchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence            999999888777653322   333333333332222221  111 11223456699999999999999999999999999


Q ss_pred             Cccccccc
Q 013897          420 YFFPIRNA  427 (434)
Q Consensus       420 ~~~~~~~~  427 (434)
                      ||..-.-+
T Consensus       339 yF~~d~lp  346 (438)
T KOG0666|consen  339 YFTEDPLP  346 (438)
T ss_pred             ccccCCCC
Confidence            99976544

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-47  Score=359.34  Aligned_cols=249  Identities=24%  Similarity=0.406  Sum_probs=206.6

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      ..|...++||+|+||.||+|.+..+++.||+|++.-.    ..+.+.+|+.+|.++ +++||.++|+.+...  ..++++
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~-~~~~it~yygsyl~g--~~Lwii   89 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQC-DSPNITEYYGSYLKG--TKLWII   89 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhc-CcchHHhhhhheeec--ccHHHH
Confidence            4577889999999999999999999999999999743    346688999999998 899999999988654  567799


Q ss_pred             EeecCCCchhhhcCC---CChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc-c
Q 013897          210 FEHVNNTDFKVLYPT---LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-Y  285 (434)
Q Consensus       210 ~e~~~~~~l~~~~~~---l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~-~  285 (434)
                      ||||.+|+...+++.   +.+..+..++++++.||.|||.++.+|||||+.|||+..++ .+||+|||.+..+..... .
T Consensus        90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g-~vkl~DfgVa~ql~~~~~rr  168 (467)
T KOG0201|consen   90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESG-DVKLADFGVAGQLTNTVKRR  168 (467)
T ss_pred             HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccC-cEEEEecceeeeeechhhcc
Confidence            999999998777643   47888999999999999999999999999999999999885 899999999977654432 3


Q ss_pred             ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChh
Q 013897          286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH  365 (434)
Q Consensus       286 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~  365 (434)
                      .+.+||++|||||++.+ ..|+.|+||||||++.+||++|.+|+-.-+. ...+..|                       
T Consensus       169 ~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s~~hP-mrvlflI-----------------------  223 (467)
T KOG0201|consen  169 KTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHSKLHP-MRVLFLI-----------------------  223 (467)
T ss_pred             ccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCcccCc-ceEEEec-----------------------
Confidence            78899999999999986 7999999999999999999999999822111 1111010                       


Q ss_pred             HHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccc
Q 013897          366 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI  424 (434)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~  424 (434)
                              ++.....     ....+++.+++|+..||.+||+.||+|.+||+|+|++..
T Consensus       224 --------pk~~PP~-----L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a  269 (467)
T KOG0201|consen  224 --------PKSAPPR-----LDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRA  269 (467)
T ss_pred             --------cCCCCCc-----cccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhc
Confidence                    1111111     112578899999999999999999999999999999974

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-45  Score=362.24  Aligned_cols=254  Identities=30%  Similarity=0.513  Sum_probs=206.9

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      ++|.+.+.||+|+||.||+|.+..+++.||||+++..      ....+.+|+.++..+ +||||+++++++.+.  ...+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~--~~~~   77 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADA-DSPWIVKLYYSFQDE--EHLY   77 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhc-CCCCccchhhheecC--CeEE
Confidence            4689999999999999999999889999999998642      234578899999998 899999999998654  5678


Q ss_pred             EEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC-
Q 013897          208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-  283 (434)
Q Consensus       208 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~-  283 (434)
                      +||||+.+++|..++   ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++....... 
T Consensus        78 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~~  156 (350)
T cd05573          78 LVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADG-HIKLADFGLCKKMNKAKD  156 (350)
T ss_pred             EEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEEeecCCCCccCcccCc
Confidence            999999999987665   3588999999999999999999999999999999999999776 89999999997654332 


Q ss_pred             -----------------------------ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCC
Q 013897          284 -----------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD  334 (434)
Q Consensus       284 -----------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~  334 (434)
                                                   ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... 
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~-  234 (350)
T cd05573         157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDT-  234 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcC-CCCCCceeeEecchhhhhhccCCCCCCCCC-
Confidence                                         2234578999999999887 689999999999999999999999985432 


Q ss_pred             CHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCcc-HH
Q 013897          335 NYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT-AK  413 (434)
Q Consensus       335 ~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt-~~  413 (434)
                      .......+....                                 ..........+++++.+||.+||. ||.+|++ ++
T Consensus       235 ~~~~~~~i~~~~---------------------------------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~  280 (350)
T cd05573         235 LQETYNKIINWK---------------------------------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFE  280 (350)
T ss_pred             HHHHHHHHhccC---------------------------------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHH
Confidence            222222221100                                 000011112267899999999997 9999999 99


Q ss_pred             HHhcCCCccccccc
Q 013897          414 EAMAHPYFFPIRNA  427 (434)
Q Consensus       414 elL~Hp~~~~~~~~  427 (434)
                      |+|+||||++++..
T Consensus       281 ~ll~hp~~~~~~~~  294 (350)
T cd05573         281 EIKSHPFFKGIDWE  294 (350)
T ss_pred             HHhcCCCcCCCCHH
Confidence            99999999987654

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.6e-45  Score=364.78  Aligned_cols=253  Identities=25%  Similarity=0.420  Sum_probs=201.5

Q ss_pred             CeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      .|++++.||+|+||.||+|++..+++.||+|++....      ...+.+|+.+++.+ +||||+++++.+.+.  ..+++
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~-~h~~iv~~~~~~~~~--~~~~l   78 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDK--DNLYF   78 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhC-CCCcCCeEEEEEEeC--CEEEE
Confidence            5889999999999999999999999999999986432      34578899999999 999999999999654  57889


Q ss_pred             EEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC---
Q 013897          209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG---  282 (434)
Q Consensus       209 v~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~---  282 (434)
                      ||||+.+++|..++   ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|..+...   
T Consensus        79 v~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g-~~kL~DFGla~~~~~~~~~  157 (382)
T cd05625          79 VMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDG-HIKLTDFGLCTGFRWTHDS  157 (382)
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEEeECCCCccccccccc
Confidence            99999999987665   3478889999999999999999999999999999999999777 8999999997532100   


Q ss_pred             ---------------------------------------------CccceeccCCcccccccccCCCCCCccccHHHHHH
Q 013897          283 ---------------------------------------------KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGC  317 (434)
Q Consensus       283 ---------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv  317 (434)
                                                                   ......+||+.|+|||++.+ ..++.++|||||||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGv  236 (382)
T cd05625         158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGV  236 (382)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC-CCCCCeeeEEechH
Confidence                                                         00112468999999999876 68999999999999


Q ss_pred             HHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHH
Q 013897          318 MFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDF  397 (434)
Q Consensus       318 il~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl  397 (434)
                      ++|||++|+.||.. .+..+....+...                                 ...........+++++.+|
T Consensus       237 il~elltG~~Pf~~-~~~~~~~~~i~~~---------------------------------~~~~~~p~~~~~s~~~~~l  282 (382)
T cd05625         237 ILYEMLVGQPPFLA-QTPLETQMKVINW---------------------------------QTSLHIPPQAKLSPEASDL  282 (382)
T ss_pred             HHHHHHhCCCCCCC-CCHHHHHHHHHcc---------------------------------CCCcCCCCcccCCHHHHHH
Confidence            99999999999843 2222222221110                                 0000111122467899999


Q ss_pred             HHHccccCCCCCcc---HHHHhcCCCccccccc
Q 013897          398 LDKLLRYDHQERPT---AKEAMAHPYFFPIRNA  427 (434)
Q Consensus       398 l~~cL~~dP~~Rpt---~~elL~Hp~~~~~~~~  427 (434)
                      |.+|+ .||++|++   ++|+++||||+.++..
T Consensus       283 i~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~~  314 (382)
T cd05625         283 IIKLC-RGPEDRLGKNGADEIKAHPFFKTIDFS  314 (382)
T ss_pred             HHHHc-cCHhHcCCCCCHHHHhcCCCcCCcChH
Confidence            99986 59999997   9999999999987644

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=6.5e-45  Score=353.95  Aligned_cols=250  Identities=24%  Similarity=0.370  Sum_probs=202.4

Q ss_pred             CeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      +|++++.||+|+||.||+|.+..+++.||+|+++..      ..+.+..|+.++..+.+|++|+++++++.+.  ..+++
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~l   78 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM--DRLYF   78 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcC--CEEEE
Confidence            588999999999999999999989999999998642      2345678999999985567789999988654  56789


Q ss_pred             EEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecC-CCCc
Q 013897          209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKE  284 (434)
Q Consensus       209 v~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~-~~~~  284 (434)
                      ||||+.+++|...+   ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.... ....
T Consensus        79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~-~~kL~Dfg~~~~~~~~~~~  157 (324)
T cd05587          79 VMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEG-HIKIADFGMCKENIFGGKT  157 (324)
T ss_pred             EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCC-CEEEeecCcceecCCCCCc
Confidence            99999999987665   3578899999999999999999999999999999999999776 89999999987532 2233


Q ss_pred             cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCCh
Q 013897          285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP  364 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  364 (434)
                      ....+|+..|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+.+..+...                   
T Consensus       158 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~-~~~~~~~~~~i~~~-------------------  216 (324)
T cd05587         158 TRTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFD-GEDEDELFQSIMEH-------------------  216 (324)
T ss_pred             eeeecCCccccChhhhcC-CCCCcccchhhhHHHHHHHHhCCCCCC-CCCHHHHHHHHHcC-------------------
Confidence            345679999999999887 678999999999999999999999984 22222222221100                   


Q ss_pred             hHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccH-----HHHhcCCCcccccc
Q 013897          365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA-----KEAMAHPYFFPIRN  426 (434)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~-----~elL~Hp~~~~~~~  426 (434)
                                        ....+..+++++.+|+.+||..||++|++.     +++++||||..++.
T Consensus       217 ------------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~  265 (324)
T cd05587         217 ------------------NVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDW  265 (324)
T ss_pred             ------------------CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence                              000112367789999999999999999986     89999999998764

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3.6e-45  Score=355.55  Aligned_cols=244  Identities=25%  Similarity=0.432  Sum_probs=198.5

Q ss_pred             eeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeec
Q 013897          140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV  213 (434)
Q Consensus       140 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  213 (434)
                      +.||+|+||.||++.+..++..||+|+++..      ....+.+|+.+++.+ +||||+++++++...  ..+++||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~--~~~~lv~E~~   77 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTH--DRLCFVMEYA   77 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCcceeeEEecC--CEEEEEEeCC
Confidence            4699999999999999999999999998643      224567899999999 999999999998654  5778999999


Q ss_pred             CCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC-CCccceec
Q 013897          214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVRV  289 (434)
Q Consensus       214 ~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~-~~~~~~~~  289 (434)
                      .+++|...+   ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.... ........
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~  156 (323)
T cd05595          78 NGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDGATMKTFC  156 (323)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCC-CEEecccHHhccccCCCCcccccc
Confidence            999986554   3588999999999999999999999999999999999999776 899999999875322 22334457


Q ss_pred             cCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHH
Q 013897          290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAAL  369 (434)
Q Consensus       290 ~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~  369 (434)
                      |+..|+|||++.+ ..++.++|||||||++|||++|+.||.... .......+..                         
T Consensus       157 gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~-~~~~~~~~~~-------------------------  209 (323)
T cd05595         157 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HERLFELILM-------------------------  209 (323)
T ss_pred             CCcCcCCcccccC-CCCCchhchhhhHHHHHHHHhCCCCCCCCC-HHHHHHHHhc-------------------------
Confidence            8999999999876 678999999999999999999999984322 1111111100                         


Q ss_pred             hcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCc-----cHHHHhcCCCcccccc
Q 013897          370 VGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-----TAKEAMAHPYFFPIRN  426 (434)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rp-----t~~elL~Hp~~~~~~~  426 (434)
                        .          ....+..+++++.+||.+||+.||++|+     ++.++++||||.++.+
T Consensus       210 --~----------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~  259 (323)
T cd05595         210 --E----------EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW  259 (323)
T ss_pred             --C----------CCCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence              0          0001123678999999999999999998     8999999999998764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=4.1e-45  Score=354.76  Aligned_cols=247  Identities=24%  Similarity=0.384  Sum_probs=199.9

Q ss_pred             eeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeec
Q 013897          140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV  213 (434)
Q Consensus       140 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  213 (434)
                      +.||+|+||.||+|.++.+++.||+|+++..      ....+..|+.++..+.+||||+++++++.+.  ..+++||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~--~~~~iv~Ey~   78 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTP--DRLFFVMEFV   78 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcC--CEEEEEEcCC
Confidence            3699999999999999999999999998642      2345678888888876899999999999654  5678999999


Q ss_pred             CCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC-CCccceec
Q 013897          214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVRV  289 (434)
Q Consensus       214 ~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~-~~~~~~~~  289 (434)
                      .+++|..++   ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.... .......+
T Consensus        79 ~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~-~~kL~DfG~~~~~~~~~~~~~~~~  157 (320)
T cd05590          79 NGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEG-HCKLADFGMCKEGIFNGKTTSTFC  157 (320)
T ss_pred             CCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC-cEEEeeCCCCeecCcCCCcccccc
Confidence            999987654   3588999999999999999999999999999999999999776 899999999875432 22334557


Q ss_pred             cCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHH
Q 013897          290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAAL  369 (434)
Q Consensus       290 ~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~  369 (434)
                      |++.|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+....+..   .                     
T Consensus       158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~-~~~~~~~~~~i~~---~---------------------  211 (320)
T cd05590         158 GTPDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFE-AENEDDLFEAILN---D---------------------  211 (320)
T ss_pred             cCccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCCC-CCCHHHHHHHHhc---C---------------------
Confidence            8999999999876 678999999999999999999999984 2222222222110   0                     


Q ss_pred             hcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccH------HHHhcCCCcccccccc
Q 013897          370 VGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA------KEAMAHPYFFPIRNAE  428 (434)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~------~elL~Hp~~~~~~~~~  428 (434)
                                   ....+..+++++.+||.+||+.||++|+++      +++++||||+.+.+..
T Consensus       212 -------------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~~  263 (320)
T cd05590         212 -------------EVVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEK  263 (320)
T ss_pred             -------------CCCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHHH
Confidence                         000112357789999999999999999998      9999999999876533

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.7e-44  Score=348.11  Aligned_cols=282  Identities=24%  Similarity=0.471  Sum_probs=203.6

Q ss_pred             EeeeeecCceEEEEEEEcC--CCeEEEEEEecccc-HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeecCC
Q 013897          139 VRKVGRGKYSEVFEGVHCT--DNEKCIIKILKPVK-KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN  215 (434)
Q Consensus       139 ~~~lG~G~fg~Vy~~~~~~--~~~~vaiK~~~~~~-~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~  215 (434)
                      ..+||+|+||.||+|.+..  ++..||+|.+.... ...+.+|+.+++.+ +||||+++++++........++|+||+.+
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLREL-KHPNVIALQKVFLSHSDRKVWLLFDYAEH   84 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhC-CCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence            4679999999999998754  55789999986543 34678999999999 99999999999876666778999999987


Q ss_pred             Cchhhhc-----------CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecC---CCCeEEEEecccceecCC
Q 013897          216 TDFKVLY-----------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH---EQRKLRLIDWGLAEFYHP  281 (434)
Q Consensus       216 ~~l~~~~-----------~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~---~~~~vkl~DFGla~~~~~  281 (434)
                      +.+..+.           ..+++..++.++.||+.||.|||+++|+||||||+|||+..   +.+.+||+|||+++....
T Consensus        85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~  164 (317)
T cd07867          85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS  164 (317)
T ss_pred             cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCC
Confidence            5433221           13778889999999999999999999999999999999932   233799999999986543


Q ss_pred             CC----ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCC--------HHHHHHHHHHhCCh
Q 013897          282 GK----EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN--------YDQLVKIAKVLGTD  349 (434)
Q Consensus       282 ~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~--------~~~~~~i~~~~g~~  349 (434)
                      ..    .....+++..|+|||++.+...++.++|||||||++|||+||+.||.....+        ..++..+...+|.+
T Consensus       165 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (317)
T cd07867         165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFP  244 (317)
T ss_pred             CcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCC
Confidence            22    2234578899999999876566899999999999999999999998543221        34455666666655


Q ss_pred             hHHHHHhhccccCChhHHHHhcccCCCCCccccc-cccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          350 ELNAYLNKYHIELDPHLAALVGRHSRKPWSKFIT-VENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                      ....|.........+................... .......+..+.+||.+||+.||.+|||++|+|+||||
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         245 ADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             ChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            4444332111111111111100000000000000 01112345679999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=8.9e-45  Score=354.14  Aligned_cols=252  Identities=25%  Similarity=0.421  Sum_probs=201.1

Q ss_pred             CeEEEeeeeecCceEEEEEEEc---CCCeEEEEEEecccc-------HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCC
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHC---TDNEKCIIKILKPVK-------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK  204 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~---~~~~~vaiK~~~~~~-------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  204 (434)
                      +|++++.||+|+||.||++.+.   .+++.||+|+++...       .+.+.+|+.+++.+.+|+||+++++++.+.  .
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--~   78 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTE--A   78 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecC--C
Confidence            4889999999999999998764   468899999986421       245678999999997799999999988643  5


Q ss_pred             ccEEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC
Q 013897          205 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP  281 (434)
Q Consensus       205 ~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~  281 (434)
                      .+++||||+.+++|..++   ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus        79 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~-~~kl~DfG~~~~~~~  157 (332)
T cd05614          79 KLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEG-HVVLTDFGLSKEFLS  157 (332)
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCC-CEEEeeCcCCccccc
Confidence            678999999999987654   4588999999999999999999999999999999999999776 899999999976533


Q ss_pred             CC--ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCC--CHHHHHHHHHHhCChhHHHHHhh
Q 013897          282 GK--EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD--NYDQLVKIAKVLGTDELNAYLNK  357 (434)
Q Consensus       282 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~--~~~~~~~i~~~~g~~~~~~~~~~  357 (434)
                      ..  .....+||..|+|||++.+...++.++|||||||++|||++|+.||.....  ....+...  ..           
T Consensus       158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~--~~-----------  224 (332)
T cd05614         158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRR--IL-----------  224 (332)
T ss_pred             cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHH--Hh-----------
Confidence            22  223457899999999987645688999999999999999999999843211  11111100  00           


Q ss_pred             ccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCc-----cHHHHhcCCCccccc
Q 013897          358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-----TAKEAMAHPYFFPIR  425 (434)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rp-----t~~elL~Hp~~~~~~  425 (434)
                                   ..          .......+++.+.+||.+||+.||++||     +++++++||||++++
T Consensus       225 -------------~~----------~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~  274 (332)
T cd05614         225 -------------KC----------DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD  274 (332)
T ss_pred             -------------cC----------CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence                         00          0011123678899999999999999999     889999999999764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=3.3e-45  Score=363.35  Aligned_cols=254  Identities=25%  Similarity=0.416  Sum_probs=201.7

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      .+|++++.||+|+||.||+|++..+++.||||++...      ....+.+|+.+|+.+ +||||+++++.+.+.  ..++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~~--~~~~   77 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEA-DNEWVVKLYYSFQDK--DNLY   77 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEEcC--CEEE
Confidence            3689999999999999999999999999999998642      235578899999999 999999999999654  5788


Q ss_pred             EEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC--
Q 013897          208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG--  282 (434)
Q Consensus       208 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~--  282 (434)
                      +||||+.+++|..++   ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|..+...  
T Consensus        78 lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~-~ikL~DFG~a~~~~~~~~  156 (376)
T cd05598          78 FVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG-HIKLTDFGLCTGFRWTHD  156 (376)
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCC-CEEEEeCCCCcccccccc
Confidence            999999999987765   3478888999999999999999999999999999999999776 8999999997432100  


Q ss_pred             ------------------------------------------CccceeccCCcccccccccCCCCCCccccHHHHHHHHH
Q 013897          283 ------------------------------------------KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFA  320 (434)
Q Consensus       283 ------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~  320 (434)
                                                                ......+||+.|+|||++.+ ..++.++|||||||++|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvily  235 (376)
T cd05598         157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILY  235 (376)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-CCCCcceeeeeccceee
Confidence                                                      00112478999999999876 67899999999999999


Q ss_pred             HHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHH
Q 013897          321 GMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDK  400 (434)
Q Consensus       321 elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~  400 (434)
                      ||++|+.||... ...+....+...                                 ...........+++++.+||.+
T Consensus       236 ell~G~~Pf~~~-~~~~~~~~i~~~---------------------------------~~~~~~~~~~~~s~~~~~li~~  281 (376)
T cd05598         236 EMLVGQPPFLAD-TPAETQLKVINW---------------------------------ETTLHIPSQAKLSREASDLILR  281 (376)
T ss_pred             ehhhCCCCCCCC-CHHHHHHHHhcc---------------------------------CccccCCCCCCCCHHHHHHHHH
Confidence            999999998432 222221111100                                 0000011122367889999999


Q ss_pred             ccccCCCCCc---cHHHHhcCCCccccccc
Q 013897          401 LLRYDHQERP---TAKEAMAHPYFFPIRNA  427 (434)
Q Consensus       401 cL~~dP~~Rp---t~~elL~Hp~~~~~~~~  427 (434)
                      |+ .+|.+|+   ++.|+++||||++++..
T Consensus       282 l~-~~p~~R~~~~t~~ell~h~~~~~~~~~  310 (376)
T cd05598         282 LC-CGAEDRLGKNGADEIKAHPFFKGIDFA  310 (376)
T ss_pred             Hh-cCHhhcCCCCCHHHHhCCCCcCCCCHH
Confidence            76 5999999   99999999999987643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2.8e-45  Score=357.33  Aligned_cols=256  Identities=26%  Similarity=0.432  Sum_probs=205.9

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      ++|++.+.||+|+||+||+|.+..+++.||+|+++..      ..+.+.+|+.+++.+ +|+||+++++++.+.  ...+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~~~~i~~~~~~~~~~--~~~~   77 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS-NSPWIPQLQYAFQDK--DNLY   77 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceeeEEecC--CeEE
Confidence            4689999999999999999999999999999998743      234577899999887 999999999998654  5678


Q ss_pred             EEEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC
Q 013897          208 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       208 lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~  283 (434)
                      +||||+.+++|..++    ..+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+||+|||++.......
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~-~~kL~Dfg~a~~~~~~~  156 (330)
T cd05601          78 LVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTG-HIKLADFGSAARLTANK  156 (330)
T ss_pred             EEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCC-CEEeccCCCCeECCCCC
Confidence            999999999987765    4588999999999999999999999999999999999999776 89999999998765433


Q ss_pred             cc--ceeccCCcccccccccC-----CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHh
Q 013897          284 EY--NVRVASRYFKGPELLVD-----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN  356 (434)
Q Consensus       284 ~~--~~~~~t~~y~aPE~~~~-----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~  356 (434)
                      ..  ....|++.|+|||++..     ...++.++|||||||++|||++|+.||... .....+..+...           
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~-~~~~~~~~i~~~-----------  224 (330)
T cd05601         157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG-TSAKTYNNIMNF-----------  224 (330)
T ss_pred             ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC-CHHHHHHHHHcC-----------
Confidence            22  23478999999999863     256789999999999999999999998432 222222221110           


Q ss_pred             hccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccccc
Q 013897          357 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~  428 (434)
                                            ...........+++++.+||.+||+ ||++|||++++++||||..++...
T Consensus       225 ----------------------~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~~  273 (330)
T cd05601         225 ----------------------QRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWNN  273 (330)
T ss_pred             ----------------------CCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHHH
Confidence                                  0000111222367889999999998 999999999999999999876443

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=5.5e-45  Score=360.67  Aligned_cols=255  Identities=25%  Similarity=0.407  Sum_probs=205.5

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      .++|++.+.||+|+||.||++.+..+++.||+|+++..      ....+.+|+.+++.+ +||||+++++++.+.  ..+
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~-~h~~iv~~~~~~~~~--~~~  118 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA-NSEWIVQLHYAFQDD--KYL  118 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEecC--CEE
Confidence            47899999999999999999999999999999998642      223467899999998 999999999998653  578


Q ss_pred             EEEEeecCCCchhhhcC--CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC-
Q 013897          207 SLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-  283 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~-  283 (434)
                      ++||||+.+++|..++.  .+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++....... 
T Consensus       119 ~lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~-~~kL~DfG~~~~~~~~~~  197 (370)
T cd05596         119 YMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG-HLKLADFGTCMKMDANGM  197 (370)
T ss_pred             EEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCC-CEEEEeccceeeccCCCc
Confidence            89999999999987764  478888999999999999999999999999999999999776 89999999997664332 


Q ss_pred             -ccceeccCCcccccccccCC---CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcc
Q 013897          284 -EYNVRVASRYFKGPELLVDL---QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH  359 (434)
Q Consensus       284 -~~~~~~~t~~y~aPE~~~~~---~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  359 (434)
                       .....+||+.|+|||++.+.   ..++.++|||||||++|||++|+.||.. .+....+..+...              
T Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~--------------  262 (370)
T cd05596         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMDH--------------  262 (370)
T ss_pred             ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCC-CCHHHHHHHHHcC--------------
Confidence             22456799999999998652   2488999999999999999999999843 2222222222110              


Q ss_pred             ccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCC--CccHHHHhcCCCccccc
Q 013897          360 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQE--RPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~--Rpt~~elL~Hp~~~~~~  425 (434)
                                   ...      ........++.++.+||.+||+.+|++  |++++|+++||||++..
T Consensus       263 -------------~~~------~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~  311 (370)
T cd05596         263 -------------KNS------LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQ  311 (370)
T ss_pred             -------------CCc------CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCC
Confidence                         000      011122236789999999999999998  99999999999998754

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=8e-45  Score=353.18  Aligned_cols=252  Identities=23%  Similarity=0.339  Sum_probs=204.0

Q ss_pred             CeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      +|++.+.||+|+||.||+|.+..+++.||+|+++...      ...+..|..++..+.+|++|+++++++.+.  ..+++
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~l   78 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTM--DRLYF   78 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecC--CEEEE
Confidence            5889999999999999999999899999999986432      234567888888876789999999998654  56789


Q ss_pred             EEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC-CCc
Q 013897          209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKE  284 (434)
Q Consensus       209 v~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~-~~~  284 (434)
                      ||||+.+++|...+   ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.... ...
T Consensus        79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~-~~kL~DfG~~~~~~~~~~~  157 (323)
T cd05616          79 VMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKENMWDGVT  157 (323)
T ss_pred             EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCC-cEEEccCCCceecCCCCCc
Confidence            99999999987654   4588999999999999999999999999999999999999777 899999999975432 223


Q ss_pred             cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCCh
Q 013897          285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP  364 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  364 (434)
                      ....+|++.|+|||++.+ ..++.++|||||||++|||++|+.||.. .+.......+...                   
T Consensus       158 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~Pf~~-~~~~~~~~~i~~~-------------------  216 (323)
T cd05616         158 TKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEH-------------------  216 (323)
T ss_pred             cccCCCChhhcCHHHhcC-CCCCCccchhchhHHHHHHHhCCCCCCC-CCHHHHHHHHHhC-------------------
Confidence            345678999999999886 6899999999999999999999999842 2222222222110                   


Q ss_pred             hHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCcc-----HHHHhcCCCcccccccc
Q 013897          365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT-----AKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt-----~~elL~Hp~~~~~~~~~  428 (434)
                                        ....+..+++++.+|+.+||+.||++|++     ..++++||||+.+++..
T Consensus       217 ------------------~~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~  267 (323)
T cd05616         217 ------------------NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK  267 (323)
T ss_pred             ------------------CCCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHH
Confidence                              00011236788999999999999999998     48999999999877444

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.7e-44  Score=355.19  Aligned_cols=253  Identities=21%  Similarity=0.377  Sum_probs=199.8

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      .++|+.+++||+|+||.||+|.+..+++.||||++....    ...+.+|+++++.+ +|+||+++++++.+.  ..+++
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~l  149 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDV-NHPNVVKCHDMFDHN--GEIQV  149 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhC-CCCCcceeeeEeccC--CeEEE
Confidence            366888999999999999999998899999999986432    35688999999999 999999999998643  56789


Q ss_pred             EEeecCCCchhhhcCCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC-ccce
Q 013897          209 IFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNV  287 (434)
Q Consensus       209 v~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~-~~~~  287 (434)
                      ||||+.+++|.... ...+..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...... ....
T Consensus       150 v~e~~~~~~L~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-~~kL~DfG~~~~~~~~~~~~~~  227 (353)
T PLN00034        150 LLEFMDGGSLEGTH-IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAK-NVKIADFGVSRILAQTMDPCNS  227 (353)
T ss_pred             EEecCCCCcccccc-cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC-CEEEcccccceecccccccccc
Confidence            99999999886532 356777889999999999999999999999999999999776 89999999998764332 2345


Q ss_pred             eccCCcccccccccCC----CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          288 RVASRYFKGPELLVDL----QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       288 ~~~t~~y~aPE~~~~~----~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                      .+|+..|+|||++...    ..++.++|||||||++|||++|+.||......  .+..+.....                
T Consensus       228 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--~~~~~~~~~~----------------  289 (353)
T PLN00034        228 SVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG--DWASLMCAIC----------------  289 (353)
T ss_pred             cccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--cHHHHHHHHh----------------
Confidence            6789999999987431    23457899999999999999999998522211  1111000000                


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI  424 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~  424 (434)
                             ..         ........+++++.+||.+||..||++|||+.|+|+||||.+-
T Consensus       290 -------~~---------~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~  334 (353)
T PLN00034        290 -------MS---------QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA  334 (353)
T ss_pred             -------cc---------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence                   00         0001122367889999999999999999999999999999975

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=4.8e-45  Score=355.42  Aligned_cols=244  Identities=25%  Similarity=0.401  Sum_probs=198.0

Q ss_pred             eeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeec
Q 013897          140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV  213 (434)
Q Consensus       140 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  213 (434)
                      +.||+|+||.||++.+..+++.||+|+++..      ....+.+|+.+++.+ +||||+++++++.+.  ..+++||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~--~~~~lv~Ey~   77 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT-RHPFLTSLKYSFQTK--DRLCFVMEYV   77 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEcC--CEEEEEEeCC
Confidence            4699999999999999999999999998642      234577899999998 999999999998654  5678999999


Q ss_pred             CCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC-CCccceec
Q 013897          214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVRV  289 (434)
Q Consensus       214 ~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~-~~~~~~~~  289 (434)
                      .+++|...+   ..+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.... .......+
T Consensus        78 ~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~-~~kL~DfG~~~~~~~~~~~~~~~~  156 (328)
T cd05593          78 NGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDG-HIKITDFGLCKEGITDAATMKTFC  156 (328)
T ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCC-cEEEecCcCCccCCCccccccccc
Confidence            999986554   3588999999999999999999999999999999999999776 899999999875422 22234457


Q ss_pred             cCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHH
Q 013897          290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAAL  369 (434)
Q Consensus       290 ~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~  369 (434)
                      |++.|+|||++.+ ..++.++|||||||++|+|++|+.||... +.......+.   ..                     
T Consensus       157 gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~Pf~~~-~~~~~~~~~~---~~---------------------  210 (328)
T cd05593         157 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-DHEKLFELIL---ME---------------------  210 (328)
T ss_pred             CCcCccChhhhcC-CCCCccCCccccchHHHHHhhCCCCCCCC-CHHHHHHHhc---cC---------------------
Confidence            8999999999876 67899999999999999999999998432 2111111110   00                     


Q ss_pred             hcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCc-----cHHHHhcCCCcccccc
Q 013897          370 VGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-----TAKEAMAHPYFFPIRN  426 (434)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rp-----t~~elL~Hp~~~~~~~  426 (434)
                                   ....+..+++++.+||.+||+.||++|+     ++.|+++||||.+++.
T Consensus       211 -------------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~  259 (328)
T cd05593         211 -------------DIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNW  259 (328)
T ss_pred             -------------CccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence                         0011123678899999999999999997     8999999999988654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-45  Score=352.82  Aligned_cols=241  Identities=24%  Similarity=0.391  Sum_probs=196.4

Q ss_pred             eeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeecCC
Q 013897          142 VGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN  215 (434)
Q Consensus       142 lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~  215 (434)
                      ||+|+||.||+|.+..+++.||+|+++..      ....+.+|+.+++++ +||||+++++++.+.  ...++||||+.+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv~e~~~~   77 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-NCPFIVPLKFSFQSP--EKLYLVLAFING   77 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCcEeceeeEEecC--CeEEEEEcCCCC
Confidence            79999999999999989999999998642      234567899999999 999999999998654  577899999999


Q ss_pred             Cchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC-CccceeccC
Q 013897          216 TDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYNVRVAS  291 (434)
Q Consensus       216 ~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~-~~~~~~~~t  291 (434)
                      ++|..++   ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..... ......+|+
T Consensus        78 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt  156 (312)
T cd05585          78 GELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQG-HIALCDFGLCKLNMKDDDKTNTFCGT  156 (312)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCC-cEEEEECcccccCccCCCccccccCC
Confidence            9987665   3588999999999999999999999999999999999999776 8999999999754322 233456799


Q ss_pred             CcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHhc
Q 013897          292 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVG  371 (434)
Q Consensus       292 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~  371 (434)
                      +.|+|||++.+ ..++.++|||||||++|+|++|+.||... +..+....+..                           
T Consensus       157 ~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~-~~~~~~~~~~~---------------------------  207 (312)
T cd05585         157 PEYLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYDE-NVNEMYRKILQ---------------------------  207 (312)
T ss_pred             cccCCHHHHcC-CCCCCccceechhHHHHHHHhCCCCcCCC-CHHHHHHHHHc---------------------------
Confidence            99999999887 68999999999999999999999998432 21111111100                           


Q ss_pred             ccCCCCCccccccccccCCchHHHHHHHHccccCCCCCc---cHHHHhcCCCccccc
Q 013897          372 RHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP---TAKEAMAHPYFFPIR  425 (434)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rp---t~~elL~Hp~~~~~~  425 (434)
                      .          ....+..+++++.+||.+||..||++||   ++.|+|+||||.+.+
T Consensus       208 ~----------~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~  254 (312)
T cd05585         208 E----------PLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS  254 (312)
T ss_pred             C----------CCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCC
Confidence            0          0011123678899999999999999997   589999999999864

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.1e-45  Score=356.88  Aligned_cols=284  Identities=31%  Similarity=0.562  Sum_probs=214.0

Q ss_pred             CCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccC----
Q 013897          132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ----  202 (434)
Q Consensus       132 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----  202 (434)
                      ..++|.+++.||+|+||.||+|.+..+++.||||++...     ....+.+|+.+++.+ +||||+++++++....    
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHM-KHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhc-CCCchhhhhhhhcccccccc
Confidence            357899999999999999999999889999999998643     234567899999999 9999999999875332    


Q ss_pred             CCccEEEEeecCCCchhhhc--CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecC
Q 013897          203 SKTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH  280 (434)
Q Consensus       203 ~~~~~lv~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~  280 (434)
                      ....+++++++ ++++..+.  ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~~~~  169 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDC-ELRILDFGLARQAD  169 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCC-CEEEcCCccceecC
Confidence            23467899987 45665554  3589999999999999999999999999999999999999776 89999999998654


Q ss_pred             CCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccc
Q 013897          281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI  360 (434)
Q Consensus       281 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  360 (434)
                      .  .....+++..|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+.+..+........ ....
T Consensus       170 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  245 (343)
T cd07878         170 D--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALF-PGNDYIDQLKRIMEVVGTPSPEVLK-KISS  245 (343)
T ss_pred             C--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHH-hcch
Confidence            3  3345678999999999877567899999999999999999999887 4555556666666666554322211 1100


Q ss_pred             cCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccccc
Q 013897          361 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA  427 (434)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~  427 (434)
                         .............+....  .......++.+.+||.+||+.||++|||+.|+|+||||.+....
T Consensus       246 ---~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~  307 (343)
T cd07878         246 ---EHARKYIQSLPHMPQQDL--KKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDP  307 (343)
T ss_pred             ---hhHHHHhhccccccchhH--HHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCC
Confidence               001111111000000000  00011245778999999999999999999999999999976543

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=3e-46  Score=336.19  Aligned_cols=260  Identities=25%  Similarity=0.441  Sum_probs=211.1

Q ss_pred             CCCCeEEE-eeeeecCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeEeeEEEcc--CCCccEE
Q 013897          132 EQDDYEVV-RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ--QSKTPSL  208 (434)
Q Consensus       132 ~~~~y~~~-~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~~~~~l  208 (434)
                      .+++|.+- .+||-|-.|+|..+.++.+++++|+|++...  ....+|++..-....|||||.++++|.+.  +..++.+
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLi  136 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLI  136 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEe
Confidence            35778774 6799999999999999999999999998643  45678888877777999999999998743  3467889


Q ss_pred             EEeecCCCchhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC--CCeEEEEecccceecCC
Q 013897          209 IFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--QRKLRLIDWGLAEFYHP  281 (434)
Q Consensus       209 v~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~--~~~vkl~DFGla~~~~~  281 (434)
                      |||.|+||.|...+     ..+++.++..|++||..|+.|||+.+|.||||||+|+|....  +..+||+|||+|+....
T Consensus       137 VmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~  216 (400)
T KOG0604|consen  137 VMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE  216 (400)
T ss_pred             eeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCC
Confidence            99999999986554     248999999999999999999999999999999999999633  33699999999998776


Q ss_pred             CCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcccc
Q 013897          282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE  361 (434)
Q Consensus       282 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  361 (434)
                      .....+.+-|++|.|||++-. ..|+..+|+||+||++|.|++|.+||+......                         
T Consensus       217 ~~~L~TPc~TPyYvaPevlg~-eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a-------------------------  270 (400)
T KOG0604|consen  217 PGDLMTPCFTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-------------------------  270 (400)
T ss_pred             CccccCCcccccccCHHHhCc-hhcCCCCCccchhHHHHHhhcCCCcccccCCcc-------------------------
Confidence            677788899999999999754 789999999999999999999999997654421                         


Q ss_pred             CChhHHHHhcccCCCCCccc-cccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccc
Q 013897          362 LDPHLAALVGRHSRKPWSKF-ITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                      +.|+....+..      .++ +..++...+|++++|+|+++|..+|.+|.|++|+++|||+.+-.
T Consensus       271 ispgMk~rI~~------gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~  329 (400)
T KOG0604|consen  271 ISPGMKRRIRT------GQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE  329 (400)
T ss_pred             CChhHHhHhhc------cCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence            11111110000      000 11122335788999999999999999999999999999998654

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=5e-45  Score=359.93  Aligned_cols=255  Identities=26%  Similarity=0.436  Sum_probs=203.3

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      ++|++++.||+|+||.||++.+..+++.||+|+++..      ....+.+|+.++..+ +||||+++++.+.+.  ..++
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~--~~~~   77 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA-DGAWVVKMFYSFQDK--RNLY   77 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEcC--CEEE
Confidence            4789999999999999999999999999999998642      234577899999998 999999999998654  5778


Q ss_pred             EEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC-
Q 013897          208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-  283 (434)
Q Consensus       208 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~-  283 (434)
                      +||||+.+++|..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||++....... 
T Consensus        78 lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~-~vkL~DfG~~~~~~~~~~  156 (360)
T cd05627          78 LIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKG-HVKLSDFGLCTGLKKAHR  156 (360)
T ss_pred             EEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC-CEEEeeccCCcccccccc
Confidence            999999999987765   3588999999999999999999999999999999999999776 89999999986542211 


Q ss_pred             -----------------------------------ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCC
Q 013897          284 -----------------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEP  328 (434)
Q Consensus       284 -----------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~p  328 (434)
                                                         .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyel~tG~~P  235 (360)
T cd05627         157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPP  235 (360)
T ss_pred             cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-CCCCCcceeccccceeeecccCCCC
Confidence                                               0123478999999999887 6899999999999999999999999


Q ss_pred             CCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCC
Q 013897          329 FFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQE  408 (434)
Q Consensus       329 f~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~  408 (434)
                      |.. .+.......+...                                 ...........+++++.+||.+|+. ||.+
T Consensus       236 f~~-~~~~~~~~~i~~~---------------------------------~~~~~~p~~~~~s~~~~~li~~l~~-~p~~  280 (360)
T cd05627         236 FCS-ETPQETYRKVMNW---------------------------------KETLVFPPEVPISEKAKDLILRFCT-DSEN  280 (360)
T ss_pred             CCC-CCHHHHHHHHHcC---------------------------------CCceecCCCCCCCHHHHHHHHHhcc-Chhh
Confidence            843 2222222222110                                 0000011112357889999999874 9999


Q ss_pred             Cc---cHHHHhcCCCcccccccc
Q 013897          409 RP---TAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       409 Rp---t~~elL~Hp~~~~~~~~~  428 (434)
                      |+   +++|+++||||+++++..
T Consensus       281 R~~~~~~~ei~~hp~f~~~~~~~  303 (360)
T cd05627         281 RIGSNGVEEIKSHPFFEGVDWGH  303 (360)
T ss_pred             cCCCCCHHHHhcCCCCCCCCHHH
Confidence            98   489999999999987544

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.3e-44  Score=351.78  Aligned_cols=250  Identities=23%  Similarity=0.404  Sum_probs=200.2

Q ss_pred             eEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHh--cCCCCeeeEeeEEEccCCCccE
Q 013897          136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNL--CGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       136 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~E~~~l~~l--~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      |++++.||+|+||.||+|.+..+++.||||+++...      .+.+.+|+.++..+  .+||||+++++++.+.  ...+
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~--~~~~   78 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTE--DHVC   78 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC--CEEE
Confidence            678999999999999999999999999999996431      24566776665433  2799999999999654  5778


Q ss_pred             EEEeecCCCchhhhcC--CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC-CCc
Q 013897          208 LIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKE  284 (434)
Q Consensus       208 lv~e~~~~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~-~~~  284 (434)
                      +||||+.+++|...+.  .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.... ...
T Consensus        79 lv~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~-~~kL~Dfg~~~~~~~~~~~  157 (324)
T cd05589          79 FVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEG-FVKIADFGLCKEGMGFGDR  157 (324)
T ss_pred             EEEcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC-cEEeCcccCCccCCCCCCc
Confidence            9999999999876653  589999999999999999999999999999999999999777 899999999875322 222


Q ss_pred             cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCCh
Q 013897          285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP  364 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  364 (434)
                      ....+|+..|+|||.+.+ ..++.++|||||||++|||++|+.||. +.+..+....+..                    
T Consensus       158 ~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~G~~pf~-~~~~~~~~~~i~~--------------------  215 (324)
T cd05589         158 TSTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFP-GDDEEEVFDSIVN--------------------  215 (324)
T ss_pred             ccccccCccccCHhHhcC-CCCCcccchhhHHHHHHHHHhCCCCCC-CCCHHHHHHHHHh--------------------
Confidence            345678999999999877 678999999999999999999999983 2222222221110                    


Q ss_pred             hHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCc-----cHHHHhcCCCccccccc
Q 013897          365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-----TAKEAMAHPYFFPIRNA  427 (434)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rp-----t~~elL~Hp~~~~~~~~  427 (434)
                             ..          ...+..+++++.+||.+||+.||++||     ++.++++||||+++...
T Consensus       216 -------~~----------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~  266 (324)
T cd05589         216 -------DE----------VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWD  266 (324)
T ss_pred             -------CC----------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHH
Confidence                   00          001123678899999999999999999     79999999999987543

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=8.4e-45  Score=352.69  Aligned_cols=246  Identities=24%  Similarity=0.358  Sum_probs=199.4

Q ss_pred             eeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeec
Q 013897          140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV  213 (434)
Q Consensus       140 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  213 (434)
                      +.||+|+||.||+|.+..+++.||+|+++..      ....+..|..++..+.+||||+++++++.+.  ...++||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~--~~~~lv~E~~   78 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTK--DRLFFVMEYV   78 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC--CeEEEEEeCC
Confidence            3699999999999999889999999998643      2244677888888877899999999999654  5678999999


Q ss_pred             CCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC-CCccceec
Q 013897          214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVRV  289 (434)
Q Consensus       214 ~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~-~~~~~~~~  289 (434)
                      .+++|...+   ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..... .......+
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~  157 (321)
T cd05591          79 NGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEG-HCKLADFGMCKEGILNGVTTTTFC  157 (321)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEEEeecccceecccCCccccccc
Confidence            999986554   3588899999999999999999999999999999999999776 899999999975432 22334557


Q ss_pred             cCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHH
Q 013897          290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAAL  369 (434)
Q Consensus       290 ~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~  369 (434)
                      |+..|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+.+..+..   .                     
T Consensus       158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~-~~~~~~~~~~i~~---~---------------------  211 (321)
T cd05591         158 GTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPFE-ADNEDDLFESILH---D---------------------  211 (321)
T ss_pred             cCccccCHHHHcC-CCCCCccceechhHHHHHHhcCCCCCC-CCCHHHHHHHHHc---C---------------------
Confidence            8999999999876 679999999999999999999999984 3232222222111   0                     


Q ss_pred             hcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCc-------cHHHHhcCCCccccccc
Q 013897          370 VGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-------TAKEAMAHPYFFPIRNA  427 (434)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rp-------t~~elL~Hp~~~~~~~~  427 (434)
                                   ....+..+++++.+||.+||+.||++|+       ++.++++||||..+++.
T Consensus       212 -------------~~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~  263 (321)
T cd05591         212 -------------DVLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWV  263 (321)
T ss_pred             -------------CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHH
Confidence                         0001123567899999999999999999       99999999999887644

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-45  Score=326.97  Aligned_cols=259  Identities=21%  Similarity=0.373  Sum_probs=213.9

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      .++.+.+..||.|+.|.||+++.+.+|...|||.+...    ..+++.+.+.++....+.|+||+.+|+|.-.  ..+.+
T Consensus        91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n--~dV~I  168 (391)
T KOG0983|consen   91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN--TDVFI  168 (391)
T ss_pred             hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC--chHHH
Confidence            35667788999999999999999999999999999643    3456778888877765689999999999754  34457


Q ss_pred             EEeecC---CCchhhhcCCCChHHHHHHHHHHHHHHHHHHHC-CceeecCCCCceEecCCCCeEEEEecccceecCCCCc
Q 013897          209 IFEHVN---NTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE  284 (434)
Q Consensus       209 v~e~~~---~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~  284 (434)
                      .||.|.   ...|....+++++..+-.+...+++||.||.++ +|+|||+||+|||+|..| .+||||||++..+.+...
T Consensus       169 cMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~G-niKlCDFGIsGrlvdSkA  247 (391)
T KOG0983|consen  169 CMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-NIKLCDFGISGRLVDSKA  247 (391)
T ss_pred             HHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCC-CEEeecccccceeecccc
Confidence            777654   344555567899999999999999999999875 899999999999999777 899999999998888888


Q ss_pred             cceeccCCcccccccccC--CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          285 YNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~--~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                      .+...|.+.|||||.+..  ...|+.++||||||+.++||.||+.||.....+.+.+.++.....               
T Consensus       248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP---------------  312 (391)
T KOG0983|consen  248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP---------------  312 (391)
T ss_pred             cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC---------------
Confidence            888899999999999854  246999999999999999999999999777777777776643111               


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccccc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~  428 (434)
                       |.                  +.....+++++.+|+..||+.|+.+||...++|+|||+...+.++
T Consensus       313 -P~------------------L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a~  359 (391)
T KOG0983|consen  313 -PL------------------LPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETAE  359 (391)
T ss_pred             -CC------------------CCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecchhh
Confidence             00                  111122688999999999999999999999999999999776554

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.2e-44  Score=352.80  Aligned_cols=254  Identities=24%  Similarity=0.420  Sum_probs=199.0

Q ss_pred             eeeeecCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeec
Q 013897          140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV  213 (434)
Q Consensus       140 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  213 (434)
                      +.||+|+||.||+|.+..+++.||+|+++...      ...+.+|..++..+.+||||+++++++.+.  ..+++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~--~~~~lv~e~~   78 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTE--SRLFFVIEFV   78 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcC--CEEEEEEeCC
Confidence            46999999999999999999999999997421      244778999999987899999999999654  5678999999


Q ss_pred             CCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceec-CCCCccceec
Q 013897          214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY-HPGKEYNVRV  289 (434)
Q Consensus       214 ~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~-~~~~~~~~~~  289 (434)
                      ++++|..++   ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.. .........+
T Consensus        79 ~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~  157 (329)
T cd05588          79 SGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEG-HIKLTDYGMCKEGIRPGDTTSTFC  157 (329)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC-CEEECcCccccccccCCCcccccc
Confidence            999986654   4689999999999999999999999999999999999999776 8999999999753 2233344568


Q ss_pred             cCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHH
Q 013897          290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAAL  369 (434)
Q Consensus       290 ~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~  369 (434)
                      |+..|+|||++.+ ..++.++|||||||++|+|++|+.||............         ...+.          ....
T Consensus       158 gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~---------~~~~~----------~~~~  217 (329)
T cd05588         158 GTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQN---------TEDYL----------FQVI  217 (329)
T ss_pred             CCccccCHHHHcC-CCCCCccceechHHHHHHHHHCCCCccccccccccccc---------chHHH----------HHHH
Confidence            9999999999887 68899999999999999999999998421100000000         00000          0000


Q ss_pred             hcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCcc------HHHHhcCCCcccccc
Q 013897          370 VGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT------AKEAMAHPYFFPIRN  426 (434)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt------~~elL~Hp~~~~~~~  426 (434)
                      ....          ...+..+++++.++|.+||+.||.+|++      ++++++||||..+++
T Consensus       218 ~~~~----------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~  270 (329)
T cd05588         218 LEKQ----------IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW  270 (329)
T ss_pred             HcCC----------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence            0000          0011236788999999999999999987      789999999997654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.5e-44  Score=352.44  Aligned_cols=280  Identities=21%  Similarity=0.340  Sum_probs=208.4

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      .++|++++.||+|+||.||++.+..++..+|+|++...    ....+.+|+++|+.+ +||||+++++++.+.  ...++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~l   80 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSD--GEISI   80 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEEC--CEEEE
Confidence            47899999999999999999999999999999998643    235688999999999 999999999998654  46789


Q ss_pred             EEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHC-CceeecCCCCceEecCCCCeEEEEecccceecCCCCc
Q 013897          209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE  284 (434)
Q Consensus       209 v~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~  284 (434)
                      ||||+.+++|..++   ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++ .+||+|||++...... .
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~-~  158 (331)
T cd06649          81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDS-M  158 (331)
T ss_pred             EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCC-cEEEccCccccccccc-c
Confidence            99999999998776   3478889999999999999999986 699999999999999776 8999999999765432 2


Q ss_pred             cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcc-----
Q 013897          285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH-----  359 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~-----  359 (434)
                      .....|+..|+|||++.+ ..++.++|||||||++|||++|+.||....  ...+..   .++............     
T Consensus       159 ~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~--~~~~~~---~~~~~~~~~~~~~~~~~~~~  232 (331)
T cd06649         159 ANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPPPD--AKELEA---IFGRPVVDGEEGEPHSISPR  232 (331)
T ss_pred             cccCCCCcCcCCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCC--HHHHHH---HhcccccccccCCccccCcc
Confidence            344578999999999887 679999999999999999999999984322  122221   122110000000000     


Q ss_pred             ------------ccCCh--hHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccc
Q 013897          360 ------------IELDP--HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       360 ------------~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                                  ....+  ....+.......    .........+++++.+||.+||+.||++|||+.|+|+||||+...
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  308 (331)
T cd06649         233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNE----PPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE  308 (331)
T ss_pred             cccccccccccccccccchhHHHHHHHHHhC----CCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence                        00000  000000000000    000001123678899999999999999999999999999999765


Q ss_pred             cc
Q 013897          426 NA  427 (434)
Q Consensus       426 ~~  427 (434)
                      ..
T Consensus       309 ~~  310 (331)
T cd06649         309 VE  310 (331)
T ss_pred             cc
Confidence            43

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.5e-44  Score=357.31  Aligned_cols=254  Identities=25%  Similarity=0.397  Sum_probs=202.7

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      .++|++.+.||+|+||.||++.+..+++.+|+|++...      ....+.+|+.+++.+ +||||+++++++.+.  ...
T Consensus        42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~~--~~~  118 (370)
T cd05621          42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFCAFQDD--KYL  118 (370)
T ss_pred             HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEcC--CEE
Confidence            47899999999999999999999999999999998632      224477899999998 999999999999653  578


Q ss_pred             EEEEeecCCCchhhhcC--CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc
Q 013897          207 SLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE  284 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~  284 (434)
                      ++||||+.+++|..++.  .+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+|........
T Consensus       119 ~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~-~~kL~DFG~a~~~~~~~~  197 (370)
T cd05621         119 YMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHG-HLKLADFGTCMKMDETGM  197 (370)
T ss_pred             EEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC-CEEEEecccceecccCCc
Confidence            89999999999977764  478888999999999999999999999999999999999776 899999999987643322


Q ss_pred             --cceeccCCcccccccccCC---CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcc
Q 013897          285 --YNVRVASRYFKGPELLVDL---QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH  359 (434)
Q Consensus       285 --~~~~~~t~~y~aPE~~~~~---~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  359 (434)
                        ....+||+.|+|||++.+.   ..++.++|||||||++|+|++|+.||.. .+.......+.....            
T Consensus       198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~-~~~~~~~~~i~~~~~------------  264 (370)
T cd05621         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA-DSLVGTYSKIMDHKN------------  264 (370)
T ss_pred             eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCc------------
Confidence              2356799999999998652   2378999999999999999999999843 222222222211000            


Q ss_pred             ccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCC--CccHHHHhcCCCcccc
Q 013897          360 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQE--RPTAKEAMAHPYFFPI  424 (434)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~--Rpt~~elL~Hp~~~~~  424 (434)
                                     .      ........+++.+.+++.+||+.++.+  |+++.|+++||||+..
T Consensus       265 ---------------~------~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         265 ---------------S------LNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             ---------------c------cCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence                           0      001112236788999999999866544  8999999999999874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-44  Score=341.50  Aligned_cols=255  Identities=25%  Similarity=0.374  Sum_probs=205.4

Q ss_pred             CeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      .|++.+.||+|+||+||++.+..+++.||+|++....      ...+.+|+.+++.+ +||||+++++.+...  ..+++
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~l   77 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYETK--DALCL   77 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhc-CCCCEeeeeeeecCC--CeEEE
Confidence            3789999999999999999998899999999986432      23467899999999 999999999998654  46889


Q ss_pred             EEeecCCCchhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC
Q 013897          209 IFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       209 v~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~  283 (434)
                      ||||+.+++|..++     ..+++..+..++.|++.||.|||+.+|+||||||+||+++.++ .++|+|||++.......
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          78 VLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYG-HIRISDLGLAVEIPEGE  156 (285)
T ss_pred             EEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCC-CEEEeeCCCceecCCCC
Confidence            99999999986553     2488899999999999999999999999999999999999666 89999999998765444


Q ss_pred             ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                      .....+|+..|+|||++.+ ..++.++|||||||++|||++|+.||.. .........+...+...              
T Consensus       157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Diws~G~~l~el~~g~~pf~~-~~~~~~~~~~~~~~~~~--------------  220 (285)
T cd05605         157 TIRGRVGTVGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQ-RKEKVKREEVERRVKED--------------  220 (285)
T ss_pred             ccccccCCCCccCcHHhcC-CCCCccccchhHHHHHHHHHHCCCCCCC-CchhhHHHHHHHHhhhc--------------
Confidence            4455678999999999876 6789999999999999999999999843 22222211111100000              


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCc-----cHHHHhcCCCcccccccc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-----TAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rp-----t~~elL~Hp~~~~~~~~~  428 (434)
                                .         ......+++.+.+|+.+||..||++||     +++++++||||...+...
T Consensus       221 ----------~---------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~  271 (285)
T cd05605         221 ----------Q---------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKR  271 (285)
T ss_pred             ----------c---------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHH
Confidence                      0         001123577899999999999999999     999999999999865443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.3e-45  Score=351.61  Aligned_cols=250  Identities=26%  Similarity=0.486  Sum_probs=196.0

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEec-----cccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~-----~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      ...|+++++||.||.++||++.. .+.+.||+|.+.     .....-+.+|+..|.+|.+|.+||+|++|-..  +.++|
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~--d~~lY  436 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT--DGYLY  436 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc--CceEE
Confidence            46799999999999999999986 566777777653     22345689999999999999999999998754  57889


Q ss_pred             EEEeecCCCchhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC
Q 013897          208 LIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       208 lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~  283 (434)
                      +||||-+. +|..++.    .++.+.++.|+.||+.|+.++|++||||.||||.|+|+. .| .+||+|||+|..+..+.
T Consensus       437 mvmE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG-~LKLIDFGIA~aI~~DT  513 (677)
T KOG0596|consen  437 MVMECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KG-RLKLIDFGIANAIQPDT  513 (677)
T ss_pred             EEeecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-ee-eEEeeeechhcccCccc
Confidence            99998665 4444442    255568999999999999999999999999999999998 45 79999999999887665


Q ss_pred             cc---ceeccCCcccccccccCCC----------CCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChh
Q 013897          284 EY---NVRVASRYFKGPELLVDLQ----------DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE  350 (434)
Q Consensus       284 ~~---~~~~~t~~y~aPE~~~~~~----------~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~  350 (434)
                      ..   ...+||..||+||.+....          ..+.++||||||||||+|+.|+.||.                   .
T Consensus       514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~-------------------~  574 (677)
T KOG0596|consen  514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFG-------------------Q  574 (677)
T ss_pred             cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchH-------------------H
Confidence            43   4569999999999985421          26789999999999999999999991                   1


Q ss_pred             HHHHHhhccccCChhHHHHhcccCCCCCccccccccccC-CchHHHHHHHHccccCCCCCccHHHHhcCCCccc
Q 013897          351 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHL-AVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP  423 (434)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~  423 (434)
                      ......++....+|+...                +.+.. -..++.++++.||.+||++||++.|||+|||++.
T Consensus       575 ~~n~~aKl~aI~~P~~~I----------------efp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~  632 (677)
T KOG0596|consen  575 IINQIAKLHAITDPNHEI----------------EFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI  632 (677)
T ss_pred             HHHHHHHHHhhcCCCccc----------------cccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence            122222333333332211                11111 1134999999999999999999999999999997

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=4e-45  Score=356.30  Aligned_cols=243  Identities=16%  Similarity=0.344  Sum_probs=195.4

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      .++..+...||+|.||+||+|.|   .-.||||+++..     ..+.|++|+.++++- +|.||+-++|+|..+.   +.
T Consensus       391 ~~ev~l~~rIGsGsFGtV~Rg~w---hGdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkT-RH~NIlLFMG~~~~p~---~A  463 (678)
T KOG0193|consen  391 PEEVLLGERIGSGSFGTVYRGRW---HGDVAVKLLNVDDPTPEQLQAFKNEVAVLKKT-RHENILLFMGACMNPP---LA  463 (678)
T ss_pred             HHHhhccceeccccccceeeccc---ccceEEEEEecCCCCHHHHHHHHHHHHHHhhc-chhhheeeehhhcCCc---ee
Confidence            35567889999999999999998   456999999743     457799999999998 9999999999997653   38


Q ss_pred             EEEeecCCCchhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEeccccee---cC
Q 013897          208 LIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF---YH  280 (434)
Q Consensus       208 lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~---~~  280 (434)
                      ||..+|+|.+|..++.    +|.....+.|++||++||.|||.++|||||||..||++.+++ +|||+||||+..   +.
T Consensus       464 IiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~-kVkIgDFGLatvk~~w~  542 (678)
T KOG0193|consen  464 IITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDL-KVKIGDFGLATVKTRWS  542 (678)
T ss_pred             eeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCC-cEEEecccceeeeeeec
Confidence            9999999999977763    478888999999999999999999999999999999999665 899999999842   34


Q ss_pred             CCCccceeccCCcccccccccC--CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHH-HHHHHhCChhHHHHHhh
Q 013897          281 PGKEYNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV-KIAKVLGTDELNAYLNK  357 (434)
Q Consensus       281 ~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~-~i~~~~g~~~~~~~~~~  357 (434)
                      .+.......|...|||||++..  ..+|++++|||||||++|||+||..||.  ..+.++.. .+.+..+.+        
T Consensus       543 g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys--i~~~dqIifmVGrG~l~p--------  612 (678)
T KOG0193|consen  543 GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS--IQNRDQIIFMVGRGYLMP--------  612 (678)
T ss_pred             cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC--CCChhheEEEecccccCc--------
Confidence            4455666778899999999854  3479999999999999999999999994  33333221 110000000        


Q ss_pred             ccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                              ........+++++++|+..||.+++++||...++|.
T Consensus       613 ------------------------d~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  613 ------------------------DLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             ------------------------cchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence                                    001122346779999999999999999999998886

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2e-44  Score=349.28  Aligned_cols=245  Identities=25%  Similarity=0.416  Sum_probs=196.9

Q ss_pred             eeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeec
Q 013897          140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV  213 (434)
Q Consensus       140 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  213 (434)
                      +.||+|+||.||+|.+..+++.||+|+++..      ..+.+..|..++..+.+||||+++++++...  ...++||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~--~~~~lv~e~~   78 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTK--EHLFFVMEYL   78 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcC--CEEEEEEcCC
Confidence            3699999999999999999999999998643      2234566777777666899999999998643  5788999999


Q ss_pred             CCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC-Cccceec
Q 013897          214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYNVRV  289 (434)
Q Consensus       214 ~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~-~~~~~~~  289 (434)
                      .+++|...+   ..+++..++.++.||+.||.|||+++|+||||||+|||++.++ .+||+|||+++..... ......+
T Consensus        79 ~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~-~~kL~Dfg~a~~~~~~~~~~~~~~  157 (316)
T cd05592          79 NGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDG-HIKIADFGMCKENMNGEGKASTFC  157 (316)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCC-CEEEccCcCCeECCCCCCcccccc
Confidence            999987654   3588999999999999999999999999999999999999776 8999999999764322 2334567


Q ss_pred             cCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHH
Q 013897          290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAAL  369 (434)
Q Consensus       290 ~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~  369 (434)
                      ||..|+|||++.+ ..++.++|||||||++|||++|+.||. +.+..+....+..   .                     
T Consensus       158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~Pf~-~~~~~~~~~~i~~---~---------------------  211 (316)
T cd05592         158 GTPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSPFH-GEDEDELFDSILN---D---------------------  211 (316)
T ss_pred             CCccccCHHHHcC-CCCCCcccchhHHHHHHHHHhCCCCCC-CCCHHHHHHHHHc---C---------------------
Confidence            8999999999877 678999999999999999999999984 2222222221110   0                     


Q ss_pred             hcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHH-HHhcCCCcccccc
Q 013897          370 VGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK-EAMAHPYFFPIRN  426 (434)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~-elL~Hp~~~~~~~  426 (434)
                           .        ...+..+++++.+||.+||..||++||++. ++++||||..++.
T Consensus       212 -----~--------~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~~  256 (316)
T cd05592         212 -----R--------PHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDW  256 (316)
T ss_pred             -----C--------CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCCH
Confidence                 0        001123567899999999999999999864 8889999998764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.9e-44  Score=343.62  Aligned_cols=274  Identities=30%  Similarity=0.542  Sum_probs=214.8

Q ss_pred             CeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      +|++.+.||+|+||.||+|.+..+|+.+|+|.++...     ...+.+|+.+++.+ +||||+++++++.+.  ...++|
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~--~~~~lv   77 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLYDVLHSD--KKLTLV   77 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhc-CCCCeeeHHHHhccC--CceEEE
Confidence            4789999999999999999999999999999986422     24577899999999 999999999998654  567899


Q ss_pred             EeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC-Ccc
Q 013897          210 FEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEY  285 (434)
Q Consensus       210 ~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~-~~~  285 (434)
                      +||+.++.+..+.   ..+++..++.++.||++||.|||+++|+||||||+||+++.++ .+||+|||++...... ...
T Consensus        78 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~  156 (284)
T cd07839          78 FEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNG-ELKLADFGLARAFGIPVRCY  156 (284)
T ss_pred             EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCC-cEEECccchhhccCCCCCCc
Confidence            9999875444332   3588999999999999999999999999999999999999776 8999999999765432 223


Q ss_pred             ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChh
Q 013897          286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH  365 (434)
Q Consensus       286 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~  365 (434)
                      ....++..|+|||.+.+...++.++|||||||++|+|++|+.|++.+.+..+.+..+.+.++......+...........
T Consensus       157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd07839         157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP  236 (284)
T ss_pred             CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence            34567889999999877556899999999999999999999999888887788888877777655444332111000000


Q ss_pred             HHHHhcccCCCCCccccc-cccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          366 LAALVGRHSRKPWSKFIT-VENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                               ...+..... ......+++++.+||.+||+.||.+|||++|+|+||||
T Consensus       237 ---------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         237 ---------YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             ---------cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence                     000000000 11123467899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=3.8e-44  Score=341.35  Aligned_cols=246  Identities=24%  Similarity=0.392  Sum_probs=196.5

Q ss_pred             eeecCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeecCC
Q 013897          142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN  215 (434)
Q Consensus       142 lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~  215 (434)
                      ||+|+||+||++.+..+++.||+|.+....      .+.+..|+.+++.+ +|+||+++.+++...  ...++||||+++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~--~~~~lv~e~~~~   77 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLAYAFQTK--TDLCLVMTIMNG   77 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhC-CCCcEeeeeEEEcCC--CeEEEEEeCCCC
Confidence            799999999999999999999999986422      24567899999999 999999999988643  567899999999


Q ss_pred             Cchhhhc-------CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc-cce
Q 013897          216 TDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-YNV  287 (434)
Q Consensus       216 ~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~-~~~  287 (434)
                      ++|...+       ..+++..+..++.||+.||+|||+++|+||||||+||+++.++ .+||+|||++........ ...
T Consensus        78 g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~  156 (280)
T cd05608          78 GDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDG-NVRISDLGLAVELKDGQSKTKG  156 (280)
T ss_pred             CCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEeeCccceecCCCCccccc
Confidence            9986543       2478899999999999999999999999999999999999766 899999999976644322 234


Q ss_pred             eccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHH
Q 013897          288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLA  367 (434)
Q Consensus       288 ~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~  367 (434)
                      ..|++.|+|||++.+ ..++.++|||||||++|+|++|+.||......... ..+....                     
T Consensus       157 ~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~-~~~~~~~---------------------  213 (280)
T cd05608         157 YAGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN-KELKQRI---------------------  213 (280)
T ss_pred             cCCCcCccCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH-HHHHHhh---------------------
Confidence            578899999999987 68899999999999999999999998433221111 1100000                     


Q ss_pred             HHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCc-----cHHHHhcCCCcccccc
Q 013897          368 ALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-----TAKEAMAHPYFFPIRN  426 (434)
Q Consensus       368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rp-----t~~elL~Hp~~~~~~~  426 (434)
                        .    ..      .......+++++.+|+.+||+.||++||     +++++++||||+.+..
T Consensus       214 --~----~~------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~  265 (280)
T cd05608         214 --L----ND------SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNW  265 (280)
T ss_pred             --c----cc------CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCH
Confidence              0    00      0011123678899999999999999999     8999999999998654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.7e-44  Score=348.34  Aligned_cols=246  Identities=23%  Similarity=0.393  Sum_probs=198.0

Q ss_pred             eeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeec
Q 013897          140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV  213 (434)
Q Consensus       140 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  213 (434)
                      +.||+|+||.||+|.++.+++.||+|+++..      ....+..|..++..+.+||||+++++++.+.  ..+++||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~lv~E~~   78 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTK--EHLFFVMEFL   78 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeC--CEEEEEECCC
Confidence            4699999999999999999999999998643      2345667888888766999999999999654  5788999999


Q ss_pred             CCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC-CCccceec
Q 013897          214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVRV  289 (434)
Q Consensus       214 ~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~-~~~~~~~~  289 (434)
                      .+++|...+   ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.... .......+
T Consensus        79 ~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~  157 (316)
T cd05620          79 NGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDG-HIKIADFGMCKENVFGDNRASTFC  157 (316)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC-CEEeCccCCCeecccCCCceeccC
Confidence            999987654   3588899999999999999999999999999999999999776 899999999875322 22334567


Q ss_pred             cCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHH
Q 013897          290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAAL  369 (434)
Q Consensus       290 ~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~  369 (434)
                      |+..|+|||++.+ ..++.++|||||||++|||++|+.||.. .+.......+..  +.                     
T Consensus       158 gt~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~Pf~~-~~~~~~~~~~~~--~~---------------------  212 (316)
T cd05620         158 GTPDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHG-DDEDELFESIRV--DT---------------------  212 (316)
T ss_pred             CCcCccCHHHHcC-CCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHh--CC---------------------
Confidence            8999999999887 6899999999999999999999999843 222211111100  00                     


Q ss_pred             hcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccH-HHHhcCCCccccccc
Q 013897          370 VGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA-KEAMAHPYFFPIRNA  427 (434)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~-~elL~Hp~~~~~~~~  427 (434)
                                    ...+..++.++.+||.+||+.||++|+++ +++++||||+.++..
T Consensus       213 --------------~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~~~  257 (316)
T cd05620         213 --------------PHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINWT  257 (316)
T ss_pred             --------------CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCCHH
Confidence                          00112357789999999999999999998 589999999987643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.2e-44  Score=353.65  Aligned_cols=279  Identities=21%  Similarity=0.347  Sum_probs=204.8

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEee
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH  212 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  212 (434)
                      ...|++++.||+|+||.||+|.+..++..||+|+...   .....|+.+++++ +||||+++++++.+.  ...++|+||
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~---~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv~e~  138 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK---GTTLIEAMLLQNV-NHPSVIRMKDTLVSG--AITCMVLPH  138 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc---cccHHHHHHHHhC-CCCCCcChhheEEeC--CeeEEEEEc
Confidence            4579999999999999999999988999999998643   2346799999999 999999999999754  456799999


Q ss_pred             cCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCccceec
Q 013897          213 VNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRV  289 (434)
Q Consensus       213 ~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~~~~~  289 (434)
                      +.+..+..+.   ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++............
T Consensus       139 ~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~~~~~~  217 (357)
T PHA03209        139 YSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVD-QVCIGDLGAAQFPVVAPAFLGLA  217 (357)
T ss_pred             cCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEEecCccccccccCccccccc
Confidence            9765444332   3588999999999999999999999999999999999999776 79999999997544333344567


Q ss_pred             cCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCH---------HHHHHHHHHhCChhHHHHHhhccc
Q 013897          290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNY---------DQLVKIAKVLGTDELNAYLNKYHI  360 (434)
Q Consensus       290 ~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~---------~~~~~i~~~~g~~~~~~~~~~~~~  360 (434)
                      ||..|+|||++.+ ..++.++|||||||++|||+++..|++......         .++..+...++.... .+...   
T Consensus       218 gt~~y~aPE~~~~-~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~-~~~~~---  292 (357)
T PHA03209        218 GTVETNAPEVLAR-DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPE-EFPRD---  292 (357)
T ss_pred             ccccccCCeecCC-CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChh-hcCCC---
Confidence            8999999999877 679999999999999999999777765543221         122223333222110 00000   


Q ss_pred             cCChhHHHHh--cccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccc
Q 013897          361 ELDPHLAALV--GRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI  424 (434)
Q Consensus       361 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~  424 (434)
                      ..........  ....+.++..+. ......++.++.+||.+||+.||++|||+.|+|+||||+++
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~  357 (357)
T PHA03209        293 PGSRLVRGFIEYASLERQPYTRYP-CFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL  357 (357)
T ss_pred             CccHHHHHHHhhcccCCCcccccH-HHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence            0000000000  111112221111 11222456788999999999999999999999999999874

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=7.4e-44  Score=342.76  Aligned_cols=281  Identities=28%  Similarity=0.549  Sum_probs=212.9

Q ss_pred             CCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       132 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      ..++|.+.+.||+|+||.||+|.+..+++.||+|.++...    ...+.+|+.+++.+ +||||+++++++.+.  ...+
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~--~~~~   80 (301)
T cd07873           4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIIHTE--KSLT   80 (301)
T ss_pred             cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhc-CCCCcceEEEEEecC--CeEE
Confidence            4578999999999999999999998899999999986332    34577899999999 999999999999654  5678


Q ss_pred             EEEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC-
Q 013897          208 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-  282 (434)
Q Consensus       208 lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~-  282 (434)
                      +||||+.+ ++...+    ..+++..++.++.||+.||+|||+++|+|+||||+|||++.++ .+||+|||++...... 
T Consensus        81 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~~~~~  158 (301)
T cd07873          81 LVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERG-ELKLADFGLARAKSIPT  158 (301)
T ss_pred             EEEecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCC-cEEECcCcchhccCCCC
Confidence            99999986 444332    3478889999999999999999999999999999999999776 8999999999754322 


Q ss_pred             CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                      .......++..|+|||.+.+...++.++|||||||++|+|++|+.|| .+.+..+++..+...++......|....... 
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  236 (301)
T cd07873         159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLF-PGSTVEEQLHFIFRILGTPTEETWPGILSNE-  236 (301)
T ss_pred             CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHcCCCChhhchhhhccc-
Confidence            22234467889999999876566889999999999999999999887 4445556666666666554333322110000 


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                        .+.    ......+...........+++.+.+||.+||+.||.+|||++|+|+||||+...
T Consensus       237 --~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~  293 (301)
T cd07873         237 --EFK----SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG  293 (301)
T ss_pred             --ccc----ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence              000    000000000000011224678899999999999999999999999999999775

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.1e-44  Score=352.39  Aligned_cols=245  Identities=27%  Similarity=0.423  Sum_probs=198.0

Q ss_pred             eeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeec
Q 013897          140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV  213 (434)
Q Consensus       140 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  213 (434)
                      +.||+|+||.||++.+..++..||+|+++..      ....+.+|+.+++.+ +||||+++++++.+.  ..+++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~-~hp~i~~~~~~~~~~--~~~~lv~E~~   77 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQTH--DRLCFVMEYA   77 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCCceEEEEEcC--CEEEEEEeCC
Confidence            4699999999999999999999999998643      224567899999998 999999999998654  5778999999


Q ss_pred             CCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHH-CCceeecCCCCceEecCCCCeEEEEecccceecCC-CCcccee
Q 013897          214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVR  288 (434)
Q Consensus       214 ~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~-~~~~~~~  288 (434)
                      .+++|...+   ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++.... .......
T Consensus        78 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~  156 (325)
T cd05594          78 NGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-HIKITDFGLCKEGIKDGATMKTF  156 (325)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCC-CEEEecCCCCeecCCCCcccccc
Confidence            999986654   358899999999999999999997 7999999999999999776 899999999875432 2233455


Q ss_pred             ccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHH
Q 013897          289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAA  368 (434)
Q Consensus       289 ~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~  368 (434)
                      +|+..|+|||++.+ ..++.++|||||||++|+|++|+.||... +.......+..                        
T Consensus       157 ~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tG~~Pf~~~-~~~~~~~~i~~------------------------  210 (325)
T cd05594         157 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-DHEKLFELILM------------------------  210 (325)
T ss_pred             cCCcccCCHHHHcc-CCCCCccccccccceeeeeccCCCCCCCC-CHHHHHHHHhc------------------------
Confidence            79999999999876 68999999999999999999999998432 21111111100                        


Q ss_pred             HhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCc-----cHHHHhcCCCccccccc
Q 013897          369 LVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-----TAKEAMAHPYFFPIRNA  427 (434)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rp-----t~~elL~Hp~~~~~~~~  427 (434)
                         .          ....+..+++++.+||.+||+.||++|+     ++.++|+||||.++...
T Consensus       211 ---~----------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~  261 (325)
T cd05594         211 ---E----------EIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQ  261 (325)
T ss_pred             ---C----------CCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHH
Confidence               0          0001123678899999999999999997     99999999999986533

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-45  Score=353.00  Aligned_cols=239  Identities=20%  Similarity=0.391  Sum_probs=200.3

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecc--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEe
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE  211 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~--~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  211 (434)
                      +.+.+++.||+|.||+||.|.+ .....||+|.++.  ...+.|.+|+.+|++| +|+|||+++++|..+  ..++||||
T Consensus       206 ~~l~l~~~LG~G~FG~V~~g~~-~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L-~H~~lV~l~gV~~~~--~piyIVtE  281 (468)
T KOG0197|consen  206 EELKLIRELGSGQFGEVWLGKW-NGSTKVAVKTIKEGSMSPEAFLREAQIMKKL-RHEKLVKLYGVCTKQ--EPIYIVTE  281 (468)
T ss_pred             HHHHHHHHhcCCccceEEEEEE-cCCCcccceEEeccccChhHHHHHHHHHHhC-cccCeEEEEEEEecC--CceEEEEE
Confidence            3455789999999999999998 3456999999986  3457899999999999 999999999999754  37899999


Q ss_pred             ecCCCchhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCccc
Q 013897          212 HVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN  286 (434)
Q Consensus       212 ~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~~  286 (434)
                      ||..|+|.++++     .+...+...++.||++||+||+++++|||||.+.||||+++. .+||+|||+|+ ...+..+.
T Consensus       282 ~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~-~vKIsDFGLAr-~~~d~~Y~  359 (468)
T KOG0197|consen  282 YMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDL-VVKISDFGLAR-LIGDDEYT  359 (468)
T ss_pred             ecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCc-eEEEccccccc-ccCCCcee
Confidence            999999988875     377888999999999999999999999999999999999776 99999999999 44455666


Q ss_pred             eeccCC---cccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          287 VRVASR---YFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       287 ~~~~t~---~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                      ...|..   .|+|||.+.. ..++.|||||||||+|+||+| |+.|| .+.++.+.+..+.+.                 
T Consensus       360 ~~~~~kfPIkWtAPEa~~~-~~FS~kSDVWSFGVlL~E~fT~G~~py-~~msn~ev~~~le~G-----------------  420 (468)
T KOG0197|consen  360 ASEGGKFPIKWTAPEALNY-GKFSSKSDVWSFGVLLWELFTYGRVPY-PGMSNEEVLELLERG-----------------  420 (468)
T ss_pred             ecCCCCCCceecCHHHHhh-CCcccccceeehhhhHHHHhccCCCCC-CCCCHHHHHHHHhcc-----------------
Confidence            665543   5999999876 789999999999999999999 66664 666666666554321                 


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHh
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAM  416 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL  416 (434)
                                         ..+..+..||+++.+++..||..+|++|||.+.+.
T Consensus       421 -------------------yRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  421 -------------------YRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLR  455 (468)
T ss_pred             -------------------CcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence                               12334456899999999999999999999998654

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=3.1e-44  Score=349.90  Aligned_cols=250  Identities=24%  Similarity=0.412  Sum_probs=198.0

Q ss_pred             eeeeecCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeec
Q 013897          140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV  213 (434)
Q Consensus       140 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  213 (434)
                      +.||+|+||.||+|.+..+++.||+|+++...      ...+.+|+.++..+.+||||+++++++.+.  ...++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~--~~~~lv~E~~   78 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--SRLFFVIEYV   78 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeC--CEEEEEEeCC
Confidence            46999999999999999999999999987431      244678888888887899999999998654  5678999999


Q ss_pred             CCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecC-CCCccceec
Q 013897          214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRV  289 (434)
Q Consensus       214 ~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~-~~~~~~~~~  289 (434)
                      .+++|...+   ..+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+++... ........+
T Consensus        79 ~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~-~~kL~DfG~~~~~~~~~~~~~~~~  157 (329)
T cd05618          79 NGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRPGDTTSTFC  157 (329)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC-CEEEeeCCccccccCCCCcccccc
Confidence            999986654   4589999999999999999999999999999999999999777 89999999997532 223334567


Q ss_pred             cCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCH----HHHHHHHHHhCChhHHHHHhhccccCChh
Q 013897          290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNY----DQLVKIAKVLGTDELNAYLNKYHIELDPH  365 (434)
Q Consensus       290 ~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~----~~~~~i~~~~g~~~~~~~~~~~~~~~~~~  365 (434)
                      |+..|+|||++.+ ..++.++|||||||++|+|++|+.||.......    .....+.+                     
T Consensus       158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~---------------------  215 (329)
T cd05618         158 GTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ---------------------  215 (329)
T ss_pred             CCccccCHHHHcC-CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHH---------------------
Confidence            8999999999887 688999999999999999999999984211100    00000000                     


Q ss_pred             HHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCcc------HHHHhcCCCcccccc
Q 013897          366 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT------AKEAMAHPYFFPIRN  426 (434)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt------~~elL~Hp~~~~~~~  426 (434)
                        ......          ...+..++..+.+||.+||+.||++||+      +.++++||||+++++
T Consensus       216 --~i~~~~----------~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~  270 (329)
T cd05618         216 --VILEKQ----------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW  270 (329)
T ss_pred             --HHhcCC----------CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence              000000          0112235678999999999999999998      589999999998754

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-45  Score=335.25  Aligned_cols=254  Identities=25%  Similarity=0.417  Sum_probs=214.0

Q ss_pred             CCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCc
Q 013897          132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT  205 (434)
Q Consensus       132 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  205 (434)
                      ..++|+.++.||+|.||+|-+++.+.+++.||+|++++.      .......|-.+|++. +||.+..+-..|  +....
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~-~HPFLt~LKYsF--Qt~dr  242 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNC-RHPFLTSLKYSF--QTQDR  242 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhc-cCcHHHHhhhhh--ccCce
Confidence            357899999999999999999999999999999999753      223456788999998 999999998888  45678


Q ss_pred             cEEEEeecCCCchhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceec-CC
Q 013897          206 PSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY-HP  281 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~-~~  281 (434)
                      +|+||||..||.|..++.   .+++...+.+..+|+.||.|||+++||+||||.+|+|+|.+| ++||+|||+++.. ..
T Consensus       243 lCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDG-HIKitDFGLCKE~I~~  321 (516)
T KOG0690|consen  243 LCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDG-HIKITDFGLCKEEIKY  321 (516)
T ss_pred             EEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCC-ceEeeecccchhcccc
Confidence            899999999999866654   489999999999999999999999999999999999999888 9999999999753 34


Q ss_pred             CCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcccc
Q 013897          282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE  361 (434)
Q Consensus       282 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  361 (434)
                      +....+.|||+.|+|||++.. ..|+..+|+|.+||++|||++|+.||+.... ...+..|..                 
T Consensus       322 g~t~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh-~kLFeLIl~-----------------  382 (516)
T KOG0690|consen  322 GDTTKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH-EKLFELILM-----------------  382 (516)
T ss_pred             cceeccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCcccccch-hHHHHHHHh-----------------
Confidence            556788999999999999987 7999999999999999999999999964332 222222110                 


Q ss_pred             CChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCcc-----HHHHhcCCCcccccccc
Q 013897          362 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT-----AKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt-----~~elL~Hp~~~~~~~~~  428 (434)
                                          ..+..+..++++++.||..+|..||.+|..     +.|+++|+||..+++..
T Consensus       383 --------------------ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~  434 (516)
T KOG0690|consen  383 --------------------EDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEA  434 (516)
T ss_pred             --------------------hhccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHH
Confidence                                011223347899999999999999999965     88999999999998754

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.9e-44  Score=347.25  Aligned_cols=246  Identities=24%  Similarity=0.382  Sum_probs=198.2

Q ss_pred             eeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeec
Q 013897          140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV  213 (434)
Q Consensus       140 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  213 (434)
                      +.||+|+||+||+|.+..+++.||+|+++..      ....+..|..++..+.+||||+++++++.+.  ..+++||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~--~~~~lv~ey~   78 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK--ENLFFVMEYL   78 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeC--CEEEEEEeCC
Confidence            4699999999999999999999999998643      2244667888887766999999999999654  5678999999


Q ss_pred             CCCchhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC-CCccceec
Q 013897          214 NNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVRV  289 (434)
Q Consensus       214 ~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~-~~~~~~~~  289 (434)
                      .+++|..++.   .+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.... .......+
T Consensus        79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~  157 (316)
T cd05619          79 NGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDG-HIKIADFGMCKENMLGDAKTCTFC  157 (316)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC-CEEEccCCcceECCCCCCceeeec
Confidence            9999977653   588899999999999999999999999999999999999776 899999999975422 22334567


Q ss_pred             cCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHH
Q 013897          290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAAL  369 (434)
Q Consensus       290 ~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~  369 (434)
                      |+..|+|||++.+ ..++.++|||||||++|||++|+.||.. .+..+.+..+..  +                      
T Consensus       158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~-~~~~~~~~~i~~--~----------------------  211 (316)
T cd05619         158 GTPDYIAPEILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFHG-HDEEELFQSIRM--D----------------------  211 (316)
T ss_pred             CCccccCHHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHh--C----------------------
Confidence            8999999999876 6799999999999999999999999843 222222111100  0                      


Q ss_pred             hcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHH-HHhcCCCccccccc
Q 013897          370 VGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK-EAMAHPYFFPIRNA  427 (434)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~-elL~Hp~~~~~~~~  427 (434)
                           .        ...+..++.++.+||.+||+.||++||++. ++++||||+.++..
T Consensus       212 -----~--------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~  257 (316)
T cd05619         212 -----N--------PCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDWS  257 (316)
T ss_pred             -----C--------CCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCHH
Confidence                 0        001113567899999999999999999996 99999999988654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=4.1e-44  Score=347.41  Aligned_cols=245  Identities=23%  Similarity=0.380  Sum_probs=199.1

Q ss_pred             eeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeec
Q 013897          140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV  213 (434)
Q Consensus       140 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  213 (434)
                      +.||+|+||+||+|.+..+++.||+|+++..      ....+.+|..+++.+.+||||+++++++.+.  ..+++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~--~~~~lv~e~~   78 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTK--DRLFFVMEYV   78 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC--CEEEEEEcCC
Confidence            4699999999999999989999999998743      2345678889998887899999999998654  5688999999


Q ss_pred             CCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC-CCccceec
Q 013897          214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVRV  289 (434)
Q Consensus       214 ~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~-~~~~~~~~  289 (434)
                      .+++|...+   ..+++..+..++.||+.||.|||+++|+||||||+|||++.++ .+||+|||+++.... .......+
T Consensus        79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~  157 (318)
T cd05570          79 NGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEG-HIKIADFGMCKEGILGGVTTSTFC  157 (318)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCC-cEEecccCCCeecCcCCCccccee
Confidence            999986654   3589999999999999999999999999999999999999776 899999999875322 22334457


Q ss_pred             cCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHH
Q 013897          290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAAL  369 (434)
Q Consensus       290 ~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~  369 (434)
                      |+..|+|||++.+ ..++.++|||||||++|+|++|+.||.. .+.......+..                         
T Consensus       158 g~~~y~aPE~~~~-~~~~~~~DiwslGvil~~l~~G~~pf~~-~~~~~~~~~i~~-------------------------  210 (318)
T cd05570         158 GTPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEG-DDEDELFQSILE-------------------------  210 (318)
T ss_pred             cCccccCHHHhcC-CCCCcchhhhhHHHHHHHHhhCCCCCCC-CCHHHHHHHHHc-------------------------
Confidence            8999999999887 6899999999999999999999999842 222111111100                         


Q ss_pred             hcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccH-----HHHhcCCCcccccc
Q 013897          370 VGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA-----KEAMAHPYFFPIRN  426 (434)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~-----~elL~Hp~~~~~~~  426 (434)
                        ..          ...+..+++++.+||.+||+.||++||++     .++++||||+.+++
T Consensus       211 --~~----------~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~  260 (318)
T cd05570         211 --DE----------VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDW  260 (318)
T ss_pred             --CC----------CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence              00          00112367889999999999999999999     99999999998764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.9e-44  Score=359.77  Aligned_cols=281  Identities=21%  Similarity=0.297  Sum_probs=204.8

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEee
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH  212 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  212 (434)
                      ...|.+.+.||+|+||.||+|.+..+++.||||...   ...+.+|+.+|+++ +|+|||++++++...  ...++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---~~~~~~E~~iL~~L-~HpnIv~l~~~~~~~--~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---YASSVHEARLLRRL-SHPAVLALLDVRVVG--GLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---ccCHHHHHHHHHHC-CCCCCCcEEEEEEEC--CEEEEEEEc
Confidence            457999999999999999999999999999999643   23467899999999 999999999998654  566799999


Q ss_pred             cCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc---cc
Q 013897          213 VNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YN  286 (434)
Q Consensus       213 ~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~---~~  286 (434)
                      +.+..+..+.   ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.......   ..
T Consensus       242 ~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~-~vkL~DFGla~~~~~~~~~~~~~  320 (461)
T PHA03211        242 YRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPE-DICLGDFGAACFARGSWSTPFHY  320 (461)
T ss_pred             cCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCC-CEEEcccCCceeccccccccccc
Confidence            9754444332   3588999999999999999999999999999999999999766 799999999986643322   12


Q ss_pred             eeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCC------HHHHHHHHHHhCChhHHHHHhhccc
Q 013897          287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN------YDQLVKIAKVLGTDELNAYLNKYHI  360 (434)
Q Consensus       287 ~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~------~~~~~~i~~~~g~~~~~~~~~~~~~  360 (434)
                      ..+||..|+|||++.+ ..++.++|||||||+||||++|..|++.....      ..++.++.+..+... ..+......
T Consensus       321 ~~~GT~~Y~APE~~~~-~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~-~~~~~~~~~  398 (461)
T PHA03211        321 GIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHV-DEFPQHAGS  398 (461)
T ss_pred             ccCCCcCCcCHHHHcC-CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccc-ccCCCCcch
Confidence            3468999999999987 67999999999999999999999887654322      234444443322110 000000000


Q ss_pred             cCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccc
Q 013897          361 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP  423 (434)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~  423 (434)
                      .+...+........ .+......+......++++.+||.+||+.||++|||+.|+|+||||+.
T Consensus       399 ~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        399 RLVSQYRHRAARNR-RPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             HHHHHHHhhhhccc-CCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence            00000110000000 111111112222235678999999999999999999999999999975

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.4e-45  Score=353.46  Aligned_cols=251  Identities=27%  Similarity=0.489  Sum_probs=215.0

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      .++|+.++.+|+|+||.++.++++.++..+|+|.+.-..     +....+|+.+++++ .|||||.+.+.|.+. +.+++
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~-~hP~iv~y~ds~~~~-~~~l~   80 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKL-LHPNIVEYKDSFEED-GQLLC   80 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhc-cCCCeeeeccchhcC-CceEE
Confidence            478999999999999999999999999999999986322     34678999999998 999999999999764 45589


Q ss_pred             EEEeecCCCchhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC
Q 013897          208 LIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG  282 (434)
Q Consensus       208 lv~e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~  282 (434)
                      |||+|++||++.+.+.     .+++..+..++.||+.|+.|||+++|+|||||+.||+++.++ .|||+|||+|+.+.+.
T Consensus        81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~-~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDK-KVKLGDFGLAKILNPE  159 (426)
T ss_pred             EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccC-ceeecchhhhhhcCCc
Confidence            9999999999987763     489999999999999999999999999999999999999888 7899999999998877


Q ss_pred             C-ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcccc
Q 013897          283 K-EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE  361 (434)
Q Consensus       283 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  361 (434)
                      . ...+.+||++|+.||++.+ .+|+.|+|||||||++|||++-+++| .+.+......+|.+....+            
T Consensus       160 ~~~a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF-~a~~m~~Li~ki~~~~~~P------------  225 (426)
T KOG0589|consen  160 DSLASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAF-KASNMSELILKINRGLYSP------------  225 (426)
T ss_pred             hhhhheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhccccc-CccchHHHHHHHhhccCCC------------
Confidence            6 5577899999999999998 89999999999999999999999887 4444444444444322111            


Q ss_pred             CChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccc
Q 013897          362 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI  424 (434)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~  424 (434)
                                              -+..++.++..+++.||+.+|+.||++.++|.+|.++..
T Consensus       226 ------------------------lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~  264 (426)
T KOG0589|consen  226 ------------------------LPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRY  264 (426)
T ss_pred             ------------------------CCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhH
Confidence                                    112356789999999999999999999999999988743

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-44  Score=348.89  Aligned_cols=257  Identities=26%  Similarity=0.400  Sum_probs=201.9

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      ++|++++.||+|+||.||++.+..+++.||+|++...      ..+.+.+|+.++..+ +|+||+++++++.+.  ..++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~--~~~~   77 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNG-DRRWITNLHYAFQDE--NNLY   77 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCceEEEEecC--CeEE
Confidence            4799999999999999999999999999999998642      234577899999998 999999999999654  5788


Q ss_pred             EEEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC
Q 013897          208 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       208 lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~  283 (434)
                      +||||+.+++|..++    ..+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+||+|||++.......
T Consensus        78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~  156 (331)
T cd05597          78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNG-HIRLADFGSCLRLLADG  156 (331)
T ss_pred             EEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCC-CEEEEECCceeecCCCC
Confidence            999999999987665    3588899999999999999999999999999999999999776 89999999997654333


Q ss_pred             c--cceeccCCcccccccccC----CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhh
Q 013897          284 E--YNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK  357 (434)
Q Consensus       284 ~--~~~~~~t~~y~aPE~~~~----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  357 (434)
                      .  ....+|++.|+|||++.+    ...++.++|||||||++|+|++|+.||.. ....+....+....           
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~-~~~~~~~~~i~~~~-----------  224 (331)
T cd05597         157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHK-----------  224 (331)
T ss_pred             CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC-CCHHHHHHHHHcCC-----------
Confidence            2  233578999999999863    24578899999999999999999999843 22222222211100           


Q ss_pred             ccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCC--CccHHHHhcCCCccccccc
Q 013897          358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQE--RPTAKEAMAHPYFFPIRNA  427 (434)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~--Rpt~~elL~Hp~~~~~~~~  427 (434)
                                      .....     ......+++++.+||++||..++++  |++++++|+||||.+++..
T Consensus       225 ----------------~~~~~-----~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~  275 (331)
T cd05597         225 ----------------EHFQF-----PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWD  275 (331)
T ss_pred             ----------------CcccC-----CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHH
Confidence                            00000     0011236788999999998765444  7899999999999887543

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-46  Score=361.72  Aligned_cols=255  Identities=25%  Similarity=0.438  Sum_probs=208.3

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccccH---HHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK---KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF  210 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  210 (434)
                      |.|+++..||.|+||+||+|..+.++-..|.|++.....   +.+.-||+||..+ .||+||+|++.|..  ...++|+.
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~C-dHP~ivkLl~ayy~--enkLwili  108 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAEC-DHPVIVKLLSAYYF--ENKLWILI  108 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcC-CChHHHHHHHHHhc--cCceEEEE
Confidence            445688999999999999999988888889999876544   4567899999998 89999999997643  35678999


Q ss_pred             eecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceec-CCCCcc
Q 013897          211 EHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY-HPGKEY  285 (434)
Q Consensus       211 e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~-~~~~~~  285 (434)
                      |||+||....++    ..+.+.+++.+++|++.||.|||+++|||||||+.|||+..+| .|+|+|||.+... ......
T Consensus       109 EFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldG-dirLADFGVSAKn~~t~qkR  187 (1187)
T KOG0579|consen  109 EFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDG-DIRLADFGVSAKNKSTRQKR  187 (1187)
T ss_pred             eecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecC-cEeeecccccccchhHHhhh
Confidence            999999765443    5689999999999999999999999999999999999999888 8999999987432 222344


Q ss_pred             ceeccCCcccccccccC----CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcccc
Q 013897          286 NVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE  361 (434)
Q Consensus       286 ~~~~~t~~y~aPE~~~~----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  361 (434)
                      ..++||+||||||++..    ..+|++++||||||+.|.||..+.+|- ...+....+.+|.+.-.+             
T Consensus       188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPH-helnpMRVllKiaKSePP-------------  253 (1187)
T KOG0579|consen  188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPH-HELNPMRVLLKIAKSEPP-------------  253 (1187)
T ss_pred             ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCc-cccchHHHHHHHhhcCCC-------------
Confidence            67899999999999864    257999999999999999999998774 444555555555432111             


Q ss_pred             CChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccccc
Q 013897          362 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA  427 (434)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~  427 (434)
                                           ++..+...+..+.|||.+||..||..||++.++|+||||+++.+.
T Consensus       254 ---------------------TLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~Sn  298 (1187)
T KOG0579|consen  254 ---------------------TLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSN  298 (1187)
T ss_pred             ---------------------cccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcc
Confidence                                 122233345689999999999999999999999999999988754

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=5.8e-44  Score=347.13  Aligned_cols=244  Identities=27%  Similarity=0.432  Sum_probs=195.8

Q ss_pred             eeeeecCceEEEEEEEc---CCCeEEEEEEecccc-------HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          140 RKVGRGKYSEVFEGVHC---TDNEKCIIKILKPVK-------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       140 ~~lG~G~fg~Vy~~~~~---~~~~~vaiK~~~~~~-------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      +.||+|+||.||++.+.   .+++.||+|+++...       ...+.+|+.+|+.+ +||||+++++++...  ...++|
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~~--~~~~lv   78 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV-KHPFIVDLIYAFQTG--GKLYLI   78 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhC-CCCchhceeeEEecC--CeEEEE
Confidence            67999999999999863   467899999986421       23467899999999 999999999999654  567899


Q ss_pred             EeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC-Ccc
Q 013897          210 FEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEY  285 (434)
Q Consensus       210 ~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~-~~~  285 (434)
                      |||+.+++|...+   ..+.+..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..... ...
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~  157 (323)
T cd05584          79 LEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQG-HVKLTDFGLCKESIHEGTVT  157 (323)
T ss_pred             EeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-CEEEeeCcCCeecccCCCcc
Confidence            9999999987665   3477888999999999999999999999999999999999776 8999999999754322 223


Q ss_pred             ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChh
Q 013897          286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH  365 (434)
Q Consensus       286 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~  365 (434)
                      ....|++.|+|||++.+ ..++.++|||||||++|||++|+.||.. .+.......+..                     
T Consensus       158 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~pf~~-~~~~~~~~~~~~---------------------  214 (323)
T cd05584         158 HTFCGTIEYMAPEILMR-SGHGKAVDWWSLGALMYDMLTGAPPFTA-ENRKKTIDKILK---------------------  214 (323)
T ss_pred             cccCCCccccChhhccC-CCCCCcceecccHHHHHHHhcCCCCCCC-CCHHHHHHHHHc---------------------
Confidence            44578999999999876 6789999999999999999999999842 222222211110                     


Q ss_pred             HHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCc-----cHHHHhcCCCcccccc
Q 013897          366 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-----TAKEAMAHPYFFPIRN  426 (434)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rp-----t~~elL~Hp~~~~~~~  426 (434)
                            .          ....+..+++++.+||.+||+.||++||     +++++++||||.....
T Consensus       215 ------~----------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~  264 (323)
T cd05584         215 ------G----------KLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNW  264 (323)
T ss_pred             ------C----------CCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCH
Confidence                  0          0011223578899999999999999999     8999999999987643

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-45  Score=305.61  Aligned_cols=278  Identities=31%  Similarity=0.567  Sum_probs=225.1

Q ss_pred             CeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      .|...++||+|.||+||+|+.+.+++.||+|.++-..     .....+|+-+|+.+ .|.|||+++++...  ...+.+|
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkel-khknivrl~dvlhs--dkkltlv   79 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHS--DKKLTLV   79 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHh-hhcceeehhhhhcc--CceeEEe
Confidence            4667789999999999999999999999999986433     25578999999999 99999999998844  3567799


Q ss_pred             EeecCCCc---hhhhcCCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC-Ccc
Q 013897          210 FEHVNNTD---FKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEY  285 (434)
Q Consensus       210 ~e~~~~~~---l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~-~~~  285 (434)
                      +|||....   +..+.+.+....++.++.|+++||.|+|++++.||||||.|+|++.++ .+||+|||+|+.+.-. ..+
T Consensus        80 fe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ng-elkladfglarafgipvrcy  158 (292)
T KOG0662|consen   80 FEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNG-ELKLADFGLARAFGIPVRCY  158 (292)
T ss_pred             HHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCC-cEEecccchhhhcCCceEee
Confidence            99998643   233345688899999999999999999999999999999999999877 8999999999876432 345


Q ss_pred             ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChh
Q 013897          286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH  365 (434)
Q Consensus       286 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~  365 (434)
                      ...+.|.+|++|.++.+.+-|+...|+||-|||+.|+.....|.|++.+..+|+.+|+..+|.+....|..-....-...
T Consensus       159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~  238 (292)
T KOG0662|consen  159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP  238 (292)
T ss_pred             eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcc
Confidence            66788999999999999888999999999999999999888899999999999999999999988777764322211100


Q ss_pred             HHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccc
Q 013897          366 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI  424 (434)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~  424 (434)
                      +..   -.....|.++     -..++...+|+++++|..+|.+|++++++|+||||..-
T Consensus       239 yp~---ypattswsqi-----vp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  239 YPI---YPATTSWSQI-----VPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             cCC---ccccchHHHH-----hhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence            000   0000111111     11244567899999999999999999999999999864

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.4e-45  Score=340.94  Aligned_cols=247  Identities=22%  Similarity=0.472  Sum_probs=210.8

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccccH------HHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK------KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      ..+|++.+.||+|.||+|-+|.....|+.||||.+++.+.      -.+.+||+||..| +||||+.+|++|+  +..-+
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsL-NHPhII~IyEVFE--NkdKI  128 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSL-NHPHIIQIYEVFE--NKDKI  128 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhc-CCCceeehhhhhc--CCceE
Confidence            4679999999999999999999989999999999975432      3478999999999 9999999999995  45678


Q ss_pred             EEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC
Q 013897          207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~  283 (434)
                      +|||||..+|.|.+++   +.+++.+++.+++||..|+.|+|.++++|||||.+|||+|.++ ++||+|||++..+..+.
T Consensus       129 vivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~-NiKIADFGLSNly~~~k  207 (668)
T KOG0611|consen  129 VIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNN-NIKIADFGLSNLYADKK  207 (668)
T ss_pred             EEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCC-Ceeeeccchhhhhcccc
Confidence            8999999999998886   4699999999999999999999999999999999999999777 89999999999999888


Q ss_pred             ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                      -..++||++.|.+||++.|...-++.+|.|||||+||-|+.|..|| .|.+.......|..                   
T Consensus       208 fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPF-DG~Dhk~lvrQIs~-------------------  267 (668)
T KOG0611|consen  208 FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPF-DGRDHKRLVRQISR-------------------  267 (668)
T ss_pred             HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhccccc-CCchHHHHHHHhhc-------------------
Confidence            8899999999999999988545578999999999999999999998 34433332222211                   


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFF  422 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~  422 (434)
                                  ..+.       ...-+.++.-||+.||.+||++|.|++++..|=|+.
T Consensus       268 ------------GaYr-------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  268 ------------GAYR-------EPETPSDASGLIRWMLMVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             ------------cccc-------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence                        0000       011234688999999999999999999999998875

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.8e-43  Score=343.65  Aligned_cols=250  Identities=22%  Similarity=0.333  Sum_probs=201.7

Q ss_pred             CeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      +|+..+.||+|+||.||+|.++.+++.||+|+++..      ..+.+..|..+++.+.+|++|+++++++.+.  ..+++
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~l   78 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTV--DRLYF   78 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecC--CEEEE
Confidence            467889999999999999999999999999998642      1244677888888886778899999988654  56789


Q ss_pred             EEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC-Cc
Q 013897          209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KE  284 (434)
Q Consensus       209 v~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~-~~  284 (434)
                      ||||+.+++|..++   ..+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..... ..
T Consensus        79 v~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~-~ikL~Dfg~~~~~~~~~~~  157 (323)
T cd05615          79 VMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEG-HIKIADFGMCKEHMVDGVT  157 (323)
T ss_pred             EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEEEeccccccccCCCCcc
Confidence            99999999987665   4589999999999999999999999999999999999999776 8999999998754322 22


Q ss_pred             cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCCh
Q 013897          285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP  364 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  364 (434)
                      ....+|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.. .........+...                   
T Consensus       158 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~-~~~~~~~~~i~~~-------------------  216 (323)
T cd05615         158 TRTFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFDG-EDEDELFQSIMEH-------------------  216 (323)
T ss_pred             ccCccCCccccCHHHHcC-CCCCCccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhC-------------------
Confidence            334568999999999876 6799999999999999999999999843 2222222221110                   


Q ss_pred             hHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCcc-----HHHHhcCCCcccccc
Q 013897          365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT-----AKEAMAHPYFFPIRN  426 (434)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt-----~~elL~Hp~~~~~~~  426 (434)
                                        ....+..+++++.+++.+||+.||.+|++     .+++++||||+.+++
T Consensus       217 ------------------~~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~  265 (323)
T cd05615         217 ------------------NVSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDW  265 (323)
T ss_pred             ------------------CCCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCH
Confidence                              00011235678999999999999999997     579999999998864

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.5e-43  Score=344.90  Aligned_cols=250  Identities=25%  Similarity=0.427  Sum_probs=199.4

Q ss_pred             eeeeecCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeec
Q 013897          140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV  213 (434)
Q Consensus       140 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  213 (434)
                      +.||+|+||+||+|.+..+++.||+|+++...      .+.+.+|+.++.++.+||||+++++++.+.  ..+++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~   78 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTT--SRLFLVIEYV   78 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeC--CEEEEEEeCC
Confidence            46999999999999999999999999997432      244778999999987899999999998654  5678999999


Q ss_pred             CCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecC-CCCccceec
Q 013897          214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRV  289 (434)
Q Consensus       214 ~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~-~~~~~~~~~  289 (434)
                      .+++|...+   ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++... ........+
T Consensus        79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~  157 (327)
T cd05617          79 NGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADG-HIKLTDYGMCKEGLGPGDTTSTFC  157 (327)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCC-CEEEeccccceeccCCCCceeccc
Confidence            999986654   4689999999999999999999999999999999999999777 89999999997532 233344567


Q ss_pred             cCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHH--HHHHHHHHhCChhHHHHHhhccccCChhHH
Q 013897          290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYD--QLVKIAKVLGTDELNAYLNKYHIELDPHLA  367 (434)
Q Consensus       290 ~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~--~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~  367 (434)
                      |++.|+|||++.+ ..++.++|||||||++|+|++|+.||.....+..  ....+.+.                      
T Consensus       158 gt~~y~aPE~~~~-~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~----------------------  214 (327)
T cd05617         158 GTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV----------------------  214 (327)
T ss_pred             CCcccCCHHHHCC-CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHH----------------------
Confidence            9999999999877 6899999999999999999999999943221110  00000000                      


Q ss_pred             HHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCcc------HHHHhcCCCcccccc
Q 013897          368 ALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT------AKEAMAHPYFFPIRN  426 (434)
Q Consensus       368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt------~~elL~Hp~~~~~~~  426 (434)
                       ....          ....+..++..+.++|.+||..||++|++      ++++++||||+.+++
T Consensus       215 -~~~~----------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~  268 (327)
T cd05617         215 -ILEK----------PIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDW  268 (327)
T ss_pred             -HHhC----------CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCH
Confidence             0000          00112236678999999999999999998      579999999998763

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.9e-43  Score=351.14  Aligned_cols=284  Identities=24%  Similarity=0.329  Sum_probs=209.2

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcC--CCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCT--DNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF  210 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  210 (434)
                      ..+|++++.||+|+||.||+|....  ++..||+|.+...  ....+|+.+|+.+ +||||+++++++...  ...++||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--~~~~~E~~il~~l-~h~~iv~~~~~~~~~--~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--KTPGREIDILKTI-SHRAIINLIHAYRWK--STVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--ccHHHHHHHHHhc-CCCCccceeeeEeeC--CEEEEEe
Confidence            3579999999999999999997643  4578999988643  3457899999999 999999999998653  5678999


Q ss_pred             eecCCCchhhh--cCCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc---c
Q 013897          211 EHVNNTDFKVL--YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---Y  285 (434)
Q Consensus       211 e~~~~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~---~  285 (434)
                      |++.+..+..+  ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .++|+|||++........   .
T Consensus       166 e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~-~~~l~DfG~a~~~~~~~~~~~~  244 (392)
T PHA03207        166 PKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPE-NAVLGDFGAACKLDAHPDTPQC  244 (392)
T ss_pred             hhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC-CEEEccCccccccCcccccccc
Confidence            99986544433  24589999999999999999999999999999999999999776 899999999976543322   2


Q ss_pred             ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--CCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH--DNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       286 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~--~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                      ...+||..|+|||++.+ ..++.++|||||||++|||++|+.||+...  ....++..+.+.++..... +.......+.
T Consensus       245 ~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~-~~~~~~~~~~  322 (392)
T PHA03207        245 YGWSGTLETNSPELLAL-DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLE-FPQNGSTNLC  322 (392)
T ss_pred             cccccccCccCHhHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccc-cCCccchhHH
Confidence            24578999999999876 679999999999999999999999996543  2345566666655533211 0000000000


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN  426 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~  426 (434)
                      ..+.... ...+.++. .........++.++.+||.+||+.||++|||+.|+|+||||++...
T Consensus       323 ~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~  383 (392)
T PHA03207        323 KHFKQYA-IVLRPPYT-IPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPI  383 (392)
T ss_pred             HHHHhhc-ccccCCcc-ccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccch
Confidence            0111110 00111111 0001111235678999999999999999999999999999987643

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=7.6e-44  Score=346.30  Aligned_cols=244  Identities=26%  Similarity=0.432  Sum_probs=193.7

Q ss_pred             eeeeecCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHH-HHHhcCCCCeeeEeeEEEccCCCccEEEEee
Q 013897          140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKI-LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH  212 (434)
Q Consensus       140 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~E~~~-l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  212 (434)
                      +.||+|+||+||+|.+..+++.||+|++....      ...+..|..+ ++.+ +||||+++++++.+.  ...++||||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l-~hp~iv~~~~~~~~~--~~~~lv~e~   77 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQTA--DKLYFVLDY   77 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhC-CCCCCCCeeEEEEeC--CEEEEEEcC
Confidence            46999999999999999999999999986421      2334555554 4556 999999999998654  567899999


Q ss_pred             cCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC-CCcccee
Q 013897          213 VNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVR  288 (434)
Q Consensus       213 ~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~-~~~~~~~  288 (434)
                      +.+++|...+   ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.... .......
T Consensus        78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~-~~kl~Dfg~~~~~~~~~~~~~~~  156 (323)
T cd05575          78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQG-HVVLTDFGLCKEGIEHSKTTSTF  156 (323)
T ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC-cEEEeccCCCcccccCCCccccc
Confidence            9999986654   3588899999999999999999999999999999999999776 899999999875422 2233455


Q ss_pred             ccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHH
Q 013897          289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAA  368 (434)
Q Consensus       289 ~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~  368 (434)
                      +|++.|+|||++.+ ..++.++|||||||++|||++|+.||... +..+....+..                        
T Consensus       157 ~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~-~~~~~~~~i~~------------------------  210 (323)
T cd05575         157 CGTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSR-DTAEMYDNILN------------------------  210 (323)
T ss_pred             cCChhhcChhhhcC-CCCCccccccccchhhhhhhcCCCCCCCC-CHHHHHHHHHc------------------------
Confidence            78999999999877 67999999999999999999999998432 22222111110                        


Q ss_pred             HhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccH----HHHhcCCCcccccc
Q 013897          369 LVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA----KEAMAHPYFFPIRN  426 (434)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~----~elL~Hp~~~~~~~  426 (434)
                         .          .......+++.+.+||.+||+.||++||++    .|+++||||..++.
T Consensus       211 ---~----------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~  259 (323)
T cd05575         211 ---K----------PLRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINW  259 (323)
T ss_pred             ---C----------CCCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence               0          000112357789999999999999999997    69999999987654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.3e-43  Score=335.35  Aligned_cols=248  Identities=23%  Similarity=0.349  Sum_probs=196.5

Q ss_pred             eeecCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeecCC
Q 013897          142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN  215 (434)
Q Consensus       142 lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~  215 (434)
                      ||+|+||.||++.++.+++.||+|.+....      ...+..|+++++.+ +||||+++++++.+.  ...++||||+.+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~i~~~~~~~~~~--~~~~lv~e~~~g   77 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV-NSPFIVNLAYAFESK--THLCLVMSLMNG   77 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhc-CCCcEEEEEEEEecC--CeEEEEEecCCC
Confidence            799999999999999999999999986321      23456799999999 999999999998653  567899999999


Q ss_pred             Cchhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCccceecc
Q 013897          216 TDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVA  290 (434)
Q Consensus       216 ~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~~~~~~  290 (434)
                      ++|..+.     ..+++..+..++.||+.||+|||+.||+||||||+||+++.++ .++|+|||++.............+
T Consensus        78 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~  156 (277)
T cd05607          78 GDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDGKTITQRAG  156 (277)
T ss_pred             CCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCC-CEEEeeceeeeecCCCceeeccCC
Confidence            9986554     2377888889999999999999999999999999999999766 899999999987655444455678


Q ss_pred             CCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHh
Q 013897          291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALV  370 (434)
Q Consensus       291 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~  370 (434)
                      +..|+|||++.+ ..++.++|||||||++|||++|+.||........ ...+....                       .
T Consensus       157 ~~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~-~~~~~~~~-----------------------~  211 (277)
T cd05607         157 TNGYMAPEILKE-EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA-KEELKRRT-----------------------L  211 (277)
T ss_pred             CCCccCHHHHcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh-HHHHHHHh-----------------------h
Confidence            899999999877 5699999999999999999999999843222111 11110000                       0


Q ss_pred             cccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccH----HHHhcCCCccccccc
Q 013897          371 GRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA----KEAMAHPYFFPIRNA  427 (434)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~----~elL~Hp~~~~~~~~  427 (434)
                      ...        ... ....+++++.+|+.+||+.||++||++    ++++.||||+.++..
T Consensus       212 ~~~--------~~~-~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~  263 (277)
T cd05607         212 EDE--------VKF-EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFP  263 (277)
T ss_pred             ccc--------ccc-ccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHH
Confidence            000        000 011357789999999999999999999    778899999988643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.6e-43  Score=350.28  Aligned_cols=255  Identities=25%  Similarity=0.397  Sum_probs=201.9

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      .++|++.+.||+|+||.||+|.++.+++.+|+|++...      ....+.+|+.+++.+ +||||+++++.+.+  ....
T Consensus        42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~--~~~~  118 (371)
T cd05622          42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQD--DRYL  118 (371)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEc--CCEE
Confidence            47899999999999999999999999999999998632      123467899999988 99999999999865  3578


Q ss_pred             EEEEeecCCCchhhhcC--CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC-
Q 013897          207 SLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-  283 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~-  283 (434)
                      ++||||+++++|..++.  .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++....... 
T Consensus       119 ~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~-~ikL~DfG~a~~~~~~~~  197 (371)
T cd05622         119 YMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG-HLKLADFGTCMKMNKEGM  197 (371)
T ss_pred             EEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCC-CEEEEeCCceeEcCcCCc
Confidence            89999999999977663  478888999999999999999999999999999999999776 89999999998764332 


Q ss_pred             -ccceeccCCcccccccccCCC---CCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcc
Q 013897          284 -EYNVRVASRYFKGPELLVDLQ---DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH  359 (434)
Q Consensus       284 -~~~~~~~t~~y~aPE~~~~~~---~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  359 (434)
                       .....+||+.|+|||++.+..   .++.++|||||||++|||++|+.||.. .+.......+....             
T Consensus       198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~-------------  263 (371)
T cd05622         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMNHK-------------  263 (371)
T ss_pred             ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC-CCHHHHHHHHHcCC-------------
Confidence             223567999999999986522   378999999999999999999999843 22222222221100             


Q ss_pred             ccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCC--CccHHHHhcCCCccccc
Q 013897          360 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQE--RPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~--Rpt~~elL~Hp~~~~~~  425 (434)
                                    .      .........+++.+.+||.+||..++.+  |++++|+++||||++..
T Consensus       264 --------------~------~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~  311 (371)
T cd05622         264 --------------N------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ  311 (371)
T ss_pred             --------------C------cccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence                          0      0011122246788999999999844433  78999999999998753

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.3e-43  Score=345.98  Aligned_cols=257  Identities=24%  Similarity=0.391  Sum_probs=202.0

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      ++|++.+.||+|+||.||++.++.+++.+|+|++...      ....+.+|+.++..+ +|+||+++++.+.+.  ..++
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~--~~~~   77 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DNQWITTLHYAFQDE--NNLY   77 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhC-CCCCEeeEEEEEecC--CEEE
Confidence            4789999999999999999999999999999998532      123477889999888 999999999999654  5678


Q ss_pred             EEEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC
Q 013897          208 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       208 lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~  283 (434)
                      +||||+.+++|..++    ..+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+||+|||++.......
T Consensus        78 lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~-~~kL~DfG~a~~~~~~~  156 (332)
T cd05623          78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG-HIRLADFGSCLKLMEDG  156 (332)
T ss_pred             EEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC-CEEEeecchheecccCC
Confidence            999999999987765    3478889999999999999999999999999999999999776 89999999997654332


Q ss_pred             c--cceeccCCcccccccccC----CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhh
Q 013897          284 E--YNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK  357 (434)
Q Consensus       284 ~--~~~~~~t~~y~aPE~~~~----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  357 (434)
                      .  ....+||+.|+|||++.+    ...++.++|||||||++|||++|+.||.. .+..+....+..   .         
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~---~---------  223 (332)
T cd05623         157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMN---H---------  223 (332)
T ss_pred             cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC-CCHHHHHHHHhC---C---------
Confidence            2  234579999999999862    24688999999999999999999999843 222222222110   0         


Q ss_pred             ccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCC--CccHHHHhcCCCccccccc
Q 013897          358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQE--RPTAKEAMAHPYFFPIRNA  427 (434)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~--Rpt~~elL~Hp~~~~~~~~  427 (434)
                                     ..+..+     ......+++++.+||++||..++++  |++++|+++||||++++..
T Consensus       224 ---------------~~~~~~-----p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~  275 (332)
T cd05623         224 ---------------KERFQF-----PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWD  275 (332)
T ss_pred             ---------------CccccC-----CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHH
Confidence                           000000     0011236789999999999765554  7899999999999987643

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.8e-43  Score=345.07  Aligned_cols=280  Identities=23%  Similarity=0.329  Sum_probs=205.7

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      .++|++.++||+|+||.||++.+..++..+|+|+++..    ....+.+|+++++.+ +||||+++++++.+.  ..+++
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~l   80 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSD--GEISI   80 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC-CCCcccceeEEEEEC--CEEEE
Confidence            47899999999999999999999989999999988643    235688999999999 899999999999764  56789


Q ss_pred             EEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHC-CceeecCCCCceEecCCCCeEEEEecccceecCCCCc
Q 013897          209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE  284 (434)
Q Consensus       209 v~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~  284 (434)
                      ||||+.+++|..++   ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++ .+||+|||++...... .
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~~~~~-~  158 (333)
T cd06650          81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDS-M  158 (333)
T ss_pred             EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCC-CEEEeeCCcchhhhhh-c
Confidence            99999999998765   3478888899999999999999985 799999999999999776 7999999999755322 2


Q ss_pred             cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH--HhCChhHHHHHhhccccC
Q 013897          285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK--VLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~--~~g~~~~~~~~~~~~~~~  362 (434)
                      .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.....  ..+..+..  ..+.......... ....
T Consensus       159 ~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~-~~~~  234 (333)
T cd06650         159 ANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIPPPDA--KELELMFGCPVEGDPAESETSPR-PRPP  234 (333)
T ss_pred             cccCCCCccccCHHHhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcch--hHHHHHhcCcccCCccccccCcc-cCCc
Confidence            344578899999999876 6789999999999999999999999854322  11111110  0000000000000 0000


Q ss_pred             ChhH-------------HHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccc
Q 013897          363 DPHL-------------AALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       363 ~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                      ....             ..+.........    .......+++++.+||.+||+.||++|||++|+|.||||+...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  306 (333)
T cd06650         235 GRPLSSYGPDSRPPMAIFELLDYIVNEPP----PKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE  306 (333)
T ss_pred             cchhhhhcccccccccHHHHHHHHhcCCC----ccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence            0000             000000000000    0000113567899999999999999999999999999998764

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=5e-43  Score=344.75  Aligned_cols=284  Identities=26%  Similarity=0.480  Sum_probs=216.0

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccC----C
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ----S  203 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----~  203 (434)
                      .++|++.+.||+|+||.||+|.+..+++.||+|.+...     ....+.+|+.+++.+ +||||+++++++....    .
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLV-NHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhc-CCCCCcceeeeeccCCCcccc
Confidence            57899999999999999999999999999999998532     234577899999998 9999999999886432    2


Q ss_pred             CccEEEEeecCCCchhhhcCCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC
Q 013897          204 KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~  283 (434)
                      ...++||||+.+.....+...++...+..++.|++.||+|||++||+||||||+||+++.++ .+||+|||++.......
T Consensus        94 ~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~~~  172 (353)
T cd07850          94 QDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSF  172 (353)
T ss_pred             CcEEEEEeccCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC-CEEEccCccceeCCCCC
Confidence            35789999998754444444588999999999999999999999999999999999999776 89999999998765443


Q ss_pred             ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                      ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.|| ...+....+..+...++.+.. .+......   
T Consensus       173 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---  246 (353)
T cd07850         173 MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLF-PGTDHIDQWNKIIEQLGTPSD-EFMSRLQP---  246 (353)
T ss_pred             CCCCCcccccccCHHHHhC-CCCCCchhhHhHHHHHHHHHHCCCCC-CCCCHHHHHHHHHHhcCCCCH-HHHHHhhh---
Confidence            3345568889999999877 68999999999999999999999987 455556677777777665432 11111110   


Q ss_pred             hhHHHHhcccCC---CCCcccc--------ccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccc
Q 013897          364 PHLAALVGRHSR---KPWSKFI--------TVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       364 ~~~~~~~~~~~~---~~~~~~~--------~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                       ...........   ..+....        ........++.+.+||.+||+.||++|||+.|+|+||||+.+-
T Consensus       247 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~  318 (353)
T cd07850         247 -TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWY  318 (353)
T ss_pred             -hhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhcc
Confidence             01111111000   0000000        0001223566789999999999999999999999999998543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=4.2e-43  Score=335.04  Aligned_cols=251  Identities=25%  Similarity=0.414  Sum_probs=203.5

Q ss_pred             eEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       136 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      |++.+.||+|+||.||++.+..+++.||+|.+....      ...+.+|+.+++.+ +|+|++.+++.+.+.  ...++|
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~--~~~~lv   78 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV-NSRFVVSLAYAYETK--DALCLV   78 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhC-CCCCeeeeeEEEecC--CEEEEE
Confidence            678899999999999999999999999999886422      23467899999999 999999999998654  578899


Q ss_pred             EeecCCCchhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc
Q 013897          210 FEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE  284 (434)
Q Consensus       210 ~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~  284 (434)
                      |||+.+++|..++     ..+++..+..++.|++.||.|||+++|+||||||+||+++.++ .++|+|||++........
T Consensus        79 ~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~-~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05630          79 LTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHG-HIRISDLGLAVHVPEGQT  157 (285)
T ss_pred             EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC-CEEEeeccceeecCCCcc
Confidence            9999999987654     2478889999999999999999999999999999999999766 799999999976654444


Q ss_pred             cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCH--HHHHHHHHHhCChhHHHHHhhccccC
Q 013897          285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNY--DQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~--~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                      .....|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.......  +....+.+..                
T Consensus       158 ~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~----------------  220 (285)
T cd05630         158 IKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV----------------  220 (285)
T ss_pred             ccCCCCCccccChHHHcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh----------------
Confidence            445578999999999876 679999999999999999999999995432211  1111100000                


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCcc-----HHHHhcCCCccccccc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT-----AKEAMAHPYFFPIRNA  427 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt-----~~elL~Hp~~~~~~~~  427 (434)
                                 .         ......+++++.+|+.+||+.||++|||     ++|+++||||+.++..
T Consensus       221 -----------~---------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~  270 (285)
T cd05630         221 -----------Q---------EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFK  270 (285)
T ss_pred             -----------h---------hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHH
Confidence                       0         0011235678999999999999999999     9999999999987544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=5.7e-43  Score=333.42  Aligned_cols=273  Identities=32%  Similarity=0.592  Sum_probs=205.4

Q ss_pred             CeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      +|++++.||+|++|.||+|.+..++..||+|.++..     ..+.+.+|+.+++.+ +||||+++++++.+.  ...++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~~v   77 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKEL-QHPNIVCLQDVLMQE--SRLYLI   77 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhc-CCCCEeeeEEEEeeC--CeEEEE
Confidence            488999999999999999999889999999998632     235678999999999 899999999999754  567899


Q ss_pred             EeecCCCchhhhc------CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC-
Q 013897          210 FEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-  282 (434)
Q Consensus       210 ~e~~~~~~l~~~~------~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~-  282 (434)
                      |||+.+ ++..+.      ..+++..++.++.||+.||.|||+++|+|+||||+|||++.++ .+||+|||++...... 
T Consensus        78 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~  155 (285)
T cd07861          78 FEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKG-VIKLADFGLARAFGIPV  155 (285)
T ss_pred             EecCCC-CHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCC-cEEECcccceeecCCCc
Confidence            999985 444332      3478899999999999999999999999999999999999776 8999999999755322 


Q ss_pred             CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                      .......++..|+|||++.+...++.++|||||||++|+|++|+.||. +....+....+.+.++......|.....   
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  231 (285)
T cd07861         156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFH-GDSEIDQLFRIFRILGTPTEDVWPGVTS---  231 (285)
T ss_pred             ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHHHhCCCChhhhhcchh---
Confidence            222334668889999998765568899999999999999999998874 4444444545544444332222211000   


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                      .+........     +...........+++++.+||.+||..||++|||+.+++.||||
T Consensus       232 ~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         232 LPDYKNTFPK-----WKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             hHHHHhhccc-----cCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence            0001100000     00000011122367899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-44  Score=335.25  Aligned_cols=284  Identities=25%  Similarity=0.475  Sum_probs=216.6

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc--HHHHHHHHHHHHHhcCC-C----CeeeEeeEEEccCCCc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGG-P----NIVKLLDIVRDQQSKT  205 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~E~~~l~~l~~h-~----niv~l~~~~~~~~~~~  205 (434)
                      .++|.++.++|+|.||.|-++.+..++..||||+++...  ++...-|+++|+++..+ |    -+|++.++|.  -..+
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd--yrgh  165 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD--YRGH  165 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh--ccCc
Confidence            578999999999999999999999999999999998765  35677899999999433 2    4678888884  3467


Q ss_pred             cEEEEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC-----------------
Q 013897          206 PSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-----------------  264 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~-----------------  264 (434)
                      +|||+|.++...+..+.    .+++...++.++.|++++++|||+.+++|-||||+|||+...                 
T Consensus       166 iCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~  245 (415)
T KOG0671|consen  166 ICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRP  245 (415)
T ss_pred             eEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceecc
Confidence            88999998866554443    358999999999999999999999999999999999998421                 


Q ss_pred             --CCeEEEEecccceecCCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHH
Q 013897          265 --QRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKI  342 (434)
Q Consensus       265 --~~~vkl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i  342 (434)
                        ...|+|+|||.|.....  .....+.|..|+|||++++ -+|+.++||||+||||+||.+|...| .+.++.++++.+
T Consensus       246 ~ks~~I~vIDFGsAtf~~e--~hs~iVsTRHYRAPEViLg-LGwS~pCDvWSiGCIL~ElytG~~LF-qtHen~EHLaMM  321 (415)
T KOG0671|consen  246 LKSTAIKVIDFGSATFDHE--HHSTIVSTRHYRAPEVILG-LGWSQPCDVWSIGCILVELYTGETLF-QTHENLEHLAMM  321 (415)
T ss_pred             CCCcceEEEecCCcceecc--CcceeeeccccCCchheec-cCcCCccCceeeeeEEEEeeccceec-ccCCcHHHHHHH
Confidence              12599999999986543  3367789999999999998 79999999999999999999999776 777899999999


Q ss_pred             HHHhCChhHHHHHhhc---------cccCChhHHHH---hcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCc
Q 013897          343 AKVLGTDELNAYLNKY---------HIELDPHLAAL---VGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP  410 (434)
Q Consensus       343 ~~~~g~~~~~~~~~~~---------~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rp  410 (434)
                      ..++|+.+. ..+.+.         .+..+.....-   .......+...+.  ........+++|||++||.+||.+|+
T Consensus       322 erIlGp~P~-~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~--~~~d~e~~~LfDLl~~mL~fDP~~Ri  398 (415)
T KOG0671|consen  322 ERILGPIPS-RMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYM--LQDDLEHVQLFDLLRRMLEFDPARRI  398 (415)
T ss_pred             HHhhCCCcH-HHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHh--ccCcHHHhHHHHHHHHHHccCccccc
Confidence            999995332 222221         11101000000   0000001111111  11112234699999999999999999


Q ss_pred             cHHHHhcCCCccccc
Q 013897          411 TAKEAMAHPYFFPIR  425 (434)
Q Consensus       411 t~~elL~Hp~~~~~~  425 (434)
                      |+.|+|.||||+...
T Consensus       399 Tl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  399 TLREALSHPFFARLT  413 (415)
T ss_pred             cHHHHhcCHHhhcCC
Confidence            999999999999764

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2.2e-42  Score=330.68  Aligned_cols=282  Identities=29%  Similarity=0.509  Sum_probs=209.2

Q ss_pred             CCCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       131 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      ++.++|.+++.||+|+||.||+|.+..++..||+|.+....    ...+.+|+.+++.+ +|+||+++++++.+.  ...
T Consensus         2 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~--~~~   78 (291)
T cd07870           2 GAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGL-KHANIVLLHDIIHTK--ETL   78 (291)
T ss_pred             CccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhc-CCCCEeEEEEEEecC--CeE
Confidence            45688999999999999999999998899999999986432    23577899999999 899999999998654  567


Q ss_pred             EEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC-
Q 013897          207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-  282 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~-  282 (434)
                      ++|+||+.++.+..+.   ..+++..++.++.|++.||.|||+++|+|+||||+|||++.++ .+||+|||+++..... 
T Consensus        79 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~~~~~~~  157 (291)
T cd07870          79 TFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLG-ELKLADFGLARAKSIPS  157 (291)
T ss_pred             EEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCC-cEEEeccccccccCCCC
Confidence            8999999765544433   2467888999999999999999999999999999999999776 8999999998754322 


Q ss_pred             CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                      .......++..|+|||.+.+...++.++|||||||++|+|++|+.||....+..+.+..+...++.+....+..-..  .
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~  235 (291)
T cd07870         158 QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK--L  235 (291)
T ss_pred             CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhh--c
Confidence            22334467889999999876456888999999999999999999998655555566666666555432222111000  0


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                      +..............   ..........++++.+++.+||+.||++|||+.|+|.||||
T Consensus       236 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         236 PNYKPEWFLPCKPQQ---LRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             ccccchhccccCCcc---hhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence            000000000000000   00000111235689999999999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=7.1e-43  Score=337.19  Aligned_cols=284  Identities=27%  Similarity=0.481  Sum_probs=215.9

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      .++|++.+.||+|+||.||+|.+..+++.||+|.++...     ...+.+|+.+++++ +|+||+++++++.+......+
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~   84 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL-RHPNIVELKEVVVGKHLDSIF   84 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhC-CCCCCcceEEEEecCCCCeEE
Confidence            478999999999999999999999999999999986332     22456899999999 999999999999766556789


Q ss_pred             EEEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC-
Q 013897          208 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-  282 (434)
Q Consensus       208 lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~-  282 (434)
                      +||||+.+. +..++    ..+++.++..++.||+.||+|||+.|++||||||+||+++.++ .+||+|||++...... 
T Consensus        85 lv~e~~~~~-l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~-~~kL~dfg~~~~~~~~~  162 (309)
T cd07845          85 LVMEYCEQD-LASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKG-CLKIADFGLARTYGLPA  162 (309)
T ss_pred             EEEecCCCC-HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEECccceeeecCCcc
Confidence            999999863 43332    4588999999999999999999999999999999999999776 8999999999876533 


Q ss_pred             CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                      .......++..|+|||.+.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+...++.+....+..-.....
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
T cd07845         163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLL-PGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL  241 (309)
T ss_pred             CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCCChhhchhhhcccc
Confidence            22333456778999999876567899999999999999999999887 45566677777777666543322211000000


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccccc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA  427 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~  427 (434)
                      ...+     .....++...  .......++++.+||.+||+.||++|||++|+|+||||+....+
T Consensus       242 ~~~~-----~~~~~~~~~~--~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~  299 (309)
T cd07845         242 VGKF-----TLPKQPYNNL--KHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP  299 (309)
T ss_pred             cccc-----cccCCCCCch--HHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence            0000     0000011000  00112357889999999999999999999999999999866544

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.8e-43  Score=371.62  Aligned_cols=257  Identities=25%  Similarity=0.437  Sum_probs=207.6

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      .++|++++.||+|+||+||+|.+..++..+|+|++...     ....+..|+.+|+.| +|||||+++++|.+.....++
T Consensus        12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L-~HPNIVrl~d~f~de~~~~ly   90 (1021)
T PTZ00266         12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMREL-KHKNIVRYIDRFLNKANQKLY   90 (1021)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEecCCCEEE
Confidence            47899999999999999999999999999999998642     235688999999999 999999999998776667789


Q ss_pred             EEEeecCCCchhhhc-------CCCChHHHHHHHHHHHHHHHHHHHC-------CceeecCCCCceEecCC---------
Q 013897          208 LIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQ-------GIMHRDVKPHNVMIDHE---------  264 (434)
Q Consensus       208 lv~e~~~~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~-------~ivHrDlKp~NIll~~~---------  264 (434)
                      |||||+.+++|..++       ..+++..++.++.||+.||.|||+.       +||||||||+||||+.+         
T Consensus        91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~  170 (1021)
T PTZ00266         91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA  170 (1021)
T ss_pred             EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence            999999999987654       3589999999999999999999984       49999999999999642         


Q ss_pred             -------CCeEEEEecccceecCCCCccceeccCCcccccccccC-CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCH
Q 013897          265 -------QRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD-LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNY  336 (434)
Q Consensus       265 -------~~~vkl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~  336 (434)
                             ...+||+|||++..+.........+||+.|+|||++.+ ...++.++||||||||||+|++|+.||... ...
T Consensus       171 ~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~-~~~  249 (1021)
T PTZ00266        171 QANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA-NNF  249 (1021)
T ss_pred             cccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC-CcH
Confidence                   12489999999987654444455679999999999864 245889999999999999999999998433 232


Q ss_pred             HHHHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHh
Q 013897          337 DQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAM  416 (434)
Q Consensus       337 ~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL  416 (434)
                      ..+.......                           ...         .....++++.+||..||..+|.+||++.|+|
T Consensus       250 ~qli~~lk~~---------------------------p~l---------pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL  293 (1021)
T PTZ00266        250 SQLISELKRG---------------------------PDL---------PIKGKSKELNILIKNLLNLSAKERPSALQCL  293 (1021)
T ss_pred             HHHHHHHhcC---------------------------CCC---------CcCCCCHHHHHHHHHHhcCChhHCcCHHHHh
Confidence            2222211100                           000         0012467899999999999999999999999


Q ss_pred             cCCCccccccc
Q 013897          417 AHPYFFPIRNA  427 (434)
Q Consensus       417 ~Hp~~~~~~~~  427 (434)
                      .||||+.+..+
T Consensus       294 ~h~~ik~i~~p  304 (1021)
T PTZ00266        294 GYQIIKNVGPP  304 (1021)
T ss_pred             ccHHHhhcCCC
Confidence            99999876543

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-42  Score=336.00  Aligned_cols=282  Identities=28%  Similarity=0.540  Sum_probs=209.0

Q ss_pred             CeEEEeeeeecCceEEEEEEEcC--CCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCT--DNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~--~~~~vaiK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      .|++.+.||+|+||.||+|.+..  ++..||+|.+....      ...+.+|+.+++.+ +||||+++++++.+.....+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~   79 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL-KHENVVSLVEVFLEHADKSV   79 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhc-CCCCccceEEEEeCCCCceE
Confidence            37899999999999999999987  78999999987522      35678899999999 99999999999987655778


Q ss_pred             EEEEeecCCCchhhhc-------CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecC----CCCeEEEEeccc
Q 013897          207 SLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH----EQRKLRLIDWGL  275 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~----~~~~vkl~DFGl  275 (434)
                      ++||||+++..+..+.       ..+++..++.++.||+.||+|||+++|+||||||+||+++.    ++ .+||+|||+
T Consensus        80 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~-~~kl~Dfg~  158 (316)
T cd07842          80 YLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERG-VVKIGDLGL  158 (316)
T ss_pred             EEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccc-eEEECCCcc
Confidence            9999999875543221       25788899999999999999999999999999999999997    55 899999999


Q ss_pred             ceecCCCCc----cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCC--------HHHHHHHH
Q 013897          276 AEFYHPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN--------YDQLVKIA  343 (434)
Q Consensus       276 a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~--------~~~~~~i~  343 (434)
                      +........    .....++..|+|||.+.+...++.++|||||||++++|++|+.||......        ...+..+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
T cd07842         159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF  238 (316)
T ss_pred             ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence            976543221    234467888999999877567899999999999999999999998533322        13444555


Q ss_pred             HHhCChhHHHHHhhccccCChhHHHHhcccCCCCCc--ccc-ccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCC
Q 013897          344 KVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWS--KFI-TVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY  420 (434)
Q Consensus       344 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~-~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~  420 (434)
                      ..++......+......   +.+...........+.  ... ..+.....+.++.+++.+||+.||++|||+.|+++|||
T Consensus       239 ~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~  315 (316)
T cd07842         239 EVLGTPTEKDWPDIKKM---PEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY  315 (316)
T ss_pred             HHhCCCchhHHHHHhhc---ccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCC
Confidence            55554433333211111   0111100011111111  000 01111246678999999999999999999999999999


Q ss_pred             c
Q 013897          421 F  421 (434)
Q Consensus       421 ~  421 (434)
                      |
T Consensus       316 f  316 (316)
T cd07842         316 F  316 (316)
T ss_pred             C
Confidence            8

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=8.8e-44  Score=345.09  Aligned_cols=244  Identities=27%  Similarity=0.432  Sum_probs=196.8

Q ss_pred             eeeeecCceEEEEEEEc---CCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEe
Q 013897          140 RKVGRGKYSEVFEGVHC---TDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE  211 (434)
Q Consensus       140 ~~lG~G~fg~Vy~~~~~---~~~~~vaiK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  211 (434)
                      +.||+|+||.||++.+.   .+++.||+|+++...     ...+.+|+.+++++ +||||+++++++.+.  ...++|||
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~~~~lv~e   78 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV-NHPFIVKLHYAFQTE--GKLYLILD   78 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhC-CCCCcccEEEEEEcC--CEEEEEEc
Confidence            57999999999998763   568999999986432     34567899999999 999999999999654  56789999


Q ss_pred             ecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC-Cccce
Q 013897          212 HVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYNV  287 (434)
Q Consensus       212 ~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~-~~~~~  287 (434)
                      |+.+++|...+   ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..... .....
T Consensus        79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~~~~~~~~  157 (318)
T cd05582          79 FLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG-HIKLTDFGLSKESIDHEKKAYS  157 (318)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCC-cEEEeeccCCcccCCCCCceec
Confidence            99999986664   3488999999999999999999999999999999999999776 8999999999765433 22344


Q ss_pred             eccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHH
Q 013897          288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLA  367 (434)
Q Consensus       288 ~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~  367 (434)
                      ..|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.. .+..+....+...                      
T Consensus       158 ~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~-~~~~~~~~~i~~~----------------------  213 (318)
T cd05582         158 FCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPFQG-KDRKETMTMILKA----------------------  213 (318)
T ss_pred             ccCChhhcCHHHHcC-CCCCCccceeccceEeeeeccCCCCCCC-CCHHHHHHHHHcC----------------------
Confidence            578999999999876 6789999999999999999999999842 2222222221100                      


Q ss_pred             HHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCcc-----HHHHhcCCCcccccc
Q 013897          368 ALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT-----AKEAMAHPYFFPIRN  426 (434)
Q Consensus       368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt-----~~elL~Hp~~~~~~~  426 (434)
                                     ....+..+++++.+||.+||+.||++||+     ++++++||||+.++.
T Consensus       214 ---------------~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~  262 (318)
T cd05582         214 ---------------KLGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDW  262 (318)
T ss_pred             ---------------CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCH
Confidence                           00011236788999999999999999999     788999999987653

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2e-43  Score=343.60  Aligned_cols=244  Identities=25%  Similarity=0.427  Sum_probs=193.5

Q ss_pred             eeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHH-HHHhcCCCCeeeEeeEEEccCCCccEEEEee
Q 013897          140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKI-LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH  212 (434)
Q Consensus       140 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~-l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  212 (434)
                      +.||+|+||+||+|.+..+++.+|+|++...      ....+..|..+ ++.+ +||||+++++++...  ...++||||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~hp~iv~~~~~~~~~--~~~~lv~e~   77 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQTT--EKLYFVLDF   77 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhC-CCCCCccEEEEEecC--CEEEEEEcC
Confidence            4699999999999999999999999998642      12345566654 4555 999999999998654  567899999


Q ss_pred             cCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC-CCcccee
Q 013897          213 VNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVR  288 (434)
Q Consensus       213 ~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~-~~~~~~~  288 (434)
                      +.+++|...+   ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.... .......
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~-~~kL~DfG~~~~~~~~~~~~~~~  156 (325)
T cd05604          78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQG-HVVLTDFGLCKEGIAQSDTTTTF  156 (325)
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC-CEEEeecCCcccCCCCCCCcccc
Confidence            9999986554   3588999999999999999999999999999999999999777 899999999875322 2233456


Q ss_pred             ccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHH
Q 013897          289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAA  368 (434)
Q Consensus       289 ~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~  368 (434)
                      +|+..|+|||++.+ ..++.++|||||||++|+|++|+.||... +..+....+..   .          .         
T Consensus       157 ~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~-~~~~~~~~~~~---~----------~---------  212 (325)
T cd05604         157 CGTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFYCR-DVAEMYDNILH---K----------P---------  212 (325)
T ss_pred             cCChhhCCHHHHcC-CCCCCcCccccccceehhhhcCCCCCCCC-CHHHHHHHHHc---C----------C---------
Confidence            78999999999876 67899999999999999999999998432 22222221110   0          0         


Q ss_pred             HhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccH----HHHhcCCCcccccc
Q 013897          369 LVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA----KEAMAHPYFFPIRN  426 (434)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~----~elL~Hp~~~~~~~  426 (434)
                                     .......+..+.++|.+||+.||.+||++    .+++.||||..+.+
T Consensus       213 ---------------~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~  259 (325)
T cd05604         213 ---------------LVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSW  259 (325)
T ss_pred             ---------------ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCH
Confidence                           00111356789999999999999999976    59999999997653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.3e-42  Score=332.58  Aligned_cols=278  Identities=31%  Similarity=0.547  Sum_probs=213.2

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      ++|++.+.||.|+||.||+|.+..+++.+|+|.++...     ...+.+|+.+++.+ +||||+++++++.+......++
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKL-QHPNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhc-CCCCEEEEEEEEEecCCCcEEE
Confidence            57889999999999999999998889999999986432     23467899999999 8999999999987665578899


Q ss_pred             EEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC-C
Q 013897          209 IFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-K  283 (434)
Q Consensus       209 v~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~-~  283 (434)
                      |+||+.+ +|..++    ..+++..++.++.||+.||+|||+++|+|+||||+|||++.++ .+||+|||++...... .
T Consensus        84 v~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~~  161 (293)
T cd07843          84 VMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRG-ILKICDFGLAREYGSPLK  161 (293)
T ss_pred             EehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC-cEEEeecCceeeccCCcc
Confidence            9999986 554433    2488999999999999999999999999999999999999776 8999999999766443 2


Q ss_pred             ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                      ......++..|+|||.+.+...++.++|+|||||++|+|++|..|| ...........+...++.+....|.........
T Consensus       162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
T cd07843         162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLF-PGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGA  240 (293)
T ss_pred             ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCchHHHHHhhccchh
Confidence            3344567888999999876556789999999999999999999887 445556666666666665544444322111111


Q ss_pred             hhHHHHhcccCCCCCccccccccccC-CchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHL-AVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                      ..     ........... ....... +++.+.+||.+||+.||++|||+.|+|.||||
T Consensus       241 ~~-----~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         241 KK-----KTFTKYPYNQL-RKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             cc-----cccccccchhh-hccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence            00     00000000000 0011111 47789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=7.1e-43  Score=341.51  Aligned_cols=246  Identities=22%  Similarity=0.372  Sum_probs=190.6

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEc-----CCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS  203 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  203 (434)
                      .++|++.++||+|+||.||+|.+.     .++..||+|+++...    ...+.+|+.++..+.+||||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-~   84 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP-N   84 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC-C
Confidence            478999999999999999999752     345689999986432    346889999999998899999999988654 3


Q ss_pred             CccEEEEeecCCCchhhhcC------------------------------------------------------------
Q 013897          204 KTPSLIFEHVNNTDFKVLYP------------------------------------------------------------  223 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~~------------------------------------------------------------  223 (434)
                      ..+++||||+++|+|..++.                                                            
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence            45789999999999865542                                                            


Q ss_pred             -----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCcc---ceeccCCccc
Q 013897          224 -----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFK  295 (434)
Q Consensus       224 -----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~---~~~~~t~~y~  295 (434)
                           .+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++........   ....++..|+
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~  243 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGSARLPLKWM  243 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCC-cEEEeecccccccccCcchhcccCCCCCcccc
Confidence                 256677888999999999999999999999999999999766 8999999999765332221   1234557899


Q ss_pred             ccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHhcccC
Q 013897          296 GPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHS  374 (434)
Q Consensus       296 aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (434)
                      |||++.+ ..++.++|||||||++|||++ |..||...... +.+..... .+                          .
T Consensus       244 aPE~~~~-~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~-~~~~~~~~-~~--------------------------~  294 (338)
T cd05102         244 APESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN-EEFCQRLK-DG--------------------------T  294 (338)
T ss_pred             CcHHhhc-CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc-HHHHHHHh-cC--------------------------C
Confidence            9999876 679999999999999999997 88887432221 11111100 00                          0


Q ss_pred             CCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          375 RKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                      .        ......+++++.+|+.+||..||++|||+.|+++
T Consensus       295 ~--------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~  329 (338)
T cd05102         295 R--------MRAPENATPEIYRIMLACWQGDPKERPTFSALVE  329 (338)
T ss_pred             C--------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            0        0011235678999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.2e-42  Score=326.13  Aligned_cols=251  Identities=31%  Similarity=0.555  Sum_probs=202.4

Q ss_pred             eEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccccHH-----HHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEE
Q 013897          136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK-----KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF  210 (434)
Q Consensus       136 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  210 (434)
                      |++++.||+|+||+||++.+..+++.+|+|++......     ...+|+.+++.+ +||||+++++++.+  ....++||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~--~~~~~~v~   77 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRL-RHPNIVQILDVFQD--DNYLYIVM   77 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHH-TBTTBCHEEEEEEE--SSEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccc-cccccccccccccc--cccccccc
Confidence            78999999999999999999999999999999765432     234599999999 99999999999976  46677999


Q ss_pred             eecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceec-CCCCccc
Q 013897          211 EHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY-HPGKEYN  286 (434)
Q Consensus       211 e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~-~~~~~~~  286 (434)
                      ||+.+++|..++   ..+++..+..++.||+.||++||+++|+|+||||+||+++.++ .++|+|||.+... .......
T Consensus        78 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~-~~~l~Dfg~~~~~~~~~~~~~  156 (260)
T PF00069_consen   78 EYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENG-EVKLIDFGSSVKLSENNENFN  156 (260)
T ss_dssp             EEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTS-EEEESSGTTTEESTSTTSEBS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccc
Confidence            999999887554   4688999999999999999999999999999999999999666 8999999999763 2334445


Q ss_pred             eeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhH
Q 013897          287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL  366 (434)
Q Consensus       287 ~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~  366 (434)
                      ...++..|+|||++.....++.++||||||+++++|++|..||... ........+.+...........           
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~-----------  224 (260)
T PF00069_consen  157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES-NSDDQLEIIEKILKRPLPSSSQ-----------  224 (260)
T ss_dssp             SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS-SHHHHHHHHHHHHHTHHHHHTT-----------
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccc-cchhhhhhhhhccccccccccc-----------
Confidence            6678899999999873378999999999999999999999998533 2223333333322221111100           


Q ss_pred             HHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          367 AALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                                         ........+.++|.+||..||++||++.++++||||
T Consensus       225 -------------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  225 -------------------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             -------------------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             -------------------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence                               000123689999999999999999999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-44  Score=338.82  Aligned_cols=260  Identities=27%  Similarity=0.392  Sum_probs=213.5

Q ss_pred             ccCCCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeEeeEEEccC
Q 013897          129 QWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ  202 (434)
Q Consensus       129 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  202 (434)
                      +....+.|..-+.||+|+||.||-++.+.+|+.||.|.+.+..      .....+|-.+|.++ +.+.||.+-..|.  .
T Consensus       180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV-~s~FiVslaYAfe--T  256 (591)
T KOG0986|consen  180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKV-SSPFIVSLAYAFE--T  256 (591)
T ss_pred             hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHh-ccCcEEEEeeeec--C
Confidence            3345678999999999999999999999999999999885432      23367899999998 8899999987774  4


Q ss_pred             CCccEEEEeecCCCchhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccce
Q 013897          203 SKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE  277 (434)
Q Consensus       203 ~~~~~lv~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~  277 (434)
                      ...+++|+..|+||+|..++     +.+++..++.|+.+|+.||++||+.+||+|||||+|||+|+.| +|+|+|.|+|.
T Consensus       257 kd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~G-hvRISDLGLAv  335 (591)
T KOG0986|consen  257 KDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHG-HVRISDLGLAV  335 (591)
T ss_pred             CCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCC-CeEeeccceEE
Confidence            46788999999999997665     3589999999999999999999999999999999999999776 99999999999


Q ss_pred             ecCCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhh
Q 013897          278 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK  357 (434)
Q Consensus       278 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  357 (434)
                      .+..+.....++||..|||||++.+ +.|+...|+|||||++|||+.|+.||.... ......++.+..-.         
T Consensus       336 ei~~g~~~~~rvGT~GYMAPEvl~n-e~Y~~s~Dwf~lGCllYemi~G~sPFr~~K-eKvk~eEvdrr~~~---------  404 (591)
T KOG0986|consen  336 EIPEGKPIRGRVGTVGYMAPEVLQN-EVYDFSPDWFSLGCLLYEMIAGHSPFRQRK-EKVKREEVDRRTLE---------  404 (591)
T ss_pred             ecCCCCccccccCcccccCHHHHcC-CcccCCccHHHHHhHHHHHHcccCchhhhh-hhhhHHHHHHHHhc---------
Confidence            9998888888899999999999988 569999999999999999999999993211 11111111000000         


Q ss_pred             ccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCcc-----HHHHhcCCCccccccc
Q 013897          358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT-----AKEAMAHPYFFPIRNA  427 (434)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt-----~~elL~Hp~~~~~~~~  427 (434)
                                              ...+....+++++++|.+.+|+.||++|..     +.++.+||||+.+++.
T Consensus       405 ------------------------~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~  455 (591)
T KOG0986|consen  405 ------------------------DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWR  455 (591)
T ss_pred             ------------------------chhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHh
Confidence                                    011122347889999999999999999965     7799999999998754

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=6.9e-43  Score=357.27  Aligned_cols=252  Identities=21%  Similarity=0.330  Sum_probs=202.8

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC----
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS----  203 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~----  203 (434)
                      .++|.+.+.||+|+||+||+|.+..+++.||||++...     ....+.+|+.++..+ +|+|++++++.+.....    
T Consensus        31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~-~h~~iv~~~~~~~~~~~~~~~  109 (496)
T PTZ00283         31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNC-DFFSIVKCHEDFAKKDPRNPE  109 (496)
T ss_pred             CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcC-CCCcEEEeecceecccccCcc
Confidence            47899999999999999999999999999999998642     234578899999998 99999999887753321    


Q ss_pred             --CccEEEEeecCCCchhhhc-------CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecc
Q 013897          204 --KTPSLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG  274 (434)
Q Consensus       204 --~~~~lv~e~~~~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFG  274 (434)
                        ..+++||||+.+++|...+       ..+++..+..++.|++.||+|||+++|+||||||+|||++.++ .+||+|||
T Consensus       110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~-~vkL~DFG  188 (496)
T PTZ00283        110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNG-LVKLGDFG  188 (496)
T ss_pred             cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCC-CEEEEecc
Confidence              2367999999999987654       2478889999999999999999999999999999999999776 89999999


Q ss_pred             cceecCCC---CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhH
Q 013897          275 LAEFYHPG---KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL  351 (434)
Q Consensus       275 la~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~  351 (434)
                      +++.+...   ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.. .+..+.+..+..  +    
T Consensus       189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~k~DVwSlGvilyeLltG~~Pf~~-~~~~~~~~~~~~--~----  260 (496)
T PTZ00283        189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRR-KPYSKKADMFSLGVLLYELLTLKRPFDG-ENMEEVMHKTLA--G----  260 (496)
T ss_pred             cCeeccccccccccccccCCcceeCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHhc--C----
Confidence            99765432   12244579999999999887 6799999999999999999999999832 222111111100  0    


Q ss_pred             HHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccc
Q 013897          352 NAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI  424 (434)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~  424 (434)
                                            ..        ......+++++.+|+.+||..||++||++.++|+|||++..
T Consensus       261 ----------------------~~--------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~  303 (496)
T PTZ00283        261 ----------------------RY--------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF  303 (496)
T ss_pred             ----------------------CC--------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence                                  00        00112367889999999999999999999999999998753

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.8e-42  Score=330.46  Aligned_cols=278  Identities=31%  Similarity=0.580  Sum_probs=207.5

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC---Cc
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS---KT  205 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~---~~  205 (434)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.++...     ...+.+|+.+++.+.+||||+++++++.....   ..
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46899999999999999999998899999999876432     24678899999999778999999998865332   23


Q ss_pred             cEEEEeecCCCchhhhc--------CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccce
Q 013897          206 PSLIFEHVNNTDFKVLY--------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE  277 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~--------~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~  277 (434)
                      .++||||+.+ ++..++        ..+++..++.++.||+.||.|||+++|+||||||+||+++.++..+||+|||++.
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~  159 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR  159 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence            7899999997 444332        2478899999999999999999999999999999999999745589999999997


Q ss_pred             ecCCC-CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHh
Q 013897          278 FYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN  356 (434)
Q Consensus       278 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~  356 (434)
                      ..... .......+++.|+|||++.+...++.++|||||||++|+|++|..|| .+.+....+..+.+.++.+....+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (295)
T cd07837         160 AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLF-PGDSELQQLLHIFKLLGTPTEQVWPG  238 (295)
T ss_pred             ecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHHHHhCCCChhhCcc
Confidence            65322 22334467788999999876566899999999999999999999887 44555555556655554433222211


Q ss_pred             hccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcc
Q 013897          357 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFF  422 (434)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~  422 (434)
                      .....   ....      ...+...........+++++.+||.+||..||.+||++.|+|.||||+
T Consensus       239 ~~~~~---~~~~------~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         239 VSKLR---DWHE------FPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             hhhcc---chhh------cCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence            00000   0000      000000000001123678899999999999999999999999999995

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.3e-42  Score=329.88  Aligned_cols=253  Identities=25%  Similarity=0.362  Sum_probs=203.9

Q ss_pred             eEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       136 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      |+..+.||+|+||+||+|.+..+++.+|+|.+....      ...+.+|+.+++.+ +|+|++.+++.+.+.  ...++|
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~--~~~~lv   78 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV-NSQFVVNLAYAYETK--DALCLV   78 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCcCceeEEEEEecC--CEEEEE
Confidence            678899999999999999999999999999986432      23467899999999 999999999988654  567899


Q ss_pred             EeecCCCchhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc
Q 013897          210 FEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE  284 (434)
Q Consensus       210 ~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~  284 (434)
                      |||+.+++|..+.     ..+++..+..++.|++.||.|||+++|+||||||+||+++.++ .+||+|||++........
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~-~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05632          79 LTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYG-HIRISDLGLAVKIPEGES  157 (285)
T ss_pred             EEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCC-CEEEecCCcceecCCCCc
Confidence            9999999886553     2488999999999999999999999999999999999999776 899999999976654444


Q ss_pred             cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCCh
Q 013897          285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP  364 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  364 (434)
                      .....|+..|+|||.+.+ ..++.++|+|||||++|+|++|+.||... ........+.......               
T Consensus       158 ~~~~~g~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~P~~~~-~~~~~~~~~~~~~~~~---------------  220 (285)
T cd05632         158 IRGRVGTVGYMAPEVLNN-QRYTLSPDYWGLGCLIYEMIEGQSPFRGR-KEKVKREEVDRRVLET---------------  220 (285)
T ss_pred             ccCCCCCcCccChHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHhhhcc---------------
Confidence            455678999999999876 67999999999999999999999998432 2221111111100000               


Q ss_pred             hHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCcc-----HHHHhcCCCccccccc
Q 013897          365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT-----AKEAMAHPYFFPIRNA  427 (434)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt-----~~elL~Hp~~~~~~~~  427 (434)
                               .         ......+++++.+|+.+||+.||++||+     +.+++.||||+.+...
T Consensus       221 ---------~---------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~  270 (285)
T cd05632         221 ---------E---------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFK  270 (285)
T ss_pred             ---------c---------cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHH
Confidence                     0         0011235678999999999999999999     8999999999987544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-42  Score=329.51  Aligned_cols=279  Identities=31%  Similarity=0.534  Sum_probs=209.3

Q ss_pred             CCCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       131 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      +..++|++.+.||+|++|.||+|.++.+++.||+|.+....    ...+.+|+.+++.+ +|+||+++++++.+  ....
T Consensus         2 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~   78 (291)
T cd07844           2 GKLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDL-KHANIVTLHDIIHT--KKTL   78 (291)
T ss_pred             CCccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhC-CCcceeeEEEEEec--CCeE
Confidence            44588999999999999999999998899999999986432    24567899999999 99999999999864  3577


Q ss_pred             EEEEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC
Q 013897          207 SLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG  282 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~  282 (434)
                      ++||||+.+ +|..++    ..+++..++.++.|++.||.|||+++|+||||||+||+++.++ .+||+|||++......
T Consensus        79 ~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~  156 (291)
T cd07844          79 TLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERG-ELKLADFGLARAKSVP  156 (291)
T ss_pred             EEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCC-CEEECccccccccCCC
Confidence            899999996 565443    2478889999999999999999999999999999999999777 8999999998654221


Q ss_pred             -CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcccc
Q 013897          283 -KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE  361 (434)
Q Consensus       283 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  361 (434)
                       .......++..|+|||.+.+...++.++|||||||++|+|++|+.||.......+++..+.+.++......+.......
T Consensus       157 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07844         157 SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP  236 (291)
T ss_pred             CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence             1223335678899999987656689999999999999999999999855544556666666666654433332211000


Q ss_pred             CChhHHHHhcccCCCCCccccccccccCCc--hHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          362 LDPHLAALVGRHSRKPWSKFITVENQHLAV--PEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                      ..   ....   ......... .......+  .++.+++.+||..||++|||+.|+|+||||
T Consensus       237 ~~---~~~~---~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         237 EF---KPYS---FPFYPPRPL-INHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             cc---cccc---ccccCChhH-HHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            00   0000   000000000 00001122  688999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=4.3e-43  Score=342.16  Aligned_cols=257  Identities=25%  Similarity=0.388  Sum_probs=201.4

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      ++|++.+.||+|+||.||++.+..+++.||+|++...      ....+.+|+.++..+ +|+||+++++++.+.  ...+
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~l~~~~~~~--~~~~   77 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNG-DCQWITTLHYAFQDE--NYLY   77 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcC--CEEE
Confidence            5799999999999999999999999999999998642      123467888888888 999999999999654  5778


Q ss_pred             EEEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC
Q 013897          208 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       208 lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~  283 (434)
                      +||||+.+++|..++    ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus        78 lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~  156 (331)
T cd05624          78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNG-HIRLADFGSCLKMNQDG  156 (331)
T ss_pred             EEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCC-CEEEEeccceeeccCCC
Confidence            999999999987665    3578889999999999999999999999999999999999776 89999999997664433


Q ss_pred             cc--ceeccCCcccccccccCC----CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhh
Q 013897          284 EY--NVRVASRYFKGPELLVDL----QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK  357 (434)
Q Consensus       284 ~~--~~~~~t~~y~aPE~~~~~----~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  357 (434)
                      ..  ...+|+..|+|||++.+.    ..++.++|||||||++|+|++|+.||.. .+..+....+..   .         
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~---~---------  223 (331)
T cd05624         157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMN---H---------  223 (331)
T ss_pred             ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC-CCHHHHHHHHHc---C---------
Confidence            22  335789999999998642    3578899999999999999999999843 222222222110   0         


Q ss_pred             ccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCC--CccHHHHhcCCCccccccc
Q 013897          358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQE--RPTAKEAMAHPYFFPIRNA  427 (434)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~--Rpt~~elL~Hp~~~~~~~~  427 (434)
                                     ..+.++.     .....+++++.+||.+||..++++  |++++++++||||+.+++.
T Consensus       224 ---------------~~~~~~p-----~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~  275 (331)
T cd05624         224 ---------------EERFQFP-----SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWE  275 (331)
T ss_pred             ---------------CCcccCC-----CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHH
Confidence                           0000000     001235788999999999976654  5799999999999987643

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2.2e-42  Score=328.95  Aligned_cols=257  Identities=21%  Similarity=0.381  Sum_probs=203.8

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+...    ....+.+|+.+++++ +||||+++++++...  ...++|
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv   77 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKC-DSPYIIGFYGAFFVE--NRISIC   77 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEEC--CEEEEE
Confidence            3578899999999999999999999999999998543    235678999999999 999999999999764  456799


Q ss_pred             EeecCCCchhhhcCCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCccceec
Q 013897          210 FEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRV  289 (434)
Q Consensus       210 ~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~~~~~  289 (434)
                      |||+.++++... ..+++..+..++.|++.||.|||+.||+|+||||+|||++.++ .++|+|||++...... .....+
T Consensus        78 ~e~~~~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~-~~~l~dfg~~~~~~~~-~~~~~~  154 (279)
T cd06619          78 TEFMDGGSLDVY-RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRG-QVKLCDFGVSTQLVNS-IAKTYV  154 (279)
T ss_pred             EecCCCCChHHh-hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCC-CEEEeeCCcceecccc-cccCCC
Confidence            999999988654 4678888999999999999999999999999999999999776 8999999999765432 334457


Q ss_pred             cCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHH--HHHHHhCChhHHHHHhhccccCChhHH
Q 013897          290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV--KIAKVLGTDELNAYLNKYHIELDPHLA  367 (434)
Q Consensus       290 ~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~--~i~~~~g~~~~~~~~~~~~~~~~~~~~  367 (434)
                      ++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...........  ...+.                      
T Consensus       155 ~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~----------------------  211 (279)
T cd06619         155 GTNAYMAPERISG-EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQC----------------------  211 (279)
T ss_pred             CChhhcCceeecC-CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHH----------------------
Confidence            8899999999876 6789999999999999999999999843221111000  00000                      


Q ss_pred             HHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccccc
Q 013897          368 ALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~  428 (434)
                       ...... .       .......++++.+|+.+||+.||++||+++|+++||||+..+...
T Consensus       212 -~~~~~~-~-------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~~~  263 (279)
T cd06619         212 -IVDEDP-P-------VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYNDGN  263 (279)
T ss_pred             -HhccCC-C-------CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccccCcc
Confidence             000000 0       000112567899999999999999999999999999999776443

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=4.5e-43  Score=341.20  Aligned_cols=244  Identities=25%  Similarity=0.430  Sum_probs=193.3

Q ss_pred             eeeeecCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHH-HHHHhcCCCCeeeEeeEEEccCCCccEEEEee
Q 013897          140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIK-ILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH  212 (434)
Q Consensus       140 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~E~~-~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  212 (434)
                      +.||+|+||+||+|++..+++.||+|++....      ...+..|.. +++.+ +||||+++++++.+.  ...++||||
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~Iv~~~~~~~~~--~~~~lv~e~   77 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQTA--DKLYFVLDY   77 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhC-CCCCCCceeEEEEcC--CeEEEEEeC
Confidence            36999999999999999999999999986422      123444544 45556 999999999998654  567899999


Q ss_pred             cCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC-CCcccee
Q 013897          213 VNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVR  288 (434)
Q Consensus       213 ~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~-~~~~~~~  288 (434)
                      +.+++|...+   ..+.+..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.... .......
T Consensus        78 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~-~~kl~DfG~a~~~~~~~~~~~~~  156 (325)
T cd05602          78 INGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG-HIVLTDFGLCKENIEHNGTTSTF  156 (325)
T ss_pred             CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC-CEEEccCCCCcccccCCCCcccc
Confidence            9999987665   3478889999999999999999999999999999999999776 899999999975422 2233456


Q ss_pred             ccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHH
Q 013897          289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAA  368 (434)
Q Consensus       289 ~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~  368 (434)
                      +|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.. .+..+.+..+...                       
T Consensus       157 ~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~-----------------------  211 (325)
T cd05602         157 CGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILNK-----------------------  211 (325)
T ss_pred             cCCccccCHHHHcC-CCCCCccccccccHHHHHHhcCCCCCCC-CCHHHHHHHHHhC-----------------------
Confidence            79999999999887 6899999999999999999999999843 2222222221110                       


Q ss_pred             HhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHH----HHhcCCCcccccc
Q 013897          369 LVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK----EAMAHPYFFPIRN  426 (434)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~----elL~Hp~~~~~~~  426 (434)
                                    .......+++.+.++|.+||+.||.+|+++.    ++++|+||...++
T Consensus       212 --------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~  259 (325)
T cd05602         212 --------------PLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINW  259 (325)
T ss_pred             --------------CcCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCH
Confidence                          0001123677899999999999999999875    8999999987653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=3.6e-42  Score=327.94  Aligned_cols=274  Identities=33%  Similarity=0.593  Sum_probs=214.0

Q ss_pred             CeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      +|++.+.||+|+||.||+|.+..+++.||+|++....     ...+.+|+.+++.+ +||||+++++++.+  ....++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~~v   77 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQAC-QHPYVVKLLDVFPH--GSGFVLV   77 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhC-CCCCCcceeeEEec--CCeeEEE
Confidence            4889999999999999999998899999999986432     35688999999999 89999999999965  4567899


Q ss_pred             EeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC--
Q 013897          210 FEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--  283 (434)
Q Consensus       210 ~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~--  283 (434)
                      +||+ +++|..++    ..+++.+++.++.||+.||+|||+++|+|+||||+||+++.++ .++|+|||++.......  
T Consensus        78 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~-~~~l~dfg~~~~~~~~~~~  155 (286)
T cd07832          78 MEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADG-VLKIADFGLARLFSEEEPR  155 (286)
T ss_pred             eccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCC-cEEEeeeeecccccCCCCC
Confidence            9999 88886654    3488999999999999999999999999999999999999766 89999999997664432  


Q ss_pred             ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                      ......++..|+|||.+.+...++.++|||||||++++|++|. |++.+..+...+..+...++.+....+..-....  
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  232 (286)
T cd07832         156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGS-PLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP--  232 (286)
T ss_pred             ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCC-cCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcc--
Confidence            2345578889999999876556799999999999999999996 4456777777777777777665544443211100  


Q ss_pred             hhHHHHh-cccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcc
Q 013897          364 PHLAALV-GRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFF  422 (434)
Q Consensus       364 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~  422 (434)
                       .+.... ......++.     ......+.++.+||.+||..||++|||++++|+||||.
T Consensus       233 -~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         233 -DYNKITFPESKPIPLE-----EIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             -hhhcccCCCCCcchHH-----HhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence             000000 000000000     01123567899999999999999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=3.1e-42  Score=327.69  Aligned_cols=275  Identities=32%  Similarity=0.575  Sum_probs=208.2

Q ss_pred             eEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEe
Q 013897          136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE  211 (434)
Q Consensus       136 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  211 (434)
                      |++++.||+|+||.||+|.+..++..+|+|.++...    .....+|+.++.++.+|+|++++++++.+......++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            568899999999999999998899999999986431    2234578999999867999999999998765567899999


Q ss_pred             ecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCcccee
Q 013897          212 HVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR  288 (434)
Q Consensus       212 ~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~~~~  288 (434)
                      |+.++.+..+.   ..+++..+..++.||+.||+|||+++|+||||||+||+++. + .+||+|||++............
T Consensus        81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~-~~kl~dfg~~~~~~~~~~~~~~  158 (282)
T cd07831          81 LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-D-ILKLADFGSCRGIYSKPPYTEY  158 (282)
T ss_pred             cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-C-CeEEEecccccccccCCCcCCC
Confidence            99875554443   24789999999999999999999999999999999999997 4 8999999999876555444556


Q ss_pred             ccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHH
Q 013897          289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAA  368 (434)
Q Consensus       289 ~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~  368 (434)
                      .++..|+|||.+.....++.++|||||||++|||++|..|| .+.+..+....+...++...... ...........+  
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~-~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~--  234 (282)
T cd07831         159 ISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLF-PGTNELDQIAKIHDVLGTPDAEV-LKKFRKSRHMNY--  234 (282)
T ss_pred             CCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCC-CCCCHHHHHHHHHHHcCCCCHHH-HHhhcccccccc--
Confidence            78889999998765456789999999999999999999887 55555566666666655433211 110000000000  


Q ss_pred             HhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          369 LVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                         ..........  ......++.++.+||.+||..||++||+++++|+||||
T Consensus       235 ---~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         235 ---NFPSKKGTGL--RKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             ---cCcccccccH--HHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence               0000000000  00012357899999999999999999999999999998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=5.9e-43  Score=339.72  Aligned_cols=244  Identities=25%  Similarity=0.420  Sum_probs=192.4

Q ss_pred             eeeeecCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHH-HHHHhcCCCCeeeEeeEEEccCCCccEEEEee
Q 013897          140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIK-ILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH  212 (434)
Q Consensus       140 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~E~~-~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  212 (434)
                      +.||+|+||.||+|++..+++.||+|++....      ...+..|+. +++.+ +||||+++++++.+.  ...++||||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~iv~~~~~~~~~--~~~~lv~e~   77 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNL-KHPFLVGLHYSFQTA--EKLYFVLDY   77 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhC-CCCCccceeeEEEcC--CEEEEEEcC
Confidence            46999999999999999999999999986422      233455554 45666 999999999998654  567899999


Q ss_pred             cCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecC-CCCcccee
Q 013897          213 VNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVR  288 (434)
Q Consensus       213 ~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~-~~~~~~~~  288 (434)
                      +++++|...+   ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++... ........
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~~~~~~~~  156 (321)
T cd05603          78 VNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQG-HVVLTDFGLCKEGVEPEETTSTF  156 (321)
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC-CEEEccCCCCccCCCCCCccccc
Confidence            9999986554   3588899999999999999999999999999999999999777 89999999987532 22233455


Q ss_pred             ccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHH
Q 013897          289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAA  368 (434)
Q Consensus       289 ~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~  368 (434)
                      +|++.|+|||++.+ ..++.++|||||||++|||++|+.||... +.......+.   ..                    
T Consensus       157 ~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~-~~~~~~~~i~---~~--------------------  211 (321)
T cd05603         157 CGTPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFYSR-DVSQMYDNIL---HK--------------------  211 (321)
T ss_pred             cCCcccCCHHHhcC-CCCCCcCcccccchhhhhhhcCCCCCCCC-CHHHHHHHHh---cC--------------------
Confidence            78999999999876 67999999999999999999999998432 2111111110   00                    


Q ss_pred             HhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccH----HHHhcCCCcccccc
Q 013897          369 LVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA----KEAMAHPYFFPIRN  426 (434)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~----~elL~Hp~~~~~~~  426 (434)
                                    ........+.++.++|.+||+.||.+|+++    .|+++||||..++.
T Consensus       212 --------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~  259 (321)
T cd05603         212 --------------PLQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINW  259 (321)
T ss_pred             --------------CCCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCH
Confidence                          001112356789999999999999999875    59999999987654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-43  Score=345.35  Aligned_cols=244  Identities=26%  Similarity=0.409  Sum_probs=193.2

Q ss_pred             eeecCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhc--CCCCeeeEeeEEEccCCCccEEEEeec
Q 013897          142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLC--GGPNIVKLLDIVRDQQSKTPSLIFEHV  213 (434)
Q Consensus       142 lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~E~~~l~~l~--~h~niv~l~~~~~~~~~~~~~lv~e~~  213 (434)
                      ||+|+||+||+|.+..+++.||+|++....      ......|..++..+.  +||||+++++++.+.  ...++||||+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~--~~~~lv~e~~   78 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTD--SDLYLVTDYM   78 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecC--CeEEEEEcCC
Confidence            799999999999999999999999985421      123445667776664  799999999999654  5678999999


Q ss_pred             CCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC-CCccceec
Q 013897          214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVRV  289 (434)
Q Consensus       214 ~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~-~~~~~~~~  289 (434)
                      .+++|...+   ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..... .......+
T Consensus        79 ~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~  157 (330)
T cd05586          79 SGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATG-HIALCDFGLSKANLTDNKTTNTFC  157 (330)
T ss_pred             CCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC-CEEEecCCcCcCCCCCCCCccCcc
Confidence            999886554   3588999999999999999999999999999999999999776 899999999875432 22334567


Q ss_pred             cCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHH
Q 013897          290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAAL  369 (434)
Q Consensus       290 ~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~  369 (434)
                      ||..|+|||++.+...++.++|||||||++|+|++|+.||... +..+....+..  +                      
T Consensus       158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~-~~~~~~~~i~~--~----------------------  212 (330)
T cd05586         158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE-DTQQMYRNIAF--G----------------------  212 (330)
T ss_pred             CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCC-CHHHHHHHHHc--C----------------------
Confidence            9999999999876556899999999999999999999998432 22111111100  0                      


Q ss_pred             hcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCc----cHHHHhcCCCccccc
Q 013897          370 VGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP----TAKEAMAHPYFFPIR  425 (434)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rp----t~~elL~Hp~~~~~~  425 (434)
                         ..+        . ....+++++.+||.+||..||++||    ++.++++||||....
T Consensus       213 ---~~~--------~-~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~  260 (330)
T cd05586         213 ---KVR--------F-PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADID  260 (330)
T ss_pred             ---CCC--------C-CCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence               000        0 0113577899999999999999998    799999999998765

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.4e-42  Score=331.48  Aligned_cols=278  Identities=33%  Similarity=0.584  Sum_probs=212.6

Q ss_pred             CeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc--------HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~--------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      +|++.+.||+|+||.||+|.+..+++.||+|.++...        ...+..|+.+++.+ +|+||+++++++.+  ....
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~   77 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL-KHPNIIGLLDVFGH--KSNI   77 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhc-CCCCChhhhheeec--CCEE
Confidence            3788999999999999999998889999999986432        23467899999999 89999999999976  4677


Q ss_pred             EEEEeecCCCchhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC
Q 013897          207 SLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG  282 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~  282 (434)
                      ++||||+ +++|..++.    .+++..+..++.||++||.|||++||+|+||||+||+++.++ .++|+|||++......
T Consensus        78 ~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~-~~~l~dfg~~~~~~~~  155 (298)
T cd07841          78 NLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDG-VLKLADFGLARSFGSP  155 (298)
T ss_pred             EEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCC-CEEEccceeeeeccCC
Confidence            8999999 778876652    478899999999999999999999999999999999999776 8999999999776443


Q ss_pred             -CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcccc
Q 013897          283 -KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE  361 (434)
Q Consensus       283 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  361 (434)
                       .......++..|+|||.+.+...++.++|||||||++|+|++|. |++.+....+.+..+...++.+....+.......
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (298)
T cd07841         156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV-PFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP  234 (298)
T ss_pred             CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCC-ccccCCccHHHHHHHHHHcCCCchhhhhhccccc
Confidence             22333456788999999866567899999999999999999995 5556666666666666655544333332111000


Q ss_pred             CChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccccc
Q 013897          362 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA  427 (434)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~  427 (434)
                         ..... ......+     ........+..+.+||.+||+.||++|||+.|+|.||||++...+
T Consensus       235 ---~~~~~-~~~~~~~-----~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~  291 (298)
T cd07841         235 ---DYVEF-KPFPPTP-----LKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAP  291 (298)
T ss_pred             ---ccccc-cccCCcc-----hhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCC
Confidence               00000 0000000     001112356789999999999999999999999999999986543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.2e-42  Score=329.03  Aligned_cols=253  Identities=25%  Similarity=0.441  Sum_probs=201.3

Q ss_pred             CCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccC----CCc
Q 013897          132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ----SKT  205 (434)
Q Consensus       132 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----~~~  205 (434)
                      +.+.|++.+.||+|+||.||+|.+..+++.+|+|.+...  ....+.+|+.+++.+.+|+||+++++++....    ...
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ   83 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence            346788999999999999999999999999999998643  34568899999999878999999999987542    245


Q ss_pred             cEEEEeecCCCchhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecC
Q 013897          206 PSLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH  280 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~  280 (434)
                      .++||||+.+++|..++.     .+++..+..++.|++.||+|||+++|+|+||||+||+++.++ .+||+|||++....
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~-~~~l~Dfg~~~~~~  162 (272)
T cd06637          84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLD  162 (272)
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCC-CEEEccCCCceecc
Confidence            789999999998877643     478888999999999999999999999999999999999776 89999999997654


Q ss_pred             CC-CccceeccCCcccccccccC----CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHH
Q 013897          281 PG-KEYNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL  355 (434)
Q Consensus       281 ~~-~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~  355 (434)
                      .. .......|+..|+|||++.+    ...++.++|||||||++|||++|+.||.... .......+..           
T Consensus       163 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~-~~~~~~~~~~-----------  230 (272)
T cd06637         163 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH-PMRALFLIPR-----------  230 (272)
T ss_pred             cccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC-HHHHHHHHhc-----------
Confidence            32 22344578889999999853    2358889999999999999999999984221 1111100000           


Q ss_pred             hhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          356 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                                      . .       ........++.++.+|+.+||..||.+|||+.|++.||||
T Consensus       231 ----------------~-~-------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         231 ----------------N-P-------APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             ----------------C-C-------CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence                            0 0       0000112356789999999999999999999999999998

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-42  Score=337.67  Aligned_cols=285  Identities=30%  Similarity=0.551  Sum_probs=212.9

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccC---CCc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ---SKT  205 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---~~~  205 (434)
                      .++|++.+.||+|+||.||+|.+..+++.||+|.++..    ....+.+|+.+++.+ +|+||+++++++....   ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~   82 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRF-KHENIIGILDIIRPPSFESFND   82 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhC-CCCCcCchhheeecccccccce
Confidence            47899999999999999999999999999999998642    234577899999999 8999999999876432   235


Q ss_pred             cEEEEeecCCCchhhhc-CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc
Q 013897          206 PSLIFEHVNNTDFKVLY-PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE  284 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~  284 (434)
                      +++|+||+.+.....+. ..+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||++........
T Consensus        83 ~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~~~  161 (336)
T cd07849          83 VYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNC-DLKICDFGLARIADPEHD  161 (336)
T ss_pred             EEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCC-CEEECcccceeecccccc
Confidence            78999999864433332 3588999999999999999999999999999999999999776 899999999976543221


Q ss_pred             ----cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccc
Q 013897          285 ----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI  360 (434)
Q Consensus       285 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  360 (434)
                          .....++..|+|||.+.+...++.++|||||||++|+|++|+.|| .+.+....+..+...++.+....+..-.  
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f-~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  238 (336)
T cd07849         162 HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLF-PGKDYLHQLNLILGVLGTPSQEDLNCII--  238 (336)
T ss_pred             ccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHcCCCCHHHHHHhh--
Confidence                123467889999998766467899999999999999999999887 4555556666666666654332221110  


Q ss_pred             cCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccc
Q 013897          361 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN  426 (434)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~  426 (434)
                        ...................  .......++++.+||.+||+.||++|||+.|+++||||.....
T Consensus       239 --~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~  300 (336)
T cd07849         239 --SLRARNYIKSLPFKPKVPW--NKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD  300 (336)
T ss_pred             --chhhhhHHhhcCcCCcccH--HHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence              0000000000000000000  0001234678999999999999999999999999999997653

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=6.7e-42  Score=326.07  Aligned_cols=277  Identities=30%  Similarity=0.537  Sum_probs=208.6

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      ++|++.+.||+|+||.||+|.++.+++.||+|.+...     ..+.+.+|+.+++.+ +|+|++++++++...  ...++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~--~~~~~   77 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQL-KHPNLVNLIEVFRRK--RKLHL   77 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhC-CCCCEeeeeeEEeeC--CEEEE
Confidence            4689999999999999999999889999999988532     234578899999999 899999999999654  56789


Q ss_pred             EEeecCCCchhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC-c
Q 013897          209 IFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-E  284 (434)
Q Consensus       209 v~e~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~-~  284 (434)
                      ||||++++.+..+..   .+++..++.++.||+.||.|||+.+|+|+||||+||+++.++ .++|+|||++....... .
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~~~  156 (286)
T cd07847          78 VFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQG-QIKLCDFGFARILTGPGDD  156 (286)
T ss_pred             EEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCC-cEEECccccceecCCCccc
Confidence            999999998876653   488999999999999999999999999999999999999776 89999999998765433 2


Q ss_pred             cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCCh
Q 013897          285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP  364 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  364 (434)
                      .....++..|+|||.+.+...++.++|||||||++|+|++|+.|| .+....+.+..+...++......... .  ....
T Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~-~--~~~~  232 (286)
T cd07847         157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLW-PGKSDVDQLYLIRKTLGDLIPRHQQI-F--STNQ  232 (286)
T ss_pred             ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCChHHhhh-c--cccc
Confidence            334567888999999876556889999999999999999999887 44455555555554444321110000 0  0000


Q ss_pred             hHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                      ......   ................++..+.+|+.+||+.||++||++.|+|.||||
T Consensus       233 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         233 FFKGLS---IPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             cccccc---CCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            000000   000000000000112357789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.5e-42  Score=329.63  Aligned_cols=258  Identities=24%  Similarity=0.402  Sum_probs=205.7

Q ss_pred             CCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       132 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      ..+.|+++++||.|+||.||+|.+..++..+|+|.+....   ...+.+|+.+++.+ +|+|++++++.+...  ...++
T Consensus        10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~l   86 (292)
T cd06644          10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATC-NHPYIVKLLGAFYWD--GKLWI   86 (292)
T ss_pred             cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCcEeeeEEEEEeC--CeEEE
Confidence            3477999999999999999999998899999999987543   34577899999998 899999999998654  46789


Q ss_pred             EEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC-C
Q 013897          209 IFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-K  283 (434)
Q Consensus       209 v~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~-~  283 (434)
                      ||||++++++..+.    ..+++..+..++.|++.||.|||+++|+||||||+||+++.++ .+||+|||++...... .
T Consensus        87 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~kl~dfg~~~~~~~~~~  165 (292)
T cd06644          87 MIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDG-DIKLADFGVSAKNVKTLQ  165 (292)
T ss_pred             EEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCC-CEEEccCccceecccccc
Confidence            99999999986553    3578999999999999999999999999999999999998666 8999999998654322 2


Q ss_pred             ccceeccCCcccccccccC----CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcc
Q 013897          284 EYNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH  359 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~~----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  359 (434)
                      ......++..|+|||.+.+    ...++.++|||||||++|+|++|..||... +.......+.   ...          
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~-~~~~~~~~~~---~~~----------  231 (292)
T cd06644         166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIA---KSE----------  231 (292)
T ss_pred             ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc-cHHHHHHHHh---cCC----------
Confidence            2345568889999999852    245788999999999999999999998332 2111111110   000          


Q ss_pred             ccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccccc
Q 013897          360 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~  428 (434)
                                     .      ........++.++.+||.+||..||++||+++|+++||||..++...
T Consensus       232 ---------------~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~  279 (292)
T cd06644         232 ---------------P------PTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNR  279 (292)
T ss_pred             ---------------C------ccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccch
Confidence                           0      00111223567899999999999999999999999999999987765

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-42  Score=323.03  Aligned_cols=247  Identities=23%  Similarity=0.412  Sum_probs=199.4

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc--------HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCc
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT  205 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~--------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  205 (434)
                      ++|++.+.||+|++|.||+|.+..++..+|+|.+....        ...+.+|+.+++++ +||||+++++++.+.  ..
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~   78 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-QHERIVQYYGCLRDD--ET   78 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEccC--Ce
Confidence            46889999999999999999998899999999885321        24578899999999 999999999999654  47


Q ss_pred             cEEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC
Q 013897          206 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG  282 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~  282 (434)
                      +++|+||+.++++...+   ..+++..++.++.|++.||.|||+.||+|+||||+||+++.++ .++|+|||+++.....
T Consensus        79 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~-~~~l~dfg~~~~~~~~  157 (263)
T cd06625          79 LSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAG-NVKLGDFGASKRLQTI  157 (263)
T ss_pred             EEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEeecccceecccc
Confidence            88999999999887665   3578888999999999999999999999999999999999766 8999999999765432


Q ss_pred             Ccc----ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhc
Q 013897          283 KEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY  358 (434)
Q Consensus       283 ~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  358 (434)
                      ...    ....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||... ........+..   ..         
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~-~~~~~~~~~~~---~~---------  223 (263)
T cd06625         158 CSSGTGMKSVTGTPYWMSPEVISG-EGYGRKADVWSVGCTVVEMLTEKPPWAEF-EAMAAIFKIAT---QP---------  223 (263)
T ss_pred             ccccccccCCCcCccccCcceecc-CCCCchhhhHHHHHHHHHHHhCCCCcccc-chHHHHHHHhc---cC---------
Confidence            211    23457788999999987 56899999999999999999999998432 11111111100   00         


Q ss_pred             cccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                                             .....+..++..+.+||.+||..||++|||+.|+|+||||
T Consensus       224 -----------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         224 -----------------------TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             -----------------------CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence                                   0001122367789999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-42  Score=339.55  Aligned_cols=261  Identities=23%  Similarity=0.347  Sum_probs=198.5

Q ss_pred             CCCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       131 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      .++++|...+.||+|+||.||+|.. .++..||||.+....   ..+|.+|+.++.++ +|||+|+|+|||.+... ..+
T Consensus        72 ~AT~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l-~H~Nlv~LlGyC~e~~~-~~~  148 (361)
T KOG1187|consen   72 KATNNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQGEREFLNEVEILSRL-RHPNLVKLLGYCLEGGE-HRL  148 (361)
T ss_pred             HHHhCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcchhHHHHHHHHHhcC-CCcCcccEEEEEecCCc-eEE
Confidence            4578899999999999999999997 455999999987644   46799999999999 79999999999986643 578


Q ss_pred             EEEeecCCCchhhhcC-----CCChHHHHHHHHHHHHHHHHHHHC---CceeecCCCCceEecCCCCeEEEEecccceec
Q 013897          208 LIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQ---GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY  279 (434)
Q Consensus       208 lv~e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~  279 (434)
                      ||||||.+|+|.+++.     .++|..+..|+.++++||+|||+.   .||||||||+|||||.+. ..||+|||+|+..
T Consensus       149 LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~-~aKlsDFGLa~~~  227 (361)
T KOG1187|consen  149 LVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDF-NAKLSDFGLAKLG  227 (361)
T ss_pred             EEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCC-CEEccCccCcccC
Confidence            9999999999977752     678999999999999999999985   399999999999999776 8999999999766


Q ss_pred             CC-CCcccee-ccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCC-HHHHHHHH-HHhCChhHHHHH
Q 013897          280 HP-GKEYNVR-VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN-YDQLVKIA-KVLGTDELNAYL  355 (434)
Q Consensus       280 ~~-~~~~~~~-~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~-~~~~~~i~-~~~g~~~~~~~~  355 (434)
                      .. ....... .||..|+|||++.. +..+.|+|||||||+|+||+||+.+....... ...+.... ..+...      
T Consensus       228 ~~~~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~------  300 (361)
T KOG1187|consen  228 PEGDTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG------  300 (361)
T ss_pred             CccccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc------
Confidence            54 3333333 89999999999876 68999999999999999999999887543211 11111111 111100      


Q ss_pred             hhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          356 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                       +....+|+.+..       ..+...       ..-..+..+..+|++.+|++||++.||+.
T Consensus       301 -~~~eiiD~~l~~-------~~~~~~-------~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  301 -KLREIVDPRLKE-------GEYPDE-------KEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             -chhheeCCCccC-------CCCChH-------HHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence             122222222110       000000       11234778889999999999999999753

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.6e-42  Score=354.03  Aligned_cols=249  Identities=23%  Similarity=0.362  Sum_probs=201.2

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCC-CeEEEEEEecccc---HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTD-NEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~-~~~vaiK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      ..|.+.+.||+|+||.||+|....+ +..||+|.+....   ...+.+|+.+|+.+ +|||||++++++...  ...+||
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~--~~~~lv  143 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAAC-DHFGIVKHFDDFKSD--DKLLLI  143 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEEEC--CEEEEE
Confidence            4599999999999999999998777 7889999764332   24567899999999 999999999999654  577899


Q ss_pred             EeecCCCchhhhc-------CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC
Q 013897          210 FEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG  282 (434)
Q Consensus       210 ~e~~~~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~  282 (434)
                      |||+.+++|...+       ..+++.++..++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+++.....
T Consensus       144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~-~~kL~DFgla~~~~~~  222 (478)
T PTZ00267        144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTG-IIKLGDFGFSKQYSDS  222 (478)
T ss_pred             EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCC-cEEEEeCcCceecCCc
Confidence            9999999986543       2478889999999999999999999999999999999999776 8999999999876433


Q ss_pred             Cc---cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcc
Q 013897          283 KE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH  359 (434)
Q Consensus       283 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  359 (434)
                      ..   ....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.. .+..+.+..+..  +.           
T Consensus       223 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~~-~~~~~~~~~~~~--~~-----------  287 (478)
T PTZ00267        223 VSLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFKG-PSQREIMQQVLY--GK-----------  287 (478)
T ss_pred             cccccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHh--CC-----------
Confidence            22   234579999999999876 6899999999999999999999999842 222222211110  00           


Q ss_pred             ccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccc
Q 013897          360 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI  424 (434)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~  424 (434)
                                   .  .        ..+..+++++.+||.+||..||++||+++++|.|||++.+
T Consensus       288 -------------~--~--------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~  329 (478)
T PTZ00267        288 -------------Y--D--------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV  329 (478)
T ss_pred             -------------C--C--------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence                         0  0        0112356789999999999999999999999999999754

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-45  Score=322.74  Aligned_cols=286  Identities=29%  Similarity=0.460  Sum_probs=225.1

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeEeeEEEcc------C
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQ------Q  202 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~------~  202 (434)
                      ..|+-+.+||+|.||+||+|+.+.++++||+|++--..     .....+|+++|+.| .|+|++.+++.|...      .
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~l-kHenv~nliEic~tk~Tp~~r~   95 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKATPTNRD   95 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHh-cchhHHHHHHHHhhccCCcccc
Confidence            55778889999999999999999999999988653211     24568999999999 999999999987532      2


Q ss_pred             CCccEEEEeecCCCchh---hhcCCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceec
Q 013897          203 SKTPSLIFEHVNNTDFK---VLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY  279 (434)
Q Consensus       203 ~~~~~lv~e~~~~~~l~---~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~  279 (434)
                      ...+++||.+|++....   ....+++..+++.++.+++.||.|+|...|+|||+||+|+||+.++ .+||+|||+++.+
T Consensus        96 r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dg-ilklADFGlar~f  174 (376)
T KOG0669|consen   96 RATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDG-ILKLADFGLARAF  174 (376)
T ss_pred             cceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCc-eEEeeccccccce
Confidence            23478999999986543   3345689999999999999999999999999999999999999777 8999999999766


Q ss_pred             CC-----CCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHH
Q 013897          280 HP-----GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAY  354 (434)
Q Consensus       280 ~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~  354 (434)
                      ..     ...++.++.|.+|++||.+.|.+.|+++.|||..|||+.||.||. |...+..+..++..|...+|......|
T Consensus       175 s~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrs-pimqgnteqqql~~Is~LcGs~tkevW  253 (376)
T KOG0669|consen  175 STSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRS-PIMQGNTEQQQLHLISQLCGSITKEVW  253 (376)
T ss_pred             ecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccC-ccccCChHHHHHHHHHHHhccCCcccC
Confidence            42     234677889999999999999999999999999999999999987 666899999999999999998776666


Q ss_pred             HhhccccCChhHHHHhcc-cCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccc
Q 013897          355 LNKYHIELDPHLAALVGR-HSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                      ++-....+-   ..+... .....+........+-.-++++.||+.++|.+||.+|+++.++|+|.||.+-.
T Consensus       254 P~~d~lpL~---~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp  322 (376)
T KOG0669|consen  254 PNVDNLPLY---QSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDP  322 (376)
T ss_pred             CCcccchHH---HhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCC
Confidence            543222211   111000 01111111111111222357899999999999999999999999999998543

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-45  Score=332.55  Aligned_cols=253  Identities=23%  Similarity=0.359  Sum_probs=209.0

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEee
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH  212 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  212 (434)
                      +-|.++++||+|+||.||++.++.+|+.+|||.+... ...++.+|+.+|+++ ..|++|++||.+..  ...+++||||
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC-~S~yVVKYYGSYFK--~sDLWIVMEY  109 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQC-KSKYVVKYYGSYFK--HSDLWIVMEY  109 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHc-CCchhhhhhhhhcc--CCceEeehhh
Confidence            4577999999999999999999999999999998754 457899999999998 99999999997743  3567899999


Q ss_pred             cCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC-Cccce
Q 013897          213 VNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYNV  287 (434)
Q Consensus       213 ~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~-~~~~~  287 (434)
                      |+.|+..+.+    +++++.++..+++..++||+|||...-+|||||+.|||++.+| ..||+|||.|..+.+. ...++
T Consensus       110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G-~AKLADFGVAGQLTDTMAKRNT  188 (502)
T KOG0574|consen  110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDG-IAKLADFGVAGQLTDTMAKRNT  188 (502)
T ss_pred             cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccc-hhhhhhccccchhhhhHHhhCc
Confidence            9999987664    5699999999999999999999999999999999999999888 8999999999766433 23467


Q ss_pred             eccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHH
Q 013897          288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLA  367 (434)
Q Consensus       288 ~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~  367 (434)
                      ..||++|||||++.. -+|+.++||||||+...||.-|++||..    ..-+..|+..                      
T Consensus       189 VIGTPFWMAPEVI~E-IGY~~~ADIWSLGITaIEMAEG~PPYsD----IHPMRAIFMI----------------------  241 (502)
T KOG0574|consen  189 VIGTPFWMAPEVIEE-IGYDTKADIWSLGITAIEMAEGRPPYSD----IHPMRAIFMI----------------------  241 (502)
T ss_pred             cccCcccccHHHHHH-hccchhhhHhhhcchhhhhhcCCCCccc----ccccceeEec----------------------
Confidence            789999999999986 6899999999999999999999999822    1111111110                      


Q ss_pred             HHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccc
Q 013897          368 ALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN  426 (434)
Q Consensus       368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~  426 (434)
                            +..+.   .++..+...+.++.||++.||...|++|-||.++++|||+++..-
T Consensus       242 ------PT~PP---PTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g  291 (502)
T KOG0574|consen  242 ------PTKPP---PTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPG  291 (502)
T ss_pred             ------cCCCC---CCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCc
Confidence                  00111   112223345678999999999999999999999999999997643

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=5.6e-42  Score=328.39  Aligned_cols=282  Identities=32%  Similarity=0.580  Sum_probs=210.3

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      ++|++.+.||+|++|.||+|.++.+++.||+|.+...     ..+.+.+|+.+++.+ +||||+++++++.+.  ...++
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~l   78 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSE--KRLYL   78 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhc-cCCCEeeEEEEEecC--CeEEE
Confidence            5799999999999999999999889999999988532     235678899999999 999999999999654  57789


Q ss_pred             EEeecCCCchhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC-C
Q 013897          209 IFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-K  283 (434)
Q Consensus       209 v~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~-~  283 (434)
                      ||||+++..+..+..    .+++..+..++.||+.||+|||+++|+|+||||+||+++.++..+||+|||++...... .
T Consensus        79 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~  158 (294)
T PLN00009         79 VFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR  158 (294)
T ss_pred             EEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence            999997644333322    24677888999999999999999999999999999999866658999999999765322 2


Q ss_pred             ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                      ......++..|+|||.+.+...++.++|||||||++|+|++|+.||. ..+..+...++....+.+....|.....   -
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~  234 (294)
T PLN00009        159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFP-GDSEIDELFKIFRILGTPNEETWPGVTS---L  234 (294)
T ss_pred             ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHHhCCCChhhcccccc---c
Confidence            23345678899999998765568899999999999999999998884 3444455555555544433222211000   0


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccccc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA  427 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~  427 (434)
                      +++....   .  .+...........+++++.+++.+||..||++||++.++|+||||..++.+
T Consensus       235 ~~~~~~~---~--~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~~  293 (294)
T PLN00009        235 PDYKSAF---P--KWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGDA  293 (294)
T ss_pred             hhhhhhc---c--cCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhcC
Confidence            1110000   0  000000011123467789999999999999999999999999999998765

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=9.6e-42  Score=324.93  Aligned_cols=273  Identities=32%  Similarity=0.618  Sum_probs=206.2

Q ss_pred             CeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      +|++++.||.|+||.||+|.+..+++.||||.++..     ....+.+|+++++++ +||||+++++++.+  ....++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~~v   77 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLDVIHT--ENKLYLV   77 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhc-CCCCCcchhhhccc--CCcEEEE
Confidence            478999999999999999999889999999988632     225688999999999 99999999999864  3567899


Q ss_pred             EeecCCCchhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC-C
Q 013897          210 FEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-K  283 (434)
Q Consensus       210 ~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~-~  283 (434)
                      |||+.+ ++..++     ..+++..+..++.|++.||+|||+++++|+||+|+||+++.++ .+||+|||++...... .
T Consensus        78 ~e~~~~-~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~-~~~l~dfg~~~~~~~~~~  155 (284)
T cd07860          78 FEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVR  155 (284)
T ss_pred             eecccc-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEEeeccchhhcccCcc
Confidence            999975 554432     3478889999999999999999999999999999999999776 8999999998765332 2


Q ss_pred             ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                      ......++..|+|||.+.+...++.++|||||||++|+|+||+.||. +.+......++.+.++.+....+.....   .
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~  231 (284)
T cd07860         156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFP-GDSEIDQLFRIFRTLGTPDEVVWPGVTS---L  231 (284)
T ss_pred             ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHHHhCCCChhhhhhhhH---H
Confidence            22334567889999998765567889999999999999999999984 4445555666666655543222211000   0


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                      +.............   ..  .....+++++.++|.+||+.||++|||++++|+||||
T Consensus       232 ~~~~~~~~~~~~~~---~~--~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         232 PDYKPSFPKWARQD---FS--KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HHHHhhcccccccC---HH--HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            00000000000000   00  0012366789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.8e-42  Score=335.06  Aligned_cols=285  Identities=31%  Similarity=0.574  Sum_probs=215.9

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC---C
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS---K  204 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~---~  204 (434)
                      .++|.+.+.||+|+||.||+|.+..++..||||.++..     ....+.+|+.+++.+ +|+||+++++++.....   .
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~~~   82 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL-DHENVIAIKDIMPPPHREAFN   82 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhc-CCCCccchHHheecccccccC
Confidence            46799999999999999999999999999999988642     234577899999998 99999999998864322   3


Q ss_pred             ccEEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC
Q 013897          205 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP  281 (434)
Q Consensus       205 ~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~  281 (434)
                      .+++|+||+.+ +|..++   ..+++..+..++.||+.||.|||+++++||||||+||+++.++ .+||+|||++.....
T Consensus        83 ~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~  160 (337)
T cd07858          83 DVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARTTSE  160 (337)
T ss_pred             cEEEEEeCCCC-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CEEECcCccccccCC
Confidence            57899999975 444433   4588999999999999999999999999999999999999776 899999999976643


Q ss_pred             C-CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccc
Q 013897          282 G-KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI  360 (434)
Q Consensus       282 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  360 (434)
                      . .......++..|+|||.+.+...++.++|||||||++|+|++|+.|| .+.+.......+....|......+.    .
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~----~  235 (337)
T cd07858         161 KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLF-PGKDYVHQLKLITELLGSPSEEDLG----F  235 (337)
T ss_pred             CcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCC-CCCChHHHHHHHHHHhCCCChHHhh----h
Confidence            3 22344567889999999875456899999999999999999999887 4545555566666666654332221    1


Q ss_pred             cCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccccc
Q 013897          361 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA  427 (434)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~  427 (434)
                      ..++..................  .....+++++.+||.+||+.||++|||++|+|+||||..+...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~  300 (337)
T cd07858         236 IRNEKARRYIRSLPYTPRQSFA--RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP  300 (337)
T ss_pred             cCchhhhHHHHhcCcccccCHH--HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence            1112222222111111111110  1112467899999999999999999999999999999876543

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.5e-41  Score=324.90  Aligned_cols=255  Identities=26%  Similarity=0.464  Sum_probs=202.0

Q ss_pred             CCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccC---CCcc
Q 013897          132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ---SKTP  206 (434)
Q Consensus       132 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---~~~~  206 (434)
                      ..++|.+.+.||+|+||.||++....+++.+|+|++...  ....+.+|+.+++++.+|||++++++++....   ....
T Consensus        20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~   99 (291)
T cd06639          20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL   99 (291)
T ss_pred             CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence            468899999999999999999999889999999998653  24567889999999878999999999987543   2467


Q ss_pred             EEEEeecCCCchhhhc-------CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceec
Q 013897          207 SLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY  279 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~  279 (434)
                      ++|+||+.+++|..++       ..+++..++.++.|++.||+|||+++|+|+||||+||+++.++ .+||+|||++...
T Consensus       100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~-~~kl~dfg~~~~~  178 (291)
T cd06639         100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEG-GVKLVDFGVSAQL  178 (291)
T ss_pred             EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCC-CEEEeecccchhc
Confidence            8999999999987654       3578889999999999999999999999999999999999776 7999999998765


Q ss_pred             CCCC-ccceeccCCcccccccccCCC----CCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHH
Q 013897          280 HPGK-EYNVRVASRYFKGPELLVDLQ----DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAY  354 (434)
Q Consensus       280 ~~~~-~~~~~~~t~~y~aPE~~~~~~----~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~  354 (434)
                      .... ......++..|+|||.+....    .++.++|||||||++|+|++|+.||... .....+..+..   ..     
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~-~~~~~~~~~~~---~~-----  249 (291)
T cd06639         179 TSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM-HPVKTLFKIPR---NP-----  249 (291)
T ss_pred             ccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCC-cHHHHHHHHhc---CC-----
Confidence            4322 223446788899999975422    3688999999999999999999998432 21111111110   00     


Q ss_pred             HhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcc
Q 013897          355 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFF  422 (434)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~  422 (434)
                                          .      .........+..+.+||.+||+.||++||++.|+++||||+
T Consensus       250 --------------------~------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         250 --------------------P------PTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             --------------------C------CCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence                                0      00011122456799999999999999999999999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.7e-42  Score=337.39  Aligned_cols=284  Identities=19%  Similarity=0.238  Sum_probs=197.0

Q ss_pred             EEeeeeec--CceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEE
Q 013897          138 VVRKVGRG--KYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF  210 (434)
Q Consensus       138 ~~~~lG~G--~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  210 (434)
                      ++++||+|  +|++||++.++.+++.||+|.++...     ...+.+|+.+++.+ +||||+++++++...  ...++||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~--~~~~lv~   78 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLF-NHPNIVPYRATFIAD--NELWVVT   78 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEEC--CEEEEEE
Confidence            46789999  78999999999999999999986432     24577899999998 999999999999754  4678999


Q ss_pred             eecCCCchhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc-
Q 013897          211 EHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-  284 (434)
Q Consensus       211 e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~-  284 (434)
                      ||+.++++..++     ..+++..++.++.||+.||+|||+++|+||||||+|||++.++ .++++||+.+........ 
T Consensus        79 e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~-~~~l~~~~~~~~~~~~~~~  157 (327)
T cd08227          79 SFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG-KVYLSGLRSNLSMINHGQR  157 (327)
T ss_pred             eccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCC-cEEEcccchhhcccccccc
Confidence            999999987665     2478899999999999999999999999999999999999776 899999987543321110 


Q ss_pred             -------cceeccCCcccccccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCC----hhH-
Q 013897          285 -------YNVRVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT----DEL-  351 (434)
Q Consensus       285 -------~~~~~~t~~y~aPE~~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~----~~~-  351 (434)
                             .....++..|+|||++.+. ..++.++|||||||++|||++|+.||............+......    ... 
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (327)
T cd08227         158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP  237 (327)
T ss_pred             ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchh
Confidence                   1123456779999998653 368999999999999999999999985332221111111100000    000 


Q ss_pred             HHHHh--hccccCChhHHHHhc-ccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccc
Q 013897          352 NAYLN--KYHIELDPHLAALVG-RHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       352 ~~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                      .....  ......+........ ...+..............+++++.+||.+||+.||++|||++|+|+||||+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~  314 (327)
T cd08227         238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK  314 (327)
T ss_pred             hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence            00000  000000000000000 000000000001112234678899999999999999999999999999998764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.1e-41  Score=324.88  Aligned_cols=254  Identities=27%  Similarity=0.465  Sum_probs=201.4

Q ss_pred             CCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc--HHHHHHHHHHHHHhcCCCCeeeEeeEEEc---cCCCcc
Q 013897          132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRD---QQSKTP  206 (434)
Q Consensus       132 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~E~~~l~~l~~h~niv~l~~~~~~---~~~~~~  206 (434)
                      ..++|++.+.||+|+||.||+|.+..+++.+|+|+++...  ...+.+|+.+++++.+||||+++++++..   ......
T Consensus        16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   95 (286)
T cd06638          16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL   95 (286)
T ss_pred             cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeE
Confidence            3578999999999999999999999999999999986532  35688899999999779999999998753   234568


Q ss_pred             EEEEeecCCCchhhhc-------CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceec
Q 013897          207 SLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY  279 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~  279 (434)
                      ++||||+++++|..++       ..+++..+..++.|++.||.|||+++|+||||||+||+++.++ .+||+|||++...
T Consensus        96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~-~~kl~dfg~~~~~  174 (286)
T cd06638          96 WLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEG-GVKLVDFGVSAQL  174 (286)
T ss_pred             EEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCC-CEEEccCCceeec
Confidence            9999999999987643       3477888999999999999999999999999999999999776 7999999999766


Q ss_pred             CCCC-ccceeccCCcccccccccC----CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHH
Q 013897          280 HPGK-EYNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAY  354 (434)
Q Consensus       280 ~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~  354 (434)
                      .... ......|+..|+|||++..    ...++.++|||||||++|||++|+.||.... ....+..+..          
T Consensus       175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~-~~~~~~~~~~----------  243 (286)
T cd06638         175 TSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH-PMRALFKIPR----------  243 (286)
T ss_pred             ccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCc-hhHHHhhccc----------
Confidence            4322 2234578899999999753    1457889999999999999999999984322 1111111000          


Q ss_pred             HhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          355 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                                        ..      .........++..+.+|+.+||+.||++|||+.|+|+|+||
T Consensus       244 ------------------~~------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         244 ------------------NP------PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             ------------------cC------CCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence                              00      00011112346689999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.1e-41  Score=328.47  Aligned_cols=281  Identities=30%  Similarity=0.475  Sum_probs=205.2

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC----
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS----  203 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~----  203 (434)
                      -++|++.++||+|+||.||+|.+..+++.||||.+....     ...+.+|+.+++.+ +||||+++++++.....    
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhC-CCCCccceEEEEecccccccC
Confidence            367999999999999999999999999999999885322     23456899999999 99999999998865432    


Q ss_pred             --CccEEEEeecCCCchhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEeccccee
Q 013897          204 --KTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF  278 (434)
Q Consensus       204 --~~~~lv~e~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~  278 (434)
                        ...++||||+.+.....+..   .+++.+++.++.||+.||.|||++|++|+||||+||+++.++ .+||+|||++..
T Consensus        90 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~  168 (310)
T cd07865          90 YKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDG-ILKLADFGLARA  168 (310)
T ss_pred             CCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCC-cEEECcCCCccc
Confidence              34689999998744333322   478999999999999999999999999999999999999776 899999999976


Q ss_pred             cCCCC-----ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHH
Q 013897          279 YHPGK-----EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA  353 (434)
Q Consensus       279 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~  353 (434)
                      .....     ......++..|+|||.+.+...++.++|||||||++|+|++|+.|| .+.+....+..+.+..|......
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  247 (310)
T cd07865         169 FSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIM-QGNTEQHQLTLISQLCGSITPEV  247 (310)
T ss_pred             ccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCChhh
Confidence            53321     1123457788999999876556789999999999999999999777 45555556666666555432221


Q ss_pred             HHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          354 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                      +........    ..... ..................++.+.+||.+||..||.+|||++|+|+||||
T Consensus       248 ~~~~~~~~~----~~~~~-~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         248 WPGVDKLEL----FKKME-LPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             cccccchhh----hhhcc-CCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            111000000    00000 0000000000000111245678999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=4.5e-42  Score=331.60  Aligned_cols=283  Identities=23%  Similarity=0.318  Sum_probs=206.4

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      ++|++.+.||+|+||.||++.+..++..+|+|.++..    ...++.+|+++++++ +||||+++++.+.+.  ..+++|
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv   77 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHEC-NSPYIVGFYGAFYSD--GEISIC   77 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeC--CEEEEE
Confidence            4689999999999999999999999999999998643    234578999999999 999999999999654  567899


Q ss_pred             EeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHH-CCceeecCCCCceEecCCCCeEEEEecccceecCCCCcc
Q 013897          210 FEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY  285 (434)
Q Consensus       210 ~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~  285 (434)
                      |||+.+++|..++   ..+++..+..++.|++.||.|||+ .+++|+||||+|||++.++ .+||+|||++...... ..
T Consensus        78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~-~~  155 (308)
T cd06615          78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDS-MA  155 (308)
T ss_pred             eeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCC-cEEEccCCCccccccc-cc
Confidence            9999999997775   357888999999999999999998 5899999999999999766 8999999998765332 23


Q ss_pred             ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHH----HHHhhcccc
Q 013897          286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELN----AYLNKYHIE  361 (434)
Q Consensus       286 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~----~~~~~~~~~  361 (434)
                      ...+++..|+|||.+.+ ..++.++|||||||++|+|++|+.||....  ......+..........    .........
T Consensus       156 ~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (308)
T cd06615         156 NSFVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPD--AKELEAMFGRPVSEGEAKESHRPVSGHPPD  232 (308)
T ss_pred             ccCCCCcCccChhHhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCcc--hhhHHHhhcCccccccccCCcccccCCCCC
Confidence            44578889999999876 578899999999999999999999984332  12222111100000000    000000000


Q ss_pred             CC--hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccccc
Q 013897          362 LD--PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       362 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~  428 (434)
                      ..  ................    ......++.++.+|+.+||..||++|||+.|+++||||.+.+..+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~  297 (308)
T cd06615         233 SPRPMAIFELLDYIVNEPPP----KLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELEE  297 (308)
T ss_pred             ccchhhHHHHHHHHhcCCCc----cCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhccccc
Confidence            00  0000000000000000    000112567899999999999999999999999999999875543

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=6.6e-42  Score=325.75  Aligned_cols=253  Identities=24%  Similarity=0.420  Sum_probs=198.0

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.++...    ...+..|+.++.+..+||||+++++++...  ...++|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~--~~~~lv   78 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFRE--GDVWIC   78 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecC--CcEEEE
Confidence            47899999999999999999999999999999986432    244566777655555999999999999654  467899


Q ss_pred             EeecCCCchhhhc-------CCCChHHHHHHHHHHHHHHHHHHHC-CceeecCCCCceEecCCCCeEEEEecccceecCC
Q 013897          210 FEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP  281 (434)
Q Consensus       210 ~e~~~~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~  281 (434)
                      |||+++. +..++       ..+++..+..++.||+.||+|||++ +++||||||+|||++.++ .+||+|||++.....
T Consensus        79 ~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~-~~kl~dfg~~~~~~~  156 (283)
T cd06617          79 MEVMDTS-LDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNG-QVKLCDFGISGYLVD  156 (283)
T ss_pred             hhhhccc-HHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC-CEEEeeccccccccc
Confidence            9999853 32221       2478899999999999999999997 999999999999999776 899999999986644


Q ss_pred             CCccceeccCCcccccccccCC---CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhc
Q 013897          282 GKEYNVRVASRYFKGPELLVDL---QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY  358 (434)
Q Consensus       282 ~~~~~~~~~t~~y~aPE~~~~~---~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  358 (434)
                      ....+...++..|+|||.+.+.   ..++.++|+|||||++|+|++|+.||.......+.+..+.....           
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----------  225 (283)
T cd06617         157 SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPS-----------  225 (283)
T ss_pred             ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCC-----------
Confidence            3333445688889999988542   35788999999999999999999998543333333222111000           


Q ss_pred             cccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccc
Q 013897          359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                                     .         ......++.++.+||.+||..||++||++.++++||||.+..
T Consensus       226 ---------------~---------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  268 (283)
T cd06617         226 ---------------P---------QLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL  268 (283)
T ss_pred             ---------------C---------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence                           0         000112567899999999999999999999999999999865

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-41  Score=332.55  Aligned_cols=284  Identities=33%  Similarity=0.592  Sum_probs=211.4

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC----
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS----  203 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~----  203 (434)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|.++..     ....+.+|+.+++.+ +||||+++++++.....    
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~   92 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHM-QHENVIGLLDVFTSAVSGDEF   92 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhc-CCCCccchhheecccccCCCC
Confidence            46899999999999999999999889999999998642     124578899999999 99999999999864322    


Q ss_pred             CccEEEEeecCCCchhhhc-CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC
Q 013897          204 KTPSLIFEHVNNTDFKVLY-PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG  282 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~  282 (434)
                      ...++|+||+.. ++.... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++ .+||+|||+++.... 
T Consensus        93 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~-~~kL~dfg~~~~~~~-  169 (342)
T cd07879          93 QDFYLVMPYMQT-DLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDC-ELKILDFGLARHADA-  169 (342)
T ss_pred             ceEEEEeccccc-CHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEeeCCCCcCCCC-
Confidence            245899999975 454443 3689999999999999999999999999999999999999776 899999999975432 


Q ss_pred             CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                       ......++..|+|||.+.+...++.++|||||||++|||++|+.||. +.+....+..+....+.+.. .+........
T Consensus       170 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~-~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  246 (342)
T cd07879         170 -EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFK-GKDYLDQLTQILKVTGVPGP-EFVQKLEDKA  246 (342)
T ss_pred             -CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHhcCCCCH-HHHHHhcccc
Confidence             23345678889999998764568899999999999999999999984 44445555555555443321 1111110000


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccccc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~  428 (434)
                      ............+..+..     .....++.+.+||.+||+.||++||+++|+|.||||..++.++
T Consensus       247 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~  307 (342)
T cd07879         247 AKSYIKSLPKYPRKDFST-----LFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDAD  307 (342)
T ss_pred             hHHHHhhcCCcccchHHH-----HhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccc
Confidence            000000000000000000     0123567899999999999999999999999999999988654

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.3e-41  Score=332.05  Aligned_cols=286  Identities=29%  Similarity=0.567  Sum_probs=216.0

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEcc--CCCc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ--QSKT  205 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~~~  205 (434)
                      .++|++.+.||+|+||.||+|.+..+++.||+|.+...     ....+.+|+.+++.+ +||||+++++++...  ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~   82 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF-KHDNIIAIRDILRPPGADFKD   82 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhc-CCCCccCHHHhccccCCCCce
Confidence            47899999999999999999999999999999998642     235577899999999 899999999987643  2356


Q ss_pred             cEEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC
Q 013897          206 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG  282 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~  282 (434)
                      +++||||+.+ ++..++   ..+++..++.++.||+.||.|||+++|+||||||+||+++.++ .+||+|||++......
T Consensus        83 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~-~~kl~dfg~~~~~~~~  160 (334)
T cd07855          83 VYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDC-ELRIGDFGMARGLSSS  160 (334)
T ss_pred             EEEEEehhhh-hHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-cEEecccccceeeccc
Confidence            7899999975 555544   3488999999999999999999999999999999999999776 8999999999765322


Q ss_pred             Cc-----cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhh
Q 013897          283 KE-----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK  357 (434)
Q Consensus       283 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  357 (434)
                      ..     ....+++..|+|||.+.+...++.++|||||||++|+|++|+.|| .+.+...++..+...+|.+....+...
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf-~~~~~~~~~~~~~~~~g~~~~~~~~~~  239 (334)
T cd07855         161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLF-PGKNYVHQLKLILSVLGSPSEEVLNRI  239 (334)
T ss_pred             CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCcc-CCCChHHHHHHHHHHhCCChhHhhhhh
Confidence            11     123478889999999866456899999999999999999999888 555556666666666665432221110


Q ss_pred             ccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccccc
Q 013897          358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~  428 (434)
                      .    ..................+  .......++++.+||.+||+.||++||++++++.||||.+....+
T Consensus       240 ~----~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~  304 (334)
T cd07855         240 G----SDRVRKYIQNLPRKQPVPW--SKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPD  304 (334)
T ss_pred             c----hhhHHHHHhhcccCCCCCH--HHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCc
Confidence            0    0111111111110000000  001123578899999999999999999999999999998776554

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.6e-41  Score=324.80  Aligned_cols=250  Identities=26%  Similarity=0.460  Sum_probs=205.1

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      ++|.+.+.||+|+||.||++.+..+++.+|+|+++..      ..+.+.+|+++++++ +||||+++++++.+.  ...+
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~   77 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-RHPFLVNLYGSFQDD--SNLY   77 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCccceeeEEEcC--CeEE
Confidence            4689999999999999999999889999999998642      235678899999999 899999999998654  5678


Q ss_pred             EEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc
Q 013897          208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE  284 (434)
Q Consensus       208 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~  284 (434)
                      +||||+.+++|..++   ..+++..+..++.||+.||.|||++||+|+||+|+|||++.++ .+||+|||++......  
T Consensus        78 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~-~~kl~dfg~~~~~~~~--  154 (290)
T cd05580          78 LVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDG-YIKITDFGFAKRVKGR--  154 (290)
T ss_pred             EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC-CEEEeeCCCccccCCC--
Confidence            999999999987665   4588999999999999999999999999999999999999776 8999999999876443  


Q ss_pred             cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCCh
Q 013897          285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP  364 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  364 (434)
                      .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.... .......+..  +.                
T Consensus       155 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~--~~----------------  214 (290)
T cd05580         155 TYTLCGTPEYLAPEIILS-KGYGKAVDWWALGILIYEMLAGYPPFFDDN-PIQIYEKILE--GK----------------  214 (290)
T ss_pred             CCCCCCCccccChhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhc--CC----------------
Confidence            334468889999999876 578899999999999999999999984332 1111111110  00                


Q ss_pred             hHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCc-----cHHHHhcCCCcccccccc
Q 013897          365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-----TAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rp-----t~~elL~Hp~~~~~~~~~  428 (434)
                                         .......++.+.++|.+||..||.+|+     +++|+++||||..+.+..
T Consensus       215 -------------------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~  264 (290)
T cd05580         215 -------------------VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIA  264 (290)
T ss_pred             -------------------ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHHH
Confidence                               001112467899999999999999999     999999999999887544

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.7e-41  Score=327.17  Aligned_cols=279  Identities=30%  Similarity=0.532  Sum_probs=208.8

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccC-----
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ-----  202 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~-----  202 (434)
                      .++|++.+.||+|+||.||+|.+..+++.+|+|.+....     ...+.+|+++++.+ +||||+++++++.+..     
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~   85 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL-KHPNVVPLIDMAVERPDKSKR   85 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhc-CCCCccchhhheecccccccc
Confidence            478999999999999999999999899999999885321     23567899999999 9999999999876533     


Q ss_pred             -CCccEEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEeccccee
Q 013897          203 -SKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF  278 (434)
Q Consensus       203 -~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~  278 (434)
                       ...+++|+||+.+..+..+.   ..+++..++.++.||++||.|||++||+|+||||+||+++.++ .++|+|||++..
T Consensus        86 ~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~  164 (311)
T cd07866          86 KRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQG-ILKIADFGLARP  164 (311)
T ss_pred             cCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEECcCccchh
Confidence             23578999999876544433   3589999999999999999999999999999999999999776 899999999975


Q ss_pred             cCCCCc------------cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh
Q 013897          279 YHPGKE------------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL  346 (434)
Q Consensus       279 ~~~~~~------------~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~  346 (434)
                      ......            .+...++..|+|||.+.+...++.++|||||||++|||++|+.|| .+.+.......+....
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~-~~~~~~~~~~~~~~~~  243 (311)
T cd07866         165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPIL-QGKSDIDQLHLIFKLC  243 (311)
T ss_pred             ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHh
Confidence            532211            123356788999999876566899999999999999999999776 5555566666666665


Q ss_pred             CChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          347 GTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       347 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                      +......+.............      ......... ......+++.+.+||.+||..||++|||+.|+|.||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         244 GTPTEETWPGWRSLPGCEGVH------SFTNYPRTL-EERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             CCCChhhchhhhhcccccccc------cCCCCCccH-HHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            544333332211111000000      000000000 00112245789999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.1e-41  Score=324.28  Aligned_cols=252  Identities=24%  Similarity=0.431  Sum_probs=200.0

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeEeeEEEcc----CCCcc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ----QSKTP  206 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~----~~~~~  206 (434)
                      .+.|++.+.||+|+||.||+|.+..+++.+|+|++...  ....+..|+.+++++.+|+||+++++++...    .....
T Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   94 (282)
T cd06636          15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQL   94 (282)
T ss_pred             hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEE
Confidence            46788999999999999999999999999999998643  3356788999999987899999999988532    24567


Q ss_pred             EEEEeecCCCchhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC
Q 013897          207 SLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP  281 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~  281 (434)
                      +++|||++++++..++.     .+++..+..++.||+.||.|||+++|+|+||||+||+++.++ .++|+|||++.....
T Consensus        95 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~-~~~l~dfg~~~~~~~  173 (282)
T cd06636          95 WLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDR  173 (282)
T ss_pred             EEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEeeCcchhhhhc
Confidence            89999999998876652     367788899999999999999999999999999999999776 799999999875432


Q ss_pred             C-CccceeccCCcccccccccC----CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHh
Q 013897          282 G-KEYNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN  356 (434)
Q Consensus       282 ~-~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~  356 (434)
                      . .......++..|+|||.+..    ...++.++|||||||++|||++|+.||.... .......+..   .        
T Consensus       174 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~-~~~~~~~~~~---~--------  241 (282)
T cd06636         174 TVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH-PMRALFLIPR---N--------  241 (282)
T ss_pred             cccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccC-HHhhhhhHhh---C--------
Confidence            2 22344578889999999752    2468889999999999999999999984321 1111110000   0        


Q ss_pred             hccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          357 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                                       ..       .......++.++.+||.+||..||.+|||+.|+|+||||
T Consensus       242 -----------------~~-------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         242 -----------------PP-------PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             -----------------CC-------CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence                             00       000112367789999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.3e-41  Score=321.24  Aligned_cols=249  Identities=24%  Similarity=0.402  Sum_probs=197.0

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc--------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCc
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT  205 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~--------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  205 (434)
                      .+|++.+.||+|+||.||+|.+..++..||+|.+...        ....+.+|+.+++.+ +||||+++++++.+.....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~   80 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-QHERIVQYYGCLRDRAEKT   80 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHc-CCCCeeeEEEEEEcCCCCE
Confidence            3688899999999999999999889999999988532        124578899999999 8999999999987655567


Q ss_pred             cEEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC
Q 013897          206 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG  282 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~  282 (434)
                      .++++||+.+++|...+   ..+++..+..++.|++.||+|||+++|+|+||||+||+++.++ .+||+|||++......
T Consensus        81 ~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~-~~~l~dfg~~~~~~~~  159 (266)
T cd06651          81 LTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAG-NVKLGDFGASKRLQTI  159 (266)
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC-CEEEccCCCccccccc
Confidence            88999999999887664   3478888999999999999999999999999999999999766 7999999998755321


Q ss_pred             ----CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhc
Q 013897          283 ----KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY  358 (434)
Q Consensus       283 ----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  358 (434)
                          .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||... ..   ...+.+.....         
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~~~-~~---~~~~~~~~~~~---------  225 (266)
T cd06651         160 CMSGTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEY-EA---MAAIFKIATQP---------  225 (266)
T ss_pred             cccCCccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCcccc-ch---HHHHHHHhcCC---------
Confidence                11223457888999999876 67899999999999999999999998422 11   11111110000         


Q ss_pred             cccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcc
Q 013897          359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFF  422 (434)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~  422 (434)
                         ..                    ...+..+++.+.+|+ +||..||++||+++|+++||||+
T Consensus       226 ---~~--------------------~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         226 ---TN--------------------PQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             ---CC--------------------CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence               00                    001122556788998 57778999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.7e-41  Score=323.35  Aligned_cols=276  Identities=29%  Similarity=0.525  Sum_probs=208.5

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+...     ..+.+.+|+++++.+ +||||+++++++.+  ....++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~l   77 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL-RHENLVNLIEVFRR--KKRLYL   77 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhc-CCcchhhHHHhccc--CCeEEE
Confidence            4689999999999999999999888999999987532     234578899999999 99999999999954  457789


Q ss_pred             EEeecCCCchhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC-Cc
Q 013897          209 IFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KE  284 (434)
Q Consensus       209 v~e~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~-~~  284 (434)
                      |+||+.++.+..+..   .+++..+..++.||+.||.|||+.+|+|+||+|+||+++.++ .++|+|||++...... ..
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~-~~~l~dfg~~~~~~~~~~~  156 (286)
T cd07846          78 VFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSG-VVKLCDFGFARTLAAPGEV  156 (286)
T ss_pred             EEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC-cEEEEeeeeeeeccCCccc
Confidence            999999998876642   478999999999999999999999999999999999999776 8999999999765433 22


Q ss_pred             cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCCh
Q 013897          285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP  364 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  364 (434)
                      .....++..|+|||++.+...++.++|||||||++|||++|+.|| .+....+.+..+....+........ .  ....+
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~-~--~~~~~  232 (286)
T cd07846         157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLF-PGDSDIDQLYHIIKCLGNLIPRHQE-I--FQKNP  232 (286)
T ss_pred             cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCC-CCCchHHHHHHHHHHhCCCchhhHH-H--hccch
Confidence            344567888999999876556788999999999999999998776 4455555555555544432111000 0  00000


Q ss_pred             hHHHHhcccCCCCCccc-cccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          365 HLAALVGRHSRKPWSKF-ITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       365 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                      ..    ........... ........++..+.+|+.+||..||++||++.++|+||||
T Consensus       233 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         233 LF----AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             Hh----hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            00    00000000000 0001122467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.8e-41  Score=325.59  Aligned_cols=254  Identities=25%  Similarity=0.437  Sum_probs=205.0

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      ..+|++.+.||+|+||.||+|.+..++..+|+|.+...   ..+.+.+|+.+++.+ +|+|++++++.+.+.  ...++|
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~-~h~~v~~~~~~~~~~--~~~~lv   95 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLVG--DELWVV   95 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhC-CCCCEeeEEEEEEeC--CEEEEe
Confidence            46799999999999999999999889999999988643   245678899999998 999999999998653  567899


Q ss_pred             EeecCCCchhhhcC--CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC-ccc
Q 013897          210 FEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYN  286 (434)
Q Consensus       210 ~e~~~~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~-~~~  286 (434)
                      |||+.+++|..++.  .+++.++..++.|++.||+|||+.||+|+||||+|||++.++ .+||+|||++....... ...
T Consensus        96 ~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~-~~kl~dfg~~~~~~~~~~~~~  174 (296)
T cd06654          96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRS  174 (296)
T ss_pred             ecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC-CEEECccccchhccccccccC
Confidence            99999999987763  478889999999999999999999999999999999999766 89999999987654332 223


Q ss_pred             eeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhH
Q 013897          287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL  366 (434)
Q Consensus       287 ~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~  366 (434)
                      ...++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.... ....+..+.. .+..                 
T Consensus       175 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~-~~~~~~~~~~-~~~~-----------------  234 (296)
T cd06654         175 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNEN-PLRALYLIAT-NGTP-----------------  234 (296)
T ss_pred             cccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCC-HHHhHHHHhc-CCCC-----------------
Confidence            4578889999999876 678899999999999999999999984322 1111111100 0000                 


Q ss_pred             HHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccc
Q 013897          367 AALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN  426 (434)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~  426 (434)
                                      .......+++.+.+|+.+||..||++|||+.++++||||...+.
T Consensus       235 ----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~  278 (296)
T cd06654         235 ----------------ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP  278 (296)
T ss_pred             ----------------CCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccCC
Confidence                            00111235678999999999999999999999999999987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.9e-42  Score=350.76  Aligned_cols=282  Identities=21%  Similarity=0.279  Sum_probs=196.5

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCC-eEEEEE------------------Eecc--ccHHHHHHHHHHHHHhcCCCCe
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDN-EKCIIK------------------ILKP--VKKKKIKREIKILQNLCGGPNI  191 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~-~~vaiK------------------~~~~--~~~~~~~~E~~~l~~l~~h~ni  191 (434)
                      .++|++++.||+|+||+||+|..+... ...++|                  .++.  .....+.+|+.+|+.+ +||||
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l-~HpnI  225 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRL-NHENI  225 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhC-CCCCc
Confidence            468999999999999999998764322 222222                  1111  1124578999999999 99999


Q ss_pred             eeEeeEEEccCCCccEEEEeecCCCchhhhcC-------CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC
Q 013897          192 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE  264 (434)
Q Consensus       192 v~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-------~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~  264 (434)
                      +++++++.+.  ...++|+|++.+..+..+..       .....+++.++.||+.||+|||++||+||||||+|||++.+
T Consensus       226 v~l~~~~~~~--~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~  303 (501)
T PHA03210        226 LKIEEILRSE--ANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD  303 (501)
T ss_pred             CcEeEEEEEC--CeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence            9999999765  45679999987665544322       23356678899999999999999999999999999999977


Q ss_pred             CCeEEEEecccceecCCCCc--cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--CCHHHHH
Q 013897          265 QRKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH--DNYDQLV  340 (434)
Q Consensus       265 ~~~vkl~DFGla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~--~~~~~~~  340 (434)
                      + .+||+|||+++.+.....  ....+|+..|+|||++.+ ..++.++|||||||++|||++|..+++...  ....++.
T Consensus       304 ~-~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~  381 (501)
T PHA03210        304 G-KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG-DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL  381 (501)
T ss_pred             C-CEEEEeCCCceecCcccccccccccCCcCCCCchhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence            6 899999999987654322  223579999999999887 679999999999999999999986654332  2334555


Q ss_pred             HHHHHhCChhHHHHHhhccccCChhHHHHhcccC-CCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCC
Q 013897          341 KIAKVLGTDELNAYLNKYHIELDPHLAALVGRHS-RKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHP  419 (434)
Q Consensus       341 ~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp  419 (434)
                      ++...++.... .+..     ....+...+.... ......+........++.++.++|.+||++||++|||+.|+|+||
T Consensus       382 ~~~~~~~~~~~-~~p~-----~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp  455 (501)
T PHA03210        382 KIIDSLSVCDE-EFPD-----PPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALP  455 (501)
T ss_pred             HHHHhcccChh-hcCC-----cHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhCh
Confidence            55544442211 0000     0000000000000 000000001111223567889999999999999999999999999


Q ss_pred             Cccccc
Q 013897          420 YFFPIR  425 (434)
Q Consensus       420 ~~~~~~  425 (434)
                      ||....
T Consensus       456 ~f~~~~  461 (501)
T PHA03210        456 LFSAEE  461 (501)
T ss_pred             hhhcCC
Confidence            998764

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-41  Score=328.31  Aligned_cols=254  Identities=25%  Similarity=0.408  Sum_probs=204.3

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      ++|++.+.||+|+||.||+|.+..+++.+|+|.+...      ..+.+..|+++++.+ +|+||+++++.+.+  ....+
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~   77 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL-DHPFLPTLYASFQT--ETYLC   77 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhC-CCCCchhheeeeec--CCEEE
Confidence            4689999999999999999999888999999998643      234578899999999 89999999999865  35678


Q ss_pred             EEEeecCCCchhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC
Q 013897          208 LIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG  282 (434)
Q Consensus       208 lv~e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~  282 (434)
                      +||||+.+++|..++.     .+++..++.++.||+.||+|||+.|++|+||||+||+++.++ .++|+|||++......
T Consensus        78 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~  156 (316)
T cd05574          78 LVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESG-HIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCC-CEEEeecchhhccccc
Confidence            9999999999877652     478889999999999999999999999999999999999776 8999999998654321


Q ss_pred             Cc------------------------------cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Q 013897          283 KE------------------------------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYG  332 (434)
Q Consensus       283 ~~------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~  332 (434)
                      ..                              ....+|+..|+|||++.+ ..++.++|||||||++|+|++|+.||. +
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~-~  234 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG-DGHGSAVDWWTLGILLYEMLYGTTPFK-G  234 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC-CCCCchHHHHHHHHHHHHHhhCCCCCC-C
Confidence            11                              112367888999999876 678999999999999999999999984 3


Q ss_pred             CCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCcc-
Q 013897          333 HDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT-  411 (434)
Q Consensus       333 ~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt-  411 (434)
                      .+....+..+..                           ..        ........+++++.+||.+||..||++||| 
T Consensus       235 ~~~~~~~~~~~~---------------------------~~--------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~  279 (316)
T cd05574         235 SNRDETFSNILK---------------------------KE--------VTFPGSPPVSSSARDLIRKLLVKDPSKRLGS  279 (316)
T ss_pred             CchHHHHHHHhc---------------------------CC--------ccCCCccccCHHHHHHHHHHccCCHhHCCCc
Confidence            232222222110                           00        000111125788999999999999999999 


Q ss_pred             ---HHHHhcCCCcccccccc
Q 013897          412 ---AKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       412 ---~~elL~Hp~~~~~~~~~  428 (434)
                         ++|+|+||||++.+.+.
T Consensus       280 ~~~~~~ll~~~~~~~~~~~~  299 (316)
T cd05574         280 KRGAAEIKQHPFFRGVNWAL  299 (316)
T ss_pred             hhhHHHHHcCchhhcCChhh
Confidence               99999999999887554

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.6e-41  Score=322.89  Aligned_cols=263  Identities=21%  Similarity=0.331  Sum_probs=203.9

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      ++|+..+.||.|++|.||+|.+..+++.+|+|.+...    ....+.+|+++++.+ +||||+++++++.+.....+++|
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv   79 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSC-KSPYIVKYYGAFLDESSSSIGIA   79 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEccCCCeEEEE
Confidence            4688999999999999999999889999999998643    235688999999999 89999999999876666678999


Q ss_pred             EeecCCCchhhhc-------CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC
Q 013897          210 FEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG  282 (434)
Q Consensus       210 ~e~~~~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~  282 (434)
                      |||+++++|..++       ..+++..+..++.||+.||.|||+.+++|+||+|+||+++.++ .++|+|||++......
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~~~  158 (287)
T cd06621          80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKG-QVKLCDFGVSGELVNS  158 (287)
T ss_pred             EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCC-eEEEeecccccccccc
Confidence            9999999986653       2378888999999999999999999999999999999999776 8999999998654322


Q ss_pred             CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                      . .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.....................            
T Consensus       159 ~-~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------  224 (287)
T cd06621         159 L-AGTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP------------  224 (287)
T ss_pred             c-cccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC------------
Confidence            2 123457788999999876 67899999999999999999999998544221000001000000000            


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN  426 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~  426 (434)
                      .+.+            .  .........++.+.+||.+||..||++|||+.|++.||||++...
T Consensus       225 ~~~~------------~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~  274 (287)
T cd06621         225 NPEL------------K--DEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMK  274 (287)
T ss_pred             chhh------------c--cCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccccc
Confidence            0000            0  000111124568999999999999999999999999999976543

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1e-41  Score=327.41  Aligned_cols=255  Identities=25%  Similarity=0.443  Sum_probs=205.7

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      ..+|.+++.||+|+||.||+|.+..+++.||+|.+...   ..+.+.+|+.+++.+ +|+||+++++++...  ...++|
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~--~~~~lv   94 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLVG--DELWVV   94 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhC-CCCCEeeEEEEEecC--CEEEEe
Confidence            47799999999999999999999889999999998642   235678899999998 999999999999653  567899


Q ss_pred             EeecCCCchhhhcC--CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc-cc
Q 013897          210 FEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-YN  286 (434)
Q Consensus       210 ~e~~~~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~-~~  286 (434)
                      |||+++++|..+..  .+++.++..++.|++.||.|||+.+|+||||||+|||++.++ .++|+|||++........ ..
T Consensus        95 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~-~~~l~Dfg~~~~~~~~~~~~~  173 (297)
T cd06656          95 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRS  173 (297)
T ss_pred             ecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEECcCccceEccCCccCcC
Confidence            99999999987753  478889999999999999999999999999999999999766 899999999976544322 23


Q ss_pred             eeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhH
Q 013897          287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL  366 (434)
Q Consensus       287 ~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~  366 (434)
                      ...++..|+|||.+.+ ..++.++|||||||++|+|++|+.||..... ......+.. .+.                  
T Consensus       174 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~-~~~~~~~~~-~~~------------------  232 (297)
T cd06656         174 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENP-LRALYLIAT-NGT------------------  232 (297)
T ss_pred             cccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc-chheeeecc-CCC------------------
Confidence            4568889999999876 6789999999999999999999999843221 111110000 000                  


Q ss_pred             HHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccccc
Q 013897          367 AALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA  427 (434)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~  427 (434)
                                     ........+++.+.+|+.+||..||++||+++++|+||||+.....
T Consensus       233 ---------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (297)
T cd06656         233 ---------------PELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPL  278 (297)
T ss_pred             ---------------CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccccc
Confidence                           0011122356789999999999999999999999999999977543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3e-41  Score=324.08  Aligned_cols=253  Identities=26%  Similarity=0.477  Sum_probs=205.3

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      ..+|++.+.||.|+||.||+|.+..+++.||+|.+...   ..+.+.+|+.+++.+ +|||++++++++.+.  ...++|
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv   94 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKEL-KNPNIVNFLDSFLVG--DELFVV   94 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhc-CCCceeeeeeeEecC--ceEEEE
Confidence            35799999999999999999999899999999988532   345678899999999 999999999998653  567899


Q ss_pred             EeecCCCchhhhcC--CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc-cc
Q 013897          210 FEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-YN  286 (434)
Q Consensus       210 ~e~~~~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~-~~  286 (434)
                      +||+.+++|..+..  .+++.++..++.|++.||+|||++|++|+||||+||+++.++ .+||+|||++........ ..
T Consensus        95 ~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~-~~kl~dfg~~~~~~~~~~~~~  173 (296)
T cd06655          95 MEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDG-SVKLTDFGFCAQITPEQSKRS  173 (296)
T ss_pred             EEecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEccCccchhcccccccCC
Confidence            99999999987654  478999999999999999999999999999999999999766 899999999876543322 23


Q ss_pred             eeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhH
Q 013897          287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL  366 (434)
Q Consensus       287 ~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~  366 (434)
                      ...++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.... ....+..+.. .+..                 
T Consensus       174 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~~~~-~~~~~~~~~~-~~~~-----------------  233 (296)
T cd06655         174 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNEN-PLRALYLIAT-NGTP-----------------  233 (296)
T ss_pred             CcCCCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHh-cCCc-----------------
Confidence            3467889999999876 678999999999999999999999984332 2222211110 0000                 


Q ss_pred             HHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccc
Q 013897          367 AALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                                      .......+++.+.+||.+||..||++||++.+++.||||+...
T Consensus       234 ----------------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~  276 (296)
T cd06655         234 ----------------ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK  276 (296)
T ss_pred             ----------------ccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence                            0111223677899999999999999999999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.6e-41  Score=331.82  Aligned_cols=287  Identities=32%  Similarity=0.582  Sum_probs=216.2

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecc-----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      .++|++.+.||+|+||.||+|.+..+++.+|+|.+..     .....+.+|+.+++++.+||||+++++++........+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            4679999999999999999999988899999998743     22345678999999987899999999998766566789


Q ss_pred             EEEeecCCCchhhhcC--CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC--
Q 013897          208 LIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--  283 (434)
Q Consensus       208 lv~e~~~~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~--  283 (434)
                      +||||+.+ +|.....  .+.+..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++.......  
T Consensus        86 lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~-~~kl~d~g~~~~~~~~~~~  163 (337)
T cd07852          86 LVFEYMET-DLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDC-RVKLADFGLARSLSELEEN  163 (337)
T ss_pred             EEeccccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-cEEEeeccchhcccccccc
Confidence            99999985 6655443  478888889999999999999999999999999999999777 89999999997654322  


Q ss_pred             ----ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcc
Q 013897          284 ----EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH  359 (434)
Q Consensus       284 ----~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  359 (434)
                          ......++..|+|||.+.+...++.++|||||||++|+|++|+.|| .+....+...++....+......+. ...
T Consensus       164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  241 (337)
T cd07852         164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLF-PGTSTLNQLEKIIEVIGPPSAEDIE-SIK  241 (337)
T ss_pred             ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCCHHHHH-HHH
Confidence                2233468889999999876567889999999999999999999887 4555566666666655543221111 000


Q ss_pred             ccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccccc
Q 013897          360 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~  428 (434)
                      .....   .+............  ......++.++.+||.+||+.||++|||+.++++||||+++....
T Consensus       242 ~~~~~---~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~  305 (337)
T cd07852         242 SPFAA---TMLDSLPSRPRKPL--DELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPS  305 (337)
T ss_pred             hhhHH---Hhhhhcccccccch--hhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCC
Confidence            00000   01111010100000  011122678999999999999999999999999999999886553

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-41  Score=320.00  Aligned_cols=254  Identities=24%  Similarity=0.434  Sum_probs=202.4

Q ss_pred             CCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc--HHHHHHHHHHHHHhcCCCCeeeEeeEEEccC----CCc
Q 013897          132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ----SKT  205 (434)
Q Consensus       132 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----~~~  205 (434)
                      ..++|++.+.||+|+||.||+|.+..+++.+++|++....  .+.+.+|+.+++++.+|+||+++++++.+..    ...
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ   83 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence            3588999999999999999999998889999999987543  4678899999999978999999999997643    345


Q ss_pred             cEEEEeecCCCchhhhc-------CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEeccccee
Q 013897          206 PSLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF  278 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~  278 (434)
                      .++||||+.+++|..+.       ..+++..++.++.|++.||.|||+++++|+||+|+||+++.++ .+||+|||++..
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~-~~~l~d~~~~~~  162 (275)
T cd06608          84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNA-EVKLVDFGVSAQ  162 (275)
T ss_pred             EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCC-eEEECCCcccee
Confidence            78999999999876553       3578889999999999999999999999999999999999776 899999999876


Q ss_pred             cCCC-CccceeccCCcccccccccC----CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHH
Q 013897          279 YHPG-KEYNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA  353 (434)
Q Consensus       279 ~~~~-~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~  353 (434)
                      .... .......++..|+|||.+..    ...++.++|||||||++|+|++|+.||... ........+...        
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~--------  233 (275)
T cd06608         163 LDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM-HPMRALFKIPRN--------  233 (275)
T ss_pred             cccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcccc-chHHHHHHhhcc--------
Confidence            5432 22244568889999998753    235788999999999999999999998432 221111111100        


Q ss_pred             HHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          354 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                                             ..   ........++.++.+||.+||..||++|||+.|+++|||+
T Consensus       234 -----------------------~~---~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         234 -----------------------PP---PTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             -----------------------CC---CCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence                                   00   0011112256789999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-41  Score=321.72  Aligned_cols=278  Identities=34%  Similarity=0.545  Sum_probs=210.2

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.++..     ..+.+.+|+++++.+ .|+||+++++++.+  ....++
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~i   77 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL-RHENIVNLKEAFRR--KGRLYL   77 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhc-CCCCeeehhheEEE--CCEEEE
Confidence            3689999999999999999999889999999988642     236788999999999 89999999999965  356789


Q ss_pred             EEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC--
Q 013897          209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--  283 (434)
Q Consensus       209 v~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~--  283 (434)
                      ||||++++.+..+.   ..+++..+..++.||+.||.|||+.+++|+||||+||+++.++ .+||+|||++.......  
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~-~~kl~d~g~~~~~~~~~~~  156 (288)
T cd07833          78 VFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESG-VLKLCDFGFARALRARPAS  156 (288)
T ss_pred             EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-CEEEEeeecccccCCCccc
Confidence            99999998876554   3488999999999999999999999999999999999999766 89999999997765443  


Q ss_pred             ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                      ......++..|+|||++.+...++.++|||||||++|+|++|+.|| .+....+.+..+....+.......... .  .+
T Consensus       157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--~~  232 (288)
T cd07833         157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLF-PGDSDIDQLYLIQKCLGPLPPSHQELF-S--SN  232 (288)
T ss_pred             cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHhhhc-c--cC
Confidence            3344577889999999987447899999999999999999999877 444445555555554443222111100 0  00


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                      +.....  ..................+++++.+|+++||..||++|||++++++||||
T Consensus       233 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         233 PRFAGV--AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             cccccc--ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence            000000  00000000000011122357889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-41  Score=320.41  Aligned_cols=276  Identities=32%  Similarity=0.594  Sum_probs=208.6

Q ss_pred             eEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEE
Q 013897          136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF  210 (434)
Q Consensus       136 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  210 (434)
                      |++.+.||.|+||.||+|.+..+++.+|+|.+...     ....+.+|+.+++.+ +|+|++++++++.+......++|+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~   79 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKL-RHPNIVRLKEIVTSKGKGSIYMVF   79 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhc-cCCCeeeheeeEecCCCCcEEEEe
Confidence            67889999999999999999888999999999754     234578899999999 899999999999765446788999


Q ss_pred             eecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC--c
Q 013897          211 EHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--E  284 (434)
Q Consensus       211 e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~--~  284 (434)
                      ||+++ ++..++    ..+++..+..++.||+.||+|||+.|++|+||||+||+++.++ .+||+|||++.......  .
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~-~~~l~d~g~~~~~~~~~~~~  157 (287)
T cd07840          80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDG-VLKLADFGLARPYTKRNSAD  157 (287)
T ss_pred             ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCC-CEEEccccceeeccCCCccc
Confidence            99986 554443    2588889999999999999999999999999999999999776 89999999997665432  2


Q ss_pred             cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCCh
Q 013897          285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP  364 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  364 (434)
                      .....++..|+|||.+.+...++.++|||||||++|||++|+.||. ..+....+..+.+..+......+......... 
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  235 (287)
T cd07840         158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQ-GSTELEQLEKIFELCGSPTDENWPGVSKLPWF-  235 (287)
T ss_pred             ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHhCCCchhhccccccchhh-
Confidence            3344667889999988765568999999999999999999998874 44455556666665554433332211110000 


Q ss_pred             hHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                        .   ...................+++.+.+++.+||..||++||++++++.||||
T Consensus       236 --~---~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         236 --E---NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             --h---hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence              0   000000000000000111247889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.7e-41  Score=318.73  Aligned_cols=249  Identities=23%  Similarity=0.412  Sum_probs=198.3

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc--------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCc
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT  205 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~--------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  205 (434)
                      ++|++.+.||+|+||.||+|.+..++..||||.+...        ..+.+.+|+.+++.+ +||||+++++++.+.....
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~   80 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL-LHERIVQYYGCLRDPMERT   80 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhc-CCCCeeeEEeEeccCCCce
Confidence            5689999999999999999999899999999987521        124678899999999 9999999999987655567


Q ss_pred             cEEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC
Q 013897          206 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG  282 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~  282 (434)
                      +++||||+++++|..++   ..+++..+..++.|++.||+|||+++|+|+||||+||+++.++ .++|+|||++......
T Consensus        81 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~-~~~l~Dfg~~~~~~~~  159 (265)
T cd06652          81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVG-NVKLGDFGASKRLQTI  159 (265)
T ss_pred             EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCC-CEEECcCccccccccc
Confidence            88999999999987665   3578888999999999999999999999999999999999766 8999999998754321


Q ss_pred             ----CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhc
Q 013897          283 ----KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY  358 (434)
Q Consensus       283 ----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  358 (434)
                          .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||... ....   .+.+.....         
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~-~~~~---~~~~~~~~~---------  225 (265)
T cd06652         160 CLSGTGMKSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWAEF-EAMA---AIFKIATQP---------  225 (265)
T ss_pred             cccccccccCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCCcc-chHH---HHHHHhcCC---------
Confidence                12233467889999999876 67899999999999999999999998321 1111   111111000         


Q ss_pred             cccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcc
Q 013897          359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFF  422 (434)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~  422 (434)
                                     .        ....+...+..+.++|.+|+. +|++||+++|+++|||+.
T Consensus       226 ---------------~--------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         226 ---------------T--------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             ---------------C--------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence                           0        000112345678999999994 999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2.8e-41  Score=321.63  Aligned_cols=254  Identities=25%  Similarity=0.405  Sum_probs=201.8

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF  210 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  210 (434)
                      +.|++.+.||+|+||.||+|.+..++..+++|.+....   .+.+.+|+.+++.+ +|||++++++++...  ...++|+
T Consensus         5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~~--~~~~~v~   81 (282)
T cd06643           5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASC-DHPNIVKLLDAFYYE--NNLWILI   81 (282)
T ss_pred             HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHC-CCCCeeeEEEEEeeC--CEEEEEE
Confidence            34678899999999999999998899999999986433   34578899999999 999999999998654  5678999


Q ss_pred             eecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC-Ccc
Q 013897          211 EHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEY  285 (434)
Q Consensus       211 e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~-~~~  285 (434)
                      ||+.++++..++    ..+++..+..++.|++.||.|||+.||+||||||+|||++.++ .+||+|||++...... ...
T Consensus        82 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~-~~kl~dfg~~~~~~~~~~~~  160 (282)
T cd06643          82 EFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRR  160 (282)
T ss_pred             EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCC-CEEEcccccccccccccccc
Confidence            999999987653    3588999999999999999999999999999999999999776 8999999998654322 122


Q ss_pred             ceeccCCcccccccccC----CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcccc
Q 013897          286 NVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE  361 (434)
Q Consensus       286 ~~~~~t~~y~aPE~~~~----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  361 (434)
                      ....++..|+|||++..    ...++.++|||||||++|+|++|+.||.. .+..+....+.....              
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~-~~~~~~~~~~~~~~~--------------  225 (282)
T cd06643         161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHE-LNPMRVLLKIAKSEP--------------  225 (282)
T ss_pred             ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccc-cCHHHHHHHHhhcCC--------------
Confidence            34568889999999742    24578899999999999999999999732 222222222111000              


Q ss_pred             CChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccc
Q 013897          362 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN  426 (434)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~  426 (434)
                                          .....+..++.++.+||.+||..||++||+++++++||||+....
T Consensus       226 --------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  270 (282)
T cd06643         226 --------------------PTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSN  270 (282)
T ss_pred             --------------------CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEeccCC
Confidence                                001112235678999999999999999999999999999996543

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.1e-41  Score=328.89  Aligned_cols=289  Identities=28%  Similarity=0.536  Sum_probs=213.6

Q ss_pred             ccCCCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccC-
Q 013897          129 QWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ-  202 (434)
Q Consensus       129 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~-  202 (434)
                      .+...++|.+.+.||+|+||.||+|.+..+++.||+|.++...     .+.+.+|+.+++++ +||||+++++++.... 
T Consensus        12 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~~iv~~~~~~~~~~~   90 (345)
T cd07877          12 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARS   90 (345)
T ss_pred             HhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHc-CCCcccceeeeeeeccc
Confidence            3445688999999999999999999998899999999986432     34577899999999 9999999999886432 


Q ss_pred             ---CCccEEEEeecCCCchhhhc--CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccce
Q 013897          203 ---SKTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE  277 (434)
Q Consensus       203 ---~~~~~lv~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~  277 (434)
                         ....+++++++ ++++..+.  ..+++..++.++.||+.||+|||++||+||||||+||+++.++ .+||+|||++.
T Consensus        91 ~~~~~~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~-~~kl~dfg~~~  168 (345)
T cd07877          91 LEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR  168 (345)
T ss_pred             ccccccEEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCC-CEEEecccccc
Confidence               23457788776 55665554  3588999999999999999999999999999999999999777 89999999997


Q ss_pred             ecCCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhh
Q 013897          278 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK  357 (434)
Q Consensus       278 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  357 (434)
                      ...  .......++..|+|||.+.+...++.++|||||||++|+|++|+.|| ...+....+..+.+..+........ .
T Consensus       169 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~-~  244 (345)
T cd07877         169 HTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAELLK-K  244 (345)
T ss_pred             ccc--ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHh-h
Confidence            543  22334567889999999876557889999999999999999999887 4444455555555555433222111 1


Q ss_pred             ccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccccccc
Q 013897          358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAES  429 (434)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~~  429 (434)
                      ........+...........+..     .....++++.+||.+||+.||.+||++.++|+||||++....+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~  311 (345)
T cd07877         245 ISSESARNYIQSLTQMPKMNFAN-----VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD  311 (345)
T ss_pred             cccHhHHHHHHHhcccCCcchhh-----hcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCc
Confidence            10000000000001111111100     01135678999999999999999999999999999997765553

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.8e-42  Score=324.65  Aligned_cols=255  Identities=25%  Similarity=0.444  Sum_probs=204.1

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      .++|++++.||.|+||.||+|.+..++..+|+|.++...   .+.+.+|+.+++++ +||||+++++++...  ...++|
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv   80 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSEC-KHPNIVGLYEAYFYE--NKLWIL   80 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhC-CCCceeEEEEEEecC--CeEEEE
Confidence            467999999999999999999998889999999986543   34678899999999 799999999999654  567899


Q ss_pred             EeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC-Cc
Q 013897          210 FEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KE  284 (434)
Q Consensus       210 ~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~-~~  284 (434)
                      |||+.+++|..++    ..+++..++.++.|++.||.|||+++|+|+||||+||+++.++ .++|+|||++...... ..
T Consensus        81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~~~  159 (280)
T cd06611          81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDG-DVKLADFGVSAKNKSTLQK  159 (280)
T ss_pred             eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCC-CEEEccCccchhhcccccc
Confidence            9999999987765    3488999999999999999999999999999999999999776 8999999998654322 22


Q ss_pred             cceeccCCcccccccccC----CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccc
Q 013897          285 YNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI  360 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  360 (434)
                      .....++..|++||.+..    ...++.++|||||||++|+|++|+.||.. .+....+..+..   ..           
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~---~~-----------  224 (280)
T cd06611         160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHE-LNPMRVLLKILK---SE-----------  224 (280)
T ss_pred             cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCccc-CCHHHHHHHHhc---CC-----------
Confidence            344568889999999752    24578899999999999999999999832 222111111100   00           


Q ss_pred             cCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccc
Q 013897          361 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN  426 (434)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~  426 (434)
                                    .      ........++.++.+||.+||..||.+||++.++|+||||....+
T Consensus       225 --------------~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  270 (280)
T cd06611         225 --------------P------PTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSD  270 (280)
T ss_pred             --------------C------CCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccch
Confidence                          0      001112235678999999999999999999999999999998743

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-41  Score=320.56  Aligned_cols=252  Identities=24%  Similarity=0.418  Sum_probs=204.8

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      ++|++.+.||.|+||.||+|.+..+++.+|+|.+....    ...+.+|+.+++.+ +|+|++++++++.+.  ...++|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~~v   77 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQC-RSPYITKYYGSFLKG--SKLWII   77 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHc-CCCCeeeeeEEEEEC--CeEEEE
Confidence            46888999999999999999998899999999986432    35678999999999 899999999998654  678899


Q ss_pred             EeecCCCchhhhcC--CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC-Cccc
Q 013897          210 FEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYN  286 (434)
Q Consensus       210 ~e~~~~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~-~~~~  286 (434)
                      +||+.+++|..++.  .+++..+..++.|++.||.|||+++++|+||+|+||+++.++ .++|+|||+++..... ....
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~~~~~~~  156 (274)
T cd06609          78 MEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEG-DVKLADFGVSGQLTSTMSKRN  156 (274)
T ss_pred             EEeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEEEcccccceeecccccccc
Confidence            99999999877764  578999999999999999999999999999999999999776 8999999999876543 2234


Q ss_pred             eeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhH
Q 013897          287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL  366 (434)
Q Consensus       287 ~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~  366 (434)
                      ...++..|+|||.+.+ ..++.++|||||||++|+|++|+.||... +.......+...                ..+  
T Consensus       157 ~~~~~~~y~~PE~~~~-~~~~~~sDv~slG~il~~l~tg~~p~~~~-~~~~~~~~~~~~----------------~~~--  216 (274)
T cd06609         157 TFVGTPFWMAPEVIKQ-SGYDEKADIWSLGITAIELAKGEPPLSDL-HPMRVLFLIPKN----------------NPP--  216 (274)
T ss_pred             cccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccC-chHHHHHHhhhc----------------CCC--
Confidence            4577888999999887 56999999999999999999999998422 211111111000                000  


Q ss_pred             HHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccc
Q 013897          367 AALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN  426 (434)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~  426 (434)
                                      .. ....+++++.+++.+||..||++|||++++++||||++...
T Consensus       217 ----------------~~-~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~  259 (274)
T cd06609         217 ----------------SL-EGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKK  259 (274)
T ss_pred             ----------------CC-cccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCCc
Confidence                            00 00115678999999999999999999999999999997654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2e-41  Score=317.32  Aligned_cols=249  Identities=25%  Similarity=0.467  Sum_probs=202.9

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc-HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEe
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE  211 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  211 (434)
                      .++|++.+.||+|+||.||+|.+..++..+++|.++... .+.+.+|+.+++.+ +|+||+++++++.+.  ...++++|
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~--~~~~l~~e   78 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQC-DSPYIVKYYGSYFKN--TDLWIVME   78 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhC-CCCcEeeeeeeeecC--CcEEEEEe
Confidence            367999999999999999999998888999999987543 56789999999999 999999999999654  67789999


Q ss_pred             ecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC-ccc
Q 013897          212 HVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYN  286 (434)
Q Consensus       212 ~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~-~~~  286 (434)
                      |+.+++|..++    ..+++..++.++.|++.||.|||+.+|+|+||+|+||+++.++ .++|+|||++....... ...
T Consensus        79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~-~~~l~dfg~~~~~~~~~~~~~  157 (256)
T cd06612          79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEG-QAKLADFGVSGQLTDTMAKRN  157 (256)
T ss_pred             cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCC-cEEEcccccchhcccCccccc
Confidence            99999987764    3478999999999999999999999999999999999999776 89999999997664332 233


Q ss_pred             eeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhH
Q 013897          287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL  366 (434)
Q Consensus       287 ~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~  366 (434)
                      ...++..|+|||.+.+ ..++.++|||||||++|+|++|+.||... ........+.                       
T Consensus       158 ~~~~~~~y~~PE~~~~-~~~~~~~Di~s~G~il~~l~~g~~p~~~~-~~~~~~~~~~-----------------------  212 (256)
T cd06612         158 TVIGTPFWMAPEVIQE-IGYNNKADIWSLGITAIEMAEGKPPYSDI-HPMRAIFMIP-----------------------  212 (256)
T ss_pred             cccCCccccCHHHHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCc-chhhhhhhhc-----------------------
Confidence            4557889999999876 67899999999999999999999998432 1111110000                       


Q ss_pred             HHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          367 AALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                           ....      ........++.++.+|+.+||+.||++|||+.|+|.||||
T Consensus       213 -----~~~~------~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         213 -----NKPP------PTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             -----cCCC------CCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence                 0000      0011122356789999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-43  Score=317.95  Aligned_cols=256  Identities=24%  Similarity=0.386  Sum_probs=201.1

Q ss_pred             eeeeecCceEEEEEEEcCCCeEEEEEEeccc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeecCCC
Q 013897          140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT  216 (434)
Q Consensus       140 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~  216 (434)
                      +.||+|+||.|-.++...++..||||++.+.   .+.++.+|++++....+|+||++|+++|+++  ...|||||.|.||
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd--~~FYLVfEKm~GG  161 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD--TRFYLVFEKMRGG  161 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc--ceEEEEEecccCc
Confidence            6799999999999999999999999999754   4678999999999999999999999999765  4567999999999


Q ss_pred             chhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCC--eEEEEecccceecCCC--------C
Q 013897          217 DFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAEFYHPG--------K  283 (434)
Q Consensus       217 ~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~--~vkl~DFGla~~~~~~--------~  283 (434)
                      .+...+.   .+++.++..++++|+.||.|||.+||.||||||+|||-...+.  -||||||.++......        .
T Consensus       162 plLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP  241 (463)
T KOG0607|consen  162 PLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTP  241 (463)
T ss_pred             hHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCc
Confidence            9866653   4999999999999999999999999999999999999865442  4899999997543221        2


Q ss_pred             ccceeccCCccccccccc----CCCCCCccccHHHHHHHHHHHHhCCCCCCCCC----------CCHHHHHHHHHHhCCh
Q 013897          284 EYNVRVASRYFKGPELLV----DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH----------DNYDQLVKIAKVLGTD  349 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~----~~~~~~~~~DvwSlGvil~elltg~~pf~~~~----------~~~~~~~~i~~~~g~~  349 (434)
                      ...+.+|+..|||||+..    ....|+.++|.||||||||.||+|++||-..-          .-...-.++++.... 
T Consensus       242 ~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQE-  320 (463)
T KOG0607|consen  242 ELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQE-  320 (463)
T ss_pred             cccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhc-
Confidence            335668888999999973    22469999999999999999999999983211          111111111111110 


Q ss_pred             hHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccc
Q 013897          350 ELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN  426 (434)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~  426 (434)
                            +++. --+.+                     ...++.+++|+++.+|..|+.+|.++.++|+|||++.+..
T Consensus       321 ------GkYe-FPdkd---------------------WahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~  369 (463)
T KOG0607|consen  321 ------GKYE-FPDKD---------------------WAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAP  369 (463)
T ss_pred             ------cCCc-CChhh---------------------hHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccch
Confidence                  0000 00111                     1236789999999999999999999999999999997753

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-43  Score=339.76  Aligned_cols=249  Identities=26%  Similarity=0.402  Sum_probs=205.6

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecc------ccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      ..|..++.||.|+||.||-|++..+.+.||||.+.-      .+...+.+|+..|+++ .|||++.+-|+|-..  ...+
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l-~HPntieYkgCyLre--~TaW  102 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQL-RHPNTIEYKGCYLRE--HTAW  102 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhc-cCCCcccccceeecc--chHH
Confidence            347778999999999999999999999999999863      3346789999999999 999999999998654  4556


Q ss_pred             EEEeecCCC---chhhhcCCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc
Q 013897          208 LIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE  284 (434)
Q Consensus       208 lv~e~~~~~---~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~  284 (434)
                      ||||||-|.   .+..+.+++.+.+|..|+.+.+.||+|||+++.||||||+.|||+++.+ .|||+|||.|....   .
T Consensus       103 LVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g-~VKLaDFGSAsi~~---P  178 (948)
T KOG0577|consen  103 LVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPG-LVKLADFGSASIMA---P  178 (948)
T ss_pred             HHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCC-eeeeccccchhhcC---c
Confidence            999999875   2456667899999999999999999999999999999999999999777 89999999997654   3


Q ss_pred             cceeccCCccccccccc--CCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          285 YNVRVASRYFKGPELLV--DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~--~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                      .+.++|||+|||||++.  +.+.|+-++||||||++..||.-.++|+|+- +..-.+..|++--.+              
T Consensus       179 AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM-NAMSALYHIAQNesP--------------  243 (948)
T KOG0577|consen  179 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESP--------------  243 (948)
T ss_pred             hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc-hHHHHHHHHHhcCCC--------------
Confidence            46789999999999984  3467999999999999999999999998643 223333333321110              


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                        .                   ......++.+..|+..||+.-|.+|||.+++|.|+|+..-+
T Consensus       244 --t-------------------Lqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~R  285 (948)
T KOG0577|consen  244 --T-------------------LQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRER  285 (948)
T ss_pred             --C-------------------CCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCC
Confidence              0                   01122457899999999999999999999999999997543

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=5.5e-41  Score=314.35  Aligned_cols=245  Identities=24%  Similarity=0.446  Sum_probs=199.3

Q ss_pred             CeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecc-----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      +|++.+.||+|+||.||+|.+..+++.|++|.+..     .....+.+|+.+++.+ +|||++++++++.+.  ...++|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv   77 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKL-DSSYIIRYYESFLDK--GKLNIV   77 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhc-CCCCeehheeeeccC--CEEEEE
Confidence            47889999999999999999999999999998853     2346688999999999 999999999998654  567899


Q ss_pred             EeecCCCchhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc
Q 013897          210 FEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE  284 (434)
Q Consensus       210 ~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~  284 (434)
                      |||+.+++|..++     ..+++..+..++.|++.||.|||++||+|+||||+||+++.++ .++|+|||+++.......
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~-~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          78 MEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYD-NVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             EEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCC-CEEEcccccceeccCccc
Confidence            9999999987664     3477888999999999999999999999999999999999766 899999999987654322


Q ss_pred             -cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          285 -YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       285 -~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                       .....++..|+|||++.+ ..++.++|+|||||++++|++|+.||... +.......+.+  +                
T Consensus       157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~--~----------------  216 (256)
T cd08529         157 FANTIVGTPYYLSPELCED-KPYNEKSDVWALGVVLYECCTGKHPFDAN-NQGALILKIIR--G----------------  216 (256)
T ss_pred             hhhccccCccccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHc--C----------------
Confidence             234467889999999876 67899999999999999999999998432 22111111110  0                


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                                ..        ......++.++.+++.+||+.+|++||++.++++|||+
T Consensus       217 ----------~~--------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         217 ----------VF--------PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             ----------CC--------CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence                      00        00011356789999999999999999999999999996

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=5.6e-41  Score=314.70  Aligned_cols=246  Identities=26%  Similarity=0.451  Sum_probs=197.9

Q ss_pred             CeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      +|++.+.||+|++|.||++.+..+++.+|+|.+...     ..+.+.+|+.+++.+ +|+|++++++.+... ...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-~~~~~lv   78 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL-KHPNIVAYRESWEGE-DGLLYIV   78 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeecCC-CCEEEEE
Confidence            488999999999999999999888999999998532     234678899999999 899999999987532 3457899


Q ss_pred             EeecCCCchhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC-C
Q 013897          210 FEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-K  283 (434)
Q Consensus       210 ~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~-~  283 (434)
                      |||++++++...+     ..+++.++..++.|++.||+|||++||+|+||||+||+++.++ .++|+|||++...... .
T Consensus        79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~-~~~l~df~~~~~~~~~~~  157 (257)
T cd08223          79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTN-IIKVGDLGIARVLENQCD  157 (257)
T ss_pred             ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCC-cEEEecccceEEecccCC
Confidence            9999999886654     2478999999999999999999999999999999999999766 8999999999766432 2


Q ss_pred             ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                      ......++..|+|||++.+ ..++.++|||||||++++|++|+.||.. .+.......+..  +.               
T Consensus       158 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~-~~~~~~~~~~~~--~~---------------  218 (257)
T cd08223         158 MASTLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLKHAFNA-KDMNSLVYRIIE--GK---------------  218 (257)
T ss_pred             ccccccCCcCccChhHhcC-CCCCchhhhHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHh--cC---------------
Confidence            2234567889999999876 6788999999999999999999999842 221111111110  00               


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                                .         ......+++++.+|+.+||+.||++||++.++++||||
T Consensus       219 ----------~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         219 ----------L---------PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             ----------C---------CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                      0         00112356789999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-43  Score=362.11  Aligned_cols=256  Identities=26%  Similarity=0.430  Sum_probs=210.2

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecc------ccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      .++|++++.||+|+||.|..++++.+++.||+|++++      ....-|..|-.+|..- +.+-|+.++..|.  +..++
T Consensus        74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~-ns~Wiv~LhyAFQ--D~~~L  150 (1317)
T KOG0612|consen   74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFG-NSEWIVQLHYAFQ--DERYL  150 (1317)
T ss_pred             HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcC-CcHHHHHHHHHhc--Cccce
Confidence            4889999999999999999999999999999999865      2234577888898886 8899999999995  45889


Q ss_pred             EEEEeecCCCchhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC
Q 013897          207 SLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~  283 (434)
                      |+||||++||+|-.++.   .+++..++.|+.+|+.||+-||+.|+|||||||+|||+|..| ++||+|||.+-.+..++
T Consensus       151 YlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~G-HikLADFGsClkm~~dG  229 (1317)
T KOG0612|consen  151 YLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSG-HIKLADFGSCLKMDADG  229 (1317)
T ss_pred             EEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccC-cEeeccchhHHhcCCCC
Confidence            99999999999877764   478999999999999999999999999999999999999887 99999999997776443


Q ss_pred             c--cceeccCCcccccccccC---C-CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhh
Q 013897          284 E--YNVRVASRYFKGPELLVD---L-QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK  357 (434)
Q Consensus       284 ~--~~~~~~t~~y~aPE~~~~---~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  357 (434)
                      .  ..+.+|||.|.+||++..   . +.|+..+|+||+||++|||+.|..|||.. .-.+...+|...   .        
T Consensus       230 ~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad-slveTY~KIm~h---k--------  297 (1317)
T KOG0612|consen  230 TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD-SLVETYGKIMNH---K--------  297 (1317)
T ss_pred             cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH-HHHHHHHHHhch---h--------
Confidence            3  467799999999999943   2 46899999999999999999999999532 222222232210   0        


Q ss_pred             ccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCcc---HHHHhcCCCccccccc
Q 013897          358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT---AKEAMAHPYFFPIRNA  427 (434)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt---~~elL~Hp~~~~~~~~  427 (434)
                                            ..+.++....+|.++++||.+++ .+|+.|..   ++++.+||||.++++.
T Consensus       298 ----------------------~~l~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~HpFF~g~~W~  347 (1317)
T KOG0612|consen  298 ----------------------ESLSFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHPFFEGIDWD  347 (1317)
T ss_pred             ----------------------hhcCCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHhCccccCCChh
Confidence                                  00111222348899999999877 57888988   9999999999999874

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.2e-41  Score=321.34  Aligned_cols=252  Identities=24%  Similarity=0.406  Sum_probs=199.4

Q ss_pred             CCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       132 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++...   ....+.+|+.+++.+ +||||+++++++...  ...++
T Consensus         7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~-~h~~ii~~~~~~~~~--~~~~i   83 (267)
T cd06646           7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKEC-KHCNIVAYFGSYLSR--EKLWI   83 (267)
T ss_pred             chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhc-CCCCeeeeeEEEEeC--CEEEE
Confidence            357899999999999999999999889999999998643   234577899999998 999999999998654  56789


Q ss_pred             EEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC-c
Q 013897          209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-E  284 (434)
Q Consensus       209 v~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~-~  284 (434)
                      ||||+++++|..++   ..+++..+..++.|++.||.|||+++|+||||||+||+++.++ .+||+|||++....... .
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~-~~~l~dfg~~~~~~~~~~~  162 (267)
T cd06646          84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNG-DVKLADFGVAAKITATIAK  162 (267)
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC-CEEECcCccceeecccccc
Confidence            99999999987664   3578899999999999999999999999999999999999776 79999999997654322 2


Q ss_pred             cceeccCCcccccccccC--CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          285 YNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~--~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                      .....++..|+|||.+..  ...++.++|||||||++|||++|+.||+..... +....+.+                  
T Consensus       163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~-~~~~~~~~------------------  223 (267)
T cd06646         163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPM-RALFLMSK------------------  223 (267)
T ss_pred             cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchh-hhheeeec------------------
Confidence            234568889999998742  245788999999999999999999998432211 10000000                  


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCC
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY  420 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~  420 (434)
                                   ..+. .........++..+.+||.+||..||++|||++++|+|+|
T Consensus       224 -------------~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         224 -------------SNFQ-PPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             -------------CCCC-CCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence                         0000 0000111235678999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-41  Score=316.12  Aligned_cols=251  Identities=27%  Similarity=0.494  Sum_probs=201.1

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      .++|++.+.||.|+||.||+|.+..+++.+++|++...   ..+.+.+|+.+++.+ +||||+++++++.+.  ..++++
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~--~~~~l~   78 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKEC-RHPNIVAYFGSYLRR--DKLWIV   78 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhC-CCCChhceEEEEEeC--CEEEEE
Confidence            47899999999999999999999888999999998643   346688999999999 999999999998654  567899


Q ss_pred             EeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC-c
Q 013897          210 FEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-E  284 (434)
Q Consensus       210 ~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~-~  284 (434)
                      |||++++++..++    ..+++..+..++.|++.||.|||+++|+|+||||+||+++.++ .+||+|||++....... .
T Consensus        79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~~~~~  157 (262)
T cd06613          79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDG-DVKLADFGVSAQLTATIAK  157 (262)
T ss_pred             EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCC-CEEECccccchhhhhhhhc
Confidence            9999999987664    4588999999999999999999999999999999999999766 89999999987654322 2


Q ss_pred             cceeccCCcccccccccCC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          285 YNVRVASRYFKGPELLVDL--QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~~--~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                      .....++..|+|||.+.+.  ..++.++|||||||++|+|++|+.||.... .......+... +              +
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~-~~~~~~~~~~~-~--------------~  221 (262)
T cd06613         158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH-PMRALFLISKS-N--------------F  221 (262)
T ss_pred             cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhc-c--------------C
Confidence            2345678889999998652  278899999999999999999999984322 22221111100 0              0


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCC
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY  420 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~  420 (434)
                      .+                 .........+.++.+|+.+||..||.+|||+.+++.|||
T Consensus       222 ~~-----------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         222 PP-----------------PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             CC-----------------ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            00                 000111224568999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-43  Score=335.41  Aligned_cols=246  Identities=26%  Similarity=0.486  Sum_probs=211.0

Q ss_pred             EeeeeecCceEEEEEEEcCCCeEEEEEEecc-----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeec
Q 013897          139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV  213 (434)
Q Consensus       139 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  213 (434)
                      .+.||.|.||+||-|+++.+|+.||||++.+     ....++.+|+.||+++ +||.||.+...|+.  ...+++|||.+
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l-~HPGiV~le~M~ET--~ervFVVMEKl  645 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNL-HHPGIVNLECMFET--PERVFVVMEKL  645 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhc-CCCCeeEEEEeecC--CceEEEEehhh
Confidence            4789999999999999999999999999864     3346789999999999 99999999999954  46678999999


Q ss_pred             CCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC--CCeEEEEecccceecCCCCccce
Q 013897          214 NNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--QRKLRLIDWGLAEFYHPGKEYNV  287 (434)
Q Consensus       214 ~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~--~~~vkl~DFGla~~~~~~~~~~~  287 (434)
                      .|.-|+.++    .++++...+.++.||+.||.|||-++|+|+||||+|||+...  ...+||||||.|+.+.+..-...
T Consensus       646 ~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrs  725 (888)
T KOG4236|consen  646 HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRS  725 (888)
T ss_pred             cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhh
Confidence            998887665    468898899999999999999999999999999999999643  34799999999999877766677


Q ss_pred             eccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHH
Q 013897          288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLA  367 (434)
Q Consensus       288 ~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~  367 (434)
                      .+||+.|+|||++.+ ++|+...|+||.|||+|--+.|..||-.+++-.+|.+.-.-                       
T Consensus       726 VVGTPAYLaPEVLrn-kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaF-----------------------  781 (888)
T KOG4236|consen  726 VVGTPAYLAPEVLRN-KGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAF-----------------------  781 (888)
T ss_pred             hcCCccccCHHHHhh-ccccccccceeeeEEEEEEecccccCCCccchhHHhhcccc-----------------------
Confidence            899999999999988 89999999999999999999999999666665555543110                       


Q ss_pred             HHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccc
Q 013897          368 ALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI  424 (434)
Q Consensus       368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~  424 (434)
                          ..+..+|.         ++++++.|||..+|++.-.+|.++++.|.|||+++.
T Consensus       782 ----MyPp~PW~---------eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y  825 (888)
T KOG4236|consen  782 ----MYPPNPWS---------EISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY  825 (888)
T ss_pred             ----ccCCCchh---------hcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence                01223333         367899999999999999999999999999999864

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.6e-41  Score=322.44  Aligned_cols=256  Identities=23%  Similarity=0.408  Sum_probs=202.8

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      ++|++++.||+|+||.||++.+..++..||+|.++..    ....+.+|+.+++++ +|+||+++++.+...  ...++|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~--~~~~lv   77 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKA-VSPYIVDFYGAFFIE--GAVYMC   77 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhc-CCCcHHhhhhheecC--CeEEEE
Confidence            4688999999999999999999889999999988642    135688999999998 999999999988653  577899


Q ss_pred             EeecCCCchhhhcC------CCChHHHHHHHHHHHHHHHHHHH-CCceeecCCCCceEecCCCCeEEEEecccceecCCC
Q 013897          210 FEHVNNTDFKVLYP------TLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG  282 (434)
Q Consensus       210 ~e~~~~~~l~~~~~------~l~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~  282 (434)
                      |||+.+++|..++.      .+++..+..++.||+.||.|||+ .+|+|+||||+||+++.++ .+||+|||++......
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~  156 (286)
T cd06622          78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG-QVKLCDFGVSGNLVAS  156 (286)
T ss_pred             EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCC-CEEEeecCCcccccCC
Confidence            99999999876642      57888999999999999999997 5999999999999999766 8999999999765322


Q ss_pred             CccceeccCCcccccccccCC-----CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhh
Q 013897          283 KEYNVRVASRYFKGPELLVDL-----QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK  357 (434)
Q Consensus       283 ~~~~~~~~t~~y~aPE~~~~~-----~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  357 (434)
                       ......++..|+|||.+.+.     ..++.++|||||||++|+|++|+.||.... .......+.......        
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~--------  226 (286)
T cd06622         157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET-YANIFAQLSAIVDGD--------  226 (286)
T ss_pred             -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc-hhhHHHHHHHHhhcC--------
Confidence             22344678889999998542     236889999999999999999999984322 111111111110000        


Q ss_pred             ccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccccc
Q 013897          358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~  428 (434)
                                      .         ......+++++.+||.+||+.||++||+++++++||||...+.+.
T Consensus       227 ----------------~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~~  272 (286)
T cd06622         227 ----------------P---------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNAD  272 (286)
T ss_pred             ----------------C---------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCCc
Confidence                            0         001123678899999999999999999999999999999887554

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=5.4e-41  Score=314.43  Aligned_cols=246  Identities=23%  Similarity=0.389  Sum_probs=201.0

Q ss_pred             CeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      +|++.+.||+|+||.||++.+..+++.+|+|.+...     ....+.+|+.+++.+ +|||++++++.+..  ....++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~lv   77 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLL-SHPNIIEYYENFLE--DKALMIV   77 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhC-CCCchhheeeeEec--CCEEEEE
Confidence            488999999999999999999889999999998543     245688999999999 89999999998854  3567899


Q ss_pred             EeecCCCchhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc
Q 013897          210 FEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE  284 (434)
Q Consensus       210 ~e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~  284 (434)
                      |||+.+++|..++.     .+++..+..++.|++.||.|||++||+|+||||+||+++.++..+||+|||.+........
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (256)
T cd08220          78 MEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK  157 (256)
T ss_pred             EecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence            99999999876652     3788899999999999999999999999999999999987666789999999987654444


Q ss_pred             cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCCh
Q 013897          285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP  364 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  364 (434)
                      .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.. .+.......+...                   
T Consensus       158 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~-~~~~~~~~~~~~~-------------------  216 (256)
T cd08220         158 AYTVVGTPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFEA-ANLPALVLKIMSG-------------------  216 (256)
T ss_pred             ccccccCCcccCchhccC-CCCCcccchHHHHHHHHHHHhCCCCccc-CchHHHHHHHHhc-------------------
Confidence            445678889999999876 6788999999999999999999999832 2222222111100                   


Q ss_pred             hHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                               ..        ......+++++.+++.+||..||++|||+.|+|+||||
T Consensus       217 ---------~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         217 ---------TF--------APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             ---------CC--------CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence                     00        00111256789999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.4e-40  Score=316.84  Aligned_cols=273  Identities=30%  Similarity=0.599  Sum_probs=205.4

Q ss_pred             CeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEE
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF  210 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  210 (434)
                      +|++.+.||.|++|.||+|.+..++..||||.++..    ....+.+|+.+++.+ +|+||+++++++.+.  ...++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~   77 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKEL-KHENIVRLHDVIHTE--NKLMLVF   77 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhh-cCCCEeeeeeeEeeC--CcEEEEE
Confidence            488999999999999999999889999999998643    235677899999999 899999999999764  5668999


Q ss_pred             eecCCCchhhhc------CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC-C
Q 013897          211 EHVNNTDFKVLY------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-K  283 (434)
Q Consensus       211 e~~~~~~l~~~~------~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~-~  283 (434)
                      ||+.+ ++..++      ..+++..+..++.||+.||.|||++|++||||||+||+++.++ .++|+|||++...... .
T Consensus        78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~-~~~l~d~g~~~~~~~~~~  155 (284)
T cd07836          78 EYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRG-ELKLADFGLARAFGIPVN  155 (284)
T ss_pred             ecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC-cEEEeecchhhhhcCCcc
Confidence            99997 444332      2478999999999999999999999999999999999999766 8999999999755332 2


Q ss_pred             ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                      ......++..|++||.+.+...++.++|||||||++|+|++|+.||. +.+..+....+....+.+....+..-.  .. 
T Consensus       156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~-  231 (284)
T cd07836         156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFP-GTNNEDQLLKIFRIMGTPTESTWPGIS--QL-  231 (284)
T ss_pred             ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC-CCCcHHHHHHHHHHhCCCChhhHHHHh--cC-
Confidence            22344678889999998765568899999999999999999998874 445555555555554433222221100  00 


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                      +.+.   ..........  .......+++.+.+++.+||+.||.+||++.|+++||||
T Consensus       232 ~~~~---~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         232 PEYK---PTFPRYPPQD--LQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             chhc---ccccCCChHH--HHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            0000   0000000000  000111356789999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=5.6e-41  Score=316.14  Aligned_cols=252  Identities=23%  Similarity=0.408  Sum_probs=201.1

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      ++|++.+.||.|+||.||+|.+..++..+|+|++...    ....+.+|+.+++.+ +|+|++++++.+.+.  ...++|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~iv   77 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQC-NHPNVVKYYTSFVVG--DELWLV   77 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhc-CCCCEEEEEEEEeeC--CEEEEE
Confidence            4789999999999999999998888999999998643    246688999999998 999999999988654  567899


Q ss_pred             EeecCCCchhhhcC------CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC
Q 013897          210 FEHVNNTDFKVLYP------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       210 ~e~~~~~~l~~~~~------~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~  283 (434)
                      +|++.++++..++.      .+++..++.++.|++.||.|||+.||+|+||||+||+++.++ .++|+|||++.......
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~-~~~l~df~~~~~~~~~~  156 (267)
T cd06610          78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDG-SVKIADFGVSASLADGG  156 (267)
T ss_pred             EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC-CEEEcccchHHHhccCc
Confidence            99999999876652      378889999999999999999999999999999999999766 89999999987665432


Q ss_pred             cc-----ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhc
Q 013897          284 EY-----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY  358 (434)
Q Consensus       284 ~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  358 (434)
                      ..     ...+++..|+|||.+.....++.++|+|||||++++|++|+.||... .....+..+.+   ..         
T Consensus       157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~-~~~~~~~~~~~---~~---------  223 (267)
T cd06610         157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKY-PPMKVLMLTLQ---ND---------  223 (267)
T ss_pred             cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCcccc-ChhhhHHHHhc---CC---------
Confidence            22     33468889999999876447899999999999999999999998432 22111111110   00         


Q ss_pred             cccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                                         ............+++.+.+|+.+||..||++||+++++++||||
T Consensus       224 -------------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         224 -------------------PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             -------------------CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence                               00000011112356789999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=9.6e-42  Score=321.98  Aligned_cols=251  Identities=23%  Similarity=0.423  Sum_probs=199.2

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|+++...   ...+.+|+.+++.+ +||||+++++.+.+.  ...++|
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l-~h~~ii~~~~~~~~~--~~~~lv   84 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDC-KHSNIVAYFGSYLRR--DKLWIC   84 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeC--CEEEEE
Confidence            367889999999999999999998899999999986543   24567899999999 999999999998654  567899


Q ss_pred             EeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC-cc
Q 013897          210 FEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EY  285 (434)
Q Consensus       210 ~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~-~~  285 (434)
                      +||+++++|..++   ..+++..+..++.|++.||.|||++||+|+||||+||+++.++ .++|+|||++....... ..
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~-~~~l~dfg~~~~~~~~~~~~  163 (267)
T cd06645          85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNG-HVKLADFGVSAQITATIAKR  163 (267)
T ss_pred             EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEECcceeeeEccCccccc
Confidence            9999999998765   3588999999999999999999999999999999999999776 79999999987653221 22


Q ss_pred             ceeccCCcccccccccC--CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          286 NVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       286 ~~~~~t~~y~aPE~~~~--~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                      ....|+..|+|||.+..  ...++.++|||||||++|+|++|..||+...... ....+..  .                
T Consensus       164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~-~~~~~~~--~----------------  224 (267)
T cd06645         164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-ALFLMTK--S----------------  224 (267)
T ss_pred             ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh-hHHhhhc--c----------------
Confidence            34578899999998742  2468899999999999999999999985433211 1111000  0                


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCC
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY  420 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~  420 (434)
                              .....      .......++..+.+|+.+||+.||++|||++++++|||
T Consensus       225 --------~~~~~------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         225 --------NFQPP------KLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             --------CCCCC------cccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence                    00000      00011125678999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=9.6e-41  Score=321.78  Aligned_cols=255  Identities=24%  Similarity=0.409  Sum_probs=202.5

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      ++|++.+.||+|+||.||++.+..+++.||+|.+....      ...+.+|+.+++.+ +||||+++++.+...  ..++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~--~~~~   77 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA-ENPFVVSMFCSFETK--RHLC   77 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEecC--CEEE
Confidence            46899999999999999999999999999999986432      34577899999998 999999999998653  5778


Q ss_pred             EEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC-
Q 013897          208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-  283 (434)
Q Consensus       208 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~-  283 (434)
                      +||||+.+++|..++   ..+++..+..++.|++.||.|||+++++||||||+||+++.++ .+||+|||+++...... 
T Consensus        78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~-~~~l~dfg~~~~~~~~~~  156 (305)
T cd05609          78 MVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMG-HIKLTDFGLSKIGLMSLT  156 (305)
T ss_pred             EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCC-CEEEeeCCCccccCcCcc
Confidence            999999999987775   3578888999999999999999999999999999999999766 89999999986421100 


Q ss_pred             ---------------ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCC
Q 013897          284 ---------------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT  348 (434)
Q Consensus       284 ---------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~  348 (434)
                                     ......++..|+|||.+.+ ..++.++|+|||||++|||++|..||.. ....+.+..+...  .
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~el~~g~~pf~~-~~~~~~~~~~~~~--~  232 (305)
T cd05609         157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFG-DTPEELFGQVISD--D  232 (305)
T ss_pred             ccccccccccchhhccccCCccCccccCchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhc--c
Confidence                           0012356778999999876 6789999999999999999999999842 2222212111100  0


Q ss_pred             hhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCcc---HHHHhcCCCccccc
Q 013897          349 DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT---AKEAMAHPYFFPIR  425 (434)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt---~~elL~Hp~~~~~~  425 (434)
                                               .  .+     ......+++++.+||.+||+.||++||+   +.++|+||||...+
T Consensus       233 -------------------------~--~~-----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~  280 (305)
T cd05609         233 -------------------------I--EW-----PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLD  280 (305)
T ss_pred             -------------------------c--CC-----CCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCC
Confidence                                     0  00     0011136778999999999999999998   79999999999887


Q ss_pred             ccc
Q 013897          426 NAE  428 (434)
Q Consensus       426 ~~~  428 (434)
                      .++
T Consensus       281 ~~~  283 (305)
T cd05609         281 WNG  283 (305)
T ss_pred             HHH
Confidence            766

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=8.5e-41  Score=327.47  Aligned_cols=285  Identities=28%  Similarity=0.488  Sum_probs=207.3

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC------
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS------  203 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~------  203 (434)
                      ..+|.+.+.||.|+||.||+|.+..+++.||+|.+...   ..+.+.+|+.+++.+ +||||+++++++.....      
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~   82 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRL-DHDNIVKVYEVLGPSGSDLTEDV   82 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhc-CCCcchhhHhhhccccccccccc
Confidence            47899999999999999999999999999999988643   245678999999999 99999999987754322      


Q ss_pred             ------CccEEEEeecCCCchhhhc--CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEeccc
Q 013897          204 ------KTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL  275 (434)
Q Consensus       204 ------~~~~lv~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGl  275 (434)
                            ...++|+||+.+ ++....  ..+++..++.++.||+.||.|||+.||+||||||+||+++.++..+||+|||+
T Consensus        83 ~~~~~~~~~~lv~e~~~~-~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~  161 (342)
T cd07854          83 GSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGL  161 (342)
T ss_pred             ccccccceEEEEeecccc-cHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCccc
Confidence                  246899999985 555444  35889999999999999999999999999999999999986666899999999


Q ss_pred             ceecCCCC----ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhH
Q 013897          276 AEFYHPGK----EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL  351 (434)
Q Consensus       276 a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~  351 (434)
                      +.......    ......++..|+|||.+.+...++.++|||||||++|+|++|+.||.. ....+....+.+.......
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~-~~~~~~~~~~~~~~~~~~~  240 (342)
T cd07854         162 ARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAG-AHELEQMQLILESVPVVRE  240 (342)
T ss_pred             ceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHHhcCCCCh
Confidence            97653221    112335788899999876546788999999999999999999999843 3333333333332222111


Q ss_pred             HHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccccc
Q 013897          352 NAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA  427 (434)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~  427 (434)
                      ..... .......... ......+.+..     .....++.++.+||.+||+.||++|||+.|+|.||||+.+..+
T Consensus       241 ~~~~~-~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~  309 (342)
T cd07854         241 EDRNE-LLNVIPSFVR-NDGGEPRRPLR-----DLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCP  309 (342)
T ss_pred             HHhhh-hhhhhhhhhh-hcccccCCCHH-----HHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCC
Confidence            11000 0000000000 00000000000     0112367789999999999999999999999999999966543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.6e-41  Score=329.50  Aligned_cols=285  Identities=32%  Similarity=0.587  Sum_probs=214.5

Q ss_pred             CCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC---
Q 013897          132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS---  203 (434)
Q Consensus       132 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~---  203 (434)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++...     ....+.+|+.+++.+ +|||++++++++.....   
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHM-DHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhc-cCCCHHHHHHHhhccccccc
Confidence            357899999999999999999999889999999998642     224567899999998 99999999987754322   


Q ss_pred             -CccEEEEeecCCCchhhhc--CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecC
Q 013897          204 -KTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH  280 (434)
Q Consensus       204 -~~~~lv~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~  280 (434)
                       ...++|+||++ ++|..++  ..+++..+..++.||++||.|||+.||+||||||+||+++.++ .++|+|||++....
T Consensus        92 ~~~~~lv~e~~~-~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~-~~kL~dfg~~~~~~  169 (343)
T cd07851          92 FQDVYLVTHLMG-ADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC-ELKILDFGLARHTD  169 (343)
T ss_pred             cccEEEEEecCC-CCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-CEEEcccccccccc
Confidence             34789999985 4665554  3589999999999999999999999999999999999999766 89999999997653


Q ss_pred             CCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccc
Q 013897          281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI  360 (434)
Q Consensus       281 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  360 (434)
                      .  ......++..|+|||.+.+...++.++|||||||++|+|++|+.||. +......+..+....+.... .+..+.. 
T Consensus       170 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~-~~~~~~~~~~i~~~~~~~~~-~~~~~~~-  244 (343)
T cd07851         170 D--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFP-GSDHIDQLKRIMNLVGTPDE-ELLQKIS-  244 (343)
T ss_pred             c--cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHhcCCCCH-HHHhhcc-
Confidence            2  23445678889999998764578899999999999999999999884 44555566666665554332 1222111 


Q ss_pred             cCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccccc
Q 013897          361 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~  428 (434)
                        .......+..........+.  ......++++.+||.+||..||++|||+.|+|+||||++....+
T Consensus       245 --~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~  308 (343)
T cd07851         245 --SESARNYIQSLPQMPKKDFK--EVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPE  308 (343)
T ss_pred             --chhHHHHHHhccccCCCCHH--HHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCc
Confidence              11111111111111111110  01122478899999999999999999999999999999876554

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=5.8e-41  Score=315.27  Aligned_cols=247  Identities=27%  Similarity=0.465  Sum_probs=201.4

Q ss_pred             CeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      +|++.+.||.|+||.||++.+..++..+|+|.++..     ..+.+..|+.+++.+ +|+||+++++++........+++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~   79 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILREL-KHPNIVRYYDRIIDRSNQTLYIV   79 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhc-CCCccceeeeeeecCCCCEEEEE
Confidence            488999999999999999999889999999998632     235678899999999 99999999998876666778899


Q ss_pred             EeecCCCchhhhc-------CCCChHHHHHHHHHHHHHHHHHH-----HCCceeecCCCCceEecCCCCeEEEEecccce
Q 013897          210 FEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCH-----SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE  277 (434)
Q Consensus       210 ~e~~~~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH-----~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~  277 (434)
                      |||+.+++|..++       ..+++..++.++.||+.||+|||     +.+++|+||||+||+++.++ .+||+|||++.
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~-~~kl~d~g~~~  158 (265)
T cd08217          80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANN-NVKLGDFGLAK  158 (265)
T ss_pred             ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCC-CEEEecccccc
Confidence            9999999987664       35788899999999999999999     89999999999999999766 89999999998


Q ss_pred             ecCCCCc-cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHh
Q 013897          278 FYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN  356 (434)
Q Consensus       278 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~  356 (434)
                      ....... .....++..|+|||.+.+ ..++.++|+||||+++++|++|+.||... + ...+.....   ..       
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~-~~~~~~~~~---~~-------  225 (265)
T cd08217         159 ILGHDSSFAKTYVGTPYYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTAR-N-QLQLASKIK---EG-------  225 (265)
T ss_pred             cccCCcccccccccCCCccChhhhcC-CCCCchhHHHHHHHHHHHHHHCCCcccCc-C-HHHHHHHHh---cC-------
Confidence            7654433 344578899999999876 56889999999999999999999998432 2 222111000   00       


Q ss_pred             hccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          357 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                                       .   .     .......+..+.+++.+||..+|++||++.++|+|||+
T Consensus       226 -----------------~---~-----~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         226 -----------------K---F-----RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             -----------------C---C-----CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence                             0   0     00112356789999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=6.6e-41  Score=316.15  Aligned_cols=251  Identities=24%  Similarity=0.431  Sum_probs=199.8

Q ss_pred             CeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc---------HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCc
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT  205 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  205 (434)
                      +|+..+.||+|+||.||+|.+..+++.+|+|++....         .+.+.+|+.+++.+ +|+||+++++++.+.  ..
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~   77 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL-NHPHIIRMLGATCED--SH   77 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHc-CCCceehhhceeccC--Ce
Confidence            3677899999999999999998999999999986422         35688999999999 999999999999654  56


Q ss_pred             cEEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC
Q 013897          206 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG  282 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~  282 (434)
                      .++|+||+.+++|..++   ..+++..+..++.||+.||.|||++|++|+||||+||+++.++..+||+|||++......
T Consensus        78 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~  157 (268)
T cd06630          78 FNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK  157 (268)
T ss_pred             EEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence            78999999999987765   357889999999999999999999999999999999999877657999999999765432


Q ss_pred             Cc-----cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhh
Q 013897          283 KE-----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK  357 (434)
Q Consensus       283 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  357 (434)
                      ..     .....++..|+|||.+.+ ..++.++|||||||++++|++|..||..... ......+.+....         
T Consensus       158 ~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~---------  226 (268)
T cd06630         158 GTGAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKH-SNHLALIFKIASA---------  226 (268)
T ss_pred             cccCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCC-cchHHHHHHHhcc---------
Confidence            11     123457888999999876 6789999999999999999999999843221 1111111110000         


Q ss_pred             ccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcc
Q 013897          358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFF  422 (434)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~  422 (434)
                                             ......+..+++++.+++.+||..||++||++.|+++||||+
T Consensus       227 -----------------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         227 -----------------------TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             -----------------------CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence                                   000111123567899999999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.7e-41  Score=327.43  Aligned_cols=281  Identities=35%  Similarity=0.628  Sum_probs=217.2

Q ss_pred             CeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccC---CCcc
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ---SKTP  206 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---~~~~  206 (434)
                      +|++.+.||.|+||.||+|.+..+++.+|||.+...     ..+.+.+|+.+++.+ +|+||+++++++.+..   ...+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~   79 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHL-RHENIIGLLDILRPPSPEDFNDV   79 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhc-CCcchhhhhhhhcccCcccccce
Confidence            488999999999999999999888999999988643     235688999999999 8999999999986543   2467


Q ss_pred             EEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC
Q 013897          207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~  283 (434)
                      ++||||+++ ++...+   ..+++..++.++.||+.||+|||++||+|+||||+|||++.++ .++|+|||++.......
T Consensus        80 ~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~-~~~L~dfg~~~~~~~~~  157 (330)
T cd07834          80 YIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNC-DLKICDFGLARGVDPDE  157 (330)
T ss_pred             EEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEcccCceEeecccc
Confidence            899999996 454443   2588999999999999999999999999999999999999776 89999999998765443


Q ss_pred             ----ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcc
Q 013897          284 ----EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH  359 (434)
Q Consensus       284 ----~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  359 (434)
                          ......++..|+|||.+.+...++.++|||||||++|+|++|..|| .+.+..+....+....+......+.. . 
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~-~-  234 (330)
T cd07834         158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLF-PGRDYIDQLNLIVEVLGTPSEEDLKF-I-  234 (330)
T ss_pred             cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCc-CCCCHHHHHHHHHHhcCCCChhHhhh-c-
Confidence                2344567889999999987448899999999999999999999887 55555666666666666544333221 0 


Q ss_pred             ccCChhHHHHhc---ccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccccc
Q 013897          360 IELDPHLAALVG---RHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       360 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~  428 (434)
                        ..........   ......+..     ....++.++.+||.+||+.||++|||++++|+||||+++...+
T Consensus       235 --~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~  299 (330)
T cd07834         235 --TSEKARNYLKSLPKKPKKPLSK-----LFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPE  299 (330)
T ss_pred             --cccchhhHHhhcccCCcchhHH-----hcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccc
Confidence              0111111111   111111111     1123678899999999999999999999999999999887654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-40  Score=326.69  Aligned_cols=286  Identities=33%  Similarity=0.581  Sum_probs=211.8

Q ss_pred             CCCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC--
Q 013897          131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS--  203 (434)
Q Consensus       131 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~--  203 (434)
                      ...++|++++.||+|+||.||+|.+..++..||||.+...     ....+.+|+.+++.+ +||||+++++++.....  
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-KHENVIGLLDVFTPDLSLD   90 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCCccceeeeecCCcccc
Confidence            3457899999999999999999999889999999998532     124577899999999 99999999998864332  


Q ss_pred             --CccEEEEeecCCCchhhhc--CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceec
Q 013897          204 --KTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY  279 (434)
Q Consensus       204 --~~~~lv~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~  279 (434)
                        ...++||||+ ++++..+.  ..+++..++.++.||+.||+|||+.||+||||||+||+++.++ .++|+|||++...
T Consensus        91 ~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~-~~kl~dfg~~~~~  168 (343)
T cd07880          91 RFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLARQT  168 (343)
T ss_pred             ccceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEeeccccccc
Confidence              2358999998 55665554  3688999999999999999999999999999999999999766 7999999999765


Q ss_pred             CCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcc
Q 013897          280 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH  359 (434)
Q Consensus       280 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  359 (434)
                      ..  ......++..|+|||.+.+...++.++|+|||||++|+|++|+.||. +.+.......+.+..+... ..+.....
T Consensus       169 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~-~~~~~~~~~~~~~~~~~~~-~~~~~~~~  244 (343)
T cd07880         169 DS--EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFK-GHDHLDQLMEIMKVTGTPS-KEFVQKLQ  244 (343)
T ss_pred             cc--CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHhcCCCC-HHHHHhhc
Confidence            32  22344678889999998764568899999999999999999999984 3344444444444333221 11111111


Q ss_pred             ccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccccc
Q 013897          360 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~  428 (434)
                      ..   .........+......+.  .....+++++.++|.+||..||++|||+.+++.||||+..+..+
T Consensus       245 ~~---~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~  308 (343)
T cd07880         245 SE---DAKNYVKKLPRFRKKDFR--SLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPE  308 (343)
T ss_pred             ch---hHHHHHHhccccCcchHH--HhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcc
Confidence            00   000111111111111110  11234677899999999999999999999999999999876544

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-42  Score=340.38  Aligned_cols=246  Identities=23%  Similarity=0.416  Sum_probs=201.9

Q ss_pred             eeeecCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeecCCCc
Q 013897          141 KVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD  217 (434)
Q Consensus       141 ~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~  217 (434)
                      .||+|.||+||-|++..+....|||-+....   ..-+..||...+.| +|.|||+++|.+.+  +.++.|.||.++||+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~L-rHkNIVrYLGs~se--nGf~kIFMEqVPGGS  658 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTL-RHKNIVRYLGSVSE--NGFFKIFMEQVPGGS  658 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHH-hhHhHHHHhhccCC--CCeEEEEeecCCCCc
Confidence            5999999999999999999999999986433   23467899999999 99999999999854  457789999999999


Q ss_pred             hhhhcC----CC--ChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc-cceecc
Q 013897          218 FKVLYP----TL--SDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-YNVRVA  290 (434)
Q Consensus       218 l~~~~~----~l--~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~-~~~~~~  290 (434)
                      |..++.    ++  .+..+..|.+||++||.|||++.|||||||-+|||++.-.+.+||+|||-++.+..-.. ..+..|
T Consensus       659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTG  738 (1226)
T KOG4279|consen  659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTG  738 (1226)
T ss_pred             HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccccccc
Confidence            987763    45  67788899999999999999999999999999999987777999999999988765443 356789


Q ss_pred             CCccccccccc-CCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHH
Q 013897          291 SRYFKGPELLV-DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAAL  369 (434)
Q Consensus       291 t~~y~aPE~~~-~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~  369 (434)
                      |..|||||++. |.++|+.++|||||||.+.||.||++||..-......+-+.    |          +. ...|.    
T Consensus       739 TLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkV----G----------my-KvHP~----  799 (1226)
T KOG4279|consen  739 TLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKV----G----------MY-KVHPP----  799 (1226)
T ss_pred             chhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhh----c----------ce-ecCCC----
Confidence            99999999994 45689999999999999999999999995443332222111    0          00 00011    


Q ss_pred             hcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccc
Q 013897          370 VGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI  424 (434)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~  424 (434)
                                      -+..++.+++.||.+|+..||.+||+|.++|..||++.-
T Consensus       800 ----------------iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  800 ----------------IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             ----------------CcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence                            112356789999999999999999999999999999965

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.2e-41  Score=320.78  Aligned_cols=254  Identities=24%  Similarity=0.401  Sum_probs=203.2

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      ++|+..+.||.|+||.||++.++.+++.+|+|.+...    ...++.+|+++++.+ +||||+++++.+...  ...++|
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~--~~~~lv   77 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKC-NSPYIVGFYGAFYNN--GDISIC   77 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHC-CCCchhhhheeeecC--CEEEEE
Confidence            3678889999999999999999889999999998643    235678999999999 799999999998654  677899


Q ss_pred             EeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHH-CCceeecCCCCceEecCCCCeEEEEecccceecCCCCc
Q 013897          210 FEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE  284 (434)
Q Consensus       210 ~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~  284 (434)
                      +||+.+++|..++    ..+++..+..++.|++.||+|||+ .+++|+||||+||+++.++ .++|+|||.+........
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~-~~~l~d~g~~~~~~~~~~  156 (265)
T cd06605          78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRG-QIKLCDFGVSGQLVNSLA  156 (265)
T ss_pred             EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCC-CEEEeecccchhhHHHHh
Confidence            9999999987765    457888999999999999999999 9999999999999999766 899999999876543222


Q ss_pred             cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH-HhCChhHHHHHhhccccCC
Q 013897          285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK-VLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~-~~g~~~~~~~~~~~~~~~~  363 (434)
                       ....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.......+......+ ....               
T Consensus       157 -~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---------------  219 (265)
T cd06605         157 -KTFVGTSSYMAPERIQG-NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE---------------  219 (265)
T ss_pred             -hcccCChhccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcC---------------
Confidence             22677888999999877 68899999999999999999999998544321111111111 0000               


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                               ...        ......+++++.+||.+||..||++|||+.|++.||||++..
T Consensus       220 ---------~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~~  264 (265)
T cd06605         220 ---------PPP--------RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKYE  264 (265)
T ss_pred             ---------CCC--------CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhccc
Confidence                     000        000011567899999999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=8.3e-41  Score=321.33  Aligned_cols=279  Identities=27%  Similarity=0.549  Sum_probs=209.8

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccC-----
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ-----  202 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~-----  202 (434)
                      .++|++.+.||+|+||.||+|.++.+++.||+|.++...     ...+.+|+.+++.+ +|||++++++++.+..     
T Consensus         6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~~~   84 (302)
T cd07864           6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQL-NHRNIVNLKEIVTDKQDALDF   84 (302)
T ss_pred             hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhC-CCCCeeeeeheecCcchhhhc
Confidence            478999999999999999999998899999999986422     24567899999999 8999999999986543     


Q ss_pred             ---CCccEEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccc
Q 013897          203 ---SKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA  276 (434)
Q Consensus       203 ---~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla  276 (434)
                         ....++|+||++++.+..+.   ..+++..++.++.||+.||.|||+.||+|+||||+||+++.++ .+||+|||++
T Consensus        85 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~-~~kl~dfg~~  163 (302)
T cd07864          85 KKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKG-QIKLADFGLA  163 (302)
T ss_pred             cccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-cEEeCccccc
Confidence               23688999999985444333   2588999999999999999999999999999999999999766 8999999999


Q ss_pred             eecCCCC--ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHH
Q 013897          277 EFYHPGK--EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAY  354 (434)
Q Consensus       277 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~  354 (434)
                      .......  ......++..|+|||.+.+...++.++|||||||++++|++|+.||. ..+..+.+..+.+..+......+
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  242 (302)
T cd07864         164 RLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQ-ANQELAQLELISRLCGSPCPAVW  242 (302)
T ss_pred             ccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHhCCCChhhc
Confidence            7664332  22333567789999988664567899999999999999999998874 44556666666666665443322


Q ss_pred             HhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          355 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                      ..-.....   ...   ........... ......+++.+.+++.+||..||.+|||+++++.||||
T Consensus       243 ~~~~~~~~---~~~---~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         243 PDVIKLPY---FNT---MKPKKQYRRRL-REEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             cccccccc---ccc---cccccccccch-hhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            21100000   000   00000000000 01112357889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=6.3e-41  Score=332.07  Aligned_cols=245  Identities=23%  Similarity=0.337  Sum_probs=189.7

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCC-----CeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTD-----NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS  203 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~-----~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  203 (434)
                      .++|++.+.||+|+||.||+|.+...     +..||+|.++...    ...+.+|+.+++.+.+|+||+++++++.+.  
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~--  114 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG--  114 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC--
Confidence            46799999999999999999986443     3579999996432    345789999999987899999999999654  


Q ss_pred             CccEEEEeecCCCchhhhcC------------------------------------------------------------
Q 013897          204 KTPSLIFEHVNNTDFKVLYP------------------------------------------------------------  223 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~~------------------------------------------------------------  223 (434)
                      ...++||||+.+++|..++.                                                            
T Consensus       115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (374)
T cd05106         115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS  194 (374)
T ss_pred             CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence            56789999999998865431                                                            


Q ss_pred             -------------CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCccc---e
Q 013897          224 -------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN---V  287 (434)
Q Consensus       224 -------------~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~~---~  287 (434)
                                   .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.........   .
T Consensus       195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~-~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGR-VAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCC-eEEEeeceeeeeccCCcceeeccC
Confidence                         256778899999999999999999999999999999999665 89999999997654332211   1


Q ss_pred             eccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhH
Q 013897          288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL  366 (434)
Q Consensus       288 ~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~  366 (434)
                      ..++..|+|||++.+ ..++.++|||||||++|||++ |+.||....... ....+... +                   
T Consensus       274 ~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~~~~~-~-------------------  331 (374)
T cd05106         274 ARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKMVKR-G-------------------  331 (374)
T ss_pred             CCCccceeCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHHHHHc-c-------------------
Confidence            234457999999876 679999999999999999997 999984322211 11111100 0                   


Q ss_pred             HHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          367 AALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                             .        .......+++++.+++.+||+.||++|||+.++++
T Consensus       332 -------~--------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         332 -------Y--------QMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             -------c--------CccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                   0        00011235688999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.4e-40  Score=314.69  Aligned_cols=248  Identities=27%  Similarity=0.398  Sum_probs=192.6

Q ss_pred             CCeEEEeee--eecCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEe
Q 013897          134 DDYEVVRKV--GRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE  211 (434)
Q Consensus       134 ~~y~~~~~l--G~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  211 (434)
                      ++|++.+.+  |+|+||.||++..+.++..+|+|.+........  |+.+...+.+|||++++++.+...  ...++|||
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--e~~~~~~~~~h~~iv~~~~~~~~~--~~~~iv~e   89 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--EPMVHQLMKDNPNFIKLYYSVTTL--KGHVLIMD   89 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh--hHHHHHHhhcCCCEEEEEEEEecC--CeeEEEEE
Confidence            455566655  999999999999999999999999865433222  333333344799999999999765  46789999


Q ss_pred             ecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCcccee
Q 013897          212 HVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR  288 (434)
Q Consensus       212 ~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~~~~  288 (434)
                      |+++++|..++   ..+++.++..++.||++||.|||+.|++||||||+||+++.++..++|+|||++......   ...
T Consensus        90 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~---~~~  166 (267)
T PHA03390         90 YIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP---SCY  166 (267)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC---ccC
Confidence            99999997665   258999999999999999999999999999999999999977657999999999765422   234


Q ss_pred             ccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHH
Q 013897          289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAA  368 (434)
Q Consensus       289 ~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~  368 (434)
                      .++..|+|||++.+ ..++.++|||||||++|+|++|+.||............+.....                     
T Consensus       167 ~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------------  224 (267)
T PHA03390        167 DGTLDYFSPEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQ---------------------  224 (267)
T ss_pred             CCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhc---------------------
Confidence            67889999999876 67899999999999999999999998533222111111110000                     


Q ss_pred             HhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCcc-HHHHhcCCCccc
Q 013897          369 LVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT-AKEAMAHPYFFP  423 (434)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt-~~elL~Hp~~~~  423 (434)
                            .       ........++.+.+||.+||+.||.+||+ ++|+|+||||++
T Consensus       225 ------~-------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        225 ------K-------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             ------c-------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence                  0       00111236789999999999999999996 699999999974

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.1e-40  Score=314.44  Aligned_cols=246  Identities=25%  Similarity=0.420  Sum_probs=195.7

Q ss_pred             CeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc---------HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCc
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT  205 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  205 (434)
                      +|.+.+.||+|+||.||+|.. .+++.+|+|.++...         ...+.+|+.+++.+ +|+||+++++++.+.  ..
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~   76 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL-KHVNIVQYLGTCLDD--NT   76 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhc-CCCCEeeEeeEeecC--Ce
Confidence            467889999999999999986 578899999886321         24578899999999 899999999999754  67


Q ss_pred             cEEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC
Q 013897          206 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG  282 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~  282 (434)
                      .++|+||+.+++|..++   ..+++..+..++.|++.||+|||+.+|+|+||||+||+++.++ .++|+|||++......
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~  155 (265)
T cd06631          77 ISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNG-IIKLIDFGCARRLAWV  155 (265)
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCC-eEEeccchhhHhhhhc
Confidence            78999999999988775   3578889999999999999999999999999999999999776 8999999998754211


Q ss_pred             -------CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHH
Q 013897          283 -------KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL  355 (434)
Q Consensus       283 -------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~  355 (434)
                             .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||... +.......+....+.       
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~-~~~~~~~~~~~~~~~-------  226 (265)
T cd06631         156 GLHGTHSNMLKSMHGTPYWMAPEVINE-SGYGRKSDIWSIGCTVFEMATGKPPLASM-DRLAAMFYIGAHRGL-------  226 (265)
T ss_pred             cccccccccccccCCCccccChhhhcC-CCCcchhhHHHHHHHHHHHHhCCCccccC-ChHHHHHHhhhccCC-------
Confidence                   11223467889999999876 67889999999999999999999998432 111111111000000       


Q ss_pred             hhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          356 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                                                 .......++.++.+||.+||..||++||++.|+|+||||
T Consensus       227 ---------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         227 ---------------------------MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             ---------------------------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                                       000112367789999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=9.4e-41  Score=315.09  Aligned_cols=244  Identities=28%  Similarity=0.517  Sum_probs=195.3

Q ss_pred             eEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc------------HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC
Q 013897          136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS  203 (434)
Q Consensus       136 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  203 (434)
                      |.+.+.||+|+||.||+|.+..+++.+|+|.+....            .+.+.+|+.+++.+ +||||+++++++.+.  
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--   78 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-QHENIVQYLGSSLDA--   78 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeC--
Confidence            567789999999999999998889999999885321            14578899999999 999999999998654  


Q ss_pred             CccEEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecC
Q 013897          204 KTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH  280 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~  280 (434)
                      ...++|+||+++++|..++   ..+++..+..++.|++.||+|||++|++||||||+||+++.++ .++|+|||+++...
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~-~~~l~dfg~~~~~~  157 (267)
T cd06628          79 DHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKG-GIKISDFGISKKLE  157 (267)
T ss_pred             CccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCC-CEEecccCCCcccc
Confidence            5678999999999987665   3578888999999999999999999999999999999999666 89999999987664


Q ss_pred             CCCc-------cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHH
Q 013897          281 PGKE-------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA  353 (434)
Q Consensus       281 ~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~  353 (434)
                      ....       .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||... ........+...        
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~--------  227 (267)
T cd06628         158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQ-TSYTRKADIWSLGCLVVEMLTGKHPFPDC-TQLQAIFKIGEN--------  227 (267)
T ss_pred             cccccCCccccccccCCCcCccChhHhcc-CCCCchhhhHHHHHHHHHHhhCCCCCCCc-cHHHHHHHHhcc--------
Confidence            2211       122357788999999876 67889999999999999999999998432 111111111000        


Q ss_pred             HHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          354 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                                                  ........++..+.++|.+||+.||++||++.|+++||||
T Consensus       228 ----------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         228 ----------------------------ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             ----------------------------CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence                                        0000112356789999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1e-40  Score=318.34  Aligned_cols=236  Identities=19%  Similarity=0.221  Sum_probs=189.0

Q ss_pred             eeeeecCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeEeeEEEc--cCCCccEEEEe
Q 013897          140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRD--QQSKTPSLIFE  211 (434)
Q Consensus       140 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~--~~~~~~~lv~e  211 (434)
                      ..||+|++|.||+|.+  +|+.||||.++...      .+.+.+|+.+|+++ +||||+++++++.+  .....+++|||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~g~~~~~~~~~~~~~lv~E  102 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRI-DSNNILKIYGFIIDIVDDLPRLSLILE  102 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhc-CCCCEEEEeeeEEecccCCCceEEEEE
Confidence            5699999999999997  68999999986432      25577999999999 99999999999876  44457889999


Q ss_pred             ecCCCchhhhcC---CCChHHHHHHHHHHHHHHHHHHHC-CceeecCCCCceEecCCCCeEEEEecccceecCCCCccce
Q 013897          212 HVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV  287 (434)
Q Consensus       212 ~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~~~  287 (434)
                      |+.+|+|..++.   .+++.....++.|++.||.|||+. +++||||||+|||++.++ .+||+|||+++.....  ...
T Consensus       103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~-~~kl~dfg~~~~~~~~--~~~  179 (283)
T PHA02988        103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENY-KLKIICHGLEKILSSP--PFK  179 (283)
T ss_pred             eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCC-cEEEcccchHhhhccc--ccc
Confidence            999999987763   478888899999999999999985 999999999999999776 8999999999765322  234


Q ss_pred             eccCCcccccccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhH
Q 013897          288 RVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL  366 (434)
Q Consensus       288 ~~~t~~y~aPE~~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~  366 (434)
                      .+++..|+|||++.+. ..++.++|||||||++|||++|+.||.. .+..+....+...                     
T Consensus       180 ~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~-~~~~~~~~~i~~~---------------------  237 (283)
T PHA02988        180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFEN-LTTKEIYDLIINK---------------------  237 (283)
T ss_pred             ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhc---------------------
Confidence            5678899999998652 5789999999999999999999999842 2222222221110                     


Q ss_pred             HHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          367 AALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                            ..+        ...+..+++++.+|+.+||+.||++|||+.|++.
T Consensus       238 ------~~~--------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        238 ------NNS--------LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             ------CCC--------CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence                  000        0011135778999999999999999999999985

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2e-40  Score=323.46  Aligned_cols=283  Identities=31%  Similarity=0.539  Sum_probs=211.1

Q ss_pred             CeEEEeeeeecCceEEEEEEEcCC--CeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEcc--CCCc
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCTD--NEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ--QSKT  205 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~~--~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~~~  205 (434)
                      +|++.+.||+|+||.||++.+..+  +..||+|.+...     ..+.+.+|+.+++++.+||||+++++.+...  ....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            478999999999999999999877  889999998632     2346788999999997799999999875432  2345


Q ss_pred             cEEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC
Q 013897          206 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG  282 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~  282 (434)
                      .++++||+.+ +|...+   ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus        81 ~~~~~e~~~~-~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~-~~kl~Dfg~a~~~~~~  158 (332)
T cd07857          81 LYLYEELMEA-DLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADC-ELKICDFGLARGFSEN  158 (332)
T ss_pred             EEEEEecccC-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCC-CEEeCcCCCceecccc
Confidence            6788888875 454443   3588999999999999999999999999999999999999776 8999999999765432


Q ss_pred             Cc-----cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhh
Q 013897          283 KE-----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK  357 (434)
Q Consensus       283 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  357 (434)
                      ..     .....|+..|+|||.+.+...++.++|||||||++|+|++|+.|| .+.+....+..+...+|.+....+...
T Consensus       159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (332)
T cd07857         159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVF-KGKDYVDQLNQILQVLGTPDEETLSRI  237 (332)
T ss_pred             cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCC-CCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            21     223468889999998876567899999999999999999999776 555566677777777776543222111


Q ss_pred             ccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccc
Q 013897          358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN  426 (434)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~  426 (434)
                       .   .+............+...+..  .....+..+.+|+.+||+.||++|||+.|++.||||+.+++
T Consensus       238 -~---~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~  300 (332)
T cd07857         238 -G---SPKAQNYIRSLPNIPKKPFES--IFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHD  300 (332)
T ss_pred             -h---hhhHHHHHHhccccCCcchHh--hCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcC
Confidence             0   011111100000000000000  01224678999999999999999999999999999987764

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-42  Score=334.53  Aligned_cols=235  Identities=19%  Similarity=0.328  Sum_probs=197.7

Q ss_pred             EEEeeeeecCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeecCCC
Q 013897          137 EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT  216 (434)
Q Consensus       137 ~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~  216 (434)
                      ..++-||.|+-|.||+|+.  .++.||||.++..    -+.+|+.|++| +||||+.|.|+|.  +..+.|||||||..|
T Consensus       127 sELeWlGSGaQGAVF~Grl--~netVAVKKV~el----kETdIKHLRkL-kH~NII~FkGVCt--qsPcyCIiMEfCa~G  197 (904)
T KOG4721|consen  127 SELEWLGSGAQGAVFLGRL--HNETVAVKKVREL----KETDIKHLRKL-KHPNIITFKGVCT--QSPCYCIIMEFCAQG  197 (904)
T ss_pred             hhhhhhccCcccceeeeec--cCceehhHHHhhh----hhhhHHHHHhc-cCcceeeEeeeec--CCceeEEeeeccccc
Confidence            3456799999999999997  5789999987533    35788999999 9999999999995  457788999999999


Q ss_pred             chhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCccceeccCCc
Q 013897          217 DFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY  293 (434)
Q Consensus       217 ~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~~~~~~t~~  293 (434)
                      -|...++   .+.......+..+|+.||.|||.+.|||||||.-||||..++ .|||+|||-++.+.+..+.-.++||..
T Consensus       198 qL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d-~VKIsDFGTS~e~~~~STkMSFaGTVa  276 (904)
T KOG4721|consen  198 QLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDD-VVKISDFGTSKELSDKSTKMSFAGTVA  276 (904)
T ss_pred             cHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccc-eEEeccccchHhhhhhhhhhhhhhhHh
Confidence            9877764   588888999999999999999999999999999999999887 899999999988877666677899999


Q ss_pred             ccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHhccc
Q 013897          294 FKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRH  373 (434)
Q Consensus       294 y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (434)
                      |||||++.+ .+.+.|+|||||||+|||||||..||.    +.+..+.|.- +|.                         
T Consensus       277 WMAPEvIrn-ePcsEKVDIwSfGVVLWEmLT~EiPYk----dVdssAIIwG-VGs-------------------------  325 (904)
T KOG4721|consen  277 WMAPEVIRN-EPCSEKVDIWSFGVVLWEMLTGEIPYK----DVDSSAIIWG-VGS-------------------------  325 (904)
T ss_pred             hhCHHHhhc-CCcccccceehhHHHHHHHHhcCCCcc----ccchheeEEe-ccC-------------------------
Confidence            999999988 899999999999999999999999993    2222222111 111                         


Q ss_pred             CCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          374 SRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                            ..+.+..+..+++.++-||+.||.-.|..||+..++|.|
T Consensus       326 ------NsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H  364 (904)
T KOG4721|consen  326 ------NSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH  364 (904)
T ss_pred             ------CcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence                  112234455688899999999999999999999999998

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=3.4e-41  Score=323.04  Aligned_cols=255  Identities=22%  Similarity=0.405  Sum_probs=203.3

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF  210 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  210 (434)
                      +.|.....||+|+||.||++.+..++..||||.+....   .+.+.+|+.+++.+ +|+||+++++.+...  ...++||
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~~--~~~~lv~   98 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDY-HHENVVDMYNSYLVG--DELWVVM   98 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhC-CCCcHHHHHHheecC--CeEEEEE
Confidence            34555677999999999999998889999999986432   35678999999998 999999999998654  5678999


Q ss_pred             eecCCCchhhhc--CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC-ccce
Q 013897          211 EHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNV  287 (434)
Q Consensus       211 e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~-~~~~  287 (434)
                      ||+.++++..++  ..+++..+..++.||+.||+|||+++|+||||||+||+++.++ .++|+|||++....... ....
T Consensus        99 e~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~-~~kL~dfg~~~~~~~~~~~~~~  177 (292)
T cd06658          99 EFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSKEVPKRKS  177 (292)
T ss_pred             eCCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC-CEEEccCcchhhcccccccCce
Confidence            999999987765  3578899999999999999999999999999999999999776 89999999986543222 2244


Q ss_pred             eccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHH
Q 013897          288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLA  367 (434)
Q Consensus       288 ~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~  367 (434)
                      ..++..|+|||.+.+ ..++.++|||||||++|||++|+.||... +....+..+.....                +   
T Consensus       178 ~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~~~-~~~~~~~~~~~~~~----------------~---  236 (292)
T cd06658         178 LVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYFNE-PPLQAMRRIRDNLP----------------P---  236 (292)
T ss_pred             eecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcCC----------------C---
Confidence            578889999999876 67899999999999999999999998532 22222211111000                0   


Q ss_pred             HHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccccc
Q 013897          368 ALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~  428 (434)
                                     ........+..+.+|+.+||..||++|||++|+|+||||.....+.
T Consensus       237 ---------------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~  282 (292)
T cd06658         237 ---------------RVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPS  282 (292)
T ss_pred             ---------------ccccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCcc
Confidence                           0001112567899999999999999999999999999999776554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-40  Score=316.33  Aligned_cols=272  Identities=34%  Similarity=0.640  Sum_probs=204.6

Q ss_pred             eEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEE
Q 013897          136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF  210 (434)
Q Consensus       136 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  210 (434)
                      |++.+.||.|++|.||+|.+..++..||+|++....     ...+.+|+.+++.+ +|||++++++++.+.  ...+++|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~iv~~~~~~~~~--~~~~iv~   77 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKEL-NHPNIVRLLDVVHSE--NKLYLVF   77 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhc-CCCCccCHhheeccC--CeEEEEE
Confidence            567889999999999999998899999999986432     24678899999999 899999999999654  6778999


Q ss_pred             eecCCCchhhhc---C--CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC-Cc
Q 013897          211 EHVNNTDFKVLY---P--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KE  284 (434)
Q Consensus       211 e~~~~~~l~~~~---~--~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~-~~  284 (434)
                      ||+++ ++..++   .  .+++..+..++.|++.||+|||+++++|+||+|+||+++.++ .++|+|||++...... ..
T Consensus        78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~-~~~l~df~~~~~~~~~~~~  155 (283)
T cd07835          78 EFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREG-ALKLADFGLARAFGVPVRT  155 (283)
T ss_pred             eccCc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC-cEEEeecccccccCCCccc
Confidence            99964 555443   2  478899999999999999999999999999999999999766 8999999999755322 22


Q ss_pred             cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCCh
Q 013897          285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP  364 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  364 (434)
                      .....++..|+|||++.+...++.++|||||||++|+|++|+.||. +.+....+..+.+..+.+....+...   ...+
T Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~  231 (283)
T cd07835         156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFP-GDSEIDQLFRIFRTLGTPDEDVWPGV---TSLP  231 (283)
T ss_pred             cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHHhCCCChHHhhhh---hhch
Confidence            2334567889999988764567899999999999999999998884 34444555555555554432222110   0001


Q ss_pred             hHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                      .+..........     ........++.++.++|.+||+.||++|||++|+++||||
T Consensus       232 ~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         232 DYKPTFPKWARQ-----DLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hhhhhccccccc-----chhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence            111000000000     0011123466789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.9e-40  Score=319.46  Aligned_cols=249  Identities=18%  Similarity=0.347  Sum_probs=188.5

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcC----------------CCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCee
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCT----------------DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIV  192 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~----------------~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv  192 (434)
                      .++|.+.++||+|+||.||+|.+..                ++..||+|++....    ...+.+|+.++.++ +||||+
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv   82 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRL-KDPNII   82 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhc-CCCCee
Confidence            3678999999999999999997632                34579999987532    35688999999999 999999


Q ss_pred             eEeeEEEccCCCccEEEEeecCCCchhhhcC----------------------CCChHHHHHHHHHHHHHHHHHHHCCce
Q 013897          193 KLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP----------------------TLSDYDVRYYIYELLKALDYCHSQGIM  250 (434)
Q Consensus       193 ~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----------------------~l~~~~~~~~~~qi~~~L~~LH~~~iv  250 (434)
                      ++++++.+.  ...++||||+.+++|..++.                      .+++..+..++.||+.||.|||++||+
T Consensus        83 ~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv  160 (304)
T cd05096          83 RLLGVCVDE--DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV  160 (304)
T ss_pred             EEEEEEecC--CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            999999754  45789999999999876542                      245677889999999999999999999


Q ss_pred             eecCCCCceEecCCCCeEEEEecccceecCCCCcc---ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh--C
Q 013897          251 HRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF--R  325 (434)
Q Consensus       251 HrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt--g  325 (434)
                      ||||||+|||++.++ .+||+|||+++........   ....++..|+|||++.+ ..++.++|||||||++|||++  +
T Consensus       161 H~dlkp~Nill~~~~-~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~  238 (304)
T cd05096         161 HRDLATRNCLVGENL-TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM-GKFTTASDVWAFGVTLWEILMLCK  238 (304)
T ss_pred             ccCcchhheEEcCCc-cEEECCCccceecccCceeEecCcCCCCccccCHHHHhc-CCCCchhhhHHHHHHHHHHHHccC
Confidence            999999999999766 8999999999765433221   22344678999999876 679999999999999999987  4


Q ss_pred             CCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccC
Q 013897          326 KEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYD  405 (434)
Q Consensus       326 ~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~d  405 (434)
                      ..||.. ....+.+..+.+....                        ....     ........++..+.+|+.+||..|
T Consensus       239 ~~p~~~-~~~~~~~~~~~~~~~~------------------------~~~~-----~~~~~~~~~~~~~~~li~~cl~~~  288 (304)
T cd05096         239 EQPYGE-LTDEQVIENAGEFFRD------------------------QGRQ-----VYLFRPPPCPQGLYELMLQCWSRD  288 (304)
T ss_pred             CCCCCc-CCHHHHHHHHHHHhhh------------------------cccc-----ccccCCCCCCHHHHHHHHHHccCC
Confidence            556632 2222222221111000                        0000     001112246778999999999999


Q ss_pred             CCCCccHHHHh
Q 013897          406 HQERPTAKEAM  416 (434)
Q Consensus       406 P~~Rpt~~elL  416 (434)
                      |++|||+.|+.
T Consensus       289 p~~RPs~~~i~  299 (304)
T cd05096         289 CRERPSFSDIH  299 (304)
T ss_pred             chhCcCHHHHH
Confidence            99999999994

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.4e-40  Score=314.27  Aligned_cols=250  Identities=22%  Similarity=0.376  Sum_probs=195.3

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF  210 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  210 (434)
                      +.......||+|+||.||+|.+..++..||+|.+....   .+.+.+|+.+++.+ +|+||+++++++...  ...++|+
T Consensus         8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv~   84 (268)
T cd06624           8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYL-KHRNIVQYLGSDSEN--GFFKIFM   84 (268)
T ss_pred             ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeccC--CEEEEEE
Confidence            33444568999999999999998889999999886543   34688999999999 999999999998654  5678999


Q ss_pred             eecCCCchhhhcC----CC--ChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc
Q 013897          211 EHVNNTDFKVLYP----TL--SDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE  284 (434)
Q Consensus       211 e~~~~~~l~~~~~----~l--~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~  284 (434)
                      ||+.+++|..++.    .+  ++..+..++.||+.||.|||++||+||||||+||+++.+...++|+|||++........
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~  164 (268)
T cd06624          85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP  164 (268)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC
Confidence            9999999877652    34  67788889999999999999999999999999999986555899999999876543222


Q ss_pred             -cceeccCCcccccccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          285 -YNVRVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       285 -~~~~~~t~~y~aPE~~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                       .....++..|+|||.+.+. ..++.++|||||||++|+|++|+.||.............. .                 
T Consensus       165 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~-~-----------------  226 (268)
T cd06624         165 CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVG-M-----------------  226 (268)
T ss_pred             ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhh-h-----------------
Confidence             2334578899999998552 3488999999999999999999999843222111110000 0                 


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                             .   ..       ....+..+++++.+|+.+||..+|++|||+.|++.||||
T Consensus       227 -------~---~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         227 -------F---KI-------HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             -------h---cc-------CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence                   0   00       000112356789999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=3.5e-41  Score=321.84  Aligned_cols=257  Identities=22%  Similarity=0.381  Sum_probs=198.4

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      ++|+..+.||+|+||.||++.+..+++.+|+|.+...    ....+.+|+.++.++.+|+||+++++++...  ...+++
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~--~~~~~~   81 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE--GDCWIC   81 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC--CcEEEE
Confidence            4566788999999999999999999999999998643    2356788999999996699999999988654  456799


Q ss_pred             EeecCCC--chhhh-----cCCCChHHHHHHHHHHHHHHHHHHHC-CceeecCCCCceEecCCCCeEEEEecccceecCC
Q 013897          210 FEHVNNT--DFKVL-----YPTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP  281 (434)
Q Consensus       210 ~e~~~~~--~l~~~-----~~~l~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~  281 (434)
                      |||+...  ++...     ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||++.....
T Consensus        82 ~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~~~  160 (288)
T cd06616          82 MELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNG-NIKLCDFGISGQLVD  160 (288)
T ss_pred             EecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCC-cEEEeecchhHHhcc
Confidence            9998753  22211     14588899999999999999999974 999999999999999766 899999999976544


Q ss_pred             CCccceeccCCcccccccccCC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcc
Q 013897          282 GKEYNVRVASRYFKGPELLVDL--QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH  359 (434)
Q Consensus       282 ~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  359 (434)
                      ........++..|+|||.+.+.  ..++.++|||||||++|+|++|+.||.....   ....+.+.....          
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~----------  227 (288)
T cd06616         161 SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS---VFDQLTQVVKGD----------  227 (288)
T ss_pred             CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch---HHHHHhhhcCCC----------
Confidence            4333445688899999998764  3689999999999999999999999843221   111111111000          


Q ss_pred             ccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccc
Q 013897          360 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                         .+          .      ........++.++.+|+.+||+.||++|||++++++||||+...
T Consensus       228 ---~~----------~------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~  274 (288)
T cd06616         228 ---PP----------I------LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE  274 (288)
T ss_pred             ---CC----------c------CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence               00          0      00011123678899999999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.6e-40  Score=316.21  Aligned_cols=247  Identities=25%  Similarity=0.389  Sum_probs=191.3

Q ss_pred             eeeecCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHh--cCCCCeeeEeeEEEccCCCccEEEEee
Q 013897          141 KVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNL--CGGPNIVKLLDIVRDQQSKTPSLIFEH  212 (434)
Q Consensus       141 ~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~E~~~l~~l--~~h~niv~l~~~~~~~~~~~~~lv~e~  212 (434)
                      .||+|+||.||++.+..+++.+|+|.+....      ...+.+|..+++.+  .+|||++.+++++...  ...++||||
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~   78 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTP--DKLCFILDL   78 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC--CeEEEEEec
Confidence            4899999999999998899999999885421      12234454444433  3789999999998654  467899999


Q ss_pred             cCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCccceec
Q 013897          213 VNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRV  289 (434)
Q Consensus       213 ~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~~~~~  289 (434)
                      +.+++|..++   ..+++..+..++.|++.||.|||+++|+||||||+|||++.++ .++|+|||++...... ......
T Consensus        79 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~-~~~l~dfg~~~~~~~~-~~~~~~  156 (279)
T cd05633          79 MNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDFSKK-KPHASV  156 (279)
T ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCC-CEEEccCCcceecccc-CccCcC
Confidence            9999997654   4589999999999999999999999999999999999999766 8999999999755332 223457


Q ss_pred             cCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCC-HHHHHHHHHHhCChhHHHHHhhccccCChhHHH
Q 013897          290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN-YDQLVKIAKVLGTDELNAYLNKYHIELDPHLAA  368 (434)
Q Consensus       290 ~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~-~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~  368 (434)
                      |+..|+|||.+.+...++.++|||||||++|+|++|..||...... ...+.....                .       
T Consensus       157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~----------------~-------  213 (279)
T cd05633         157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL----------------T-------  213 (279)
T ss_pred             CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh----------------c-------
Confidence            8899999999864356899999999999999999999998533221 111111000                0       


Q ss_pred             HhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCc-----cHHHHhcCCCccccccc
Q 013897          369 LVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-----TAKEAMAHPYFFPIRNA  427 (434)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rp-----t~~elL~Hp~~~~~~~~  427 (434)
                                   ........+++++.++|.+||..||++|+     ++.|+++||||++++..
T Consensus       214 -------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~  264 (279)
T cd05633         214 -------------VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQ  264 (279)
T ss_pred             -------------CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHh
Confidence                         00011123567899999999999999999     69999999999987643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=6.8e-41  Score=327.12  Aligned_cols=277  Identities=27%  Similarity=0.476  Sum_probs=208.5

Q ss_pred             CCeEE-EeeeeecCceEEEEEEEcCCCeEEEEEEeccccH-----------------HHHHHHHHHHHHhcCCCCeeeEe
Q 013897          134 DDYEV-VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK-----------------KKIKREIKILQNLCGGPNIVKLL  195 (434)
Q Consensus       134 ~~y~~-~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-----------------~~~~~E~~~l~~l~~h~niv~l~  195 (434)
                      ++|.. .+.||.|+||+||+|.+..+++.||||.++....                 ..+.+|+++++.+ +|+||++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~   86 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEI-KHENIMGLV   86 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhC-CCcceeeee
Confidence            55654 4779999999999999988999999999864321                 1467899999999 999999999


Q ss_pred             eEEEccCCCccEEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEe
Q 013897          196 DIVRDQQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLID  272 (434)
Q Consensus       196 ~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~D  272 (434)
                      +++...  ...++||||+.+ ++..++   ..+++..+..++.|++.||.|||++||+|+||||+||+++.++ .++|+|
T Consensus        87 ~~~~~~--~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~-~~kl~d  162 (335)
T PTZ00024         87 DVYVEG--DFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKG-ICKIAD  162 (335)
T ss_pred             EEEecC--CcEEEEEecccc-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCC-CEEECC
Confidence            998644  577899999985 554443   3478899999999999999999999999999999999999776 899999


Q ss_pred             cccceecCCC---------------CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHH
Q 013897          273 WGLAEFYHPG---------------KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYD  337 (434)
Q Consensus       273 FGla~~~~~~---------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~  337 (434)
                      ||++......               .......++..|+|||.+.+...++.++|||||||++|+|++|+.|| .+.+..+
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~-~~~~~~~  241 (335)
T PTZ00024        163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLF-PGENEID  241 (335)
T ss_pred             ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHH
Confidence            9999765411               11223356778999999876556799999999999999999999887 5556667


Q ss_pred             HHHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          338 QLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       338 ~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                      .+..+...++.+....|............    .....   ..  ........++++.+||.+||+.||++|||++|+|.
T Consensus       242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~---~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        242 QLGRIFELLGTPNEDNWPQAKKLPLYTEF----TPRKP---KD--LKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             HHHHHHHHhCCCchhhCcchhhccccccc----CcCCc---cc--HHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            77777776665543333221110000000    00000   00  00111235678999999999999999999999999


Q ss_pred             CCCccccc
Q 013897          418 HPYFFPIR  425 (434)
Q Consensus       418 Hp~~~~~~  425 (434)
                      ||||+...
T Consensus       313 ~~~~~~~~  320 (335)
T PTZ00024        313 HEYFKSDP  320 (335)
T ss_pred             CcccCCCC
Confidence            99999654

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=8.4e-41  Score=331.40  Aligned_cols=246  Identities=22%  Similarity=0.348  Sum_probs=189.5

Q ss_pred             CCCeEEEeeeeecCceEEEEEEE-----cCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVH-----CTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS  203 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~-----~~~~~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  203 (434)
                      .++|++.+.||+|+||.||+|.+     ..++..||||+++..    ..+.+.+|+.++..+.+||||+++++++.+.  
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~--  111 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG--  111 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC--
Confidence            46799999999999999999974     345678999998743    2346789999999987899999999999654  


Q ss_pred             CccEEEEeecCCCchhhhcC------------------------------------------------------------
Q 013897          204 KTPSLIFEHVNNTDFKVLYP------------------------------------------------------------  223 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~~------------------------------------------------------------  223 (434)
                      ...++||||+.+|+|..++.                                                            
T Consensus       112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (375)
T cd05104         112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS  191 (375)
T ss_pred             CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence            46789999999998865541                                                            


Q ss_pred             ------------------CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCcc
Q 013897          224 ------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY  285 (434)
Q Consensus       224 ------------------~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~  285 (434)
                                        .+++..+..++.||+.||.|||+++|+||||||+|||++.++ .+||+|||+++........
T Consensus       192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGR-ITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCC-cEEEecCccceeccCcccc
Confidence                              256677889999999999999999999999999999999665 8999999999766433221


Q ss_pred             c---eeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcccc
Q 013897          286 N---VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE  361 (434)
Q Consensus       286 ~---~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  361 (434)
                      .   ...++..|+|||.+.+ ..++.++|||||||++|||++ |..||... .....+.....                 
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDi~slG~~l~ellt~g~~p~~~~-~~~~~~~~~~~-----------------  331 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSSPYPGM-PVDSKFYKMIK-----------------  331 (375)
T ss_pred             cccCCCCCCcceeChhHhcC-CCCCCCCCHHHHHHHHHHHHhcCCCCCCCC-CchHHHHHHHH-----------------
Confidence            1   1234456999999876 689999999999999999998 78777322 21111111100                 


Q ss_pred             CChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          362 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                                ...+        .......+.++.+|+.+||+.||++||++.|+++.
T Consensus       332 ----------~~~~--------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         332 ----------EGYR--------MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             ----------hCcc--------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence                      0000        00112246789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2e-40  Score=312.04  Aligned_cols=245  Identities=26%  Similarity=0.460  Sum_probs=198.6

Q ss_pred             eeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeecCC
Q 013897          142 VGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN  215 (434)
Q Consensus       142 lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~  215 (434)
                      ||.|+||.||+|.+..+++.+|+|++...      ..+.+.+|+.+++.+ +||||+++++.+.+.  ...++|+||+.+
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~e~~~~   77 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC-NHPFIVKLYRTFKDK--KYIYMLMEYCLG   77 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhC-CCCCEeeeeeeEEcC--CccEEEEecCCC
Confidence            69999999999999888999999998642      235688999999999 999999999998654  567899999999


Q ss_pred             CchhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCccceeccCC
Q 013897          216 TDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASR  292 (434)
Q Consensus       216 ~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~~~~~~t~  292 (434)
                      ++|..++.   .+++..+..++.||+.||+|||+++++|+||||+||+++.++ .++|+|||++.............++.
T Consensus        78 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~  156 (262)
T cd05572          78 GELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNG-YVKLVDFGFAKKLKSGQKTWTFCGTP  156 (262)
T ss_pred             CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCC-CEEEeeCCcccccCcccccccccCCc
Confidence            99987653   478889999999999999999999999999999999999776 89999999998765443334457888


Q ss_pred             cccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHH-HHHHHHHhCChhHHHHHhhccccCChhHHHHhc
Q 013897          293 YFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQ-LVKIAKVLGTDELNAYLNKYHIELDPHLAALVG  371 (434)
Q Consensus       293 ~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~-~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~  371 (434)
                      .|++||.+.+ ..++.++|+|||||++|+|++|..||.....+... ...+..  +.                       
T Consensus       157 ~~~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~-----------------------  210 (262)
T cd05572         157 EYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILK--GN-----------------------  210 (262)
T ss_pred             CccChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhc--cC-----------------------
Confidence            9999999876 67899999999999999999999998544322111 111100  00                       


Q ss_pred             ccCCCCCccccccccccCCchHHHHHHHHccccCCCCCcc-----HHHHhcCCCcccccc
Q 013897          372 RHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT-----AKEAMAHPYFFPIRN  426 (434)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt-----~~elL~Hp~~~~~~~  426 (434)
                        .        ....+...++++.+||.+||..||++||+     ++|+++||||++.++
T Consensus       211 --~--------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~  260 (262)
T cd05572         211 --G--------KLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDW  260 (262)
T ss_pred             --C--------CCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCC
Confidence              0        00111124678999999999999999999     999999999998754

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-41  Score=318.46  Aligned_cols=291  Identities=27%  Similarity=0.482  Sum_probs=222.8

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc--HHHHHHHHHHHHHhcCC-------CCeeeEeeEEE--cc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGG-------PNIVKLLDIVR--DQ  201 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~E~~~l~~l~~h-------~niv~l~~~~~--~~  201 (434)
                      ..+|.+.++||.|.|++||+|.+..+.+.||+|+.+...  .+....||++|++++.+       ..||+|++.|.  .+
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            378999999999999999999999999999999998543  46678999999998543       47999999987  45


Q ss_pred             CCCccEEEEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHC-CceeecCCCCceEecCCCC----------
Q 013897          202 QSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQR----------  266 (434)
Q Consensus       202 ~~~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlKp~NIll~~~~~----------  266 (434)
                      ++.++|+|+|+++...|..+.    +.++...++.|++||+.||.|||.. ||||-||||+|||+.....          
T Consensus       157 NG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~~a~  236 (590)
T KOG1290|consen  157 NGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAREAG  236 (590)
T ss_pred             CCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhhhhc
Confidence            677999999999998887654    5699999999999999999999975 9999999999999922100          


Q ss_pred             --------------------------------------------------------------------------------
Q 013897          267 --------------------------------------------------------------------------------  266 (434)
Q Consensus       267 --------------------------------------------------------------------------------  266 (434)
                                                                                                      
T Consensus       237 e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v  316 (590)
T KOG1290|consen  237 EATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNESTV  316 (590)
T ss_pred             cccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccccch
Confidence                                                                                            


Q ss_pred             ---------------------------------------------------------------------------eEEEE
Q 013897          267 ---------------------------------------------------------------------------KLRLI  271 (434)
Q Consensus       267 ---------------------------------------------------------------------------~vkl~  271 (434)
                                                                                                 .|||+
T Consensus       317 ~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIa  396 (590)
T KOG1290|consen  317 ERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKIA  396 (590)
T ss_pred             hhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEEEe
Confidence                                                                                       07899


Q ss_pred             ecccceecCCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-----CCHHHHHHHHHHh
Q 013897          272 DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH-----DNYDQLVKIAKVL  346 (434)
Q Consensus       272 DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~-----~~~~~~~~i~~~~  346 (434)
                      |||.|.+..  ..++.-+.|..|+|||++.+ .+|+..+||||++|++|||+||...|.+..     .+.++++.|.+.+
T Consensus       397 DlGNACW~~--khFT~DIQTRQYRapEVllG-sgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELL  473 (590)
T KOG1290|consen  397 DLGNACWVH--KHFTEDIQTRQYRAPEVLLG-SGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELL  473 (590)
T ss_pred             eccchhhhh--hhhchhhhhhhccCcceeec-CCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHH
Confidence            999998754  45666788999999999999 799999999999999999999999986543     3467889999999


Q ss_pred             CChhHHHHH-hhccccCChhHHHHhcccCCCCCcccccc----ccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          347 GTDELNAYL-NKYHIELDPHLAALVGRHSRKPWSKFITV----ENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       347 g~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                      |.-...-.. +++...+.-.-..+.....-.+|.-..-+    .....-..++.|||.-||+.+|++||||.++|+|||+
T Consensus       474 G~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPwL  553 (590)
T KOG1290|consen  474 GKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPWL  553 (590)
T ss_pred             hhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCccc
Confidence            964332222 11111110000001111122233322111    1122234578899999999999999999999999999


Q ss_pred             ccccc
Q 013897          422 FPIRN  426 (434)
Q Consensus       422 ~~~~~  426 (434)
                      ..+.-
T Consensus       554 n~~~~  558 (590)
T KOG1290|consen  554 NPVAG  558 (590)
T ss_pred             cCCCC
Confidence            96643

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.6e-40  Score=315.67  Aligned_cols=248  Identities=26%  Similarity=0.412  Sum_probs=197.2

Q ss_pred             eeecCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeecCC
Q 013897          142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN  215 (434)
Q Consensus       142 lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~  215 (434)
                      ||+|+||+||+|.+..+++.||+|++....      ...+.+|+++++.+ +||||+++++++...  ...++||||+.+
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~lv~e~~~~   77 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSLAYAFETK--DDLCLVMTLMNG   77 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhC-CCCCEeeeeeEEecC--CeEEEEEecCCC
Confidence            699999999999998899999999985422      23457899999999 899999999998654  567899999999


Q ss_pred             Cchhhhc---C--CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCccceecc
Q 013897          216 TDFKVLY---P--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVA  290 (434)
Q Consensus       216 ~~l~~~~---~--~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~~~~~~  290 (434)
                      ++|..++   .  .+++..+..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++.............+
T Consensus        78 ~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~  156 (277)
T cd05577          78 GDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHG-NVRISDLGLAVELKGGKKIKGRAG  156 (277)
T ss_pred             CcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEEEccCcchhhhccCCccccccC
Confidence            9987654   2  478889999999999999999999999999999999999776 899999999976654434445567


Q ss_pred             CCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHh
Q 013897          291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALV  370 (434)
Q Consensus       291 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~  370 (434)
                      +..|+|||.+.+ ..++.++|||||||++|+|++|+.||........ ...+.+..                        
T Consensus       157 ~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~------------------------  210 (277)
T cd05577         157 TPGYMAPEVLQG-EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE-KEELKRRT------------------------  210 (277)
T ss_pred             CCCcCCHHHhcC-CCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc-HHHHHhcc------------------------
Confidence            888999999876 5689999999999999999999999843322111 00100000                        


Q ss_pred             cccCCCCCccccccccccCCchHHHHHHHHccccCCCCCc-----cHHHHhcCCCcccccccc
Q 013897          371 GRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-----TAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rp-----t~~elL~Hp~~~~~~~~~  428 (434)
                         ..      ........+++.+.++|.+||+.||++||     ++.++++||||..++...
T Consensus       211 ---~~------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~  264 (277)
T cd05577         211 ---LE------MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRR  264 (277)
T ss_pred             ---cc------ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChhh
Confidence               00      00111223578899999999999999999     999999999999877543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=7.5e-41  Score=314.28  Aligned_cols=246  Identities=28%  Similarity=0.469  Sum_probs=201.9

Q ss_pred             CeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      +|++.+.||.|+||.||+|.+..+++.||+|++...      ..+.+.+|+.+++++ +||||+++++.+.+  ....++
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~l   77 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHPFLVNLWYSFQD--EENMYL   77 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhC-CCCChHHHHHhhcC--CCeEEE
Confidence            488999999999999999999888999999998632      246788999999999 99999999999854  457889


Q ss_pred             EEeecCCCchhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCcc
Q 013897          209 IFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY  285 (434)
Q Consensus       209 v~e~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~  285 (434)
                      |+||+.+++|...+.   .+++..+..++.||++||.|||+++++|+||||+||+++.++ .++|+|||++.........
T Consensus        78 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~  156 (258)
T cd05578          78 VVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQG-HVHITDFNIATKVTPDTLT  156 (258)
T ss_pred             EEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCC-CEEEeecccccccCCCccc
Confidence            999999999876653   588899999999999999999999999999999999999776 8999999999776554444


Q ss_pred             ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCC-HHHHHHHHHHhCChhHHHHHhhccccCCh
Q 013897          286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN-YDQLVKIAKVLGTDELNAYLNKYHIELDP  364 (434)
Q Consensus       286 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~-~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  364 (434)
                      ....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...... .+.+...   ...                
T Consensus       157 ~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~~~----------------  216 (258)
T cd05578         157 TSTSGTPGYMAPEVLCR-QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAK---QET----------------  216 (258)
T ss_pred             cccCCChhhcCHHHHcc-cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHH---hcc----------------
Confidence            55667888999999876 56899999999999999999999998544322 1111110   000                


Q ss_pred             hHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccH--HHHhcCCCc
Q 013897          365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA--KEAMAHPYF  421 (434)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~--~elL~Hp~~  421 (434)
                               .        ........+.++.++|.+||..||.+||++  .|+++||||
T Consensus       217 ---------~--------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         217 ---------A--------DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             ---------c--------cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence                     0        000111256789999999999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-41  Score=343.81  Aligned_cols=245  Identities=20%  Similarity=0.305  Sum_probs=192.6

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHHHhcCCCCeeeEee-EEEc---cC-CC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLD-IVRD---QQ-SK  204 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~-~~~~---~~-~~  204 (434)
                      ..++++.+.|.+|||+.||+|.+...+..||+|.+-...   .+.+.+||.+|+.|.+|+|||.+++ ....   .+ ..
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~  115 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW  115 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence            456889999999999999999998777999999875433   4567899999999999999999999 3221   12 23


Q ss_pred             ccEEEEeecCCCchhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCC--ceeecCCCCceEecCCCCeEEEEecccce
Q 013897          205 TPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHEQRKLRLIDWGLAE  277 (434)
Q Consensus       205 ~~~lv~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlKp~NIll~~~~~~vkl~DFGla~  277 (434)
                      -++|+||||.+|.|.+++     ..|++.++.+|+.|+++|+.+||..+  |||||||-|||||+.++ ..||||||.|.
T Consensus       116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g-~~KLCDFGSat  194 (738)
T KOG1989|consen  116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADG-NYKLCDFGSAT  194 (738)
T ss_pred             EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCC-CEEeCcccccc
Confidence            467899999988776554     35999999999999999999999987  99999999999999777 89999999984


Q ss_pred             ecCCCCc----------cceeccCCcccccccccC--CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHH
Q 013897          278 FYHPGKE----------YNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV  345 (434)
Q Consensus       278 ~~~~~~~----------~~~~~~t~~y~aPE~~~~--~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~  345 (434)
                      --.....          ......|+.|++||++.-  ..++++|+|||+|||+||-|+....||..+....         
T Consensus       195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la---------  265 (738)
T KOG1989|consen  195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA---------  265 (738)
T ss_pred             cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee---------
Confidence            3221111          112357889999999842  2578999999999999999999999994332110         


Q ss_pred             hCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          346 LGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       346 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                                     ++..                -..+.....++..+.+||+.||+.||++||++.|++.+
T Consensus       266 ---------------Ilng----------------~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~  307 (738)
T KOG1989|consen  266 ---------------ILNG----------------NYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE  307 (738)
T ss_pred             ---------------EEec----------------cccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence                           0000                01122223467889999999999999999999999864

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.4e-40  Score=310.37  Aligned_cols=245  Identities=20%  Similarity=0.433  Sum_probs=198.2

Q ss_pred             CeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      +|++.+.||+|+||.||++....+++.||+|.+...     ..+++.+|+.+++.+ +||||+++++++.+.  ...++|
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~lv   77 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNM-KHPNIVQYQESFEEN--GNLYIV   77 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhC-CCCCeeeeEeeecCC--CeEEEE
Confidence            488999999999999999999889999999988532     235688999999999 999999999998643  577899


Q ss_pred             EeecCCCchhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc
Q 013897          210 FEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE  284 (434)
Q Consensus       210 ~e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~  284 (434)
                      +||+.++++.....     .+++..+..++.|++.||.|||+++++|+||+|+||+++.++ .++|+|||++........
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~-~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          78 MDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG-TIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CEEEeeccceeecCcchh
Confidence            99999998866542     367888999999999999999999999999999999999766 899999999976543322


Q ss_pred             -cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          285 -YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       285 -~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                       .....++..|+|||++.+ ..++.++|+|||||++++|++|+.||.... ..+....+..  +.               
T Consensus       157 ~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-~~~~~~~~~~--~~---------------  217 (256)
T cd08218         157 LARTCIGTPYYLSPEICEN-RPYNNKSDIWALGCVLYEMCTLKHAFEAGN-MKNLVLKIIR--GS---------------  217 (256)
T ss_pred             hhhhccCCccccCHHHhCC-CCCCCccchhHHHHHHHHHHcCCCCccCCC-HHHHHHHHhc--CC---------------
Confidence             223457888999999876 678899999999999999999999985332 1111111100  00               


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                               .          ......++.++.++|.+||+.+|++||++.++|+||||
T Consensus       218 ---------~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         218 ---------Y----------PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             ---------C----------CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence                     0          00112356789999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2e-40  Score=310.73  Aligned_cols=246  Identities=27%  Similarity=0.457  Sum_probs=198.1

Q ss_pred             eEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc--------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       136 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~--------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      |+..+.||+|+||+||+|....++..|++|.+...        ..+.+.+|+.+++.+ +|+||+++++++.+.  ...+
T Consensus         2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~--~~~~   78 (258)
T cd06632           2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-QHPNIVQYLGTEREE--DNLY   78 (258)
T ss_pred             ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhc-CCCCchheeeeEecC--CeEE
Confidence            56778899999999999999888999999988542        235688999999999 999999999998654  5678


Q ss_pred             EEEeecCCCchhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc
Q 013897          208 LIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE  284 (434)
Q Consensus       208 lv~e~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~  284 (434)
                      +|+||+++++|..++.   .+++..+..++.||+.||.|||+.||+|+||||+||+++.++ .+||+|||++........
T Consensus        79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~-~~kl~d~~~~~~~~~~~~  157 (258)
T cd06632          79 IFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNG-VVKLADFGMAKQVVEFSF  157 (258)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEccCccceecccccc
Confidence            9999999999877653   478888999999999999999999999999999999999766 899999999977654433


Q ss_pred             cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCCh
Q 013897          285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP  364 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  364 (434)
                      .....++..|++||.+.....++.++|+|||||++|+|++|+.||.... .......+....                  
T Consensus       158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~-~~~~~~~~~~~~------------------  218 (258)
T cd06632         158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE-GVAAVFKIGRSK------------------  218 (258)
T ss_pred             ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc-HHHHHHHHHhcc------------------
Confidence            4456688899999998763348999999999999999999999984332 111111110000                  


Q ss_pred             hHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                               ..        ......+++++.+|+.+||..||++||++.++|.|||+
T Consensus       219 ---------~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         219 ---------EL--------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             ---------cC--------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence                     00        00112356789999999999999999999999999997

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3.6e-40  Score=310.11  Aligned_cols=252  Identities=25%  Similarity=0.452  Sum_probs=205.7

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      ++|++.+.||+|++|.||+|.+..+++.||+|++....    ...+.+|+.++..+ +|+|++++++++...  ...++|
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~lv   77 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSC-ESPYVVKCYGAFYKE--GEISIV   77 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEccC--CeEEEE
Confidence            36889999999999999999998899999999987542    46789999999999 799999999998654  677899


Q ss_pred             EeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHH-CCceeecCCCCceEecCCCCeEEEEecccceecCCCCcc
Q 013897          210 FEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY  285 (434)
Q Consensus       210 ~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~  285 (434)
                      +||+.+++|..++   ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++ .++|+|||++.........
T Consensus        78 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~-~~~l~df~~~~~~~~~~~~  156 (264)
T cd06623          78 LEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKG-EVKIADFGISKVLENTLDQ  156 (264)
T ss_pred             EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCC-CEEEccCccceecccCCCc
Confidence            9999999998776   458899999999999999999999 9999999999999999776 8999999999876543332


Q ss_pred             -ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCC-CHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          286 -NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD-NYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       286 -~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~-~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                       ....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||..... ....+..  .....               
T Consensus       157 ~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~--~~~~~---------------  218 (264)
T cd06623         157 CNTFVGTVTYMSPERIQG-ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQ--AICDG---------------  218 (264)
T ss_pred             ccceeecccccCHhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHH--HHhcC---------------
Confidence             25567889999999876 6889999999999999999999999843321 1111110  00000               


Q ss_pred             hhHHHHhcccCCCCCccccccccccC-CchHHHHHHHHccccCCCCCccHHHHhcCCCccccc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHL-AVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                                ..        ...... ++..+.++|.+||..+|++||++.|+|+||||+..+
T Consensus       219 ----------~~--------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~  263 (264)
T cd06623         219 ----------PP--------PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD  263 (264)
T ss_pred             ----------CC--------CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence                      00        000112 567899999999999999999999999999998764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-40  Score=314.39  Aligned_cols=274  Identities=36%  Similarity=0.645  Sum_probs=207.5

Q ss_pred             eEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEE
Q 013897          136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF  210 (434)
Q Consensus       136 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  210 (434)
                      |++.+.||+|++|.||+|.+..+++.+++|.++...     ...+.+|+.+++.+ +|+||+++++++.+.  ...++|+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~~v~   77 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKEL-NHPNIIKLLDVFRHK--GDLYLVF   77 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHh-cCCCcchHHHhhccC--CCEEEEE
Confidence            567889999999999999998899999999986432     35678899999999 899999999998654  6778999


Q ss_pred             eecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC-ccc
Q 013897          211 EHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYN  286 (434)
Q Consensus       211 e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~-~~~  286 (434)
                      ||+.+..+..+.   ..+++..+..++.||+.||.|||+++|+|+||||+||+++.++ .++|+|||.+....... ...
T Consensus        78 e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~-~~~l~df~~~~~~~~~~~~~~  156 (283)
T cd05118          78 EFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEG-VLKLADFGLARSFGSPVRPYT  156 (283)
T ss_pred             eccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCC-cEEEeeeeeeEecCCCccccc
Confidence            999874433332   2578899999999999999999999999999999999999766 89999999997765443 333


Q ss_pred             eeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhH
Q 013897          287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL  366 (434)
Q Consensus       287 ~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~  366 (434)
                      ...++..|+|||.+.+...++.++|+|||||++|+|++|+.|| .+.+..+.+..+...++......+.......  ...
T Consensus       157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  233 (283)
T cd05118         157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLF-PGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA--RNY  233 (283)
T ss_pred             CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHcCCCchHhcccchhhh--hhh
Confidence            4567888999999877447899999999999999999999887 5555666666666655544322211100000  000


Q ss_pred             HHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          367 AALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                      ..   .........  .......++.++.+||.+||..||.+||++.+++.||||
T Consensus       234 ~~---~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         234 KF---SFPKKAGMP--LPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hh---hhccccccC--HHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence            00   000000000  001112367889999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1e-39  Score=317.97  Aligned_cols=284  Identities=32%  Similarity=0.574  Sum_probs=210.9

Q ss_pred             CCCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecc-----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCc
Q 013897          131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT  205 (434)
Q Consensus       131 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  205 (434)
                      ...++|++++.||.|+||.||+|.+..++..||+|.+..     ...+.+.+|+.+++.+ +||||+++++++... ...
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~-~~~   84 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL-RHENIISLSDIFISP-LED   84 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhc-CCCCeeeEeeeEecC-CCc
Confidence            346889999999999999999999999999999998753     1235678899999999 999999999998653 346


Q ss_pred             cEEEEeecCCCchhhhc--CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC
Q 013897          206 PSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~  283 (434)
                      .++|+||+++ ++..++  ..+++..+..++.||+.||.|||+++|+||||||+||+++.++ .++|+|||++.....  
T Consensus        85 ~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~-~~~l~dfg~~~~~~~--  160 (328)
T cd07856          85 IYFVTELLGT-DLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENC-DLKICDFGLARIQDP--  160 (328)
T ss_pred             EEEEeehhcc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCC-CEEeCccccccccCC--
Confidence            7899999864 565554  3577888899999999999999999999999999999999666 899999999975432  


Q ss_pred             ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                      ......++..|+|||.+.+...++.++|||||||++|+|++|+.|| .+.........+.+.+|..... +....   .+
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f-~~~~~~~~~~~~~~~~~~~~~~-~~~~~---~~  235 (328)
T cd07856         161 QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLF-PGKDHVNQFSIITDLLGTPPDD-VINTI---CS  235 (328)
T ss_pred             CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHH-HHHhc---cc
Confidence            2234467888999999866457899999999999999999999887 4444444455555555543211 11110   00


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccccc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA  427 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~  427 (434)
                      ..................  ......+++++.++|.+||+.||++|||++++|.||||......
T Consensus       236 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~  297 (328)
T cd07856         236 ENTLRFVQSLPKREPVPF--SEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP  297 (328)
T ss_pred             hhhHHHHhhccccCCCcH--HHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence            000001100000000000  01112356789999999999999999999999999999866543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.1e-40  Score=318.05  Aligned_cols=258  Identities=22%  Similarity=0.390  Sum_probs=200.6

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      .++|++.+.||+|+||.||+|.+..+++.||||.++..    ....+.+|+.++.++.+|+||+++++++.+.  ...++
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~~   91 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITD--SDVFI   91 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecC--CeEEE
Confidence            47799999999999999999999888999999998643    2345667888777776799999999999654  56789


Q ss_pred             EEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHH-CCceeecCCCCceEecCCCCeEEEEecccceecCCCC
Q 013897          209 IFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       209 v~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~  283 (434)
                      ||||+.+ ++..+.    ..+++..+..++.||+.||+|||+ .+|+||||+|+||+++.++ .+||+|||++.......
T Consensus        92 v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~-~~kL~dfg~~~~~~~~~  169 (296)
T cd06618          92 CMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG-NVKLCDFGISGRLVDSK  169 (296)
T ss_pred             EeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCC-CEEECccccchhccCCC
Confidence            9999875 333332    357888899999999999999997 5999999999999999666 89999999997665444


Q ss_pred             ccceeccCCcccccccccCC---CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccc
Q 013897          284 EYNVRVASRYFKGPELLVDL---QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI  360 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~~~---~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  360 (434)
                      ......++..|+|||.+.+.   ..++.++|||||||++|+|++|+.||.......+.+..+.   ...           
T Consensus       170 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~-----------  235 (296)
T cd06618         170 AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKIL---QEE-----------  235 (296)
T ss_pred             cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHh---cCC-----------
Confidence            44445677889999998652   2478899999999999999999999843322222222111   000           


Q ss_pred             cCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccccc
Q 013897          361 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~  428 (434)
                                  ..        .......++.++.+|+.+||..||++||+++++++||||+......
T Consensus       236 ------------~~--------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~  283 (296)
T cd06618         236 ------------PP--------SLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAE  283 (296)
T ss_pred             ------------CC--------CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccchhH
Confidence                        00        0001113567899999999999999999999999999999776544

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-41  Score=318.12  Aligned_cols=256  Identities=25%  Similarity=0.371  Sum_probs=213.7

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      .+|..+..||+|+||+|.+|..+++.+.||||++++.-      .+-...|-.+|.-...-|.++++...|  +.-..+|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF--QTmDRLy  426 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF--QTMDRLY  426 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh--hhhhhee
Confidence            57889999999999999999999999999999997532      222345666776665678999999888  4456788


Q ss_pred             EEEeecCCCchhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceec-CCCC
Q 013897          208 LIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY-HPGK  283 (434)
Q Consensus       208 lv~e~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~-~~~~  283 (434)
                      +||||+.||+|...++   .+-+..+..|+.+|+-||-+||++|||+||||.+|||+|.++ ++||+|||+++.- -++.
T Consensus       427 FVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eG-HiKi~DFGmcKEni~~~~  505 (683)
T KOG0696|consen  427 FVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKENIFDGV  505 (683)
T ss_pred             eEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCC-ceEeeecccccccccCCc
Confidence            9999999999976654   588889999999999999999999999999999999999888 8999999999753 3445


Q ss_pred             ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                      ...+.+||+.|+|||++.- .+|+..+|+||+||+||||+.|++|| .+++..+.++.|.+..                 
T Consensus       506 TTkTFCGTPdYiAPEIi~Y-qPYgksvDWWa~GVLLyEmlaGQpPF-dGeDE~elF~aI~ehn-----------------  566 (683)
T KOG0696|consen  506 TTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPF-DGEDEDELFQAIMEHN-----------------  566 (683)
T ss_pred             ceeeecCCCcccccceEEe-cccccchhHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHHHcc-----------------
Confidence            6678899999999999875 89999999999999999999999997 6777767766654321                 


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccH-----HHHhcCCCccccccccccc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA-----KEAMAHPYFFPIRNAESSR  431 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~-----~elL~Hp~~~~~~~~~~~~  431 (434)
                                          ...++.++.++.++.+.+|...|.+|...     .++-.||||+.+++...+|
T Consensus       567 --------------------vsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~  619 (683)
T KOG0696|consen  567 --------------------VSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLER  619 (683)
T ss_pred             --------------------CcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhh
Confidence                                12234578899999999999999999653     5888999999998765443

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.2e-40  Score=319.90  Aligned_cols=251  Identities=22%  Similarity=0.423  Sum_probs=201.5

Q ss_pred             CeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEe
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE  211 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  211 (434)
                      .|+....||+|+||.||+|.+..++..||+|.+...   ..+.+.+|+.+++.+ +||||+++++.+...  ...++|+|
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~--~~~~iv~e   98 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-QHQNVVEMYKSYLVG--EELWVLME   98 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhC-CCCchhhhhhheeeC--CeEEEEEe
Confidence            344566799999999999999888999999998532   345678999999999 899999999998654  56789999


Q ss_pred             ecCCCchhhhcC--CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC-cccee
Q 013897          212 HVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNVR  288 (434)
Q Consensus       212 ~~~~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~-~~~~~  288 (434)
                      |+.+++|..+..  .+++..+..++.|++.||.|||+++|+|+||||+||+++.++ .+||+|||++....... .....
T Consensus        99 ~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~-~~kL~dfg~~~~~~~~~~~~~~~  177 (297)
T cd06659          99 FLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPKRKSL  177 (297)
T ss_pred             cCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCC-cEEEeechhHhhcccccccccce
Confidence            999999877653  478899999999999999999999999999999999999776 89999999987554332 22445


Q ss_pred             ccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHH
Q 013897          289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAA  368 (434)
Q Consensus       289 ~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~  368 (434)
                      .++..|+|||++.+ ..++.++|||||||++|||++|+.||+.. +..+.+..+..   .                    
T Consensus       178 ~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~-~~~~~~~~~~~---~--------------------  232 (297)
T cd06659         178 VGTPYWMAPEVISR-TPYGTEVDIWSLGIMVIEMVDGEPPYFSD-SPVQAMKRLRD---S--------------------  232 (297)
T ss_pred             ecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhc---c--------------------
Confidence            78889999999876 67899999999999999999999998532 22222211110   0                    


Q ss_pred             HhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccc
Q 013897          369 LVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                           ..      ........+++.+.++|.+||+.||++||+++++++||||.+..
T Consensus       233 -----~~------~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~  278 (297)
T cd06659         233 -----PP------PKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTG  278 (297)
T ss_pred             -----CC------CCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence                 00      00011123567899999999999999999999999999999774

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=6.3e-40  Score=307.52  Aligned_cols=245  Identities=25%  Similarity=0.470  Sum_probs=200.1

Q ss_pred             CeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      +|++++.||.|+||.||.+....++..+++|.+...     ....+.+|+.+++++ +|+||+++++++.+.  ..++++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~--~~~~~~   77 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLL-QHPNIIAYYNHFMDD--NTLLIE   77 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhC-CCCCeeEEEeEEecC--CeEEEE
Confidence            488999999999999999999999999999987532     235688999999999 999999999999754  567899


Q ss_pred             EeecCCCchhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC-
Q 013897          210 FEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-  283 (434)
Q Consensus       210 ~e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~-  283 (434)
                      |||+.+++|..++.     .+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .+||+|||++....... 
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~-~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          78 MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAG-LIKLGDFGISKILGSEYS  156 (256)
T ss_pred             EEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCC-CEEECcCcceEEcccccc
Confidence            99999999876653     378889999999999999999999999999999999999776 89999999997664333 


Q ss_pred             ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                      ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||.. ....+....+..  +.               
T Consensus       157 ~~~~~~~~~~y~ape~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~-~~~~~~~~~~~~--~~---------------  217 (256)
T cd08221         157 MAETVVGTPYYMSPELCQG-VKYNFKSDIWALGCVLYELLTLKRTFDA-TNPLNLVVKIVQ--GN---------------  217 (256)
T ss_pred             cccccCCCccccCHhhcCC-CCCCCcchhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHc--CC---------------
Confidence            2344578899999999876 5688999999999999999999998832 222222222110  00               


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                                    +.     .....++.++.+++.+||..||++||+++++|+|||+
T Consensus       218 --------------~~-----~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         218 --------------YT-----PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             --------------CC-----CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence                          00     0012356789999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.5e-40  Score=311.44  Aligned_cols=251  Identities=25%  Similarity=0.458  Sum_probs=196.0

Q ss_pred             CeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc-------------HHHHHHHHHHHHHhcCCCCeeeEeeEEEcc
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-------------KKKIKREIKILQNLCGGPNIVKLLDIVRDQ  201 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-------------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  201 (434)
                      +|.+.+.||+|+||.||+|....+++.+|+|.++...             .+.+.+|+.+++.+ +|||++++++++...
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~   80 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL-DHLNIVQYLGFETTE   80 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhc-CCCCcceEEEEeccC
Confidence            4778899999999999999998889999999875311             13577899999999 899999999998654


Q ss_pred             CCCccEEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEeccccee
Q 013897          202 QSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF  278 (434)
Q Consensus       202 ~~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~  278 (434)
                        ...++||||+.+++|...+   ..+++..++.++.||+.||.|||+++++|+||||+||+++.++ .++|+|||+++.
T Consensus        81 --~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~-~~~l~d~~~~~~  157 (272)
T cd06629          81 --EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADG-ICKISDFGISKK  157 (272)
T ss_pred             --CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCC-eEEEeecccccc
Confidence              5678999999999987765   3478888999999999999999999999999999999999766 899999999975


Q ss_pred             cCCCC---ccceeccCCcccccccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHH
Q 013897          279 YHPGK---EYNVRVASRYFKGPELLVDLQ-DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAY  354 (434)
Q Consensus       279 ~~~~~---~~~~~~~t~~y~aPE~~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~  354 (434)
                      .....   ......++..|+|||.+.... .++.++|+|||||++++|++|..||... ...   ..+.+....      
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~-~~~---~~~~~~~~~------  227 (272)
T cd06629         158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE-EAI---AAMFKLGNK------  227 (272)
T ss_pred             ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCc-chH---HHHHHhhcc------
Confidence            43211   123345788899999987533 4889999999999999999999998322 111   111110000      


Q ss_pred             HhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          355 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                                        ......    .......++.++.+||.+||..||++|||++++|+||||
T Consensus       228 ------------------~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         228 ------------------RSAPPI----PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             ------------------ccCCcC----CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence                              000000    001112357789999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.8e-40  Score=315.36  Aligned_cols=251  Identities=25%  Similarity=0.417  Sum_probs=201.9

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      ..|+..+.||.|+||.||+|.+..++..||+|+++...    ...+.+|+.+++.+ +|+||+++++.+.+.  ...++|
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv   80 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKG--TKLWII   80 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEEC--CEEEEE
Confidence            45778899999999999999998889999999986432    35678899999999 999999999999754  577899


Q ss_pred             EeecCCCchhhhcC--CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC-ccc
Q 013897          210 FEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYN  286 (434)
Q Consensus       210 ~e~~~~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~-~~~  286 (434)
                      |||+.+++|..++.  .+++..+..++.|++.||+|||+.+++|+||+|+||+++.++ .++|+|||++....... ...
T Consensus        81 ~e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~-~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06640          81 MEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRN  159 (277)
T ss_pred             EecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCC-CEEEcccccceeccCCccccc
Confidence            99999999877653  478888999999999999999999999999999999999766 89999999997654332 223


Q ss_pred             eeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhH
Q 013897          287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL  366 (434)
Q Consensus       287 ~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~  366 (434)
                      ...++..|+|||.+.+ ..++.++|+|||||++|||++|..||.... .......+..                      
T Consensus       160 ~~~~~~~y~apE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~-~~~~~~~~~~----------------------  215 (277)
T cd06640         160 TFVGTPFWMAPEVIQQ-SAYDSKADIWSLGITAIELAKGEPPNSDMH-PMRVLFLIPK----------------------  215 (277)
T ss_pred             cccCcccccCHhHhcc-CCCccHHHHHHHHHHHHHHHHCCCCCCCcC-hHhHhhhhhc----------------------
Confidence            3467888999999876 678999999999999999999999984221 1111110000                      


Q ss_pred             HHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccc
Q 013897          367 AALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN  426 (434)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~  426 (434)
                            ...        ......++..+.+|+.+||..||++||++.++++||||.....
T Consensus       216 ------~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  261 (277)
T cd06640         216 ------NNP--------PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAK  261 (277)
T ss_pred             ------CCC--------CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcch
Confidence                  000        0011125578999999999999999999999999999987654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=6.8e-40  Score=308.38  Aligned_cols=249  Identities=28%  Similarity=0.507  Sum_probs=198.7

Q ss_pred             CeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      +|.+.+.||+|+||.||+|.+..+++.+|+|.++..     ....+.+|+.+++.+ +|+||+++++++.+  ....++|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~--~~~~~lv   77 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELL-KHPNLVKYYGVEVH--REKVYIF   77 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhC-CCCChhheeeeEec--CCEEEEE
Confidence            478999999999999999999888999999998643     235688999999999 99999999998854  3567899


Q ss_pred             EeecCCCchhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCcc-
Q 013897          210 FEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-  285 (434)
Q Consensus       210 ~e~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~-  285 (434)
                      +||+.+++|..+..   .+++..++.++.|++.||.|||+.+|+|+||||+||+++.++ .+||+|||++......... 
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~-~~kl~d~g~~~~~~~~~~~~  156 (264)
T cd06626          78 MEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNG-VIKLGDFGCAVKLKNNTTTM  156 (264)
T ss_pred             EecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEcccccccccCCCCCcc
Confidence            99999999987753   378888999999999999999999999999999999999766 8999999999766433221 


Q ss_pred             ----ceeccCCcccccccccCCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcc
Q 013897          286 ----NVRVASRYFKGPELLVDLQ--DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH  359 (434)
Q Consensus       286 ----~~~~~t~~y~aPE~~~~~~--~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  359 (434)
                          ....++..|+|||.+.+..  .++.++|||||||++++|++|+.||............+..  +.           
T Consensus       157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~-----------  223 (264)
T cd06626         157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA--GH-----------  223 (264)
T ss_pred             cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc--CC-----------
Confidence                1245678899999987632  3889999999999999999999998433322211111110  00           


Q ss_pred             ccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          360 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                                     .      ........+++.+.+|+.+||+.||++|||+.|++.|||+
T Consensus       224 ---------------~------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         224 ---------------K------PPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             ---------------C------CCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence                           0      0011111246789999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-40  Score=312.57  Aligned_cols=274  Identities=31%  Similarity=0.565  Sum_probs=209.1

Q ss_pred             eEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEe
Q 013897          136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE  211 (434)
Q Consensus       136 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  211 (434)
                      |.+.+.||+|+||+||+|....+++.||||.+....    .....+|+..++++.+|+|++++++++.+  ....++|||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~~~~lv~e   78 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE--NDELYFVFE   78 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc--CCcEEEEEe
Confidence            568899999999999999998889999999986432    23456799999999449999999999866  456789999


Q ss_pred             ecCCCchhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCccc
Q 013897          212 HVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN  286 (434)
Q Consensus       212 ~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~~  286 (434)
                      |+ ++++...+     ..+++..+..++.|++.+|.|||+++++|+||||+||+++.++ .++|+|||++..........
T Consensus        79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~-~~~l~d~~~~~~~~~~~~~~  156 (283)
T cd07830          79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPE-VVKIADFGLAREIRSRPPYT  156 (283)
T ss_pred             cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC-CEEEeecccceeccCCCCcC
Confidence            99 55554433     2578899999999999999999999999999999999999766 89999999998776555555


Q ss_pred             eeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhH
Q 013897          287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL  366 (434)
Q Consensus       287 ~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~  366 (434)
                      ...++..|+|||++.....++.++|+||||+++++|++|+.|| ......+....+...++......+..........  
T Consensus       157 ~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  233 (283)
T cd07830         157 DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLF-PGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL--  233 (283)
T ss_pred             CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCcc-CCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc--
Confidence            6678889999999866567899999999999999999999886 5556666777777777665444333221111000  


Q ss_pred             HHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          367 AALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                      ..........    .. .......+..+.+||.+||+.||++|||++|++.||||
T Consensus       234 ~~~~~~~~~~----~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         234 GFRFPQFAPT----SL-HQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             cccccccccc----cH-HHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            0000000000    00 00011235789999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-39  Score=310.32  Aligned_cols=272  Identities=29%  Similarity=0.562  Sum_probs=203.4

Q ss_pred             eEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhc--CCCCeeeEeeEEEccCC---Cc
Q 013897          136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLC--GGPNIVKLLDIVRDQQS---KT  205 (434)
Q Consensus       136 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~E~~~l~~l~--~h~niv~l~~~~~~~~~---~~  205 (434)
                      |++.+.||+|+||.||+|.+..+++.+|+|.++...     ...+.+|+.+++++.  .|+|++++++++.+...   ..
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            678899999999999999998889999999986321     234667888887773  59999999999875432   24


Q ss_pred             cEEEEeecCCCchhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecC
Q 013897          206 PSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH  280 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~  280 (434)
                      .+++|||+.+ ++..++     ..+++..++.++.|++.||.|||+.+++|+||||+||+++.++ .+||+|||++....
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~-~~~l~dfg~~~~~~  158 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDG-QVKIADFGLARIYS  158 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCC-CEEEeccCcceecc
Confidence            7899999986 444332     2478999999999999999999999999999999999999776 89999999997765


Q ss_pred             CCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccc
Q 013897          281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI  360 (434)
Q Consensus       281 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  360 (434)
                      .........++..|+|||.+.+ ..++.++|||||||++|+|++|..|| .+....+.+.++.+..+......+......
T Consensus       159 ~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~s~G~~l~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07838         159 FEMALTSVVVTLWYRAPEVLLQ-SSYATPVDMWSVGCIFAELFRRRPLF-RGTSEADQLDKIFDVIGLPSEEEWPRNVSL  236 (287)
T ss_pred             CCcccccccccccccChHHhcc-CCCCCcchhhhHHHHHHHHHhCCCcc-cCCChHHHHHHHHHHcCCCChHhcCCCccc
Confidence            4444344567888999999877 67899999999999999999998776 555666666666555443322222111000


Q ss_pred             cCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          361 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                      .. .    ..........     .......++.+.+||.+||+.||++||++.|+|+||||
T Consensus       237 ~~-~----~~~~~~~~~~-----~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         237 PR-S----SFPSYTPRSF-----KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             ch-h----hcccccccch-----hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence            00 0    0000000000     00111345788999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=3e-41  Score=320.57  Aligned_cols=251  Identities=25%  Similarity=0.410  Sum_probs=200.7

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      +.|+..+.||+|+||.||+|.+..++..||+|.++...    .+.+.+|+.+++.+ +||||+++++++...  ...++|
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv   80 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYITRYYGSYLKG--TKLWII   80 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcC-CCCccHhhhcccccC--CceEEE
Confidence            34667888999999999999998889999999986322    34688999999998 899999999998654  567899


Q ss_pred             EeecCCCchhhhcC--CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC-ccc
Q 013897          210 FEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYN  286 (434)
Q Consensus       210 ~e~~~~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~-~~~  286 (434)
                      |||++++++..++.  .+++..++.++.||+.||.|||+++++|+||+|+||+++.++ .++|+|||++....... ...
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06642          81 MEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRN  159 (277)
T ss_pred             EEccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCC-CEEEccccccccccCcchhhh
Confidence            99999999877653  478889999999999999999999999999999999999766 89999999997654332 223


Q ss_pred             eeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhH
Q 013897          287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL  366 (434)
Q Consensus       287 ~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~  366 (434)
                      ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||.... .......+.                       
T Consensus       160 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~-~~~~~~~~~-----------------------  214 (277)
T cd06642         160 TFVGTPFWMAPEVIKQ-SAYDFKADIWSLGITAIELAKGEPPNSDLH-PMRVLFLIP-----------------------  214 (277)
T ss_pred             cccCcccccCHHHhCc-CCCchhhhHHHHHHHHHHHHhCCCCCcccc-hhhHHhhhh-----------------------
Confidence            3467888999999876 678999999999999999999999973221 111110000                       


Q ss_pred             HHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccc
Q 013897          367 AALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN  426 (434)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~  426 (434)
                          .. ..        ......++.++.+++.+||+.+|++||++.++++||||.....
T Consensus       215 ----~~-~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  261 (277)
T cd06642         215 ----KN-SP--------PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTK  261 (277)
T ss_pred             ----cC-CC--------CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHhh
Confidence                00 00        0011135678999999999999999999999999999986653

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-39  Score=307.38  Aligned_cols=248  Identities=23%  Similarity=0.411  Sum_probs=198.5

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc--------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCc
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT  205 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~--------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  205 (434)
                      .+|.+.+.||+|+||.||+|.+..++..||+|.+...        ....+.+|+.+++++ +|+||+++++++.+.....
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~~   80 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL-RHDRIVQYYGCLRDPEEKK   80 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHc-CCCCcceEEEEEEcCCCCE
Confidence            4689999999999999999999889999999987421        224678899999999 9999999999987665567


Q ss_pred             cEEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC
Q 013897          206 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG  282 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~  282 (434)
                      .++++||+.+++|...+   ..+++..+..++.|++.||.|||+++++|+||||+||+++.++ .++|+|||+++.....
T Consensus        81 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~~  159 (264)
T cd06653          81 LSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAG-NVKLGDFGASKRIQTI  159 (264)
T ss_pred             EEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CEEECccccccccccc
Confidence            78999999999887665   3478888999999999999999999999999999999999766 8999999999765321


Q ss_pred             ----CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhc
Q 013897          283 ----KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY  358 (434)
Q Consensus       283 ----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  358 (434)
                          .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||... .   ....+.+....+         
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~-~---~~~~~~~~~~~~---------  225 (264)
T cd06653         160 CMSGTGIKSVTGTPYWMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPWAEY-E---AMAAIFKIATQP---------  225 (264)
T ss_pred             cccCccccccCCcccccCHhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCcc-C---HHHHHHHHHcCC---------
Confidence                12233467888999999877 67889999999999999999999998322 1   111111111100         


Q ss_pred             cccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                                     .        ....+..+++++.+++.+||+ +|.+||++.+++.|||.
T Consensus       226 ---------------~--------~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         226 ---------------T--------KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             ---------------C--------CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence                           0        001122366789999999999 57999999999999995

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1e-39  Score=305.28  Aligned_cols=249  Identities=30%  Similarity=0.508  Sum_probs=203.5

Q ss_pred             CeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      +|.+.+.||+|++|.||+|.+..++..+++|++....     .+.+.+|+.+++++ +|+||+++++.+.+......++|
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv   79 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSL-QHPNIVRYYGSERDEEKNTLNIF   79 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHc-CCCCEeeEEEEEecCCCCeEEEE
Confidence            4778899999999999999998899999999987544     56788999999999 89999999999976533677899


Q ss_pred             EeecCCCchhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc--
Q 013897          210 FEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE--  284 (434)
Q Consensus       210 ~e~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~--  284 (434)
                      +||+.+++|..++.   .+++..+..++.|++.||+|||+.+++|+||+|+||+++.++ .++|+|||.+........  
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~~~  158 (260)
T cd06606          80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDG-VVKLADFGCAKRLGDIETGE  158 (260)
T ss_pred             EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC-CEEEcccccEEecccccccc
Confidence            99999999877653   578999999999999999999999999999999999999766 899999999987755432  


Q ss_pred             -cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          285 -YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       285 -~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                       .....++..|++||.+.+ ..++.++|||||||++++|++|..||....+.......+..   .               
T Consensus       159 ~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~---------------  219 (260)
T cd06606         159 GTGSVRGTPYWMAPEVIRG-EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS---S---------------  219 (260)
T ss_pred             cccCCCCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccc---c---------------
Confidence             345578888999999876 56899999999999999999999998543321111111100   0               


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                                 ..      ........++.+.+|+.+||..||++||++.|+++||||
T Consensus       220 -----------~~------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         220 -----------GE------PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             -----------CC------CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence                       00      000112346789999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-41  Score=331.80  Aligned_cols=246  Identities=27%  Similarity=0.399  Sum_probs=202.8

Q ss_pred             CCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEe
Q 013897          132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE  211 (434)
Q Consensus       132 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  211 (434)
                      ..++|++...+|.|+|+.|-.+.+..+++..++|++... ..+..+|+.++....+||||+++.+++.+  ....++|||
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~-~~~~~~e~~~~~~~~~h~niv~~~~v~~~--~~~~~~v~e  396 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR-ADDNQDEIPISLLVRDHPNIVKSHDVYED--GKEIYLVME  396 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheecccc-ccccccccchhhhhcCCCcceeecceecC--Cceeeeeeh
Confidence            367899999999999999999999999999999999655 34556788888888899999999999965  467889999


Q ss_pred             ecCCCchhhhcCC--CChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEec-CCCCeEEEEecccceecCCCCcccee
Q 013897          212 HVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID-HEQRKLRLIDWGLAEFYHPGKEYNVR  288 (434)
Q Consensus       212 ~~~~~~l~~~~~~--l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~-~~~~~vkl~DFGla~~~~~~~~~~~~  288 (434)
                      .+.++.+...+..  ....++..|+.+|+.|+.|||++|||||||||+|||++ ..+ +++|+|||.++.....  +.+.
T Consensus       397 ~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g-~lrltyFG~a~~~~~~--~~tp  473 (612)
T KOG0603|consen  397 LLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAG-HLRLTYFGFWSELERS--CDTP  473 (612)
T ss_pred             hccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCC-cEEEEEechhhhCchh--hccc
Confidence            9999977554432  33357778999999999999999999999999999995 444 8999999999876544  4455


Q ss_pred             ccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHH
Q 013897          289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAA  368 (434)
Q Consensus       289 ~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~  368 (434)
                      +-|..|.|||++.. ..|++++||||||++||+||+|+.||.......+.+.++    +.+.                  
T Consensus       474 ~~t~~y~APEvl~~-~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i----~~~~------------------  530 (612)
T KOG0603|consen  474 ALTLQYVAPEVLAI-QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI----QMPK------------------  530 (612)
T ss_pred             chhhcccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh----cCCc------------------
Confidence            77888999999985 799999999999999999999999985544442222221    1111                  


Q ss_pred             HhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccc
Q 013897          369 LVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP  423 (434)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~  423 (434)
                                       ....+|++++|||..||+.||.+|+++.+++.||||..
T Consensus       531 -----------------~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~~  568 (612)
T KOG0603|consen  531 -----------------FSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWFLS  568 (612)
T ss_pred             -----------------cccccCHHHHHHHHHhccCChhhCcChhhhccCcchhc
Confidence                             11347899999999999999999999999999999943

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=3e-40  Score=314.47  Aligned_cols=243  Identities=18%  Similarity=0.333  Sum_probs=192.8

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCC-----eEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCC
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDN-----EKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK  204 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~-----~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  204 (434)
                      ++|++.+.||+|+||.||+|.+...+     ..+|+|.++...    ...+.+|+.++..+ +||||+++++++.+.  .
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~--~   81 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL-QHPNIVCLLGVCTKE--Q   81 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhc-CCcccceEEEEEcCC--C
Confidence            57889999999999999999876554     689999986432    35678999999998 999999999998643  5


Q ss_pred             ccEEEEeecCCCchhhhc-------------------CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCC
Q 013897          205 TPSLIFEHVNNTDFKVLY-------------------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ  265 (434)
Q Consensus       205 ~~~lv~e~~~~~~l~~~~-------------------~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~  265 (434)
                      ..+++|||+.+++|..++                   ..+++..+..++.|++.||.|||+++|+|+||||+||+++.++
T Consensus        82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC
Confidence            678999999999987664                   2367778899999999999999999999999999999999766


Q ss_pred             CeEEEEecccceecCCCCc---cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHH
Q 013897          266 RKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVK  341 (434)
Q Consensus       266 ~~vkl~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~  341 (434)
                       .+||+|||++........   .....++..|+|||.+.+ ..++.++|||||||++|||++ |..||+.. ...+....
T Consensus       162 -~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~slG~il~el~~~g~~p~~~~-~~~~~~~~  238 (283)
T cd05048         162 -TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQPYYGF-SNQEVIEM  238 (283)
T ss_pred             -cEEECCCcceeeccccccccccCCCcccccccCHHHhcc-CcCchhhhHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHH
Confidence             899999999976543321   223456778999999876 678999999999999999998 99898432 22221111


Q ss_pred             HHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          342 IAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       342 i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                      +..                            ...        ......+++++.+|+.+||+.||.+||++.|++++
T Consensus       239 i~~----------------------------~~~--------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         239 IRS----------------------------RQL--------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHc----------------------------CCc--------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            110                            000        00122467899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.6e-41  Score=328.88  Aligned_cols=252  Identities=25%  Similarity=0.470  Sum_probs=212.0

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      ..|.+.+.||+|.|++|.+|++..++..||||++.+.     ....+.+|+++|+.| +|||||+++.+...  ...+|+
T Consensus        56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l-~HPnIvkl~~v~~t--~~~lyl  132 (596)
T KOG0586|consen   56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSL-NHPNIVKLFSVIET--EATLYL  132 (596)
T ss_pred             cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhc-CCcceeeeeeeeee--cceeEE
Confidence            5699999999999999999999999999999999653     234588999999999 99999999999853  467899


Q ss_pred             EEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCcc
Q 013897          209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY  285 (434)
Q Consensus       209 v~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~  285 (434)
                      ||||+.+|.+.+++   ..+.+..++.++.|+..|++|||+++|||||||++||||+.+. .+||+|||++..+..+...
T Consensus       133 V~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~m-nikIaDfgfS~~~~~~~~l  211 (596)
T KOG0586|consen  133 VMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENM-NIKIADFGFSTFFDYGLML  211 (596)
T ss_pred             EEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccccccc-ceeeeccccceeecccccc
Confidence            99999999987775   3577788999999999999999999999999999999999777 7999999999999888888


Q ss_pred             ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChh
Q 013897          286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH  365 (434)
Q Consensus       286 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~  365 (434)
                      .+.+|++.|.|||++.+....++++|+||+|++||-|+.|..||. +.+-.+ +.          ......++.      
T Consensus       212 qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFD-G~~lk~-Lr----------~rvl~gk~r------  273 (596)
T KOG0586|consen  212 QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFD-GQNLKE-LR----------PRVLRGKYR------  273 (596)
T ss_pred             cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccC-Cccccc-cc----------chheeeeec------
Confidence            999999999999999987777899999999999999999999993 211110 00          000011111      


Q ss_pred             HHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccccc
Q 013897          366 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA  427 (434)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~  427 (434)
                                          -+-.++-++.++|+++|..+|.+|++.++++.|.|+....+.
T Consensus       274 --------------------Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  274 --------------------IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             --------------------ccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence                                111255689999999999999999999999999999855443

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=4.2e-40  Score=308.59  Aligned_cols=246  Identities=22%  Similarity=0.457  Sum_probs=198.3

Q ss_pred             CeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      +|++.+.||+|+||.||+|.+..++..+|+|.+...     ..+.+.+|+.+++.+ +|+||+++++.+.+  ....++|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~-~h~~i~~~~~~~~~--~~~~~lv   77 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKM-KHPNIVTFFASFQE--NGRLFIV   77 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhC-CCCChhhhhheecc--CCeEEEE
Confidence            478999999999999999999999999999998542     345678999999999 89999999999854  3577899


Q ss_pred             EeecCCCchhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc
Q 013897          210 FEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE  284 (434)
Q Consensus       210 ~e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~  284 (434)
                      +||+.+++|..++.     .+++..+..++.|++.||.|||+.+++|+||||+||+++.++..+||+|||.+........
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          78 MEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            99999999876652     3688889999999999999999999999999999999997765689999999976643322


Q ss_pred             -cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          285 -YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       285 -~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                       .....|+..|+|||.+.+ ..++.++|+|||||++++|++|+.||... +..+....+.   ..            .  
T Consensus       158 ~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~---~~------------~--  218 (257)
T cd08225         158 LAYTCVGTPYYLSPEICQN-RPYNNKTDIWSLGCVLYELCTLKHPFEGN-NLHQLVLKIC---QG------------Y--  218 (257)
T ss_pred             cccccCCCccccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCc-cHHHHHHHHh---cc------------c--
Confidence             233467888999999876 57889999999999999999999998322 1111111110   00            0  


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                                    ..     .....++.++.+++.+||..+|++|||+.|+++||||
T Consensus       219 --------------~~-----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         219 --------------FA-----PISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             --------------CC-----CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence                          00     0011356789999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=4e-40  Score=315.73  Aligned_cols=254  Identities=24%  Similarity=0.441  Sum_probs=204.2

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      .++|.+.+.||+|+||.||++.+..++..||+|.+...   ..+.+.+|+.+++.+ +|||++++++++.+.  ...++|
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~--~~~~lv   94 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMREN-KHPNIVNYLDSYLVG--DELWVV   94 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhc-CCCCeeehhheeeeC--CcEEEE
Confidence            47899999999999999999998888999999998532   235678899999998 899999999998654  567899


Q ss_pred             EeecCCCchhhhcC--CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc-cc
Q 013897          210 FEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-YN  286 (434)
Q Consensus       210 ~e~~~~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~-~~  286 (434)
                      +||+.+++|..++.  .+++.++..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++........ ..
T Consensus        95 ~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~-~~kL~dfg~~~~~~~~~~~~~  173 (293)
T cd06647          95 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRS  173 (293)
T ss_pred             EecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCC-CEEEccCcceecccccccccc
Confidence            99999999987764  478889999999999999999999999999999999999766 899999999876543322 23


Q ss_pred             eeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhH
Q 013897          287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL  366 (434)
Q Consensus       287 ~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~  366 (434)
                      ...++..|+|||.+.+ ..++.++|||||||++|+|++|+.||... +..+.+..+..                      
T Consensus       174 ~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~~~-~~~~~~~~~~~----------------------  229 (293)
T cd06647         174 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNE-NPLRALYLIAT----------------------  229 (293)
T ss_pred             cccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC-Chhhheeehhc----------------------
Confidence            3467888999999876 67899999999999999999999998432 22111111000                      


Q ss_pred             HHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccc
Q 013897          367 AALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN  426 (434)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~  426 (434)
                            ....      .......++..+.+|+.+||..||++||++.+++.||||+..+.
T Consensus       230 ------~~~~------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~  277 (293)
T cd06647         230 ------NGTP------ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKP  277 (293)
T ss_pred             ------CCCC------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcc
Confidence                  0000      01111235678999999999999999999999999999997763

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=8.2e-41  Score=339.13  Aligned_cols=243  Identities=22%  Similarity=0.408  Sum_probs=201.8

Q ss_pred             CCCCeEEEeeeeecCceEEEEEEEc-----CCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccC
Q 013897          132 EQDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ  202 (434)
Q Consensus       132 ~~~~y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  202 (434)
                      ...+....+.||+|+||+||+|+..     .....||||.++...    +.+|++|+++|..| +|||||+|+|+|.+. 
T Consensus       484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l-~H~nIVrLlGVC~~~-  561 (774)
T KOG1026|consen  484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAEL-QHPNIVRLLGVCREG-  561 (774)
T ss_pred             chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhc-cCCCeEEEEEEEccC-
Confidence            3567788999999999999999763     234789999998543    56799999999999 999999999999654 


Q ss_pred             CCccEEEEeecCCCchhhhcC-------------C----CChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCC
Q 013897          203 SKTPSLIFEHVNNTDFKVLYP-------------T----LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ  265 (434)
Q Consensus       203 ~~~~~lv~e~~~~~~l~~~~~-------------~----l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~  265 (434)
                       ..+++|+|||..|||.+++.             .    ++..+...++.||+.||+||-++.+|||||-.+|+||.++.
T Consensus       562 -~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l  640 (774)
T KOG1026|consen  562 -DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENL  640 (774)
T ss_pred             -CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccce
Confidence             67789999999999988861             2    67788999999999999999999999999999999999665


Q ss_pred             CeEEEEecccceecCCCCcccee---ccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHH
Q 013897          266 RKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVK  341 (434)
Q Consensus       266 ~~vkl~DFGla~~~~~~~~~~~~---~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~  341 (434)
                       .|||+|||+++.....+.+...   .-...|||||.+.. ++|+.++|||||||+|||+++ |+.|| .+..+.+.+..
T Consensus       641 -~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly-~kFTteSDVWs~GVvLWEIFsyG~QPy-~glSn~EVIe~  717 (774)
T KOG1026|consen  641 -VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY-GKFTTESDVWSFGVVLWEIFSYGKQPY-YGLSNQEVIEC  717 (774)
T ss_pred             -EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc-CcccchhhhhhhhhhhhhhhccccCcc-cccchHHHHHH
Confidence             9999999999876544444333   23457999999986 899999999999999999997 88887 56666666655


Q ss_pred             HHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHh
Q 013897          342 IAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAM  416 (434)
Q Consensus       342 i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL  416 (434)
                      |.+.                                  +  -++.+..++.++.+|+..||+.+|++||+++|+=
T Consensus       718 i~~g----------------------------------~--lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~  756 (774)
T KOG1026|consen  718 IRAG----------------------------------Q--LLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH  756 (774)
T ss_pred             HHcC----------------------------------C--cccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence            4321                                  0  0334456899999999999999999999999873

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-40  Score=311.44  Aligned_cols=253  Identities=24%  Similarity=0.420  Sum_probs=201.6

Q ss_pred             CeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhc--CCCCeeeEeeEEEccCCCccEE
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLC--GGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~E~~~l~~l~--~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      .|++.+.||+|+||.||+|.+..+++.+|+|.++..    ..+.+.+|+.+++.+.  .|||++++++++.+  ....++
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~--~~~~~l   79 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK--GPRLWI   79 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee--CCEEEE
Confidence            477889999999999999999889999999998532    2456888999999984  49999999999864  356789


Q ss_pred             EEeecCCCchhhhcC--CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC-cc
Q 013897          209 IFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EY  285 (434)
Q Consensus       209 v~e~~~~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~-~~  285 (434)
                      ||||+.+++|..++.  .+++..+..++.|++.||.|||+.||+|+||+|+||+++.++ .++|+|||++....... ..
T Consensus        80 v~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06917          80 IMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTG-NVKLCDFGVAALLNQNSSKR  158 (277)
T ss_pred             EEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCC-CEEEccCCceeecCCCcccc
Confidence            999999999876653  578889999999999999999999999999999999999766 89999999997765432 23


Q ss_pred             ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChh
Q 013897          286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH  365 (434)
Q Consensus       286 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~  365 (434)
                      ....|+..|+|||.+.+...++.++|+|||||++|+|++|..||... ........+    .                  
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~-~~~~~~~~~----~------------------  215 (277)
T cd06917         159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDV-DAFRAMMLI----P------------------  215 (277)
T ss_pred             ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCC-Chhhhhhcc----c------------------
Confidence            34568889999999876456789999999999999999999998322 111100000    0                  


Q ss_pred             HHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccc
Q 013897          366 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN  426 (434)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~  426 (434)
                            ...   ...   . ....++.++.+|+.+||..||++||++.|++.||||++...
T Consensus       216 ------~~~---~~~---~-~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~~  263 (277)
T cd06917         216 ------KSK---PPR---L-EDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHSK  263 (277)
T ss_pred             ------cCC---CCC---C-CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhcccc
Confidence                  000   000   0 00125678999999999999999999999999999987654

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=6.9e-40  Score=309.20  Aligned_cols=246  Identities=24%  Similarity=0.455  Sum_probs=196.6

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      ++|++.+.||+|+||.||+|++..+++.||||.++..      ....+.+|+.+++.+ +||||+++++++.+.  ...+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~   78 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NHPNVIKYLDSFIED--NELN   78 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCcceeeeeeeEEEC--CeEE
Confidence            5799999999999999999999889999999987531      234578899999999 999999999998754  4667


Q ss_pred             EEEeecCCCchhhhc-------CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecC
Q 013897          208 LIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH  280 (434)
Q Consensus       208 lv~e~~~~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~  280 (434)
                      +|+||+++++|..++       ..+++..+..++.||+.||.|||+++++|+||||+||+++.++ .++|+|||++....
T Consensus        79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~-~~~l~d~g~~~~~~  157 (267)
T cd08228          79 IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATG-VVKLGDLGLGRFFS  157 (267)
T ss_pred             EEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCC-CEEECccccceecc
Confidence            999999999987654       2378888999999999999999999999999999999999776 79999999997664


Q ss_pred             CCCc-cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcc
Q 013897          281 PGKE-YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH  359 (434)
Q Consensus       281 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  359 (434)
                      .... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||+....+...+.......+..          
T Consensus       158 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~----------  226 (267)
T cd08228         158 SKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYP----------  226 (267)
T ss_pred             chhHHHhcCCCCccccChhhhcc-CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCC----------
Confidence            3322 223467888999999876 6789999999999999999999999865443322222211100000          


Q ss_pred             ccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          360 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                                     .         .....++..+.+++.+||..||++||++.++++.
T Consensus       227 ---------------~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         227 ---------------P---------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             ---------------C---------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence                           0         0011245689999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.6e-41  Score=331.61  Aligned_cols=247  Identities=23%  Similarity=0.407  Sum_probs=204.4

Q ss_pred             EEeeeeecCceEEEEEEEcCCCeEEEEEEec-------cccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEE
Q 013897          138 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-------PVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF  210 (434)
Q Consensus       138 ~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~-------~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  210 (434)
                      ....||+|+|-+||+|.+..+|..||--.++       +...++|..|+.+|+.| .||||+++|+++.+.....+.+|.
T Consensus        44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL-~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSL-KHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccC-CCCceeeeeeheecCCCceeeeee
Confidence            3568999999999999998888888743332       22347899999999999 999999999999998888889999


Q ss_pred             eecCCCchhhhcC---CCChHHHHHHHHHHHHHHHHHHHC--CceeecCCCCceEecCCCCeEEEEecccceecCCCCcc
Q 013897          211 EHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQ--GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY  285 (434)
Q Consensus       211 e~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~--~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~  285 (434)
                      |.+..|+|..+..   .+....++.|++||++||.|||++  .|||||||-+||+|+.+.+.|||+|+|||...... ..
T Consensus       123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s-~a  201 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS-HA  201 (632)
T ss_pred             ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc-cc
Confidence            9999999988864   578888999999999999999998  49999999999999988889999999999876533 33


Q ss_pred             ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChh
Q 013897          286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH  365 (434)
Q Consensus       286 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~  365 (434)
                      ...+|||.|||||++.  ..|+..+||||||.+++||+|+..||-...+......++.....    +..+.         
T Consensus       202 ksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiK----P~sl~---------  266 (632)
T KOG0584|consen  202 KSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIK----PAALS---------  266 (632)
T ss_pred             ceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCC----HHHhh---------
Confidence            4479999999999987  58999999999999999999999999555544433333322111    11111         


Q ss_pred             HHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccc
Q 013897          366 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI  424 (434)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~  424 (434)
                                            +.-.+++++||.+||.. .++|+|+.|||.||||..-
T Consensus       267 ----------------------kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  267 ----------------------KVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             ----------------------ccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence                                  11247899999999999 9999999999999999964

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.2e-40  Score=323.71  Aligned_cols=247  Identities=19%  Similarity=0.328  Sum_probs=191.5

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcC-----CCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS  203 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~-----~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  203 (434)
                      .++|++.+.||+|+||.||+|.+..     +++.||+|+++...    .+.+.+|+.++.++.+|+||+++++++... .
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~-~   84 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP-G   84 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC-C
Confidence            4689999999999999999997543     34789999986422    245778999999997899999999988644 3


Q ss_pred             CccEEEEeecCCCchhhhcC------------------------------------------------------------
Q 013897          204 KTPSLIFEHVNNTDFKVLYP------------------------------------------------------------  223 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~~------------------------------------------------------------  223 (434)
                      ..++++|||+.+++|..++.                                                            
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence            56789999999998865531                                                            


Q ss_pred             ----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc---cceeccCCcccc
Q 013897          224 ----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKG  296 (434)
Q Consensus       224 ----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~---~~~~~~t~~y~a  296 (434)
                          .+++..+..++.||+.||+|||+++|+||||||+|||++.++ .++|+|||++..+.....   .....++..|+|
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~-~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  243 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMA  243 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCC-cEEEeccccchhcccCcchhhccCCCCCccccC
Confidence                467788999999999999999999999999999999999766 899999999976543221   122345667999


Q ss_pred             cccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCC
Q 013897          297 PELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSR  375 (434)
Q Consensus       297 PE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  375 (434)
                      ||++.+ ..++.++|||||||++|||++ |..||... ...+.+.....                           ... 
T Consensus       244 PE~~~~-~~~~~~~Di~SlGv~l~el~t~g~~p~~~~-~~~~~~~~~~~---------------------------~~~-  293 (337)
T cd05054         244 PESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGV-QIDEEFCRRLK---------------------------EGT-  293 (337)
T ss_pred             cHHhcC-CCCCccccHHHHHHHHHHHHHcCCCCCCCC-CccHHHHHHHh---------------------------ccC-
Confidence            999877 689999999999999999998 98887322 11111111000                           000 


Q ss_pred             CCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          376 KPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                             ........++++.+++.+||+.+|++||++.|+++|
T Consensus       294 -------~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~  329 (337)
T cd05054         294 -------RMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI  329 (337)
T ss_pred             -------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                   000112356789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=9.7e-40  Score=311.77  Aligned_cols=254  Identities=22%  Similarity=0.405  Sum_probs=202.2

Q ss_pred             CeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEe
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE  211 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  211 (434)
                      .|...+.||+|++|.||++.+..+++.+++|.++..   ..+.+.+|+.+++.+ +||||+++++++...  ...++|+|
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~-~h~~vv~~~~~~~~~--~~~~~v~e   96 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDY-QHPNIVEMYSSYLVG--DELWVVME   96 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHc-CCCChheEEEEEEcC--CeEEEEEe
Confidence            455667899999999999999889999999988532   235578899999998 999999999998654  56789999


Q ss_pred             ecCCCchhhhcC--CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC-cccee
Q 013897          212 HVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNVR  288 (434)
Q Consensus       212 ~~~~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~-~~~~~  288 (434)
                      |+.+++|..++.  .+++..+..++.|++.||+|||++||+||||||+||+++.++ .++|+|||.+....... .....
T Consensus        97 ~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~~l~d~g~~~~~~~~~~~~~~~  175 (285)
T cd06648          97 FLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDG-RVKLSDFGFCAQVSKEVPRRKSL  175 (285)
T ss_pred             ccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCC-cEEEcccccchhhccCCcccccc
Confidence            999999877653  578889999999999999999999999999999999999766 89999999886543322 22334


Q ss_pred             ccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHH
Q 013897          289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAA  368 (434)
Q Consensus       289 ~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~  368 (434)
                      .++..|+|||.+.+ ..++.++|||||||++|+|++|+.||... +.......+... .               .     
T Consensus       176 ~~~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~ell~g~~p~~~~-~~~~~~~~~~~~-~---------------~-----  232 (285)
T cd06648         176 VGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMVDGEPPYFNE-PPLQAMKRIRDN-L---------------P-----  232 (285)
T ss_pred             cCCccccCHHHhcC-CCCCCcccHHHHHHHHHHHHhCCCCCcCC-CHHHHHHHHHhc-C---------------C-----
Confidence            68889999999876 57899999999999999999999998532 221121111100 0               0     


Q ss_pred             HhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccccc
Q 013897          369 LVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~  428 (434)
                                   ........++..+.+|+.+||..||++|||+.++++||||++....+
T Consensus       233 -------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~  279 (285)
T cd06648         233 -------------PKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPPS  279 (285)
T ss_pred             -------------CCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCCcc
Confidence                         00111122567899999999999999999999999999999876543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=5.6e-40  Score=310.16  Aligned_cols=243  Identities=14%  Similarity=0.251  Sum_probs=190.5

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEc---CCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHC---TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT  205 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~---~~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  205 (434)
                      .++|++.+.||+|+||.||+|.++   ..+..||+|.++...    ...+.+|+.+++.+ +||||+++++++...  ..
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~   80 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQF-DHSNIVRLEGVITRG--NT   80 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEecC--CC
Confidence            367999999999999999999865   346789999987532    24578999999998 999999999998653  56


Q ss_pred             cEEEEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC
Q 013897          206 PSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP  281 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~  281 (434)
                      .++||||+++++|..++    ..+++..++.++.||+.||+|||+++++||||||+|||++.++ .++++|||.+.....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~-~~~l~dfg~~~~~~~  159 (266)
T cd05064          81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDL-VCKISGFRRLQEDKS  159 (266)
T ss_pred             cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCC-cEEECCCcccccccc
Confidence            78999999999987664    2478899999999999999999999999999999999999766 899999998765432


Q ss_pred             CCccc--eeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhc
Q 013897          282 GKEYN--VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY  358 (434)
Q Consensus       282 ~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  358 (434)
                      .....  ...++..|+|||.+.+ ..++.++|||||||++|||++ |..||.. ....+....+.+.             
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~~-~~~~~~~~~~~~~-------------  224 (266)
T cd05064         160 EAIYTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYWD-MSGQDVIKAVEDG-------------  224 (266)
T ss_pred             cchhcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcCc-CCHHHHHHHHHCC-------------
Confidence            22111  1234567999999876 689999999999999999775 9988842 2222221111100             


Q ss_pred             cccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                     .        .......++..+.+++.+||+.+|++||+++|+++
T Consensus       225 ---------------~--------~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         225 ---------------F--------RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             ---------------C--------CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence                           0        00112236778999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=6.8e-40  Score=315.65  Aligned_cols=244  Identities=19%  Similarity=0.296  Sum_probs=189.1

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCe--EEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNE--KCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~--~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      ++|++.+.||+|+||.||+|.++.++.  .+|+|.++..    ....+.+|+.++.++.+|+||+++++++.+.  ...+
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~--~~~~   84 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYLY   84 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC--CCce
Confidence            679999999999999999999877665  4577776542    2346788999999998899999999998653  5678


Q ss_pred             EEEeecCCCchhhhcC-------------------CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeE
Q 013897          208 LIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKL  268 (434)
Q Consensus       208 lv~e~~~~~~l~~~~~-------------------~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~v  268 (434)
                      +||||+++++|..++.                   .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~-~~  163 (303)
T cd05088          85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY-VA  163 (303)
T ss_pred             EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC-cE
Confidence            9999999998876642                   367888999999999999999999999999999999999776 89


Q ss_pred             EEEecccceecCCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC
Q 013897          269 RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG  347 (434)
Q Consensus       269 kl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g  347 (434)
                      ||+|||++.............++..|+|||.+.+ ..++.++|||||||++|||+| |..||.. .+..+....+..   
T Consensus       164 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~~~~~~~---  238 (303)
T cd05088         164 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQ---  238 (303)
T ss_pred             EeCccccCcccchhhhcccCCCcccccCHHHHhc-cCCcccccchhhhhHHHHHHhcCCCCccc-CChHHHHHHHhc---
Confidence            9999999864321111122233556999998866 678999999999999999998 9988832 222111111000   


Q ss_pred             ChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          348 TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                                              .         ........+++++.+|+.+||+.||++||+++++|.+
T Consensus       239 ------------------------~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         239 ------------------------G---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             ------------------------C---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                    0         0001112356789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.6e-40  Score=314.40  Aligned_cols=261  Identities=22%  Similarity=0.354  Sum_probs=201.7

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      .++|++++.||+|+||+||++.+..++..||+|++...    ..+.+.+|+++++.+ +||||+++++++.+.  ...++
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~--~~~~l   80 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHEC-RSPYIVSFYGAFLNE--NNICM   80 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHc-CCCCcceEeeeEecC--CEEEE
Confidence            36788999999999999999999889999999987543    235688999999999 899999999999765  57789


Q ss_pred             EEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHH-CCceeecCCCCceEecCCCCeEEEEecccceecCCCCc
Q 013897          209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE  284 (434)
Q Consensus       209 v~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~  284 (434)
                      ||||+++++|..++   +.+++..++.++.+++.||.|||+ ++++|+||||+||+++.++ .++|+|||++...... .
T Consensus        81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~d~gl~~~~~~~-~  158 (284)
T cd06620          81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG-QIKLCDFGVSGELINS-I  158 (284)
T ss_pred             EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCC-cEEEccCCcccchhhh-c
Confidence            99999999987665   357889999999999999999997 6899999999999999766 8999999998654322 2


Q ss_pred             cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCCh
Q 013897          285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP  364 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  364 (434)
                      ....+++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.......+....-.      ......         
T Consensus       159 ~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~------~~~~~~---------  222 (284)
T cd06620         159 ADTFVGTSTYMSPERIQG-GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPM------GILDLL---------  222 (284)
T ss_pred             cCccccCcccCCHHHHcc-CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhh------HHHHHH---------
Confidence            234578899999999876 5889999999999999999999999853322111000000      000000         


Q ss_pred             hHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccc
Q 013897          365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI  424 (434)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~  424 (434)
                        .........    .+    ....++.++.+|+.+||+.||++|||+.|+++||||.+-
T Consensus       223 --~~~~~~~~~----~~----~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         223 --QQIVQEPPP----RL----PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA  272 (284)
T ss_pred             --HHHhhccCC----CC----CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence              000000000    00    001256789999999999999999999999999999754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1e-39  Score=316.32  Aligned_cols=243  Identities=18%  Similarity=0.347  Sum_probs=190.4

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCe----EEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK  204 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~----~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  204 (434)
                      ..+|++.+.||+|+||.||+|.+..++.    .||+|.++...    ..++.+|+.+++.+ +||||+++++++...   
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~g~~~~~---   81 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS---   81 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEcCC---
Confidence            3679999999999999999999866655    48999986432    35688899999999 999999999998643   


Q ss_pred             ccEEEEeecCCCchhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecC
Q 013897          205 TPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH  280 (434)
Q Consensus       205 ~~~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~  280 (434)
                      ..++|+||+.+|++...+.    .+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus        82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~-~~kl~DfG~a~~~~  160 (316)
T cd05108          82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLG  160 (316)
T ss_pred             CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCC-cEEEcccccccccc
Confidence            4569999999999876542    377888899999999999999999999999999999999766 89999999998765


Q ss_pred             CCCccc---eeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHh
Q 013897          281 PGKEYN---VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN  356 (434)
Q Consensus       281 ~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~  356 (434)
                      ......   ...++..|+|||.+.+ ..++.++|||||||++|||++ |+.||. +.. ...+..+..   .        
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slGv~l~el~t~g~~p~~-~~~-~~~~~~~~~---~--------  226 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYD-GIP-ASEISSILE---K--------  226 (316)
T ss_pred             CCCcceeccCCccceeecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCC-CCC-HHHHHHHHh---C--------
Confidence            433221   1223557999999876 688999999999999999997 888873 222 111111111   0        


Q ss_pred             hccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          357 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                                      ..        .......++.++.+++.+||..||.+||++.+++.+
T Consensus       227 ----------------~~--------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         227 ----------------GE--------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             ----------------CC--------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                            00        001112356789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-40  Score=307.87  Aligned_cols=246  Identities=28%  Similarity=0.448  Sum_probs=192.0

Q ss_pred             eeeeecCceEEEEEEEcCCCeEEEEEEeccccH------HHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeec
Q 013897          140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK------KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV  213 (434)
Q Consensus       140 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  213 (434)
                      +.||+|+||.||+|.+..+++.||+|.++....      ..+..|..++....+|+|++++++++..  ....++|+||+
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~   79 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS--KDYLYLVMEYL   79 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc--CCeEEEEEecc
Confidence            569999999999999988999999999864321      2244555555555589999999999965  35778999999


Q ss_pred             CCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCccceecc
Q 013897          214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVA  290 (434)
Q Consensus       214 ~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~~~~~~  290 (434)
                      .+++|..++   ..+++..+..++.||+.||.|||+.+++|+||+|+||+++.++ .++|+|||++.....   .....+
T Consensus        80 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~---~~~~~~  155 (260)
T cd05611          80 NGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTG-HLKLTDFGLSRNGLE---NKKFVG  155 (260)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-cEEEeecccceeccc---cccCCC
Confidence            999998776   3588899999999999999999999999999999999999766 899999999875432   233467


Q ss_pred             CCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHh
Q 013897          291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALV  370 (434)
Q Consensus       291 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~  370 (434)
                      +..|++||.+.+ ..++.++||||||+++|+|++|..||... +.......+...                         
T Consensus       156 ~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~-------------------------  208 (260)
T cd05611         156 TPDYLAPETILG-VGDDKMSDWWSLGCVIFEFLFGYPPFHAE-TPDAVFDNILSR-------------------------  208 (260)
T ss_pred             CcCccChhhhcC-CCCcchhhhHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHHhc-------------------------
Confidence            788999999877 45899999999999999999999998432 222211111100                         


Q ss_pred             cccCCCCCccccccccccCCchHHHHHHHHccccCCCCCcc---HHHHhcCCCcccccc
Q 013897          371 GRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT---AKEAMAHPYFFPIRN  426 (434)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt---~~elL~Hp~~~~~~~  426 (434)
                          ...+.    ......+++++.+++.+||+.||++||+   ++|+|.||||+++++
T Consensus       209 ----~~~~~----~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~  259 (260)
T cd05611         209 ----RINWP----EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINW  259 (260)
T ss_pred             ----ccCCC----CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence                00000    0011136788999999999999999995   579999999988754

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.9e-39  Score=310.16  Aligned_cols=252  Identities=19%  Similarity=0.361  Sum_probs=194.8

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcC-----CCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS  203 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~-----~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  203 (434)
                      .++|++.+.||+|+||.||+|.++.     .+..||+|.++...    ...+.+|+.+++.+ +||||+++++++.+.  
T Consensus         5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--   81 (288)
T cd05061           5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGF-TCHHVVRLLGVVSKG--   81 (288)
T ss_pred             HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcCC--
Confidence            4789999999999999999997642     34589999886332    23577899999999 899999999998654  


Q ss_pred             CccEEEEeecCCCchhhhcCC-------------CChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEE
Q 013897          204 KTPSLIFEHVNNTDFKVLYPT-------------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRL  270 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~~~-------------l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl  270 (434)
                      ...++||||+.+++|..++..             +....+..++.|++.||.|||+++|+||||||+|||++.++ .++|
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~-~~~L  160 (288)
T cd05061          82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDF-TVKI  160 (288)
T ss_pred             CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCC-cEEE
Confidence            467899999999999777531             34567888999999999999999999999999999999766 8999


Q ss_pred             EecccceecCCCCc---cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHh
Q 013897          271 IDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL  346 (434)
Q Consensus       271 ~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~  346 (434)
                      +|||+++.......   .....++..|+|||.+.+ ..++.++|||||||++|||++ |..||. +....+....+..  
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~DvwslG~~l~el~~~~~~p~~-~~~~~~~~~~~~~--  236 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQ-GLSNEQVLKFVMD--  236 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhcc-CCCChHhHHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHc--
Confidence            99999975533221   122344567999999876 678999999999999999998 677773 2222111111100  


Q ss_pred             CChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc------CCC
Q 013897          347 GTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA------HPY  420 (434)
Q Consensus       347 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~------Hp~  420 (434)
                      +                          .        .......+++.+.+++.+||+.||++|||+.++++      |||
T Consensus       237 ~--------------------------~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~  282 (288)
T cd05061         237 G--------------------------G--------YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPS  282 (288)
T ss_pred             C--------------------------C--------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCC
Confidence            0                          0        00011234678999999999999999999999987      999


Q ss_pred             cccccc
Q 013897          421 FFPIRN  426 (434)
Q Consensus       421 ~~~~~~  426 (434)
                      |.+++.
T Consensus       283 ~~~~~~  288 (288)
T cd05061         283 FPEVSF  288 (288)
T ss_pred             CCCCCC
Confidence            998863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1e-39  Score=313.48  Aligned_cols=244  Identities=18%  Similarity=0.293  Sum_probs=188.8

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCe--EEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNE--KCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~--~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      ++|++.+.||+|+||.||+|.++.++.  .+++|.++..    ..+.+.+|+.++.++.+||||+++++++.+.  ...+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~~~~   79 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENR--GYLY   79 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccC--Ccce
Confidence            578999999999999999999876664  4688888642    2346788999999997899999999998654  4678


Q ss_pred             EEEeecCCCchhhhcC-------------------CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeE
Q 013897          208 LIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKL  268 (434)
Q Consensus       208 lv~e~~~~~~l~~~~~-------------------~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~v  268 (434)
                      +|+||+++++|..++.                   .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~-~~  158 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENL-AS  158 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCC-eE
Confidence            9999999999876642                   367788999999999999999999999999999999999766 89


Q ss_pred             EEEecccceecCCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC
Q 013897          269 RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG  347 (434)
Q Consensus       269 kl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g  347 (434)
                      ||+|||++..............+..|+|||.+.+ ..++.++|||||||++|||++ |..||.. ....+....+..   
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~t~g~~pf~~-~~~~~~~~~~~~---  233 (297)
T cd05089         159 KIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNY-SVYTTKSDVWSFGVLLWEIVSLGGTPYCG-MTCAELYEKLPQ---  233 (297)
T ss_pred             EECCcCCCccccceeccCCCCcCccccCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhc---
Confidence            9999999864322111122223456999999876 678999999999999999997 9889832 222111111100   


Q ss_pred             ChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          348 TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                                              .         ........+++++.+|+.+||+.||.+|||++++++.
T Consensus       234 ------------------------~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         234 ------------------------G---------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             ------------------------C---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                    0         0011112367889999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.5e-39  Score=309.31  Aligned_cols=248  Identities=25%  Similarity=0.394  Sum_probs=192.3

Q ss_pred             eeeecCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHh--cCCCCeeeEeeEEEccCCCccEEEEee
Q 013897          141 KVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNL--CGGPNIVKLLDIVRDQQSKTPSLIFEH  212 (434)
Q Consensus       141 ~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~E~~~l~~l--~~h~niv~l~~~~~~~~~~~~~lv~e~  212 (434)
                      .||+|+||.||+|.+..+++.||+|.+....      ...+..|..+++.+  .+||||+++++++.+.  ...++||||
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~~v~e~   78 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--DKLSFILDL   78 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC--CEEEEEEec
Confidence            4899999999999998889999999885421      12234444333332  3799999999998654  567899999


Q ss_pred             cCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCccceec
Q 013897          213 VNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRV  289 (434)
Q Consensus       213 ~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~~~~~  289 (434)
                      +.+++|..++   ..+++..++.++.|++.||+|||+.+|+||||||+||+++.++ .+||+|||++...... .....+
T Consensus        79 ~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~-~~kl~dfg~~~~~~~~-~~~~~~  156 (278)
T cd05606          79 MNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDFSKK-KPHASV  156 (278)
T ss_pred             CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCC-CEEEccCcCccccCcc-CCcCcC
Confidence            9999987665   3488999999999999999999999999999999999999776 8999999998755332 223457


Q ss_pred             cCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCH-HHHHHHHHHhCChhHHHHHhhccccCChhHHH
Q 013897          290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNY-DQLVKIAKVLGTDELNAYLNKYHIELDPHLAA  368 (434)
Q Consensus       290 ~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~-~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~  368 (434)
                      |+..|+|||.+.+...++.++||||+||++|+|++|+.||....... ........  .                     
T Consensus       157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~---------------------  213 (278)
T cd05606         157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--T---------------------  213 (278)
T ss_pred             CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhh--c---------------------
Confidence            89999999998754568999999999999999999999985432111 11100000  0                     


Q ss_pred             HhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCc-----cHHHHhcCCCcccccccc
Q 013897          369 LVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-----TAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rp-----t~~elL~Hp~~~~~~~~~  428 (434)
                                   ........+++++.+++.+||..||.+||     ++.++++||||+.++...
T Consensus       214 -------------~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~  265 (278)
T cd05606         214 -------------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQM  265 (278)
T ss_pred             -------------cCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchH
Confidence                         00011123568899999999999999999     999999999999887554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=9.5e-40  Score=310.34  Aligned_cols=251  Identities=25%  Similarity=0.414  Sum_probs=201.1

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      +-|++.+.||.|+||.||+|.+..++..+|+|++...    ....+.+|+.++..+ +||||+++++++.+.  ...++|
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv   80 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKD--TKLWII   80 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhc-CCCCEeEEEEEEEeC--CeEEEE
Confidence            3477889999999999999999888999999997632    235678899999998 999999999999654  567899


Q ss_pred             EeecCCCchhhhcC--CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC-ccc
Q 013897          210 FEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYN  286 (434)
Q Consensus       210 ~e~~~~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~-~~~  286 (434)
                      |||+.++++..++.  .+++..+..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++....... ...
T Consensus        81 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~-~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06641          81 MEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRN  159 (277)
T ss_pred             EEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCC-CEEEeecccceecccchhhhc
Confidence            99999999887763  478899999999999999999999999999999999999766 89999999987654322 223


Q ss_pred             eeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhH
Q 013897          287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL  366 (434)
Q Consensus       287 ~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~  366 (434)
                      ...++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.. .........+..                      
T Consensus       160 ~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~----------------------  215 (277)
T cd06641         160 TFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHSE-LHPMKVLFLIPK----------------------  215 (277)
T ss_pred             cccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCc-cchHHHHHHHhc----------------------
Confidence            3467888999999876 6788999999999999999999999832 111111111000                      


Q ss_pred             HHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccc
Q 013897          367 AALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN  426 (434)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~  426 (434)
                            ...        ......++.++.+++.+||+.||++||++.++++||||.+...
T Consensus       216 ------~~~--------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~~  261 (277)
T cd06641         216 ------NNP--------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAK  261 (277)
T ss_pred             ------CCC--------CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhhhh
Confidence                  000        0011235678999999999999999999999999999986543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.6e-39  Score=309.62  Aligned_cols=259  Identities=23%  Similarity=0.350  Sum_probs=195.1

Q ss_pred             CCe-EEEeeeeecCceEEEEEEE----cCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCC
Q 013897          134 DDY-EVVRKVGRGKYSEVFEGVH----CTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK  204 (434)
Q Consensus       134 ~~y-~~~~~lG~G~fg~Vy~~~~----~~~~~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  204 (434)
                      ++| .+.+.||+|+||+||++..    ..++..||+|.++..    ....+.+|+.+++.+ +||||+++++++......
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~   81 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL-YHENIVKYKGCCSEQGGK   81 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCCc
Confidence            345 8899999999999988653    356789999998743    245678999999999 999999999998766566


Q ss_pred             ccEEEEeecCCCchhhhcC--CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC
Q 013897          205 TPSLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG  282 (434)
Q Consensus       205 ~~~lv~e~~~~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~  282 (434)
                      ..++||||+.+++|..++.  .+++.+++.++.|++.||+|||+++|+||||||+|||++.++ .+||+|||++......
T Consensus        82 ~~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~  160 (283)
T cd05080          82 GLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDR-LVKIGDFGLAKAVPEG  160 (283)
T ss_pred             eEEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCC-cEEEeecccccccCCc
Confidence            7889999999999977653  589999999999999999999999999999999999999766 8999999999866433


Q ss_pred             Ccc----ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhc
Q 013897          283 KEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY  358 (434)
Q Consensus       283 ~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  358 (434)
                      ...    ....++..|+|||.+.+ ..++.++|||||||++|||++|..||............  ...+           
T Consensus       161 ~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~--~~~~-----------  226 (283)
T cd05080         161 HEYYRVREDGDSPVFWYAVECLKE-NKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIG--PKQG-----------  226 (283)
T ss_pred             chhhccCCCCCCCceeeCHhHhcc-cCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhc--cccc-----------
Confidence            221    12245567999999876 67899999999999999999999998433222111110  0000           


Q ss_pred             cccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                       ......+........        .......++.++.+++.+||..||++|||++++++
T Consensus       227 -~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         227 -QMTVVRLIELLERGM--------RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             -ccchhhhhhhhhcCC--------CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence             000001111111000        01112346789999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-39  Score=309.34  Aligned_cols=272  Identities=35%  Similarity=0.625  Sum_probs=209.4

Q ss_pred             eEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEE
Q 013897          136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF  210 (434)
Q Consensus       136 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  210 (434)
                      |++.+.||+|+||.||+|....+++.+|+|+++...     .+.+..|+.+++.+ +|+|++++++++.+.  ...++|+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~--~~~~~v~   77 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKEL-KHPNIVKLLDVIHTE--RKLYLVF   77 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhc-CCCCHHHHHhhhhcC--CceEEEe
Confidence            567889999999999999998889999999987532     24577899999999 899999999998654  6778999


Q ss_pred             eecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC-cc
Q 013897          211 EHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EY  285 (434)
Q Consensus       211 e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~-~~  285 (434)
                      ||+++ +|..++    ..+++..+..++.|++.||.|||++||+||||+|+||+++.++ .++|+|||++....... ..
T Consensus        78 e~~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~-~~~l~d~g~~~~~~~~~~~~  155 (282)
T cd07829          78 EYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDG-VLKLADFGLARAFGIPLRTY  155 (282)
T ss_pred             cCcCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCC-CEEEecCCcccccCCCcccc
Confidence            99985 665554    3588999999999999999999999999999999999999766 89999999997654332 23


Q ss_pred             ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChh
Q 013897          286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH  365 (434)
Q Consensus       286 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~  365 (434)
                      ....++..|+|||.+.+...++.++|||||||+++||++|+.|| .+....+.+..+.+.++......|..-....   .
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~  231 (282)
T cd07829         156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLF-PGDSEIDQLFKIFQILGTPTEESWPGVTKLP---D  231 (282)
T ss_pred             CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCC-CCccHHHHHHHHHHHhCCCcHHHHHhhcccc---c
Confidence            34456778999999876447899999999999999999998776 5555666677777777665544443221111   0


Q ss_pred             HHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          366 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                      .............     .......+.++.++|.+||..||++||++.+++.||||
T Consensus       232 ~~~~~~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         232 YKPTFPKFPPKDL-----EKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             ccccccccCccch-----HHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            0000000000000     01111246789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2.8e-39  Score=309.09  Aligned_cols=255  Identities=22%  Similarity=0.390  Sum_probs=200.0

Q ss_pred             CeEEEeeeeecCceEEEEEEEc---CCCeEEEEEEeccc-------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCC
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHC---TDNEKCIIKILKPV-------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK  204 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~---~~~~~vaiK~~~~~-------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  204 (434)
                      +|++.+.||+|+||.||++.+.   .++..||+|+++..       ..+.+.+|+.++..+.+|+||+++++.+...  .
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--~   78 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTD--T   78 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecC--C
Confidence            4789999999999999999874   37889999998642       2356788999999997899999999988653  5


Q ss_pred             ccEEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC
Q 013897          205 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP  281 (434)
Q Consensus       205 ~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~  281 (434)
                      ..++|+||+.+++|..++   ..+++..+..++.||+.||.|||+.|++||||||+|||++.++ .+||+|||++.....
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~  157 (290)
T cd05613          79 KLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNG-HVVLTDFGLSKEFHE  157 (290)
T ss_pred             eEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCC-CEEEeeCccceeccc
Confidence            678999999999887664   3478889999999999999999999999999999999999776 899999999976543


Q ss_pred             CC--ccceeccCCcccccccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhc
Q 013897          282 GK--EYNVRVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY  358 (434)
Q Consensus       282 ~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  358 (434)
                      ..  ......++..|+|||.+.+. ..++.++|||||||++|+|++|..||..... ......+.+...           
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~~~~~~~~~-----------  225 (290)
T cd05613         158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE-KNSQAEISRRIL-----------  225 (290)
T ss_pred             ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc-cccHHHHHHHhh-----------
Confidence            32  12345688899999998642 3578899999999999999999999842211 111111111000           


Q ss_pred             cccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCc-----cHHHHhcCCCcccccc
Q 013897          359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-----TAKEAMAHPYFFPIRN  426 (434)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rp-----t~~elL~Hp~~~~~~~  426 (434)
                                  ...          ......+++.+.+|+.+||+.||++||     ++++++.||||+.++.
T Consensus       226 ------------~~~----------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~  276 (290)
T cd05613         226 ------------KSE----------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINW  276 (290)
T ss_pred             ------------ccC----------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCH
Confidence                        000          001123567899999999999999997     8999999999998874

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.5e-39  Score=313.78  Aligned_cols=251  Identities=26%  Similarity=0.437  Sum_probs=197.8

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      ...|.+.+.||+|+||.||+|.+..+++.||+|.+...      ....+.+|+.+++.+ +||||+++++++.+.  ...
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~--~~~   90 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQL-RHPNTIEYKGCYLRE--HTA   90 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEEeC--CeE
Confidence            35688999999999999999999888999999988532      124578999999999 999999999999754  456


Q ss_pred             EEEEeecCCCchhhh---cCCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC
Q 013897          207 SLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~  283 (434)
                      ++|+||+.+..+..+   ...+++..+..++.||+.||.|||+.+|+|+||+|+||+++.++ .++|+|||++...... 
T Consensus        91 ~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~-~~kL~dfg~~~~~~~~-  168 (307)
T cd06607          91 WLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPG-TVKLADFGSASLVSPA-  168 (307)
T ss_pred             EEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCC-CEEEeecCcceecCCC-
Confidence            799999986543332   24588999999999999999999999999999999999999776 8999999999765432 


Q ss_pred             ccceeccCCcccccccccC--CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcccc
Q 013897          284 EYNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE  361 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~~--~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  361 (434)
                        ....++..|+|||++.+  ...++.++|||||||++|||++|+.||... +.......+..   ..            
T Consensus       169 --~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~-~~~~~~~~~~~---~~------------  230 (307)
T cd06607         169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQ---ND------------  230 (307)
T ss_pred             --CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCc-cHHHHHHHHhc---CC------------
Confidence              34567888999998742  256889999999999999999999998432 11111111100   00            


Q ss_pred             CChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccc
Q 013897          362 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN  426 (434)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~  426 (434)
                       .+                   ......++..+.++|.+||..||++||++.+++.||||.....
T Consensus       231 -~~-------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  275 (307)
T cd06607         231 -SP-------------------TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERP  275 (307)
T ss_pred             -CC-------------------CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccCC
Confidence             00                   0001124568999999999999999999999999999987653

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.5e-39  Score=303.67  Aligned_cols=241  Identities=19%  Similarity=0.322  Sum_probs=190.3

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEe
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE  211 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  211 (434)
                      ++|++.+.||+|+||.||++.++ ++..+|+|.++..  ....+.+|+.+++.+ +||||+++++++.+.  ...++|||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~iv~e   79 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKL-SHPKLVQLYGVCTQQ--KPLYIVTE   79 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHC-CCCCceeEEEEEccC--CCEEEEEE
Confidence            56889999999999999999874 5568999988643  346788999999999 999999999998654  56789999


Q ss_pred             ecCCCchhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCcc--
Q 013897          212 HVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY--  285 (434)
Q Consensus       212 ~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~--  285 (434)
                      |+++++|..++.    .+++..+..++.|++.||+|||++||+||||||+||+++.++ .+||+|||+++........  
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~-~~kl~d~g~~~~~~~~~~~~~  158 (256)
T cd05114          80 FMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTG-VVKVSDFGMTRYVLDDEYTSS  158 (256)
T ss_pred             cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCC-eEEECCCCCccccCCCceecc
Confidence            999999876652    378888999999999999999999999999999999999666 8999999999765332221  


Q ss_pred             ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCCh
Q 013897          286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP  364 (434)
Q Consensus       286 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  364 (434)
                      ....++..|+|||.+.+ ..++.++|||||||++|||++ |+.||. ..+..+....+.+.                   
T Consensus       159 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~s~G~~l~el~~~g~~p~~-~~~~~~~~~~i~~~-------------------  217 (256)
T cd05114         159 SGAKFPVKWSPPEVFNF-SKYSSKSDVWSFGVLMWEVFTEGKMPFE-KKSNYEVVEMISRG-------------------  217 (256)
T ss_pred             CCCCCchhhCChhhccc-CccchhhhhHHHHHHHHHHHcCCCCCCC-CCCHHHHHHHHHCC-------------------
Confidence            11234457999999876 678999999999999999999 888873 32222222222110                   


Q ss_pred             hHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                               .+        .......++++.+++.+||+.||++||+++++++
T Consensus       218 ---------~~--------~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         218 ---------FR--------LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             ---------CC--------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                     00        0011124578999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-40  Score=293.15  Aligned_cols=252  Identities=21%  Similarity=0.294  Sum_probs=197.5

Q ss_pred             CCCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEEcc---CCC
Q 013897          131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ---QSK  204 (434)
Q Consensus       131 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---~~~  204 (434)
                      ...++|.+.++||+|||+.||++....++..||+|.+.-.   ..+...+|++..+++ +|||+++++++....   ...
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf-~s~~vl~l~dh~l~~~~D~~~   96 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKF-NSPNVLRLVDHQLREEKDGKH   96 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhh-CCcchHHHHHHHHHhhccCce
Confidence            3468899999999999999999999999999999988643   346678999999999 999999999976532   345


Q ss_pred             ccEEEEeecCCCchhhhcC-------CCChHHHHHHHHHHHHHHHHHHHCC--ceeecCCCCceEecCCCCeEEEEeccc
Q 013897          205 TPSLIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHEQRKLRLIDWGL  275 (434)
Q Consensus       205 ~~~lv~e~~~~~~l~~~~~-------~l~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlKp~NIll~~~~~~vkl~DFGl  275 (434)
                      ..||+++|...|+|.+.+.       .+++.++..++.+|++||++||+..  ++||||||.|||+..++ .++|.|||.
T Consensus        97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~-~~vl~D~GS  175 (302)
T KOG2345|consen   97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSG-LPVLMDLGS  175 (302)
T ss_pred             eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCC-ceEEEeccC
Confidence            6889999999998866642       4899999999999999999999998  99999999999999656 899999999


Q ss_pred             ceecCCCC----------ccceeccCCcccccccccC--CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 013897          276 AEFYHPGK----------EYNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA  343 (434)
Q Consensus       276 a~~~~~~~----------~~~~~~~t~~y~aPE~~~~--~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~  343 (434)
                      +....-.-          .......|..|+|||.+.-  ....+.++|||||||+||.|+.|..||...          .
T Consensus       176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~----------~  245 (302)
T KOG2345|consen  176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI----------Y  245 (302)
T ss_pred             ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH----------h
Confidence            86542111          1122235778999999853  235789999999999999999999999311          1


Q ss_pred             HHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          344 KVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       344 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                      +..|.-...                        ....-+.+.+...++..+.+||+.||+.||.+||++.+++.+
T Consensus       246 ~~GgSlaLA------------------------v~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  246 QQGGSLALA------------------------VQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             hcCCeEEEe------------------------eeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            111100000                        000012244445588999999999999999999999999864

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.2e-39  Score=324.90  Aligned_cols=245  Identities=23%  Similarity=0.338  Sum_probs=189.1

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCC-----CeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTD-----NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS  203 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~-----~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  203 (434)
                      .++|.++++||+|+||.||+|.+...     +..||||+++...    .+.+.+|+.+|+++..||||+++++++.+  .
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~--~  113 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK--S  113 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc--C
Confidence            57899999999999999999986432     3579999996432    35688999999999559999999999964  3


Q ss_pred             CccEEEEeecCCCchhhhc-------------------------------------------------------------
Q 013897          204 KTPSLIFEHVNNTDFKVLY-------------------------------------------------------------  222 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~-------------------------------------------------------------  222 (434)
                      ..++|||||+.+++|..++                                                             
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (400)
T cd05105         114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE  193 (400)
T ss_pred             CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence            5678999999999886543                                                             


Q ss_pred             --------------------------------------CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC
Q 013897          223 --------------------------------------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE  264 (434)
Q Consensus       223 --------------------------------------~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~  264 (434)
                                                            ..+++..+..++.||+.||.|||+++|+||||||+|||++.+
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~  273 (400)
T cd05105         194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQG  273 (400)
T ss_pred             hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCC
Confidence                                                  125666778899999999999999999999999999999976


Q ss_pred             CCeEEEEecccceecCCCCcc---ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHH
Q 013897          265 QRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLV  340 (434)
Q Consensus       265 ~~~vkl~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~  340 (434)
                      + .+||+|||+++........   ....++..|+|||.+.+ ..++.++|||||||++|||++ |..||.....+.....
T Consensus       274 ~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~  351 (400)
T cd05105         274 K-IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD-NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN  351 (400)
T ss_pred             C-EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH
Confidence            6 8999999999765433221   22345677999999876 678999999999999999997 8888843221111111


Q ss_pred             HHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          341 KIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       341 ~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                      .+..                            ..        .......+++++.+++.+||..||++||++.++.+
T Consensus       352 ~~~~----------------------------~~--------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         352 KIKS----------------------------GY--------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             HHhc----------------------------CC--------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            1000                            00        00111235678999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=4.5e-40  Score=320.48  Aligned_cols=280  Identities=16%  Similarity=0.253  Sum_probs=193.6

Q ss_pred             eeeeec--CceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEee
Q 013897          140 RKVGRG--KYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH  212 (434)
Q Consensus       140 ~~lG~G--~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  212 (434)
                      ..||+|  +||+||++.+..+++.||+|++....     .+.+.+|+.+++.+ +||||+++++++...  ...++|+||
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~--~~~~~v~e~   80 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFF-RHPNIMTSWTVFTTG--SWLWVISPF   80 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcceEeeeEecC--CceEEEEec
Confidence            456666  99999999998999999999986432     35678899988888 899999999999764  567899999


Q ss_pred             cCCCchhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC-cc-
Q 013897          213 VNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EY-  285 (434)
Q Consensus       213 ~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~-~~-  285 (434)
                      +.++++..++.     .+++..++.++.||+.||+|||++||+||||||+|||++.++ .++++||+.+....... .. 
T Consensus        81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~-~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          81 MAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDG-LVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             ccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCC-cEEEechHHHhhhhccCcccc
Confidence            99998876653     378888999999999999999999999999999999999776 89999998653322111 00 


Q ss_pred             ------ceeccCCcccccccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhc
Q 013897          286 ------NVRVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY  358 (434)
Q Consensus       286 ------~~~~~t~~y~aPE~~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  358 (434)
                            ....++..|+|||++.+. ..++.++|||||||++|+|++|+.||.... .........   .......+....
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~-~~~~~~~~~---~~~~~~~~~~~~  235 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDML-RTQMLLQKL---KGPPYSPLDITT  235 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcC-hHHHHHHHh---cCCCCCCccccc
Confidence                  112345569999998652 357899999999999999999999984332 222221111   110000000000


Q ss_pred             -----cc------cCChhHH-HHhc-ccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccc
Q 013897          359 -----HI------ELDPHLA-ALVG-RHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       359 -----~~------~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                           ..      ..+.... .... ..................+++.+.+||++||+.||++|||++|+|+||||.++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~  315 (328)
T cd08226         236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK  315 (328)
T ss_pred             cchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence                 00      0000000 0000 000000000011112234567899999999999999999999999999999876


Q ss_pred             cc
Q 013897          426 NA  427 (434)
Q Consensus       426 ~~  427 (434)
                      ..
T Consensus       316 ~~  317 (328)
T cd08226         316 EQ  317 (328)
T ss_pred             Hh
Confidence            53

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=5.1e-39  Score=299.29  Aligned_cols=246  Identities=34%  Similarity=0.563  Sum_probs=200.3

Q ss_pred             CeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEe
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE  211 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  211 (434)
                      +|++.+.||+|++|.||++.+..+++.+++|++...   ....+.+|+.+++.+ +|+|++++++.+...  ...++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~l~~e   77 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKC-KHPNIVKYYGSYLKK--DELWIVME   77 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhC-CCCCEeEEEEEEecC--CeEEEEEe
Confidence            478899999999999999999888999999998754   346788999999999 799999999998654  56779999


Q ss_pred             ecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCccce
Q 013897          212 HVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV  287 (434)
Q Consensus       212 ~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~~~  287 (434)
                      |+++++|..++    ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||.+...........
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~~~~  156 (253)
T cd05122          78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDG-EVKLIDFGLSAQLSDTKARNT  156 (253)
T ss_pred             cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCC-eEEEeeccccccccccccccc
Confidence            99999987765    3578999999999999999999999999999999999999766 899999999977654433345


Q ss_pred             eccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHH
Q 013897          288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLA  367 (434)
Q Consensus       288 ~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~  367 (434)
                      ..++..|++||.+.+ ..++.++|||||||++|+|++|+.||..... ......+.. ...                   
T Consensus       157 ~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~-~~~-------------------  214 (253)
T cd05122         157 MVGTPYWMAPEVING-KPYDYKADIWSLGITAIELAEGKPPYSELPP-MKALFKIAT-NGP-------------------  214 (253)
T ss_pred             eecCCcccCHHHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCch-HHHHHHHHh-cCC-------------------
Confidence            678889999999876 5688999999999999999999999843321 111111100 000                   


Q ss_pred             HHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCC
Q 013897          368 ALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY  420 (434)
Q Consensus       368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~  420 (434)
                                    ........++..+.+++.+||+.||++|||+.|+|+|||
T Consensus       215 --------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         215 --------------PGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             --------------CCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence                          000111123678999999999999999999999999999

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=1.4e-40  Score=313.01  Aligned_cols=294  Identities=29%  Similarity=0.515  Sum_probs=234.8

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcC---CCeEEEEEEecc-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCT---DNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~---~~~~vaiK~~~~-~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      .+.|.++++||+|.|++||++.+..   .++.||+|.+.. .....+.+|+++|..+.++.||+++.+.+..  +..+.+
T Consensus        35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rn--nd~v~i  112 (418)
T KOG1167|consen   35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRN--NDQVAI  112 (418)
T ss_pred             hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhcc--CCeeEE
Confidence            3668899999999999999998876   678999998865 4567899999999999999999999999954  456779


Q ss_pred             EEeecCCCchhhhcCCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecC--------
Q 013897          209 IFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH--------  280 (434)
Q Consensus       209 v~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~--------  280 (434)
                      |+||+++..+..++..++..+++.+++.++.||.++|.+|||||||||.|+|.+.....-.|+|||+|....        
T Consensus       113 vlp~~~H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s  192 (418)
T KOG1167|consen  113 VLPYFEHDRFRDLYRSLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHS  192 (418)
T ss_pred             EecccCccCHHHHHhcCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhh
Confidence            999999999999999999999999999999999999999999999999999999877788999999995210        


Q ss_pred             ---------C--CC--------------cc------------ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHH
Q 013897          281 ---------P--GK--------------EY------------NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI  323 (434)
Q Consensus       281 ---------~--~~--------------~~------------~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell  323 (434)
                               +  +.              .+            ..+.||++|+|||++..+..-+.++||||.|||+..++
T Consensus       193 ~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lsll  272 (418)
T KOG1167|consen  193 RSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLL  272 (418)
T ss_pred             hhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhh
Confidence                     0  00              00            12368999999999988788899999999999999999


Q ss_pred             hCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccc--cCC----hhHHHHhcccCCC------CCcc--ccccccccC
Q 013897          324 FRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI--ELD----PHLAALVGRHSRK------PWSK--FITVENQHL  389 (434)
Q Consensus       324 tg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~--~~~----~~~~~~~~~~~~~------~~~~--~~~~~~~~~  389 (434)
                      +++.|||...++.+.+.+|+-.+|...+.....-.+.  ...    +.+.++.......      +..+  .........
T Consensus       273 s~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~  352 (418)
T KOG1167|consen  273 SRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDV  352 (418)
T ss_pred             ccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecccccc
Confidence            9999999999999999999999998777665433322  111    1111111111110      0000  011112234


Q ss_pred             CchHHHHHHHHccccCCCCCccHHHHhcCCCcccccccc
Q 013897          390 AVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       390 ~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~  428 (434)
                      .+..+.|||.+||..||.+|+||+++|.||||...+..+
T Consensus       353 ~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~~~  391 (418)
T KOG1167|consen  353 FPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADRTE  391 (418)
T ss_pred             ccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhhhh
Confidence            556899999999999999999999999999999766443

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.3e-39  Score=305.28  Aligned_cols=242  Identities=19%  Similarity=0.354  Sum_probs=192.8

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc--HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEe
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE  211 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  211 (434)
                      .+|.+.+.||+|+||.||+|.+..++..+|+|+++...  ...+.+|+.+++.+ .|+||+++++++...  ...++|||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~e   82 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTRE--PPFYIITE   82 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhC-CCCChhheEEEEcCC--CCcEEEEE
Confidence            56889999999999999999998889999999987543  35688999999998 999999999998654  56789999


Q ss_pred             ecCCCchhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCccc
Q 013897          212 HVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN  286 (434)
Q Consensus       212 ~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~~  286 (434)
                      |+++++|..++.     .+++..+..++.|++.||+|||+++++||||||+|||++.++ .+||+|||++..........
T Consensus        83 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~-~~kl~df~~~~~~~~~~~~~  161 (263)
T cd05052          83 FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTYTA  161 (263)
T ss_pred             eCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC-cEEeCCCccccccccceeec
Confidence            999999877652     378888999999999999999999999999999999999766 89999999997654322111


Q ss_pred             --eeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          287 --VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       287 --~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                        ...++..|+|||.+.+ ..++.++|||||||++|||++ |..||. +.+..+....+...                  
T Consensus       162 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~-~~~~~~~~~~~~~~------------------  221 (263)
T cd05052         162 HAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYP-GIDLSQVYELLEKG------------------  221 (263)
T ss_pred             cCCCCCccccCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCC-CCCHHHHHHHHHCC------------------
Confidence              1123456999999876 678999999999999999998 887873 33222221111100                  


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                        ........+++++.+++.+||..||++||++.++++
T Consensus       222 ------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         222 ------------------YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             ------------------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                              001112236788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.2e-39  Score=307.71  Aligned_cols=244  Identities=18%  Similarity=0.352  Sum_probs=188.9

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcC-----CCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS  203 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~-----~~~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  203 (434)
                      .++|++.+.||+|+||.||+|.+..     ++..||+|.++..    ...++.+|+.+++.+ +||||+++++++.+  .
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~--~   81 (277)
T cd05062           5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQ--G   81 (277)
T ss_pred             HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcC--C
Confidence            4789999999999999999998642     3568999988642    234578999999998 99999999999854  3


Q ss_pred             CccEEEEeecCCCchhhhcCC-------------CChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEE
Q 013897          204 KTPSLIFEHVNNTDFKVLYPT-------------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRL  270 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~~~-------------l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl  270 (434)
                      ...++||||+.+++|..++..             +++..+..++.|++.||+|||+.+++|+||||+||+++.++ .++|
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~-~~~l  160 (277)
T cd05062          82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF-TVKI  160 (277)
T ss_pred             CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCC-CEEE
Confidence            567899999999998766532             35567888999999999999999999999999999999766 8999


Q ss_pred             EecccceecCCCCcc---ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHh
Q 013897          271 IDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL  346 (434)
Q Consensus       271 ~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~  346 (434)
                      +|||+++........   ....++..|+|||.+.+ ..++.++|||||||++|||++ |..||. +....+....+.. .
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~p~~-~~~~~~~~~~~~~-~  237 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQ-GMSNEQVLRFVME-G  237 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhc-CCcCchhHHHHHHHHHHHHHcCCCCCCC-CCCHHHHHHHHHc-C
Confidence            999998755332211   12345677999999876 678999999999999999999 677763 3322222211110 0


Q ss_pred             CChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          347 GTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       347 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                      +                           .        ......+++.+.+++.+||+.||++|||+.|++++
T Consensus       238 ~---------------------------~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         238 G---------------------------L--------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             C---------------------------c--------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            0                           0        00112356789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.8e-39  Score=304.16  Aligned_cols=242  Identities=19%  Similarity=0.336  Sum_probs=191.1

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF  210 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  210 (434)
                      .++|+++++||+|+||.||+|.+ .++..||+|.+...  ..+.+.+|+.+++.+ +|+||+++++.+.+.  ...+++|
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~   80 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGTMSVQAFLEEANLMKTL-QHDKLVRLYAVVTKE--EPIYIIT   80 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCchhHHHHHHHHHHHHhC-CCCCeeeEEEEEcCC--CCcEEEE
Confidence            47899999999999999999987 46678999988643  346788999999999 999999999998543  5678999


Q ss_pred             eecCCCchhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCcc
Q 013897          211 EHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY  285 (434)
Q Consensus       211 e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~  285 (434)
                      ||+.+++|..++     ..+++..+..++.|++.||+|||+.+++||||||+||+++.++ .++|+|||++.........
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05072          81 EYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESL-MCKIADFGLARVIEDNEYT  159 (261)
T ss_pred             ecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCC-cEEECCCccceecCCCcee
Confidence            999999987665     2367788899999999999999999999999999999999766 8999999999765432211


Q ss_pred             --ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          286 --NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       286 --~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                        ....++..|+|||.+.+ ..++.++|||||||++|+|++ |+.||. +....+....+...                 
T Consensus       160 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~-~~~~~~~~~~~~~~-----------------  220 (261)
T cd05072         160 AREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLYEIVTYGKIPYP-GMSNSDVMSALQRG-----------------  220 (261)
T ss_pred             ccCCCccceecCCHHHhcc-CCCChhhhhhhhHHHHHHHHccCCCCCC-CCCHHHHHHHHHcC-----------------
Confidence              12234567999999876 678999999999999999998 888873 32222222211100                 


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                 .        .......++.++.+++.+||..||++||+++++++
T Consensus       221 -----------~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         221 -----------Y--------RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             -----------C--------CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                       0        00111235678999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=3.2e-39  Score=333.45  Aligned_cols=276  Identities=22%  Similarity=0.296  Sum_probs=183.2

Q ss_pred             CCCCeEEEeeeeecCceEEEEEEEcCC----CeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeEeeEE----EccCC
Q 013897          132 EQDDYEVVRKVGRGKYSEVFEGVHCTD----NEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIV----RDQQS  203 (434)
Q Consensus       132 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~----~~~vaiK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~----~~~~~  203 (434)
                      ..++|++.+.||+|+||.||+|.+..+    +..||+|.++.....+...+. .++.. .+.+++.++..+    .....
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e-~l~~~-~~~~~~~~~~~~~~~~~~~~~  207 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNE-RVRRA-CPNSCADFVYGFLEPVSSKKE  207 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHH-HHHhh-chhhHHHHHHhhhcccccccC
Confidence            458899999999999999999999888    899999988643322221111 11222 222333222211    11234


Q ss_pred             CccEEEEeecCCCchhhhcCCC-----------------------ChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceE
Q 013897          204 KTPSLIFEHVNNTDFKVLYPTL-----------------------SDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVM  260 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~~~l-----------------------~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIl  260 (434)
                      ...++|+||+.+++|..++...                       ....+..++.||+.||+|||+++|+||||||+|||
T Consensus       208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NIL  287 (566)
T PLN03225        208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNII  287 (566)
T ss_pred             CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEE
Confidence            5678999999999886664311                       12345678999999999999999999999999999


Q ss_pred             ecCCCCeEEEEecccceecCCCCc--cceeccCCcccccccccCCC---------------------CCCccccHHHHHH
Q 013897          261 IDHEQRKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDLQ---------------------DYDYSLDLWSLGC  317 (434)
Q Consensus       261 l~~~~~~vkl~DFGla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~---------------------~~~~~~DvwSlGv  317 (434)
                      ++.+...+||+|||+|+.+.....  ....++++.|+|||.+....                     .++.++|||||||
T Consensus       288 l~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGv  367 (566)
T PLN03225        288 FSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL  367 (566)
T ss_pred             EeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHH
Confidence            986555899999999986543322  24567899999999763211                     2445679999999


Q ss_pred             HHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHH
Q 013897          318 MFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDF  397 (434)
Q Consensus       318 il~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl  397 (434)
                      +||||+++..|+   .+....+..+.+..+.. ...|.........+....            .  ..........+.||
T Consensus       368 iL~el~~~~~~~---~~~~~~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~~------------~--~~~~d~~~~~~~dL  429 (566)
T PLN03225        368 IFLQMAFPNLRS---DSNLIQFNRQLKRNDYD-LVAWRKLVEPRASPDLRR------------G--FEVLDLDGGAGWEL  429 (566)
T ss_pred             HHHHHHhCcCCC---chHHHHHHHHHHhcCCc-HHHHHHhhccccchhhhh------------h--hhhccccchHHHHH
Confidence            999999866443   33344444444333322 122221111110111000            0  00011123467799


Q ss_pred             HHHccccCCCCCccHHHHhcCCCccccccc
Q 013897          398 LDKLLRYDHQERPTAKEAMAHPYFFPIRNA  427 (434)
Q Consensus       398 l~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~  427 (434)
                      |.+||+.||++|||+.|+|+||||++....
T Consensus       430 i~~mL~~dP~kR~ta~e~L~Hpff~~~~~~  459 (566)
T PLN03225        430 LKSMMRFKGRQRISAKAALAHPYFDREGLL  459 (566)
T ss_pred             HHHHccCCcccCCCHHHHhCCcCcCCCCcc
Confidence            999999999999999999999999976643

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=9.8e-40  Score=315.83  Aligned_cols=280  Identities=19%  Similarity=0.228  Sum_probs=192.4

Q ss_pred             EEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEee
Q 013897          138 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH  212 (434)
Q Consensus       138 ~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  212 (434)
                      +.+.+|.|  |.||.++...+++.||||+++..     ..+.+.+|+.+++.+ +|+||+++++++.+.  ...+++|||
T Consensus         6 i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~--~~~~~~~e~   80 (314)
T cd08216           6 IGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQL-QHPNILPYVTSFIVD--SELYVVSPL   80 (314)
T ss_pred             hhHhhcCC--ceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhc-CCcchhhhhheeecC--CeEEEEEec
Confidence            33444444  55555555568999999998643     235788999999999 899999999998654  557899999


Q ss_pred             cCCCchhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc---
Q 013897          213 VNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---  284 (434)
Q Consensus       213 ~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~---  284 (434)
                      +.++++..++.     .+++..++.++.|++.||.|||+++|+||||||+||+++.++ .+||+|||.+........   
T Consensus        81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~-~~kl~d~~~~~~~~~~~~~~~  159 (314)
T cd08216          81 MAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDG-KVVLSGLRYSVSMIKHGKRQR  159 (314)
T ss_pred             cCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCC-ceEEecCccceeecccccccc
Confidence            99998876653     478888999999999999999999999999999999999766 899999999865532211   


Q ss_pred             -----cceeccCCcccccccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhc
Q 013897          285 -----YNVRVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY  358 (434)
Q Consensus       285 -----~~~~~~t~~y~aPE~~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  358 (434)
                           .....++..|+|||++... ..++.++|||||||++|||++|+.||.........+..   ..+...  ......
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~---~~~~~~--~~~~~~  234 (314)
T cd08216         160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEK---VRGTVP--CLLDKS  234 (314)
T ss_pred             ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HhccCc--cccccC
Confidence                 1233466789999998652 35889999999999999999999998543322222211   111100  000000


Q ss_pred             cccCC-hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccccc
Q 013897          359 HIELD-PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       359 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~  428 (434)
                      ..... ..........................++.++.+|+.+||..||++|||++|+|+||||+++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~~~  305 (314)
T cd08216         235 TYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRRN  305 (314)
T ss_pred             chhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhcccc
Confidence            00000 00000000000000000001111223457899999999999999999999999999999987544

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2e-39  Score=308.96  Aligned_cols=243  Identities=18%  Similarity=0.339  Sum_probs=190.4

Q ss_pred             CCeEEEeeeeecCceEEEEEEEc----CCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCc
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHC----TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT  205 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~----~~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  205 (434)
                      ++|++.+.||+|+||.||+|.+.    .++..+|+|.++...    ...+.+|+.+++.+ +||||+++++++...  ..
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~~   81 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAEL-HHPNIVCLLGVVTQE--QP   81 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecC--Cc
Confidence            67889999999999999999853    355789999986422    35688999999999 999999999998654  46


Q ss_pred             cEEEEeecCCCchhhhcC--------------------CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCC
Q 013897          206 PSLIFEHVNNTDFKVLYP--------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ  265 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~~--------------------~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~  265 (434)
                      .++||||+.+++|..++.                    .+++..+..++.||+.||.|||+++|+||||||+|||++.++
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC
Confidence            789999999999876641                    366778889999999999999999999999999999999766


Q ss_pred             CeEEEEecccceecCCCCc---cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHH
Q 013897          266 RKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVK  341 (434)
Q Consensus       266 ~~vkl~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~  341 (434)
                       .+||+|||+++.......   .....++..|+|||.+.+ ..++.++|||||||++|||++ |..||.. .........
T Consensus       162 -~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~g~~p~~~-~~~~~~~~~  238 (283)
T cd05090         162 -HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY-GKFSSDSDIWSFGVVLWEIFSFGLQPYYG-FSNQEVIEM  238 (283)
T ss_pred             -cEEeccccccccccCCcceecccCCCccceecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCC-CCHHHHHHH
Confidence             899999999976543321   122344567999999876 678999999999999999998 8888732 222222111


Q ss_pred             HHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          342 IAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       342 i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                      +.. .                           ..        ......+++.+.+++.+||+.||.+||++.+++++
T Consensus       239 ~~~-~---------------------------~~--------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         239 VRK-R---------------------------QL--------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHc-C---------------------------Cc--------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            110 0                           00        00112367789999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-39  Score=306.09  Aligned_cols=243  Identities=19%  Similarity=0.367  Sum_probs=188.6

Q ss_pred             eEEEeeeeecCceEEEEEEEcCC---CeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC----
Q 013897          136 YEVVRKVGRGKYSEVFEGVHCTD---NEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS----  203 (434)
Q Consensus       136 y~~~~~lG~G~fg~Vy~~~~~~~---~~~vaiK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~----  203 (434)
                      |.+.+.||+|+||.||+|.+..+   +..||+|.++...     ...+.+|+..++.+ +||||+++++++.....    
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~   79 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDF-DHPNVMKLIGVCFEASSLQKI   79 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhC-CCCCeeeEEeeeccCCccccC
Confidence            45788999999999999987654   3789999987432     24678999999998 99999999998865332    


Q ss_pred             CccEEEEeecCCCchhhhc---------CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecc
Q 013897          204 KTPSLIFEHVNNTDFKVLY---------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG  274 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~---------~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFG  274 (434)
                      ...++|+||+.+++|..++         ..+++..+..++.|++.||.|||+++|+||||||+||+++.++ .+||+|||
T Consensus        80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~dfg  158 (273)
T cd05035          80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDM-TVCVADFG  158 (273)
T ss_pred             cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCC-eEEECCcc
Confidence            3478999999999986554         2478888999999999999999999999999999999999766 89999999


Q ss_pred             cceecCCCCcc---ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChh
Q 013897          275 LAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDE  350 (434)
Q Consensus       275 la~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~  350 (434)
                      +++........   ....++..|+|||.+.+ ..++.++|||||||++|||++ |..|| .+..+.+....+..      
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~-~~~~~~~~~~~~~~------  230 (273)
T cd05035         159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPY-PGVENHEIYDYLRH------  230 (273)
T ss_pred             ceeeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHc------
Confidence            99876443322   12234567999999865 678999999999999999999 77776 33333222211110      


Q ss_pred             HHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          351 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                                           . .        .......+++++.+++.+||+.||++|||+.|++.+
T Consensus       231 ---------------------~-~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         231 ---------------------G-N--------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             ---------------------C-C--------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                 0 0        000112356789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.3e-39  Score=303.67  Aligned_cols=242  Identities=21%  Similarity=0.404  Sum_probs=194.3

Q ss_pred             CeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEE
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF  210 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  210 (434)
                      +|++.+.||+|+||.||++.+..+++.+|+|.++..    ..+.+.+|+.+++.+ +|+||+++++.+.+.  ..+++||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~   77 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKM-KHPNIVAFKESFEAD--GHLYIVM   77 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEEC--CEEEEEE
Confidence            478999999999999999999999999999988532    235678899999998 999999999998654  5778999


Q ss_pred             eecCCCchhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc-
Q 013897          211 EHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-  284 (434)
Q Consensus       211 e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~-  284 (434)
                      ||++++++...+     ..+++..+..++.||+.||.|||++||+|+||||+||+++.++ .++|+|||++........ 
T Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~~~~~~  156 (255)
T cd08219          78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNG-KVKLGDFGSARLLTSPGAY  156 (255)
T ss_pred             eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCC-cEEEcccCcceeecccccc
Confidence            999999886654     2378888999999999999999999999999999999999766 899999999976643322 


Q ss_pred             cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCCh
Q 013897          285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP  364 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  364 (434)
                      .....++..|+|||++.+ ..++.++|+||||+++|+|++|+.||... +.......+..  +                 
T Consensus       157 ~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~-~~~~~~~~~~~--~-----------------  215 (255)
T cd08219         157 ACTYVGTPYYVPPEIWEN-MPYNNKSDIWSLGCILYELCTLKHPFQAN-SWKNLILKVCQ--G-----------------  215 (255)
T ss_pred             cccccCCccccCHHHHcc-CCcCchhhhhhhchhheehhhccCCCCCC-CHHHHHHHHhc--C-----------------
Confidence            234568888999999876 67899999999999999999999998432 11111111100  0                 


Q ss_pred             hHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                               ...        .....++..+.+|+.+||..||++||++.++++-
T Consensus       216 ---------~~~--------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         216 ---------SYK--------PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             ---------CCC--------CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                     000        0112356789999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.2e-39  Score=310.52  Aligned_cols=251  Identities=23%  Similarity=0.417  Sum_probs=200.7

Q ss_pred             eEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEee
Q 013897          136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH  212 (434)
Q Consensus       136 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  212 (434)
                      |+...+||+|+||.||++....+++.||+|.+...   ....+.+|+.+++.+ +|+|++++++.+...  ...++||||
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv~e~   98 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLVG--DELWVVMEF   98 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhc-CCcchhheeeEEEeC--CEEEEEEec
Confidence            33456799999999999999899999999987532   235678899999998 899999999999654  567899999


Q ss_pred             cCCCchhhhc--CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC-ccceec
Q 013897          213 VNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNVRV  289 (434)
Q Consensus       213 ~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~-~~~~~~  289 (434)
                      +++++|..+.  ..+++..++.++.|++.||+|||+.|++|+||||+||+++.++ .++|+|||++....... ......
T Consensus        99 ~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~-~~~l~dfg~~~~~~~~~~~~~~~~  177 (292)
T cd06657          99 LEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEVPRRKSLV  177 (292)
T ss_pred             CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEEcccccceecccccccccccc
Confidence            9999987765  3578889999999999999999999999999999999999776 79999999987654322 223456


Q ss_pred             cCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHH
Q 013897          290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAAL  369 (434)
Q Consensus       290 ~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~  369 (434)
                      ++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.. .........+.....                +     
T Consensus       178 ~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~-~~~~~~~~~~~~~~~----------------~-----  234 (292)
T cd06657         178 GTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLP----------------P-----  234 (292)
T ss_pred             cCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhhCC----------------c-----
Confidence            7889999998865 6788999999999999999999999843 222222221111000                0     


Q ss_pred             hcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccc
Q 013897          370 VGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN  426 (434)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~  426 (434)
                                   .......+++.+.+++.+||+.||.+||++.++|+||||..+..
T Consensus       235 -------------~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~  278 (292)
T cd06657         235 -------------KLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP  278 (292)
T ss_pred             -------------ccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence                         00111235678999999999999999999999999999998764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.2e-40  Score=321.23  Aligned_cols=255  Identities=25%  Similarity=0.460  Sum_probs=206.9

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      .-|..++.||-|+||+|.+++...+...||+|.+++..      ....+.|..||... +.+-||+||..|.|  ..++|
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEA-Dn~WVVrLyySFQD--kdnLY  705 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEA-DNEWVVRLYYSFQD--KDNLY  705 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhc-CCcceEEEEEEecc--CCceE
Confidence            45889999999999999999988899999999886432      34467899999997 99999999999954  57889


Q ss_pred             EEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceec---CC
Q 013897          208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY---HP  281 (434)
Q Consensus       208 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~---~~  281 (434)
                      +||+|++||++..++   +-|.+..++.|+.++..|+++.|..|+|||||||+|||||.+| ++||+||||+.-+   ++
T Consensus       706 FVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdG-HIKLTDFGLCTGfRWTHd  784 (1034)
T KOG0608|consen  706 FVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG-HIKLTDFGLCTGFRWTHD  784 (1034)
T ss_pred             EEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCC-ceeeeeccccccceeccc
Confidence            999999999986554   4588899999999999999999999999999999999999888 9999999998322   11


Q ss_pred             ------CCc-----------c-----------------------ceeccCCcccccccccCCCCCCccccHHHHHHHHHH
Q 013897          282 ------GKE-----------Y-----------------------NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAG  321 (434)
Q Consensus       282 ------~~~-----------~-----------------------~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~e  321 (434)
                            +..           +                       ...+||+.|+|||++.. .+|+.-+|+||.||||||
T Consensus       785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-~g~~q~cdwws~gvil~e  863 (1034)
T KOG0608|consen  785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-TGYTQLCDWWSVGVILYE  863 (1034)
T ss_pred             cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-cCccccchhhHhhHHHHH
Confidence                  100           0                       11369999999999987 789999999999999999


Q ss_pred             HHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHc
Q 013897          322 MIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKL  401 (434)
Q Consensus       322 lltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~c  401 (434)
                      |+.|+.||........+.                                  .-.+|..++.+.....+++++.++|.++
T Consensus       864 m~~g~~pf~~~tp~~tq~----------------------------------kv~nw~~~l~~~~~~~ls~e~~~li~kL  909 (1034)
T KOG0608|consen  864 MLVGQPPFLADTPGETQY----------------------------------KVINWRNFLHIPYQGNLSKEALDLIQKL  909 (1034)
T ss_pred             HhhCCCCccCCCCCccee----------------------------------eeeehhhccccccccccCHHHHHHHHHH
Confidence            999999995443321111                                  1123445555666667899999999975


Q ss_pred             cccCCCCCcc---HHHHhcCCCcccccccc
Q 013897          402 LRYDHQERPT---AKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       402 L~~dP~~Rpt---~~elL~Hp~~~~~~~~~  428 (434)
                      . .+++.|..   ++||..||||++++...
T Consensus       910 c-~sad~RLGkng~d~vKaHpfFkgIDfss  938 (1034)
T KOG0608|consen  910 C-CSADSRLGKNGADQVKAHPFFKGIDFSS  938 (1034)
T ss_pred             h-cChhhhhcccchhhhhcCccccccchHh
Confidence            4 56777764   77899999999998765

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-42  Score=304.69  Aligned_cols=257  Identities=21%  Similarity=0.353  Sum_probs=205.0

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      ++.+-+..||.|+||+|++..++..|+..|||.++..    ..+++..|.++..+-.+.||||++||.+..++  ..++.
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EG--dcWiC  141 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEG--DCWIC  141 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC--ceeee
Confidence            5566778899999999999999999999999998643    34678899988887779999999999875443  34588


Q ss_pred             EeecCCCchhhhc--------CCCChHHHHHHHHHHHHHHHHHHH-CCceeecCCCCceEecCCCCeEEEEecccceecC
Q 013897          210 FEHVNNTDFKVLY--------PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH  280 (434)
Q Consensus       210 ~e~~~~~~l~~~~--------~~l~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~  280 (434)
                      ||.|.-. +..++        ..+++..+-.+...++.||.||.+ .+|||||+||+|||++..| .|||||||++..+.
T Consensus       142 MELMd~S-lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G-~vKLCDFGIcGqLv  219 (361)
T KOG1006|consen  142 MELMDIS-LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHG-DVKLCDFGICGQLV  219 (361)
T ss_pred             HHHHhhh-HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCC-CEeeecccchHhHH
Confidence            8888743 33332        357888888888889999999986 4899999999999999777 89999999998887


Q ss_pred             CCCccceeccCCcccccccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcc
Q 013897          281 PGKEYNVRVASRYFKGPELLVDLQ-DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH  359 (434)
Q Consensus       281 ~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  359 (434)
                      ..-..+.-.|...|||||.+.... +|+.++||||||++|||+.||+.||....+..+|+..+..  |.+          
T Consensus       220 ~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~--gdp----------  287 (361)
T KOG1006|consen  220 DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVI--GDP----------  287 (361)
T ss_pred             HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHc--CCC----------
Confidence            666667778999999999997644 4999999999999999999999999655554455444321  111          


Q ss_pred             ccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccc
Q 013897          360 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                                         .......+...++..+..||..||.+|-+.||...+++.+||++.-.
T Consensus       288 -------------------p~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~  334 (361)
T KOG1006|consen  288 -------------------PILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA  334 (361)
T ss_pred             -------------------CeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence                               00111112234778999999999999999999999999999998543

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=3.2e-39  Score=306.72  Aligned_cols=245  Identities=18%  Similarity=0.340  Sum_probs=191.5

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcC-----CCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS  203 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~-----~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  203 (434)
                      .++|.+.+.||+|+||.||+|.+..     ++..||+|.++...    ...+.+|+.+++.+ +|+||+++++++.+.  
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--   81 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF-NHQNIVRLIGVSFER--   81 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEccC--
Confidence            4679999999999999999999876     67899999886432    34588899999999 999999999988654  


Q ss_pred             CccEEEEeecCCCchhhhcC----------CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCC--CeEEEE
Q 013897          204 KTPSLIFEHVNNTDFKVLYP----------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ--RKLRLI  271 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~~----------~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~--~~vkl~  271 (434)
                      ...++||||+.+++|..++.          .+++..+..++.||+.||+|||+++++||||||+|||++.++  ..+||+
T Consensus        82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence            45679999999999877642          377888999999999999999999999999999999998543  368999


Q ss_pred             ecccceecCCCCcc---ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC
Q 013897          272 DWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG  347 (434)
Q Consensus       272 DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g  347 (434)
                      |||+++........   .....+..|+|||++.+ ..++.++|||||||++|||++ |..||. +.+..+....+..   
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~~g~~pf~-~~~~~~~~~~~~~---  236 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPYP-GRTNQEVMEFVTG---  236 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhc-CCcCchhHHHHHHHHHHHHHcCCCCCCC-CCCHHHHHHHHHc---
Confidence            99999765322111   11223457999999876 679999999999999999997 888873 3222221111100   


Q ss_pred             ChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          348 TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                                               ..+        ......++..+.+|+.+||+.||++||++.++|+|
T Consensus       237 -------------------------~~~--------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         237 -------------------------GGR--------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             -------------------------CCc--------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                                     000        01112356789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=5.6e-39  Score=300.34  Aligned_cols=245  Identities=25%  Similarity=0.504  Sum_probs=199.4

Q ss_pred             CeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      +|.+.+.||.|+||.||++.+..++..+|+|.+...     ....+.+|+++++.+ +|+|++++++.+.+.  ...++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~--~~~~lv   77 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKL-NHPNIIKYYESFEEK--GKLCIV   77 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhc-CCCChhheEEEEecC--CEEEEE
Confidence            478999999999999999999888999999998643     345688999999999 899999999998654  677899


Q ss_pred             EeecCCCchhhhc-------CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC
Q 013897          210 FEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG  282 (434)
Q Consensus       210 ~e~~~~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~  282 (434)
                      +||+++++|...+       ..+++..+..++.+++.||.|||++|++|+||+|+||+++.++ .++|+|||.+......
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~-~~~l~d~~~~~~~~~~  156 (258)
T cd08215          78 MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNG-LVKLGDFGISKVLSST  156 (258)
T ss_pred             EEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCC-cEEECCccceeecccC
Confidence            9999999886654       3478899999999999999999999999999999999999766 8999999999766443


Q ss_pred             C-ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcccc
Q 013897          283 K-EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE  361 (434)
Q Consensus       283 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  361 (434)
                      . ......++..|+|||.+.+ ..++.++|+||+|+++++|++|+.||.... .......+..                 
T Consensus       157 ~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-~~~~~~~~~~-----------------  217 (258)
T cd08215         157 VDLAKTVVGTPYYLSPELCQN-KPYNYKSDIWSLGCVLYELCTLKHPFEGEN-LLELALKILK-----------------  217 (258)
T ss_pred             cceecceeeeecccChhHhcc-CCCCccccHHHHHHHHHHHHcCCCCCCCCc-HHHHHHHHhc-----------------
Confidence            3 2234578889999999876 678999999999999999999999984322 1111111000                 


Q ss_pred             CChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          362 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                                ..    ..     .....++.++.+++.+||..+|++|||+.|+|+||||
T Consensus       218 ----------~~----~~-----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         218 ----------GQ----YP-----PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             ----------CC----CC-----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence                      00    00     0011356789999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.6e-39  Score=308.88  Aligned_cols=243  Identities=21%  Similarity=0.365  Sum_probs=192.1

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcC-----CCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS  203 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~-----~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  203 (434)
                      .++|.+.+.||+|+||.||+|.+..     ++..||+|.++...    .+.+.+|+++++.+ +|+||+++++++...  
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--   80 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNF-QHENIVKFYGVCTEG--   80 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhc-CCCCchheeeEEecC--
Confidence            3568899999999999999998743     35789999986532    35788999999999 899999999999654  


Q ss_pred             CccEEEEeecCCCchhhhcC-----------------CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCC
Q 013897          204 KTPSLIFEHVNNTDFKVLYP-----------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR  266 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~~-----------------~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~  266 (434)
                      ...++||||+.+++|..++.                 .+++..+..++.||+.||.|||++|++||||||+||+++.++ 
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~-  159 (280)
T cd05049          81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL-  159 (280)
T ss_pred             CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCC-
Confidence            56789999999999876642                 367788899999999999999999999999999999999776 


Q ss_pred             eEEEEecccceecCCCCc---cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHH
Q 013897          267 KLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKI  342 (434)
Q Consensus       267 ~vkl~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i  342 (434)
                      .+||+|||++........   .....++..|+|||++.+ ..++.++|||||||++|||++ |..||+... ..+....+
T Consensus       160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~e~~~~g~~p~~~~~-~~~~~~~~  237 (280)
T cd05049         160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVVLWEIFTYGKQPWYGLS-NEEVIECI  237 (280)
T ss_pred             eEEECCcccceecccCcceecCCCCcccceecChhhhcc-CCcchhhhHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHH
Confidence            899999999976533221   122345677999999876 679999999999999999998 999985332 22211111


Q ss_pred             HHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          343 AKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       343 ~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                      ..  +.                                  .......++..+.+|+.+||+.||++||++.|+++
T Consensus       238 ~~--~~----------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         238 TQ--GR----------------------------------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             Hc--CC----------------------------------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            10  00                                  00011235678999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=5.7e-39  Score=306.80  Aligned_cols=243  Identities=20%  Similarity=0.337  Sum_probs=190.7

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEc-----CCCeEEEEEEecccc---HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK  204 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vaiK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  204 (434)
                      .++|.+.+.||+|+||+||++.+.     .++..+|+|.+....   .+.+.+|+.+++++ +||||+++++++...  .
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~   80 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHEHIVKFYGVCVEG--D   80 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEecC--C
Confidence            367999999999999999999752     345679999986433   35688999999999 899999999999653  5


Q ss_pred             ccEEEEeecCCCchhhhcC----------------CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeE
Q 013897          205 TPSLIFEHVNNTDFKVLYP----------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKL  268 (434)
Q Consensus       205 ~~~lv~e~~~~~~l~~~~~----------------~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~v  268 (434)
                      ..++||||+.+++|..++.                .+++..+..++.|++.||+|||++|++||||||+|||++.++ .+
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~-~~  159 (288)
T cd05093          81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL-LV  159 (288)
T ss_pred             ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC-cE
Confidence            6789999999999876642                378889999999999999999999999999999999999776 89


Q ss_pred             EEEecccceecCCCCc---cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHH
Q 013897          269 RLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAK  344 (434)
Q Consensus       269 kl~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~  344 (434)
                      ||+|||+++.......   .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.. ....+....+..
T Consensus       160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~~-~~~~~~~~~i~~  237 (288)
T cd05093         160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQ-LSNNEVIECITQ  237 (288)
T ss_pred             EeccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHc
Confidence            9999999976543221   122334667999999876 678999999999999999998 8888732 222222221110


Q ss_pred             HhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          345 VLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       345 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                        +.                          .        ......++.++.+|+.+||+.||.+|||+.|+++
T Consensus       238 --~~--------------------------~--------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         238 --GR--------------------------V--------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             --CC--------------------------c--------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence              00                          0        0011235678999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=6.9e-39  Score=300.99  Aligned_cols=242  Identities=18%  Similarity=0.326  Sum_probs=190.2

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc--HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEe
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE  211 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  211 (434)
                      ++|++.+.||+|+||.||+|.+. ++..+|+|.++...  .+.+.+|+.+++.+ +||||+++++++.+.  ...++|||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~e   79 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMKL-SHEKLVQLYGVCTKQ--RPIYIVTE   79 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcccHHHHHHHHHHHhcC-CCCCeeeEEEEEccC--CCcEEEEE
Confidence            57899999999999999999874 45569999887432  46789999999999 899999999998654  45789999


Q ss_pred             ecCCCchhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCccc-
Q 013897          212 HVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN-  286 (434)
Q Consensus       212 ~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~~-  286 (434)
                      |+.+++|..++.    .+++..+..++.||+.||+|||++|++|+||||+||+++.++ .+||+|||+++......... 
T Consensus        80 ~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~-~~kl~d~g~~~~~~~~~~~~~  158 (256)
T cd05113          80 YMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQG-CVKVSDFGLSRYVLDDEYTSS  158 (256)
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC-CEEECCCccceecCCCceeec
Confidence            999998876652    478889999999999999999999999999999999999766 89999999997654332111 


Q ss_pred             -eeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCCh
Q 013897          287 -VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP  364 (434)
Q Consensus       287 -~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  364 (434)
                       ...++..|++||.+.+ ..++.++|||||||++|+|++ |..||.. ....+....+...                   
T Consensus       159 ~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~-~~~~~~~~~~~~~-------------------  217 (256)
T cd05113         159 VGSKFPVRWSPPEVLLY-SKFSSKSDVWAFGVLMWEVYSLGKMPYER-FNNSETVEKVSQG-------------------  217 (256)
T ss_pred             CCCccChhhCCHHHHhc-CcccchhHHHHHHHHHHHHhcCCCCCcCc-CCHHHHHHHHhcC-------------------
Confidence             1223456999999876 578999999999999999998 8888732 2221111111100                   


Q ss_pred             hHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                               .+        .......+..+.+++.+||..||.+||++.+++.+
T Consensus       218 ---------~~--------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         218 ---------LR--------LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             ---------CC--------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence                     00        00111246789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=7.4e-39  Score=301.80  Aligned_cols=241  Identities=19%  Similarity=0.330  Sum_probs=189.6

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF  210 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  210 (434)
                      .++|++.++||+|+||.||+|.+..+ ..||+|.++..  ..+.+.+|+.+++.+ +||||+++++++.+   ...++||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~---~~~~lv~   79 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE---EPIYIVT   79 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhC-CCCCcceEEEEECC---CCcEEEE
Confidence            46799999999999999999988554 56999998743  346789999999999 89999999998743   3468999


Q ss_pred             eecCCCchhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCcc
Q 013897          211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY  285 (434)
Q Consensus       211 e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~  285 (434)
                      ||+.+++|..++.     .+++..+..++.|++.||+|||+.+|+|+||||+||+++.++ .++|+|||.+.........
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~-~~~L~dfg~~~~~~~~~~~  158 (262)
T cd05071          80 EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYT  158 (262)
T ss_pred             EcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCC-cEEeccCCceeeccccccc
Confidence            9999999877753     367888999999999999999999999999999999999766 8999999999766433221


Q ss_pred             --ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          286 --NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       286 --~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                        ....++..|+|||.+.+ ..++.++|||||||++|+|++ |..|| .+....+....+...            .    
T Consensus       159 ~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~ellt~g~~p~-~~~~~~~~~~~~~~~------------~----  220 (262)
T cd05071         159 ARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVLDQVERG------------Y----  220 (262)
T ss_pred             cccCCcccceecCHhHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCC-CCCChHHHHHHHhcC------------C----
Confidence              12235567999998866 678999999999999999999 77676 333322222221100            0    


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                  .        ......++..+.+++.+||+.||++||++.++++
T Consensus       221 ------------~--------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         221 ------------R--------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             ------------C--------CCCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                        0        0011235678999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=8.1e-39  Score=304.87  Aligned_cols=260  Identities=20%  Similarity=0.365  Sum_probs=194.4

Q ss_pred             CCeEEEeeeeecCceEEEEEEE----cCCCeEEEEEEecccc---HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVH----CTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~----~~~~~~vaiK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      .+|++++.||+|+||.||+|..    ..++..||+|.++...   .+.+.+|+.+++.+ +||||+++++++.......+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEccCCCCce
Confidence            5788999999999999999974    3567899999986543   34678999999999 99999999998866555678


Q ss_pred             EEEEeecCCCchhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC
Q 013897          207 SLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG  282 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~  282 (434)
                      ++|+||+++++|..++.    .+++..+..++.|++.||+|||++||+||||||+||+++.++ .+||+|||++......
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~-~~~l~dfg~~~~~~~~  161 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESEN-RVKIGDFGLTKVLPQD  161 (284)
T ss_pred             EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCC-eEEECCCcccccccCC
Confidence            89999999999987652    478889999999999999999999999999999999999766 8999999999876443


Q ss_pred             Ccc----ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhc
Q 013897          283 KEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY  358 (434)
Q Consensus       283 ~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  358 (434)
                      ...    ....++..|+|||.+.+ ..++.++|||||||++|||++|..|+.....   .+   .+.++....       
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~---~~---~~~~~~~~~-------  227 (284)
T cd05081         162 KEYYKVREPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYSDKSCSPPA---EF---MRMMGNDKQ-------  227 (284)
T ss_pred             CcceeecCCCCCceEeeCHHHhcc-CCcChHHHHHHHHHHHHHHhhcCCcCCCcch---hh---hhhcccccc-------
Confidence            321    11123446999999876 6789999999999999999998876532211   00   111111100       


Q ss_pred             cccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                      .......+........+        ......++.++.+|+.+||..+|++|||+.|+++
T Consensus       228 ~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         228 GQMIVYHLIELLKNNGR--------LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             cccchHHHHHHHhcCCc--------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            00000111111111110        1122346778999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=3.4e-39  Score=316.28  Aligned_cols=247  Identities=20%  Similarity=0.352  Sum_probs=189.8

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEc-----CCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS  203 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  203 (434)
                      .++|++.+.||+|+||.||+|.+.     .+++.||||+++...    ...+.+|+.++.++.+||||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-~   84 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-G   84 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC-C
Confidence            468999999999999999999853     456899999996432    245778999999997899999999988654 3


Q ss_pred             CccEEEEeecCCCchhhhcC------------------------------------------------------------
Q 013897          204 KTPSLIFEHVNNTDFKVLYP------------------------------------------------------------  223 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~~------------------------------------------------------------  223 (434)
                      ...++||||+.+++|..++.                                                            
T Consensus        85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (343)
T cd05103          85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  164 (343)
T ss_pred             CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence            46789999999998865531                                                            


Q ss_pred             ----------CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCcc---ceecc
Q 013897          224 ----------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY---NVRVA  290 (434)
Q Consensus       224 ----------~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~---~~~~~  290 (434)
                                .+++..+..++.||+.||+|||+++|+||||||+|||++.++ .+||+|||++.........   ....+
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~  243 (343)
T cd05103         165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDARL  243 (343)
T ss_pred             hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCC-cEEEEecccccccccCcchhhcCCCCC
Confidence                      245667788999999999999999999999999999999766 8999999999765332221   11234


Q ss_pred             CCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHH
Q 013897          291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAAL  369 (434)
Q Consensus       291 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~  369 (434)
                      +..|+|||.+.+ ..++.++|||||||++|+|++ |..||............+.                          
T Consensus       244 ~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~--------------------------  296 (343)
T cd05103         244 PLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK--------------------------  296 (343)
T ss_pred             CcceECcHHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHh--------------------------
Confidence            566999999876 678999999999999999997 8888743222111111100                          


Q ss_pred             hcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          370 VGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                        ...+        ...+...++++.+++.+||+.||++|||+.|+++|
T Consensus       297 --~~~~--------~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         297 --EGTR--------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             --ccCC--------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence              0000        00111256789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=3.6e-39  Score=305.09  Aligned_cols=242  Identities=17%  Similarity=0.352  Sum_probs=186.6

Q ss_pred             EEEeeeeecCceEEEEEEEcCCCe--EEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEcc----CCCc
Q 013897          137 EVVRKVGRGKYSEVFEGVHCTDNE--KCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ----QSKT  205 (434)
Q Consensus       137 ~~~~~lG~G~fg~Vy~~~~~~~~~--~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~----~~~~  205 (434)
                      .+.+.||+|+||.||+|.+..++.  .+|+|.++..     ..+.+.+|+.+++.+ +|+||+++++++...    ....
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEF-DHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEccCCcccCCCC
Confidence            467889999999999999876664  6899987642     235678899999999 999999999987532    2235


Q ss_pred             cEEEEeecCCCchhhhc---------CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccc
Q 013897          206 PSLIFEHVNNTDFKVLY---------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA  276 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~---------~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla  276 (434)
                      .+++|||+.+++|..++         ..+++..+..++.||+.||.|||+++|+||||||+|||++.++ .+||+|||++
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~  159 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENM-NVCVADFGLS  159 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCC-CEEECCCCcc
Confidence            68999999999886553         2367888999999999999999999999999999999999766 8999999999


Q ss_pred             eecCCCCc---cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHH
Q 013897          277 EFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELN  352 (434)
Q Consensus       277 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~  352 (434)
                      +.......   .....++..|++||.+.+ ..++.++|||||||++|||++ |+.|| .+....+....+..        
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~g~~p~-~~~~~~~~~~~~~~--------  229 (272)
T cd05075         160 KKIYNGDYYRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPY-PGVENSEIYDYLRQ--------  229 (272)
T ss_pred             cccCcccceecCCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcCCCCCC-CCCCHHHHHHHHHc--------
Confidence            87643322   122345667999999876 678999999999999999999 77776 33332221111110        


Q ss_pred             HHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          353 AYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                                          ...        ......++..+.+++.+||+.||++|||+.+++++
T Consensus       230 --------------------~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         230 --------------------GNR--------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             --------------------CCC--------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                                000        00112356789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=4.9e-39  Score=339.21  Aligned_cols=244  Identities=23%  Similarity=0.350  Sum_probs=190.2

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      ++|++.++||+|+||.||+|.+..+++.||+|+++..      ..+++.+|+.+++.+ +||||+++++++.+.  ...+
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L-~HPNIVkl~~v~~d~--~~ly   78 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADL-IHPGIVPVYSICSDG--DPVY   78 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhC-CCcCcCeEEEEEeeC--CEEE
Confidence            5799999999999999999999889999999998642      235688999999999 999999999999654  5678


Q ss_pred             EEEeecCCCchhhhcC--------------CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEec
Q 013897          208 LIFEHVNNTDFKVLYP--------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDW  273 (434)
Q Consensus       208 lv~e~~~~~~l~~~~~--------------~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DF  273 (434)
                      +||||+++++|..++.              .++...+..++.||+.||+|||++||+||||||+|||++.++ .+||+||
T Consensus        79 LVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg-~vKLiDF  157 (932)
T PRK13184         79 YTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFG-EVVILDW  157 (932)
T ss_pred             EEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCC-CEEEEec
Confidence            9999999999876542              234556788999999999999999999999999999999776 8999999


Q ss_pred             ccceecCCCC-------------------ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCC
Q 013897          274 GLAEFYHPGK-------------------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD  334 (434)
Q Consensus       274 Gla~~~~~~~-------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~  334 (434)
                      |+++......                   .....+||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.....
T Consensus       158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g-~~~S~kSDIWSLGVILyELLTG~~PF~~~~~  236 (932)
T PRK13184        158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQMLTLSFPYRRKKG  236 (932)
T ss_pred             CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC-CCCCcHhHHHHHHHHHHHHHHCCCCCCCcch
Confidence            9997652110                   0112468999999999877 6789999999999999999999999843211


Q ss_pred             CHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHH
Q 013897          335 NYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKE  414 (434)
Q Consensus       335 ~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~e  414 (434)
                       ......  .....               +                 ........+++.+.+++.+||..||++|++..+
T Consensus       237 -~ki~~~--~~i~~---------------P-----------------~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~e  281 (932)
T PRK13184        237 -RKISYR--DVILS---------------P-----------------IEVAPYREIPPFLSQIAMKALAVDPAERYSSVQ  281 (932)
T ss_pred             -hhhhhh--hhccC---------------h-----------------hhccccccCCHHHHHHHHHHccCChhhCcCHHH
Confidence             111000  00000               0                 000011236778999999999999999987665


Q ss_pred             Hhc
Q 013897          415 AMA  417 (434)
Q Consensus       415 lL~  417 (434)
                      .|.
T Consensus       282 eLl  284 (932)
T PRK13184        282 ELK  284 (932)
T ss_pred             HHH
Confidence            553

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=6.4e-39  Score=306.99  Aligned_cols=245  Identities=19%  Similarity=0.351  Sum_probs=191.2

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCC-----CeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTD-----NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS  203 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~-----~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  203 (434)
                      .++|++.+.||+|+||.||++.+...     ...+|+|.+....    ...+.+|+.+++.+.+|+||+++++++...  
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--   88 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE--   88 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC--
Confidence            46799999999999999999987643     3789999986432    245778999999987899999999998643  


Q ss_pred             CccEEEEeecCCCchhhhc-------------------CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC
Q 013897          204 KTPSLIFEHVNNTDFKVLY-------------------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE  264 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~-------------------~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~  264 (434)
                      ...+++|||+.+++|..++                   ..+++..+..++.||+.||.|||+++|+||||||+|||++.+
T Consensus        89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~  168 (293)
T cd05053          89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTED  168 (293)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCC
Confidence            5678999999999987664                   246788899999999999999999999999999999999976


Q ss_pred             CCeEEEEecccceecCCCCcc---ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHH
Q 013897          265 QRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLV  340 (434)
Q Consensus       265 ~~~vkl~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~  340 (434)
                      + .+||+|||+++........   ....++..|+|||.+.+ ..++.++|||||||++|||++ |..||. +....+...
T Consensus       169 ~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~-~~~~~~~~~  245 (293)
T cd05053         169 H-VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYP-GIPVEELFK  245 (293)
T ss_pred             C-eEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCCCC-CCCHHHHHH
Confidence            6 8999999999866433211   11223457999999876 678999999999999999997 888873 222222111


Q ss_pred             HHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          341 KIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       341 ~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                      .+..                            ..        .......++.++.+|+.+||..||++|||+.|++++
T Consensus       246 ~~~~----------------------------~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         246 LLKE----------------------------GY--------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHc----------------------------CC--------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            1100                            00        001112356789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=3.5e-39  Score=306.03  Aligned_cols=246  Identities=33%  Similarity=0.564  Sum_probs=198.7

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      ++|.+.+.||+|+||.||+|.+..+++.||+|++...      ....+.+|+.+++++.+|+||+++++++.+.  ...+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~--~~~~   78 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE--ENLY   78 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC--ceEE
Confidence            4689999999999999999999889999999998642      2356788999999994499999999998643  5678


Q ss_pred             EEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc
Q 013897          208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE  284 (434)
Q Consensus       208 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~  284 (434)
                      +||||+.+++|..++   ..+++..+..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++........
T Consensus        79 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~-~~~l~df~~~~~~~~~~~  157 (280)
T cd05581          79 FVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDM-HIKITDFGTAKVLDPNSS  157 (280)
T ss_pred             EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC-CEEecCCccccccCCccc
Confidence            999999999987665   3588999999999999999999999999999999999999776 899999999876543221


Q ss_pred             ---------------------cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 013897          285 ---------------------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA  343 (434)
Q Consensus       285 ---------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~  343 (434)
                                           .....++..|+|||.+.+ ..++.++|||||||++++|++|+.||.... ....+..+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~~~  235 (280)
T cd05581         158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSN-EYLTFQKIL  235 (280)
T ss_pred             cccCCCCCccccccccccccccccccCCccccCHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCcc-HHHHHHHHH
Confidence                                 123356788999999876 568899999999999999999999984322 111111111


Q ss_pred             HHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccH----HHHhcCC
Q 013897          344 KVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA----KEAMAHP  419 (434)
Q Consensus       344 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~----~elL~Hp  419 (434)
                      .             .                        .......+++.+.+||.+||..||++||++    +++|+||
T Consensus       236 ~-------------~------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~  278 (280)
T cd05581         236 K-------------L------------------------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHP  278 (280)
T ss_pred             h-------------c------------------------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCC
Confidence            0             0                        001112246789999999999999999999    9999999


Q ss_pred             Cc
Q 013897          420 YF  421 (434)
Q Consensus       420 ~~  421 (434)
                      ||
T Consensus       279 ~~  280 (280)
T cd05581         279 FF  280 (280)
T ss_pred             CC
Confidence            98

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=4.8e-39  Score=306.88  Aligned_cols=254  Identities=28%  Similarity=0.488  Sum_probs=204.8

Q ss_pred             CCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc--HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       132 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      ..+.|++.+.||+|+||.||+|.+..++..+++|+++...  .+.+.+|+++++.+ +|+|++++++.+...  ...++|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~lv   93 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDC-KHPNIVDYYDSYLVG--DELWVV   93 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHC-CCCCeeEEEEEEEEC--CEEEEE
Confidence            4577899999999999999999998889999999997554  56788999999999 999999999998765  567899


Q ss_pred             EeecCCCchhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC-c
Q 013897          210 FEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-E  284 (434)
Q Consensus       210 ~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~-~  284 (434)
                      +||+.+++|..++.    .+++..+..++.|++.||.|||+.||+|+||||+||+++.++ .++|+|||++....... .
T Consensus        94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~~  172 (286)
T cd06614          94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDG-SVKLADFGFAAQLTKEKSK  172 (286)
T ss_pred             EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCC-CEEECccchhhhhccchhh
Confidence            99999999877753    588889999999999999999999999999999999999766 89999999986543221 1


Q ss_pred             cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCCh
Q 013897          285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP  364 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  364 (434)
                      .....++..|++||.+.+ ..++.++|||||||++|+|++|+.||.. .........+.. .+.                
T Consensus       173 ~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slGvil~~l~~g~~p~~~-~~~~~~~~~~~~-~~~----------------  233 (286)
T cd06614         173 RNSVVGTPYWMAPEVIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYLR-EPPLRALFLITT-KGI----------------  233 (286)
T ss_pred             hccccCCcccCCHhHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHh-cCC----------------
Confidence            233457788999999876 6789999999999999999999999832 222211111110 000                


Q ss_pred             hHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccc
Q 013897          365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                                       ........++..+.+||.+||+.+|.+|||+.++|+||||++..
T Consensus       234 -----------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  277 (286)
T cd06614         234 -----------------PPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKAC  277 (286)
T ss_pred             -----------------CCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccC
Confidence                             00111112567899999999999999999999999999999853

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=3.5e-39  Score=304.32  Aligned_cols=245  Identities=24%  Similarity=0.454  Sum_probs=194.2

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      ++|++.+.||+|+||.||+|.+..++..+|||.+...      ....+.+|+.+++.+ +|+||+++++++.+.  ...+
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~--~~~~   78 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIED--NELN   78 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHc-cCCchhhhhheeEeC--CeEE
Confidence            4688899999999999999999889999999987532      235678899999999 999999999998654  4678


Q ss_pred             EEEeecCCCchhhhc-------CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecC
Q 013897          208 LIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH  280 (434)
Q Consensus       208 lv~e~~~~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~  280 (434)
                      ++|||+.+++|..++       ..+++..+..++.||+.||.|||++|++|+||||+||+++.++ .++|+|||++....
T Consensus        79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~  157 (267)
T cd08229          79 IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG-VVKLGDLGLGRFFS  157 (267)
T ss_pred             EEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-CEEECcchhhhccc
Confidence            999999999987654       2378889999999999999999999999999999999999766 89999999987654


Q ss_pred             CCCc-cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcc
Q 013897          281 PGKE-YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH  359 (434)
Q Consensus       281 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  359 (434)
                      .... .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||.........+.......             
T Consensus       158 ~~~~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------  223 (267)
T cd08229         158 SKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC-------------  223 (267)
T ss_pred             cCCcccccccCCcCccCHHHhcC-CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC-------------
Confidence            3322 233468889999999876 6788999999999999999999999854322211111100000             


Q ss_pred             ccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          360 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                  ...         ......+++.+.+|+.+||..||++|||+.++++
T Consensus       224 ------------~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         224 ------------DYP---------PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             ------------CCC---------CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence                        000         0011235678999999999999999999997764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=4e-39  Score=302.76  Aligned_cols=244  Identities=30%  Similarity=0.512  Sum_probs=194.9

Q ss_pred             eeecCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeecCC
Q 013897          142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN  215 (434)
Q Consensus       142 lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~  215 (434)
                      ||.|+||.||++.+..+++.+|+|++....      .+.+.+|+.+++++ +||||+++++.+..  ....++|+||+.+
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~~lv~e~~~~   77 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQA-QSPYVVKLYYSFQG--KKNLYLVMEYLPG   77 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhC-CCcchhHHHHheec--CcEEEEEEecCCC
Confidence            689999999999998889999999986432      35678899999999 89999999998854  4567899999999


Q ss_pred             Cchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC---------
Q 013897          216 TDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK---------  283 (434)
Q Consensus       216 ~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~---------  283 (434)
                      ++|..++   ..+++..+..++.||+.||.|||+.+++|+||+|+||+++.++ .++|+|||++.......         
T Consensus        78 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~  156 (265)
T cd05579          78 GDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNG-HLKLTDFGLSKVGLVRRQINLNDDEK  156 (265)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCC-CEEEEecccchhcccCcccccccccc
Confidence            9987665   3588999999999999999999999999999999999999776 89999999986543321         


Q ss_pred             ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                      ......++..|++||.+.+ ..++.++|||||||++|+|++|..||.... ..+....+..  +                
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-~~~~~~~~~~--~----------------  216 (265)
T cd05579         157 EDKRIVGTPDYIAPEVILG-QGHSKTVDWWSLGCILYEFLVGIPPFHGET-PEEIFQNILN--G----------------  216 (265)
T ss_pred             cccCcccCccccCHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhc--C----------------
Confidence            1233467788999999876 568899999999999999999999984332 1111111100  0                


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccH---HHHhcCCCcccccc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA---KEAMAHPYFFPIRN  426 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~---~elL~Hp~~~~~~~  426 (434)
                                 ...+.      .....++.+.+|+.+||+.+|++|||+   .++|+||||+++++
T Consensus       217 -----------~~~~~------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~  265 (265)
T cd05579         217 -----------KIEWP------EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW  265 (265)
T ss_pred             -----------CcCCC------ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence                       00000      111146789999999999999999999   99999999998753

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.2e-38  Score=298.63  Aligned_cols=245  Identities=24%  Similarity=0.472  Sum_probs=196.0

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecc------ccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.++.      ...+.+.+|+++++++ +|+|++++++++.+.  ...+
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~-~~~~i~~~~~~~~~~--~~~~   78 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-DHPNVIKYLASFIEN--NELN   78 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCeeeeeeeeecC--CeEE
Confidence            579999999999999999999988999999998853      1245688999999999 999999999999754  5678


Q ss_pred             EEEeecCCCchhhhc-------CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecC
Q 013897          208 LIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH  280 (434)
Q Consensus       208 lv~e~~~~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~  280 (434)
                      +||||+++++|..++       ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++ .++|+|||++....
T Consensus        79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~-~~~l~d~~~~~~~~  157 (267)
T cd08224          79 IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATG-VVKLGDLGLGRFFS  157 (267)
T ss_pred             EEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCC-cEEEeccceeeecc
Confidence            999999999987654       2378889999999999999999999999999999999999776 79999999997654


Q ss_pred             CCC-ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcc
Q 013897          281 PGK-EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH  359 (434)
Q Consensus       281 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  359 (434)
                      ... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.....+...+.....   ..          
T Consensus       158 ~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~----------  223 (267)
T cd08224         158 SKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE---KC----------  223 (267)
T ss_pred             CCCcccceecCCccccCHHHhcc-CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhh---cC----------
Confidence            332 2234568888999999876 67899999999999999999999998544322211111000   00          


Q ss_pred             ccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          360 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                  ....         .....++.++.++|.+||..+|++|||+.++++
T Consensus       224 ------------~~~~---------~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         224 ------------DYPP---------LPADHYSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             ------------CCCC---------CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                        0000         001135678999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-38  Score=300.36  Aligned_cols=241  Identities=20%  Similarity=0.362  Sum_probs=191.0

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF  210 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  210 (434)
                      .++|++.+.||+|+||.||+|.+. +++.||+|.++..  ..+.+.+|+.+++++ +||||+++++++...  ...++||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~   80 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKL-RHPKLIQLYAVCTLE--EPIYIVT   80 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHC-CCCCccceeEEEecC--CCeeeee
Confidence            467999999999999999999874 5678999998753  346788999999999 899999999998654  4678999


Q ss_pred             eecCCCchhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCcc
Q 013897          211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY  285 (434)
Q Consensus       211 e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~  285 (434)
                      ||+.+++|..++.     .+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++....... 
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~~l~dfg~~~~~~~~~~-  158 (261)
T cd05068          81 ELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENN-ICKVADFGLARVIKEDIY-  158 (261)
T ss_pred             ecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCC-CEEECCcceEEEccCCcc-
Confidence            9999999877752     478889999999999999999999999999999999999776 899999999987653221 


Q ss_pred             ceecc---CCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcccc
Q 013897          286 NVRVA---SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE  361 (434)
Q Consensus       286 ~~~~~---t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  361 (434)
                      ....+   +..|+|||.+.+ ..++.++|||||||++|||++ |+.|| .+......+..+...                
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~-~~~~~~~~~~~~~~~----------------  220 (261)
T cd05068         159 EAREGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPY-PGMTNAEVLQQVDQG----------------  220 (261)
T ss_pred             cccCCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCC-CCCCHHHHHHHHHcC----------------
Confidence            11222   346999999876 678999999999999999999 88887 333322222211100                


Q ss_pred             CChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          362 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                  ..        ......++..+.+++.+||+.||++||++.++++
T Consensus       221 ------------~~--------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         221 ------------YR--------MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             ------------CC--------CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence                        00        0011235678999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=9e-39  Score=305.27  Aligned_cols=257  Identities=26%  Similarity=0.424  Sum_probs=198.5

Q ss_pred             CeEEEeeeeecCceEEEEEEEc---CCCeEEEEEEecccc-------HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCC
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHC---TDNEKCIIKILKPVK-------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK  204 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~---~~~~~vaiK~~~~~~-------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  204 (434)
                      +|++.+.||+|+||.||++.+.   .++..||||+++...       .+.+.+|+.++.++.+||||+++++.+..  ..
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~--~~   78 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT--DT   78 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec--CC
Confidence            4789999999999999999864   356889999986321       24577899999999789999999998854  35


Q ss_pred             ccEEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC
Q 013897          205 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP  281 (434)
Q Consensus       205 ~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~  281 (434)
                      ..++||||+.+++|...+   ..+++..++.++.|++.||.|||+.+++|+||||+||+++.++ .++|+|||++.....
T Consensus        79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~  157 (288)
T cd05583          79 KLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEG-HVVLTDFGLSKEFLA  157 (288)
T ss_pred             EEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEEEEECcccccccc
Confidence            678999999999887654   3478889999999999999999999999999999999999766 899999999876543


Q ss_pred             CCcc--ceeccCCcccccccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhc
Q 013897          282 GKEY--NVRVASRYFKGPELLVDLQ-DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY  358 (434)
Q Consensus       282 ~~~~--~~~~~t~~y~aPE~~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  358 (434)
                      ....  ....++..|+|||.+.+.. ..+.++||||||+++|+|++|..||...... .....+.+..            
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~~~~~~~~~~------------  224 (288)
T cd05583         158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-NSQSEISRRI------------  224 (288)
T ss_pred             ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-chHHHHHHHH------------
Confidence            3221  2345788999999986522 3788999999999999999999998432111 1111111100            


Q ss_pred             cccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCcc---HHHHhcCCCcccccccc
Q 013897          359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT---AKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt---~~elL~Hp~~~~~~~~~  428 (434)
                                 ....          ...+..+++.+.++|.+||+.||++|||   +.++|+||||+.+.+..
T Consensus       225 -----------~~~~----------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~~  276 (288)
T cd05583         225 -----------LKSK----------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDD  276 (288)
T ss_pred             -----------HccC----------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHHH
Confidence                       0000          0111235678999999999999999998   56789999999987653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-40  Score=299.02  Aligned_cols=286  Identities=27%  Similarity=0.455  Sum_probs=221.4

Q ss_pred             CCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecc-----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccC----
Q 013897          132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ----  202 (434)
Q Consensus       132 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----  202 (434)
                      ...+|.-+..+|.|.- .|..+.+.-.++.||+|.+..     ...++..+|..++..+ .|+|+++++.+|....    
T Consensus        15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v-~~~nii~l~n~ftP~~~l~~   92 (369)
T KOG0665|consen   15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCV-NHKNIISLLNVFTPQKTLEE   92 (369)
T ss_pred             eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhh-cccceeeeeeccCccccHHH
Confidence            3467888999999988 788888888899999998742     3346778999999999 9999999999987432    


Q ss_pred             CCccEEEEeecCCCchhhhcCCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC
Q 013897          203 SKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG  282 (434)
Q Consensus       203 ~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~  282 (434)
                      ....|+|||+|....-....-.+....+.+++.|++.|+.|||+.||+||||||+||++..+. .+||.|||+|+.....
T Consensus        93 ~~e~y~v~e~m~~nl~~vi~~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~-~lKi~dfg~ar~e~~~  171 (369)
T KOG0665|consen   93 FQEVYLVMELMDANLCQVILMELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDC-TLKILDFGLARTEDTD  171 (369)
T ss_pred             HHhHHHHHHhhhhHHHHHHHHhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchh-heeeccchhhcccCcc
Confidence            234679999998776555555788889999999999999999999999999999999999776 8999999999876666


Q ss_pred             CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHH--hhccc
Q 013897          283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL--NKYHI  360 (434)
Q Consensus       283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~--~~~~~  360 (434)
                      ...+..+.+.+|+|||++.+. .|...+||||+||++.||++|+..| +|.+..+++.++.+.+|.++..-+.  .....
T Consensus       172 ~~mtpyVvtRyyrapevil~~-~~ke~vdiwSvGci~gEli~~~Vlf-~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r  249 (369)
T KOG0665|consen  172 FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELILGTVLF-PGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVR  249 (369)
T ss_pred             cccCchhheeeccCchheecc-CCcccchhhhhhhHHHHHhhceEEe-cCchHHHHHHHHHHHhcCCCHHHHHHhhHHHH
Confidence            567888999999999999984 5999999999999999999998665 7999999999999999986543221  11111


Q ss_pred             cCChhHHHHhc--ccCCCCCcccc-ccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcc
Q 013897          361 ELDPHLAALVG--RHSRKPWSKFI-TVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFF  422 (434)
Q Consensus       361 ~~~~~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~  422 (434)
                      ..-....+...  -....+-..+. ..+..+.-...+.|++.+||..||++|.+++++|+||||+
T Consensus       250 ~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  250 NYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             HHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence            10001111000  00001111111 1112223345789999999999999999999999999997

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-38  Score=301.51  Aligned_cols=243  Identities=18%  Similarity=0.337  Sum_probs=191.1

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCC-----CeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTD-----NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS  203 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~-----~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  203 (434)
                      .++|.+.+.||+|+||.||+|.+...     +..||+|.+....    ...+.+|+.+++.+ +||||+++++++.+.  
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~--   81 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSTG--   81 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhC-CCCceeEEEEEEcCC--
Confidence            47899999999999999999987643     3789999986432    34578899999998 999999999998654  


Q ss_pred             CccEEEEeecCCCchhhhcC-------------CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEE
Q 013897          204 KTPSLIFEHVNNTDFKVLYP-------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRL  270 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~~-------------~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl  270 (434)
                      ...++||||+.+++|..++.             .+++..+..++.||+.||.|||+++|+||||||+|||++.++ .+||
T Consensus        82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~-~~kl  160 (277)
T cd05032          82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDL-TVKI  160 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCC-CEEE
Confidence            56789999999999876652             256678889999999999999999999999999999999776 8999


Q ss_pred             EecccceecCCCCc---cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHh
Q 013897          271 IDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL  346 (434)
Q Consensus       271 ~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~  346 (434)
                      +|||+++.......   .....++..|+|||.+.+ ..++.++|||||||++|||++ |..||. +.+.......+ .. 
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~-~~~~~~~~~~~-~~-  236 (277)
T cd05032         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPYQ-GLSNEEVLKFV-ID-  236 (277)
T ss_pred             CCcccchhhccCcccccCCCCCccccccCHHHHhc-CCCCcccchHHHHHHHHHhhccCCCCCc-cCCHHHHHHHH-hc-
Confidence            99999976543321   223456678999999876 678999999999999999998 888873 22222211111 00 


Q ss_pred             CChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          347 GTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       347 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                      +                          .        ....+..++.++.+++.+||+.+|++|||+.++++
T Consensus       237 ~--------------------------~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         237 G--------------------------G--------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             C--------------------------C--------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            0                          0        00112235678999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=2.1e-38  Score=301.41  Aligned_cols=242  Identities=19%  Similarity=0.358  Sum_probs=189.0

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCe----EEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK  204 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~----~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  204 (434)
                      .++|++.+.||+|+||.||+|.+..++.    .||+|+++...    ...+.+|+.+++.+ +||||+++++++..   .
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~---~   81 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGV-GSPYVCRLLGICLT---S   81 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhc-CCCCCceEEEEEcC---C
Confidence            4679999999999999999999876665    48999986432    35678899999998 99999999999854   3


Q ss_pred             ccEEEEeecCCCchhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecC
Q 013897          205 TPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH  280 (434)
Q Consensus       205 ~~~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~  280 (434)
                      ..++++||++++++..++.    .+++..+..++.||+.||.|||+++|+||||||+|||++.++ .+||+|||+++...
T Consensus        82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~-~~kL~dfG~~~~~~  160 (279)
T cd05109          82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPN-HVKITDFGLARLLD  160 (279)
T ss_pred             CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC-cEEECCCCceeecc
Confidence            4679999999998876652    478889999999999999999999999999999999998666 89999999998764


Q ss_pred             CCCcc---ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHh
Q 013897          281 PGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN  356 (434)
Q Consensus       281 ~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~  356 (434)
                      .....   ....++..|+|||.+.+ ..++.++|||||||++|||++ |..||. .... ..+......           
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~-~~~~-~~~~~~~~~-----------  226 (279)
T cd05109         161 IDETEYHADGGKVPIKWMALESILH-RRFTHQSDVWSYGVTVWELMTFGAKPYD-GIPA-REIPDLLEK-----------  226 (279)
T ss_pred             cccceeecCCCccchhhCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCC-CCCH-HHHHHHHHC-----------
Confidence            33221   11233567999999876 679999999999999999998 888872 2221 111111100           


Q ss_pred             hccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          357 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                      ...        ......+++++.+++.+||..||++||++.+++.
T Consensus       227 ----------------~~~--------~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         227 ----------------GER--------LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             ----------------CCc--------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                            000        0111235678999999999999999999999984

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=3.3e-39  Score=307.39  Aligned_cols=243  Identities=19%  Similarity=0.320  Sum_probs=189.2

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCC-----CeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCC
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTD-----NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK  204 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~-----~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  204 (434)
                      .+|.+.+.||+|+||.||+|.+..+     +..||+|.++...    ...+.+|+.++..+ +||||+++++++.+.  .
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~--~   81 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRL-QHPNIVCLLGVVTKE--Q   81 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEcCC--C
Confidence            4577889999999999999987543     5789999997432    34578899999998 999999999999654  4


Q ss_pred             ccEEEEeecCCCchhhhc-------------------CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCC
Q 013897          205 TPSLIFEHVNNTDFKVLY-------------------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ  265 (434)
Q Consensus       205 ~~~lv~e~~~~~~l~~~~-------------------~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~  265 (434)
                      ..++++||+.+++|..++                   ..+++..+..++.|++.||.|||++||+||||||+|||++.++
T Consensus        82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~  161 (283)
T cd05091          82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL  161 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC
Confidence            577999999999887664                   1367778889999999999999999999999999999999666


Q ss_pred             CeEEEEecccceecCCCCc---cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHH
Q 013897          266 RKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVK  341 (434)
Q Consensus       266 ~~vkl~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~  341 (434)
                       .+||+|||+++.......   .....++..|+|||.+.+ ..++.++|||||||++|||++ |..|| .+....+....
T Consensus       162 -~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~-~~~~~~~~~~~  238 (283)
T cd05091         162 -NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPY-CGYSNQDVIEM  238 (283)
T ss_pred             -ceEecccccccccccchheeeccCccCCccccCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCC-CCCCHHHHHHH
Confidence             799999999876543222   122345678999999876 678999999999999999998 66666 33333222222


Q ss_pred             HHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          342 IAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       342 i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                      +...                            ..        ......++..+.+|+.+||+.||++||++.++++.
T Consensus       239 i~~~----------------------------~~--------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         239 IRNR----------------------------QV--------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HHcC----------------------------Cc--------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            1110                            00        00112367789999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.4e-38  Score=306.41  Aligned_cols=245  Identities=22%  Similarity=0.350  Sum_probs=191.1

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEc-----CCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS  203 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  203 (434)
                      .++|.+.+.||+|+||.||++.+.     .++..+|+|.++...    .+.+.+|+.+++++.+||||+++++++...  
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--  111 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG--  111 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC--
Confidence            367999999999999999999752     345689999886432    345889999999997799999999998654  


Q ss_pred             CccEEEEeecCCCchhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEeccccee
Q 013897          204 KTPSLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF  278 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~  278 (434)
                      ...++||||+.+++|..++.     .+++.++..++.||+.||.|||+++|+|+||||+|||++.++ .++|+|||+++.
T Consensus       112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~~l~dfg~~~~  190 (302)
T cd05055         112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGK-IVKICDFGLARD  190 (302)
T ss_pred             CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCC-eEEECCCccccc
Confidence            56789999999999876653     278899999999999999999999999999999999999665 899999999976


Q ss_pred             cCCCCcc---ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHH
Q 013897          279 YHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAY  354 (434)
Q Consensus       279 ~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~  354 (434)
                      .......   ....++..|+|||.+.+ ..++.++|||||||++|||++ |..||... ...+.+.....          
T Consensus       191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~t~g~~p~~~~-~~~~~~~~~~~----------  258 (302)
T cd05055         191 IMNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSNPYPGM-PVDSKFYKLIK----------  258 (302)
T ss_pred             ccCCCceeecCCCCcccccCCHhhhcc-CCCCcHhHHHHHHHHHHHHHhCCCCCcCCC-CchHHHHHHHH----------
Confidence            5433221   12234567999999876 678999999999999999998 88887432 22111111110          


Q ss_pred             HhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          355 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                       ...        ........++++.+|+.+||..+|++|||+.|+++
T Consensus       259 -----------------~~~--------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         259 -----------------EGY--------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             -----------------cCC--------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                             000        00111235678999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.4e-38  Score=299.25  Aligned_cols=241  Identities=18%  Similarity=0.345  Sum_probs=189.8

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF  210 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  210 (434)
                      .++|++.++||+|+||.||+|.+. ++..+|+|.+...  ..+.+.+|+.+++++ +|+|++++++++.+   ...+++|
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~---~~~~lv~   79 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKL-RHDKLVQLYAVVSE---EPIYIVT   79 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhc-CCCceEEEEeEECC---CCcEEEE
Confidence            467899999999999999999874 5677999998753  346789999999999 99999999998742   3468999


Q ss_pred             eecCCCchhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCcc
Q 013897          211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY  285 (434)
Q Consensus       211 e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~  285 (434)
                      ||+.+++|..++.     .+++..+..++.|++.||+|||+++|+||||||+||+++.++ .++|+|||++.........
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~-~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05070          80 EYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGL-VCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCc-eEEeCCceeeeeccCcccc
Confidence            9999999877652     378889999999999999999999999999999999999665 8999999999765432211


Q ss_pred             --ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          286 --NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       286 --~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                        ....++..|+|||.+.+ ..++.++|||||||++|+|++ |..|| .+.+..+....+...                 
T Consensus       159 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~-~~~~~~~~~~~~~~~-----------------  219 (260)
T cd05070         159 ARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPY-PGMNNREVLEQVERG-----------------  219 (260)
T ss_pred             cccCCCCCccccChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCCC-CCCCHHHHHHHHHcC-----------------
Confidence              11234457999999866 678999999999999999999 77777 333332222221100                 


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                 .        ........+..+.+|+.+||..||++|||+.++++
T Consensus       220 -----------~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         220 -----------Y--------RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             -----------C--------CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence                       0        00111235678999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1e-38  Score=301.23  Aligned_cols=243  Identities=18%  Similarity=0.312  Sum_probs=191.4

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCC---CeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTD---NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~---~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      ++|++.+.||+|+||.||+|.+..+   ...||+|.++...    ...+.+|+.+++.+ +||||+++++++.+.  ...
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~   80 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQF-DHPNIIRLEGVVTKS--RPV   80 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhC-CCCCcceEeEEEecC--Cce
Confidence            6789999999999999999988643   4689999986432    35678899999999 999999999998653  567


Q ss_pred             EEEEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC
Q 013897          207 SLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG  282 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~  282 (434)
                      ++||||+.+++|..++    ..+++..+..++.|++.||.|||+++|+|+||||+|||++.++ .++|+|||++......
T Consensus        81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~-~~~l~dfg~~~~~~~~  159 (266)
T cd05033          81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNL-VCKVSDFGLSRRLEDS  159 (266)
T ss_pred             EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC-CEEECccchhhccccc
Confidence            8999999999988775    2478899999999999999999999999999999999999766 8999999999876422


Q ss_pred             -Cccce--eccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhc
Q 013897          283 -KEYNV--RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY  358 (434)
Q Consensus       283 -~~~~~--~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  358 (434)
                       .....  ..++..|+|||.+.+ ..++.++|||||||++|+|++ |..||... ...+....+.+.             
T Consensus       160 ~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~-~~~~~~~~~~~~-------------  224 (266)
T cd05033         160 EATYTTKGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERPYWDM-SNQDVIKAVEDG-------------  224 (266)
T ss_pred             ccceeccCCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHHcC-------------
Confidence             11111  233467999999876 678999999999999999998 99888432 211111111100             


Q ss_pred             cccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                                     ..        ......+++.+.+|+.+||+.||++||++.|++++
T Consensus       225 ---------------~~--------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         225 ---------------YR--------LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             ---------------CC--------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                           00        00112356789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=8.7e-39  Score=299.28  Aligned_cols=244  Identities=22%  Similarity=0.434  Sum_probs=198.0

Q ss_pred             CeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      +|++.++||+|+||.||++.+..+++.+|+|.+...     ....+.+|+.+++.+ +|+||+++++++.+.  ...++|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~~v   77 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASV-NHPNIISYKEAFLDG--NKLCIV   77 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhC-CCCCchhhhhhhccC--CEEEEE
Confidence            488999999999999999999889999999998642     234577899999999 899999999988654  667899


Q ss_pred             EeecCCCchhhhc-------CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC
Q 013897          210 FEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG  282 (434)
Q Consensus       210 ~e~~~~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~  282 (434)
                      +||+++++|..++       ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .+||+|||++......
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~-~~kl~d~g~~~~~~~~  156 (256)
T cd08530          78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAND-LVKIGDLGISKVLKKN  156 (256)
T ss_pred             ehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCC-cEEEeeccchhhhccC
Confidence            9999999987664       3478888999999999999999999999999999999999766 8999999999776544


Q ss_pred             CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                       ......++..|++||.+.+ ..++.++|+||||+++++|++|+.||... +.......+..    .             
T Consensus       157 -~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~-~~~~~~~~~~~----~-------------  216 (256)
T cd08530         157 -MAKTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEAR-SMQDLRYKVQR----G-------------  216 (256)
T ss_pred             -CcccccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhc----C-------------
Confidence             3334567889999999876 67889999999999999999999998322 21111111100    0             


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                                    .+.     .....++.++.+++.+||..+|++||++.|+|+||++
T Consensus       217 --------------~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         217 --------------KYP-----PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             --------------CCC-----CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence                          000     0011356789999999999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=8.8e-39  Score=299.15  Aligned_cols=236  Identities=22%  Similarity=0.388  Sum_probs=184.0

Q ss_pred             eeeeecCceEEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeecCC
Q 013897          140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN  215 (434)
Q Consensus       140 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~  215 (434)
                      +.||+|+||.||+|.+..+++.+|+|.+...    ....+.+|+++++.+ +||||+++++++...  ...++||||+.+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~e~~~~   77 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQK--QPIYIVMELVQG   77 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcCC--CCeEEEEeeccC
Confidence            3699999999999999889999999987532    235688999999999 999999999998654  567899999999


Q ss_pred             CchhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCccc---ee
Q 013897          216 TDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN---VR  288 (434)
Q Consensus       216 ~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~~---~~  288 (434)
                      ++|..++.    .+++..+..++.|++.||+|||+++|+||||||+|||++.++ .+||+|||++..........   ..
T Consensus        78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~  156 (252)
T cd05084          78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKN-VLKISDFGMSREEEDGVYASTGGMK  156 (252)
T ss_pred             CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCC-cEEECccccCcccccccccccCCCC
Confidence            99887652    478889999999999999999999999999999999999766 89999999987543221111   11


Q ss_pred             ccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHH
Q 013897          289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLA  367 (434)
Q Consensus       289 ~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~  367 (434)
                      ..+..|+|||.+.+ ..++.++|||||||++|||++ |..||.. .........+..                       
T Consensus       157 ~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~e~~~~~~~p~~~-~~~~~~~~~~~~-----------------------  211 (252)
T cd05084         157 QIPVKWTAPEALNY-GRYSSESDVWSFGILLWEAFSLGAVPYAN-LSNQQTREAIEQ-----------------------  211 (252)
T ss_pred             CCceeecCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccc-cCHHHHHHHHHc-----------------------
Confidence            22346999999876 678999999999999999998 7777732 111111111100                       


Q ss_pred             HHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          368 ALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                           ..        .......++..+.+|+.+||+.||++|||+.++++
T Consensus       212 -----~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         212 -----GV--------RLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             -----CC--------CCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                 00        00111235678999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.3e-38  Score=301.30  Aligned_cols=242  Identities=18%  Similarity=0.330  Sum_probs=187.7

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCe----EEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK  204 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~----~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  204 (434)
                      .++|++.+.||+|+||+||+|.+..++.    .+++|.+....    ..++..|+.++..+ +||||+++++++.+   .
T Consensus         6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l-~h~~iv~~~~~~~~---~   81 (279)
T cd05111           6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSL-DHAYIVRLLGICPG---A   81 (279)
T ss_pred             HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcC-CCCCcceEEEEECC---C
Confidence            3678899999999999999999876665    47778775332    24567788888888 99999999998743   3


Q ss_pred             ccEEEEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecC
Q 013897          205 TPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH  280 (434)
Q Consensus       205 ~~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~  280 (434)
                      ..++++||+.+++|..++    ..+++..+..++.||+.||.|||+++++||||||+|||++.++ .+||+|||+++...
T Consensus        82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~-~~kl~Dfg~~~~~~  160 (279)
T cd05111          82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDS-IVQIADFGVADLLY  160 (279)
T ss_pred             ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC-cEEEcCCccceecc
Confidence            467899999999987665    2478889999999999999999999999999999999999766 89999999998664


Q ss_pred             CCCc---cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHh
Q 013897          281 PGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN  356 (434)
Q Consensus       281 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~  356 (434)
                      +...   .....++..|+|||.+.+ ..++.++|||||||++|||++ |..||. +... .....+.+            
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~-~~~~-~~~~~~~~------------  225 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILF-GRYTHQSDVWSYGVTVWEMMSYGAEPYA-GMRP-HEVPDLLE------------  225 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCC-CCCH-HHHHHHHH------------
Confidence            3322   123345667999999876 679999999999999999998 988873 2221 11111110            


Q ss_pred             hccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          357 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                     .....        .....++.++.+++.+||..||++|||+.|+++
T Consensus       226 ---------------~~~~~--------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         226 ---------------KGERL--------AQPQICTIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             ---------------CCCcC--------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                           00000        011124567899999999999999999999976

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-38  Score=295.66  Aligned_cols=245  Identities=28%  Similarity=0.517  Sum_probs=199.9

Q ss_pred             CeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      +|++.+.||+|++|.||++.+..+++.|++|.+....     ...+.+|++++.++ +|+|++++++++.+.  ...++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~~v   77 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNL-KHPNIVKYIGSIETS--DSLYII   77 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhC-CCCCccEEEEEEEeC--CEEEEE
Confidence            4788999999999999999998889999999986543     35688999999999 899999999998654  567899


Q ss_pred             EeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc-c
Q 013897          210 FEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-Y  285 (434)
Q Consensus       210 ~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~-~  285 (434)
                      +||+.+++|..+.   ..+++..+..++.|++.||.|||++||+|+||||+||+++.++ .++|+|||++........ .
T Consensus        78 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~~~  156 (254)
T cd06627          78 LEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDG-VVKLADFGVATKLNDVSKDD  156 (254)
T ss_pred             EecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCC-CEEEeccccceecCCCcccc
Confidence            9999999987765   3588999999999999999999999999999999999999766 899999999987654332 2


Q ss_pred             ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChh
Q 013897          286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH  365 (434)
Q Consensus       286 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~  365 (434)
                      ....++..|+|||.+.+ ..++.++||||||+++++|++|+.||.... .......+..                     
T Consensus       157 ~~~~~~~~y~~pe~~~~-~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~-~~~~~~~~~~---------------------  213 (254)
T cd06627         157 ASVVGTPYWMAPEVIEM-SGASTASDIWSLGCTVIELLTGNPPYYDLN-PMAALFRIVQ---------------------  213 (254)
T ss_pred             cccccchhhcCHhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCcc-HHHHHHHHhc---------------------
Confidence            34467888999999876 458899999999999999999999984322 1111111100                     


Q ss_pred             HHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          366 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                             ...        ......+++.+.+++.+||..+|++|||+.+++.||||
T Consensus       214 -------~~~--------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         214 -------DDH--------PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             -------cCC--------CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence                   000        00112356789999999999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.9e-38  Score=304.09  Aligned_cols=250  Identities=19%  Similarity=0.341  Sum_probs=191.7

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCC----------------eEEEEEEecccc----HHHHHHHHHHHHHhcCCCCee
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDN----------------EKCIIKILKPVK----KKKIKREIKILQNLCGGPNIV  192 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~----------------~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv  192 (434)
                      .++|++++.||+|+||.||+|.+...+                ..||+|.+....    .+.+.+|+.+++++ +||||+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~   82 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRL-SDPNIA   82 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhc-CCCCEe
Confidence            367899999999999999999875433                568999986432    45688999999999 899999


Q ss_pred             eEeeEEEccCCCccEEEEeecCCCchhhhcC--------------CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCc
Q 013897          193 KLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP--------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHN  258 (434)
Q Consensus       193 ~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--------------~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~N  258 (434)
                      ++++++.+.  ...++|+||+.+++|..++.              .+++..+..++.|++.||+|||+++|+||||||+|
T Consensus        83 ~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N  160 (296)
T cd05051          83 RLLGVCTVD--PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN  160 (296)
T ss_pred             EEEEEEecC--CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence            999999654  56789999999998876642              47788899999999999999999999999999999


Q ss_pred             eEecCCCCeEEEEecccceecCCCCc---cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh--CCCCCCCCC
Q 013897          259 VMIDHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF--RKEPFFYGH  333 (434)
Q Consensus       259 Ill~~~~~~vkl~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt--g~~pf~~~~  333 (434)
                      |+++.++ .++|+|||+++.......   .....++..|+|||.+.+ ..++.++|||||||++|||++  |..||. ..
T Consensus       161 ili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~p~~-~~  237 (296)
T cd05051         161 CLVGKNY-TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL-GKFTTKSDVWAFGVTLWEILTLCREQPYE-HL  237 (296)
T ss_pred             eeecCCC-ceEEccccceeecccCcceeecCcCCCCceecCHHHhhc-CCCCccchhhhhHHHHHHHHhcCCCCCCC-Cc
Confidence            9999775 899999999976543321   123345678999999876 578999999999999999998  666763 22


Q ss_pred             CCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHH
Q 013897          334 DNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK  413 (434)
Q Consensus       334 ~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~  413 (434)
                      ...+.+..+.......                        .     ..........++.++.+++.+||+.||++|||+.
T Consensus       238 ~~~~~~~~~~~~~~~~------------------------~-----~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~  288 (296)
T cd05051         238 TDQQVIENAGHFFRDD------------------------G-----RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFR  288 (296)
T ss_pred             ChHHHHHHHHhccccc------------------------c-----ccccCCCccCCCHHHHHHHHHHhccChhcCCCHH
Confidence            2222222221110000                        0     0000111223567899999999999999999999


Q ss_pred             HHhc
Q 013897          414 EAMA  417 (434)
Q Consensus       414 elL~  417 (434)
                      |+++
T Consensus       289 el~~  292 (296)
T cd05051         289 EIHL  292 (296)
T ss_pred             HHHH
Confidence            9964

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-38  Score=299.30  Aligned_cols=241  Identities=18%  Similarity=0.330  Sum_probs=190.3

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEe
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE  211 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  211 (434)
                      .+|++.+.||+|+||.||+|.++ ++..+|+|++...  ....+.+|+.+++.+ +||||+++++++.+.  ...++|||
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~lv~e   79 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKL-SHPNLVQLYGVCTKQ--RPIFIVTE   79 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhC-CCCCEEEEEEEEcCC--CceEEEEe
Confidence            45789999999999999999875 5678999998643  345788999999999 999999999998644  56789999


Q ss_pred             ecCCCchhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCccce
Q 013897          212 HVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV  287 (434)
Q Consensus       212 ~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~~~  287 (434)
                      |+++++|..++.    .+++..+..++.||+.||+|||++||+||||||+||+++.++ .+||+|||+++....... ..
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~-~~kl~dfg~~~~~~~~~~-~~  157 (256)
T cd05059          80 YMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDN-VVKVSDFGLARYVLDDQY-TS  157 (256)
T ss_pred             cCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCC-cEEECCcccceecccccc-cc
Confidence            999999876642    478889999999999999999999999999999999999776 899999999976543221 11


Q ss_pred             ec---cCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          288 RV---ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       288 ~~---~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                      ..   ++..|+|||.+.+ ..++.++|||||||++|+|++ |+.||. ..+..+....+...                  
T Consensus       158 ~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~-~~~~~~~~~~~~~~------------------  217 (256)
T cd05059         158 SQGTKFPVKWAPPEVFDY-SRFSSKSDVWSFGVLMWEVFSEGKMPYE-RFSNSEVVESVSAG------------------  217 (256)
T ss_pred             cCCCCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHhccCCCCCC-CCCHHHHHHHHHcC------------------
Confidence            22   2346999999876 678999999999999999999 788873 22222222111100                  


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                                        ........++.++.+++.+||..+|++|||+.|+++.
T Consensus       218 ------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         218 ------------------YRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             ------------------CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence                              0011122367889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2.6e-38  Score=306.02  Aligned_cols=249  Identities=25%  Similarity=0.389  Sum_probs=195.8

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      +-|...+.||+|+||+||+|.+..+++.+++|.+....      ...+.+|+.+++.+ +|||++++++++.+.  ...+
T Consensus        21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~   97 (313)
T cd06633          21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-KHPNTIEYKGCYLKE--HTAW   97 (313)
T ss_pred             HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhC-CCCCCccEEEEEEeC--CEEE
Confidence            34667788999999999999998899999999986321      24577899999999 899999999999754  5678


Q ss_pred             EEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc
Q 013897          208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE  284 (434)
Q Consensus       208 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~  284 (434)
                      +||||+.+..+..+.   ..+++..+..++.||+.||.|||++||+|+||||+||+++.++ .+||+|||++....   .
T Consensus        98 lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~-~~kL~dfg~~~~~~---~  173 (313)
T cd06633          98 LVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG-QVKLADFGSASKSS---P  173 (313)
T ss_pred             EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCC-CEEEeecCCCcccC---C
Confidence            999999865443332   3578889999999999999999999999999999999999766 89999999986432   2


Q ss_pred             cceeccCCcccccccccC--CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          285 YNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~--~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                      .....++..|+|||.+..  ...++.++|||||||++|+|++|..||.... .......+... ..              
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~-~~~~~~~~~~~-~~--------------  237 (313)
T cd06633         174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-AMSALYHIAQN-DS--------------  237 (313)
T ss_pred             CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhc-CC--------------
Confidence            234578889999999742  2468889999999999999999999985432 22222211100 00              


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                                 .         ......++..+.+|+.+||+.+|.+||++.++++||||...+
T Consensus       238 -----------~---------~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~  280 (313)
T cd06633         238 -----------P---------TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDR  280 (313)
T ss_pred             -----------C---------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence                       0         000112456799999999999999999999999999998754

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-38  Score=304.23  Aligned_cols=250  Identities=19%  Similarity=0.346  Sum_probs=188.6

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCC--------------CeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTD--------------NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKL  194 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~--------------~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l  194 (434)
                      .++|++.+.||+|+||.||+|.+..+              ...||+|.++...    ...+.+|+++++++ +|+|++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~   82 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRL-KNPNIIRL   82 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCcCeE
Confidence            36799999999999999999987433              2358999986532    34688999999999 99999999


Q ss_pred             eeEEEccCCCccEEEEeecCCCchhhhcC---------------CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCce
Q 013897          195 LDIVRDQQSKTPSLIFEHVNNTDFKVLYP---------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNV  259 (434)
Q Consensus       195 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---------------~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NI  259 (434)
                      ++++...  ...++||||+.+++|..++.               .+++..+..++.|++.||.|||+++++|+||||+||
T Consensus        83 ~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni  160 (295)
T cd05097          83 LGVCVSD--DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC  160 (295)
T ss_pred             EEEEcCC--CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence            9999644  56789999999999876542               256778889999999999999999999999999999


Q ss_pred             EecCCCCeEEEEecccceecCCCCcc---ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh--CCCCCCCCCC
Q 013897          260 MIDHEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF--RKEPFFYGHD  334 (434)
Q Consensus       260 ll~~~~~~vkl~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt--g~~pf~~~~~  334 (434)
                      +++.++ .+||+|||++.........   ....++..|+|||.+.+ ..++.++|||||||++|+|++  |..||. ...
T Consensus       161 ll~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~~l~el~~~~~~~p~~-~~~  237 (295)
T cd05097         161 LVGNHY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEMFTLCKEQPYS-LLS  237 (295)
T ss_pred             EEcCCC-cEEecccccccccccCcceeccCcCcCceeecChhhhcc-CCcCchhhHHHHHHHHHHHHHcCCCCCCc-ccC
Confidence            999666 8999999999765433221   12234567999999876 678999999999999999988  556663 222


Q ss_pred             CHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHH
Q 013897          335 NYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKE  414 (434)
Q Consensus       335 ~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~e  414 (434)
                      ..+....+.+.....                        ..     .........+++.+.+|+.+||+.||++||++++
T Consensus       238 ~~~~~~~~~~~~~~~------------------------~~-----~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~  288 (295)
T cd05097         238 DEQVIENTGEFFRNQ------------------------GR-----QIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNK  288 (295)
T ss_pred             hHHHHHHHHHhhhhc------------------------cc-----cccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHH
Confidence            222222211110000                        00     0001112235678999999999999999999999


Q ss_pred             Hhc
Q 013897          415 AMA  417 (434)
Q Consensus       415 lL~  417 (434)
                      +++
T Consensus       289 i~~  291 (295)
T cd05097         289 IHH  291 (295)
T ss_pred             HHH
Confidence            864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=6.9e-39  Score=305.55  Aligned_cols=260  Identities=22%  Similarity=0.357  Sum_probs=194.9

Q ss_pred             CCeEEEeeeeecCceEEEEEEE----cCCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCc
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVH----CTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT  205 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~----~~~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  205 (434)
                      ..|++++.||+|+||.||++.+    ..++..||+|.++...    ...+.+|+.+++.+ +|||++++++++.+.....
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~   82 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGGNG   82 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEecCCCCc
Confidence            3478899999999999999975    3567899999987432    35688999999999 9999999999997765567


Q ss_pred             cEEEEeecCCCchhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC
Q 013897          206 PSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP  281 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~  281 (434)
                      .++||||+++++|..++.    .+++..+..++.||+.||+|||++||+||||||+||+++.++ .++|+|||++.....
T Consensus        83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~-~~~l~dfg~~~~~~~  161 (284)
T cd05079          83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH-QVKIGDFGLTKAIET  161 (284)
T ss_pred             eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCC-CEEECCCcccccccc
Confidence            889999999999987652    478889999999999999999999999999999999999766 899999999986643


Q ss_pred             CCcc----ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhh
Q 013897          282 GKEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK  357 (434)
Q Consensus       282 ~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  357 (434)
                      ....    ....++..|+|||.+.+ ..++.++|||||||++|||++++.|........      .+..+......    
T Consensus       162 ~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~------~~~~~~~~~~~----  230 (284)
T cd05079         162 DKEYYTVKDDLDSPVFWYAPECLIQ-SKFYIASDVWSFGVTLYELLTYCDSESSPMTLF------LKMIGPTHGQM----  230 (284)
T ss_pred             CccceeecCCCCCCccccCHHHhcc-CCCCccccchhhhhhhhhhhcCCCCCccccchh------hhhcccccccc----
Confidence            3221    23345667999999876 678999999999999999999887653321111      11111100000    


Q ss_pred             ccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                         ...... ........        ......++..+.+|+.+||+.||++|||+.+++++
T Consensus       231 ---~~~~~~-~~~~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         231 ---TVTRLV-RVLEEGKR--------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             ---cHHHHH-HHHHcCcc--------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence               000000 00000000        11122367899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-39  Score=318.99  Aligned_cols=243  Identities=23%  Similarity=0.405  Sum_probs=191.6

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCe---E-EEEEEecc------ccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNE---K-CIIKILKP------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS  203 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~---~-vaiK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  203 (434)
                      ++-.+.++||+|+||+||+|..+..+.   . ||+|..+.      ....++.+|.++|+++ +|||||++||++.+.  
T Consensus       157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l-~H~NVVr~yGVa~~~--  233 (474)
T KOG0194|consen  157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQL-NHPNVVRFYGVAVLE--  233 (474)
T ss_pred             cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEcCC--
Confidence            555677999999999999998875432   3 89998873      2346788999999998 999999999999754  


Q ss_pred             CccEEEEeecCCCchhhhcCC----CChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceec
Q 013897          204 KTPSLIFEHVNNTDFKVLYPT----LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY  279 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~~~----l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~  279 (434)
                      ..++||||+|.||+|..+++.    ++..+...++.+.+.||+|||+++++||||-++|+|++.++ .+||+|||+++..
T Consensus       234 ~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~-~vKISDFGLs~~~  312 (474)
T KOG0194|consen  234 EPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKG-VVKISDFGLSRAG  312 (474)
T ss_pred             CccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCC-eEEeCccccccCC
Confidence            567899999999999888753    78899999999999999999999999999999999999766 7899999998754


Q ss_pred             CCCCccc-eeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhh
Q 013897          280 HPGKEYN-VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK  357 (434)
Q Consensus       280 ~~~~~~~-~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  357 (434)
                      ....... ..--...|+|||.+.. .-|+.++|||||||++||+++ |..|| .+....+....|...           .
T Consensus       313 ~~~~~~~~~~klPirWLAPEtl~~-~~~s~kTDV~sfGV~~~Eif~~g~~Py-~g~~~~~v~~kI~~~-----------~  379 (474)
T KOG0194|consen  313 SQYVMKKFLKKLPIRWLAPETLNT-GIFSFKTDVWSFGVLLWEIFENGAEPY-PGMKNYEVKAKIVKN-----------G  379 (474)
T ss_pred             cceeeccccccCcceecChhhhcc-CccccccchhheeeeEEeeeccCCCCC-CCCCHHHHHHHHHhc-----------C
Confidence            3111111 1124567999999887 589999999999999999998 78886 455544444433210           0


Q ss_pred             ccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                      +.                        ...+...+.++..++.+|+..||++|||+.++.+
T Consensus       380 ~r------------------------~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  380 YR------------------------MPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             cc------------------------CCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence            00                        1111134578899999999999999999988764

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-38  Score=300.65  Aligned_cols=237  Identities=19%  Similarity=0.293  Sum_probs=182.2

Q ss_pred             eeeeecCceEEEEEEEcCCCe--EEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeec
Q 013897          140 RKVGRGKYSEVFEGVHCTDNE--KCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV  213 (434)
Q Consensus       140 ~~lG~G~fg~Vy~~~~~~~~~--~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  213 (434)
                      +.||+|+||.||+|.+..++.  .+++|.++..    ....+.+|+.++.++.+||||+++++++...  ...++||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--~~~~lv~e~~   78 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYLYLAIEYA   78 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC--CCceEEEEeC
Confidence            358999999999999877764  5688888642    2356788999999998899999999999654  4578999999


Q ss_pred             CCCchhhhcC-------------------CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecc
Q 013897          214 NNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG  274 (434)
Q Consensus       214 ~~~~l~~~~~-------------------~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFG  274 (434)
                      .+++|..++.                   .+++..+..++.|++.||+|||++|++||||||+|||++.++ .+||+|||
T Consensus        79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~-~~kl~dfg  157 (270)
T cd05047          79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY-VAKIADFG  157 (270)
T ss_pred             CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCC-eEEECCCC
Confidence            9999876642                   367888999999999999999999999999999999999776 89999999


Q ss_pred             cceecCCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHH
Q 013897          275 LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNA  353 (434)
Q Consensus       275 la~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~  353 (434)
                      ++..............+..|+|||++.. ..++.++|||||||++|||++ |..||.. .+..+....+.          
T Consensus       158 l~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~-~~~~~~~~~~~----------  225 (270)
T cd05047         158 LSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLP----------  225 (270)
T ss_pred             CccccchhhhccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCccc-cCHHHHHHHHh----------
Confidence            9853321111122233456999999865 678999999999999999997 8888832 22111111110          


Q ss_pred             HHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          354 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                       ..         ........++.++.+++.+||..||.+|||+.++++
T Consensus       226 -----------------~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         226 -----------------QG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             -----------------CC---------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence                             00         000111235678999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.9e-38  Score=335.20  Aligned_cols=141  Identities=28%  Similarity=0.505  Sum_probs=125.2

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      .++|.++++||+|+||.||+|.+..+++.||||+++...      ...+..|+.+++.+ +||||+++++++...  ..+
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~--~~~   79 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS-KSPFIVHLYYSLQSA--NNV   79 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhc-CCCCcCeEEEEEEEC--CEE
Confidence            368999999999999999999998899999999986432      35678899999988 999999999988643  577


Q ss_pred             EEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccce
Q 013897          207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE  277 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~  277 (434)
                      ++||||+.+++|..++   ..+++..++.++.||+.||+|||.++|+||||||+|||++.++ .+||+|||+++
T Consensus        80 ~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g-~vkL~DFGls~  152 (669)
T cd05610          80 YLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEG-HIKLTDFGLSK  152 (669)
T ss_pred             EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCC-CEEEEeCCCCc
Confidence            8999999999987765   3578889999999999999999999999999999999999776 89999999975

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.8e-38  Score=298.48  Aligned_cols=241  Identities=18%  Similarity=0.341  Sum_probs=190.9

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF  210 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  210 (434)
                      .++|+++++||+|+||.||+|.. .+++.||+|.+...  ....+.+|+.+++.+ +|+|++++++++.+   ...++||
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~---~~~~~v~   79 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMSPEAFLAEANLMKQL-QHPRLVRLYAVVTQ---EPIYIIT   79 (260)
T ss_pred             hHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCcHHHHHHHHHHHHhc-CCcCeeeEEEEEcc---CCcEEEE
Confidence            47799999999999999999986 46788999998743  346789999999999 89999999998743   3578999


Q ss_pred             eecCCCchhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCcc
Q 013897          211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY  285 (434)
Q Consensus       211 e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~  285 (434)
                      ||+.+++|..++.     .+++.++..++.|++.||+|||+.|++||||||+||+++.++ .++|+|||++.........
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05067          80 EYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETL-CCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             EcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCC-CEEEccCcceeecCCCCcc
Confidence            9999999876642     478888999999999999999999999999999999999766 8999999999766422211


Q ss_pred             --ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          286 --NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       286 --~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                        ....++..|+|||.+.. ..++.++|||||||++|||++ |+.||. +.+..+....+....                
T Consensus       159 ~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~-~~~~~~~~~~~~~~~----------------  220 (260)
T cd05067         159 AREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTYGRIPYP-GMTNPEVIQNLERGY----------------  220 (260)
T ss_pred             cccCCcccccccCHHHhcc-CCcCcccchHHHHHHHHHHHhCCCCCCC-CCChHHHHHHHHcCC----------------
Confidence              12234567999999876 678899999999999999999 898883 333222222211000                


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                          ........+.++.+++.+||..||++||+++++++
T Consensus       221 --------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         221 --------------------RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             --------------------CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                                00111235678999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=5.5e-40  Score=314.42  Aligned_cols=284  Identities=28%  Similarity=0.449  Sum_probs=215.8

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc--HHHHHHHHHHHHHhcC-----CCCeeeEeeEEEccCCCc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCG-----GPNIVKLLDIVRDQQSKT  205 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~E~~~l~~l~~-----h~niv~l~~~~~~~~~~~  205 (434)
                      ...|.+....|+|-|++|..|.+...|..||||+|....  .+.-..|++||++|..     --++++|+..|..  ..+
T Consensus       431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h--knH  508 (752)
T KOG0670|consen  431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH--KNH  508 (752)
T ss_pred             cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh--cce
Confidence            478999999999999999999999999999999997654  3567899999999932     2578888888854  468


Q ss_pred             cEEEEeecCCCchhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecC
Q 013897          206 PSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH  280 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~  280 (434)
                      +|||+|-+.-..-..+.     -.|....++.|+.|++.||..|-..||+|.||||+|||++.....+||||||.|....
T Consensus       509 LClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~  588 (752)
T KOG0670|consen  509 LCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFAS  588 (752)
T ss_pred             eEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccccccc
Confidence            88999987654333222     1367788999999999999999999999999999999999888899999999997553


Q ss_pred             CCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccc
Q 013897          281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI  360 (434)
Q Consensus       281 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  360 (434)
                       ....+.+..+.+|+|||+++| .+|+...|+||.||+||||.||+..| +|..+.+++....++-|.......  ..+.
T Consensus       589 -eneitPYLVSRFYRaPEIiLG-~~yd~~iD~WSvgctLYElYtGkIlF-pG~TNN~MLrl~me~KGk~p~Kml--RKgq  663 (752)
T KOG0670|consen  589 -ENEITPYLVSRFYRAPEIILG-LPYDYPIDTWSVGCTLYELYTGKILF-PGRTNNQMLRLFMELKGKFPNKML--RKGQ  663 (752)
T ss_pred             -cccccHHHHHHhccCcceeec-CcccCCccceeeceeeEEeeccceec-CCCCcHHHHHHHHHhcCCCcHHHh--hhcc
Confidence             456677888999999999999 79999999999999999999999776 888888888877777775322211  1111


Q ss_pred             cCChhHHHH-----------hcc-----cCC-CC---C-ccccc----cccccCCchHHHHHHHHccccCCCCCccHHHH
Q 013897          361 ELDPHLAAL-----------VGR-----HSR-KP---W-SKFIT----VENQHLAVPEAVDFLDKLLRYDHQERPTAKEA  415 (434)
Q Consensus       361 ~~~~~~~~~-----------~~~-----~~~-~~---~-~~~~~----~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~el  415 (434)
                      ..+.++.+-           ..+     ... .|   . ..++.    .......-.++.+||.+||..||++|+|+.++
T Consensus       664 F~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqA  743 (752)
T KOG0670|consen  664 FKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQA  743 (752)
T ss_pred             hhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHH
Confidence            111111100           000     000 00   0 00000    01122234578999999999999999999999


Q ss_pred             hcCCCccc
Q 013897          416 MAHPYFFP  423 (434)
Q Consensus       416 L~Hp~~~~  423 (434)
                      |.||||+.
T Consensus       744 L~HpFi~~  751 (752)
T KOG0670|consen  744 LKHPFITE  751 (752)
T ss_pred             hcCCcccC
Confidence            99999975

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=5.6e-39  Score=301.96  Aligned_cols=242  Identities=19%  Similarity=0.347  Sum_probs=193.4

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      ..+|++.++||.|+||.||+|.+.. +..+|+|++....   ...+.+|+.+++.+ +|+||+++++++.+.  ...++|
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~lv   80 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRL-RHKHLISLFAVCSVG--EPVYII   80 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcC-CCcchhheeeeEecC--CCeEEE
Confidence            3578899999999999999999866 8999999987543   46788999999999 999999999998654  567899


Q ss_pred             EeecCCCchhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc
Q 013897          210 FEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE  284 (434)
Q Consensus       210 ~e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~  284 (434)
                      |||+++++|..++.     .+++..+..++.||+.||.|||++||+|+||||+||+++.++ .+||+|||++........
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~-~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDL-VCKVADFGLARLIKEDVY  159 (261)
T ss_pred             EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCc-eEEEccccchhhcCCccc
Confidence            99999999987753     378888999999999999999999999999999999999766 899999999976543221


Q ss_pred             c-ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          285 Y-NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       285 ~-~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                      . ....++..|+|||.+.+ ..++.++|||||||++|+|++ |+.||. +....+.+..+....                
T Consensus       160 ~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~~-~~~~~~~~~~~~~~~----------------  221 (261)
T cd05148         160 LSSDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPYP-GMNNHEVYDQITAGY----------------  221 (261)
T ss_pred             cccCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCCC-cCCHHHHHHHHHhCC----------------
Confidence            1 12234567999999876 678999999999999999998 788873 333222222221100                


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                          .......+++++.+++.+||+.||++|||+.++++
T Consensus       222 --------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         222 --------------------RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             --------------------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                                00111236688999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.7e-38  Score=304.00  Aligned_cols=242  Identities=21%  Similarity=0.329  Sum_probs=190.0

Q ss_pred             CCeEEEeeeeecCceEEEEEEEc-----CCCeEEEEEEecccc---HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCc
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT  205 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vaiK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  205 (434)
                      .+|.+.+.||+|+||.||+|.+.     .++..+++|.++...   .+.+.+|+.+++.+ +|+||+++++++.+.  ..
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~   81 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL-QHEHIVKFYGVCGDG--DP   81 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcC-CCCCcceEEEEEccC--Cc
Confidence            56889999999999999999853     245678999986543   35688999999999 899999999999653  56


Q ss_pred             cEEEEeecCCCchhhhcC-------------------CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCC
Q 013897          206 PSLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR  266 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~~-------------------~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~  266 (434)
                      .++||||+.+++|..++.                   .+++..++.++.||+.||+|||++||+||||||+|||++.++ 
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~-  160 (291)
T cd05094          82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL-  160 (291)
T ss_pred             eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC-
Confidence            789999999999877652                   267888999999999999999999999999999999999776 


Q ss_pred             eEEEEecccceecCCCCc---cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHH
Q 013897          267 KLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKI  342 (434)
Q Consensus       267 ~vkl~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i  342 (434)
                      .++|+|||++........   .....++..|+|||.+.+ ..++.++|||||||++|||++ |+.||.... ..+....+
T Consensus       161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~-~~~~~~~~  238 (291)
T cd05094         161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWFQLS-NTEVIECI  238 (291)
T ss_pred             cEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHH
Confidence            899999999976543221   123345678999999876 678999999999999999998 998874322 11111111


Q ss_pred             HHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          343 AKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       343 ~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                      ..                           . .   +     ......++..+.+++.+||+.||++||++.++++
T Consensus       239 ~~---------------------------~-~---~-----~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         239 TQ---------------------------G-R---V-----LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             hC---------------------------C-C---C-----CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            00                           0 0   0     0011225678999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.8e-38  Score=296.88  Aligned_cols=234  Identities=20%  Similarity=0.355  Sum_probs=183.3

Q ss_pred             eeeecCceEEEEEEE--cCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeec
Q 013897          141 KVGRGKYSEVFEGVH--CTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV  213 (434)
Q Consensus       141 ~lG~G~fg~Vy~~~~--~~~~~~vaiK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  213 (434)
                      .||+|+||.||+|.+  ..++..+|+|+++...     .+.+.+|+.+++.+ +||||+++++++.+   ...++||||+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~---~~~~lv~e~~   77 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQL-DNPYIVRMIGICEA---ESWMLVMELA   77 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcC---CCcEEEEecC
Confidence            589999999999965  3567899999986432     35688999999998 99999999998843   3567999999


Q ss_pred             CCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCcc----c
Q 013897          214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY----N  286 (434)
Q Consensus       214 ~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~----~  286 (434)
                      .+++|..++   ..+++..+..++.|++.||+|||++||+||||||+||+++.++ .+||+|||++.........    .
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05116          78 ELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQH-YAKISDFGLSKALGADENYYKAKT  156 (257)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCC-eEEECCCccccccCCCCCeeeecC
Confidence            999887665   3578899999999999999999999999999999999999766 8999999999766433221    1


Q ss_pred             eeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChh
Q 013897          287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH  365 (434)
Q Consensus       287 ~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~  365 (434)
                      ...++..|+|||.+.. ..++.++|||||||++|||++ |..||.. ....+....+.+                     
T Consensus       157 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~i~~---------------------  213 (257)
T cd05116         157 HGKWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKG-MKGNEVTQMIES---------------------  213 (257)
T ss_pred             CCCCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHC---------------------
Confidence            1223467999998865 678899999999999999998 8888832 222222222110                     


Q ss_pred             HHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          366 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                             ...        ...+..+++++.+||.+||+.||++||++.++..
T Consensus       214 -------~~~--------~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         214 -------GER--------MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             -------CCC--------CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence                   000        0111236789999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.8e-38  Score=303.64  Aligned_cols=241  Identities=18%  Similarity=0.351  Sum_probs=186.8

Q ss_pred             CeEEEeeeeecCceEEEEEEEcC-----CCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCc
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT  205 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~-----~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  205 (434)
                      +|.+.+.||+|+||.||+|.+..     ....+++|.+....    ...+.+|+.+++.+ +||||+++++.+...  ..
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~   77 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV-NHPHVIKLYGACSQD--GP   77 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCCEeeEEEEEecC--CC
Confidence            46788999999999999998743     23578999886432    34688999999999 999999999998654  45


Q ss_pred             cEEEEeecCCCchhhhcC---------------------------CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCc
Q 013897          206 PSLIFEHVNNTDFKVLYP---------------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHN  258 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~~---------------------------~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~N  258 (434)
                      .++|+||+.+++|..++.                           .+++..+..++.|++.||+|||+++|+||||||+|
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n  157 (290)
T cd05045          78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN  157 (290)
T ss_pred             cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence            689999999999876532                           36677889999999999999999999999999999


Q ss_pred             eEecCCCCeEEEEecccceecCCCCcc---ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCC
Q 013897          259 VMIDHEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHD  334 (434)
Q Consensus       259 Ill~~~~~~vkl~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~  334 (434)
                      ||++.++ .+||+|||+++........   ....++..|+|||.+.+ ..++.++|||||||+++||++ |..|| .+..
T Consensus       158 ill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~-~~~~  234 (290)
T cd05045         158 VLVAEGR-KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPY-PGIA  234 (290)
T ss_pred             EEEcCCC-cEEeccccccccccCccchhcccCCCCCccccCHHHHcc-CCcchHhHHHHHHHHHHHHHhcCCCCC-CCCC
Confidence            9999766 8999999999765433221   22244567999999876 678999999999999999998 88887 3322


Q ss_pred             CHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHH
Q 013897          335 NYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKE  414 (434)
Q Consensus       335 ~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~e  414 (434)
                      .. .+.....                           ..        ........++.++.+|+.+||+.||++||++.|
T Consensus       235 ~~-~~~~~~~---------------------------~~--------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~  278 (290)
T cd05045         235 PE-RLFNLLK---------------------------TG--------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFAD  278 (290)
T ss_pred             HH-HHHHHHh---------------------------CC--------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence            21 1111100                           00        001112235678999999999999999999999


Q ss_pred             Hhc
Q 013897          415 AMA  417 (434)
Q Consensus       415 lL~  417 (434)
                      +++
T Consensus       279 i~~  281 (290)
T cd05045         279 ISK  281 (290)
T ss_pred             HHH
Confidence            975

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-40  Score=348.18  Aligned_cols=253  Identities=24%  Similarity=0.420  Sum_probs=203.7

Q ss_pred             CeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      ++.-..+||.|.||.||.|....+|+..|+|-++-.     ..+.+.+|..++..+ .|||+|+++|+-.+.+.  ++|-
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~l-nHpNlV~YyGVEvHRek--v~IF 1312 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGL-NHPNLVRYYGVEVHREK--VYIF 1312 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhc-cCccccccCceeecHHH--HHHH
Confidence            345677899999999999999999999999987532     225578999999999 99999999998776544  4588


Q ss_pred             EeecCCCchhhhcCC---CChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC---
Q 013897          210 FEHVNNTDFKVLYPT---LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK---  283 (434)
Q Consensus       210 ~e~~~~~~l~~~~~~---l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~---  283 (434)
                      ||||.+|+|..+...   .++...+.+..|++.|+.|||++|||||||||+||+++.+| .+|++|||.|.......   
T Consensus      1313 MEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g-~iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNG-LIKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred             HHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCC-cEEeecccceeEecCchhcC
Confidence            999999999877642   56667788999999999999999999999999999999887 99999999998775442   


Q ss_pred             --ccceeccCCcccccccccCCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcc
Q 013897          284 --EYNVRVASRYFKGPELLVDLQ--DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH  359 (434)
Q Consensus       284 --~~~~~~~t~~y~aPE~~~~~~--~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  359 (434)
                        .....+||+.|||||++.+..  +-..+.|||||||++.||+||+.||..-+++...+.....    .          
T Consensus      1392 ~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~----g---------- 1457 (1509)
T KOG4645|consen 1392 PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAA----G---------- 1457 (1509)
T ss_pred             CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhc----c----------
Confidence              234568999999999997743  4567899999999999999999999544444333333211    0          


Q ss_pred             ccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccccc
Q 013897          360 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA  427 (434)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~  427 (434)
                        -.|.                  +  +..++.+..|||..||+.||++|.++.|+|+|.|-+.-.+.
T Consensus      1458 --h~Pq------------------~--P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d~ 1503 (1509)
T KOG4645|consen 1458 --HKPQ------------------I--PERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTDE 1503 (1509)
T ss_pred             --CCCC------------------C--chhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccccccc
Confidence              0000                  1  11267899999999999999999999999999998755443

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-39  Score=296.79  Aligned_cols=259  Identities=26%  Similarity=0.460  Sum_probs=208.2

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccccH------HHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK------KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      ..+|.+++.||+|+|++|.+++++.+.+.||+|++++.-.      +=...|-.+..+..+||.+|-+...|  +....+
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscf--qtesrl  326 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF--QTESRL  326 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhh--cccceE
Confidence            4789999999999999999999999999999999975321      22567777888888999999999988  455778


Q ss_pred             EEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEeccccee-cCCC
Q 013897          207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF-YHPG  282 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~-~~~~  282 (434)
                      ++|.||+++|+|..++   .+++++.++.+..+|+.||.|||++|||+||||.+|+|+|.++ ++||+|+|+++. +.++
T Consensus       327 ffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeg-hikltdygmcke~l~~g  405 (593)
T KOG0695|consen  327 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEG-HIKLTDYGMCKEGLGPG  405 (593)
T ss_pred             EEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCC-ceeecccchhhcCCCCC
Confidence            8999999999986554   4699999999999999999999999999999999999999888 899999999975 3556


Q ss_pred             CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCC-CCCCHHHHHHHHHHhCChhHHHHHhhcccc
Q 013897          283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFY-GHDNYDQLVKIAKVLGTDELNAYLNKYHIE  361 (434)
Q Consensus       283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~-~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  361 (434)
                      ....+.|||+.|.|||++.+ ..|++.+|+|+|||+++||+.|+.||.- +.++.++-.           ..+.      
T Consensus       406 d~tstfcgtpnyiapeilrg-eeygfsvdwwalgvlmfemmagrspfdivgm~n~d~nt-----------edyl------  467 (593)
T KOG0695|consen  406 DTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNT-----------EDYL------  467 (593)
T ss_pred             cccccccCCCcccchhhhcc-cccCceehHHHHHHHHHHHHcCCCCcceecCCCcccch-----------hHHH------
Confidence            67788999999999999998 7999999999999999999999999931 111111100           0000      


Q ss_pred             CChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCcc------HHHHhcCCCcccccc
Q 013897          362 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT------AKEAMAHPYFFPIRN  426 (434)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt------~~elL~Hp~~~~~~~  426 (434)
                          +..++.+..+.          +..++-.+..+|+..|.+||.+|..      ..++-.|+||+.+++
T Consensus       468 ----fqvilekqiri----------prslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idw  524 (593)
T KOG0695|consen  468 ----FQVILEKQIRI----------PRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDW  524 (593)
T ss_pred             ----HHHHhhhcccc----------cceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCH
Confidence                00011111111          1224556778999999999999954      689999999998875

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.3e-38  Score=305.46  Aligned_cols=244  Identities=21%  Similarity=0.344  Sum_probs=189.4

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcC-------CCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccC
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCT-------DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ  202 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~-------~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  202 (434)
                      ++|.+.+.||+|+||.||++.+..       +...+|+|.++...    ...+.+|+.+++.+.+||||+++++++.+. 
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~-   96 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD-   96 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC-
Confidence            679999999999999999998643       23579999997532    245778999999997899999999999654 


Q ss_pred             CCccEEEEeecCCCchhhhcC-------------------CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecC
Q 013897          203 SKTPSLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH  263 (434)
Q Consensus       203 ~~~~~lv~e~~~~~~l~~~~~-------------------~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~  263 (434)
                       ...++||||+.+++|..++.                   .+++.++..++.|++.||+|||++|++||||||+|||++.
T Consensus        97 -~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~  175 (307)
T cd05098          97 -GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE  175 (307)
T ss_pred             -CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcC
Confidence             46789999999999876652                   2677889999999999999999999999999999999997


Q ss_pred             CCCeEEEEecccceecCCCCcc---ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHH
Q 013897          264 EQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQL  339 (434)
Q Consensus       264 ~~~~vkl~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~  339 (434)
                      ++ .+||+|||++.........   ....++..|+|||.+.+ ..++.++|||||||++|||++ |..|| .+. +.+.+
T Consensus       176 ~~-~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~~g~~p~-~~~-~~~~~  251 (307)
T cd05098         176 DN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPY-PGV-PVEEL  251 (307)
T ss_pred             CC-cEEECCCcccccccccchhhccccCCCccceeChHHhcc-CCCCcHHHHHHHHHHHHHHHcCCCCCC-CcC-CHHHH
Confidence            76 8999999999765432111   11223457999999876 678999999999999999998 77776 322 22222


Q ss_pred             HHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          340 VKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       340 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                      .....   ..                        .        .......++.++.+|+.+||..+|++|||+.+++++
T Consensus       252 ~~~~~---~~------------------------~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         252 FKLLK---EG------------------------H--------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHHHH---cC------------------------C--------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            21110   00                        0        001112356789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=3.9e-38  Score=296.37  Aligned_cols=240  Identities=19%  Similarity=0.320  Sum_probs=187.9

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEe
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE  211 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  211 (434)
                      ++|.+.+.||+|+||.||+|.+..+ ..+|+|.+...  ..+.+.+|+.+++.+ +|+|++++++++..   ...++|||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~---~~~~~v~e   80 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKL-RHDKLVPLYAVVSE---EPIYIVTE   80 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhC-CCCCeeeEEEEEcC---CCcEEEEE
Confidence            6799999999999999999987544 56999988643  345688999999999 99999999998743   34689999


Q ss_pred             ecCCCchhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCcc-
Q 013897          212 HVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-  285 (434)
Q Consensus       212 ~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~-  285 (434)
                      |+.+++|..++.     .+++..+..++.|++.||.|||+.||+|+||||+||+++.++ .++|+|||++......... 
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~-~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05069          81 FMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNL-VCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC-eEEECCCccceEccCCcccc
Confidence            999998876653     267888999999999999999999999999999999999766 8999999999765432211 


Q ss_pred             -ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          286 -NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       286 -~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                       ....++..|+|||...+ ..++.++|||||||++|+|++ |..||. +....+....+....                 
T Consensus       160 ~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~-~~~~~~~~~~~~~~~-----------------  220 (260)
T cd05069         160 RQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYP-GMVNREVLEQVERGY-----------------  220 (260)
T ss_pred             cCCCccchhhCCHHHhcc-CCcChHHHHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHcCC-----------------
Confidence             12234567999998876 678999999999999999999 888873 333222222211000                 


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                 .        .......+..+.+++.+||..||++||+++++++
T Consensus       221 -----------~--------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         221 -----------R--------MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             -----------C--------CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                       0        0011135678999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=3.3e-38  Score=305.84  Aligned_cols=249  Identities=26%  Similarity=0.416  Sum_probs=196.1

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      ..|+..+.||+|+||.||++.+..++..+|+|.+...      ....+.+|+.+++.+ +|||++++++++.+.  ...+
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~~  101 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI-KHPNSIEYKGCYLRE--HTAW  101 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeeC--CeEE
Confidence            4477889999999999999999889999999998632      124578899999999 899999999999654  4567


Q ss_pred             EEEeecCCCchhhh---cCCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc
Q 013897          208 LIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE  284 (434)
Q Consensus       208 lv~e~~~~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~  284 (434)
                      +||||+.+..+..+   ...+++..+..++.||+.||.|||+++|+||||+|+||+++.++ .++|+|||++.....   
T Consensus       102 lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~-~~kl~dfg~~~~~~~---  177 (317)
T cd06635         102 LVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG-QVKLADFGSASIASP---  177 (317)
T ss_pred             EEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCC-CEEEecCCCccccCC---
Confidence            99999987543332   23578899999999999999999999999999999999999766 899999999875432   


Q ss_pred             cceeccCCcccccccccC--CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          285 YNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~--~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                      .....++..|+|||.+..  ...++.++|||||||++|+|++|+.||... ........+.....               
T Consensus       178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~-~~~~~~~~~~~~~~---------------  241 (317)
T cd06635         178 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNES---------------  241 (317)
T ss_pred             cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc-cHHHHHHHHHhccC---------------
Confidence            234568889999999742  246889999999999999999999998542 21122211111000               


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                                          .......+++.+.+|+.+||+.+|++||++.++++|+|+....
T Consensus       242 --------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  284 (317)
T cd06635         242 --------------------PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER  284 (317)
T ss_pred             --------------------CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence                                0001112556899999999999999999999999999997544

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.4e-38  Score=299.27  Aligned_cols=244  Identities=24%  Similarity=0.438  Sum_probs=192.4

Q ss_pred             CeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc--------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~--------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      +|.+.+.||+|+||.||++.+...+..+++|+++..        ....+..|+.+++.+ +||||+++++++.+.  ...
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~   77 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL-DHPAIVKFHASFLER--DAF   77 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhC-CCCcHHHHHHHHhcC--Cce
Confidence            478899999999999999998777777777776532        223466789999998 999999999998654  457


Q ss_pred             EEEEeecCCCchhhhc-------CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceec
Q 013897          207 SLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY  279 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~  279 (434)
                      ++|+||+.++++..++       ..+++..++.++.|++.||.|||++|++|+||||+||+++. + .++|+|||++...
T Consensus        78 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~-~~~l~d~g~~~~~  155 (260)
T cd08222          78 CIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-N-LLKIGDFGVSRLL  155 (260)
T ss_pred             EEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-C-CEeecccCceeec
Confidence            8999999999987553       34788999999999999999999999999999999999984 4 6999999999766


Q ss_pred             CCCCc-cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhc
Q 013897          280 HPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY  358 (434)
Q Consensus       280 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  358 (434)
                      ..... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||. ..........+.   ...         
T Consensus       156 ~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~-~~~~~~~~~~~~---~~~---------  221 (260)
T cd08222         156 MGSCDLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFE-GQNFLSVVLRIV---EGP---------  221 (260)
T ss_pred             CCCcccccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCC-CccHHHHHHHHH---cCC---------
Confidence            43322 234467888999999865 678889999999999999999999983 222211111110   000         


Q ss_pred             cccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                          .                    ......++.++.++|.+||..||++||++.|+++||||
T Consensus       222 ----~--------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         222 ----T--------------------PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             ----C--------------------CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence                0                    00112356789999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-40  Score=293.79  Aligned_cols=280  Identities=28%  Similarity=0.507  Sum_probs=219.9

Q ss_pred             EEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCC---ccEEE
Q 013897          138 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK---TPSLI  209 (434)
Q Consensus       138 ~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~---~~~lv  209 (434)
                      -.+.||.|+||.||.+.+..+|+.||+|.+...     ..+.+.+|+++|.-+ +|.|++..++......-.   .+|+|
T Consensus        57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfF-kHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSF-RHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhh-ccccHHHHHHhcCCCCchHHHHHHHH
Confidence            456799999999999999999999999988643     457789999999998 999999998876533221   24566


Q ss_pred             EeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC--c
Q 013897          210 FEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--E  284 (434)
Q Consensus       210 ~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~--~  284 (434)
                      .|.|... |..++   +.++...++.++.||++||.|||+.+|.||||||.|+|++.+- .+||||||+|+....+.  .
T Consensus       136 TELmQSD-LHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNC-vLKICDFGLARvee~d~~~h  213 (449)
T KOG0664|consen  136 TELMQSD-LHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNC-ILKICDFGLARTWDQRDRLN  213 (449)
T ss_pred             HHHHHhh-hhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCc-eEEecccccccccchhhhhh
Confidence            7777643 33333   3588889999999999999999999999999999999999665 89999999999876553  3


Q ss_pred             cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCCh
Q 013897          285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP  364 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  364 (434)
                      .+..+.|.+|+|||+++|.+.|+.++||||.|||+.||+.++.. |...+..+++..|.+.+|.+..........    .
T Consensus       214 MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrIL-FQAq~PiqQL~lItdLLGTPs~EaMr~ACE----G  288 (449)
T KOG0664|consen  214 MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKIL-FQAAGPIEQLQMIIDLLGTPSQEAMKYACE----G  288 (449)
T ss_pred             hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhh-hhccChHHHHHHHHHHhCCCcHHHHHHHhh----h
Confidence            45668899999999999989999999999999999999966654 578888999999999999987765543221    1


Q ss_pred             hHHHHhcccCCCCCcc-ccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccc
Q 013897          365 HLAALVGRHSRKPWSK-FITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       365 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                      --..++....+.+... ..++..+.....+..+++.++|..||++|++.++++.|+|+...+
T Consensus       289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R  350 (449)
T KOG0664|consen  289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR  350 (449)
T ss_pred             hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence            1122333333333222 223333334456789999999999999999999999999987654

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-38  Score=320.87  Aligned_cols=257  Identities=25%  Similarity=0.460  Sum_probs=210.0

Q ss_pred             CCCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeEeeEEEc---cCCCc
Q 013897          131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRD---QQSKT  205 (434)
Q Consensus       131 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~---~~~~~  205 (434)
                      ...+.|++.+.||.|.+|.||+++.+.+++..|+|++...  ..++++.|.++|+.+.+|||++.++|++.-   ....-
T Consensus        16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq   95 (953)
T KOG0587|consen   16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ   95 (953)
T ss_pred             CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence            3457799999999999999999999999999999998754  457788999999999999999999998752   23456


Q ss_pred             cEEEEeecCCCchhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecC
Q 013897          206 PSLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH  280 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~  280 (434)
                      ++||||||.+|+..++.+     .+.|..+.+|++.++.||.+||.+.++|||||-.|||++.++ .|||+|||.+..+.
T Consensus        96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~-~VKLvDFGvSaQld  174 (953)
T KOG0587|consen   96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLD  174 (953)
T ss_pred             EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccC-cEEEeeeeeeeeee
Confidence            899999999999877753     478889999999999999999999999999999999999887 79999999987664


Q ss_pred             CC-CccceeccCCcccccccccCCC----CCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHH
Q 013897          281 PG-KEYNVRVASRYFKGPELLVDLQ----DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL  355 (434)
Q Consensus       281 ~~-~~~~~~~~t~~y~aPE~~~~~~----~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~  355 (434)
                      .. ...++.+||++|||||++....    .|+..+|+||||++..||.-|.+|+..-..    +..++.           
T Consensus       175 sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP----mraLF~-----------  239 (953)
T KOG0587|consen  175 STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP----MRALFL-----------  239 (953)
T ss_pred             cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch----hhhhcc-----------
Confidence            33 3457789999999999996532    478899999999999999999999832211    111111           


Q ss_pred             hhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccc
Q 013897          356 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP  423 (434)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~  423 (434)
                                       .++.+...   ...+..-+.++.|||..||..|-++||+..++|.|||++.
T Consensus       240 -----------------IpRNPPPk---Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e  287 (953)
T KOG0587|consen  240 -----------------IPRNPPPK---LKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE  287 (953)
T ss_pred             -----------------CCCCCCcc---ccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence                             11111111   1122234678999999999999999999999999999983

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2.5e-38  Score=296.89  Aligned_cols=239  Identities=17%  Similarity=0.331  Sum_probs=188.5

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc-HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEee
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH  212 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  212 (434)
                      ++|.+.+.||+|+||.||++..  .+..+|+|.++... .+.+.+|+.+++.+ +|+|++++++++... ....++|+||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-~~~~~lv~e~   81 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEE-KGGLYIVTEY   81 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCchHHHHHHHHHHHHhC-CCCCeeeEEEEEEcC-CCceEEEEEC
Confidence            5789999999999999999976  47889999987543 45688999999999 999999999986543 3457899999


Q ss_pred             cCCCchhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCccce
Q 013897          213 VNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV  287 (434)
Q Consensus       213 ~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~~~  287 (434)
                      +.+++|..++.     .+++..+..++.|++.||+|||++||+||||||+||+++.++ .+||+|||++.......  ..
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~~--~~  158 (256)
T cd05082          82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASSTQ--DT  158 (256)
T ss_pred             CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCC-cEEecCCccceeccccC--CC
Confidence            99999876642     267888999999999999999999999999999999999776 89999999987543222  22


Q ss_pred             eccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhH
Q 013897          288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL  366 (434)
Q Consensus       288 ~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~  366 (434)
                      ..++..|+|||++.+ ..++.++|||||||++|+|++ |+.||... +..+....+.+                      
T Consensus       159 ~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~-~~~~~~~~~~~----------------------  214 (256)
T cd05082         159 GKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEK----------------------  214 (256)
T ss_pred             CccceeecCHHHHcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHhc----------------------
Confidence            334567999999876 678999999999999999997 88887321 11111111100                      


Q ss_pred             HHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          367 AALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                           . .        .......+++.+.+++.+||..||++|||+.++++
T Consensus       215 -----~-~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         215 -----G-Y--------KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             -----C-C--------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                 0 0        00111236788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=4.9e-38  Score=295.45  Aligned_cols=234  Identities=18%  Similarity=0.349  Sum_probs=182.0

Q ss_pred             eeeecCceEEEEEEEc--CCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeecC
Q 013897          141 KVGRGKYSEVFEGVHC--TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVN  214 (434)
Q Consensus       141 ~lG~G~fg~Vy~~~~~--~~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~  214 (434)
                      .||+|+||.||+|.+.  .++..||+|+++...    .+.+.+|+.+++.+ +||||+++++++..   ...++||||++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~---~~~~lv~e~~~   77 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQL-DNPYIVRMIGVCEA---EALMLVMEMAS   77 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhc-CCCCeEEEEEEEcC---CCeEEEEEeCC
Confidence            3899999999999775  445679999986543    35588999999999 99999999998843   45789999999


Q ss_pred             CCchhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCcc----c
Q 013897          215 NTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY----N  286 (434)
Q Consensus       215 ~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~----~  286 (434)
                      +++|..++.    .+++..+..++.||+.||.|||++|++||||||+|||++.++ .+||+|||++.........    .
T Consensus        78 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05115          78 GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQH-YAKISDFGLSKALGADDSYYKARS  156 (257)
T ss_pred             CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCC-cEEeccCCccccccCCccceeccC
Confidence            999877652    478899999999999999999999999999999999999766 8999999999765433221    1


Q ss_pred             eeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChh
Q 013897          287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH  365 (434)
Q Consensus       287 ~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~  365 (434)
                      ...++..|+|||.+.+ ..++.++|||||||++|+|++ |..||... ...+....+.+                     
T Consensus       157 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~---------------------  213 (257)
T cd05115         157 AGKWPLKWYAPECINF-RKFSSRSDVWSYGITMWEAFSYGQKPYKKM-KGPEVMSFIEQ---------------------  213 (257)
T ss_pred             CCCCCcccCCHHHHcc-CCCCchhhHHHHHHHHHHHhcCCCCCcCcC-CHHHHHHHHHC---------------------
Confidence            1122467999999876 678999999999999999996 99888432 22111111100                     


Q ss_pred             HHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          366 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                             ..+        ...+..+++++.+++.+||..||++||++.++++
T Consensus       214 -------~~~--------~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         214 -------GKR--------LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             -------CCC--------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                   000        0111235789999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.5e-38  Score=301.12  Aligned_cols=242  Identities=18%  Similarity=0.333  Sum_probs=189.1

Q ss_pred             CCeEEEeeeeecCceEEEEEEEc-----CCCeEEEEEEecccc---HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCc
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT  205 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vaiK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  205 (434)
                      .+|.+.++||+|+||.||++...     .++..+|+|.++...   ...+.+|+.+++.+ +|+||+++++++.+.  ..
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~   81 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVL-QHQHIVRFYGVCTEG--RP   81 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcC-CCCCCceEEEEEecC--Cc
Confidence            56788999999999999999742     346789999886433   35688999999999 999999999998654  45


Q ss_pred             cEEEEeecCCCchhhhcC------------------CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCe
Q 013897          206 PSLIFEHVNNTDFKVLYP------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRK  267 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~~------------------~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~  267 (434)
                      .++||||+.+++|..++.                  .+++..+..++.||+.||+|||++||+||||||+|||++.++ .
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~-~  160 (280)
T cd05092          82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL-V  160 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC-C
Confidence            789999999999876642                  367788999999999999999999999999999999999766 8


Q ss_pred             EEEEecccceecCCCCcc---ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHH
Q 013897          268 LRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIA  343 (434)
Q Consensus       268 vkl~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~  343 (434)
                      +||+|||++.........   ....++..|+|||.+.+ ..++.++|||||||++|||++ |..||... ...+....+.
T Consensus       161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~-~~~~~~~~~~  238 (280)
T cd05092         161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDIWSFGVVLWEIFTYGKQPWYQL-SNTEAIECIT  238 (280)
T ss_pred             EEECCCCceeEcCCCceeecCCCccccccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCccC-CHHHHHHHHH
Confidence            999999999765433221   12234577999999876 678999999999999999998 88887432 2222111110


Q ss_pred             HHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          344 KVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       344 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                      +                           ..         .......+++.+.+|+.+||+.||++||++.|+++
T Consensus       239 ~---------------------------~~---------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         239 Q---------------------------GR---------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             c---------------------------Cc---------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            0                           00         00111236788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=3.7e-38  Score=302.39  Aligned_cols=250  Identities=18%  Similarity=0.337  Sum_probs=187.7

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcC----------------CCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCee
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCT----------------DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIV  192 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~----------------~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv  192 (434)
                      .++|++.+.||+|+||.||++.+..                ++..+|+|+++...    ...+.+|+.+++.+ +|+||+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~   82 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRL-KDPNII   82 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcc
Confidence            3579999999999999999986432                34579999987432    35688999999999 999999


Q ss_pred             eEeeEEEccCCCccEEEEeecCCCchhhhcC--------------CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCc
Q 013897          193 KLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP--------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHN  258 (434)
Q Consensus       193 ~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--------------~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~N  258 (434)
                      ++++++.+.  ...++||||+.+++|..++.              .+++..+..++.||+.||+|||++||+|+||||+|
T Consensus        83 ~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N  160 (296)
T cd05095          83 RLLAVCITS--DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN  160 (296)
T ss_pred             eEEEEEecC--CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence            999998654  45789999999999876642              24566789999999999999999999999999999


Q ss_pred             eEecCCCCeEEEEecccceecCCCCcc---ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh--CCCCCCCCC
Q 013897          259 VMIDHEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF--RKEPFFYGH  333 (434)
Q Consensus       259 Ill~~~~~~vkl~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt--g~~pf~~~~  333 (434)
                      ||++.++ .++|+|||++..+......   ....++..|++||...+ ..++.++|||||||++|||++  |..||.. .
T Consensus       161 ili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~DiwSlG~~l~el~~~~~~~p~~~-~  237 (296)
T cd05095         161 CLVGKNY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL-GKFTTASDVWAFGVTLWEILTLCKEQPYSQ-L  237 (296)
T ss_pred             EEEcCCC-CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc-CCccchhhhhHHHHHHHHHHHhCCCCCccc-c
Confidence            9999666 8999999999765433211   12234567999998776 679999999999999999998  6777732 2


Q ss_pred             CCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHH
Q 013897          334 DNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK  413 (434)
Q Consensus       334 ~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~  413 (434)
                      ...+........         .....              .      .........+++.+.+|+.+||+.||++||++.
T Consensus       238 ~~~~~~~~~~~~---------~~~~~--------------~------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~  288 (296)
T cd05095         238 SDEQVIENTGEF---------FRDQG--------------R------QVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQ  288 (296)
T ss_pred             ChHHHHHHHHHH---------Hhhcc--------------c------cccCCCCCCCCHHHHHHHHHHcCCCcccCCCHH
Confidence            222211111000         00000              0      000111223567899999999999999999999


Q ss_pred             HHhc
Q 013897          414 EAMA  417 (434)
Q Consensus       414 elL~  417 (434)
                      |+++
T Consensus       289 ~i~~  292 (296)
T cd05095         289 EIHA  292 (296)
T ss_pred             HHHH
Confidence            9864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=3.2e-38  Score=305.48  Aligned_cols=244  Identities=19%  Similarity=0.331  Sum_probs=188.6

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEc-------CCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEcc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHC-------TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQ  201 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~-------~~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  201 (434)
                      .++|.+.+.||+|+||.||+|.+.       .....+|+|.++...    ...+.+|+.+++.+.+||||+++++++.+.
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            367899999999999999999753       234579999987432    245788999999986799999999998653


Q ss_pred             CCCccEEEEeecCCCchhhhcC-------------------CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEec
Q 013897          202 QSKTPSLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID  262 (434)
Q Consensus       202 ~~~~~~lv~e~~~~~~l~~~~~-------------------~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~  262 (434)
                        ...++||||+.+++|..++.                   .+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus        91 --~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~  168 (314)
T cd05099          91 --GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT  168 (314)
T ss_pred             --CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEc
Confidence              56789999999999876642                   267778889999999999999999999999999999999


Q ss_pred             CCCCeEEEEecccceecCCCCcc---ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHH
Q 013897          263 HEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQ  338 (434)
Q Consensus       263 ~~~~~vkl~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~  338 (434)
                      .++ .+||+|||+++........   ....++..|+|||.+.+ ..++.++|||||||++|+|++ |..|| .+....+.
T Consensus       169 ~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~~g~~p~-~~~~~~~~  245 (314)
T cd05099         169 EDN-VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSPY-PGIPVEEL  245 (314)
T ss_pred             CCC-cEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccchhhHHHHHHHHHHhCCCCCC-CCCCHHHH
Confidence            776 8999999999765432211   11223457999999876 678999999999999999999 78787 33222222


Q ss_pred             HHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          339 LVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       339 ~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                      +..+..                           . .        .......++.++.+++.+||..||++|||+.|+++
T Consensus       246 ~~~~~~---------------------------~-~--------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         246 FKLLRE---------------------------G-H--------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             HHHHHc---------------------------C-C--------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            221110                           0 0        00011235678999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=4.8e-38  Score=313.24  Aligned_cols=246  Identities=22%  Similarity=0.328  Sum_probs=189.5

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEc-----CCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS  203 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  203 (434)
                      .++|.+.++||+|+||.||+|++.     ..+..||+|+++...    ...+.+|+.+|..+..||||+++++++...  
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~--  113 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG--  113 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC--
Confidence            467889999999999999999864     345689999997432    245788999999995599999999999654  


Q ss_pred             CccEEEEeecCCCchhhhcC------------------------------------------------------------
Q 013897          204 KTPSLIFEHVNNTDFKVLYP------------------------------------------------------------  223 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~~------------------------------------------------------------  223 (434)
                      ..+++||||+.+++|..++.                                                            
T Consensus       114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (401)
T cd05107         114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ  193 (401)
T ss_pred             CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence            56789999999999865541                                                            


Q ss_pred             -----------------------------------------CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEec
Q 013897          224 -----------------------------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID  262 (434)
Q Consensus       224 -----------------------------------------~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~  262 (434)
                                                               .+++..+..++.||+.||+|||+.+|+||||||+|||++
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~  273 (401)
T cd05107         194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC  273 (401)
T ss_pred             cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEe
Confidence                                                     145556788999999999999999999999999999999


Q ss_pred             CCCCeEEEEecccceecCCCCc---cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHH
Q 013897          263 HEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQ  338 (434)
Q Consensus       263 ~~~~~vkl~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~  338 (434)
                      .++ .+||+|||+++.......   .....++..|+|||.+.+ ..++.++|||||||++|||++ |+.||.. ....+.
T Consensus       274 ~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~e~l~~g~~P~~~-~~~~~~  350 (401)
T cd05107         274 EGK-LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN-NLYTTLSDVWSFGILLWEIFTLGGTPYPE-LPMNEQ  350 (401)
T ss_pred             CCC-EEEEEecCcceecccccccccCCCcCCCCceeChHHhcC-CCCCcHhHHHHHHHHHHHHHHcCCCCCCC-CCchHH
Confidence            665 899999999976533221   122356778999999876 678999999999999999998 8888732 222222


Q ss_pred             HHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          339 LVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       339 ~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                      +.....                           ...+        ...+..++.++.+|+.+||..||.+||++.|+++.
T Consensus       351 ~~~~~~---------------------------~~~~--------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         351 FYNAIK---------------------------RGYR--------MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             HHHHHH---------------------------cCCC--------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            111100                           0000        00112356789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.4e-38  Score=297.41  Aligned_cols=234  Identities=18%  Similarity=0.272  Sum_probs=178.5

Q ss_pred             eeeeecCceEEEEEEEcCC------------CeEEEEEEeccccH---HHHHHHHHHHHHhcCCCCeeeEeeEEEccCCC
Q 013897          140 RKVGRGKYSEVFEGVHCTD------------NEKCIIKILKPVKK---KKIKREIKILQNLCGGPNIVKLLDIVRDQQSK  204 (434)
Q Consensus       140 ~~lG~G~fg~Vy~~~~~~~------------~~~vaiK~~~~~~~---~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  204 (434)
                      +.||+|+||.||+|.....            ...+++|.+.....   ..+.+|+.++..+ +||||+++++++.+.  .
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l-~hp~iv~~~~~~~~~--~   77 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQV-SHKHIVLLYGVCVRD--V   77 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhC-CCCCEeeEEEEEecC--C
Confidence            3689999999999985322            23689998865432   3577888999998 999999999998654  4


Q ss_pred             ccEEEEeecCCCchhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCC------eEEEEecc
Q 013897          205 TPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR------KLRLIDWG  274 (434)
Q Consensus       205 ~~~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~------~vkl~DFG  274 (434)
                      ..++||||++++++..++.    .+++..+..++.||+.||+|||+++|+||||||+|||++.++.      .++++|||
T Consensus        78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            5679999999998866542    4788899999999999999999999999999999999985542      38999999


Q ss_pred             cceecCCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHH-hCCCCCCCCCCCHHHHHHHHHHhCChhHHH
Q 013897          275 LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI-FRKEPFFYGHDNYDQLVKIAKVLGTDELNA  353 (434)
Q Consensus       275 la~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell-tg~~pf~~~~~~~~~~~~i~~~~g~~~~~~  353 (434)
                      ++.....   .....++..|+|||.+.+...++.++|||||||++|||+ +|..||. .....+. ..+.          
T Consensus       158 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~-~~~~~~~-~~~~----------  222 (262)
T cd05077         158 IPITVLS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLK-DKTLAEK-ERFY----------  222 (262)
T ss_pred             CCccccC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC-CcchhHH-HHHH----------
Confidence            9865432   233567788999999875567899999999999999998 4776662 2211110 0000          


Q ss_pred             HHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          354 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                        ...                         .......++++.+|+.+||+.||++||++.++|++
T Consensus       223 --~~~-------------------------~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         223 --EGQ-------------------------CMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             --hcC-------------------------ccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence              000                         00001134678999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=6.4e-38  Score=296.04  Aligned_cols=243  Identities=19%  Similarity=0.340  Sum_probs=190.2

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCe---EEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNE---KCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT  205 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~---~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  205 (434)
                      .++|+..+.||+|+||.||+|.+..++.   .+|+|.++..    ....+.+|+.+++.+ +|+|++++++++.+.  ..
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~   80 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQF-SHHNIIRLEGVVTKF--KP   80 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEccC--CC
Confidence            3578899999999999999999865554   7999998643    235688999999999 999999999999654  56


Q ss_pred             cEEEEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC
Q 013897          206 PSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP  281 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~  281 (434)
                      .++||||+++++|..++    ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++ .+||+|||++.....
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~-~~kl~dfg~~~~~~~  159 (268)
T cd05063          81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNL-ECKVSDFGLSRVLED  159 (268)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCC-cEEECCCccceeccc
Confidence            78999999999987665    2478889999999999999999999999999999999999766 899999999976643


Q ss_pred             CCcc--ce--eccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHh
Q 013897          282 GKEY--NV--RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN  356 (434)
Q Consensus       282 ~~~~--~~--~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~  356 (434)
                      ....  ..  ...+..|+|||.+.+ ..++.++|||||||++|||++ |+.||... ...+....+...           
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~il~ell~~g~~p~~~~-~~~~~~~~i~~~-----------  226 (268)
T cd05063         160 DPEGTYTTSGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSFGERPYWDM-SNHEVMKAINDG-----------  226 (268)
T ss_pred             ccccceeccCCCcCceecCHHHhhc-CCcChHhHHHHHHHHHHHHHhCCCCCCCcC-CHHHHHHHHhcC-----------
Confidence            2211  11  112346999999876 678999999999999999997 99998432 222222221110           


Q ss_pred             hccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          357 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                       .+        ......++.++.+++.+||+.||++||++.++++
T Consensus       227 -----------------~~--------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         227 -----------------FR--------LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             -----------------CC--------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                             00        0011135678999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=9.9e-39  Score=300.19  Aligned_cols=235  Identities=15%  Similarity=0.264  Sum_probs=181.5

Q ss_pred             eeeeecCceEEEEEEEcCCCe-------EEEEEEecccc---HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          140 RKVGRGKYSEVFEGVHCTDNE-------KCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       140 ~~lG~G~fg~Vy~~~~~~~~~-------~vaiK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      +.||+|+||.||+|.+...+.       .+|+|.+....   .+.+.+|+.+++.+ +|||++++++++...  ...++|
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~~--~~~~lv   77 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQL-SHKHLVLNYGVCVCG--DESIMV   77 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhC-CCCChhheeeEEEeC--CCcEEE
Confidence            369999999999998865443       48888875432   24678899999998 899999999999754  456799


Q ss_pred             EeecCCCchhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCe-------EEEEeccccee
Q 013897          210 FEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRK-------LRLIDWGLAEF  278 (434)
Q Consensus       210 ~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~-------vkl~DFGla~~  278 (434)
                      |||+.+++|..++.    .+++..+..++.||+.||+|||++||+||||||+|||++.++..       ++++|||++..
T Consensus        78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            99999999977653    37888889999999999999999999999999999999866532       79999999865


Q ss_pred             cCCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhc
Q 013897          279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY  358 (434)
Q Consensus       279 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  358 (434)
                      ...   .....++..|+|||++.+...++.++|||||||++|+|++|..+++...+........                
T Consensus       158 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~----------------  218 (258)
T cd05078         158 VLP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY----------------  218 (258)
T ss_pred             cCC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH----------------
Confidence            432   2335678889999998765568999999999999999999965543332222111100                


Q ss_pred             cccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                                  ....          ..+...+.++.+|+.+||+.||++|||++++++.
T Consensus       219 ------------~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         219 ------------EDRH----------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             ------------Hccc----------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence                        0000          0011234679999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7e-38  Score=294.49  Aligned_cols=242  Identities=19%  Similarity=0.347  Sum_probs=192.4

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecc--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF  210 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~--~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  210 (434)
                      .++|.+.+.||+|+||.||+|.+. ++..+|||.+..  ...+.+.+|+.+++.+ +|+||+++++++...  ...++||
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~~v~   80 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKL-RHDKLVQLYAVCSEE--EPIYIVT   80 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhC-CCCCEeeeeeeeecC--CceEEEE
Confidence            478999999999999999999974 567899999874  3356789999999999 899999999998643  5678999


Q ss_pred             eecCCCchhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCcc
Q 013897          211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY  285 (434)
Q Consensus       211 e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~  285 (434)
                      ||+.+++|..++.     .+++..+..++.||+.||.|||+++++|+||||+||+++.++ .+||+|||++.........
T Consensus        81 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~~~~~~  159 (261)
T cd05034          81 EYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENL-VCKIADFGLARLIEDDEYT  159 (261)
T ss_pred             eccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCC-CEEECccccceeccchhhh
Confidence            9999999877652     478889999999999999999999999999999999999776 8999999999766432111


Q ss_pred             --ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          286 --NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       286 --~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                        ....++..|+|||.+.+ ..++.++|||||||++|+|++ |+.|| .+......+..+....                
T Consensus       160 ~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~-~~~~~~~~~~~~~~~~----------------  221 (261)
T cd05034         160 AREGAKFPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPY-PGMTNREVLEQVERGY----------------  221 (261)
T ss_pred             hhhccCCCccccCHHHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcCC----------------
Confidence              11223457999999876 678999999999999999998 88887 3333333332221100                


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                          ........+.++.+++.+||..||++||+++++++
T Consensus       222 --------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         222 --------------------RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             --------------------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                                00111224678999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=4.2e-38  Score=303.18  Aligned_cols=245  Identities=18%  Similarity=0.299  Sum_probs=189.8

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEc-------CCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEcc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHC-------TDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ  201 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~-------~~~~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  201 (434)
                      .++|.+.+.||+|+||.||+|.+.       .++..+|+|.++..    ....+.+|+.+++.+.+||||+++++++.+.
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            478999999999999999999753       23457999998642    2356889999999987899999999999654


Q ss_pred             CCCccEEEEeecCCCchhhhcC-------------------CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEec
Q 013897          202 QSKTPSLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID  262 (434)
Q Consensus       202 ~~~~~~lv~e~~~~~~l~~~~~-------------------~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~  262 (434)
                        ...++||||+.+++|..++.                   .++...+..++.||+.||.|||++||+||||||+|||++
T Consensus        94 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~  171 (304)
T cd05101          94 --GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT  171 (304)
T ss_pred             --CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEc
Confidence              56789999999999876642                   256677889999999999999999999999999999999


Q ss_pred             CCCCeEEEEecccceecCCCCc---cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHH
Q 013897          263 HEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQ  338 (434)
Q Consensus       263 ~~~~~vkl~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~  338 (434)
                      .++ .+||+|||+++.......   .....++..|+|||++.+ ..++.++|||||||++|+|++ |..|| .+....+.
T Consensus       172 ~~~-~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~-~~~~~~~~  248 (304)
T cd05101         172 ENN-VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPY-PGIPVEEL  248 (304)
T ss_pred             CCC-cEEECCCccceecccccccccccCCCCCceeeCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCc-ccCCHHHH
Confidence            666 899999999986643221   122234567999999876 678999999999999999998 67776 33222221


Q ss_pred             HHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          339 LVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       339 ~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                      ...+..    .                        .        .......++.++.+|+.+||..+|++|||+.|+++.
T Consensus       249 ~~~~~~----~------------------------~--------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         249 FKLLKE----G------------------------H--------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HHHHHc----C------------------------C--------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            111100    0                        0        000112356789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.4e-38  Score=305.65  Aligned_cols=251  Identities=26%  Similarity=0.420  Sum_probs=196.5

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      .+.|...+.||+|+||.||+|.+..++..+|+|.+...      ....+.+|+.+++.+ +|+|++++++++.+.  ...
T Consensus        14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~   90 (308)
T cd06634          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLRE--HTA   90 (308)
T ss_pred             HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCcccEEEEEEcC--Cee
Confidence            35577889999999999999999889999999988532      124577899999999 999999999998754  567


Q ss_pred             EEEEeecCCCchhhh---cCCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC
Q 013897          207 SLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~  283 (434)
                      ++||||+.+..+..+   ...+++..+..++.|++.||.|||+++++||||||+||+++.++ .++|+|||++...... 
T Consensus        91 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~-  168 (308)
T cd06634          91 WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG-LVKLGDFGSASIMAPA-  168 (308)
T ss_pred             EEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCC-cEEECCcccceeecCc-
Confidence            899999986433322   23478889999999999999999999999999999999999766 8999999998765432 


Q ss_pred             ccceeccCCcccccccccC--CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcccc
Q 013897          284 EYNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE  361 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~~--~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  361 (434)
                        ....++..|+|||.+.+  ...++.++|||||||++|+|++|+.||..... ......+.+.                
T Consensus       169 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-~~~~~~~~~~----------------  229 (308)
T cd06634         169 --NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-MSALYHIAQN----------------  229 (308)
T ss_pred             --ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH-HHHHHHHhhc----------------
Confidence              34467889999999752  24578899999999999999999999843211 1111111100                


Q ss_pred             CChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccc
Q 013897          362 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN  426 (434)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~  426 (434)
                                   ..+      ......++..+.+||.+||..+|++||++++++.|||+.+...
T Consensus       230 -------------~~~------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~  275 (308)
T cd06634         230 -------------ESP------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP  275 (308)
T ss_pred             -------------CCC------CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccCC
Confidence                         000      0011135678999999999999999999999999999987643

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.4e-38  Score=300.00  Aligned_cols=259  Identities=20%  Similarity=0.365  Sum_probs=195.7

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcC----CCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCc
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCT----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT  205 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~----~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  205 (434)
                      ++|.+.+.||+|+||.||+|.+..    ++..+|+|+++...    ...+.+|+++++.+ .|+||+++++++.+.....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l-~~~~i~~~~~~~~~~~~~~   82 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL-DHENIVKYKGVCEKPGGRS   82 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhC-CCCChheEEeeeecCCCCc
Confidence            567888999999999999998643    47899999997543    35789999999999 9999999999997766677


Q ss_pred             cEEEEeecCCCchhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC
Q 013897          206 PSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP  281 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~  281 (434)
                      .++||||+++++|..++.    .+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++.....
T Consensus        83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~  161 (284)
T cd05038          83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESED-LVKISDFGLAKVLPE  161 (284)
T ss_pred             eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC-CEEEccccccccccc
Confidence            899999999999877763    378889999999999999999999999999999999999776 899999999987653


Q ss_pred             CCcc----ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhh
Q 013897          282 GKEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK  357 (434)
Q Consensus       282 ~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  357 (434)
                      ....    ....++..|++||.+.+ ..++.++|||||||+++||++|+.|+.........      ..+...       
T Consensus       162 ~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~------~~~~~~-------  227 (284)
T cd05038         162 DKDYYYVKEPGESPIFWYAPECLRT-SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR------MIGIAQ-------  227 (284)
T ss_pred             CCcceeccCCCCCcccccCcHHHcc-CCCCcccchHHHhhhhheeeccCCCcccccchhcc------cccccc-------
Confidence            3221    12234556999999876 57899999999999999999999997433221100      000000       


Q ss_pred             ccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                       .....+.+........+        ......++.++.+|+.+||..||++|||+.|+++
T Consensus       228 -~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         228 -GQMIVTRLLELLKEGER--------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             -ccccHHHHHHHHHcCCc--------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence             00000011111111000        1112235678999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=8.1e-38  Score=293.17  Aligned_cols=237  Identities=23%  Similarity=0.402  Sum_probs=190.7

Q ss_pred             eeeeecCceEEEEEEEcCC---CeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEee
Q 013897          140 RKVGRGKYSEVFEGVHCTD---NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH  212 (434)
Q Consensus       140 ~~lG~G~fg~Vy~~~~~~~---~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  212 (434)
                      +.||+|+||.||+|.+...   +..+++|.++...    .+.+.+|+.+++.+ +|+|++++++++.+  ....++||||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~lv~e~   77 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKL-GHPNVVRLLGVCTE--EEPLYLVLEY   77 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhc-CCCChheeeeeecC--CCceEEEEEe
Confidence            4699999999999998765   8899999997543    46788999999999 79999999999865  4677899999


Q ss_pred             cCCCchhhhc------------CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecC
Q 013897          213 VNNTDFKVLY------------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH  280 (434)
Q Consensus       213 ~~~~~l~~~~------------~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~  280 (434)
                      +.+++|..++            ..+++..+..++.|++.||+|||+++|+|+||||+||+++.++ .+||+|||.+....
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~-~~~l~dfg~~~~~~  156 (262)
T cd00192          78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDL-VVKISDFGLSRDVY  156 (262)
T ss_pred             ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCC-cEEEcccccccccc
Confidence            9999987664            3478899999999999999999999999999999999999776 89999999998765


Q ss_pred             CCC---ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHh
Q 013897          281 PGK---EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN  356 (434)
Q Consensus       281 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~  356 (434)
                      ...   ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.. ....+....+..  +         
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~--~---------  223 (262)
T cd00192         157 DDDYYRKKTGGKLPIRWMAPESLKD-GIFTSKSDVWSFGVLLWEIFTLGATPYPG-LSNEEVLEYLRK--G---------  223 (262)
T ss_pred             cccccccccCCCcCccccCHHHhcc-CCcchhhccHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHc--C---------
Confidence            432   1233456778999999876 578999999999999999999 5888733 222222221110  0         


Q ss_pred             hccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          357 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                                               ........+++++.+++.+||..||++|||+.|+++|
T Consensus       224 -------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         224 -------------------------YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             -------------------------CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence                                     0011122357889999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=5e-38  Score=296.83  Aligned_cols=242  Identities=18%  Similarity=0.317  Sum_probs=189.6

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCC---eEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDN---EKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~---~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      ++|++.+.||+|+||.||+|.+..++   ..+|+|.++...    .+.+.+|+.+++.+ +||||+++++++.+.  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~   80 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTKS--KPV   80 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEecC--Ccc
Confidence            57889999999999999999876443   479999986432    35688999999999 999999999998644  567


Q ss_pred             EEEEeecCCCchhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC
Q 013897          207 SLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG  282 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~  282 (434)
                      ++||||+++++|..++.    .+++.++..++.|++.||.|||+++++||||||+|||++.++ .++|+|||++......
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~-~~~l~dfg~~~~~~~~  159 (267)
T cd05066          81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNL-VCKVSDFGLSRVLEDD  159 (267)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCC-eEEeCCCCcccccccc
Confidence            89999999999877753    478888999999999999999999999999999999999766 8999999999866433


Q ss_pred             Cccc----eeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhh
Q 013897          283 KEYN----VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK  357 (434)
Q Consensus       283 ~~~~----~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  357 (434)
                      ....    ...++..|+|||.+.+ ..++.++|+|||||++||+++ |..||... ...+....+.+.            
T Consensus       160 ~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~ell~~g~~p~~~~-~~~~~~~~~~~~------------  225 (267)
T cd05066         160 PEAAYTTRGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWEM-SNQDVIKAIEEG------------  225 (267)
T ss_pred             cceeeecCCCccceeecCHhHhcc-CccCchhhhHHHHHHHHHHhcCCCCCcccC-CHHHHHHHHhCC------------
Confidence            2211    1122456999999876 678999999999999999886 99998432 222222211100            


Q ss_pred             ccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                      .+        ......+++.+.+++.+||+.+|++||++.++++
T Consensus       226 ----------------~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         226 ----------------YR--------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             ----------------Cc--------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence                            00        0011235678999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.5e-38  Score=293.97  Aligned_cols=239  Identities=19%  Similarity=0.343  Sum_probs=190.9

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc--HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF  210 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  210 (434)
                      .++|++.+.||.|+||.||+|..  .++.||+|.++...  .+++.+|+.+++.+ +|+||+++++++.+  ....++||
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~~v~   79 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTL-RHPNLVQLLGVVLQ--GNPLYIVT   79 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhc-CCcceeeeEEEEcC--CCCeEEEE
Confidence            36788999999999999999986  47889999997543  46788999999999 89999999999865  45678999


Q ss_pred             eecCCCchhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCcc
Q 013897          211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY  285 (434)
Q Consensus       211 e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~  285 (434)
                      ||+++++|..++.     .+++..+..++.|++.||.|||+++++|+||||+||+++.++ .+||+|||+++......  
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~-~~~l~d~g~~~~~~~~~--  156 (256)
T cd05039          80 EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDL-VAKVSDFGLAKEASQGQ--  156 (256)
T ss_pred             EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCC-CEEEccccccccccccc--
Confidence            9999999877652     478899999999999999999999999999999999999766 89999999997663222  


Q ss_pred             ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCCh
Q 013897          286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP  364 (434)
Q Consensus       286 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  364 (434)
                      .....+..|+|||.+.+ ..++.++|||||||++++|++ |..||... . ...+.....   .                
T Consensus       157 ~~~~~~~~~~ape~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~-~-~~~~~~~~~---~----------------  214 (256)
T cd05039         157 DSGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRI-P-LKDVVPHVE---K----------------  214 (256)
T ss_pred             ccCCCcccccCchhhcC-CcCCcHHHHHHHHHHHHHHHhcCCCCCCCC-C-HHHHHHHHh---c----------------
Confidence            22334567999999876 678899999999999999997 88887322 2 111111100   0                


Q ss_pred             hHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                             . .        .......+++++.++|.+||..+|++||+++|+++
T Consensus       215 -------~-~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         215 -------G-Y--------RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             -------C-C--------CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence                   0 0        00011235688999999999999999999999985

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=8.7e-38  Score=294.01  Aligned_cols=241  Identities=16%  Similarity=0.310  Sum_probs=189.3

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc--HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF  210 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  210 (434)
                      .++|.+.++||+|+||.||++.+ ..+..+|+|.+....  .+.+.+|+.+++.+ +|+||+++++++.+   ...+++|
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~-~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~---~~~~~v~   79 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATY-NKHTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHDKLVKLHAVVTK---EPIYIIT   79 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEe-cCCccEEEEecCCChhHHHHHHHHHHHHHhc-CCCCcceEEEEEcC---CCeEEEE
Confidence            47899999999999999999986 456779999886543  35688999999999 89999999999854   4568999


Q ss_pred             eecCCCchhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCcc
Q 013897          211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY  285 (434)
Q Consensus       211 e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~  285 (434)
                      ||+.+++|..++.     .+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .+||+|||++.........
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~~  158 (260)
T cd05073          80 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL-VCKIADFGLARVIEDNEYT  158 (260)
T ss_pred             EeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC-cEEECCCcceeeccCCCcc
Confidence            9999999877653     367778889999999999999999999999999999999766 8999999999765432211


Q ss_pred             --ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          286 --NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       286 --~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                        ....++..|+|||++.. ..++.++|+|||||++|+|++ |+.||. +.+.......+....                
T Consensus       159 ~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~-~~~~~~~~~~~~~~~----------------  220 (260)
T cd05073         159 AREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYP-GMSNPEVIRALERGY----------------  220 (260)
T ss_pred             cccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCC-CCCHHHHHHHHhCCC----------------
Confidence              12234566999999876 678999999999999999999 888873 322222221111000                


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                          ........+.++.+++.+||+.||++||++.++++
T Consensus       221 --------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         221 --------------------RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             --------------------CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence                                00111235678999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.7e-38  Score=293.08  Aligned_cols=235  Identities=19%  Similarity=0.335  Sum_probs=184.0

Q ss_pred             eeeeecCceEEEEEEEcCCC---eEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEee
Q 013897          140 RKVGRGKYSEVFEGVHCTDN---EKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH  212 (434)
Q Consensus       140 ~~lG~G~fg~Vy~~~~~~~~---~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  212 (434)
                      ++||+|+||.||+|.+...+   ..+|+|.+....    .+.+.+|+.+++.+ .|+||+++++++..   ...++||||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~---~~~~~v~e~   76 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL-DHPCIVRLIGVCKG---EPLMLVMEL   76 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEcC---CceEEEEEe
Confidence            46999999999999876554   789999987433    35688999999998 99999999998753   356899999


Q ss_pred             cCCCchhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCccc-e-
Q 013897          213 VNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN-V-  287 (434)
Q Consensus       213 ~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~~-~-  287 (434)
                      +.+++|..++.   .+++..+..++.|++.||+|||+.+++|+||||+|||++.++ .+||+|||+++......... . 
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~-~~kl~df~~~~~~~~~~~~~~~~  155 (257)
T cd05060          77 APLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRH-QAKISDFGMSRALGAGSDYYRAT  155 (257)
T ss_pred             CCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCC-cEEeccccccceeecCCcccccc
Confidence            99999877663   488999999999999999999999999999999999999776 89999999998664333211 1 


Q ss_pred             --eccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCCh
Q 013897          288 --RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP  364 (434)
Q Consensus       288 --~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  364 (434)
                        ..++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.. .+..+....+.. .                  
T Consensus       156 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~~g~~p~~~-~~~~~~~~~~~~-~------------------  214 (257)
T cd05060         156 TAGRWPLKWYAPECINY-GKFSSKSDVWSYGVTLWEAFSYGAKPYGE-MKGAEVIAMLES-G------------------  214 (257)
T ss_pred             cCccccccccCHHHhcC-CCCCccchHHHHHHHHHHHHcCCCCCccc-CCHHHHHHHHHc-C------------------
Confidence              112356999999876 679999999999999999998 8888732 222211111110 0                  


Q ss_pred             hHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                               .        .......+++.+.+++.+||..||++||++.++++
T Consensus       215 ---------~--------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         215 ---------E--------RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             ---------C--------cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                     0        01112235678999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=3.7e-38  Score=296.68  Aligned_cols=239  Identities=24%  Similarity=0.439  Sum_probs=182.1

Q ss_pred             EEEeeeeecCceEEEEEEEc----CCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          137 EVVRKVGRGKYSEVFEGVHC----TDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       137 ~~~~~lG~G~fg~Vy~~~~~----~~~~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      ++.+.||.|.||.||+|.+.    ..+..|+||.++..    ..+.+.+|++.++++ +||||++++|++...  ...++
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~g~~~~~--~~~~l   78 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKL-RHPNIVKLYGFCIEN--EPLFL   78 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTH-SBTTBE-EEEEEESS--SSEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccc-ccccccccccccccc--ccccc
Confidence            46789999999999999987    34678999999643    246789999999999 999999999999743  44789


Q ss_pred             EEeecCCCchhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC
Q 013897          209 IFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       209 v~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~  283 (434)
                      |+||+.+++|..++     ..+++..+..++.||+.||.|||+++++|+||+++|||++.++ .+||+|||++.......
T Consensus        79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~-~~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNG-QVKLSDFGLSRPISEKS  157 (259)
T ss_dssp             EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTT-EEEEESTTTGEETTTSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccc
Confidence            99999999987654     3588899999999999999999999999999999999999776 99999999998763222


Q ss_pred             cc---ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcc
Q 013897          284 EY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH  359 (434)
Q Consensus       284 ~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  359 (434)
                      ..   ........|+|||.+.+ ..++.++||||||+++|||++ |+.|| ...+..+....+.+   .           
T Consensus       158 ~~~~~~~~~~~~~~~aPE~~~~-~~~~~ksDVysfG~~l~ei~~~~~~p~-~~~~~~~~~~~~~~---~-----------  221 (259)
T PF07714_consen  158 KYKNDSSQQLPLRYLAPEVLKD-GEYTKKSDVYSFGMLLYEILTLGKFPF-SDYDNEEIIEKLKQ---G-----------  221 (259)
T ss_dssp             SEEESTTSESGGGGS-HHHHHH-SEESHHHHHHHHHHHHHHHHTTSSGTT-TTSCHHHHHHHHHT---T-----------
T ss_pred             cccccccccccccccccccccc-ccccccccccccccccccccccccccc-cccccccccccccc---c-----------
Confidence            21   22345567999999876 568999999999999999999 67776 33333222222210   0           


Q ss_pred             ccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          360 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                            ........++..+.++|.+||..||++||++.++++
T Consensus       222 ----------------------~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  222 ----------------------QRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             ----------------------EETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             ----------------------ccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                                  001122246788999999999999999999999974

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=6.3e-38  Score=298.10  Aligned_cols=244  Identities=19%  Similarity=0.357  Sum_probs=191.5

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcC----CCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCT----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK  204 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~----~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  204 (434)
                      .++|.+.+.||+|+||.||+|.+..    ++..|++|.++...    ...+.+|+.+++.+ +|+||+++++++.+. ..
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~-~~   82 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL-SHQNILPILHVCIED-GE   82 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecC-CC
Confidence            4789999999999999999999865    26889999886432    35578899999999 999999999988654 35


Q ss_pred             ccEEEEeecCCCchhhhc-----------CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEec
Q 013897          205 TPSLIFEHVNNTDFKVLY-----------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDW  273 (434)
Q Consensus       205 ~~~lv~e~~~~~~l~~~~-----------~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DF  273 (434)
                      ..++++||+.+++|..++           ..+++..+..++.||+.||+|||+++++|+||||+||+++.++ .+||+||
T Consensus        83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~-~~kl~d~  161 (280)
T cd05043          83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEEL-QVKITDN  161 (280)
T ss_pred             CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCC-cEEECCC
Confidence            668999999999887664           2377888999999999999999999999999999999999666 8999999


Q ss_pred             ccceecCCCCcc---ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCh
Q 013897          274 GLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTD  349 (434)
Q Consensus       274 Gla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~  349 (434)
                      |+++.+.+....   ....++..|+|||.+.+ ..++.++|||||||++||+++ |+.||.. .+..+ +.....  .  
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~-~~~~~-~~~~~~--~--  234 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQTPYVE-IDPFE-MAAYLK--D--  234 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhc-CCCCchhhHHHhHHHHHHHhcCCCCCcCc-CCHHH-HHHHHH--c--
Confidence            999865433211   12234567999999876 678999999999999999998 9988832 22211 111000  0  


Q ss_pred             hHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          350 ELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                             ..        .......+++++.+++.+||..||++|||+.++++
T Consensus       235 -----------------------~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         235 -----------------------GY--------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             -----------------------CC--------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                                   00        00111235678999999999999999999999984

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=7e-38  Score=299.11  Aligned_cols=243  Identities=19%  Similarity=0.320  Sum_probs=189.2

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcC-----CCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS  203 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~-----~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  203 (434)
                      .++|++.+.||+|+||.||+|.+..     ++..+|+|++....    ...+.+|+.+++.+ +||||+++++++.+.  
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l-~h~~iv~~~~~~~~~--   80 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DHPNIVKLLGVCAVG--   80 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhc-CCCchheEEEEEcCC--
Confidence            4789999999999999999998743     57899999986432    35688999999999 999999999998654  


Q ss_pred             CccEEEEeecCCCchhhhcC-------------------------CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCc
Q 013897          204 KTPSLIFEHVNNTDFKVLYP-------------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHN  258 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~~-------------------------~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~N  258 (434)
                      ...++|+||+.+++|..++.                         .+++..+..++.||+.||+|||+++++||||||+|
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n  160 (288)
T cd05050          81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN  160 (288)
T ss_pred             CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence            46789999999998876652                         25677888999999999999999999999999999


Q ss_pred             eEecCCCCeEEEEecccceecCCCCcc---ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCC
Q 013897          259 VMIDHEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHD  334 (434)
Q Consensus       259 Ill~~~~~~vkl~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~  334 (434)
                      |+++.++ .++|+|||++.........   .....+..|+|||.+.+ ..++.++|||||||++|||++ |..||+.. .
T Consensus       161 il~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~~~~p~~~~-~  237 (288)
T cd05050         161 CLVGENM-VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGMQPYYGM-A  237 (288)
T ss_pred             eEecCCC-ceEECccccceecccCccccccCCCccChhhcCHHHHhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC-C
Confidence            9999776 8999999998755322211   12233556999999876 679999999999999999997 77787422 2


Q ss_pred             CHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHH
Q 013897          335 NYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKE  414 (434)
Q Consensus       335 ~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~e  414 (434)
                      ..+....+..    .                        ..        ......++.++.+|+.+||+.||++|||+.|
T Consensus       238 ~~~~~~~~~~----~------------------------~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~e  281 (288)
T cd05050         238 HEEVIYYVRD----G------------------------NV--------LSCPDNCPLELYNLMRLCWSKLPSDRPSFAS  281 (288)
T ss_pred             HHHHHHHHhc----C------------------------CC--------CCCCCCCCHHHHHHHHHHcccCcccCCCHHH
Confidence            1111111100    0                        00        0011235678999999999999999999999


Q ss_pred             Hhc
Q 013897          415 AMA  417 (434)
Q Consensus       415 lL~  417 (434)
                      +++
T Consensus       282 l~~  284 (288)
T cd05050         282 INR  284 (288)
T ss_pred             HHH
Confidence            874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-40  Score=314.06  Aligned_cols=255  Identities=25%  Similarity=0.420  Sum_probs=218.1

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      ..+++.+..||-|+||.|=++..+.....+|+|++++..      .+.+..|-.||..+ +.|.||++|..|.+  ..++
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~-~s~fIvrLYrTfrd--~kyv  495 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMEC-RSDFIVRLYRTFRD--SKYV  495 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhc-CchHHHHHHHHhcc--chhh
Confidence            356778889999999999999886666669999987532      35577899999998 79999999999965  4788


Q ss_pred             EEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC
Q 013897          207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~  283 (434)
                      |++||-|-||.+...+   +.|.+..++.++..+++|++|||.+|||+|||||+|++++.+| -+||.|||+|+.+..+.
T Consensus       496 YmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~G-y~KLVDFGFAKki~~g~  574 (732)
T KOG0614|consen  496 YMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRG-YLKLVDFGFAKKIGSGR  574 (732)
T ss_pred             hhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCC-ceEEeehhhHHHhccCC
Confidence            9999999999987776   3588999999999999999999999999999999999999888 69999999999998888


Q ss_pred             ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                      ..-+.|||+.|.|||++.+ ++.+.++|.||||+++|||++|.+|| .+.+.......|.+.+..               
T Consensus       575 KTwTFcGTpEYVAPEIILn-KGHD~avDyWaLGIli~ELL~G~pPF-s~~dpmktYn~ILkGid~---------------  637 (732)
T KOG0614|consen  575 KTWTFCGTPEYVAPEIILN-KGHDRAVDYWALGILIYELLTGSPPF-SGVDPMKTYNLILKGIDK---------------  637 (732)
T ss_pred             ceeeecCCcccccchhhhc-cCcchhhHHHHHHHHHHHHHcCCCCC-CCCchHHHHHHHHhhhhh---------------
Confidence            8889999999999999998 88999999999999999999999998 566655555555442211               


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCcc-----HHHHhcCCCcccccccc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT-----AKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt-----~~elL~Hp~~~~~~~~~  428 (434)
                                          +..+..++..+.+||+++.+.+|.+|..     +.++-.|.||.+.++.-
T Consensus       638 --------------------i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweg  687 (732)
T KOG0614|consen  638 --------------------IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEG  687 (732)
T ss_pred             --------------------hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhh
Confidence                                2223346678999999999999999987     89999999999887643

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=5.7e-38  Score=296.65  Aligned_cols=242  Identities=17%  Similarity=0.317  Sum_probs=189.3

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCe---EEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNE---KCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~---~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      .+|++.+.||+|+||.||+|.+..++.   .||||.++..    ....+..|+.+++.+ +||||+++++++.+  ....
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~--~~~~   80 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTK--SRPV   80 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCcCcceEEEEECC--CCce
Confidence            468899999999999999999876654   6999998643    235688999999998 99999999999854  4567


Q ss_pred             EEEEeecCCCchhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC
Q 013897          207 SLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG  282 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~  282 (434)
                      ++||||+.+++|..++.    .+++.+++.++.|++.||.|||++|++|+||||+||+++.++ .+||+|||++......
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~-~~kl~dfg~~~~~~~~  159 (269)
T cd05065          81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDD  159 (269)
T ss_pred             EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCC-cEEECCCccccccccC
Confidence            89999999999876653    478889999999999999999999999999999999999666 8999999998765432


Q ss_pred             Ccc---ceecc---CCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHH
Q 013897          283 KEY---NVRVA---SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYL  355 (434)
Q Consensus       283 ~~~---~~~~~---t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~  355 (434)
                      ...   ....+   +..|+|||.+.+ ..++.++|||||||++|||++ |..||... ...+....+...          
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~~~-~~~~~~~~i~~~----------  227 (269)
T cd05065         160 TSDPTYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDM-SNQDVINAIEQD----------  227 (269)
T ss_pred             ccccccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCCCC-CHHHHHHHHHcC----------
Confidence            211   11111   346999999876 678999999999999999886 99898432 222211111100          


Q ss_pred             hhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          356 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                                ........++..+.+++.+||..+|++||++.+++.
T Consensus       228 --------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         228 --------------------------YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             --------------------------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                      000111235678999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=2.5e-39  Score=336.50  Aligned_cols=252  Identities=26%  Similarity=0.435  Sum_probs=191.9

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEcc--------
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ--------  201 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--------  201 (434)
                      .+|+.++.||+||||.||+++.+-+|+.||||.+.-.    ....+.+|+.+|.+| +|||||+++..+.+.        
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArL-nHpNVVRYysAWVEs~~~~~~~e  557 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARL-NHPNVVRYYSAWVESTAELTVLE  557 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhc-CCcceeeeehhhhccCCcccccc
Confidence            6788899999999999999999999999999998643    235688999999999 999999997522110        


Q ss_pred             --------------------------------------------------------------------------------
Q 013897          202 --------------------------------------------------------------------------------  201 (434)
Q Consensus       202 --------------------------------------------------------------------------------  201 (434)
                                                                                                      
T Consensus       558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e  637 (1351)
T KOG1035|consen  558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE  637 (1351)
T ss_pred             ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence                                                                                            


Q ss_pred             ---------------------CC--------CccEEEEeecCCCchhhhcCC--C--ChHHHHHHHHHHHHHHHHHHHCC
Q 013897          202 ---------------------QS--------KTPSLIFEHVNNTDFKVLYPT--L--SDYDVRYYIYELLKALDYCHSQG  248 (434)
Q Consensus       202 ---------------------~~--------~~~~lv~e~~~~~~l~~~~~~--l--~~~~~~~~~~qi~~~L~~LH~~~  248 (434)
                                           ..        ..+||-||||+..++.+++..  +  .....+.++++|++||.|+|++|
T Consensus       638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g  717 (1351)
T KOG1035|consen  638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG  717 (1351)
T ss_pred             CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence                                 00        346778888888888777643  3  25678899999999999999999


Q ss_pred             ceeecCCCCceEecCCCCeEEEEecccceecC-------------------CCCccceeccCCcccccccccCCC--CCC
Q 013897          249 IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-------------------PGKEYNVRVASRYFKGPELLVDLQ--DYD  307 (434)
Q Consensus       249 ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~-------------------~~~~~~~~~~t~~y~aPE~~~~~~--~~~  307 (434)
                      ||||||||.||+++.++ .|||+|||+|+...                   .....+..+||..|+|||++.+..  .|+
T Consensus       718 iIHRDLKP~NIFLd~~~-~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn  796 (1351)
T KOG1035|consen  718 IIHRDLKPRNIFLDSRN-SVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN  796 (1351)
T ss_pred             eeeccCCcceeEEcCCC-CeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccccc
Confidence            99999999999999776 89999999997621                   112346678999999999998765  699


Q ss_pred             ccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccc
Q 013897          308 YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQ  387 (434)
Q Consensus       308 ~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  387 (434)
                      .|+|+|||||||+||+   .||.   ...+....+.. +....         .+.++                    +..
T Consensus       797 ~KiDmYSLGIVlFEM~---yPF~---TsMERa~iL~~-LR~g~---------iP~~~--------------------~f~  840 (1351)
T KOG1035|consen  797 SKIDMYSLGIVLFEML---YPFG---TSMERASILTN-LRKGS---------IPEPA--------------------DFF  840 (1351)
T ss_pred             chhhhHHHHHHHHHHh---ccCC---chHHHHHHHHh-cccCC---------CCCCc--------------------ccc
Confidence            9999999999999998   4662   22222222211 11110         00000                    000


Q ss_pred             cCCchHHHHHHHHccccCCCCCccHHHHhcCCCccc
Q 013897          388 HLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP  423 (434)
Q Consensus       388 ~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~  423 (434)
                      ..--+.-..+|+.||+.||.+||||.|+|++.||-.
T Consensus       841 ~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llpp  876 (1351)
T KOG1035|consen  841 DPEHPEEASLIRWLLSHDPSKRPTATELLNSELLPP  876 (1351)
T ss_pred             cccchHHHHHHHHHhcCCCccCCCHHHHhhccCCCc
Confidence            011245678999999999999999999999999985

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=4.3e-38  Score=307.29  Aligned_cols=244  Identities=19%  Similarity=0.311  Sum_probs=188.8

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCC-------CeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccC
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTD-------NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ  202 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~-------~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  202 (434)
                      .+|++.+.||+|+||.||+|.+...       +..+|+|.++...    ...+.+|+.+++++.+||||+++++++.+. 
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-   90 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD-   90 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC-
Confidence            5689999999999999999986432       2478999886432    356889999999997899999999999654 


Q ss_pred             CCccEEEEeecCCCchhhhcC-------------------CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecC
Q 013897          203 SKTPSLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH  263 (434)
Q Consensus       203 ~~~~~lv~e~~~~~~l~~~~~-------------------~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~  263 (434)
                       ..+++++||+++++|..++.                   .+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus        91 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~  169 (334)
T cd05100          91 -GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTE  169 (334)
T ss_pred             -CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcC
Confidence             56789999999999876642                   2566778889999999999999999999999999999997


Q ss_pred             CCCeEEEEecccceecCCCCcc---ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHH
Q 013897          264 EQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQL  339 (434)
Q Consensus       264 ~~~~vkl~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~  339 (434)
                      ++ .+||+|||+++........   ....++..|+|||++.+ ..++.++|||||||++|||++ |..|| .+.+..+..
T Consensus       170 ~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~-~~~~~~~~~  246 (334)
T cd05100         170 DN-VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPY-PGIPVEELF  246 (334)
T ss_pred             CC-cEEECCcccceecccccccccccCCCcCceEcCHHHhcc-CCcCchhhhHHHHHHHHHHHhcCCCCC-CCCCHHHHH
Confidence            76 8999999999765432211   12233456999999876 678999999999999999998 77777 332222211


Q ss_pred             HHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          340 VKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       340 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                      ..+..                           ..         .......++.++.+|+.+||..+|++||++.|++++
T Consensus       247 ~~~~~---------------------------~~---------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         247 KLLKE---------------------------GH---------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             HHHHc---------------------------CC---------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            11100                           00         001112356789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-39  Score=306.27  Aligned_cols=256  Identities=24%  Similarity=0.452  Sum_probs=206.5

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc----------HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS  203 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  203 (434)
                      ++|-++++||+|||++||+|.+....+.||+|+-...+          .+..-+|..|.+.| +||.||++|++|.-+. 
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeL-DHpRIVKlYDyfslDt-  540 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKEL-DHPRIVKLYDYFSLDT-  540 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhcc-Ccceeeeeeeeeeecc-
Confidence            67889999999999999999998889999999864221          13456899999999 9999999999998543 


Q ss_pred             CccEEEEeecCCCchhhhcC---CCChHHHHHHHHHHHHHHHHHHHC--CceeecCCCCceEecCCC--CeEEEEecccc
Q 013897          204 KTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQ--GIMHRDVKPHNVMIDHEQ--RKLRLIDWGLA  276 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~--~ivHrDlKp~NIll~~~~--~~vkl~DFGla  276 (434)
                      ...|-|+|||+|.+|..+++   .+++.+++.|+.||+.||.||.+.  .|||-||||.|||+..+.  +.+||+|||++
T Consensus       541 dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS  620 (775)
T KOG1151|consen  541 DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS  620 (775)
T ss_pred             ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence            45689999999999987764   489999999999999999999987  599999999999996432  37999999999


Q ss_pred             eecCCCCcc--------ceeccCCcccccccccC---CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHH
Q 013897          277 EFYHPGKEY--------NVRVASRYFKGPELLVD---LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV  345 (434)
Q Consensus       277 ~~~~~~~~~--------~~~~~t~~y~aPE~~~~---~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~  345 (434)
                      +.+.++...        ....||.+|++||.+.-   ...++.|+||||+|||+|..+.|+.||.......+.+..-.. 
T Consensus       621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTI-  699 (775)
T KOG1151|consen  621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTI-  699 (775)
T ss_pred             hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhch-
Confidence            988644321        23468999999999853   346889999999999999999999999655554444443110 


Q ss_pred             hCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccc
Q 013897          346 LGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP  423 (434)
Q Consensus       346 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~  423 (434)
                               +...                      ...++..+.++.++.+||++||++.-++|..+.++..||||..
T Consensus       700 ---------lkAt----------------------EVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP  746 (775)
T KOG1151|consen  700 ---------LKAT----------------------EVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP  746 (775)
T ss_pred             ---------hcce----------------------eccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence                     0000                      0112233457889999999999999999999999999999985

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-38  Score=292.12  Aligned_cols=237  Identities=29%  Similarity=0.494  Sum_probs=192.6

Q ss_pred             eeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeecCC
Q 013897          142 VGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN  215 (434)
Q Consensus       142 lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~  215 (434)
                      ||+|+||.||++.+..+++.+|+|+++..      ....+..|+.+++.+ +|+||+++++.+.+  ....++||||+.+
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~~v~e~~~~   77 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-NHPFIVKLHYAFQT--EEKLYLVLEYAPG   77 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHc-CCCcHHHHHHHeec--CCeeEEEEecCCC
Confidence            69999999999999888999999998643      234688999999999 89999999998854  4677899999999


Q ss_pred             CchhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC-CccceeccC
Q 013897          216 TDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYNVRVAS  291 (434)
Q Consensus       216 ~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~-~~~~~~~~t  291 (434)
                      ++|..++.   .+++..+..++.|++.||.|||+.+++|+||||+||+++.++ .++|+|||++...... .......++
T Consensus        78 ~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~  156 (250)
T cd05123          78 GELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADG-HIKLTDFGLAKELSSEGSRTNTFCGT  156 (250)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCC-cEEEeecCcceecccCCCcccCCcCC
Confidence            98876653   478899999999999999999999999999999999999776 8999999999765433 223445678


Q ss_pred             CcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHhc
Q 013897          292 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVG  371 (434)
Q Consensus       292 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~  371 (434)
                      ..|++||.+.+ ..++.++|+||||+++|+|++|+.||... +.......+.+  +                        
T Consensus       157 ~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~-~~~~~~~~~~~--~------------------------  208 (250)
T cd05123         157 PEYLAPEVLLG-KGYGKAVDWWSLGVLLYEMLTGKPPFYAE-DRKEIYEKILK--D------------------------  208 (250)
T ss_pred             ccccChHHhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHhc--C------------------------
Confidence            88999999876 56888999999999999999999998432 22111111110  0                        


Q ss_pred             ccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccH---HHHhcCCCc
Q 013897          372 RHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA---KEAMAHPYF  421 (434)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~---~elL~Hp~~  421 (434)
                                 ........++.+.+|+.+||..||++||++   +++++||||
T Consensus       209 -----------~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         209 -----------PLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             -----------CCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence                       001112246789999999999999999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=8.7e-38  Score=295.56  Aligned_cols=243  Identities=23%  Similarity=0.432  Sum_probs=190.4

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCC---CeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTD---NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT  205 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~---~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  205 (434)
                      .++|.+.+.||+|+||.||+|.+...   ...+|+|......    .+.+.+|+.+++.+ +||||+++++++.+   ..
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~---~~   80 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQF-DHPHIVKLIGVITE---NP   80 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhC-CCCchhceeEEEcC---CC
Confidence            36788999999999999999987543   3578999886432    35688999999999 89999999999864   34


Q ss_pred             cEEEEeecCCCchhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC
Q 013897          206 PSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP  281 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~  281 (434)
                      .++||||+.+++|..++.    .+++..+..++.|++.||+|||+.+++|+||||+||+++.++ .+||+|||+++....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~-~~~l~d~g~~~~~~~  159 (270)
T cd05056          81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPD-CVKLGDFGLSRYLED  159 (270)
T ss_pred             cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCC-CeEEccCceeeeccc
Confidence            579999999999977753    378889999999999999999999999999999999999766 899999999986654


Q ss_pred             CCccc--eeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhc
Q 013897          282 GKEYN--VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY  358 (434)
Q Consensus       282 ~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  358 (434)
                      .....  ...++..|+|||.+.. ..++.++|||||||++|||++ |..||. +....+....+..  +           
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~-~~~~~~~~~~~~~--~-----------  224 (270)
T cd05056         160 ESYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQ-GVKNNDVIGRIEN--G-----------  224 (270)
T ss_pred             ccceecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCC-CCCHHHHHHHHHc--C-----------
Confidence            32221  1223457999999865 678999999999999999986 999983 3222222222110  0           


Q ss_pred             cccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                                     .        .......++.++.+++.+||..+|++|||+.+++..
T Consensus       225 ---------------~--------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         225 ---------------E--------RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             ---------------C--------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                           0        001122367789999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-38  Score=331.55  Aligned_cols=243  Identities=21%  Similarity=0.421  Sum_probs=198.6

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCe-----EEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNE-----KCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS  203 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~-----~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  203 (434)
                      .+..++.+.||+|.||.||.|.......     .||||.++..    ...+|.+|..+|.++ +|||||+++|++-+  .
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f-~HpNiv~liGv~l~--~  767 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKF-DHPNIVSLIGVCLD--S  767 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcC-CCcceeeEEEeecC--C
Confidence            4667889999999999999998764433     4999998754    456799999999999 99999999999976  4


Q ss_pred             CccEEEEeecCCCchhhhcC----------CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEec
Q 013897          204 KTPSLIFEHVNNTDFKVLYP----------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDW  273 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~~----------~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DF  273 (434)
                      ...+|++|||.+|+|..+++          .+...+...++.||++|+.||+++++|||||-.+|+||+... .|||+||
T Consensus       768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r-~VKIaDF  846 (1025)
T KOG1095|consen  768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERR-VVKIADF  846 (1025)
T ss_pred             CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccC-cEEEccc
Confidence            56679999999999988763          377889999999999999999999999999999999999775 8999999


Q ss_pred             ccceecCCCCcccee---ccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCh
Q 013897          274 GLAEFYHPGKEYNVR---VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTD  349 (434)
Q Consensus       274 Gla~~~~~~~~~~~~---~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~  349 (434)
                      |+|+.+.....+...   .-...|||||.+.. ..++.|+|||||||+|||++| |..|| .+.++.+.+....+.    
T Consensus       847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY-~~~~n~~v~~~~~~g----  920 (1025)
T KOG1095|consen  847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPY-PSRSNFEVLLDVLEG----  920 (1025)
T ss_pred             chhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCC-CCcchHHHHHHHHhC----
Confidence            999855443333221   22346999999987 789999999999999999999 55554 666665554432110    


Q ss_pred             hHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          350 ELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                              .        .++.+..|+..+.++|..||+.+|++||+...+++
T Consensus       921 ------------------------g--------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  921 ------------------------G--------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             ------------------------C--------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence                                    0        13345568999999999999999999999999986

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=4.4e-38  Score=292.17  Aligned_cols=226  Identities=21%  Similarity=0.311  Sum_probs=180.0

Q ss_pred             cCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeecCCCchhhhc--
Q 013897          145 GKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY--  222 (434)
Q Consensus       145 G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~--  222 (434)
                      |.||.||++.+..+++.||+|.++...  ...+|...+... .||||+++++++.+.  ...++||||+.+++|...+  
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--~~~~~~~~~~~~-~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS--EYSRERLTIIPH-CVPNMVCLHKYIVSE--DSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh--hhhhHHHHHHhc-CCCceeehhhheecC--CeEEEEEecCCCCCHHHHHHH
Confidence            889999999999999999999986543  344555555555 799999999998653  5678999999999986654  


Q ss_pred             -CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCccceeccCCccccccccc
Q 013897          223 -PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV  301 (434)
Q Consensus       223 -~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~  301 (434)
                       ..+++..+..++.|++.||+|||++||+||||||+||+++.++ .++|+|||.+......  .....++..|+|||.+.
T Consensus        79 ~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~~~  155 (237)
T cd05576          79 FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRG-HIQLTYFSRWSEVEDS--CDGEAVENMYCAPEVGG  155 (237)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCC-CEEEecccchhccccc--cccCCcCccccCCcccC
Confidence             3588999999999999999999999999999999999999776 7999999988655332  22344567799999876


Q ss_pred             CCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccc
Q 013897          302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKF  381 (434)
Q Consensus       302 ~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  381 (434)
                      + ..++.++||||+||++|||++|+.|+......                  ...                        .
T Consensus       156 ~-~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------------------~~~------------------------~  192 (237)
T cd05576         156 I-SEETEACDWWSLGAILFELLTGKTLVECHPSG------------------INT------------------------H  192 (237)
T ss_pred             C-CCCCchhhHHHHHHHHHHHHHCcchhhcCchh------------------ccc------------------------c
Confidence            5 67889999999999999999999876211000                  000                        0


Q ss_pred             cccccccCCchHHHHHHHHccccCCCCCccH-----HHHhcCCCc
Q 013897          382 ITVENQHLAVPEAVDFLDKLLRYDHQERPTA-----KEAMAHPYF  421 (434)
Q Consensus       382 ~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~-----~elL~Hp~~  421 (434)
                      .....+..+++.+.+||.+||+.||++|+++     +++++||||
T Consensus       193 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         193 TTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             cccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence            0011122367789999999999999999996     999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-37  Score=294.58  Aligned_cols=242  Identities=20%  Similarity=0.331  Sum_probs=189.8

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCe----EEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK  204 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~----~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  204 (434)
                      .++|++.+.||+|+||.||+|.+..++.    .+|+|.++...    ...+.+|+.+++.+ +||||+++++++..   .
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~---~   81 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV-DHPHVVRLLGICLS---S   81 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEec---C
Confidence            3678999999999999999999866554    68999886442    35678999999999 99999999999865   5


Q ss_pred             ccEEEEeecCCCchhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecC
Q 013897          205 TPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH  280 (434)
Q Consensus       205 ~~~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~  280 (434)
                      ..++|+||+.+++|..++.    .+++..+..++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+++...
T Consensus        82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~-~~kL~dfg~~~~~~  160 (279)
T cd05057          82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLD  160 (279)
T ss_pred             ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCC-eEEECCCccccccc
Confidence            6789999999999877652    478999999999999999999999999999999999999766 89999999998765


Q ss_pred             CCCccce---eccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHh
Q 013897          281 PGKEYNV---RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN  356 (434)
Q Consensus       281 ~~~~~~~---~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~  356 (434)
                      .......   ..++..|+|||.+.. ..++.++|+|||||++|||++ |+.||.. ....+....+..            
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~------------  226 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEG-IPAVEIPDLLEK------------  226 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCC-CCHHHHHHHHhC------------
Confidence            3322211   122457999999865 678999999999999999998 9988732 221111111100            


Q ss_pred             hccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          357 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                      ..        ....+..++.++.+++.+||..||++||++.++++
T Consensus       227 ----------------~~--------~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         227 ----------------GE--------RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             ----------------CC--------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                            00        01112235678999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.6e-37  Score=297.92  Aligned_cols=252  Identities=18%  Similarity=0.238  Sum_probs=178.0

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCC---CeEEEEEEeccccH----H----------HHHHHHHHHHHhcCCCCeeeEe
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTD---NEKCIIKILKPVKK----K----------KIKREIKILQNLCGGPNIVKLL  195 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~---~~~vaiK~~~~~~~----~----------~~~~E~~~l~~l~~h~niv~l~  195 (434)
                      .++|.+.++||+|+||.||+|.+..+   +..+|+|+......    +          ....+...+..+ .|+|+++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~   89 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNI-DHLGIPKYY   89 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccC-CCCCCCcEE
Confidence            36799999999999999999998777   66778876432211    0          111223334445 899999999


Q ss_pred             eEEEccCC--CccEEEEeecCCCch--hhhcCCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEE
Q 013897          196 DIVRDQQS--KTPSLIFEHVNNTDF--KVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLI  271 (434)
Q Consensus       196 ~~~~~~~~--~~~~lv~e~~~~~~l--~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~  271 (434)
                      +.+.....  .+.++++|++.....  .......++..++.++.|++.||+|||+++|+||||||+|||++.++ .++|+
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~-~~~l~  168 (294)
T PHA02882         90 GCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNN-RGYII  168 (294)
T ss_pred             EeeeEecCCceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-cEEEE
Confidence            87653322  234677777654322  22223467888899999999999999999999999999999999766 89999


Q ss_pred             ecccceecCCCC--------ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 013897          272 DWGLAEFYHPGK--------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA  343 (434)
Q Consensus       272 DFGla~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~  343 (434)
                      |||+|+.+....        ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..............
T Consensus       169 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~  247 (294)
T PHA02882        169 DYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK  247 (294)
T ss_pred             EcCCceeeccCCcccccccccccccCCCccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH
Confidence            999997653221        1123468999999999876 6799999999999999999999999843322222111110


Q ss_pred             HHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          344 KVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       344 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                      .        .+....               ...       ......+++++.+++..|+..+|++||++.++++
T Consensus       248 ~--------~~~~~~---------------~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        248 C--------DFIKRL---------------HEG-------KIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             H--------HHHHHh---------------hhh-------hhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            0        000000               000       0011225678999999999999999999999874

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.8e-37  Score=291.83  Aligned_cols=238  Identities=20%  Similarity=0.348  Sum_probs=181.5

Q ss_pred             eeeeecCceEEEEEEEcC---CCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEee
Q 013897          140 RKVGRGKYSEVFEGVHCT---DNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH  212 (434)
Q Consensus       140 ~~lG~G~fg~Vy~~~~~~---~~~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  212 (434)
                      +.||+|+||.||+|.+..   .+..+|+|.+...    ..+.+.+|+.+++.+ +||||+++++++...+ ...++|+||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~-~~~~lv~e~   78 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDF-SHPNVLSLLGICLPSE-GSPLVVLPY   78 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccC-CCCCcceEEEEeecCC-CCcEEEEec
Confidence            468999999999998643   3467999988532    235677899999998 9999999999875433 456799999


Q ss_pred             cCCCchhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc----
Q 013897          213 VNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE----  284 (434)
Q Consensus       213 ~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~----  284 (434)
                      +.+++|..++.    .+.+..+..++.||+.||+|||+.+++||||||+|||++.++ .+||+|||+++.......    
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~-~~kl~dfg~~~~~~~~~~~~~~  157 (262)
T cd05058          79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESF-TVKVADFGLARDIYDKEYYSVH  157 (262)
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC-cEEECCccccccccCCcceeec
Confidence            99999987753    356677888999999999999999999999999999999766 899999999975533211    


Q ss_pred             -cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          285 -YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       285 -~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                       .....++..|+|||.+.+ ..++.++|||||||++|||++|+.|++...+..+....+..                   
T Consensus       158 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~-------------------  217 (262)
T cd05058         158 NHTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ-------------------  217 (262)
T ss_pred             ccccCcCCccccChhHhcc-CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc-------------------
Confidence             112234567999999876 67899999999999999999976665444332222111100                   


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                               ..        .......+++.+.+++.+||..||++||++.|++.
T Consensus       218 ---------~~--------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~  254 (262)
T cd05058         218 ---------GR--------RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS  254 (262)
T ss_pred             ---------CC--------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                     00        00011235678999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3.2e-37  Score=289.11  Aligned_cols=242  Identities=17%  Similarity=0.362  Sum_probs=190.0

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEe
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE  211 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  211 (434)
                      .+|++.+.||+|+||.||+|.+. ++..+|+|.++..  ....+.+|+++++.+ +|||++++++++.+.  ...++|||
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~~v~e   79 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKL-SHPKLVQLYGVCTER--SPICLVFE   79 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhC-CCCCeeeEEEEEccC--CceEEEEE
Confidence            57889999999999999999874 4678999988643  346789999999999 999999999998654  46789999


Q ss_pred             ecCCCchhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCcc--
Q 013897          212 HVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY--  285 (434)
Q Consensus       212 ~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~--  285 (434)
                      |+.+++|..++.    .+++..+..++.|++.||+|||+.+++|+||||+||+++.++ .+||+|||++.........  
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~~~~~~~  158 (256)
T cd05112          80 FMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQ-VVKVSDFGMTRFVLDDQYTSS  158 (256)
T ss_pred             cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCC-eEEECCCcceeecccCccccc
Confidence            999999876652    478888999999999999999999999999999999999665 8999999998755322111  


Q ss_pred             ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCCh
Q 013897          286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP  364 (434)
Q Consensus       286 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  364 (434)
                      ....++..|+|||.+.+ ..++.++|||||||++|||++ |..||.. .........+.+                    
T Consensus       159 ~~~~~~~~~~aPe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~--------------------  216 (256)
T cd05112         159 TGTKFPVKWSSPEVFSF-SKYSSKSDVWSFGVLMWEVFSEGKTPYEN-RSNSEVVETINA--------------------  216 (256)
T ss_pred             CCCccchhhcCHhHhcc-CCcChHHHHHHHHHHHHHHHcCCCCCCCc-CCHHHHHHHHhC--------------------
Confidence            11233457999999876 678999999999999999998 8888732 221111111100                    


Q ss_pred             hHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                             ..         ........++.+.+|+.+||..+|++|||+.|++++
T Consensus       217 -------~~---------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         217 -------GF---------RLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             -------CC---------CCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence                   00         000112356789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.2e-37  Score=293.53  Aligned_cols=245  Identities=18%  Similarity=0.358  Sum_probs=191.0

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcC-----CCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS  203 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~-----~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  203 (434)
                      .++|++...||+|+||.||+|+.+.     +.+.+++|.+....    ...+.+|+.+++++ +|+||+++++++.+.  
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--   80 (275)
T cd05046           4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL-SHKNVVRLLGLCREA--   80 (275)
T ss_pred             hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhc-CCcceeeeEEEECCC--
Confidence            3678999999999999999998753     34689999886433    35688999999999 999999999998653  


Q ss_pred             CccEEEEeecCCCchhhhcC------------CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEE
Q 013897          204 KTPSLIFEHVNNTDFKVLYP------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLI  271 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~~------------~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~  271 (434)
                      ...++||||+++++|..++.            .+++..+..++.||+.||.|||+++|+||||||+||+++.++ .++|+
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~-~~~l~  159 (275)
T cd05046          81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQR-EVKVS  159 (275)
T ss_pred             CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCC-cEEEc
Confidence            56789999999999976652            478889999999999999999999999999999999999776 89999


Q ss_pred             ecccceecCCCC--ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCC
Q 013897          272 DWGLAEFYHPGK--EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGT  348 (434)
Q Consensus       272 DFGla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~  348 (434)
                      |||++.......  ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||. .......+..+..    
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~~~~~p~~-~~~~~~~~~~~~~----  233 (275)
T cd05046         160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQE-DDFSTKSDVWSFGVLMWEVFTQGELPFY-GLSDEEVLNRLQA----  233 (275)
T ss_pred             ccccccccCcccccccCCceeEEeecChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCcc-ccchHHHHHHHHc----
Confidence            999986543221  1233355677999999876 568899999999999999998 777873 2222111111100    


Q ss_pred             hhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          349 DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                                               ...      .+.....++..+.+++.+||+.||++|||+.|++++
T Consensus       234 -------------------------~~~------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         234 -------------------------GKL------ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             -------------------------CCc------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence                                     000      011112366789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=316.32  Aligned_cols=200  Identities=26%  Similarity=0.447  Sum_probs=177.0

Q ss_pred             CeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecc----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccC----CCcc
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ----SKTP  206 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----~~~~  206 (434)
                      .+...+.||+|+||.||+|+++.+|+.||||.++.    ...+..-+|+++|++| +|+|||+++++-....    ....
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKL-nh~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKL-NHPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHc-CchhhhhhcccCCccccCcccccc
Confidence            35567889999999999999999999999999875    3457788999999999 7999999999876555    5567


Q ss_pred             EEEEeecCCCchhhhcC------CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC--C-CeEEEEecccce
Q 013897          207 SLIFEHVNNTDFKVLYP------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--Q-RKLRLIDWGLAE  277 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~~------~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~--~-~~vkl~DFGla~  277 (434)
                      ++|||||.+|+|...+.      .+++.++..++.++..||.|||++|||||||||.||++-..  + ..-||+|||.|+
T Consensus        93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar  172 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR  172 (732)
T ss_pred             eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence            89999999999987764      38999999999999999999999999999999999998422  2 246999999999


Q ss_pred             ecCCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCC
Q 013897          278 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN  335 (434)
Q Consensus       278 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~  335 (434)
                      .+.++......+||+.|++||.+...+.|+..+|.|||||++|+..||..||.+...+
T Consensus       173 el~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p  230 (732)
T KOG4250|consen  173 ELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP  230 (732)
T ss_pred             cCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence            9998888899999999999999875578999999999999999999999999765554

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.9e-37  Score=290.41  Aligned_cols=239  Identities=23%  Similarity=0.400  Sum_probs=190.4

Q ss_pred             EEEeeeeecCceEEEEEEEcCCC----eEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          137 EVVRKVGRGKYSEVFEGVHCTDN----EKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       137 ~~~~~lG~G~fg~Vy~~~~~~~~----~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      ++.+.||.|+||.||++.+...+    ..+|+|.++...    .+.+..|+.+++.+ +|+||+++++++.+.  ...++
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~~   78 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKL-DHPNIVKLLGVCTEE--EPLMI   78 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhc-CCCchheEEEEEcCC--CeeEE
Confidence            46788999999999999987766    899999997543    45788999999999 999999999999654  56789


Q ss_pred             EEeecCCCchhhhcC---C--CChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC
Q 013897          209 IFEHVNNTDFKVLYP---T--LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       209 v~e~~~~~~l~~~~~---~--l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~  283 (434)
                      +|||+.++++..++.   .  +++..+..++.|++.||+|||+.+++|+||||+||+++.++ .++|+|||++.......
T Consensus        79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~-~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENL-VVKISDFGLSRDLYDDD  157 (258)
T ss_pred             EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCC-eEEEcccCCceeccccc
Confidence            999999999876653   2  88999999999999999999999999999999999999776 89999999997765442


Q ss_pred             ccce--eccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccc
Q 013897          284 EYNV--RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI  360 (434)
Q Consensus       284 ~~~~--~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  360 (434)
                      ....  ..++..|+|||.+.+ ..++.++|||||||++++|++ |..|| ...+.......+...               
T Consensus       158 ~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~-~~~~~~~~~~~~~~~---------------  220 (258)
T smart00219      158 YYKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPY-PGMSNEEVLEYLKKG---------------  220 (258)
T ss_pred             ccccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHhcC---------------
Confidence            2222  235678999999865 678999999999999999998 66666 332222222221100               


Q ss_pred             cCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          361 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                   .        .......++.++.+++.+||..||++|||+.|+++
T Consensus       221 -------------~--------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      221 -------------Y--------RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             -------------C--------CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence                         0        00111225778999999999999999999999985

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.7e-37  Score=294.71  Aligned_cols=233  Identities=15%  Similarity=0.244  Sum_probs=177.9

Q ss_pred             eeeecCceEEEEEEEcCC------------------------CeEEEEEEecccc---HHHHHHHHHHHHHhcCCCCeee
Q 013897          141 KVGRGKYSEVFEGVHCTD------------------------NEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVK  193 (434)
Q Consensus       141 ~lG~G~fg~Vy~~~~~~~------------------------~~~vaiK~~~~~~---~~~~~~E~~~l~~l~~h~niv~  193 (434)
                      .||+|+||.||+|....+                        ...||+|++....   ...+.+|+.+++.+ +||||++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l-~h~niv~   80 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQV-SHIHLAF   80 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcC-CCCCeee
Confidence            599999999999975321                        2468899886543   24577888899888 9999999


Q ss_pred             EeeEEEccCCCccEEEEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCC----
Q 013897          194 LLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ----  265 (434)
Q Consensus       194 l~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~----  265 (434)
                      +++++.+.  ...++||||+++++|..++    ..+++..+..++.||+.||+|||+++|+||||||+|||++..+    
T Consensus        81 ~~~~~~~~--~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          81 VHGVCVRG--SENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             EEEEEEeC--CceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence            99999754  4667999999999987665    2478889999999999999999999999999999999997543    


Q ss_pred             --CeEEEEecccceecCCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHH-hCCCCCCCCCCCHHHHHHH
Q 013897          266 --RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI-FRKEPFFYGHDNYDQLVKI  342 (434)
Q Consensus       266 --~~vkl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell-tg~~pf~~~~~~~~~~~~i  342 (434)
                        ..+|++|||++......   ....++..|+|||.+.+...++.++|||||||++|||+ +|+.||... ...+. ...
T Consensus       159 ~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~-~~~~~-~~~  233 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKER-TPSEK-ERF  233 (274)
T ss_pred             ccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcccc-ChHHH-HHH
Confidence              14899999998644222   23456788999999876567899999999999999985 688887322 21111 110


Q ss_pred             HHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          343 AKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       343 ~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                      ..                           ....          ......+.+.++|.+||+.+|++|||+.++|++
T Consensus       234 ~~---------------------------~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         234 YE---------------------------KKHR----------LPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             HH---------------------------hccC----------CCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            00                           0000          001134578999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.3e-37  Score=298.07  Aligned_cols=243  Identities=18%  Similarity=0.317  Sum_probs=188.8

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCe----EEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK  204 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~----~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  204 (434)
                      .++|+..+.||+|+||.||+|.+..++.    .+|+|.+....    ..++.+|+.+++.+ +||||+++++++...   
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~---   81 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM-DHPHLVRLLGVCLSP---   81 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEEEcCC---
Confidence            4678899999999999999999876665    57889886432    23578899999998 999999999998543   


Q ss_pred             ccEEEEeecCCCchhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecC
Q 013897          205 TPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH  280 (434)
Q Consensus       205 ~~~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~  280 (434)
                      ..++++||++++++..+..    .+++..+..++.|++.||.|||+++|+||||||+|||++.++ .+||+|||+++...
T Consensus        82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~-~~kL~Dfg~~~~~~  160 (303)
T cd05110          82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPN-HVKITDFGLARLLE  160 (303)
T ss_pred             CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCC-ceEEcccccccccc
Confidence            3568999999998876642    478888999999999999999999999999999999998666 79999999998664


Q ss_pred             CCCcc---ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHh
Q 013897          281 PGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN  356 (434)
Q Consensus       281 ~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~  356 (434)
                      .....   ....++..|+|||.+.+ ..++.++|||||||++|||++ |+.||.. .. ......+.+.           
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~p~~~-~~-~~~~~~~~~~-----------  226 (303)
T cd05110         161 GDEKEYNADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYDG-IP-TREIPDLLEK-----------  226 (303)
T ss_pred             CcccccccCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCCCCCC-CC-HHHHHHHHHC-----------
Confidence            33221   22334667999999876 678999999999999999997 8888732 11 1112111110           


Q ss_pred             hccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          357 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                                      ...        ......++.++.+++.+||..||++||+++++++.
T Consensus       227 ----------------~~~--------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         227 ----------------GER--------LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             ----------------CCC--------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                            000        00112355689999999999999999999998874

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=3.3e-37  Score=289.24  Aligned_cols=236  Identities=19%  Similarity=0.298  Sum_probs=185.0

Q ss_pred             eeeeecCceEEEEEEEcC-CC--eEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEee
Q 013897          140 RKVGRGKYSEVFEGVHCT-DN--EKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH  212 (434)
Q Consensus       140 ~~lG~G~fg~Vy~~~~~~-~~--~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  212 (434)
                      +.||+|++|.||+|.+.. ++  ..+|||.+....    .+.+.+|+.+++++ +||||+++++++.+   ...++|+||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~---~~~~~v~e~   76 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSL-DHENLIRLYGVVLT---HPLMMVTEL   76 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhc-CCCCccceeEEEcC---CeEEEEEEe
Confidence            468999999999998855 33  368999987543    35688999999999 99999999999865   567899999


Q ss_pred             cCCCchhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc---
Q 013897          213 VNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---  284 (434)
Q Consensus       213 ~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~---  284 (434)
                      +.+++|...+     ..+++..+..++.|++.||+|||+++++|+||||+||+++.++ .+||+|||++........   
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDD-KVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCC-EEEecccccccccccccccee
Confidence            9999987664     2468888999999999999999999999999999999999776 899999999977643221   


Q ss_pred             -cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          285 -YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       285 -~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                       .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.. ....+....+.. .+               
T Consensus       156 ~~~~~~~~~~y~~pE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~~~~-~~---------------  217 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRT-RTFSHASDVWMFGVTLWEMFTYGEEPWAG-LSGSQILKKIDK-EG---------------  217 (257)
T ss_pred             cccCCCCCceecCHHHhcc-cCcCchhhhHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHh-cC---------------
Confidence             112345678999999876 678999999999999999998 9999832 222222222110 00               


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                 .        .......++..+.+++.+||..+|++||++.++++
T Consensus       218 -----------~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         218 -----------E--------RLERPEACPQDIYNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             -----------C--------cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence                       0        00011235678999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.6e-37  Score=290.99  Aligned_cols=237  Identities=16%  Similarity=0.316  Sum_probs=187.0

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEee
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH  212 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  212 (434)
                      ++|++.+.||+|+||.||++..  +++.+|+|.++.. ....+.+|+.+++.+ +|||++++++++...   ..++||||
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~---~~~~v~e~   79 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAVMTKL-HHKNLVRLLGVILHN---GLYIVMEL   79 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcchHHHHHHHHHHHHhC-CCCCcCeEEEEEcCC---CcEEEEEC
Confidence            5689999999999999999974  6788999998653 345788999999999 999999999998543   36899999


Q ss_pred             cCCCchhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCccce
Q 013897          213 VNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV  287 (434)
Q Consensus       213 ~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~~~  287 (434)
                      +.+++|..++.     .+++..+..++.|++.||.|||+.|++||||||+||+++.++ .+||+|||++......  ...
T Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~-~~kl~Dfg~~~~~~~~--~~~  156 (254)
T cd05083          80 MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDG-VAKVSDFGLARVGSMG--VDN  156 (254)
T ss_pred             CCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC-cEEECCCccceecccc--CCC
Confidence            99999876652     367888899999999999999999999999999999999766 8999999999764322  122


Q ss_pred             eccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhH
Q 013897          288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL  366 (434)
Q Consensus       288 ~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~  366 (434)
                      ...+..|+|||.+.+ ..++.++|+|||||++|+|++ |+.||.. ....+....+.+                      
T Consensus       157 ~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~----------------------  212 (254)
T cd05083         157 SKLPVKWTAPEALKH-KKFSSKSDVWSYGVLLWEVFSYGRAPYPK-MSLKEVKECVEK----------------------  212 (254)
T ss_pred             CCCCceecCHHHhcc-CCcCchhhHHHHHHHHHHHHhCCCCCCcc-CCHHHHHHHHhC----------------------
Confidence            234567999999876 678999999999999999997 8888732 221111111100                      


Q ss_pred             HHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          367 AALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                           . .+        ......+++.+.+++.+||..+|++||++++++.
T Consensus       213 -----~-~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         213 -----G-YR--------MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             -----C-CC--------CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                 0 00        0011235678999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=3.2e-37  Score=288.08  Aligned_cols=235  Identities=22%  Similarity=0.375  Sum_probs=183.2

Q ss_pred             eeeeecCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeecCC
Q 013897          140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN  215 (434)
Q Consensus       140 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~  215 (434)
                      +.||+|+||.||+|.. .++..+|+|.++...    ...+.+|+.+++.+ +||||+++++++...  ...++||||+.+
T Consensus         1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~e~~~~   76 (250)
T cd05085           1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQY-DHPNIVKLIGVCTQR--QPIYIVMELVPG   76 (250)
T ss_pred             CccCCCCCceEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhC-CCCCcCeEEEEEecC--CccEEEEECCCC
Confidence            3689999999999986 568899999986432    34578899999998 999999999998654  467899999999


Q ss_pred             CchhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCcc--ceec
Q 013897          216 TDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY--NVRV  289 (434)
Q Consensus       216 ~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~--~~~~  289 (434)
                      ++|..++.    .+.+..+..++.|++.||.|||++|++|+||||+||+++.++ .+||+|||++.........  ....
T Consensus        77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~  155 (250)
T cd05085          77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENN-VLKISDFGMSRQEDDGIYSSSGLKQ  155 (250)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCC-eEEECCCccceeccccccccCCCCC
Confidence            99876652    367888999999999999999999999999999999999766 8999999999754332211  1123


Q ss_pred             cCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHH
Q 013897          290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAA  368 (434)
Q Consensus       290 ~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~  368 (434)
                      ++..|+|||++.+ ..++.++|||||||++|+|++ |..||. +.........+..                        
T Consensus       156 ~~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~-~~~~~~~~~~~~~------------------------  209 (250)
T cd05085         156 IPIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYP-GMTNQQAREQVEK------------------------  209 (250)
T ss_pred             CcccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCC-CCCHHHHHHHHHc------------------------
Confidence            3456999999876 678999999999999999998 888873 2222111111100                        


Q ss_pred             HhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          369 LVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                         . .        .......++..+.+|+.+||..+|++||++.|+++
T Consensus       210 ---~-~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  246 (250)
T cd05085         210 ---G-Y--------RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK  246 (250)
T ss_pred             ---C-C--------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence               0 0        00111235678999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=2.8e-37  Score=292.07  Aligned_cols=241  Identities=17%  Similarity=0.231  Sum_probs=177.8

Q ss_pred             eeeeecCceEEEEEEEcC--CCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeec
Q 013897          140 RKVGRGKYSEVFEGVHCT--DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV  213 (434)
Q Consensus       140 ~~lG~G~fg~Vy~~~~~~--~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  213 (434)
                      +.||+|+||.||+|.+..  ++..+|+|.++...    ...+.+|+.+++.+ +||||+++++++.+.  ...++||||+
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv~e~~   77 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSL-QHSNLLQCLGQCTEV--TPYLLVMEFC   77 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcCC--CCcEEEEECC
Confidence            369999999999998643  44679999886432    24678899999999 999999999998654  4578999999


Q ss_pred             CCCchhhhcC--------CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCcc
Q 013897          214 NNTDFKVLYP--------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY  285 (434)
Q Consensus       214 ~~~~l~~~~~--------~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~  285 (434)
                      .+++|..++.        ..++..++.++.|++.||+|||+++++|+||||+||+++.++ .+||+|||+++........
T Consensus        78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~-~~kL~dfg~~~~~~~~~~~  156 (269)
T cd05087          78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADL-TVKIGDYGLSHNKYKEDYY  156 (269)
T ss_pred             CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC-cEEECCccccccccCccee
Confidence            9999876652        234566778999999999999999999999999999999766 8999999999654322211


Q ss_pred             ---ceeccCCcccccccccCC------CCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHH
Q 013897          286 ---NVRVASRYFKGPELLVDL------QDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYL  355 (434)
Q Consensus       286 ---~~~~~t~~y~aPE~~~~~------~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~  355 (434)
                         ....++..|+|||++.+.      ..++.++|||||||++|||++ |+.||... ...+.......  +.       
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~-~~~~~~~~~~~--~~-------  226 (269)
T cd05087         157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHL-SDEQVLTYTVR--EQ-------  226 (269)
T ss_pred             ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCC-ChHHHHHHHhh--cc-------
Confidence               223566789999998542      135789999999999999996 99898432 22221111100  00       


Q ss_pred             hhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          356 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                       ..+.     .........++.+.+++.+|+ .+|++|||++|++.
T Consensus       227 -----------------~~~~-----~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         227 -----------------QLKL-----PKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             -----------------cCCC-----CCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence                             0000     000011124567899999998 68999999999974

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3.7e-37  Score=291.07  Aligned_cols=240  Identities=18%  Similarity=0.281  Sum_probs=176.4

Q ss_pred             eeeecCceEEEEEEEcC--CCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeecC
Q 013897          141 KVGRGKYSEVFEGVHCT--DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVN  214 (434)
Q Consensus       141 ~lG~G~fg~Vy~~~~~~--~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~  214 (434)
                      .||+|+||+||+|....  ....+|+|.+....    ...+.+|+.+++.+ +|+||+++++.+...  ...++||||+.
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~h~nii~~~~~~~~~--~~~~lv~e~~~   78 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYREL-NHPNVLQCLGQCIES--IPYLLVLEFCP   78 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhC-CCCCcceEEEEECCC--CceEEEEEeCC
Confidence            59999999999996533  34578888875432    24578899999998 999999999998643  56789999999


Q ss_pred             CCchhhhcCC--------CChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCcc-
Q 013897          215 NTDFKVLYPT--------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-  285 (434)
Q Consensus       215 ~~~l~~~~~~--------l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~-  285 (434)
                      +++|..++..        .++..+..++.||+.||+|||+++|+||||||+|||++.++ .+||+|||++......... 
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADL-SVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCC-cEEEeccccccccccchhee
Confidence            9999876521        34667788999999999999999999999999999999776 8999999998654322211 


Q ss_pred             --ceeccCCcccccccccC------CCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHh
Q 013897          286 --NVRVASRYFKGPELLVD------LQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN  356 (434)
Q Consensus       286 --~~~~~t~~y~aPE~~~~------~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~  356 (434)
                        ....++..|+|||++..      ...++.++|||||||++|||++ |..|| ....+.+.+..+......        
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~-~~~~~~~~~~~~~~~~~~--------  228 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPY-PDLSDEQVLKQVVREQDI--------  228 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCC-CcCCHHHHHHHHhhccCc--------
Confidence              22344567999998742      2357889999999999999999 66666 333333222221110000        


Q ss_pred             hccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          357 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                          .                   .........+++.+.+++..|+ .||++|||++||++
T Consensus       229 ----~-------------------~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         229 ----K-------------------LPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             ----c-------------------CCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence                0                   0000011235678889999998 59999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.5e-37  Score=287.25  Aligned_cols=235  Identities=22%  Similarity=0.385  Sum_probs=183.5

Q ss_pred             eeeeecCceEEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeecCC
Q 013897          140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN  215 (434)
Q Consensus       140 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~  215 (434)
                      ++||+|+||.||++.+.. ++.||+|.+...    ....+.+|+.+++++ .|+||+++++++.+.  ...++||||+.+
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~~v~e~~~~   76 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQY-DHPNIVKLIGVCVQK--QPIYIVMELVPG   76 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCeEEEEEEEecC--CCeEEEEEcCCC
Confidence            469999999999999866 999999988643    235688999999999 999999999998654  567899999999


Q ss_pred             Cchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCcc---cee
Q 013897          216 TDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY---NVR  288 (434)
Q Consensus       216 ~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~---~~~  288 (434)
                      +++..++    ..+++..+..++.+++.||+|||+++++||||||+|||++.++ .+||+|||++.........   ...
T Consensus        77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENN-VLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCC-cEEEeeccccccccCCcceeccccC
Confidence            9887665    2467888899999999999999999999999999999999776 8999999999755322111   112


Q ss_pred             ccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHH
Q 013897          289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLA  367 (434)
Q Consensus       289 ~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~  367 (434)
                      ..+..|+|||.+.+ ..++.++|||||||++|+|++ |..||. +.........+..                       
T Consensus       156 ~~~~~y~~PE~~~~-~~~~~~~Di~slG~i~~~l~t~~~~p~~-~~~~~~~~~~~~~-----------------------  210 (251)
T cd05041         156 QIPIKWTAPEALNY-GRYTSESDVWSYGILLWETFSLGDTPYP-GMSNQQTRERIES-----------------------  210 (251)
T ss_pred             cceeccCChHhhcc-CCCCcchhHHHHHHHHHHHHhccCCCCc-cCCHHHHHHHHhc-----------------------
Confidence            23456999999876 678999999999999999999 777763 2222111111100                       


Q ss_pred             HHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          368 ALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                           ..        .......++.++.+++.+||..+|++|||+.|+|+
T Consensus       211 -----~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         211 -----GY--------RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             -----CC--------CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence                 00        00011235678999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-38  Score=307.05  Aligned_cols=240  Identities=21%  Similarity=0.411  Sum_probs=194.8

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCC----CeEEEEEEecc----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCc
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTD----NEKCIIKILKP----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT  205 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~----~~~vaiK~~~~----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  205 (434)
                      +...+.++||.|.||.||+|.+..-    .-.||||..+.    .+.+.|..|..+|+++ +||||++++|+|++   ..
T Consensus       389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnf-dHphIikLIGv~~e---~P  464 (974)
T KOG4257|consen  389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNF-DHPHIIKLIGVCVE---QP  464 (974)
T ss_pred             hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhC-CCcchhheeeeeec---cc
Confidence            4455678899999999999987432    34689998875    4567899999999999 99999999999975   45


Q ss_pred             cEEEEeecCCCchhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC
Q 013897          206 PSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP  281 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~  281 (434)
                      .+||||.++.|.|..+++    .++......++.||+.||.|||++++|||||-..|||+.... .|||+|||+++++.+
T Consensus       465 ~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~-CVKLaDFGLSR~~ed  543 (974)
T KOG4257|consen  465 MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQ-CVKLADFGLSRYLED  543 (974)
T ss_pred             eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcc-eeeecccchhhhccc
Confidence            789999999999988774    377778889999999999999999999999999999999777 899999999999887


Q ss_pred             CCccceeccC--CcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhc
Q 013897          282 GKEYNVRVAS--RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY  358 (434)
Q Consensus       282 ~~~~~~~~~t--~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  358 (434)
                      +..+....|-  ..|||||.+. .+.++.++|||.|||++||++. |..||. +-.+.+....|.               
T Consensus       544 ~~yYkaS~~kLPIKWmaPESIN-fRrFTtASDVWMFgVCmWEIl~lGvkPfq-gvkNsDVI~~iE---------------  606 (974)
T KOG4257|consen  544 DAYYKASRGKLPIKWMAPESIN-FRRFTTASDVWMFGVCMWEILSLGVKPFQ-GVKNSDVIGHIE---------------  606 (974)
T ss_pred             cchhhccccccceeecCccccc-hhcccchhhHHHHHHHHHHHHHhcCCccc-cccccceEEEec---------------
Confidence            7766666553  4599999975 4889999999999999999875 888984 222222211111               


Q ss_pred             cccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHh
Q 013897          359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAM  416 (434)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL  416 (434)
                                   +.        ...+.+..|++.+..|+.+||.+||.+||+..|+.
T Consensus       607 -------------nG--------eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~  643 (974)
T KOG4257|consen  607 -------------NG--------ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIK  643 (974)
T ss_pred             -------------CC--------CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence                         00        11233456899999999999999999999987765

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=4e-37  Score=290.73  Aligned_cols=244  Identities=20%  Similarity=0.410  Sum_probs=191.1

Q ss_pred             CeEEEeeeeecCceEEEEEEEcC-CCeEEEEEEeccc-------------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEc
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCT-DNEKCIIKILKPV-------------KKKKIKREIKILQNLCGGPNIVKLLDIVRD  200 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~-~~~~vaiK~~~~~-------------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  200 (434)
                      +|++.+.||+|+||.||+|.+.. +++.+|+|.+...             ...++.+|+.++.+..+||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            37788999999999999999877 6789999987521             123466788888765599999999999865


Q ss_pred             cCCCccEEEEeecCCCchhhhc-------CCCChHHHHHHHHHHHHHHHHHHH-CCceeecCCCCceEecCCCCeEEEEe
Q 013897          201 QQSKTPSLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLID  272 (434)
Q Consensus       201 ~~~~~~~lv~e~~~~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlKp~NIll~~~~~~vkl~D  272 (434)
                      .  ...++||||+.++++..++       ..+++..++.++.|++.||.|||+ .+++|+||||+|||++.++ .+||+|
T Consensus        81 ~--~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~-~~~l~d  157 (269)
T cd08528          81 N--DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD-KVTITD  157 (269)
T ss_pred             C--CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCC-cEEEec
Confidence            3  5778999999999886553       247888999999999999999996 6899999999999999776 899999


Q ss_pred             cccceecCCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHH
Q 013897          273 WGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELN  352 (434)
Q Consensus       273 FGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~  352 (434)
                      ||++.............++..|++||.+.+ ..++.++|||||||++|+|++|+.||... ........+...       
T Consensus       158 fg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~~g~~p~~~~-~~~~~~~~~~~~-------  228 (269)
T cd08528         158 FGLAKQKQPESKLTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYST-NMLSLATKIVEA-------  228 (269)
T ss_pred             ccceeecccccccccccCcccCcChhhhcC-CCCchHHHHHHHHHHHHHHHhCCCccccc-CHHHHHHHHhhc-------
Confidence            999987654444455678889999999876 67899999999999999999999998422 111111111100       


Q ss_pred             HHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          353 AYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                                           ...       ......+++++.+|+.+||+.||++||++.|+.++
T Consensus       229 ---------------------~~~-------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         229 ---------------------VYE-------PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             ---------------------cCC-------cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence                                 000       00011356789999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.5e-37  Score=287.73  Aligned_cols=232  Identities=17%  Similarity=0.264  Sum_probs=180.3

Q ss_pred             eeeeecCceEEEEEEEcCCC----------eEEEEEEecccc--HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          140 RKVGRGKYSEVFEGVHCTDN----------EKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       140 ~~lG~G~fg~Vy~~~~~~~~----------~~vaiK~~~~~~--~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      +.||+|+||.||+|.+..++          ..+++|++....  ...+.+|+.+++.+ +||||+++++++..   ...+
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~---~~~~   76 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQL-SHKHLVKLYGVCVR---DENI   76 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcC-CCcchhheeeEEec---CCcE
Confidence            46999999999999997666          458888876543  46788999999999 89999999999865   3457


Q ss_pred             EEEeecCCCchhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCC------eEEEEecccce
Q 013897          208 LIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR------KLRLIDWGLAE  277 (434)
Q Consensus       208 lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~------~vkl~DFGla~  277 (434)
                      +||||+.+++|..++.    .++...+..++.||+.||.|||++||+||||||+|||++.++.      .+||+|||++.
T Consensus        77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~  156 (259)
T cd05037          77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI  156 (259)
T ss_pred             EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence            9999999999876653    4788889999999999999999999999999999999986542      59999999997


Q ss_pred             ecCCCCccceeccCCcccccccccCC-CCCCccccHHHHHHHHHHHHhC-CCCCCCCCCCHHHHHHHHHHhCChhHHHHH
Q 013897          278 FYHPGKEYNVRVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMIFR-KEPFFYGHDNYDQLVKIAKVLGTDELNAYL  355 (434)
Q Consensus       278 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DvwSlGvil~elltg-~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~  355 (434)
                      ....   .....++..|+|||.+.+. ..++.++|||||||++|+|++| ..||... ......... .           
T Consensus       157 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~-~~~~~~~~~-~-----------  220 (259)
T cd05037         157 TVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTL-SSSEKERFY-Q-----------  220 (259)
T ss_pred             cccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccC-CchhHHHHH-h-----------
Confidence            6543   2334566789999998763 3789999999999999999995 6665322 111111000 0           


Q ss_pred             hhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          356 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                      .                ...          ........+.+++.+||..||.+|||+.++++
T Consensus       221 ~----------------~~~----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         221 D----------------QHR----------LPMPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             c----------------CCC----------CCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence            0                000          00001257899999999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=3.6e-37  Score=290.93  Aligned_cols=237  Identities=22%  Similarity=0.360  Sum_probs=182.8

Q ss_pred             eeeeecCceEEEEEEEcCCC------eEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          140 RKVGRGKYSEVFEGVHCTDN------EKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       140 ~~lG~G~fg~Vy~~~~~~~~------~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      +.||+|+||.||+|.+....      ..+|+|.+...    ....+.+|+.+++.+ +||||+++++++.+.  ...++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~~v   77 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNF-NHPNIVKLLGVCLLN--EPQYII   77 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhc-CCCCeeeEeeeecCC--CCeEEE
Confidence            36999999999999875433      68999987543    345788999999999 999999999998654  467899


Q ss_pred             EeecCCCchhhhcC----------CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCC----CeEEEEeccc
Q 013897          210 FEHVNNTDFKVLYP----------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ----RKLRLIDWGL  275 (434)
Q Consensus       210 ~e~~~~~~l~~~~~----------~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~----~~vkl~DFGl  275 (434)
                      |||+++++|..++.          .+++.++..++.|++.||.|||+++++|+||||+||+++.++    ..++|+|||+
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999999876642          267788899999999999999999999999999999998544    2699999999


Q ss_pred             ceecCCCCc---cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhH
Q 013897          276 AEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDEL  351 (434)
Q Consensus       276 a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~  351 (434)
                      +........   .....++..|+|||.+.+ ..++.++|||||||++|+|++ |+.||. ..+..+....+..  +    
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~ellt~g~~p~~-~~~~~~~~~~~~~--~----  229 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPYP-ALNNQEVLQHVTA--G----  229 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHcc-CCcccchhHHHHHHHHHHHHHcCCCCCc-ccCHHHHHHHHhc--C----
Confidence            976533221   112344677999999876 678999999999999999998 888873 2222222111100  0    


Q ss_pred             HHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          352 NAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                            .        .......++..+.+|+.+||..+|++||++.++++
T Consensus       230 ----------------------~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         230 ----------------------G--------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             ----------------------C--------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                                  0        00011235678999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.1e-36  Score=288.12  Aligned_cols=243  Identities=19%  Similarity=0.366  Sum_probs=185.0

Q ss_pred             eEEEeeeeecCceEEEEEEEcC---CCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC----
Q 013897          136 YEVVRKVGRGKYSEVFEGVHCT---DNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS----  203 (434)
Q Consensus       136 y~~~~~lG~G~fg~Vy~~~~~~---~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~----  203 (434)
                      |.+.+.||+|+||.||+|.+..   ++..+|||+++..     ..+++.+|+.+++.+ +||||+++++++.....    
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~   79 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEF-DHPNVIKLIGVSLRSRAKGRL   79 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcC-CCCCcceEEEEEccCCCCCcc
Confidence            4577899999999999998643   5689999998643     234678999999999 89999999998864322    


Q ss_pred             CccEEEEeecCCCchhhhc---------CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecc
Q 013897          204 KTPSLIFEHVNNTDFKVLY---------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG  274 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~---------~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFG  274 (434)
                      ...++++||+.++++..++         ..++...+..++.||+.||+|||+++|+||||||+||+++.++ .+||+|||
T Consensus        80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~-~~kl~dfg  158 (273)
T cd05074          80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENM-TVCVADFG  158 (273)
T ss_pred             cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCC-CEEECccc
Confidence            2346889999999886543         1367788999999999999999999999999999999999666 89999999


Q ss_pred             cceecCCCCc---cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChh
Q 013897          275 LAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDE  350 (434)
Q Consensus       275 la~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~  350 (434)
                      +++.......   .....++..|++||.+.+ ..++.++|||||||++|+|++ |+.|| .+.+..+....+..  +   
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~sDi~slG~il~el~~~g~~p~-~~~~~~~~~~~~~~--~---  231 (273)
T cd05074         159 LSKKIYSGDYYRQGCASKLPVKWLALESLAD-NVYTTHSDVWAFGVTMWEIMTRGQTPY-AGVENSEIYNYLIK--G---  231 (273)
T ss_pred             ccccccCCcceecCCCccCchhhcCHhHHhc-CccchhhhhHHHHHHHHHHhhCCCCCC-CCCCHHHHHHHHHc--C---
Confidence            9976543321   122334567999999876 678899999999999999999 77776 33322211111110  0   


Q ss_pred             HHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          351 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                                             ..        .......++.+.+++.+||..+|++||++.|++++
T Consensus       232 -----------------------~~--------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         232 -----------------------NR--------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             -----------------------Cc--------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                   00        00111256789999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-37  Score=302.31  Aligned_cols=240  Identities=20%  Similarity=0.406  Sum_probs=196.8

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecc--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEe
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE  211 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~--~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  211 (434)
                      .+....++||.|.||.||.|.|+.-.-.||||.++.  ...++|..|..+|+.+ +|||+|+|+|+|...  ...|||.|
T Consensus       267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKei-kHpNLVqLLGVCT~E--pPFYIiTE  343 (1157)
T KOG4278|consen  267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTHE--PPFYIITE  343 (1157)
T ss_pred             hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhh-cCccHHHHhhhhccC--CCeEEEEe
Confidence            445688999999999999999998889999999985  4568899999999999 999999999999654  56789999


Q ss_pred             ecCCCchhhhcCC-----CChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCccc
Q 013897          212 HVNNTDFKVLYPT-----LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN  286 (434)
Q Consensus       212 ~~~~~~l~~~~~~-----l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~~  286 (434)
                      ||..|+|.+++..     ++.....+++-||..||+||..+++|||||-..|+|+.++. .||++|||+++++. +..++
T Consensus       344 fM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnh-iVKvADFGLsRlMt-gDTYT  421 (1157)
T KOG4278|consen  344 FMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-IVKVADFGLSRLMT-GDTYT  421 (1157)
T ss_pred             cccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccc-eEEeeccchhhhhc-CCcee
Confidence            9999998877653     45556678889999999999999999999999999999666 89999999999875 45666


Q ss_pred             eeccCC---cccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          287 VRVASR---YFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       287 ~~~~t~---~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                      ...|..   .|.|||-+.- ..++.|+|||+|||+|||+.| |-.|| ++.+-......+.+.                 
T Consensus       422 AHAGAKFPIKWTAPEsLAy-NtFSiKSDVWAFGVLLWEIATYGMsPY-PGidlSqVY~LLEkg-----------------  482 (1157)
T KOG4278|consen  422 AHAGAKFPIKWTAPESLAY-NTFSIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYGLLEKG-----------------  482 (1157)
T ss_pred             cccCccCcccccCcccccc-cccccchhhHHHHHHHHHHHhcCCCCC-CCccHHHHHHHHhcc-----------------
Confidence            666654   4999999875 689999999999999999987 77776 554432222222110                 


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHh
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAM  416 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL  416 (434)
                                         ..++.+.-|++...+|++.||++.|.+||+..|+-
T Consensus       483 -------------------yRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiH  517 (1157)
T KOG4278|consen  483 -------------------YRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIH  517 (1157)
T ss_pred             -------------------ccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence                               11233445889999999999999999999988763

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=4e-36  Score=284.10  Aligned_cols=240  Identities=16%  Similarity=0.238  Sum_probs=175.2

Q ss_pred             eeeecCceEEEEEEEcCC--CeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeecC
Q 013897          141 KVGRGKYSEVFEGVHCTD--NEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVN  214 (434)
Q Consensus       141 ~lG~G~fg~Vy~~~~~~~--~~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~  214 (434)
                      .||+|+||.||+|....+  ...+++|.++..    ..+.+.+|+.+++.+ +||||+++++.+.+.  ...++||||+.
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~--~~~~lv~e~~~   78 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRIL-QHPNILQCLGQCVEA--IPYLLVFEYCE   78 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhcc-CCcchhheEEEecCC--CccEEEEecCC
Confidence            599999999999975433  245667776543    235688999999998 999999999999654  56789999999


Q ss_pred             CCchhhhcC-------CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC---c
Q 013897          215 NTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK---E  284 (434)
Q Consensus       215 ~~~l~~~~~-------~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~---~  284 (434)
                      +++|..++.       .++...+..++.||+.||+|||+++|+||||||+|||++.++ .+||+|||++.......   .
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~-~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDL-TVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCc-cEEecccccccccCcchhhhc
Confidence            999876652       245566788999999999999999999999999999999776 89999999986432211   1


Q ss_pred             cceeccCCcccccccccC------CCCCCccccHHHHHHHHHHHHhC-CCCCCCCCCCHHHHHHHHHHhCChhHHHHHhh
Q 013897          285 YNVRVASRYFKGPELLVD------LQDYDYSLDLWSLGCMFAGMIFR-KEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK  357 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~------~~~~~~~~DvwSlGvil~elltg-~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  357 (434)
                      .....++..|+|||++..      ...++.++|||||||++|||+++ ..|| ......+.+..+......         
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~-~~~~~~~~~~~~~~~~~~---------  227 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPY-SHLSDREVLNHVIKDQQV---------  227 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHhhccc---------
Confidence            123467788999998743      12457899999999999999975 5555 333333333322110000         


Q ss_pred             ccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                         .                   .........+++.+.+++..|+ .+|++||+++|+++
T Consensus       228 ---~-------------------~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         228 ---K-------------------LFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             ---c-------------------cCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence               0                   0000001125678899999999 68999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=3e-37  Score=299.25  Aligned_cols=250  Identities=20%  Similarity=0.349  Sum_probs=196.6

Q ss_pred             CCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       132 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      ..+...++++||+|.||+|.+|.. ..+.+||+|.+++..    +.+|.+|+++|.+| .|||||+++|+|..+  ..++
T Consensus       536 PRs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqL-khPNIveLvGVC~~D--ePic  611 (807)
T KOG1094|consen  536 PRSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKNARNDFLKEIKILSRL-KHPNIVELLGVCVQD--DPLC  611 (807)
T ss_pred             chhheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchhHHHHHHHHHHHHhcc-CCCCeeEEEeeeecC--CchH
Confidence            346678899999999999999986 457999999998643    46799999999999 999999999999654  5677


Q ss_pred             EEEeecCCCchhhhcCC-----CChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC
Q 013897          208 LIFEHVNNTDFKVLYPT-----LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG  282 (434)
Q Consensus       208 lv~e~~~~~~l~~~~~~-----l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~  282 (434)
                      +|+|||++|+|.+++..     +.......++.||+.||+||.+.++|||||.+.|+|++.+. ++||+|||+++.+..+
T Consensus       612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~-~iKiadfgmsR~lysg  690 (807)
T KOG1094|consen  612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEF-TIKIADFGMSRNLYSG  690 (807)
T ss_pred             HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcc-cEEecCcccccccccC
Confidence            99999999999888642     23445567999999999999999999999999999999777 8999999999877666


Q ss_pred             Ccccee---ccCCcccccccccCCCCCCccccHHHHHHHHHHHH--hCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhh
Q 013897          283 KEYNVR---VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI--FRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK  357 (434)
Q Consensus       283 ~~~~~~---~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell--tg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  357 (434)
                      ..+...   +-...|||+|.+.. ++++.++|||+||+++||++  +...||..- .+.+........+..+        
T Consensus       691 ~yy~vqgr~vlpiRwmawEsill-gkFttaSDvWafgvTlwE~~~~C~e~Py~~l-t~e~vven~~~~~~~~--------  760 (807)
T KOG1094|consen  691 DYYRVQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEVFMLCREQPYSQL-TDEQVVENAGEFFRDQ--------  760 (807)
T ss_pred             CceeeecceeeeeeehhHHHHHh-ccccchhhhhhhHHHHHHHHHHHhhCchhhh-hHHHHHHhhhhhcCCC--------
Confidence            554333   55678999999987 79999999999999999975  577787221 1111111211111111        


Q ss_pred             ccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                      .+.   .  -...+..++..+.++|.+||..|-++||+.+++-.
T Consensus       761 ----------------~~~---~--~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  761 ----------------GRQ---V--VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL  799 (807)
T ss_pred             ----------------Ccc---e--eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence                            111   0  12234457889999999999999999999999854

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4.4e-36  Score=303.15  Aligned_cols=264  Identities=19%  Similarity=0.314  Sum_probs=180.2

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEc----------------CCCeEEEEEEeccccH---HH--------------HHHHH
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHC----------------TDNEKCIIKILKPVKK---KK--------------IKREI  179 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~----------------~~~~~vaiK~~~~~~~---~~--------------~~~E~  179 (434)
                      .++|++.++||+|+||.||+|.+.                ..++.||||.++....   ++              ...|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            578999999999999999999752                2346799999864321   12              23466


Q ss_pred             HHHHHhcCCCC-----eeeEeeEEEcc------CCCccEEEEeecCCCchhhhcC-------------------------
Q 013897          180 KILQNLCGGPN-----IVKLLDIVRDQ------QSKTPSLIFEHVNNTDFKVLYP-------------------------  223 (434)
Q Consensus       180 ~~l~~l~~h~n-----iv~l~~~~~~~------~~~~~~lv~e~~~~~~l~~~~~-------------------------  223 (434)
                      .++.++ +|.+     +++++++|...      .....+|||||+.+++|..++.                         
T Consensus       224 ~~l~~l-~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        224 YMCAKI-KRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHh-hcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            677777 4443     46777877532      1245789999999998866542                         


Q ss_pred             --CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCccce--eccCCccccccc
Q 013897          224 --TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV--RVASRYFKGPEL  299 (434)
Q Consensus       224 --~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~~~--~~~t~~y~aPE~  299 (434)
                        .+++..++.++.|++.||.|||+++|+||||||+|||++.++ .+||+|||++...........  ..+++.|+|||.
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~  381 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDG-QVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEE  381 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCC-cEEEEeCcCccccccCCccCccccCCCcceeChhh
Confidence              124456788999999999999999999999999999999776 899999999976543332222  234788999999


Q ss_pred             ccCCCC-------------------CC--ccccHHHHHHHHHHHHhCCC-CCCCCCCCHHHHHHHHHHhCChhHHHHHhh
Q 013897          300 LVDLQD-------------------YD--YSLDLWSLGCMFAGMIFRKE-PFFYGHDNYDQLVKIAKVLGTDELNAYLNK  357 (434)
Q Consensus       300 ~~~~~~-------------------~~--~~~DvwSlGvil~elltg~~-pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  357 (434)
                      +.....                   |+  .+.||||+||++|+|++|.. ||. +..   .+....+... .....|...
T Consensus       382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~-~~~---~f~~~~~~~~-~~~~~~r~~  456 (507)
T PLN03224        382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA-NIR---LFNTELRQYD-NDLNRWRMY  456 (507)
T ss_pred             hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc-chh---hhhhHHhhcc-chHHHHHhh
Confidence            753211                   11  34799999999999999876 552 111   1110000000 001111100


Q ss_pred             ccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCC---CCCccHHHHhcCCCccc
Q 013897          358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDH---QERPTAKEAMAHPYFFP  423 (434)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP---~~Rpt~~elL~Hp~~~~  423 (434)
                                      ....    ..+......++.++||+.+||..+|   .+|+|++|+|+||||.+
T Consensus       457 ----------------~~~~----~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        457 ----------------KGQK----YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             ----------------cccC----CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence                            0000    0111223367889999999999876   68999999999999965

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-37  Score=310.30  Aligned_cols=243  Identities=18%  Similarity=0.325  Sum_probs=203.3

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCC---eEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDN---EKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~---~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      ....+.+.||.|.||+|++|+.+..+   ..||||.+|..    .+.+|..|..||-++ +||||++|.|++..  ...+
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF-dHPNIIrLEGVVTk--s~Pv  705 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF-DHPNIIRLEGVVTK--SKPV  705 (996)
T ss_pred             hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC-CCCcEEEEEEEEec--Ccee
Confidence            34678899999999999999987665   58999999853    356799999999999 99999999999954  4778


Q ss_pred             EEEEeecCCCchhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC
Q 013897          207 SLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG  282 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~  282 (434)
                      +||.|||++|.|+.+++    +|...+...+++.|+.||.||-+.++|||||-+.|||++.+- .+|++|||+++.+.++
T Consensus       706 MIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnL-vCKVsDFGLSRvledd  784 (996)
T KOG0196|consen  706 MIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNL-VCKVSDFGLSRVLEDD  784 (996)
T ss_pred             EEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccce-EEEeccccceeecccC
Confidence            89999999999988874    588889999999999999999999999999999999999766 8999999999988665


Q ss_pred             C--ccceeccC--CcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhh
Q 013897          283 K--EYNVRVAS--RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK  357 (434)
Q Consensus       283 ~--~~~~~~~t--~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  357 (434)
                      .  .+++..|-  ..|.|||.+.- ++++.++|||||||+|||.++ |..||+ .-.+++.+..|.+...          
T Consensus       785 ~~~~ytt~GGKIPiRWTAPEAIa~-RKFTsASDVWSyGIVmWEVmSyGERPYW-dmSNQdVIkaIe~gyR----------  852 (996)
T KOG0196|consen  785 PEAAYTTLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYW-DMSNQDVIKAIEQGYR----------  852 (996)
T ss_pred             CCccccccCCccceeecChhHhhh-cccCchhhccccceEEEEecccCCCccc-ccchHHHHHHHHhccC----------
Confidence            4  23333332  46999999886 899999999999999999775 999984 4455666665544322          


Q ss_pred             ccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                                                +..+..++..+.+|+..||++|-.+||...|++++
T Consensus       853 --------------------------LPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  853 --------------------------LPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             --------------------------CCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence                                      22233488899999999999999999999999863

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.5e-35  Score=325.99  Aligned_cols=254  Identities=21%  Similarity=0.288  Sum_probs=188.3

Q ss_pred             CeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeecC
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVN  214 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~  214 (434)
                      .|...+.||+|+||.||+|.+..++..||+|.++... .....|+++++++ +|||||+++++|.+.  ...++||||++
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~l~~l-~HpnIv~~~~~~~~~--~~~~lv~Ey~~  766 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVN-SIPSSEIADMGKL-QHPNIVKLIGLCRSE--KGAYLIHEYIE  766 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCc-cccHHHHHHHhhC-CCCCcceEEEEEEcC--CCCEEEEeCCC
Confidence            4566778999999999999998899999999986433 2234678899999 999999999999764  45689999999


Q ss_pred             CCchhhhcCCCChHHHHHHHHHHHHHHHHHH---HCCceeecCCCCceEecCCCCeEEEEecccceecCCCCccceeccC
Q 013897          215 NTDFKVLYPTLSDYDVRYYIYELLKALDYCH---SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS  291 (434)
Q Consensus       215 ~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~~~~~~t  291 (434)
                      +++|..++..+++..+..++.||+.||+|||   +.+|+||||||+||+++.++ ..++. ||.+.....   .....++
T Consensus       767 ~g~L~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~-~~~~~-~~~~~~~~~---~~~~~~t  841 (968)
T PLN00113        767 GKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKD-EPHLR-LSLPGLLCT---DTKCFIS  841 (968)
T ss_pred             CCcHHHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCC-ceEEE-ecccccccc---CCCcccc
Confidence            9999999888999999999999999999999   66999999999999999665 56664 666543321   1234678


Q ss_pred             CcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHhc
Q 013897          292 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVG  371 (434)
Q Consensus       292 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~  371 (434)
                      ..|+|||++.+ ..++.++|||||||++|||++|+.||...........+..+..-..              .......+
T Consensus       842 ~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~  906 (968)
T PLN00113        842 SAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSD--------------CHLDMWID  906 (968)
T ss_pred             ccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCc--------------cchhheeC
Confidence            99999999876 6899999999999999999999999854332222222211110000              00000000


Q ss_pred             ccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          372 RHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                      ......      .........++.+++.+||+.||++|||+.|+++.
T Consensus       907 ~~~~~~------~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        907 PSIRGD------VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             ccccCC------CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            000000      00000122467899999999999999999999875

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=9.7e-35  Score=268.47  Aligned_cols=237  Identities=34%  Similarity=0.596  Sum_probs=191.3

Q ss_pred             CceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeecCCCchhhh
Q 013897          146 KYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL  221 (434)
Q Consensus       146 ~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~  221 (434)
                      +||.||+|.+..+++.+|+|++....    .+.+.+|+..++++ +|+|++++++.+...  ...++++||+.+++|..+
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~--~~~~l~~e~~~~~~L~~~   77 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKL-KHPNIVRLYDVFEDE--DKLYLVMEYCDGGDLFDL   77 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhC-CCCcHHHHHhheeeC--CEEEEEEeCCCCCCHHHH
Confidence            58999999998889999999987543    57889999999999 999999999998654  567899999999988776


Q ss_pred             cCC---CChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCccceeccCCcccccc
Q 013897          222 YPT---LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE  298 (434)
Q Consensus       222 ~~~---l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~~~~~~t~~y~aPE  298 (434)
                      +..   ++...+..++.+++.+|.|||+.+++|+||+|+||+++.++ .++|+|||.+.............++..|++||
T Consensus        78 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE  156 (244)
T smart00220       78 LKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDG-HVKLADFGLARQLDPGGLLTTFVGTPEYMAPE  156 (244)
T ss_pred             HHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCC-cEEEccccceeeeccccccccccCCcCCCCHH
Confidence            532   78889999999999999999999999999999999999776 89999999998776544455667888999999


Q ss_pred             cccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCC
Q 013897          299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPW  378 (434)
Q Consensus       299 ~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  378 (434)
                      .+.+ ..++.++||||||+++++|++|..||....+. ......   +...                        ..   
T Consensus       157 ~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~-~~~~~~---~~~~------------------------~~---  204 (244)
T smart00220      157 VLLG-KGYGKAVDVWSLGVILYELLTGKPPFPGDDQL-LELFKK---IGKP------------------------KP---  204 (244)
T ss_pred             HHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHH---Hhcc------------------------CC---
Confidence            9875 67888999999999999999999998443222 111111   1000                        00   


Q ss_pred             ccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          379 SKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       379 ~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                      .   .......++.++.+++.+||..||++||++.++++||||
T Consensus       205 ~---~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      205 P---FPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF  244 (244)
T ss_pred             C---CccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence            0   000000155789999999999999999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-36  Score=294.21  Aligned_cols=244  Identities=18%  Similarity=0.314  Sum_probs=197.2

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCC---eEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDN---EKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~---~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      ++..+.++||+|.||.|++|.|..-+   -.||||.++...    ...|.+|+.+|.+| +|+|+++|||++.+   ..+
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L-~H~hliRLyGvVl~---qp~  185 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKL-QHPHLIRLYGVVLD---QPA  185 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhc-cCcceeEEeeeecc---chh
Confidence            45667889999999999999986432   478999997543    46899999999999 99999999999965   356


Q ss_pred             EEEEeecCCCchhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC
Q 013897          207 SLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP  281 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~  281 (434)
                      .+|+|.+..|+|.+.+.     .|.......|+.||+.||.||..+++|||||-..|+|+.... .|||+||||.+.+..
T Consensus       186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllaspr-tVKI~DFGLmRaLg~  264 (1039)
T KOG0199|consen  186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPR-TVKICDFGLMRALGE  264 (1039)
T ss_pred             hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccc-eeeeecccceeccCC
Confidence            79999999999866553     366777889999999999999999999999999999998765 899999999988866


Q ss_pred             CCccceecc----CCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHh
Q 013897          282 GKEYNVRVA----SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN  356 (434)
Q Consensus       282 ~~~~~~~~~----t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~  356 (434)
                      ...+....+    ...|+|||.+.. ..++.++|||+|||++|||++ |..|| .|......+.+|.+            
T Consensus       265 ned~Yvm~p~rkvPfAWCaPEsLrh-~kFShaSDvWmyGVTiWEMFtyGEePW-~G~~g~qIL~~iD~------------  330 (1039)
T KOG0199|consen  265 NEDMYVMAPQRKVPFAWCAPESLRH-RKFSHASDVWMYGVTIWEMFTYGEEPW-VGCRGIQILKNIDA------------  330 (1039)
T ss_pred             CCcceEecCCCcCcccccCHhHhcc-ccccccchhhhhhhhHHhhhccCCCCC-CCCCHHHHHHhccc------------
Confidence            554433322    235999999876 799999999999999999998 66676 55555444444321            


Q ss_pred             hccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCC
Q 013897          357 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY  420 (434)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~  420 (434)
                                      .        ..+..++.|+.++.++++.||..+|.+|||...+.+.-+
T Consensus       331 ----------------~--------erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~  370 (1039)
T KOG0199|consen  331 ----------------G--------ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV  370 (1039)
T ss_pred             ----------------c--------ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence                            0        123445668999999999999999999999988764433

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-36  Score=256.82  Aligned_cols=207  Identities=20%  Similarity=0.405  Sum_probs=176.6

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecc----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      ++...+..||+|++|.|-+.++..+|...|+|.++.    ...++..+|+.+..+...+|.+|++||.....  ..+++.
T Consensus        46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re--gdvwIc  123 (282)
T KOG0984|consen   46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE--GDVWIC  123 (282)
T ss_pred             hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc--ccEEEe
Confidence            556677889999999999999999999999998863    34566889999988877899999999976443  456788


Q ss_pred             EeecCCCchhhhc-------CCCChHHHHHHHHHHHHHHHHHHHC-CceeecCCCCceEecCCCCeEEEEecccceecCC
Q 013897          210 FEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP  281 (434)
Q Consensus       210 ~e~~~~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~  281 (434)
                      ||.|... +..++       ..+++..+-+++..++.||.|||++ .|+|||+||+|||++.+| .||+||||++..+.+
T Consensus       124 ME~M~tS-ldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~G-qVKiCDFGIsG~L~d  201 (282)
T KOG0984|consen  124 MELMDTS-LDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDG-QVKICDFGISGYLVD  201 (282)
T ss_pred             HHHhhhh-HHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCC-cEEEcccccceeehh
Confidence            9988754 33332       3488889999999999999999987 899999999999999888 899999999988877


Q ss_pred             CCccceeccCCcccccccccC---CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 013897          282 GKEYNVRVASRYFKGPELLVD---LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK  344 (434)
Q Consensus       282 ~~~~~~~~~t~~y~aPE~~~~---~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~  344 (434)
                      ....+...|...|||||.+..   ...|+.++||||||+.++||.+++.||..+....+++..+.+
T Consensus       202 SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe  267 (282)
T KOG0984|consen  202 SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE  267 (282)
T ss_pred             hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence            666666788999999999843   247999999999999999999999999999999888887654

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-35  Score=276.39  Aligned_cols=262  Identities=20%  Similarity=0.262  Sum_probs=194.2

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHh-cCCCCeeeEeeEEEccC--CCccEEEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNL-CGGPNIVKLLDIVRDQQ--SKTPSLIF  210 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~E~~~l~~l-~~h~niv~l~~~~~~~~--~~~~~lv~  210 (434)
                      +...+.+.||+|.||.||+|..  +++.||||++....+..+..|-+|.... ..|+||+++++.-....  ..-..||+
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt  287 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT  287 (534)
T ss_pred             CchhhHHHhhcCccceeehhhc--cCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence            4456788999999999999987  5699999999999999999998887754 48999999998754322  33567999


Q ss_pred             eecCCCchhhhcC--CCChHHHHHHHHHHHHHHHHHHHC---------CceeecCCCCceEecCCCCeEEEEecccceec
Q 013897          211 EHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQ---------GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY  279 (434)
Q Consensus       211 e~~~~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~---------~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~  279 (434)
                      +|.+.|+|.+++.  .++|.....++..|++||+|||+-         .|+|||||..||||..|. +..|+|||+|..+
T Consensus       288 ~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl-TccIaDFGLAl~~  366 (534)
T KOG3653|consen  288 EFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL-TCCIADFGLALRL  366 (534)
T ss_pred             eeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC-cEEeeccceeEEe
Confidence            9999999988875  489999999999999999999973         599999999999999777 8999999999887


Q ss_pred             CCCCcc---ceeccCCcccccccccCCCCCC-----ccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCC-hh
Q 013897          280 HPGKEY---NVRVASRYFKGPELLVDLQDYD-----YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT-DE  350 (434)
Q Consensus       280 ~~~~~~---~~~~~t~~y~aPE~~~~~~~~~-----~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~-~~  350 (434)
                      .++...   ...+||..|||||++.+.-.+.     .+.||||+|.+||||+++..-++++.....++--- ..+|. +.
T Consensus       367 ~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe-~evG~hPt  445 (534)
T KOG3653|consen  367 EPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE-AEVGNHPT  445 (534)
T ss_pred             cCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh-HHhcCCCC
Confidence            665432   3468999999999997643333     46899999999999999876665443333332211 12222 11


Q ss_pred             HHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHH
Q 013897          351 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK  413 (434)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~  413 (434)
                      .....           .-++....|..+...  +... .....+.+.+..||..||+.|.|+.
T Consensus       446 ~e~mq-----------~~VV~kK~RP~~p~~--W~~h-~~~~~l~et~EeCWDhDaeARLTA~  494 (534)
T KOG3653|consen  446 LEEMQ-----------ELVVRKKQRPKIPDA--WRKH-AGMAVLCETIEECWDHDAEARLTAG  494 (534)
T ss_pred             HHHHH-----------HHHHhhccCCCChhh--hhcC-ccHHHHHHHHHHHcCCchhhhhhhH
Confidence            11111           011222222222111  1111 2335689999999999999999975

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-35  Score=294.05  Aligned_cols=246  Identities=26%  Similarity=0.407  Sum_probs=187.2

Q ss_pred             eEEEeeeeecCceE-EEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeecC
Q 013897          136 YEVVRKVGRGKYSE-VFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVN  214 (434)
Q Consensus       136 y~~~~~lG~G~fg~-Vy~~~~~~~~~~vaiK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~  214 (434)
                      |.-.+.+|.|+.|+ ||+|..  .++.||||.+-....+.+.+|+..|+.--.|||||++++.-  .+..++||..|.|.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E--~d~qF~YIalELC~  586 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSE--QDRQFLYIALELCA  586 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee--CCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeec--cCCceEEEEehHhh
Confidence            44456789999975 699997  68899999998777788899999999988999999998765  45577889999887


Q ss_pred             CCchhhhcCC-------CChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecC---CC-CeEEEEecccceecCCCC
Q 013897          215 NTDFKVLYPT-------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH---EQ-RKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       215 ~~~l~~~~~~-------l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~---~~-~~vkl~DFGla~~~~~~~  283 (434)
                      ... .+++..       ......+.++.|+++||++||+.+||||||||.||||+.   ++ ..++|+|||+++.+..+.
T Consensus       587 ~sL-~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~  665 (903)
T KOG1027|consen  587 CSL-QDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK  665 (903)
T ss_pred             hhH-HHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence            643 333221       122456788899999999999999999999999999986   23 478999999999987665


Q ss_pred             cc----ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhC-CCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhc
Q 013897          284 EY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFR-KEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY  358 (434)
Q Consensus       284 ~~----~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg-~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  358 (434)
                      ..    ....||.+|+|||.+.. ..-..++||+||||++|+.++| ..||.   +..+.-+.|..  |..         
T Consensus       666 sS~~r~s~~sGt~GW~APE~L~~-~~~~~avDiFslGCvfyYvltgG~HpFG---d~~~R~~NIl~--~~~---------  730 (903)
T KOG1027|consen  666 SSFSRLSGGSGTSGWQAPEQLRE-DRKTQAVDIFSLGCVFYYVLTGGSHPFG---DSLERQANILT--GNY---------  730 (903)
T ss_pred             chhhcccCCCCcccccCHHHHhc-cccCcccchhhcCceEEEEecCCccCCC---chHHhhhhhhc--Ccc---------
Confidence            43    34478999999999977 4556699999999999999886 88983   22222222211  000         


Q ss_pred             cccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccc
Q 013897          359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI  424 (434)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~  424 (434)
                                          . .......  ...++.|||.+||..||..||+|.+||.||||...
T Consensus       731 --------------------~-L~~L~~~--~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~  773 (903)
T KOG1027|consen  731 --------------------T-LVHLEPL--PDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS  773 (903)
T ss_pred             --------------------c-eeeeccC--chHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence                                0 0000000  01179999999999999999999999999999865

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-33  Score=265.43  Aligned_cols=189  Identities=19%  Similarity=0.313  Sum_probs=158.5

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHh-cCCCCeeeEeeEEEccCC--CccEEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNL-CGGPNIVKLLDIVRDQQS--KTPSLI  209 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~E~~~l~~l-~~h~niv~l~~~~~~~~~--~~~~lv  209 (434)
                      -.+..+.+.||+|.||+||+|.+  .|+.||||++.......+.+|.+|.+.+ .+|+||+.+++.-....+  ..++||
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLv  287 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLV  287 (513)
T ss_pred             hheeEEEEEecCccccceeeccc--cCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEe
Confidence            35678999999999999999998  5899999999988888899999998863 599999999986543222  247899


Q ss_pred             EeecCCCchhhhcC--CCChHHHHHHHHHHHHHHHHHHHC--------CceeecCCCCceEecCCCCeEEEEecccceec
Q 013897          210 FEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQ--------GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY  279 (434)
Q Consensus       210 ~e~~~~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~--------~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~  279 (434)
                      .+|.+.|+|.+++.  .++......++..++.||++||..        .|.|||||+.|||+..++ .+.|+|+|||...
T Consensus       288 TdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~-~C~IADLGLAv~h  366 (513)
T KOG2052|consen  288 TDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVRH  366 (513)
T ss_pred             eecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC-cEEEeeceeeEEe
Confidence            99999999988875  478888999999999999999963        499999999999999777 8999999999765


Q ss_pred             CCC-----CccceeccCCcccccccccCCCC---C-C-ccccHHHHHHHHHHHHh
Q 013897          280 HPG-----KEYNVRVASRYFKGPELLVDLQD---Y-D-YSLDLWSLGCMFAGMIF  324 (434)
Q Consensus       280 ~~~-----~~~~~~~~t~~y~aPE~~~~~~~---~-~-~~~DvwSlGvil~ellt  324 (434)
                      ..+     ...+.++||..|||||++.+.-.   + + ..+||||||.++||+..
T Consensus       367 ~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar  421 (513)
T KOG2052|consen  367 DSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR  421 (513)
T ss_pred             cccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence            443     23477899999999999865222   1 1 35899999999999874

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-32  Score=286.04  Aligned_cols=243  Identities=23%  Similarity=0.390  Sum_probs=191.3

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcC-------CCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccC
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCT-------DNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ  202 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~-------~~~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  202 (434)
                      ++..+.+.||+|.||.|++|....       ....||||.++..    ..+.+..|+++|+.+..|+||+.++|.|..  
T Consensus       296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~--  373 (609)
T KOG0200|consen  296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ--  373 (609)
T ss_pred             hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc--
Confidence            344567799999999999997531       1468999998743    346789999999999999999999999976  


Q ss_pred             CCccEEEEeecCCCchhhhcC--C-----------------CChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecC
Q 013897          203 SKTPSLIFEHVNNTDFKVLYP--T-----------------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH  263 (434)
Q Consensus       203 ~~~~~lv~e~~~~~~l~~~~~--~-----------------l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~  263 (434)
                      ...+++|+||+..|+|..++.  +                 ++..+...++.||+.|++||+++++|||||-++|||+..
T Consensus       374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~  453 (609)
T KOG0200|consen  374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITK  453 (609)
T ss_pred             CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecC
Confidence            567889999999999876642  2                 777889999999999999999999999999999999996


Q ss_pred             CCCeEEEEecccceecCCCCcccee--cc--CCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCC-CHH
Q 013897          264 EQRKLRLIDWGLAEFYHPGKEYNVR--VA--SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHD-NYD  337 (434)
Q Consensus       264 ~~~~vkl~DFGla~~~~~~~~~~~~--~~--t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~-~~~  337 (434)
                      +. .+||+|||+|+.......+...  .+  ...|||||.+.. ..|+.++|||||||+|||+++ |..|| ++-. ..+
T Consensus       454 ~~-~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PY-p~~~~~~~  530 (609)
T KOG0200|consen  454 NK-VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPY-PGIPPTEE  530 (609)
T ss_pred             CC-EEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCC-CCCCcHHH
Confidence            65 8999999999876555544322  22  234999999987 789999999999999999998 66666 4322 212


Q ss_pred             HHHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          338 QLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       338 ~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                      .+..+.                            ..        .....+..+++++.++++.||..+|++||+..|+..
T Consensus       531 l~~~l~----------------------------~G--------~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  531 LLEFLK----------------------------EG--------NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             HHHHHh----------------------------cC--------CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            211110                            00        012334457899999999999999999999887753

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-34  Score=283.95  Aligned_cols=256  Identities=26%  Similarity=0.435  Sum_probs=204.4

Q ss_pred             CCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       132 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      ..++|+++..+|.|+||.||+++++.+++..|+|+++-.   ..+-+.+|+-+++.. +|||||.+++.+-..  ..+++
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc-~h~nivay~gsylr~--dklwi   89 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDC-RHPNIVAYFGSYLRR--DKLWI   89 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecC-CCcChHHHHhhhhhh--cCcEE
Confidence            358899999999999999999999999999999999743   345567899899887 999999999988543  45679


Q ss_pred             EEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC-Cc
Q 013897          209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KE  284 (434)
Q Consensus       209 v~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~-~~  284 (434)
                      +||||++|+|++.+   ..+++.++.+++++.++||+|||+.|-+|||||-.|||+++.+ .+|++|||.+..+... ..
T Consensus        90 cMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~g-DvklaDfgvsaqitati~K  168 (829)
T KOG0576|consen   90 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEG-DVKLADFGVSAQITATIAK  168 (829)
T ss_pred             EEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccC-ceeecccCchhhhhhhhhh
Confidence            99999999998876   4689999999999999999999999999999999999999777 8999999998554322 23


Q ss_pred             cceeccCCcccccccccC--CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          285 YNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~--~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                      .....||++|||||+-.-  .+.|...+|||++|+...|+---+.|.|.-.. ...+..+.+ -+               
T Consensus       169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp-mr~l~LmTk-S~---------------  231 (829)
T KOG0576|consen  169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP-MRALFLMTK-SG---------------  231 (829)
T ss_pred             hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch-HHHHHHhhc-cC---------------
Confidence            356789999999999632  24799999999999999999888877642211 111111111 00               


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI  424 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~  424 (434)
                                      .+.........-++.+.+|++.+|..+|++||+++.+|.|||+..-
T Consensus       232 ----------------~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~  277 (829)
T KOG0576|consen  232 ----------------FQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT  277 (829)
T ss_pred             ----------------CCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence                            0111222333456779999999999999999999999999999764

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-33  Score=281.88  Aligned_cols=239  Identities=21%  Similarity=0.366  Sum_probs=191.3

Q ss_pred             eEEEeeeeecCceEEEEEEEcCCCe----EEEEEEecc----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          136 YEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKP----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       136 y~~~~~lG~G~fg~Vy~~~~~~~~~----~vaiK~~~~----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      ....++||+|+||+||+|.+-..++    +||||++..    .+..++..|+.+|.++ +|||+++|+++|...   .+.
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masl-dHpnl~RLLgvc~~s---~~q  773 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASL-DHPNLLRLLGVCMLS---TLQ  773 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcC-CCchHHHHhhhcccc---hHH
Confidence            4467889999999999999876664    678888853    3457899999999999 999999999999543   378


Q ss_pred             EEEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC
Q 013897          208 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       208 lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~  283 (434)
                      ||.+|++.|.|.++.    ..+.......+..||++||.|||+++++||||-.+|||+...+ .+||.|||+|+.+.++.
T Consensus       774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~-hvkitdfgla~ll~~d~  852 (1177)
T KOG1025|consen  774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPN-HVKITDFGLAKLLAPDE  852 (1177)
T ss_pred             HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCC-eEEEEecchhhccCccc
Confidence            999999999987765    3577888899999999999999999999999999999999777 89999999999886654


Q ss_pred             c-cceecc--CCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcc
Q 013897          284 E-YNVRVA--SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH  359 (434)
Q Consensus       284 ~-~~~~~~--t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  359 (434)
                      . +....|  .+.|||=|.+.. ..|+.++|||||||.+||++| |..|++ +....+    |-+.+             
T Consensus       853 ~ey~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~-gi~~~e----I~dll-------------  913 (1177)
T KOG1025|consen  853 KEYSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYD-GIPAEE----IPDLL-------------  913 (1177)
T ss_pred             ccccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccC-CCCHHH----hhHHH-------------
Confidence            3 333332  345899998876 789999999999999999998 888873 222111    11111             


Q ss_pred             ccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          360 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                 ...        ..+..+..++-++.-++.+||..|+..||+++++..
T Consensus       914 -----------e~g--------eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  914 -----------EKG--------ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             -----------hcc--------ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence                       000        123345568889999999999999999999988753

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=3.3e-32  Score=264.18  Aligned_cols=196  Identities=27%  Similarity=0.501  Sum_probs=168.7

Q ss_pred             CCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccccH-----------HHHHHHHHHHHHhc--CCCCeeeEeeEE
Q 013897          132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK-----------KKIKREIKILQNLC--GGPNIVKLLDIV  198 (434)
Q Consensus       132 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-----------~~~~~E~~~l~~l~--~h~niv~l~~~~  198 (434)
                      ...+|..+..+|.|+||.|++|.++.+...|+||.+.+.+.           ..+-.||.||..|.  .|+||++++++|
T Consensus       559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF  638 (772)
T KOG1152|consen  559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF  638 (772)
T ss_pred             ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence            34679999999999999999999999999999999865431           23567999999992  399999999999


Q ss_pred             EccCCCccEEEEeecCCC-chhhh---cCCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecc
Q 013897          199 RDQQSKTPSLIFEHVNNT-DFKVL---YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG  274 (434)
Q Consensus       199 ~~~~~~~~~lv~e~~~~~-~l~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFG  274 (434)
                      +++  .+.||+||--+.| +|-.+   .+.+.+.+++.+++|++.|+++||+.||||||||-+||.++.+| .+||+|||
T Consensus       639 Edd--d~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g-~~klidfg  715 (772)
T KOG1152|consen  639 EDD--DYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNG-FVKLIDFG  715 (772)
T ss_pred             ecC--CeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCC-eEEEeecc
Confidence            765  5667999976544 44444   46799999999999999999999999999999999999999777 89999999


Q ss_pred             cceecCCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCC
Q 013897          275 LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFY  331 (434)
Q Consensus       275 la~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~  331 (434)
                      .|.... .....+.+||..|.|||++.|....+..-|||+||++||-++...-||++
T Consensus       716 saa~~k-sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  716 SAAYTK-SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             chhhhc-CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            997554 55778899999999999999866678889999999999999999999863

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=8.3e-30  Score=229.58  Aligned_cols=205  Identities=34%  Similarity=0.614  Sum_probs=177.5

Q ss_pred             eeecCceEEEEEEEcCCCeEEEEEEeccccH----HHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeecCCCc
Q 013897          142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKK----KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD  217 (434)
Q Consensus       142 lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~  217 (434)
                      ||+|++|.||++....+++.+++|++.....    ..+.+|+.+++.+ .|++++++++++...  ...++++|++.+++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~--~~~~~~~e~~~~~~   77 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKL-NHPNIVKLYGVFEDE--NHLYLVMEYCEGGS   77 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhc-CCCCeeeEeeeeecC--CeEEEEEecCCCCc
Confidence            6899999999999977799999999986654    6799999999999 889999999999654  56789999999999


Q ss_pred             hhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecC-CCCeEEEEecccceecCCCC-ccceeccC
Q 013897          218 FKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH-EQRKLRLIDWGLAEFYHPGK-EYNVRVAS  291 (434)
Q Consensus       218 l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~-~~~~vkl~DFGla~~~~~~~-~~~~~~~t  291 (434)
                      |..++.    .++...+..++.+++.+|.+||++|++|+||+|.||+++. ++ .++|+|||.+....... ......+.
T Consensus        78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~  156 (215)
T cd00180          78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNG-KVKLADFGLSKLLTSDKSLLKTIVGT  156 (215)
T ss_pred             HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCC-cEEEecCCceEEccCCcchhhcccCC
Confidence            887763    4788899999999999999999999999999999999997 45 89999999997664332 13345677


Q ss_pred             CcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHhc
Q 013897          292 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVG  371 (434)
Q Consensus       292 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~  371 (434)
                      ..|++||.+.....++.+.|+|+||+++++|                                                 
T Consensus       157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------------  187 (215)
T cd00180         157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------------  187 (215)
T ss_pred             CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------------
Confidence            8899999987633788999999999999998                                                 


Q ss_pred             ccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCC
Q 013897          372 RHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHP  419 (434)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp  419 (434)
                                          ..+.+++.+|+..||++||++.++++|+
T Consensus       188 --------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 --------------------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             --------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                                0467899999999999999999999985

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=9.5e-32  Score=239.62  Aligned_cols=256  Identities=19%  Similarity=0.310  Sum_probs=188.5

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecc--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF  210 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~--~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  210 (434)
                      .|.|.+.+.||+|.||.+-++.++.+++.+|+|.+..  ....+|.+|...--.|..|.||+.-|++.-.. ....++++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt-~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQT-SDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhc-CceEEEee
Confidence            3779999999999999999999999999999999864  34578999998777778899999988865433 34667899


Q ss_pred             eecCCCchhhhcC--CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEe-cCCCCeEEEEecccceecCCCCccce
Q 013897          211 EHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI-DHEQRKLRLIDWGLAEFYHPGKEYNV  287 (434)
Q Consensus       211 e~~~~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll-~~~~~~vkl~DFGla~~~~~~~~~~~  287 (434)
                      ||++.|+|..-..  .+.+...+.++.|++.|++|+|++++||||||.+|||| +.|...|||||||+.+...  .....
T Consensus       102 E~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g--~tV~~  179 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG--TTVKY  179 (378)
T ss_pred             ccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccC--ceehh
Confidence            9999999987765  47888889999999999999999999999999999998 4556689999999986432  11111


Q ss_pred             eccCCcccccccccCC--C--CCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          288 RVASRYFKGPELLVDL--Q--DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       288 ~~~t~~y~aPE~~~~~--~--~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                      .--+..|.+||++...  +  ...+.+|||.||+++|.++||++||-..........+..+         |.......+ 
T Consensus       180 ~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~---------w~~rk~~~~-  249 (378)
T KOG1345|consen  180 LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQ---------WLKRKNPAL-  249 (378)
T ss_pred             hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHH---------HhcccCccC-
Confidence            2234458899987431  1  2467899999999999999999999322111111111111         111100000 


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCC---ccHHHHhcCCCc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQER---PTAKEAMAHPYF  421 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~R---pt~~elL~Hp~~  421 (434)
                                          ..+...+++.+..+.++-|..++++|   -+++.....-|.
T Consensus       250 --------------------P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~  290 (378)
T KOG1345|consen  250 --------------------PKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK  290 (378)
T ss_pred             --------------------chhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence                                01112367789999999999999999   555555555554

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=3.5e-29  Score=229.09  Aligned_cols=192  Identities=33%  Similarity=0.623  Sum_probs=165.3

Q ss_pred             eEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEe
Q 013897          136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE  211 (434)
Q Consensus       136 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  211 (434)
                      |.+.+.||.|++|.||++.+..+++.+|+|.+...    ..+.+.+|++.++++ +|+|++++++++...  ...++++|
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~--~~~~~v~e   77 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKL-KHPNIVKLYGVFEDP--EPLYLVME   77 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhC-CCCChhhheeeeecC--CceEEEEe
Confidence            45788999999999999999888899999999754    456788999999999 899999999998654  56679999


Q ss_pred             ecCCCchhhhcC---C-CChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC--cc
Q 013897          212 HVNNTDFKVLYP---T-LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--EY  285 (434)
Q Consensus       212 ~~~~~~l~~~~~---~-l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~--~~  285 (434)
                      |+.+++|..++.   . +++..+..++.+++.+|.+||+++++|+||+|+||+++.++ .++|+|||++.......  ..
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~-~~~l~d~g~~~~~~~~~~~~~  156 (225)
T smart00221       78 YCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDG-LVKLADFGLARFIHRDLAALL  156 (225)
T ss_pred             ccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEeeCceeeEecCcccccc
Confidence            999988877753   2 78888999999999999999999999999999999999765 89999999998775443  33


Q ss_pred             ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCC
Q 013897          286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFY  331 (434)
Q Consensus       286 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~  331 (434)
                      ....++..|++||.+.....++.++|||+||+++++|++|+.||..
T Consensus       157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            4557788899999974336788899999999999999999999943

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=1.2e-29  Score=236.27  Aligned_cols=244  Identities=17%  Similarity=0.326  Sum_probs=187.1

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCC-----eEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDN-----EKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS  203 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~-----~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  203 (434)
                      .+++.+...+-+|.||.||.|.+...+     +.|-+|.++..    ....+..|--.+..+ .|||+..+.+++.+. .
T Consensus       283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~-sH~nll~V~~V~ie~-~  360 (563)
T KOG1024|consen  283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGA-SHPNLLSVLGVSIED-Y  360 (563)
T ss_pred             hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcC-cCCCccceeEEEeec-c
Confidence            356778888999999999999876433     33445555432    234567888888888 799999999998764 4


Q ss_pred             CccEEEEeecCCCchhhhcC-----------CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEe
Q 013897          204 KTPSLIFEHVNNTDFKVLYP-----------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLID  272 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~~-----------~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~D  272 (434)
                      ...++++.+++-|+|..++.           .++..+...++.|++.|++|||++||||.||-..|++||+. -.|||+|
T Consensus       361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~-LqVkltD  439 (563)
T KOG1024|consen  361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQ-LQVKLTD  439 (563)
T ss_pred             CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhh-eeEEecc
Confidence            56678899999999887763           35667788899999999999999999999999999999955 4899999


Q ss_pred             cccceecCCCCcc---ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCC
Q 013897          273 WGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGT  348 (434)
Q Consensus       273 FGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~  348 (434)
                      =.+++.+-+....   ...-....||+||.+.+ ..|+.++|||||||+||||+| |+.|+ ..-+..+....+.+    
T Consensus       440 saLSRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~yssasDvWsfGVllWELmtlg~~Py-aeIDPfEm~~ylkd----  513 (563)
T KOG1024|consen  440 SALSRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELMTLGKLPY-AEIDPFEMEHYLKD----  513 (563)
T ss_pred             chhccccCcccccccCCCCCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHHhcCCCCc-cccCHHHHHHHHhc----
Confidence            9999876554321   11123446999999987 789999999999999999998 88887 33333222222111    


Q ss_pred             hhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          349 DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                             +         ..+.++-.++++++.++..||+.+|++||+.+|+..
T Consensus       514 -----------------------G---------yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  514 -----------------------G---------YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             -----------------------c---------ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence                                   0         112234458999999999999999999999999864

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=4.2e-30  Score=277.82  Aligned_cols=195  Identities=13%  Similarity=0.197  Sum_probs=137.5

Q ss_pred             CCeeeEeeEEEcc-----CCCccEEEEeecCCCchhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCce
Q 013897          189 PNIVKLLDIVRDQ-----QSKTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNV  259 (434)
Q Consensus       189 ~niv~l~~~~~~~-----~~~~~~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NI  259 (434)
                      +||++++++|...     ....+++++||+.+ +|..++.    .+++.+++.++.||++||+|||++||+||||||+||
T Consensus        33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~-~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni  111 (793)
T PLN00181         33 DYVRSLLGSHKEGNLDGLDDDSIVRALECEDV-SLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF  111 (793)
T ss_pred             HHHHHhhcccCCccccccccchhhhhhccCCc-cHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence            5777777776211     12456678888755 6665552    388999999999999999999999999999999999


Q ss_pred             EecCCC------------------CeEEEEecccceecCCCC-----------------ccceeccCCcccccccccCCC
Q 013897          260 MIDHEQ------------------RKLRLIDWGLAEFYHPGK-----------------EYNVRVASRYFKGPELLVDLQ  304 (434)
Q Consensus       260 ll~~~~------------------~~vkl~DFGla~~~~~~~-----------------~~~~~~~t~~y~aPE~~~~~~  304 (434)
                      ||+..+                  ..+||+|||+++......                 .....+||++|||||++.+ .
T Consensus       112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~  190 (793)
T PLN00181        112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNG-S  190 (793)
T ss_pred             EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhcc-C
Confidence            995322                  256777777765321100                 0112467889999999887 6


Q ss_pred             CCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCcccccc
Q 013897          305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITV  384 (434)
Q Consensus       305 ~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (434)
                      .|+.++|||||||+||||++|..|+...   ...+..+...               ..++..                  
T Consensus       191 ~~~~~sDVwSlGviL~ELl~~~~~~~~~---~~~~~~~~~~---------------~~~~~~------------------  234 (793)
T PLN00181        191 SSNCASDVYRLGVLLFELFCPVSSREEK---SRTMSSLRHR---------------VLPPQI------------------  234 (793)
T ss_pred             CCCchhhhhhHHHHHHHHhhCCCchhhH---HHHHHHHHHh---------------hcChhh------------------
Confidence            7999999999999999999988775210   0111111000               000000                  


Q ss_pred             ccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccc
Q 013897          385 ENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI  424 (434)
Q Consensus       385 ~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~  424 (434)
                         ....+...+++.+||+.||.+||++.|+|+||||...
T Consensus       235 ---~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~  271 (793)
T PLN00181        235 ---LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP  271 (793)
T ss_pred             ---hhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence               0012456789999999999999999999999999864

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=1.7e-27  Score=210.50  Aligned_cols=157  Identities=23%  Similarity=0.306  Sum_probs=117.4

Q ss_pred             CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCccceeccCCcccccccccCC
Q 013897          224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL  303 (434)
Q Consensus       224 ~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~  303 (434)
                      .+++.+++.++.||+.||.|||+++      ||+|||++.++ .+|+  ||++.......    ..|++.|+|||++.+ 
T Consensus        13 ~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~-~~~~--fG~~~~~~~~~----~~g~~~y~aPE~~~~-   78 (176)
T smart00750       13 PLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDG-LLKL--DGSVAFKTPEQ----SRVDPYFMAPEVIQG-   78 (176)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCcc-ceee--ccceEeecccc----CCCcccccChHHhcC-
Confidence            4899999999999999999999998      99999999776 7888  99998654322    368899999999987 


Q ss_pred             CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccc
Q 013897          304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFIT  383 (434)
Q Consensus       304 ~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (434)
                      ..++.++|||||||++|||++|+.||.........+..+........             +.        .+        
T Consensus        79 ~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------------~~--------~~--------  129 (176)
T smart00750       79 QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD-------------PR--------DR--------  129 (176)
T ss_pred             CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCC-------------cc--------cc--------
Confidence            68999999999999999999999998433222222222211110000             00        00        


Q ss_pred             cccccCCch--HHHHHHHHccccCCCCCccHHHHhcCCCcccc
Q 013897          384 VENQHLAVP--EAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI  424 (434)
Q Consensus       384 ~~~~~~~~~--~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~  424 (434)
                       .....+++  ++.+|+.+||..||++||++.|+++|+|+...
T Consensus       130 -~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      130 -SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             -ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence             00001222  68999999999999999999999999998743

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=7.4e-26  Score=219.84  Aligned_cols=158  Identities=18%  Similarity=0.262  Sum_probs=125.0

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcC-CCeEEEEEEeccc--------cHHHHHHHHHHHHHhcCCCCeee-EeeEEEccC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCT-DNEKCIIKILKPV--------KKKKIKREIKILQNLCGGPNIVK-LLDIVRDQQ  202 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~-~~~~vaiK~~~~~--------~~~~~~~E~~~l~~l~~h~niv~-l~~~~~~~~  202 (434)
                      .+.|.+.+.||+|+||+||+|.++. +++.+|||.+...        ....+.+|+++|+.+ +|+|++. +++.     
T Consensus        17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L-~h~~iv~~l~~~-----   90 (365)
T PRK09188         17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTV-RGIGVVPQLLAT-----   90 (365)
T ss_pred             cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhc-cCCCCCcEEEEc-----
Confidence            3679999999999999999998875 6788899986422        235589999999999 8999885 5432     


Q ss_pred             CCccEEEEeecCCCchhhhcCCCChHHHHHHHHHHHHHHHHHHHCCceeecC-CCCceEecCCCCeEEEEecccceecCC
Q 013897          203 SKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDV-KPHNVMIDHEQRKLRLIDWGLAEFYHP  281 (434)
Q Consensus       203 ~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDl-Kp~NIll~~~~~~vkl~DFGla~~~~~  281 (434)
                       ...++||||+.+++|.... ...   ...++.|+++||.|||++||+|||| ||+|||++.++ .+||+|||+|+.+..
T Consensus        91 -~~~~LVmE~~~G~~L~~~~-~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~-~ikLiDFGlA~~~~~  164 (365)
T PRK09188         91 -GKDGLVRGWTEGVPLHLAR-PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDG-EAAVIDFQLASVFRR  164 (365)
T ss_pred             -CCcEEEEEccCCCCHHHhC-ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCC-CEEEEECccceeccc
Confidence             2358999999999986432 111   2567889999999999999999999 99999998666 799999999987654


Q ss_pred             CCc---------cceeccCCcccccccccC
Q 013897          282 GKE---------YNVRVASRYFKGPELLVD  302 (434)
Q Consensus       282 ~~~---------~~~~~~t~~y~aPE~~~~  302 (434)
                      ...         ....+++..|+|||.+..
T Consensus       165 ~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        165 RGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             CcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            321         133467778999999853

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=3.2e-27  Score=243.78  Aligned_cols=257  Identities=24%  Similarity=0.363  Sum_probs=185.8

Q ss_pred             EEEeeeeecCceEEEEEEEcCCCeEEEEEEec----ccc-H----HHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          137 EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK----PVK-K----KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       137 ~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~----~~~-~----~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      ...+.+|.|++|.|+.+......+.++.|...    +.. .    ..+..|+-+-..+ .|+|++..+..+.+.....  
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l-~h~~~~e~l~~~~~~~~~~--  397 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSL-SHPNIIETLDIVQEIDGIL--  397 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccc-cCCchhhhHHHHhhcccch--
Confidence            45678999999988888776666666666543    111 1    1144455555566 8999988877665443322  


Q ss_pred             EEEeecCCCchhhhc-C--CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc
Q 013897          208 LIFEHVNNTDFKVLY-P--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE  284 (434)
Q Consensus       208 lv~e~~~~~~l~~~~-~--~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~  284 (434)
                      -+||||+. +|..++ .  .+...++..+++|++.||.|||+.||.|||||++|+++..++ .+||+|||.+..+.....
T Consensus       398 ~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g-~lki~Dfg~~~vf~~~~e  475 (601)
T KOG0590|consen  398 QSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENG-ILKIIDFGAASVFRYPWE  475 (601)
T ss_pred             hhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCC-ceEEeecCcceeeccCcc
Confidence            33999999 665444 3  588999999999999999999999999999999999999777 899999999977643322


Q ss_pred             -----cceeccCCcccccccccCCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhc
Q 013897          285 -----YNVRVASRYFKGPELLVDLQDYD-YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY  358 (434)
Q Consensus       285 -----~~~~~~t~~y~aPE~~~~~~~~~-~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  358 (434)
                           ....+|+..|+|||++.+ ..|+ ...||||.|++++.|++|+.||........++..+   .+.       .+ 
T Consensus       476 ~~~~~~~g~~gS~pY~apE~~~~-~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~---~~~-------~~-  543 (601)
T KOG0590|consen  476 KNIHESSGIVGSDPYLAPEVLTG-KEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN---NYS-------DQ-  543 (601)
T ss_pred             hhhhhhcCcccCCcCcCcccccc-cccCcchhhhhhccceEEEEecCCCccccccccccchhhh---ccc-------cc-
Confidence                 244588999999999988 4555 56799999999999999999996544433322000   000       00 


Q ss_pred             cccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccccc
Q 013897          359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~  428 (434)
                       .........                 -...++...+.+|.+||++||.+|+|++++|+.+||+.++-+.
T Consensus       544 -~~~~~~~~~-----------------~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c~  595 (601)
T KOG0590|consen  544 -RNIFEGPNR-----------------LLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECCH  595 (601)
T ss_pred             -cccccChHH-----------------HHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceEE
Confidence             000000000                 0112566789999999999999999999999999999987554

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.93  E-value=4.9e-24  Score=204.41  Aligned_cols=258  Identities=32%  Similarity=0.517  Sum_probs=194.9

Q ss_pred             eEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       136 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      |.+...||.|+||.||++.+.   ..+++|.+...      ....+.+|+.++..+.++++++++++.+...  ...+++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~~~   76 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDE--GSLYLV   76 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecC--CEEEEE
Confidence            678899999999999999985   88899988642      2456889999999994444899999999433  336899


Q ss_pred             EeecCCCchhhhcC------CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC
Q 013897          210 FEHVNNTDFKVLYP------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       210 ~e~~~~~~l~~~~~------~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~  283 (434)
                      ++++.++.+..+..      .+....+..++.|++.++.|+|+.+++|||+||+||+++..+..++++|||++.......
T Consensus        77 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          77 MEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             EecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            99999999875543      578889999999999999999999999999999999999766469999999997654432


Q ss_pred             -------ccceeccCCcccccccccCC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCCC--HHHHHHHHHHhCChhHH
Q 013897          284 -------EYNVRVASRYFKGPELLVDL--QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN--YDQLVKIAKVLGTDELN  352 (434)
Q Consensus       284 -------~~~~~~~t~~y~aPE~~~~~--~~~~~~~DvwSlGvil~elltg~~pf~~~~~~--~~~~~~i~~~~g~~~~~  352 (434)
                             ......++..|++||.+.+.  ..++...|+||+|++++++++|..||......  ..............   
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---  233 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP---  233 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc---
Confidence                   24667899999999998763  47889999999999999999999996433321  22222222111111   


Q ss_pred             HHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccc
Q 013897          353 AYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                              .....            ..    ..........+.+++.+|+..+|..|.+..+...++|.....
T Consensus       234 --------~~~~~------------~~----~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~  282 (384)
T COG0515         234 --------SLASP------------LS----PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLK  282 (384)
T ss_pred             --------ccccc------------cC----ccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcc
Confidence                    00000            00    000011124688999999999999999999999987776544

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.92  E-value=2.2e-26  Score=227.51  Aligned_cols=236  Identities=26%  Similarity=0.379  Sum_probs=188.0

Q ss_pred             eeecCceEEEEEEEc---CCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeec
Q 013897          142 VGRGKYSEVFEGVHC---TDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV  213 (434)
Q Consensus       142 lG~G~fg~Vy~~~~~---~~~~~vaiK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  213 (434)
                      +|+|.||.|+++...   ..+..+|+|++++..     +.....|..++..+.+||.+|++...+..+  ..++++++|.
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~--~kl~l~ld~~   79 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTD--GKLYLILDFL   79 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccc--cchhHhhhhc
Confidence            799999999977532   346788999886422     124556888888886799999999988544  4556999999


Q ss_pred             CCCchhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCccceecc
Q 013897          214 NNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVA  290 (434)
Q Consensus       214 ~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~~~~~~  290 (434)
                      .++++.....   .+.+...+.+...++.+++++|+.+|+|||+|++||+++.+| ++++.|||+++.......   .||
T Consensus        80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~G-hi~~tdfglske~v~~~~---~cg  155 (612)
T KOG0603|consen   80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEG-HIKLTDFGLSKEAVKEKI---ACG  155 (612)
T ss_pred             ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccC-ccccCCchhhhHhHhhhh---ccc
Confidence            9988755543   367778889999999999999999999999999999999888 899999999987654433   299


Q ss_pred             CCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHh
Q 013897          291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALV  370 (434)
Q Consensus       291 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~  370 (434)
                      |..|||||++.   +....+|+||||++++||+||-.||..     +.+..|.+.                         
T Consensus       156 t~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~~Il~~-------------------------  202 (612)
T KOG0603|consen  156 TYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRILKA-------------------------  202 (612)
T ss_pred             chhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch-----HHHHHHhhh-------------------------
Confidence            99999999986   467799999999999999999999943     333333220                         


Q ss_pred             cccCCCCCccccccccccCCchHHHHHHHHccccCCCCCcc-----HHHHhcCCCcccccccc
Q 013897          371 GRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT-----AKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt-----~~elL~Hp~~~~~~~~~  428 (434)
                                  ....+...+..+.+++..++..+|..|..     +.|+++|+||+.+++.+
T Consensus       203 ------------~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~  253 (612)
T KOG0603|consen  203 ------------ELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNE  253 (612)
T ss_pred             ------------ccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhh
Confidence                        01122235678999999999999999976     47999999999999875

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=4.4e-23  Score=200.15  Aligned_cols=193  Identities=24%  Similarity=0.324  Sum_probs=154.7

Q ss_pred             CeEEEeeeeecCceEEEEEEEcCCC-eEEEEEEeccccH---HHHHHHHHHHHHhcC---CCCeeeEeeEEEccCCCccE
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCTDN-EKCIIKILKPVKK---KKIKREIKILQNLCG---GPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~~~-~~vaiK~~~~~~~---~~~~~E~~~l~~l~~---h~niv~l~~~~~~~~~~~~~  207 (434)
                      .|.+.++||+|+||.||.|.+..++ ..+|+|+......   ..+..|+.++..+..   .+++..+++... ....+-+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~~~~~   97 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STEDFNF   97 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc-CCCceeE
Confidence            7999999999999999999986664 6889998764322   268899999999852   368888888774 2345667


Q ss_pred             EEEeecCCCchhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCC----CeEEEEecccce-
Q 013897          208 LIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ----RKLRLIDWGLAE-  277 (434)
Q Consensus       208 lv~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~----~~vkl~DFGla~-  277 (434)
                      +||+.++.. |.++.     +.++...+..++.|++.+|++||+.|++||||||+|+++....    ..+.|.|||+|+ 
T Consensus        98 iVM~l~G~s-L~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~  176 (322)
T KOG1164|consen   98 IVMSLLGPS-LEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARR  176 (322)
T ss_pred             EEEeccCcc-HHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCcc
Confidence            888877654 33333     4689999999999999999999999999999999999998653    479999999998 


Q ss_pred             -ecCCCC--------c-cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCC
Q 013897          278 -FYHPGK--------E-YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF  330 (434)
Q Consensus       278 -~~~~~~--------~-~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~  330 (434)
                       .+....        . .....||..|.++....+ ...+.+.|+||++.++.+|+.|..||.
T Consensus       177 ~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~-~e~~r~DDles~~Y~l~el~~g~LPW~  238 (322)
T KOG1164|consen  177 FKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG-IEQGRRDDLESLFYMLLELLKGSLPWE  238 (322)
T ss_pred             ccccCCCCcccccCCCCccCCCCccccccHHHhCC-CccCCchhhhhHHHHHHHHhcCCCCCc
Confidence             321111        1 123458999999998777 788999999999999999999999983

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.90  E-value=3.2e-24  Score=221.93  Aligned_cols=224  Identities=25%  Similarity=0.404  Sum_probs=157.5

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEee
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH  212 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  212 (434)
                      .++|+.++.|..|+||-||.++++.+.+.+|+|+=+ +.  .+.+-  ++... ..|.+|                    
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~--lilRn--ilt~a-~npfvv--------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QN--LILRN--ILTFA-GNPFVV--------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcccc-cc--hhhhc--ccccc-CCccee--------------------
Confidence            478999999999999999999999999999995432 21  11111  11111 222222                    


Q ss_pred             cCCCchhhhcCCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC---------
Q 013897          213 VNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK---------  283 (434)
Q Consensus       213 ~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~---------  283 (434)
                      ....++....+.++..        ++.+++|||+.||+|||+||+|.||..-| ++|++|||+++..-...         
T Consensus       136 gDc~tllk~~g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mG-hiKlTDfgLsk~GLms~atnl~eg~I  206 (1205)
T KOG0606|consen  136 GDCATLLKNIGPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMG-HIKLTDFGLSKKGLMSLATNLKEGHI  206 (1205)
T ss_pred             chhhhhcccCCCCcch--------hhHHhHhhccCCeecCCCCCCcceeeecc-cccccchhhhhhhhhhccchhhhcch
Confidence            1111222222334332        37899999999999999999999999766 89999999985431110         


Q ss_pred             -------ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHh
Q 013897          284 -------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN  356 (434)
Q Consensus       284 -------~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~  356 (434)
                             .....+||+.|.|||++.. .+|+..+|+|++|+|+||.+.|+.||+. +...+.+...+...     ..|  
T Consensus       207 ~k~t~Ef~dKqvcgTPeyiaPeVilr-qgygkpvdwwamGiIlyeFLVgcvpffG-dtpeelfg~visd~-----i~w--  277 (1205)
T KOG0606|consen  207 EKDTHEFQDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFG-DTPEELFGQVISDD-----IEW--  277 (1205)
T ss_pred             HHHHHHhhhccccCCccccChhhhhh-hccCCCccHHHHHHHHHHHheeeeeccC-CCHHHHHhhhhhhh-----ccc--
Confidence                   0122389999999999987 7899999999999999999999999953 33333333221110     000  


Q ss_pred             hccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCC---ccHHHHhcCCCccccccc
Q 013897          357 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQER---PTAKEAMAHPYFFPIRNA  427 (434)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~R---pt~~elL~Hp~~~~~~~~  427 (434)
                                                 .+....+++++++++.++|+.+|..|   ..+-++.+|+||+.+++.
T Consensus       278 ---------------------------pE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~  324 (1205)
T KOG0606|consen  278 ---------------------------PEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK  324 (1205)
T ss_pred             ---------------------------cccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence                                       11122367899999999999999999   457789999999999876

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=1.6e-22  Score=185.64  Aligned_cols=208  Identities=22%  Similarity=0.349  Sum_probs=167.3

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecc-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEee
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH  212 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~-~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  212 (434)
                      -.|.+.++||+|+||+.+.|...-+++.||||.-.. ....++..|....+.|.+.++|...|.+-  +.+.+-.||+|.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFG--qeG~~NiLVidL  105 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFG--QEGKYNILVIDL  105 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeec--cccchhhhhhhh
Confidence            368999999999999999999999999999997543 34467889999999998889999988765  445666799998


Q ss_pred             cCCC--chhhhc-CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCC----CeEEEEecccceecCCCCc-
Q 013897          213 VNNT--DFKVLY-PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ----RKLRLIDWGLAEFYHPGKE-  284 (434)
Q Consensus       213 ~~~~--~l~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~----~~vkl~DFGla~~~~~~~~-  284 (434)
                      ++..  +|.++. ..|+...+..++.|++.-++|+|++.+|+|||||+|+||...+    ..|.|+|||+|+.+.+..+ 
T Consensus       106 LGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~Tk  185 (449)
T KOG1165|consen  106 LGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTK  185 (449)
T ss_pred             hCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcccc
Confidence            8754  333333 5699999999999999999999999999999999999996432    3799999999988754332 


Q ss_pred             -------cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCC--CCCCCHHHHHHHHH
Q 013897          285 -------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF--YGHDNYDQLVKIAK  344 (434)
Q Consensus       285 -------~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~--~~~~~~~~~~~i~~  344 (434)
                             .....||..||+-....+ +.-+.+-|+-|||=+++..|-|..||-  ...++.+...+|.+
T Consensus       186 qHIPYrE~KSLsGTARYMSINTHlG-rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe  253 (449)
T KOG1165|consen  186 QHIPYREHKSLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGE  253 (449)
T ss_pred             ccCccccccccccceeeeEeecccc-chhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcc
Confidence                   244579999999777777 678889999999999999999999983  22344444444433

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.90  E-value=8.1e-23  Score=181.47  Aligned_cols=181  Identities=17%  Similarity=0.137  Sum_probs=138.0

Q ss_pred             EEeeeeecCceEEEEEEEcCCCeEEEEEEeccccH-------HHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEE
Q 013897          138 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK-------KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF  210 (434)
Q Consensus       138 ~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  210 (434)
                      +...|++|+||+||.+..  .+.+++.+.+.....       ..+.+|+++|++|.+|+++++++++.      ..+++|
T Consensus         6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~------~~~lvm   77 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD------GRHLDR   77 (218)
T ss_pred             cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc------CEEEEE
Confidence            567899999999997764  678888777754332       25789999999997779999999862      247999


Q ss_pred             eecCCCchhhhcCCCChHHHHHHHHHHHHHHHHHHHCCceeecC-CCCceEecCCCCeEEEEecccceecCCCCcc----
Q 013897          211 EHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDV-KPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY----  285 (434)
Q Consensus       211 e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDl-Kp~NIll~~~~~~vkl~DFGla~~~~~~~~~----  285 (434)
                      ||+.|.+|......    ....++.|++.+|.++|++||+|||| ||+|||++.++ .++|+|||+|.........    
T Consensus        78 eyI~G~~L~~~~~~----~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g-~i~LIDFG~A~~~~~~~~~~r~L  152 (218)
T PRK12274         78 SYLAGAAMYQRPPR----GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDG-SPAVIDFQLAVRGNPRARWMRLL  152 (218)
T ss_pred             eeecCccHHhhhhh----hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCC-CEEEEECCCceecCCcchHHHHH
Confidence            99999988654321    12357789999999999999999999 79999999766 7999999999865543321    


Q ss_pred             c----------eeccCCcccccccccCCCCCC-ccccHHHHHHHHHHHHhCCCCCCC
Q 013897          286 N----------VRVASRYFKGPELLVDLQDYD-YSLDLWSLGCMFAGMIFRKEPFFY  331 (434)
Q Consensus       286 ~----------~~~~t~~y~aPE~~~~~~~~~-~~~DvwSlGvil~elltg~~pf~~  331 (434)
                      .          ....++.|+.|+........+ ...++++.|+-+|.++|++.+.+.
T Consensus       153 ~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        153 AREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             HHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence            0          112466677776643322333 567899999999999999988754

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.90  E-value=2.7e-23  Score=188.38  Aligned_cols=169  Identities=14%  Similarity=0.182  Sum_probs=130.7

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc--HH----------HHHHHHHHHHHhcCCCCeeeEeeEEEc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KK----------KIKREIKILQNLCGGPNIVKLLDIVRD  200 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~--~~----------~~~~E~~~l~~l~~h~niv~l~~~~~~  200 (434)
                      .++|.+++.||.|+||.||+...  ++..+|||++.+..  .+          .+++|+..+.++ .|++|..+.+++..
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL-~~~GI~~~~d~~~~  106 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRV-RSEGLASLNDFYLL  106 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHH-HHCCCCcceEeeee
Confidence            47899999999999999999754  46789999996422  11          157899999999 99999999988654


Q ss_pred             cC------CCccEEEEeecCCCchhhhcCCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecc
Q 013897          201 QQ------SKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG  274 (434)
Q Consensus       201 ~~------~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFG  274 (434)
                      ..      ....+|||||++|.+|.++. .+++    ....+++.+|..+|+.|++|||+||+||+++.++  ++|+|||
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~-~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g--i~liDfg  179 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMP-EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG--LRIIDLS  179 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhh-hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC--EEEEECC
Confidence            32      23468999999999987763 2332    3456999999999999999999999999999665  9999999


Q ss_pred             cceecCCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHH
Q 013897          275 LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI  323 (434)
Q Consensus       275 la~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell  323 (434)
                      .............           ++.. ..|+.++|+|+||+.+..+.
T Consensus       180 ~~~~~~e~~a~d~-----------~vle-r~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        180 GKRCTAQRKAKDR-----------IDLE-RHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CcccccchhhHHH-----------HHHH-hHhcccccccceeEeehHHH
Confidence            8865532221111           2233 56778999999999887654

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.89  E-value=1.1e-22  Score=178.96  Aligned_cols=193  Identities=22%  Similarity=0.384  Sum_probs=157.4

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecc-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEe
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE  211 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~-~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  211 (434)
                      ...|.++++||.|+||.+|.|....+|+.||||+-.. ....++..|..+...|++...|+.+..+..+  ..+-++||+
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e--~~ynvlVMd   91 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTE--KDYNVLVMD   91 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccc--cccceeeee
Confidence            4789999999999999999999999999999998754 3446788999999999778889888888754  456679999


Q ss_pred             ecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC--CCeEEEEecccceecCCCCc-
Q 013897          212 HVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--QRKLRLIDWGLAEFYHPGKE-  284 (434)
Q Consensus       212 ~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~--~~~vkl~DFGla~~~~~~~~-  284 (434)
                      .++.. |+++.    ..++...+.-++-|++.-++|+|.+++|||||||+|+|..-+  -..+.|+|||+|+.+.+..+ 
T Consensus        92 LLGPs-LEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~  170 (341)
T KOG1163|consen   92 LLGPS-LEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTR  170 (341)
T ss_pred             ccCcc-HHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccccc
Confidence            88754 33332    468888899999999999999999999999999999998533  23689999999987653321 


Q ss_pred             -------cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCC
Q 013897          285 -------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF  329 (434)
Q Consensus       285 -------~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf  329 (434)
                             .....||..|.+--...+ ..-+.+-|+-|+|.+|..+.-|..||
T Consensus       171 ~HIpyre~r~ltGTaRYASinAh~g-~eqSRRDDmeSvgYvLmYfnrG~LPW  221 (341)
T KOG1163|consen  171 QHIPYREDRNLTGTARYASINAHLG-IEQSRRDDMESVGYVLMYFNRGSLPW  221 (341)
T ss_pred             ccCccccCCccceeeeehhhhhhhh-hhhhhhhhhhhhcceeeeeecCCCcc
Confidence                   234578888877655554 45677899999999999999999998

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.88  E-value=2e-22  Score=180.14  Aligned_cols=133  Identities=19%  Similarity=0.245  Sum_probs=104.0

Q ss_pred             EeeeeecCceEEEEEEEcCCCeEEEEEEeccccH------------H-----------------HHHHHHHHHHHhcCCC
Q 013897          139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK------------K-----------------KIKREIKILQNLCGGP  189 (434)
Q Consensus       139 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------------~-----------------~~~~E~~~l~~l~~h~  189 (434)
                      .+.||+|+||.||+|.+. +|+.||||+++....            .                 ...+|+.++.++ .++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~   79 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRL-VTA   79 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHH-HHC
Confidence            357999999999999985 899999999964321            1                 123499999999 666


Q ss_pred             CeeeEeeEEEccCCCccEEEEeecCCCchhhh---cCCCChHHHHHHHHHHHHHHHHH-HHCCceeecCCCCceEecCCC
Q 013897          190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYC-HSQGIMHRDVKPHNVMIDHEQ  265 (434)
Q Consensus       190 niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~L-H~~~ivHrDlKp~NIll~~~~  265 (434)
                      ++.....+..  .  ..+|||||++++++...   ...++...+..++.|++.+|.+| |+.||+||||||+|||++ ++
T Consensus        80 ~v~~p~~~~~--~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~  154 (190)
T cd05147          80 GIPCPEPILL--K--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DG  154 (190)
T ss_pred             CCCCCcEEEe--c--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CC
Confidence            6644333221  1  12699999998766432   24588889999999999999999 799999999999999998 44


Q ss_pred             CeEEEEecccceec
Q 013897          266 RKLRLIDWGLAEFY  279 (434)
Q Consensus       266 ~~vkl~DFGla~~~  279 (434)
                       .++|+|||+|...
T Consensus       155 -~v~LiDFG~a~~~  167 (190)
T cd05147         155 -KLYIIDVSQSVEH  167 (190)
T ss_pred             -cEEEEEccccccC
Confidence             7999999999643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.87  E-value=7.8e-22  Score=184.11  Aligned_cols=229  Identities=19%  Similarity=0.252  Sum_probs=138.2

Q ss_pred             CeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcC---------CCCeeeEeeEEE
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCG---------GPNIVKLLDIVR  199 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~---------h~niv~l~~~~~  199 (434)
                      .+...+.||.|+++.||.+++..+++.+|+|++...      ..+++++|.-....+.+         |-.++..++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            356788999999999999999999999999997421      23445555544333211         223333333322


Q ss_pred             ccC---------C---C---ccEEEEeecCCCchhhhcC------CC----ChHHHHHHHHHHHHHHHHHHHCCceeecC
Q 013897          200 DQQ---------S---K---TPSLIFEHVNNTDFKVLYP------TL----SDYDVRYYIYELLKALDYCHSQGIMHRDV  254 (434)
Q Consensus       200 ~~~---------~---~---~~~lv~e~~~~~~l~~~~~------~l----~~~~~~~~~~qi~~~L~~LH~~~ivHrDl  254 (434)
                      -.+         +   .   +.+++|+-+. ++|..+..      ..    .......+..|+++.+++||..|++|+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi  171 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI  171 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence            111         0   1   2345666664 34444431      11    11122345589999999999999999999


Q ss_pred             CCCceEecCCCCeEEEEecccceecCCCCccceeccCCcccccccccCC-------CCCCccccHHHHHHHHHHHHhCCC
Q 013897          255 KPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL-------QDYDYSLDLWSLGCMFAGMIFRKE  327 (434)
Q Consensus       255 Kp~NIll~~~~~~vkl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~-------~~~~~~~DvwSlGvil~elltg~~  327 (434)
                      ||+|++++.+| .+.|+||+......  ........+..|.+||.....       ..++.+.|.|+||+++|.|.+|..
T Consensus       172 ~~~nfll~~~G-~v~Lg~F~~~~r~g--~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l  248 (288)
T PF14531_consen  172 KPENFLLDQDG-GVFLGDFSSLVRAG--TRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL  248 (288)
T ss_dssp             SGGGEEE-TTS--EEE--GGGEEETT--EEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred             ceeeEEEcCCC-CEEEcChHHHeecC--ceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence            99999999887 89999999875432  222224455678899976431       247889999999999999999999


Q ss_pred             CCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCC
Q 013897          328 PFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQ  407 (434)
Q Consensus       328 pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~  407 (434)
                      ||.......                  ..      +.                  .+..-..+++.+++||..+|+.||.
T Consensus       249 Pf~~~~~~~------------------~~------~~------------------~f~~C~~~Pe~v~~LI~~lL~~~~~  286 (288)
T PF14531_consen  249 PFGLSSPEA------------------DP------EW------------------DFSRCRDMPEPVQFLIRGLLQRNPE  286 (288)
T ss_dssp             STCCCGGGS------------------TS------GG------------------GGTTSS---HHHHHHHHHHT-SSGG
T ss_pred             CCCCCCccc------------------cc------cc------------------cchhcCCcCHHHHHHHHHHccCCcc
Confidence            993211100                  00      00                  0111114678899999999999999


Q ss_pred             CC
Q 013897          408 ER  409 (434)
Q Consensus       408 ~R  409 (434)
                      +|
T Consensus       287 ~R  288 (288)
T PF14531_consen  287 DR  288 (288)
T ss_dssp             GS
T ss_pred             cC
Confidence            88

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.87  E-value=2.4e-22  Score=188.38  Aligned_cols=202  Identities=20%  Similarity=0.275  Sum_probs=134.7

Q ss_pred             cCCCCeeeEeeEEEcc-------------------------CCCccEEEEeecCCCchhhhc-CCCChHHHHHHHHHHHH
Q 013897          186 CGGPNIVKLLDIVRDQ-------------------------QSKTPSLIFEHVNNTDFKVLY-PTLSDYDVRYYIYELLK  239 (434)
Q Consensus       186 ~~h~niv~l~~~~~~~-------------------------~~~~~~lv~e~~~~~~l~~~~-~~l~~~~~~~~~~qi~~  239 (434)
                      ..|||||++.+.|.+.                         ....+|+||.......-..+. ...+....+.++.|+++
T Consensus       273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~~s~r~~~~~laQlLE  352 (598)
T KOG4158|consen  273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRHRSYRTGRVILAQLLE  352 (598)
T ss_pred             CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCCCchHHHHHHHHHHHH
Confidence            5799999999977652                         133466777655543322222 34666778889999999


Q ss_pred             HHHHHHHCCceeecCCCCceEecCCC---CeEEEEecccceecCC-------CCccceeccCCcccccccccCCCC----
Q 013897          240 ALDYCHSQGIMHRDVKPHNVMIDHEQ---RKLRLIDWGLAEFYHP-------GKEYNVRVASRYFKGPELLVDLQD----  305 (434)
Q Consensus       240 ~L~~LH~~~ivHrDlKp~NIll~~~~---~~vkl~DFGla~~~~~-------~~~~~~~~~t~~y~aPE~~~~~~~----  305 (434)
                      |+.|||.+||.|||||.+|||+.-++   ..+.|+|||.+-....       ....-...|....||||+.....+    
T Consensus       353 av~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~av  432 (598)
T KOG4158|consen  353 AVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAV  432 (598)
T ss_pred             HHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCcee
Confidence            99999999999999999999994332   2589999998732111       111223356677899999753211    


Q ss_pred             -CCccccHHHHHHHHHHHHhCCCCCCCCCCC-HHHHHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccc
Q 013897          306 -YDYSLDLWSLGCMFAGMIFRKEPFFYGHDN-YDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFIT  383 (434)
Q Consensus       306 -~~~~~DvwSlGvil~elltg~~pf~~~~~~-~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (434)
                       --.|+|.|+.|.+.||++...-||+.-... .+..             .|..                        ..-
T Consensus       433 vny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r-------------~Yqe------------------------~qL  475 (598)
T KOG4158|consen  433 VNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTR-------------TYQE------------------------SQL  475 (598)
T ss_pred             eccchhhhhhhhhhHHHHhccCCcccccchheechh-------------hhhh------------------------hhC
Confidence             124899999999999999999999652111 0000             0000                        000


Q ss_pred             cccccCCchHHHHHHHHccccCCCCCccHH---HHhc------CCCcccc
Q 013897          384 VENQHLAVPEAVDFLDKLLRYDHQERPTAK---EAMA------HPYFFPI  424 (434)
Q Consensus       384 ~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~---elL~------Hp~~~~~  424 (434)
                      ..-+..+++.+++++..+|+.||++|+++.   .+|+      |.|++++
T Consensus       476 Palp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~LsLw~~~~~vka~  525 (598)
T KOG4158|consen  476 PALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLNLSLWRMGEDVKAM  525 (598)
T ss_pred             CCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHHHHHhcCchHHHHh
Confidence            011234788999999999999999998853   4443      5555544

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.87  E-value=2.1e-21  Score=173.99  Aligned_cols=134  Identities=17%  Similarity=0.211  Sum_probs=106.1

Q ss_pred             EeeeeecCceEEEEEEEcCCCeEEEEEEecccc-----------------------------HHHHHHHHHHHHHhcCCC
Q 013897          139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------------------------KKKIKREIKILQNLCGGP  189 (434)
Q Consensus       139 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----------------------------~~~~~~E~~~l~~l~~h~  189 (434)
                      .+.||+|+||.||+|.+. +|+.||||+++...                             ...+.+|...+.++ .|+
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~   79 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRL-YEA   79 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHH-HhC
Confidence            467999999999999986 89999999987431                             11235788999998 788


Q ss_pred             CeeeEeeEEEccCCCccEEEEeecCCCchhh-hc--CCCChHHHHHHHHHHHHHHHHHHH-CCceeecCCCCceEecCCC
Q 013897          190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKV-LY--PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQ  265 (434)
Q Consensus       190 niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~-~~--~~l~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlKp~NIll~~~~  265 (434)
                      ++.....+...    ..++||||++++++.. ..  ..++..++..++.|++.+|.+||. .||+||||||+|||++ ++
T Consensus        80 ~i~~p~~~~~~----~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~  154 (190)
T cd05145          80 GVPVPEPILLK----KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DG  154 (190)
T ss_pred             CCCCceEEEec----CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CC
Confidence            87554443322    1379999999875322 12  346778889999999999999999 9999999999999998 55


Q ss_pred             CeEEEEecccceecC
Q 013897          266 RKLRLIDWGLAEFYH  280 (434)
Q Consensus       266 ~~vkl~DFGla~~~~  280 (434)
                       .++|+|||+|....
T Consensus       155 -~~~liDFG~a~~~~  168 (190)
T cd05145         155 -KPYIIDVSQAVELD  168 (190)
T ss_pred             -CEEEEEcccceecC
Confidence             79999999997654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.85  E-value=2.3e-21  Score=204.45  Aligned_cols=193  Identities=21%  Similarity=0.408  Sum_probs=153.0

Q ss_pred             CCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhc--CCCCeeeEeeEEEccCCCccEEE
Q 013897          132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLC--GGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       132 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~E~~~l~~l~--~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      ..+.|.|.+.||+|+||+||+|.... |+.||||+=++....+|.--.+++.+|.  --+-|..+...+.-.+.  -+||
T Consensus       696 ~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~--S~lv  772 (974)
T KOG1166|consen  696 GGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNA--SVLV  772 (974)
T ss_pred             cceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCc--ceee
Confidence            35789999999999999999999854 9999999988776655544444555551  01233333333332332  3599


Q ss_pred             EeecCCCchhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEec------CCCCeEEEEecccce---
Q 013897          210 FEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID------HEQRKLRLIDWGLAE---  277 (434)
Q Consensus       210 ~e~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~------~~~~~vkl~DFGla~---  277 (434)
                      +||.+-|+|.+++.   .+++..+..++.|++..++.||..+|||+||||+|+||.      .+...++|+|||.+-   
T Consensus       773 ~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~  852 (974)
T KOG1166|consen  773 SEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMK  852 (974)
T ss_pred             eeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeee
Confidence            99999999887764   488889999999999999999999999999999999993      223369999999984   


Q ss_pred             ecCCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCC
Q 013897          278 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEP  328 (434)
Q Consensus       278 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~p  328 (434)
                      .+.++......++|..+-.+|+..| ++|++++|.|.|..+++.||.|+..
T Consensus       853 lfp~~~~F~~~~~td~f~C~EM~~g-rpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  853 LFPDGTKFKAVWHTDLFDCIEMREG-RPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             EcCCCcEEeeeeccccchhHHHhcC-CCCchhhhhHHHHHHHHHHHHHHHH
Confidence            3455556677789999999999888 8999999999999999999999743

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.85  E-value=1.2e-21  Score=203.24  Aligned_cols=241  Identities=19%  Similarity=0.365  Sum_probs=166.2

Q ss_pred             CeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHH-HHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKIL-QNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~E~~~l-~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      +|...+.||.+.|=+|.+|++ ..|. |+||++-+..    ...+.++++-+ ..+.++||++.+.-+.+  .....|||
T Consensus        24 e~~~~~~LGstRFlKv~r~k~-~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~--t~kAAylv   99 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKD-REGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLV--TDKAAYLV   99 (1431)
T ss_pred             ceeeecccCchhhhhhhhccC-CCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHH--hhHHHHHH
Confidence            577889999999999999987 3444 8899884332    23344333322 23358999999877643  33556788


Q ss_pred             EeecCCCchhhhc--CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEeccccee--cCCCC--
Q 013897          210 FEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF--YHPGK--  283 (434)
Q Consensus       210 ~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~--~~~~~--  283 (434)
                      -+|+.+.....+-  +-+...+.+.|+.||+.||.-+|..||+|+|||.+|||++.=++ +.|+||..-+-  ++.+.  
T Consensus       100 RqyvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW-~~LtDFAsFKPtYLPeDNPa  178 (1431)
T KOG1240|consen  100 RQYVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNW-LYLTDFASFKPTYLPEDNPA  178 (1431)
T ss_pred             HHHHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeech-hhhhcccccCCccCCCCCcc
Confidence            8898876655442  23667788899999999999999999999999999999986664 89999997643  22222  


Q ss_pred             cccee----ccCCcccccccccCCC---------C-CCccccHHHHHHHHHHHHhC-CCCCCCCCCCHHHHHHHHHHhC-
Q 013897          284 EYNVR----VASRYFKGPELLVDLQ---------D-YDYSLDLWSLGCMFAGMIFR-KEPFFYGHDNYDQLVKIAKVLG-  347 (434)
Q Consensus       284 ~~~~~----~~t~~y~aPE~~~~~~---------~-~~~~~DvwSlGvil~elltg-~~pf~~~~~~~~~~~~i~~~~g-  347 (434)
                      .++..    ..-.+|.|||.+....         . ..++-||||+||+++||++- ++||     +.-|+-.  ..-| 
T Consensus       179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF-----~LSQL~a--Yr~~~  251 (1431)
T KOG1240|consen  179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLF-----TLSQLLA--YRSGN  251 (1431)
T ss_pred             cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcc-----cHHHHHh--HhccC
Confidence            12222    2334799999985421         1 56788999999999999984 6556     1112111  1111 


Q ss_pred             ChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          348 TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                      .......               +.                ..-+..++.+|..|++.||++|.+|++.|+-
T Consensus       252 ~~~~e~~---------------Le----------------~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  252 ADDPEQL---------------LE----------------KIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             ccCHHHH---------------HH----------------hCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            0000000               00                0123468899999999999999999999974

>PRK10345 hypothetical protein; Provisional

Probab=99.84  E-value=2.2e-20  Score=168.68  Aligned_cols=134  Identities=19%  Similarity=0.238  Sum_probs=102.8

Q ss_pred             EEeeeeecCceEEEEEEEcCCCeEEEEEEeccc---cHHHHHHHHHHHHHhc----CCCCeeeEeeEEEccCC-CccE-E
Q 013897          138 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLC----GGPNIVKLLDIVRDQQS-KTPS-L  208 (434)
Q Consensus       138 ~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~E~~~l~~l~----~h~niv~l~~~~~~~~~-~~~~-l  208 (434)
                      -...||+|+||.||.  +..++.. +||++...   ..+.+.+|+.+++.+.    .||||++++|++....+ ..++ +
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            346799999999995  5555555 69988654   4567899999999994    47999999999976532 2333 7


Q ss_pred             EEee--cCCCchhhhcCC--CChHHHHHHHHHHHHHH-HHHHHCCceeecCCCCceEecCC---CCeEEEEecccc
Q 013897          209 IFEH--VNNTDFKVLYPT--LSDYDVRYYIYELLKAL-DYCHSQGIMHRDVKPHNVMIDHE---QRKLRLIDWGLA  276 (434)
Q Consensus       209 v~e~--~~~~~l~~~~~~--l~~~~~~~~~~qi~~~L-~~LH~~~ivHrDlKp~NIll~~~---~~~vkl~DFGla  276 (434)
                      |+||  +.+++|.+++..  +++.  ..++.|++.++ +|||+++|+||||||+|||++..   ...++|+||+.+
T Consensus        83 I~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             EecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            8999  447899877753  3333  45678888888 99999999999999999999742   237999995444

>smart00090 RIO RIO-like kinase

Probab=99.81  E-value=2.8e-19  Score=165.26  Aligned_cols=136  Identities=15%  Similarity=0.192  Sum_probs=107.1

Q ss_pred             CeEEEeeeeecCceEEEEEE-EcCCCeEEEEEEecccc---------------------------HHHHHHHHHHHHHhc
Q 013897          135 DYEVVRKVGRGKYSEVFEGV-HCTDNEKCIIKILKPVK---------------------------KKKIKREIKILQNLC  186 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~-~~~~~~~vaiK~~~~~~---------------------------~~~~~~E~~~l~~l~  186 (434)
                      .|.+.+.||+|+||.||+|. +..+|+.||+|+++...                           ...+.+|+.++.++ 
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L-  107 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL-  107 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH-
Confidence            47788999999999999998 66789999999986421                           02256899999999 


Q ss_pred             CC--CCeeeEeeEEEccCCCccEEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCC-ceeecCCCCceE
Q 013897          187 GG--PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQG-IMHRDVKPHNVM  260 (434)
Q Consensus       187 ~h--~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~-ivHrDlKp~NIl  260 (434)
                      .+  ..+++++++.      ..++||||+++.++....   ..+....+..++.||+.+|.+||++| |+||||||+||+
T Consensus       108 ~~~~i~~p~~~~~~------~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIl  181 (237)
T smart00090      108 YEAGVPVPKPIAWR------RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNIL  181 (237)
T ss_pred             HhcCCCCCeeeEec------CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEE
Confidence            43  3344555431      236999999998775433   23455567889999999999999999 999999999999


Q ss_pred             ecCCCCeEEEEecccceec
Q 013897          261 IDHEQRKLRLIDWGLAEFY  279 (434)
Q Consensus       261 l~~~~~~vkl~DFGla~~~  279 (434)
                      ++ ++ .++|+|||.|...
T Consensus       182 i~-~~-~i~LiDFg~a~~~  198 (237)
T smart00090      182 VH-DG-KVVIIDVSQSVEL  198 (237)
T ss_pred             EE-CC-CEEEEEChhhhcc
Confidence            98 55 7999999998643

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.79  E-value=5.5e-20  Score=179.10  Aligned_cols=243  Identities=19%  Similarity=0.285  Sum_probs=161.2

Q ss_pred             CeEEEeeeeecCceEEEEEEEcCC---CeEEEEEEecccc---HHHHHHHHHHHHHhcCCCCeeeEe------eEEEc-c
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCTD---NEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLL------DIVRD-Q  201 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~~---~~~vaiK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~------~~~~~-~  201 (434)
                      .+.+.+..+.++++.+....-..+   .+.++-+..+..+   .....+++..+....+|++.+..-      ..+.. .
T Consensus       245 s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~  324 (516)
T KOG1033|consen  245 SSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNK  324 (516)
T ss_pred             cccccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhccccc
Confidence            344555566666666665443222   2233333322222   233445555555554554443332      01111 1


Q ss_pred             --CCCccEEEEeecCCCchhhhcC------CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEec
Q 013897          202 --QSKTPSLIFEHVNNTDFKVLYP------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDW  273 (434)
Q Consensus       202 --~~~~~~lv~e~~~~~~l~~~~~------~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DF  273 (434)
                        ...+++|.|++|...+|.+++.      ..+......++.|++.|++|   ++.+|+|+||.||++..+. .+||.||
T Consensus       325 v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~-q~kIgDF  400 (516)
T KOG1033|consen  325 VGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDD-QLKIGDF  400 (516)
T ss_pred             cccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccch-hhhhhhh
Confidence              1346889999999999998873      25666788899999999999   9999999999999998666 8999999


Q ss_pred             ccceecCCCC-------ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHH
Q 013897          274 GLAEFYHPGK-------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKV  345 (434)
Q Consensus       274 Gla~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~  345 (434)
                      |+........       ..+..+||..||+||.+.+ ..|+.++||||||+||+||+. =...+       +......+ 
T Consensus       401 gl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g-~~y~~kvdIyaLGlil~EL~~~f~T~~-------er~~t~~d-  471 (516)
T KOG1033|consen  401 GLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRG-QQYSEKVDIYALGLILAELLIQFSTQF-------ERIATLTD-  471 (516)
T ss_pred             hheeecccCCcccchhhhhhhcccccccCCHHHHhh-hhhhhhcchhhHHHHHHHHHHHhccHH-------HHHHhhhh-
Confidence            9987665444       4566789999999999998 789999999999999999996 22222       11110000 


Q ss_pred             hCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcc
Q 013897          346 LGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFF  422 (434)
Q Consensus       346 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~  422 (434)
                                 --...++|.+..                     --++-.+||..||...|.+||++.+.-.|+|.+
T Consensus       472 -----------~r~g~ip~~~~~---------------------d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~  516 (516)
T KOG1033|consen  472 -----------IRDGIIPPEFLQ---------------------DYPEEYTLLQQLLSPSPEERPSAIEVALHEFLQ  516 (516)
T ss_pred             -----------hhcCCCChHHhh---------------------cCcHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence                       000111111110                     114567999999999999999999998898864

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.79  E-value=1.4e-18  Score=158.18  Aligned_cols=131  Identities=24%  Similarity=0.364  Sum_probs=107.9

Q ss_pred             eeeeecCceEEEEEEEcCCCeEEEEEEecccc-----------HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       140 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      +.||+|++|.||+|.+  .+..+++|+.....           ...+.+|+.++..+ .|++++....++.+.  ...++
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~--~~~~l   76 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRA-RKAGVNVPAVYFVDP--ENFII   76 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHH-HHCCCCCCeEEEEeC--CCCEE
Confidence            5799999999999987  67789999865321           23577899999998 788887766666443  34579


Q ss_pred             EEeecCCCchhhhcCCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEeccccee
Q 013897          209 IFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF  278 (434)
Q Consensus       209 v~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~  278 (434)
                      ||||+++++|..+...... ....++.+++.+|.+||+.+++|+|++|.|||++ ++ .++|+|||++..
T Consensus        77 v~e~~~G~~L~~~~~~~~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~-~~~liDf~~a~~  143 (211)
T PRK14879         77 VMEYIEGEPLKDLINSNGM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GG-KIYLIDFGLAEF  143 (211)
T ss_pred             EEEEeCCcCHHHHHHhccH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CC-CEEEEECCcccC
Confidence            9999999999877655444 7788999999999999999999999999999999 54 799999999864

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.78  E-value=1.2e-19  Score=162.49  Aligned_cols=235  Identities=17%  Similarity=0.233  Sum_probs=168.8

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      .+..++.+|.+...|+.|+|++.  |..+++|+++..     ....|..|.-.|+-+ .||||+.+++.|..+  .++.+
T Consensus       190 ~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrif-shpnilpvlgacnsp--pnlv~  264 (448)
T KOG0195|consen  190 SSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIF-SHPNILPVLGACNSP--PNLVI  264 (448)
T ss_pred             hhhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeee-cCCchhhhhhhccCC--CCceE
Confidence            34567788999999999999984  556777877532     335688899888888 999999999999544  67889


Q ss_pred             EEeecCCCchhhhcCC-----CChHHHHHHHHHHHHHHHHHHHCC--ceeecCCCCceEecCCCCeEEEE--ecccceec
Q 013897          209 IFEHVNNTDFKVLYPT-----LSDYDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHEQRKLRLI--DWGLAEFY  279 (434)
Q Consensus       209 v~e~~~~~~l~~~~~~-----l~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlKp~NIll~~~~~~vkl~--DFGla~~~  279 (434)
                      +..||+-++|...+..     ....++..++.+|++|++|||+..  |.---|....+++|++. +.+|.  |--++.  
T Consensus       265 isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedl-tarismad~kfsf--  341 (448)
T KOG0195|consen  265 ISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDL-TARISMADTKFSF--  341 (448)
T ss_pred             eeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchh-hhheecccceeee--
Confidence            9999999998766543     456788999999999999999874  44557889999999765 55543  322221  


Q ss_pred             CCCCccceeccCCcccccccccCCCC--CCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhh
Q 013897          280 HPGKEYNVRVASRYFKGPELLVDLQD--YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK  357 (434)
Q Consensus       280 ~~~~~~~~~~~t~~y~aPE~~~~~~~--~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  357 (434)
                          ....+...+.||+||.+.....  --..+|+|||.+++|||.|...||.. -.+.+.-.+|+           ...
T Consensus       342 ----qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfad-lspmecgmkia-----------leg  405 (448)
T KOG0195|consen  342 ----QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFAD-LSPMECGMKIA-----------LEG  405 (448)
T ss_pred             ----eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhcccccccc-CCchhhhhhhh-----------hcc
Confidence                1122345678999999865211  23578999999999999999999832 22222222211           011


Q ss_pred             ccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHh
Q 013897          358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAM  416 (434)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL  416 (434)
                      ....                        .+.-++..+..|+.-|...||.+||....++
T Consensus       406 lrv~------------------------ippgis~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  406 LRVH------------------------IPPGISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             cccc------------------------CCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence            1111                        1223567889999999999999999977653

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.78  E-value=2.7e-18  Score=154.91  Aligned_cols=133  Identities=20%  Similarity=0.345  Sum_probs=105.2

Q ss_pred             eEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc-------------------------HHHHHHHHHHHHHhcCCC-
Q 013897          136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-------------------------KKKIKREIKILQNLCGGP-  189 (434)
Q Consensus       136 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-------------------------~~~~~~E~~~l~~l~~h~-  189 (434)
                      |.+.+.||+|+||.||++.. .+++.+|||+++...                         ......|+.++..+ .|+ 
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~   94 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKAL-YEEG   94 (198)
T ss_pred             hhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHH-HHcC
Confidence            67789999999999999987 479999999865321                         12356788889888 666 


Q ss_pred             -CeeeEeeEEEccCCCccEEEEeecCCCchhhhcCCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeE
Q 013897          190 -NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKL  268 (434)
Q Consensus       190 -niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~v  268 (434)
                       .++..++.      ...++||||+.++++..+...   .....++.+++.++.++|+.||+||||||+||+++.++ .+
T Consensus        95 i~v~~~~~~------~~~~lv~e~~~g~~L~~~~~~---~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~-~~  164 (198)
T cd05144          95 FPVPKPIDW------NRHAVVMEYIDGVELYRVRVL---EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE-KI  164 (198)
T ss_pred             CCCCceeec------CCceEEEEEeCCcchhhcccc---ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC-cE
Confidence             44444432      234799999999988765431   44567889999999999999999999999999999765 89


Q ss_pred             EEEecccceecC
Q 013897          269 RLIDWGLAEFYH  280 (434)
Q Consensus       269 kl~DFGla~~~~  280 (434)
                      +|+|||++....
T Consensus       165 ~liDfg~~~~~~  176 (198)
T cd05144         165 YIIDWPQMVSTD  176 (198)
T ss_pred             EEEECCccccCC
Confidence            999999996543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.75  E-value=4.3e-18  Score=168.79  Aligned_cols=203  Identities=20%  Similarity=0.292  Sum_probs=146.2

Q ss_pred             HHhcCCCCeeeEeeEEEccCCCccEEEEeecCCCchhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCc-eeecCCCC
Q 013897          183 QNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGI-MHRDVKPH  257 (434)
Q Consensus       183 ~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~i-vHrDlKp~  257 (434)
                      +.+ .|.|+.+++|.+.+.  ...++|.+||..|+|.+.+.    .+++.-...++++|++||.|||...| .|+.|++.
T Consensus         2 ~~l-~h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~   78 (484)
T KOG1023|consen    2 RQL-DHDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS   78 (484)
T ss_pred             ccc-chhhhhhheeeEecC--CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence            455 899999999999876  66779999999999988764    46777788899999999999999866 99999999


Q ss_pred             ceEecCCCCeEEEEecccceecCCC---CccceeccCCcccccccccCCC--C----CCccccHHHHHHHHHHHHhCCCC
Q 013897          258 NVMIDHEQRKLRLIDWGLAEFYHPG---KEYNVRVASRYFKGPELLVDLQ--D----YDYSLDLWSLGCMFAGMIFRKEP  328 (434)
Q Consensus       258 NIll~~~~~~vkl~DFGla~~~~~~---~~~~~~~~t~~y~aPE~~~~~~--~----~~~~~DvwSlGvil~elltg~~p  328 (434)
                      |+++|.. +.+||+|||+.......   .......-...|.|||.+.+..  .    .+.+.||||||++++|+++.+.|
T Consensus        79 nClvd~~-w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   79 NCLVDSR-WVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             cceeeee-EEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            9999954 59999999998765321   1111112334599999987631  1    46679999999999999999999


Q ss_pred             CCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCC
Q 013897          329 FFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQE  408 (434)
Q Consensus       329 f~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~  408 (434)
                      |.......+....+..+.+ .        ....+-|.+.                ..  ....+++..++..||..+|.+
T Consensus       158 ~~~~~~~~~~~eii~~~~~-~--------~~~~~rP~i~----------------~~--~e~~~~l~~l~~~cw~e~P~~  210 (484)
T KOG1023|consen  158 FDLRNLVEDPDEIILRVKK-G--------GSNPFRPSIE----------------LL--NELPPELLLLVARCWEEIPEK  210 (484)
T ss_pred             cccccccCChHHHHHHHHh-c--------CCCCcCcchh----------------hh--hhcchHHHHHHHHhcccChhh
Confidence            9665444433111111100 0        0000001100                00  134557999999999999999


Q ss_pred             CccHHHHh
Q 013897          409 RPTAKEAM  416 (434)
Q Consensus       409 Rpt~~elL  416 (434)
                      ||+++++-
T Consensus       211 rPs~~~i~  218 (484)
T KOG1023|consen  211 RPSIEQIR  218 (484)
T ss_pred             CccHHHHH
Confidence            99998764

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.75  E-value=1.4e-17  Score=150.24  Aligned_cols=127  Identities=20%  Similarity=0.371  Sum_probs=98.5

Q ss_pred             eeeecCceEEEEEEEcCCCeEEEEEEecccc-----------HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          141 KVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       141 ~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      .||+|+||.||+|.+  ++..+++|......           ..++.+|+.++..+ .|+++.....++.+.  ...++|
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~--~~~~lv   75 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRA-RKAGVNTPVVYDVDP--DNKTIV   75 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHH-HHCCCCCCEEEEEEC--CCCEEE
Confidence            489999999999985  56789999864321           24567899999998 666554433333333  345799


Q ss_pred             EeecCCCchhhhcCCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEeccccee
Q 013897          210 FEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF  278 (434)
Q Consensus       210 ~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~  278 (434)
                      |||++++++.........    .++.+++.+|.+||+.|++|+|++|.||+++ ++ .++++|||++..
T Consensus        76 ~e~~~g~~l~~~~~~~~~----~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~-~~~liDfg~a~~  138 (199)
T TIGR03724        76 MEYIEGKPLKDVIEEGND----ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DD-KLYLIDFGLGKY  138 (199)
T ss_pred             EEEECCccHHHHHhhcHH----HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CC-cEEEEECCCCcC
Confidence            999999998766433211    7889999999999999999999999999999 55 799999999865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.74  E-value=1.5e-17  Score=172.27  Aligned_cols=134  Identities=18%  Similarity=0.314  Sum_probs=105.2

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEe--ccc---------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccC
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL--KPV---------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ  202 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~--~~~---------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  202 (434)
                      ..|...+.||+|+||.||+|.+...  .+++|+.  +..         ..+.+.+|+.+++.+ +|++++....++.+. 
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~-  408 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEA-RRAGVPTPVIYDVDP-  408 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhh-cccCCCeeEEEEEeC-
Confidence            3456678999999999999987433  3333332  111         124578999999999 899998877766543 


Q ss_pred             CCccEEEEeecCCCchhhhcCCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceec
Q 013897          203 SKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY  279 (434)
Q Consensus       203 ~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~  279 (434)
                       ...++||||+++++|...+.     ....++.+++.+|.+||+.+|+||||||+|||++ ++ .++|+|||+++..
T Consensus       409 -~~~~lv~E~~~g~~L~~~l~-----~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~~-~~~liDFGla~~~  477 (535)
T PRK09605        409 -EEKTIVMEYIGGKDLKDVLE-----GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-DD-RLYLIDFGLGKYS  477 (535)
T ss_pred             -CCCEEEEEecCCCcHHHHHH-----HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-CC-cEEEEeCcccccC
Confidence             34579999999999977653     4577899999999999999999999999999995 44 7999999999753

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.72  E-value=2.7e-19  Score=185.05  Aligned_cols=255  Identities=22%  Similarity=0.350  Sum_probs=189.0

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcC-CCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCT-DNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~-~~~~vaiK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      ..|.+.+.||+|+|+.|-...... ....+|.|.+....     ...+..|..+-+.+..|+|++.+++...+.  ...+
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~--~~~~   97 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSP--RSYL   97 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCC--cccc
Confidence            457788889999999998887633 34566777664322     234456777777775599999999988655  4556


Q ss_pred             EEEeecCCCchhhhc-C----CCChHHHHHHHHHHHHHHHHHH-HCCceeecCCCCceEecCCCCeEEEEecccceecCC
Q 013897          208 LIFEHVNNTDFKVLY-P----TLSDYDVRYYIYELLKALDYCH-SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP  281 (434)
Q Consensus       208 lv~e~~~~~~l~~~~-~----~l~~~~~~~~~~qi~~~L~~LH-~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~  281 (434)
                      +.++|..++++-... .    ..+...+..++.|+..++.|+| ..++.|+|+||+|.+++..+..++++|||+|..+..
T Consensus        98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~  177 (601)
T KOG0590|consen   98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN  177 (601)
T ss_pred             cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence            899998888775544 1    3567788899999999999999 999999999999999996654799999999987755


Q ss_pred             -CCc---cceecc-CCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHh
Q 013897          282 -GKE---YNVRVA-SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN  356 (434)
Q Consensus       282 -~~~---~~~~~~-t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~  356 (434)
                       ...   ....+| +..|+|||...+........|+||.|+++.-+++|..|+..........            ..|..
T Consensus       178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~------------~~~~~  245 (601)
T KOG0590|consen  178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY------------SSWKS  245 (601)
T ss_pred             cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc------------eeecc
Confidence             222   244578 9999999998874456788999999999999999999984332211000            00000


Q ss_pred             hccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccc
Q 013897          357 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP  423 (434)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~  423 (434)
                                     ...+      .........+....+++.+++..+|..|.+.+++..+||+..
T Consensus       246 ---------------~~~~------~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  246 ---------------NKGR------FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             ---------------cccc------cccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence                           0000      001111235667899999999999999999999999999998

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.71  E-value=9e-17  Score=143.39  Aligned_cols=133  Identities=20%  Similarity=0.314  Sum_probs=96.2

Q ss_pred             EeeeeecCceEEEEEEEcCCCeEEEEEEeccccH-----HH----------------------HHHHHHHHHHhcCC-CC
Q 013897          139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK-----KK----------------------IKREIKILQNLCGG-PN  190 (434)
Q Consensus       139 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-----~~----------------------~~~E~~~l~~l~~h-~n  190 (434)
                      .+.||+|+||.||+|.+. +++.||||+++....     ..                      ...|...+..+..+ -.
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            467999999999999875 789999999864321     11                      13566666666222 23


Q ss_pred             eeeEeeEEEccCCCccEEEEeecCCCchhh-hcCCCCh-HHHHHHHHHHHHHHHHHHH-CCceeecCCCCceEecCCCCe
Q 013897          191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKV-LYPTLSD-YDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRK  267 (434)
Q Consensus       191 iv~l~~~~~~~~~~~~~lv~e~~~~~~l~~-~~~~l~~-~~~~~~~~qi~~~L~~LH~-~~ivHrDlKp~NIll~~~~~~  267 (434)
                      +.+.++..      ..++||||++++.+.. .+..... .+++.++.+++.++.++|. .+|+|+||||+||+++ ++ .
T Consensus        81 ~~~~~~~~------~~~lv~e~~~g~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~-~  152 (187)
T cd05119          81 VPKPIDLN------RHVLVMEFIGGDGIPAPRLKDVRLLEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG-K  152 (187)
T ss_pred             CCceEecC------CCEEEEEEeCCCCccChhhhhhhhcccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC-c
Confidence            45554432      2479999999954321 1111112 6778899999999999999 9999999999999999 55 7


Q ss_pred             EEEEecccceecC
Q 013897          268 LRLIDWGLAEFYH  280 (434)
Q Consensus       268 vkl~DFGla~~~~  280 (434)
                      ++|+|||.+....
T Consensus       153 ~~liDfg~a~~~~  165 (187)
T cd05119         153 VYIIDVPQAVEID  165 (187)
T ss_pred             EEEEECccccccc
Confidence            9999999996543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.69  E-value=3.4e-16  Score=144.96  Aligned_cols=131  Identities=18%  Similarity=0.307  Sum_probs=99.3

Q ss_pred             eeee-ecCceEEEEEEEcCCCeEEEEEEeccc----------------cHHHHHHHHHHHHHhcCCCCe--eeEeeEEEc
Q 013897          140 RKVG-RGKYSEVFEGVHCTDNEKCIIKILKPV----------------KKKKIKREIKILQNLCGGPNI--VKLLDIVRD  200 (434)
Q Consensus       140 ~~lG-~G~fg~Vy~~~~~~~~~~vaiK~~~~~----------------~~~~~~~E~~~l~~l~~h~ni--v~l~~~~~~  200 (434)
                      ..|| .|+.|+||.+..  .+..+|||.+...                ....+.+|+.++..| .|+++  ++.+++...
T Consensus        37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L-~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQL-YEAGLPVPRPIAARVV  113 (239)
T ss_pred             ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHH-HhCCCCCceeEeeeee
Confidence            4577 888888998876  3778899877421                124578899999999 77664  777776543


Q ss_pred             cCCC--ccEEEEeecCC-CchhhhcCC--CChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEeccc
Q 013897          201 QQSK--TPSLIFEHVNN-TDFKVLYPT--LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL  275 (434)
Q Consensus       201 ~~~~--~~~lv~e~~~~-~~l~~~~~~--l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGl  275 (434)
                      ....  ..++|+|++++ .+|..++..  +++    ..+.+|+.+|.+||++||+||||||+|||++.++ .++|+|||.
T Consensus       114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~----~~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~-~v~LIDfg~  188 (239)
T PRK01723        114 RHGLFYRADILIERIEGARDLVALLQEAPLSE----EQWQAIGQLIARFHDAGVYHADLNAHNILLDPDG-KFWLIDFDR  188 (239)
T ss_pred             ecCcceeeeEEEEecCCCCCHHHHHhcCCCCH----HHHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCC-CEEEEECCC
Confidence            3222  23599999997 577766543  333    2367899999999999999999999999999766 799999999


Q ss_pred             cee
Q 013897          276 AEF  278 (434)
Q Consensus       276 a~~  278 (434)
                      +..
T Consensus       189 ~~~  191 (239)
T PRK01723        189 GEL  191 (239)
T ss_pred             ccc
Confidence            865

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.68  E-value=7.7e-16  Score=131.46  Aligned_cols=133  Identities=22%  Similarity=0.303  Sum_probs=109.5

Q ss_pred             EEeeeeecCceEEEEEEEcCCCeEEEEEEecccc-HHHHHHHHHHHHHhcCC-CCeeeEeeEEEccCCCccEEEEeecCC
Q 013897          138 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-KKKIKREIKILQNLCGG-PNIVKLLDIVRDQQSKTPSLIFEHVNN  215 (434)
Q Consensus       138 ~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~E~~~l~~l~~h-~niv~l~~~~~~~~~~~~~lv~e~~~~  215 (434)
                      +++.||.|.++.||++...  +..+++|...... ...+.+|+.+++.+.++ .++++++++....  ...++++||+.+
T Consensus         2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~--~~~~~v~e~~~g   77 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESD--GWSYLLMEWIEG   77 (155)
T ss_pred             cceecccccccceEEEEec--CCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC--CccEEEEEecCC
Confidence            4578999999999999973  3789999986543 35789999999999544 6889998877543  467899999999


Q ss_pred             CchhhhcCCCChHHHHHHHHHHHHHHHHHHHC---CceeecCCCCceEecCCCCeEEEEecccceec
Q 013897          216 TDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ---GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY  279 (434)
Q Consensus       216 ~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~  279 (434)
                      ..+..+    +......++.+++.+|++||..   +++|+||+|+||+++.++ .++++|||.+...
T Consensus        78 ~~~~~~----~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~-~~~l~Df~~~~~~  139 (155)
T cd05120          78 ETLDEV----SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK-ILGIIDWEYAGYG  139 (155)
T ss_pred             eecccC----CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCc-EEEEEecccccCC
Confidence            877544    5566778889999999999985   699999999999999655 8999999998643

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.54  E-value=6.9e-15  Score=146.24  Aligned_cols=249  Identities=20%  Similarity=0.194  Sum_probs=184.1

Q ss_pred             CeEEEeeeee--cCceEEEEEEE--cCCCeEEEEEEecc-----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCc
Q 013897          135 DYEVVRKVGR--GKYSEVFEGVH--CTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT  205 (434)
Q Consensus       135 ~y~~~~~lG~--G~fg~Vy~~~~--~~~~~~vaiK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  205 (434)
                      .+.+...+|.  |.+|.||.+..  ..++..+|+|.-+.     .....-.+|+...+.+..|+|.++.+..+..  ...
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~--~~~  192 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG--SGI  192 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc--CCc
Confidence            3557788999  99999999988  78889999997431     2233446788888888889999998777754  456


Q ss_pred             cEEEEeecCCCchhhhc---CCCChHHHHHHHHHHHH----HHHHHHHCCceeecCCCCceEecCCCCeEEEEeccccee
Q 013897          206 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLK----ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF  278 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~----~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~  278 (434)
                      +++-.|++.........   .-++...++....+...    ||.++|+.+++|-|+||+||+...+....+++|||+...
T Consensus       193 lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~  272 (524)
T KOG0601|consen  193 LFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSK  272 (524)
T ss_pred             ceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEE
Confidence            67888888844333222   23778888999999999    999999999999999999999997745899999999987


Q ss_pred             cCCCCccce------eccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHH
Q 013897          279 YHPGKEYNV------RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELN  352 (434)
Q Consensus       279 ~~~~~~~~~------~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~  352 (434)
                      +.+..-...      .-|..-|++||...+  -++...|+++||.++.+..++..+...+..+.....+           
T Consensus       273 i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r-----------  339 (524)
T KOG0601|consen  273 ISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR-----------  339 (524)
T ss_pred             ccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc-----------
Confidence            765542211      146667999999764  6888999999999999999888776444222110000           


Q ss_pred             HHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccc
Q 013897          353 AYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI  424 (434)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~  424 (434)
                                 .               .++..+.-...+.++...+..|++.||..|+++..+++|+++...
T Consensus       340 -----------~---------------~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~  385 (524)
T KOG0601|consen  340 -----------Q---------------GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK  385 (524)
T ss_pred             -----------c---------------ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence                       0               001111111233456668999999999999999999999999844

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.51  E-value=1e-13  Score=139.28  Aligned_cols=136  Identities=19%  Similarity=0.336  Sum_probs=93.5

Q ss_pred             eeeeecCceEEEEEEEcCCCeEEEEEEeccccHHHHH-------------------------------------------
Q 013897          140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-------------------------------------------  176 (434)
Q Consensus       140 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~-------------------------------------------  176 (434)
                      +.||.|++|.||+|+. .+|+.||||+.++...+.+.                                           
T Consensus       123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            5699999999999997 57899999998764333322                                           


Q ss_pred             HHHHHHHHhc----CCCCeeeEeeEEEccCCCccEEEEeecCCCchhhhcCC--CChHHHHHHHHHHHH-HHHHHHHCCc
Q 013897          177 REIKILQNLC----GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELLK-ALDYCHSQGI  249 (434)
Q Consensus       177 ~E~~~l~~l~----~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--l~~~~~~~~~~qi~~-~L~~LH~~~i  249 (434)
                      +|...+.++.    ++++ +.+-.++.+.. ...+|||||+.|.++.+....  .. .....++.+++. .+..+|..|+
T Consensus       202 ~Ea~n~~~~~~~~~~~~~-v~vP~v~~~~~-~~~vLvmE~i~G~~L~~~~~~~~~~-~~~~~ia~~~~~~~l~ql~~~g~  278 (437)
T TIGR01982       202 REAANASELGENFKNDPG-VYVPEVYWDRT-SERVLTMEWIDGIPLSDIAALDEAG-LDRKALAENLARSFLNQVLRDGF  278 (437)
T ss_pred             HHHHHHHHHHHhcCCCCC-EEeCCEehhhc-CCceEEEEeECCcccccHHHHHhcC-CCHHHHHHHHHHHHHHHHHhCCc
Confidence            3444333331    2233 33333333222 235799999999988655321  11 123445556655 4788999999


Q ss_pred             eeecCCCCceEecCCCCeEEEEecccceecC
Q 013897          250 MHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH  280 (434)
Q Consensus       250 vHrDlKp~NIll~~~~~~vkl~DFGla~~~~  280 (434)
                      +|+|++|.||+++.++ .++|+|||++..+.
T Consensus       279 ~H~D~hPgNilv~~~g-~i~liDfG~~~~l~  308 (437)
T TIGR01982       279 FHADLHPGNIFVLKDG-KIIALDFGIVGRLS  308 (437)
T ss_pred             eeCCCCcccEEECCCC-cEEEEeCCCeeECC
Confidence            9999999999998776 89999999997764

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.50  E-value=2.4e-13  Score=119.07  Aligned_cols=126  Identities=21%  Similarity=0.262  Sum_probs=96.4

Q ss_pred             EeeeeecCceEEEEEEEcCCCeEEEEEEecccc--HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeecCCC
Q 013897          139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT  216 (434)
Q Consensus       139 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~  216 (434)
                      ++.|+.|.++.||++..  .+..+++|+.....  ...+.+|+.+++.+.+...+++++....  .  ..++||||+++.
T Consensus         3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~--~~~lv~e~i~G~   76 (170)
T cd05151           3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP--E--TGVLITEFIEGS   76 (170)
T ss_pred             eeecCCcccCceEEEEE--CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC--C--CCeEEEEecCCC
Confidence            46789999999999986  47889999986543  2456889999999844434556665542  1  236999999998


Q ss_pred             chhhhcCCCChHHHHHHHHHHHHHHHHHHHCCc-----eeecCCCCceEecCCCCeEEEEecccce
Q 013897          217 DFKVLYPTLSDYDVRYYIYELLKALDYCHSQGI-----MHRDVKPHNVMIDHEQRKLRLIDWGLAE  277 (434)
Q Consensus       217 ~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i-----vHrDlKp~NIll~~~~~~vkl~DFGla~  277 (434)
                      .+...     .......+.+++++|+.||..++     +|+|++|.||+++ ++ .++++|||.+.
T Consensus        77 ~l~~~-----~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~-~~~liDf~~a~  135 (170)
T cd05151          77 ELLTE-----DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DG-RLWLIDWEYAG  135 (170)
T ss_pred             ccccc-----cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CC-eEEEEeccccc
Confidence            87543     11123456789999999999885     9999999999999 54 79999999985

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.47  E-value=1.2e-14  Score=151.69  Aligned_cols=257  Identities=22%  Similarity=0.306  Sum_probs=180.9

Q ss_pred             CCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCc
Q 013897          132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT  205 (434)
Q Consensus       132 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  205 (434)
                      ..+.+.+.+-+-.|.++.++.+.-...+...++|+....      ..+....+-.++-.. ++|-++.....+  .....
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p-~~P~v~~~~~s~--~~rsP  878 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITP-RSPAVVRSFPSF--PCRSP  878 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccC-CCCceecccCCC--CCCCC
Confidence            457888999999999999999987777766666654321      122223333332222 456666555443  33456


Q ss_pred             cEEEEeecCCCchhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecC--
Q 013897          206 PSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH--  280 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~--  280 (434)
                      ..||++|+++++|...+.   ..+.+-.+.++..+..+++|||...+.|+|++|.|+|...++ ..++.|||......  
T Consensus       879 ~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~g-h~~l~~~~t~~~vg~~  957 (1205)
T KOG0606|consen  879 LPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDG-HRPLTDFGTLSKVGLI  957 (1205)
T ss_pred             cchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccC-CcccCccccccccccc
Confidence            779999999988765543   355667788888999999999999999999999999999777 89999998432110  


Q ss_pred             ----CC--------------------------CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCC
Q 013897          281 ----PG--------------------------KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF  330 (434)
Q Consensus       281 ----~~--------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~  330 (434)
                          +.                          ......++|+.|.+||.+.+ ......+|+|++|++++|.++|..||-
T Consensus       958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg-~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen  958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG-RRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred             cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc-ccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence                00                          00112368889999999988 677788999999999999999999982


Q ss_pred             CCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCc
Q 013897          331 YGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP  410 (434)
Q Consensus       331 ~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rp  410 (434)
                       .......+..|..                             ...+|..     -....++.+.+++.++|..+|.+|.
T Consensus      1037 -a~tpq~~f~ni~~-----------------------------~~~~~p~-----g~~~~s~~aq~~~~~ll~~~~~qr~ 1081 (1205)
T KOG0606|consen 1037 -AETPQQIFENILN-----------------------------RDIPWPE-----GPEEGSYEAQDLINRLLTEEPTQRL 1081 (1205)
T ss_pred             -Ccchhhhhhcccc-----------------------------CCCCCCC-----CccccChhhhhhhhhhhccCchhcc
Confidence             2222222211110                             0011111     1123567899999999999999999


Q ss_pred             cHH---HHhcCCCcccccccc
Q 013897          411 TAK---EAMAHPYFFPIRNAE  428 (434)
Q Consensus       411 t~~---elL~Hp~~~~~~~~~  428 (434)
                      .+.   ++-.||||+.+++..
T Consensus      1082 ~a~~~~e~k~~~~~~~~~~~~ 1102 (1205)
T KOG0606|consen 1082 GAKGAAEVKGHPFFQDVDWEN 1102 (1205)
T ss_pred             CcccccccccCCccCCCCccc
Confidence            987   999999999988654

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.43  E-value=2.5e-12  Score=114.37  Aligned_cols=132  Identities=17%  Similarity=0.264  Sum_probs=97.4

Q ss_pred             eeeeecCceEEEEEEEcC------CCeEEEEEEecccc-------------------------HHHH----HHHHHHHHH
Q 013897          140 RKVGRGKYSEVFEGVHCT------DNEKCIIKILKPVK-------------------------KKKI----KREIKILQN  184 (434)
Q Consensus       140 ~~lG~G~fg~Vy~~~~~~------~~~~vaiK~~~~~~-------------------------~~~~----~~E~~~l~~  184 (434)
                      ..||.|.-+.||.|....      .+..+|||+.+...                         .+.+    ++|+..|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            569999999999997543      35799999875210                         1122    389999999


Q ss_pred             hcCC-CCeeeEeeEEEccCCCccEEEEeecCCCchh-hhcC--CCChHHHHHHHHHHHHHHHHH-HHCCceeecCCCCce
Q 013897          185 LCGG-PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK-VLYP--TLSDYDVRYYIYELLKALDYC-HSQGIMHRDVKPHNV  259 (434)
Q Consensus       185 l~~h-~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~-~~~~--~l~~~~~~~~~~qi~~~L~~L-H~~~ivHrDlKp~NI  259 (434)
                      +... -++++++++.      .-+|||||++++.+. ..+.  .++..+...+..+++.+|..| |..||||+||++.||
T Consensus        83 l~~~Gv~vP~pi~~~------~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI  156 (197)
T cd05146          83 MQKAGIPCPEVVVLK------KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM  156 (197)
T ss_pred             HHHcCCCCCeEEEec------CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence            8433 5777777652      235999999876431 1111  244456677889999999998 899999999999999


Q ss_pred             EecCCCCeEEEEecccceec
Q 013897          260 MIDHEQRKLRLIDWGLAEFY  279 (434)
Q Consensus       260 ll~~~~~~vkl~DFGla~~~  279 (434)
                      |++ ++ .+.|+|||.|...
T Consensus       157 L~~-~~-~v~iIDF~qav~~  174 (197)
T cd05146         157 LWH-DG-KVWFIDVSQSVEP  174 (197)
T ss_pred             EEE-CC-cEEEEECCCceeC
Confidence            998 44 6999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.38  E-value=3.2e-13  Score=134.42  Aligned_cols=245  Identities=20%  Similarity=0.143  Sum_probs=175.0

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEc-CCCeEEEEEEeccccH-----HHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHC-TDNEKCIIKILKPVKK-----KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~~vaiK~~~~~~~-----~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      ..+|..+..||.|.|+.|+..... .++..|++|-+.....     ..-..|+.+...+..|.+++..+..+...  ...
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~--r~~  341 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL--RQG  341 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccc--ccc
Confidence            467889999999999999998765 6778899987754321     22356777777777889999887766433  344


Q ss_pred             EEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC
Q 013897          207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~  283 (434)
                      ++--|||.+++.....   ..+.+...+.+..|++.++.++|++.++|+|+||+||++..++...++.|||.+..+.  .
T Consensus       342 ~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~--~  419 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA--F  419 (524)
T ss_pred             cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccc--e
Confidence            5888999988765433   3477788889999999999999999999999999999999765578999999986421  1


Q ss_pred             ccceeccCCccc-ccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          284 EYNVRVASRYFK-GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       284 ~~~~~~~t~~y~-aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                      ..........++ .+|++.....+..+.|++|||.-+.+.+++. ++....+.   +..|...                 
T Consensus       420 ~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~-~ls~~~~~---~~~i~~~-----------------  478 (524)
T KOG0601|consen  420 SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGS-PLSESGVQ---SLTIRSG-----------------  478 (524)
T ss_pred             ecccccccccccccchhhccccccccccccccccccccccccCc-ccCccccc---ceeeecc-----------------
Confidence            112222333344 3666665567889999999999999999886 44222111   1110000                 


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFF  422 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~  422 (434)
                                          ...+......++..+.+.+...|+..|+.+.++..|.=|.
T Consensus       479 --------------------~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  479 --------------------DTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             --------------------cccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence                                0011111225677888999999999999999998887554

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.38  E-value=1.8e-12  Score=132.14  Aligned_cols=143  Identities=13%  Similarity=0.254  Sum_probs=90.9

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccccHHH---------------------------------------
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK---------------------------------------  174 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~---------------------------------------  174 (434)
                      .+|+. +.||.|++|.||+|+.+.+|+.||||++++...+.                                       
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            34555 78999999999999997779999999997542211                                       


Q ss_pred             ----HHHHHHHHHHhc---CCCCeeeEeeEEEccCCCccEEEEeecCCCchhhhc--C--CCChHHHHHHHHHHHH-HHH
Q 013897          175 ----IKREIKILQNLC---GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY--P--TLSDYDVRYYIYELLK-ALD  242 (434)
Q Consensus       175 ----~~~E~~~l~~l~---~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~--~--~l~~~~~~~~~~qi~~-~L~  242 (434)
                          +.+|...+.++.   .+.+.+.+-.++.+- ....+|||||+.|+.+.+..  .  .....   .++...+. -+.
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~-st~~VLvmE~i~G~~l~d~~~l~~~g~d~~---~la~~~v~~~~~  274 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDY-CSETVMVMERMYGIPVSDVAALRAAGTDMK---LLAERGVEVFFT  274 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeeccc-CCCceEEEeeecCccHHhHHHHHhcCCCHH---HHHHHHHHHHHH
Confidence                223333333331   123334433444332 23457999999999876531  1  11111   12221111 123


Q ss_pred             HHHHCCceeecCCCCceEecCCC---CeEEEEecccceecCC
Q 013897          243 YCHSQGIMHRDVKPHNVMIDHEQ---RKLRLIDWGLAEFYHP  281 (434)
Q Consensus       243 ~LH~~~ivHrDlKp~NIll~~~~---~~vkl~DFGla~~~~~  281 (434)
                      -+...|++|+|+||.||+++.++   +.++++|||++..+.+
T Consensus       275 Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        275 QVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            34568999999999999998664   3799999999977653

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.35  E-value=1.2e-11  Score=124.62  Aligned_cols=165  Identities=22%  Similarity=0.359  Sum_probs=122.1

Q ss_pred             EEEEcCCCeEEEEEEeccccH---HHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeecCCCchhhhcCCCChH
Q 013897          152 EGVHCTDNEKCIIKILKPVKK---KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY  228 (434)
Q Consensus       152 ~~~~~~~~~~vaiK~~~~~~~---~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~l~~~  228 (434)
                      .|..+.++..|.|...+....   ....+-++.|+.+ +||||+++++.++..  ..+|||+|-+..-.  ..+..+...
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtl-RHP~Il~yL~t~e~~--~~~ylvTErV~Pl~--~~lk~l~~~  104 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTL-RHPNILSYLDTTEEE--GTLYLVTERVRPLE--TVLKELGKE  104 (690)
T ss_pred             ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhc-cCchhhhhhhhhccc--CceEEEeeccccHH--HHHHHhHHH
Confidence            455667788888888765443   5567778889998 999999999998654  47889999887533  333455677


Q ss_pred             HHHHHHHHHHHHHHHHH-HCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc-cceeccCCcccccccccCCCCC
Q 013897          229 DVRYYIYELLKALDYCH-SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQDY  306 (434)
Q Consensus       229 ~~~~~~~qi~~~L~~LH-~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~  306 (434)
                      .+...+.||+.||.||| +.+++|++|..+.|+++..| ..||++|.++........ .....--..|..|+.+.. .. 
T Consensus       105 ~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~G-eWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~-s~-  181 (690)
T KOG1243|consen  105 EVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESG-EWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDP-SE-  181 (690)
T ss_pred             HHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCC-cEEEeeeEEEeccccCCcccccchhhhcccChhhcCc-cc-
Confidence            88888999999999998 56899999999999999877 899999999854432221 011111123556665432 11 


Q ss_pred             CccccHHHHHHHHHHHHhC
Q 013897          307 DYSLDLWSLGCMFAGMIFR  325 (434)
Q Consensus       307 ~~~~DvwSlGvil~elltg  325 (434)
                       -..|.|.|||+++|++.|
T Consensus       182 -~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 -WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             -cchhhhhHHHHHHHHhCc
Confidence             357999999999999988

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.32  E-value=2e-12  Score=119.59  Aligned_cols=202  Identities=22%  Similarity=0.276  Sum_probs=138.3

Q ss_pred             HHHHhcCCCCeeeEeeEEEccC---CCccEEEEeecCCCchhhhcC-------CCChHHHHHHHHHHHHHHHHHHHC--C
Q 013897          181 ILQNLCGGPNIVKLLDIVRDQQ---SKTPSLIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQ--G  248 (434)
Q Consensus       181 ~l~~l~~h~niv~l~~~~~~~~---~~~~~lv~e~~~~~~l~~~~~-------~l~~~~~~~~~~qi~~~L~~LH~~--~  248 (434)
                      -|..+ .|-|||+++.|+.+..   .....++.|||..|++..+++       .+.....++++-||+.||.|||+.  -
T Consensus       120 nllql-vHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp  198 (458)
T KOG1266|consen  120 NLLQL-VHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP  198 (458)
T ss_pred             HHHHH-HHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence            34444 6899999999987543   345678999999999887764       366777889999999999999987  5


Q ss_pred             ceeecCCCCceEecCCCCeEEEEecccceecCCC------CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHH
Q 013897          249 IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG------KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGM  322 (434)
Q Consensus       249 ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~el  322 (434)
                      |+|+++..+-|++.+++ -+|+.- +--...++.      .......+-++|.+||.=.. ...+-.+|||+||....+|
T Consensus       199 iihgnlTc~tifiq~ng-LIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~-tn~~~a~dIy~fgmcAlem  275 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNG-LIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTT-TNTTGASDIYKFGMCALEM  275 (458)
T ss_pred             cccCCcchhheeecCCc-eEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcc-cccccchhhhhhhHHHHHH
Confidence            99999999999999766 566642 111111111      01122345678889987332 3566789999999999999


Q ss_pred             HhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHcc
Q 013897          323 IFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLL  402 (434)
Q Consensus       323 ltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL  402 (434)
                      ..+..---.+....+.-..+...                                   .+..++     +--.+++.+||
T Consensus       276 ailEiq~tnseS~~~~ee~ia~~-----------------------------------i~~len-----~lqr~~i~kcl  315 (458)
T KOG1266|consen  276 AILEIQSTNSESKVEVEENIANV-----------------------------------IIGLEN-----GLQRGSITKCL  315 (458)
T ss_pred             HHheeccCCCcceeehhhhhhhh-----------------------------------eeeccC-----ccccCcCcccc
Confidence            88764432332222221111110                                   000111     12247899999


Q ss_pred             ccCCCCCccHHHHhcCCCcccccc
Q 013897          403 RYDHQERPTAKEAMAHPYFFPIRN  426 (434)
Q Consensus       403 ~~dP~~Rpt~~elL~Hp~~~~~~~  426 (434)
                      +-.|..||+|.++|.||.+-.|..
T Consensus       316 ~~eP~~rp~ar~llfHpllfeVhs  339 (458)
T KOG1266|consen  316 EGEPNGRPDARLLLFHPLLFEVHS  339 (458)
T ss_pred             cCCCCCCcchhhhhcCceeeecch
Confidence            999999999999999999877653

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.31  E-value=2.6e-11  Score=104.52  Aligned_cols=127  Identities=20%  Similarity=0.346  Sum_probs=91.7

Q ss_pred             eeeeecCceEEEEEEEcCCCeEEEEEEeccc-----------cHHHHHHHHHHHHHhcC-CCCeeeEeeEEEccCCCccE
Q 013897          140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----------KKKKIKREIKILQNLCG-GPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       140 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----------~~~~~~~E~~~l~~l~~-h~niv~l~~~~~~~~~~~~~  207 (434)
                      ..+++|+-+.+|.+.+  -|..+++|.-.+.           ...+..+|..++.++.. --+++.++++  ++.  ...
T Consensus         2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv--D~~--~~~   75 (204)
T COG3642           2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV--DPD--NGL   75 (204)
T ss_pred             chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE--cCC--CCE
Confidence            3578999999999976  3445777753221           13456789999998722 2333444443  343  335


Q ss_pred             EEEeecCCCchhhhcCCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEeccccee
Q 013897          208 LIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF  278 (434)
Q Consensus       208 lv~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~  278 (434)
                      |+|||++|..+.+.+..-    ...++..+-.-+.-||..||+|+||.++||++..+  .+.++|||++..
T Consensus        76 I~me~I~G~~lkd~l~~~----~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~--~i~~IDfGLg~~  140 (204)
T COG3642          76 IVMEYIEGELLKDALEEA----RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG--RIYFIDFGLGEF  140 (204)
T ss_pred             EEEEEeCChhHHHHHHhc----chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC--cEEEEECCcccc
Confidence            999999999988665443    24566777777888999999999999999999844  499999999974

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.25  E-value=9.7e-11  Score=100.52  Aligned_cols=136  Identities=20%  Similarity=0.288  Sum_probs=97.7

Q ss_pred             EEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          138 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       138 ~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      .+..|-+|+-+.|+++.+  .|+.++||--.+.           .+.+.++|+.+|.++ .--.|.-..-++.|....  
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~-~~~GI~~P~l~~~D~~~~--   85 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKC-RALGIPAPRLIFIDTYGG--   85 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHH-HHhCCCCceEEEEecCCC--
Confidence            466788999999999986  6888888853221           235678899999987 333443333344444333  


Q ss_pred             EEEEeecCCC-chhhhc----C-CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeE--EEEeccccee
Q 013897          207 SLIFEHVNNT-DFKVLY----P-TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKL--RLIDWGLAEF  278 (434)
Q Consensus       207 ~lv~e~~~~~-~l~~~~----~-~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~v--kl~DFGla~~  278 (434)
                      .|+|||+.+. ++..++    . .........++.+|-+.+.-||..+|||+||..+||++..++..+  .++|||++..
T Consensus        86 ~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   86 QIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             eEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            4999999883 333332    2 222333368889999999999999999999999999997666544  8999999853

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.22  E-value=1.8e-10  Score=105.19  Aligned_cols=138  Identities=25%  Similarity=0.428  Sum_probs=104.0

Q ss_pred             eeeeecCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHHHhcC-CCCeeeEeeEEEccC-CCccEEEEeec
Q 013897          140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCG-GPNIVKLLDIVRDQQ-SKTPSLIFEHV  213 (434)
Q Consensus       140 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~-h~niv~l~~~~~~~~-~~~~~lv~e~~  213 (434)
                      +.||.|..+.||++.. .+|..+++|+.....    ...+.+|+++++.+.. +.++++++.+..+.. ....++||||+
T Consensus         4 ~~l~~G~~n~~~~v~~-~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           4 RQLSGGQSNLTYLLTA-GGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             eecCCCccceEEEEEe-cCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            5689999999999987 346889999976432    4578999999999844 245677777764321 12457999999


Q ss_pred             CCCchhhhc--CCCChHHHHHHHHHHHHHHHHHHH---------------------------------------------
Q 013897          214 NNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHS---------------------------------------------  246 (434)
Q Consensus       214 ~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~---------------------------------------------  246 (434)
                      ++.++....  ..++..+...++.+++++|..||+                                             
T Consensus        83 ~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (223)
T cd05154          83 DGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLR  162 (223)
T ss_pred             CCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHH
Confidence            998876654  356667777778888888888873                                             


Q ss_pred             -----------CCceeecCCCCceEecCC-CCeEEEEeccccee
Q 013897          247 -----------QGIMHRDVKPHNVMIDHE-QRKLRLIDWGLAEF  278 (434)
Q Consensus       247 -----------~~ivHrDlKp~NIll~~~-~~~vkl~DFGla~~  278 (434)
                                 ..++|+|+.+.||+++.+ +..+.|+||+.+..
T Consensus       163 ~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         163 WLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                       235899999999999963 33689999999864

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.21  E-value=5.3e-10  Score=109.60  Aligned_cols=164  Identities=16%  Similarity=0.260  Sum_probs=125.2

Q ss_pred             CceEEEEEEEcCCCeEEEEEEecc---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEEc--cCCCccEEEEeecCCC-chh
Q 013897          146 KYSEVFEGVHCTDNEKCIIKILKP---VKKKKIKREIKILQNLCGGPNIVKLLDIVRD--QQSKTPSLIFEHVNNT-DFK  219 (434)
Q Consensus       146 ~fg~Vy~~~~~~~~~~vaiK~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--~~~~~~~lv~e~~~~~-~l~  219 (434)
                      ...+.|++....+|..|++|.+.-   ........-+++++++ .|+|+|.+.+++.-  .....+++||+|.++. +|.
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl-~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~  366 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKL-CHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY  366 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHh-ccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence            346789999999999999999932   2223345567889999 99999999998752  2345788999999874 443


Q ss_pred             hhc------------------CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC
Q 013897          220 VLY------------------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP  281 (434)
Q Consensus       220 ~~~------------------~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~  281 (434)
                      +++                  ...++..++.|+.|+..||.++|+.|...+-|.|.+||++.+. .++|.-.|+......
T Consensus       367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~-RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKM-RIRISGCGIMDVLQE  445 (655)
T ss_pred             HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcc-eEEEecccceeeecC
Confidence            332                  1257788999999999999999999999999999999999665 788888887766654


Q ss_pred             CCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCC
Q 013897          282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEP  328 (434)
Q Consensus       282 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~p  328 (434)
                      +.           .+|  +.+    -.+-|.=.||.+++.|.||..-
T Consensus       446 d~-----------~~~--le~----~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  446 DP-----------TEP--LES----QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CC-----------Ccc--hhH----HhhhhHHHHHHHHHHHhhcccc
Confidence            43           111  111    1267999999999999999744

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.14  E-value=6.2e-10  Score=98.64  Aligned_cols=122  Identities=24%  Similarity=0.385  Sum_probs=82.1

Q ss_pred             EEEEEEEcCCCeEEEEEEecccc-----------------------------HHHHHHHHHHHHHhcCC-CCeeeEeeEE
Q 013897          149 EVFEGVHCTDNEKCIIKILKPVK-----------------------------KKKIKREIKILQNLCGG-PNIVKLLDIV  198 (434)
Q Consensus       149 ~Vy~~~~~~~~~~vaiK~~~~~~-----------------------------~~~~~~E~~~l~~l~~h-~niv~l~~~~  198 (434)
                      .||.|.. .++..+|||+.+...                             .....+|...|.++... -++++++++-
T Consensus         1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            3899986 678899999975210                             12357899999999433 3677777653


Q ss_pred             EccCCCccEEEEeecC--CCchhhhcCC-CChHHHHHHHHHHHHHHHH-HHHCCceeecCCCCceEecCCCCeEEEEecc
Q 013897          199 RDQQSKTPSLIFEHVN--NTDFKVLYPT-LSDYDVRYYIYELLKALDY-CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG  274 (434)
Q Consensus       199 ~~~~~~~~~lv~e~~~--~~~l~~~~~~-l~~~~~~~~~~qi~~~L~~-LH~~~ivHrDlKp~NIll~~~~~~vkl~DFG  274 (434)
                            .-+|||||++  +..+..+... ++..+...++.+++..+.. +|..||+|+||.+.|||++.+  .+.|+|||
T Consensus        80 ------~~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~--~~~iIDf~  151 (188)
T PF01163_consen   80 ------RNVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG--KVYIIDFG  151 (188)
T ss_dssp             ------TTEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT--CEEE--GT
T ss_pred             ------CCEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc--eEEEEecC
Confidence                  1259999999  6555444322 2345677788888886655 579999999999999999955  69999999


Q ss_pred             cceec
Q 013897          275 LAEFY  279 (434)
Q Consensus       275 la~~~  279 (434)
                      .+...
T Consensus       152 qav~~  156 (188)
T PF01163_consen  152 QAVDS  156 (188)
T ss_dssp             TEEET
T ss_pred             cceec
Confidence            98654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.10  E-value=1.3e-09  Score=104.52  Aligned_cols=188  Identities=16%  Similarity=0.214  Sum_probs=126.4

Q ss_pred             EEeeeeecCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeEeeE----EEc-cCCCccEEEEee
Q 013897          138 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDI----VRD-QQSKTPSLIFEH  212 (434)
Q Consensus       138 ~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~----~~~-~~~~~~~lv~e~  212 (434)
                      ..+.||+|+-+.+|-.-.   -...+.|++.......-.+-+..|.+...||-+-.=+.+    ... .....+-++|..
T Consensus        15 ~gr~LgqGgea~ly~l~e---~~d~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~   91 (637)
T COG4248          15 PGRPLGQGGEADLYTLGE---VRDQVAKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPK   91 (637)
T ss_pred             CCccccCCccceeeecch---hhchhheeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEeccc
Confidence            457799999999996543   233456777543332223334445555455544331111    111 112224566666


Q ss_pred             cCCCc-h---------hhhcCCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC
Q 013897          213 VNNTD-F---------KVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG  282 (434)
Q Consensus       213 ~~~~~-l---------~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~  282 (434)
                      +.+.. .         .+.++...|.-....+++++.+.+.||+.|.+-+|+.++|+|+++++ .|.|.|=..-.....+
T Consensus        92 v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~-~V~LVdsDsfqi~~ng  170 (637)
T COG4248          92 VSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDS-KVVLVDSDSFQINANG  170 (637)
T ss_pred             CCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCc-eEEEEcccceeeccCC
Confidence            65531 1         12223467778889999999999999999999999999999999776 8999985554433445


Q ss_pred             CccceeccCCcccccccccC----CCCCCccccHHHHHHHHHHHHhC-CCCC
Q 013897          283 KEYNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFR-KEPF  329 (434)
Q Consensus       283 ~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DvwSlGvil~elltg-~~pf  329 (434)
                      ..+...+|...|++||...-    .-.-+...|.|.||+++++|+.| +.||
T Consensus       171 ~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPy  222 (637)
T COG4248         171 TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPY  222 (637)
T ss_pred             ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCC
Confidence            55667789999999998531    12345689999999999999987 8898

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.05  E-value=8.4e-09  Score=96.83  Aligned_cols=128  Identities=18%  Similarity=0.184  Sum_probs=90.8

Q ss_pred             EEEEEEEcCCCeEEEEEEeccccH--------------HHHHHHHHHHHHhcC-CCCeeeEeeEEEccC---CCccEEEE
Q 013897          149 EVFEGVHCTDNEKCIIKILKPVKK--------------KKIKREIKILQNLCG-GPNIVKLLDIVRDQQ---SKTPSLIF  210 (434)
Q Consensus       149 ~Vy~~~~~~~~~~vaiK~~~~~~~--------------~~~~~E~~~l~~l~~-h~niv~l~~~~~~~~---~~~~~lv~  210 (434)
                      .|+++..  +|+.|.||.......              ..+.+|...+..|.. .-.++..+++.+...   ....+||+
T Consensus        37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt  114 (268)
T PRK15123         37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT  114 (268)
T ss_pred             eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence            3666654  567888886643221              137799999888822 123344455543221   23457999


Q ss_pred             eecCCC-chhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecC------CCCeEEEEeccccee
Q 013897          211 EHVNNT-DFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH------EQRKLRLIDWGLAEF  278 (434)
Q Consensus       211 e~~~~~-~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~------~~~~vkl~DFGla~~  278 (434)
                      |++++. ++.++..     .........++.+++..+.-||+.||+|+||++.|||++.      +...+.|+||+.+..
T Consensus       115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            999986 6766642     3445567789999999999999999999999999999984      234899999998853

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.94  E-value=3.9e-10  Score=114.28  Aligned_cols=155  Identities=17%  Similarity=0.266  Sum_probs=110.5

Q ss_pred             HHHHHHHHHHHC-CceeecCCCCceEecCCCCeEEEEecccceecCCCCcc-----cee-----ccCCcccccccccCCC
Q 013897          236 ELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-----NVR-----VASRYFKGPELLVDLQ  304 (434)
Q Consensus       236 qi~~~L~~LH~~-~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~-----~~~-----~~t~~y~aPE~~~~~~  304 (434)
                      +.+.||.|+|.. ++||+.|.|++|.++..+ ..||+.|+.+....+...+     +..     .....|.|||++.+ .
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~-~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~  184 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANG-DWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-T  184 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCc-ceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-c
Confidence            444899999976 899999999999999766 8999999998655442222     111     23456999999887 6


Q ss_pred             CCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCcccccc
Q 013897          305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITV  384 (434)
Q Consensus       305 ~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (434)
                      ..+.++|++||||++|-+..|+.+.....+....... ....                        .....        .
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~-~~~~------------------------~~~~~--------~  231 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSF-SRNL------------------------LNAGA--------F  231 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCcchhhh-hhcc------------------------ccccc--------c
Confidence            7889999999999999998555565443322111110 0000                        00000        0


Q ss_pred             ccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccc
Q 013897          385 ENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       385 ~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                      .....++.++.+=|.++|..|+..||++.+++..|||....
T Consensus       232 ~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~  272 (700)
T KOG2137|consen  232 GYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSIPFFSDPG  272 (700)
T ss_pred             cccccCcHHHHHHHHHHhcCCcccCcchhhhhcccccCCch
Confidence            11134778999999999999999999999999999998654

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.91  E-value=1.1e-08  Score=93.62  Aligned_cols=132  Identities=21%  Similarity=0.359  Sum_probs=99.7

Q ss_pred             eEEEeeeeecCceEEEEEEEcCCCeEEEEEEecc-------c------------------cHHHHHHHHHHHHHhcCC-C
Q 013897          136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-------V------------------KKKKIKREIKILQNLCGG-P  189 (434)
Q Consensus       136 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~-------~------------------~~~~~~~E~~~l~~l~~h-~  189 (434)
                      +.+...||-|.-+.||.|.+ ..|..+|||.=+.       .                  .+...++|.++|+.|..+ -
T Consensus        93 e~iG~~IGvGKEsdVY~~~~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAID-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEEC-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            45778999999999999987 5789999997431       0                  123467899999999433 3


Q ss_pred             CeeeEeeEEEccCCCccEEEEeecCCCchhhhcCCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEE
Q 013897          190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLR  269 (434)
Q Consensus       190 niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vk  269 (434)
                      .+++.+++-      .-++|||++.+..|....  +.......++..|+.-+.-+-..||||+|+.+=||+++.++ .+.
T Consensus       172 ~VP~P~~~n------RHaVvMe~ieG~eL~~~r--~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg-~~~  242 (304)
T COG0478         172 KVPKPIAWN------RHAVVMEYIEGVELYRLR--LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDG-DIV  242 (304)
T ss_pred             CCCCccccc------cceeeeehcccceeeccc--CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCC-CEE
Confidence            677776643      336999999997765442  24555566666666666666689999999999999999877 799


Q ss_pred             EEecccce
Q 013897          270 LIDWGLAE  277 (434)
Q Consensus       270 l~DFGla~  277 (434)
                      ++||--+.
T Consensus       243 vIDwPQ~v  250 (304)
T COG0478         243 VIDWPQAV  250 (304)
T ss_pred             EEeCcccc
Confidence            99998764

>PRK09902 hypothetical protein; Provisional

Probab=98.81  E-value=1.1e-07  Score=84.89  Aligned_cols=135  Identities=17%  Similarity=0.160  Sum_probs=95.9

Q ss_pred             eeecCceEEEEEEEcCCCeEEEEEEec---------cccHHHHHHHHHHHHHhcCC-CCeeeEee--EEEccCCCccEEE
Q 013897          142 VGRGKYSEVFEGVHCTDNEKCIIKILK---------PVKKKKIKREIKILQNLCGG-PNIVKLLD--IVRDQQSKTPSLI  209 (434)
Q Consensus       142 lG~G~fg~Vy~~~~~~~~~~vaiK~~~---------~~~~~~~~~E~~~l~~l~~h-~niv~l~~--~~~~~~~~~~~lv  209 (434)
                      -|+||-+.|+....  .|..+=+|.-.         +.....|.+|+..|+.|... -.+++...  .-........+||
T Consensus        26 ~~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence            46688888998775  34457777653         33457799999999998322 22444442  1122333446799


Q ss_pred             EeecCCC-chhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCC-CeEEEEeccccee
Q 013897          210 FEHVNNT-DFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ-RKLRLIDWGLAEF  278 (434)
Q Consensus       210 ~e~~~~~-~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~-~~vkl~DFGla~~  278 (434)
                      +|-+++. +|..++.     +.+......++.+++..+.-||+.|+.|+|+-+.|||++.++ ..++++||.-++.
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            9988754 5655542     345666788999999999999999999999999999998555 2499999997753

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.78  E-value=8.6e-08  Score=86.85  Aligned_cols=108  Identities=25%  Similarity=0.369  Sum_probs=81.9

Q ss_pred             HHHHHHHHHHHHHhcC-CCCeeeEeeEEEccC--CCccEEEEeecCCC-chhhhcCC---CChHHHHHHHHHHHHHHHHH
Q 013897          172 KKKIKREIKILQNLCG-GPNIVKLLDIVRDQQ--SKTPSLIFEHVNNT-DFKVLYPT---LSDYDVRYYIYELLKALDYC  244 (434)
Q Consensus       172 ~~~~~~E~~~l~~l~~-h~niv~l~~~~~~~~--~~~~~lv~e~~~~~-~l~~~~~~---l~~~~~~~~~~qi~~~L~~L  244 (434)
                      .....+|...+..|.. .=.+++.+++.+...  ....++|+|++++. +|..+...   .+......++.+++..+.-|
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence            4567889888887732 233456666655422  23347999999985 67776654   56677889999999999999


Q ss_pred             HHCCceeecCCCCceEecCCC--CeEEEEecccceec
Q 013897          245 HSQGIMHRDVKPHNVMIDHEQ--RKLRLIDWGLAEFY  279 (434)
Q Consensus       245 H~~~ivHrDlKp~NIll~~~~--~~vkl~DFGla~~~  279 (434)
                      |+.||+|+|+++.|||++.++  ..+.|+||+.++..
T Consensus       135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            999999999999999998654  36999999988753

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.64  E-value=4.7e-07  Score=82.15  Aligned_cols=133  Identities=16%  Similarity=0.263  Sum_probs=95.5

Q ss_pred             EEeeeeecCceEEEEEEEcCCCeEEEEEEeccccH----------------------HH-----HHHHHHHHHHhc-CCC
Q 013897          138 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK----------------------KK-----IKREIKILQNLC-GGP  189 (434)
Q Consensus       138 ~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----------------------~~-----~~~E~~~l~~l~-~h~  189 (434)
                      +...|.+|.-+.||+|.. .++..+|+|+++....                      .+     ..+|+..|+++. .+-
T Consensus        52 ~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGV  130 (268)
T COG1718          52 LVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGV  130 (268)
T ss_pred             eEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCC
Confidence            455889999999999975 6789999999863210                      11     246888887772 235


Q ss_pred             CeeeEeeEEEccCCCccEEEEeecCCCch-hhhcC--CCChHHHHHHHHHHHHHHHHHHH-CCceeecCCCCceEecCCC
Q 013897          190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDF-KVLYP--TLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQ  265 (434)
Q Consensus       190 niv~l~~~~~~~~~~~~~lv~e~~~~~~l-~~~~~--~l~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlKp~NIll~~~~  265 (434)
                      .+++.+++.      .-.|||||++.... .-.+.  ++...++..+..++++.+.-|-. .++||+||..=|||+. ++
T Consensus       131 rvP~Pi~~~------~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~  203 (268)
T COG1718         131 RVPEPIAFR------NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DG  203 (268)
T ss_pred             CCCCceeec------CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CC
Confidence            666666654      22599999987632 11111  12333577778888888888766 8999999999999999 55


Q ss_pred             CeEEEEecccceec
Q 013897          266 RKLRLIDWGLAEFY  279 (434)
Q Consensus       266 ~~vkl~DFGla~~~  279 (434)
                       .+.|+|||-|...
T Consensus       204 -~p~iID~~QaV~~  216 (268)
T COG1718         204 -EPYIIDVSQAVTI  216 (268)
T ss_pred             -eEEEEECcccccc
Confidence             7999999988644

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.59  E-value=1.3e-06  Score=80.13  Aligned_cols=138  Identities=20%  Similarity=0.403  Sum_probs=83.8

Q ss_pred             EeeeeecCceEEEEEEEcCCCeEEEEEEeccc-cHHHHHHHHHHHHHhcCC-CCeeeEeeEEEcc-CCCccEEEEeecCC
Q 013897          139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGG-PNIVKLLDIVRDQ-QSKTPSLIFEHVNN  215 (434)
Q Consensus       139 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~E~~~l~~l~~h-~niv~l~~~~~~~-~~~~~~lv~e~~~~  215 (434)
                      ++.|+.|..+.||+.....  ..+++|+.... ....+.+|..+++.+..+ ..+++++...... .....+++|+++.+
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g   79 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG   79 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence            4679999999999998733  59999998765 556788999999988544 2366777654332 23346899999999


Q ss_pred             Cchhhh----------------c-------CC---CChHH------HHH---H------------HHHHHH-HHHHHHH-
Q 013897          216 TDFKVL----------------Y-------PT---LSDYD------VRY---Y------------IYELLK-ALDYCHS-  246 (434)
Q Consensus       216 ~~l~~~----------------~-------~~---l~~~~------~~~---~------------~~qi~~-~L~~LH~-  246 (434)
                      ..+...                +       ..   +....      ...   .            ...+.. .+..+++ 
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (239)
T PF01636_consen   80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL  159 (239)
T ss_dssp             EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence            876650                0       00   00000      000   0            111222 2333332 


Q ss_pred             ------CCceeecCCCCceEecCCCCeEEEEeccccee
Q 013897          247 ------QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF  278 (434)
Q Consensus       247 ------~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~  278 (434)
                            ..++|+|+.|.|||++.+++.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             hccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence                  35999999999999994443668999998753

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.57  E-value=1.6e-06  Score=77.90  Aligned_cols=136  Identities=16%  Similarity=0.252  Sum_probs=90.4

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccccH------------HHHHHHHHHHHHhc--CCCCeeeEeeEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK------------KKIKREIKILQNLC--GGPNIVKLLDIV  198 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------------~~~~~E~~~l~~l~--~h~niv~l~~~~  198 (434)
                      ..+|.+.+.+-......|.+-.-  ++..+++|..+....            ....+++..+..+.  +--..+.++.+.
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            36788888888888888877764  689999998865321            11234444444441  223333333333


Q ss_pred             EccC---CCccEEEEeecCCCchhhhcCCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEeccc
Q 013897          199 RDQQ---SKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL  275 (434)
Q Consensus       199 ~~~~---~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGl  275 (434)
                      +-..   ....++||||++|..+.++. .+.+    .+...+.+++.-||+.|+.|+|..|.|++++.+  .++++||+.
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~-~i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~--~i~iID~~~  180 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIE-DIDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN--GIRIIDTQG  180 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccch-hcCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC--cEEEEECcc
Confidence            2111   12345899999998775542 2222    244567778999999999999999999999954  499999987


Q ss_pred             ce
Q 013897          276 AE  277 (434)
Q Consensus       276 a~  277 (434)
                      .+
T Consensus       181 k~  182 (229)
T PF06176_consen  181 KR  182 (229)
T ss_pred             cc
Confidence            64

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.50  E-value=2.1e-06  Score=78.89  Aligned_cols=130  Identities=19%  Similarity=0.248  Sum_probs=80.2

Q ss_pred             eeeeecCceEEEEEEEcCCCeEEEEEEeccc-cHHHHHHHHHHHHHhcCC-CCeeeEeeEEEccCCCccEEEEeecCCCc
Q 013897          140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGG-PNIVKLLDIVRDQQSKTPSLIFEHVNNTD  217 (434)
Q Consensus       140 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~E~~~l~~l~~h-~niv~l~~~~~~~~~~~~~lv~e~~~~~~  217 (434)
                      ..||+|..+.||+.    .+..+++|..... ......+|.++++.+... -.+++.+++..+.  ....+|||++.|..
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~--~~~glv~e~i~G~~   80 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDG--GRLGLIYELIVGKR   80 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecC--CeeeeeeeecCCcc
Confidence            56899999999984    2446789988653 345689999999998433 2356777776543  23458999999963


Q ss_pred             -hhhhc---------------------CC-----CChHH-HHHHHH----------HHHH-HHHHHHH----CCceeecC
Q 013897          218 -FKVLY---------------------PT-----LSDYD-VRYYIY----------ELLK-ALDYCHS----QGIMHRDV  254 (434)
Q Consensus       218 -l~~~~---------------------~~-----l~~~~-~~~~~~----------qi~~-~L~~LH~----~~ivHrDl  254 (434)
                       +....                     ..     ..... ...+..          .+.. ...+|..    ..++|+|+
T Consensus        81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~  160 (226)
T TIGR02172        81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF  160 (226)
T ss_pred             chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence             11110                     00     00000 000100          0111 1222221    24789999


Q ss_pred             CCCceEecCCCCeEEEEecccce
Q 013897          255 KPHNVMIDHEQRKLRLIDWGLAE  277 (434)
Q Consensus       255 Kp~NIll~~~~~~vkl~DFGla~  277 (434)
                      .|.||+++.++  +.|+||+.+.
T Consensus       161 ~~~Nii~~~~~--~~iIDwe~a~  181 (226)
T TIGR02172       161 QIGNLITSGKG--TYWIDLGDFG  181 (226)
T ss_pred             CCCcEEEcCCC--cEEEechhcC
Confidence            99999998654  8999999885

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.50  E-value=3.9e-06  Score=74.52  Aligned_cols=125  Identities=24%  Similarity=0.324  Sum_probs=91.0

Q ss_pred             CCeEEEeeeeecCc-eEEEEEEEcCCCeEEEEEEecc------------c------------cHHHHHHHHHHHHHhc--
Q 013897          134 DDYEVVRKVGRGKY-SEVFEGVHCTDNEKCIIKILKP------------V------------KKKKIKREIKILQNLC--  186 (434)
Q Consensus       134 ~~y~~~~~lG~G~f-g~Vy~~~~~~~~~~vaiK~~~~------------~------------~~~~~~~E~~~l~~l~--  186 (434)
                      .+++.++.||.|.- |.||++..  +|..||||+++.            .            ...-|..|..+..+|.  
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            67889999999999 99999986  678999999421            0            0123678888877773  


Q ss_pred             CCCCe--eeEeeEEEcc----------------CCCccEEEEeecCCCchhhhcCCCChHHHHHHHHHHHHHHHHHHHCC
Q 013897          187 GGPNI--VKLLDIVRDQ----------------QSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQG  248 (434)
Q Consensus       187 ~h~ni--v~l~~~~~~~----------------~~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~  248 (434)
                      ++.++  |+++||..-.                ......||.||+....      .+    ...-+.+|++-|..+|..|
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------~~----~~~~~~~~~~dl~~~~k~g  184 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------PL----QIRDIPQMLRDLKILHKLG  184 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------cc----chhHHHHHHHHHHHHHHCC
Confidence            34566  9999987421                0112356778776543      12    2234567778889999999


Q ss_pred             ceeecCCCCceEecCCCCeEEEEecccc
Q 013897          249 IMHRDVKPHNVMIDHEQRKLRLIDWGLA  276 (434)
Q Consensus       249 ivHrDlKp~NIll~~~~~~vkl~DFGla  276 (434)
                      |+-+|+|+.|..   +|   ||+|||.+
T Consensus       185 I~~~Dv~~~ny~---~G---~lvDfs~~  206 (207)
T PF13095_consen  185 IVPRDVKPRNYR---GG---KLVDFSSS  206 (207)
T ss_pred             eeeccCcccccc---CC---EEEecccC
Confidence            999999999987   44   89999965

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.44  E-value=1.9e-06  Score=87.79  Aligned_cols=136  Identities=15%  Similarity=0.339  Sum_probs=86.3

Q ss_pred             eeeeecCceEEEEEEEcCCCeEEEEEEeccccHHHHH-------------------------------------------
Q 013897          140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-------------------------------------------  176 (434)
Q Consensus       140 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~-------------------------------------------  176 (434)
                      +-|+.++-|.||+|+. .+|+.||||+.++.-.+.+.                                           
T Consensus       131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            5799999999999998 45999999998764333222                                           


Q ss_pred             HHHHHHHHh----cCCCCeeeEeeEEEccCCCccEEEEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCC
Q 013897          177 REIKILQNL----CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQG  248 (434)
Q Consensus       177 ~E~~~l~~l----~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~  248 (434)
                      +|...+.++    .+.+++ ++=.++++-. ..-+|+|||+.|.-+.+..    ..++...+.....++  -+..+=..|
T Consensus       210 ~EA~n~~~~~~nf~~~~~v-~VP~V~we~t-~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~--f~~q~~~dg  285 (517)
T COG0661         210 REAANAERFRENFKDDPDV-YVPKVYWEYT-TRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRA--FLRQLLRDG  285 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCe-Eeceeehhcc-CCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHH--HHHHHHhcC
Confidence            343333333    122222 2222333222 3346999999997665442    224433332222221  123333489


Q ss_pred             ceeecCCCCceEecCCCCeEEEEecccceecCC
Q 013897          249 IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP  281 (434)
Q Consensus       249 ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~  281 (434)
                      ++|.|..|.||+++.++ .+.+.|||+...+.+
T Consensus       286 ffHaDpHpGNi~v~~~g-~i~~lDfGi~g~l~~  317 (517)
T COG0661         286 FFHADPHPGNILVRSDG-RIVLLDFGIVGRLDP  317 (517)
T ss_pred             ccccCCCccceEEecCC-cEEEEcCcceecCCH
Confidence            99999999999999887 899999999876654

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.43  E-value=7.7e-07  Score=95.44  Aligned_cols=201  Identities=18%  Similarity=0.219  Sum_probs=136.1

Q ss_pred             HHHHHHHHHHhcCCCCeeeEeeEEEccCCCc--cEEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCc
Q 013897          175 IKREIKILQNLCGGPNIVKLLDIVRDQQSKT--PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGI  249 (434)
Q Consensus       175 ~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~--~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~i  249 (434)
                      .+.|+..+.++ .|+|++.++.|-.......  +.+..+++...++....   ...+....+.+..++++||.|+|+...
T Consensus       229 ~E~e~~~l~k~-~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l  307 (1351)
T KOG1035|consen  229 TEIELESLSKI-AHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSL  307 (1351)
T ss_pred             HHHHHHHHHhh-ccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhcc
Confidence            34567777787 8999999999876543333  12234566665554443   457888899999999999999999976


Q ss_pred             eeecCCCC---ceEecCCCCeEEEE--ecccceecCCCCccceeccCCcccccccccCCCCCC--ccccHHHHHHHHHHH
Q 013897          250 MHRDVKPH---NVMIDHEQRKLRLI--DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD--YSLDLWSLGCMFAGM  322 (434)
Q Consensus       250 vHrDlKp~---NIll~~~~~~vkl~--DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~--~~~DvwSlGvil~el  322 (434)
                      .|.-|..+   +.-.+.++ .+.+.  ||+..+.+..............+.++|.... ..+.  ...|+|.+|..+..+
T Consensus       308 ~~v~L~~s~~~~~~~~~e~-~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~-~~~~~~r~~dL~~lgll~~~~  385 (1351)
T KOG1035|consen  308 EHVVLSASSSKESTVDGEG-VVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKE-NTAKKSRLTDLWCLGLLLLQL  385 (1351)
T ss_pred             ceeEEecccccccccCccc-eeecchhhhcccccCCCcccchhhcCcccccccccccc-ccchhhhhhHHHHHHHHHhhh
Confidence            66666555   33344344 56666  8888877665544444455556778887654 3333  347999999999999


Q ss_pred             HhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHcc
Q 013897          323 IFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLL  402 (434)
Q Consensus       323 ltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL  402 (434)
                      ..|..+-....       .....++.                                        .......+++.+|+
T Consensus       386 ~~~~~i~~~~~-------~~~~~l~~----------------------------------------~~~~~~~d~~~~~~  418 (1351)
T KOG1035|consen  386 SQGEDISEKSA-------VPVSLLDV----------------------------------------LSTSELLDALPKCL  418 (1351)
T ss_pred             hhcCccccccc-------chhhhhcc----------------------------------------ccchhhhhhhhhhc
Confidence            98875531110       00000000                                        01125778999999


Q ss_pred             ccCCCCCccHHHHhcCCCccccc
Q 013897          403 RYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       403 ~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                      ..|+++|+++.++|.|||.+.-.
T Consensus       419 ~~~~~~Rl~~~~ll~~~f~~~~~  441 (1351)
T KOG1035|consen  419 DEDSEERLSALELLTHPFLRFPT  441 (1351)
T ss_pred             chhhhhccchhhhhhchhccccc
Confidence            99999999999999999998544

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.42  E-value=1.7e-06  Score=74.36  Aligned_cols=127  Identities=20%  Similarity=0.316  Sum_probs=90.6

Q ss_pred             EEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeecCC
Q 013897          137 EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN  215 (434)
Q Consensus       137 ~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~  215 (434)
                      .+.+.||+|++|.||+|.+  .+..+|+|+-+.. .+..++.|.++|..+..----.+++.|-.+      .+.|||+.|
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~------~i~me~i~G   96 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGED------FIRMEYIDG   96 (201)
T ss_pred             hhhhhhhcccccEEEEeec--cCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEechh------hhhhhhhcC
Confidence            4678899999999999997  4568888887654 467799999999998444444666666432      256999999


Q ss_pred             CchhhhcCCCChHHHHHHHHHHHHHHHHHHHCCceeecCC-CC-ceEecCCCCeEEEEecccce
Q 013897          216 TDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVK-PH-NVMIDHEQRKLRLIDWGLAE  277 (434)
Q Consensus       216 ~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlK-p~-NIll~~~~~~vkl~DFGla~  277 (434)
                      -.|..+.....    +.-+..+++.---|-..||-|..|. |. ||++. ++ .+.|+||..|.
T Consensus        97 ~~L~~~~~~~~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~-~~-~~~iIDFd~At  154 (201)
T COG2112          97 RPLGKLEIGGD----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVN-DR-DVYIIDFDSAT  154 (201)
T ss_pred             cchhhhhhccc----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEec-CC-cEEEEEccchh
Confidence            87765532222    3344555666445667799999886 44 55554 54 69999999996

>PLN02876 acyl-CoA dehydrogenase

Probab=98.42  E-value=5.4e-06  Score=90.47  Aligned_cols=80  Identities=18%  Similarity=0.254  Sum_probs=58.0

Q ss_pred             EEeeeeecCceEEEEEEEcCCC--eEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCe--eeEeeEEEccC-CCccEE
Q 013897          138 VVRKVGRGKYSEVFEGVHCTDN--EKCIIKILKPV----KKKKIKREIKILQNLCGGPNI--VKLLDIVRDQQ-SKTPSL  208 (434)
Q Consensus       138 ~~~~lG~G~fg~Vy~~~~~~~~--~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~ni--v~l~~~~~~~~-~~~~~l  208 (434)
                      .++.|+.|.++.+|+.....++  ..+++|+....    ....+.+|+.+|+.+..|.++  ++++.++.+.. ....++
T Consensus        42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl  121 (822)
T PLN02876         42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY  121 (822)
T ss_pred             eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence            3577899999999998764332  46788876432    235688999999999546655  88888886532 234679


Q ss_pred             EEeecCCCc
Q 013897          209 IFEHVNNTD  217 (434)
Q Consensus       209 v~e~~~~~~  217 (434)
                      ||||+.+..
T Consensus       122 VME~v~G~~  130 (822)
T PLN02876        122 IMEYLEGRI  130 (822)
T ss_pred             EEEecCCcc
Confidence            999998864

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.41  E-value=7.2e-08  Score=97.13  Aligned_cols=240  Identities=17%  Similarity=0.161  Sum_probs=160.5

Q ss_pred             eEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCC-eeeEeeEEEccCCCccEEEEeecC
Q 013897          136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPN-IVKLLDIVRDQQSKTPSLIFEHVN  214 (434)
Q Consensus       136 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~E~~~l~~l~~h~n-iv~l~~~~~~~~~~~~~lv~e~~~  214 (434)
                      |...+-+++|++++++|.+...+...+ .+.+...  ....-++++|.++ +||| .+..++-+  +.+.+..++++++.
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--l~~rl~~eLLdK~-n~P~~~v~~~~d~--~~E~~~~i~~~i~s  317 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--LSRRLAIELLDKV-NNPNPVVRYLEDY--DGEDYLWIPMRICS  317 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--hhhHHHHHHHHHc-cCCCCcccccccC--Ccccccchhhhhhc
Confidence            455677899999999999865544433 5555333  4456688899998 9999 44444433  45567889999998


Q ss_pred             CC-chhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCccceec
Q 013897          215 NT-DFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRV  289 (434)
Q Consensus       215 ~~-~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~~~~~  289 (434)
                      ++ +-.....    .+...+...+.+.-+++|++||+.-=+|+|    ||+...+  ..+..||+....+......++..
T Consensus       318 ~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~--~~~~~~~~v~~~L~~~~~~~t~~  391 (829)
T KOG0576|consen  318 TGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEE--EVKLLDFAVPPQLTRTMKPRTAI  391 (829)
T ss_pred             CCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccccc--ccccccccCCcccCcccccccCC
Confidence            87 2111111    134445566677778899999998878999    8888753  68999999998776665567778


Q ss_pred             cCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHH
Q 013897          290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAAL  369 (434)
Q Consensus       290 ~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~  369 (434)
                      +++.++|||+..+ ..+....|+|++|+--.+|.-|-+|--.   .......    .|..              ++...+
T Consensus       392 ~~~~~~~pev~~~-~~~~~~p~~~~~~~~~~~~ap~~pPr~~---P~~~~~~----~g~~--------------p~s~~L  449 (829)
T KOG0576|consen  392 GTPEPLAPEVIQE-NTIDGCPDSGSLAVSAIQMAPGLPPRSS---PPAVLPM----IGNG--------------PNSPML  449 (829)
T ss_pred             CCCCCCCchhhcc-cccccCCCccCCCcchhhcCCCCCCCCC---CccccCC----CCCC--------------CCcccc
Confidence            9999999998776 6899999999999877777666655311   0000000    0000              000000


Q ss_pred             hcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccc
Q 013897          370 VGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP  423 (434)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~  423 (434)
                      ...   ..|.           +..-.++...|+...|..|+...+++-|.+|.+
T Consensus       450 ~~~---~aw~-----------~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfng  489 (829)
T KOG0576|consen  450 TDK---SAWS-----------PVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNG  489 (829)
T ss_pred             chh---hhcC-----------cccccCCcccccCCCCCCCcchhhHHHHHHhcc
Confidence            000   0000           011125788899999999999999999988874

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.40  E-value=4.4e-06  Score=77.69  Aligned_cols=74  Identities=20%  Similarity=0.209  Sum_probs=54.4

Q ss_pred             eeecCc-eEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeecCCCchh
Q 013897          142 VGRGKY-SEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK  219 (434)
Q Consensus       142 lG~G~f-g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~  219 (434)
                      |-.|.+ +.||+...  .+..+++|+........+.+|+.+++.+..+--+++++++....  ...++|||+++|..+.
T Consensus         6 ~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~~lv~e~i~G~~l~   80 (244)
T cd05150           6 VTEGQSGATVYRLDG--KNPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGSDD--GRAWLLTSAVPGVPAA   80 (244)
T ss_pred             cCCCCCcCeEEEEcC--CCCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEecC--CccEEEEEeeCCccHh
Confidence            445555 88999864  34788899886554456789999999996665667888877543  3457999999987664

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.34  E-value=1.3e-05  Score=71.70  Aligned_cols=130  Identities=21%  Similarity=0.383  Sum_probs=90.5

Q ss_pred             EeeeeecCceEEEEEEEcCCCeEEEEEEecccc-------------------HHHHHHHHHHHHHhc-----CCCCeeeE
Q 013897          139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-------------------KKKIKREIKILQNLC-----GGPNIVKL  194 (434)
Q Consensus       139 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-------------------~~~~~~E~~~l~~l~-----~h~niv~l  194 (434)
                      ...||+|+.-.||.-   ..+...+||++.+..                   .++..+|+.....+.     .+.+|.++
T Consensus         6 ~~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    6 SDLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CcccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            346999999999963   556778899998766                   567788888877773     26889999


Q ss_pred             eeEEEccCCCccEEEEeecCCC------chhhhcC--CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC--
Q 013897          195 LDIVRDQQSKTPSLIFEHVNNT------DFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--  264 (434)
Q Consensus       195 ~~~~~~~~~~~~~lv~e~~~~~------~l~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~--  264 (434)
                      +|++..  ..-+.+|+|.+.+.      +|..+..  .++.    .+...+-+-..||-+.+|+.+||+|.||++...  
T Consensus        83 ~G~veT--~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~  156 (199)
T PF10707_consen   83 YGFVET--NLGLGLVVELIRDADGNISPTLEDYLKEGGLTE----ELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDS  156 (199)
T ss_pred             eEEEec--CCceEEEEEEEECCCCCcCccHHHHHHcCCccH----HHHHHHHHHHHHHHHcCCeecCCCcccEEEEecCC
Confidence            999854  34556888877543      2444432  2333    222333344568889999999999999999533  


Q ss_pred             CC-eEEEEe-cccce
Q 013897          265 QR-KLRLID-WGLAE  277 (434)
Q Consensus       265 ~~-~vkl~D-FGla~  277 (434)
                      +. .+.|+| ||...
T Consensus       157 ~~~~lvlIDG~G~~~  171 (199)
T PF10707_consen  157 GEFRLVLIDGLGEKE  171 (199)
T ss_pred             CceEEEEEeCCCCcc
Confidence            22 578888 55443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PRK10593 hypothetical protein; Provisional

Probab=98.15  E-value=3.8e-05  Score=73.64  Aligned_cols=79  Identities=10%  Similarity=0.169  Sum_probs=58.6

Q ss_pred             EEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-cHHHHHHHHHHHHHhcCC--CCeeeEeeEEEccC-CCccEEEEeec
Q 013897          138 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGG--PNIVKLLDIVRDQQ-SKTPSLIFEHV  213 (434)
Q Consensus       138 ~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~E~~~l~~l~~h--~niv~l~~~~~~~~-~~~~~lv~e~~  213 (434)
                      -.+.||.|..+.||.... .++ .+++|..+.. ....+..|...|+.|..+  -.++++++++.+.. ....+||||++
T Consensus        18 ~~~~i~~G~~~~vy~~~~-~~~-~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i   95 (297)
T PRK10593         18 RVECISEQPYAALWALYD-SQG-NPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL   95 (297)
T ss_pred             eeeecCCccceeEEEEEc-CCC-CEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence            456799999999999864 233 5777886552 456899999999999654  47889998875432 23468999999


Q ss_pred             CCCch
Q 013897          214 NNTDF  218 (434)
Q Consensus       214 ~~~~l  218 (434)
                      .+..+
T Consensus        96 ~G~~~  100 (297)
T PRK10593         96 RGVSV  100 (297)
T ss_pred             CCEec
Confidence            88643

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.14  E-value=2.6e-05  Score=72.16  Aligned_cols=74  Identities=11%  Similarity=0.162  Sum_probs=47.2

Q ss_pred             eeeeecCce-EEEEEEEcCCCeEEEEEEeccc-cHHHHHHHHHHHHHhcCC--CCeeeEeeEEEccCC-CccEEEEeecC
Q 013897          140 RKVGRGKYS-EVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGG--PNIVKLLDIVRDQQS-KTPSLIFEHVN  214 (434)
Q Consensus       140 ~~lG~G~fg-~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~E~~~l~~l~~h--~niv~l~~~~~~~~~-~~~~lv~e~~~  214 (434)
                      +.|+.|+.. .||+.     +..+++|+.+.. ....+.+|.+++..+..+  -.+.+.++....... ...+++|+++.
T Consensus         3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~   77 (235)
T cd05155           3 EPVDSGGTDNATFRL-----GDDMSVRLPSAAGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE   77 (235)
T ss_pred             eeccCCCcccceEEc-----CCceEEEcCCccchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence            457777776 58875     235778886653 345789999999988443  134555554322211 24478999999


Q ss_pred             CCch
Q 013897          215 NTDF  218 (434)
Q Consensus       215 ~~~l  218 (434)
                      |.++
T Consensus        78 G~~l   81 (235)
T cd05155          78 GETA   81 (235)
T ss_pred             CCCC
Confidence            8665

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.07  E-value=3.9e-05  Score=78.11  Aligned_cols=134  Identities=19%  Similarity=0.268  Sum_probs=84.8

Q ss_pred             eeeeecCceEEEEEEEcCCCeEEEEEEeccccHH----------------------------------H------HHHHH
Q 013897          140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK----------------------------------K------IKREI  179 (434)
Q Consensus       140 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~----------------------------------~------~~~E~  179 (434)
                      +.||.-+.|.||+|+.+ +|+.||||+-++.-++                                  .      |.+|.
T Consensus       167 ~piaaASlaQVhrA~L~-~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLK-NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEec-CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            57999999999999985 4999999997653211                                  1      23343


Q ss_pred             HHHHHhc---CCCC------eeeEeeEEEccCCCccEEEEeecCCCchhhh---c-CCCChHHHHHHHHHHHHHHHHHHH
Q 013897          180 KILQNLC---GGPN------IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---Y-PTLSDYDVRYYIYELLKALDYCHS  246 (434)
Q Consensus       180 ~~l~~l~---~h~n------iv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~---~-~~l~~~~~~~~~~qi~~~L~~LH~  246 (434)
                      +...++.   .|-+      |++++-.+    ...-+|+||||+|.-+.++   . ..++...+...+.++.  ++-|=.
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~----st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~--~~qIf~  319 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDL----STKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAY--LEQIFK  319 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhc----CcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHH--HHHHHh
Confidence            3333221   2333      33333222    2345799999999755433   2 2355554433333221  122335


Q ss_pred             CCceeecCCCCceEecC---CCCeEEEEecccceecC
Q 013897          247 QGIMHRDVKPHNVMIDH---EQRKLRLIDWGLAEFYH  280 (434)
Q Consensus       247 ~~ivHrDlKp~NIll~~---~~~~vkl~DFGla~~~~  280 (434)
                      .|++|+|-.|-||++..   .+..+.+-|||+.....
T Consensus       320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            78999999999999983   35589999999987654

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.05  E-value=5.6e-05  Score=69.75  Aligned_cols=74  Identities=14%  Similarity=0.253  Sum_probs=50.6

Q ss_pred             EeeeeecCceEEEEEEEcC-CCeEEEEEEeccccH--HHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeecCC
Q 013897          139 VRKVGRGKYSEVFEGVHCT-DNEKCIIKILKPVKK--KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN  215 (434)
Q Consensus       139 ~~~lG~G~fg~Vy~~~~~~-~~~~vaiK~~~~~~~--~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~  215 (434)
                      ++.|..|-...||+..... .+..|++|+......  -...+|+.+++.+..+.-.+++++.+.    .  .+||||++|
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~--~~l~e~i~G   76 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ----N--GLIYEFIPG   76 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC----C--cEEEEeeCC
Confidence            4568888889999987532 257899998764322  123579999998855555566665542    1  289999988


Q ss_pred             Cch
Q 013897          216 TDF  218 (434)
Q Consensus       216 ~~l  218 (434)
                      ..+
T Consensus        77 ~~l   79 (235)
T cd05157          77 RTL   79 (235)
T ss_pred             CcC
Confidence            654

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.96  E-value=3.9e-05  Score=68.25  Aligned_cols=95  Identities=22%  Similarity=0.195  Sum_probs=77.5

Q ss_pred             HHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeecCCCchh-------hhcCCCChHHHHHHHHHHHHHHHHHHH--
Q 013897          176 KREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK-------VLYPTLSDYDVRYYIYELLKALDYCHS--  246 (434)
Q Consensus       176 ~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~-------~~~~~l~~~~~~~~~~qi~~~L~~LH~--  246 (434)
                      ..|.-+++.+.+.+++++++|+|-    .  ++|.||...+.+.       ++. ..+|..+..++.++++.+++|+.  
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~--~~v~E~~~~~~~~~~~~~l~~~~-~~~w~~R~~iA~~lL~~l~~l~~~~   79 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----R--FYVVEYVGAGSLYGIYRPLSQFL-QSPWEQRAKIALQLLELLEELDHGP   79 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----C--EEEEEeecCcccccccccccccc-ccCHHHHHHHHHHHHHHHHHHhcCC
Confidence            458888898866689999999992    1  4789999977542       222 46888999999999999999997  


Q ss_pred             -CCceeecCCCCceEecCCCCeEEEEeccccee
Q 013897          247 -QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF  278 (434)
Q Consensus       247 -~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~  278 (434)
                       ..+.-.|++++|+-++.++ .+|++|...+..
T Consensus        80 ~~~~~lcDv~~~nfgv~~~~-~lk~iDld~v~~  111 (188)
T PF12260_consen   80 LGFFYLCDVSPDNFGVNDDG-RLKLIDLDDVFV  111 (188)
T ss_pred             CCcEEEeecchHHeEEeCCC-cEEEEechhcch
Confidence             3588899999999999666 799999998743

Proteins in this uncharacterised family are described as transmembrane proteins.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.94  E-value=7.1e-05  Score=70.12  Aligned_cols=127  Identities=23%  Similarity=0.259  Sum_probs=76.9

Q ss_pred             eeecCceEEEEEEEcCCCeEEEEEEeccccH---HHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeecCCCch
Q 013897          142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKK---KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF  218 (434)
Q Consensus       142 lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l  218 (434)
                      +..|-.+.+|+..  .++..+++|+......   -...+|..+++.+..+.-.++++....      -.+|+||++|..+
T Consensus         4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~------~~~v~e~i~G~~~   75 (256)
T TIGR02721         4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE------HWLLVEWLEGEVI   75 (256)
T ss_pred             CCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC------CEEEEEeccCccc
Confidence            5567788999886  4567888998654321   135789999999854433455555442      2489999998654


Q ss_pred             hhh------------------c--C----CCCh-HHHHHHHHHH---------HHHHHHHHH--------CCceeecCCC
Q 013897          219 KVL------------------Y--P----TLSD-YDVRYYIYEL---------LKALDYCHS--------QGIMHRDVKP  256 (434)
Q Consensus       219 ~~~------------------~--~----~l~~-~~~~~~~~qi---------~~~L~~LH~--------~~ivHrDlKp  256 (434)
                      ...                  .  .    ++.. ..+..+..++         ...+..+-.        ..++|+|+.|
T Consensus        76 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~  155 (256)
T TIGR02721        76 TLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHA  155 (256)
T ss_pred             ccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCc
Confidence            321                  0  0    0111 1111221111         111222221        1489999999


Q ss_pred             CceEecCCCCeEEEEeccccee
Q 013897          257 HNVMIDHEQRKLRLIDWGLAEF  278 (434)
Q Consensus       257 ~NIll~~~~~~vkl~DFGla~~  278 (434)
                      .||+++.++  +.|+||+.|..
T Consensus       156 ~Nil~~~~~--~~lIDwE~a~~  175 (256)
T TIGR02721       156 YNLVVTPQG--LKLIDWEYASD  175 (256)
T ss_pred             CcEEEeCCC--CEEEeccccCc
Confidence            999998654  78999999864

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.86  E-value=9.4e-05  Score=70.82  Aligned_cols=137  Identities=13%  Similarity=0.185  Sum_probs=84.7

Q ss_pred             EeeeeecCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCC-CeeeEeeEEEc----cCCCccEEEEeec
Q 013897          139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGP-NIVKLLDIVRD----QQSKTPSLIFEHV  213 (434)
Q Consensus       139 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~E~~~l~~l~~h~-niv~l~~~~~~----~~~~~~~lv~e~~  213 (434)
                      ++.|..|....+|+...  ++..+++|+........+..|+.++..|.++- .+++++.....    ......++|++|+
T Consensus        19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i   96 (296)
T cd05153          19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL   96 (296)
T ss_pred             eecccCccccceEEEEe--CCCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence            56788888889999864  34578999987655667888999999884331 35555442100    1123457899999


Q ss_pred             CCCchhhh---------------c---CCCC----------hHHH--H--------HHHHHHHHHHHHHHH-------CC
Q 013897          214 NNTDFKVL---------------Y---PTLS----------DYDV--R--------YYIYELLKALDYCHS-------QG  248 (434)
Q Consensus       214 ~~~~l~~~---------------~---~~l~----------~~~~--~--------~~~~qi~~~L~~LH~-------~~  248 (434)
                      +|..+...               .   ..+.          +...  .        .....+..++.++.+       .+
T Consensus        97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~  176 (296)
T cd05153          97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG  176 (296)
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence            88654220               0   0000          0000  0        011112334445443       36


Q ss_pred             ceeecCCCCceEecCCCCeEEEEeccccee
Q 013897          249 IMHRDVKPHNVMIDHEQRKLRLIDWGLAEF  278 (434)
Q Consensus       249 ivHrDlKp~NIll~~~~~~vkl~DFGla~~  278 (434)
                      ++|+|+.|.|||++.++ .+.|+||+.+..
T Consensus       177 l~HgD~~~~Nil~~~~~-~~~iIDfe~a~~  205 (296)
T cd05153         177 VIHADLFRDNVLFDGDE-LSGVIDFYFACT  205 (296)
T ss_pred             CCccCcCcccEEEeCCc-eEEEeehhhhcC
Confidence            99999999999999654 568999998853

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.82  E-value=0.00021  Score=68.67  Aligned_cols=74  Identities=18%  Similarity=0.213  Sum_probs=50.3

Q ss_pred             EeeeeecCceEEEEEEEcC------CCeEEEEEEecccc--HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEE
Q 013897          139 VRKVGRGKYSEVFEGVHCT------DNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF  210 (434)
Q Consensus       139 ~~~lG~G~fg~Vy~~~~~~------~~~~vaiK~~~~~~--~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  210 (434)
                      ++.|..|-...||+.....      .++.+++|+.....  .....+|..++..+..+--.+++++++.+      .+|+
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~------~~v~   76 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN------GRIE   76 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC------Cchh
Confidence            3556677778999887532      25789999976532  24567899899988554445667766632      2588


Q ss_pred             eecCCCch
Q 013897          211 EHVNNTDF  218 (434)
Q Consensus       211 e~~~~~~l  218 (434)
                      ||++|..+
T Consensus        77 e~i~G~~l   84 (302)
T cd05156          77 EFIPSRTL   84 (302)
T ss_pred             heeCCCcC
Confidence            99887654

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.67  E-value=0.00063  Score=67.46  Aligned_cols=74  Identities=16%  Similarity=0.255  Sum_probs=53.4

Q ss_pred             EeeeeecCceEEEEEEEcCCCeEEEEEEecc----------ccHHHHHHHHHHHHHhcCC--CCeeeEeeEEEccCCCcc
Q 013897          139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKP----------VKKKKIKREIKILQNLCGG--PNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       139 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~----------~~~~~~~~E~~~l~~l~~h--~niv~l~~~~~~~~~~~~  206 (434)
                      .+.||.|.+..||++....+++.++||.-.+          ...++...|.+.|+.+..+  .++++++.+-  .  ...
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~--~~~  106 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--E--ELA  106 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--C--CCC
Confidence            4679999999999999854336899997431          2345677888888886433  4678888774  2  335


Q ss_pred             EEEEeecCCC
Q 013897          207 SLIFEHVNNT  216 (434)
Q Consensus       207 ~lv~e~~~~~  216 (434)
                      ++||||+++.
T Consensus       107 ~lVME~L~~~  116 (401)
T PRK09550        107 VTVMEDLSDH  116 (401)
T ss_pred             EEEEecCCCc
Confidence            6999998763

>PRK05231 homoserine kinase; Provisional

Probab=97.64  E-value=0.00073  Score=65.42  Aligned_cols=136  Identities=13%  Similarity=0.221  Sum_probs=77.4

Q ss_pred             EeeeeecCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCC-CCeeeEeeE-----EEccCCCccEEEEee
Q 013897          139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGG-PNIVKLLDI-----VRDQQSKTPSLIFEH  212 (434)
Q Consensus       139 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~E~~~l~~l~~h-~niv~l~~~-----~~~~~~~~~~lv~e~  212 (434)
                      ++.|+.|....+|.... . +..+++|++.....+.+..|+.+++.|..+ -.+++.+..     +.. -....+++++|
T Consensus        27 ~~~l~~G~~n~~y~v~t-~-~g~~vLK~~~~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~-~~g~~~~l~~~  103 (319)
T PRK05231         27 LKGIAEGIENSNFFLTT-T-QGEYVLTLFERLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGE-LAGKPAAIVTF  103 (319)
T ss_pred             cchhccccccceEEEEe-C-CCcEEEEEeccCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeee-eCCEEEEEEEe
Confidence            45577888889999874 2 347899988633445666777787777322 123444431     111 12345789999


Q ss_pred             cCCCchhh-----h----------c---CCC----------ChH-HH-H-----------HHHHH-HHHHHHHHH-----
Q 013897          213 VNNTDFKV-----L----------Y---PTL----------SDY-DV-R-----------YYIYE-LLKALDYCH-----  245 (434)
Q Consensus       213 ~~~~~l~~-----~----------~---~~l----------~~~-~~-~-----------~~~~q-i~~~L~~LH-----  245 (434)
                      ++|.....     .          .   ..+          .+. .. .           ..+.+ +...++.+.     
T Consensus       104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  183 (319)
T PRK05231        104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP  183 (319)
T ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence            98864211     1          0   011          011 10 0           01111 111222332     


Q ss_pred             --HCCceeecCCCCceEecCCCCeEEEEeccccee
Q 013897          246 --SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF  278 (434)
Q Consensus       246 --~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~  278 (434)
                        ..++||+|+.|.|||++.+. ..-|+||+.+..
T Consensus       184 ~lp~~liHgD~~~~Nil~~~~~-~~~iIDf~~~~~  217 (319)
T PRK05231        184 ALPRGVIHADLFRDNVLFEGDR-LSGFIDFYFACN  217 (319)
T ss_pred             cCCcccCCCCCCCCcEEEECCc-eEEEEecccccC
Confidence              23799999999999998443 458999998853

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.50  E-value=9.6e-05  Score=69.71  Aligned_cols=132  Identities=18%  Similarity=0.297  Sum_probs=94.3

Q ss_pred             CeEEEeeeeecCceEEEEEEEcCCCeEEEEEEec-------ccc------------------HHHHHHHHHHHHHhcCCC
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-------PVK------------------KKKIKREIKILQNLCGGP  189 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~-------~~~------------------~~~~~~E~~~l~~l~~h~  189 (434)
                      -+.+.+.||-|.-+-||.+-+ ..|+..++|+-+       ..+                  +-...+|+..|+.|..|-
T Consensus        93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g  171 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG  171 (465)
T ss_pred             hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence            467899999999999999987 678889988632       111                  112467999999885442


Q ss_pred             -CeeeEeeEEEccCCCccEEEEeecCCCchhhhcCCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeE
Q 013897          190 -NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKL  268 (434)
Q Consensus       190 -niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~v  268 (434)
                       -+++.+++.      ..++|||++.+-.+.+...-..   +..+...+..-+.-|-.+|+||+|..-=||+++.++ .+
T Consensus       172 fpVPkpiD~~------RH~Vvmelv~g~Pl~~v~~v~d---~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~-~i  241 (465)
T KOG2268|consen  172 FPVPKPIDHN------RHCVVMELVDGYPLRQVRHVED---PPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDD-KI  241 (465)
T ss_pred             CCCCCccccc------ceeeHHHhhcccceeeeeecCC---hHHHHHHHHHHHHHHHHcCceecccchheeEEecCC-CE
Confidence             344555543      3368999999887765543332   333444455556678889999999999999999666 79


Q ss_pred             EEEecccce
Q 013897          269 RLIDWGLAE  277 (434)
Q Consensus       269 kl~DFGla~  277 (434)
                      +++||--..
T Consensus       242 ~vIDFPQmv  250 (465)
T KOG2268|consen  242 VVIDFPQMV  250 (465)
T ss_pred             EEeechHhh
Confidence            999998653

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.48  E-value=0.0012  Score=63.61  Aligned_cols=138  Identities=17%  Similarity=0.253  Sum_probs=82.5

Q ss_pred             EEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-cHHHHHHHHHHHHHhcCC-CCeeeEeeEEEc----cCCCccEEEEe
Q 013897          138 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGG-PNIVKLLDIVRD----QQSKTPSLIFE  211 (434)
Q Consensus       138 ~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~E~~~l~~l~~h-~niv~l~~~~~~----~~~~~~~lv~e  211 (434)
                      .++.++.|.-..||+...  ++..+++|+.... ....+..|+.++..|..+ -.+++++.....    ......++|++
T Consensus        26 ~i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        26 SLKGIAEGVENSNYLLTT--DVGRYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             eccccCCccccceEEEEe--CCCcEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            456678888889998864  3446888987653 345677888888887322 224555442110    11234578999


Q ss_pred             ecCCCchhh---------------hc---CCC----------ChH-H--HH----------HHHHHHHHHHHHHHH----
Q 013897          212 HVNNTDFKV---------------LY---PTL----------SDY-D--VR----------YYIYELLKALDYCHS----  246 (434)
Q Consensus       212 ~~~~~~l~~---------------~~---~~l----------~~~-~--~~----------~~~~qi~~~L~~LH~----  246 (434)
                      |++|.....               +.   ..+          ..+ .  ..          .....+...++++..    
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            998854210               00   111          000 0  00          001123334555542    


Q ss_pred             ---CCceeecCCCCceEecCCCCeEEEEeccccee
Q 013897          247 ---QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF  278 (434)
Q Consensus       247 ---~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~  278 (434)
                         .++||+|+.+.||+++.++ .+.|+||+.+..
T Consensus       184 ~~~~~l~HgD~~~~Nvl~~~~~-~~~vIDfd~~~~  217 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLFDGDS-VKGVIDFYFACT  217 (307)
T ss_pred             cCCCccCCCCCCcCcEEEECCc-eEEEeecccccC
Confidence               5799999999999998665 568999998853

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.43  E-value=0.0024  Score=61.53  Aligned_cols=134  Identities=21%  Similarity=0.300  Sum_probs=93.3

Q ss_pred             EEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc-------------------------HHH----HHHHHHHHHHhcC
Q 013897          137 EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-------------------------KKK----IKREIKILQNLCG  187 (434)
Q Consensus       137 ~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-------------------------~~~----~~~E~~~l~~l~~  187 (434)
                      ++-..|..|.-+.||.+.. .+|..+|||+++..-                         ++.    .+.|+..|+++ +
T Consensus       147 ~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl-~  224 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRL-N  224 (520)
T ss_pred             ecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHH-H
Confidence            3557899999999999986 678889999986310                         111    35788888888 4


Q ss_pred             CCCeeeEeeEEEccCCCccEEEEeecCCCchhh-hc--CCCChHHHHHHHHHHHHHHHHH-HHCCceeecCCCCceEecC
Q 013897          188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKV-LY--PTLSDYDVRYYIYELLKALDYC-HSQGIMHRDVKPHNVMIDH  263 (434)
Q Consensus       188 h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~-~~--~~l~~~~~~~~~~qi~~~L~~L-H~~~ivHrDlKp~NIll~~  263 (434)
                      ...|...--...    ..-+|||+|++...... .+  -.++...+..+-.+++..|.-| |.+++||.||.-=|+|+- 
T Consensus       225 ~aGIP~PePIlL----k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-  299 (520)
T KOG2270|consen  225 NAGIPCPEPILL----KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-  299 (520)
T ss_pred             hcCCCCCCceee----ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-
Confidence            333322111111    22359999998655321 11  1366667888778888887776 567999999999999997 


Q ss_pred             CCCeEEEEeccccee
Q 013897          264 EQRKLRLIDWGLAEF  278 (434)
Q Consensus       264 ~~~~vkl~DFGla~~  278 (434)
                      +| .+.|+|.+-+..
T Consensus       300 dG-~lyiIDVSQSVE  313 (520)
T KOG2270|consen  300 DG-KLYIIDVSQSVE  313 (520)
T ss_pred             CC-EEEEEEcccccc
Confidence            55 799999997743

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.41  E-value=0.0018  Score=61.34  Aligned_cols=31  Identities=35%  Similarity=0.705  Sum_probs=25.7

Q ss_pred             CceeecCCCCceEecCCCCeEEEEeccccee
Q 013897          248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF  278 (434)
Q Consensus       248 ~ivHrDlKp~NIll~~~~~~vkl~DFGla~~  278 (434)
                      .++|+|+.|.|||++.++...-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            4899999999999996453467999999864

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.33  E-value=0.0017  Score=63.22  Aligned_cols=134  Identities=16%  Similarity=0.230  Sum_probs=78.5

Q ss_pred             EeeeeecCceEEEEEEEcCC---CeEEEEEEeccccH--HHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeec
Q 013897          139 VRKVGRGKYSEVFEGVHCTD---NEKCIIKILKPVKK--KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV  213 (434)
Q Consensus       139 ~~~lG~G~fg~Vy~~~~~~~---~~~vaiK~~~~~~~--~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  213 (434)
                      ++.|..|=-..+|+......   +..|++|+......  -.-.+|..+++.+..+.--+++++++.  ++    +|.+|+
T Consensus        19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~--~G----~i~~fi   92 (330)
T PLN02421         19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFG--NG----MIQSFI   92 (330)
T ss_pred             EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeC--Cc----Eeehhh
Confidence            34455577788998865332   24889998754322  123678889998855544467777662  21    588888


Q ss_pred             CCCchhhh------------------cC-C------CC-hHHHHHHHHHH----------------------HHHHHHHH
Q 013897          214 NNTDFKVL------------------YP-T------LS-DYDVRYYIYEL----------------------LKALDYCH  245 (434)
Q Consensus       214 ~~~~l~~~------------------~~-~------l~-~~~~~~~~~qi----------------------~~~L~~LH  245 (434)
                      .+..+...                  +. .      .. +..+..+..++                      ..-+..+.
T Consensus        93 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~  172 (330)
T PLN02421         93 NARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELK  172 (330)
T ss_pred             cCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHH
Confidence            77654210                  00 0      11 12222222211                      11122221


Q ss_pred             ----HC----CceeecCCCCceEecCCCCeEEEEeccccee
Q 013897          246 ----SQ----GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF  278 (434)
Q Consensus       246 ----~~----~ivHrDlKp~NIll~~~~~~vkl~DFGla~~  278 (434)
                          ..    -.+|.||.+.|||++.++..++++||+.|..
T Consensus       173 ~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        173 EITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence                11    2799999999999975544799999999853

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.24  E-value=0.0059  Score=58.56  Aligned_cols=144  Identities=19%  Similarity=0.322  Sum_probs=84.9

Q ss_pred             EEEeeeeecCceEEEEEEEcCCCeEEEEEEecc-----ccHHHHHHHHHHHHHhcC-CCCeeeEeeEEEccCCCccEEEE
Q 013897          137 EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----VKKKKIKREIKILQNLCG-GPNIVKLLDIVRDQQSKTPSLIF  210 (434)
Q Consensus       137 ~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~-----~~~~~~~~E~~~l~~l~~-h~niv~l~~~~~~~~~~~~~lv~  210 (434)
                      .+++.+-.|..-.+|....  +++.++++ ...     .......+|..+|+.+.. ---+...+++|.+......+.||
T Consensus        28 ~~v~~~~~G~sn~t~~~~~--~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~  104 (321)
T COG3173          28 LIVEEISGGWSNDTFRLGD--TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM  104 (321)
T ss_pred             ceeeeccCCcccceEEEec--CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence            3455554454455565554  37888888 331     223556789999998733 23445566777654434678999


Q ss_pred             eecCCCchhhhcCCCC-----------------------------------hHHHHHHHHH--------------HHHHH
Q 013897          211 EHVNNTDFKVLYPTLS-----------------------------------DYDVRYYIYE--------------LLKAL  241 (434)
Q Consensus       211 e~~~~~~l~~~~~~l~-----------------------------------~~~~~~~~~q--------------i~~~L  241 (434)
                      +|+.|...........                                   ..++..+..+              +..-.
T Consensus       105 ~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~  184 (321)
T COG3173         105 EWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLI  184 (321)
T ss_pred             EEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHH
Confidence            9999843211111100                                   0011111111              11224


Q ss_pred             HHHHHC--------CceeecCCCCceEecCCCCeEEEEecccceecCCCCc
Q 013897          242 DYCHSQ--------GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE  284 (434)
Q Consensus       242 ~~LH~~--------~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~  284 (434)
                      .+|+.+        .++|+|+.+.||+++.++ .+-+.||+++..-.+...
T Consensus       185 ~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~-~~gVlDwe~~~lGDP~~D  234 (321)
T COG3173         185 KWLEANRPPWAGPPVLVHGDYRPGNLIIDPGR-PTGVLDWELATLGDPLED  234 (321)
T ss_pred             HHHHhcCCCcCCCceeeeCCcccCCEEEeCCC-eeEEEeccccccCCcHHH
Confidence            455543        479999999999999777 599999999976554433

>PLN02236 choline kinase

Probab=97.18  E-value=0.0037  Score=61.27  Aligned_cols=134  Identities=19%  Similarity=0.254  Sum_probs=81.0

Q ss_pred             EeeeeecCceEEEEEEEcC----CCeEEEEEEeccccHH--HHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEee
Q 013897          139 VRKVGRGKYSEVFEGVHCT----DNEKCIIKILKPVKKK--KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH  212 (434)
Q Consensus       139 ~~~lG~G~fg~Vy~~~~~~----~~~~vaiK~~~~~~~~--~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  212 (434)
                      +..|-.|-.-.+|++....    .++.|++|+.......  .-.+|..+++.+..+.--+++++.+..  .    .|.+|
T Consensus        41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~--g----~v~ef  114 (344)
T PLN02236         41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPN--G----RVEEF  114 (344)
T ss_pred             EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECC--c----eEEEe
Confidence            3456558888999987532    2468999988543211  126799999988665555677776622  1    57899


Q ss_pred             cCCCchhhh--c----------------C---C----C-ChHHHHHHHHHH-----------------HHHHHHH----H
Q 013897          213 VNNTDFKVL--Y----------------P---T----L-SDYDVRYYIYEL-----------------LKALDYC----H  245 (434)
Q Consensus       213 ~~~~~l~~~--~----------------~---~----l-~~~~~~~~~~qi-----------------~~~L~~L----H  245 (434)
                      +.+..+...  .                .   +    . ...++..+..++                 ...+..|    .
T Consensus       115 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~  194 (344)
T PLN02236        115 IHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELS  194 (344)
T ss_pred             eCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhc
Confidence            877654311  0                0   0    0 112222222111                 1112222    1


Q ss_pred             ----HCCceeecCCCCceEecCCCCeEEEEeccccee
Q 013897          246 ----SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF  278 (434)
Q Consensus       246 ----~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~  278 (434)
                          ...++|+|+++.|||++.++..+.|+||..|..
T Consensus       195 ~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        195 GDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             ccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence                125899999999999986544799999999864

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=97.18  E-value=0.0015  Score=59.21  Aligned_cols=54  Identities=15%  Similarity=0.112  Sum_probs=34.5

Q ss_pred             CeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeecCCCch
Q 013897          159 NEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF  218 (434)
Q Consensus       159 ~~~vaiK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l  218 (434)
                      ++.|+||+....  ..-.-..|..+++.+..+-.-+++++.+.+.      +|.+|+.+..+
T Consensus         2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g------~v~e~i~g~~l   57 (211)
T PF01633_consen    2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFFENG------RVEEFIEGRTL   57 (211)
T ss_dssp             TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEETTE------EEEE--SSEE-
T ss_pred             CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEcCCC------cEEEEeccccc
Confidence            467888888654  2344567888998886666667888876322      67899877554

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=97.09  E-value=0.0044  Score=60.02  Aligned_cols=133  Identities=25%  Similarity=0.312  Sum_probs=81.6

Q ss_pred             eeecCceEEEEEEEcCCCeEEEEEEeccc-cHHHHHHHHHHHHHhcCCCC-----eeeEeeEEEccCC--CccEEEEeec
Q 013897          142 VGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPN-----IVKLLDIVRDQQS--KTPSLIFEHV  213 (434)
Q Consensus       142 lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~E~~~l~~l~~h~n-----iv~l~~~~~~~~~--~~~~lv~e~~  213 (434)
                      |.+ .-..||+... .+|. +++|+..+. ...++..|+..|+.|..+.-     +..+-|-....-.  ...+-|++|+
T Consensus        34 l~s-~eN~~f~~~~-~~g~-~iLki~~~~~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l  110 (331)
T COG2334          34 LNS-EENSNFRVQT-EDGR-YILKIYRPGWTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYL  110 (331)
T ss_pred             ccc-ccCceEEEEe-cCCC-eEEEEecCCCCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEec
Confidence            444 4567898875 3343 499999885 67788999999999854411     2222221111111  3667889999


Q ss_pred             CCCchhh-hc------------------CC-----------CChH----HH---------HHHHHHHHHHHHHHHHC---
Q 013897          214 NNTDFKV-LY------------------PT-----------LSDY----DV---------RYYIYELLKALDYCHSQ---  247 (434)
Q Consensus       214 ~~~~l~~-~~------------------~~-----------l~~~----~~---------~~~~~qi~~~L~~LH~~---  247 (434)
                      +|..+.. ..                  +.           ..+.    ..         .....++...++.+.+.   
T Consensus       111 ~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~  190 (331)
T COG2334         111 PGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPA  190 (331)
T ss_pred             CCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchh
Confidence            9877652 10                  00           1111    00         01223444555555542   


Q ss_pred             -----C--ceeecCCCCceEecCCCCeEEEEecccce
Q 013897          248 -----G--IMHRDVKPHNVMIDHEQRKLRLIDWGLAE  277 (434)
Q Consensus       248 -----~--ivHrDlKp~NIll~~~~~~vkl~DFGla~  277 (434)
                           +  +||+|+.|.|||++.+...+.++||+.+.
T Consensus       191 ~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         191 HLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence                 3  99999999999999665238999999884

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.03  E-value=0.00015  Score=80.34  Aligned_cols=150  Identities=11%  Similarity=-0.044  Sum_probs=104.6

Q ss_pred             HHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeecCCCchhhhc-C------CCChHHHHHHHHHHHHHHHHHHHC--
Q 013897          177 REIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY-P------TLSDYDVRYYIYELLKALDYCHSQ--  247 (434)
Q Consensus       177 ~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~------~l~~~~~~~~~~qi~~~L~~LH~~--  247 (434)
                      .|..-++.. .|+++.....-..+......+.+++|+..|.+...+ +      .+...-+.....+.+.+..-+|..  
T Consensus      1278 ~e~de~~~~-~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1278 SERDELREA-KHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred             hhhhhhhhh-hceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence            344444445 788888777666554455567889999988875543 2      222333333333435566666643  


Q ss_pred             ---CceeecCCCCceEecCCCCeEEEEecccceecCC-CCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHH
Q 013897          248 ---GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI  323 (434)
Q Consensus       248 ---~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell  323 (434)
                         -.+|++||+-|.+|+.+. .+|+.++|+.+...+ .......++++.|+.|++... -.++.++|+|..|+-+|++-
T Consensus      1357 lg~T~v~~~Lkf~lpmIVtny-~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~-ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNY-NVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNE-IKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred             CCccchhhhhhhhccceecCC-cccccccccccccCchHhhhhhhhCCHHHHHHHHHHH-HhhhhHHHHHHHHHHHHHHh
Confidence               278999999999998665 799999999983332 233355678888999988654 57888899999999999998


Q ss_pred             hCCCCC
Q 013897          324 FRKEPF  329 (434)
Q Consensus       324 tg~~pf  329 (434)
                      -|..+|
T Consensus      1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred             cccHHH
Confidence            888776

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.03  E-value=0.0024  Score=63.96  Aligned_cols=175  Identities=19%  Similarity=0.216  Sum_probs=99.0

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeecCCCchhhhcCCCChHHHHHHHHHHHHHHHHHHHCCcee
Q 013897          172 KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMH  251 (434)
Q Consensus       172 ~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH  251 (434)
                      ..++.....+++.+ .|+|+...+++-... .....+|+|++.-.+........  ..          +-.++ .+++.|
T Consensus        26 s~~ilgr~~~lktl-~~~~l~~yl~~~r~~-~~r~IVV~e~~~~Sled~~~~~~--l~----------~~s~~-~~~~~~   90 (725)
T KOG1093|consen   26 SIQILGRFQYLKSL-QHDNLCQYLDFSRGK-HERVIVVMEHYTMSLEDILKTGN--LK----------DESLL-AHGVLH   90 (725)
T ss_pred             HHHHhhhhHHHHhh-cCccceeeEeeecCc-cceEEEEehhhccchHHHHHhcc--cc----------hhhhc-ccccce
Confidence            34566677788888 999999999876543 34478899998754432221111  00          00011 122221


Q ss_pred             ecCCCCceEecCCCCeEEEEecccceecCCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCC
Q 013897          252 RDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFY  331 (434)
Q Consensus       252 rDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~  331 (434)
                      -     |        .++++| -++.               +|  |      ....+|+||||+|.++.++..|..-+ .
T Consensus        91 ~-----~--------~~~~td-~~~t---------------~~--~------~~~~pKsdVwsl~~i~~el~L~~~l~-~  132 (725)
T KOG1093|consen   91 L-----N--------IIYITD-HFLT---------------KY--P------SPIGPKSDVWSLGFIILELYLGISLE-A  132 (725)
T ss_pred             e-----h--------hhhccc-cccc---------------cC--C------CCCCcchhhhhHHHHHHHHHHhhHHH-H
Confidence            1     1        234444 0000               01  1      11224999999999999999887554 3


Q ss_pred             CCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCcc
Q 013897          332 GHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT  411 (434)
Q Consensus       332 ~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt  411 (434)
                      .....+++..+.+..-.+.........      +                   .....++....+++.+|+-..|..||.
T Consensus       133 ~~~~s~~l~~i~k~~~~d~~~~~~a~e------~-------------------~~~~~~d~~~~~~~~~c~~~~~~ir~l  187 (725)
T KOG1093|consen  133 ELTESEYLEILLKYYTDDQELLSTAME------H-------------------LIQLLADKKRLPLLKKCLWLEPIIRPL  187 (725)
T ss_pred             HHHHHHHHHHHHHhccCchhHHHHHHH------H-------------------HHHHhhhHhHHHHhccCCccccccccc
Confidence            333334444443332221111100000      0                   001124567889999999999999999


Q ss_pred             HHHHhcCCCcccc
Q 013897          412 AKEAMAHPYFFPI  424 (434)
Q Consensus       412 ~~elL~Hp~~~~~  424 (434)
                      ..++++|+-|..+
T Consensus       188 ~~~~~k~~i~~ev  200 (725)
T KOG1093|consen  188 PMELSKRCSFTEV  200 (725)
T ss_pred             hhHHhcCccHHHH
Confidence            9999999988755

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.72  E-value=0.021  Score=55.65  Aligned_cols=71  Identities=17%  Similarity=0.288  Sum_probs=47.1

Q ss_pred             eeeecCceEEEEEEEcCCCeEEEEEEecc----------ccHHHHHHHHHHHHHhcCC-C-CeeeEeeEEEccCCCccEE
Q 013897          141 KVGRGKYSEVFEGVHCTDNEKCIIKILKP----------VKKKKIKREIKILQNLCGG-P-NIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       141 ~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~----------~~~~~~~~E~~~l~~l~~h-~-niv~l~~~~~~~~~~~~~l  208 (434)
                      .||.|...-||++....+++.++||.-.+          ...++..-|..+|+..... | .+++++.+-    .....+
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D----~e~~~~   77 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFD----TEMAVT   77 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEc----ccccee
Confidence            47999999999999754346899997432          1234556777788776332 3 466666653    233458


Q ss_pred             EEeecCC
Q 013897          209 IFEHVNN  215 (434)
Q Consensus       209 v~e~~~~  215 (434)
                      |||+++.
T Consensus        78 vMEdL~~   84 (370)
T TIGR01767        78 VMEDLSH   84 (370)
T ss_pred             hHhhCcc
Confidence            9999865

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PTZ00384 choline kinase; Provisional

Probab=96.64  E-value=0.023  Score=56.35  Aligned_cols=75  Identities=16%  Similarity=0.166  Sum_probs=47.9

Q ss_pred             EEeeeeecCceEEEEEEEcCCC-e-----EEEEEEeccccH--HHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          138 VVRKVGRGKYSEVFEGVHCTDN-E-----KCIIKILKPVKK--KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       138 ~~~~lG~G~fg~Vy~~~~~~~~-~-----~vaiK~~~~~~~--~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      .++.|..|-...+|++...... .     .|.+++......  -.-.+|+.+++.+..+..-.++++.+..      .+|
T Consensus        54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~------g~l  127 (383)
T PTZ00384         54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD------FTI  127 (383)
T ss_pred             EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC------EEE
Confidence            3455666888899998753321 2     244444321111  1235789999999777777888888732      389


Q ss_pred             EeecCCCch
Q 013897          210 FEHVNNTDF  218 (434)
Q Consensus       210 ~e~~~~~~l  218 (434)
                      .||++|..+
T Consensus       128 ~efIeGr~l  136 (383)
T PTZ00384        128 QEWVEGNTM  136 (383)
T ss_pred             EEEeccccC
Confidence            999998765

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.63  E-value=0.022  Score=54.12  Aligned_cols=76  Identities=16%  Similarity=0.206  Sum_probs=50.0

Q ss_pred             EEEeeeeecCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhc--CCCCeeeEeeEEEccCCCccEEEEeecC
Q 013897          137 EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLC--GGPNIVKLLDIVRDQQSKTPSLIFEHVN  214 (434)
Q Consensus       137 ~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~E~~~l~~l~--~h~niv~l~~~~~~~~~~~~~lv~e~~~  214 (434)
                      +-.+.|+.|.-..+|+..  .+++.+.||+-.......+..|.+-|+.|.  ..-.+++.+++....+.  .+||+||++
T Consensus        20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~--~fLlle~l~   95 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDD--AFLLLEFLE   95 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSC--CEEEEE---
T ss_pred             eeeEecCCCChhheEEEE--CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCC--ceEEEEeec
Confidence            356779999999999986  678889999887666678999999999882  34457788887755433  379999987


Q ss_pred             CC
Q 013897          215 NT  216 (434)
Q Consensus       215 ~~  216 (434)
                      .+
T Consensus        96 ~~   97 (288)
T PF03881_consen   96 MG   97 (288)
T ss_dssp             --
T ss_pred             CC
Confidence            76

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.32  E-value=0.025  Score=54.50  Aligned_cols=30  Identities=17%  Similarity=0.303  Sum_probs=26.6

Q ss_pred             CceeecCCCCceEecCCCCeEEEEeccccee
Q 013897          248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF  278 (434)
Q Consensus       248 ~ivHrDlKp~NIll~~~~~~vkl~DFGla~~  278 (434)
                      ++||+|+.+.|||++.++ .+.++||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~-~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETR-GGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCC-CEEEEEhhhccc
Confidence            699999999999998666 689999998864

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.26  E-value=0.11  Score=51.72  Aligned_cols=72  Identities=17%  Similarity=0.224  Sum_probs=50.4

Q ss_pred             EEeeeeecCceEEEEEEEcCCCeEEEEEEecc----------ccHHHHHHHHHHHHHhcC--CCCeeeEeeEEEccCCCc
Q 013897          138 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP----------VKKKKIKREIKILQNLCG--GPNIVKLLDIVRDQQSKT  205 (434)
Q Consensus       138 ~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~----------~~~~~~~~E~~~l~~l~~--h~niv~l~~~~~~~~~~~  205 (434)
                      ..+.||.|....||+...  .+..++||.-.+          ....+...|...|+.+..  ..++++++.++.+    .
T Consensus        36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded----~  109 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT----M  109 (418)
T ss_pred             eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC----C
Confidence            467799999999999876  345688987541          133445566777776632  2488899988852    2


Q ss_pred             cEEEEeecCC
Q 013897          206 PSLIFEHVNN  215 (434)
Q Consensus       206 ~~lv~e~~~~  215 (434)
                      -+++||++.+
T Consensus       110 ~vlvME~L~~  119 (418)
T PLN02756        110 ALIGMRYLEP  119 (418)
T ss_pred             CEEEEeecCC
Confidence            3589999976

>PRK06148 hypothetical protein; Provisional

Probab=96.22  E-value=0.071  Score=59.76  Aligned_cols=137  Identities=19%  Similarity=0.288  Sum_probs=78.1

Q ss_pred             eeeeecCceEEEEEEEcCCCeEEEEEEeccc-cHHHHHHHHHHHHHhcCC-CC--eeeEee--------EEEc-cCCCcc
Q 013897          140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGG-PN--IVKLLD--------IVRD-QQSKTP  206 (434)
Q Consensus       140 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~E~~~l~~l~~h-~n--iv~l~~--------~~~~-~~~~~~  206 (434)
                      +.|+ |..-.+|+... .++..+++|+.++. .......|..+|..|..+ +.  +.+++-        .+.+ ......
T Consensus        31 ~~L~-s~~d~nf~v~~-~~g~~yVLKi~~~~~~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~  108 (1013)
T PRK06148         31 TPLD-GERDLNFRLTT-DDGADYILKIVNPSEPRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRL  108 (1013)
T ss_pred             eecC-CcCCceEEEEe-CCCCeEEEEEcCCccchhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEE
Confidence            4564 34577888764 56778999999854 334556677777776432 22  233332        1112 122245


Q ss_pred             EEEEeecCCCchhhhc---------------------C---------CCChH-----------------HHHHHHHHHHH
Q 013897          207 SLIFEHVNNTDFKVLY---------------------P---------TLSDY-----------------DVRYYIYELLK  239 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~---------------------~---------~l~~~-----------------~~~~~~~qi~~  239 (434)
                      +.+++|++|..+....                     .         .+.|.                 ..+.++.+++.
T Consensus       109 vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~~  188 (1013)
T PRK06148        109 LRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFLA  188 (1013)
T ss_pred             EEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHHH
Confidence            6789999987654310                     0         01111                 11222333333


Q ss_pred             HHH-----HHHH--CCceeecCCCCceEecCCC--CeEEEEeccccee
Q 013897          240 ALD-----YCHS--QGIMHRDVKPHNVMIDHEQ--RKLRLIDWGLAEF  278 (434)
Q Consensus       240 ~L~-----~LH~--~~ivHrDlKp~NIll~~~~--~~vkl~DFGla~~  278 (434)
                      ...     .|.+  +++||+|+.+.|||++.++  ...-|+|||.+..
T Consensus       189 ~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        189 RFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             HHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            222     1211  4799999999999998653  2345999998853

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.07  E-value=0.025  Score=55.91  Aligned_cols=73  Identities=19%  Similarity=0.230  Sum_probs=49.3

Q ss_pred             EeeeeecCceEEEEEEEcCCCeEEEEEEecc---------ccHHHHHHHHHHHHHhcCC-C-CeeeEeeEEEccCCCccE
Q 013897          139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---------VKKKKIKREIKILQNLCGG-P-NIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       139 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~---------~~~~~~~~E~~~l~~l~~h-~-niv~l~~~~~~~~~~~~~  207 (434)
                      .+.||.|.-.-||++.+...++.++||.-.+         ...++..-|.++|+.+... | .+++++.+-.    ....
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~----e~~~  109 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDS----VMNC  109 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECc----HHhh
Confidence            6779999999999998743356789986431         2245667788888876332 3 5667776532    2335


Q ss_pred             EEEeecCC
Q 013897          208 LIFEHVNN  215 (434)
Q Consensus       208 lv~e~~~~  215 (434)
                      +|||+++.
T Consensus       110 ~vMEdL~~  117 (409)
T PRK12396        110 CVMEDLSD  117 (409)
T ss_pred             HHHHhCcc
Confidence            78888755

>PTZ00296 choline kinase; Provisional

Probab=95.81  E-value=0.13  Score=52.10  Aligned_cols=74  Identities=14%  Similarity=0.150  Sum_probs=48.1

Q ss_pred             EEeeeeecCceEEEEEEEcCC--------CeEEEEEEeccccHH--HHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          138 VVRKVGRGKYSEVFEGVHCTD--------NEKCIIKILKPVKKK--KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       138 ~~~~lG~G~fg~Vy~~~~~~~--------~~~vaiK~~~~~~~~--~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      -++.|..|=--.+|++.....        ++.|++|+.-.....  .-..|..+++.+..+---.++++.+..      .
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f~g------g  182 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTFSG------G  182 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEeCC------C
Confidence            456677777788898875422        468999987543221  235688888888554444567776621      2


Q ss_pred             EEEeecCCCc
Q 013897          208 LIFEHVNNTD  217 (434)
Q Consensus       208 lv~e~~~~~~  217 (434)
                      .|.||+++..
T Consensus       183 ~I~efi~g~~  192 (442)
T PTZ00296        183 RIEEWLYGDP  192 (442)
T ss_pred             EEEEeeCCcc
Confidence            6789998763

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.79  E-value=0.16  Score=49.37  Aligned_cols=70  Identities=14%  Similarity=0.193  Sum_probs=42.5

Q ss_pred             CceEEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCC-CCeeeEe---e-EEEccCCCccEEEEeecCCCc
Q 013897          146 KYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGG-PNIVKLL---D-IVRDQQSKTPSLIFEHVNNTD  217 (434)
Q Consensus       146 ~fg~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~E~~~l~~l~~h-~niv~l~---~-~~~~~~~~~~~lv~e~~~~~~  217 (434)
                      .-..||+... .++..+++|+.++.  ...++..|+..+..|..+ -.++...   | .+.. .+...+.|+++++|..
T Consensus        37 ~eN~vy~v~~-~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~-~~g~~~~l~~~~~G~~  113 (325)
T PRK11768         37 YENRVYQFGD-EDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHE-HQGFRFALFPRRGGRA  113 (325)
T ss_pred             ccceEEEEec-CCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEE-ECCEEEEEEeeeCCCC
Confidence            3467898875 45678999998754  356678899988887432 1122211   1 1111 1234567888888753

>PRK06149 hypothetical protein; Provisional

Probab=95.70  E-value=0.16  Score=56.77  Aligned_cols=76  Identities=9%  Similarity=0.176  Sum_probs=44.4

Q ss_pred             eeeeecCceEEEEEEEcCCCeEEEEEEeccc-cHHHHHHHHHHHHHhcCC---CCeeeEee--------EEEccCCCccE
Q 013897          140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGG---PNIVKLLD--------IVRDQQSKTPS  207 (434)
Q Consensus       140 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~E~~~l~~l~~h---~niv~l~~--------~~~~~~~~~~~  207 (434)
                      ..|+.+. -.+|+...  ++..+++|+.+.. ...++..|..++..|...   -.+.+++-        .....+....+
T Consensus        37 ~~L~s~~-d~nf~v~t--~~~~yVLKi~~~~~~~~~l~~e~~~l~hL~~~~~glpvp~pi~t~~G~~~~~~~~~g~~~~v  113 (972)
T PRK06149         37 TELGSQQ-DRNFRVDS--DGGRFVLKICHAAYAAVELEAQHAALRHLAEREPALRVPVVIPALDGEELLTLDVRGQGLRV  113 (972)
T ss_pred             EecCCcC-cceEEEEe--cCCcEEEEeCCccCChHHHHHHHHHHHHHHhhCCCCCCceeeECCCCCeEEEEecCCceEEE
Confidence            4454333 36787764  2357889998743 446677888888887443   22333332        11112234556


Q ss_pred             EEEeecCCCch
Q 013897          208 LIFEHVNNTDF  218 (434)
Q Consensus       208 lv~e~~~~~~l  218 (434)
                      .+++|++|..+
T Consensus       114 rL~~~l~G~~~  124 (972)
T PRK06149        114 RLLDYLPGQPL  124 (972)
T ss_pred             EEEEecCCccc
Confidence            78999988544

>PF07914 DUF1679: Protein of unknown function (DUF1679); InterPro: IPR012877 This region is found in a number of Caenorhabditis elegans and Caenorhabditis briggsae proteins, in one case (Q19034 from SWISSPROT) as a repeat

Probab=95.29  E-value=0.059  Score=54.00  Aligned_cols=32  Identities=22%  Similarity=0.417  Sum_probs=25.4

Q ss_pred             ceeecCCCCceEecCCCC----eEEEEecccceecC
Q 013897          249 IMHRDVKPHNVMIDHEQR----KLRLIDWGLAEFYH  280 (434)
Q Consensus       249 ivHrDlKp~NIll~~~~~----~vkl~DFGla~~~~  280 (434)
                      ++|+||...|||.+.++.    -..|+||-.+....
T Consensus       270 L~HGDLw~~NiLw~k~~~g~~~l~AIIDwQ~vh~G~  305 (414)
T PF07914_consen  270 LVHGDLWSSNILWDKDSDGKLKLKAIIDWQCVHRGS  305 (414)
T ss_pred             eecCCccHHheeeecCCchhHHHHHHHHHHHhhcCc
Confidence            799999999999987553    45788988875443

In many of the family members, this region is associated with the CHK region described by SMART as being found in zinc finger-C4 and HLH domain-containing kinases. In fact, one member of this family (Q9GUC1 from SWISSPROT) is annotated as being a member of the nuclear hormone receptor family, and contains regions typical of such proteins (IPR000536 from INTERPRO, IPR008946 from INTERPRO, and IPR001628 from INTERPRO).

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.05  E-value=0.07  Score=52.41  Aligned_cols=125  Identities=20%  Similarity=0.190  Sum_probs=74.1

Q ss_pred             eeeeecCceEEEEEEE---------------cCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeEeeEEE-----
Q 013897          140 RKVGRGKYSEVFEGVH---------------CTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVR-----  199 (434)
Q Consensus       140 ~~lG~G~fg~Vy~~~~---------------~~~~~~vaiK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~-----  199 (434)
                      ..||.|.-+.||+|..               +.+.+.+|||+..+.-.+.+...+.+|.....-+|+|.-..+..     
T Consensus       195 ~PIGsG~IAQVY~atl~~a~lekd~~~~~~~~~~tq~~AiKv~Hp~V~~~ir~Dl~Il~f~Akl~~~vP~l~wL~l~~~v  274 (565)
T KOG1236|consen  195 EPIGSGCIAQVYRATLKTAYLEKDSGKEYVQKLGTQSCAIKVLHPNVEKQIRLDLGILGFGAKLINNVPDLSWLSLPLEV  274 (565)
T ss_pred             cccccchhhhhhhhhhhHHHhhcccchhhhcCCccceeeeeccCccHHHHHHHHHHHHhhhhhhhhhcCccccccCcchH
Confidence            4599999999998853               22346799999988777777666666654432233221111100     


Q ss_pred             ---------------------------------------ccCCCccEEEEeecCCCchhhhcCC--CChHHHHHHHHHHH
Q 013897          200 ---------------------------------------DQQSKTPSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELL  238 (434)
Q Consensus       200 ---------------------------------------~~~~~~~~lv~e~~~~~~l~~~~~~--l~~~~~~~~~~qi~  238 (434)
                                                             .+-.....++=+|..|-.+..+...  .++..++.++.-..
T Consensus       275 kqF~v~ln~QvdL~~EA~hL~rF~~NF~~s~~V~fP~P~~~~~~~~vl~E~~~~Gl~v~~~v~~~~~pe~l~kkva~lg~  354 (565)
T KOG1236|consen  275 KQFSVGLNAQVDLRQEALHLPRFTNNFSGSKKVLFPKPIAPLHTDLVLVETYERGLSVLRFVKWKSQPEALVKKVAKLGV  354 (565)
T ss_pred             HHHHHHHHhhcchhhhhhhhHHHHHhcccceeecCCcccccccccceeeeeccccccHHhhhhcccChHHHHHHHHHHHH
Confidence                                                   0011123345556666666555543  44444555555445


Q ss_pred             HHHHH-HHHCCceeecCCCCceEecCC
Q 013897          239 KALDY-CHSQGIMHRDVKPHNVMIDHE  264 (434)
Q Consensus       239 ~~L~~-LH~~~ivHrDlKp~NIll~~~  264 (434)
                      .|+-- |--.+.+|.|+.|.||++...
T Consensus       355 ~AllkMl~vDNFvHaDlHPGNVlirf~  381 (565)
T KOG1236|consen  355 NALLKMLIVDNFVHADLHPGNVLIRFN  381 (565)
T ss_pred             HHHHHHHHhhcceecccCCCcEEEEec
Confidence            55433 345689999999999999543

>KOG4720 consensus Ethanolamine kinase [Lipid transport and metabolism]

Probab=94.74  E-value=0.078  Score=49.70  Aligned_cols=96  Identities=18%  Similarity=0.225  Sum_probs=62.7

Q ss_pred             HHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeecCCCchhhh--cC-------------------------CCChH
Q 013897          176 KREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YP-------------------------TLSDY  228 (434)
Q Consensus       176 ~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~--~~-------------------------~l~~~  228 (434)
                      ++|+...+.|..|-.-.+|++.|...      ||+||++|.+|..-  ..                         +.-|.
T Consensus       126 e~Ev~afk~L~a~G~ap~Ly~tF~NG------Lvyefi~g~tL~p~~mr~pki~~lIAr~mak~H~~~~~g~~pkp~lw~  199 (391)
T KOG4720|consen  126 ENEVIAFKLLAAYGFAPKLYGTFNNG------LVYEFIQGKTLEPEHMREPKIFRLIARRMAKIHSIVATGGNPKPPLWE  199 (391)
T ss_pred             HHHHHHHHHHHHcCcChhhhheecCc------eEEeeecCcccChhhccChHHHHHHHHHHHHhheeccCCCCCCCcHHH
Confidence            57788888887888889999998432      99999999877422  10                         00011


Q ss_pred             HHHHHH--------------------------HHHHHHHHHHHHCC----ceeecCCCCceEecCCCCeEEEEecccce
Q 013897          229 DVRYYI--------------------------YELLKALDYCHSQG----IMHRDVKPHNVMIDHEQRKLRLIDWGLAE  277 (434)
Q Consensus       229 ~~~~~~--------------------------~qi~~~L~~LH~~~----ivHrDlKp~NIll~~~~~~vkl~DFGla~  277 (434)
                      ..+.+.                          .+|..-=++|-..+    .+|.||=..||+.+...++|..+||..|.
T Consensus       200 km~~f~~lv~~~f~de~~kq~~~~~~~~~~L~~Ei~~l~E~l~~L~sPVVFcHNDLL~~Niiy~~~~~~v~fIDYEYa~  278 (391)
T KOG4720|consen  200 KMRKFLQLVPTSFEDEINKQNLFDEPSPEDLGEEISKLKEMLSMLKSPVVFCHNDLLCGNIIYDSEKGSVEFIDYEYAG  278 (391)
T ss_pred             HHHHHHHhcCchhhcccchhhcccCCCHHHHHHHHHHHHHHHHhhCCCeEEeecchhhcceeeccccCcEEEEeecccc
Confidence            111111                          11211122222222    57999999999999888899999999884

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	434
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		1e-163
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		1e-162
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		1e-162
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		1e-161
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		1e-161
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		1e-161
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		1e-160
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		1e-159
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-159
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-159
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		1e-140
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		1e-139
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		1e-139
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		1e-139
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		1e-139
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		1e-139
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		1e-139
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		1e-139
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		1e-139
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		1e-139
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		1e-139
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		1e-139
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		1e-139
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		1e-138
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		1e-138
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		1e-135
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		1e-135
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		4e-34
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-33
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-33
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-32
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		6e-31
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-30
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-30
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-30
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-30
4exu_A	371	Mapk13, Inactive Form Length = 371		5e-30
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		7e-30
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		7e-30
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		9e-30
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-29
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-29
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-29
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-29
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-29
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-29
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-29
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-29
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-29
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-29
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-29
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-29
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-29
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-29
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-29
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-29
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-29
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-29
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-29
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-29
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-29
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-29
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-29
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-29
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-29
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-29
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-29
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-29
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-29
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-29
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-29
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-29
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-29
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-29
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-29
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-29
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		6e-29
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		6e-29
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		6e-29
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		7e-29
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		7e-29
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		7e-29
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		7e-29
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		7e-29
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		7e-29
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		8e-29
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-28
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-28
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-28
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-28
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-28
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-28
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-28
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-28
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-28
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-28
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		5e-28
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-27
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-27
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-27
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-27
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-27
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-27
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		4e-27
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		6e-27
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-26
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-26
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-26
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-26
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-26
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-26
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-26
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-26
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-26
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-26
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-26
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-26
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-26
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-26
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-26
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-26
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-26
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-26
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-26
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-26
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-26
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-26
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-26
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-26
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-26
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-26
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-26
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-26
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-26
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-26
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-26
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-26
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		3e-26
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-26
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-26
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		4e-26
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		4e-26
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		4e-26
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		4e-26
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		4e-26
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		4e-26
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-26
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-26
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-26
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		4e-26
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-26
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		4e-26
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		4e-26
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		4e-26
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		4e-26
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-26
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		5e-26
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		5e-26
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		5e-26
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-26
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		5e-26
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-26
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		5e-26
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		5e-26
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		5e-26
3hec_A	348	P38 In Complex With Imatinib Length = 348		5e-26
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		5e-26
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		5e-26
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		5e-26
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		5e-26
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		5e-26
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		5e-26
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		5e-26
2oza_B	366	Structure Of P38alpha Complex Length = 366		5e-26
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		6e-26
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		6e-26
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		6e-26
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		6e-26
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		7e-26
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		8e-26
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-26
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-25
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-25
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-25
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-25
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		4e-25
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		4e-25
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		5e-25
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		8e-25
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-23
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-23
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-23
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-23
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-23
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-23
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		5e-23
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		7e-22
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-21
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-21
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-21
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-21
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-21
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-21
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-21
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		3e-21
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-21
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		3e-21
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-21
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-21
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		4e-21
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		4e-21
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-21
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		4e-21
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-21
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		5e-21
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		5e-21
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		6e-21
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		6e-21
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		6e-21
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-21
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		7e-21
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		7e-21
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		7e-21
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		8e-21
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		8e-21
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		8e-21
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		8e-21
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		8e-21
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		9e-21
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		9e-21
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		9e-21
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		9e-21
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-20
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-20
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-20
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-20
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		3e-20
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		4e-20
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		6e-20
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-20
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-19
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		7e-18
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		3e-17
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		5e-17
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		6e-15
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		6e-15
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		8e-15
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		9e-15
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-14
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-14
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-14
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-14
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-14
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		3e-14
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		4e-14
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		6e-14
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		6e-14
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		8e-14
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		8e-14
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		8e-14
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		9e-14
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-13
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-13
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-13
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		2e-13
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-13
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-13
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-13
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		4e-13
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-13
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		4e-13
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		5e-13
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		5e-13
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		5e-13
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		5e-13
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		6e-13
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		6e-13
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		6e-13
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		6e-13
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		7e-13
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		7e-13
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		9e-13
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		9e-13
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		9e-13
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-12
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-12
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-12
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-12
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-12
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-12
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-12
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-12
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-12
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-12
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-12
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-12
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-12
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-12
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-12
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-12
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-12
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-12
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-12
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-12
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-12
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-12
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-12
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-12
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-12
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-12
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-12
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-12
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-12
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-12
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-12
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-12
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-12
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-12
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-12
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-12
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-12
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-12
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-12
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-12
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-12
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-12
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		3e-12
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-12
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-12
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		4e-12
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-12
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-12
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-12
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-12
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		4e-12
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		4e-12
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		4e-12
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		4e-12
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		5e-12
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		5e-12
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		5e-12
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-12
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		5e-12
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-12
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-12
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		5e-12
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		6e-12
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		6e-12
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		6e-12
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		6e-12
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		6e-12
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		7e-12
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		7e-12
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		7e-12
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		7e-12
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		8e-12
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-12
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-12
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		8e-12
3g51_A	325	Structural Diversity Of The Active Conformation Of		9e-12
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		9e-12
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-11
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-11
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-11
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-11
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-11
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-11
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-11
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-11
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-11
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-11
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-11
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-11
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-11
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-11
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-11
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-11
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		3e-11
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-11
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-11
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-11
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-11
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		5e-11
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		7e-11
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		7e-11
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		7e-11
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-11
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		8e-11
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		1e-10
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-10
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-10
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-10
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-10
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-10
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-10
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-10
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-10
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-10
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-10
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-10
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-10
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		3e-10
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-10
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-10
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-10
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		4e-10
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		4e-10
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		4e-10
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-10
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-10
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		4e-10
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		4e-10
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		4e-10
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		5e-10
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		5e-10
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-10
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-10
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		5e-10
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		5e-10
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		5e-10
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		5e-10
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		5e-10
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		6e-10
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		6e-10
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		6e-10
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		6e-10
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		6e-10
3soa_A	444	Full-Length Human Camkii Length = 444		7e-10
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		7e-10
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		7e-10
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		7e-10
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		8e-10
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		9e-10
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		9e-10
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		9e-10
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		9e-10
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		9e-10
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-09
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-09
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-09
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-09
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-09
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-09
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-09
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		1e-09
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-09
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-09
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-09
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-09
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-09
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-09
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-09
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		1e-09
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-09
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		1e-09
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-09
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-09
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-09
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-09
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-09
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-09
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-09
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-09
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-09
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-09
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-09
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-09
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-09
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-09
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-09
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-09
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-09
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		2e-09
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-09
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-09
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-09
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-09
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-09
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-09
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-09
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-09
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-09
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-09
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-09
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-09
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-09
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-09
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-09
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-09
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-09
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-09
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-09
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-09
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-09
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-09
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		4e-09
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		4e-09
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		4e-09
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		4e-09
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		4e-09
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		4e-09
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-09
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		4e-09
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		4e-09
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-09
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		4e-09
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		4e-09
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		4e-09
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		5e-09
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		5e-09
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		5e-09
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		5e-09
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		5e-09
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		5e-09
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		5e-09
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		5e-09
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		5e-09
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		5e-09
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		5e-09
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		5e-09
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		6e-09
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		6e-09
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		6e-09
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		6e-09
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		6e-09
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		6e-09
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		7e-09
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		7e-09
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		8e-09
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		8e-09
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		8e-09
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		9e-09
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-08
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-08
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-08
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-08
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-08
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-08
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-08
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-08
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-08
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-08
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-08
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-08
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-08
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-08
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-08
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-08
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		2e-08
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-08
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-08
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-08
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-08
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		3e-08
2oza_A	356	Structure Of P38alpha Complex Length = 356		3e-08
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		3e-08
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		3e-08
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-08
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-08
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		3e-08
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		4e-08
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-08
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		4e-08
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		4e-08
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		4e-08
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		4e-08
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		4e-08
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		4e-08
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		4e-08
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		4e-08
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		4e-08
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		4e-08
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		4e-08
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-08
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		4e-08
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		4e-08
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		5e-08
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-08
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		5e-08
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		5e-08
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		5e-08
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		5e-08
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		5e-08
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		5e-08
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		6e-08
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		6e-08
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		7e-08
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		7e-08
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		7e-08
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		7e-08
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		7e-08
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		8e-08
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		8e-08
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		9e-08
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-07
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-07
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-07
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-07
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-07
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-07
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-07
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-07
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-07
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-07
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-07
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-07
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-07
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-07
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-07
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-07
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-07
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-07
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-07
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-07
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-07
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-07
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-07
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-07
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-07
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-07
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-07
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-07
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-07
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-07
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-07
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-07
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-07
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-07
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-07
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-07
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-07
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-07
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-07
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-07
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-07
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		3e-07
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-07
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		3e-07
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		3e-07
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-07
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		3e-07
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-07
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-07
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-07
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-07
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-07
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-07
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-07
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-07
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		4e-07
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		4e-07
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		4e-07
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		5e-07
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		5e-07
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		5e-07
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		6e-07
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		6e-07
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-07
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		7e-07
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		7e-07
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		8e-07
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		8e-07
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		9e-07
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-06
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-06
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-06
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-06
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-06
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-06
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-06
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-06
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-06
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-06
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-06
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		3e-06
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		3e-06
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-06
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		4e-06
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		4e-06
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		4e-06
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		5e-06
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		5e-06
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		5e-06
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		5e-06
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		6e-06
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		6e-06
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		6e-06
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		8e-06
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		8e-06
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		9e-06
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-05
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-05
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-05
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-05
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-05
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-05
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-05
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-05
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-05
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-05
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-05
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-05
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-05
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-05
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		3e-05
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-05
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		4e-05
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-05
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-05
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-05
3a4o_X	286	Lyn Kinase Domain Length = 286		5e-05
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-05
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		6e-05
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		6e-05
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-05
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		7e-05
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		7e-05
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		7e-05
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		7e-05
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		7e-05
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		7e-05
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		7e-05
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		8e-05
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		8e-05
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		9e-05
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-04
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-04
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-04
3gni_B	389	Structure Of Strad And Mo25 Length = 389		1e-04
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-04
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-04
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-04
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-04
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-04
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-04
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-04
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-04
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-04
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-04
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-04
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-04
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-04
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-04
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		1e-04
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-04
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-04
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-04
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-04
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-04
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-04
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-04
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-04
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-04
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-04
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-04
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-04
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-04
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-04
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-04
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		2e-04
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-04
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-04
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-04
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-04
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-04
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-04
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-04
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		4e-04
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-04
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		5e-04
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-04
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		7e-04
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		7e-04
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-04
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		7e-04
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		7e-04
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-04
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		8e-04

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score =  569 bits (1467), Expect = e-163,   Method: Compositional matrix adjust.
 Identities = 270/333 (81%), Positives = 290/333 (87%)
Query: 102 APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEX 161
             SKARVY+D+NV+RP+EYWDYE+LTVQWGEQDDYEVVRKVGRGKYSEVFEG++  +NE 
Sbjct: 1   GSSKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEK 60
Query: 162 XXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL 221
                               LQNLCGGPNIVKLLDIVRDQ SKTPSLIFE+VNNTDFKVL
Sbjct: 61  CIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVL 120
Query: 222 YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281
           YPTL+DYD+RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHP
Sbjct: 121 YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 180
Query: 282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 341
           GKEYNVRVASRYFKGPELLVDLQDYDYSLD+WSLGCMFAGMIFRKEPFFYGHDN+DQLVK
Sbjct: 181 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVK 240
Query: 342 IAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKL 401
           IAKVLGTD LN YLNKY IELDP L ALVGRHSRKPW KF+  +NQHL  PEA+DFLDKL
Sbjct: 241 IAKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKL 300
Query: 402 LRYDHQERPTAKEAMAHPYFFPIRNAESSRSRS 434
           LRYDHQER TA EAM HPYF  +R AE+SR+R+
Sbjct: 301 LRYDHQERLTALEAMTHPYFQQVRAAENSRTRA 333

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score =  569 bits (1466), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 270/331 (81%), Positives = 290/331 (87%)
Query: 104 SKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEXXX 163
           SKARVY+D+NV+RP+EYWDYE+LTVQWGEQDDYEVVRKVGRGKYSEVFEG++  +NE   
Sbjct: 2   SKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI 61
Query: 164 XXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP 223
                             LQNLCGGPNIVKLLDIVRDQ SKTPSLIFE+VNNTDFKVLYP
Sbjct: 62  IKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP 121
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
           TL+DYD+RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPGK
Sbjct: 122 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 181
Query: 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA 343
           EYNVRVASRYFKGPELLVDLQDYDYSLD+WSLGCMFAGMIFRKEPFFYGHDN+DQLVKIA
Sbjct: 182 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 241
Query: 344 KVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLR 403
           KVLGTD LN YLNKY IELDP L ALVGRHSRKPW KF+  +NQHL  PEA+DFLDKLLR
Sbjct: 242 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 301
Query: 404 YDHQERPTAKEAMAHPYFFPIRNAESSRSRS 434
           YDHQER TA EAM HPYF  +R AE+SR+R+
Sbjct: 302 YDHQERLTALEAMTHPYFQQVRAAENSRTRA 332

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score =  568 bits (1463), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 272/338 (80%), Positives = 292/338 (86%)
Query: 97  VRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHC 156
           V R    SKARVY+D+NV+RP+EYWDYE+LTVQWGEQDDYEVVRKVGRGKYSEVFEG++ 
Sbjct: 15  VPRGSHMSKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINV 74
Query: 157 TDNEXXXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT 216
            +NE                     LQNL GGPNIVKLLDIVRDQ SKTPSLIFE+VNNT
Sbjct: 75  NNNEKCIIKILKPVKKKKIKREIKILQNLXGGPNIVKLLDIVRDQHSKTPSLIFEYVNNT 134
Query: 217 DFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
           DFKVLYPTL+DYD+RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE RKLRLIDWGLA
Sbjct: 135 DFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 194
Query: 277 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNY 336
           EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD+WSLGCMFAGMIFRKEPFFYGHDN+
Sbjct: 195 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH 254
Query: 337 DQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVD 396
           DQLVKIAKVLGTD LNAYLNKY IELDP L ALVGRHSRKPW KF+  +NQHL  PEA+D
Sbjct: 255 DQLVKIAKVLGTDGLNAYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAID 314
Query: 397 FLDKLLRYDHQERPTAKEAMAHPYFFPIRNAESSRSRS 434
           FLDKLLRYDHQER TA EAM HPYF  +R AE+SR+R+
Sbjct: 315 FLDKLLRYDHQERLTALEAMTHPYFQQVRAAENSRTRA 352

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score =  565 bits (1455), Expect = e-161,   Method: Compositional matrix adjust.
 Identities = 269/331 (81%), Positives = 289/331 (87%)
Query: 104 SKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEXXX 163
           SKARVY+D+NV+RP+EYWDYE+LTVQWGEQDDYEVVRKVGRGKYSEVFEG++  +NE   
Sbjct: 2   SKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI 61
Query: 164 XXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP 223
                             LQNL GGPNIVKLLDIVRDQ SKTPSLIFE+VNNTDFKVLYP
Sbjct: 62  IKILKPVKKKKIKREIKILQNLXGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP 121
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
           TL+DYD+RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPGK
Sbjct: 122 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 181
Query: 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA 343
           EYNVRVASRYFKGPELLVDLQDYDYSLD+WSLGCMFAGMIFRKEPFFYGHDN+DQLVKIA
Sbjct: 182 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 241
Query: 344 KVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLR 403
           KVLGTD LN YLNKY IELDP L ALVGRHSRKPW KF+  +NQHL  PEA+DFLDKLLR
Sbjct: 242 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 301
Query: 404 YDHQERPTAKEAMAHPYFFPIRNAESSRSRS 434
           YDHQER TA EAM HPYF  +R AE+SR+R+
Sbjct: 302 YDHQERLTALEAMTHPYFQQVRAAENSRTRA 332

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score =  564 bits (1454), Expect = e-161,   Method: Compositional matrix adjust.
 Identities = 269/331 (81%), Positives = 289/331 (87%)
Query: 104 SKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEXXX 163
           SKARVY+D+NV+RP+EYWDYE+LTVQWGEQDDYEVVRKVGRGKYSEVFEG++  +NE   
Sbjct: 1   SKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI 60
Query: 164 XXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP 223
                             LQNL GGPNIVKLLDIVRDQ SKTPSLIFE+VNNTDFKVLYP
Sbjct: 61  IKILKPVKKKKIKREIKILQNLXGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP 120
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
           TL+DYD+RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPGK
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA 343
           EYNVRVASRYFKGPELLVDLQDYDYSLD+WSLGCMFAGMIFRKEPFFYGHDN+DQLVKIA
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 344 KVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLR 403
           KVLGTD LN YLNKY IELDP L ALVGRHSRKPW KF+  +NQHL  PEA+DFLDKLLR
Sbjct: 241 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 300
Query: 404 YDHQERPTAKEAMAHPYFFPIRNAESSRSRS 434
           YDHQER TA EAM HPYF  +R AE+SR+R+
Sbjct: 301 YDHQERLTALEAMTHPYFQQVRAAENSRTRA 331

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score =  563 bits (1452), Expect = e-161,   Method: Compositional matrix adjust.
 Identities = 268/327 (81%), Positives = 286/327 (87%)
Query: 104 SKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEXXX 163
           SKARVY+D+NV+RP+EYWDYE+LTVQWGEQDDYEVVRKVGRGKYSEVFEG++  +NE   
Sbjct: 1   SKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI 60
Query: 164 XXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP 223
                             LQNLCGGPNIVKLLDIVRDQ SKTPSLIFE+VNNTDFKVLYP
Sbjct: 61  IKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP 120
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
           TL+DYD+RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPGK
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA 343
           EYNVRVASRYFKGPELLVDLQDYDYSLD+WSLGCMFAGMIFRKEPFFYGHDN+DQLVKIA
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 344 KVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLR 403
           KVLGTD LN YLNKY IELDP L ALVGRHSRKPW KF+  +NQHL  PEA+DFLDKLLR
Sbjct: 241 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 300
Query: 404 YDHQERPTAKEAMAHPYFFPIRNAESS 430
           YDHQER TA EAM HPYF  +R AE+S
Sbjct: 301 YDHQERLTALEAMTHPYFQQVRAAENS 327

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score =  561 bits (1446), Expect = e-160,   Method: Compositional matrix adjust.
 Identities = 267/325 (82%), Positives = 284/325 (87%)
Query: 104 SKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEXXX 163
           SKARVY+D+NV+RP+EYWDYE+LTVQWGEQDDYEVVRKVGRGKYSEVFEG++  +NE   
Sbjct: 1   SKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI 60
Query: 164 XXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP 223
                             LQNLCGGPNIVKLLDIVRDQ SKTPSLIFE+VNNTDFKVLYP
Sbjct: 61  IKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP 120
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
           TL+DYD+RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPGK
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA 343
           EYNVRVASRYFKGPELLVDLQDYDYSLD+WSLGCMFAGMIFRKEPFFYGHDN+DQLVKIA
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 344 KVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLR 403
           KVLGTD LN YLNKY IELDP L ALVGRHSRKPW KF+  +NQHL  PEA+DFLDKLLR
Sbjct: 241 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 300
Query: 404 YDHQERPTAKEAMAHPYFFPIRNAE 428
           YDHQER TA EAM HPYF  +R AE
Sbjct: 301 YDHQERLTALEAMTHPYFQQVRAAE 325

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score =  559 bits (1441), Expect = e-159,   Method: Compositional matrix adjust.
 Identities = 267/327 (81%), Positives = 285/327 (87%)
Query: 104 SKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEXXX 163
           SKARVY+D+NV+RP+EYWDYE+LTVQWGEQDDYEVVRKVGRGKYSEVFEG++  +NE   
Sbjct: 1   SKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI 60
Query: 164 XXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP 223
                             LQNL GGPNIVKLLDIVRDQ SKTPSLIFE+VNNTDFKVLYP
Sbjct: 61  IKILKPVKKKKIKREIKILQNLXGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP 120
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
           TL+DYD+RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPGK
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA 343
           EYNVRVASRYFKGPELLVDLQDYDYSLD+WSLGCMFAGMIFRKEPFFYGHDN+DQLVKIA
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 344 KVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLR 403
           KVLGTD LN YLNKY IELDP L ALVGRHSRKPW KF+  +NQHL  PEA+DFLDKLLR
Sbjct: 241 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 300
Query: 404 YDHQERPTAKEAMAHPYFFPIRNAESS 430
           YDHQER TA EAM HPYF  +R AE+S
Sbjct: 301 YDHQERLTALEAMTHPYFQQVRAAENS 327

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score =  558 bits (1438), Expect = e-159,   Method: Compositional matrix adjust.
 Identities = 266/326 (81%), Positives = 284/326 (87%)
Query: 104 SKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEXXX 163
           SKARVY+D+NV+RP+EYWDYE+LTVQWGEQDDYEVVRKVGRGKYSEVFEG++  +NE   
Sbjct: 1   SKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI 60
Query: 164 XXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP 223
                             LQNL GGPNIVKLLDIVRDQ SKTPSLIFE+VNNTDFKVLYP
Sbjct: 61  IKILKPVKKKKIKREIKILQNLMGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP 120
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
           TL+DYD+RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPGK
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA 343
           EYNVRVASRYFKGPELLVDLQDYDYSLD+WSLGCMFAGMIFRKEPFFYGHDN+DQLVKIA
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 344 KVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLR 403
           KVLGTD LN YLNKY IELDP L ALVGRHSRKPW KF+  +NQHL  PEA+DFLDKLLR
Sbjct: 241 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 300
Query: 404 YDHQERPTAKEAMAHPYFFPIRNAES 429
           YDHQER TA EAM HPYF  +R AE+
Sbjct: 301 YDHQERLTALEAMTHPYFQQVRAAEN 326

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score =  557 bits (1435), Expect = e-159,   Method: Compositional matrix adjust.
 Identities = 266/326 (81%), Positives = 284/326 (87%)
Query: 104 SKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEXXX 163
           SKARVY+D+NV+RP+EYWDYE+LTVQWGEQDDYEVVRKVGRGKYSEVFEG++  +NE   
Sbjct: 1   SKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI 60
Query: 164 XXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP 223
                             LQNL GGPNIVKLLDIVRDQ SKTPSLIFE+VNNTDFKVLYP
Sbjct: 61  IKILKPVKKKKIKREIKILQNLXGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP 120
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
           TL+DYD+RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPGK
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA 343
           EYNVRVASRYFKGPELLVDLQDYDYSLD+WSLGCMFAGMIFRKEPFFYGHDN+DQLVKIA
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 344 KVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLR 403
           KVLGTD LN YLNKY IELDP L ALVGRHSRKPW KF+  +NQHL  PEA+DFLDKLLR
Sbjct: 241 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 300
Query: 404 YDHQERPTAKEAMAHPYFFPIRNAES 429
           YDHQER TA EAM HPYF  +R AE+
Sbjct: 301 YDHQERLTALEAMTHPYFQQVRAAEN 326

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score =  495 bits (1274), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 229/328 (69%), Positives = 268/328 (81%)
Query: 102 APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEX 161
            PS+ARVY+D+N  RPREYWDYES  V+WG QDDY++VRK+GRGKYSEVFE ++ T+NE 
Sbjct: 5   VPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEK 64
Query: 162 XXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL 221
                               L+NL GGPNI+ L DIV+D  S+TP+L+FEHVNNTDFK L
Sbjct: 65  VVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL 124
Query: 222 YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281
           Y TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHP
Sbjct: 125 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 184
Query: 282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 341
           G+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFRKEPFF+GHDNYDQLV+
Sbjct: 185 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 244
Query: 342 IAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKL 401
           IAKVLGT++L  Y++KY+IELDP    ++GRHSRK W +F+  ENQHL  PEA+DFLDKL
Sbjct: 245 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKL 304
Query: 402 LRYDHQERPTAKEAMAHPYFFPIRNAES 429
           LRYDHQ R TA+EAM HPYF+P+   +S
Sbjct: 305 LRYDHQSRLTAREAMEHPYFYPVVKEQS 332

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  491 bits (1265), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 228/331 (68%), Positives = 268/331 (80%)
Query: 102 APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEX 161
            PS+ARVY+D+N  RPREYWDYES  V+WG QDDY++VRK+GRGKYSEVFE ++ T+NE 
Sbjct: 5   VPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEK 64
Query: 162 XXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL 221
                               L+NL GGPNI+ L DIV+D  S+TP+L+FEHVNNTDFK L
Sbjct: 65  VVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL 124
Query: 222 YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281
           Y TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHP
Sbjct: 125 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 184
Query: 282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 341
           G+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFRKEPFF+GHDNYDQLV+
Sbjct: 185 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 244
Query: 342 IAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKL 401
           IAKVLGT++L  Y++KY+IELDP    ++GRHSRK W +F+  ENQHL  PEA+DFLDKL
Sbjct: 245 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKL 304
Query: 402 LRYDHQERPTAKEAMAHPYFFPIRNAESSRS 432
           LRYDHQ R TA+EAM HPYF+ +   ++  S
Sbjct: 305 LRYDHQSRLTAREAMEHPYFYTVVKDQARMS 335

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score =  491 bits (1264), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 227/323 (70%), Positives = 265/323 (82%)
Query: 102 APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEX 161
            PS+ARVY+D+N  RPREYWDYES  V+WG QDDY++VRK+GRGKYSEVFE ++ T+NE 
Sbjct: 5   VPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEK 64
Query: 162 XXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL 221
                               L+NL GGPNI+ L DIV+D  S+TP+L+FEHVNNTDFK L
Sbjct: 65  VVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL 124
Query: 222 YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281
           Y TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHP
Sbjct: 125 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 184
Query: 282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 341
           G+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFRKEPFF+GHDNYDQLV+
Sbjct: 185 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 244
Query: 342 IAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKL 401
           IAKVLGT++L  Y++KY+IELDP    ++GRHSRK W +F+  ENQHL  PEA+DFLDKL
Sbjct: 245 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKL 304
Query: 402 LRYDHQERPTAKEAMAHPYFFPI 424
           LRYDHQ R TA+EAM HPYF+ +
Sbjct: 305 LRYDHQSRLTAREAMEHPYFYTV 327

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score =  491 bits (1264), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 227/323 (70%), Positives = 265/323 (82%)
Query: 102 APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEX 161
            PS+ARVY+D+N  RPREYWDYES  V+WG QDDY++VRK+GRGKYSEVFE ++ T+NE 
Sbjct: 5   VPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEK 64
Query: 162 XXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL 221
                               L+NL GGPNI+ L DIV+D  S+TP+L+FEHVNNTDFK L
Sbjct: 65  VVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL 124
Query: 222 YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281
           Y TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHP
Sbjct: 125 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 184
Query: 282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 341
           G+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFRKEPFF+GHDNYDQLV+
Sbjct: 185 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 244
Query: 342 IAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKL 401
           IAKVLGT++L  Y++KY+IELDP    ++GRHSRK W +F+  ENQHL  PEA+DFLDKL
Sbjct: 245 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKL 304
Query: 402 LRYDHQERPTAKEAMAHPYFFPI 424
           LRYDHQ R TA+EAM HPYF+ +
Sbjct: 305 LRYDHQSRLTAREAMEHPYFYTV 327

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score =  491 bits (1263), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 227/323 (70%), Positives = 265/323 (82%)
Query: 102 APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEX 161
            PS+ARVY+D+N  RPREYWDYES  V+WG QDDY++VRK+GRGKYSEVFE ++ T+NE 
Sbjct: 5   VPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEK 64
Query: 162 XXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL 221
                               L+NL GGPNI+ L DIV+D  S+TP+L+FEHVNNTDFK L
Sbjct: 65  VVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL 124
Query: 222 YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281
           Y TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHP
Sbjct: 125 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 184
Query: 282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 341
           G+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFRKEPFF+GHDNYDQLV+
Sbjct: 185 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 244
Query: 342 IAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKL 401
           IAKVLGT++L  Y++KY+IELDP    ++GRHSRK W +F+  ENQHL  PEA+DFLDKL
Sbjct: 245 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKL 304
Query: 402 LRYDHQERPTAKEAMAHPYFFPI 424
           LRYDHQ R TA+EAM HPYF+ +
Sbjct: 305 LRYDHQSRLTAREAMEHPYFYTV 327

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score =  491 bits (1263), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 227/323 (70%), Positives = 265/323 (82%)
Query: 102 APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEX 161
            PS+ARVY+D+N  RPREYWDYES  V+WG QDDY++VRK+GRGKYSEVFE ++ T+NE 
Sbjct: 4   VPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEK 63
Query: 162 XXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL 221
                               L+NL GGPNI+ L DIV+D  S+TP+L+FEHVNNTDFK L
Sbjct: 64  VVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL 123
Query: 222 YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281
           Y TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHP
Sbjct: 124 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183
Query: 282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 341
           G+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFRKEPFF+GHDNYDQLV+
Sbjct: 184 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 243
Query: 342 IAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKL 401
           IAKVLGT++L  Y++KY+IELDP    ++GRHSRK W +F+  ENQHL  PEA+DFLDKL
Sbjct: 244 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKL 303
Query: 402 LRYDHQERPTAKEAMAHPYFFPI 424
           LRYDHQ R TA+EAM HPYF+ +
Sbjct: 304 LRYDHQSRLTAREAMEHPYFYTV 326

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score =  491 bits (1263), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 227/323 (70%), Positives = 265/323 (82%)
Query: 102 APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEX 161
            PS+ARVY+D+N  RPREYWDYES  V+WG QDDY++VRK+GRGKYSEVFE ++ T+NE 
Sbjct: 5   VPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEK 64
Query: 162 XXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL 221
                               L+NL GGPNI+ L DIV+D  S+TP+L+FEHVNNTDFK L
Sbjct: 65  VVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL 124
Query: 222 YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281
           Y TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHP
Sbjct: 125 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 184
Query: 282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 341
           G+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFRKEPFF+GHDNYDQLV+
Sbjct: 185 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 244
Query: 342 IAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKL 401
           IAKVLGT++L  Y++KY+IELDP    ++GRHSRK W +F+  ENQHL  PEA+DFLDKL
Sbjct: 245 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKL 304
Query: 402 LRYDHQERPTAKEAMAHPYFFPI 424
           LRYDHQ R TA+EAM HPYF+ +
Sbjct: 305 LRYDHQSRLTAREAMEHPYFYTV 327

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  491 bits (1263), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 227/323 (70%), Positives = 265/323 (82%)
Query: 102 APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEX 161
            PS+ARVY+D+N  RPREYWDYES  V+WG QDDY++VRK+GRGKYSEVFE ++ T+NE 
Sbjct: 5   VPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEK 64
Query: 162 XXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL 221
                               L+NL GGPNI+ L DIV+D  S+TP+L+FEHVNNTDFK L
Sbjct: 65  VVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL 124
Query: 222 YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281
           Y TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHP
Sbjct: 125 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 184
Query: 282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 341
           G+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFRKEPFF+GHDNYDQLV+
Sbjct: 185 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 244
Query: 342 IAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKL 401
           IAKVLGT++L  Y++KY+IELDP    ++GRHSRK W +F+  ENQHL  PEA+DFLDKL
Sbjct: 245 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKL 304
Query: 402 LRYDHQERPTAKEAMAHPYFFPI 424
           LRYDHQ R TA+EAM HPYF+ +
Sbjct: 305 LRYDHQSRLTAREAMEHPYFYTV 327

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score =  490 bits (1262), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 227/323 (70%), Positives = 265/323 (82%)
Query: 102 APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEX 161
            PS+ARVY+D+N  RPREYWDYES  V+WG QDDY++VRK+GRGKYSEVFE ++ T+NE 
Sbjct: 4   VPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEK 63
Query: 162 XXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL 221
                               L+NL GGPNI+ L DIV+D  S+TP+L+FEHVNNTDFK L
Sbjct: 64  VVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL 123
Query: 222 YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281
           Y TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHP
Sbjct: 124 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183
Query: 282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 341
           G+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFRKEPFF+GHDNYDQLV+
Sbjct: 184 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 243
Query: 342 IAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKL 401
           IAKVLGT++L  Y++KY+IELDP    ++GRHSRK W +F+  ENQHL  PEA+DFLDKL
Sbjct: 244 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKL 303
Query: 402 LRYDHQERPTAKEAMAHPYFFPI 424
           LRYDHQ R TA+EAM HPYF+ +
Sbjct: 304 LRYDHQSRLTAREAMEHPYFYTV 326

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score =  490 bits (1262), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 226/323 (69%), Positives = 264/323 (81%)
Query: 102 APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEX 161
            PS+ARVY+D+N  RPREYWDY S  V+WG QDDY++VRK+GRGKYSEVFE ++ T+NE 
Sbjct: 5   VPSRARVYTDVNTHRPREYWDYASHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEK 64
Query: 162 XXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL 221
                               L+NL GGPNI+ L DIV+D  S+TP+L+FEHVNNTDFK L
Sbjct: 65  VVVKILKPVKKNKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL 124
Query: 222 YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281
           Y TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHP
Sbjct: 125 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 184
Query: 282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 341
           G+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFRKEPFF+GHDNYDQLV+
Sbjct: 185 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 244
Query: 342 IAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKL 401
           IAKVLGT++L  Y++KY+IELDP    ++GRHSRK W +F+  ENQHL  PEA+DFLDKL
Sbjct: 245 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKL 304
Query: 402 LRYDHQERPTAKEAMAHPYFFPI 424
           LRYDHQ R TA+EAM HPYF+ +
Sbjct: 305 LRYDHQSRLTAREAMEHPYFYTV 327

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score =  490 bits (1262), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 227/323 (70%), Positives = 265/323 (82%)
Query: 102 APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEX 161
            PS+ARVY+D+N  RPREYWDYES  V+WG QDDY++VRK+GRGKYSEVFE ++ T+NE 
Sbjct: 5   VPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEK 64
Query: 162 XXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL 221
                               L+NL GGPNI+ L DIV+D  S+TP+L+FEHVNNTDFK L
Sbjct: 65  VVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL 124
Query: 222 YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281
           Y TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHP
Sbjct: 125 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 184
Query: 282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 341
           G+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFRKEPFF+GHDNYDQLV+
Sbjct: 185 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 244
Query: 342 IAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKL 401
           IAKVLGT++L  Y++KY+IELDP    ++GRHSRK W +F+  ENQHL  PEA+DFLDKL
Sbjct: 245 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKL 304
Query: 402 LRYDHQERPTAKEAMAHPYFFPI 424
           LRYDHQ R TA+EAM HPYF+ +
Sbjct: 305 LRYDHQSRLTAREAMEHPYFYTV 327

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score =  490 bits (1261), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 227/323 (70%), Positives = 265/323 (82%)
Query: 102 APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEX 161
            PS+ARVY+D+N  RPREYWDYES  V+WG QDDY++VRK+GRGKYSEVFE ++ T+NE 
Sbjct: 3   VPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEK 62
Query: 162 XXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL 221
                               L+NL GGPNI+ L DIV+D  S+TP+L+FEHVNNTDFK L
Sbjct: 63  VVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL 122
Query: 222 YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281
           Y TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHP
Sbjct: 123 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182
Query: 282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 341
           G+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFRKEPFF+GHDNYDQLV+
Sbjct: 183 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 242
Query: 342 IAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKL 401
           IAKVLGT++L  Y++KY+IELDP    ++GRHSRK W +F+  ENQHL  PEA+DFLDKL
Sbjct: 243 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKL 302
Query: 402 LRYDHQERPTAKEAMAHPYFFPI 424
           LRYDHQ R TA+EAM HPYF+ +
Sbjct: 303 LRYDHQSRLTAREAMEHPYFYTV 325

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score =  490 bits (1261), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 227/323 (70%), Positives = 265/323 (82%)
Query: 102 APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEX 161
            PS+ARVY+D+N  RPREYWDYES  V+WG QDDY++VRK+GRGKYSEVFE ++ T+NE 
Sbjct: 10  VPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEK 69
Query: 162 XXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL 221
                               L+NL GGPNI+ L DIV+D  S+TP+L+FEHVNNTDFK L
Sbjct: 70  VVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL 129
Query: 222 YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281
           Y TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHP
Sbjct: 130 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 189
Query: 282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 341
           G+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFRKEPFF+GHDNYDQLV+
Sbjct: 190 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 249
Query: 342 IAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKL 401
           IAKVLGT++L  Y++KY+IELDP    ++GRHSRK W +F+  ENQHL  PEA+DFLDKL
Sbjct: 250 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKL 309
Query: 402 LRYDHQERPTAKEAMAHPYFFPI 424
           LRYDHQ R TA+EAM HPYF+ +
Sbjct: 310 LRYDHQSRLTAREAMEHPYFYTV 332

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score =  489 bits (1259), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 226/323 (69%), Positives = 265/323 (82%)
Query: 102 APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEX 161
            PS+ARVY+D+N  RPREYWDYES  V+WG QDDY++VRK+GRGKYSEVFE ++ T+NE 
Sbjct: 5   VPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEK 64
Query: 162 XXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL 221
                               L+NL GGPNI+ L DIV+D  S+TP+L+FEHVNNTDFK L
Sbjct: 65  VAVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL 124
Query: 222 YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281
           Y TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNV+IDHE RKLRLIDWGLAEFYHP
Sbjct: 125 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHP 184
Query: 282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 341
           G+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFRKEPFF+GHDNYDQLV+
Sbjct: 185 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 244
Query: 342 IAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKL 401
           IAKVLGT++L  Y++KY+IELDP    ++GRHSRK W +F+  ENQHL  PEA+DFLDKL
Sbjct: 245 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKL 304
Query: 402 LRYDHQERPTAKEAMAHPYFFPI 424
           LRYDHQ R TA+EAM HPYF+ +
Sbjct: 305 LRYDHQSRLTAREAMEHPYFYTV 327

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score =  488 bits (1255), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 226/323 (69%), Positives = 264/323 (81%)
Query: 102 APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEX 161
            PS+ARVY+D+N  RPREYWDYES  V+WG QDDY++VRK+GRGKYSEVFE ++ T+NE 
Sbjct: 5   VPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEK 64
Query: 162 XXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL 221
                               L+NL GGPNI+ L DIV+D  S+TP+L+FEHVNNTDFK L
Sbjct: 65  VVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL 124
Query: 222 YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281
             TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHP
Sbjct: 125 RQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 184
Query: 282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 341
           G+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFRKEPFF+GHDNYDQLV+
Sbjct: 185 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 244
Query: 342 IAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKL 401
           IAKVLGT++L  Y++KY+IELDP    ++GRHSRK W +F+  ENQHL  PEA+DFLDKL
Sbjct: 245 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKL 304
Query: 402 LRYDHQERPTAKEAMAHPYFFPI 424
           LRYDHQ R TA+EAM HPYF+ +
Sbjct: 305 LRYDHQSRLTAREAMEHPYFYTV 327

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score =  478 bits (1231), Expect = e-135,   Method: Compositional matrix adjust.
 Identities = 221/332 (66%), Positives = 265/332 (79%)
Query: 101 GAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNE 160
            A S+ARVY+++N +R REYWDYE+    WG QDDY++VRK+GRGKYSEVFE ++ T+NE
Sbjct: 5   AAGSRARVYAEVNSLRSREYWDYEAHVPSWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 64
Query: 161 XXXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKV 220
                                L+NL GG NI+KL+D V+D  SKTP+L+FE++NNTDFK 
Sbjct: 65  RVVVKILKPVKKKKIKREVKILENLRGGTNIIKLIDTVKDPVSKTPALVFEYINNTDFKQ 124
Query: 221 LYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280
           LY  L+D+D+R+Y+YELLKALDYCHS+GIMHRDVKPHNVMIDH+Q+KLRLIDWGLAEFYH
Sbjct: 125 LYQILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYH 184
Query: 281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
           P +EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFR+EPFF+G DNYDQLV
Sbjct: 185 PAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLV 244
Query: 341 KIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDK 400
           +IAKVLGT+EL  YL KYHI+LDPH   ++G+HSRK W  FI  EN+HL  PEA+D LDK
Sbjct: 245 RIAKVLGTEELYGYLKKYHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDK 304
Query: 401 LLRYDHQERPTAKEAMAHPYFFPIRNAESSRS 432
           LLRYDHQ+R TAKEAM HPYF+P+   +S  S
Sbjct: 305 LLRYDHQQRLTAKEAMEHPYFYPVVKEQSQPS 336

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score =  477 bits (1227), Expect = e-135,   Method: Compositional matrix adjust.
 Identities = 220/329 (66%), Positives = 264/329 (80%)
Query: 101 GAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNE 160
            A S+ARVY+++N +R REYWDYE+    WG QDDY++VRK+GRGKYSEVFE ++ T+NE
Sbjct: 10  AAGSRARVYAEVNSLRSREYWDYEAHVPSWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 69
Query: 161 XXXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKV 220
                                L+NL GG NI+KL+D V+D  SKTP+L+FE++NNTDFK 
Sbjct: 70  RVVVKILKPVKKKKIKREVKILENLRGGTNIIKLIDTVKDPVSKTPALVFEYINNTDFKQ 129
Query: 221 LYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280
           LY  L+D+D+R+Y+YELLKALDYCHS+GIMHRDVKPHNVMIDH+Q+KLRLIDWGLAEFYH
Sbjct: 130 LYQILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYH 189
Query: 281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
           P +EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFR+EPFF+G DNYDQLV
Sbjct: 190 PAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLV 249
Query: 341 KIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDK 400
           +IAKVLGT+EL  YL KYHI+LDPH   ++G+HSRK W  FI  EN+HL  PEA+D LDK
Sbjct: 250 RIAKVLGTEELYGYLKKYHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDK 309
Query: 401 LLRYDHQERPTAKEAMAHPYFFPIRNAES 429
           LLRYDHQ+R TAKEAM HPYF+P+   +S
Sbjct: 310 LLRYDHQQRLTAKEAMEHPYFYPVVKEQS 338

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score =  142 bits (358), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 85/247 (34%), Positives = 138/247 (55%), Gaps = 21/247 (8%)
Query: 197 IVRDQQSKTPSLIFEHVNNTDFKVLYP------TLSDYDVRYYIYELLKALDYCHSQGIM 250
           IV   Q+K  ++I E+V +T  KVL        ++    +  YIY+L +A+ + HS GI 
Sbjct: 104 IVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGIC 163
Query: 251 HRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSL 310
           HRD+KP N++++ +   L+L D+G A+   P +     + SR+++ PEL++   +Y  S+
Sbjct: 164 HRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAXICSRFYRAPELMLGATEYTPSI 223
Query: 311 DLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--TDELNAYLNKYHIELD-PHLA 367
           DLWS+GC+F  +I  K P F G  + DQLV+I +++G  T E    +N ++ E+  P L 
Sbjct: 224 DLWSIGCVFGELILGK-PLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLK 282
Query: 368 ALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 427
           A       K W K +      L    A+D L+++LRY+   R    EAMAHP+F  +RN+
Sbjct: 283 A-------KDWRKILPEGTPSL----AIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNS 331
Query: 428 ESSRSRS 434
             S  ++
Sbjct: 332 YESEVKN 338

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 85/237 (35%), Positives = 132/237 (55%), Gaps = 15/237 (6%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCH 245
           PNIV L+D++  ++  T  L+FE +     KVL      L D  ++ Y+Y+LL+ + +CH
Sbjct: 79  PNIVSLIDVIHSERCLT--LVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH 136
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 304
              I+HRD+KP N++I+ +   L+L D+GLA  F  P + Y   V + +++ P++L+  +
Sbjct: 137 QHRILHRDLKPQNLLINSDG-ALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSK 195
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y  S+D+WS+GC+FA MI  K P F G  + DQL KI  +LGT     +     + L  
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGK-PLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWK 254
Query: 365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
                V    +KPWS  I    Q     E +D L  +L +D  +R +A++AM HPYF
Sbjct: 255 QRTFQV--FEKKPWSSIIPGFCQ-----EGIDLLSNMLCFDPNKRISARDAMNHPYF 304

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 85/237 (35%), Positives = 132/237 (55%), Gaps = 15/237 (6%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCH 245
           PNIV L+D++  ++  T  L+FE +     KVL      L D  ++ Y+Y+LL+ + +CH
Sbjct: 79  PNIVSLIDVIHSERCLT--LVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH 136
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 304
              I+HRD+KP N++I+ +   L+L D+GLA  F  P + Y   V + +++ P++L+  +
Sbjct: 137 QHRILHRDLKPQNLLINSDG-ALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSK 195
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y  S+D+WS+GC+FA MI  K P F G  + DQL KI  +LGT     +     + L  
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGK-PLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWK 254
Query: 365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
                V    +KPWS  I    Q     E +D L  +L +D  +R +A++AM HPYF
Sbjct: 255 QRTFQV--FEKKPWSSIIPGFCQ-----EGIDLLSNMLCFDPNKRISARDAMNHPYF 304

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 94/315 (29%), Positives = 151/315 (47%), Gaps = 28/315 (8%)
Query: 129 QWGEQDD--YEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQNLC 186
           + GEQ +  Y   + +G G +  VF+      +E                     +  + 
Sbjct: 33  KTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQ---IMRIV 89
Query: 187 GGPNIVKLLDIVRDQQSKTP----SLIFEHVNNTDFKV------LYPTLSDYDVRYYIYE 236
             PN+V L         K      +L+ E+V  T ++       L  T+    ++ Y+Y+
Sbjct: 90  KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQ 149
Query: 237 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 296
           LL++L Y HS GI HRD+KP N+++D     L+LID+G A+    G+     + SRY++ 
Sbjct: 150 LLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRYYRA 209
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTD--ELNAY 354
           PEL+    +Y  ++D+WS GC+ A ++ + +P F G    DQLV+I KVLGT   E    
Sbjct: 210 PELIFGATNYTTNIDIWSTGCVMAELM-QGQPLFPGESGIDQLVEIIKVLGTPSREQIKT 268
Query: 355 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKE 414
           +N  ++E   H    +  H   P+SK           P+A+D + +LL Y    R TA E
Sbjct: 269 MNPNYME---HKFPQIRPH---PFSKVFRPRTP----PDAIDLISRLLEYTPSARLTAIE 318
Query: 415 AMAHPYFFPIRNAES 429
           A+ HP+F  +R  E+
Sbjct: 319 ALCHPFFDELRTGEA 333

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  131 bits (330), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 87/300 (29%), Positives = 151/300 (50%), Gaps = 21/300 (7%)
Query: 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXX----XXXXXXXXXXXXXXXLQNLC 186
           G  ++++ V K+G G Y  V++  +    E                         L    
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-YPTLSDYD---VRYYIYELLKALD 242
             PNIVKLLD++  +      L+FEHV+    K +    L+      ++ Y+++LL+ L 
Sbjct: 63  NHPNIVKLLDVIHTENKL--YLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 301
           +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+
Sbjct: 121 FCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 179
Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 361
             + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     + 
Sbjct: 180 GCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM- 237
Query: 362 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
             P       + +R+ +SK +   ++     +    L ++L YD  +R +AK A+AHP+F
Sbjct: 238 --PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 77/238 (32%), Positives = 133/238 (55%), Gaps = 20/238 (8%)
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPT----LSDYDVRYYIYELLKALDYCH 245
           NIVKL D++  +  K   L+FEH++  D K L       L     + ++ +LL  + YCH
Sbjct: 61  NIVKLYDVIHTK--KRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 304
            + ++HRD+KP N++I+ E  +L++ D+GLA  F  P ++Y   V + +++ P++L+  +
Sbjct: 118 DRRVLHRDLKPQNLLINREG-ELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSK 176
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI-ELD 363
            Y  ++D+WS+GC+FA M+    P F G    DQL++I ++LGT     + N   + + D
Sbjct: 177 KYSTTIDIWSVGCIFAEMV-NGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
           P+       +   PW  F+   ++       +D L K+L+ D  +R TAK+A+ H YF
Sbjct: 236 PNFTV----YEPLPWESFLKGLDE-----SGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  130 bits (327), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 77/238 (32%), Positives = 133/238 (55%), Gaps = 20/238 (8%)
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPT----LSDYDVRYYIYELLKALDYCH 245
           NIVKL D++  +  K   L+FEH++  D K L       L     + ++ +LL  + YCH
Sbjct: 61  NIVKLYDVIHTK--KRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 304
            + ++HRD+KP N++I+ E  +L++ D+GLA  F  P ++Y   V + +++ P++L+  +
Sbjct: 118 DRRVLHRDLKPQNLLINREG-ELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSK 176
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI-ELD 363
            Y  ++D+WS+GC+FA M+    P F G    DQL++I ++LGT     + N   + + D
Sbjct: 177 KYSTTIDIWSVGCIFAEMV-NGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
           P+       +   PW  F+   ++       +D L K+L+ D  +R TAK+A+ H YF
Sbjct: 236 PNFTV----YEPLPWESFLKGLDE-----SGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 149/299 (49%), Gaps = 23/299 (7%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXX----XXXXXXXXXXXXXXXLQNLCGG 188
            ++++ V K+G G Y  V++  +    E                         L      
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDV-----RYYIYELLKALDY 243
           PNIVKLLD++  +      L+FEHV+  D K      +   +     + Y+++LL+ L +
Sbjct: 61  PNIVKLLDVIHTENKL--YLVFEHVHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVD 302
           CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+ 
Sbjct: 118 CHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 362
            + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +  
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM-- 233
Query: 363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            P       + +R+ +SK +   ++     +    L ++L YD  +R +AK A+AHP+F
Sbjct: 234 -PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 76/238 (31%), Positives = 133/238 (55%), Gaps = 20/238 (8%)
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPT----LSDYDVRYYIYELLKALDYCH 245
           NIVKL D++  +  K   L+FEH++  D K L       L     + ++ +LL  + YCH
Sbjct: 61  NIVKLYDVIHTK--KRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 304
            + ++HRD+KP N++I+ E  +L++ D+GLA  F  P ++Y   + + +++ P++L+  +
Sbjct: 118 DRRVLHRDLKPQNLLINREG-ELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI-ELD 363
            Y  ++D+WS+GC+FA M+    P F G    DQL++I ++LGT     + N   + + D
Sbjct: 177 KYSTTIDIWSVGCIFAEMV-NGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
           P+       +   PW  F+   ++       +D L K+L+ D  +R TAK+A+ H YF
Sbjct: 236 PNFTV----YEPLPWESFLKGLDE-----SGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  128 bits (322), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 82/249 (32%), Positives = 134/249 (53%), Gaps = 26/249 (10%)
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVN---NTDF-KVLYPTLSDYDVRYYIYELLKALDYCH 245
           N++ LLD+     S      F  V     TD  K++    S+  ++Y +Y++LK L Y H
Sbjct: 102 NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIH 161
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
           S G++HRD+KP N+ ++ E  +L+++D+GLA   H   E    V +R+++ PE+++    
Sbjct: 162 SAGVVHRDLKPGNLAVN-EDCELKILDFGLAR--HADAEMTGYVVTRWYRAPEVILSWMH 218
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------TDELNAYLNKYH 359
           Y+ ++D+WS+GC+ A M+  K   F G D  DQL +I KV G        +LN    K +
Sbjct: 219 YNQTVDIWSVGCIMAEMLTGKT-LFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSY 277
Query: 360 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHP 419
           I+  P       +  RK +++         A P+A D L+K+L  D  +R TA +A+ HP
Sbjct: 278 IQSLP-------QTPRKDFTQLFP-----RASPQAADLLEKMLELDVDKRLTAAQALTHP 325
Query: 420 YFFPIRNAE 428
           +F P R+ E
Sbjct: 326 FFEPFRDPE 334

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  128 bits (321), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 79/229 (34%), Positives = 119/229 (51%), Gaps = 21/229 (9%)
Query: 207 SLIFEHVNNTDFKVL------YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVM 260
           +L+ ++V  T ++V         TL    V+ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 129 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 188
Query: 261 IDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFA 320
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 189 LDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 248
Query: 321 GMIFRKEPFFYGHDNYDQLVKIAKVLGTD--ELNAYLNKYHIELD-PHLAALVGRHSRKP 377
            ++   +P F G    DQLV+I KVLGT   E    +N  + E   P + A        P
Sbjct: 249 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKA-------HP 300
Query: 378 WSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 426
           W+K           PEA+    +LL Y    R T  EA AH +F  +R+
Sbjct: 301 WTKVFRPRTP----PEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 345

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  128 bits (321), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 82/249 (32%), Positives = 134/249 (53%), Gaps = 26/249 (10%)
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVN---NTDF-KVLYPTLSDYDVRYYIYELLKALDYCH 245
           N++ LLD+     S      F  V     TD  K++    S+  ++Y +Y++LK L Y H
Sbjct: 84  NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIH 143
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
           S G++HRD+KP N+ ++ E  +L+++D+GLA   H   E    V +R+++ PE+++    
Sbjct: 144 SAGVVHRDLKPGNLAVN-EDCELKILDFGLAR--HADAEMTGYVVTRWYRAPEVILSWMH 200
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------TDELNAYLNKYH 359
           Y+ ++D+WS+GC+ A M+  K   F G D  DQL +I KV G        +LN    K +
Sbjct: 201 YNQTVDIWSVGCIMAEMLTGKT-LFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSY 259
Query: 360 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHP 419
           I+  P       +  RK +++         A P+A D L+K+L  D  +R TA +A+ HP
Sbjct: 260 IQSLP-------QTPRKDFTQLFP-----RASPQAADLLEKMLELDVDKRLTAAQALTHP 307
Query: 420 YFFPIRNAE 428
           +F P R+ E
Sbjct: 308 FFEPFRDPE 316

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  127 bits (320), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 85/301 (28%), Positives = 149/301 (49%), Gaps = 23/301 (7%)
Query: 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXX----XXXXXXXXXXXXXXXLQNLC 186
           G  ++++ V K+G G Y  V++  +    E                         L    
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDV-----RYYIYELLKAL 241
             PNIVKLLD++  +      L+FE ++  D K      +   +     + Y+++LL+ L
Sbjct: 63  NHPNIVKLLDVIHTENKL--YLVFEFLHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELL 300
            +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L
Sbjct: 120 AFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 178
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 360
           +  + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 237
Query: 361 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 420
              P       + +R+ +SK +   ++     +    L ++L YD  +R +AK A+AHP+
Sbjct: 238 ---PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPF 289
Query: 421 F 421
           F
Sbjct: 290 F 290

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 79/229 (34%), Positives = 119/229 (51%), Gaps = 21/229 (9%)
Query: 207 SLIFEHVNNTDFKVL------YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVM 260
           +L+ ++V  T ++V         TL    V+ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 129 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 188
Query: 261 IDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFA 320
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 189 LDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 248
Query: 321 GMIFRKEPFFYGHDNYDQLVKIAKVLGTD--ELNAYLNKYHIELD-PHLAALVGRHSRKP 377
            ++   +P F G    DQLV+I KVLGT   E    +N  + E   P + A        P
Sbjct: 249 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKA-------HP 300
Query: 378 WSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 426
           W+K           PEA+    +LL Y    R T  EA AH +F  +R+
Sbjct: 301 WTKVFRPRTP----PEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 345

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 79/229 (34%), Positives = 119/229 (51%), Gaps = 21/229 (9%)
Query: 207 SLIFEHVNNTDFKVL------YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVM 260
           +L+ ++V  T ++V         TL    V+ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 133 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 192
Query: 261 IDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFA 320
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 193 LDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 252
Query: 321 GMIFRKEPFFYGHDNYDQLVKIAKVLGTD--ELNAYLNKYHIELD-PHLAALVGRHSRKP 377
            ++   +P F G    DQLV+I KVLGT   E    +N  + E   P + A        P
Sbjct: 253 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKA-------HP 304
Query: 378 WSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 426
           W+K           PEA+    +LL Y    R T  EA AH +F  +R+
Sbjct: 305 WTKVFRPRTP----PEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 349

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 79/229 (34%), Positives = 119/229 (51%), Gaps = 21/229 (9%)
Query: 207 SLIFEHVNNTDFKVL------YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVM 260
           +L+ ++V  T ++V         TL    V+ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 174 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 233
Query: 261 IDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFA 320
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 234 LDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 293
Query: 321 GMIFRKEPFFYGHDNYDQLVKIAKVLGTD--ELNAYLNKYHIELD-PHLAALVGRHSRKP 377
            ++   +P F G    DQLV+I KVLGT   E    +N  + E   P + A        P
Sbjct: 294 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKA-------HP 345
Query: 378 WSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 426
           W+K           PEA+    +LL Y    R T  EA AH +F  +R+
Sbjct: 346 WTKVFRPRTP----PEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 390

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 79/229 (34%), Positives = 119/229 (51%), Gaps = 21/229 (9%)
Query: 207 SLIFEHVNNTDFKVL------YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVM 260
           +L+ ++V  T ++V         TL    V+ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 107 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 166
Query: 261 IDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFA 320
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 167 LDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 226
Query: 321 GMIFRKEPFFYGHDNYDQLVKIAKVLGTD--ELNAYLNKYHIELD-PHLAALVGRHSRKP 377
            ++   +P F G    DQLV+I KVLGT   E    +N  + E   P + A        P
Sbjct: 227 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKA-------HP 278
Query: 378 WSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 426
           W+K           PEA+    +LL Y    R T  EA AH +F  +R+
Sbjct: 279 WTKVFRPRTP----PEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 323

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 79/229 (34%), Positives = 119/229 (51%), Gaps = 21/229 (9%)
Query: 207 SLIFEHVNNTDFKVL------YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVM 260
           +L+ ++V  T ++V         TL    V+ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 131 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 190
Query: 261 IDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFA 320
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 191 LDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 250
Query: 321 GMIFRKEPFFYGHDNYDQLVKIAKVLGTD--ELNAYLNKYHIELD-PHLAALVGRHSRKP 377
            ++   +P F G    DQLV+I KVLGT   E    +N  + E   P + A        P
Sbjct: 251 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKA-------HP 302
Query: 378 WSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 426
           W+K           PEA+    +LL Y    R T  EA AH +F  +R+
Sbjct: 303 WTKVFRPRTP----PEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 347

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 79/229 (34%), Positives = 119/229 (51%), Gaps = 21/229 (9%)
Query: 207 SLIFEHVNNTDFKVL------YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVM 260
           +L+ ++V  T ++V         TL    V+ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 123 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 182
Query: 261 IDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFA 320
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 183 LDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 242
Query: 321 GMIFRKEPFFYGHDNYDQLVKIAKVLGTD--ELNAYLNKYHIELD-PHLAALVGRHSRKP 377
            ++   +P F G    DQLV+I KVLGT   E    +N  + E   P + A        P
Sbjct: 243 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKA-------HP 294
Query: 378 WSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 426
           W+K           PEA+    +LL Y    R T  EA AH +F  +R+
Sbjct: 295 WTKVFRPRTP----PEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 339

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 85/300 (28%), Positives = 150/300 (50%), Gaps = 21/300 (7%)
Query: 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXX----XXXXXXXXXXXXXXXLQNLC 186
           G  ++++ V K+G G Y  V++  +    E                         L    
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-YPTLSDYD---VRYYIYELLKALD 242
             PNIVKLLD++  +      L+FE ++    K +    L+      ++ Y+++LL+ L 
Sbjct: 61  NHPNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 301
           +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+
Sbjct: 119 FCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 177
Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 361
             + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     + 
Sbjct: 178 GCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM- 235
Query: 362 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
             P       + +R+ +SK +   ++     +    L ++L YD  +R +AK A+AHP+F
Sbjct: 236 --PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 79/229 (34%), Positives = 119/229 (51%), Gaps = 21/229 (9%)
Query: 207 SLIFEHVNNTDFKVL------YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVM 260
           +L+ ++V  T ++V         TL    V+ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 114 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 173
Query: 261 IDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFA 320
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 174 LDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 233
Query: 321 GMIFRKEPFFYGHDNYDQLVKIAKVLGTD--ELNAYLNKYHIELD-PHLAALVGRHSRKP 377
            ++   +P F G    DQLV+I KVLGT   E    +N  + E   P + A        P
Sbjct: 234 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKA-------HP 285
Query: 378 WSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 426
           W+K           PEA+    +LL Y    R T  EA AH +F  +R+
Sbjct: 286 WTKVFRPRTP----PEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 330

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 79/229 (34%), Positives = 119/229 (51%), Gaps = 21/229 (9%)
Query: 207 SLIFEHVNNTDFKVL------YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVM 260
           +L+ ++V  T ++V         TL    V+ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 103 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 162
Query: 261 IDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFA 320
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 163 LDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 222
Query: 321 GMIFRKEPFFYGHDNYDQLVKIAKVLGTD--ELNAYLNKYHIELD-PHLAALVGRHSRKP 377
            ++   +P F G    DQLV+I KVLGT   E    +N  + E   P + A        P
Sbjct: 223 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKA-------HP 274
Query: 378 WSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 426
           W+K           PEA+    +LL Y    R T  EA AH +F  +R+
Sbjct: 275 WTKVFRPRTP----PEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 319

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 79/229 (34%), Positives = 119/229 (51%), Gaps = 21/229 (9%)
Query: 207 SLIFEHVNNTDFKVL------YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVM 260
           +L+ ++V  T ++V         TL    V+ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 107 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 166
Query: 261 IDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFA 320
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 167 LDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 226
Query: 321 GMIFRKEPFFYGHDNYDQLVKIAKVLGTD--ELNAYLNKYHIELD-PHLAALVGRHSRKP 377
            ++   +P F G    DQLV+I KVLGT   E    +N  + E   P + A        P
Sbjct: 227 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKA-------HP 278
Query: 378 WSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 426
           W+K           PEA+    +LL Y    R T  EA AH +F  +R+
Sbjct: 279 WTKVFRPRTP----PEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 323

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 85/300 (28%), Positives = 150/300 (50%), Gaps = 21/300 (7%)
Query: 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXX----XXXXXXXXXXXXXXXLQNLC 186
           G  ++++ V K+G G Y  V++  +    E                         L    
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-YPTLSDYD---VRYYIYELLKALD 242
             PNIVKLLD++  +      L+FE ++    K +    L+      ++ Y+++LL+ L 
Sbjct: 62  NHPNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 301
           +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+
Sbjct: 120 FCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 178
Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 361
             + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     + 
Sbjct: 179 GCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM- 236
Query: 362 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
             P       + +R+ +SK +   ++     +    L ++L YD  +R +AK A+AHP+F
Sbjct: 237 --PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 79/229 (34%), Positives = 119/229 (51%), Gaps = 21/229 (9%)
Query: 207 SLIFEHVNNTDFKVL------YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVM 260
           +L+ ++V  T ++V         TL    V+ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 100 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 159
Query: 261 IDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFA 320
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 160 LDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 219
Query: 321 GMIFRKEPFFYGHDNYDQLVKIAKVLGTD--ELNAYLNKYHIELD-PHLAALVGRHSRKP 377
            ++   +P F G    DQLV+I KVLGT   E    +N  + E   P + A        P
Sbjct: 220 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKA-------HP 271
Query: 378 WSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 426
           W+K           PEA+    +LL Y    R T  EA AH +F  +R+
Sbjct: 272 WTKVFRPRTP----PEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 316

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 79/229 (34%), Positives = 119/229 (51%), Gaps = 21/229 (9%)
Query: 207 SLIFEHVNNTDFKVL------YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVM 260
           +L+ ++V  T ++V         TL    V+ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 95  NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 154
Query: 261 IDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFA 320
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 155 LDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 214
Query: 321 GMIFRKEPFFYGHDNYDQLVKIAKVLGTD--ELNAYLNKYHIELD-PHLAALVGRHSRKP 377
            ++   +P F G    DQLV+I KVLGT   E    +N  + E   P + A        P
Sbjct: 215 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKA-------HP 266
Query: 378 WSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 426
           W+K           PEA+    +LL Y    R T  EA AH +F  +R+
Sbjct: 267 WTKVFRPRTP----PEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 85/300 (28%), Positives = 150/300 (50%), Gaps = 21/300 (7%)
Query: 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXX----XXXXXXXXXXXXXXXLQNLC 186
           G  ++++ V K+G G Y  V++  +    E                         L    
Sbjct: 4   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 63
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-YPTLSDYD---VRYYIYELLKALD 242
             PNIVKLLD++  +      L+FE ++    K +    L+      ++ Y+++LL+ L 
Sbjct: 64  NHPNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 121
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 301
           +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+
Sbjct: 122 FCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 180
Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 361
             + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     + 
Sbjct: 181 GCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM- 238
Query: 362 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
             P       + +R+ +SK +   ++     +    L ++L YD  +R +AK A+AHP+F
Sbjct: 239 --PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPFF 291

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 85/300 (28%), Positives = 150/300 (50%), Gaps = 21/300 (7%)
Query: 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXX----XXXXXXXXXXXXXXXLQNLC 186
           G  ++++ V K+G G Y  V++  +    E                         L    
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-YPTLSDYD---VRYYIYELLKALD 242
             PNIVKLLD++  +      L+FE ++    K +    L+      ++ Y+++LL+ L 
Sbjct: 63  NHPNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 301
           +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+
Sbjct: 121 FCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 179
Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 361
             + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     + 
Sbjct: 180 GCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM- 237
Query: 362 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
             P       + +R+ +SK +   ++     +    L ++L YD  +R +AK A+AHP+F
Sbjct: 238 --PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 85/300 (28%), Positives = 150/300 (50%), Gaps = 21/300 (7%)
Query: 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXX----XXXXXXXXXXXXXXXLQNLC 186
           G  ++++ V K+G G Y  V++  +    E                         L    
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-YPTLSDYD---VRYYIYELLKALD 242
             PNIVKLLD++  +      L+FE ++    K +    L+      ++ Y+++LL+ L 
Sbjct: 62  NHPNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 301
           +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+
Sbjct: 120 FCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 178
Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 361
             + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     + 
Sbjct: 179 GCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM- 236
Query: 362 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
             P       + +R+ +SK +   ++     +    L ++L YD  +R +AK A+AHP+F
Sbjct: 237 --PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 79/229 (34%), Positives = 119/229 (51%), Gaps = 21/229 (9%)
Query: 207 SLIFEHVNNTDFKVL------YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVM 260
           +L+ ++V  T ++V         TL    V+ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 96  NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 155
Query: 261 IDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFA 320
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 156 LDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 215
Query: 321 GMIFRKEPFFYGHDNYDQLVKIAKVLGTD--ELNAYLNKYHIELD-PHLAALVGRHSRKP 377
            ++   +P F G    DQLV+I KVLGT   E    +N  + E   P + A        P
Sbjct: 216 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKA-------HP 267
Query: 378 WSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 426
           W+K           PEA+    +LL Y    R T  EA AH +F  +R+
Sbjct: 268 WTKVFRPRTP----PEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 312

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 79/229 (34%), Positives = 119/229 (51%), Gaps = 21/229 (9%)
Query: 207 SLIFEHVNNTDFKVL------YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVM 260
           +L+ ++V  T ++V         TL    V+ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 95  NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 154
Query: 261 IDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFA 320
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 155 LDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 214
Query: 321 GMIFRKEPFFYGHDNYDQLVKIAKVLGTD--ELNAYLNKYHIELD-PHLAALVGRHSRKP 377
            ++   +P F G    DQLV+I KVLGT   E    +N  + E   P + A        P
Sbjct: 215 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKA-------HP 266
Query: 378 WSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 426
           W+K           PEA+    +LL Y    R T  EA AH +F  +R+
Sbjct: 267 WTKVFRPRTP----PEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 79/229 (34%), Positives = 119/229 (51%), Gaps = 21/229 (9%)
Query: 207 SLIFEHVNNTDFKVL------YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVM 260
           +L+ ++V  T ++V         TL    V+ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 95  NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 154
Query: 261 IDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFA 320
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 155 LDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 214
Query: 321 GMIFRKEPFFYGHDNYDQLVKIAKVLGTD--ELNAYLNKYHIELD-PHLAALVGRHSRKP 377
            ++   +P F G    DQLV+I KVLGT   E    +N  + E   P + A        P
Sbjct: 215 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKA-------HP 266
Query: 378 WSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 426
           W+K           PEA+    +LL Y    R T  EA AH +F  +R+
Sbjct: 267 WTKVFRPRTP----PEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 85/301 (28%), Positives = 149/301 (49%), Gaps = 23/301 (7%)
Query: 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXX----XXXXXXXXXXXXXXXLQNLC 186
           G  ++++ V K+G G Y  V++  +    E                         L    
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDV-----RYYIYELLKAL 241
             PNIVKLLD++  +      L+FE ++  D K      +   +     + Y+++LL+ L
Sbjct: 63  NHPNIVKLLDVIHTENKL--YLVFEFLS-MDLKKFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELL 300
            +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L
Sbjct: 120 AFCHSHRVLHRDLKPENLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 178
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 360
           +  + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 237
Query: 361 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 420
              P       + +R+ +SK +   ++     +    L ++L YD  +R +AK A+AHP+
Sbjct: 238 ---PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPF 289
Query: 421 F 421
           F
Sbjct: 290 F 290

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 85/300 (28%), Positives = 150/300 (50%), Gaps = 21/300 (7%)
Query: 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXX----XXXXXXXXXXXXXXXLQNLC 186
           G  ++++ V K+G G Y  V++  +    E                         L    
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-YPTLSDYD---VRYYIYELLKALD 242
             PNIVKLLD++  +      L+FE ++    K +    L+      ++ Y+++LL+ L 
Sbjct: 63  NHPNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 301
           +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+
Sbjct: 121 FCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 179
Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 361
             + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     + 
Sbjct: 180 GCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM- 237
Query: 362 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
             P       + +R+ +SK +   ++     +    L ++L YD  +R +AK A+AHP+F
Sbjct: 238 --PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 79/229 (34%), Positives = 119/229 (51%), Gaps = 21/229 (9%)
Query: 207 SLIFEHVNNTDFKVL------YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVM 260
           +L+ ++V  T ++V         TL    V+ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 99  NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 158
Query: 261 IDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFA 320
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 159 LDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 218
Query: 321 GMIFRKEPFFYGHDNYDQLVKIAKVLGTD--ELNAYLNKYHIELD-PHLAALVGRHSRKP 377
            ++   +P F G    DQLV+I KVLGT   E    +N  + E   P + A        P
Sbjct: 219 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKA-------HP 270
Query: 378 WSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 426
           W+K           PEA+    +LL Y    R T  EA AH +F  +R+
Sbjct: 271 WTKVFRPRTP----PEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 315

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 85/300 (28%), Positives = 150/300 (50%), Gaps = 21/300 (7%)
Query: 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXX----XXXXXXXXXXXXXXXLQNLC 186
           G  ++++ V K+G G Y  V++  +    E                         L    
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-YPTLSDYD---VRYYIYELLKALD 242
             PNIVKLLD++  +      L+FE ++    K +    L+      ++ Y+++LL+ L 
Sbjct: 62  NHPNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 301
           +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+
Sbjct: 120 FCHSHRVLHRDLKPENLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 178
Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 361
             + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     + 
Sbjct: 179 GCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM- 236
Query: 362 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
             P       + +R+ +SK +   ++     +    L ++L YD  +R +AK A+AHP+F
Sbjct: 237 --PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 85/300 (28%), Positives = 150/300 (50%), Gaps = 21/300 (7%)
Query: 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXX----XXXXXXXXXXXXXXXLQNLC 186
           G  ++++ V K+G G Y  V++  +    E                         L    
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-YPTLSDYD---VRYYIYELLKALD 242
             PNIVKLLD++  +      L+FE ++    K +    L+      ++ Y+++LL+ L 
Sbjct: 61  NHPNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 301
           +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+
Sbjct: 119 FCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 177
Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 361
             + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     + 
Sbjct: 178 GCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM- 235
Query: 362 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
             P       + +R+ +SK +   ++     +    L ++L YD  +R +AK A+AHP+F
Sbjct: 236 --PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 83/298 (27%), Positives = 146/298 (48%), Gaps = 17/298 (5%)
Query: 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXX----XXXXXXXXXXXXXXXLQNLC 186
           G  ++++ V K+G G Y  V++  +    E                         L    
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF--KVLYPTLSDYDVRYYIYELLKALDYC 244
             PNIVKLLD++  +        F  ++  DF        +    ++ Y+++LL+ L +C
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDL 303
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  
Sbjct: 123 HSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 181
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363
           + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   
Sbjct: 182 KYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM--- 237
Query: 364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
           P       + +R+ +SK +   ++     +    L ++L YD  +R +AK A+AHP+F
Sbjct: 238 PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 85/300 (28%), Positives = 150/300 (50%), Gaps = 21/300 (7%)
Query: 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXX----XXXXXXXXXXXXXXXLQNLC 186
           G  ++++ V K+G G Y  V++  +    E                         L    
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-YPTLSDYD---VRYYIYELLKALD 242
             PNIVKLLD++  +      L+FE ++    K +    L+      ++ Y+++LL+ L 
Sbjct: 61  NHPNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 301
           +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+
Sbjct: 119 FCHSHRVLHRDLKPENLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 177
Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 361
             + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     + 
Sbjct: 178 GCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM- 235
Query: 362 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
             P       + +R+ +SK +   ++     +    L ++L YD  +R +AK A+AHP+F
Sbjct: 236 --PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 83/298 (27%), Positives = 146/298 (48%), Gaps = 17/298 (5%)
Query: 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXX----XXXXXXXXLQNLC 186
           G  ++++ V K+G G Y  V++  +    E                         L    
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF--KVLYPTLSDYDVRYYIYELLKALDYC 244
             PNIVKLLD++  +        F  ++  DF        +    ++ Y+++LL+ L +C
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDL 303
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  
Sbjct: 122 HSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 180
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363
           + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   
Sbjct: 181 KYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM--- 236
Query: 364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
           P       + +R+ +SK +   ++     +    L ++L YD  +R +AK A+AHP+F
Sbjct: 237 PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 85/301 (28%), Positives = 149/301 (49%), Gaps = 23/301 (7%)
Query: 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXX----XXXXXXXXXXXXXXXLQNLC 186
           G  ++++ V K+G G Y  V++  +    E                         L    
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDV-----RYYIYELLKAL 241
             PNIVKLLD++  +      L+FE ++  D K      +   +     + Y+++LL+ L
Sbjct: 61  NHPNIVKLLDVIHTENKL--YLVFEFLS-MDLKKFMDASALTGIPLPLIKSYLFQLLQGL 117
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELL 300
            +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L
Sbjct: 118 AFCHSHRVLHRDLKPENLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 176
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 360
           +  + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 235
Query: 361 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 420
              P       + +R+ +SK +   ++     +    L ++L YD  +R +AK A+AHP+
Sbjct: 236 ---PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPF 287
Query: 421 F 421
           F
Sbjct: 288 F 288

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 79/229 (34%), Positives = 119/229 (51%), Gaps = 21/229 (9%)
Query: 207 SLIFEHVNNTDFKVL------YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVM 260
           +L+ ++V  T ++V         TL    V+ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 108 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 167
Query: 261 IDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFA 320
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 168 LDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 227
Query: 321 GMIFRKEPFFYGHDNYDQLVKIAKVLGTD--ELNAYLNKYHIELD-PHLAALVGRHSRKP 377
            ++   +P F G    DQLV+I KVLGT   E    +N  + E   P + A        P
Sbjct: 228 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKA-------HP 279
Query: 378 WSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 426
           W+K           PEA+    +LL Y    R T  EA AH +F  +R+
Sbjct: 280 WTKVFRPRTP----PEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 324

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 79/229 (34%), Positives = 119/229 (51%), Gaps = 21/229 (9%)
Query: 207 SLIFEHVNNTDFKVL------YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVM 260
           +L+ ++V  T ++V         TL    V+ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 95  NLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 154
Query: 261 IDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFA 320
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 155 LDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 214
Query: 321 GMIFRKEPFFYGHDNYDQLVKIAKVLGTD--ELNAYLNKYHIELD-PHLAALVGRHSRKP 377
            ++   +P F G    DQLV+I KVLGT   E    +N  + E   P + A        P
Sbjct: 215 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFAFPQIKA-------HP 266
Query: 378 WSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 426
           W+K           PEA+    +LL Y    R T  EA AH +F  +R+
Sbjct: 267 WTKVFRPRTP----PEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 85/300 (28%), Positives = 150/300 (50%), Gaps = 21/300 (7%)
Query: 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXX----XXXXXXXXXXXXXXXLQNLC 186
           G  ++++ V K+G G Y  V++  +    E                         L    
Sbjct: 1   GHMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-YPTLSDYD---VRYYIYELLKALD 242
             PNIVKLLD++  +      L+FE ++    K +    L+      ++ Y+++LL+ L 
Sbjct: 61  NHPNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 301
           +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+
Sbjct: 119 FCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 177
Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 361
             + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     + 
Sbjct: 178 GCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM- 235
Query: 362 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
             P       + +R+ +SK +   ++     +    L ++L YD  +R +AK A+AHP+F
Sbjct: 236 --PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 79/229 (34%), Positives = 119/229 (51%), Gaps = 21/229 (9%)
Query: 207 SLIFEHVNNTDFKVL------YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVM 260
           +L+ ++V  T ++V         TL    V+ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 95  NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 154
Query: 261 IDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFA 320
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 155 LDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 214
Query: 321 GMIFRKEPFFYGHDNYDQLVKIAKVLGTD--ELNAYLNKYHIELD-PHLAALVGRHSRKP 377
            ++   +P F G    DQLV+I KVLGT   E    +N  + E   P + A        P
Sbjct: 215 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKA-------HP 266
Query: 378 WSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 426
           W+K           PEA+    +LL Y    R T  EA AH +F  +R+
Sbjct: 267 WTKVFRPRTP----PEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 79/229 (34%), Positives = 119/229 (51%), Gaps = 21/229 (9%)
Query: 207 SLIFEHVNNTDFKVL------YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVM 260
           +L+ ++V  T ++V         TL    V+ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 95  NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 154
Query: 261 IDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFA 320
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 155 LDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 214
Query: 321 GMIFRKEPFFYGHDNYDQLVKIAKVLGTD--ELNAYLNKYHIELD-PHLAALVGRHSRKP 377
            ++   +P F G    DQLV+I KVLGT   E    +N  + E   P + A        P
Sbjct: 215 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKA-------HP 266
Query: 378 WSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 426
           W+K           PEA+    +LL Y    R T  EA AH +F  +R+
Sbjct: 267 WTKVFRPRTP----PEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 79/229 (34%), Positives = 119/229 (51%), Gaps = 21/229 (9%)
Query: 207 SLIFEHVNNTDFKVL------YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVM 260
           +L+ ++V  T ++V         TL    V+ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 95  NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 154
Query: 261 IDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFA 320
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 155 LDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 214
Query: 321 GMIFRKEPFFYGHDNYDQLVKIAKVLGTD--ELNAYLNKYHIELD-PHLAALVGRHSRKP 377
            ++   +P F G    DQLV+I KVLGT   E    +N  + E   P + A        P
Sbjct: 215 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFAFPQIKA-------HP 266
Query: 378 WSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 426
           W+K           PEA+    +LL Y    R T  EA AH +F  +R+
Sbjct: 267 WTKVFRPRTP----PEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 83/296 (28%), Positives = 145/296 (48%), Gaps = 17/296 (5%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXX----XXXXXXXXLQNLCGG 188
            ++++ V K+G G Y  V++  +    E                         L      
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDF--KVLYPTLSDYDVRYYIYELLKALDYCHS 246
           PNIVKLLD++  +        F H +  DF        +    ++ Y+++LL+ L +CHS
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQD 305
             ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  + 
Sbjct: 122 HRVLHRDLKPENLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 180
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH 365
           Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   P 
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM---PD 236
Query: 366 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
                 + +R+ +SK +   ++     +    L ++L YD  +R +AK A+AHP+F
Sbjct: 237 YKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  125 bits (314), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 149/298 (50%), Gaps = 21/298 (7%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXX----XXXXXXXXLQNLCGG 188
            ++++ V K+G G Y  V++  +    E                         L      
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-YPTLSDYD---VRYYIYELLKALDYC 244
           PNIVKLLD++  +      L+FE ++    K +    L+      ++ Y+++LL+ L +C
Sbjct: 62  PNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFC 119
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDL 303
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  
Sbjct: 120 HSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 178
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363
           + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM--- 234
Query: 364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
           P       + +R+ +SK +   ++     +    L ++L YD  +R +AK A+AHP+F
Sbjct: 235 PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  125 bits (313), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 149/298 (50%), Gaps = 21/298 (7%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXX----XXXXXXXXXXXXXXXLQNLCGG 188
            ++++ V K+G G Y  V++  +    E                         L      
Sbjct: 9   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 68
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-YPTLSDYD---VRYYIYELLKALDYC 244
           PNIVKLLD++  +      L+FE ++    K +    L+      ++ Y+++LL+ L +C
Sbjct: 69  PNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 126
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDL 303
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  
Sbjct: 127 HSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGX 185
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363
           + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   
Sbjct: 186 KYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM--- 241
Query: 364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
           P       + +R+ +SK +   ++     +    L ++L YD  +R +AK A+AHP+F
Sbjct: 242 PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPFF 294

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  125 bits (313), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 84/299 (28%), Positives = 150/299 (50%), Gaps = 21/299 (7%)
Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXX----XXXXXXXXXXXXXXXLQNLCG 187
           + ++++ V K+G G Y  V++  +    E                         L     
Sbjct: 5   DMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-YPTLSDYD---VRYYIYELLKALDY 243
            PNIVKLLD++  +      L+FE ++    K +    L+      ++ Y+++LL+ L +
Sbjct: 65  HPNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 122
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVD 302
           CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+ 
Sbjct: 123 CHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 181
Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 362
            + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +  
Sbjct: 182 CKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM-- 238
Query: 363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            P       + +R+ +SK +   ++     +    L ++L YD  +R +AK A+AHP+F
Sbjct: 239 -PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPFF 291

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  125 bits (313), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 149/298 (50%), Gaps = 21/298 (7%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXX----XXXXXXXXXXXXXXXLQNLCGG 188
            ++++ V K+G G Y  V++  +    E                         L      
Sbjct: 9   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 68
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-YPTLSDYD---VRYYIYELLKALDYC 244
           PNIVKLLD++  +      L+FE ++    K +    L+      ++ Y+++LL+ L +C
Sbjct: 69  PNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 126
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDL 303
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  
Sbjct: 127 HSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 185
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363
           + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   
Sbjct: 186 KYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM--- 241
Query: 364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
           P       + +R+ +SK +   ++     +    L ++L YD  +R +AK A+AHP+F
Sbjct: 242 PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPFF 294

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  124 bits (312), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 149/298 (50%), Gaps = 21/298 (7%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXX----XXXXXXXXLQNLCGG 188
            ++++ V K+G G Y  V++  +    E                         L      
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-YPTLSDYD---VRYYIYELLKALDYC 244
           PNIVKLLD++  +      L+FE ++    K +    L+      ++ Y+++LL+ L +C
Sbjct: 62  PNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDL 303
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  
Sbjct: 120 HSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGX 178
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363
           + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM--- 234
Query: 364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
           P       + +R+ +SK +   ++     +    L ++L YD  +R +AK A+AHP+F
Sbjct: 235 PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  124 bits (312), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 149/298 (50%), Gaps = 21/298 (7%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXX----XXXXXXXXLQNLCGG 188
            ++++ V K+G G Y  V++  +    E                         L      
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-YPTLSDYD---VRYYIYELLKALDYC 244
           PNIVKLLD++  +      L+FE ++    K +    L+      ++ Y+++LL+ L +C
Sbjct: 62  PNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDL 303
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  
Sbjct: 120 HSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 178
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363
           + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM--- 234
Query: 364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
           P       + +R+ +SK +   ++     +    L ++L YD  +R +AK A+AHP+F
Sbjct: 235 PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  124 bits (312), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 149/298 (50%), Gaps = 21/298 (7%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXX----XXXXXXXXLQNLCGG 188
            ++++ V K+G G Y  V++  +    E                         L      
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-YPTLSDYD---VRYYIYELLKALDYC 244
           PNIVKLLD++  +      L+FE ++    K +    L+      ++ Y+++LL+ L +C
Sbjct: 61  PNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDL 303
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  
Sbjct: 119 HSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363
           + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM--- 233
Query: 364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
           P       + +R+ +SK +   ++     +    L ++L YD  +R +AK A+AHP+F
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  124 bits (312), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 150/298 (50%), Gaps = 21/298 (7%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXX----XXXXXXXXLQNLCGG 188
            ++++ V K+G G Y  V++  +    E                         L      
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-YPTLSDYD---VRYYIYELLKALDYC 244
           PNIVKLLD++  +      L+FE ++    K +    L+      ++ Y+++LL+ L +C
Sbjct: 62  PNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDL 303
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  
Sbjct: 120 HSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 178
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363
           + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM--- 234
Query: 364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
           P       + +R+ +SK +   ++     +    L ++L YD  +R +AK A+AHP+F
Sbjct: 235 PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  124 bits (312), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 150/298 (50%), Gaps = 21/298 (7%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXX----XXXXXXXXLQNLCGG 188
            ++++ V K+G G Y  V++  +    E                         L      
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-YPTLSDYD---VRYYIYELLKALDYC 244
           PNIVKLLD++  +      L+FE ++    K +    L+      ++ Y+++LL+ L +C
Sbjct: 61  PNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDL 303
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  
Sbjct: 119 HSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363
           + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM--- 233
Query: 364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
           P       + +R+ +SK +   ++     +    L ++L YD  +R +AK A+AHP+F
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  124 bits (312), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 149/298 (50%), Gaps = 21/298 (7%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXX----XXXXXXXXXXXXXXXLQNLCGG 188
            ++++ V K+G G Y  V++  +    E                         L      
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-YPTLSDYD---VRYYIYELLKALDYC 244
           PNIVKLLD++  +      L+FE ++    K +    L+      ++ Y+++LL+ L +C
Sbjct: 62  PNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDL 303
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  
Sbjct: 120 HSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 178
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363
           + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM--- 234
Query: 364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
           P       + +R+ +SK +   ++     +    L ++L YD  +R +AK A+AHP+F
Sbjct: 235 PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  124 bits (312), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 84/297 (28%), Positives = 149/297 (50%), Gaps = 21/297 (7%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXX----XXXXXXXXXXXXXXXLQNLCGGP 189
           ++++ V K+G G Y  V++  +    E                         L      P
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-YPTLSDYD---VRYYIYELLKALDYCH 245
           NIVKLLD++  +      L+FE ++    K +    L+      ++ Y+++LL+ L +CH
Sbjct: 62  NIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 304
           S  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  +
Sbjct: 120 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   P
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM---P 234
Query: 365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
                  + +R+ +SK +   ++     +    L ++L YD  +R +AK A+AHP+F
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 79/246 (32%), Positives = 130/246 (52%), Gaps = 33/246 (13%)
Query: 190 NIVKLLDIVRDQQS--------KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKAL 241
           N++ LLD+     S           +L+   +NN    V    LSD  V++ +Y+LL+ L
Sbjct: 88  NVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNI---VKSQALSDEHVQFLVYQLLRGL 144
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 301
            Y HS GI+HRD+KP NV ++ E  +LR++D+GLA      +E    VA+R+++ PE+++
Sbjct: 145 KYIHSAGIIHRDLKPSNVAVN-EDSELRILDFGLAR--QADEEMTGYVATRWYRAPEIML 201
Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 361
           +   Y+ ++D+WS+GC+ A ++ + +  F G D  DQL +I +V+GT             
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELL-QGKALFPGSDYIDQLKRIMEVVGTPSPEV-------- 252
Query: 362 LDPHLAALVGRHSRKPWSKFITVENQHL------AVPEAVDFLDKLLRYDHQERPTAKEA 415
               LA +   H+R        +  + L      A P A+D L ++L  D  +R +A EA
Sbjct: 253 ----LAKISSEHARTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEA 308
Query: 416 MAHPYF 421
           +AH YF
Sbjct: 309 LAHAYF 314

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 149/298 (50%), Gaps = 21/298 (7%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXX----XXXXXXXXLQNLCGG 188
            ++++ V K+G G Y  V++  +    E                         L      
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-YPTLSDYD---VRYYIYELLKALDYC 244
           PNIVKLLD++  +      L+FE ++    K +    L+      ++ Y+++LL+ L +C
Sbjct: 62  PNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDL 303
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  
Sbjct: 120 HSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 178
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363
           + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM--- 234
Query: 364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
           P       + +R+ +SK +   ++     +    L ++L YD  +R +AK A+AHP+F
Sbjct: 235 PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 149/298 (50%), Gaps = 21/298 (7%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXX----XXXXXXXXXXXXXXXLQNLCGG 188
            ++++ V K+G G Y  V++  +    E                         L      
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-YPTLSDYD---VRYYIYELLKALDYC 244
           PNIVKLLD++  +      L+FE ++    K +    L+      ++ Y+++LL+ L +C
Sbjct: 62  PNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDL 303
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  
Sbjct: 120 HSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 178
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363
           + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM--- 234
Query: 364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
           P       + +R+ +SK +   ++     +    L ++L YD  +R +AK A+AHP+F
Sbjct: 235 PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 149/298 (50%), Gaps = 21/298 (7%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXX----XXXXXXXXXXXXXXXLQNLCGG 188
            ++++ V K+G G Y  V++  +    E                         L      
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-YPTLSDYD---VRYYIYELLKALDYC 244
           PNIVKLLD++  +      L+FE ++    K +    L+      ++ Y+++LL+ L +C
Sbjct: 62  PNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDL 303
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  
Sbjct: 120 HSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 178
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363
           + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM--- 234
Query: 364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
           P       + +R+ +SK +   ++     +    L ++L YD  +R +AK A+AHP+F
Sbjct: 235 PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 149/298 (50%), Gaps = 21/298 (7%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXX----XXXXXXXXLQNLCGG 188
            ++++ V K+G G Y  V++  +    E                         L      
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-YPTLSDYD---VRYYIYELLKALDYC 244
           PNIVKLLD++  +      L+FE ++    K +    L+      ++ Y+++LL+ L +C
Sbjct: 61  PNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDL 303
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  
Sbjct: 119 HSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 177
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363
           + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM--- 233
Query: 364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
           P       + +R+ +SK +   ++     +    L ++L YD  +R +AK A+AHP+F
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 79/246 (32%), Positives = 130/246 (52%), Gaps = 33/246 (13%)
Query: 190 NIVKLLDIVRDQQS--------KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKAL 241
           N++ LLD+     S           +L+   +NN    V    LSD  V++ +Y+LL+ L
Sbjct: 88  NVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNI---VKCQALSDEHVQFLVYQLLRGL 144
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 301
            Y HS GI+HRD+KP NV ++ E  +LR++D+GLA      +E    VA+R+++ PE+++
Sbjct: 145 KYIHSAGIIHRDLKPSNVAVN-EDSELRILDFGLAR--QADEEMTGYVATRWYRAPEIML 201
Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 361
           +   Y+ ++D+WS+GC+ A ++ + +  F G D  DQL +I +V+GT             
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELL-QGKALFPGSDYIDQLKRIMEVVGTPSPEV-------- 252
Query: 362 LDPHLAALVGRHSRKPWSKFITVENQHL------AVPEAVDFLDKLLRYDHQERPTAKEA 415
               LA +   H+R        +  + L      A P A+D L ++L  D  +R +A EA
Sbjct: 253 ----LAKISSEHARTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEA 308
Query: 416 MAHPYF 421
           +AH YF
Sbjct: 309 LAHAYF 314

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 149/298 (50%), Gaps = 21/298 (7%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXX----XXXXXXXXXXXXXXXLQNLCGG 188
            ++++ V K+G G Y  V++  +    E                         L      
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-YPTLSDYD---VRYYIYELLKALDYC 244
           PNIVKLLD++  +      L+FE ++    K +    L+      ++ Y+++LL+ L +C
Sbjct: 61  PNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDL 303
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  
Sbjct: 119 HSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 177
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363
           + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM--- 233
Query: 364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
           P       + +R+ +SK +   ++     +    L ++L YD  +R +AK A+AHP+F
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 84/297 (28%), Positives = 149/297 (50%), Gaps = 21/297 (7%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXX----XXXXXXXXLQNLCGGP 189
           ++++ V K+G G Y  V++  +    E                         L      P
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-YPTLSDYD---VRYYIYELLKALDYCH 245
           NIVKLLD++  +      L+FE ++    K +    L+      ++ Y+++LL+ L +CH
Sbjct: 63  NIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 304
           S  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  +
Sbjct: 121 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   P
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM---P 235
Query: 365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
                  + +R+ +SK +   ++     +    L ++L YD  +R +AK A+AHP+F
Sbjct: 236 DYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 79/246 (32%), Positives = 130/246 (52%), Gaps = 33/246 (13%)
Query: 190 NIVKLLDIVRDQQS--------KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKAL 241
           N++ LLD+     S           +L+   +NN    V    LSD  V++ +Y+LL+ L
Sbjct: 80  NVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNI---VKCQALSDEHVQFLVYQLLRGL 136
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 301
            Y HS GI+HRD+KP NV ++ E  +LR++D+GLA      +E    VA+R+++ PE+++
Sbjct: 137 KYIHSAGIIHRDLKPSNVAVN-EDCELRILDFGLAR--QADEEMTGYVATRWYRAPEIML 193
Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 361
           +   Y+ ++D+WS+GC+ A ++ + +  F G D  DQL +I +V+GT             
Sbjct: 194 NWMHYNQTVDIWSVGCIMAELL-QGKALFPGSDYIDQLKRIMEVVGTPSPEV-------- 244
Query: 362 LDPHLAALVGRHSRKPWSKFITVENQHL------AVPEAVDFLDKLLRYDHQERPTAKEA 415
               LA +   H+R        +  + L      A P A+D L ++L  D  +R +A EA
Sbjct: 245 ----LAKISSEHARTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEA 300
Query: 416 MAHPYF 421
           +AH YF
Sbjct: 301 LAHAYF 306

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 82/258 (31%), Positives = 138/258 (53%), Gaps = 43/258 (16%)
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP-------------TLSDYDVRYYIYE 236
           N++ LLD+       TP    +  + TDF ++ P              L +  +++ +Y+
Sbjct: 85  NVIGLLDVF------TPDETLD--DFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQ 136
Query: 237 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 296
           +LK L Y H+ GI+HRD+KP N+ ++ E  +L+++D+GLA       E    V +R+++ 
Sbjct: 137 MLKGLRYIHAAGIIHRDLKPGNLAVN-EDCELKILDFGLAR--QADSEMXGXVVTRWYRA 193
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT------DE 350
           PE++++   Y  ++D+WS+GC+ A MI  K   F G D+ DQL +I KV GT        
Sbjct: 194 PEVILNWMRYTQTVDIWSVGCIMAEMITGKT-LFKGSDHLDQLKEIMKVTGTPPAEFVQR 252
Query: 351 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP 410
           L +   K +++  P L        +K ++  +T      A P AV+ L+K+L  D ++R 
Sbjct: 253 LQSDEAKNYMKGLPEL-------EKKDFASILTN-----ASPLAVNLLEKMLVLDAEQRV 300
Query: 411 TAKEAMAHPYFFPIRNAE 428
           TA EA+AHPYF  + + E
Sbjct: 301 TAGEALAHPYFESLHDTE 318

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 88/299 (29%), Positives = 146/299 (48%), Gaps = 29/299 (9%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQNLC-----GGPN 190
           YE + K+G G Y  VF+  +   +E                     L+ +C        N
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA-LREICLLKELKHKN 62
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD---VRYYIYELLKALDYCHSQ 247
           IV+L D++   +  T  L+FE  +    K       D D   V+ ++++LLK L +CHS+
Sbjct: 63  IVRLHDVLHSDKKLT--LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQDY 306
            ++HRD+KP N++I+    +L+L D+GLA  F  P + Y+  V + +++ P++L   + Y
Sbjct: 121 NVLHRDLKPQNLLINRNG-ELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 307 DYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL 366
             S+D+WS GC+FA +     P F G+D  DQL +I ++LGT     +         P +
Sbjct: 180 STSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQW---------PSM 230
Query: 367 AALVGRHSRKPWSKFITVENQHLAVPE----AVDFLDKLLRYDHQERPTAKEAMAHPYF 421
             L      KP+  +    +    VP+      D L  LL+ +  +R +A+EA+ HPYF
Sbjct: 231 TKL---PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 79/243 (32%), Positives = 130/243 (53%), Gaps = 27/243 (11%)
Query: 190 NIVKLLDIVRDQQSKTPSLIFE---------HVNNTDFK--VLYPTLSDYDVRYYIYELL 238
           N++ LLD+       TP+   E         H+   D    V    L+D  V++ IY++L
Sbjct: 111 NVIGLLDVF------TPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 164
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
           + L Y HS  I+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+R+++ PE
Sbjct: 165 RGLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPE 221
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 358
           ++++   Y+ ++D+WS+GC+ A ++  +   F G D+ +QL +I ++ GT   +      
Sbjct: 222 IMLNWMHYNMTVDIWSVGCIMAELLTGRT-LFPGTDHINQLQQIMRLTGTPPASVISRMP 280
Query: 359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
             E   ++ +L     R     FI       A P AVD L+K+L  D  +R TA EA+AH
Sbjct: 281 SHEARNYINSLPQMPKRNFADVFIG------ANPLAVDLLEKMLVLDTDKRITASEALAH 334
Query: 419 PYF 421
           PYF
Sbjct: 335 PYF 337

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 87/299 (29%), Positives = 146/299 (48%), Gaps = 29/299 (9%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQNLC-----GGPN 190
           YE + K+G G Y  VF+  +   +E                     L+ +C        N
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA-LREICLLKELKHKN 62
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD---VRYYIYELLKALDYCHSQ 247
           IV+L D++   +  T  L+FE  +    K       D D   V+ ++++LLK L +CHS+
Sbjct: 63  IVRLHDVLHSDKKLT--LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQDY 306
            ++HRD+KP N++I+    +L+L ++GLA  F  P + Y+  V + +++ P++L   + Y
Sbjct: 121 NVLHRDLKPQNLLINRNG-ELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 307 DYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL 366
             S+D+WS GC+FA +     P F G+D  DQL +I ++LGT     +         P +
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW---------PSM 230
Query: 367 AALVGRHSRKPWSKFITVENQHLAVPE----AVDFLDKLLRYDHQERPTAKEAMAHPYF 421
             L      KP+  +    +    VP+      D L  LL+ +  +R +A+EA+ HPYF
Sbjct: 231 TKL---PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 73/243 (30%), Positives = 138/243 (56%), Gaps = 22/243 (9%)
Query: 190 NIVKLLDIVRDQ--QSKTPSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYCH 245
           N++ + DI+R    ++     I + +  TD   L  +  LS+  + Y++Y++L+ L Y H
Sbjct: 102 NVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIH 161
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 301
           S  ++HRD+KP N++I+     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 162 SANVLHRDLKPSNLLIN-TTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIML 220
Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---DELNAYLNKY 358
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N  
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN-- 277
Query: 359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
            ++   +L +L  + ++  W+K     +      +A+D LD++L ++  +R T +EA+AH
Sbjct: 278 -MKARNYLQSLPSK-TKVAWAKLFPKSDS-----KALDLLDRMLTFNPNKRITVEEALAH 330
Query: 419 PYF 421
           PY 
Sbjct: 331 PYL 333

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 85/301 (28%), Positives = 144/301 (47%), Gaps = 28/301 (9%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQNLC--------G 187
           YE V ++G G Y +VF+     +                       ++ +          
Sbjct: 13  YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 72
Query: 188 GPNIVKLLDIV---RDQQSKTPSLIFEHVNN--TDF--KVLYPTLSDYDVRYYIYELLKA 240
            PN+V+L D+    R  +    +L+FEHV+   T +  KV  P +    ++  +++LL+ 
Sbjct: 73  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 132
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 300
           LD+ HS  ++HRD+KP N+++     +++L D+GLA  Y         V + +++ PE+L
Sbjct: 133 LDFLHSHRVVHRDLKPQNILVTSSG-QIKLADFGLARIYSFQMALTSVVVTLWYRAPEVL 191
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 360
           +    Y   +DLWS+GC+FA M FR++P F G  + DQL KI  V+G      +     +
Sbjct: 192 LQ-SSYATPVDLWSVGCIFAEM-FRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 249
Query: 361 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 420
              P  A      S +P  KF+T  ++        D L K L ++  +R +A  A++HPY
Sbjct: 250 ---PRQA--FHSKSAQPIEKFVTDIDEL-----GKDLLLKCLTFNPAKRISAYSALSHPY 299
Query: 421 F 421
           F
Sbjct: 300 F 300

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 85/301 (28%), Positives = 144/301 (47%), Gaps = 28/301 (9%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQNLC--------G 187
           YE V ++G G Y +VF+     +                       ++ +          
Sbjct: 13  YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 72
Query: 188 GPNIVKLLDIV---RDQQSKTPSLIFEHVNN--TDF--KVLYPTLSDYDVRYYIYELLKA 240
            PN+V+L D+    R  +    +L+FEHV+   T +  KV  P +    ++  +++LL+ 
Sbjct: 73  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 132
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 300
           LD+ HS  ++HRD+KP N+++     +++L D+GLA  Y         V + +++ PE+L
Sbjct: 133 LDFLHSHRVVHRDLKPQNILVTSSG-QIKLADFGLARIYSFQMALTSVVVTLWYRAPEVL 191
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 360
           +    Y   +DLWS+GC+FA M FR++P F G  + DQL KI  V+G      +     +
Sbjct: 192 LQ-SSYATPVDLWSVGCIFAEM-FRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 249
Query: 361 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 420
              P  A      S +P  KF+T  ++        D L K L ++  +R +A  A++HPY
Sbjct: 250 ---PRQA--FHSKSAQPIEKFVTDIDEL-----GKDLLLKCLTFNPAKRISAYSALSHPY 299
Query: 421 F 421
           F
Sbjct: 300 F 300

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 85/301 (28%), Positives = 144/301 (47%), Gaps = 28/301 (9%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQNLC--------G 187
           YE V ++G G Y +VF+     +                       ++ +          
Sbjct: 13  YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 72
Query: 188 GPNIVKLLDIV---RDQQSKTPSLIFEHVNN--TDF--KVLYPTLSDYDVRYYIYELLKA 240
            PN+V+L D+    R  +    +L+FEHV+   T +  KV  P +    ++  +++LL+ 
Sbjct: 73  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 132
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 300
           LD+ HS  ++HRD+KP N+++     +++L D+GLA  Y         V + +++ PE+L
Sbjct: 133 LDFLHSHRVVHRDLKPQNILVTSSG-QIKLADFGLARIYSFQMALTSVVVTLWYRAPEVL 191
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 360
           +    Y   +DLWS+GC+FA M FR++P F G  + DQL KI  V+G      +     +
Sbjct: 192 LQ-SSYATPVDLWSVGCIFAEM-FRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 249
Query: 361 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 420
              P  A      S +P  KF+T  ++        D L K L ++  +R +A  A++HPY
Sbjct: 250 ---PRQA--FHSKSAQPIEKFVTDIDEL-----GKDLLLKCLTFNPAKRISAYSALSHPY 299
Query: 421 F 421
           F
Sbjct: 300 F 300

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 66/196 (33%), Positives = 112/196 (57%), Gaps = 12/196 (6%)
Query: 230 VRYYIYELLKALDYCH--SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV 287
           ++ ++++L++++   H  S  + HRD+KPHNV+++     L+L D+G A+   P +    
Sbjct: 131 IKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA 190
Query: 288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG 347
            + SRY++ PEL+   Q Y  ++D+WS+GC+FA M+   EP F G ++  QL +I +VLG
Sbjct: 191 YICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMML-GEPIFRGDNSAGQLHEIVRVLG 249
Query: 348 --TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYD 405
             + E+   LN  H ++D + +  +      PWS   + ++      EA D L  LL+Y 
Sbjct: 250 CPSREVLRKLNPSHTDVDLYNSKGI------PWSNVFS-DHSLKDAKEAYDLLSALLQYL 302
Query: 406 HQERPTAKEAMAHPYF 421
            +ER    EA+ HPYF
Sbjct: 303 PEERMKPYEALCHPYF 318

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  118 bits (296), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 75/244 (30%), Positives = 139/244 (56%), Gaps = 24/244 (9%)
Query: 190 NIVKLLDIVRD---QQSKTPSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYC 244
           NI+ + DI+R    +Q K   L+  H+   D   L  T  LS+  + Y++Y++L+ L Y 
Sbjct: 102 NIIGINDIIRAPTIEQMKDVYLV-THLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYI 160
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELL 300
           HS  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE++
Sbjct: 161 HSANVLHRDLKPSNLLLN-TTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 219
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---DELNAYLNK 357
           ++ + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N 
Sbjct: 220 LNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN- 277
Query: 358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 417
             ++   +L +L  + ++ PW++     +      +A+D LDK+L ++  +R   ++A+A
Sbjct: 278 --LKARNYLLSLPHK-NKVPWNRLFPNADS-----KALDLLDKMLTFNPHKRIEVEQALA 329
Query: 418 HPYF 421
           HPY 
Sbjct: 330 HPYL 333

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 75/244 (30%), Positives = 139/244 (56%), Gaps = 24/244 (9%)
Query: 190 NIVKLLDIVRD---QQSKTPSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYC 244
           NI+ + DI+R    +Q K    I + +  TD   L  T  LS+  + Y++Y++L+ L Y 
Sbjct: 86  NIIGINDIIRAPTIEQMKD-VYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 144
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELL 300
           HS  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE++
Sbjct: 145 HSANVLHRDLKPSNLLLN-TTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---DELNAYLNK 357
           ++ + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N 
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN- 261
Query: 358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 417
             ++   +L +L  + ++ PW++     +      +A+D LDK+L ++  +R   ++A+A
Sbjct: 262 --LKARNYLLSLPHK-NKVPWNRLFPNADS-----KALDLLDKMLTFNPHKRIEVEQALA 313
Query: 418 HPYF 421
           HPY 
Sbjct: 314 HPYL 317

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 75/244 (30%), Positives = 139/244 (56%), Gaps = 24/244 (9%)
Query: 190 NIVKLLDIVRD---QQSKTPSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYC 244
           NI+ + DI+R    +Q K    I + +  TD   L  T  LS+  + Y++Y++L+ L Y 
Sbjct: 82  NIIGINDIIRAPTIEQMKD-VYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 140
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELL 300
           HS  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE++
Sbjct: 141 HSANVLHRDLKPSNLLLN-TTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---DELNAYLNK 357
           ++ + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N 
Sbjct: 200 LNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN- 257
Query: 358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 417
             ++   +L +L  + ++ PW++     +      +A+D LDK+L ++  +R   ++A+A
Sbjct: 258 --LKARNYLLSLPHK-NKVPWNRLFPNADS-----KALDLLDKMLTFNPHKRIEVEQALA 309
Query: 418 HPYF 421
           HPY 
Sbjct: 310 HPYL 313

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 75/244 (30%), Positives = 139/244 (56%), Gaps = 24/244 (9%)
Query: 190 NIVKLLDIVRD---QQSKTPSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYC 244
           NI+ + DI+R    +Q K    I + +  TD   L  T  LS+  + Y++Y++L+ L Y 
Sbjct: 86  NIIGINDIIRAPTIEQMKD-VYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 144
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN----VRVASRYFKGPELL 300
           HS  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE++
Sbjct: 145 HSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIM 203
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---DELNAYLNK 357
           ++ + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N 
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN- 261
Query: 358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 417
             ++   +L +L  + ++ PW++     +      +A+D LDK+L ++  +R   ++A+A
Sbjct: 262 --LKARNYLLSLPHK-NKVPWNRLFPNADS-----KALDLLDKMLTFNPHKRIEVEQALA 313
Query: 418 HPYF 421
           HPY 
Sbjct: 314 HPYL 317

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 75/244 (30%), Positives = 139/244 (56%), Gaps = 24/244 (9%)
Query: 190 NIVKLLDIVRD---QQSKTPSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYC 244
           NI+ + DI+R    +Q K    I + +  TD   L  T  LS+  + Y++Y++L+ L Y 
Sbjct: 87  NIIGINDIIRAPTIEQMKD-VYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 145
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN----VRVASRYFKGPELL 300
           HS  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE++
Sbjct: 146 HSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIM 204
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---DELNAYLNK 357
           ++ + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N 
Sbjct: 205 LNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN- 262
Query: 358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 417
             ++   +L +L  + ++ PW++     +      +A+D LDK+L ++  +R   ++A+A
Sbjct: 263 --LKARNYLLSLPHK-NKVPWNRLFPNADS-----KALDLLDKMLTFNPHKRIEVEQALA 314
Query: 418 HPYF 421
           HPY 
Sbjct: 315 HPYL 318

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 74/240 (30%), Positives = 132/240 (55%), Gaps = 21/240 (8%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 148
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+R+++ PE++++  
Sbjct: 149 HSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTADEMTGYVATRWYRAPEIMLNWM 205
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT            EL  
Sbjct: 206 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTP---------GAELLK 255
Query: 365 HLAALVGRHSRKPWSKFITVENQHL---AVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            +++   R+  +  ++   +   ++   A P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 75/244 (30%), Positives = 139/244 (56%), Gaps = 24/244 (9%)
Query: 190 NIVKLLDIVRD---QQSKTPSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYC 244
           NI+ + DI+R    +Q K    I + +  TD   L  T  LS+  + Y++Y++L+ L Y 
Sbjct: 86  NIIGINDIIRAPTIEQMKD-VYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 144
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELL 300
           HS  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE++
Sbjct: 145 HSANVLHRDLKPSNLLLN-TTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---DELNAYLNK 357
           ++ + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N 
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN- 261
Query: 358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 417
             ++   +L +L  + ++ PW++     +      +A+D LDK+L ++  +R   ++A+A
Sbjct: 262 --LKARNYLLSLPHK-NKVPWNRLFPNADS-----KALDLLDKMLTFNPHKRIEVEQALA 313
Query: 418 HPYF 421
           HPY 
Sbjct: 314 HPYL 317

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 75/244 (30%), Positives = 139/244 (56%), Gaps = 24/244 (9%)
Query: 190 NIVKLLDIVRD---QQSKTPSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYC 244
           NI+ + DI+R    +Q K    I + +  TD   L  T  LS+  + Y++Y++L+ L Y 
Sbjct: 84  NIIGINDIIRAPTIEQMKD-VYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 142
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELL 300
           HS  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE++
Sbjct: 143 HSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 201
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---DELNAYLNK 357
           ++ + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N 
Sbjct: 202 LNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN- 259
Query: 358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 417
             ++   +L +L  + ++ PW++     +      +A+D LDK+L ++  +R   ++A+A
Sbjct: 260 --LKARNYLLSLPHK-NKVPWNRLFPNADS-----KALDLLDKMLTFNPHKRIEVEQALA 311
Query: 418 HPYF 421
           HPY 
Sbjct: 312 HPYL 315

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 75/244 (30%), Positives = 139/244 (56%), Gaps = 24/244 (9%)
Query: 190 NIVKLLDIVRD---QQSKTPSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYC 244
           NI+ + DI+R    +Q K    I + +  TD   L  T  LS+  + Y++Y++L+ L Y 
Sbjct: 84  NIIGINDIIRAPTIEQMKD-VYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 142
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELL 300
           HS  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE++
Sbjct: 143 HSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 201
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---DELNAYLNK 357
           ++ + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N 
Sbjct: 202 LNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN- 259
Query: 358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 417
             ++   +L +L  + ++ PW++     +      +A+D LDK+L ++  +R   ++A+A
Sbjct: 260 --LKARNYLLSLPHK-NKVPWNRLFPNADS-----KALDLLDKMLTFNPHKRIEVEQALA 311
Query: 418 HPYF 421
           HPY 
Sbjct: 312 HPYL 315

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 75/244 (30%), Positives = 139/244 (56%), Gaps = 24/244 (9%)
Query: 190 NIVKLLDIVRD---QQSKTPSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYC 244
           NI+ + DI+R    +Q K    I + +  TD   L  T  LS+  + Y++Y++L+ L Y 
Sbjct: 84  NIIGINDIIRAPTIEQMKD-VYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 142
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELL 300
           HS  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE++
Sbjct: 143 HSANVLHRDLKPSNLLLN-TTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 201
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---DELNAYLNK 357
           ++ + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N 
Sbjct: 202 LNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCGIN- 259
Query: 358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 417
             ++   +L +L  + ++ PW++     +      +A+D LDK+L ++  +R   ++A+A
Sbjct: 260 --LKARNYLLSLPHK-NKVPWNRLFPNADS-----KALDLLDKMLTFNPHKRIEVEQALA 311
Query: 418 HPYF 421
           HPY 
Sbjct: 312 HPYL 315

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 75/244 (30%), Positives = 139/244 (56%), Gaps = 24/244 (9%)
Query: 190 NIVKLLDIVRD---QQSKTPSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYC 244
           NI+ + DI+R    +Q K    I + +  TD   L  T  LS+  + Y++Y++L+ L Y 
Sbjct: 86  NIIGINDIIRAPTIEQMKD-VYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 144
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELL 300
           HS  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE++
Sbjct: 145 HSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---DELNAYLNK 357
           ++ + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N 
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN- 261
Query: 358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 417
             ++   +L +L  + ++ PW++     +      +A+D LDK+L ++  +R   ++A+A
Sbjct: 262 --LKARNYLLSLPHK-NKVPWNRLFPNADS-----KALDLLDKMLTFNPHKRIEVEQALA 313
Query: 418 HPYF 421
           HPY 
Sbjct: 314 HPYL 317

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 75/244 (30%), Positives = 139/244 (56%), Gaps = 24/244 (9%)
Query: 190 NIVKLLDIVRD---QQSKTPSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYC 244
           NI+ + DI+R    +Q K    I + +  TD   L  T  LS+  + Y++Y++L+ L Y 
Sbjct: 102 NIIGINDIIRAPTIEQMKD-VYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 160
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELL 300
           HS  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE++
Sbjct: 161 HSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 219
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---DELNAYLNK 357
           ++ + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N 
Sbjct: 220 LNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN- 277
Query: 358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 417
             ++   +L +L  + ++ PW++     +      +A+D LDK+L ++  +R   ++A+A
Sbjct: 278 --LKARNYLLSLPHK-NKVPWNRLFPNADS-----KALDLLDKMLTFNPHKRIEVEQALA 329
Query: 418 HPYF 421
           HPY 
Sbjct: 330 HPYL 333

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 74/240 (30%), Positives = 132/240 (55%), Gaps = 21/240 (8%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 148
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+R+++ PE++++  
Sbjct: 149 HSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTADEMTGYVATRWYRAPEIMLNWM 205
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT            EL  
Sbjct: 206 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTP---------GAELLK 255
Query: 365 HLAALVGRHSRKPWSKFITVENQHL---AVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            +++   R+  +  ++   +   ++   A P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 75/244 (30%), Positives = 139/244 (56%), Gaps = 24/244 (9%)
Query: 190 NIVKLLDIVRD---QQSKTPSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYC 244
           NI+ + DI+R    +Q K    I + +  TD   L  T  LS+  + Y++Y++L+ L Y 
Sbjct: 82  NIIGINDIIRAPTIEQMKD-VYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 140
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELL 300
           HS  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE++
Sbjct: 141 HSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---DELNAYLNK 357
           ++ + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N 
Sbjct: 200 LNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN- 257
Query: 358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 417
             ++   +L +L  + ++ PW++     +      +A+D LDK+L ++  +R   ++A+A
Sbjct: 258 --LKARNYLLSLPHK-NKVPWNRLFPNADS-----KALDLLDKMLTFNPHKRIEVEQALA 309
Query: 418 HPYF 421
           HPY 
Sbjct: 310 HPYL 313

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 76/244 (31%), Positives = 138/244 (56%), Gaps = 24/244 (9%)
Query: 190 NIVKLLDIVRD---QQSKTPSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYC 244
           NI+ + DI+R    +Q K    I + +  TD   L  T  LS+  + Y++Y++L+ L Y 
Sbjct: 80  NIIGINDIIRAPTIEQMKD-VYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 138
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELL 300
           HS  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE++
Sbjct: 139 HSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 197
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE---LNAYLNK 357
           ++ + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+ E   LN  +N 
Sbjct: 198 LNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPEQEDLNCIIN- 255
Query: 358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 417
             ++   +L +L  + ++ PW++     +      +A+D LDK+L ++  +R   ++A+A
Sbjct: 256 --LKARNYLLSLPHK-NKVPWNRLFPNADS-----KALDLLDKMLTFNPHKRIEVEQALA 307
Query: 418 HPYF 421
           HPY 
Sbjct: 308 HPYL 311

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 75/244 (30%), Positives = 139/244 (56%), Gaps = 24/244 (9%)
Query: 190 NIVKLLDIVRD---QQSKTPSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYC 244
           NI+ + DI+R    +Q K    I + +  TD   L  T  LS+  + Y++Y++L+ L Y 
Sbjct: 87  NIIGINDIIRAPTIEQMKD-VYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 145
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELL 300
           HS  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE++
Sbjct: 146 HSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 204
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---DELNAYLNK 357
           ++ + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N 
Sbjct: 205 LNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN- 262
Query: 358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 417
             ++   +L +L  + ++ PW++     +      +A+D LDK+L ++  +R   ++A+A
Sbjct: 263 --LKARNYLLSLPHK-NKVPWNRLFPNADS-----KALDLLDKMLTFNPHKRIEVEQALA 314
Query: 418 HPYF 421
           HPY 
Sbjct: 315 HPYL 318

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 75/244 (30%), Positives = 139/244 (56%), Gaps = 24/244 (9%)
Query: 190 NIVKLLDIVRD---QQSKTPSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYC 244
           NI+ + DI+R    +Q K    I + +  TD   L  T  LS+  + Y++Y++L+ L Y 
Sbjct: 88  NIIGINDIIRAPTIEQMKD-VYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 146
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELL 300
           HS  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE++
Sbjct: 147 HSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 205
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---DELNAYLNK 357
           ++ + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N 
Sbjct: 206 LNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN- 263
Query: 358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 417
             ++   +L +L  + ++ PW++     +      +A+D LDK+L ++  +R   ++A+A
Sbjct: 264 --LKARNYLLSLPHK-NKVPWNRLFPNADS-----KALDLLDKMLTFNPHKRIEVEQALA 315
Query: 418 HPYF 421
           HPY 
Sbjct: 316 HPYL 319

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 75/244 (30%), Positives = 139/244 (56%), Gaps = 24/244 (9%)
Query: 190 NIVKLLDIVRD---QQSKTPSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYC 244
           NI+ + DI+R    +Q K    I + +  TD   L  T  LS+  + Y++Y++L+ L Y 
Sbjct: 79  NIIGINDIIRAPTIEQMKD-VYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 137
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELL 300
           HS  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE++
Sbjct: 138 HSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 196
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---DELNAYLNK 357
           ++ + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N 
Sbjct: 197 LNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN- 254
Query: 358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 417
             ++   +L +L  + ++ PW++     +      +A+D LDK+L ++  +R   ++A+A
Sbjct: 255 --LKARNYLLSLPHK-NKVPWNRLFPNADS-----KALDLLDKMLTFNPHKRIEVEQALA 306
Query: 418 HPYF 421
           HPY 
Sbjct: 307 HPYL 310

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 75/244 (30%), Positives = 139/244 (56%), Gaps = 24/244 (9%)
Query: 190 NIVKLLDIVRD---QQSKTPSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYC 244
           NI+ + DI+R    +Q K    I + +  TD   L  T  LS+  + Y++Y++L+ L Y 
Sbjct: 86  NIIGINDIIRAPTIEQMKD-VYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 144
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELL 300
           HS  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE++
Sbjct: 145 HSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---DELNAYLNK 357
           ++ + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N 
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN- 261
Query: 358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 417
             ++   +L +L  + ++ PW++     +      +A+D LDK+L ++  +R   ++A+A
Sbjct: 262 --LKARNYLLSLPHK-NKVPWNRLFPNADS-----KALDLLDKMLTFNPHKRIEVEQALA 313
Query: 418 HPYF 421
           HPY 
Sbjct: 314 HPYL 317

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 74/240 (30%), Positives = 132/240 (55%), Gaps = 21/240 (8%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 143
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+R+++ PE++++  
Sbjct: 144 HSADIIHRDLKPSNLAVN-EDSELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 200
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT            EL  
Sbjct: 201 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTP---------GAELLK 250
Query: 365 HLAALVGRHSRKPWSKFITVENQHL---AVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            +++   R+  +  ++   +   ++   A P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 251 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 310

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 74/240 (30%), Positives = 132/240 (55%), Gaps = 21/240 (8%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 148
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+R+++ PE++++  
Sbjct: 149 HSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTADEMTGYVATRWYRAPEIMLNWM 205
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT            EL  
Sbjct: 206 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTP---------GAELLK 255
Query: 365 HLAALVGRHSRKPWSKFITVENQHL---AVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            +++   R+  +  ++   +   ++   A P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 75/244 (30%), Positives = 139/244 (56%), Gaps = 24/244 (9%)
Query: 190 NIVKLLDIVRD---QQSKTPSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYC 244
           NI+ + DI+R    +Q K    I + +  TD   L  T  LS+  + Y++Y++L+ L Y 
Sbjct: 82  NIIGINDIIRAPTIEQMKD-VYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 140
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELL 300
           HS  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE++
Sbjct: 141 HSANVLHRDLKPSNLLLN-TTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---DELNAYLNK 357
           ++ + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N 
Sbjct: 200 LNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNXIIN- 257
Query: 358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 417
             ++   +L +L  + ++ PW++     +      +A+D LDK+L ++  +R   ++A+A
Sbjct: 258 --LKARNYLLSLPHK-NKVPWNRLFPNADS-----KALDLLDKMLTFNPHKRIEVEQALA 309
Query: 418 HPYF 421
           HPY 
Sbjct: 310 HPYL 313

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 75/244 (30%), Positives = 139/244 (56%), Gaps = 24/244 (9%)
Query: 190 NIVKLLDIVRD---QQSKTPSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYC 244
           NI+ + DI+R    +Q K    I + +  TD   L  T  LS+  + Y++Y++L+ L Y 
Sbjct: 80  NIIGINDIIRAPTIEQMKD-VYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 138
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELL 300
           HS  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE++
Sbjct: 139 HSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 197
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---DELNAYLNK 357
           ++ + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N 
Sbjct: 198 LNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN- 255
Query: 358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 417
             ++   +L +L  + ++ PW++     +      +A+D LDK+L ++  +R   ++A+A
Sbjct: 256 --LKARNYLLSLPHK-NKVPWNRLFPNADS-----KALDLLDKMLTFNPHKRIEVEQALA 307
Query: 418 HPYF 421
           HPY 
Sbjct: 308 HPYL 311

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 74/240 (30%), Positives = 132/240 (55%), Gaps = 21/240 (8%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYI 141
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+R+++ PE++++  
Sbjct: 142 HSADIIHRDLKPSNLAVN-EDXELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT            EL  
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTP---------GAELLK 248
Query: 365 HLAALVGRHSRKPWSKFITVENQHL---AVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            +++   R+  +  ++   +   ++   A P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 249 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 74/240 (30%), Positives = 132/240 (55%), Gaps = 21/240 (8%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 93  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 152
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+R+++ PE++++  
Sbjct: 153 HSADIIHRDLKPSNLAVN-EDXELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 209
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT            EL  
Sbjct: 210 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTP---------GAELLK 259
Query: 365 HLAALVGRHSRKPWSKFITVENQHL---AVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            +++   R+  +  ++   +   ++   A P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 260 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 319

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 74/237 (31%), Positives = 128/237 (54%), Gaps = 15/237 (6%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLKYI 137
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+R+++ PE++++  
Sbjct: 138 HSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 194
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT      L K   E   
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 252
Query: 365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
           +    + +  +  ++      N     P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 253 NYIQSLAQMPKMNFANVFIGAN-----PLAVDLLEKMLVLDSDKRITAAQALAHAYF 304

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 74/240 (30%), Positives = 132/240 (55%), Gaps = 21/240 (8%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 147
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+R+++ PE++++  
Sbjct: 148 HSADIIHRDLKPSNLAVN-EDSELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 204
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT            EL  
Sbjct: 205 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTP---------GAELLK 254
Query: 365 HLAALVGRHSRKPWSKFITVENQHL---AVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            +++   R+  +  ++   +   ++   A P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 255 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 314

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 75/244 (30%), Positives = 139/244 (56%), Gaps = 24/244 (9%)
Query: 190 NIVKLLDIVRD---QQSKTPSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYC 244
           NI+ + DI+R    +Q K    I + +  TD   L  T  LS+  + Y++Y++L+ L Y 
Sbjct: 90  NIIGINDIIRAPTIEQMKD-VYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 148
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELL 300
           HS  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE++
Sbjct: 149 HSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 207
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---DELNAYLNK 357
           ++ + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N 
Sbjct: 208 LNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN- 265
Query: 358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 417
             ++   +L +L  + ++ PW++     +      +A+D LDK+L ++  +R   ++A+A
Sbjct: 266 --LKARNYLLSLPHK-NKVPWNRLFPNADS-----KALDLLDKMLTFNPHKRIEVEQALA 317
Query: 418 HPYF 421
           HPY 
Sbjct: 318 HPYL 321

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 75/244 (30%), Positives = 139/244 (56%), Gaps = 24/244 (9%)
Query: 190 NIVKLLDIVRD---QQSKTPSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYC 244
           NI+ + DI+R    +Q K    I + +  TD   L  T  LS+  + Y++Y++L+ L Y 
Sbjct: 82  NIIGINDIIRAPTIEQMKD-VYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 140
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELL 300
           HS  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE++
Sbjct: 141 HSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---DELNAYLNK 357
           ++ + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N 
Sbjct: 200 LNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN- 257
Query: 358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 417
             ++   +L +L  + ++ PW++     +      +A+D LDK+L ++  +R   ++A+A
Sbjct: 258 --LKARNYLLSLPHK-NKVPWNRLFPNADS-----KALDLLDKMLTFNPHKRIEVEQALA 309
Query: 418 HPYF 421
           HPY 
Sbjct: 310 HPYL 313

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 74/240 (30%), Positives = 132/240 (55%), Gaps = 21/240 (8%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 141
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+R+++ PE++++  
Sbjct: 142 HSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGXVATRWYRAPEIMLNWM 198
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT            EL  
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTP---------GAELLK 248
Query: 365 HLAALVGRHSRKPWSKFITVENQHL---AVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            +++   R+  +  ++   +   ++   A P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 249 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 74/240 (30%), Positives = 132/240 (55%), Gaps = 21/240 (8%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 146
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+R+++ PE++++  
Sbjct: 147 HSADIIHRDLKPSNLAVN-EDXELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 203
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT            EL  
Sbjct: 204 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTP---------GAELLK 253
Query: 365 HLAALVGRHSRKPWSKFITVENQHL---AVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            +++   R+  +  ++   +   ++   A P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 254 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 313

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 74/237 (31%), Positives = 128/237 (54%), Gaps = 15/237 (6%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 161
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+R+++ PE++++  
Sbjct: 162 HSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMXGXVATRWYRAPEIMLNWM 218
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT      L K   E   
Sbjct: 219 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 276
Query: 365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
           +    + +  +  ++      N     P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 277 NYIQSLAQMPKMNFANVFIGAN-----PLAVDLLEKMLVLDSDKRITAAQALAHAYF 328

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 74/240 (30%), Positives = 132/240 (55%), Gaps = 21/240 (8%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 146
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+R+++ PE++++  
Sbjct: 147 HSADIIHRDLKPSNLAVN-EDXELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 203
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT            EL  
Sbjct: 204 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTP---------GAELLK 253
Query: 365 HLAALVGRHSRKPWSKFITVENQHL---AVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            +++   R+  +  ++   +   ++   A P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 254 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 313

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 75/244 (30%), Positives = 139/244 (56%), Gaps = 24/244 (9%)
Query: 190 NIVKLLDIVRD---QQSKTPSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYC 244
           NI+ + DI+R    +Q K    I + +  TD   L  T  LS+  + Y++Y++L+ L Y 
Sbjct: 82  NIIGINDIIRAPTIEQMKD-VYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 140
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELL 300
           HS  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE++
Sbjct: 141 HSANVLHRDLKPSNLLLN-TTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---DELNAYLNK 357
           ++ + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N 
Sbjct: 200 LNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNXIIN- 257
Query: 358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 417
             ++   +L +L  + ++ PW++     +      +A+D LDK+L ++  +R   ++A+A
Sbjct: 258 --LKARNYLLSLPHK-NKVPWNRLFPNADS-----KALDLLDKMLTFNPHKRIEVEQALA 309
Query: 418 HPYF 421
           HPY 
Sbjct: 310 HPYL 313

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 74/237 (31%), Positives = 128/237 (54%), Gaps = 15/237 (6%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 161
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+R+++ PE++++  
Sbjct: 162 HSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 218
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT      L K   E   
Sbjct: 219 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 276
Query: 365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
           +    + +  +  ++      N     P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 277 NYIQSLAQMPKMNFANVFIGAN-----PLAVDLLEKMLVLDSDKRITAAQALAHAYF 328

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 74/237 (31%), Positives = 128/237 (54%), Gaps = 15/237 (6%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 141
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+R+++ PE++++  
Sbjct: 142 HSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT      L K   E   
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 256
Query: 365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
           +    + +  +  ++      N     P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 257 NYIQSLAQMPKMNFANVFIGAN-----PLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 74/237 (31%), Positives = 128/237 (54%), Gaps = 15/237 (6%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 92  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 151
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+R+++ PE++++  
Sbjct: 152 HSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 208
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT      L K   E   
Sbjct: 209 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 266
Query: 365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
           +    + +  +  ++      N     P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 267 NYIQSLAQMPKMNFANVFIGAN-----PLAVDLLEKMLVLDSDKRITAAQALAHAYF 318

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 74/240 (30%), Positives = 132/240 (55%), Gaps = 21/240 (8%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 94  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 153
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+R+++ PE++++  
Sbjct: 154 HSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 210
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT            EL  
Sbjct: 211 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTP---------GAELLK 260
Query: 365 HLAALVGRHSRKPWSKFITVENQHL---AVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            +++   R+  +  ++   +   ++   A P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 261 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 320

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 74/240 (30%), Positives = 132/240 (55%), Gaps = 21/240 (8%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 94  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 153
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+R+++ PE++++  
Sbjct: 154 HSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 210
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT            EL  
Sbjct: 211 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTP---------GAELLK 260
Query: 365 HLAALVGRHSRKPWSKFITVENQHL---AVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            +++   R+  +  ++   +   ++   A P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 261 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 320

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 72/243 (29%), Positives = 140/243 (57%), Gaps = 22/243 (9%)
Query: 190 NIVKLLDIVRD---QQSKTPSLIFEHVNNTDFKVLYPT-LSDYDVRYYIYELLKALDYCH 245
           NI+ + DI+R    +Q K   ++ + +    +K+L    LS+  + Y++Y++L+ L Y H
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIH 145
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 301
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 146 SANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---DELNAYLNKY 358
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N  
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN-- 261
Query: 359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
            ++   +L +L  + ++ PW++     +      +A+D LDK+L ++  +R   ++A+AH
Sbjct: 262 -LKARNYLLSLPHK-NKVPWNRLFPNADS-----KALDLLDKMLTFNPHKRIEVEQALAH 314
Query: 419 PYF 421
           PY 
Sbjct: 315 PYL 317

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 74/240 (30%), Positives = 132/240 (55%), Gaps = 21/240 (8%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 94  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 153
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+R+++ PE++++  
Sbjct: 154 HSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 210
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT            EL  
Sbjct: 211 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTP---------GAELLK 260
Query: 365 HLAALVGRHSRKPWSKFITVENQHL---AVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            +++   R+  +  ++   +   ++   A P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 261 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 320

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 74/237 (31%), Positives = 128/237 (54%), Gaps = 15/237 (6%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 101 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 160
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+R+++ PE++++  
Sbjct: 161 HSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 217
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT      L K   E   
Sbjct: 218 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 275
Query: 365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
           +    + +  +  ++      N     P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 276 NYIQSLAQMPKMNFANVFIGAN-----PLAVDLLEKMLVLDSDKRITAAQALAHAYF 327

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 74/240 (30%), Positives = 132/240 (55%), Gaps = 21/240 (8%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 141
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+R+++ PE++++  
Sbjct: 142 HSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNAM 198
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT            EL  
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTP---------GAELLK 248
Query: 365 HLAALVGRHSRKPWSKFITVENQHL---AVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            +++   R+  +  ++   +   ++   A P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 249 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 74/240 (30%), Positives = 132/240 (55%), Gaps = 21/240 (8%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 141
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+R+++ PE++++  
Sbjct: 142 HSADIIHRDLKPSNLAVN-EDCELKILDYGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT            EL  
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTP---------GAELLK 248
Query: 365 HLAALVGRHSRKPWSKFITVENQHL---AVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            +++   R+  +  ++   +   ++   A P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 249 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 74/237 (31%), Positives = 128/237 (54%), Gaps = 15/237 (6%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 137
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+R+++ PE++++  
Sbjct: 138 HSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 194
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT      L K   E   
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 252
Query: 365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
           +    + +  +  ++      N     P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 253 NYIQSLAQMPKMNFANVFIGAN-----PLAVDLLEKMLVLDSDKRITAAQALAHAYF 304

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 74/240 (30%), Positives = 132/240 (55%), Gaps = 21/240 (8%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 141
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+R+++ PE++++  
Sbjct: 142 HSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT            EL  
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTP---------GAELLK 248
Query: 365 HLAALVGRHSRKPWSKFITVENQHL---AVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            +++   R+  +  ++   +   ++   A P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 249 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 74/240 (30%), Positives = 132/240 (55%), Gaps = 21/240 (8%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 161
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+R+++ PE++++  
Sbjct: 162 HSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 218
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT            EL  
Sbjct: 219 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTP---------GAELLK 268
Query: 365 HLAALVGRHSRKPWSKFITVENQHL---AVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            +++   R+  +  ++   +   ++   A P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 269 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 328

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 74/240 (30%), Positives = 132/240 (55%), Gaps = 21/240 (8%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 93  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 152
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+R+++ PE++++  
Sbjct: 153 HSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 209
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT            EL  
Sbjct: 210 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTP---------GAELLK 259
Query: 365 HLAALVGRHSRKPWSKFITVENQHL---AVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            +++   R+  +  ++   +   ++   A P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 260 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 319

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 74/240 (30%), Positives = 132/240 (55%), Gaps = 21/240 (8%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 80  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 139
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+R+++ PE++++  
Sbjct: 140 HSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 196
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT            EL  
Sbjct: 197 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTP---------GAELLK 246
Query: 365 HLAALVGRHSRKPWSKFITVENQHL---AVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            +++   R+  +  ++   +   ++   A P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 247 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 306

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 74/240 (30%), Positives = 132/240 (55%), Gaps = 21/240 (8%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 143
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+R+++ PE++++  
Sbjct: 144 HSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 200
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT            EL  
Sbjct: 201 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTP---------GAELLK 250
Query: 365 HLAALVGRHSRKPWSKFITVENQHL---AVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            +++   R+  +  ++   +   ++   A P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 251 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 310

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 74/240 (30%), Positives = 132/240 (55%), Gaps = 21/240 (8%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 143
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+R+++ PE++++  
Sbjct: 144 HSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 200
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT            EL  
Sbjct: 201 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTP---------GAELLK 250
Query: 365 HLAALVGRHSRKPWSKFITVENQHL---AVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            +++   R+  +  ++   +   ++   A P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 251 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 310

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 74/240 (30%), Positives = 132/240 (55%), Gaps = 21/240 (8%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 105 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 164
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+R+++ PE++++  
Sbjct: 165 HSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 221
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT            EL  
Sbjct: 222 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTP---------GAELLK 271
Query: 365 HLAALVGRHSRKPWSKFITVENQHL---AVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            +++   R+  +  ++   +   ++   A P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 272 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 331

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 74/240 (30%), Positives = 132/240 (55%), Gaps = 21/240 (8%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 141
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+R+++ PE++++  
Sbjct: 142 HSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT            EL  
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTP---------GAELLK 248
Query: 365 HLAALVGRHSRKPWSKFITVENQHL---AVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            +++   R+  +  ++   +   ++   A P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 249 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 74/240 (30%), Positives = 132/240 (55%), Gaps = 21/240 (8%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 148
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+R+++ PE++++  
Sbjct: 149 HSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 205
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT            EL  
Sbjct: 206 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTP---------GAELLK 255
Query: 365 HLAALVGRHSRKPWSKFITVENQHL---AVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            +++   R+  +  ++   +   ++   A P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 74/240 (30%), Positives = 132/240 (55%), Gaps = 21/240 (8%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 141
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+R+++ PE++++  
Sbjct: 142 HSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT            EL  
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTP---------GAELLK 248
Query: 365 HLAALVGRHSRKPWSKFITVENQHL---AVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            +++   R+  +  ++   +   ++   A P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 249 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 74/240 (30%), Positives = 132/240 (55%), Gaps = 21/240 (8%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 141
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+R+++ PE++++  
Sbjct: 142 HSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT            EL  
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTP---------GAELLK 248
Query: 365 HLAALVGRHSRKPWSKFITVENQHL---AVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            +++   R+  +  ++   +   ++   A P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 249 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 74/240 (30%), Positives = 132/240 (55%), Gaps = 21/240 (8%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 141
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+R+++ PE++++  
Sbjct: 142 HSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT            EL  
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTP---------GAELLK 248
Query: 365 HLAALVGRHSRKPWSKFITVENQHL---AVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            +++   R+  +  ++   +   ++   A P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 249 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 74/240 (30%), Positives = 132/240 (55%), Gaps = 21/240 (8%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYI 141
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+R+++ PE++++  
Sbjct: 142 HSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT            EL  
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTP---------GAELLK 248
Query: 365 HLAALVGRHSRKPWSKFITVENQHL---AVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            +++   R+  +  ++   +   ++   A P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 249 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 74/240 (30%), Positives = 132/240 (55%), Gaps = 21/240 (8%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 101 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 160
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+R+++ PE++++  
Sbjct: 161 HSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 217
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT            EL  
Sbjct: 218 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTP---------GAELLK 267
Query: 365 HLAALVGRHSRKPWSKFITVENQHL---AVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            +++   R+  +  ++   +   ++   A P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 268 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 327

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 74/240 (30%), Positives = 132/240 (55%), Gaps = 21/240 (8%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 141
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+R+++ PE++++  
Sbjct: 142 HSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT            EL  
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTP---------GAELLK 248
Query: 365 HLAALVGRHSRKPWSKFITVENQHL---AVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            +++   R+  +  ++   +   ++   A P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 249 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 74/240 (30%), Positives = 132/240 (55%), Gaps = 21/240 (8%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 143
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+R+++ PE++++  
Sbjct: 144 HSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 200
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT            EL  
Sbjct: 201 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTP---------GAELLK 250
Query: 365 HLAALVGRHSRKPWSKFITVENQHL---AVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            +++   R+  +  ++   +   ++   A P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 251 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 310

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 74/240 (30%), Positives = 132/240 (55%), Gaps = 21/240 (8%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 137
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+R+++ PE++++  
Sbjct: 138 HSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 194
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT            EL  
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTP---------GAELLK 244
Query: 365 HLAALVGRHSRKPWSKFITVENQHL---AVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            +++   R+  +  ++   +   ++   A P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 304

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 74/240 (30%), Positives = 132/240 (55%), Gaps = 21/240 (8%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 146
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+R+++ PE++++  
Sbjct: 147 HSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 203
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT            EL  
Sbjct: 204 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTP---------GAELLK 253
Query: 365 HLAALVGRHSRKPWSKFITVENQHL---AVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            +++   R+  +  ++   +   ++   A P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 254 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 313

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 74/240 (30%), Positives = 132/240 (55%), Gaps = 21/240 (8%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 105 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 164
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+R+++ PE++++  
Sbjct: 165 HSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMXGYVATRWYRAPEIMLNWM 221
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT            EL  
Sbjct: 222 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTP---------GAELLK 271
Query: 365 HLAALVGRHSRKPWSKFITVENQHL---AVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            +++   R+  +  ++   +   ++   A P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 272 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 331

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 74/240 (30%), Positives = 132/240 (55%), Gaps = 21/240 (8%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 81  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 140
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+R+++ PE++++  
Sbjct: 141 HSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 197
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT            EL  
Sbjct: 198 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTP---------GAELLK 247
Query: 365 HLAALVGRHSRKPWSKFITVENQHL---AVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            +++   R+  +  ++   +   ++   A P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 248 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 307

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 74/240 (30%), Positives = 132/240 (55%), Gaps = 21/240 (8%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 141
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+R+++ PE++++  
Sbjct: 142 HSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT            EL  
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTP---------GAELLK 248
Query: 365 HLAALVGRHSRKPWSKFITVENQHL---AVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            +++   R+  +  ++   +   ++   A P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 249 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 74/240 (30%), Positives = 132/240 (55%), Gaps = 21/240 (8%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 79  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 138
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+R+++ PE++++  
Sbjct: 139 HSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 195
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT            EL  
Sbjct: 196 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTP---------GAELLK 245
Query: 365 HLAALVGRHSRKPWSKFITVENQHL---AVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            +++   R+  +  ++   +   ++   A P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 246 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 305

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 74/240 (30%), Positives = 132/240 (55%), Gaps = 21/240 (8%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 147
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+R+++ PE++++  
Sbjct: 148 HSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 204
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT            EL  
Sbjct: 205 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTP---------GAELLK 254
Query: 365 HLAALVGRHSRKPWSKFITVENQHL---AVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            +++   R+  +  ++   +   ++   A P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 255 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 314

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 74/240 (30%), Positives = 132/240 (55%), Gaps = 21/240 (8%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 146
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+R+++ PE++++  
Sbjct: 147 HSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 203
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT            EL  
Sbjct: 204 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTP---------GAELLK 253
Query: 365 HLAALVGRHSRKPWSKFITVENQHL---AVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            +++   R+  +  ++   +   ++   A P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 254 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 313

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 74/237 (31%), Positives = 128/237 (54%), Gaps = 15/237 (6%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 147
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+R+++ PE++++  
Sbjct: 148 HSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 204
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT      L K   E   
Sbjct: 205 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 262
Query: 365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
           +    + +  +  ++      N     P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 263 NYIQSLAQMPKMNFANVFIGAN-----PLAVDLLEKMLVLDSDKRITAAQALAHAYF 314

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 74/240 (30%), Positives = 132/240 (55%), Gaps = 21/240 (8%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 79  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 138
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+R+++ PE++++  
Sbjct: 139 HSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 195
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT            EL  
Sbjct: 196 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTP---------GAELLK 245
Query: 365 HLAALVGRHSRKPWSKFITVENQHL---AVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            +++   R+  +  ++   +   ++   A P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 246 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 305

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 74/237 (31%), Positives = 128/237 (54%), Gaps = 15/237 (6%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 141
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+R+++ PE++++  
Sbjct: 142 HSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMAGFVATRWYRAPEIMLNWM 198
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT      L K   E   
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 256
Query: 365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
           +    + +  +  ++      N     P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 257 NYIQSLAQMPKMNFANVFIGAN-----PLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 72/240 (30%), Positives = 132/240 (55%), Gaps = 21/240 (8%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D   +  +  L+D  V++ IY++L+ L Y 
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYI 141
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D+GL    H   E    VA+R+++ PE++++  
Sbjct: 142 HSADIIHRDLKPSNLAVN-EDSELKILDFGLCR--HTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT            EL  
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTP---------GAELLK 248
Query: 365 HLAALVGRHSRKPWSKFITVENQHL---AVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            +++   R+  +  ++   +   ++   A P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 249 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 74/237 (31%), Positives = 128/237 (54%), Gaps = 15/237 (6%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 137
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+R+++ PE++++  
Sbjct: 138 HSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMAGFVATRWYRAPEIMLNWM 194
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT      L K   E   
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 252
Query: 365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
           +    + +  +  ++      N     P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 253 NYIQSLAQMPKMNFANVFIGAN-----PLAVDLLEKMLVLDSDKRITAAQALAHAYF 304

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  114 bits (286), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 74/240 (30%), Positives = 132/240 (55%), Gaps = 21/240 (8%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 147
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+R+++ PE++++  
Sbjct: 148 HSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 204
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT            EL  
Sbjct: 205 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTPG---------AELLK 254
Query: 365 HLAALVGRHSRKPWSKFITVENQHL---AVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            +++   R+  +  ++   +   ++   A P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 255 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 314

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  114 bits (286), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 74/240 (30%), Positives = 132/240 (55%), Gaps = 21/240 (8%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 141
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+R+++ PE++++  
Sbjct: 142 HSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMAGFVATRWYRAPEIMLNWM 198
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT            EL  
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTP---------GAELLK 248
Query: 365 HLAALVGRHSRKPWSKFITVENQHL---AVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            +++   R+  +  ++   +   ++   A P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 249 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  114 bits (285), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 74/240 (30%), Positives = 131/240 (54%), Gaps = 21/240 (8%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 141
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D GLA   H   E    VA+R+++ PE++++  
Sbjct: 142 HSADIIHRDLKPSNLAVN-EDCELKILDGGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT            EL  
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTP---------GAELLK 248
Query: 365 HLAALVGRHSRKPWSKFITVENQHL---AVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            +++   R+  +  ++   +   ++   A P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 249 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 74/240 (30%), Positives = 131/240 (54%), Gaps = 21/240 (8%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 141
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D GLA   H   E    VA+R+++ PE++++  
Sbjct: 142 HSADIIHRDLKPSNLAVN-EDCELKILDAGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT            EL  
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTP---------GAELLK 248
Query: 365 HLAALVGRHSRKPWSKFITVENQHL---AVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            +++   R+  +  ++   +   ++   A P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 249 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 74/240 (30%), Positives = 131/240 (54%), Gaps = 21/240 (8%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 141
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D GLA   H   E    VA+R+++ PE++++  
Sbjct: 142 HSADIIHRDLKPSNLAVN-EDCELKILDRGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT            EL  
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTP---------GAELLK 248
Query: 365 HLAALVGRHSRKPWSKFITVENQHL---AVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            +++   R+  +  ++   +   ++   A P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 249 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 73/240 (30%), Positives = 131/240 (54%), Gaps = 21/240 (8%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 141
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++ +GLA   H   E    VA+R+++ PE++++  
Sbjct: 142 HSADIIHRDLKPSNLAVN-EDCELKILGFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT            EL  
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTP---------GAELLK 248
Query: 365 HLAALVGRHSRKPWSKFITVENQHL---AVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            +++   R+  +  ++   +   ++   A P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 249 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 85/307 (27%), Positives = 155/307 (50%), Gaps = 37/307 (12%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDN---EXXXXXXXXXXXXXXXXXXXXXLQNLCGGPNIV 192
           ++ + K+G G Y+ V++G++ T                           L       NIV
Sbjct: 7   FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIV 66
Query: 193 KLLDIVRDQQSKTPSLIFEHVNN-----TDFKVLYPTLSDYD---VRYYIYELLKALDYC 244
           +L D++  +   T  L+FE ++N      D + +  T    +   V+Y+ ++LL+ L +C
Sbjct: 67  RLYDVIHTENKLT--LVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDL 303
           H   I+HRD+KP N++I+ ++ +L+L D+GLA  F  P   ++  V + +++ P++L+  
Sbjct: 125 HENKILHRDLKPQNLLIN-KRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGS 183
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAY-----LNKY 358
           + Y  S+D+WS GC+ A MI  K P F G ++ +QL  I  ++GT   + +     L KY
Sbjct: 184 RTYSTSIDIWSCGCILAEMITGK-PLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKY 242
Query: 359 --HIELDP--HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKE 414
             +I+  P   L  ++  H+++P    +            +DFL  LL+ +   R +AK+
Sbjct: 243 NPNIQQRPPRDLRQVLQPHTKEPLDGNL------------MDFLHGLLQLNPDMRLSAKQ 290
Query: 415 AMAHPYF 421
           A+ HP+F
Sbjct: 291 ALHHPWF 297

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 89/312 (28%), Positives = 150/312 (48%), Gaps = 46/312 (14%)
Query: 134 DDYEVVRKVGRGKYSEVFEG-VHCTDNEXXXXXXXXXXXXXXXXXXXXXLQNL--CGGPN 190
           + Y  + K+G G Y+ V++G    TDN                      +  L      N
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSD----YDVRYYIYELLKALDYCHS 246
           IV L DI+  ++S T  L+FE+++  D K       +    ++V+ ++++LL+ L YCH 
Sbjct: 62  IVTLHDIIHTEKSLT--LVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR 118
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQD 305
           Q ++HRD+KP N++I+ E+ +L+L D+GLA     P K Y+  V + +++ P++L+   D
Sbjct: 119 QKVLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTD 177
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT------------DELNA 353
           Y   +D+W +GC+F  M   + P F G    +QL  I ++LGT            +E   
Sbjct: 178 YSTQIDMWGVGCIFYEMATGR-PLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT 236
Query: 354 Y-LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA 412
           Y   KY  E      AL+    R                 +  D L KLL+++ + R +A
Sbjct: 237 YNYPKYRAE------ALLSHAPRLD--------------SDGADLLTKLLQFEGRNRISA 276
Query: 413 KEAMAHPYFFPI 424
           ++AM HP+F  +
Sbjct: 277 EDAMKHPFFLSL 288

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 82/328 (25%), Positives = 149/328 (45%), Gaps = 50/328 (15%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEXXXXXX-----XXXXXXXXXXXXXXXLQNLCGGPN 190
           YE+V+K+G+G Y  V++ +     E                          L  L G  N
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHEN 70
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPT-LSDYDVRYYIYELLKALDYCHSQGI 249
           IV LL+++R    +   L+F+++      V+    L     +Y +Y+L+K + Y HS G+
Sbjct: 71  IVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGL 130
Query: 250 MHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR--------------------- 288
           +HRD+KP N++++ E   +++ D+GL+  +      N+R                     
Sbjct: 131 LHRDMKPSNILLNAECH-VKVADFGLSRSF-----VNIRRVTNNIPLSINENTENFDDDQ 184
Query: 289 ------VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKI 342
                 VA+R+++ PE+L+    Y   +D+WSLGC+  G I   +P F G    +QL +I
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCIL-GEILCGKPIFPGSSTMNQLERI 243
Query: 343 AKVL------GTDELNAYLNKYHIELDPHLAALVGRHSRKPWSK----FITVENQHLAVP 392
             V+        + + +   K  IE       +   + R  ++K     + +  +     
Sbjct: 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNE 303
Query: 393 EAVDFLDKLLRYDHQERPTAKEAMAHPY 420
           EA+D LDKLL+++  +R +A +A+ HP+
Sbjct: 304 EALDLLDKLLQFNPNKRISANDALKHPF 331

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 80/242 (33%), Positives = 128/242 (52%), Gaps = 26/242 (10%)
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNT--DFKVLYPTLSDYDV-RYYIYELLKALDYCHS 246
           N+V LL++ +  + K   L+FE V++T  D   L+P   DY V + Y+++++  + +CHS
Sbjct: 85  NLVNLLEVCK--KKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHS 142
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQD 305
             I+HRD+KP N+++  +   ++L D+G A     PG+ Y+  VA+R+++ PELLV    
Sbjct: 143 HNIIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVK 201
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL--- 362
           Y  ++D+W++GC+   M F  EP F G  + DQL  I   LG       L   H EL   
Sbjct: 202 YGKAVDVWAIGCLVTEM-FMGEPLFPGDSDIDQLYHIMMCLGN------LIPRHQELFNK 254
Query: 363 DPHLAA--LVGRHSRKPWSKFITVENQHLAVPEAV-DFLDKLLRYDHQERPTAKEAMAHP 419
           +P  A   L     R+P      +E ++  + E V D   K L  D  +RP   E + H 
Sbjct: 255 NPVFAGVRLPEIKEREP------LERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHD 308
Query: 420 YF 421
           +F
Sbjct: 309 FF 310

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  111 bits (278), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 73/240 (30%), Positives = 131/240 (54%), Gaps = 21/240 (8%)
Query: 190 NIVKLLDI---VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           N++ LLD+    R  +      +  H+   D    V    L+D  V++ IY++L+ L Y 
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 141
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  I+HRD+KP N+ ++ E  +L+++D+ LA   H   E    VA+R+++ PE++++  
Sbjct: 142 HSADIIHRDLKPSNLAVN-EDCELKILDFYLAR--HTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT            EL  
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTP---------GAELLK 248
Query: 365 HLAALVGRHSRKPWSKFITVENQHL---AVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            +++   R+  +  ++   +   ++   A P AVD L+K+L  D  +R TA +A+AH YF
Sbjct: 249 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 133/246 (54%), Gaps = 25/246 (10%)
Query: 190 NIVKLLDIVRDQ----QSKTPSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELLKALDY 243
           NI+ + DI+R      + K+  ++ + + +   ++++ +  L+   VRY++Y+LL+ L Y
Sbjct: 115 NIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKY 174
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA--------EFYHPGKEYNVRVASRYFK 295
            HS  ++HRD+KP N++++ E  +L++ D+G+A        E  +   EY   VA+R+++
Sbjct: 175 MHSAQVIHRDLKPSNLLVN-ENCELKIGDFGMARGLCTSPAEHQYFMTEY---VATRWYR 230
Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 355
            PEL++ L +Y  ++DLWS+GC+F  M+ R++  F G +   QL  I  VLGT       
Sbjct: 231 APELMLSLHEYTQAIDLWSVGCIFGEMLARRQ-LFPGKNYVHQLQLIMMVLGTPSPAVIQ 289
Query: 356 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEA 415
                 +  ++ +L  R    PW       ++     +A+  L ++LR++   R +A  A
Sbjct: 290 AVGAERVRAYIQSLPPRQP-VPWETVYPGADR-----QALSLLGRMLRFEPSARISAAAA 343
Query: 416 MAHPYF 421
           + HP+ 
Sbjct: 344 LRHPFL 349

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 133/246 (54%), Gaps = 25/246 (10%)
Query: 190 NIVKLLDIVRDQ----QSKTPSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELLKALDY 243
           NI+ + DI+R      + K+  ++ + + +   ++++ +  L+   VRY++Y+LL+ L Y
Sbjct: 114 NIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKY 173
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA--------EFYHPGKEYNVRVASRYFK 295
            HS  ++HRD+KP N++++ E  +L++ D+G+A        E  +   EY   VA+R+++
Sbjct: 174 MHSAQVIHRDLKPSNLLVN-ENCELKIGDFGMARGLCTSPAEHQYFMTEY---VATRWYR 229
Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 355
            PEL++ L +Y  ++DLWS+GC+F  M+ R++  F G +   QL  I  VLGT       
Sbjct: 230 APELMLSLHEYTQAIDLWSVGCIFGEMLARRQ-LFPGKNYVHQLQLIMMVLGTPSPAVIQ 288
Query: 356 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEA 415
                 +  ++ +L  R    PW       ++     +A+  L ++LR++   R +A  A
Sbjct: 289 AVGAERVRAYIQSLPPRQP-VPWETVYPGADR-----QALSLLGRMLRFEPSARISAAAA 342
Query: 416 MAHPYF 421
           + HP+ 
Sbjct: 343 LRHPFL 348

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 70/247 (28%), Positives = 119/247 (48%), Gaps = 22/247 (8%)
Query: 190 NIVKLLDIVRDQ--QSKTPSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYCH 245
           NI+ + +I R    ++     I + +  TD   +  T  LSD  ++Y+IY+ L+A+   H
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH 129
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR-----------VASRYF 294
              ++HRD+KP N++I+     L++ D+GLA         N             VA+R++
Sbjct: 130 GSNVIHRDLKPSNLLIN-SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWY 188
Query: 295 KGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAY 354
           + PE+++    Y  ++D+WS GC+ A +  R+ P F G D   QL+ I  ++GT   +  
Sbjct: 189 RAPEVMLTSAKYSRAMDVWSCGCILAELFLRR-PIFPGRDYRHQLLLIFGIIGTPHSDND 247
Query: 355 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKE 414
           L              +  +   P  K     N     P+ +D L ++L +D  +R TAKE
Sbjct: 248 LRCIESPRAREYIKSLPMYPAAPLEKMFPRVN-----PKGIDLLQRMLVFDPAKRITAKE 302
Query: 415 AMAHPYF 421
           A+ HPY 
Sbjct: 303 ALEHPYL 309

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 70/247 (28%), Positives = 119/247 (48%), Gaps = 22/247 (8%)
Query: 190 NIVKLLDIVRDQ--QSKTPSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYCH 245
           NI+ + +I R    ++     I + +  TD   +  T  LSD  ++Y+IY+ L+A+   H
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH 129
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR-----------VASRYF 294
              ++HRD+KP N++I+     L++ D+GLA         N             VA+R++
Sbjct: 130 GSNVIHRDLKPSNLLIN-SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWY 188
Query: 295 KGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAY 354
           + PE+++    Y  ++D+WS GC+ A +  R+ P F G D   QL+ I  ++GT   +  
Sbjct: 189 RAPEVMLTSAKYSRAMDVWSCGCILAELFLRR-PIFPGRDYRHQLLLIFGIIGTPHSDND 247
Query: 355 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKE 414
           L              +  +   P  K     N     P+ +D L ++L +D  +R TAKE
Sbjct: 248 LRCIESPRAREYIKSLPMYPAAPLEKMFPRVN-----PKGIDLLQRMLVFDPAKRITAKE 302
Query: 415 AMAHPYF 421
           A+ HPY 
Sbjct: 303 ALEHPYL 309

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 126/241 (52%), Gaps = 25/241 (10%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYC 244
           PNI+ LLD    + +   SL+F+ +  TD +V+       L+   ++ Y+   L+ L+Y 
Sbjct: 72  PNIIGLLDAFGHKSNI--SLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYL 128
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDL 303
           H   I+HRD+KP+N+++D E   L+L D+GLA+ F  P + Y  +V +R+++ PELL   
Sbjct: 129 HQHWILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGA 187
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363
           + Y   +D+W++GC+ A ++ R  PF  G  + DQL +I + LGT     +         
Sbjct: 188 RMYGVGVDMWAVGCILAELLLRV-PFLPGDSDLDQLTRIFETLGTPTEEQW--------- 237
Query: 364 PHLAALVGRHSRKPWSKFITVENQHL---AVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 420
           P + +L    + K    F  +   H+   A  + +D +  L  ++   R TA +A+   Y
Sbjct: 238 PDMCSLPDYVTFK---SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294
Query: 421 F 421
           F
Sbjct: 295 F 295

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 70/247 (28%), Positives = 119/247 (48%), Gaps = 22/247 (8%)
Query: 190 NIVKLLDIVRDQ--QSKTPSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYCH 245
           NI+ + +I R    ++     I + +  TD   +  T  LSD  ++Y+IY+ L+A+   H
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH 129
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR-----------VASRYF 294
              ++HRD+KP N++I+     L++ D+GLA         N             VA+R++
Sbjct: 130 GSNVIHRDLKPSNLLIN-SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWY 188
Query: 295 KGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAY 354
           + PE+++    Y  ++D+WS GC+ A +  R+ P F G D   QL+ I  ++GT   +  
Sbjct: 189 RAPEVMLTSAKYSRAMDVWSCGCILAELFLRR-PIFPGRDYRHQLLLIFGIIGTPHSDND 247
Query: 355 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKE 414
           L              +  +   P  K     N     P+ +D L ++L +D  +R TAKE
Sbjct: 248 LRCIESPRAREYIKSLPMYPAAPLEKMFPRVN-----PKGIDLLQRMLVFDPAKRITAKE 302
Query: 415 AMAHPYF 421
           A+ HPY 
Sbjct: 303 ALEHPYL 309

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 83/301 (27%), Positives = 143/301 (47%), Gaps = 25/301 (8%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXX----XXXXXXXLQNLCGGP 189
           D Y  + K+G G Y EV++ +    NE                         L       
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHR 93
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPTLSDYDVRYYIYELLKALDYCHSQ 247
           NI++L  ++    +    LIFE+  N   K +   P +S   ++ ++Y+L+  +++CHS+
Sbjct: 94  NIIELKSVI--HHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR 151
Query: 248 GIMHRDVKPHNVMID----HEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVD 302
             +HRD+KP N+++      E   L++ D+GLA  F  P +++   + + +++ PE+L+ 
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLG 211
Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 362
            + Y  S+D+WS+ C++A M+  K P F G    DQL KI +VLG  +   +        
Sbjct: 212 SRHYSTSVDIWSIACIWAEMLM-KTPLFPGDSEIDQLFKIFEVLGLPDDTTW-------- 262
Query: 363 DPHLAALVGRHSRKPWSKFITVENQHLA--VPEAVDFLDKLLRYDHQERPTAKEAMAHPY 420
            P + AL       P  +  T++    A    E +D L  +L  D  +R +AK A+ HPY
Sbjct: 263 -PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321
Query: 421 F 421
           F
Sbjct: 322 F 322

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 122/241 (50%), Gaps = 12/241 (4%)
Query: 190 NIVKLLDIVRDQQS----KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCH 245
           NI+ LL++   Q++    +   L+ E ++    +V++  L    + Y +Y++L  + + H
Sbjct: 82  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH 141
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 142 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTASTNFMMTPYVVTRYYRAPEVILGM-G 199
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT--DELNAYLN---KYHI 360
           Y  ++D+WS+GC+  G + +    F G D+ DQ  K+ + LGT   E  A L    + ++
Sbjct: 200 YKENVDIWSVGCIM-GELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYV 258
Query: 361 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 420
           E  P    +        W      E   +   +A D L K+L  D  +R +  EA+ HPY
Sbjct: 259 ENRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPY 318
Query: 421 F 421
Sbjct: 319 I 319

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 127/252 (50%), Gaps = 30/252 (11%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCH 245
           PN+V LL++ R  + +   L+FE+ ++T    L      + ++ V+   ++ L+A+++CH
Sbjct: 62  PNLVNLLEVFR--RKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQ 304
               +HRDVKP N++I  +   ++L D+G A     P   Y+  VA+R+++ PELLV   
Sbjct: 120 KHNCIHRDVKPENILIT-KHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDT 178
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--------TDELNAYLN 356
            Y   +D+W++GC+FA ++    P + G  + DQL  I K LG            N Y +
Sbjct: 179 QYGPPVDVWAIGCVFAELL-SGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237
Query: 357 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAM 416
              I  DP           +P    + ++  +++ P A+  L   L  D  ER T ++ +
Sbjct: 238 GVKIP-DP--------EDMEP----LELKFPNISYP-ALGLLKGCLHMDPTERLTCEQLL 283
Query: 417 AHPYFFPIRNAE 428
            HPYF  IR  E
Sbjct: 284 HHPYFENIREIE 295

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 123/246 (50%), Gaps = 22/246 (8%)
Query: 190 NIVKLLDIVRDQQS----KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCH 245
           NI+ LL++   Q++    +   L+ E ++    +V++  L    + Y +Y++L  + + H
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH 143
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 144 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGM-G 201
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH 365
           Y  ++D+WS+GC+  G + +    F G D+ DQ  K+ + LGT        ++   L P 
Sbjct: 202 YAANVDIWSVGCIM-GELVKGCVIFQGTDHIDQWNKVIEQLGTPS-----AEFMAALQPT 255
Query: 366 LAALVGRHSRKPWSKFITV----------ENQHLAVPEAVDFLDKLLRYDHQERPTAKEA 415
           +   V    + P  KF  +          E   +   +A D L K+L  D  +R +  EA
Sbjct: 256 VRNYVENRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEA 315
Query: 416 MAHPYF 421
           + HPY 
Sbjct: 316 LRHPYI 321

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/309 (26%), Positives = 139/309 (44%), Gaps = 25/309 (8%)
Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXX----XXXXXXXLQNLCG 187
           E   YE + K+G+G + EVF+  H    +                         +  L  
Sbjct: 16  EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK 75
Query: 188 GPNIVKLLDIVRDQQS------KTPSLIFEHVNNTDFKVLYPTLSDY---DVRYYIYELL 238
             N+V L++I R + S       +  L+F+   +    +L   L  +   +++  +  LL
Sbjct: 76  HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 135
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-----YNVRVASRY 293
             L Y H   I+HRD+K  NV+I  +   L+L D+GLA  +   K      Y  RV + +
Sbjct: 136 NGLYYIHRNKILHRDMKAANVLITRDG-VLKLADFGLARAFSLAKNSQPNRYXNRVVTLW 194
Query: 294 FKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 353
           ++ PELL+  +DY   +DLW  GC+ A M + + P   G+    QL  I+++ G+     
Sbjct: 195 YRPPELLLGERDYGPPIDLWGAGCIMAEM-WTRSPIMQGNTEQHQLALISQLCGSITPEV 253
Query: 354 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK 413
           + N  + EL   L  LV    RK   +       ++  P A+D +DKLL  D  +R  + 
Sbjct: 254 WPNVDNYELYEKL-ELVKGQKRKVKDRL----KAYVRDPYALDLIDKLLVLDPAQRIDSD 308
Query: 414 EAMAHPYFF 422
           +A+ H +F+
Sbjct: 309 DALNHDFFW 317

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 55/167 (32%), Positives = 95/167 (56%), Gaps = 12/167 (7%)
Query: 189 PNIVKLLDIV---RDQQSKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKA 240
           PN+V+L+D+    R  +    +L+FEHV+  D +        P L    ++  + + L+ 
Sbjct: 66  PNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRG 124
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 300
           LD+ H+  I+HRD+KP N+++      ++L D+GLA  Y      +  V + +++ PE+L
Sbjct: 125 LDFLHANCIVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALDPVVVTLWYRAPEVL 183
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG 347
           +    Y   +D+WS+GC+FA M FR++P F G+   DQL KI  ++G
Sbjct: 184 LQ-STYATPVDMWSVGCIFAEM-FRRKPLFCGNSEADQLGKIFDLIG 228

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 56/167 (33%), Positives = 94/167 (56%), Gaps = 12/167 (7%)
Query: 189 PNIVKLLDIV---RDQQSKTPSLIFEHVNNTDF-----KVLYPTLSDYDVRYYIYELLKA 240
           PN+V+L+D+    R  +    +L+FEHV+  D      K   P L    ++  + + L+ 
Sbjct: 74  PNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRG 132
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 300
           LD+ H+  I+HRD+KP N+++      ++L D+GLA  Y         V + +++ PE+L
Sbjct: 133 LDFLHANCIVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVL 191
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG 347
           +    Y   +D+WS+GC+FA M FR++P F G+   DQL KI  ++G
Sbjct: 192 LQ-STYATPVDMWSVGCIFAEM-FRRKPLFCGNSEADQLGKIFDLIG 236

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 83/309 (26%), Positives = 139/309 (44%), Gaps = 25/309 (8%)
Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXX----XXXXXXXLQNLCG 187
           E   YE + K+G+G + EVF+  H    +                         +  L  
Sbjct: 16  EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK 75
Query: 188 GPNIVKLLDIVRDQQS------KTPSLIFEHVNNTDFKVLYPTLSDY---DVRYYIYELL 238
             N+V L++I R + S       +  L+F+   +    +L   L  +   +++  +  LL
Sbjct: 76  HENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 135
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-----YNVRVASRY 293
             L Y H   I+HRD+K  NV+I  +   L+L D+GLA  +   K      Y  RV + +
Sbjct: 136 NGLYYIHRNKILHRDMKAANVLITRDG-VLKLADFGLARAFSLAKNSQPNRYXNRVVTLW 194
Query: 294 FKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 353
           ++ PELL+  +DY   +DLW  GC+ A M + + P   G+    QL  I+++ G+     
Sbjct: 195 YRPPELLLGERDYGPPIDLWGAGCIMAEM-WTRSPIMQGNTEQHQLALISQLCGSITPEV 253
Query: 354 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK 413
           + N  + EL   L  LV    RK   +       ++  P A+D +DKLL  D  +R  + 
Sbjct: 254 WPNVDNYELYEKL-ELVKGQKRKVKDRL----KAYVRDPYALDLIDKLLVLDPAQRIDSD 308
Query: 414 EAMAHPYFF 422
           +A+ H +F+
Sbjct: 309 DALNHDFFW 317

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 83/309 (26%), Positives = 139/309 (44%), Gaps = 25/309 (8%)
Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXX----XXXXXXXLQNLCG 187
           E   YE + K+G+G + EVF+  H    +                         +  L  
Sbjct: 15  EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK 74
Query: 188 GPNIVKLLDIVRDQQS------KTPSLIFEHVNNTDFKVLYPTLSDY---DVRYYIYELL 238
             N+V L++I R + S       +  L+F+   +    +L   L  +   +++  +  LL
Sbjct: 75  HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 134
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-----YNVRVASRY 293
             L Y H   I+HRD+K  NV+I  +   L+L D+GLA  +   K      Y  RV + +
Sbjct: 135 NGLYYIHRNKILHRDMKAANVLITRDG-VLKLADFGLARAFSLAKNSQPNRYXNRVVTLW 193
Query: 294 FKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 353
           ++ PELL+  +DY   +DLW  GC+ A M + + P   G+    QL  I+++ G+     
Sbjct: 194 YRPPELLLGERDYGPPIDLWGAGCIMAEM-WTRSPIMQGNTEQHQLALISQLCGSITPEV 252
Query: 354 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK 413
           + N  + EL   L  LV    RK   +       ++  P A+D +DKLL  D  +R  + 
Sbjct: 253 WPNVDNYELYEKL-ELVKGQKRKVKDRL----KAYVRDPYALDLIDKLLVLDPAQRIDSD 307
Query: 414 EAMAHPYFF 422
           +A+ H +F+
Sbjct: 308 DALNHDFFW 316

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 121/246 (49%), Gaps = 22/246 (8%)
Query: 190 NIVKLLDIVRDQQS----KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCH 245
           NI+ LL++   Q+S    +   ++ E ++    +V+   L    + Y +Y++L  + + H
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 144 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGM-G 201
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH 365
           Y  ++DLWS+GC+   M+  K   F G D  DQ  K+ + LGT        ++  +L P 
Sbjct: 202 YKENVDLWSVGCIMGEMVCHK-ILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKLQPT 255
Query: 366 LAALVGRHSRKPWSKFITV----------ENQHLAVPEAVDFLDKLLRYDHQERPTAKEA 415
           +   V    +     F  +          E+  L   +A D L K+L  D  +R +  EA
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 416 MAHPYF 421
           + HPY 
Sbjct: 316 LQHPYI 321

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 83/309 (26%), Positives = 139/309 (44%), Gaps = 25/309 (8%)
Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXX----XXXXXXXLQNLCG 187
           E   YE + K+G+G + EVF+  H    +                         +  L  
Sbjct: 16  EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK 75
Query: 188 GPNIVKLLDIVRDQQS------KTPSLIFEHVNNTDFKVLYPTLSDY---DVRYYIYELL 238
             N+V L++I R + S       +  L+F+   +    +L   L  +   +++  +  LL
Sbjct: 76  HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 135
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-----YNVRVASRY 293
             L Y H   I+HRD+K  NV+I  +   L+L D+GLA  +   K      Y  RV + +
Sbjct: 136 NGLYYIHRNKILHRDMKAANVLITRDG-VLKLADFGLARAFSLAKNSQPNRYXNRVVTLW 194
Query: 294 FKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 353
           ++ PELL+  +DY   +DLW  GC+ A M + + P   G+    QL  I+++ G+     
Sbjct: 195 YRPPELLLGERDYGPPIDLWGAGCIMAEM-WTRSPIMQGNTEQHQLALISQLCGSITPEV 253
Query: 354 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK 413
           + N  + EL   L  LV    RK   +       ++  P A+D +DKLL  D  +R  + 
Sbjct: 254 WPNVDNYELYEKL-ELVKGQKRKVKDRL----KAYVRDPYALDLIDKLLVLDPAQRIDSD 308
Query: 414 EAMAHPYFF 422
           +A+ H +F+
Sbjct: 309 DALNHDFFW 317

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 122/246 (49%), Gaps = 22/246 (8%)
Query: 190 NIVKLLDIVRDQQS----KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCH 245
           NI+ LL++   Q+S    +   ++ E ++    +V+   L    + Y +Y++L  + + H
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 144 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGM-G 201
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH 365
           Y  ++D+WS+GC+   M+  K   F G D  DQ  K+ + LGT    A++ K    L P 
Sbjct: 202 YKENVDIWSVGCIMGEMVCHK-ILFPGRDYIDQWNKVIEQLGT-PCPAFMKK----LQPT 255
Query: 366 LAALVGRHSRKPWSKFITV----------ENQHLAVPEAVDFLDKLLRYDHQERPTAKEA 415
           +   V    +     F  +          E+  L   +A D L K+L  D  +R +  EA
Sbjct: 256 VRNYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 416 MAHPYF 421
           + HPY 
Sbjct: 316 LQHPYI 321

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 56/167 (33%), Positives = 94/167 (56%), Gaps = 12/167 (7%)
Query: 189 PNIVKLLDIV---RDQQSKTPSLIFEHVNNTDF-----KVLYPTLSDYDVRYYIYELLKA 240
           PN+V+L+D+    R  +    +L+FEHV+  D      K   P L    ++  + + L+ 
Sbjct: 66  PNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRG 124
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 300
           LD+ H+  I+HRD+KP N+++      ++L D+GLA  Y         V + +++ PE+L
Sbjct: 125 LDFLHANCIVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALAPVVVTLWYRAPEVL 183
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG 347
           +    Y   +D+WS+GC+FA M FR++P F G+   DQL KI  ++G
Sbjct: 184 LQ-STYATPVDMWSVGCIFAEM-FRRKPLFCGNSEADQLGKIFDLIG 228

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 124/248 (50%), Gaps = 30/248 (12%)
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYC 244
           GP+  +L D V          I +    TD   +    P L ++  R ++Y+LL+ L Y 
Sbjct: 78  GPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEH-ARLFMYQLLRGLKYI 136
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVA----SRYFKGPELL 300
           HS  ++HRD+KP N+ I+ E   L++ D+GLA    P   +   ++    +++++ P LL
Sbjct: 137 HSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLL 196
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 360
           +   +Y  ++D+W+ GC+FA M+  K   F G    +Q+  I + +            H 
Sbjct: 197 LSPNNYTKAIDMWAAGCIFAEMLTGKT-LFAGAHELEQMQLILESIPV---------VHE 246
Query: 361 ELDPHLAALVGRHSR-------KPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK 413
           E    L +++  + R       KP ++ +   ++     EAVDFL+++L +   +R TA+
Sbjct: 247 EDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISR-----EAVDFLEQILTFSPMDRLTAE 301
Query: 414 EAMAHPYF 421
           EA++HPY 
Sbjct: 302 EALSHPYM 309

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 122/246 (49%), Gaps = 22/246 (8%)
Query: 190 NIVKLLDIVRDQQS----KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCH 245
           NI+ LL++   Q+S    +   ++ E ++    +V+   L    + Y +Y++L  + + H
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 144 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPEVVTRYYRAPEVILGM-G 201
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH 365
           Y  ++D+WS+GC+   MI +    F G D+ DQ  K+ + LGT        ++  +L P 
Sbjct: 202 YKENVDIWSVGCIMGEMI-KGGVLFPGTDHIDQWNKVIEQLGTP-----CPEFMKKLQPT 255
Query: 366 LAALVGRHSRKPWSKFITV----------ENQHLAVPEAVDFLDKLLRYDHQERPTAKEA 415
           +   V    +     F  +          E+  L   +A D L K+L  D  +R +  EA
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNALKASQARDLLSKMLVIDASKRISVDEA 315
Query: 416 MAHPYF 421
           + HPY 
Sbjct: 316 LQHPYI 321

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 124/243 (51%), Gaps = 16/243 (6%)
Query: 190 NIVKLLDIVRDQQS----KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCH 245
           NI+ LL++   Q++    +   L+ E ++    +V+   L    + Y +Y++L  + + H
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLH 143
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 144 SAGIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 201
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT------DELNAYLNKYH 359
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ + LGT       +L   +  Y 
Sbjct: 202 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY- 259
Query: 360 IELDPHLAALVGRHSRKPWSKF-ITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
           +E  P  A L       P S F    E+  L   +A D L K+L  D  +R +  +A+ H
Sbjct: 260 VENRPKYAGLTF-PKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 318
Query: 419 PYF 421
           PY 
Sbjct: 319 PYI 321

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 124/243 (51%), Gaps = 16/243 (6%)
Query: 190 NIVKLLDIVRDQQS----KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCH 245
           NI+ LL++   Q++    +   L+ E ++    +V+   L    + Y +Y++L  + + H
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLH 143
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 144 SAGIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 201
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT------DELNAYLNKYH 359
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ + LGT       +L   +  Y 
Sbjct: 202 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY- 259
Query: 360 IELDPHLAALVGRHSRKPWSKF-ITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
           +E  P  A L       P S F    E+  L   +A D L K+L  D  +R +  +A+ H
Sbjct: 260 VENRPKYAGLTFP-KLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 318
Query: 419 PYF 421
           PY 
Sbjct: 319 PYI 321

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 124/254 (48%), Gaps = 22/254 (8%)
Query: 182 LQNLCGGPNIVKLLDIVRDQQS----KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYEL 237
           L  +    NI+ LL++   Q+S    +   ++ E ++    +V+   L    + Y +Y++
Sbjct: 76  LMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 297
           L  + + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ P
Sbjct: 136 LVGIKHLHSAGIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 298 ELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 357
           E+++ +  Y  ++D+WS+GC+   MI +    F G D+ DQ  K+ + LGT        +
Sbjct: 195 EVILGM-GYKENVDIWSVGCIMGEMI-KGGVLFPGTDHIDQWNKVIEQLGTPS-----PE 247
Query: 358 YHIELDPHLAALVGRHSRKPWSKFITV----------ENQHLAVPEAVDFLDKLLRYDHQ 407
           +  +L P +   V    +     F  +          E+  L   +A D L K+L  D  
Sbjct: 248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDAS 307
Query: 408 ERPTAKEAMAHPYF 421
           +R +  EA+ HPY 
Sbjct: 308 KRISVDEALQHPYI 321

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 124/254 (48%), Gaps = 22/254 (8%)
Query: 182 LQNLCGGPNIVKLLDIVRDQQS----KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYEL 237
           L  +    NI+ LL++   Q+S    +   ++ E ++    +V+   L    + Y +Y++
Sbjct: 76  LMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 297
           L  + + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ P
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 298 ELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 357
           E+++ +  Y  ++D+WS+GC+   MI +    F G D+ DQ  K+ + LGT        +
Sbjct: 195 EVILGM-GYKENVDIWSVGCIMGEMI-KGGVLFPGTDHIDQWNKVIEQLGTPS-----PE 247
Query: 358 YHIELDPHLAALVGRHSRKPWSKFITV----------ENQHLAVPEAVDFLDKLLRYDHQ 407
           +  +L P +   V    +     F  +          E+  L   +A D L K+L  D  
Sbjct: 248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDAS 307
Query: 408 ERPTAKEAMAHPYF 421
           +R +  EA+ HPY 
Sbjct: 308 KRISVDEALQHPYI 321

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 124/243 (51%), Gaps = 16/243 (6%)
Query: 190 NIVKLLDIVRDQQS----KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCH 245
           NI+ LL++   Q++    +   L+ E ++    +V+   L    + Y +Y++L  + + H
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLH 136
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 137 SAGIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 194
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT------DELNAYLNKYH 359
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ + LGT       +L   +  Y 
Sbjct: 195 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY- 252
Query: 360 IELDPHLAALVGRHSRKPWSKF-ITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
           +E  P  A L       P S F    E+  L   +A D L K+L  D  +R +  +A+ H
Sbjct: 253 VENRPKYAGLTFP-KLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311
Query: 419 PYF 421
           PY 
Sbjct: 312 PYI 314

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 121/246 (49%), Gaps = 22/246 (8%)
Query: 190 NIVKLLDIVRDQQS----KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCH 245
           NI+ LL++   Q+S    +   ++ E ++    +V+   L    + Y +Y++L  + + H
Sbjct: 89  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 148
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 149 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 206
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH 365
           Y  ++DLWS+GC+   M+  K   F G D  DQ  K+ + LGT        ++  +L P 
Sbjct: 207 YKENVDLWSVGCIMGEMVCHK-ILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKLQPT 260
Query: 366 LAALVGRHSRKPWSKFITV----------ENQHLAVPEAVDFLDKLLRYDHQERPTAKEA 415
           +   V    +     F  +          E+  L   +A D L K+L  D  +R +  EA
Sbjct: 261 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 320
Query: 416 MAHPYF 421
           + HPY 
Sbjct: 321 LQHPYI 326

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 121/246 (49%), Gaps = 22/246 (8%)
Query: 190 NIVKLLDIVRDQQS----KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCH 245
           NI+ LL++   Q+S    +   ++ E ++    +V+   L    + Y +Y++L  + + H
Sbjct: 78  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 137
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 138 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 195
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH 365
           Y  ++DLWS+GC+   M+  K   F G D  DQ  K+ + LGT        ++  +L P 
Sbjct: 196 YKENVDLWSVGCIMGEMVCHK-ILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKLQPT 249
Query: 366 LAALVGRHSRKPWSKFITV----------ENQHLAVPEAVDFLDKLLRYDHQERPTAKEA 415
           +   V    +     F  +          E+  L   +A D L K+L  D  +R +  EA
Sbjct: 250 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 309
Query: 416 MAHPYF 421
           + HPY 
Sbjct: 310 LQHPYI 315

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 124/243 (51%), Gaps = 16/243 (6%)
Query: 190 NIVKLLDIVRDQQS----KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCH 245
           NI+ LL++   Q++    +   L+ E ++    +V+   L    + Y +Y++L  + + H
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 144 SAGIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 201
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT------DELNAYLNKYH 359
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ + LGT       +L   +  Y 
Sbjct: 202 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY- 259
Query: 360 IELDPHLAALVGRHSRKPWSKF-ITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
           +E  P  A L       P S F    E+  L   +A D L K+L  D  +R +  +A+ H
Sbjct: 260 VENRPKYAGLTFP-KLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 318
Query: 419 PYF 421
           PY 
Sbjct: 319 PYI 321

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 122/246 (49%), Gaps = 22/246 (8%)
Query: 190 NIVKLLDIVRDQQS----KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCH 245
           NI+ LL++   Q+S    +   ++ E ++    +V+   L    + Y +Y++L  + + H
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 144 SAGIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 201
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH 365
           Y  ++D+WS+GC+   MI +    F G D+ DQ  K+ + LGT        ++  +L P 
Sbjct: 202 YKENVDIWSVGCIMGEMI-KGGVLFPGTDHIDQWNKVIEQLGTPS-----PEFMKKLQPT 255
Query: 366 LAALVGRHSRKPWSKFITV----------ENQHLAVPEAVDFLDKLLRYDHQERPTAKEA 415
           +   V    +     F  +          E+  L   +A D L K+L  D  +R +  EA
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 416 MAHPYF 421
           + HPY 
Sbjct: 316 LQHPYI 321

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 55/167 (32%), Positives = 94/167 (56%), Gaps = 12/167 (7%)
Query: 189 PNIVKLLDIV---RDQQSKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKA 240
           PN+V+L+D+    R  +    +L+FEHV+  D +        P L    ++  + + L+ 
Sbjct: 66  PNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRG 124
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 300
           LD+ H+  I+HRD+KP N+++      ++L D+GLA  Y         V + +++ PE+L
Sbjct: 125 LDFLHANCIVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALFPVVVTLWYRAPEVL 183
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG 347
           +    Y   +D+WS+GC+FA M FR++P F G+   DQL KI  ++G
Sbjct: 184 LQ-STYATPVDMWSVGCIFAEM-FRRKPLFCGNSEADQLGKIFDLIG 228

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 124/243 (51%), Gaps = 16/243 (6%)
Query: 190 NIVKLLDIVRDQQS----KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCH 245
           NI+ LL++   Q++    +   L+ E ++    +V+   L    + Y +Y++L  + + H
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 181
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 182 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 239
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT------DELNAYLNKYH 359
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ + LGT       +L   +  Y 
Sbjct: 240 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY- 297
Query: 360 IELDPHLAALVGRHSRKPWSKF-ITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
           +E  P  A L       P S F    E+  L   +A D L K+L  D  +R +  +A+ H
Sbjct: 298 VENRPKYAGLT-FPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356
Query: 419 PYF 421
           PY 
Sbjct: 357 PYI 359

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 124/243 (51%), Gaps = 16/243 (6%)
Query: 190 NIVKLLDIVRDQQS----KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCH 245
           NI+ LL++   Q++    +   L+ E ++    +V+   L    + Y +Y++L  + + H
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 144 SAGIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 201
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT------DELNAYLNKYH 359
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ + LGT       +L   +  Y 
Sbjct: 202 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY- 259
Query: 360 IELDPHLAALVGRHSRKPWSKF-ITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
           +E  P  A L       P S F    E+  L   +A D L K+L  D  +R +  +A+ H
Sbjct: 260 VENRPKYAGLTFP-KLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 318
Query: 419 PYF 421
           PY 
Sbjct: 319 PYI 321

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 122/246 (49%), Gaps = 22/246 (8%)
Query: 190 NIVKLLDIVRDQQS----KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCH 245
           NI+ LL++   Q+S    +   ++ E ++    +V+   L    + Y +Y++L  + + H
Sbjct: 85  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 144
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 145 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 202
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH 365
           Y  ++D+WS+GC+   MI +    F G D+ DQ  K+ + LGT        ++  +L P 
Sbjct: 203 YKENVDIWSVGCIMGEMI-KGGVLFPGTDHIDQWNKVIEQLGTP-----CPEFMKKLQPT 256
Query: 366 LAALVGRHSRKPWSKFITV----------ENQHLAVPEAVDFLDKLLRYDHQERPTAKEA 415
           +   V    +     F  +          E+  L   +A D L K+L  D  +R +  EA
Sbjct: 257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 316
Query: 416 MAHPYF 421
           + HPY 
Sbjct: 317 LQHPYI 322

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 122/246 (49%), Gaps = 22/246 (8%)
Query: 190 NIVKLLDIVRDQQS----KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCH 245
           NI+ LL++   Q+S    +   ++ E ++    +V+   L    + Y +Y++L  + + H
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 144 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 201
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH 365
           Y  ++D+WS+GC+   MI +    F G D+ DQ  K+ + LGT        ++  +L P 
Sbjct: 202 YKENVDIWSVGCIMGEMI-KGGVLFPGTDHIDQWNKVIEQLGTPS-----PEFMKKLQPT 255
Query: 366 LAALVGRHSRKPWSKFITV----------ENQHLAVPEAVDFLDKLLRYDHQERPTAKEA 415
           +   V    +     F  +          E+  L   +A D L K+L  D  +R +  EA
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 416 MAHPYF 421
           + HPY 
Sbjct: 316 LQHPYI 321

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 124/243 (51%), Gaps = 16/243 (6%)
Query: 190 NIVKLLDIVRDQQS----KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCH 245
           NI+ LL++   Q++    +   L+ E ++    +V+   L    + Y +Y++L  + + H
Sbjct: 85  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 144
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 145 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 202
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT------DELNAYLNKYH 359
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ + LGT       +L   +  Y 
Sbjct: 203 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY- 260
Query: 360 IELDPHLAALVGRHSRKPWSKF-ITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
           +E  P  A L       P S F    E+  L   +A D L K+L  D  +R +  +A+ H
Sbjct: 261 VENRPKYAGLTF-PKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 319
Query: 419 PYF 421
           PY 
Sbjct: 320 PYI 322

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 124/243 (51%), Gaps = 16/243 (6%)
Query: 190 NIVKLLDIVRDQQS----KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCH 245
           NI+ LL++   Q++    +   L+ E ++    +V+   L    + Y +Y++L  + + H
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 181
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 182 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 239
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT------DELNAYLNKYH 359
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ + LGT       +L   +  Y 
Sbjct: 240 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY- 297
Query: 360 IELDPHLAALVGRHSRKPWSKF-ITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
           +E  P  A L       P S F    E+  L   +A D L K+L  D  +R +  +A+ H
Sbjct: 298 VENRPKYAGLTFP-KLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356
Query: 419 PYF 421
           PY 
Sbjct: 357 PYI 359

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 122/246 (49%), Gaps = 22/246 (8%)
Query: 190 NIVKLLDIVRDQQS----KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCH 245
           NI+ LL++   Q+S    +   ++ E ++    +V+   L    + Y +Y++L  + + H
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 144 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 201
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH 365
           Y  ++D+WS+GC+   MI +    F G D+ DQ  K+ + LGT        ++  +L P 
Sbjct: 202 YKENVDIWSVGCIMGEMI-KGGVLFPGTDHIDQWNKVIEQLGTP-----CPEFMKKLQPT 255
Query: 366 LAALVGRHSRKPWSKFITV----------ENQHLAVPEAVDFLDKLLRYDHQERPTAKEA 415
           +   V    +     F  +          E+  L   +A D L K+L  D  +R +  EA
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 416 MAHPYF 421
           + HPY 
Sbjct: 316 LQHPYI 321

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 124/243 (51%), Gaps = 16/243 (6%)
Query: 190 NIVKLLDIVRDQQS----KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCH 245
           NI+ LL++   Q++    +   L+ E ++    +V+   L    + Y +Y++L  + + H
Sbjct: 85  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 144
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 145 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 202
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT------DELNAYLNKYH 359
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ + LGT       +L   +  Y 
Sbjct: 203 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY- 260
Query: 360 IELDPHLAALVGRHSRKPWSKF-ITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
           +E  P  A L       P S F    E+  L   +A D L K+L  D  +R +  +A+ H
Sbjct: 261 VENRPKYAGLTF-PKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 319
Query: 419 PYF 421
           PY 
Sbjct: 320 PYI 322

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 98.2 bits (243), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 124/243 (51%), Gaps = 16/243 (6%)
Query: 190 NIVKLLDIVRDQQS----KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCH 245
           NI+ LL++   Q++    +   L+ E ++    +V+   L    + Y +Y++L  + + H
Sbjct: 83  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 142
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 143 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 200
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT------DELNAYLNKYH 359
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ + LGT       +L   +  Y 
Sbjct: 201 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY- 258
Query: 360 IELDPHLAALVGRHSRKPWSKF-ITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
           +E  P  A L       P S F    E+  L   +A D L K+L  D  +R +  +A+ H
Sbjct: 259 VENRPKYAGLTF-PKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 317
Query: 419 PYF 421
           PY 
Sbjct: 318 PYI 320

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 98.2 bits (243), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 124/243 (51%), Gaps = 16/243 (6%)
Query: 190 NIVKLLDIVRDQQS----KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCH 245
           NI+ LL++   Q++    +   L+ E ++    +V+   L    + Y +Y++L  + + H
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 144 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 201
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT------DELNAYLNKYH 359
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ + LGT       +L   +  Y 
Sbjct: 202 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY- 259
Query: 360 IELDPHLAALVGRHSRKPWSKF-ITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
           +E  P  A L       P S F    E+  L   +A D L K+L  D  +R +  +A+ H
Sbjct: 260 VENRPKYAGLTF-PKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 318
Query: 419 PYF 421
           PY 
Sbjct: 319 PYI 321

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 124/243 (51%), Gaps = 16/243 (6%)
Query: 190 NIVKLLDIVRDQQS----KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCH 245
           NI+ LL++   Q++    +   L+ E ++    +V+   L    + Y +Y++L  + + H
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 144 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 201
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT------DELNAYLNKYH 359
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ + LGT       +L   +  Y 
Sbjct: 202 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY- 259
Query: 360 IELDPHLAALVGRHSRKPWSKF-ITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
           +E  P  A L       P S F    E+  L   +A D L K+L  D  +R +  +A+ H
Sbjct: 260 VENRPKYAGLTF-PKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 318
Query: 419 PYF 421
           PY 
Sbjct: 319 PYI 321

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 124/243 (51%), Gaps = 16/243 (6%)
Query: 190 NIVKLLDIVRDQQS----KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCH 245
           NI+ LL++   Q++    +   L+ E ++    +V+   L    + Y +Y++L  + + H
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 136
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 137 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 194
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT------DELNAYLNKYH 359
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ + LGT       +L   +  Y 
Sbjct: 195 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY- 252
Query: 360 IELDPHLAALVGRHSRKPWSKF-ITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
           +E  P  A L       P S F    E+  L   +A D L K+L  D  +R +  +A+ H
Sbjct: 253 VENRPKYAGLTFP-KLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311
Query: 419 PYF 421
           PY 
Sbjct: 312 PYI 314

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 122/246 (49%), Gaps = 22/246 (8%)
Query: 190 NIVKLLDIVRDQQS----KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCH 245
           NI+ LL++   Q+S    +   ++ E ++    +V+   L    + Y +Y++L  + + H
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 144 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 201
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH 365
           Y  ++D+WS+GC+   MI +    F G D+ DQ  K+ + LGT        ++  +L P 
Sbjct: 202 YKENVDIWSVGCIMGEMI-KGGVLFPGTDHIDQWNKVIEQLGTPS-----PEFMKKLQPT 255
Query: 366 LAALVGRHSRKPWSKFITV----------ENQHLAVPEAVDFLDKLLRYDHQERPTAKEA 415
           +   V    +     F  +          E+  L   +A D L K+L  D  +R +  EA
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 416 MAHPYF 421
           + HPY 
Sbjct: 316 LQHPYI 321

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 124/243 (51%), Gaps = 16/243 (6%)
Query: 190 NIVKLLDIVRDQQS----KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCH 245
           NI+ LL++   Q++    +   L+ E ++    +V+   L    + Y +Y++L  + + H
Sbjct: 78  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 137
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 138 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 195
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT------DELNAYLNKYH 359
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ + LGT       +L   +  Y 
Sbjct: 196 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY- 253
Query: 360 IELDPHLAALVGRHSRKPWSKF-ITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
           +E  P  A L       P S F    E+  L   +A D L K+L  D  +R +  +A+ H
Sbjct: 254 VENRPKYAGLTFP-KLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 312
Query: 419 PYF 421
           PY 
Sbjct: 313 PYI 315

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 124/243 (51%), Gaps = 16/243 (6%)
Query: 190 NIVKLLDIVRDQQS----KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCH 245
           NI+ LL++   Q++    +   L+ E ++    +V+   L    + Y +Y++L  + + H
Sbjct: 78  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 137
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 138 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 195
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT------DELNAYLNKYH 359
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ + LGT       +L   +  Y 
Sbjct: 196 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY- 253
Query: 360 IELDPHLAALVGRHSRKPWSKF-ITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
           +E  P  A L       P S F    E+  L   +A D L K+L  D  +R +  +A+ H
Sbjct: 254 VENRPKYAGLTFP-KLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 312
Query: 419 PYF 421
           PY 
Sbjct: 313 PYI 315

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 122/246 (49%), Gaps = 22/246 (8%)
Query: 190 NIVKLLDIVRDQQS----KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCH 245
           NI+ LL++   Q+S    +   ++ E ++    +V+   L    + Y +Y++L  + + H
Sbjct: 86  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 145
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 146 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMVPFVVTRYYRAPEVILGM-G 203
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH 365
           Y  ++D+WS+GC+   MI +    F G D+ DQ  K+ + LGT        ++  +L P 
Sbjct: 204 YKENVDIWSVGCIMGEMI-KGGVLFPGTDHIDQWNKVIEQLGTP-----CPEFMKKLQPT 257
Query: 366 LAALVGRHSRKPWSKFITV----------ENQHLAVPEAVDFLDKLLRYDHQERPTAKEA 415
           +   V    +     F  +          E+  L   +A D L K+L  D  +R +  EA
Sbjct: 258 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 317
Query: 416 MAHPYF 421
           + HPY 
Sbjct: 318 LQHPYI 323

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 101/198 (51%), Gaps = 7/198 (3%)
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
            +S   ++Y++Y +L  L   H  G++HRD+ P N+++  +   + + D+ LA       
Sbjct: 130 VISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLA-DNNDITICDFNLAREDTADA 188
Query: 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA 343
                V  R+++ PEL++  + +   +D+WS GC+ A M F ++  F G   Y+QL KI 
Sbjct: 189 NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEM-FNRKALFRGSTFYNQLNKIV 247
Query: 344 KVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLR 403
           +V+GT ++   +         +L   +     + W+  +       A P A+D + K+L 
Sbjct: 248 EVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPT-----ADPVALDLIAKMLE 302
Query: 404 YDHQERPTAKEAMAHPYF 421
           ++ Q R + ++A+ HPYF
Sbjct: 303 FNPQRRISTEQALRHPYF 320

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 101/198 (51%), Gaps = 7/198 (3%)
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
            +S   ++Y++Y +L  L   H  G++HRD+ P N+++  +   + + D+ LA       
Sbjct: 130 VISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLA-DNNDITICDFNLAREDTADA 188
Query: 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA 343
                V  R+++ PEL++  + +   +D+WS GC+ A M F ++  F G   Y+QL KI 
Sbjct: 189 NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEM-FNRKALFRGSTFYNQLNKIV 247
Query: 344 KVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLR 403
           +V+GT ++   +         +L   +     + W+  +   +     P A+D + K+L 
Sbjct: 248 EVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTAD-----PVALDLIAKMLE 302
Query: 404 YDHQERPTAKEAMAHPYF 421
           ++ Q R + ++A+ HPYF
Sbjct: 303 FNPQRRISTEQALRHPYF 320

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 123/254 (48%), Gaps = 22/254 (8%)
Query: 182 LQNLCGGPNIVKLLDIVRDQQS----KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYEL 237
           L  +    NI+ LL++   Q+S    +   ++ E ++    +V+   L    + Y +Y++
Sbjct: 76  LMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 297
           L  + + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ P
Sbjct: 136 LVGIKHLHSAGIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 298 ELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 357
           E+++ +  Y  ++D+WS+G +   MI +    F G D+ DQ  K+ + LGT        +
Sbjct: 195 EVILGM-GYKENVDIWSVGVIMGEMI-KGGVLFPGTDHIDQWNKVIEQLGTPS-----PE 247
Query: 358 YHIELDPHLAALVGRHSRKPWSKFITV----------ENQHLAVPEAVDFLDKLLRYDHQ 407
           +  +L P +   V    +     F  +          E+  L   +A D L K+L  D  
Sbjct: 248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDAS 307
Query: 408 ERPTAKEAMAHPYF 421
           +R +  EA+ HPY 
Sbjct: 308 KRISVDEALQHPYI 321

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 123/254 (48%), Gaps = 22/254 (8%)
Query: 182 LQNLCGGPNIVKLLDIVRDQQS----KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYEL 237
           L  +    NI+ LL++   Q+S    +   ++ E ++    +V+   L    + Y +Y++
Sbjct: 76  LMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 297
           L  + + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ P
Sbjct: 136 LVGIKHLHSAGIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 298 ELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 357
           E+++ +  Y  ++D+WS+G +   MI +    F G D+ DQ  K+ + LGT        +
Sbjct: 195 EVILGM-GYKENVDIWSVGVIMGEMI-KGGVLFPGTDHIDQWNKVIEQLGTPS-----PE 247
Query: 358 YHIELDPHLAALVGRHSRKPWSKFITV----------ENQHLAVPEAVDFLDKLLRYDHQ 407
           +  +L P +   V    +     F  +          E+  L   +A D L K+L  D  
Sbjct: 248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDAS 307
Query: 408 ERPTAKEAMAHPYF 421
           +R +  EA+ HPY 
Sbjct: 308 KRISVDEALQHPYI 321

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 85/360 (23%), Positives = 150/360 (41%), Gaps = 62/360 (17%)
Query: 130 WGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXX----XXXXXXXXXXXLQNL 185
           W   D YE+   +G G Y  V E     +                           + N 
Sbjct: 49  WQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNR 108
Query: 186 CGGPNIVKLLDIV--RDQQSKTPSLIFEHVNNTDFKVLYPT---LSDYDVRYYIYELLKA 240
               ++VK+LDIV  +D +      +   + ++DFK L+ T   L++  ++  +Y LL  
Sbjct: 109 LNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVG 168
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE----------------------- 277
           + Y HS GI+HRD+KP N +++ +   +++ D+GLA                        
Sbjct: 169 VKYVHSAGILHRDLKPANCLVNQDC-SVKVCDFGLARTVDYPENGNSQLPISPREDDMNL 227
Query: 278 --FYHPG---KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI--------- 323
             F H     ++    V +R+++ PEL++  ++Y  ++D+WS+GC+FA ++         
Sbjct: 228 VTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287
Query: 324 -FRKEPFFYGHDNY----DQLV----KIAKVLGTDELNAYLNKYHIELDPHLAALVGRHS 374
              + P F G   +    DQ      K       D+LN   N      +  + AL    +
Sbjct: 288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDA 347
Query: 375 RKPWSKFITVENQHLA------VPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 428
           ++    F   E   LA        +A+  L ++L ++  +R T  E +AHP+F  +R AE
Sbjct: 348 KRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAE 407

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 80/348 (22%), Positives = 144/348 (41%), Gaps = 57/348 (16%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXX----XXXXXXXXXXXLQNLCGGP 189
           D+YE+   +GRG Y  V+       N+                         + N     
Sbjct: 28  DNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 87
Query: 190 NIVKLLDIV--RDQQSKTPSLIFEHVNNTDFKVLYPT---LSDYDVRYYIYELLKALDYC 244
            I++L D++   D        I   + ++D K L+ T   L++  V+  +Y LL    + 
Sbjct: 88  YIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNLLLGEKFI 147
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-------------------PG--- 282
           H  GI+HRD+KP N +++ +   +++ D+GLA   +                   PG   
Sbjct: 148 HESGIIHRDLKPANCLLNQDC-SVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPHN 206
Query: 283 ----KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI----------FRKEP 328
               K+    V +R+++ PEL++  ++Y  S+D+WS GC+FA ++            + P
Sbjct: 207 KNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSHINNPTNRFP 266
Query: 329 FFYGHDNY-----DQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFIT 383
            F G   +         K+ +    D+LN   N      +  L  +  +   K    F T
Sbjct: 267 LFPGSSCFPLSPDHNSKKVHEKSNRDQLNIIFNVIGTPPEEDLKCITKQEVIKYIKLFPT 326
Query: 384 VENQHLA------VPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR 425
            +   L+        E +D L+ +LR++ Q+R T  +A++HPY   +R
Sbjct: 327 RDGIDLSKKYSSISKEGIDLLESMLRFNAQKRITIDKALSHPYLKDVR 374

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/298 (25%), Positives = 141/298 (47%), Gaps = 78/298 (26%)
Query: 191 IVKLLD-IVRDQQSKTPSL-IFEHVNNTDFKVLYPT---LSDYDVRYYIYELLKALDYCH 245
           I++L D I+ D   K   L I   + ++D K L+ T   L++  ++  +Y LL   ++ H
Sbjct: 87  IIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIH 146
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV------------------ 287
             GI+HRD+KP N +++ +   +++ D+GLA   +  K+ N+                  
Sbjct: 147 ESGIIHRDLKPANCLLNQDC-SVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLK 205
Query: 288 -----RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI----------FRKEPFFYG 332
                 V +R+++ PEL++  ++Y  S+D+WS GC+FA ++            + P F G
Sbjct: 206 KQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPG 265
Query: 333 -----------------HDNYDQLVKIAKVLGT---DELNAYLNK----YHIELDPHLAA 368
                              N DQL  I  ++GT   D+L   +NK     +I+L PH   
Sbjct: 266 SSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKN-INKPEVIKYIKLFPH--- 321
Query: 369 LVGRHSRKPWSKFITVENQHLAVP-EAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR 425
                 RKP    I ++ ++ ++  + ++ L+ +L+++  +R T  +A+ HPY   +R
Sbjct: 322 ------RKP----INLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVR 369

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 111/213 (52%), Gaps = 24/213 (11%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYH----PG 282
           V+  +Y++L  + Y H+  ++HRD+KP N+++     E+ ++++ D G A  ++    P 
Sbjct: 130 VKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 189
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD-------- 334
            + +  V + +++ PELL+  + Y  ++D+W++GC+FA ++   EP F+           
Sbjct: 190 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNP 248
Query: 335 -NYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWS--KFITVENQHLAV 391
            ++DQL +I  V+G     A  +   I+  P  + L+    R  ++    I    +H   
Sbjct: 249 YHHDQLDRIFNVMG---FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVK 305
Query: 392 PEAVDF--LDKLLRYDHQERPTAKEAMAHPYFF 422
           P++  F  L KLL  D  +R T+++AM  PYF 
Sbjct: 306 PDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFL 338

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 68/300 (22%), Positives = 127/300 (42%), Gaps = 57/300 (19%)
Query: 136 YEVVRKVGRGKYSEVF----EGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQNLCGGPNI 191
           Y+ V+K+G G Y EV     +  H                          +  L   PNI
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI 98
Query: 192 VKLLDIVRDQQS--------KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDY 243
           +KL D   D+++        K   L  E ++   F       ++ D    I ++L  + Y
Sbjct: 99  MKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKF-------NEVDAAVIIKQVLSGVTY 151
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 301
            H   I+HRD+KP N++++ +++   ++++D+GL+  +   K+   R+ + Y+  PE+L 
Sbjct: 152 LHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL- 210
Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 361
             + YD   D+WS+G +   ++    P F G  + + L K+ K            KY  +
Sbjct: 211 -RKKYDEKCDVWSIGVILF-ILLAGYPPFGGQTDQEILRKVEK-----------GKYTFD 257
Query: 362 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
                          P  K ++          A D + ++L++D Q R +A++A+ HP+ 
Sbjct: 258 --------------SPEWKNVS--------EGAKDLIKQMLQFDSQRRISAQQALEHPWI 295

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/242 (23%), Positives = 107/242 (44%), Gaps = 51/242 (21%)
Query: 189 PNIVKLLDIVRDQQS-------KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKAL 241
           PNI+KL +I+ D  S        T   +F+ +      +     S++D    I ++   +
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEI------IKRKRFSEHDAARIIKQVFSGI 134
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 299
            Y H   I+HRD+KP N++++ +++   +++ID+GL+  +    +   R+ + Y+  PE+
Sbjct: 135 TYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV 194
Query: 300 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 359
           L     YD   D+WS G +   ++    P FYG + YD L ++              KY 
Sbjct: 195 LRGT--YDEKCDVWSAGVILY-ILLSGTPPFYGKNEYDILKRVET-----------GKYA 240
Query: 360 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHP 419
            +L              P  + I+         +A D + K+L +    R TA + + HP
Sbjct: 241 FDL--------------PQWRTIS--------DDAKDLIRKMLTFHPSLRITATQCLEHP 278
Query: 420 YF 421
           + 
Sbjct: 279 WI 280

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 113/231 (48%), Gaps = 45/231 (19%)
Query: 228 YDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI---DHE---------------QRKLR 269
           + VR+  ++L +A+ + H   + H D+KP N++    D+E                  +R
Sbjct: 137 HQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVR 196
Query: 270 LIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCM----FAGMIFR 325
           ++D+G A F H  + ++  V++R+++ PE++++L  +    D+WS+GC+    + G    
Sbjct: 197 VVDFGSATFDH--EHHSTIVSTRHYRAPEVILEL-GWSQPCDVWSIGCIIFEYYVGFT-- 251
Query: 326 KEPFFYGHDNYDQLVKIAKVLG--------TDELNAYLNKYHIELDPHLAALVGRHSR-- 375
               F  HDN + L  + ++LG              Y  +  ++ D + +A  GR+ R  
Sbjct: 252 ---LFQTHDNREHLAMMERILGPIPSRMIRKTRKQKYFYRGRLDWDENTSA--GRYVREN 306
Query: 376 -KPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR 425
            KP  +++T E +     +  D ++ +L Y+  +R T  EA+ HP+F  +R
Sbjct: 307 CKPLRRYLTSEAEEHH--QLFDLIESMLEYEPAKRLTLGEALQHPFFARLR 355

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 93/202 (46%), Gaps = 10/202 (4%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQN-----LCGGP 189
           +Y++V+ +G G + +V    H T  +                      +      L   P
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 73
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNT--DFKVLYPTLSDYDVRYYIYELLKALDYCHSQ 247
           +I+KL D+++ +      ++ E+  N   D+ V    +S+ + R +  +++ A++YCH  
Sbjct: 74  HIIKLYDVIKSKDEII--MVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH 131
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 307
            I+HRD+KP N+++D E   +++ D+GL+     G        S  +  PE++       
Sbjct: 132 KIVHRDLKPENLLLD-EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 190
Query: 308 YSLDLWSLGCMFAGMIFRKEPF 329
             +D+WS G +   M+ R+ PF
Sbjct: 191 PEVDVWSCGVILYVMLCRRLPF 212

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 93/202 (46%), Gaps = 10/202 (4%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQN-----LCGGP 189
           +Y++V+ +G G + +V    H T  +                      +      L   P
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 74
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNT--DFKVLYPTLSDYDVRYYIYELLKALDYCHSQ 247
           +I+KL D+++ +      ++ E+  N   D+ V    +S+ + R +  +++ A++YCH  
Sbjct: 75  HIIKLYDVIKSKDEII--MVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH 132
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 307
            I+HRD+KP N+++D E   +++ D+GL+     G        S  +  PE++       
Sbjct: 133 KIVHRDLKPENLLLD-EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 191
Query: 308 YSLDLWSLGCMFAGMIFRKEPF 329
             +D+WS G +   M+ R+ PF
Sbjct: 192 PEVDVWSCGVILYVMLCRRLPF 213

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 93/202 (46%), Gaps = 10/202 (4%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQN-----LCGGP 189
           +Y++V+ +G G + +V    H T  +                      +      L   P
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 64
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNT--DFKVLYPTLSDYDVRYYIYELLKALDYCHSQ 247
           +I+KL D+++ +      ++ E+  N   D+ V    +S+ + R +  +++ A++YCH  
Sbjct: 65  HIIKLYDVIKSKDEII--MVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH 122
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 307
            I+HRD+KP N+++D E   +++ D+GL+     G        S  +  PE++       
Sbjct: 123 KIVHRDLKPENLLLD-EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 181
Query: 308 YSLDLWSLGCMFAGMIFRKEPF 329
             +D+WS G +   M+ R+ PF
Sbjct: 182 PEVDVWSCGVILYVMLCRRLPF 203

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 93/202 (46%), Gaps = 10/202 (4%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQN-----LCGGP 189
           +Y++V+ +G G + +V    H T  +                      +      L   P
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 68
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNT--DFKVLYPTLSDYDVRYYIYELLKALDYCHSQ 247
           +I+KL D+++ +      ++ E+  N   D+ V    +S+ + R +  +++ A++YCH  
Sbjct: 69  HIIKLYDVIKSKDEII--MVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH 126
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 307
            I+HRD+KP N+++D E   +++ D+GL+     G        S  +  PE++       
Sbjct: 127 KIVHRDLKPENLLLD-EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 185
Query: 308 YSLDLWSLGCMFAGMIFRKEPF 329
             +D+WS G +   M+ R+ PF
Sbjct: 186 PEVDVWSCGVILYVMLCRRLPF 207

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/242 (23%), Positives = 107/242 (44%), Gaps = 51/242 (21%)
Query: 189 PNIVKLLDIVRDQQS-------KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKAL 241
           PNI+KL +I+ D  S        T   +F+ +      +     S++D    I ++   +
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEI------IKRKRFSEHDAARIIKQVFSGI 134
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 299
            Y H   I+HRD+KP N++++ +++   +++ID+GL+  +    +   R+ + Y+  PE+
Sbjct: 135 TYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV 194
Query: 300 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 359
           L     YD   D+WS G +   ++    P FYG + YD L ++              KY 
Sbjct: 195 LRG--TYDEKCDVWSAGVILY-ILLSGTPPFYGKNEYDILKRVET-----------GKYA 240
Query: 360 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHP 419
            +L              P  + I+         +A D + K+L +    R TA + + HP
Sbjct: 241 FDL--------------PQWRTIS--------DDAKDLIRKMLTFHPSLRITATQCLEHP 278
Query: 420 YF 421
           + 
Sbjct: 279 WI 280

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/242 (23%), Positives = 107/242 (44%), Gaps = 51/242 (21%)
Query: 189 PNIVKLLDIVRDQQS-------KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKAL 241
           PNI+KL +I+ D  S        T   +F+ +      +     S++D    I ++   +
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEI------IKRKRFSEHDAARIIKQVFSGI 134
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 299
            Y H   I+HRD+KP N++++ +++   +++ID+GL+  +    +   R+ + Y+  PE+
Sbjct: 135 TYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV 194
Query: 300 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 359
           L     YD   D+WS G +   ++    P FYG + YD L ++              KY 
Sbjct: 195 LRG--TYDEKCDVWSAGVILY-ILLSGTPPFYGKNEYDILKRVET-----------GKYA 240
Query: 360 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHP 419
            +L              P  + I+         +A D + K+L +    R TA + + HP
Sbjct: 241 FDL--------------PQWRTIS--------DDAKDLIRKMLTFHPSLRITATQCLEHP 278
Query: 420 YF 421
           + 
Sbjct: 279 WI 280

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 71/156 (45%), Gaps = 29/156 (18%)
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
           +LS  +VR Y+  L KAL   H  GI+HRDVKP N + +   +K  L+D+GLA+  H  K
Sbjct: 113 SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK 172
Query: 284 -----------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDLWS 314
                                        +   R  +  F+ PE+L    +   ++D+WS
Sbjct: 173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWS 232
Query: 315 LGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE 350
            G +F  ++  + PF+   D+   L +I  + G+ E
Sbjct: 233 AGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRE 268

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 27/215 (12%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRK-LRLIDWGLAEFYHPGKEYNVR 288
           VR + + +L+ LD  H   I+H D+KP N+++  + R  +++ID+G + + H  +     
Sbjct: 202 VRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH--QRVYTX 259
Query: 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
           + SR+++ PE+++  + Y   +D+WSLGC+ A ++    P   G D  DQL  + ++LG 
Sbjct: 260 IQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELL-TGYPLLPGEDEGDQLACMIELLGM 317
Query: 349 DE---LNAYLNKYHI-------------ELDPHLAALVGRHSRK------PWSKFITVEN 386
                L+A     +               L      L G  SR+      P S+      
Sbjct: 318 PSQKLLDASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNAL 377
Query: 387 QHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
           +    P  +DFL + L +D   R T  +A+ HP+ 
Sbjct: 378 KGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWL 412

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 27/215 (12%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRK-LRLIDWGLAEFYHPGKEYNVR 288
           VR + + +L+ LD  H   I+H D+KP N+++  + R  +++ID+G + + H  +     
Sbjct: 202 VRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH--QRVYTX 259
Query: 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
           + SR+++ PE+++  + Y   +D+WSLGC+ A ++    P   G D  DQL  + ++LG 
Sbjct: 260 IQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELL-TGYPLLPGEDEGDQLACMIELLGM 317
Query: 349 DE---LNAYLNKYHI-------------ELDPHLAALVGRHSRK------PWSKFITVEN 386
                L+A     +               L      L G  SR+      P S+      
Sbjct: 318 PSQKLLDASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNAL 377
Query: 387 QHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
           +    P  +DFL + L +D   R T  +A+ HP+ 
Sbjct: 378 KGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWL 412

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 91/196 (46%), Gaps = 9/196 (4%)
Query: 140 RKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVR 199
           + +G G +S   + VH   N+                     L+   G PNIVKL ++  
Sbjct: 17  KPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFH 76
Query: 200 DQQSKTPSLIFEHVNNTD-FKVLYPT--LSDYDVRYYIYELLKALDYCHSQGIMHRDVKP 256
           DQ      L+ E +N  + F+ +      S+ +  Y + +L+ A+ + H  G++HRD+KP
Sbjct: 77  DQLHTF--LVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKP 134
Query: 257 HNVMIDHEQRKL--RLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDLW 313
            N++   E   L  ++ID+G A    P  +       + ++  PELL +   YD S DLW
Sbjct: 135 ENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELL-NQNGYDESCDLW 193
Query: 314 SLGCMFAGMIFRKEPF 329
           SLG +   M+  + PF
Sbjct: 194 SLGVILYTMLSGQVPF 209

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 72/303 (23%), Positives = 121/303 (39%), Gaps = 58/303 (19%)
Query: 134 DDYEVVRKVGRGKYSEVF------EGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQNLCG 187
           D Y+  R +G+G + EV        G  C                         L+ L  
Sbjct: 49  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL-D 107
Query: 188 GPNIVKLLDIVRDQ-------QSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKA 240
            PNI+KL +   D+       +  T   +F+ +      +     S+ D    I ++L  
Sbjct: 108 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI------ISRKRFSEVDAARIIRQVLSG 161
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
           + Y H   I+HRD+KP N++++ + +   +R+ID+GL+  +   K+   ++ + Y+  PE
Sbjct: 162 ITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 221
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 358
           +L     YD   D+WS G +   ++    P F G + YD L K+ K            KY
Sbjct: 222 VLHGT--YDEKCDVWSTGVILY-ILLSGCPPFNGANEYDILKKVEK-----------GKY 267
Query: 359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
             EL P             W K             A D + K+L Y    R +A++A+ H
Sbjct: 268 TFEL-PQ------------WKK---------VSESAKDLIRKMLTYVPSMRISARDALDH 305
Query: 419 PYF 421
            + 
Sbjct: 306 EWI 308

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 27/215 (12%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRK-LRLIDWGLAEFYHPGKEYNVR 288
           VR + + +L+ LD  H   I+H D+KP N+++  + R  +++ID+G + + H  +     
Sbjct: 202 VRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH--QRVYXX 259
Query: 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
           + SR+++ PE+++  + Y   +D+WSLGC+ A ++    P   G D  DQL  + ++LG 
Sbjct: 260 IQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELL-TGYPLLPGEDEGDQLACMIELLGM 317
Query: 349 DE---LNAYLNKYHI-------------ELDPHLAALVGRHSRK------PWSKFITVEN 386
                L+A     +               L      L G  SR+      P S+      
Sbjct: 318 PXQKLLDASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNAL 377
Query: 387 QHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
           +    P  +DFL + L +D   R T  +A+ HP+ 
Sbjct: 378 KGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWL 412

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 80/148 (54%), Gaps = 8/148 (5%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKALDYCH 245
           PN+VKL++++ D       ++FE VN     +   L P LS+   R+Y  +L+K ++Y H
Sbjct: 96  PNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP-LSEDQARFYFQDLIKGIEYLH 154
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQ 304
            Q I+HRD+KP N+++  E   +++ D+G++ EF       +  V +  F  PE L + +
Sbjct: 155 YQKIIHRDIKPSNLLVG-EDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETR 213
Query: 305 DY--DYSLDLWSLGCMFAGMIFRKEPFF 330
                 +LD+W++G      +F + PF 
Sbjct: 214 KIFSGKALDVWAMGVTLYCFVFGQCPFM 241

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 72/303 (23%), Positives = 121/303 (39%), Gaps = 58/303 (19%)
Query: 134 DDYEVVRKVGRGKYSEVF------EGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQNLCG 187
           D Y+  R +G+G + EV        G  C                         L+ L  
Sbjct: 50  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL-D 108
Query: 188 GPNIVKLLDIVRDQ-------QSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKA 240
            PNI+KL +   D+       +  T   +F+ +      +     S+ D    I ++L  
Sbjct: 109 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI------ISRKRFSEVDAARIIRQVLSG 162
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
           + Y H   I+HRD+KP N++++ + +   +R+ID+GL+  +   K+   ++ + Y+  PE
Sbjct: 163 ITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 222
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 358
           +L     YD   D+WS G +   ++    P F G + YD L K+ K            KY
Sbjct: 223 VLHGT--YDEKCDVWSTGVILY-ILLSGCPPFNGANEYDILKKVEK-----------GKY 268
Query: 359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
             EL P             W K             A D + K+L Y    R +A++A+ H
Sbjct: 269 TFEL-PQ------------WKK---------VSESAKDLIRKMLTYVPSMRISARDALDH 306
Query: 419 PYF 421
            + 
Sbjct: 307 EWI 309

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/303 (23%), Positives = 121/303 (39%), Gaps = 58/303 (19%)
Query: 134 DDYEVVRKVGRGKYSEVF------EGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQNLCG 187
           D Y+  R +G+G + EV        G  C                         L+ L  
Sbjct: 32  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL-D 90
Query: 188 GPNIVKLLDIVRDQ-------QSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKA 240
            PNI+KL +   D+       +  T   +F+ +      +     S+ D    I ++L  
Sbjct: 91  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI------ISRKRFSEVDAARIIRQVLSG 144
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
           + Y H   I+HRD+KP N++++ + +   +R+ID+GL+  +   K+   ++ + Y+  PE
Sbjct: 145 ITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 204
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 358
           +L     YD   D+WS G +   ++    P F G + YD L K+ K            KY
Sbjct: 205 VLHG--TYDEKCDVWSTGVILY-ILLSGCPPFNGANEYDILKKVEK-----------GKY 250
Query: 359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
             EL P             W K             A D + K+L Y    R +A++A+ H
Sbjct: 251 TFEL-PQ------------WKK---------VSESAKDLIRKMLTYVPSMRISARDALDH 288
Query: 419 PYF 421
            + 
Sbjct: 289 EWI 291

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/303 (23%), Positives = 121/303 (39%), Gaps = 58/303 (19%)
Query: 134 DDYEVVRKVGRGKYSEVF------EGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQNLCG 187
           D Y+  R +G+G + EV        G  C                         L+ L  
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL-D 84
Query: 188 GPNIVKLLDIVRDQ-------QSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKA 240
            PNI+KL +   D+       +  T   +F+ +      +     S+ D    I ++L  
Sbjct: 85  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI------ISRKRFSEVDAARIIRQVLSG 138
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
           + Y H   I+HRD+KP N++++ + +   +R+ID+GL+  +   K+   ++ + Y+  PE
Sbjct: 139 ITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 198
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 358
           +L     YD   D+WS G +   ++    P F G + YD L K+ K            KY
Sbjct: 199 VLHGT--YDEKCDVWSTGVILY-ILLSGCPPFNGANEYDILKKVEK-----------GKY 244
Query: 359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
             EL P             W K             A D + K+L Y    R +A++A+ H
Sbjct: 245 TFEL-PQ------------WKK---------VSESAKDLIRKMLTYVPSMRISARDALDH 282
Query: 419 PYF 421
            + 
Sbjct: 283 EWI 285

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/302 (22%), Positives = 124/302 (41%), Gaps = 50/302 (16%)
Query: 131 GEQDDYEVVRKVGRGKYSEVF------EGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQN 184
           G  D Y+ V+K+G G Y EV        G                            L+ 
Sbjct: 18  GLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQ 77
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSL-IFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDY 243
           L   PNI+KL +   D+++    + ++      D  +L    S+ D    + ++L    Y
Sbjct: 78  L-DHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTY 136
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 301
            H   I+HRD+KP N++++ + R   ++++D+GL+  +  G +   R+ + Y+  PE+L 
Sbjct: 137 LHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL- 195
Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 361
             + YD   D+WS G +   ++    P F G  + + L ++ K                 
Sbjct: 196 -RKKYDEKCDVWSCGVILY-ILLCGYPPFGGQTDQEILKRVEK----------------- 236
Query: 362 LDPHLAALVGRHSRKP--WSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHP 419
                    G+ S  P  W++            EA   +  +L Y+  +R +A+EA+ HP
Sbjct: 237 ---------GKFSFDPPDWTQ---------VSDEAKQLVKLMLTYEPSKRISAEEALNHP 278
Query: 420 YF 421
           + 
Sbjct: 279 WI 280

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 109/221 (49%), Gaps = 37/221 (16%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVM-------------IDHEQRKL-----RLI 271
           +R   Y++ K++++ HS  + H D+KP N++             I  ++R L     +++
Sbjct: 120 IRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVV 179
Query: 272 DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFY 331
           D+G A +    + ++  V++R+++ PE+++ L  +    D+WS+GC+     +     F 
Sbjct: 180 DFGSATY--DDEHHSTLVSTRHYRAPEVILAL-GWSQPCDVWSIGCILIEY-YLGFTVFP 235
Query: 332 GHDNYDQLVKIAKVLG--------TDELNAYLNKYHIELDPHLAALVGRH---SRKPWSK 380
            HD+ + L  + ++LG              Y +   ++ D H +A  GR+   + KP  +
Sbjct: 236 THDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSA--GRYVSRACKPLKE 293
Query: 381 FITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
           F+   +Q +      D + K+L YD  +R T +EA+ HP+F
Sbjct: 294 FML--SQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFF 332

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 73/308 (23%), Positives = 125/308 (40%), Gaps = 56/308 (18%)
Query: 124 ESLTVQWGEQDDYEVVRKVGRGKYSEVF-----EGVHCTDNEXXXXXXXXXXXXXXXXXX 178
           ES   QW   +D+E+ R +G+GK+  V+     +       +                  
Sbjct: 4   ESKKRQWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 62
Query: 179 XXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD---VRYYIY 235
              +Q+    PNI++L     D  +    LI E+    +       LS +D      YI 
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYIT 120
Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 295
           EL  AL YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  + 
Sbjct: 121 ELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDYL 178
Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 355
            PE +++ + +D  +DLWSLG +    +  K PF                    E N Y 
Sbjct: 179 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQ 217
Query: 356 NKYHIELDPHLAALVGRHSRKPWS--KFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK 413
             Y             R SR  ++   F+T          A D + +LL+++  +RP  +
Sbjct: 218 ETYK------------RISRVEFTFPDFVT--------EGARDLISRLLKHNPSQRPMLR 257
Query: 414 EAMAHPYF 421
           E + HP+ 
Sbjct: 258 EVLEHPWI 265

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 74/296 (25%), Positives = 119/296 (40%), Gaps = 46/296 (15%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVK 193
           D Y V   +G G YSE    VH   N                      L+     PNI+ 
Sbjct: 27  DGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLR-YGQHPNIIT 85
Query: 194 LLDIVRDQQSKTPSLIFEHVNNTDF--KVLYPTL-SDYDVRYYIYELLKALDYCHSQGIM 250
           L D+  D   K   L+ E +   +   K+L     S+ +  + ++ + K ++Y HSQG++
Sbjct: 86  LKDVYDD--GKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVV 143
Query: 251 HRDVKPHNVMIDHEQRK---LRLIDWGLAEFYHPGKEYNVRVASRY---FKGPELLVDLQ 304
           HRD+KP N++   E      LR+ D+G A+      E  + +   Y   F  PE+L   Q
Sbjct: 144 HRDLKPSNILYVDESGNPECLRICDFGFAKQLR--AENGLLMTPCYTANFVAPEVL-KRQ 200
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            YD   D+WSLG +   M+    PF  G  +  +  +I   +G+ +              
Sbjct: 201 GYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPE--EILTRIGSGKFT------------ 246
Query: 365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 420
                            ++  N +     A D + K+L  D  +R TAK+ + HP+
Sbjct: 247 -----------------LSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPW 285

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/302 (22%), Positives = 124/302 (41%), Gaps = 50/302 (16%)
Query: 131 GEQDDYEVVRKVGRGKYSEVF------EGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQN 184
           G  D Y+ V+K+G G Y EV        G                            L+ 
Sbjct: 1   GLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQ 60
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSL-IFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDY 243
           L   PNI+KL +   D+++    + ++      D  +L    S+ D    + ++L    Y
Sbjct: 61  L-DHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTY 119
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 301
            H   I+HRD+KP N++++ + R   ++++D+GL+  +  G +   R+ + Y+  PE+L 
Sbjct: 120 LHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL- 178
Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 361
             + YD   D+WS G +   ++    P F G  + + L ++ K                 
Sbjct: 179 -RKKYDEKCDVWSCGVILY-ILLCGYPPFGGQTDQEILKRVEK----------------- 219
Query: 362 LDPHLAALVGRHSRKP--WSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHP 419
                    G+ S  P  W++            EA   +  +L Y+  +R +A+EA+ HP
Sbjct: 220 ---------GKFSFDPPDWTQ---------VSDEAKQLVKLMLTYEPSKRISAEEALNHP 261
Query: 420 YF 421
           + 
Sbjct: 262 WI 263

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 107/230 (46%), Gaps = 37/230 (16%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ------------------RKLRLI 271
           VR+  Y+L  AL + H   + H D+KP N++  + +                    +R+ 
Sbjct: 157 VRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 216
Query: 272 DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFY 331
           D+G A F H  + +   VA+R+++ PE++++L  +    D+WS+GC+     +R    F 
Sbjct: 217 DFGSATFDH--EHHTTIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEY-YRGFTLFQ 272
Query: 332 GHDNYDQLVKIAKVLG--------TDELNAYLNKYHIELDPHLAALVGRHSR---KPWSK 380
            H+N + LV + K+LG              Y  K  +  D + +   GR+ +   KP   
Sbjct: 273 THENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSD--GRYVKENCKPLKS 330
Query: 381 FITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAESS 430
           ++  ++  L   +  D + ++L +D  +R T  EA+ HP+F  +   E S
Sbjct: 331 YMLQDS--LEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERS 378

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 72/303 (23%), Positives = 119/303 (39%), Gaps = 58/303 (19%)
Query: 134 DDYEVVRKVGRGKYSEVF------EGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQNLCG 187
           D Y+  R +G+G + EV        G  C                         L+ L  
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL-D 84
Query: 188 GPNIVKLLDIVRDQ-------QSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKA 240
            PNI KL +   D+       +  T   +F+ +      +     S+ D    I ++L  
Sbjct: 85  HPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEI------ISRKRFSEVDAARIIRQVLSG 138
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
           + Y H   I+HRD+KP N++++ + +   +R+ID+GL+  +   K+   ++ + Y+  PE
Sbjct: 139 ITYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPE 198
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 358
           +L     YD   D+WS G +   ++    P F G + YD L K+ K            KY
Sbjct: 199 VLHGT--YDEKCDVWSTGVILY-ILLSGCPPFNGANEYDILKKVEK-----------GKY 244
Query: 359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
             EL P             W K             A D + K L Y    R +A++A+ H
Sbjct: 245 TFEL-PQ------------WKK---------VSESAKDLIRKXLTYVPSXRISARDALDH 282
Query: 419 PYF 421
            + 
Sbjct: 283 EWI 285

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 107/230 (46%), Gaps = 37/230 (16%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ------------------RKLRLI 271
           VR+  Y+L  AL + H   + H D+KP N++  + +                    +R+ 
Sbjct: 134 VRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 193
Query: 272 DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFY 331
           D+G A F H  + +   VA+R+++ PE++++L  +    D+WS+GC+     +R    F 
Sbjct: 194 DFGSATFDH--EHHTTIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEY-YRGFTLFQ 249
Query: 332 GHDNYDQLVKIAKVLG--------TDELNAYLNKYHIELDPHLAALVGRHSR---KPWSK 380
            H+N + LV + K+LG              Y  K  +  D + +   GR+ +   KP   
Sbjct: 250 THENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSD--GRYVKENCKPLKS 307
Query: 381 FITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAESS 430
           ++  ++  L   +  D + ++L +D  +R T  EA+ HP+F  +   E S
Sbjct: 308 YMLQDS--LEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERS 355

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 107/230 (46%), Gaps = 37/230 (16%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ------------------RKLRLI 271
           VR+  Y+L  AL + H   + H D+KP N++  + +                    +R+ 
Sbjct: 125 VRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 184
Query: 272 DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFY 331
           D+G A F H  + +   VA+R+++ PE++++L  +    D+WS+GC+     +R    F 
Sbjct: 185 DFGSATFDH--EHHTTIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEY-YRGFTLFQ 240
Query: 332 GHDNYDQLVKIAKVLG--------TDELNAYLNKYHIELDPHLAALVGRHSR---KPWSK 380
            H+N + LV + K+LG              Y  K  +  D + +   GR+ +   KP   
Sbjct: 241 THENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSD--GRYVKENCKPLKS 298
Query: 381 FITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAESS 430
           ++  ++  L   +  D + ++L +D  +R T  EA+ HP+F  +   E S
Sbjct: 299 YMLQDS--LEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERS 346

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 74/296 (25%), Positives = 119/296 (40%), Gaps = 46/296 (15%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVK 193
           D Y V   +G G YSE    VH   N                      L+     PNI+ 
Sbjct: 27  DGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLR-YGQHPNIIT 85
Query: 194 LLDIVRDQQSKTPSLIFEHVNNTDF--KVLYPTL-SDYDVRYYIYELLKALDYCHSQGIM 250
           L D+  D   K   L+ E +   +   K+L     S+ +  + ++ + K ++Y HSQG++
Sbjct: 86  LKDVYDD--GKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVV 143
Query: 251 HRDVKPHNVMIDHEQRK---LRLIDWGLAEFYHPGKEYNVRVASRY---FKGPELLVDLQ 304
           HRD+KP N++   E      LR+ D+G A+      E  + +   Y   F  PE+L   Q
Sbjct: 144 HRDLKPSNILYVDESGNPECLRICDFGFAKQLR--AENGLLMTPCYTANFVAPEVL-KRQ 200
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            YD   D+WSLG +   M+    PF  G  +  +  +I   +G+ +              
Sbjct: 201 GYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPE--EILTRIGSGKFT------------ 246
Query: 365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 420
                            ++  N +     A D + K+L  D  +R TAK+ + HP+
Sbjct: 247 -----------------LSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPW 285

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/249 (23%), Positives = 114/249 (45%), Gaps = 47/249 (18%)
Query: 182 LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELL 238
           L+ + G P+I+ L+D    + S    L+F+ +      D+      LS+ + R  +  LL
Sbjct: 153 LRQVAGHPHIITLIDSY--ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLL 210
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
           +A+ + H+  I+HRD+KP N+++D +  ++RL D+G +    PG++      +  +  PE
Sbjct: 211 EAVSFLHANNIVHRDLKPENILLD-DNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPE 269
Query: 299 LLVDLQD-----YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 353
           +L    D     Y   +DLW+ G +   ++    PF++      Q++ +  ++       
Sbjct: 270 ILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR----QILMLRMIME------ 319
Query: 354 YLNKYHIELDPHLAALVGRHSRKPW-SKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA 412
              +Y               S   W  +  TV+          D + +LL+ D + R TA
Sbjct: 320 --GQYQF-------------SSPEWDDRSSTVK----------DLISRLLQVDPEARLTA 354
Query: 413 KEAMAHPYF 421
           ++A+ HP+F
Sbjct: 355 EQALQHPFF 363

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 83/142 (58%), Gaps = 11/142 (7%)
Query: 209 IFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ--GIMHRDVKPHNVMIDHEQR 266
           +++ + NT+F+ +   L+    R +  ++  AL +  +    I+H D+KP N+++ + +R
Sbjct: 123 LYDLLRNTNFRGVSLNLT----RKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKR 178
Query: 267 K-LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFR 325
             ++++D+G +     G+     + SR+++ PE+L+ +  YD ++D+WSLGC+   M   
Sbjct: 179 SAIKIVDFGSS--CQLGQRIYQXIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEM-HT 234
Query: 326 KEPFFYGHDNYDQLVKIAKVLG 347
            EP F G +  DQ+ KI +VLG
Sbjct: 235 GEPLFSGANEVDQMNKIVEVLG 256

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 107/221 (48%), Gaps = 37/221 (16%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVM-------------IDHEQRKL-----RLI 271
           +R   Y++ K++++ HS  + H D+KP N++             I  ++R L     +++
Sbjct: 120 IRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVV 179
Query: 272 DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFY 331
           D+G A +    + ++  V  R+++ PE+++ L  +    D+WS+GC+     +     F 
Sbjct: 180 DFGSATY--DDEHHSTLVXXRHYRAPEVILAL-GWSQPCDVWSIGCILIEY-YLGFTVFP 235
Query: 332 GHDNYDQLVKIAKVLG--------TDELNAYLNKYHIELDPHLAALVGRH---SRKPWSK 380
            HD+ + L  + ++LG              Y +   ++ D H +A  GR+   + KP  +
Sbjct: 236 THDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSA--GRYVSRACKPLKE 293
Query: 381 FITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
           F+   +Q +      D + K+L YD  +R T +EA+ HP+F
Sbjct: 294 FML--SQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFF 332

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 37/118 (31%), Positives = 69/118 (58%), Gaps = 7/118 (5%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YN 286
            R+Y  E++ AL+Y H +GI+HRD+KP N++++ E   +++ D+G A+   P  +    N
Sbjct: 134 TRFYTAEIVSALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARAN 192
Query: 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN--YDQLVKI 342
             V +  +  PELL + +    S DLW+LGC+   ++    PF  G++   + +++K+
Sbjct: 193 XFVGTAQYVSPELLTE-KSAXKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL 249

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 83/142 (58%), Gaps = 11/142 (7%)
Query: 209 IFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ--GIMHRDVKPHNVMIDHEQR 266
           +++ + NT+F+ +   L+    R +  ++  AL +  +    I+H D+KP N+++ + +R
Sbjct: 142 LYDLLRNTNFRGVSLNLT----RKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKR 197
Query: 267 K-LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFR 325
             ++++D+G +     G+     + SR+++ PE+L+ +  YD ++D+WSLGC+   M   
Sbjct: 198 SAIKIVDFGSS--CQLGQRIYQXIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEM-HT 253
Query: 326 KEPFFYGHDNYDQLVKIAKVLG 347
            EP F G +  DQ+ KI +VLG
Sbjct: 254 GEPLFSGANEVDQMNKIVEVLG 275

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 73/308 (23%), Positives = 125/308 (40%), Gaps = 56/308 (18%)
Query: 124 ESLTVQWGEQDDYEVVRKVGRGKYSEVF-----EGVHCTDNEXXXXXXXXXXXXXXXXXX 178
           ES   QW   +D+E+ R +G+GK+  V+     +       +                  
Sbjct: 4   ESKKRQWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 62
Query: 179 XXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD---VRYYIY 235
              +Q+    PNI++L     D  +    LI E+    +       LS +D      YI 
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYIT 120
Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 295
           EL  AL YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  + 
Sbjct: 121 ELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRXXLXGTLDYL 178
Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 355
            PE +++ + +D  +DLWSLG +    +  K PF                    E N Y 
Sbjct: 179 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQ 217
Query: 356 NKYHIELDPHLAALVGRHSRKPWS--KFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK 413
             Y             R SR  ++   F+T          A D + +LL+++  +RP  +
Sbjct: 218 ETYK------------RISRVEFTFPDFVT--------EGARDLISRLLKHNPSQRPMLR 257
Query: 414 EAMAHPYF 421
           E + HP+ 
Sbjct: 258 EVLEHPWI 265

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 83/142 (58%), Gaps = 11/142 (7%)
Query: 209 IFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ--GIMHRDVKPHNVMIDHEQR 266
           +++ + NT+F+ +   L+    R +  ++  AL +  +    I+H D+KP N+++ + +R
Sbjct: 142 LYDLLRNTNFRGVSLNLT----RKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKR 197
Query: 267 -KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFR 325
             ++++D+G +     G+     + SR+++ PE+L+ +  YD ++D+WSLGC+   M   
Sbjct: 198 XAIKIVDFGSS--CQLGQRIYQXIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEM-HT 253
Query: 326 KEPFFYGHDNYDQLVKIAKVLG 347
            EP F G +  DQ+ KI +VLG
Sbjct: 254 GEPLFSGANEVDQMNKIVEVLG 275

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 116/270 (42%), Gaps = 36/270 (13%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVK 193
           D YEV   +G G YS     +H   N                      L+     PNI+ 
Sbjct: 22  DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLR-YGQHPNIIT 80
Query: 194 LLDIVRDQQSKTPSLIFEHVNNTDF--KVLYPTL-SDYDVRYYIYELLKALDYCHSQGIM 250
           L D+  D   K   ++ E +   +   K+L     S+ +    ++ + K ++Y H+QG++
Sbjct: 81  LKDVYDD--GKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVV 138
Query: 251 HRDVKPHNVMIDHEQ---RKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGPELLVDLQ 304
           HRD+KP N++   E      +R+ D+G A+      E  + +   Y   F  PE+L + Q
Sbjct: 139 HRDLKPSNILYVDESGNPESIRICDFGFAKQLR--AENGLLMTPCYTANFVAPEVL-ERQ 195
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELN---AYLNKYH-- 359
            YD + D+WSLG +   M+    PF  G D+  +  +I   +G+ + +    Y N     
Sbjct: 196 GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPE--EILARIGSGKFSLSGGYWNSVSDT 253
Query: 360 --------IELDPH---LAALVGRHSRKPW 378
                   + +DPH    AALV RH   PW
Sbjct: 254 AKDLVSKMLHVDPHQRLTAALVLRH---PW 280

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 110/250 (44%), Gaps = 43/250 (17%)
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCHS 246
           N++ L D+  ++      LI E V+     DF     +LS+ +   +I ++L  ++Y H+
Sbjct: 76  NVITLHDVYENRTDVV--LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 247 QGIMHRDVKPHNVMIDHEQR---KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 303
           + I H D+KP N+M+  +      ++LID+GLA     G E+     +  F  PE +V+ 
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNY 192
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363
           +      D+WS+G +   ++    PF  G    + L  I  V       +Y   +  E  
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANITSV-------SY--DFDEEFF 242
Query: 364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP 423
            H + L                        A DF+ KLL  + ++R T +EA+ HP+  P
Sbjct: 243 SHTSEL------------------------AKDFIRKLLVKETRKRLTIQEALRHPWITP 278
Query: 424 IRNAESSRSR 433
           + N ++   R
Sbjct: 279 VDNQQAMVRR 288

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 110/250 (44%), Gaps = 43/250 (17%)
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCHS 246
           N++ L D+  ++      LI E V+     DF     +LS+ +   +I ++L  ++Y H+
Sbjct: 76  NVITLHDVYENRTDVV--LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 247 QGIMHRDVKPHNVMIDHEQR---KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 303
           + I H D+KP N+M+  +      ++LID+GLA     G E+     +  F  PE +V+ 
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNY 192
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363
           +      D+WS+G +   ++    PF  G    + L  I  V       +Y   +  E  
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANITSV-------SY--DFDEEFF 242
Query: 364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP 423
            H + L                        A DF+ KLL  + ++R T +EA+ HP+  P
Sbjct: 243 SHTSEL------------------------AKDFIRKLLVKETRKRLTIQEALRHPWITP 278
Query: 424 IRNAESSRSR 433
           + N ++   R
Sbjct: 279 VDNQQAMVRR 288

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 110/250 (44%), Gaps = 43/250 (17%)
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCHS 246
           N++ L D+  ++      LI E V+     DF     +LS+ +   +I ++L  ++Y H+
Sbjct: 76  NVITLHDVYENRTDVV--LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 247 QGIMHRDVKPHNVMIDHEQR---KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 303
           + I H D+KP N+M+  +      ++LID+GLA     G E+     +  F  PE +V+ 
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNY 192
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363
           +      D+WS+G +   ++    PF  G    + L  I  V       +Y   +  E  
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANITSV-------SY--DFDEEFF 242
Query: 364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP 423
            H + L                        A DF+ KLL  + ++R T +EA+ HP+  P
Sbjct: 243 SHTSEL------------------------AKDFIRKLLVKETRKRLTIQEALRHPWITP 278
Query: 424 IRNAESSRSR 433
           + N ++   R
Sbjct: 279 VDNQQAMVRR 288

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 37/118 (31%), Positives = 69/118 (58%), Gaps = 7/118 (5%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YN 286
            R+Y  E++ AL+Y H +GI+HRD+KP N++++ E   +++ D+G A+   P  +    N
Sbjct: 134 TRFYTAEIVSALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARAN 192
Query: 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN--YDQLVKI 342
             V +  +  PELL + +    S DLW+LGC+   ++    PF  G++   + +++K+
Sbjct: 193 XFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL 249

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 63/108 (58%), Gaps = 5/108 (4%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YN 286
            R+Y  E++ AL+Y H +GI+HRD+KP N++++ E   +++ D+G A+   P  +    N
Sbjct: 134 TRFYTAEIVSALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARAN 192
Query: 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD 334
             V +  +  PELL + +    S DLW+LGC+   ++    PF  G++
Sbjct: 193 SFVGTAQYVSPELLTE-KSASKSSDLWALGCIIYQLVAGLPPFRAGNE 239

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/303 (23%), Positives = 122/303 (40%), Gaps = 56/303 (18%)
Query: 129 QWGEQDDYEVVRKVGRGKYSEVFEGVHCTDN-----EXXXXXXXXXXXXXXXXXXXXXLQ 183
           QW   +D+E+ R +G+GK+  V+             +                     +Q
Sbjct: 4   QWA-LEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD---VRYYIYELLKA 240
           +    PNI++L     D  S    LI E+            LS +D      YI EL  A
Sbjct: 63  SHLRHPNILRLYGYFHD--STRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 300
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 121 LSYCHSKKVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPE-M 177
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 360
           ++ + +D  +DLWSLG +    +  K PF                    E N Y + Y  
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQDTYK- 216
Query: 361 ELDPHLAALVGRHSRKPWS--KFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
                      R SR  ++   F+T          A D + +LL+++  +RP  +E + H
Sbjct: 217 -----------RISRVEFTFPDFVT--------EGARDLISRLLKHNPSQRPMLREVLEH 257
Query: 419 PYF 421
           P+ 
Sbjct: 258 PWI 260

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 75/309 (24%), Positives = 127/309 (41%), Gaps = 58/309 (18%)
Query: 124 ESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDN-----EXXXXXXXXXXXXXXXXXX 178
           ES   QW   +D+E+ R +G+GK+  V+             +                  
Sbjct: 25  ESKKRQWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 83
Query: 179 XXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVN-NTDFKVLYPTLSDYD---VRYYI 234
              +Q+    PNI++L     D  +    LI E+    T ++ L   LS +D      YI
Sbjct: 84  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQ-KLSKFDEQRTATYI 140
Query: 235 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYF 294
            EL  AL YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +
Sbjct: 141 TELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDY 198
Query: 295 KGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAY 354
             PE +++ + +D  +DLWSLG +    +  K PF                    E N Y
Sbjct: 199 LPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTY 237
Query: 355 LNKYHIELDPHLAALVGRHSRKPWS--KFITVENQHLAVPEAVDFLDKLLRYDHQERPTA 412
              Y             R SR  ++   F+T          A D + +LL+++  +RP  
Sbjct: 238 QETYK------------RISRVEFTFPDFVT--------EGARDLISRLLKHNPSQRPML 277
Query: 413 KEAMAHPYF 421
           +E + HP+ 
Sbjct: 278 REVLEHPWI 286

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 73/308 (23%), Positives = 124/308 (40%), Gaps = 56/308 (18%)
Query: 124 ESLTVQWGEQDDYEVVRKVGRGKYSEVF-----EGVHCTDNEXXXXXXXXXXXXXXXXXX 178
           ES   QW   +D+E+ R +G+GK+  V+     +       +                  
Sbjct: 2   ESKKRQWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 179 XXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD---VRYYIY 235
              +Q+    PNI++L     D  +    LI E+            LS +D      YI 
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 118
Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 295
           EL  AL YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  + 
Sbjct: 119 ELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDYL 176
Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 355
            PE +++ + +D  +DLWSLG +    +  K PF                    E N Y 
Sbjct: 177 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQ 215
Query: 356 NKYHIELDPHLAALVGRHSRKPWS--KFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK 413
             Y             R SR  ++   F+T          A D + +LL+++  +RP  +
Sbjct: 216 ETYK------------RISRVEFTFPDFVT--------EGARDLISRLLKHNPSQRPMLR 255
Query: 414 EAMAHPYF 421
           E + HP+ 
Sbjct: 256 EVLEHPWI 263

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 63/108 (58%), Gaps = 5/108 (4%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YN 286
            R+Y  E++ AL+Y H +GI+HRD+KP N++++ E   +++ D+G A+   P  +    N
Sbjct: 132 TRFYTAEIVSALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARAN 190
Query: 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD 334
             V +  +  PELL + +    S DLW+LGC+   ++    PF  G++
Sbjct: 191 AFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE 237

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 73/308 (23%), Positives = 124/308 (40%), Gaps = 56/308 (18%)
Query: 124 ESLTVQWGEQDDYEVVRKVGRGKYSEVF-----EGVHCTDNEXXXXXXXXXXXXXXXXXX 178
           ES   QW   +D+E+ R +G+GK+  V+     +       +                  
Sbjct: 2   ESKKRQWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 179 XXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD---VRYYIY 235
              +Q+    PNI++L     D  +    LI E+            LS +D      YI 
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 118
Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 295
           EL  AL YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  + 
Sbjct: 119 ELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDYL 176
Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 355
            PE +++ + +D  +DLWSLG +    +  K PF                    E N Y 
Sbjct: 177 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQ 215
Query: 356 NKYHIELDPHLAALVGRHSRKPWS--KFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK 413
             Y             R SR  ++   F+T          A D + +LL+++  +RP  +
Sbjct: 216 ETYK------------RISRVEFTFPDFVT--------EGARDLISRLLKHNPSQRPMLR 255
Query: 414 EAMAHPYF 421
           E + HP+ 
Sbjct: 256 EVLEHPWI 263

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 91/203 (44%), Gaps = 38/203 (18%)
Query: 220 VLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEF 278
           V +  +++  +      +L+AL   H+QG++HRD+K  ++++ H+ R ++L D+G  A+ 
Sbjct: 239 VTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCAQV 297
Query: 279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQ 338
                     V + Y+  PEL+  L  Y   +D+WSLG M   M+  + P+F      + 
Sbjct: 298 SKEVPRRKXLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYF-----NEP 351
Query: 339 LVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFL 398
            +K  K++  +            L P L                  +N H   P    FL
Sbjct: 352 PLKAMKMIRDN------------LPPRL------------------KNLHKVSPSLKGFL 381
Query: 399 DKLLRYDHQERPTAKEAMAHPYF 421
           D+LL  D  +R TA E + HP+ 
Sbjct: 382 DRLLVRDPAQRATAAELLKHPFL 404

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 73/308 (23%), Positives = 124/308 (40%), Gaps = 56/308 (18%)
Query: 124 ESLTVQWGEQDDYEVVRKVGRGKYSEVF-----EGVHCTDNEXXXXXXXXXXXXXXXXXX 178
           ES   QW   +D+E+ R +G+GK+  V+     +       +                  
Sbjct: 4   ESKKRQWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 62
Query: 179 XXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD---VRYYIY 235
              +Q+    PNI++L     D  +    LI E+            LS +D      YI 
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 120
Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 295
           EL  AL YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  + 
Sbjct: 121 ELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDYL 178
Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 355
            PE +++ + +D  +DLWSLG +    +  K PF                    E N Y 
Sbjct: 179 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQ 217
Query: 356 NKYHIELDPHLAALVGRHSRKPWS--KFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK 413
             Y             R SR  ++   F+T          A D + +LL+++  +RP  +
Sbjct: 218 ETYK------------RISRVEFTFPDFVT--------EGARDLISRLLKHNPSQRPMLR 257
Query: 414 EAMAHPYF 421
           E + HP+ 
Sbjct: 258 EVLEHPWI 265

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 73/308 (23%), Positives = 123/308 (39%), Gaps = 56/308 (18%)
Query: 124 ESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDN-----EXXXXXXXXXXXXXXXXXX 178
           ES   QW   +D+E+ R +G+GK+  V+             +                  
Sbjct: 16  ESKKRQWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 74
Query: 179 XXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD---VRYYIY 235
              +Q+    PNI++L     D  +    LI E+            LS +D      YI 
Sbjct: 75  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 132
Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 295
           EL  AL YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  + 
Sbjct: 133 ELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDYL 190
Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 355
            PE +++ + +D  +DLWSLG +    +  K PF                    E N Y 
Sbjct: 191 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQ 229
Query: 356 NKYHIELDPHLAALVGRHSRKPWS--KFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK 413
             Y             R SR  ++   F+T          A D + +LL+++  +RP  +
Sbjct: 230 ETYK------------RISRVEFTFPDFVT--------EGARDLISRLLKHNPSQRPMLR 269
Query: 414 EAMAHPYF 421
           E + HP+ 
Sbjct: 270 EVLEHPWI 277

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/237 (22%), Positives = 105/237 (44%), Gaps = 51/237 (21%)
Query: 189 PNIVKLLDIVRDQ-------QSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKAL 241
           PNI+KL D+  D+       +      +FE + N           + D    + ++L  +
Sbjct: 106 PNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR------HKFDECDAANIMKQILSGI 159
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 299
            Y H   I+HRD+KP N++++++     ++++D+GL+ F+    +   R+ + Y+  PE+
Sbjct: 160 CYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEV 219
Query: 300 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 359
           L   + Y+   D+WS G +   ++    P F G ++ D + K+ K            KY+
Sbjct: 220 LK--KKYNEKCDVWSCGVIMY-ILLCGYPPFGGQNDQDIIKKVEK-----------GKYY 265
Query: 360 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAM 416
            + +              W              EA + +  +L YD+ +R TA+EA+
Sbjct: 266 FDFN-------------DWKNI---------SDEAKELIKLMLTYDYNKRCTAEEAL 300

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 63/108 (58%), Gaps = 5/108 (4%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YN 286
            R+Y  E++ AL+Y H +GI+HRD+KP N++++ E   +++ D+G A+   P  +    N
Sbjct: 137 TRFYTAEIVSALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARAN 195
Query: 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD 334
             V +  +  PELL + +    S DLW+LGC+   ++    PF  G++
Sbjct: 196 XFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE 242

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 63/108 (58%), Gaps = 5/108 (4%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YN 286
            R+Y  E++ AL+Y H +GI+HRD+KP N++++ E   +++ D+G A+   P  +    N
Sbjct: 132 TRFYTAEIVSALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARAN 190
Query: 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD 334
             V +  +  PELL + +    S DLW+LGC+   ++    PF  G++
Sbjct: 191 XFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE 237

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 63/108 (58%), Gaps = 5/108 (4%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YN 286
            R+Y  E++ AL+Y H +GI+HRD+KP N++++ E   +++ D+G A+   P  +    N
Sbjct: 135 TRFYTAEIVSALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARAN 193
Query: 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD 334
             V +  +  PELL + +    S DLW+LGC+   ++    PF  G++
Sbjct: 194 XFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE 240

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 63/108 (58%), Gaps = 5/108 (4%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YN 286
            R+Y  E++ AL+Y H +GI+HRD+KP N++++ E   +++ D+G A+   P  +    N
Sbjct: 134 TRFYTAEIVSALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARAN 192
Query: 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD 334
             V +  +  PELL + +    S DLW+LGC+   ++    PF  G++
Sbjct: 193 XFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE 239

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/308 (23%), Positives = 123/308 (39%), Gaps = 56/308 (18%)
Query: 124 ESLTVQWGEQDDYEVVRKVGRGKYSEVF-----EGVHCTDNEXXXXXXXXXXXXXXXXXX 178
           ES   QW   +D+E+ R +G+GK+  V+     +       +                  
Sbjct: 4   ESKKRQWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 62
Query: 179 XXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD---VRYYIY 235
              +Q+    PNI++L     D  +    LI E+            LS +D      YI 
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 120
Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 295
           EL  AL YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  + 
Sbjct: 121 ELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDYL 178
Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 355
            PE  ++ + +D  +DLWSLG +    +  K PF                    E N Y 
Sbjct: 179 PPE-XIEGRXHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQ 217
Query: 356 NKYHIELDPHLAALVGRHSRKPWS--KFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK 413
             Y             R SR  ++   F+T          A D + +LL+++  +RP  +
Sbjct: 218 ETYK------------RISRVEFTFPDFVT--------EGARDLISRLLKHNPSQRPXLR 257
Query: 414 EAMAHPYF 421
           E + HP+ 
Sbjct: 258 EVLEHPWI 265

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 63/108 (58%), Gaps = 5/108 (4%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YN 286
            R+Y  E++ AL+Y H +GI+HRD+KP N++++ E   +++ D+G A+   P  +    N
Sbjct: 132 TRFYTAEIVSALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARAN 190
Query: 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD 334
             V +  +  PELL + +    S DLW+LGC+   ++    PF  G++
Sbjct: 191 XFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE 237

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 63/108 (58%), Gaps = 5/108 (4%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YN 286
            R+Y  E++ AL+Y H +GI+HRD+KP N++++ E   +++ D+G A+   P  +    N
Sbjct: 134 TRFYTAEIVSALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARAN 192
Query: 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD 334
             V +  +  PELL + +    S DLW+LGC+   ++    PF  G++
Sbjct: 193 XFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE 239

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 91/199 (45%), Gaps = 38/199 (19%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGK 283
           L++  +      +L+AL Y H+QG++HRD+K  ++++  + R ++L D+G  A+      
Sbjct: 138 LNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGR-VKLSDFGFCAQISKDVP 196
Query: 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA 343
           +    V + Y+  PE ++    Y   +D+WSLG M   M+  + P+F      D  V+  
Sbjct: 197 KRKXLVGTPYWMAPE-VISRSLYATEVDIWSLGIMVIEMVDGEPPYF-----SDSPVQAM 250
Query: 344 KVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLR 403
           K L                         R S  P      ++N H   P   DFL+++L 
Sbjct: 251 KRL-------------------------RDSPPP-----KLKNSHKVSPVLRDFLERMLV 280
Query: 404 YDHQERPTAKEAMAHPYFF 422
            D QER TA+E + HP+  
Sbjct: 281 RDPQERATAQELLDHPFLL 299

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 63/108 (58%), Gaps = 5/108 (4%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YN 286
            R+Y  E++ AL+Y H +GI+HRD+KP N++++ E   +++ D+G A+   P  +    N
Sbjct: 134 TRFYTAEIVSALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARAN 192
Query: 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD 334
             V +  +  PELL + +    S DLW+LGC+   ++    PF  G++
Sbjct: 193 XFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE 239

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 63/108 (58%), Gaps = 5/108 (4%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YN 286
            R+Y  E++ AL+Y H +GI+HRD+KP N++++ E   +++ D+G A+   P  +    N
Sbjct: 132 TRFYTAEIVSALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARAN 190
Query: 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD 334
             V +  +  PELL + +    S DLW+LGC+   ++    PF  G++
Sbjct: 191 XFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE 237

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 63/108 (58%), Gaps = 5/108 (4%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YN 286
            R+Y  E++ AL+Y H +GI+HRD+KP N++++ E   +++ D+G A+   P  +    N
Sbjct: 112 TRFYTAEIVSALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARAN 170
Query: 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD 334
             V +  +  PELL + +    S DLW+LGC+   ++    PF  G++
Sbjct: 171 XFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE 217

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 106/242 (43%), Gaps = 43/242 (17%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCH 245
           PNI+ L D+  ++      LI E V+     DF     +LS+ +   +I ++L  ++Y H
Sbjct: 75  PNIITLHDVYENRTDVV--LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 246 SQGIMHRDVKPHNVMIDHEQR---KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
           ++ I H D+KP N+M+  +      ++LID+GLA     G E+     +  F  PE +V+
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVN 191
Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 362
            +      D+WS+G +   ++    PF  G    + L  I  V       +Y   +  E 
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANITAV-------SY--DFDEEF 241
Query: 363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFF 422
               + L                        A DF+ KLL  + ++R T +EA+ HP+  
Sbjct: 242 FSQTSEL------------------------AKDFIRKLLVKETRKRLTIQEALRHPWIT 277
Query: 423 PI 424
           P+
Sbjct: 278 PV 279

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 63/108 (58%), Gaps = 5/108 (4%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YN 286
            R+Y  E++ AL+Y H +GI+HRD+KP N++++ E   +++ D+G A+   P  +    N
Sbjct: 135 TRFYTAEIVSALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARAN 193
Query: 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD 334
             V +  +  PELL + +    S DLW+LGC+   ++    PF  G++
Sbjct: 194 SFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE 240

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/303 (23%), Positives = 123/303 (40%), Gaps = 56/303 (18%)
Query: 129 QWGEQDDYEVVRKVGRGKYSEVF-----EGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQ 183
           QW   +D+E+ R +G+GK+  V+     +       +                     +Q
Sbjct: 5   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 63
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD---VRYYIYELLKA 240
           +    PNI++L     D  +    LI E+            LS +D      YI EL  A
Sbjct: 64  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 300
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P    +    +  +  PE +
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRDTLCGTLDYLPPE-M 178
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 360
           ++ + +D  +DLWSLG +    +  K PF                    E N Y   Y  
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQETYK- 217
Query: 361 ELDPHLAALVGRHSRKPWS--KFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
                      R SR  ++   F+T          A D + +LL+++  +RP  +E + H
Sbjct: 218 -----------RISRVEFTFPDFVT--------EGARDLISRLLKHNPSQRPMLREVLEH 258
Query: 419 PYF 421
           P+ 
Sbjct: 259 PWI 261

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 43/125 (34%), Positives = 68/125 (54%), Gaps = 19/125 (15%)
Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-------------PG 282
           ++L+AL Y HSQGI+HRD+KP N+ ID E R +++ D+GLA+  H             PG
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 283 KEYNVR--VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
              N+   + +  +   E+L     Y+  +D++SLG +F  MI+   PF  G +  + L 
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILK 239
Query: 341 KIAKV 345
           K+  V
Sbjct: 240 KLRSV 244

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 39/144 (27%), Positives = 76/144 (52%), Gaps = 6/144 (4%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCH 245
           PNIVKL +++  +  KT  LI E+ +     D+ V +  + + + R    +++ A+ YCH
Sbjct: 71  PNIVKLFEVI--ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCH 128
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
            + I+HRD+K  N+++D +   +++ D+G +  +  G + +    S  +  PEL    + 
Sbjct: 129 QKRIVHRDLKAENLLLDADM-NIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKY 187
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPF 329
               +D+WSLG +   ++    PF
Sbjct: 188 DGPEVDVWSLGVILYTLVSGSLPF 211

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/303 (23%), Positives = 122/303 (40%), Gaps = 56/303 (18%)
Query: 129 QWGEQDDYEVVRKVGRGKYSEVF-----EGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQ 183
           QW   +D+E+ R +G+GK+  V+     +       +                     +Q
Sbjct: 4   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD---VRYYIYELLKA 240
           +    PNI++L     D  +    LI E+            LS +D      YI EL  A
Sbjct: 63  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 300
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-M 177
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 360
           ++ + +D  +DLWSLG +    +  K PF                    E N Y   Y  
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQETYK- 216
Query: 361 ELDPHLAALVGRHSRKPWS--KFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
                      R SR  ++   F+T          A D + +LL+++  +RP  +E + H
Sbjct: 217 -----------RISRVEFTFPDFVT--------EGARDLISRLLKHNPSQRPMLREVLEH 257
Query: 419 PYF 421
           P+ 
Sbjct: 258 PWI 260

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 43/125 (34%), Positives = 68/125 (54%), Gaps = 19/125 (15%)
Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-------------PG 282
           ++L+AL Y HSQGI+HRD+KP N+ ID E R +++ D+GLA+  H             PG
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 283 KEYNVR--VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
              N+   + +  +   E+L     Y+  +D++SLG +F  MI+   PF  G +  + L 
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILK 239
Query: 341 KIAKV 345
           K+  V
Sbjct: 240 KLRSV 244

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/303 (23%), Positives = 122/303 (40%), Gaps = 56/303 (18%)
Query: 129 QWGEQDDYEVVRKVGRGKYSEVF-----EGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQ 183
           QW   +D+E+ R +G+GK+  V+     +       +                     +Q
Sbjct: 8   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 66
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD---VRYYIYELLKA 240
           +    PNI++L     D  +    LI E+            LS +D      YI EL  A
Sbjct: 67  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 124
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 300
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 125 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-M 181
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 360
           ++ + +D  +DLWSLG +    +  K PF                    E N Y   Y  
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQETYK- 220
Query: 361 ELDPHLAALVGRHSRKPWS--KFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
                      R SR  ++   F+T          A D + +LL+++  +RP  +E + H
Sbjct: 221 -----------RISRVEFTFPDFVT--------EGARDLISRLLKHNPSQRPMLREVLEH 261
Query: 419 PYF 421
           P+ 
Sbjct: 262 PWI 264

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/308 (23%), Positives = 124/308 (40%), Gaps = 56/308 (18%)
Query: 124 ESLTVQWGEQDDYEVVRKVGRGKYSEVF-----EGVHCTDNEXXXXXXXXXXXXXXXXXX 178
           ES   QW   +D+E+ R +G+GK+  V+     +       +                  
Sbjct: 1   ESKKRQWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 59
Query: 179 XXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD---VRYYIY 235
              +Q+    PNI++L     D  +    LI E+            LS +D      YI 
Sbjct: 60  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 117
Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 295
           EL  AL YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  + 
Sbjct: 118 ELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRXXLCGTLDYL 175
Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 355
            PE +++ + +D  +DLWSLG +    +  K PF                    E N Y 
Sbjct: 176 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQ 214
Query: 356 NKYHIELDPHLAALVGRHSRKPWS--KFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK 413
             Y             R SR  ++   F+T          A D + +LL+++  +RP  +
Sbjct: 215 ETYK------------RISRVEFTFPDFVT--------EGARDLISRLLKHNPSQRPMLR 254
Query: 414 EAMAHPYF 421
           E + HP+ 
Sbjct: 255 EVLEHPWI 262

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 63/108 (58%), Gaps = 5/108 (4%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YN 286
            R+Y  E++ AL+Y H +GI+HRD+KP N++++ E   +++ D+G A+   P  +    N
Sbjct: 139 TRFYTAEIVSALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARAN 197
Query: 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD 334
             V +  +  PELL + +    S DLW+LGC+   ++    PF  G++
Sbjct: 198 XFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE 244

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/303 (23%), Positives = 122/303 (40%), Gaps = 56/303 (18%)
Query: 129 QWGEQDDYEVVRKVGRGKYSEVF-----EGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQ 183
           QW   +D+E+ R +G+GK+  V+     +       +                     +Q
Sbjct: 3   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 61
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD---VRYYIYELLKA 240
           +    PNI++L     D  +    LI E+            LS +D      YI EL  A
Sbjct: 62  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 119
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 300
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 120 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-M 176
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 360
           ++ + +D  +DLWSLG +    +  K PF                    E N Y   Y  
Sbjct: 177 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQETYK- 215
Query: 361 ELDPHLAALVGRHSRKPWS--KFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
                      R SR  ++   F+T          A D + +LL+++  +RP  +E + H
Sbjct: 216 -----------RISRVEFTFPDFVT--------EGARDLISRLLKHNPSQRPMLREVLEH 256
Query: 419 PYF 421
           P+ 
Sbjct: 257 PWI 259

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 63/108 (58%), Gaps = 5/108 (4%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YN 286
            R+Y  E++ AL+Y H +GI+HRD+KP N++++ E   +++ D+G A+   P  +    N
Sbjct: 111 TRFYTAEIVSALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARAN 169
Query: 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD 334
             V +  +  PELL + +    S DLW+LGC+   ++    PF  G++
Sbjct: 170 XFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE 216

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 63/108 (58%), Gaps = 5/108 (4%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YN 286
            R+Y  E++ AL+Y H +GI+HRD+KP N++++ E   +++ D+G A+   P  +    N
Sbjct: 109 TRFYTAEIVSALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARAN 167
Query: 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD 334
             V +  +  PELL + +    S DLW+LGC+   ++    PF  G++
Sbjct: 168 XFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE 214

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 63/108 (58%), Gaps = 5/108 (4%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YN 286
            R+Y  E++ AL+Y H +GI+HRD+KP N++++ E   +++ D+G A+   P  +    N
Sbjct: 110 TRFYTAEIVSALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARAN 168
Query: 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD 334
             V +  +  PELL + +    S DLW+LGC+   ++    PF  G++
Sbjct: 169 XFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE 215

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 91/204 (44%), Gaps = 40/204 (19%)
Query: 220 VLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEF 278
           V +  +++  +      +L+AL   H+QG++HRD+K  ++++ H+ R ++L D+G  A+ 
Sbjct: 119 VTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCAQV 177
Query: 279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQ 338
                     V + Y+  PEL+  L  Y   +D+WSLG M   M+  + P+F        
Sbjct: 178 SKEVPRRKXLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFN------- 229
Query: 339 LVKIAKVLGTDELNAYLNKYHIELDPHLAAL-VGRHSRKPWSKFITVENQHLAVPEAVDF 397
                                   +P L A+ + R +  P      ++N H   P    F
Sbjct: 230 ------------------------EPPLKAMKMIRDNLPP-----RLKNLHKVSPSLKGF 260
Query: 398 LDKLLRYDHQERPTAKEAMAHPYF 421
           LD+LL  D  +R TA E + HP+ 
Sbjct: 261 LDRLLVRDPAQRATAAELLKHPFL 284

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 73/308 (23%), Positives = 124/308 (40%), Gaps = 56/308 (18%)
Query: 124 ESLTVQWGEQDDYEVVRKVGRGKYSEVF-----EGVHCTDNEXXXXXXXXXXXXXXXXXX 178
           ES   QW   +D+E+ R +G+GK+  V+     +       +                  
Sbjct: 2   ESKKRQWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 179 XXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD---VRYYIY 235
              +Q+    PNI++L     D  +    LI E+            LS +D      YI 
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 118
Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 295
           EL  AL YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  + 
Sbjct: 119 ELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRXXLCGTLDYL 176
Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 355
            PE +++ + +D  +DLWSLG +    +  K PF                    E N Y 
Sbjct: 177 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQ 215
Query: 356 NKYHIELDPHLAALVGRHSRKPWS--KFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK 413
             Y             R SR  ++   F+T          A D + +LL+++  +RP  +
Sbjct: 216 ETYK------------RISRVEFTFPDFVT--------EGARDLISRLLKHNPSQRPMLR 255
Query: 414 EAMAHPYF 421
           E + HP+ 
Sbjct: 256 EVLEHPWI 263

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 91/204 (44%), Gaps = 40/204 (19%)
Query: 220 VLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEF 278
           V +  +++  +      +L+AL   H+QG++HRD+K  ++++ H+ R ++L D+G  A+ 
Sbjct: 117 VTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCAQV 175
Query: 279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQ 338
                     V + Y+  PEL+  L  Y   +D+WSLG M   M+  + P+F        
Sbjct: 176 SKEVPRRKXLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFN------- 227
Query: 339 LVKIAKVLGTDELNAYLNKYHIELDPHLAAL-VGRHSRKPWSKFITVENQHLAVPEAVDF 397
                                   +P L A+ + R +  P      ++N H   P    F
Sbjct: 228 ------------------------EPPLKAMKMIRDNLPP-----RLKNLHKVSPSLKGF 258
Query: 398 LDKLLRYDHQERPTAKEAMAHPYF 421
           LD+LL  D  +R TA E + HP+ 
Sbjct: 259 LDRLLVRDPAQRATAAELLKHPFL 282

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 75/309 (24%), Positives = 128/309 (41%), Gaps = 58/309 (18%)
Query: 124 ESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDN-----EXXXXXXXXXXXXXXXXXX 178
           ES   QW   +D+E+ R +G+GK+  V+             +                  
Sbjct: 25  ESKKRQWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 83
Query: 179 XXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVN-NTDFKVLYPTLSDYD---VRYYI 234
              +Q+    PNI++L     D  +    LI E+    T ++ L   LS +D      YI
Sbjct: 84  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQ-KLSKFDEQRTATYI 140
Query: 235 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYF 294
            EL  AL YCHS+ ++HRD+KP N+++     +L++ D+G +  + P    +    +  +
Sbjct: 141 TELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRDDLCGTLDY 198
Query: 295 KGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAY 354
             PE +++ + +D  +DLWSLG +    +  K PF                    E N Y
Sbjct: 199 LPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTY 237
Query: 355 LNKYHIELDPHLAALVGRHSRKPWS--KFITVENQHLAVPEAVDFLDKLLRYDHQERPTA 412
              Y             R SR  ++   F+T          A D + +LL+++  +RP  
Sbjct: 238 QETYK------------RISRVEFTFPDFVT--------EGARDLISRLLKHNPSQRPML 277
Query: 413 KEAMAHPYF 421
           +E + HP+ 
Sbjct: 278 REVLEHPWI 286

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 63/108 (58%), Gaps = 5/108 (4%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YN 286
            R+Y  E++ AL+Y H +GI+HRD+KP N++++ E   +++ D+G A+   P  +    N
Sbjct: 116 TRFYTAEIVSALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARAN 174
Query: 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD 334
             V +  +  PELL + +    S DLW+LGC+   ++    PF  G++
Sbjct: 175 XFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE 221

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 72/308 (23%), Positives = 124/308 (40%), Gaps = 56/308 (18%)
Query: 124 ESLTVQWGEQDDYEVVRKVGRGKYSEVF-----EGVHCTDNEXXXXXXXXXXXXXXXXXX 178
           ES   QW   +D+E+ R +G+GK+  V+     +       +                  
Sbjct: 2   ESKKRQWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 179 XXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD---VRYYIY 235
              +Q+    PNI++L     D  +    LI E+            LS +D      YI 
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 118
Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 295
           EL  AL YCHS+ ++HRD+KP N+++     +L++ ++G +  + P         +  + 
Sbjct: 119 ELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIANFGWS-VHAPSSRRTTLCGTLDYL 176
Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 355
            PE +++ + +D  +DLWSLG +    +  K PF                    E N Y 
Sbjct: 177 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQ 215
Query: 356 NKYHIELDPHLAALVGRHSRKPWS--KFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK 413
             Y             R SR  ++   F+T          A D + +LL+++  +RP  +
Sbjct: 216 ETYK------------RISRVEFTFPDFVT--------EGARDLISRLLKHNPSQRPMLR 255
Query: 414 EAMAHPYF 421
           E + HP+ 
Sbjct: 256 EVLEHPWI 263

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 91/204 (44%), Gaps = 40/204 (19%)
Query: 220 VLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEF 278
           V +  +++  +      +L+AL   H+QG++HRD+K  ++++ H+ R ++L D+G  A+ 
Sbjct: 162 VTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCAQV 220
Query: 279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQ 338
                     V + Y+  PEL+  L  Y   +D+WSLG M   M+  + P+F        
Sbjct: 221 SKEVPRRKXLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFN------- 272
Query: 339 LVKIAKVLGTDELNAYLNKYHIELDPHLAAL-VGRHSRKPWSKFITVENQHLAVPEAVDF 397
                                   +P L A+ + R +  P      ++N H   P    F
Sbjct: 273 ------------------------EPPLKAMKMIRDNLPP-----RLKNLHKVSPSLKGF 303
Query: 398 LDKLLRYDHQERPTAKEAMAHPYF 421
           LD+LL  D  +R TA E + HP+ 
Sbjct: 304 LDRLLVRDPAQRATAAELLKHPFL 327

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 63/108 (58%), Gaps = 5/108 (4%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YN 286
            R+Y  E++ AL+Y H +GI+HRD+KP N++++ E   +++ D+G A+   P  +    N
Sbjct: 131 TRFYTAEIVSALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARAN 189
Query: 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD 334
             V +  +  PELL + +    S DLW+LGC+   ++    PF  G++
Sbjct: 190 XFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE 236

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 76/144 (52%), Gaps = 6/144 (4%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCH 245
           PNIVKL +++  +  KT  L+ E+ +     D+ V +  + + + R    +++ A+ YCH
Sbjct: 74  PNIVKLFEVI--ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH 131
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
            + I+HRD+K  N+++D +   +++ D+G +  +  G + +    S  +  PEL    + 
Sbjct: 132 QKYIVHRDLKAENLLLDGDM-NIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKY 190
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPF 329
               +D+WSLG +   ++    PF
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPF 214

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 91/204 (44%), Gaps = 40/204 (19%)
Query: 220 VLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEF 278
           V +  +++  +      +L+AL   H+QG++HRD+K  ++++ H+ R ++L D+G  A+ 
Sbjct: 108 VTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCAQV 166
Query: 279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQ 338
                     V + Y+  PEL+  L  Y   +D+WSLG M   M+  + P+F        
Sbjct: 167 SKEVPRRKXLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFN------- 218
Query: 339 LVKIAKVLGTDELNAYLNKYHIELDPHLAAL-VGRHSRKPWSKFITVENQHLAVPEAVDF 397
                                   +P L A+ + R +  P      ++N H   P    F
Sbjct: 219 ------------------------EPPLKAMKMIRDNLPP-----RLKNLHKVSPSLKGF 249
Query: 398 LDKLLRYDHQERPTAKEAMAHPYF 421
           LD+LL  D  +R TA E + HP+ 
Sbjct: 250 LDRLLVRDPAQRATAAELLKHPFL 273

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 71/303 (23%), Positives = 122/303 (40%), Gaps = 56/303 (18%)
Query: 129 QWGEQDDYEVVRKVGRGKYSEVF-----EGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQ 183
           QW   +D+E+ R +G+GK+  V+     +       +                     +Q
Sbjct: 7   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 65
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD---VRYYIYELLKA 240
           +    PNI++L     D  +    LI E+            LS +D      YI EL  A
Sbjct: 66  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 123
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 300
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 124 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPE-M 180
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 360
           ++ + +D  +DLWSLG +    +  K PF                    E N Y   Y  
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQETYK- 219
Query: 361 ELDPHLAALVGRHSRKPWS--KFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
                      R SR  ++   F+T          A D + +LL+++  +RP  +E + H
Sbjct: 220 -----------RISRVEFTFPDFVT--------EGARDLISRLLKHNPSQRPMLREVLEH 260
Query: 419 PYF 421
           P+ 
Sbjct: 261 PWI 263

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 71/303 (23%), Positives = 122/303 (40%), Gaps = 56/303 (18%)
Query: 129 QWGEQDDYEVVRKVGRGKYSEVF-----EGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQ 183
           QW   +D+E+ R +G+GK+  V+     +       +                     +Q
Sbjct: 4   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD---VRYYIYELLKA 240
           +    PNI++L     D  +    LI E+            LS +D      YI EL  A
Sbjct: 63  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 300
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPE-M 177
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 360
           ++ + +D  +DLWSLG +    +  K PF                    E N Y   Y  
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQETYK- 216
Query: 361 ELDPHLAALVGRHSRKPWS--KFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
                      R SR  ++   F+T          A D + +LL+++  +RP  +E + H
Sbjct: 217 -----------RISRVEFTFPDFVT--------EGARDLISRLLKHNPSQRPMLREVLEH 257
Query: 419 PYF 421
           P+ 
Sbjct: 258 PWI 260

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 71/303 (23%), Positives = 122/303 (40%), Gaps = 56/303 (18%)
Query: 129 QWGEQDDYEVVRKVGRGKYSEVF-----EGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQ 183
           QW   +D+E+ R +G+GK+  V+     +       +                     +Q
Sbjct: 4   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD---VRYYIYELLKA 240
           +    PNI++L     D  +    LI E+            LS +D      YI EL  A
Sbjct: 63  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 300
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTXLCGTLDYLPPE-M 177
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 360
           ++ + +D  +DLWSLG +    +  K PF                    E N Y   Y  
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQETYK- 216
Query: 361 ELDPHLAALVGRHSRKPWS--KFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
                      R SR  ++   F+T          A D + +LL+++  +RP  +E + H
Sbjct: 217 -----------RISRVEFTFPDFVT--------EGARDLISRLLKHNPSQRPMLREVLEH 257
Query: 419 PYF 421
           P+ 
Sbjct: 258 PWI 260

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 63/108 (58%), Gaps = 5/108 (4%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YN 286
            R+Y  E++ AL+Y H +GI+HRD+KP N++++ E   +++ D+G A+   P  +    N
Sbjct: 131 TRFYTAEIVSALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARAN 189
Query: 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD 334
             V +  +  PELL + +    S DLW+LGC+   ++    PF  G++
Sbjct: 190 SFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE 236

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 91/204 (44%), Gaps = 40/204 (19%)
Query: 220 VLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEF 278
           V +  +++  +      +L+AL   H+QG++HRD+K  ++++ H+ R ++L D+G  A+ 
Sbjct: 112 VTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCAQV 170
Query: 279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQ 338
                     V + Y+  PEL+  L  Y   +D+WSLG M   M+  + P+F        
Sbjct: 171 SKEVPRRKXLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFN------- 222
Query: 339 LVKIAKVLGTDELNAYLNKYHIELDPHLAAL-VGRHSRKPWSKFITVENQHLAVPEAVDF 397
                                   +P L A+ + R +  P      ++N H   P    F
Sbjct: 223 ------------------------EPPLKAMKMIRDNLPP-----RLKNLHKVSPSLKGF 253
Query: 398 LDKLLRYDHQERPTAKEAMAHPYF 421
           LD+LL  D  +R TA E + HP+ 
Sbjct: 254 LDRLLVRDPAQRATAAELLKHPFL 277

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 71/303 (23%), Positives = 122/303 (40%), Gaps = 56/303 (18%)
Query: 129 QWGEQDDYEVVRKVGRGKYSEVF-----EGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQ 183
           QW   +D+E+ R +G+GK+  V+     +       +                     +Q
Sbjct: 5   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 63
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD---VRYYIYELLKA 240
           +    PNI++L     D  +    LI E+            LS +D      YI EL  A
Sbjct: 64  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 300
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-CHAPSSRRTTLSGTLDYLPPE-M 178
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 360
           ++ + +D  +DLWSLG +    +  K PF                    E N Y   Y  
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQETYK- 217
Query: 361 ELDPHLAALVGRHSRKPWS--KFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
                      R SR  ++   F+T          A D + +LL+++  +RP  +E + H
Sbjct: 218 -----------RISRVEFTFPDFVT--------EGARDLISRLLKHNPSQRPMLREVLEH 258
Query: 419 PYF 421
           P+ 
Sbjct: 259 PWI 261

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 72/308 (23%), Positives = 124/308 (40%), Gaps = 56/308 (18%)
Query: 124 ESLTVQWGEQDDYEVVRKVGRGKYSEVF-----EGVHCTDNEXXXXXXXXXXXXXXXXXX 178
           ES   QW   +D+E+ R +G+GK+  V+     +       +                  
Sbjct: 1   ESKKRQWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 59
Query: 179 XXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD---VRYYIY 235
              +Q+    PNI++L     D  +    LI E+            LS +D      YI 
Sbjct: 60  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 117
Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 295
           EL  AL YCHS+ ++HRD+KP N+++     +L++ ++G +  + P         +  + 
Sbjct: 118 ELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIANFGWS-VHAPSSRRTTLCGTLDYL 175
Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 355
            PE +++ + +D  +DLWSLG +    +  K PF                    E N Y 
Sbjct: 176 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQ 214
Query: 356 NKYHIELDPHLAALVGRHSRKPWS--KFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK 413
             Y             R SR  ++   F+T          A D + +LL+++  +RP  +
Sbjct: 215 ETYK------------RISRVEFTFPDFVT--------EGARDLISRLLKHNPSQRPMLR 254
Query: 414 EAMAHPYF 421
           E + HP+ 
Sbjct: 255 EVLEHPWI 262

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 76/144 (52%), Gaps = 6/144 (4%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCH 245
           PNIVKL +++  +  KT  LI E+ +     D+ V +  + + + R    +++ A+ YCH
Sbjct: 74  PNIVKLFEVI--ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCH 131
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
            + I+HRD+K  N+++D +   +++ D+G +  +  G + +    +  +  PEL    + 
Sbjct: 132 QKRIVHRDLKAENLLLDADM-NIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKY 190
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPF 329
               +D+WSLG +   ++    PF
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPF 214

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 69/150 (46%), Gaps = 17/150 (11%)
Query: 189 PNIVKLLDIVRDQ-------QSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKAL 241
           PNI++L +   D        +  T   +FE V      V      + D    + ++L A+
Sbjct: 66  PNIIRLYETFEDNTDIYLVMELCTGGELFERV------VHKRVFRESDAARIMKDVLSAV 119
Query: 242 DYCHSQGIMHRDVKPHNVMI--DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 299
            YCH   + HRD+KP N +   D     L+LID+GLA  + PGK    +V + Y+  P++
Sbjct: 120 AYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQV 179
Query: 300 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
           L  L  Y    D WS G M   ++    PF
Sbjct: 180 LEGL--YGPECDEWSAGVMMYVLLCGYPPF 207

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 69/150 (46%), Gaps = 17/150 (11%)
Query: 189 PNIVKLLDIVRDQ-------QSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKAL 241
           PNI++L +   D        +  T   +FE V      V      + D    + ++L A+
Sbjct: 83  PNIIRLYETFEDNTDIYLVMELCTGGELFERV------VHKRVFRESDAARIMKDVLSAV 136
Query: 242 DYCHSQGIMHRDVKPHNVMI--DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 299
            YCH   + HRD+KP N +   D     L+LID+GLA  + PGK    +V + Y+  P++
Sbjct: 137 AYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQV 196
Query: 300 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
           L  L  Y    D WS G M   ++    PF
Sbjct: 197 LEGL--YGPECDEWSAGVMMYVLLCGYPPF 224

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 43/202 (21%), Positives = 93/202 (46%), Gaps = 10/202 (4%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXXXXXXX----XXLQNLCGGPN 190
           +Y +++ +G+G +++V    H    +                         +  +   PN
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCHSQ 247
           IVKL +++  +  KT  L+ E+ +     D+ V +  + + + R    +++ A+ YCH +
Sbjct: 75  IVKLFEVI--ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQK 132
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 307
            I+HRD+K  N+++D +   +++ D+G +  +  G + +    S  +  PEL    +   
Sbjct: 133 FIVHRDLKAENLLLDADM-NIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDG 191
Query: 308 YSLDLWSLGCMFAGMIFRKEPF 329
             +D+WSLG +   ++    PF
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPF 213

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 71/303 (23%), Positives = 122/303 (40%), Gaps = 56/303 (18%)
Query: 129 QWGEQDDYEVVRKVGRGKYSEVF-----EGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQ 183
           QW   +D+E+ R +G+GK+  V+     +       +                     +Q
Sbjct: 4   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD---VRYYIYELLKA 240
           +    PNI++L     D  +    LI E+            LS +D      YI EL  A
Sbjct: 63  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 300
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTELCGTLDYLPPE-M 177
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 360
           ++ + +D  +DLWSLG +    +  K PF                    E N Y   Y  
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQETYK- 216
Query: 361 ELDPHLAALVGRHSRKPWS--KFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
                      R SR  ++   F+T          A D + +LL+++  +RP  +E + H
Sbjct: 217 -----------RISRVEFTFPDFVT--------EGARDLISRLLKHNPSQRPMLREVLEH 257
Query: 419 PYF 421
           P+ 
Sbjct: 258 PWI 260

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 71/303 (23%), Positives = 121/303 (39%), Gaps = 56/303 (18%)
Query: 129 QWGEQDDYEVVRKVGRGKYSEVFEGVHCTDN-----EXXXXXXXXXXXXXXXXXXXXXLQ 183
           QW   +D+E+ R +G+GK+  V+             +                     +Q
Sbjct: 1   QWA-LEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQ 59
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD---VRYYIYELLKA 240
           +    PNI++L     D  +    LI E+            LS +D      YI EL  A
Sbjct: 60  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 117
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 300
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 118 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-M 174
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 360
           ++ + +D  +DLWSLG +    +  K PF                    E N Y   Y  
Sbjct: 175 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQETYK- 213
Query: 361 ELDPHLAALVGRHSRKPWS--KFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
                      R SR  ++   F+T          A D + +LL+++  +RP  +E + H
Sbjct: 214 -----------RISRVEFTFPDFVT--------EGARDLISRLLKHNPSQRPMLREVLEH 254
Query: 419 PYF 421
           P+ 
Sbjct: 255 PWI 257

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 43/202 (21%), Positives = 93/202 (46%), Gaps = 10/202 (4%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEXXXX----XXXXXXXXXXXXXXXXXLQNLCGGPN 190
           +Y +++ +G+G +++V    H    +                         +  +   PN
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCHSQ 247
           IVKL +++  +  KT  L+ E+ +     D+ V +  + + + R    +++ A+ YCH +
Sbjct: 75  IVKLFEVI--ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQK 132
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 307
            I+HRD+K  N+++D +   +++ D+G +  +  G + +    S  +  PEL    +   
Sbjct: 133 FIVHRDLKAENLLLDADM-NIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDG 191
Query: 308 YSLDLWSLGCMFAGMIFRKEPF 329
             +D+WSLG +   ++    PF
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPF 213

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 43/202 (21%), Positives = 93/202 (46%), Gaps = 10/202 (4%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXXXXXXX----XXLQNLCGGPN 190
           +Y +++ +G+G +++V    H    +                         +  +   PN
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCHSQ 247
           IVKL +++  +  KT  L+ E+ +     D+ V +  + + + R    +++ A+ YCH +
Sbjct: 75  IVKLFEVI--ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQK 132
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 307
            I+HRD+K  N+++D +   +++ D+G +  +  G + +    S  +  PEL    +   
Sbjct: 133 FIVHRDLKAENLLLDADM-NIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDG 191
Query: 308 YSLDLWSLGCMFAGMIFRKEPF 329
             +D+WSLG +   ++    PF
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPF 213

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 71/303 (23%), Positives = 122/303 (40%), Gaps = 56/303 (18%)
Query: 129 QWGEQDDYEVVRKVGRGKYSEVF-----EGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQ 183
           QW   +D+E+ R +G+GK+  V+     +       +                     +Q
Sbjct: 4   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD---VRYYIYELLKA 240
           +    PNI++L     D  +    LI E+            LS +D      YI EL  A
Sbjct: 63  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 300
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPE-M 177
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 360
           ++ + +D  +DLWSLG +    +  K PF                    E N Y   Y  
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQETYK- 216
Query: 361 ELDPHLAALVGRHSRKPWS--KFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
                      R SR  ++   F+T          A D + +LL+++  +RP  +E + H
Sbjct: 217 -----------RISRVEFTFPDFVT--------EGARDLISRLLKHNPSQRPMLREVLEH 257
Query: 419 PYF 421
           P+ 
Sbjct: 258 PWI 260

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 109/250 (43%), Gaps = 43/250 (17%)
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCHS 246
           N++ L D+  ++      LI E V+     DF     +LS+ +   +I ++L  ++Y H+
Sbjct: 76  NVITLHDVYENRTDVV--LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 247 QGIMHRDVKPHNVMIDHEQR---KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 303
           + I H D+KP N+M+  +      ++LID+GLA     G E+     +  F  PE +V+ 
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNY 192
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363
           +      D+WS+G +   ++    PF  G    + L  I  V       +Y   +  E  
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANITAV-------SY--DFDEEFF 242
Query: 364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP 423
              + L                        A DF+ KLL  + ++R T +EA+ HP+  P
Sbjct: 243 SQTSEL------------------------AKDFIRKLLVKETRKRLTIQEALRHPWITP 278
Query: 424 IRNAESSRSR 433
           + N ++   R
Sbjct: 279 VDNQQAMVRR 288

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 71/303 (23%), Positives = 123/303 (40%), Gaps = 56/303 (18%)
Query: 129 QWGEQDDYEVVRKVGRGKYSEVF-----EGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQ 183
           QW   +D+E+ R +G+GK+  V+     +       +                     +Q
Sbjct: 7   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 65
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD---VRYYIYELLKA 240
           +    PNI++L     D  +    LI E+            LS +D      YI EL  A
Sbjct: 66  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 123
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 300
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P    +    +  +  PE +
Sbjct: 124 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPE-M 180
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 360
           ++ + +D  +DLWSLG +    +  K PF                    E N Y   Y  
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQETYK- 219
Query: 361 ELDPHLAALVGRHSRKPWS--KFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
                      R SR  ++   F+T          A D + +LL+++  +RP  +E + H
Sbjct: 220 -----------RISRVEFTFPDFVT--------EGARDLISRLLKHNPSQRPMLREVLEH 260
Query: 419 PYF 421
           P+ 
Sbjct: 261 PWI 263

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 99/218 (45%), Gaps = 44/218 (20%)
Query: 208 LIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRK 267
           L FE V   D   +Y   S+    +Y+ ++L+AL YCH   I+HRDVKP NV++  ++  
Sbjct: 113 LCFEIVKRADAGFVY---SEAVASHYMRQILEALRYCHDNNIIHRDVKPENVLLASKENS 169
Query: 268 --LRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF 324
             ++L D+G+A +    G     RV + +F  PE +V  + Y   +D+W  G +   ++ 
Sbjct: 170 APVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPE-VVKREPYGKPVDVWGCGVILFILLS 228
Query: 325 RKEPFFYGHDNYDQLVKIAKVLGTDE-LNAYLNKYHIELDPHLAALVGRHSRKPWSKFIT 383
              PF+                GT E L   + K   +++P           + WS    
Sbjct: 229 GCLPFY----------------GTKERLFEGIIKGKYKMNP-----------RQWS---- 257
Query: 384 VENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
               H++   A D + ++L  D  ER T  EA+ HP+ 
Sbjct: 258 ----HIS-ESAKDLVRRMLMLDPAERITVYEALNHPWL 290

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 109/250 (43%), Gaps = 43/250 (17%)
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCHS 246
           N++ L D+  ++      LI E V+     DF     +LS+ +   +I ++L  ++Y H+
Sbjct: 76  NVITLHDVYENRTDVV--LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 247 QGIMHRDVKPHNVMIDHEQR---KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 303
           + I H D+KP N+M+  +      ++LID+GLA     G E+     +  F  PE +V+ 
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNY 192
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363
           +      D+WS+G +   ++    PF  G    + L  I  V       +Y   +  E  
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANITAV-------SY--DFDEEFF 242
Query: 364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP 423
              + L                        A DF+ KLL  + ++R T +EA+ HP+  P
Sbjct: 243 SQTSEL------------------------AKDFIRKLLVKETRKRLTIQEALRHPWITP 278
Query: 424 IRNAESSRSR 433
           + N ++   R
Sbjct: 279 VDNQQAMVRR 288

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 111/268 (41%), Gaps = 32/268 (11%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVK 193
           D YEV   +G G YS     +H   N                      L+     PNI+ 
Sbjct: 22  DGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEILLR-YGQHPNIIT 80
Query: 194 LLDIVRDQQSKTPSLIFEHVNNTDF--KVLYPTL-SDYDVRYYIYELLKALDYCHSQGIM 250
           L D+  D   K   ++ E     +   K+L     S+ +    ++ + K ++Y H+QG++
Sbjct: 81  LKDVYDD--GKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVV 138
Query: 251 HRDVKPHNVMIDHEQ---RKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDY 306
           HRD+KP N++   E      +R+ D+G A +             +  F  PE+L + Q Y
Sbjct: 139 HRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVAPEVL-ERQGY 197
Query: 307 DYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELN---AYLNKYH---- 359
           D + D+WSLG +    +    PF  G D+  +  +I   +G+ + +    Y N       
Sbjct: 198 DAACDIWSLGVLLYTXLTGYTPFANGPDDTPE--EILARIGSGKFSLSGGYWNSVSDTAK 255
Query: 360 ------IELDPH---LAALVGRHSRKPW 378
                 + +DPH    AALV RH   PW
Sbjct: 256 DLVSKXLHVDPHQRLTAALVLRH---PW 280

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/248 (22%), Positives = 108/248 (43%), Gaps = 48/248 (19%)
Query: 182 LQNLCGGPNIVKLLDIVRDQQSKTPSL-------IFEHVNNTDFKVLYPTLSDYDVRYYI 234
           + N    P ++ L D   D+      L       +F+ +   D+K     +S+ +V  Y+
Sbjct: 101 IMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-----MSEAEVINYM 155
Query: 235 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQ-RKLRLIDWGLAEFYHPGKEYNVRVASRY 293
            +  + L + H   I+H D+KP N+M + ++   +++ID+GLA   +P +   V  A+  
Sbjct: 156 RQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAE 215
Query: 294 FKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 353
           F  PE +VD +   +  D+W++G +   ++    P F G D+ + L  + +     + +A
Sbjct: 216 FAAPE-IVDREPVGFYTDMWAIGVLGYVLLSGLSP-FAGEDDLETLQNVKRCDWEFDEDA 273
Query: 354 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK 413
           + +                                   PEA DF+  LL+ + ++R T  
Sbjct: 274 FSS---------------------------------VSPEAKDFIKNLLQKEPRKRLTVH 300
Query: 414 EAMAHPYF 421
           +A+ HP+ 
Sbjct: 301 DALEHPWL 308

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/260 (23%), Positives = 115/260 (44%), Gaps = 57/260 (21%)
Query: 207 SLIFEHVNNTDFKVL----YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 262
            LIFE +  + ++++    Y      D++ Y  E+LKAL+Y     + H D+KP N+++D
Sbjct: 112 CLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLD 171
Query: 263 H------------------------EQRKLRLIDWGLAEF---YHPGKEYNVRVASRYFK 295
                                    +   ++LID+G A F   YH        + +R ++
Sbjct: 172 DPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGS-----IINTRQYR 226
Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA-- 353
            PE++++L  +D S D+WS GC+ A + +     F  H++ + L  +  ++     N   
Sbjct: 227 APEVILNL-GWDVSSDMWSFGCVLAEL-YTGSLLFRTHEHMEHLAMMESIIQPIPKNMLY 284
Query: 354 ---------YLNKYHIELD-PHLAALVG--RHSRKPWSKFITVENQHLAVPEAVDFLDKL 401
                    Y+NK  ++L  P  A+ +   +H +K    +  ++++        DFL  +
Sbjct: 285 EATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFC-----DFLYSI 339
Query: 402 LRYDHQERPTAKEAMAHPYF 421
           L+ D   RP+  E + H + 
Sbjct: 340 LQIDPTLRPSPAELLKHKFL 359

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 129/297 (43%), Gaps = 46/297 (15%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDN-EXXXXXXXXXXXXXXXXXXXXXLQNLCGG---P 189
           D+Y+V  ++G+G +S V   VH T   E                        +C     P
Sbjct: 29  DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 88
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDF---KVLYPTLSDYDVRYYIYELLKALDYCHS 246
           NIV+L D +  Q+     L+F+ V   +     V     S+ D  + I ++L+++ YCHS
Sbjct: 89  NIVRLHDSI--QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS 146
Query: 247 QGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
            GI+HR++KP N+++  + +   ++L D+GLA   +  + ++    +  +  PE+L    
Sbjct: 147 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK-D 205
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y   +D+W+ G +   ++    PF+    + DQ    A++    +  AY          
Sbjct: 206 PYSKPVDIWACGVILYILLVGYPPFW----DEDQHRLYAQI----KAGAY---------- 247
Query: 365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
                       P  ++ TV       PEA   +D +L  + ++R TA +A+  P+ 
Sbjct: 248 ----------DYPSPEWDTV------TPEAKSLIDSMLTVNPKKRITADQALKVPWI 288

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 71/303 (23%), Positives = 122/303 (40%), Gaps = 56/303 (18%)
Query: 129 QWGEQDDYEVVRKVGRGKYSEVF-----EGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQ 183
           QW   +D+E+ R +G+GK+  V+     +       +                     +Q
Sbjct: 5   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 63
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD---VRYYIYELLKA 240
           +    PNI++L     D  +    LI E+            LS +D      YI EL  A
Sbjct: 64  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 300
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPE-M 178
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 360
           ++ + +D  +DLWSLG +    +  K PF                    E N Y   Y  
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQETYK- 217
Query: 361 ELDPHLAALVGRHSRKPWS--KFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
                      R SR  ++   F+T          A D + +LL+++  +RP  +E + H
Sbjct: 218 -----------RISRVEFTFPDFVT--------EGARDLISRLLKHNPSQRPMLREVLEH 258
Query: 419 PYF 421
           P+ 
Sbjct: 259 PWI 261

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 71/303 (23%), Positives = 122/303 (40%), Gaps = 56/303 (18%)
Query: 129 QWGEQDDYEVVRKVGRGKYSEVF-----EGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQ 183
           QW   +D+E+ R +G+GK+  V+     +       +                     +Q
Sbjct: 4   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD---VRYYIYELLKA 240
           +    PNI++L     D  +    LI E+            LS +D      YI EL  A
Sbjct: 63  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 300
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPE-M 177
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 360
           ++ + +D  +DLWSLG +    +  K PF                    E N Y   Y  
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQETYK- 216
Query: 361 ELDPHLAALVGRHSRKPWS--KFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
                      R SR  ++   F+T          A D + +LL+++  +RP  +E + H
Sbjct: 217 -----------RISRVEFTFPDFVT--------EGARDLISRLLKHNPSQRPMLREVLEH 257
Query: 419 PYF 421
           P+ 
Sbjct: 258 PWI 260

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 71/303 (23%), Positives = 122/303 (40%), Gaps = 56/303 (18%)
Query: 129 QWGEQDDYEVVRKVGRGKYSEVF-----EGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQ 183
           QW   +D+E+ R +G+GK+  V+     +       +                     +Q
Sbjct: 4   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD---VRYYIYELLKA 240
           +    PNI++L     D  +    LI E+            LS +D      YI EL  A
Sbjct: 63  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 300
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPE-M 177
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 360
           ++ + +D  +DLWSLG +    +  K PF                    E N Y   Y  
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQETYK- 216
Query: 361 ELDPHLAALVGRHSRKPWS--KFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
                      R SR  ++   F+T          A D + +LL+++  +RP  +E + H
Sbjct: 217 -----------RISRVEFTFPDFVT--------EGARDLISRLLKHNPSQRPMLREVLEH 257
Query: 419 PYF 421
           P+ 
Sbjct: 258 PWI 260

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 71/303 (23%), Positives = 122/303 (40%), Gaps = 56/303 (18%)
Query: 129 QWGEQDDYEVVRKVGRGKYSEVF-----EGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQ 183
           QW   +D+E+ R +G+GK+  V+     +       +                     +Q
Sbjct: 9   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 67
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD---VRYYIYELLKA 240
           +    PNI++L     D  +    LI E+            LS +D      YI EL  A
Sbjct: 68  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 125
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 300
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 126 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPE-M 182
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 360
           ++ + +D  +DLWSLG +    +  K PF                    E N Y   Y  
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQETYK- 221
Query: 361 ELDPHLAALVGRHSRKPWS--KFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
                      R SR  ++   F+T          A D + +LL+++  +RP  +E + H
Sbjct: 222 -----------RISRVEFTFPDFVT--------EGARDLISRLLKHNPSQRPMLREVLEH 262
Query: 419 PYF 421
           P+ 
Sbjct: 263 PWI 265

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 42/123 (34%), Positives = 69/123 (56%), Gaps = 6/123 (4%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE--FYHPG 282
            ++ DV++Y+ EL   LD+ HS GI++RD+KP N+++D E+  ++L D+GL++    H  
Sbjct: 127 FTEEDVKFYLAELALGLDHLHSLGIIYRDLKPENILLD-EEGHIKLTDFGLSKEAIDHEK 185
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKI 342
           K Y+      Y   PE +V+ Q + +S D WS G +   M+    P F G D  + +  I
Sbjct: 186 KAYSFCGTVEYM-APE-VVNRQGHSHSADWWSYGVLMFEMLTGSLP-FQGKDRKETMTLI 242
Query: 343 AKV 345
            K 
Sbjct: 243 LKA 245

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 42/123 (34%), Positives = 69/123 (56%), Gaps = 6/123 (4%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE--FYHPG 282
            ++ DV++Y+ EL  ALD+ HS GI++RD+KP N+++D E+  ++L D+GL++    H  
Sbjct: 123 FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEK 181
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKI 342
           K Y+      Y   PE +V+ + +  S D WS G +   M+    P F G D  + +  I
Sbjct: 182 KAYSFCGTVEYM-APE-VVNRRGHTQSADWWSFGVLMFEMLTGTLP-FQGKDRKETMTMI 238
Query: 343 AKV 345
            K 
Sbjct: 239 LKA 241

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 44/137 (32%), Positives = 71/137 (51%), Gaps = 8/137 (5%)
Query: 208 LIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 264
            + E+VN  D          L +   R+Y  E+  AL+Y H +GI++RD+K  NV++D E
Sbjct: 130 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE 189
Query: 265 QRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI 323
              ++L D+G+  E   PG   +    +  +  PE+L   +DY +S+D W+LG +   M+
Sbjct: 190 GH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMM 247
Query: 324 FRKEPF--FYGHDNYDQ 338
             + PF      DN DQ
Sbjct: 248 AGRSPFDIVGSSDNPDQ 264

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 97/206 (47%), Gaps = 12/206 (5%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDN-EXXXXXXXXXXXXXXXXXXXXXLQNLCGG---P 189
           D+Y+V  ++G+G +S V   VH T   E                        +C     P
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 65
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDF---KVLYPTLSDYDVRYYIYELLKALDYCHS 246
           NIV+L D +  Q+     L+F+ V   +     V     S+ D  + I ++L+++ YCHS
Sbjct: 66  NIVRLHDSI--QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS 123
Query: 247 QGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
            GI+HR++KP N+++  + +   ++L D+GLA   +  + ++    +  +  PE+L    
Sbjct: 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK-D 182
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFF 330
            Y   +D+W+ G +   ++    PF+
Sbjct: 183 PYSKPVDIWACGVILYILLVGYPPFW 208

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 97/206 (47%), Gaps = 12/206 (5%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDN-EXXXXXXXXXXXXXXXXXXXXXLQNLCGG---P 189
           D+Y+V  ++G+G +S V   VH T   E                        +C     P
Sbjct: 5   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 64
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDF---KVLYPTLSDYDVRYYIYELLKALDYCHS 246
           NIV+L D +  Q+     L+F+ V   +     V     S+ D  + I ++L+++ YCHS
Sbjct: 65  NIVRLHDSI--QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS 122
Query: 247 QGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
            GI+HR++KP N+++  + +   ++L D+GLA   +  + ++    +  +  PE+L    
Sbjct: 123 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK-D 181
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFF 330
            Y   +D+W+ G +   ++    PF+
Sbjct: 182 PYSKPVDIWACGVILYILLVGYPPFW 207

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/123 (34%), Positives = 69/123 (56%), Gaps = 6/123 (4%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE--FYHPG 282
            ++ DV++Y+ EL  ALD+ HS GI++RD+KP N+++D E+  ++L D+GL++    H  
Sbjct: 124 FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEK 182
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKI 342
           K Y+      Y   PE +V+ + +  S D WS G +   M+    P F G D  + +  I
Sbjct: 183 KAYSFCGTVEYM-APE-VVNRRGHTQSADWWSFGVLMFEMLTGTLP-FQGKDRKETMTMI 239
Query: 343 AKV 345
            K 
Sbjct: 240 LKA 242

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 95/221 (42%), Gaps = 19/221 (8%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQNL-----CGGP 189
           ++ + +K+GRG++SEV+      D                       ++ +        P
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 190 NIVKL-LDIVRDQQSKTPSLIFEHVNNTD-------FKVLYPTLSDYDVRYYIYELLKAL 241
           N++K     + D +    +++ E  +  D       FK     + +  V  Y  +L  AL
Sbjct: 93  NVIKYYASFIEDNEL---NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSAL 149
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVRVASRYFKGPELL 300
           ++ HS+ +MHRD+KP NV I      ++L D GL  F+       +  V + Y+  PE +
Sbjct: 150 EHMHSRRVMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 208
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 341
            +   Y++  D+WSLGC+   M   + PF+    N   L K
Sbjct: 209 HE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK 248

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/202 (20%), Positives = 93/202 (46%), Gaps = 10/202 (4%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXXXXXXX----XXLQNLCGGPN 190
           +Y +++ +G+G +++V    H    +                         +  +   PN
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCHSQ 247
           IVKL +++  +  KT  L+ E+ +     D+ V +  + + + R    +++ A+ YCH +
Sbjct: 75  IVKLFEVI--ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQK 132
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 307
            I+HRD+K  N+++D +   +++ D+G +  +  G + +    +  +  PEL    +   
Sbjct: 133 FIVHRDLKAENLLLDADM-NIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDG 191
Query: 308 YSLDLWSLGCMFAGMIFRKEPF 329
             +D+WSLG +   ++    PF
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPF 213

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/202 (21%), Positives = 93/202 (46%), Gaps = 10/202 (4%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXXXXXXX----XXLQNLCGGPN 190
           +Y +++ +G+G +++V    H    +                         +  +   PN
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 67
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCHSQ 247
           IVKL +++  +  KT  L+ E+ +     D+ V +  + + + R    +++ A+ YCH +
Sbjct: 68  IVKLFEVI--ETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQK 125
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 307
            I+HRD+K  N+++D +   +++ D+G +  +  G + +    S  +  PEL    +   
Sbjct: 126 FIVHRDLKAENLLLDADM-NIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDG 184
Query: 308 YSLDLWSLGCMFAGMIFRKEPF 329
             +D+WSLG +   ++    PF
Sbjct: 185 PEVDVWSLGVILYTLVSGSLPF 206

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 76/144 (52%), Gaps = 6/144 (4%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCH 245
           PNIVKL +++  +  KT  L+ E+ +     D+ V +  + + + R    +++ A+ YCH
Sbjct: 73  PNIVKLFEVI--ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH 130
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
            + I+HRD+K  N+++D +   +++ D+G +  +  G + +    S  +  PEL    + 
Sbjct: 131 QKFIVHRDLKAENLLLDADM-NIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKY 189
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPF 329
               +D+WSLG +   ++    PF
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/123 (34%), Positives = 69/123 (56%), Gaps = 6/123 (4%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE--FYHPG 282
            ++ DV++Y+ EL  ALD+ HS GI++RD+KP N+++D E+  ++L D+GL++    H  
Sbjct: 123 FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEK 181
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKI 342
           K Y+      Y   PE +V+ + +  S D WS G +   M+    P F G D  + +  I
Sbjct: 182 KAYSFCGTVEYM-APE-VVNRRGHTQSADWWSFGVLMFEMLTGTLP-FQGKDRKETMTMI 238
Query: 343 AKV 345
            K 
Sbjct: 239 LKA 241

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 97/206 (47%), Gaps = 12/206 (5%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDN-EXXXXXXXXXXXXXXXXXXXXXLQNLCGG---P 189
           D+Y+V  ++G+G +S V   VH T   E                        +C     P
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 65
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDF---KVLYPTLSDYDVRYYIYELLKALDYCHS 246
           NIV+L D +  Q+     L+F+ V   +     V     S+ D  + I ++L+++ YCHS
Sbjct: 66  NIVRLHDSI--QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS 123
Query: 247 QGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
            GI+HR++KP N+++  + +   ++L D+GLA   +  + ++    +  +  PE+L    
Sbjct: 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK-D 182
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFF 330
            Y   +D+W+ G +   ++    PF+
Sbjct: 183 PYSKPVDIWACGVILYILLVGYPPFW 208

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/137 (32%), Positives = 71/137 (51%), Gaps = 8/137 (5%)
Query: 208 LIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 264
            + E+VN  D          L +   R+Y  E+  AL+Y H +GI++RD+K  NV++D E
Sbjct: 98  FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE 157
Query: 265 QRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI 323
              ++L D+G+  E   PG   +    +  +  PE+L   +DY +S+D W+LG +   M+
Sbjct: 158 GH-IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMM 215
Query: 324 FRKEPF--FYGHDNYDQ 338
             + PF      DN DQ
Sbjct: 216 AGRSPFDIVGSSDNPDQ 232

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 44/218 (20%)
Query: 208 LIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRK 267
           L FE V   D   +Y   S+    +Y+ ++L+AL YCH   I+HRDVKPH V++  ++  
Sbjct: 115 LCFEIVKRADAGFVY---SEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENS 171
Query: 268 --LRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF 324
             ++L  +G+A +    G     RV + +F  PE +V  + Y   +D+W  G +   ++ 
Sbjct: 172 APVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPE-VVKREPYGKPVDVWGCGVILFILLS 230
Query: 325 RKEPFFYGHDNYDQLVKIAKVLGTDE-LNAYLNKYHIELDPHLAALVGRHSRKPWSKFIT 383
              PF+                GT E L   + K   +++P           + WS    
Sbjct: 231 GCLPFY----------------GTKERLFEGIIKGKYKMNP-----------RQWS---- 259
Query: 384 VENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
               H++   A D + ++L  D  ER T  EA+ HP+ 
Sbjct: 260 ----HIS-ESAKDLVRRMLMLDPAERITVYEALNHPWL 292

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 86/196 (43%), Gaps = 46/196 (23%)
Query: 232 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVA 290
           +Y+ E+  AL + H +GI++RD+KP N+M++H Q  ++L D+GL  E  H G   +    
Sbjct: 125 FYLAEISMALGHLHQKGIIYRDLKPENIMLNH-QGHVKLTDFGLCKESIHDGTVTHTFCG 183
Query: 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE 350
           +  +  PE+L+    ++ ++D WSLG +   M+    P F G +    + KI K      
Sbjct: 184 TIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPP-FTGENRKKTIDKILKC----- 236
Query: 351 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQER- 409
                    + L P+L                          EA D L KLL+ +   R 
Sbjct: 237 --------KLNLPPYLTQ------------------------EARDLLKKLLKRNAASRL 264
Query: 410 ----PTAKEAMAHPYF 421
                 A E  AHP+F
Sbjct: 265 GAGPGDAGEVQAHPFF 280

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/137 (32%), Positives = 71/137 (51%), Gaps = 8/137 (5%)
Query: 208 LIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 264
            + E+VN  D          L +   R+Y  E+  AL+Y H +GI++RD+K  NV++D E
Sbjct: 83  FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE 142
Query: 265 QRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI 323
              ++L D+G+  E   PG   +    +  +  PE+L   +DY +S+D W+LG +   M+
Sbjct: 143 GH-IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMM 200
Query: 324 FRKEPF--FYGHDNYDQ 338
             + PF      DN DQ
Sbjct: 201 AGRSPFDIVGSSDNPDQ 217

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/137 (32%), Positives = 71/137 (51%), Gaps = 8/137 (5%)
Query: 208 LIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 264
            + E+VN  D          L +   R+Y  E+  AL+Y H +GI++RD+K  NV++D E
Sbjct: 87  FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE 146
Query: 265 QRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI 323
              ++L D+G+  E   PG   +    +  +  PE+L   +DY +S+D W+LG +   M+
Sbjct: 147 GH-IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMM 204
Query: 324 FRKEPF--FYGHDNYDQ 338
             + PF      DN DQ
Sbjct: 205 AGRSPFDIVGSSDNPDQ 221

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 86/196 (43%), Gaps = 46/196 (23%)
Query: 232 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVA 290
           +Y+ E+  AL + H +GI++RD+KP N+M++H Q  ++L D+GL  E  H G   +    
Sbjct: 125 FYLAEISMALGHLHQKGIIYRDLKPENIMLNH-QGHVKLTDFGLCKESIHDGTVTHXFCG 183
Query: 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE 350
           +  +  PE+L+    ++ ++D WSLG +   M+    P F G +    + KI K      
Sbjct: 184 TIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPP-FTGENRKKTIDKILKC----- 236
Query: 351 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQER- 409
                    + L P+L                          EA D L KLL+ +   R 
Sbjct: 237 --------KLNLPPYLTQ------------------------EARDLLKKLLKRNAASRL 264
Query: 410 ----PTAKEAMAHPYF 421
                 A E  AHP+F
Sbjct: 265 GAGPGDAGEVQAHPFF 280

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 80/163 (49%), Gaps = 10/163 (6%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCH 245
           PNI+ L DI  ++      LI E V+     DF     +L++ +   ++ ++L  + Y H
Sbjct: 68  PNIITLHDIFENKTDVV--LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 125
Query: 246 SQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
           S+ I H D+KP N+M+   +    +++LID+G+A     G E+     +  F  PE +V+
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE-IVN 184
Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV 345
            +      D+WS+G +   ++    PF  G    + L  I+ V
Sbjct: 185 YEPLGLEADMWSIGVITYILLSGASPFL-GETKQETLTNISAV 226

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 44/218 (20%)
Query: 208 LIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRK 267
           L FE V   D   +Y   S+    +Y+ ++L+AL YCH   I+HRDVKPH V++  ++  
Sbjct: 113 LCFEIVKRADAGFVY---SEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENS 169
Query: 268 --LRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF 324
             ++L  +G+A +    G     RV + +F  PE +V  + Y   +D+W  G +   ++ 
Sbjct: 170 APVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPE-VVKREPYGKPVDVWGCGVILFILLS 228
Query: 325 RKEPFFYGHDNYDQLVKIAKVLGTDE-LNAYLNKYHIELDPHLAALVGRHSRKPWSKFIT 383
              PF+                GT E L   + K   +++P           + WS    
Sbjct: 229 GCLPFY----------------GTKERLFEGIIKGKYKMNP-----------RQWS---- 257
Query: 384 VENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
               H++   A D + ++L  D  ER T  EA+ HP+ 
Sbjct: 258 ----HIS-ESAKDLVRRMLMLDPAERITVYEALNHPWL 290

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 37/144 (25%), Positives = 75/144 (52%), Gaps = 6/144 (4%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCH 245
           PNIVKL +++  +  KT  L+ E+ +     D+ V +    + + R    +++ A+ YCH
Sbjct: 73  PNIVKLFEVI--ETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCH 130
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
            + I+HRD+K  N+++D +   +++ D+G +  +  G + +    +  +  PEL    + 
Sbjct: 131 QKFIVHRDLKAENLLLDADX-NIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKY 189
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPF 329
               +D+WSLG +   ++    PF
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 80/163 (49%), Gaps = 10/163 (6%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCH 245
           PNI+ L DI  ++      LI E V+     DF     +L++ +   ++ ++L  + Y H
Sbjct: 75  PNIITLHDIFENKTDVV--LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 132
Query: 246 SQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
           S+ I H D+KP N+M+   +    +++LID+G+A     G E+     +  F  PE +V+
Sbjct: 133 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE-IVN 191
Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV 345
            +      D+WS+G +   ++    PF  G    + L  I+ V
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFL-GETKQETLTNISAV 233

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 80/163 (49%), Gaps = 10/163 (6%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCH 245
           PNI+ L DI  ++      LI E V+     DF     +L++ +   ++ ++L  + Y H
Sbjct: 89  PNIITLHDIFENKTDVV--LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 146
Query: 246 SQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
           S+ I H D+KP N+M+   +    +++LID+G+A     G E+     +  F  PE +V+
Sbjct: 147 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE-IVN 205
Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV 345
            +      D+WS+G +   ++    PF  G    + L  I+ V
Sbjct: 206 YEPLGLEADMWSIGVITYILLSGASPFL-GETKQETLTNISAV 247

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 92/212 (43%), Gaps = 25/212 (11%)
Query: 134 DDYEVVRKVGRGKYSEVFE----------GVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQ 183
           +D+ V R +GRG + EV+            + C D +                       
Sbjct: 188 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 247
Query: 184 NLCGGPNIVKLLDIVRDQQSKTP---SLIFEHVNNTDFK---VLYPTLSDYDVRYYIYEL 237
             C  P IV +          TP   S I + +N  D       +   S+ D+R+Y  E+
Sbjct: 248 GDC--PFIVCM-----SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEI 300
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 297
           +  L++ H++ +++RD+KP N+++D E   +R+ D GLA  +   K +   V +  +  P
Sbjct: 301 ILGLEHMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPH-ASVGTHGYMAP 358
Query: 298 ELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
           E+L     YD S D +SLGCM   ++    PF
Sbjct: 359 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 390

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 92/212 (43%), Gaps = 25/212 (11%)
Query: 134 DDYEVVRKVGRGKYSEVFE----------GVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQ 183
           +D+ V R +GRG + EV+            + C D +                       
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 184 NLCGGPNIVKLLDIVRDQQSKTP---SLIFEHVNNTDFK---VLYPTLSDYDVRYYIYEL 237
             C  P IV +          TP   S I + +N  D       +   S+ D+R+Y  E+
Sbjct: 249 GDC--PFIVCM-----SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEI 301
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 297
           +  L++ H++ +++RD+KP N+++D E   +R+ D GLA  +   K +   V +  +  P
Sbjct: 302 ILGLEHMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPH-ASVGTHGYMAP 359
Query: 298 ELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
           E+L     YD S D +SLGCM   ++    PF
Sbjct: 360 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 92/212 (43%), Gaps = 25/212 (11%)
Query: 134 DDYEVVRKVGRGKYSEVFE----------GVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQ 183
           +D+ V R +GRG + EV+            + C D +                       
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 184 NLCGGPNIVKLLDIVRDQQSKTP---SLIFEHVNNTDFK---VLYPTLSDYDVRYYIYEL 237
             C  P IV +          TP   S I + +N  D       +   S+ D+R+Y  E+
Sbjct: 249 GDC--PFIVCM-----SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEI 301
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 297
           +  L++ H++ +++RD+KP N+++D E   +R+ D GLA  +   K +   V +  +  P
Sbjct: 302 ILGLEHMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPH-ASVGTHGYMAP 359
Query: 298 ELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
           E+L     YD S D +SLGCM   ++    PF
Sbjct: 360 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 92/212 (43%), Gaps = 25/212 (11%)
Query: 134 DDYEVVRKVGRGKYSEVFE----------GVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQ 183
           +D+ V R +GRG + EV+            + C D +                       
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 184 NLCGGPNIVKLLDIVRDQQSKTP---SLIFEHVNNTDFK---VLYPTLSDYDVRYYIYEL 237
             C  P IV +          TP   S I + +N  D       +   S+ D+R+Y  E+
Sbjct: 249 GDC--PFIVCM-----SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEI 301
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 297
           +  L++ H++ +++RD+KP N+++D E   +R+ D GLA  +   K +   V +  +  P
Sbjct: 302 ILGLEHMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPH-ASVGTHGYMAP 359
Query: 298 ELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
           E+L     YD S D +SLGCM   ++    PF
Sbjct: 360 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/242 (21%), Positives = 101/242 (41%), Gaps = 48/242 (19%)
Query: 189 PNIVKLLDIVRD-------QQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKAL 241
           PNI+K+ ++  D        ++     + E + +   +     LS+  V   + +++ AL
Sbjct: 80  PNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQAR--GKALSEGYVAELMKQMMNAL 137
Query: 242 DYCHSQGIMHRDVKPHNVMIDHE--QRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 299
            Y HSQ ++H+D+KP N++         +++ID+GLAE +   +       +  +  PE+
Sbjct: 138 AYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEV 197
Query: 300 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 359
               +D  +  D+WS G +   ++    PF         L ++ +     E N     Y 
Sbjct: 198 FK--RDVTFKCDIWSAGVVMYFLLTGCLPF-----TGTSLEEVQQKATYKEPN-----YA 245
Query: 360 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHP 419
           +E  P                           P+AVD L ++L  D + RP+A + + H 
Sbjct: 246 VECRP-------------------------LTPQAVDLLKQMLTKDPERRPSAAQVLHHE 280
Query: 420 YF 421
           +F
Sbjct: 281 WF 282

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 41/125 (32%), Positives = 66/125 (52%), Gaps = 19/125 (15%)
Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-------------PG 282
           ++L+AL Y HSQGI+HR++KP N+ ID E R +++ D+GLA+  H             PG
Sbjct: 124 QILEALSYIHSQGIIHRNLKPXNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 283 KEYNVR--VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
              N+   + +  +   E+L     Y+  +D +SLG +F   I+   PF  G +  + L 
Sbjct: 183 SSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIY---PFSTGXERVNILK 239
Query: 341 KIAKV 345
           K+  V
Sbjct: 240 KLRSV 244

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 37/147 (25%), Positives = 72/147 (48%), Gaps = 12/147 (8%)
Query: 189 PNIVKLLDIVRDQQSKTPS---LIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALD 242
           P+I+KL  ++      TP+   ++ E+V+     D+   +  + + + R    ++L A+D
Sbjct: 71  PHIIKLYQVI-----STPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD 125
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
           YCH   ++HRD+KP NV++D      ++ D+GL+     G+       S  +  PE++  
Sbjct: 126 YCHRHMVVHRDLKPENVLLD-AHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISG 184
Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPF 329
                  +D+WS G +   ++    PF
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCGTLPF 211

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 99/217 (45%), Gaps = 47/217 (21%)
Query: 209 IFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRK- 267
           IFE +N + F+     L++ ++  Y++++ +AL + HS  I H D++P N++  ++ R+ 
Sbjct: 88  IFERINTSAFE-----LNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENII--YQTRRS 140
Query: 268 --LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD-YDYSLDLWSLGCMFAGMIF 324
             +++I++G A    PG  + +   +  +  PE  V   D    + D+WSLG +   ++ 
Sbjct: 141 STIKIIEFGQARQLKPGDNFRLLFTAPEYYAPE--VHQHDVVSTATDMWSLGTLVYVLLS 198
Query: 325 RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITV 384
              PF     N   +  I     T +  A+                         K I++
Sbjct: 199 GINPFL-AETNQQIIENIMNAEYTFDEEAF-------------------------KEISI 232
Query: 385 ENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
                   EA+DF+D+LL  + + R TA EA+ HP+ 
Sbjct: 233 --------EAMDFVDRLLVKERKSRMTASEALQHPWL 261

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 71/147 (48%), Gaps = 7/147 (4%)
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHV----NNTDFKVLYPTLSDYDVRYYIYELLKALD 242
           G P +++LLD    Q+     L+ E      +  D+      L +   R +  +++ A+ 
Sbjct: 96  GHPGVIRLLDWFETQEGFM--LVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQ 153
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
           +CHS+G++HRD+K  N++ID  +   +LID+G     H  + Y     +R +  PE +  
Sbjct: 154 HCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH-DEPYTDFDGTRVYSPPEWISR 212
Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPF 329
            Q +     +WSLG +   M+    PF
Sbjct: 213 HQYHALPATVWSLGILLYDMVCGDIPF 239

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 101/242 (41%), Gaps = 54/242 (22%)
Query: 195 LDIVRDQQSKTPSLIFEHVNNT--------DFKVLYPTLSDYDVRYYIYELLKALDYCHS 246
           +D+V+ Q    P    E +N +        DF      +S+      + ++  AL Y H+
Sbjct: 132 MDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNI-----MRQIFSALHYLHN 186
Query: 247 QGIMHRDVKPHNVMIDHEQR-KLRLIDWGLA-EFY--HPGKEYNV--RVASRYFKGPELL 300
           QGI HRD+KP N +    +  +++L+D+GL+ EFY  + G+ Y +  +  + YF  PE+L
Sbjct: 187 QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVL 246
Query: 301 -VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 359
               + Y    D WS G +   ++    PF   +D              D ++  LNK  
Sbjct: 247 NTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVND-------------ADTISQVLNKKL 293
Query: 360 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHP 419
              +P                     N ++  P A D L  LL  +  ER  A  A+ HP
Sbjct: 294 CFENP---------------------NYNVLSPLARDLLSNLLNRNVDERFDAMRALQHP 332
Query: 420 YF 421
           + 
Sbjct: 333 WI 334

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/146 (25%), Positives = 75/146 (51%), Gaps = 11/146 (7%)
Query: 189 PNIVKLLDIVRDQQSKTPS---LIFEHVNNT--DFKVLYPTLSDYDVRYYIYELLKALDY 243
           P+I+KL D++      TP+   ++ E+      D+ V    +++ + R +  +++ A++Y
Sbjct: 69  PHIIKLYDVI-----TTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEY 123
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 303
           CH   I+HRD+KP N+++D +   +++ D+GL+     G        S  +  PE++   
Sbjct: 124 CHRHKIVHRDLKPENLLLD-DNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGK 182
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPF 329
                 +D+WS G +   M+  + PF
Sbjct: 183 LYAGPEVDVWSCGIVLYVMLVGRLPF 208

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 86/200 (43%), Gaps = 42/200 (21%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
           L + ++    +  L+ L Y HS  ++HRDVK  N+++  E   ++L D+G A    P   
Sbjct: 151 LQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS-EPGLVKLGDFGSASIMAPA-- 207
Query: 285 YNVRVASRYFKGPELLVDLQD--YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKI 342
            N  V + Y+  PE+++ + +  YD  +D+WSLG     +  RK P F            
Sbjct: 208 -NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF------------ 254
Query: 343 AKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLL 402
                   +NA    YHI  +   A   G      WS++              +F+D  L
Sbjct: 255 -------NMNAMSALYHIAQNESPALQSGH-----WSEYFR------------NFVDSCL 290
Query: 403 RYDHQERPTAKEAMAHPYFF 422
           +   Q+RPT++  + H +  
Sbjct: 291 QKIPQDRPTSEVLLKHRFVL 310

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 72/144 (50%), Gaps = 7/144 (4%)
Query: 190 NIVKLLDIVRDQQSKTPSLIFE-HVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCH 245
           NI+K+LDI  +Q      L+ E H +  D       +P L +    Y   +L+ A+ Y  
Sbjct: 90  NIIKVLDIFENQGFF--QLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLR 147
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
            + I+HRD+K  N++I  E   ++LID+G A +   GK +     +  +  PE+L+    
Sbjct: 148 LKDIIHRDIKDENIVI-AEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPY 206
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPF 329
               L++WSLG     ++F + PF
Sbjct: 207 RGPELEMWSLGVTLYTLVFEENPF 230

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 88/201 (43%), Gaps = 37/201 (18%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRK--LRLIDWGLAEFYHPG 282
           L +   + Y Y++L A+ Y H  GI+HRD+KP NV++  ++    +++ D+G ++     
Sbjct: 110 LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 169
Query: 283 KEYNVRVASRYFKGPELLVDL--QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
                   +  +  PE+LV +    Y+ ++D WSLG +   +     P F  H     L 
Sbjct: 170 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF-ICLSGYPPFSEHRTQVSL- 227
Query: 341 KIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDK 400
                   D++ +   KY+    P + A V                      +A+D + K
Sbjct: 228 -------KDQITS--GKYN--FIPEVWAEVSE--------------------KALDLVKK 256
Query: 401 LLRYDHQERPTAKEAMAHPYF 421
           LL  D + R T +EA+ HP+ 
Sbjct: 257 LLVVDPKARFTTEEALRHPWL 277

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 88/201 (43%), Gaps = 37/201 (18%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRK--LRLIDWGLAEFYHPG 282
           L +   + Y Y++L A+ Y H  GI+HRD+KP NV++  ++    +++ D+G ++     
Sbjct: 111 LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 170
Query: 283 KEYNVRVASRYFKGPELLVDL--QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
                   +  +  PE+LV +    Y+ ++D WSLG +   +     P F  H     L 
Sbjct: 171 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF-ICLSGYPPFSEHRTQVSL- 228
Query: 341 KIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDK 400
                   D++ +   KY+    P + A V                      +A+D + K
Sbjct: 229 -------KDQITS--GKYN--FIPEVWAEVSE--------------------KALDLVKK 257
Query: 401 LLRYDHQERPTAKEAMAHPYF 421
           LL  D + R T +EA+ HP+ 
Sbjct: 258 LLVVDPKARFTTEEALRHPWL 278

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/300 (23%), Positives = 127/300 (42%), Gaps = 51/300 (17%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHC-TDNEXXXXXXXXXXXXXXXXXXXXXLQNLC---GGP 189
           D+Y++  ++G+G +S V   +   T  E                        +C     P
Sbjct: 4   DEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHP 63
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDF---KVLYPTLSDYDVRYYIYELLKALDYCHS 246
           NIV+L D + ++      L+F+ V   +     V     S+ D  + I ++L+++++CH 
Sbjct: 64  NIVRLHDSISEEGFHY--LVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHL 121
Query: 247 QGIMHRDVKPHNVMIDHEQR--KLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDL 303
            GI+HRD+KP N+++  + +   ++L D+GLA E     + +     +  +  PE+L   
Sbjct: 122 NGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRK- 180
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFF--YGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 361
             Y   +D+W+ G +   ++    PF+    H  Y Q+          +  AY       
Sbjct: 181 DPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQI----------KAGAY------- 223
Query: 362 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
                          P  ++ TV       PEA D ++K+L  +  +R TA EA+ HP+ 
Sbjct: 224 -------------DFPSPEWDTV------TPEAKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 88/201 (43%), Gaps = 37/201 (18%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRK--LRLIDWGLAEFYHPG 282
           L +   + Y Y++L A+ Y H  GI+HRD+KP NV++  ++    +++ D+G ++     
Sbjct: 111 LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 170
Query: 283 KEYNVRVASRYFKGPELLVDL--QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
                   +  +  PE+LV +    Y+ ++D WSLG +   +     P F  H     L 
Sbjct: 171 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF-ICLSGYPPFSEHRTQVSL- 228
Query: 341 KIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDK 400
                   D++ +   KY+    P + A V                      +A+D + K
Sbjct: 229 -------KDQITS--GKYN--FIPEVWAEVSE--------------------KALDLVKK 257
Query: 401 LLRYDHQERPTAKEAMAHPYF 421
           LL  D + R T +EA+ HP+ 
Sbjct: 258 LLVVDPKARFTTEEALRHPWL 278

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 88/201 (43%), Gaps = 37/201 (18%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRK--LRLIDWGLAEFYHPG 282
           L +   + Y Y++L A+ Y H  GI+HRD+KP NV++  ++    +++ D+G ++     
Sbjct: 111 LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 170
Query: 283 KEYNVRVASRYFKGPELLVDL--QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
                   +  +  PE+LV +    Y+ ++D WSLG +   +     P F  H     L 
Sbjct: 171 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF-ICLSGYPPFSEHRTQVSL- 228
Query: 341 KIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDK 400
                   D++ +   KY+    P + A V                      +A+D + K
Sbjct: 229 -------KDQITS--GKYN--FIPEVWAEVSE--------------------KALDLVKK 257
Query: 401 LLRYDHQERPTAKEAMAHPYF 421
           LL  D + R T +EA+ HP+ 
Sbjct: 258 LLVVDPKARFTTEEALRHPWL 278

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 86/200 (43%), Gaps = 42/200 (21%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
           L + ++    +  L+ L Y HS  ++HRDVK  N+++  E   ++L D+G A    P   
Sbjct: 112 LQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS-EPGLVKLGDFGSASIMAPA-- 168
Query: 285 YNVRVASRYFKGPELLVDLQD--YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKI 342
            N  V + Y+  PE+++ + +  YD  +D+WSLG     +  RK P F            
Sbjct: 169 -NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF------------ 215
Query: 343 AKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLL 402
                   +NA    YHI  +   A   G      WS++              +F+D  L
Sbjct: 216 -------NMNAMSALYHIAQNESPALQSGH-----WSEYFR------------NFVDSCL 251
Query: 403 RYDHQERPTAKEAMAHPYFF 422
           +   Q+RPT++  + H +  
Sbjct: 252 QKIPQDRPTSEVLLKHRFVL 271

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 88/201 (43%), Gaps = 37/201 (18%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRK--LRLIDWGLAEFYHPG 282
           L +   + Y Y++L A+ Y H  GI+HRD+KP NV++  ++    +++ D+G ++     
Sbjct: 117 LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 176
Query: 283 KEYNVRVASRYFKGPELLVDL--QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
                   +  +  PE+LV +    Y+ ++D WSLG +   +     P F  H     L 
Sbjct: 177 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF-ICLSGYPPFSEHRTQVSL- 234
Query: 341 KIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDK 400
                   D++ +   KY+    P + A V                      +A+D + K
Sbjct: 235 -------KDQITS--GKYN--FIPEVWAEVSE--------------------KALDLVKK 263
Query: 401 LLRYDHQERPTAKEAMAHPYF 421
           LL  D + R T +EA+ HP+ 
Sbjct: 264 LLVVDPKARFTTEEALRHPWL 284

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/147 (25%), Positives = 72/147 (48%), Gaps = 12/147 (8%)
Query: 189 PNIVKLLDIVRDQQSKTPS---LIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALD 242
           P+I+KL  ++      TP+   ++ E+V+     D+   +  + + + R    ++L A+D
Sbjct: 71  PHIIKLYQVI-----STPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD 125
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
           YCH   ++HRD+KP NV++D      ++ D+GL+     G+       S  +  PE++  
Sbjct: 126 YCHRHMVVHRDLKPENVLLD-AHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISG 184
Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPF 329
                  +D+WS G +   ++    PF
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCGTLPF 211

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 69/300 (23%), Positives = 127/300 (42%), Gaps = 51/300 (17%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHC-TDNEXXXXXXXXXXXXXXXXXXXXXLQNLC---GGP 189
           D+Y++  ++G+G +S V   +   T  E                        +C     P
Sbjct: 4   DEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHP 63
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDF---KVLYPTLSDYDVRYYIYELLKALDYCHS 246
           NIV+L D + ++      L+F+ V   +     V     S+ D  + I ++L+++++CH 
Sbjct: 64  NIVRLHDSISEEGFHY--LVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHL 121
Query: 247 QGIMHRDVKPHNVMIDHEQR--KLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDL 303
            GI+HRD+KP N+++  + +   ++L D+GLA E     + +     +  +  PE+L   
Sbjct: 122 NGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRK- 180
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFF--YGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 361
             Y   +D+W+ G +   ++    PF+    H  Y Q+          +  AY       
Sbjct: 181 DPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQI----------KAGAY------- 223
Query: 362 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
                          P  ++ TV       PEA D ++K+L  +  +R TA EA+ HP+ 
Sbjct: 224 -------------DFPSPEWDTV------TPEAKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 108/239 (45%), Gaps = 43/239 (17%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDF---KVLYPTLSDYDVRYYIYELLKALDYCH 245
           PNIV+L D + ++      LIF+ V   +     V     S+ D  + I ++L+A+ +CH
Sbjct: 81  PNIVRLHDSISEEGHHY--LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCH 138
Query: 246 SQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVD 302
             G++HRD+KP N+++  + +   ++L D+GLA E     + +     +  +  PE+L  
Sbjct: 139 QMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK 198
Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 362
              Y   +DLW+ G +   ++    PF+   ++  +L +  K    D             
Sbjct: 199 -DPYGKPVDLWACGVILYILLVGYPPFW--DEDQHRLYQQIKAGAYD------------- 242
Query: 363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
                         P  ++ TV       PEA D ++K+L  +  +R TA EA+ HP+ 
Sbjct: 243 -------------FPSPEWDTV------TPEAKDLINKMLTINPSKRITAAEALKHPWI 282

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 82/165 (49%), Gaps = 20/165 (12%)
Query: 189 PNIVKLLDIVRD-------QQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKAL 241
           PNIV L DI           Q  +   +F+ +    F       ++ D    I+++L A+
Sbjct: 76  PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF------YTERDASRLIFQVLDAV 129
Query: 242 DYCHSQGIMHRDVKPHNVM---IDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
            Y H  GI+HRD+KP N++   +D E  K+ + D+GL++   PG   +    +  +  PE
Sbjct: 130 KYLHDLGIVHRDLKPENLLYYSLD-EDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE 188
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN--YDQLVK 341
           +L   + Y  ++D WS+G +   ++    PF+  +D   ++Q++K
Sbjct: 189 VLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK 232

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 93/216 (43%), Gaps = 25/216 (11%)
Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXXXXXXX-----XXLQNLC 186
           + +DYEVV+ +GRG + EV    H +  +                          +    
Sbjct: 72  KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 131
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDV-----RYYIYELLKAL 241
             P +V+L    +D   +   ++ E++   D   L   +S+YDV     R+Y  E++ AL
Sbjct: 132 NSPWVVQLFYAFQDD--RYLYMVMEYMPGGD---LVNLMSNYDVPEKWARFYTAEVVLAL 186
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKGP 297
           D  HS G +HRDVKP N+++D +   L+L D+G        KE  VR    V +  +  P
Sbjct: 187 DAIHSMGFIHRDVKPDNMLLD-KSGHLKLADFGTC--MKMNKEGMVRCDTAVGTPDYISP 243
Query: 298 ELLVDLQD---YDYSLDLWSLGCMFAGMIFRKEPFF 330
           E+L        Y    D WS+G     M+    PF+
Sbjct: 244 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 279

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 84/189 (44%), Gaps = 40/189 (21%)
Query: 237 LLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 295
           ++KAL++ HS+  ++HRDVKP NV+I +   ++++ D+G++ +        +    + + 
Sbjct: 162 IVKALEHLHSKLSVIHRDVKPSNVLI-NALGQVKMCDFGISGYLVDSVAKTIDAGCKPYM 220
Query: 296 GPELL---VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELN 352
            PE +   ++ + Y    D+WSLG     +   + P+      + QL ++ +        
Sbjct: 221 APERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE-------- 272
Query: 353 AYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA 412
                   E  P L          P  KF           E VDF  + L+ + +ERPT 
Sbjct: 273 --------EPSPQL----------PADKFSA---------EFVDFTSQCLKKNSKERPTY 305
Query: 413 KEAMAHPYF 421
            E M HP+F
Sbjct: 306 PELMQHPFF 314

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 93/216 (43%), Gaps = 25/216 (11%)
Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXXXXXXX-----XXLQNLC 186
           + +DYEVV+ +GRG + EV    H +  +                          +    
Sbjct: 67  KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 126
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDV-----RYYIYELLKAL 241
             P +V+L    +D   +   ++ E++   D   L   +S+YDV     R+Y  E++ AL
Sbjct: 127 NSPWVVQLFYAFQDD--RYLYMVMEYMPGGD---LVNLMSNYDVPEKWARFYTAEVVLAL 181
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKGP 297
           D  HS G +HRDVKP N+++D +   L+L D+G        KE  VR    V +  +  P
Sbjct: 182 DAIHSMGFIHRDVKPDNMLLD-KSGHLKLADFGTC--MKMNKEGMVRCDTAVGTPDYISP 238
Query: 298 ELLVDLQD---YDYSLDLWSLGCMFAGMIFRKEPFF 330
           E+L        Y    D WS+G     M+    PF+
Sbjct: 239 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 274

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 89/203 (43%), Gaps = 41/203 (20%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRK--LRLIDWGLAEFYHPG 282
           L +   + Y Y++L A+ Y H  GI+HRD+KP NV++  ++    +++ D+G ++     
Sbjct: 250 LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 309
Query: 283 KEYNVRVASRYFKGPELLVDL--QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
                   +  +  PE+LV +    Y+ ++D WSLG +   +     P F  H       
Sbjct: 310 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF-ICLSGYPPFSEH------- 361
Query: 341 KIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKP--WSKFITVENQHLAVPEAVDFL 398
                           +  + L   + +  G+++  P  W++            +A+D +
Sbjct: 362 ----------------RTQVSLKDQITS--GKYNFIPEVWAE---------VSEKALDLV 394
Query: 399 DKLLRYDHQERPTAKEAMAHPYF 421
            KLL  D + R T +EA+ HP+ 
Sbjct: 395 KKLLVVDPKARFTTEEALRHPWL 417

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/255 (22%), Positives = 107/255 (41%), Gaps = 59/255 (23%)
Query: 182 LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELL 238
           L+ + G PNI++L D    + +    L+F+ +      D+     TLS+ + R  +  LL
Sbjct: 77  LRKVSGHPNIIQLKDTY--ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALL 134
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
           + +   H   I+HRD+KP N+++D +   ++L D+G +    PG++      +  +  PE
Sbjct: 135 EVICALHKLNIVHRDLKPENILLD-DDMNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPE 193
Query: 299 LL-VDLQD----YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 353
           ++   + D    Y   +D+WS G +   ++    PF++      Q++ +           
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH----RKQMLML----------- 238
Query: 354 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLD-------KLLRYDH 406
                                     + I   N     PE  D+ D       + L    
Sbjct: 239 --------------------------RMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQP 272
Query: 407 QERPTAKEAMAHPYF 421
           Q+R TA+EA+AHP+F
Sbjct: 273 QKRYTAEEALAHPFF 287

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 88/201 (43%), Gaps = 37/201 (18%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRK--LRLIDWGLAEFYHPG 282
           L +   + Y Y++L A+ Y H  GI+HRD+KP NV++  ++    +++ D+G ++     
Sbjct: 236 LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 295
Query: 283 KEYNVRVASRYFKGPELLVDL--QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
                   +  +  PE+LV +    Y+ ++D WSLG +   +     P F  H     L 
Sbjct: 296 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF-ICLSGYPPFSEHRTQVSL- 353
Query: 341 KIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDK 400
                   D++ +   KY+    P + A V                      +A+D + K
Sbjct: 354 -------KDQITS--GKYN--FIPEVWAEVSE--------------------KALDLVKK 382
Query: 401 LLRYDHQERPTAKEAMAHPYF 421
           LL  D + R T +EA+ HP+ 
Sbjct: 383 LLVVDPKARFTTEEALRHPWL 403

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 82/165 (49%), Gaps = 20/165 (12%)
Query: 189 PNIVKLLDIVRD-------QQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKAL 241
           PNIV L DI           Q  +   +F+ +    F       ++ D    I+++L A+
Sbjct: 76  PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF------YTERDASRLIFQVLDAV 129
Query: 242 DYCHSQGIMHRDVKPHNVM---IDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
            Y H  GI+HRD+KP N++   +D E  K+ + D+GL++   PG   +    +  +  PE
Sbjct: 130 KYLHDLGIVHRDLKPENLLYYSLD-EDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE 188
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN--YDQLVK 341
           +L   + Y  ++D WS+G +   ++    PF+  +D   ++Q++K
Sbjct: 189 VLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK 232

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 92/216 (42%), Gaps = 25/216 (11%)
Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXXXXXXX-----XXLQNLC 186
           + +DYEVV+ +GRG + EV    H +  +                          +    
Sbjct: 72  KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 131
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDV-----RYYIYELLKAL 241
             P +V+L    +D   +   ++ E++   D   L   +S+YDV     R+Y  E++ AL
Sbjct: 132 NSPWVVQLFYAFQDD--RYLYMVMEYMPGGD---LVNLMSNYDVPEKWARFYTAEVVLAL 186
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKGP 297
           D  HS G +HRDVKP N+++D     L+L D+G        KE  VR    V +  +  P
Sbjct: 187 DAIHSMGFIHRDVKPDNMLLDKSGH-LKLADFGTC--MKMNKEGMVRCDTAVGTPDYISP 243
Query: 298 ELLVDLQD---YDYSLDLWSLGCMFAGMIFRKEPFF 330
           E+L        Y    D WS+G     M+    PF+
Sbjct: 244 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 279

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 71/143 (49%), Gaps = 22/143 (15%)
Query: 207 SLIFEHVNNTDFKVLYPTLSDYDVRYYIY-------------------ELLKALDYCHSQ 247
           SL +     TD  ++   ++  D+RY+IY                   +++  L++ H +
Sbjct: 249 SLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASR-YFKGPELLVDLQDY 306
            I++RD+KP NV++D +   +R+ D GLA     G+      A    F  PELL+  ++Y
Sbjct: 309 NIIYRDLKPENVLLDDDG-NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-EEY 366
Query: 307 DYSLDLWSLGCMFAGMIFRKEPF 329
           D+S+D ++LG     MI  + PF
Sbjct: 367 DFSVDYFALGVTLYEMIAARGPF 389

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 82/165 (49%), Gaps = 20/165 (12%)
Query: 189 PNIVKLLDIVRD-------QQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKAL 241
           PNIV L DI           Q  +   +F+ +    F       ++ D    I+++L A+
Sbjct: 76  PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF------YTERDASRLIFQVLDAV 129
Query: 242 DYCHSQGIMHRDVKPHNVM---IDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
            Y H  GI+HRD+KP N++   +D E  K+ + D+GL++   PG   +    +  +  PE
Sbjct: 130 KYLHDLGIVHRDLKPENLLYYSLD-EDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE 188
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN--YDQLVK 341
           +L   + Y  ++D WS+G +   ++    PF+  +D   ++Q++K
Sbjct: 189 VLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK 232

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 71/143 (49%), Gaps = 22/143 (15%)
Query: 207 SLIFEHVNNTDFKVLYPTLSDYDVRYYIY-------------------ELLKALDYCHSQ 247
           SL +     TD  ++   ++  D+RY+IY                   +++  L++ H +
Sbjct: 249 SLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASR-YFKGPELLVDLQDY 306
            I++RD+KP NV++D +   +R+ D GLA     G+      A    F  PELL+  ++Y
Sbjct: 309 NIIYRDLKPENVLLDDDG-NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-EEY 366
Query: 307 DYSLDLWSLGCMFAGMIFRKEPF 329
           D+S+D ++LG     MI  + PF
Sbjct: 367 DFSVDYFALGVTLYEMIAARGPF 389

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 71/143 (49%), Gaps = 22/143 (15%)
Query: 207 SLIFEHVNNTDFKVLYPTLSDYDVRYYIY-------------------ELLKALDYCHSQ 247
           SL +     TD  ++   ++  D+RY+IY                   +++  L++ H +
Sbjct: 249 SLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASR-YFKGPELLVDLQDY 306
            I++RD+KP NV++D +   +R+ D GLA     G+      A    F  PELL+  ++Y
Sbjct: 309 NIIYRDLKPENVLLDDDG-NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-EEY 366
Query: 307 DYSLDLWSLGCMFAGMIFRKEPF 329
           D+S+D ++LG     MI  + PF
Sbjct: 367 DFSVDYFALGVTLYEMIAARGPF 389

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 56/98 (57%), Gaps = 2/98 (2%)
Query: 232 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS 291
           +Y  E+   L+  H + I++RD+KP N+++D +   +R+ D GLA     G+    RV +
Sbjct: 290 FYAAEICCGLEDLHRERIVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVGT 348
Query: 292 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
             +  PE++ + + Y +S D W+LGC+   MI  + PF
Sbjct: 349 VGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPF 385

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 82/165 (49%), Gaps = 20/165 (12%)
Query: 189 PNIVKLLDIVRD-------QQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKAL 241
           PNIV L DI           Q  +   +F+ +    F       ++ D    I+++L A+
Sbjct: 76  PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF------YTERDASRLIFQVLDAV 129
Query: 242 DYCHSQGIMHRDVKPHNVM---IDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
            Y H  GI+HRD+KP N++   +D E  K+ + D+GL++   PG   +    +  +  PE
Sbjct: 130 KYLHDLGIVHRDLKPENLLYYSLD-EDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE 188
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN--YDQLVK 341
           +L   + Y  ++D WS+G +   ++    PF+  +D   ++Q++K
Sbjct: 189 VLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK 232

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 70/147 (47%), Gaps = 12/147 (8%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIF---EHVNNT---DFKVLYPTLSDYDVRYYIYELLKALD 242
           P+I+KL  ++      TPS IF   E+V+     D+      L + + R    ++L  +D
Sbjct: 76  PHIIKLYQVI-----STPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVD 130
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
           YCH   ++HRD+KP NV++D      ++ D+GL+     G+       S  +  PE++  
Sbjct: 131 YCHRHMVVHRDLKPENVLLD-AHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISG 189
Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPF 329
                  +D+WS G +   ++    PF
Sbjct: 190 RLYAGPEVDIWSSGVILYALLCGTLPF 216

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/305 (22%), Positives = 122/305 (40%), Gaps = 60/305 (19%)
Query: 129 QWGEQDDYEVVRKVGRGKYSEVF-----EGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQ 183
           QW   +D+++ R +G+GK+  V+     +       +                     +Q
Sbjct: 8   QW-TLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQ 66
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD---VRYYIYELLKA 240
           +    PNI++L     D  +    LI E+            LS +D      YI EL  A
Sbjct: 67  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANA 124
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 300
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P    +    +  +  PE +
Sbjct: 125 LSYCHSKRVIHRDIKPENLLLG-SNGELKIADFGWS-VHAPSSRRDTLCGTLDYLPPE-M 181
Query: 301 VDLQDYDYSLDLWSLGCM----FAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 356
           ++ + +D  +DLWSLG +      GM     P F  H   +   +I++V  T        
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVGM-----PPFEAHTYQETYRRISRVEFT-------- 228
Query: 357 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAM 416
                                +  F+T          A D + +LL+++  +R T  E +
Sbjct: 229 ---------------------FPDFVT--------EGARDLISRLLKHNASQRLTLAEVL 259
Query: 417 AHPYF 421
            HP+ 
Sbjct: 260 EHPWI 264

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 71/143 (49%), Gaps = 22/143 (15%)
Query: 207 SLIFEHVNNTDFKVLYPTLSDYDVRYYIY-------------------ELLKALDYCHSQ 247
           SL +     TD  ++   ++  D+RY+IY                   +++  L++ H +
Sbjct: 249 SLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASR-YFKGPELLVDLQDY 306
            I++RD+KP NV++D +   +R+ D GLA     G+      A    F  PELL+  ++Y
Sbjct: 309 NIIYRDLKPENVLLDDDG-NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-EEY 366
Query: 307 DYSLDLWSLGCMFAGMIFRKEPF 329
           D+S+D ++LG     MI  + PF
Sbjct: 367 DFSVDYFALGVTLYEMIAARGPF 389

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/255 (22%), Positives = 107/255 (41%), Gaps = 59/255 (23%)
Query: 182 LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELL 238
           L+ + G PNI++L D    + +    L+F+ +      D+     TLS+ + R  +  LL
Sbjct: 77  LRKVSGHPNIIQLKDTY--ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALL 134
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
           + +   H   I+HRD+KP N+++D +   ++L D+G +    PG++      +  +  PE
Sbjct: 135 EVICALHKLNIVHRDLKPENILLDDDM-NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 193
Query: 299 LL-VDLQD----YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 353
           ++   + D    Y   +D+WS G +   ++    PF++      Q++ +           
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH----RKQMLML----------- 238
Query: 354 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLD-------KLLRYDH 406
                                     + I   N     PE  D+ D       + L    
Sbjct: 239 --------------------------RMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQP 272
Query: 407 QERPTAKEAMAHPYF 421
           Q+R TA+EA+AHP+F
Sbjct: 273 QKRYTAEEALAHPFF 287

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 56/98 (57%), Gaps = 2/98 (2%)
Query: 232 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS 291
           +Y  E+   L+  H + I++RD+KP N+++D +   +R+ D GLA     G+    RV +
Sbjct: 290 FYAAEICCGLEDLHRERIVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVGT 348
Query: 292 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
             +  PE++ + + Y +S D W+LGC+   MI  + PF
Sbjct: 349 VGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPF 385

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/211 (23%), Positives = 92/211 (43%), Gaps = 17/211 (8%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN---------EXXXXXXXXXXXXXXXXXXXXXLQ 183
           +  Y+V   +G G +  V+ G+  +DN         +                     L+
Sbjct: 7   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 66
Query: 184 NLCGG-PNIVKLLDIVRDQQSKTPSLIFEHVNNT----DFKVLYPTLSDYDVRYYIYELL 238
            +  G   +++LLD    ++  +  LI E +       DF      L +   R + +++L
Sbjct: 67  KVSSGFSGVIRLLDWF--ERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVL 124
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
           +A+ +CH+ G++HRD+K  N++ID  + +L+LID+G          Y     +R +  PE
Sbjct: 125 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 183
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
            +   + +  S  +WSLG +   M+    PF
Sbjct: 184 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 214

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 91/194 (46%), Gaps = 22/194 (11%)
Query: 230 VRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR 288
           ++  I  +L +  Y H++  I HRDVKP N+++D   R ++L D+G +E Y   K+    
Sbjct: 153 IKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGR-VKLSDFGESE-YMVDKKIKGS 210
Query: 289 VASRYFKGPELLVDLQDYDYS-LDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG 347
             +  F  PE   +   Y+ + +D+WSLG     M +   PF          +KI+ V  
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF---------SLKISLVEL 261
Query: 348 TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQ 407
            + +     +Y ++ +  L  L  + S        T  N  L+  E +DFL   LR +  
Sbjct: 262 FNNIRTKNIEYPLDRNHFLYPLTNKKS--------TCSNNFLS-NEDIDFLKLFLRKNPA 312
Query: 408 ERPTAKEAMAHPYF 421
           ER T+++A+ H + 
Sbjct: 313 ERITSEDALKHEWL 326

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 68/305 (22%), Positives = 121/305 (39%), Gaps = 60/305 (19%)
Query: 129 QWGEQDDYEVVRKVGRGKYSEVF-----EGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQ 183
           QW   +D+++ R +G+GK+  V+     +       +                     +Q
Sbjct: 8   QW-TLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQ 66
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD---VRYYIYELLKA 240
           +    PNI++L     D  +    LI E+            LS +D      YI EL  A
Sbjct: 67  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANA 124
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 300
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 125 LSYCHSKRVIHRDIKPENLLLG-SNGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-M 181
Query: 301 VDLQDYDYSLDLWSLGCM----FAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 356
           ++ + +D  +DLWSLG +      GM     P F  H   +   +I++V  T        
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVGM-----PPFEAHTYQETYRRISRVEFT-------- 228
Query: 357 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAM 416
                                +  F+T          A D + +LL+++  +R T  E +
Sbjct: 229 ---------------------FPDFVT--------EGARDLISRLLKHNASQRLTLAEVL 259
Query: 417 AHPYF 421
            HP+ 
Sbjct: 260 EHPWI 264

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 104/241 (43%), Gaps = 47/241 (19%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDF---KVLYPTLSDYDVRYYIYELLKALDYCH 245
           PNIV+L D + ++      LIF+ V   +     V     S+ D  + I ++L+A+ +CH
Sbjct: 70  PNIVRLHDSISEEGHHY--LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCH 127
Query: 246 SQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVD 302
             G++HR++KP N+++  + +   ++L D+GLA E     + +     +  +  PE+L  
Sbjct: 128 QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK 187
Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFF--YGHDNYDQLVKIAKVLGTDELNAYLNKYHI 360
              Y   +DLW+ G +   ++    PF+    H  Y Q+   A    + E +        
Sbjct: 188 -DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDT------- 239
Query: 361 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 420
                                          PEA D ++K+L  +  +R TA EA+ HP+
Sbjct: 240 -----------------------------VTPEAKDLINKMLTINPSKRITAAEALKHPW 270
Query: 421 F 421
Sbjct: 271 I 271

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/255 (22%), Positives = 107/255 (41%), Gaps = 59/255 (23%)
Query: 182 LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELL 238
           L+ + G PNI++L D    + +    L+F+ +      D+     TLS+ + R  +  LL
Sbjct: 64  LRKVSGHPNIIQLKDTY--ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALL 121
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
           + +   H   I+HRD+KP N+++D +   ++L D+G +    PG++      +  +  PE
Sbjct: 122 EVICALHKLNIVHRDLKPENILLDDDM-NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 180
Query: 299 LL-VDLQD----YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 353
           ++   + D    Y   +D+WS G +   ++    PF++      Q++ +           
Sbjct: 181 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH----RKQMLML----------- 225
Query: 354 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLD-------KLLRYDH 406
                                     + I   N     PE  D+ D       + L    
Sbjct: 226 --------------------------RMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQP 259
Query: 407 QERPTAKEAMAHPYF 421
           Q+R TA+EA+AHP+F
Sbjct: 260 QKRYTAEEALAHPFF 274

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 75/154 (48%), Gaps = 15/154 (9%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPT-------LSDYDVRYYIYELLKAL 241
           PNIV+  D + D+ + T  ++ E+    D   +          L +  V   + +L  AL
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 242 DYCHSQG-----IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR-VASRYFK 295
             CH +      ++HRD+KP NV +D +Q  ++L D+GLA   +  +++    V + Y+ 
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDFGLARILNHDEDFAKEFVGTPYYM 183
Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
            PE + +   Y+   D+WSLGC+   +     PF
Sbjct: 184 SPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 105/238 (44%), Gaps = 46/238 (19%)
Query: 189 PNIVKLLD--IVRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           PNIV  LD  +V D+      ++ E++        V    + +  +     E L+AL++ 
Sbjct: 77  PNIVNYLDSYLVGDELW----VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFL 132
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDL 303
           HS  ++HRD+K  N+++  +   ++L D+G      P + + +  V + Y+  PE +V  
Sbjct: 133 HSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPE-VVTR 190
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363
           + Y   +D+WSLG M   MI  + P+   ++N  + + +    GT EL           +
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYL--NENPLRALYLIATNGTPELQ----------N 238
Query: 364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
           P   + + R                       DFL++ L  D ++R +AKE + H + 
Sbjct: 239 PEKLSAIFR-----------------------DFLNRCLEMDVEKRGSAKELLQHQFL 273

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 90/203 (44%), Gaps = 38/203 (18%)
Query: 220 VLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEF 278
           V +  +++  +      +L+AL Y H+QG++HRD+K  ++++  + R ++L D+G  A+ 
Sbjct: 133 VTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGR-IKLSDFGFCAQV 191
Query: 279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQ 338
                +    V + Y+  PE++  L  Y   +D+WSLG M   MI  + P+F    N   
Sbjct: 192 SKEVPKRKXLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMIDGEPPYF----NEPP 246
Query: 339 LVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFL 398
           L  + ++                          R S  P      V++ H        FL
Sbjct: 247 LQAMRRI--------------------------RDSLPP-----RVKDLHKVSSVLRGFL 275
Query: 399 DKLLRYDHQERPTAKEAMAHPYF 421
           D +L  +  +R TA+E + HP+ 
Sbjct: 276 DLMLVREPSQRATAQELLGHPFL 298

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 85/189 (44%), Gaps = 40/189 (21%)
Query: 237 LLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 295
           ++KAL++ HS+  ++HRDVKP NV+I +   ++++ D+G++ +       ++    + + 
Sbjct: 118 IVKALEHLHSKLSVIHRDVKPSNVLI-NALGQVKMCDFGISGYLVDDVAKDIDAGCKPYM 176
Query: 296 GPELL---VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELN 352
            PE +   ++ + Y    D+WSLG     +   + P+      + QL ++ +        
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE-------- 228
Query: 353 AYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA 412
                   E  P L          P  KF           E VDF  + L+ + +ERPT 
Sbjct: 229 --------EPSPQL----------PADKFSA---------EFVDFTSQCLKKNSKERPTY 261
Query: 413 KEAMAHPYF 421
            E M HP+F
Sbjct: 262 PELMQHPFF 270

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 15/154 (9%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPT-------LSDYDVRYYIYELLKAL 241
           PNIV+  D + D+ + T  ++ E+    D   +          L +  V   + +L  AL
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 242 DYCHSQG-----IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY-HPGKEYNVRVASRYFK 295
             CH +      ++HRD+KP NV +D +Q  ++L D+GLA    H        V + Y+ 
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDFGLARILNHDTSFAKAFVGTPYYM 183
Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
            PE + +   Y+   D+WSLGC+   +     PF
Sbjct: 184 SPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 15/154 (9%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPT-------LSDYDVRYYIYELLKAL 241
           PNIV+  D + D+ + T  ++ E+    D   +          L +  V   + +L  AL
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 242 DYCHSQG-----IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY-HPGKEYNVRVASRYFK 295
             CH +      ++HRD+KP NV +D +Q  ++L D+GLA    H        V + Y+ 
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDFGLARILNHDTSFAKTFVGTPYYM 183
Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
            PE + +   Y+   D+WSLGC+   +     PF
Sbjct: 184 SPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 89/211 (42%), Gaps = 17/211 (8%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN---------EXXXXXXXXXXXXXXXXXXXXXLQ 183
           +  Y+V   +G G +  V+ G+  +DN         +                     L+
Sbjct: 23  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 82
Query: 184 NLCGG-PNIVKLLDIVRDQQSKTPSLIFEHVNNT----DFKVLYPTLSDYDVRYYIYELL 238
            +  G   +++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 83  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 140
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
           +A+ +CH+ G++HRD+K  N++ID  + +L+LID+G          Y     +R +  PE
Sbjct: 141 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 199
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
            +   + +  S  +WSLG +   M+    PF
Sbjct: 200 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 230

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 105/238 (44%), Gaps = 46/238 (19%)
Query: 189 PNIVKLLD--IVRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           PNIV  LD  +V D+      ++ E++        V    + +  +     E L+AL++ 
Sbjct: 77  PNIVNYLDSYLVGDELW----VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFL 132
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDL 303
           HS  ++HRD+K  N+++  +   ++L D+G      P + + +  V + Y+  PE +V  
Sbjct: 133 HSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE-VVTR 190
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363
           + Y   +D+WSLG M   MI  + P+   ++N  + + +    GT EL           +
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYL--NENPLRALYLIATNGTPELQ----------N 238
Query: 364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
           P   + + R                       DFL++ L  D ++R +AKE + H + 
Sbjct: 239 PEKLSAIFR-----------------------DFLNRCLDMDVEKRGSAKELLQHQFL 273

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 89/211 (42%), Gaps = 17/211 (8%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN---------EXXXXXXXXXXXXXXXXXXXXXLQ 183
           +  Y+V   +G G +  V+ G+  +DN         +                     L+
Sbjct: 42  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 101
Query: 184 NLCGG-PNIVKLLDIVRDQQSKTPSLIFEHVNNT----DFKVLYPTLSDYDVRYYIYELL 238
            +  G   +++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 102 KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 159
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
           +A+ +CH+ G++HRD+K  N++ID  + +L+LID+G          Y     +R +  PE
Sbjct: 160 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 218
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
            +   + +  S  +WSLG +   M+    PF
Sbjct: 219 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 249

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/251 (23%), Positives = 113/251 (45%), Gaps = 44/251 (17%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCH 245
           PN++ L ++  ++      LI E V      DF     +L++ +   ++ ++L  + Y H
Sbjct: 74  PNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 246 SQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
           S  I H D+KP N+M+   +  + ++++ID+GLA     G E+     +  F  PE +V+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVN 190
Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 362
            +      D+WS+G +   ++    PF  G    + L  ++ V        Y  ++  E 
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAV-------NY--EFEDEY 240
Query: 363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFF 422
             + +AL                        A DF+ +LL  D ++R T ++++ HP+  
Sbjct: 241 FSNTSAL------------------------AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276
Query: 423 PIRNAESSRSR 433
           P ++ + + SR
Sbjct: 277 P-KDTQQALSR 286

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/251 (23%), Positives = 113/251 (45%), Gaps = 44/251 (17%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCH 245
           PN++ L ++  ++      LI E V      DF     +L++ +   ++ ++L  + Y H
Sbjct: 74  PNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 246 SQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
           S  I H D+KP N+M+   +  + ++++ID+GLA     G E+     +  F  PE +V+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAPE-IVN 190
Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 362
            +      D+WS+G +   ++    PF  G    + L  ++ V        Y  ++  E 
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAV-------NY--EFEDEY 240
Query: 363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFF 422
             + +AL                        A DF+ +LL  D ++R T ++++ HP+  
Sbjct: 241 FSNTSAL------------------------AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276
Query: 423 PIRNAESSRSR 433
           P ++ + + SR
Sbjct: 277 P-KDTQQALSR 286

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 89/211 (42%), Gaps = 17/211 (8%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN---------EXXXXXXXXXXXXXXXXXXXXXLQ 183
           +  Y+V   +G G +  V+ G+  +DN         +                     L+
Sbjct: 50  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 109
Query: 184 NLCGG-PNIVKLLDIVRDQQSKTPSLIFEHVNNT----DFKVLYPTLSDYDVRYYIYELL 238
            +  G   +++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 110 KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 167
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
           +A+ +CH+ G++HRD+K  N++ID  + +L+LID+G          Y     +R +  PE
Sbjct: 168 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 226
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
            +   + +  S  +WSLG +   M+    PF
Sbjct: 227 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 257

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 89/211 (42%), Gaps = 17/211 (8%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN---------EXXXXXXXXXXXXXXXXXXXXXLQ 183
           +  Y+V   +G G +  V+ G+  +DN         +                     L+
Sbjct: 55  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 114
Query: 184 NLCGG-PNIVKLLDIVRDQQSKTPSLIFEHVNNT----DFKVLYPTLSDYDVRYYIYELL 238
            +  G   +++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 115 KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 172
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
           +A+ +CH+ G++HRD+K  N++ID  + +L+LID+G          Y     +R +  PE
Sbjct: 173 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 231
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
            +   + +  S  +WSLG +   M+    PF
Sbjct: 232 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 262

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 105/238 (44%), Gaps = 46/238 (19%)
Query: 189 PNIVKLLD--IVRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           PNIV  LD  +V D+      ++ E++        V    + +  +     E L+AL++ 
Sbjct: 78  PNIVNYLDSYLVGDELW----VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFL 133
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDL 303
           HS  ++HRD+K  N+++  +   ++L D+G      P + + +  V + Y+  PE +V  
Sbjct: 134 HSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPE-VVTR 191
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363
           + Y   +D+WSLG M   MI  + P+   ++N  + + +    GT EL           +
Sbjct: 192 KAYGPKVDIWSLGIMAIEMIEGEPPYL--NENPLRALYLIATNGTPELQ----------N 239
Query: 364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
           P   + + R                       DFL++ L  D ++R +AKE + H + 
Sbjct: 240 PEKLSAIFR-----------------------DFLNRCLEMDVEKRGSAKELIQHQFL 274

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 89/211 (42%), Gaps = 17/211 (8%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN---------EXXXXXXXXXXXXXXXXXXXXXLQ 183
           +  Y+V   +G G +  V+ G+  +DN         +                     L+
Sbjct: 36  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 95
Query: 184 NLCGG-PNIVKLLDIVRDQQSKTPSLIFEHVNNT----DFKVLYPTLSDYDVRYYIYELL 238
            +  G   +++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 96  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 153
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
           +A+ +CH+ G++HRD+K  N++ID  + +L+LID+G          Y     +R +  PE
Sbjct: 154 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 212
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
            +   + +  S  +WSLG +   M+    PF
Sbjct: 213 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 89/211 (42%), Gaps = 17/211 (8%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN---------EXXXXXXXXXXXXXXXXXXXXXLQ 183
           +  Y+V   +G G +  V+ G+  +DN         +                     L+
Sbjct: 35  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 94
Query: 184 NLCGG-PNIVKLLDIVRDQQSKTPSLIFEHVNNT----DFKVLYPTLSDYDVRYYIYELL 238
            +  G   +++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 95  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 152
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
           +A+ +CH+ G++HRD+K  N++ID  + +L+LID+G          Y     +R +  PE
Sbjct: 153 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 211
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
            +   + +  S  +WSLG +   M+    PF
Sbjct: 212 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 242

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/251 (23%), Positives = 113/251 (45%), Gaps = 44/251 (17%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCH 245
           PN++ L ++  ++      LI E V      DF     +L++ +   ++ ++L  + Y H
Sbjct: 74  PNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 246 SQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
           S  I H D+KP N+M+   +  + ++++ID+GLA     G E+     +  F  PE +V+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVN 190
Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 362
            +      D+WS+G +   ++    PF  G    + L  ++ V        Y  ++  E 
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAV-------NY--EFEDEY 240
Query: 363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFF 422
             + +AL                        A DF+ +LL  D ++R T ++++ HP+  
Sbjct: 241 FSNTSAL------------------------AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276
Query: 423 PIRNAESSRSR 433
           P ++ + + SR
Sbjct: 277 P-KDTQQALSR 286

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 89/211 (42%), Gaps = 17/211 (8%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN---------EXXXXXXXXXXXXXXXXXXXXXLQ 183
           +  Y+V   +G G +  V+ G+  +DN         +                     L+
Sbjct: 50  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 109
Query: 184 NLCGG-PNIVKLLDIVRDQQSKTPSLIFEHVNNT----DFKVLYPTLSDYDVRYYIYELL 238
            +  G   +++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 110 KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 167
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
           +A+ +CH+ G++HRD+K  N++ID  + +L+LID+G          Y     +R +  PE
Sbjct: 168 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 226
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
            +   + +  S  +WSLG +   M+    PF
Sbjct: 227 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 257

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 89/211 (42%), Gaps = 17/211 (8%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN---------EXXXXXXXXXXXXXXXXXXXXXLQ 183
           +  Y+V   +G G +  V+ G+  +DN         +                     L+
Sbjct: 35  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 94
Query: 184 NLCGG-PNIVKLLDIVRDQQSKTPSLIFEHVNNT----DFKVLYPTLSDYDVRYYIYELL 238
            +  G   +++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 95  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 152
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
           +A+ +CH+ G++HRD+K  N++ID  + +L+LID+G          Y     +R +  PE
Sbjct: 153 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 211
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
            +   + +  S  +WSLG +   M+    PF
Sbjct: 212 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 242

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 89/211 (42%), Gaps = 17/211 (8%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN---------EXXXXXXXXXXXXXXXXXXXXXLQ 183
           +  Y+V   +G G +  V+ G+  +DN         +                     L+
Sbjct: 8   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 67
Query: 184 NLCGG-PNIVKLLDIVRDQQSKTPSLIFEHVNNT----DFKVLYPTLSDYDVRYYIYELL 238
            +  G   +++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 68  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 125
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
           +A+ +CH+ G++HRD+K  N++ID  + +L+LID+G          Y     +R +  PE
Sbjct: 126 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 184
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
            +   + +  S  +WSLG +   M+    PF
Sbjct: 185 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 215

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 89/211 (42%), Gaps = 17/211 (8%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN---------EXXXXXXXXXXXXXXXXXXXXXLQ 183
           +  Y+V   +G G +  V+ G+  +DN         +                     L+
Sbjct: 36  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 95
Query: 184 NLCGG-PNIVKLLDIVRDQQSKTPSLIFEHVNNT----DFKVLYPTLSDYDVRYYIYELL 238
            +  G   +++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 96  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 153
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
           +A+ +CH+ G++HRD+K  N++ID  + +L+LID+G          Y     +R +  PE
Sbjct: 154 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 212
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
            +   + +  S  +WSLG +   M+    PF
Sbjct: 213 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 89/211 (42%), Gaps = 17/211 (8%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN---------EXXXXXXXXXXXXXXXXXXXXXLQ 183
           +  Y+V   +G G +  V+ G+  +DN         +                     L+
Sbjct: 36  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 95
Query: 184 NLCGG-PNIVKLLDIVRDQQSKTPSLIFEHVNNT----DFKVLYPTLSDYDVRYYIYELL 238
            +  G   +++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 96  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 153
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
           +A+ +CH+ G++HRD+K  N++ID  + +L+LID+G          Y     +R +  PE
Sbjct: 154 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 212
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
            +   + +  S  +WSLG +   M+    PF
Sbjct: 213 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 89/211 (42%), Gaps = 17/211 (8%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN---------EXXXXXXXXXXXXXXXXXXXXXLQ 183
           +  Y+V   +G G +  V+ G+  +DN         +                     L+
Sbjct: 35  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 94
Query: 184 NLCGG-PNIVKLLDIVRDQQSKTPSLIFEHVNNT----DFKVLYPTLSDYDVRYYIYELL 238
            +  G   +++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 95  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 152
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
           +A+ +CH+ G++HRD+K  N++ID  + +L+LID+G          Y     +R +  PE
Sbjct: 153 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 211
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
            +   + +  S  +WSLG +   M+    PF
Sbjct: 212 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 242

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 89/211 (42%), Gaps = 17/211 (8%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN---------EXXXXXXXXXXXXXXXXXXXXXLQ 183
           +  Y+V   +G G +  V+ G+  +DN         +                     L+
Sbjct: 35  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 94
Query: 184 NLCGG-PNIVKLLDIVRDQQSKTPSLIFEHVNNT----DFKVLYPTLSDYDVRYYIYELL 238
            +  G   +++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 95  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 152
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
           +A+ +CH+ G++HRD+K  N++ID  + +L+LID+G          Y     +R +  PE
Sbjct: 153 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 211
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
            +   + +  S  +WSLG +   M+    PF
Sbjct: 212 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 242

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 89/211 (42%), Gaps = 17/211 (8%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN---------EXXXXXXXXXXXXXXXXXXXXXLQ 183
           +  Y+V   +G G +  V+ G+  +DN         +                     L+
Sbjct: 36  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 95
Query: 184 NLCGG-PNIVKLLDIVRDQQSKTPSLIFEHVNNT----DFKVLYPTLSDYDVRYYIYELL 238
            +  G   +++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 96  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 153
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
           +A+ +CH+ G++HRD+K  N++ID  + +L+LID+G          Y     +R +  PE
Sbjct: 154 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 212
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
            +   + +  S  +WSLG +   M+    PF
Sbjct: 213 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 89/211 (42%), Gaps = 17/211 (8%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN---------EXXXXXXXXXXXXXXXXXXXXXLQ 183
           +  Y+V   +G G +  V+ G+  +DN         +                     L+
Sbjct: 22  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 81
Query: 184 NLCGG-PNIVKLLDIVRDQQSKTPSLIFEHVNNT----DFKVLYPTLSDYDVRYYIYELL 238
            +  G   +++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 82  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 139
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
           +A+ +CH+ G++HRD+K  N++ID  + +L+LID+G          Y     +R +  PE
Sbjct: 140 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 198
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
            +   + +  S  +WSLG +   M+    PF
Sbjct: 199 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 229

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 68/299 (22%), Positives = 127/299 (42%), Gaps = 51/299 (17%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVH-CTDNEXXXXXXXXXXXXXXXXXXXXXLQNLC---GGP 189
           D+Y++   +G+G +S V   V  CT +E                        +C      
Sbjct: 4   DEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHS 63
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDF---KVLYPTLSDYDVRYYIYELLKALDYCHS 246
           NIV+L D + ++      L+F+ V   +     V     S+ D  + I ++L+A+ +CH 
Sbjct: 64  NIVRLHDSISEEGFHY--LVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ 121
Query: 247 QGIMHRDVKPHNVMIDHEQR--KLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDL 303
            G++HRD+KP N+++  + +   ++L D+GLA E     + +     +  +  PE+L   
Sbjct: 122 MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRK- 180
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFF--YGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 361
           + Y   +D+W+ G +   ++    PF+    H  Y Q+          +  AY       
Sbjct: 181 EAYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQI----------KAGAY------- 223
Query: 362 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 420
                          P  ++ TV       PEA + ++++L  +  +R TA EA+ HP+
Sbjct: 224 -------------DFPSPEWDTV------TPEAKNLINQMLTINPAKRITAHEALKHPW 263

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 89/211 (42%), Gaps = 17/211 (8%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN---------EXXXXXXXXXXXXXXXXXXXXXLQ 183
           +  Y+V   +G G +  V+ G+  +DN         +                     L+
Sbjct: 8   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 67
Query: 184 NLCGG-PNIVKLLDIVRDQQSKTPSLIFEHVNNT----DFKVLYPTLSDYDVRYYIYELL 238
            +  G   +++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 68  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 125
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
           +A+ +CH+ G++HRD+K  N++ID  + +L+LID+G          Y     +R +  PE
Sbjct: 126 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 184
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
            +   + +  S  +WSLG +   M+    PF
Sbjct: 185 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 215

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/211 (23%), Positives = 91/211 (43%), Gaps = 17/211 (8%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN---------EXXXXXXXXXXXXXXXXXXXXXLQ 183
           +  Y+V   +G G +  V+ G+  +DN         +                     L+
Sbjct: 3   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62
Query: 184 NLCGG-PNIVKLLDIVRDQQSKTPSLIFEHVNNT----DFKVLYPTLSDYDVRYYIYELL 238
            +  G   +++LLD    ++  +  LI E         DF      L +   R + +++L
Sbjct: 63  KVSSGFSGVIRLLDWF--ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 120
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
           +A+ +CH+ G++HRD+K  N++ID  + +L+LID+G          Y     +R +  PE
Sbjct: 121 EAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 179
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
            +   + +  S  +WSLG +   M+    PF
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 210

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 89/211 (42%), Gaps = 17/211 (8%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN---------EXXXXXXXXXXXXXXXXXXXXXLQ 183
           +  Y+V   +G G +  V+ G+  +DN         +                     L+
Sbjct: 22  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 81
Query: 184 NLCGG-PNIVKLLDIVRDQQSKTPSLIFEHVNNT----DFKVLYPTLSDYDVRYYIYELL 238
            +  G   +++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 82  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 139
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
           +A+ +CH+ G++HRD+K  N++ID  + +L+LID+G          Y     +R +  PE
Sbjct: 140 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 198
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
            +   + +  S  +WSLG +   M+    PF
Sbjct: 199 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 229

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/240 (22%), Positives = 113/240 (47%), Gaps = 48/240 (20%)
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDF--KVLYPT--LSDYDVRYYIYELLKALDYCH 245
           N+++L D    +      L+ E+V+  +   +++  +  L++ D   ++ ++ + + + H
Sbjct: 147 NLIQLYDAFESKNDIV--LVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH 204
Query: 246 SQGIMHRDVKPHNVM-IDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
              I+H D+KP N++ ++ + +++++ID+GLA  Y P ++  V   +  F  PE++    
Sbjct: 205 QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVV---- 260
Query: 305 DYD---YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 361
           +YD   +  D+WS+G +   ++    PF   +D        A+ L     N    ++ +E
Sbjct: 261 NYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND--------AETLN----NILACRWDLE 308
Query: 362 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            +                     E Q ++  EA +F+ KLL  +   R +A EA+ HP+ 
Sbjct: 309 DE---------------------EFQDIS-EEAKEFISKLLIKEKSWRISASEALKHPWL 346

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 89/211 (42%), Gaps = 17/211 (8%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN---------EXXXXXXXXXXXXXXXXXXXXXLQ 183
           +  Y+V   +G G +  V+ G+  +DN         +                     L+
Sbjct: 23  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 82
Query: 184 NLCGG-PNIVKLLDIVRDQQSKTPSLIFEHVNNT----DFKVLYPTLSDYDVRYYIYELL 238
            +  G   +++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 83  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 140
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
           +A+ +CH+ G++HRD+K  N++ID  + +L+LID+G          Y     +R +  PE
Sbjct: 141 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 199
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
            +   + +  S  +WSLG +   M+    PF
Sbjct: 200 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 230

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 89/211 (42%), Gaps = 17/211 (8%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN---------EXXXXXXXXXXXXXXXXXXXXXLQ 183
           +  Y+V   +G G +  V+ G+  +DN         +                     L+
Sbjct: 23  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 82
Query: 184 NLCGG-PNIVKLLDIVRDQQSKTPSLIFEHVNNT----DFKVLYPTLSDYDVRYYIYELL 238
            +  G   +++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 83  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 140
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
           +A+ +CH+ G++HRD+K  N++ID  + +L+LID+G          Y     +R +  PE
Sbjct: 141 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 199
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
            +   + +  S  +WSLG +   M+    PF
Sbjct: 200 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 230

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/251 (23%), Positives = 113/251 (45%), Gaps = 44/251 (17%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCH 245
           PN++ L ++  ++      LI E V      DF     +L++ +   ++ ++L  + Y H
Sbjct: 74  PNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 246 SQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
           S  I H D+KP N+M+   +  + ++++ID+GLA     G E+     +  F  PE +V+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVN 190
Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 362
            +      D+WS+G +   ++    PF  G    + L  ++ V        Y  ++  E 
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAV-------NY--EFEDEY 240
Query: 363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFF 422
             + +AL                        A DF+ +LL  D ++R T ++++ HP+  
Sbjct: 241 FSNTSAL------------------------AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276
Query: 423 PIRNAESSRSR 433
           P ++ + + SR
Sbjct: 277 P-KDTQQALSR 286

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/214 (22%), Positives = 88/214 (41%), Gaps = 41/214 (19%)
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
            L +  +   + E+L+ L+Y H  G +HRDVK  N+++  E   +++ D+G++ F   G 
Sbjct: 117 VLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGG 175
Query: 284 EYNVRVASRYFKG------PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYD 337
           +       + F G      PE++  ++ YD+  D+WS G     +     P+        
Sbjct: 176 DITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY-------- 227
Query: 338 QLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDF 397
                             +KY     P +  L+      P S    V+++ +       F
Sbjct: 228 ------------------HKY-----PPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSF 264
Query: 398 ---LDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 428
              +   L+ D ++RPTA E + H +F   +N E
Sbjct: 265 RKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKE 298

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 89/211 (42%), Gaps = 17/211 (8%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN---------EXXXXXXXXXXXXXXXXXXXXXLQ 183
           +  Y+V   +G G +  V+ G+  +DN         +                     L+
Sbjct: 8   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 67
Query: 184 NLCGG-PNIVKLLDIVRDQQSKTPSLIFEHVNNT----DFKVLYPTLSDYDVRYYIYELL 238
            +  G   +++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 68  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 125
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
           +A+ +CH+ G++HRD+K  N++ID  + +L+LID+G          Y     +R +  PE
Sbjct: 126 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 184
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
            +   + +  S  +WSLG +   M+    PF
Sbjct: 185 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 215

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 89/211 (42%), Gaps = 17/211 (8%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN---------EXXXXXXXXXXXXXXXXXXXXXLQ 183
           +  Y+V   +G G +  V+ G+  +DN         +                     L+
Sbjct: 7   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 66
Query: 184 NLCGG-PNIVKLLDIVRDQQSKTPSLIFEHVNNT----DFKVLYPTLSDYDVRYYIYELL 238
            +  G   +++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 67  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 124
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
           +A+ +CH+ G++HRD+K  N++ID  + +L+LID+G          Y     +R +  PE
Sbjct: 125 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 183
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
            +   + +  S  +WSLG +   M+    PF
Sbjct: 184 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 214

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 73/302 (24%), Positives = 128/302 (42%), Gaps = 57/302 (18%)
Query: 139 VRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQ------NLCGGPNIV 192
           + K+G+G + EVF+G+   DN                      +Q      + C  P + 
Sbjct: 12  LEKIGKGSFGEVFKGI---DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 193 KLL-DIVRDQQSKTPSLIFEHVNN-TDFKVLYPT-LSDYDVRYYIYELLKALDYCHSQGI 249
           K     ++D +     +I E++   +   +L P  L +  +   + E+LK LDY HS+  
Sbjct: 69  KYYGSYLKDTKL---WIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKK 125
Query: 250 MHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 308
           +HRD+K  NV++  E  +++L D+G+A +      + N  V + ++  PE ++    YD 
Sbjct: 126 IHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIKQSAYDS 183
Query: 309 SLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAA 368
             D+WSLG + A  + R EP                              H EL P    
Sbjct: 184 KADIWSLG-ITAIELARGEP-----------------------------PHSELHPMKVL 213
Query: 369 LVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 428
            +   +  P     T+E  + + P   +F++  L  +   RPTAKE + H +   +RNA+
Sbjct: 214 FLIPKNNPP-----TLEGNY-SKP-LKEFVEACLNKEPSFRPTAKELLKHKFI--LRNAK 264
Query: 429 SS 430
            +
Sbjct: 265 KT 266

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/251 (23%), Positives = 113/251 (45%), Gaps = 44/251 (17%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCH 245
           PN++ L ++  ++      LI E V      DF     +L++ +   ++ ++L  + Y H
Sbjct: 74  PNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 246 SQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
           S  I H D+KP N+M+   +  + ++++ID+GLA     G E+     +  F  PE +V+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVN 190
Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 362
            +      D+WS+G +   ++    PF  G    + L  ++ V        Y  ++  E 
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAV-------NY--EFEDEY 240
Query: 363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFF 422
             + +AL                        A DF+ +LL  D ++R T ++++ HP+  
Sbjct: 241 FSNTSAL------------------------AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276
Query: 423 PIRNAESSRSR 433
           P ++ + + SR
Sbjct: 277 P-KDTQQALSR 286

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 89/211 (42%), Gaps = 17/211 (8%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN---------EXXXXXXXXXXXXXXXXXXXXXLQ 183
           +  Y+V   +G G +  V+ G+  +DN         +                     L+
Sbjct: 30  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 89
Query: 184 NLCGG-PNIVKLLDIVRDQQSKTPSLIFEHVNNT----DFKVLYPTLSDYDVRYYIYELL 238
            +  G   +++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 90  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 147
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
           +A+ +CH+ G++HRD+K  N++ID  + +L+LID+G          Y     +R +  PE
Sbjct: 148 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 206
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
            +   + +  S  +WSLG +   M+    PF
Sbjct: 207 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 237

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/250 (22%), Positives = 111/250 (44%), Gaps = 50/250 (20%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTD----FKVLYPTLSDYDVRYYIYELLKALDYC 244
           P+I++L +   D  S    L+ E  +N +     K      S+ + R+++++++  + Y 
Sbjct: 71  PSILELYNYFED--SNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYL 128
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDL 303
           HS GI+HRD+   N+++      +++ D+GLA +   P +++     +  +  PE+    
Sbjct: 129 HSHGILHRDLTLSNLLLT-RNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATR- 186
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363
             +    D+WSLGCMF  ++  + PF                  TD +   LNK  +   
Sbjct: 187 SAHGLESDVWSLGCMFYTLLIGRPPF-----------------DTDTVKNTLNKVVL--- 226
Query: 364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP 423
                     +      F+++        EA D + +LLR +  +R +    + HP  F 
Sbjct: 227 ----------ADYEMPSFLSI--------EAKDLIHQLLRRNPADRLSLSSVLDHP--FM 266
Query: 424 IRNAESSRSR 433
            RN+ S++S+
Sbjct: 267 SRNS-STKSK 275

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/211 (23%), Positives = 91/211 (43%), Gaps = 17/211 (8%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN---------EXXXXXXXXXXXXXXXXXXXXXLQ 183
           +  Y+V   +G G +  V+ G+  +DN         +                     L+
Sbjct: 3   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62
Query: 184 NLCGG-PNIVKLLDIVRDQQSKTPSLIFEHVNNT----DFKVLYPTLSDYDVRYYIYELL 238
            +  G   +++LLD    ++  +  LI E         DF      L +   R + +++L
Sbjct: 63  KVSSGFSGVIRLLDWF--ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 120
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
           +A+ +CH+ G++HRD+K  N++ID  + +L+LID+G          Y     +R +  PE
Sbjct: 121 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 179
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
            +   + +  S  +WSLG +   M+    PF
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 210

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/211 (23%), Positives = 91/211 (43%), Gaps = 17/211 (8%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN---------EXXXXXXXXXXXXXXXXXXXXXLQ 183
           +  Y+V   +G G +  V+ G+  +DN         +                     L+
Sbjct: 3   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62
Query: 184 NLCGG-PNIVKLLDIVRDQQSKTPSLIFEHVNNT----DFKVLYPTLSDYDVRYYIYELL 238
            +  G   +++LLD    ++  +  LI E         DF      L +   R + +++L
Sbjct: 63  KVSSGFSGVIRLLDWF--ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 120
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
           +A+ +CH+ G++HRD+K  N++ID  + +L+LID+G          Y     +R +  PE
Sbjct: 121 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 179
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
            +   + +  S  +WSLG +   M+    PF
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 210

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/211 (23%), Positives = 91/211 (43%), Gaps = 17/211 (8%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN---------EXXXXXXXXXXXXXXXXXXXXXLQ 183
           +  Y+V   +G G +  V+ G+  +DN         +                     L+
Sbjct: 6   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 65
Query: 184 NLCGG-PNIVKLLDIVRDQQSKTPSLIFEHVNNT----DFKVLYPTLSDYDVRYYIYELL 238
            +  G   +++LLD    ++  +  LI E         DF      L +   R + +++L
Sbjct: 66  KVSSGFSGVIRLLDWF--ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 123
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
           +A+ +CH+ G++HRD+K  N++ID  + +L+LID+G          Y     +R +  PE
Sbjct: 124 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 182
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
            +   + +  S  +WSLG +   M+    PF
Sbjct: 183 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 213

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 73/302 (24%), Positives = 128/302 (42%), Gaps = 57/302 (18%)
Query: 139 VRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQ------NLCGGPNIV 192
           + K+G+G + EVF+G+   DN                      +Q      + C  P + 
Sbjct: 32  LEKIGKGSFGEVFKGI---DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 193 KLL-DIVRDQQSKTPSLIFEHVNN-TDFKVLYPT-LSDYDVRYYIYELLKALDYCHSQGI 249
           K     ++D +     +I E++   +   +L P  L +  +   + E+LK LDY HS+  
Sbjct: 89  KYYGSYLKDTKL---WIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKK 145
Query: 250 MHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 308
           +HRD+K  NV++  E  +++L D+G+A +      + N  V + ++  PE ++    YD 
Sbjct: 146 IHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIKQSAYDS 203
Query: 309 SLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAA 368
             D+WSLG + A  + R EP                              H EL P    
Sbjct: 204 KADIWSLG-ITAIELARGEP-----------------------------PHSELHPMKVL 233
Query: 369 LVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 428
            +   +  P     T+E  + + P   +F++  L  +   RPTAKE + H +   +RNA+
Sbjct: 234 FLIPKNNPP-----TLEGNY-SKP-LKEFVEACLNKEPSFRPTAKELLKHKFI--LRNAK 284
Query: 429 SS 430
            +
Sbjct: 285 KT 286

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 21/214 (9%)
Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXXXXXXX-----XXLQNLC 186
           + +DY+VV+ +GRG + EV    H    +                          +    
Sbjct: 73  KAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 132
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDV-----RYYIYELLKAL 241
             P +V+L    +D   K   ++ E++   D   L   +S+YDV     ++Y  E++ AL
Sbjct: 133 NSPWVVQLFCAFQDD--KYLYMVMEYMPGGD---LVNLMSNYDVPEKWAKFYTAEVVLAL 187
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEY-NVRVASRYFKGPEL 299
           D  HS G++HRDVKP N+++D +   L+L D+G   +    G  + +  V +  +  PE+
Sbjct: 188 DAIHSMGLIHRDVKPDNMLLD-KHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEV 246
Query: 300 LVDLQD---YDYSLDLWSLGCMFAGMIFRKEPFF 330
           L        Y    D WS+G     M+    PF+
Sbjct: 247 LKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY 280

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/241 (23%), Positives = 107/241 (44%), Gaps = 43/241 (17%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCH 245
           PN++ L ++  ++      LI E V      DF     +L++ +   ++ ++L  + Y H
Sbjct: 74  PNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 246 SQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
           S  I H D+KP N+M+   +  + ++++ID+GLA     G E+     +  F  PE +V+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVN 190
Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 362
            +      D+WS+G +   ++    PF  G    + L  ++ V        Y  ++  E 
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAV-------NY--EFEDEY 240
Query: 363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFF 422
             + +AL                        A DF+ +LL  D ++R T ++++ HP+  
Sbjct: 241 FSNTSAL------------------------AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276
Query: 423 P 423
           P
Sbjct: 277 P 277

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/241 (23%), Positives = 107/241 (44%), Gaps = 43/241 (17%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCH 245
           PN++ L ++  ++      LI E V      DF     +L++ +   ++ ++L  + Y H
Sbjct: 74  PNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 246 SQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
           S  I H D+KP N+M+   +  + ++++ID+GLA     G E+     +  F  PE +V+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVN 190
Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 362
            +      D+WS+G +   ++    PF  G    + L  ++ V        Y  ++  E 
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAV-------NY--EFEDEY 240
Query: 363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFF 422
             + +AL                        A DF+ +LL  D ++R T ++++ HP+  
Sbjct: 241 FSNTSAL------------------------AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276
Query: 423 P 423
           P
Sbjct: 277 P 277

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/241 (23%), Positives = 107/241 (44%), Gaps = 43/241 (17%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCH 245
           PN++ L ++  ++      LI E V      DF     +L++ +   ++ ++L  + Y H
Sbjct: 73  PNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 246 SQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
           S  I H D+KP N+M+   +  + ++++ID+GLA     G E+     +  F  PE +V+
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVN 189
Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 362
            +      D+WS+G +   ++    PF  G    + L  ++ V        Y  ++  E 
Sbjct: 190 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAV-------NY--EFEDEY 239
Query: 363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFF 422
             + +AL                        A DF+ +LL  D ++R T ++++ HP+  
Sbjct: 240 FSNTSAL------------------------AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275
Query: 423 P 423
           P
Sbjct: 276 P 276

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/241 (23%), Positives = 107/241 (44%), Gaps = 43/241 (17%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCH 245
           PN++ L ++  ++      LI E V      DF     +L++ +   ++ ++L  + Y H
Sbjct: 74  PNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 246 SQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
           S  I H D+KP N+M+   +  + ++++ID+GLA     G E+     +  F  PE +V+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVN 190
Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 362
            +      D+WS+G +   ++    PF  G    + L  ++ V        Y  ++  E 
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAV-------NY--EFEDEY 240
Query: 363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFF 422
             + +AL                        A DF+ +LL  D ++R T ++++ HP+  
Sbjct: 241 FSNTSAL------------------------AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276
Query: 423 P 423
           P
Sbjct: 277 P 277

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/241 (23%), Positives = 107/241 (44%), Gaps = 43/241 (17%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCH 245
           PN++ L ++  ++      LI E V      DF     +L++ +   ++ ++L  + Y H
Sbjct: 73  PNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 246 SQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
           S  I H D+KP N+M+   +  + ++++ID+GLA     G E+     +  F  PE +V+
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVN 189
Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 362
            +      D+WS+G +   ++    PF  G    + L  ++ V        Y  ++  E 
Sbjct: 190 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAV-------NY--EFEDEY 239
Query: 363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFF 422
             + +AL                        A DF+ +LL  D ++R T ++++ HP+  
Sbjct: 240 FSNTSAL------------------------AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275
Query: 423 P 423
           P
Sbjct: 276 P 276

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 105/238 (44%), Gaps = 46/238 (19%)
Query: 189 PNIVKLLD--IVRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           PNIV  LD  +V D+      ++ E++        V    + +  +     E L+AL++ 
Sbjct: 78  PNIVNYLDSYLVGDELW----VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFL 133
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDL 303
           HS  ++HR++K  N+++  +   ++L D+G      P + + +  V + Y+  PE +V  
Sbjct: 134 HSNQVIHRNIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE-VVTR 191
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363
           + Y   +D+WSLG M   MI  + P+   ++N  + + +    GT EL           +
Sbjct: 192 KAYGPKVDIWSLGIMAIEMIEGEPPYL--NENPLRALYLIATNGTPELQ----------N 239
Query: 364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
           P   + + R                       DFL++ L  D ++R +AKE + H + 
Sbjct: 240 PEKLSAIFR-----------------------DFLNRCLEMDVEKRGSAKELIQHQFL 274

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/241 (23%), Positives = 107/241 (44%), Gaps = 43/241 (17%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCH 245
           PN++ L ++  ++      LI E V      DF     +L++ +   ++ ++L  + Y H
Sbjct: 74  PNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 246 SQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
           S  I H D+KP N+M+   +  + ++++ID+GLA     G E+     +  F  PE +V+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVN 190
Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 362
            +      D+WS+G +   ++    PF  G    + L  ++ V        Y  ++  E 
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAV-------NY--EFEDEY 240
Query: 363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFF 422
             + +AL                        A DF+ +LL  D ++R T ++++ HP+  
Sbjct: 241 FSNTSAL------------------------AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276
Query: 423 P 423
           P
Sbjct: 277 P 277

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 72/302 (23%), Positives = 126/302 (41%), Gaps = 57/302 (18%)
Query: 139 VRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQ------NLCGGPNIV 192
           + K+G+G + EVF+G+   DN                      +Q      + C  P + 
Sbjct: 12  LEKIGKGSFGEVFKGI---DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 193 KLL-DIVRDQQSKTPSLIFEHVNN-TDFKVLYPT-LSDYDVRYYIYELLKALDYCHSQGI 249
           K     ++D +     +I E++   +   +L P  L +  +   + E+LK LDY HS+  
Sbjct: 69  KYYGSYLKDTKL---WIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKK 125
Query: 250 MHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 308
           +HRD+K  NV++  E  +++L D+G+A +      + N  V + ++  PE ++    YD 
Sbjct: 126 IHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPE-VIKQSAYDS 183
Query: 309 SLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAA 368
             D+WSLG + A  + R EP                              H EL P    
Sbjct: 184 KADIWSLG-ITAIELARGEP-----------------------------PHSELHPMKVL 213
Query: 369 LVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 428
            +   +  P     T+E  +       +F++  L  +   RPTAKE + H +   +RNA+
Sbjct: 214 FLIPKNNPP-----TLEGNY--SKPLKEFVEACLNKEPSFRPTAKELLKHKFI--LRNAK 264
Query: 429 SS 430
            +
Sbjct: 265 KT 266

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/225 (21%), Positives = 93/225 (41%), Gaps = 35/225 (15%)
Query: 122 DYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXXXXXXXXX 181
           D +SLT Q   ++ ++V+ K+G G Y  V++ +H    +                     
Sbjct: 19  DEDSLTKQ--PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEIS 76
Query: 182 LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----------------PTL 225
           +   C  P++VK                  +  NTD  ++                  TL
Sbjct: 77  IMQQCDSPHVVKYYG--------------SYFKNTDLWIVMEYCGAGSVSDIIRLRNKTL 122
Query: 226 SDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKE 284
           ++ ++   +   LK L+Y H    +HRD+K  N++++ E    +L D+G+A +      +
Sbjct: 123 TEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHA-KLADFGVAGQLTDXMAK 181
Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
            N  + + ++  PE++ ++  Y+   D+WSLG     M   K P+
Sbjct: 182 RNXVIGTPFWMAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPPY 225

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/241 (23%), Positives = 107/241 (44%), Gaps = 43/241 (17%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCH 245
           PN++ L ++  ++      LI E V      DF     +L++ +   ++ ++L  + Y H
Sbjct: 74  PNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 246 SQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
           S  I H D+KP N+M+   +  + ++++ID+GLA     G E+     +  F  PE +V+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVN 190
Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 362
            +      D+WS+G +   ++    PF  G    + L  ++ V        Y  ++  E 
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAV-------NY--EFEDEY 240
Query: 363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFF 422
             + +AL                        A DF+ +LL  D ++R T ++++ HP+  
Sbjct: 241 FSNTSAL------------------------AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276
Query: 423 P 423
           P
Sbjct: 277 P 277

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 105/238 (44%), Gaps = 46/238 (19%)
Query: 189 PNIVKLLD--IVRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYC 244
           PNIV  LD  +V D+      ++ E++        V    + +  +     E L+AL++ 
Sbjct: 77  PNIVNYLDSYLVGDELW----VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFL 132
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDL 303
           HS  ++HRD+K  N+++  +   ++L D+G      P + + +  V + Y+  PE +V  
Sbjct: 133 HSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPE-VVTR 190
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363
           + Y   +D+WSLG M   MI  + P+   ++N  + + +    GT EL           +
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYL--NENPLRALYLIATNGTPELQ----------N 238
Query: 364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
           P   + + R                       DFL++ L  D ++R +AKE + H + 
Sbjct: 239 PEKLSAIFR-----------------------DFLNRCLDMDVEKRGSAKELLQHQFL 273

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/240 (22%), Positives = 100/240 (41%), Gaps = 42/240 (17%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDF--KVL--YPTLSDYDVRYYIYELLKALDYC 244
           P +V L D   D       +I+E ++  +   KV   +  +S+ +   Y+ ++ K L + 
Sbjct: 214 PTLVNLHDAFEDDNEMV--MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 271
Query: 245 HSQGIMHRDVKPHNVMIDHEQ-RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 303
           H    +H D+KP N+M   ++  +L+LID+GL     P +   V   +  F  PE + + 
Sbjct: 272 HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPE-VAEG 330
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363
           +   Y  D+WS+G +   ++    PF  G +N D+ ++  K    +            +D
Sbjct: 331 KPVGYYTDMWSVGVLSYILLSGLSPF--GGENDDETLRNVKSCDWN------------MD 376
Query: 364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP 423
               + +    +                    DF+ KLL  D   R T  +A+ HP+  P
Sbjct: 377 DSAFSGISEDGK--------------------DFIRKLLLADPNTRMTIHQALEHPWLTP 416

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 59/113 (52%), Gaps = 1/113 (0%)
Query: 217 DFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
           DF      L +   R + +++L+A+ +CH+ G++HRD+K  N++ID  + +L+LID+G  
Sbjct: 146 DFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 205
Query: 277 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
                   Y     +R +  PE +   + +  S  +WSLG +   M+    PF
Sbjct: 206 ALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 257

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 72/302 (23%), Positives = 126/302 (41%), Gaps = 57/302 (18%)
Query: 139 VRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQ------NLCGGPNIV 192
           + K+G+G + EVF+G+   DN                      +Q      + C  P + 
Sbjct: 27  LEKIGKGSFGEVFKGI---DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 193 KLL-DIVRDQQSKTPSLIFEHVNN-TDFKVLYPT-LSDYDVRYYIYELLKALDYCHSQGI 249
           K     ++D +     +I E++   +   +L P  L +  +   + E+LK LDY HS+  
Sbjct: 84  KYYGSYLKDTKL---WIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKK 140
Query: 250 MHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 308
           +HRD+K  NV++  E  +++L D+G+A +      + N  V + ++  PE ++    YD 
Sbjct: 141 IHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPE-VIKQSAYDS 198
Query: 309 SLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAA 368
             D+WSLG + A  + R EP                              H EL P    
Sbjct: 199 KADIWSLG-ITAIELARGEP-----------------------------PHSELHPMKVL 228
Query: 369 LVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 428
            +   +  P     T+E  +       +F++  L  +   RPTAKE + H +   +RNA+
Sbjct: 229 FLIPKNNPP-----TLEGNY--SKPLKEFVEACLNKEPSFRPTAKELLKHKFI--LRNAK 279
Query: 429 SS 430
            +
Sbjct: 280 KT 281

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/241 (23%), Positives = 107/241 (44%), Gaps = 43/241 (17%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCH 245
           PN++ L ++  ++      LI E V      DF     +L++ +   ++ ++L  + Y H
Sbjct: 74  PNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 246 SQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
           S  I H D+KP N+M+   +  + ++++ID+GLA     G E+     +  F  PE +V+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVN 190
Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 362
            +      D+WS+G +   ++    PF  G    + L  ++ V        Y  ++  E 
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAV-------NY--EFEDEY 240
Query: 363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFF 422
             + +AL                        A DF+ +LL  D ++R T ++++ HP+  
Sbjct: 241 FSNTSAL------------------------AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276
Query: 423 P 423
           P
Sbjct: 277 P 277

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 92/205 (44%), Gaps = 12/205 (5%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 190
           +D+++V+ +G G Y EV   V+    E                        +  +    N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYPTLS--DYDVRYYIYELLKALDYCHSQ 247
           +VK     R  +     L  E+ +  + F  + P +   + D + + ++L+  + Y H  
Sbjct: 66  VVKFYGHRR--EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 304
           GI HRD+KP N+++D E+  L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 124 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPF 329
            +   +D+WS G +   M+  + P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 92/205 (44%), Gaps = 12/205 (5%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 190
           +D+++V+ +G G Y EV   V+    E                        +  +    N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYPTLS--DYDVRYYIYELLKALDYCHSQ 247
           +VK     R  +     L  E+ +  + F  + P +   + D + + ++L+  + Y H  
Sbjct: 67  VVKFYGHRR--EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 304
           GI HRD+KP N+++D E+  L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 125 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPF 329
            +   +D+WS G +   M+  + P+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/240 (23%), Positives = 100/240 (41%), Gaps = 42/240 (17%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDF--KVL--YPTLSDYDVRYYIYELLKALDYC 244
           P +V L D   D       +I+E ++  +   KV   +  +S+ +   Y+ ++ K L + 
Sbjct: 108 PTLVNLHDAFEDDNEMV--MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 165
Query: 245 HSQGIMHRDVKPHNVMIDHEQ-RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 303
           H    +H D+KP N+M   ++  +L+LID+GL     P +   V   +  F  PE + + 
Sbjct: 166 HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPE-VAEG 224
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363
           +   Y  D+WS+G +   ++    PF  G +N D+ ++  K                + +
Sbjct: 225 KPVGYYTDMWSVGVLSYILLSGLSPF--GGENDDETLRNVK--------------SCDWN 268
Query: 364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP 423
              +A  G                     +  DF+ KLL  D   R T  +A+ HP+  P
Sbjct: 269 MDDSAFSG------------------ISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTP 310

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 56/105 (53%), Gaps = 9/105 (8%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRV 289
            R+Y  E+  AL Y HS  I++RD+KP N+++D  Q  + L D+GL +      E+N   
Sbjct: 141 ARFYAAEIASALGYLHSLNIVYRDLKPENILLD-SQGHIVLTDFGLCK---ENIEHN-ST 195
Query: 290 ASRYFKGPELL----VDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
            S +   PE L    +  Q YD ++D W LG +   M++   PF+
Sbjct: 196 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFY 240

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 93/205 (45%), Gaps = 12/205 (5%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 190
           +D+++V+ +G G Y EV   V+    E                        +  +    N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHEN 65
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYPTLS--DYDVRYYIYELLKALDYCHSQ 247
           +VK     R  +     L  E+ +  + F  + P +   + D + + ++L+  + Y H  
Sbjct: 66  VVKFYGHRR--EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 304
           GI HRD+KP N+++D E+  L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 124 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPF 329
            +   +D+WS G +   M+  + P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 84/203 (41%), Gaps = 42/203 (20%)
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPG 282
           TL +  + Y   E+L+ L + H   ++HRD+K  NV++  E  +++L+D+G+ A+     
Sbjct: 125 TLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTV 183
Query: 283 KEYNVRVASRYFKGPELLVDLQD----YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQ 338
              N  + + Y+  PE++   ++    YD+  DLWSLG     M     P          
Sbjct: 184 GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC-------- 235
Query: 339 LVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFL 398
                      +++     + I  +P       R   K WSK                F+
Sbjct: 236 -----------DMHPMRALFLIPRNP-----APRLKSKKWSKKFQ------------SFI 267
Query: 399 DKLLRYDHQERPTAKEAMAHPYF 421
           +  L  +H +RP  ++ M HP+ 
Sbjct: 268 ESCLVKNHSQRPATEQLMKHPFI 290

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 92/205 (44%), Gaps = 12/205 (5%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 190
           +D+++V+ +G G Y EV   V+    E                        +  +    N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYPTLS--DYDVRYYIYELLKALDYCHSQ 247
           +VK     R  +     L  E+ +  + F  + P +   + D + + ++L+  + Y H  
Sbjct: 67  VVKFYGHRR--EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 304
           GI HRD+KP N+++D E+  L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 125 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPF 329
            +   +D+WS G +   M+  + P+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 92/205 (44%), Gaps = 12/205 (5%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 190
           +D+++V+ +G G Y EV   V+    E                        +  +    N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYPTLS--DYDVRYYIYELLKALDYCHSQ 247
           +VK     R  +     L  E+ +  + F  + P +   + D + + ++L+  + Y H  
Sbjct: 67  VVKFYGHRR--EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 304
           GI HRD+KP N+++D E+  L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 125 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPF 329
            +   +D+WS G +   M+  + P+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 93/205 (45%), Gaps = 12/205 (5%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 190
           +D+++V+ +G G Y EV   V+    E                        +  +    N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHEN 65
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYPTLS--DYDVRYYIYELLKALDYCHSQ 247
           +VK     R  +     L  E+ +  + F  + P +   + D + + ++L+  + Y H  
Sbjct: 66  VVKFYGHRR--EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 304
           GI HRD+KP N+++D E+  L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 124 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPF 329
            +   +D+WS G +   M+  + P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 92/205 (44%), Gaps = 12/205 (5%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 190
           +D+++V+ +G G Y EV   V+    E                        +  +    N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYPTLS--DYDVRYYIYELLKALDYCHSQ 247
           +VK     R  +     L  E+ +  + F  + P +   + D + + ++L+  + Y H  
Sbjct: 67  VVKFYGHRR--EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 304
           GI HRD+KP N+++D E+  L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 125 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPF 329
            +   +D+WS G +   M+  + P+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 36/138 (26%), Positives = 73/138 (52%), Gaps = 7/138 (5%)
Query: 201 QQSKTPSLIFEHVNNTDFKVLYPTLSDYDVR---YYIYELLKALDYCHSQGIMHRDVKPH 257
           Q  +    + E++N  D      +   +D+    +Y  E++  L + HS+GI++RD+K  
Sbjct: 88  QTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLD 147
Query: 258 NVMIDHEQRKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLG 316
           N+++D +   +++ D+G+ +    G  + N    +  +  PE+L+  Q Y++S+D WS G
Sbjct: 148 NILLDKDGH-IKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLG-QKYNHSVDWWSFG 205
Query: 317 CMFAGMIFRKEPFFYGHD 334
            +   M+  + P F+G D
Sbjct: 206 VLLYEMLIGQSP-FHGQD 222

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 92/205 (44%), Gaps = 12/205 (5%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 190
           +D+++V+ +G G Y EV   V+    E                        +  +    N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYPTLS--DYDVRYYIYELLKALDYCHSQ 247
           +VK     R  +     L  E+ +  + F  + P +   + D + + ++L+  + Y H  
Sbjct: 66  VVKFYGHRR--EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 304
           GI HRD+KP N+++D E+  L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 124 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPF 329
            +   +D+WS G +   M+  + P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 92/205 (44%), Gaps = 12/205 (5%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 190
           +D+++V+ +G G Y EV   V+    E                        +  +    N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYPTLS--DYDVRYYIYELLKALDYCHSQ 247
           +VK     R  +     L  E+ +  + F  + P +   + D + + ++L+  + Y H  
Sbjct: 65  VVKFYGHRR--EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 122
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 304
           GI HRD+KP N+++D E+  L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 123 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPF 329
            +   +D+WS G +   M+  + P+
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPW 206

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 92/205 (44%), Gaps = 12/205 (5%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 190
           +D+++V+ +G G Y EV   V+    E                        +  +    N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYPTLS--DYDVRYYIYELLKALDYCHSQ 247
           +VK     R  +     L  E+ +  + F  + P +   + D + + ++L+  + Y H  
Sbjct: 66  VVKFYGHRR--EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 304
           GI HRD+KP N+++D E+  L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 124 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPF 329
            +   +D+WS G +   M+  + P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 87/174 (50%), Gaps = 11/174 (6%)
Query: 226 SDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI--DHEQRKLRLIDWGLAEFYHPGK 283
           ++ D    I ++L A+ Y H  GI+HRD+KP N++     E+ K+ + D+GL++    G 
Sbjct: 118 TEKDASTLIRQVLDAVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGD 177
Query: 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN--YDQLVK 341
             +    +  +  PE+L   + Y  ++D WS+G +   ++    PF+  +D+  ++Q++K
Sbjct: 178 VMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILK 236
Query: 342 IAKVLGT---DELNAYLNKY---HIELDPHLAALVGRHSRKPWSKFITVENQHL 389
                 +   D+++     +    +E DP+      + +R PW    T  N+++
Sbjct: 237 AEYEFDSPYWDDISDSAKDFIRNLMEKDPNKRYTCEQAARHPWIAGDTALNKNI 290

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 3/92 (3%)
Query: 227 DYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEY 285
           ++ +   + E+LK LDY HS+  +HRD+K  NV++  EQ  ++L D+G+A +      + 
Sbjct: 119 EFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKR 177
Query: 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGC 317
           N  V + ++  PE ++    YD   D+WSLG 
Sbjct: 178 NTFVGTPFWMAPE-VIQQSAYDSKADIWSLGI 208

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 57/102 (55%), Gaps = 3/102 (2%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVR 288
            R+Y  E++ AL+Y HS+ +++RD+K  N+M+D +   +++ D+GL  E    G      
Sbjct: 107 ARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTF 165
Query: 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
             +  +  PE+L D  DY  ++D W LG +   M+  + PF+
Sbjct: 166 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY 206

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 92/205 (44%), Gaps = 12/205 (5%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 190
           +D+++V+ +G G Y EV   V+    E                        +  +    N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYPTLS--DYDVRYYIYELLKALDYCHSQ 247
           +VK     R  +     L  E+ +  + F  + P +   + D + + ++L+  + Y H  
Sbjct: 66  VVKFYGHRR--EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 304
           GI HRD+KP N+++D E+  L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 124 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPF 329
            +   +D+WS G +   M+  + P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 29/107 (27%), Positives = 62/107 (57%), Gaps = 3/107 (2%)
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPG 282
            L++ + RYY+ +++    Y H   ++HRD+K  N+ ++ E  ++++ D+GLA +  + G
Sbjct: 137 ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDG 195
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
           +   V   +  +  PE+L   + + + +D+WS+GC+   ++  K PF
Sbjct: 196 ERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPF 241

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 92/205 (44%), Gaps = 12/205 (5%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 190
           +D+++V+ +G G Y EV   V+    E                        +  +    N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYPTLS--DYDVRYYIYELLKALDYCHSQ 247
           +VK     R  +     L  E+ +  + F  + P +   + D + + ++L+  + Y H  
Sbjct: 67  VVKFYGHRR--EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 304
           GI HRD+KP N+++D E+  L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 125 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPF 329
            +   +D+WS G +   M+  + P+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 93/205 (45%), Gaps = 12/205 (5%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 190
           +D+++V+ +G G Y EV   V+    E                        +  +    N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHEN 66
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYPTLS--DYDVRYYIYELLKALDYCHSQ 247
           +VK     R  +     L  E+ +  + F  + P +   + D + + ++L+  + Y H  
Sbjct: 67  VVKFYGHRR--EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 304
           GI HRD+KP N+++D E+  L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 125 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 183
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPF 329
            +   +D+WS G +   M+  + P+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/241 (23%), Positives = 107/241 (44%), Gaps = 43/241 (17%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCH 245
           PN++ L ++  ++      LI E V      DF     +L++ +   ++ ++L  + Y H
Sbjct: 74  PNVITLHEVYENKTDVI--LIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 246 SQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
           S  I H D+KP N+M+   +  + ++++ID+GLA     G E+     +  F  PE +V+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVN 190
Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 362
            +      D+WS+G +   ++    PF  G    + L  ++ V        Y  ++  E 
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAV-------NY--EFEDEY 240
Query: 363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFF 422
             + +AL                        A DF+ +LL  D ++R T ++++ HP+  
Sbjct: 241 FSNTSAL------------------------AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276
Query: 423 P 423
           P
Sbjct: 277 P 277

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 29/107 (27%), Positives = 62/107 (57%), Gaps = 3/107 (2%)
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPG 282
            L++ + RYY+ +++    Y H   ++HRD+K  N+ ++ E  ++++ D+GLA +  + G
Sbjct: 135 ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDG 193
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
           +   V   +  +  PE+L   + + + +D+WS+GC+   ++  K PF
Sbjct: 194 ERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPF 239

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 92/205 (44%), Gaps = 12/205 (5%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 190
           +D+++V+ +G G Y EV   V+    E                        +  +    N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYPTLS--DYDVRYYIYELLKALDYCHSQ 247
           +VK     R  +     L  E+ +  + F  + P +   + D + + ++L+  + Y H  
Sbjct: 66  VVKFYGHRR--EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 304
           GI HRD+KP N+++D E+  L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 124 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPF 329
            +   +D+WS G +   M+  + P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 57/102 (55%), Gaps = 3/102 (2%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVR 288
            R+Y  E++ AL+Y HS+ +++RD+K  N+M+D +   +++ D+GL  E    G      
Sbjct: 110 ARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTF 168
Query: 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
             +  +  PE+L D  DY  ++D W LG +   M+  + PF+
Sbjct: 169 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY 209

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 57/102 (55%), Gaps = 3/102 (2%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVR 288
            R+Y  E++ AL+Y HS+ +++RD+K  N+M+D +   +++ D+GL  E    G      
Sbjct: 107 ARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTF 165
Query: 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
             +  +  PE+L D  DY  ++D W LG +   M+  + PF+
Sbjct: 166 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY 206

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 96/216 (44%), Gaps = 31/216 (14%)
Query: 189 PNIVKLLDIVRDQQSKTPS---LIFEHVNNTDFKVLYPTL------SDYDVRYYIYELLK 239
           PNIV+  +++      TP+   +I E+ +  +   LY  +      S+ + R++  +LL 
Sbjct: 76  PNIVRFKEVIL-----TPTHLAIIMEYASGGE---LYERICNAGRFSEDEARFFFQQLLS 127
Query: 240 ALDYCHSQGIMHRDVKPHNVMIDHEQR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
            + YCHS  I HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE
Sbjct: 128 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 187
Query: 299 LLVDLQDYDYSL-DLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 357
           +L+  Q+YD  + D+WS G     M+    PF    +  D    I ++L       Y   
Sbjct: 188 VLLR-QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSV----KYSIP 242
Query: 358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPE 393
             I + P    L+ R        F+      +++PE
Sbjct: 243 DDIRISPECCHLISR-------IFVADPATRISIPE 271

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 92/205 (44%), Gaps = 12/205 (5%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 190
           +D+++V+ +G G Y EV   V+    E                        +  +    N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYPTLS--DYDVRYYIYELLKALDYCHSQ 247
           +VK     R  +     L  E+ +  + F  + P +   + D + + ++L+  + Y H  
Sbjct: 66  VVKFYGHRR--EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 304
           GI HRD+KP N+++D E+  L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 124 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPF 329
            +   +D+WS G +   M+  + P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 92/205 (44%), Gaps = 12/205 (5%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 190
           +D+++V+ +G G Y EV   V+    E                        +  +    N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYPTLS--DYDVRYYIYELLKALDYCHSQ 247
           +VK     R  +     L  E+ +  + F  + P +   + D + + ++L+  + Y H  
Sbjct: 66  VVKFYGHRR--EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 304
           GI HRD+KP N+++D E+  L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 124 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPF 329
            +   +D+WS G +   M+  + P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 92/205 (44%), Gaps = 12/205 (5%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 190
           +D+++V+ +G G Y EV   V+    E                        +  +    N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYPTLS--DYDVRYYIYELLKALDYCHSQ 247
           +VK     R  +     L  E+ +  + F  + P +   + D + + ++L+  + Y H  
Sbjct: 66  VVKFYGHRR--EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 304
           GI HRD+KP N+++D E+  L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 124 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPF 329
            +   +D+WS G +   M+  + P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 92/205 (44%), Gaps = 12/205 (5%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 190
           +D+++V+ +G G Y EV   V+    E                        +  +    N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYPTLS--DYDVRYYIYELLKALDYCHSQ 247
           +VK     R  +     L  E+ +  + F  + P +   + D + + ++L+  + Y H  
Sbjct: 67  VVKFYGHRR--EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 304
           GI HRD+KP N+++D E+  L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 125 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPF 329
            +   +D+WS G +   M+  + P+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 29/107 (27%), Positives = 62/107 (57%), Gaps = 3/107 (2%)
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPG 282
            L++ + RYY+ +++    Y H   ++HRD+K  N+ ++ E  ++++ D+GLA +  + G
Sbjct: 111 ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDG 169
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
           +   V   +  +  PE+L   + + + +D+WS+GC+   ++  K PF
Sbjct: 170 ERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPF 215

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 92/205 (44%), Gaps = 12/205 (5%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 190
           +D+++V+ +G G Y EV   V+    E                        +  +    N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHEN 66
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYPTLS--DYDVRYYIYELLKALDYCHSQ 247
           +VK     R  +     L  E+ +  + F  + P +   + D + + ++L+  + Y H  
Sbjct: 67  VVKFYGHRR--EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 304
           GI HRD+KP N+++D E+  L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 125 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPF 329
            +   +D+WS G +   M+  + P+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 36/138 (26%), Positives = 73/138 (52%), Gaps = 7/138 (5%)
Query: 201 QQSKTPSLIFEHVNNTDFKVLYPTLSDYDVR---YYIYELLKALDYCHSQGIMHRDVKPH 257
           Q  +    + E++N  D      +   +D+    +Y  E++  L + HS+GI++RD+K  
Sbjct: 89  QTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLD 148
Query: 258 NVMIDHEQRKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLG 316
           N+++D +   +++ D+G+ +    G  + N    +  +  PE+L+  Q Y++S+D WS G
Sbjct: 149 NILLDKDGH-IKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLG-QKYNHSVDWWSFG 206
Query: 317 CMFAGMIFRKEPFFYGHD 334
            +   M+  + P F+G D
Sbjct: 207 VLLYEMLIGQSP-FHGQD 223

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 92/205 (44%), Gaps = 12/205 (5%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 190
           +D+++V+ +G G Y EV   V+    E                        +  +    N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYPTLS--DYDVRYYIYELLKALDYCHSQ 247
           +VK     R  +     L  E+ +  + F  + P +   + D + + ++L+  + Y H  
Sbjct: 66  VVKFYGHRR--EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 304
           GI HRD+KP N+++D E+  L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 124 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPF 329
            +   +D+WS G +   M+  + P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/245 (22%), Positives = 106/245 (43%), Gaps = 57/245 (23%)
Query: 208 LIFEHVNNTD-FKVLYPTL----SDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 262
           LI E+    + F +  P L    S+ DV   I ++L+ + Y H   I+H D+KP N+++ 
Sbjct: 106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLS 165
Query: 263 --HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD---YSLDLWSLGC 317
             +    ++++D+G++       E    + +  +  PE+L    +YD    + D+W++G 
Sbjct: 166 SIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEIL----NYDPITTATDMWNIGI 221
Query: 318 MFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKP 377
           +   ++    PF                +G D    YLN   + +D         +S + 
Sbjct: 222 IAYMLLTHTSPF----------------VGEDNQETYLNISQVNVD---------YSEET 256
Query: 378 WSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY---------FFPIRNAE 428
           +S    +         A DF+  LL  + ++RPTA+  ++H +         F P   + 
Sbjct: 257 FSSVSQL---------ATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSS 307
Query: 429 SSRSR 433
           SS+++
Sbjct: 308 SSQTQ 312

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 57/102 (55%), Gaps = 3/102 (2%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVR 288
            R+Y  E++ AL+Y HS+ +++RD+K  N+M+D +   +++ D+GL  E    G      
Sbjct: 107 ARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXF 165
Query: 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
             +  +  PE+L D  DY  ++D W LG +   M+  + PF+
Sbjct: 166 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY 206

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 72/290 (24%), Positives = 124/290 (42%), Gaps = 53/290 (18%)
Query: 141 KVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQ------NLCGGPNIVKL 194
           ++G+G + EV++G+   DN                      +Q      + C  P I + 
Sbjct: 26  RIGKGSFGEVYKGI---DNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRY 82
Query: 195 LDIVRDQQSKTPSLIFEHVNN-TDFKVLYPT-LSDYDVRYYIYELLKALDYCHSQGIMHR 252
                  +S    +I E++   +   +L P  L +  +   + E+LK LDY HS+  +HR
Sbjct: 83  FGSYL--KSTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHR 140
Query: 253 DVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD 311
           D+K  NV++  EQ  ++L D+G+A +      + N  V + ++  PE ++    YD+  D
Sbjct: 141 DIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPE-VIKQSAYDFKAD 198
Query: 312 LWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVG 371
           +WSLG + A  + + EP      N D  +   +VL     N+               L G
Sbjct: 199 IWSLG-ITAIELAKGEP-----PNSD--LHPMRVLFLIPKNSP------------PTLEG 238
Query: 372 RHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
           +HS KP+ +F+                +  L  D + RPTAKE + H + 
Sbjct: 239 QHS-KPFKEFV----------------EACLNKDPRFRPTAKELLKHKFI 271

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 57/102 (55%), Gaps = 3/102 (2%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVR 288
            R+Y  E++ AL+Y HS+ +++RD+K  N+M+D +   +++ D+GL  E    G      
Sbjct: 107 ARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXF 165
Query: 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
             +  +  PE+L D  DY  ++D W LG +   M+  + PF+
Sbjct: 166 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY 206

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 57/102 (55%), Gaps = 3/102 (2%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVR 288
            R+Y  E++ AL+Y HS+ +++RD+K  N+M+D +   +++ D+GL  E    G      
Sbjct: 112 ARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXF 170
Query: 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
             +  +  PE+L D  DY  ++D W LG +   M+  + PF+
Sbjct: 171 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY 211

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 58/101 (57%), Gaps = 4/101 (3%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRV 289
            ++Y  E+  AL+Y HS+ I++RD+KP N+++D +   +++ D+G A+ Y P   Y +  
Sbjct: 108 AKFYAAEVCLALEYLHSKDIIYRDLKPENILLD-KNGHIKITDFGFAK-YVPDVTYXLCG 165
Query: 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
              Y   PE +V  + Y+ S+D WS G +   M+    PF+
Sbjct: 166 TPDYI-APE-VVSTKPYNKSIDWWSFGILIYEMLAGYTPFY 204

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 57/102 (55%), Gaps = 3/102 (2%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVR 288
            R+Y  E++ AL+Y HS+ +++RD+K  N+M+D +   +++ D+GL  E    G      
Sbjct: 107 ARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXF 165
Query: 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
             +  +  PE+L D  DY  ++D W LG +   M+  + PF+
Sbjct: 166 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY 206

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 83/189 (43%), Gaps = 40/189 (21%)
Query: 237 LLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 295
           ++KAL++ HS+  ++HRDVKP NV+I +   +++  D+G++ +       ++    + + 
Sbjct: 145 IVKALEHLHSKLSVIHRDVKPSNVLI-NALGQVKXCDFGISGYLVDDVAKDIDAGCKPYX 203
Query: 296 GPELL---VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELN 352
            PE +   ++ + Y    D+WSLG     +   + P+      + QL ++ +        
Sbjct: 204 APERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVE-------- 255
Query: 353 AYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA 412
                   E  P L          P  KF           E VDF  + L+ + +ERPT 
Sbjct: 256 --------EPSPQL----------PADKFSA---------EFVDFTSQCLKKNSKERPTY 288
Query: 413 KEAMAHPYF 421
            E   HP+F
Sbjct: 289 PELXQHPFF 297

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/207 (22%), Positives = 85/207 (41%), Gaps = 41/207 (19%)
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
            L +  +   + E+L+ L+Y H  G +HRDVK  N+++  E   +++ D+G++ F   G 
Sbjct: 112 VLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGG 170
Query: 284 EYNVRVASRYFKG------PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYD 337
           +       + F G      PE++  ++ YD+  D+WS G     +     P+        
Sbjct: 171 DITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY-------- 222
Query: 338 QLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDF 397
                             +KY     P +  L+      P S    V+++ +       F
Sbjct: 223 ------------------HKY-----PPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSF 259
Query: 398 ---LDKLLRYDHQERPTAKEAMAHPYF 421
              +   L+ D ++RPTA E + H +F
Sbjct: 260 RKMISLCLQKDPEKRPTAAELLRHKFF 286

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 55/102 (53%), Gaps = 3/102 (2%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRV 289
           V+ +I EL+ ALDY  +Q I+HRD+KP N+++D E   + + D+ +A       +     
Sbjct: 117 VKLFICELVMALDYLQNQRIIHRDMKPDNILLD-EHGHVHITDFNIAAMLPRETQITTMA 175
Query: 290 ASRYFKGPELLVDLQ--DYDYSLDLWSLGCMFAGMIFRKEPF 329
            ++ +  PE+    +   Y +++D WSLG     ++  + P+
Sbjct: 176 GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPY 217

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/151 (25%), Positives = 76/151 (50%), Gaps = 15/151 (9%)
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-------YPTLSDYDVRYYIYELLKALD 242
           N+++L+D++ +++ +   ++ E+      ++L       +P    +    Y  +L+  L+
Sbjct: 67  NVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHG---YFCQLIDGLE 123
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVRVA--SRYFKGPEL 299
           Y HSQGI+H+D+KP N+++      L++   G+AE  HP   +   R +  S  F+ PE+
Sbjct: 124 YLHSQGIVHKDIKPGNLLLT-TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEI 182
Query: 300 LVDLQDYD-YSLDLWSLGCMFAGMIFRKEPF 329
              L  +  + +D+WS G     +     PF
Sbjct: 183 ANGLDTFSGFKVDIWSAGVTLYNITTGLYPF 213

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 28/107 (26%), Positives = 61/107 (57%), Gaps = 3/107 (2%)
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPG 282
            L++ + RYY+ +++    Y H   ++HRD+K  N+ ++ E  ++++ D+GLA +  + G
Sbjct: 117 ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDG 175
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
           +       +  +  PE+L   + + + +D+WS+GC+   ++  K PF
Sbjct: 176 ERKKTLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPF 221

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 28/107 (26%), Positives = 61/107 (57%), Gaps = 3/107 (2%)
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPG 282
            L++ + RYY+ +++    Y H   ++HRD+K  N+ ++ E  ++++ D+GLA +  + G
Sbjct: 113 ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDG 171
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
           +       +  +  PE+L   + + + +D+WS+GC+   ++  K PF
Sbjct: 172 ERKKTLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPF 217

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 28/107 (26%), Positives = 61/107 (57%), Gaps = 3/107 (2%)
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPG 282
            L++ + RYY+ +++    Y H   ++HRD+K  N+ ++ E  ++++ D+GLA +  + G
Sbjct: 113 ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDG 171
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
           +       +  +  PE+L   + + + +D+WS+GC+   ++  K PF
Sbjct: 172 ERKKTLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPF 217

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/108 (29%), Positives = 60/108 (55%), Gaps = 4/108 (3%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGK 283
           + + D + + ++L+  + Y H  GI HRD+KP N+++D E+  L++ D+GLA  F +  +
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNR 159
Query: 284 E--YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
           E   N    +  +  PELL   + +   +D+WS G +   M+  + P+
Sbjct: 160 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 74/323 (22%), Positives = 135/323 (41%), Gaps = 45/323 (13%)
Query: 118 REYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXXXXX 177
           R+  +YE +       + +E+V ++G G + +V++  +                      
Sbjct: 3   RKSREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED 62
Query: 178 XXXXLQNL--CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY--PTLSDYDVRYY 233
               ++ L  C  P IVKLL            + F      D  +L     L++  ++  
Sbjct: 63  YIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVV 122
Query: 234 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASR 292
             ++L+AL++ HS+ I+HRD+K  NV++  E   +RL D+G+ A+     ++ +  + + 
Sbjct: 123 CRQMLEALNFLHSKRIIHRDLKAGNVLMTLEG-DIRLADFGVSAKNLKTLQKRDSFIGTP 181
Query: 293 YFKGPELLV--DLQD--YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
           Y+  PE+++   ++D  YDY  D+WSLG     M  + EP  +  +    L+KIAK    
Sbjct: 182 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMA-QIEPPHHELNPMRVLLKIAKS--- 237
Query: 349 DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQE 408
                         DP       +     WS             E  DFL   L  + + 
Sbjct: 238 --------------DPPTLLTPSK-----WSV------------EFRDFLKIALDKNPET 266
Query: 409 RPTAKEAMAHPYFFPIRNAESSR 431
           RP+A + + HP+   I + ++ R
Sbjct: 267 RPSAAQLLEHPFVSSITSNKALR 289

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 41/212 (19%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGK 283
           L++  ++    ++L+AL++ HS+ I+HRD+K  NV++  E   +RL D+G+ A+     +
Sbjct: 106 LTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEG-DIRLADFGVSAKNLKTLQ 164
Query: 284 EYNVRVASRYFKGPELLV--DLQD--YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQL 339
           + +  + + Y+  PE+++   ++D  YDY  D+WSLG     M  + EP  +  +    L
Sbjct: 165 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMA-QIEPPHHELNPMRVL 223
Query: 340 VKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLD 399
           +KIAK                  DP       +     WS             E  DFL 
Sbjct: 224 LKIAKS-----------------DPPTLLTPSK-----WSV------------EFRDFLK 249
Query: 400 KLLRYDHQERPTAKEAMAHPYFFPIRNAESSR 431
             L  + + RP+A + + HP+   I + ++ R
Sbjct: 250 IALDKNPETRPSAAQLLEHPFVSSITSNKALR 281

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 103/231 (44%), Gaps = 11/231 (4%)
Query: 123 YESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXXXXXXXXXL 182
           YE +T     +D +E++ ++G G + +V++  +   +                      +
Sbjct: 26  YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 85
Query: 183 QNL--CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELL 238
             L  C  PNIVKLLD    + +    + F      D  +L     L++  ++    + L
Sbjct: 86  DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 145
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGP 297
            AL+Y H   I+HRD+K  N++   +   ++L D+G+ A+     +  +  + + Y+  P
Sbjct: 146 DALNYLHDNKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAP 204
Query: 298 ELLV----DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
           E+++      + YDY  D+WSLG     M    EP  +  +    L+KIAK
Sbjct: 205 EVVMCETSKDRPYDYKADVWSLGITLIEMA-EIEPPHHELNPMRVLLKIAK 254

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/124 (29%), Positives = 67/124 (54%), Gaps = 5/124 (4%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPG 282
            S+   R+Y  E++ ALDY HS+  +++RD+K  N+M+D +   +++ D+GL  E    G
Sbjct: 245 FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDG 303
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF-YGHDNYDQLVK 341
                   +  +  PE+L D  DY  ++D W LG +   M+  + PF+   H+   +L+ 
Sbjct: 304 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 362
Query: 342 IAKV 345
           + ++
Sbjct: 363 MEEI 366

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/124 (29%), Positives = 67/124 (54%), Gaps = 5/124 (4%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPG 282
            S+   R+Y  E++ ALDY HS+  +++RD+K  N+M+D +   +++ D+GL  E    G
Sbjct: 248 FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDG 306
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF-YGHDNYDQLVK 341
                   +  +  PE+L D  DY  ++D W LG +   M+  + PF+   H+   +L+ 
Sbjct: 307 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 365
Query: 342 IAKV 345
           + ++
Sbjct: 366 MEEI 369

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 103/231 (44%), Gaps = 11/231 (4%)
Query: 123 YESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXXXXXXXXXL 182
           YE +T     +D +E++ ++G G + +V++  +   +                      +
Sbjct: 26  YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 85
Query: 183 QNL--CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELL 238
             L  C  PNIVKLLD    + +    + F      D  +L     L++  ++    + L
Sbjct: 86  DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 145
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGP 297
            AL+Y H   I+HRD+K  N++   +   ++L D+G+ A+     +  +  + + Y+  P
Sbjct: 146 DALNYLHDNKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRXIQRRDXFIGTPYWMAP 204
Query: 298 ELLV----DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
           E+++      + YDY  D+WSLG     M    EP  +  +    L+KIAK
Sbjct: 205 EVVMCETSKDRPYDYKADVWSLGITLIEMA-EIEPPHHELNPMRVLLKIAK 254

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 61/106 (57%), Gaps = 4/106 (3%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
            S+   R+Y  +++   +Y HS  +++RD+KP N+MID +Q  +++ D+GLA+    G+ 
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMID-QQGYIKVTDFGLAKRVK-GRT 195
Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
           + +     Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 196 WXLCGTPEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 103/231 (44%), Gaps = 11/231 (4%)
Query: 123 YESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXXXXXXXXXL 182
           YE +T     +D +E++ ++G G + +V++  +   +                      +
Sbjct: 26  YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 85
Query: 183 QNL--CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELL 238
             L  C  PNIVKLLD    + +    + F      D  +L     L++  ++    + L
Sbjct: 86  DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 145
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGP 297
            AL+Y H   I+HRD+K  N++   +   ++L D+G+ A+     +  +  + + Y+  P
Sbjct: 146 DALNYLHDNKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRXIQRRDSFIGTPYWMAP 204
Query: 298 ELLV----DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
           E+++      + YDY  D+WSLG     M    EP  +  +    L+KIAK
Sbjct: 205 EVVMCETSKDRPYDYKADVWSLGITLIEMA-EIEPPHHELNPMRVLLKIAK 254

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 74/155 (47%), Gaps = 12/155 (7%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYI----YELLK----A 240
           P+IV+++D+  +  +    L+   +   D   L+  + D   + +      E++K    A
Sbjct: 85  PHIVRIVDVYENLYAGRKCLLIV-MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 143
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
           + Y HS  I HRDVKP N++   ++    L+L D+G A+             + Y+  PE
Sbjct: 144 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 203
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH 333
           +L   + YD S D+WSLG +   ++    PF+  H
Sbjct: 204 VL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 237

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 74/155 (47%), Gaps = 12/155 (7%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYI----YELLK----A 240
           P+IV+++D+  +  +    L+   +   D   L+  + D   + +      E++K    A
Sbjct: 69  PHIVRIVDVYENLYAGRKCLLIV-MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 127
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
           + Y HS  I HRDVKP N++   ++    L+L D+G A+             + Y+  PE
Sbjct: 128 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 187
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH 333
           +L   + YD S D+WSLG +   ++    PF+  H
Sbjct: 188 VL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 221

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 74/155 (47%), Gaps = 12/155 (7%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYI----YELLK----A 240
           P+IV+++D+  +  +    L+   +   D   L+  + D   + +      E++K    A
Sbjct: 77  PHIVRIVDVYENLYAGRKCLLIV-MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 135
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
           + Y HS  I HRDVKP N++   ++    L+L D+G A+             + Y+  PE
Sbjct: 136 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 195
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH 333
           +L   + YD S D+WSLG +   ++    PF+  H
Sbjct: 196 VL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 229

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 74/155 (47%), Gaps = 12/155 (7%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYI----YELLK----A 240
           P+IV+++D+  +  +    L+   +   D   L+  + D   + +      E++K    A
Sbjct: 70  PHIVRIVDVYENLYAGRKCLLIV-MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 128
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
           + Y HS  I HRDVKP N++   ++    L+L D+G A+             + Y+  PE
Sbjct: 129 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 188
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH 333
           +L   + YD S D+WSLG +   ++    PF+  H
Sbjct: 189 VL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 222

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 74/155 (47%), Gaps = 12/155 (7%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYI----YELLK----A 240
           P+IV+++D+  +  +    L+   +   D   L+  + D   + +      E++K    A
Sbjct: 75  PHIVRIVDVYENLYAGRKCLLIV-MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 133
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
           + Y HS  I HRDVKP N++   ++    L+L D+G A+             + Y+  PE
Sbjct: 134 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 193
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH 333
           +L   + YD S D+WSLG +   ++    PF+  H
Sbjct: 194 VL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 227

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 74/155 (47%), Gaps = 12/155 (7%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYI----YELLK----A 240
           P+IV+++D+  +  +    L+   +   D   L+  + D   + +      E++K    A
Sbjct: 76  PHIVRIVDVYENLYAGRKCLLIV-MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 134
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
           + Y HS  I HRDVKP N++   ++    L+L D+G A+             + Y+  PE
Sbjct: 135 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 194
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH 333
           +L   + YD S D+WSLG +   ++    PF+  H
Sbjct: 195 VL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 228

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 74/155 (47%), Gaps = 12/155 (7%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYI----YELLK----A 240
           P+IV+++D+  +  +    L+   +   D   L+  + D   + +      E++K    A
Sbjct: 71  PHIVRIVDVYENLYAGRKCLLIV-MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 129
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
           + Y HS  I HRDVKP N++   ++    L+L D+G A+             + Y+  PE
Sbjct: 130 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 189
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH 333
           +L   + YD S D+WSLG +   ++    PF+  H
Sbjct: 190 VL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 223

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 50/97 (51%), Gaps = 3/97 (3%)
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKG 296
           +A+ Y HS  I HRDVKP N++   ++    L+L D+G A+             + Y+  
Sbjct: 172 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 231
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH 333
           PE+L   + YD S D+WSLG +   ++    PF+  H
Sbjct: 232 PEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 267

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 74/155 (47%), Gaps = 12/155 (7%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYI----YELLK----A 240
           P+IV+++D+  +  +    L+   +   D   L+  + D   + +      E++K    A
Sbjct: 71  PHIVRIVDVYENLYAGRKCLLIV-MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 129
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
           + Y HS  I HRDVKP N++   ++    L+L D+G A+             + Y+  PE
Sbjct: 130 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 189
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH 333
           +L   + YD S D+WSLG +   ++    PF+  H
Sbjct: 190 VL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 223

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 66/133 (49%), Gaps = 9/133 (6%)
Query: 204 KTPSLIF---EHVNNTDFKVLYPTLSDYD---VRYYIYELLKALDYCHSQGIMHRDVKPH 257
           +TP  +F   E VN  D          +D    R+Y  E++ AL + H +GI++RD+K  
Sbjct: 94  QTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLD 153
Query: 258 NVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLG 316
           NV++DHE    +L D+G+  E    G        +  +  PE+L ++  Y  ++D W++G
Sbjct: 154 NVLLDHEGH-CKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEML-YGPAVDWWAMG 211
Query: 317 CMFAGMIFRKEPF 329
            +   M+    PF
Sbjct: 212 VLLYEMLCGHAPF 224

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 61/106 (57%), Gaps = 4/106 (3%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
            S+   R+Y  +++   +Y HS  +++RD+KP N+MID +Q  +++ D+GLA+    G+ 
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMID-QQGYIQVTDFGLAKRVK-GRT 195
Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
           + +     Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 196 WXLCGTPEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 74/155 (47%), Gaps = 12/155 (7%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYI----YELLK----A 240
           P+IV+++D+  +  +    L+   +   D   L+  + D   + +      E++K    A
Sbjct: 121 PHIVRIVDVYENLYAGRKCLLIV-MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 179
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
           + Y HS  I HRDVKP N++   ++    L+L D+G A+             + Y+  PE
Sbjct: 180 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 239
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH 333
           +L   + YD S D+WSLG +   ++    PF+  H
Sbjct: 240 VL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 273

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 86/211 (40%), Gaps = 50/211 (23%)
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
           ++  ++ + Y   +L+A+   H  GI+H D+KP N +I      L+LID+G+A    P  
Sbjct: 107 SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDT 164
Query: 284 EYNVR---VASRYFKGPELLVDLQD----------YDYSLDLWSLGCMFAGMIFRKEPFF 330
              V+   V +  +  PE + D+                 D+WSLGC+   M + K PF 
Sbjct: 165 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF- 223
Query: 331 YGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLA 390
                              ++   ++K H  +DP+       H          +E   + 
Sbjct: 224 ------------------QQIINQISKLHAIIDPN-------HE---------IEFPDIP 249
Query: 391 VPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
             +  D L   L+ D ++R +  E +AHPY 
Sbjct: 250 EKDLQDVLKCCLKRDPKQRISIPELLAHPYV 280

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 59/109 (54%), Gaps = 4/109 (3%)
Query: 224 TLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHP 281
             S+   R+Y  E++ ALDY HS+  +++RD+K  N+M+D +   +++ D+GL  E    
Sbjct: 105 VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKD 163
Query: 282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
           G        +  +  PE+L D  DY  ++D W LG +   M+  + PF+
Sbjct: 164 GATMKXFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY 211

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 26/107 (24%), Positives = 61/107 (57%), Gaps = 3/107 (2%)
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPG 282
            +++ + RY++ + ++ + Y H+  ++HRD+K  N+ ++ +   +++ D+GLA +    G
Sbjct: 138 AVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDM-DVKIGDFGLATKIEFDG 196
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
           +       +  +  PE+L   + + + +D+WSLGC+   ++  K PF
Sbjct: 197 ERKKTLCGTPNYIAPEVLCK-KGHSFEVDIWSLGCILYTLLVGKPPF 242

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 86/211 (40%), Gaps = 50/211 (23%)
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
           ++  ++ + Y   +L+A+   H  GI+H D+KP N +I      L+LID+G+A    P  
Sbjct: 151 SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDT 208
Query: 284 EYNVR---VASRYFKGPELLVDLQD----------YDYSLDLWSLGCMFAGMIFRKEPFF 330
              V+   V +  +  PE + D+                 D+WSLGC+   M + K PF 
Sbjct: 209 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF- 267
Query: 331 YGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLA 390
                              ++   ++K H  +DP+       H          +E   + 
Sbjct: 268 ------------------QQIINQISKLHAIIDPN-------HE---------IEFPDIP 293
Query: 391 VPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
             +  D L   L+ D ++R +  E +AHPY 
Sbjct: 294 EKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 25/215 (11%)
Query: 236 ELLKALDYCHSQ-GIMHRDVKPHNVMID-----HEQRKLRLIDWGLAEFYHPGKEYNVRV 289
           +LL  LDY H + GI+H D+KP NV+++         ++++ D G A +Y   + Y   +
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHYTNSI 196
Query: 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI---FRKEP---FFYGHDNYDQLVKIA 343
            +R ++ PE+L+    +    D+WS  C+   +I   F  EP     Y  D+ D + +I 
Sbjct: 197 QTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD-DHIAQII 254
Query: 344 KVLGTDELNAYL---NKYHIELDPHLAALVGRHSRKPWS-KFITVENQHLAVPEA---VD 396
           ++LG  EL +YL    KY          L      K W  + +  E    +  EA    D
Sbjct: 255 ELLG--ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 312
Query: 397 FLDKLLRYDHQERPTAKEAMAHPYFFPIRNAESSR 431
           FL  +L+ D ++R  A   + HP+       E  R
Sbjct: 313 FLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIR 347

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/211 (23%), Positives = 85/211 (40%), Gaps = 50/211 (23%)
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
           ++  ++ + Y   +L+A+   H  GI+H D+KP N +I      L+LID+G+A    P  
Sbjct: 151 SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDT 208
Query: 284 EYNVR---VASRYFKGPELLVDLQD----------YDYSLDLWSLGCMFAGMIFRKEPFF 330
              V+   V +  +  PE + D+                 D+WSLGC+   M + K PF 
Sbjct: 209 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF- 267
Query: 331 YGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLA 390
                              ++   ++K H  +DP+                  +E   + 
Sbjct: 268 ------------------QQIINQISKLHAIIDPNHE----------------IEFPDIP 293
Query: 391 VPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
             +  D L   L+ D ++R +  E +AHPY 
Sbjct: 294 EKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 25/215 (11%)
Query: 236 ELLKALDYCHSQ-GIMHRDVKPHNVMID-----HEQRKLRLIDWGLAEFYHPGKEYNVRV 289
           +LL  LDY H + GI+H D+KP NV+++         ++++ D G A +Y   + Y   +
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHYTNSI 196
Query: 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI---FRKEP---FFYGHDNYDQLVKIA 343
            +R ++ PE+L+    +    D+WS  C+   +I   F  EP     Y  D+ D + +I 
Sbjct: 197 QTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD-DHIAQII 254
Query: 344 KVLGTDELNAYL---NKYHIELDPHLAALVGRHSRKPWS-KFITVENQHLAVPEA---VD 396
           ++LG  EL +YL    KY          L      K W  + +  E    +  EA    D
Sbjct: 255 ELLG--ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 312
Query: 397 FLDKLLRYDHQERPTAKEAMAHPYFFPIRNAESSR 431
           FL  +L+ D ++R  A   + HP+       E  R
Sbjct: 313 FLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIR 347

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 59/109 (54%), Gaps = 4/109 (3%)
Query: 224 TLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHP 281
             S+   R+Y  E++ ALDY HS+  +++RD+K  N+M+D +   +++ D+GL  E    
Sbjct: 106 VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKD 164
Query: 282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
           G        +  +  PE+L D  DY  ++D W LG +   M+  + PF+
Sbjct: 165 GATMKXFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY 212

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 59/109 (54%), Gaps = 4/109 (3%)
Query: 224 TLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHP 281
             S+   R+Y  E++ ALDY HS+  +++RD+K  N+M+D +   +++ D+GL  E    
Sbjct: 104 VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKD 162
Query: 282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
           G        +  +  PE+L D  DY  ++D W LG +   M+  + PF+
Sbjct: 163 GATMKXFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY 210

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 86/211 (40%), Gaps = 50/211 (23%)
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
           ++  ++ + Y   +L+A+   H  GI+H D+KP N +I      L+LID+G+A    P  
Sbjct: 103 SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDT 160
Query: 284 EYNVR---VASRYFKGPELLVDLQD----------YDYSLDLWSLGCMFAGMIFRKEPFF 330
              V+   V +  +  PE + D+                 D+WSLGC+   M + K PF 
Sbjct: 161 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF- 219
Query: 331 YGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLA 390
                              ++   ++K H  +DP+       H          +E   + 
Sbjct: 220 ------------------QQIINQISKLHAIIDPN-------HE---------IEFPDIP 245
Query: 391 VPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
             +  D L   L+ D ++R +  E +AHPY 
Sbjct: 246 EKDLQDVLKCCLKRDPKQRISIPELLAHPYV 276

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/210 (22%), Positives = 88/210 (41%), Gaps = 33/210 (15%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAEFYH-- 280
            ++ +    + ++  ALD+ H++GI HRD+KP N++ +H  +   +++ D+GL       
Sbjct: 108 FNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLN 167
Query: 281 ------PGKEYNVRVASRYFKGPELLVDLQD----YDYSLDLWSLGCMFAGMIFRKEPFF 330
                    E      S  +  PE++    +    YD   DLWSLG +   ++    P F
Sbjct: 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILY-ILLSGYPPF 226
Query: 331 YGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLA 390
            G    D         G D   A          P    ++    ++   +F   +  H++
Sbjct: 227 VGRCGSD--------CGWDRGEAC---------PACQNMLFESIQEGKYEFPDKDWAHIS 269
Query: 391 VPEAVDFLDKLLRYDHQERPTAKEAMAHPY 420
              A D + KLL  D ++R +A + + HP+
Sbjct: 270 CA-AKDLISKLLVRDAKQRLSAAQVLQHPW 298

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 78/337 (23%), Positives = 133/337 (39%), Gaps = 65/337 (19%)
Query: 96  SVRRSGAPSKARVYSDINVVRPREYW----DYESLTVQWGEQDDYEVVRKVGRGKYSEVF 151
           SV  S AP  A +  D        YW    + ++L+      D +EV  ++GRG  S V+
Sbjct: 25  SVTASAAPGTASLVPD--------YWIDGSNRDALS------DFFEVESELGRGATSIVY 70
Query: 152 EGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTP---SL 208
                   +                     +      PNI+KL +I      +TP   SL
Sbjct: 71  RCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIF-----ETPTEISL 125
Query: 209 IFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVM--IDH 263
           + E V      D  V     S+ D    + ++L+A+ Y H  GI+HRD+KP N++     
Sbjct: 126 VLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPA 185
Query: 264 EQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI 323
               L++ D+GL++             +  +  PE+L     Y   +D+WS+G +   ++
Sbjct: 186 PDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCA-YGPEVDMWSVGIITYILL 244
Query: 324 FRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFIT 383
              EPF+   +  DQ +   ++L  +        Y I                PW   ++
Sbjct: 245 CGFEPFY--DERGDQFM-FRRILNCE-------YYFIS---------------PWWDEVS 279
Query: 384 VENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 420
           +         A D + KL+  D ++R T  +A+ HP+
Sbjct: 280 L--------NAKDLVRKLIVLDPKKRLTTFQALQHPW 308

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 86/211 (40%), Gaps = 50/211 (23%)
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
           ++  ++ + Y   +L+A+   H  GI+H D+KP N +I      L+LID+G+A    P  
Sbjct: 151 SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDT 208
Query: 284 EYNVR---VASRYFKGPELLVDLQD----------YDYSLDLWSLGCMFAGMIFRKEPFF 330
              V+   V +  +  PE + D+                 D+WSLGC+   M + K PF 
Sbjct: 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF- 267
Query: 331 YGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLA 390
                  Q++              ++K H  +DP+                  +E   + 
Sbjct: 268 ------QQIIN------------QISKLHAIIDPNHE----------------IEFPDIP 293
Query: 391 VPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
             +  D L   L+ D ++R +  E +AHPY 
Sbjct: 294 EKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 86/210 (40%), Gaps = 50/210 (23%)
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
           ++  ++ + Y   +L+A+   H  GI+H D+KP N +I      L+LID+G+A    P  
Sbjct: 123 SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDX 180
Query: 284 EYNVR---VASRYFKGPELLVDLQD----------YDYSLDLWSLGCMFAGMIFRKEPFF 330
              V+   V +  +  PE + D+                 D+WSLGC+   M + K PF 
Sbjct: 181 XXVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF- 239
Query: 331 YGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLA 390
                              ++   ++K H  +DP+       H          +E   + 
Sbjct: 240 ------------------QQIINQISKLHAIIDPN-------HE---------IEFPDIP 265
Query: 391 VPEAVDFLDKLLRYDHQERPTAKEAMAHPY 420
             +  D L   L+ D ++R +  E +AHPY
Sbjct: 266 EKDLQDVLKCCLKRDPKQRISIPELLAHPY 295

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/211 (23%), Positives = 85/211 (40%), Gaps = 50/211 (23%)
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
           ++  ++ + Y   +L+A+   H  GI+H D+KP N +I      L+LID+G+A    P  
Sbjct: 104 SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDT 161
Query: 284 EYNVR---VASRYFKGPELLVDLQD----------YDYSLDLWSLGCMFAGMIFRKEPFF 330
              V+   V +  +  PE + D+                 D+WSLGC+   M + K PF 
Sbjct: 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF- 220
Query: 331 YGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLA 390
                              ++   ++K H  +DP+                  +E   + 
Sbjct: 221 ------------------QQIINQISKLHAIIDPNHE----------------IEFPDIP 246
Query: 391 VPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
             +  D L   L+ D ++R +  E +AHPY 
Sbjct: 247 EKDLQDVLKCCLKRDPKQRISIPELLAHPYV 277

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/299 (21%), Positives = 126/299 (42%), Gaps = 51/299 (17%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXX----XXXXXXXLQNLCGGP 189
           DDY++  ++G+G +S V   V  T  +                         +  L   P
Sbjct: 31  DDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHP 90
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDF---KVLYPTLSDYDVRYYIYELLKALDYCHS 246
           NIV+L D + ++      L+F+ V   +     V     S+ D  + I+++L+++++ H 
Sbjct: 91  NIVRLHDSISEEGFHY--LVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQ 148
Query: 247 QGIMHRDVKPHNVMIDHEQR--KLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDL 303
             I+HRD+KP N+++  + +   ++L D+GLA E     + +     +  +  PE+L   
Sbjct: 149 HDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRK- 207
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFF--YGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 361
             Y   +D+W+ G +   ++    PF+    H  Y Q+          +  AY       
Sbjct: 208 DPYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQI----------KAGAY------- 250
Query: 362 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 420
                          P  ++ TV       PEA + ++++L  +  +R TA +A+ HP+
Sbjct: 251 -------------DFPSPEWDTV------TPEAKNLINQMLTINPAKRITADQALKHPW 290

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/253 (23%), Positives = 104/253 (41%), Gaps = 42/253 (16%)
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRY---YIYELLKALDY 243
           G  NI++L++   D       L+FE +              ++ R     + ++  ALD+
Sbjct: 69  GNKNILELIEFFEDDTRFY--LVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDF 126
Query: 244 CHSQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAEFYHPGK--------EYNVRVASRY 293
            H++GI HRD+KP N++ +  ++   +++ D+ L                E      S  
Sbjct: 127 LHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAE 186
Query: 294 FKGPELLVDLQD----YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV--LG 347
           +  PE++    D    YD   DLWSLG +   M+    PF  GH   D      +V  + 
Sbjct: 187 YMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFV-GHCGADCGWDRGEVCRVC 245
Query: 348 TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQ 407
            ++L   + +   E              K W+        H++  EA D + KLL  D +
Sbjct: 246 QNKLFESIQEGKYEF-----------PDKDWA--------HIS-SEAKDLISKLLVRDAK 285
Query: 408 ERPTAKEAMAHPY 420
           +R +A + + HP+
Sbjct: 286 QRLSAAQVLQHPW 298

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 86/210 (40%), Gaps = 50/210 (23%)
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
           ++  ++ + Y   +L+A+   H  GI+H D+KP N +I      L+LID+G+A    P  
Sbjct: 123 SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDT 180
Query: 284 EYNVR---VASRYFKGPELLVDLQD----------YDYSLDLWSLGCMFAGMIFRKEPFF 330
              V+   V +  +  PE + D+                 D+WSLGC+   M + K PF 
Sbjct: 181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF- 239
Query: 331 YGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLA 390
                              ++   ++K H  +DP+       H          +E   + 
Sbjct: 240 ------------------QQIINQISKLHAIIDPN-------HE---------IEFPDIP 265
Query: 391 VPEAVDFLDKLLRYDHQERPTAKEAMAHPY 420
             +  D L   L+ D ++R +  E +AHPY
Sbjct: 266 EKDLQDVLKCCLKRDPKQRISIPELLAHPY 295

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 60/106 (56%), Gaps = 4/106 (3%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
            S+   R+Y  +++   +Y HS  +++RD+KP N+MID +Q  +++ D+G A+    G+ 
Sbjct: 139 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMID-QQGYIKVTDFGFAKRVK-GRT 196
Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
           + +     Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 197 WXLCGTPEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 26/107 (24%), Positives = 61/107 (57%), Gaps = 3/107 (2%)
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPG 282
            +++ + RY++ + ++ + Y H+  ++HRD+K  N+ ++ +   +++ D+GLA +    G
Sbjct: 138 AVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDM-DVKIGDFGLATKIEFDG 196
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
           +       +  +  PE+L   + + + +D+WSLGC+   ++  K PF
Sbjct: 197 ERKKXLCGTPNYIAPEVLCK-KGHSFEVDIWSLGCILYTLLVGKPPF 242

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 60/106 (56%), Gaps = 4/106 (3%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
            S+   R+Y  +++   +Y HS  +++RD+KP N+MID +Q  +++ D+G A+    G+ 
Sbjct: 139 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMID-QQGYIKVTDFGFAKRVK-GRT 196
Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
           + +     Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 197 WXLCGTPEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 94/218 (43%), Gaps = 55/218 (25%)
Query: 227 DYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR----------KLRLI--DWG 274
           +Y+    + ++   + + HS  I+HRD+KP N+++    R           LR++  D+G
Sbjct: 132 EYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 191
Query: 275 LAEFYHPGK-----EYNVRVASRYFKGPELLVDL--QDYDYSLDLWSLGCMFAGMIFR-K 326
           L +    G+       N    +  ++ PELL +   +    S+D++S+GC+F  ++ + K
Sbjct: 192 LCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGK 251
Query: 327 EPFFYGHDNYDQLVKIAK-VLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVE 385
            PF    D Y +   I + +   DE+                     H R          
Sbjct: 252 HPF---GDKYSRESNIIRGIFSLDEMKCL------------------HDRS--------- 281
Query: 386 NQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP 423
                + EA D + +++ +D  +RPTA + + HP F+P
Sbjct: 282 ----LIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 315

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 74/155 (47%), Gaps = 12/155 (7%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYI----YELLK----A 240
           P+IV+++D+  +  +    L+   +   D   L+  + D   + +      E++K    A
Sbjct: 69  PHIVRIVDVYENLYAGRKCLLIV-MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 127
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
           + Y HS  I HRDVKP N++   ++    L+L D+G A+             + Y+  PE
Sbjct: 128 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPE 187
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH 333
           +L   + YD S D+WSLG +   ++    PF+  H
Sbjct: 188 VL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 221

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 60/106 (56%), Gaps = 4/106 (3%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
            S+   R+Y  +++   +Y HS  +++RD+KP N+MID +Q  +++ D+G A+    G+ 
Sbjct: 139 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMID-QQGYIKVTDFGFAKRVK-GRT 196
Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
           + +     Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 197 WXLCGTPEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 60/106 (56%), Gaps = 4/106 (3%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
            S+   R+Y  +++   +Y HS  +++RD+KP N+MID +Q  +++ D+G A+    G+ 
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMID-QQGYIKVTDFGFAKRVK-GRT 195
Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
           + +     Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 196 WXLCGTPEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 94/218 (43%), Gaps = 55/218 (25%)
Query: 227 DYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR----------KLRLI--DWG 274
           +Y+    + ++   + + HS  I+HRD+KP N+++    R           LR++  D+G
Sbjct: 132 EYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 191
Query: 275 LAEFYHPGK-----EYNVRVASRYFKGPELLVDL--QDYDYSLDLWSLGCMFAGMIFR-K 326
           L +    G+       N    +  ++ PELL +   +    S+D++S+GC+F  ++ + K
Sbjct: 192 LCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGK 251
Query: 327 EPFFYGHDNYDQLVKIAK-VLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVE 385
            PF    D Y +   I + +   DE+                     H R          
Sbjct: 252 HPF---GDKYSRESNIIRGIFSLDEMKCL------------------HDRS--------- 281
Query: 386 NQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP 423
                + EA D + +++ +D  +RPTA + + HP F+P
Sbjct: 282 ----LIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 315

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/222 (22%), Positives = 94/222 (42%), Gaps = 59/222 (26%)
Query: 227 DYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR----------KLRLI--DWG 274
           +Y+    + ++   + + HS  I+HRD+KP N+++    R           LR++  D+G
Sbjct: 114 EYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173
Query: 275 LAEFYHPGKE-----YNVRVASRYFKGPELLVDLQDYDY------SLDLWSLGCMFAGMI 323
           L +    G+       N    +  ++ PELL +  +         S+D++S+GC+F  ++
Sbjct: 174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL 233
Query: 324 FR-KEPFFYGHDNYDQLVKIAK-VLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKF 381
            + K PF    D Y +   I + +   DE+                     H R      
Sbjct: 234 SKGKHPF---GDKYSRESNIIRGIFSLDEMKCL------------------HDRS----- 267
Query: 382 ITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP 423
                    + EA D + +++ +D  +RPTA + + HP F+P
Sbjct: 268 --------LIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 58/101 (57%), Gaps = 4/101 (3%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRV 289
            R+Y  +++   +Y HS  +++RD+KP N+MID +Q  +++ D+G A+    G+ + +  
Sbjct: 144 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLMID-QQGYIKVTDFGFAKRVK-GRTWXLCG 201
Query: 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
              Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 TPEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 58/101 (57%), Gaps = 4/101 (3%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRV 289
            R+Y  +++   +Y HS  +++RD+KP N+MID +Q  +++ D+G A+    G+ + +  
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLMID-QQGYIKVTDFGFAKRVK-GRTWXLCG 200
Query: 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
              Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 201 TPEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 49/97 (50%), Gaps = 3/97 (3%)
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKG 296
           +A+ Y HS  I HRDVKP N++   ++    L+L D+G A+             + Y+  
Sbjct: 172 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 231
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH 333
           PE+L   + YD S D WSLG +   ++    PF+  H
Sbjct: 232 PEVL-GPEKYDKSCDXWSLGVIXYILLCGYPPFYSNH 267

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/222 (22%), Positives = 94/222 (42%), Gaps = 59/222 (26%)
Query: 227 DYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR----------KLRLI--DWG 274
           +Y+    + ++   + + HS  I+HRD+KP N+++    R           LR++  D+G
Sbjct: 114 EYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173
Query: 275 LAEFYHPGK-----EYNVRVASRYFKGPELLVDLQDYDY------SLDLWSLGCMFAGMI 323
           L +    G+       N    +  ++ PELL +  +         S+D++S+GC+F  ++
Sbjct: 174 LCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL 233
Query: 324 FR-KEPFFYGHDNYDQLVKIAK-VLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKF 381
            + K PF    D Y +   I + +   DE+                     H R      
Sbjct: 234 SKGKHPF---GDKYSRESNIIRGIFSLDEMKCL------------------HDRS----- 267
Query: 382 ITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP 423
                    + EA D + +++ +D  +RPTA + + HP F+P
Sbjct: 268 --------LIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 60/106 (56%), Gaps = 4/106 (3%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
            S+   R+Y  +++   +Y HS  +++RD+KP N+MID +Q  +++ D+G A+    G+ 
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMID-QQGYIQVTDFGFAKRVK-GRT 195
Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
           + +     Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 196 WXLCGTPEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 54/105 (51%), Gaps = 6/105 (5%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE---FYHPGKEYN 286
           + +Y  ++L+ L Y H   I+HRD+K  NV+I+     L++ D+G ++     +P  E  
Sbjct: 124 IGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTE-- 181
Query: 287 VRVASRYFKGPELL-VDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
               +  +  PE++    + Y  + D+WSLGC    M   K PF+
Sbjct: 182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFY 226

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 56/107 (52%), Gaps = 4/107 (3%)
Query: 226 SDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNV--MIDHEQRKLRLIDWGLAEFYHPGK 283
           ++ D    I ++L A+ Y H  GI+HRD+KP N+  +   E  K+ + D+GL++    G 
Sbjct: 104 TEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI 163
Query: 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
             +    +  +  PE+L   + Y  ++D WS+G +   ++    PF+
Sbjct: 164 -MSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFY 208

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 57/107 (53%), Gaps = 7/107 (6%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG-LAEFYHPGK-EYNV 287
            R+YI E++ A+D  H    +HRD+KP NV++D     +RL D+G   +    G  + +V
Sbjct: 193 ARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLLD-VNGHIRLADFGSCLKMNDDGTVQSSV 251
Query: 288 RVASRYFKGPELLVDLQD----YDYSLDLWSLGCMFAGMIFRKEPFF 330
            V +  +  PE+L  ++D    Y    D WSLG     M++ + PF+
Sbjct: 252 AVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY 298

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 60/106 (56%), Gaps = 4/106 (3%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
            S+   R+Y  +++   +Y HS  +++RD+KP N++ID EQ  +++ D+G A+    G+ 
Sbjct: 125 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-EQGYIQVTDFGFAKRVK-GRT 182
Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
           + +     Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 183 WXLCGTPEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 226

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 54/105 (51%), Gaps = 6/105 (5%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE---FYHPGKEYN 286
           + +Y  ++L+ L Y H   I+HRD+K  NV+I+     L++ D+G ++     +P  E  
Sbjct: 110 IGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTE-- 167
Query: 287 VRVASRYFKGPELL-VDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
               +  +  PE++    + Y  + D+WSLGC    M   K PF+
Sbjct: 168 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFY 212

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 26/107 (24%), Positives = 61/107 (57%), Gaps = 3/107 (2%)
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPG 282
            +++ + RY++ + ++ + Y H+  ++HRD+K  N+ ++ +   +++ D+GLA +    G
Sbjct: 138 AVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDM-DVKIGDFGLATKIEFDG 196
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
           +       +  +  PE+L   + + + +D+WSLGC+   ++  K PF
Sbjct: 197 ERKKDLCGTPNYIAPEVLCK-KGHSFEVDIWSLGCILYTLLVGKPPF 242

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 57/107 (53%), Gaps = 7/107 (6%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG-LAEFYHPGK-EYNV 287
            R+YI E++ A+D  H    +HRD+KP NV++D     +RL D+G   +    G  + +V
Sbjct: 177 ARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLLD-VNGHIRLADFGSCLKMNDDGTVQSSV 235
Query: 288 RVASRYFKGPELLVDLQD----YDYSLDLWSLGCMFAGMIFRKEPFF 330
            V +  +  PE+L  ++D    Y    D WSLG     M++ + PF+
Sbjct: 236 AVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY 282

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 60/106 (56%), Gaps = 4/106 (3%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
            S+   R+Y  +++   +Y HS  +++RD+KP N++ID +Q  +++ D+G A+    G+ 
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVK-GRT 195
Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
           + +     Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 196 WXLXGTPEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 73/153 (47%), Gaps = 11/153 (7%)
Query: 187 GGPNIVKLLDIVRDQQSKTPSL--IFEHVNNTD-FKVLYP----TLSDYDVRYYIYELLK 239
           GGP+IV +LD+  +       L  I E +   + F  +        ++ +    + ++  
Sbjct: 61  GGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGT 120
Query: 240 ALDYCHSQGIMHRDVKPHNVMIDHEQRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGP 297
           A+ + HS  I HRDVKP N++   +++   L+L D+G A+             + Y+  P
Sbjct: 121 AIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK-ETTQNALQTPCYTPYYVAP 179
Query: 298 ELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
           E+L   + YD S D+WSLG +   ++    PF+
Sbjct: 180 EVL-GPEKYDKSCDMWSLGVIMYILLCGFPPFY 211

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 73/153 (47%), Gaps = 11/153 (7%)
Query: 187 GGPNIVKLLDIVRDQQSKTPSL--IFEHVNNTD-FKVLYP----TLSDYDVRYYIYELLK 239
           GGP+IV +LD+  +       L  I E +   + F  +        ++ +    + ++  
Sbjct: 80  GGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGT 139
Query: 240 ALDYCHSQGIMHRDVKPHNVMIDHEQRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGP 297
           A+ + HS  I HRDVKP N++   +++   L+L D+G A+             + Y+  P
Sbjct: 140 AIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK-ETTQNALQTPCYTPYYVAP 198
Query: 298 ELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
           E+L   + YD S D+WSLG +   ++    PF+
Sbjct: 199 EVL-GPEKYDKSCDMWSLGVIMYILLCGFPPFY 230

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 60/106 (56%), Gaps = 4/106 (3%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
            S+   R+Y  +++   +Y HS  +++RD+KP N++ID +Q  +++ D+G A+    G+ 
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVK-GRT 195
Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
           + +     Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 196 WXLAGTPEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 26/107 (24%), Positives = 61/107 (57%), Gaps = 3/107 (2%)
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPG 282
            +++ + RY++ + ++ + Y H+  ++HRD+K  N+ ++ +   +++ D+GLA +    G
Sbjct: 122 AVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDM-DVKIGDFGLATKIEFDG 180
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
           +       +  +  PE+L   + + + +D+WSLGC+   ++  K PF
Sbjct: 181 ERKKDLCGTPNYIAPEVLCK-KGHSFEVDIWSLGCILYTLLVGKPPF 226

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/253 (22%), Positives = 108/253 (42%), Gaps = 57/253 (22%)
Query: 189 PNIVKLLDIVRDQQSK------TPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALD 242
           PN+++     +D+Q +        + + E+V   DF  L       +    + +    L 
Sbjct: 78  PNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHL-----GLEPITLLQQTTSGLA 132
Query: 243 YCHSQGIMHRDVKPHNVMID----HEQRKLRLIDWGLAEFYHPGKEYNVRVA----SRYF 294
           + HS  I+HRD+KPHN++I     H + K  + D+GL +    G+    R +    +  +
Sbjct: 133 HLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
Query: 295 KGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV-LGTDEL 351
             PE+L +   ++  Y++D++S GC+F  +I         H     L + A + LG   L
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEG-----SHPFGKSLQRQANILLGACSL 247
Query: 352 NAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT 411
           +    + H ++                               A + ++K++  D Q+RP+
Sbjct: 248 DCLHPEKHEDVI------------------------------ARELIEKMIAMDPQKRPS 277
Query: 412 AKEAMAHPYFFPI 424
           AK  + HP+F+ +
Sbjct: 278 AKHVLKHPFFWSL 290

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 60/106 (56%), Gaps = 4/106 (3%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
            S+   R+Y  +++   +Y HS  +++RD+KP N++ID +Q  +++ D+G A+    G+ 
Sbjct: 139 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVK-GRT 196
Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
           + +     Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 197 WTLCGTPEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 60/106 (56%), Gaps = 4/106 (3%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
            S+   R+Y  +++   +Y HS  +++RD+KP N++ID +Q  +++ D+G A+    G+ 
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLIID-QQGYIQVTDFGFAKRVK-GRT 195
Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
           + +     Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 196 WXLCGTPEYL-APEIIIS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/207 (21%), Positives = 91/207 (43%), Gaps = 19/207 (9%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDN-----EXXXXXXXXXXXXXXXXXXXXXLQNLCGG 188
           DD+++VR +G+GK+  V+      +      +                     +Q+    
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD------VRYYIYELLKALD 242
           PNI+++ +   D+  K   L+ E     +   LY  L  +          ++ EL  AL 
Sbjct: 74  PNILRMYNYFHDR--KRIYLMLEFAPRGE---LYKELQKHGRFDEQRSATFMEELADALH 128
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
           YCH + ++HRD+KP N+++ ++  +L++ D+G +  + P         +  +  PE +++
Sbjct: 129 YCHERKVIHRDIKPENLLMGYKG-ELKIADFGWS-VHAPSLRRRXMCGTLDYLPPE-MIE 185
Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPF 329
            + +D  +DLW  G +    +    PF
Sbjct: 186 GKTHDEKVDLWCAGVLCYEFLVGMPPF 212

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 60/106 (56%), Gaps = 4/106 (3%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
            S+   R+Y  +++   +Y HS  +++RD+KP N++ID +Q  +++ D+G A+    G+ 
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIKVADFGFAKRVK-GRT 195
Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
           + +     Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 196 WXLCGTPEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 60/106 (56%), Gaps = 4/106 (3%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
            S+   R+Y  +++   +Y HS  +++RD+KP N++ID +Q  +++ D+G A+    G+ 
Sbjct: 139 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIKVADFGFAKRVK-GRT 196
Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
           + +     Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 197 WXLCGTPEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 60/106 (56%), Gaps = 4/106 (3%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
            S+   R+Y  +++   +Y HS  +++RD+KP N++ID +Q  +++ D+G A+    G+ 
Sbjct: 124 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVK-GRT 181
Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
           + +     Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 182 WTLCGTPEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 225

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 60/106 (56%), Gaps = 4/106 (3%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
            S+   R+Y  +++   +Y HS  +++RD+KP N++ID +Q  +++ D+G A+    G+ 
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVK-GRT 195
Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
           + +     Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 196 WXLCGTPEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 60/106 (56%), Gaps = 4/106 (3%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
            S+   R+Y  +++   +Y HS  +++RD+KP N++ID +Q  +++ D+G A+    G+ 
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIKVADFGFAKRVK-GRT 195
Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
           + +     Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 196 WXLCGTPEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 60/106 (56%), Gaps = 4/106 (3%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
            S+   R+Y  +++   +Y HS  +++RD+KP N++ID +Q  +++ D+G A+    G+ 
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIKVADFGFAKRVK-GRT 195
Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
           + +     Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 196 WXLCGTPEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 60/106 (56%), Gaps = 4/106 (3%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
            S+   R+Y  +++   +Y HS  +++RD+KP N++ID +Q  +++ D+G A+    G+ 
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVK-GRT 195
Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
           + +     Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 196 WXLCGTPEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 60/106 (56%), Gaps = 4/106 (3%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
            S+   R+Y  +++   +Y HS  +++RD+KP N++ID +Q  +++ D+G A+    G+ 
Sbjct: 139 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVK-GRT 196
Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
           + +     Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 197 WXLCGTPEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 60/106 (56%), Gaps = 4/106 (3%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
            S+   R+Y  +++   +Y HS  +++RD+KP N++ID +Q  +++ D+G A+    G+ 
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVK-GRT 195
Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
           + +     Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 196 WXLCGTPEYL-APEIILS-KGYNKAVDWWALGVLIYQMAAGYPPFF 239

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 60/106 (56%), Gaps = 4/106 (3%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
            S+   R+Y  +++   +Y HS  +++RD+KP N++ID +Q  +++ D+G A+    G+ 
Sbjct: 159 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVK-GRT 216
Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
           + +     Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 217 WXLCGTPEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 260

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 60/106 (56%), Gaps = 4/106 (3%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
            S+   R+Y  +++   +Y HS  +++RD+KP N++ID +Q  +++ D+G A+    G+ 
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVK-GRT 195
Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
           + +     Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 196 WXLCGTPEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 60/106 (56%), Gaps = 4/106 (3%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
            S+   R+Y  +++   +Y HS  +++RD+KP N++ID +Q  +++ D+G A+    G+ 
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVK-GRT 195
Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
           + +     Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 196 WXLCGTPEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 60/106 (56%), Gaps = 4/106 (3%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
            S+   R+Y  +++   +Y HS  +++RD+KP N++ID +Q  +++ D+G A+    G+ 
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVK-GRT 195
Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
           + +     Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 196 WXLCGTPEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 60/106 (56%), Gaps = 4/106 (3%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
            S+   R+Y  +++   +Y HS  +++RD+KP N++ID +Q  +++ D+G A+    G+ 
Sbjct: 139 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVK-GRT 196
Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
           + +     Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 197 WXLCGTPEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 60/106 (56%), Gaps = 4/106 (3%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
            S+   R+Y  +++   +Y HS  +++RD+KP N++ID +Q  +++ D+G A+    G+ 
Sbjct: 139 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVK-GRT 196
Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
           + +     Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 197 WXLCGTPEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 60/106 (56%), Gaps = 4/106 (3%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
            S+   R+Y  +++   +Y HS  +++RD+KP N++ID +Q  +++ D+G A+    G+ 
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVK-GRT 195
Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
           + +     Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 196 WXLCGTPEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 60/106 (56%), Gaps = 4/106 (3%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
            S+   R+Y  +++   +Y HS  +++RD+KP N++ID +Q  +++ D+G A+    G+ 
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVK-GRT 195
Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
           + +     Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 196 WXLCGTPEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 60/106 (56%), Gaps = 4/106 (3%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
            S+   R+Y  +++   +Y HS  +++RD+KP N++ID +Q  +++ D+G A+    G+ 
Sbjct: 139 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVK-GRT 196
Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
           + +     Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 197 WXLCGTPEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 60/106 (56%), Gaps = 4/106 (3%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
            S+   R+Y  +++   +Y HS  +++RD+KP N++ID +Q  +++ D+G A+    G+ 
Sbjct: 139 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVK-GRT 196
Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
           + +     Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 197 WXLCGTPEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 60/106 (56%), Gaps = 4/106 (3%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
            S+   R+Y  +++   +Y HS  +++RD+KP N++ID +Q  +++ D+G A+    G+ 
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVK-GRT 195
Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
           + +     Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 196 WXLCGTPEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 60/106 (56%), Gaps = 4/106 (3%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
            S+   R+Y  +++   +Y HS  +++RD+KP N++ID +Q  +++ D+G A+    G+ 
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVK-GRT 195
Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
           + +     Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 196 WXLCGTPEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 69/154 (44%), Gaps = 13/154 (8%)
Query: 189 PNIVKLLDIVRDQQSKTPS----LIFEHVNNTDFKVLYPT------LSDYDVRYYIYELL 238
           PN+V   ++    Q   P+    L  E+    D +           L +  +R  + ++ 
Sbjct: 73  PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 132
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKL--RLIDWGLAEFYHPGKEYNVRVASRYFKG 296
            AL Y H   I+HRD+KP N+++    ++L  ++ID G A+    G+     V +  +  
Sbjct: 133 SALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLA 192
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
           PELL + + Y  ++D WS G +    I    PF 
Sbjct: 193 PELL-EQKKYTVTVDYWSFGTLAFECITGFRPFL 225

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 60/106 (56%), Gaps = 4/106 (3%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
            S+   R+Y  +++   +Y HS  +++RD+KP N++ID +Q  +++ D+G A+    G+ 
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVK-GRT 195
Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
           + +     Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 196 WXLCGTPEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 60/106 (56%), Gaps = 4/106 (3%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
            S+   R+Y  +++   +Y HS  +++RD+KP N++ID +Q  +++ D+G A+    G+ 
Sbjct: 131 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVK-GRT 188
Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
           + +     Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 189 WXLCGTPEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 232

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 60/106 (56%), Gaps = 4/106 (3%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
            S+   R+Y  +++   +Y HS  +++RD+KP N++ID +Q  +++ D+G A+    G+ 
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVK-GRT 195
Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
           + +     Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 196 WXLCGTPEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 69/154 (44%), Gaps = 13/154 (8%)
Query: 189 PNIVKLLDIVRDQQSKTPS----LIFEHVNNTDFKVLYPT------LSDYDVRYYIYELL 238
           PN+V   ++    Q   P+    L  E+    D +           L +  +R  + ++ 
Sbjct: 72  PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 131
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKL--RLIDWGLAEFYHPGKEYNVRVASRYFKG 296
            AL Y H   I+HRD+KP N+++    ++L  ++ID G A+    G+     V +  +  
Sbjct: 132 SALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLA 191
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
           PELL + + Y  ++D WS G +    I    PF 
Sbjct: 192 PELL-EQKKYTVTVDYWSFGTLAFECITGFRPFL 224

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 60/106 (56%), Gaps = 4/106 (3%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
            S+   R+Y  +++   +Y HS  +++RD+KP N++ID +Q  +++ D+G A+    G+ 
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVK-GRT 195
Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
           + +     Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 196 WXLCGTPEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/150 (23%), Positives = 71/150 (47%), Gaps = 16/150 (10%)
Query: 189 PNIVKLLDIVRD-------QQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKAL 241
           PNIV+  +++          +  +   +FE + N          S+ + R++  +L+  +
Sbjct: 74  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG------RFSEDEARFFFQQLISGV 127
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 300
            YCH+  + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L
Sbjct: 128 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 187
Query: 301 VDLQDYDYSL-DLWSLGCMFAGMIFRKEPF 329
           +  ++YD  + D+WS G     M+    PF
Sbjct: 188 LK-KEYDGKVADVWSCGVTLYVMLVGAYPF 216

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 29/101 (28%), Positives = 58/101 (57%), Gaps = 4/101 (3%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRV 289
            R+Y  +++   +Y HS  +++RD+KP N++ID +Q  +++ D+G A+    G+ + +  
Sbjct: 164 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVK-GRTWXLCG 221
Query: 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
              Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 222 TPEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 260

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 59/106 (55%), Gaps = 4/106 (3%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
            S+   R+Y  +++   +Y HS  +++RD+KP N++ID +Q  +++ D+G A+    G  
Sbjct: 159 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVK-GAT 216
Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
           + +     Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 217 WTLCGTPEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 260

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/107 (29%), Positives = 56/107 (52%), Gaps = 7/107 (6%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG-LAEFYHPGK-EYNV 287
            R+Y+ E++ A+D  H    +HRD+KP N+++D     +RL D+G   +    G  + +V
Sbjct: 177 ARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSV 235
Query: 288 RVASRYFKGPELLVDLQD----YDYSLDLWSLGCMFAGMIFRKEPFF 330
            V +  +  PE+L  ++     Y    D WSLG     M++ + PF+
Sbjct: 236 AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFY 282

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/150 (23%), Positives = 71/150 (47%), Gaps = 16/150 (10%)
Query: 189 PNIVKLLDIVRD-------QQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKAL 241
           PNIV+  +++          +  +   +FE + N          S+ + R++  +L+  +
Sbjct: 75  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG------RFSEDEARFFFQQLISGV 128
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 300
            YCH+  + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L
Sbjct: 129 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 188
Query: 301 VDLQDYDYSL-DLWSLGCMFAGMIFRKEPF 329
           +  ++YD  + D+WS G     M+    PF
Sbjct: 189 LK-KEYDGKVADVWSCGVTLYVMLVGAYPF 217

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 29/101 (28%), Positives = 58/101 (57%), Gaps = 4/101 (3%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRV 289
            R+Y  +++   +Y HS  +++RD+KP N++ID +Q  +++ D+G A+    G+ + +  
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVK-GRTWXLCG 200
Query: 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
              Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 201 TPEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 29/101 (28%), Positives = 58/101 (57%), Gaps = 4/101 (3%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRV 289
            R+Y  +++   +Y HS  +++RD+KP N++ID +Q  +++ D+G A+    G+ + +  
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVK-GRTWXLCG 200
Query: 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
              Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 201 TPEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 29/101 (28%), Positives = 58/101 (57%), Gaps = 4/101 (3%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRV 289
            R+Y  +++   +Y HS  +++RD+KP N++ID +Q  +++ D+G A+    G+ + +  
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVK-GRTWXLCG 200
Query: 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
              Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 201 TPEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 29/101 (28%), Positives = 58/101 (57%), Gaps = 4/101 (3%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRV 289
            R+Y  +++   +Y HS  +++RD+KP N++ID +Q  +++ D+G A+    G+ + +  
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVK-GRTWXLCG 200
Query: 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
              Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 201 TPEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 29/101 (28%), Positives = 58/101 (57%), Gaps = 4/101 (3%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRV 289
            R+Y  +++   +Y HS  +++RD+KP N++ID +Q  +++ D+G A+    G+ + +  
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVK-GRTWXLCG 200
Query: 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
              Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 201 TPEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 29/101 (28%), Positives = 58/101 (57%), Gaps = 4/101 (3%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRV 289
            R+Y  +++   +Y HS  +++RD+KP N++ID +Q  +++ D+G A+    G+ + +  
Sbjct: 138 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVK-GRTWXLCG 195
Query: 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
              Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 196 TPEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 234

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 29/101 (28%), Positives = 58/101 (57%), Gaps = 4/101 (3%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRV 289
            R+Y  +++   +Y HS  +++RD+KP N++ID +Q  +++ D+G A+    G+ + +  
Sbjct: 136 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVK-GRTWXLCG 193
Query: 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
              Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 194 TPEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 232

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 29/101 (28%), Positives = 58/101 (57%), Gaps = 4/101 (3%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRV 289
            R+Y  +++   +Y HS  +++RD+KP N++ID +Q  +++ D+G A+    G+ + +  
Sbjct: 144 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVK-GRTWXLCG 201
Query: 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
              Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 TPEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 29/101 (28%), Positives = 58/101 (57%), Gaps = 4/101 (3%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRV 289
            R+Y  +++   +Y HS  +++RD+KP N++ID +Q  +++ D+G A+    G+ + +  
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVK-GRTWXLCG 200
Query: 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
              Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 201 TPEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 68/162 (41%), Gaps = 18/162 (11%)
Query: 186 CGG---PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLK 239
           C G   P IV L   VR+      ++  E +       L      L +    YY+ + L+
Sbjct: 139 CAGLTSPRIVPLYGAVRE--GPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALE 196
Query: 240 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG--- 296
            L+Y HS+ I+H DVK  NV++  +     L D+G A    P       +   Y  G   
Sbjct: 197 GLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTET 256
Query: 297 ---PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEP---FFYG 332
              PE+++  +  D  +D+WS  CM   M+    P   FF G
Sbjct: 257 HMAPEVVLG-RSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRG 297

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/210 (22%), Positives = 87/210 (41%), Gaps = 33/210 (15%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAEFYH-- 280
            ++ +    + ++  ALD+ H++GI HRD+KP N++ +H  +   +++ D+ L       
Sbjct: 108 FNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167
Query: 281 ------PGKEYNVRVASRYFKGPELLVDLQD----YDYSLDLWSLGCMFAGMIFRKEPFF 330
                    E      S  +  PE++    +    YD   DLWSLG +   ++    P F
Sbjct: 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILY-ILLSGYPPF 226
Query: 331 YGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLA 390
            G    D         G D   A          P    ++    ++   +F   +  H++
Sbjct: 227 VGRCGSD--------CGWDRGEAC---------PACQNMLFESIQEGKYEFPDKDWAHIS 269
Query: 391 VPEAVDFLDKLLRYDHQERPTAKEAMAHPY 420
              A D + KLL  D ++R +A + + HP+
Sbjct: 270 CA-AKDLISKLLVRDAKQRLSAAQVLQHPW 298

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 73/154 (47%), Gaps = 19/154 (12%)
Query: 189 PNIVKLLDIVRDQQSKTPS-----LIFEHVNNTDFKVLYPT---LSDYDVRYYIYELLKA 240
           P IV + D     +++TP+     ++ E+V+    + +  T   ++       I +  +A
Sbjct: 72  PAIVAVYDT---GEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 128
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVA-----SRYFK 295
           L++ H  GI+HRDVKP N+MI      ++++D+G+A           + A     ++Y  
Sbjct: 129 LNFSHQNGIIHRDVKPANIMIS-ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
             +   D    D   D++SLGC+   ++  + PF
Sbjct: 188 PEQARGD--SVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 73/154 (47%), Gaps = 19/154 (12%)
Query: 189 PNIVKLLDIVRDQQSKTPS-----LIFEHVNNTDFKVLYPT---LSDYDVRYYIYELLKA 240
           P IV + D     +++TP+     ++ E+V+    + +  T   ++       I +  +A
Sbjct: 72  PAIVAVYDT---GEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 128
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVA-----SRYFK 295
           L++ H  GI+HRDVKP N+MI      ++++D+G+A           + A     ++Y  
Sbjct: 129 LNFSHQNGIIHRDVKPANIMIS-ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
             +   D    D   D++SLGC+   ++  + PF
Sbjct: 188 PEQARGD--SVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 73/154 (47%), Gaps = 19/154 (12%)
Query: 189 PNIVKLLDIVRDQQSKTPS-----LIFEHVNNTDFKVLYPT---LSDYDVRYYIYELLKA 240
           P IV + D     +++TP+     ++ E+V+    + +  T   ++       I +  +A
Sbjct: 72  PAIVAVYDT---GEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 128
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVA-----SRYFK 295
           L++ H  GI+HRDVKP N+MI      ++++D+G+A           + A     ++Y  
Sbjct: 129 LNFSHQNGIIHRDVKPANIMIS-ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
             +   D    D   D++SLGC+   ++  + PF
Sbjct: 188 PEQARGD--SVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 37/152 (24%), Positives = 73/152 (48%), Gaps = 23/152 (15%)
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRY----------YIYELLK 239
           NIV ++D+  D++     L+ E++         PTLS+Y   +          +  ++L 
Sbjct: 72  NIVSMIDV--DEEDDCYYLVMEYIEG-------PTLSEYIESHGPLSVDTAINFTNQILD 122
Query: 240 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--EYNVRVASRYFKGP 297
            + + H   I+HRD+KP N++ID   + L++ D+G+A+        + N  + +  +  P
Sbjct: 123 GIKHAHDMRIVHRDIKPQNILID-SNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSP 181
Query: 298 ELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
           E     +  D   D++S+G +   M+  + PF
Sbjct: 182 E-QAKGEATDECTDIYSIGIVLYEMLVGEPPF 212

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 68/162 (41%), Gaps = 18/162 (11%)
Query: 186 CGG---PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLK 239
           C G   P IV L   VR+      ++  E +       L      L +    YY+ + L+
Sbjct: 120 CAGLTSPRIVPLYGAVRE--GPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALE 177
Query: 240 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG--- 296
            L+Y HS+ I+H DVK  NV++  +     L D+G A    P       +   Y  G   
Sbjct: 178 GLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTET 237
Query: 297 ---PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEP---FFYG 332
              PE+++  +  D  +D+WS  CM   M+    P   FF G
Sbjct: 238 HMAPEVVLG-RSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRG 278

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 73/154 (47%), Gaps = 19/154 (12%)
Query: 189 PNIVKLLDIVRDQQSKTPS-----LIFEHVNNTDFKVLYPT---LSDYDVRYYIYELLKA 240
           P IV + D     +++TP+     ++ E+V+    + +  T   ++       I +  +A
Sbjct: 89  PAIVAVYDT---GEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 145
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVA-----SRYFK 295
           L++ H  GI+HRDVKP N+MI      ++++D+G+A           + A     ++Y  
Sbjct: 146 LNFSHQNGIIHRDVKPANIMIS-ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 204
Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
             +   D    D   D++SLGC+   ++  + PF
Sbjct: 205 PEQARGD--SVDARSDVYSLGCVLYEVLTGEPPF 236

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 54/90 (60%), Gaps = 6/90 (6%)
Query: 236 ELLKALDYCHSQGIMHRDVKPHNV-MIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRY 293
           ++ K +DY HS+ ++HRD+KP N+ ++D +Q  +++ D+GL     + GK    +   RY
Sbjct: 144 QITKGVDYIHSKKLIHRDLKPSNIFLVDTKQ--VKIGDFGLVTSLKNDGKRTRSKGTLRY 201
Query: 294 FKGPELLVDLQDYDYSLDLWSLGCMFAGMI 323
              PE  +  QDY   +DL++LG + A ++
Sbjct: 202 M-SPE-QISSQDYGKEVDLYALGLILAELL 229

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 67/156 (42%), Gaps = 15/156 (9%)
Query: 186 CGG---PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLK 239
           C G   P IV L   VR+      ++  E +       L      L +    YY+ + L+
Sbjct: 120 CAGLSSPRIVPLYGAVRE--GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALE 177
Query: 240 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG--- 296
            L+Y H++ I+H DVK  NV++  +  +  L D+G A    P       +   Y  G   
Sbjct: 178 GLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTET 237
Query: 297 ---PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
              PE+++  +  D  +D+WS  CM   M+    P+
Sbjct: 238 HMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPW 272

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 67/156 (42%), Gaps = 15/156 (9%)
Query: 186 CGG---PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLK 239
           C G   P IV L   VR+      ++  E +       L      L +    YY+ + L+
Sbjct: 104 CAGLSSPRIVPLYGAVRE--GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALE 161
Query: 240 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG--- 296
            L+Y H++ I+H DVK  NV++  +  +  L D+G A    P       +   Y  G   
Sbjct: 162 GLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTET 221
Query: 297 ---PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
              PE+++  +  D  +D+WS  CM   M+    P+
Sbjct: 222 HMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPW 256

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 67/156 (42%), Gaps = 15/156 (9%)
Query: 186 CGG---PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLK 239
           C G   P IV L   VR+      ++  E +       L      L +    YY+ + L+
Sbjct: 118 CAGLSSPRIVPLYGAVRE--GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALE 175
Query: 240 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG--- 296
            L+Y H++ I+H DVK  NV++  +  +  L D+G A    P       +   Y  G   
Sbjct: 176 GLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTET 235
Query: 297 ---PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
              PE+++  +  D  +D+WS  CM   M+    P+
Sbjct: 236 HMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPW 270

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 33/132 (25%), Positives = 63/132 (47%), Gaps = 11/132 (8%)
Query: 206 PSLIFEHVNNTDFKVLYPT---LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 262
           P ++ E+V+    + +  T   ++       I +  +AL++ H  GI+HRDVKP N+MI 
Sbjct: 91  PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS 150
Query: 263 HEQRKLRLIDWGLAEFYHPGKEYNVRVA-----SRYFKGPELLVDLQDYDYSLDLWSLGC 317
                ++++D+G+A           + A     ++Y    +   D    D   D++SLGC
Sbjct: 151 -ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSDVYSLGC 207
Query: 318 MFAGMIFRKEPF 329
           +   ++  + PF
Sbjct: 208 VLYEVLTGEPPF 219

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 29/106 (27%), Positives = 59/106 (55%), Gaps = 4/106 (3%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
            S+   R+Y  +++   +Y HS  +++RD+KP N++ID +Q  +++ D+G A+    G+ 
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVK-GRT 195
Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
           + +     Y   P +++  + Y+ ++D W+LG +   M     PFF
Sbjct: 196 WXLCGTPEYL-APAIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 70/133 (52%), Gaps = 8/133 (6%)
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQ 247
           +I+K      DQ  K+  L+ E+V     +   P  ++    +  +  ++ + + Y HSQ
Sbjct: 77  HIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHSQ 136
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-YNVRV---ASRYFKGPELLVDL 303
             +HR++   NV++D++ R +++ D+GLA+    G E Y VR    +  ++  PE L + 
Sbjct: 137 HYIHRNLAARNVLLDND-RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY 195
Query: 304 QDYDYSLDLWSLG 316
           + Y Y+ D+WS G
Sbjct: 196 KFY-YASDVWSFG 207

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/207 (21%), Positives = 90/207 (43%), Gaps = 19/207 (9%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDN-----EXXXXXXXXXXXXXXXXXXXXXLQNLCGG 188
           DD+++ R +G+GK+  V+      +      +                     +Q+    
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD------VRYYIYELLKALD 242
           PNI+++ +   D+  K   L+ E     +   LY  L  +          ++ EL  AL 
Sbjct: 75  PNILRMYNYFHDR--KRIYLMLEFAPRGE---LYKELQKHGRFDEQRSATFMEELADALH 129
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
           YCH + ++HRD+KP N+++ ++  +L++ D+G +  + P         +  +  PE +++
Sbjct: 130 YCHERKVIHRDIKPENLLMGYKG-ELKIADFGWS-VHAPSLRRRXMCGTLDYLPPE-MIE 186
Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPF 329
            + +D  +DLW  G +    +    PF
Sbjct: 187 GKTHDEKVDLWCAGVLCYEFLVGMPPF 213

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/154 (24%), Positives = 73/154 (47%), Gaps = 19/154 (12%)
Query: 189 PNIVKLLDIVRDQQSKTPS-----LIFEHVNNTDFKVLYPT---LSDYDVRYYIYELLKA 240
           P IV + D     +++TP+     ++ E+V+    + +  T   ++       I +  +A
Sbjct: 72  PAIVAVYDT---GEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 128
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVA-----SRYFK 295
           L++ H  GI+HRDVKP N++I      ++++D+G+A           + A     ++Y  
Sbjct: 129 LNFSHQNGIIHRDVKPANILIS-ATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLS 187
Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
             +   D    D   D++SLGC+   ++  + PF
Sbjct: 188 PEQARGD--SVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/114 (27%), Positives = 59/114 (51%), Gaps = 20/114 (17%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
            S+   R+Y  +++   +Y HS  +++RD+KP N++ID +Q  +++ D+G A+       
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAK------- 189
Query: 285 YNVRVASRYFK--------GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
              RV  R +          PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 190 ---RVKGRTWXLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/189 (22%), Positives = 76/189 (40%), Gaps = 37/189 (19%)
Query: 238 LKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 296
           +KAL++      I+HRD+KP N+++D     ++L D+G++               R +  
Sbjct: 135 VKALNHLKENLKIIHRDIKPSNILLDRSGN-IKLCDFGISGQLVDSIAKTRDAGCRPYMA 193
Query: 297 PELL---VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 353
           PE +      Q YD   D+WSLG     +   + P+   +  +DQL ++ K         
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKG-------- 245
Query: 354 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK 413
                    DP               +    E +  + P  ++F++  L  D  +RP  K
Sbjct: 246 ---------DP--------------PQLSNSEEREFS-PSFINFVNLCLTKDESKRPKYK 281
Query: 414 EAMAHPYFF 422
           E + HP+  
Sbjct: 282 ELLKHPFIL 290

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/133 (27%), Positives = 70/133 (52%), Gaps = 8/133 (6%)
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQ 247
           +I+K      DQ  K+  L+ E+V     +   P  ++    +  +  ++ + + Y H+Q
Sbjct: 77  HIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQ 136
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-YNVRV---ASRYFKGPELLVDL 303
             +HR++   NV++D++ R +++ D+GLA+    G E Y VR    +  ++  PE L + 
Sbjct: 137 HYIHRNLAARNVLLDND-RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY 195
Query: 304 QDYDYSLDLWSLG 316
           + Y Y+ D+WS G
Sbjct: 196 KFY-YASDVWSFG 207

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/111 (27%), Positives = 57/111 (51%), Gaps = 6/111 (5%)
Query: 237 LLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 295
           ++KAL Y   + G++HRDVKP N+++D E+ +++L D+G++      K  +       + 
Sbjct: 133 IVKALYYLKEKHGVIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYM 191
Query: 296 GPELL----VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKI 342
            PE +        DYD   D+WSLG     +   + P+     +++ L K+
Sbjct: 192 APERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV 242

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/150 (22%), Positives = 70/150 (46%), Gaps = 16/150 (10%)
Query: 189 PNIVKLLDIVRD-------QQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKAL 241
           PNIV+  +++          +  +   +FE + N          S+ + R++  +L+  +
Sbjct: 75  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG------RFSEDEARFFFQQLISGV 128
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 300
            YCH+  + HRD+K  N ++D     +L++  +G ++      +    V +  +  PE+L
Sbjct: 129 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVL 188
Query: 301 VDLQDYDYSL-DLWSLGCMFAGMIFRKEPF 329
           +  ++YD  + D+WS G     M+    PF
Sbjct: 189 LK-KEYDGKVADVWSCGVTLYVMLVGAYPF 217

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 68/133 (51%), Gaps = 8/133 (6%)
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQ 247
           +IVK      DQ  K+  L+ E+V     +   P   +    +  +  ++ + + Y H+Q
Sbjct: 72  HIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQICEGMAYLHAQ 131
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-YNVRV---ASRYFKGPELLVDL 303
             +HR +   NV++D++ R +++ D+GLA+    G E Y VR    +  ++  PE L + 
Sbjct: 132 HYIHRALAARNVLLDND-RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEC 190
Query: 304 QDYDYSLDLWSLG 316
           + Y Y+ D+WS G
Sbjct: 191 KFY-YASDVWSFG 202

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 68/133 (51%), Gaps = 8/133 (6%)
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQ 247
           +IVK      DQ  K+  L+ E+V     +   P   +    +  +  ++ + + Y H+Q
Sbjct: 71  HIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQICEGMAYLHAQ 130
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-YNVRV---ASRYFKGPELLVDL 303
             +HR +   NV++D++ R +++ D+GLA+    G E Y VR    +  ++  PE L + 
Sbjct: 131 HYIHRALAARNVLLDND-RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEC 189
Query: 304 QDYDYSLDLWSLG 316
           + Y Y+ D+WS G
Sbjct: 190 KFY-YASDVWSFG 201

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 68/297 (22%), Positives = 114/297 (38%), Gaps = 70/297 (23%)
Query: 191 IVKLLD--IVRDQQSKTPSLIFE----HVNNTDFKVLYPTLSDYDVRYYIYELLKALDYC 244
           +V+LLD   +         ++FE    H+     K  Y  L    V+  I ++L+ LDY 
Sbjct: 87  VVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYL 146
Query: 245 HSQG-IMHRDVKPHNVMI------------------------------------------ 261
           H++  I+H D+KP N+++                                          
Sbjct: 147 HTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLV 206
Query: 262 ------DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSL 315
                 + E+ K+++ D G A + H  K +   + +R ++  E+L+    Y+   D+WS 
Sbjct: 207 NPLEPKNAEKLKVKIADLGNACWVH--KHFTEDIQTRQYRSLEVLIG-SGYNTPADIWST 263
Query: 316 GCMFAGMIFRKEPFFYGHD------NYDQLVKIAKVLGTDELNAYL-NKYHIELDPHLAA 368
            CM A  +   +  F  H       + D +  I ++LG       +  KY  E       
Sbjct: 264 ACM-AFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGD 322
Query: 369 LVGRHSRKPWSKF-ITVENQHLAVPEAV---DFLDKLLRYDHQERPTAKEAMAHPYF 421
           L      KPW  F + VE    +  EA    DFL  +L    ++R TA E + HP+ 
Sbjct: 323 LKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWL 379

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/252 (23%), Positives = 98/252 (38%), Gaps = 64/252 (25%)
Query: 230 VRYYIYELLKALDYCHSQG-IMHRDVKPHNVMI--------------------------- 261
           V+  I ++L+ LDY H++  I+H D+KP N+++                           
Sbjct: 148 VKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 207
Query: 262 ---------------------DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 300
                                + E+ K+++ D G A + H  K +   + +R ++  E+L
Sbjct: 208 SAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH--KHFTEDIQTRQYRSLEVL 265
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD------NYDQLVKIAKVLGTDELNAY 354
           +    Y+   D+WS  CM A  +   +  F  H       + D +  I ++LG       
Sbjct: 266 IG-SGYNTPADIWSTACM-AFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLI 323
Query: 355 L-NKYHIELDPHLAALVGRHSRKPWSKF-ITVENQHLAVPEAV---DFLDKLLRYDHQER 409
           +  KY  E       L      KPW  F + VE    +  EA    DFL  +L    ++R
Sbjct: 324 VAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKR 383
Query: 410 PTAKEAMAHPYF 421
            TA E + HP+ 
Sbjct: 384 ATAAECLRHPWL 395

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 54/90 (60%), Gaps = 6/90 (6%)
Query: 236 ELLKALDYCHSQGIMHRDVKPHNV-MIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRY 293
           ++ K +DY HS+ +++RD+KP N+ ++D +Q  +++ D+GL     + GK    +   RY
Sbjct: 130 QITKGVDYIHSKKLINRDLKPSNIFLVDTKQ--VKIGDFGLVTSLKNDGKRXRSKGTLRY 187
Query: 294 FKGPELLVDLQDYDYSLDLWSLGCMFAGMI 323
              PE  +  QDY   +DL++LG + A ++
Sbjct: 188 M-SPE-QISSQDYGKEVDLYALGLILAELL 215

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 34/150 (22%), Positives = 70/150 (46%), Gaps = 16/150 (10%)
Query: 189 PNIVKLLDIVRD-------QQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKAL 241
           PNIV+  +++          +  +   +FE + N          S+ + R++  +L+  +
Sbjct: 75  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG------RFSEDEARFFFQQLISGV 128
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 300
            Y H+  + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L
Sbjct: 129 SYAHAMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVL 188
Query: 301 VDLQDYDYSL-DLWSLGCMFAGMIFRKEPF 329
           +  ++YD  + D+WS G     M+    PF
Sbjct: 189 LK-KEYDGKVADVWSCGVTLYVMLVGAYPF 217

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 34/150 (22%), Positives = 70/150 (46%), Gaps = 16/150 (10%)
Query: 189 PNIVKLLDIVRD-------QQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKAL 241
           PNIV+  +++          +  +   +FE + N          S+ + R++  +L+  +
Sbjct: 75  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG------RFSEDEARFFFQQLISGV 128
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 300
            YCH+  + HRD+K  N ++D     +L++  +G ++      +    V +  +  PE+L
Sbjct: 129 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVL 188
Query: 301 VDLQDYDYSL-DLWSLGCMFAGMIFRKEPF 329
           +  ++YD  + D+WS G     M+    PF
Sbjct: 189 LK-KEYDGKVADVWSCGVTLYVMLVGAYPF 217

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/226 (23%), Positives = 94/226 (41%), Gaps = 37/226 (16%)
Query: 129 QWG-EQDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXXX-------XXXXX 180
           Q+G  ++D  + R +G G + EV+EGV+                                
Sbjct: 18  QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAV 77
Query: 181 XLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV------------NNTDFKVLYPTLSDY 228
            ++NL   P+IVKL+ I+ ++    P+ I   +            N    KVL   L   
Sbjct: 78  IMKNL-DHPHIVKLIGIIEEE----PTWIIMELYPYGELGHYLERNKNSLKVLTLVL--- 129
Query: 229 DVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR 288
               Y  ++ KA+ Y  S   +HRD+   N+++   +  ++L D+GL+ +      Y   
Sbjct: 130 ----YSLQICKAMAYLESINCVHRDIAVRNILVASPE-CVKLGDFGLSRYIEDEDYYKAS 184
Query: 289 VASRYFK--GPELLVDLQDYDYSLDLWSLG-CMFAGMIFRKEPFFY 331
           V     K   PE  ++ + +  + D+W    CM+  + F K+PFF+
Sbjct: 185 VTRLPIKWMSPE-SINFRRFTTASDVWMFAVCMWEILSFGKQPFFW 229

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 32/125 (25%), Positives = 59/125 (47%), Gaps = 21/125 (16%)
Query: 233 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASR 292
           Y+ E+L AL Y HS G+++ D+KP N+M+  EQ  L+LID G     +    +     + 
Sbjct: 187 YLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ--LKLIDLGAVSRIN---SFGYLYGTP 241
Query: 293 YFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF--------------RKEPFFYGHDNYDQ 338
            F+ PE++        + D++++G   A +                  +P    +D+Y +
Sbjct: 242 GFQAPEIV--RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGR 299
Query: 339 LVKIA 343
           L++ A
Sbjct: 300 LLRRA 304

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/226 (23%), Positives = 94/226 (41%), Gaps = 37/226 (16%)
Query: 129 QWG-EQDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXXX-------XXXXX 180
           Q+G  ++D  + R +G G + EV+EGV+                                
Sbjct: 2   QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAV 61
Query: 181 XLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV------------NNTDFKVLYPTLSDY 228
            ++NL   P+IVKL+ I+ ++    P+ I   +            N    KVL   L   
Sbjct: 62  IMKNL-DHPHIVKLIGIIEEE----PTWIIMELYPYGELGHYLERNKNSLKVLTLVL--- 113
Query: 229 DVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR 288
               Y  ++ KA+ Y  S   +HRD+   N+++   +  ++L D+GL+ +      Y   
Sbjct: 114 ----YSLQICKAMAYLESINCVHRDIAVRNILVASPE-CVKLGDFGLSRYIEDEDYYKAS 168
Query: 289 VASRYFK--GPELLVDLQDYDYSLDLWSLG-CMFAGMIFRKEPFFY 331
           V     K   PE  ++ + +  + D+W    CM+  + F K+PFF+
Sbjct: 169 VTRLPIKWMSPE-SINFRRFTTASDVWMFAVCMWEILSFGKQPFFW 213

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 81/370 (21%), Positives = 134/370 (36%), Gaps = 99/370 (26%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLL 195
           Y V+RK+G G +S V+    C D +                      +        +KLL
Sbjct: 33  YHVIRKLGWGHFSTVWL---CWDMQGKRFVAMKVVKSAQHYTETALDE--------IKLL 81
Query: 196 DIVRDQQSKTPS----------------------LIFE----HVNNTDFKVLYPTLSDYD 229
             VR+     P+                      ++FE    H+     K  Y  L    
Sbjct: 82  KCVRESDPSDPNKDMVVQLIDDFKISGMNGIHVCMVFEVLGHHLLKWIIKSNYQGLPVRC 141
Query: 230 VRYYIYELLKALDYCHSQG-IMHRDVKPHNVMI--------------------------- 261
           V+  I ++L+ LDY HS+  I+H D+KP N+++                           
Sbjct: 142 VKSIIRQVLQGLDYLHSKCKIIHTDIKPENILMCVDDAYVRRMAAEATEWQKAGAPPPSG 201
Query: 262 -------------------DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
                              + ++ ++++ D G A + H  K +   + +R ++  E+L+ 
Sbjct: 202 SAVSTAPAADLLVNPLDPRNADKIRVKIADLGNACWVH--KHFTEDIQTRQYRSIEVLIG 259
Query: 303 LQDYDYSLDLWSLGCM---FAGMIFRKEPFFYGHD---NYDQLVKIAKVLGTDELN-AYL 355
              Y    D+WS  CM    A   +  EP   G D   + D +  I ++LG+   + A  
Sbjct: 260 -AGYSTPADIWSTACMAFELATGDYLFEPH-SGEDYSRDEDHIAHIIELLGSIPRHFALS 317
Query: 356 NKYHIELDPHLAALVGRHSRKPWSKF-ITVEN---QHLAVPEAVDFLDKLLRYDHQERPT 411
            KY  E       L      KPWS F + VE     H    +  DFL  +L    ++R +
Sbjct: 318 GKYSREFFNRRGELRHITKLKPWSLFDVLVEKYGWPHEDAAQFTDFLIPMLEMVPEKRAS 377
Query: 412 AKEAMAHPYF 421
           A E + HP+ 
Sbjct: 378 AGECLRHPWL 387

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 35/133 (26%), Positives = 69/133 (51%), Gaps = 8/133 (6%)
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQ 247
           +I+K      D  + +  L+ E+V     +   P  ++    +  +  ++ + + Y H+Q
Sbjct: 94  HIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQ 153
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-YNVRV---ASRYFKGPELLVDL 303
             +HRD+   NV++D++ R +++ D+GLA+    G E Y VR    +  ++  PE L + 
Sbjct: 154 HYIHRDLAARNVLLDND-RLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEY 212
Query: 304 QDYDYSLDLWSLG 316
           + Y Y+ D+WS G
Sbjct: 213 KFY-YASDVWSFG 224

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 36/131 (27%), Positives = 67/131 (51%), Gaps = 13/131 (9%)
Query: 208 LIFEHVNNTDFKVLYPTLS------DYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI 261
           LI +++N  +   L+  LS      +++V+ Y+ E++ AL++ H  GI++RD+K  N+++
Sbjct: 136 LILDYINGGE---LFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL 192
Query: 262 DHEQRKLRLIDWGLA-EFYHPGKE--YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCM 318
           D     + L D+GL+ EF     E  Y+      Y     +      +D ++D WSLG +
Sbjct: 193 D-SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVL 251
Query: 319 FAGMIFRKEPF 329
              ++    PF
Sbjct: 252 MYELLTGASPF 262

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/226 (23%), Positives = 94/226 (41%), Gaps = 37/226 (16%)
Query: 129 QWG-EQDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXXX-------XXXXX 180
           Q+G  ++D  + R +G G + EV+EGV+                                
Sbjct: 6   QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAV 65
Query: 181 XLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV------------NNTDFKVLYPTLSDY 228
            ++NL   P+IVKL+ I+ ++    P+ I   +            N    KVL   L   
Sbjct: 66  IMKNL-DHPHIVKLIGIIEEE----PTWIIMELYPYGELGHYLERNKNSLKVLTLVL--- 117
Query: 229 DVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR 288
               Y  ++ KA+ Y  S   +HRD+   N+++   +  ++L D+GL+ +      Y   
Sbjct: 118 ----YSLQICKAMAYLESINCVHRDIAVRNILVASPE-CVKLGDFGLSRYIEDEDYYKAS 172
Query: 289 VASRYFK--GPELLVDLQDYDYSLDLWSLG-CMFAGMIFRKEPFFY 331
           V     K   PE  ++ + +  + D+W    CM+  + F K+PFF+
Sbjct: 173 VTRLPIKWMSPE-SINFRRFTTASDVWMFAVCMWEILSFGKQPFFW 217

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 64/132 (48%), Gaps = 18/132 (13%)
Query: 208 LIFEHVNNTDFKVLYPTLSDY---DVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 264
            + E+VN  D       +  +      +Y  E+   L + H +GI++RD+K  NVM+D E
Sbjct: 97  FVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRGIIYRDLKLDNVMLDSE 156
Query: 265 QRKLRLIDWGLAEFYHPGKEYNV-RVASRYFKG------PELLVDLQDYDYSLDLWSLGC 317
              +++ D+G+       KE+ +  V +R F G      PE++   Q Y  S+D W+ G 
Sbjct: 157 GH-IKIADFGMC------KEHMMDGVTTREFCGTPDYIAPEIIA-YQPYGKSVDWWAYGV 208
Query: 318 MFAGMIFRKEPF 329
           +   M+  + PF
Sbjct: 209 LLYEMLAGQPPF 220

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 33/126 (26%), Positives = 59/126 (46%), Gaps = 6/126 (4%)
Query: 208 LIFEHVNNTDFKVLYPTLSDYD---VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 264
            + E+VN  D       +  +      +Y  E+   L +  S+GI++RD+K  NVM+D E
Sbjct: 419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE 478
Query: 265 QRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI 323
              +++ D+G+  E    G        +  +  PE++   Q Y  S+D W+ G +   M+
Sbjct: 479 GH-IKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEML 536
Query: 324 FRKEPF 329
             + PF
Sbjct: 537 AGQAPF 542

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 55/116 (47%), Gaps = 4/116 (3%)
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
           +L +  V  Y+ + L AL + HSQG++H DVKP N+ +    R  +L D+GL        
Sbjct: 153 SLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGR-CKLGDFGLLVELGTAG 211
Query: 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQL 339
              V+     +  PELL     Y  + D++SLG     +    E   +G + + QL
Sbjct: 212 AGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNME-LPHGGEGWQQL 264

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 33/126 (26%), Positives = 59/126 (46%), Gaps = 6/126 (4%)
Query: 208 LIFEHVNNTDFKVLYPTLSDYD---VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 264
            + E+VN  D       +  +      +Y  E+   L +  S+GI++RD+K  NVM+D E
Sbjct: 98  FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE 157
Query: 265 QRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI 323
              +++ D+G+  E    G        +  +  PE++   Q Y  S+D W+ G +   M+
Sbjct: 158 GH-IKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEML 215
Query: 324 FRKEPF 329
             + PF
Sbjct: 216 AGQAPF 221

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/219 (22%), Positives = 98/219 (44%), Gaps = 15/219 (6%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDN-----EXXXXXXXXXXXXXXXXXXXXXLQNLCGG 188
           DD+E+ R +G+GK+  V+       +     +                     +Q     
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYP--TLSDYDVRYYIYELLKALDYCH 245
           PNI++L +   D+  +   LI E+    + +K L    T  +      + EL  AL YCH
Sbjct: 83  PNILRLYNYFYDR--RRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCH 140
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
            + ++HRD+KP N+++   + +L++ D+G +  + P         +  +  PE +++ + 
Sbjct: 141 GKKVIHRDIKPENLLLG-LKGELKIADFGWS-VHAPSLRRKTMCGTLDYLPPE-MIEGRM 197
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDN--YDQLVKI 342
           ++  +DLW +G +   ++    PF     N  Y ++VK+
Sbjct: 198 HNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKV 236

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/118 (25%), Positives = 62/118 (52%), Gaps = 15/118 (12%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG---LAEFYHP 281
           L++  + + +  + + L+  H++G  HRD+KP N+++  E + + L+D G    A  +  
Sbjct: 131 LTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPV-LMDLGSMNQACIHVE 189
Query: 282 G-------KEYNVRVASRYFKGPELLVDLQDY---DYSLDLWSLGCMFAGMIFRKEPF 329
           G       +++  +  +  ++ PEL   +Q +   D   D+WSLGC+   M+F + P+
Sbjct: 190 GSRQALTLQDWAAQRCTISYRAPELF-SVQSHCVIDERTDVWSLGCVLYAMMFGEGPY 246

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 26/101 (25%), Positives = 52/101 (51%), Gaps = 3/101 (2%)
Query: 233 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVAS 291
           +  ++  AL + H + I+HRD+K  N+ +  +   ++L D+G+A   +   E     + +
Sbjct: 130 WFVQICLALKHVHDRKILHRDIKSQNIFLTKDG-TVQLGDFGIARVLNSTVELARACIGT 188
Query: 292 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYG 332
            Y+  PE+  + + Y+   D+W+LGC+   +   K  F  G
Sbjct: 189 PYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAG 228

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/233 (22%), Positives = 96/233 (41%), Gaps = 28/233 (12%)
Query: 131 GEQDDYEVVRK-------VGRGKYSEVFEGVHCT-DNEXXXXXXXXXXXXXXXXXXXXXL 182
           G   DYE+ R+       +G G++ +V +G++ + +N                      L
Sbjct: 3   GSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL 62
Query: 183 QNLCGG-----PNIVKLLDIVRDQQSKTPSLIFEHVNNTD-----FKVLYPTLSDYDVRY 232
           Q          P+IVKL+ ++    ++ P  I   +          +V   +L    +  
Sbjct: 63  QEALTMRQFDHPHIVKLIGVI----TENPVWIIMELCTLGELRSFLQVRKYSLDLASLIL 118
Query: 233 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASR 292
           Y Y+L  AL Y  S+  +HRD+   NV++      ++L D+GL+ +      Y       
Sbjct: 119 YAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDSTYYKASKGKL 177
Query: 293 YFK--GPELLVDLQDYDYSLDLWSLG-CMFAGMIFRKEPFFYGHDNYDQLVKI 342
             K   PE  ++ + +  + D+W  G CM+  ++   +P F G  N D + +I
Sbjct: 178 PIKWMAPE-SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 228

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/225 (21%), Positives = 95/225 (42%), Gaps = 21/225 (9%)
Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCT-DNEXXXXXXXXXXXXXXXXXXXXXLQNLCGG-- 188
           +++  E+ R +G G++ +V +G++ + +N                      LQ       
Sbjct: 8   QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQ 67
Query: 189 ---PNIVKLLDIVRDQQSKTPSLIFEHVNNTD-----FKVLYPTLSDYDVRYYIYELLKA 240
              P+IVKL+ ++    ++ P  I   +          +V   +L    +  Y Y+L  A
Sbjct: 68  FDHPHIVKLIGVI----TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 123
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK--GPE 298
           L Y  S+  +HRD+   NV++      ++L D+GL+ +      Y         K   PE
Sbjct: 124 LAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 182
Query: 299 LLVDLQDYDYSLDLWSLG-CMFAGMIFRKEPFFYGHDNYDQLVKI 342
             ++ + +  + D+W  G CM+  ++   +P F G  N D + +I
Sbjct: 183 -SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 225

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/225 (21%), Positives = 95/225 (42%), Gaps = 21/225 (9%)
Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCT-DNEXXXXXXXXXXXXXXXXXXXXXLQNLCGG-- 188
           +++  E+ R +G G++ +V +G++ + +N                      LQ       
Sbjct: 36  QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQ 95
Query: 189 ---PNIVKLLDIVRDQQSKTPSLIFEHVNNTD-----FKVLYPTLSDYDVRYYIYELLKA 240
              P+IVKL+ ++    ++ P  I   +          +V   +L    +  Y Y+L  A
Sbjct: 96  FDHPHIVKLIGVI----TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 151
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK--GPE 298
           L Y  S+  +HRD+   NV++      ++L D+GL+ +      Y         K   PE
Sbjct: 152 LAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 210
Query: 299 LLVDLQDYDYSLDLWSLG-CMFAGMIFRKEPFFYGHDNYDQLVKI 342
             ++ + +  + D+W  G CM+  ++   +P F G  N D + +I
Sbjct: 211 -SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 253

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 87/202 (43%), Gaps = 30/202 (14%)
Query: 237 LLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 295
           ++K L Y   +  IMHRDVKP N++++  + +++L D+G++         N  V +R + 
Sbjct: 140 VIKGLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYM 197
Query: 296 GPELLVDLQDYDYSL--DLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------ 347
            PE    LQ   YS+  D+WS+G     M   + P         +L+   +V G      
Sbjct: 198 SPE---RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 254
Query: 348 --TDELNAYLNKYHIELDPHLAA------LVGRHSRKPWSKFITVENQHLAVPEAVDFLD 399
                    LNK+ ++  P +A       +V     K  S   ++E Q        DF++
Sbjct: 255 PRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQ--------DFVN 306
Query: 400 KLLRYDHQERPTAKEAMAHPYF 421
           K L  +  ER   K+ M H + 
Sbjct: 307 KCLIKNPAERADLKQLMVHAFI 328

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 36/157 (22%), Positives = 80/157 (50%), Gaps = 17/157 (10%)
Query: 207 SLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR 266
           S ++ H++ ++ K     L D        +  + +DY H++ I+HRD+K +N+ + HE  
Sbjct: 92  SSLYHHLHASETKFEMKKLIDI-----ARQTARGMDYLHAKSIIHRDLKSNNIFL-HEDN 145
Query: 267 KLRLIDWGLAEF---YHPGKEYNVRVASRYFKGPELLVDLQD---YDYSLDLWSLGCMFA 320
            +++ D+GLA     +    ++     S  +  PE ++ +QD   Y +  D+++ G +  
Sbjct: 146 TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE-VIRMQDSNPYSFQSDVYAFGIVLY 204
Query: 321 GMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 357
            ++  + P +   +N DQ++++   +G   L+  L+K
Sbjct: 205 ELMTGQLP-YSNINNRDQIIEM---VGRGSLSPDLSK 237

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/225 (21%), Positives = 95/225 (42%), Gaps = 21/225 (9%)
Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCT-DNEXXXXXXXXXXXXXXXXXXXXXLQNLCGG-- 188
           +++  E+ R +G G++ +V +G++ + +N                      LQ       
Sbjct: 10  QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQ 69
Query: 189 ---PNIVKLLDIVRDQQSKTPSLIFEHVNNTD-----FKVLYPTLSDYDVRYYIYELLKA 240
              P+IVKL+ ++    ++ P  I   +          +V   +L    +  Y Y+L  A
Sbjct: 70  FDHPHIVKLIGVI----TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 125
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK--GPE 298
           L Y  S+  +HRD+   NV++      ++L D+GL+ +      Y         K   PE
Sbjct: 126 LAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 184
Query: 299 LLVDLQDYDYSLDLWSLG-CMFAGMIFRKEPFFYGHDNYDQLVKI 342
             ++ + +  + D+W  G CM+  ++   +P F G  N D + +I
Sbjct: 185 -SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 227

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/225 (21%), Positives = 95/225 (42%), Gaps = 21/225 (9%)
Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCT-DNEXXXXXXXXXXXXXXXXXXXXXLQNLCGG-- 188
           +++  E+ R +G G++ +V +G++ + +N                      LQ       
Sbjct: 13  QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQ 72
Query: 189 ---PNIVKLLDIVRDQQSKTPSLIFEHVNNTD-----FKVLYPTLSDYDVRYYIYELLKA 240
              P+IVKL+ ++    ++ P  I   +          +V   +L    +  Y Y+L  A
Sbjct: 73  FDHPHIVKLIGVI----TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 128
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK--GPE 298
           L Y  S+  +HRD+   NV++      ++L D+GL+ +      Y         K   PE
Sbjct: 129 LAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 187
Query: 299 LLVDLQDYDYSLDLWSLG-CMFAGMIFRKEPFFYGHDNYDQLVKI 342
             ++ + +  + D+W  G CM+  ++   +P F G  N D + +I
Sbjct: 188 -SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 230

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/225 (21%), Positives = 95/225 (42%), Gaps = 21/225 (9%)
Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCT-DNEXXXXXXXXXXXXXXXXXXXXXLQNLCGG-- 188
           +++  E+ R +G G++ +V +G++ + +N                      LQ       
Sbjct: 8   QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQ 67
Query: 189 ---PNIVKLLDIVRDQQSKTPSLIFEHVNNTD-----FKVLYPTLSDYDVRYYIYELLKA 240
              P+IVKL+ ++    ++ P  I   +          +V   +L    +  Y Y+L  A
Sbjct: 68  FDHPHIVKLIGVI----TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA 123
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK--GPE 298
           L Y  S+  +HRD+   NV++      ++L D+GL+ +      Y         K   PE
Sbjct: 124 LAYLESKRFVHRDIAARNVLVSATD-CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 182
Query: 299 LLVDLQDYDYSLDLWSLG-CMFAGMIFRKEPFFYGHDNYDQLVKI 342
             ++ + +  + D+W  G CM+  ++   +P F G  N D + +I
Sbjct: 183 -SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 225

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/225 (21%), Positives = 95/225 (42%), Gaps = 21/225 (9%)
Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCT-DNEXXXXXXXXXXXXXXXXXXXXXLQNLCGG-- 188
           +++  E+ R +G G++ +V +G++ + +N                      LQ       
Sbjct: 8   QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQ 67
Query: 189 ---PNIVKLLDIVRDQQSKTPSLIFEHVNNTD-----FKVLYPTLSDYDVRYYIYELLKA 240
              P+IVKL+ ++    ++ P  I   +          +V   +L    +  Y Y+L  A
Sbjct: 68  FDHPHIVKLIGVI----TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 123
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK--GPE 298
           L Y  S+  +HRD+   NV++      ++L D+GL+ +      Y         K   PE
Sbjct: 124 LAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 182
Query: 299 LLVDLQDYDYSLDLWSLG-CMFAGMIFRKEPFFYGHDNYDQLVKI 342
             ++ + +  + D+W  G CM+  ++   +P F G  N D + +I
Sbjct: 183 -SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 225

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/225 (21%), Positives = 95/225 (42%), Gaps = 21/225 (9%)
Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCT-DNEXXXXXXXXXXXXXXXXXXXXXLQNLCGG-- 188
           +++  E+ R +G G++ +V +G++ + +N                      LQ       
Sbjct: 5   QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQ 64
Query: 189 ---PNIVKLLDIVRDQQSKTPSLIFEHVNNTD-----FKVLYPTLSDYDVRYYIYELLKA 240
              P+IVKL+ ++    ++ P  I   +          +V   +L    +  Y Y+L  A
Sbjct: 65  FDHPHIVKLIGVI----TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 120
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK--GPE 298
           L Y  S+  +HRD+   NV++      ++L D+GL+ +      Y         K   PE
Sbjct: 121 LAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179
Query: 299 LLVDLQDYDYSLDLWSLG-CMFAGMIFRKEPFFYGHDNYDQLVKI 342
             ++ + +  + D+W  G CM+  ++   +P F G  N D + +I
Sbjct: 180 -SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 222

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/134 (24%), Positives = 71/134 (52%), Gaps = 18/134 (13%)
Query: 221 LYPTLSDYDVRYYIYELL-------KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDW 273
           LY  L   + ++ +++L+       + +DY H++ I+HRD+K +N+ + HE   +++ D+
Sbjct: 118 LYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFL-HEGLTVKIGDF 176
Query: 274 GLAEF---YHPGKEYNVRVASRYFKGPELLVDLQD---YDYSLDLWSLGCMFAGMIFRKE 327
           GLA     +   ++      S  +  PE ++ +QD   + +  D++S G +   ++  + 
Sbjct: 177 GLATVKSRWSGSQQVEQPTGSVLWMAPE-VIRMQDNNPFSFQSDVYSYGIVLYELMTGEL 235
Query: 328 PFFYGH-DNYDQLV 340
           P  Y H +N DQ++
Sbjct: 236 P--YSHINNRDQII 247

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 84/199 (42%), Gaps = 24/199 (12%)
Query: 237 LLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 295
           ++K L Y   +  IMHRDVKP N++++  + +++L D+G++         N  V +R + 
Sbjct: 175 VIKGLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLI-DSMANSFVGTRSYM 232
Query: 296 GPELLVDLQDYDYSL--DLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-TDELN 352
            PE    LQ   YS+  D+WS+G     M   + P         +L+   +V G   E  
Sbjct: 233 SPE---RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 289
Query: 353 AYLNKYHIELDPHLAALVGRHSRKPWSKF----ITVENQHLAVPEAV------DFLDKLL 402
                    L  +     G  SR P + F      V      +P AV      DF++K L
Sbjct: 290 PRPRTPGRPLSSY-----GMDSRPPMAIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCL 344
Query: 403 RYDHQERPTAKEAMAHPYF 421
             +  ER   K+ M H + 
Sbjct: 345 IKNPAERADLKQLMVHAFI 363

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/225 (21%), Positives = 95/225 (42%), Gaps = 21/225 (9%)
Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCT-DNEXXXXXXXXXXXXXXXXXXXXXLQNLCGG-- 188
           +++  E+ R +G G++ +V +G++ + +N                      LQ       
Sbjct: 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQ 447
Query: 189 ---PNIVKLLDIVRDQQSKTPSLIFEHVNNTD-----FKVLYPTLSDYDVRYYIYELLKA 240
              P+IVKL+ ++    ++ P  I   +          +V   +L    +  Y Y+L  A
Sbjct: 448 FDHPHIVKLIGVI----TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA 503
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK--GPE 298
           L Y  S+  +HRD+   NV++      ++L D+GL+ +      Y         K   PE
Sbjct: 504 LAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 562
Query: 299 LLVDLQDYDYSLDLWSLG-CMFAGMIFRKEPFFYGHDNYDQLVKI 342
             ++ + +  + D+W  G CM+  ++   +P F G  N D + +I
Sbjct: 563 -SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 605

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 31/109 (28%), Positives = 53/109 (48%), Gaps = 9/109 (8%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG-LAEFYHPGKEYN-V 287
            R+Y+ E++ A+D  H  G +HRD+KP N+++D     +RL D+G   +    G   + V
Sbjct: 164 ARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDR-CGHIRLADFGSCLKLRADGTVRSLV 222
Query: 288 RVASRYFKGPELLVDLQDYDY------SLDLWSLGCMFAGMIFRKEPFF 330
            V +  +  PE+L  +             D W+LG     M + + PF+
Sbjct: 223 AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFY 271

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/157 (22%), Positives = 80/157 (50%), Gaps = 17/157 (10%)
Query: 207 SLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR 266
           S ++ H++ ++ K     L D        +  + +DY H++ I+HRD+K +N+ + HE  
Sbjct: 104 SSLYHHLHASETKFEMKKLIDI-----ARQTARGMDYLHAKSIIHRDLKSNNIFL-HEDN 157
Query: 267 KLRLIDWGLA---EFYHPGKEYNVRVASRYFKGPELLVDLQD---YDYSLDLWSLGCMFA 320
            +++ D+GLA     +    ++     S  +  PE ++ +QD   Y +  D+++ G +  
Sbjct: 158 TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE-VIRMQDSNPYSFQSDVYAFGIVLY 216
Query: 321 GMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 357
            ++  + P +   +N DQ++++   +G   L+  L+K
Sbjct: 217 ELMTGQLP-YSNINNRDQIIEM---VGRGSLSPDLSK 249

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/225 (21%), Positives = 95/225 (42%), Gaps = 21/225 (9%)
Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCT-DNEXXXXXXXXXXXXXXXXXXXXXLQNLCGG-- 188
           +++  E+ R +G G++ +V +G++ + +N                      LQ       
Sbjct: 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQ 447
Query: 189 ---PNIVKLLDIVRDQQSKTPSLIFEHVNNTD-----FKVLYPTLSDYDVRYYIYELLKA 240
              P+IVKL+ ++    ++ P  I   +          +V   +L    +  Y Y+L  A
Sbjct: 448 FDHPHIVKLIGVI----TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA 503
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK--GPE 298
           L Y  S+  +HRD+   NV++      ++L D+GL+ +      Y         K   PE
Sbjct: 504 LAYLESKRFVHRDIAARNVLVSATD-CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 562
Query: 299 LLVDLQDYDYSLDLWSLG-CMFAGMIFRKEPFFYGHDNYDQLVKI 342
             ++ + +  + D+W  G CM+  ++   +P F G  N D + +I
Sbjct: 563 -SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 605

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/157 (22%), Positives = 80/157 (50%), Gaps = 17/157 (10%)
Query: 207 SLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR 266
           S ++ H++ ++ K     L D        +  + +DY H++ I+HRD+K +N+ + HE  
Sbjct: 104 SSLYHHLHASETKFEMKKLIDI-----ARQTARGMDYLHAKSIIHRDLKSNNIFL-HEDN 157
Query: 267 KLRLIDWGLA---EFYHPGKEYNVRVASRYFKGPELLVDLQD---YDYSLDLWSLGCMFA 320
            +++ D+GLA     +    ++     S  +  PE ++ +QD   Y +  D+++ G +  
Sbjct: 158 TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE-VIRMQDSNPYSFQSDVYAFGIVLY 216
Query: 321 GMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 357
            ++  + P +   +N DQ++++   +G   L+  L+K
Sbjct: 217 ELMTGQLP-YSNINNRDQIIEM---VGRGSLSPDLSK 249

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/235 (18%), Positives = 97/235 (41%), Gaps = 22/235 (9%)
Query: 121 WDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXXXXXXXX 180
           WD ++  +    ++  ++V+++G G++ EV+ G +    +                    
Sbjct: 3   WDKDAWEIP---RESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEA 59
Query: 181 XLQNLCGGPNIVKLLDIVRDQQS--------KTPSLIFEHVNNTDFKVLYPTLSDYDVRY 232
            L        +V+L  +V  ++            SL+    ++   KVL P L D+    
Sbjct: 60  NLMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA-- 117
Query: 233 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASR 292
              ++ + + Y   +  +HRD++  NV++  E    ++ D+GLA       EY  R  ++
Sbjct: 118 ---QIAEGMAYIERKNYIHRDLRAANVLV-SESLMCKIADFGLARVIE-DNEYTAREGAK 172
Query: 293 Y---FKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
           +   +  PE  ++   +    D+WS G +   ++   +  + G  N D +  +++
Sbjct: 173 FPIKWTAPE-AINFGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQ 226

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 51/97 (52%), Gaps = 11/97 (11%)
Query: 229 DVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA------EFYHPG 282
           D+    Y+L + ++Y  SQ  +HRD+   NV++  E   +R+ D+GLA      ++Y   
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLV-TENNVMRIADFGLARDINNIDYYK-- 214
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMF 319
           K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 215 KTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLM 249

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 36/164 (21%), Positives = 75/164 (45%), Gaps = 18/164 (10%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALD 242
           PN++ LL I    +  +P ++  ++ + D +         PT+ D  +  +  ++ K + 
Sbjct: 83  PNVLSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGMK 139
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA------EFYHPGKEYNVRVASRYFKG 296
           Y  S+  +HRD+   N M+D E+  +++ D+GLA      E+Y    +   ++  ++   
Sbjct: 140 YLASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 198
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
             L    Q +    D+WS G +   ++ R  P +   + +D  V
Sbjct: 199 ESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 240

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 36/164 (21%), Positives = 75/164 (45%), Gaps = 18/164 (10%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALD 242
           PN++ LL I    +  +P ++  ++ + D +         PT+ D  +  +  ++ K + 
Sbjct: 109 PNVLSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGMK 165
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA------EFYHPGKEYNVRVASRYFKG 296
           Y  S+  +HRD+   N M+D E+  +++ D+GLA      E+Y    +   ++  ++   
Sbjct: 166 YLASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 224
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
             L    Q +    D+WS G +   ++ R  P +   + +D  V
Sbjct: 225 ESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 266

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/99 (29%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH---- 280
           LS  D+    Y++ + ++Y  S+  +HRD+   NV++  E   +++ D+GLA   H    
Sbjct: 147 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT-EDNVMKIADFGLARDIHHIDX 205
Query: 281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMF 319
             K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 206 XKKTTNGRLPVKWM-APEALFD-RIYTHQSDVWSFGVLL 242

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 36/164 (21%), Positives = 75/164 (45%), Gaps = 18/164 (10%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALD 242
           PN++ LL I    +  +P ++  ++ + D +         PT+ D  +  +  ++ K + 
Sbjct: 91  PNVLSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGMK 147
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA------EFYHPGKEYNVRVASRYFKG 296
           Y  S+  +HRD+   N M+D E+  +++ D+GLA      E+Y    +   ++  ++   
Sbjct: 148 YLASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 206
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
             L    Q +    D+WS G +   ++ R  P +   + +D  V
Sbjct: 207 ESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 248

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 36/164 (21%), Positives = 75/164 (45%), Gaps = 18/164 (10%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALD 242
           PN++ LL I    +  +P ++  ++ + D +         PT+ D  +  +  ++ K + 
Sbjct: 110 PNVLSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGMK 166
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA------EFYHPGKEYNVRVASRYFKG 296
           Y  S+  +HRD+   N M+D E+  +++ D+GLA      E+Y    +   ++  ++   
Sbjct: 167 YLASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 225
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
             L    Q +    D+WS G +   ++ R  P +   + +D  V
Sbjct: 226 ESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 267

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 36/164 (21%), Positives = 75/164 (45%), Gaps = 18/164 (10%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALD 242
           PN++ LL I    +  +P ++  ++ + D +         PT+ D  +  +  ++ K + 
Sbjct: 88  PNVLSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGMK 144
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA------EFYHPGKEYNVRVASRYFKG 296
           Y  S+  +HRD+   N M+D E+  +++ D+GLA      E+Y    +   ++  ++   
Sbjct: 145 YLASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 203
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
             L    Q +    D+WS G +   ++ R  P +   + +D  V
Sbjct: 204 ESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 245

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 36/164 (21%), Positives = 75/164 (45%), Gaps = 18/164 (10%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALD 242
           PN++ LL I    +  +P ++  ++ + D +         PT+ D  +  +  ++ K + 
Sbjct: 89  PNVLSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGMK 145
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA------EFYHPGKEYNVRVASRYFKG 296
           Y  S+  +HRD+   N M+D E+  +++ D+GLA      E+Y    +   ++  ++   
Sbjct: 146 YLASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 204
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
             L    Q +    D+WS G +   ++ R  P +   + +D  V
Sbjct: 205 ESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 246

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 36/164 (21%), Positives = 75/164 (45%), Gaps = 18/164 (10%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALD 242
           PN++ LL I    +  +P ++  ++ + D +         PT+ D  +  +  ++ K + 
Sbjct: 91  PNVLSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGMK 147
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA------EFYHPGKEYNVRVASRYFKG 296
           Y  S+  +HRD+   N M+D E+  +++ D+GLA      E+Y    +   ++  ++   
Sbjct: 148 YLASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 206
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
             L    Q +    D+WS G +   ++ R  P +   + +D  V
Sbjct: 207 ESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 248

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 36/164 (21%), Positives = 75/164 (45%), Gaps = 18/164 (10%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALD 242
           PN++ LL I    +  +P ++  ++ + D +         PT+ D  +  +  ++ K + 
Sbjct: 90  PNVLSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGMK 146
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA------EFYHPGKEYNVRVASRYFKG 296
           Y  S+  +HRD+   N M+D E+  +++ D+GLA      E+Y    +   ++  ++   
Sbjct: 147 YLASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 205
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
             L    Q +    D+WS G +   ++ R  P +   + +D  V
Sbjct: 206 ESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 247

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 36/164 (21%), Positives = 75/164 (45%), Gaps = 18/164 (10%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALD 242
           PN++ LL I    +  +P ++  ++ + D +         PT+ D  +  +  ++ K + 
Sbjct: 86  PNVLSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGMK 142
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA------EFYHPGKEYNVRVASRYFKG 296
           Y  S+  +HRD+   N M+D E+  +++ D+GLA      E+Y    +   ++  ++   
Sbjct: 143 YLASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 201
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
             L    Q +    D+WS G +   ++ R  P +   + +D  V
Sbjct: 202 ESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 243

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 48/225 (21%), Positives = 94/225 (41%), Gaps = 21/225 (9%)
Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCT-DNEXXXXXXXXXXXXXXXXXXXXXLQNLCGG-- 188
           +++  E+ R +G G++ +V +G++ + +N                      LQ       
Sbjct: 8   QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQ 67
Query: 189 ---PNIVKLLDIVRDQQSKTPSLIFEHVNNTD-----FKVLYPTLSDYDVRYYIYELLKA 240
              P+IVKL+ ++    ++ P  I   +          +V   +L    +  Y Y+L  A
Sbjct: 68  FDHPHIVKLIGVI----TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA 123
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK--GPE 298
           L Y  S+  +HRD+   NV++      ++L D+GL+ +                K   PE
Sbjct: 124 LAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPE 182
Query: 299 LLVDLQDYDYSLDLWSLG-CMFAGMIFRKEPFFYGHDNYDQLVKI 342
             ++ + +  + D+W  G CM+  ++   +P F G  N D + +I
Sbjct: 183 -SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 225

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 51/97 (52%), Gaps = 11/97 (11%)
Query: 229 DVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA------EFYHPG 282
           D+    Y+L + ++Y  SQ  +HRD+   NV++  E   +++ D+GLA      ++Y   
Sbjct: 204 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLV-TENNVMKIADFGLARDINNIDYYK-- 260
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMF 319
           K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 261 KTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLM 295

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 38/160 (23%), Positives = 75/160 (46%), Gaps = 31/160 (19%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRY-------YIYELLKAL 241
           PN++K + ++   + K  + I E++     + +  ++   D +Y       +  ++   +
Sbjct: 67  PNVLKFIGVL--YKDKRLNFITEYIKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGM 121
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-----EFYHP-----------GKEY 285
            Y HS  I+HRD+  HN ++  E + + + D+GLA     E   P            K Y
Sbjct: 122 AYLHSMNIIHRDLNSHNCLV-RENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRY 180
Query: 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFR 325
            V V + Y+  PE +++ + YD  +D++S G +   +I R
Sbjct: 181 TV-VGNPYWMAPE-MINGRSYDEKVDVFSFGIVLCEIIGR 218

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 57/115 (49%), Gaps = 12/115 (10%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR--------KLRLIDWGLA 276
           +++  + Y +  +LKALDY H  G +HR VK  +++I  + +         L +I  G  
Sbjct: 109 MNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQR 168
Query: 277 E-FYHPGKEYNVRVASRYFKGPELL-VDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
           +   H   +Y+V+V    +  PE+L  +LQ YD   D++S+G     +     PF
Sbjct: 169 QRVVHDFPKYSVKVLP--WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 221

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/99 (29%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP--- 281
           LS  D+    Y++ + ++Y  S+  +HRD+   NV++  E   +++ D+GLA   H    
Sbjct: 139 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT-EDNVMKIADFGLARDIHHIDY 197
Query: 282 -GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMF 319
             K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 198 YKKTTNGRLPVKWM-APEALFD-RIYTHQSDVWSFGVLL 234

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/135 (26%), Positives = 62/135 (45%), Gaps = 10/135 (7%)
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPT----LSDYDVRYYIYELLKALDYCH 245
           NIVK   I  +       LI E + +   K   P     ++      Y  ++ K +DY  
Sbjct: 84  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG 143
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV----RVASRYFKGPELLV 301
           S+  +HRD+   NV+++ E + +++ D+GL +     KE       R +  ++  PE L+
Sbjct: 144 SRQYVHRDLAARNVLVESEHQ-VKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLM 202
Query: 302 DLQDYDYSLDLWSLG 316
             + Y  S D+WS G
Sbjct: 203 QSKFYIAS-DVWSFG 216

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 57/115 (49%), Gaps = 12/115 (10%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR--------KLRLIDWGLA 276
           +++  + Y +  +LKALDY H  G +HR VK  +++I  + +         L +I  G  
Sbjct: 125 MNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQR 184
Query: 277 E-FYHPGKEYNVRVASRYFKGPELL-VDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
           +   H   +Y+V+V    +  PE+L  +LQ YD   D++S+G     +     PF
Sbjct: 185 QRVVHDFPKYSVKVLP--WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 237

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/99 (29%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP--- 281
           LS  D+    Y++ + ++Y  S+  +HRD+   NV++  E   +++ D+GLA   H    
Sbjct: 140 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT-EDNVMKIADFGLARDIHHIDY 198
Query: 282 -GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMF 319
             K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 199 YKKTTNGRLPVKWM-APEALFD-RIYTHQSDVWSFGVLL 235

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/99 (29%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP--- 281
           LS  D+    Y++ + ++Y  S+  +HRD+   NV++  E   +++ D+GLA   H    
Sbjct: 188 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT-EDNVMKIADFGLARDIHHIDY 246
Query: 282 -GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMF 319
             K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 247 YKKTTNGRLPVKWM-APEALFD-RIYTHQSDVWSFGVLL 283

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/135 (26%), Positives = 62/135 (45%), Gaps = 10/135 (7%)
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPT----LSDYDVRYYIYELLKALDYCH 245
           NIVK   I  +       LI E + +   K   P     ++      Y  ++ K +DY  
Sbjct: 72  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG 131
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV----RVASRYFKGPELLV 301
           S+  +HRD+   NV+++ E + +++ D+GL +     KE       R +  ++  PE L+
Sbjct: 132 SRQYVHRDLAARNVLVESEHQ-VKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLM 190
Query: 302 DLQDYDYSLDLWSLG 316
             + Y  S D+WS G
Sbjct: 191 QSKFYIAS-DVWSFG 204

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/99 (29%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP--- 281
           LS  D+    Y++ + ++Y  S+  +HRD+   NV++  E   +++ D+GLA   H    
Sbjct: 147 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT-EDNVMKIADFGLARDIHHIDY 205
Query: 282 -GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMF 319
             K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 206 YKKTTNGRLPVKWM-APEALFD-RIYTHQSDVWSFGVLL 242

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/99 (29%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP--- 281
           LS  D+    Y++ + ++Y  S+  +HRD+   NV++  E   +++ D+GLA   H    
Sbjct: 147 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT-EDNVMKIADFGLARDIHHIDY 205
Query: 282 -GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMF 319
             K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 206 YKKTTNGRLPVKWM-APEALFD-RIYTHQSDVWSFGVLL 242

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/108 (25%), Positives = 59/108 (54%), Gaps = 9/108 (8%)
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF---YHPGKEYNVRVASRYFK 295
           + +DY H++ I+HRD+K +N+ + HE   +++ D+GLA     +    ++     S  + 
Sbjct: 120 QGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 178
Query: 296 GPELLVDLQD---YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
            PE ++ +QD   Y +  D+++ G +   ++  + P +   +N DQ++
Sbjct: 179 APE-VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQII 224

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/99 (29%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP--- 281
           LS  D+    Y++ + ++Y  S+  +HRD+   NV++  E   +++ D+GLA   H    
Sbjct: 136 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT-EDNVMKIADFGLARDIHHIDY 194
Query: 282 -GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMF 319
             K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 195 YKKTTNGRLPVKWM-APEALFD-RIYTHQSDVWSFGVLL 231

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/99 (29%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP--- 281
           LS  D+    Y++ + ++Y  S+  +HRD+   NV++  E   +++ D+GLA   H    
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT-EDNVMKIADFGLARDIHHIDY 190
Query: 282 -GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMF 319
             K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 191 YKKTTNGRLPVKWM-APEALFD-RIYTHQSDVWSFGVLL 227

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 83/199 (41%), Gaps = 24/199 (12%)
Query: 237 LLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 295
           ++K L Y   +  IMHRDVKP N++++  + +++L D+G++         N  V +R + 
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMA-NSFVGTRSYM 170
Query: 296 GPELLVDLQDYDYSL--DLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-TDELN 352
            PE    LQ   YS+  D+WS+G     M   + P         +L+   +V G   E  
Sbjct: 171 SPE---RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 227
Query: 353 AYLNKYHIELDPHLAALVGRHSRKPWSKF----ITVENQHLAVPEAV------DFLDKLL 402
                    L  +     G  SR P + F      V      +P  V      DF++K L
Sbjct: 228 PRPRTPGRPLSSY-----GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCL 282
Query: 403 RYDHQERPTAKEAMAHPYF 421
             +  ER   K+ M H + 
Sbjct: 283 IKNPAERADLKQLMVHAFI 301

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 51/97 (52%), Gaps = 11/97 (11%)
Query: 229 DVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA------EFYHPG 282
           D+    Y+L + ++Y  SQ  +HRD+   NV++  E   +++ D+GLA      ++Y   
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLV-TENNVMKIADFGLARDINNIDYYK-- 214
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMF 319
           K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 215 KTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLM 249

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 51/97 (52%), Gaps = 11/97 (11%)
Query: 229 DVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA------EFYHPG 282
           D+    Y+L + ++Y  SQ  +HRD+   NV++  E   +++ D+GLA      ++Y   
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLV-TENNVMKIADFGLARDINNIDYYK-- 214
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMF 319
           K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 215 KTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLM 249

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 51/97 (52%), Gaps = 11/97 (11%)
Query: 229 DVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA------EFYHPG 282
           D+    Y+L + ++Y  SQ  +HRD+   NV++  E   +++ D+GLA      ++Y   
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLV-TENNVMKIADFGLARDINNIDYYK-- 214
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMF 319
           K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 215 KTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLM 249

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/108 (25%), Positives = 59/108 (54%), Gaps = 9/108 (8%)
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF---YHPGKEYNVRVASRYFK 295
           + +DY H++ I+HRD+K +N+ + HE   +++ D+GLA     +    ++     S  + 
Sbjct: 120 QGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 178
Query: 296 GPELLVDLQD---YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
            PE ++ +QD   Y +  D+++ G +   ++  + P +   +N DQ++
Sbjct: 179 APE-VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQII 224

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/108 (25%), Positives = 59/108 (54%), Gaps = 9/108 (8%)
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF---YHPGKEYNVRVASRYFK 295
           + +DY H++ I+HRD+K +N+ + HE   +++ D+GLA     +    ++     S  + 
Sbjct: 117 QGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 175
Query: 296 GPELLVDLQD---YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
            PE ++ +QD   Y +  D+++ G +   ++  + P +   +N DQ++
Sbjct: 176 APE-VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQII 221

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 68/155 (43%), Gaps = 33/155 (21%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYI----YELLK----A 240
           P+IV+++D+  +  +    L+   +   D   L+  + D   + +      E++K    A
Sbjct: 71  PHIVRIVDVYENLYAGRKCLLIV-MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 129
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
           + Y HS  I HRDVKP N++   ++    L+L D+G A      KE              
Sbjct: 130 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA------KETTG----------- 172
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH 333
                + YD S D+WSLG +   ++    PF+  H
Sbjct: 173 -----EKYDKSCDMWSLGVIMYILLCGYPPFYSNH 202

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 51/97 (52%), Gaps = 11/97 (11%)
Query: 229 DVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA------EFYHPG 282
           D+    Y+L + ++Y  SQ  +HRD+   NV++  E   +++ D+GLA      ++Y   
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLV-TENNVMKIADFGLARDINNIDYYK-- 214
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMF 319
           K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 215 KTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLM 249

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 83/199 (41%), Gaps = 24/199 (12%)
Query: 237 LLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 295
           ++K L Y   +  IMHRDVKP N++++  + +++L D+G++         N  V +R + 
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMA-NSFVGTRSYM 170
Query: 296 GPELLVDLQDYDYSL--DLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-TDELN 352
            PE    LQ   YS+  D+WS+G     M   + P         +L+   +V G   E  
Sbjct: 171 SPE---RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 227
Query: 353 AYLNKYHIELDPHLAALVGRHSRKPWSKF----ITVENQHLAVPEAV------DFLDKLL 402
                    L  +     G  SR P + F      V      +P  V      DF++K L
Sbjct: 228 PRPRTPGRPLSSY-----GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCL 282
Query: 403 RYDHQERPTAKEAMAHPYF 421
             +  ER   K+ M H + 
Sbjct: 283 IKNPAERADLKQLMVHAFI 301

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 83/199 (41%), Gaps = 24/199 (12%)
Query: 237 LLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 295
           ++K L Y   +  IMHRDVKP N++++  + +++L D+G++         N  V +R + 
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMA-NSFVGTRSYM 170
Query: 296 GPELLVDLQDYDYSL--DLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-TDELN 352
            PE    LQ   YS+  D+WS+G     M   + P         +L+   +V G   E  
Sbjct: 171 SPE---RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 227
Query: 353 AYLNKYHIELDPHLAALVGRHSRKPWSKF----ITVENQHLAVPEAV------DFLDKLL 402
                    L  +     G  SR P + F      V      +P  V      DF++K L
Sbjct: 228 PRPRTPGRPLSSY-----GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCL 282
Query: 403 RYDHQERPTAKEAMAHPYF 421
             +  ER   K+ M H + 
Sbjct: 283 IKNPAERADLKQLMVHAFI 301

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 83/199 (41%), Gaps = 24/199 (12%)
Query: 237 LLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 295
           ++K L Y   +  IMHRDVKP N++++  + +++L D+G++         N  V +R + 
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMA-NSFVGTRSYM 170
Query: 296 GPELLVDLQDYDYSL--DLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-TDELN 352
            PE    LQ   YS+  D+WS+G     M   + P         +L+   +V G   E  
Sbjct: 171 SPE---RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 227
Query: 353 AYLNKYHIELDPHLAALVGRHSRKPWSKF----ITVENQHLAVPEAV------DFLDKLL 402
                    L  +     G  SR P + F      V      +P  V      DF++K L
Sbjct: 228 PRPRTPGRPLSSY-----GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCL 282
Query: 403 RYDHQERPTAKEAMAHPYF 421
             +  ER   K+ M H + 
Sbjct: 283 IKNPAERADLKQLMVHAFI 301

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/108 (25%), Positives = 59/108 (54%), Gaps = 9/108 (8%)
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF---YHPGKEYNVRVASRYFK 295
           + +DY H++ I+HRD+K +N+ + HE   +++ D+GLA     +    ++     S  + 
Sbjct: 115 QGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 173
Query: 296 GPELLVDLQD---YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
            PE ++ +QD   Y +  D+++ G +   ++  + P +   +N DQ++
Sbjct: 174 APE-VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQII 219

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 51/97 (52%), Gaps = 11/97 (11%)
Query: 229 DVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA------EFYHPG 282
           D+    Y+L + ++Y  SQ  +HRD+   NV++  E   +++ D+GLA      ++Y   
Sbjct: 147 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLV-TENNVMKIADFGLARDINNIDYYK-- 203
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMF 319
           K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 204 KTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLM 238

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 51/97 (52%), Gaps = 11/97 (11%)
Query: 229 DVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA------EFYHPG 282
           D+    Y+L + ++Y  SQ  +HRD+   NV++  E   +++ D+GLA      ++Y   
Sbjct: 150 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLV-TENNVMKIADFGLARDINNIDYYK-- 206
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMF 319
           K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 207 KTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLM 241

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 51/97 (52%), Gaps = 11/97 (11%)
Query: 229 DVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA------EFYHPG 282
           D+    Y+L + ++Y  SQ  +HRD+   NV++  E   +++ D+GLA      ++Y   
Sbjct: 145 DLVSCTYQLARGMEYLASQKCIHRDLTARNVLV-TENNVMKIADFGLARDINNIDYYK-- 201
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMF 319
           K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 202 KTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLM 236

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/108 (25%), Positives = 59/108 (54%), Gaps = 9/108 (8%)
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF---YHPGKEYNVRVASRYFK 295
           + +DY H++ I+HRD+K +N+ + HE   +++ D+GLA     +    ++     S  + 
Sbjct: 115 QGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 173
Query: 296 GPELLVDLQD---YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
            PE ++ +QD   Y +  D+++ G +   ++  + P +   +N DQ++
Sbjct: 174 APE-VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQII 219

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/108 (25%), Positives = 59/108 (54%), Gaps = 9/108 (8%)
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF---YHPGKEYNVRVASRYFK 295
           + +DY H++ I+HRD+K +N+ + HE   +++ D+GLA     +    ++     S  + 
Sbjct: 142 QGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 200
Query: 296 GPELLVDLQD---YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
            PE ++ +QD   Y +  D+++ G +   ++  + P +   +N DQ++
Sbjct: 201 APE-VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQII 246

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/223 (18%), Positives = 92/223 (41%), Gaps = 19/223 (8%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQNLCGGPNIV 192
           ++  ++V+K+G G++ EV+ G +    +                     L        +V
Sbjct: 11  RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLV 70
Query: 193 KLLDIVRDQQS--------KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYC 244
           +L  +V  ++            SL+    ++   KVL P L D+       ++ + + Y 
Sbjct: 71  RLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSA-----QIAEGMAYI 125
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGPELLV 301
             +  +HRD++  NV++  E    ++ D+GLA       EY  R  +++   +  PE  +
Sbjct: 126 ERKNYIHRDLRAANVLV-SESLMCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPE-AI 182
Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
           +   +    ++WS G +   ++   +  + G  N D +  +++
Sbjct: 183 NFGCFTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQ 225

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/108 (25%), Positives = 59/108 (54%), Gaps = 9/108 (8%)
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF---YHPGKEYNVRVASRYFK 295
           + +DY H++ I+HRD+K +N+ + HE   +++ D+GLA     +    ++     S  + 
Sbjct: 143 QGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 201
Query: 296 GPELLVDLQD---YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
            PE ++ +QD   Y +  D+++ G +   ++  + P +   +N DQ++
Sbjct: 202 APE-VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQII 247

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 51/97 (52%), Gaps = 11/97 (11%)
Query: 229 DVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA------EFYHPG 282
           D+    Y+L + ++Y  SQ  +HRD+   NV++  E   +++ D+GLA      ++Y   
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLV-TENNVMKIADFGLARDINNIDYYK-- 214
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMF 319
           K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 215 KTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLM 249

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/99 (29%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP--- 281
           LS  D+    Y++ + ++Y  S+  +HRD+   NV++  E   +++ D+GLA   H    
Sbjct: 147 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT-EDNVMKIADFGLARDIHHIDY 205
Query: 282 -GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMF 319
             K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 206 YKKTTNGRLPVKWM-APEALFD-RIYTHQSDVWSFGVLL 242

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 51/99 (51%), Gaps = 8/99 (8%)
Query: 237 LLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 295
           ++K L Y   +  IMHRDVKP N++++  + +++L D+G++         N  V +R + 
Sbjct: 132 VIKGLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMA-NSFVGTRSYM 189
Query: 296 GPELLVDLQDYDYSL--DLWSLGCMFAGMIFRKEPFFYG 332
            PE    LQ   YS+  D+WS+G     M   + P   G
Sbjct: 190 SPE---RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSG 225

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/152 (23%), Positives = 65/152 (42%), Gaps = 8/152 (5%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXXXXXXXXX----LQNLCGGP 189
           + + + RK+G G + E++ G +   NE                         LQ   G P
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIP 66
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGI 249
           N V+   +  D       L+   + +  F      LS   V     +++  +++ HS+  
Sbjct: 67  N-VRWFGVEGDYNVLVMDLLGPSLEDL-FNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
Query: 250 MHRDVKPHNVMIDHEQR--KLRLIDWGLAEFY 279
           +HRD+KP N ++   +R  ++ +ID+GLA+ Y
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/165 (23%), Positives = 72/165 (43%), Gaps = 40/165 (24%)
Query: 182 LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKAL 241
           L  LC G    +L++ ++  +S+ P                  LS   V    Y+  +A+
Sbjct: 112 LTELCKG----QLVEFLKKMESRGP------------------LSCDTVLKIFYQTCRAV 149
Query: 242 DYCHSQG--IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN------------- 286
            + H Q   I+HRD+K  N+++ + Q  ++L D+G A       +Y+             
Sbjct: 150 QHMHRQKPPIIHRDLKVENLLLSN-QGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208
Query: 287 VRVASRYFKGPELLVDLQDYDYS--LDLWSLGCMFAGMIFRKEPF 329
            R  +  ++ PE++    ++      D+W+LGC+   + FR+ PF
Sbjct: 209 TRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF 253

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/95 (29%), Positives = 48/95 (50%), Gaps = 7/95 (7%)
Query: 229 DVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA----EFYHPGKE 284
           D+    Y+L + ++Y  SQ  +HRD+   NV++  E   +++ D+GLA          K 
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLV-TENNVMKIADFGLARDINNIDXXKKT 216
Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMF 319
            N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 217 TNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLM 249

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/108 (25%), Positives = 59/108 (54%), Gaps = 9/108 (8%)
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA---EFYHPGKEYNVRVASRYFK 295
           + +DY H++ I+HRD+K +N+ + HE   +++ D+GLA     +    ++     S  + 
Sbjct: 135 QGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 193
Query: 296 GPELLVDLQD---YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
            PE ++ +QD   Y +  D+++ G +   ++  + P +   +N DQ++
Sbjct: 194 APE-VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQII 239

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/95 (29%), Positives = 49/95 (51%), Gaps = 7/95 (7%)
Query: 229 DVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH----PGKE 284
           D+    Y+L + ++Y  SQ  +HRD+   NV++  E   +++ D+GLA   +      K 
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLV-TENNVMKIADFGLARDINNIDXXKKT 216
Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMF 319
            N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 217 TNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLM 249

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/163 (22%), Positives = 76/163 (46%), Gaps = 22/163 (13%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALD 242
           PN++ L+ I+   +   P ++  ++ + D           PT+ D  +  +  ++ + ++
Sbjct: 82  PNVLALIGIMLPPEG-LPHVLLPYMCHGDLLQFIRSPQRNPTVKD--LISFGLQVARGME 138
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA------EFYHPGKEYNVRVASRYFKG 296
           Y   Q  +HRD+   N M+D E   +++ D+GLA      E+Y   +  + R+  ++   
Sbjct: 139 YLAEQKFVHRDLAARNCMLD-ESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTA- 196
Query: 297 PELLVDLQDYDYSL--DLWSLGCMFAGMIFRKEPFFYGHDNYD 337
              L  LQ Y ++   D+WS G +   ++ R  P +   D +D
Sbjct: 197 ---LESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD 236

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/108 (25%), Positives = 59/108 (54%), Gaps = 9/108 (8%)
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA---EFYHPGKEYNVRVASRYFK 295
           + +DY H++ I+HRD+K +N+ + HE   +++ D+GLA     +    ++     S  + 
Sbjct: 115 QGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 173
Query: 296 GPELLVDLQD---YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
            PE ++ +QD   Y +  D+++ G +   ++  + P +   +N DQ++
Sbjct: 174 APE-VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQII 219

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/108 (25%), Positives = 59/108 (54%), Gaps = 9/108 (8%)
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA---EFYHPGKEYNVRVASRYFK 295
           + +DY H++ I+HRD+K +N+ + HE   +++ D+GLA     +    ++     S  + 
Sbjct: 143 QGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 201
Query: 296 GPELLVDLQD---YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
            PE ++ +QD   Y +  D+++ G +   ++  + P +   +N DQ++
Sbjct: 202 APE-VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQII 247

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 50/96 (52%), Gaps = 8/96 (8%)
Query: 237 LLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 295
           ++K L Y   +  IMHRDVKP N++++  + +++L D+G++         N  V +R + 
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMA-NSFVGTRSYM 170
Query: 296 GPELLVDLQDYDYSL--DLWSLGCMFAGMIFRKEPF 329
            PE    LQ   YS+  D+WS+G     M   + P 
Sbjct: 171 SPE---RLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 50/97 (51%), Gaps = 11/97 (11%)
Query: 229 DVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA------EFYHPG 282
           D+    Y+L + ++Y  SQ  +HRD+   NV++  E   +++ D+GLA      ++Y   
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLV-TENNVMKIADFGLARDINNIDYYK-- 214
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMF 319
              N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 215 NTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLM 249

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 51/95 (53%), Gaps = 8/95 (8%)
Query: 237 LLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 295
           ++K L Y   +  IMHRDVKP N++++  + +++L D+G++      +  N  V +R + 
Sbjct: 116 VIKGLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLI-DEMANEFVGTRSYM 173
Query: 296 GPELLVDLQDYDYSL--DLWSLGCMFAGMIFRKEP 328
            PE    LQ   YS+  D+WS+G     M   + P
Sbjct: 174 SPE---RLQGTHYSVQSDIWSMGLSLVEMAVGRYP 205

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 35/164 (21%), Positives = 74/164 (45%), Gaps = 18/164 (10%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALD 242
           PN++ LL I    +  +P ++  ++ + D +         PT+ D  +  +  ++ K + 
Sbjct: 150 PNVLSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGMK 206
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA------EFYHPGKEYNVRVASRYFKG 296
           +  S+  +HRD+   N M+D E+  +++ D+GLA      EF     +   ++  ++   
Sbjct: 207 FLASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 265
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
             L    Q +    D+WS G +   ++ R  P +   + +D  V
Sbjct: 266 ESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 307

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 35/164 (21%), Positives = 74/164 (45%), Gaps = 18/164 (10%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALD 242
           PN++ LL I    +  +P ++  ++ + D +         PT+ D  +  +  ++ K + 
Sbjct: 92  PNVLSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGMK 148
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA------EFYHPGKEYNVRVASRYFKG 296
           +  S+  +HRD+   N M+D E+  +++ D+GLA      EF     +   ++  ++   
Sbjct: 149 FLASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMAL 207
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
             L    Q +    D+WS G +   ++ R  P +   + +D  V
Sbjct: 208 ESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 249

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 35/164 (21%), Positives = 74/164 (45%), Gaps = 18/164 (10%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALD 242
           PN++ LL I    +  +P ++  ++ + D +         PT+ D  +  +  ++ K + 
Sbjct: 92  PNVLSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGMK 148
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA------EFYHPGKEYNVRVASRYFKG 296
           +  S+  +HRD+   N M+D E+  +++ D+GLA      EF     +   ++  ++   
Sbjct: 149 FLASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 207
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
             L    Q +    D+WS G +   ++ R  P +   + +D  V
Sbjct: 208 ESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 249

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 35/164 (21%), Positives = 74/164 (45%), Gaps = 18/164 (10%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALD 242
           PN++ LL I    +  +P ++  ++ + D +         PT+ D  +  +  ++ K + 
Sbjct: 91  PNVLSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGMK 147
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA------EFYHPGKEYNVRVASRYFKG 296
           +  S+  +HRD+   N M+D E+  +++ D+GLA      EF     +   ++  ++   
Sbjct: 148 FLASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 206
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
             L    Q +    D+WS G +   ++ R  P +   + +D  V
Sbjct: 207 ESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 248

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 35/164 (21%), Positives = 74/164 (45%), Gaps = 18/164 (10%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALD 242
           PN++ LL I    +  +P ++  ++ + D +         PT+ D  +  +  ++ K + 
Sbjct: 91  PNVLSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGMK 147
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA------EFYHPGKEYNVRVASRYFKG 296
           +  S+  +HRD+   N M+D E+  +++ D+GLA      EF     +   ++  ++   
Sbjct: 148 FLASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 206
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
             L    Q +    D+WS G +   ++ R  P +   + +D  V
Sbjct: 207 ESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 248

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 29/107 (27%), Positives = 50/107 (46%), Gaps = 11/107 (10%)
Query: 233 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASR 292
           + Y++ K + +  S+  +HRD+   N+++ H  R  ++ D+GLA        Y V+  +R
Sbjct: 173 FSYQVAKGMAFLASKNCIHRDLAARNILLTH-GRITKICDFGLARHIKNDSNYVVKGNAR 231
Query: 293 Y---FKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNY 336
               +  PE + +   Y +  D+WS G      IF  E F  G   Y
Sbjct: 232 LPVKWMAPESIFNCV-YTFESDVWSYG------IFLWELFSLGSSPY 271

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 35/164 (21%), Positives = 74/164 (45%), Gaps = 18/164 (10%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALD 242
           PN++ LL I    +  +P ++  ++ + D +         PT+ D  +  +  ++ K + 
Sbjct: 89  PNVLSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGMK 145
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA------EFYHPGKEYNVRVASRYFKG 296
           +  S+  +HRD+   N M+D E+  +++ D+GLA      EF     +   ++  ++   
Sbjct: 146 FLASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 204
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
             L    Q +    D+WS G +   ++ R  P +   + +D  V
Sbjct: 205 ESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 246

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 35/164 (21%), Positives = 74/164 (45%), Gaps = 18/164 (10%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALD 242
           PN++ LL I    +  +P ++  ++ + D +         PT+ D  +  +  ++ K + 
Sbjct: 96  PNVLSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGMK 152
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA------EFYHPGKEYNVRVASRYFKG 296
           +  S+  +HRD+   N M+D E+  +++ D+GLA      EF     +   ++  ++   
Sbjct: 153 FLASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 211
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
             L    Q +    D+WS G +   ++ R  P +   + +D  V
Sbjct: 212 ESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 253

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	434
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	0.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-71
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	5e-71
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	6e-70
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-66
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	8e-64
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-62
3o0g_A	292	Cell division protein kinase 5; kinase activator c	7e-62
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-61
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	4e-61
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	4e-61
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	9e-61
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-60
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-60
3niz_A	311	Rhodanese family protein; structural genomics, str	6e-60
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	7e-60
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	7e-60
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	7e-60
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	5e-59
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	9e-59
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-58
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	4e-58
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	6e-58
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-57
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-57
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-56
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-56
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	5e-54
3rp9_A	458	Mitogen-activated protein kinase; structural genom	7e-53
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-51
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-50
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-49
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	6e-49
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-48
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-46
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-45
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	5e-45
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	5e-45
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	6e-45
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	7e-45
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	7e-45
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	5e-44
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	7e-44
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-43
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-43
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-43
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-43
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	5e-43
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	7e-43
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-42
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-42
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-42
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	7e-42
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	9e-42
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-41
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-41
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-41
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-41
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	8e-41
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	8e-41
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-40
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-40
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-40
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-40
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-40
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-40
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-40
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	4e-40
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	9e-40
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-39
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-39
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-39
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	4e-39
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	4e-39
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	5e-39
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	5e-39
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	9e-39
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-38
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-38
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-38
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-38
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-38
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	7e-38
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-37
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-37
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-36
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	9e-36
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-35
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-35
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-35
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	9e-35
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-34
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-34
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	5e-34
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-33
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-33
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	7e-33
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	8e-33
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-32
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-32
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	7e-32
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	8e-32
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-31
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-31
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-30
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-29
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	9e-29
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-28
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-28
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-28
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	4e-28
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	7e-28
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-27
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	4e-27
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	8e-27
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-26
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-26
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-26
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-26
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-25
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-25
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-25
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-25
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-25
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-25
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	4e-25
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	5e-25
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-24
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-23
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-23
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-22
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-21
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-21
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-20
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	6e-20
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	4e-19
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-18
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	5e-18
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	6e-18
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	6e-18
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	9e-18
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-17
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-17
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	5e-17
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	5e-17
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	5e-17
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	6e-17
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	6e-17
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	7e-17
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	7e-17
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	8e-17
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-16
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-16
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-16
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-16
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-16
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-16
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	5e-16
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	5e-16
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	9e-16
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-15
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-15
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-15
3ork_A	311	Serine/threonine protein kinase; structural genomi	8e-15
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	8e-15
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-13
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-13
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-13
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	4e-13
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-12
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-12
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	5e-12
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	8e-12
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-11
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-11
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	5e-11
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	9e-11
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-10
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-10
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-09
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-09
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-08
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-08
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	5e-08
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	7e-08
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	7e-08
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-07
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-07
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-07
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-07
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-07
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	7e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-06
3pls_A	298	Macrophage-stimulating protein receptor; protein k	4e-07
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	5e-07
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	6e-07
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	6e-07
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-06
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	1e-06
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-06
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-06
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-06
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-06
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-06
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-06
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	5e-06
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	5e-06
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	6e-06
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	7e-06
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	7e-06
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-05
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-05
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-05
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-05
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-05
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-05
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-05
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-05
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	4e-05
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	5e-05
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	8e-05
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	9e-05
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-04
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	2e-04
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-04
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-04
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-04
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-04
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-04
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	4e-04

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  572 bits (1476), Expect = 0.0
 Identities = 245/326 (75%), Positives = 286/326 (87%)

Query: 103 PSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKC 162
           PS+ARVY+D+N  RPREYWDYES  V+WG QDDY++VRK+GRGKYSEVFE ++ T+NEK 
Sbjct: 5   PSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKV 64

Query: 163 IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY 222
           ++KILKPVKKKKIKREIKIL+NL GGPNI+ L DIV+D  S+TP+L+FEHVNNTDFK LY
Sbjct: 65  VVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY 124

Query: 223 PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282
            TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPG
Sbjct: 125 QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184

Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKI 342
           +EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFRKEPFF+GHDNYDQLV+I
Sbjct: 185 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI 244

Query: 343 AKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLL 402
           AKVLGT++L  Y++KY+IELDP    ++GRHSRK W +F+  ENQHL  PEA+DFLDKLL
Sbjct: 245 AKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLL 304

Query: 403 RYDHQERPTAKEAMAHPYFFPIRNAE 428
           RYDHQ R TA+EAM HPYF+ +   +
Sbjct: 305 RYDHQSRLTAREAMEHPYFYTVVKDQ 330

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  230 bits (589), Expect = 1e-71
 Identities = 102/355 (28%), Positives = 163/355 (45%), Gaps = 27/355 (7%)

Query: 85  PPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGR 144
           P  T   +  K V++  A    +V  D +  +               ++  Y   + +G 
Sbjct: 5   PRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGN 64

Query: 145 GKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204
           G +  V++   C   E   IK +   K+ K  RE++I++ L    NIV+L         K
Sbjct: 65  GSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-RELQIMRKL-DHCNIVRLRYFFYSSGEK 122

Query: 205 TPS----LIFEHVNNTDFKVLYP------TLSDYDVRYYIYELLKALDYCHSQGIMHRDV 254
                  L+ ++V  T ++V         TL    V+ Y+Y+L ++L Y HS GI HRD+
Sbjct: 123 KDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDI 182

Query: 255 KPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWS 314
           KP N+++D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS
Sbjct: 183 KPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWS 242

Query: 315 LGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---DELNAYLNKYHIELDPHLAALVG 371
            GC+ A ++  + P F G    DQLV+I KVLGT   +++      Y     P +     
Sbjct: 243 AGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI----- 296

Query: 372 RHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 426
                PW+K      +    PEA+    +LL Y    R T  EA AH +F  +R+
Sbjct: 297 --KAHPWTKVF----RPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 345

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  228 bits (583), Expect = 5e-71
 Identities = 95/312 (30%), Positives = 154/312 (49%), Gaps = 28/312 (8%)

Query: 130 WGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGP 189
              +  Y   + +G G +  VF+      +E  I K+L+   K+   RE++I++ +   P
Sbjct: 36  EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD--KRFKNRELQIMRIV-KHP 92

Query: 190 NIVKLLDIVRDQQSKTPS----LIFEHVNNTDFKVL--YP----TLSDYDVRYYIYELLK 239
           N+V L         K       L+ E+V  T ++    Y     T+    ++ Y+Y+LL+
Sbjct: 93  NVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152

Query: 240 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 299
           +L Y HS GI HRD+KP N+++D     L+LID+G A+    G+     + SRY++ PEL
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPEL 212

Query: 300 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---DELNAYLN 356
           +    +Y  ++D+WS GC+ A ++  + P F G    DQLV+I KVLGT   +++     
Sbjct: 213 IFGATNYTTNIDIWSTGCVMAELMQGQ-PLFPGESGIDQLVEIIKVLGTPSREQIKTMNP 271

Query: 357 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAM 416
            Y     P +          P+SK           P+A+D + +LL Y    R TA EA+
Sbjct: 272 NYMEHKFPQI-------RPHPFSKVFRPR----TPPDAIDLISRLLEYTPSARLTAIEAL 320

Query: 417 AHPYFFPIRNAE 428
            HP+F  +R  E
Sbjct: 321 CHPFFDELRTGE 332

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  224 bits (573), Expect = 6e-70
 Identities = 84/315 (26%), Positives = 145/315 (46%), Gaps = 28/315 (8%)

Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK--ILKPVKKKKIKREIKILQNLCGGP 189
           E D ++V R  G+G +  V  G   +      IK  I  P  + +  + ++ L  L   P
Sbjct: 21  EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL-HHP 79

Query: 190 NIVKLLDIVRDQQSKTPS-----LIFEHVNNTDFKVL--YP----TLSDYDVRYYIYELL 238
           NIV+L         +        ++ E+V +T  +    Y           ++ ++++L+
Sbjct: 80  NIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLI 139

Query: 239 KALDYCH--SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 296
           +++   H  S  + HRD+KPHNV+++     L+L D+G A+   P +     + SRY++ 
Sbjct: 140 RSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRA 199

Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---DELNA 353
           PEL+   Q Y  ++D+WS+GC+FA M+  + P F G ++  QL +I +VLG    + L  
Sbjct: 200 PELIFGNQHYTTAVDIWSVGCIFAEMMLGE-PIFRGDNSAGQLHEIVRVLGCPSREVLRK 258

Query: 354 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK 413
               +      +           PWS   +  +      EA D L  LL+Y  +ER    
Sbjct: 259 LNPSHTDVDLYNS-------KGIPWSNVFSDHSLK-DAKEAYDLLSALLQYLPEERMKPY 310

Query: 414 EAMAHPYFFPIRNAE 428
           EA+ HPYF  + +  
Sbjct: 311 EALCHPYFDELHDPA 325

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  215 bits (550), Expect = 3e-66
 Identities = 93/338 (27%), Positives = 156/338 (46%), Gaps = 59/338 (17%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLL 195
           Y + + +G G +  V E       ++  +K +    + K  RE+ I++ L    NI+KL+
Sbjct: 9   YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN-RELDIMKVLDH-VNIIKLV 66

Query: 196 DIVRDQQSKTPS------------------------------------LIFEHVNNTDFK 219
           D       + P                                     +I E+V +T  K
Sbjct: 67  DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHK 126

Query: 220 VLYP------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDW 273
           VL        ++    +  YIY+L +A+ + HS GI HRD+KP N++++ +   L+L D+
Sbjct: 127 VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDF 186

Query: 274 GLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH 333
           G A+   P +     + SR+++ PEL++   +Y  S+DLWS+GC+F  +I  K P F G 
Sbjct: 187 GSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK-PLFSGE 245

Query: 334 DNYDQLVKIAKVLGT---DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLA 390
            + DQLV+I +++GT   +++      Y     P L         K W K +        
Sbjct: 246 TSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTL-------KAKDWRKIL----PEGT 294

Query: 391 VPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 428
              A+D L+++LRY+   R    EAMAHP+F  +RN+ 
Sbjct: 295 PSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSY 332

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  207 bits (528), Expect = 8e-64
 Identities = 89/313 (28%), Positives = 146/313 (46%), Gaps = 38/313 (12%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-------------REIK 180
           + YE + K+G G Y  VF+  +    +   IK        K               REI+
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK--------KFLESEDDPVIKKIALREIR 54

Query: 181 ILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPT-LSDYDVRYYIYEL 237
           +L+ L   PN+V LL++ R ++     L+FE+ ++T    L  Y   + ++ V+   ++ 
Sbjct: 55  MLKQLKH-PNLVNLLEVFRRKRRLH--LVFEYCDHTVLHELDRYQRGVPEHLVKSITWQT 111

Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKG 296
           L+A+++CH    +HRDVKP N++I      ++L D+G A     P   Y+  VA+R+++ 
Sbjct: 112 LQAVNFCHKHNCIHRDVKPENILITKHSV-IKLCDFGFARLLTGPSDYYDDEVATRWYRS 170

Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 356
           PELLV    Y   +D+W++GC+FA ++    P + G  + DQL  I K LG       L 
Sbjct: 171 PELLVGDTQYGPPVDVWAIGCVFAELL-SGVPLWPGKSDVDQLYLIRKTLGD------LI 223

Query: 357 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAV-PEAVDFLDKLLRYDHQERPTAKEA 415
             H ++        G            +E +   +   A+  L   L  D  ER T ++ 
Sbjct: 224 PRHQQVFSTNQYFSG-VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQL 282

Query: 416 MAHPYFFPIRNAE 428
           + HPYF  IR  E
Sbjct: 283 LHHPYFENIREIE 295

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  203 bits (520), Expect = 2e-62
 Identities = 85/302 (28%), Positives = 139/302 (46%), Gaps = 30/302 (9%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK-IK----REIKILQNLCGG 188
           + YE +  VG G Y  V +  +        IK        K +K    REIK+L+ L   
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRH- 83

Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPT-LSDYDVRYYIYELLKALDYCH 245
            N+V LL++ + ++     L+FE V++T    L  +P  L    V+ Y+++++  + +CH
Sbjct: 84  ENLVNLLEVCKKKKRWY--LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCH 141

Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           S  I+HRD+KP N+++      ++L D+G A     PG+ Y+  VA+R+++ PELLV   
Sbjct: 142 SHNIIHRDIKPENILVSQSGV-VKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDV 200

Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT-DELN----AYLNKYH 359
            Y  ++D+W++GC+   M F  EP F G  + DQL  I   LG     +         + 
Sbjct: 201 KYGKAVDVWAIGCLVTEM-FMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA 259

Query: 360 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHP 419
               P          R+P  +              +D   K L  D  +RP   E + H 
Sbjct: 260 GVRLPE------IKEREPLERRYP-----KLSEVVIDLAKKCLHIDPDKRPFCAELLHHD 308

Query: 420 YF 421
           +F
Sbjct: 309 FF 310

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  201 bits (513), Expect = 7e-62
 Identities = 90/308 (29%), Positives = 150/308 (48%), Gaps = 43/308 (13%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-------------REIK 180
             YE + K+G G Y  VF+  +   +E         V  K+++             REI 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEI--------VALKRVRLDDDDEGVPSSALREIC 53

Query: 181 ILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL----YPTLSDYDVRYYIYE 236
           +L+ L    NIV+L D++   +  T  L+FE  +  D K         L    V+ ++++
Sbjct: 54  LLKELKH-KNIVRLHDVLHSDKKLT--LVFEFCD-QDLKKYFDSCNGDLDPEIVKSFLFQ 109

Query: 237 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFK 295
           LLK L +CHS+ ++HRD+KP N++I+     L+L ++GLA  +  P + Y+  V + +++
Sbjct: 110 LLKGLGFCHSRNVLHRDLKPQNLLINRNGE-LKLANFGLARAFGIPVRCYSAEVVTLWYR 168

Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT-DELNAY 354
            P++L   + Y  S+D+WS GC+FA +     P F G+D  DQL +I ++LGT  E    
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE---- 224

Query: 355 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQ-HLAVPEAVDFLDKLLRYDHQERPTAK 413
                 E  P +  L        +    ++ N          D L  LL+ +  +R +A+
Sbjct: 225 ------EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAE 278

Query: 414 EAMAHPYF 421
           EA+ HPYF
Sbjct: 279 EALQHPYF 286

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  199 bits (509), Expect = 3e-61
 Identities = 90/311 (28%), Positives = 152/311 (48%), Gaps = 51/311 (16%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-------------REIK 180
           + Y  + K+G G Y  V++  +            +    KKI+             REI 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYG---------ETFALKKIRLEKEDEGIPSTTIREIS 52

Query: 181 ILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL----YPTLSDYDVRYYIYE 236
           IL+ L    NIVKL D++  ++     L+FEH++  D K L       L     + ++ +
Sbjct: 53  ILKELKH-SNIVKLYDVIHTKKRLV--LVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQ 108

Query: 237 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFK 295
           LL  + YCH + ++HRD+KP N++I+ E   L++ D+GLA  +  P ++Y   + + +++
Sbjct: 109 LLNGIAYCHDRRVLHRDLKPQNLLINREGE-LKIADFGLARAFGIPVRKYTHEIVTLWYR 167

Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT-DELN-- 352
            P++L+  + Y  ++D+WS+GC+FA M+    P F G    DQL++I ++LGT +  N  
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMV-NGTPLFPGVSEADQLMRIFRILGTPNSKNWP 226

Query: 353 --AYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP 410
               L KY              +   PW  F+            +D L K+L+ D  +R 
Sbjct: 227 NVTELPKYDPNFT--------VYEPLPWESFLKG-----LDESGIDLLSKMLKLDPNQRI 273

Query: 411 TAKEAMAHPYF 421
           TAK+A+ H YF
Sbjct: 274 TAKQALEHAYF 284

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  200 bits (510), Expect = 4e-61
 Identities = 81/318 (25%), Positives = 145/318 (45%), Gaps = 39/318 (12%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL---KPVKKKKIKREIKILQNLCGGPNIV 192
           Y  ++ +G G    VF  V    +++  IK +    P   K   REIKI++ L    NIV
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRL-DHDNIV 71

Query: 193 KLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP-------------TLSDYDVRYYIYELLK 239
           K+ +I+    S+    +          ++                L +   R ++Y+LL+
Sbjct: 72  KVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLR 131

Query: 240 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR----VASRYFK 295
            L Y HS  ++HRD+KP N+ I+ E   L++ D+GLA    P   +       + +++++
Sbjct: 132 GLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYR 191

Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---DELN 352
            P LL+   +Y  ++D+W+ GC+FA M+  K   F G    +Q+  I + +     ++  
Sbjct: 192 SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK-TLFAGAHELEQMQLILESIPVVHEEDRQ 250

Query: 353 AYLNKY--HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP 410
             L+    +I  D            KP ++ +   +      EAVDFL+++L +   +R 
Sbjct: 251 ELLSVIPVYIRNDMT-------EPHKPLTQLLPGIS-----REAVDFLEQILTFSPMDRL 298

Query: 411 TAKEAMAHPYFFPIRNAE 428
           TA+EA++HPY        
Sbjct: 299 TAEEALSHPYMSIYSFPM 316

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  200 bits (510), Expect = 9e-61
 Identities = 93/331 (28%), Positives = 169/331 (51%), Gaps = 30/331 (9%)

Query: 112 INVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPV 170
           ++++R + ++  +     W     Y     VG G Y  V   +     EK  IK + +P 
Sbjct: 2   LSLIRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF 61

Query: 171 KK----KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS----LIFEHVNNTDF-KVL 221
           +     K+  RE+ +L+++    N++ LLD+     S        L+   +  TD  K++
Sbjct: 62  QSEIFAKRAYRELLLLKHMQH-ENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIM 119

Query: 222 YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281
               S+  ++Y +Y++LK L Y HS G++HRD+KP N+ ++ E  +L+++D+GLA     
Sbjct: 120 GLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN-EDCELKILDFGLARHADA 178

Query: 282 GK-EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
               Y   V +R+++ PE+++    Y+ ++D+WS+GC+ A M+  K   F G D  DQL 
Sbjct: 179 EMTGY---VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK-TLFKGKDYLDQLT 234

Query: 341 KIAKVLGT---DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDF 397
           +I KV G    + +    +K       ++ +L  +  RK +++     +     P+A D 
Sbjct: 235 QILKVTGVPGTEFVQKLNDKAAKS---YIQSL-PQTPRKDFTQLFPRAS-----PQAADL 285

Query: 398 LDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 428
           L+K+L  D  +R TA +A+ HP+F P R+ E
Sbjct: 286 LEKMLELDVDKRLTAAQALTHPFFEPFRDPE 316

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  198 bits (505), Expect = 2e-60
 Identities = 85/315 (26%), Positives = 155/315 (49%), Gaps = 49/315 (15%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK------------REIKI 181
             ++ + K+G G Y+ V++G++ T            V  K++K            REI +
Sbjct: 5   SQFKQLEKLGNGTYATVYKGLNKTTGVY--------VALKEVKLDSEEGTPSTAIREISL 56

Query: 182 LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---------YPTLSDYDVRY 232
           ++ L    NIV+L D++  +   T  L+FE ++  D K              L    V+Y
Sbjct: 57  MKELKH-ENIVRLYDVIHTENKLT--LVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKY 112

Query: 233 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVAS 291
           + ++LL+ L +CH   I+HRD+KP N++I+   + L+L D+GLA  +  P   ++  V +
Sbjct: 113 FQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQ-LKLGDFGLARAFGIPVNTFSSEVVT 171

Query: 292 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT-DE 350
            +++ P++L+  + Y  S+D+WS GC+ A MI   +P F G ++ +QL  I  ++GT +E
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMI-TGKPLFPGTNDEEQLKLIFDIMGTPNE 230

Query: 351 LN----AYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDH 406
                   L KY+  +         +   +   + +    +       +DFL  LL+ + 
Sbjct: 231 SLWPSVTKLPKYNPNI--------QQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNP 282

Query: 407 QERPTAKEAMAHPYF 421
             R +AK+A+ HP+F
Sbjct: 283 DMRLSAKQALHHPWF 297

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  197 bits (504), Expect = 3e-60
 Identities = 81/322 (25%), Positives = 139/322 (43%), Gaps = 64/322 (19%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK----------------R 177
             YE V ++G G Y  V++                 V  K ++                R
Sbjct: 9   SRYEPVAEIGVGAYGTVYKARDPHSGHF--------VALKSVRVPNGGGGGGGLPISTVR 60

Query: 178 EIKILQNLCGG--PNIVKLLDIVRDQQSKTPS---LIFEHVNNTDFKVL-----YPTLSD 227
           E+ +L+ L     PN+V+L+D+    ++       L+FEHV+  D +        P L  
Sbjct: 61  EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPA 119

Query: 228 YDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV 287
             ++  + + L+ LD+ H+  I+HRD+KP N+++      ++L D+GLA  Y        
Sbjct: 120 ETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT-VKLADFGLARIYSYQMALTP 178

Query: 288 RVASRYFKGPELLVDLQD-YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL 346
            V + +++ PE+L  LQ  Y   +D+WS+GC+FA M FR++P F G+   DQL KI  ++
Sbjct: 179 VVVTLWYRAPEVL--LQSTYATPVDMWSVGCIFAEM-FRRKPLFCGNSEADQLGKIFDLI 235

Query: 347 GT-DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAV------PEAVDFLD 399
           G   E          +  P   +L       P   F     + +              L 
Sbjct: 236 GLPPE----------DDWPRDVSL-------PRGAFPPRGPRPVQSVVPEMEESGAQLLL 278

Query: 400 KLLRYDHQERPTAKEAMAHPYF 421
           ++L ++  +R +A  A+ H Y 
Sbjct: 279 EMLTFNPHKRISAFRALQHSYL 300

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  197 bits (502), Expect = 6e-60
 Identities = 97/314 (30%), Positives = 156/314 (49%), Gaps = 50/314 (15%)

Query: 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-------------R 177
           G  + Y+ + KVG G Y  V++               + V  K+I+             R
Sbjct: 18  GLMEKYQKLEKVGEGTYGVVYKAKDSQG---------RIVALKRIRLDAEDEGIPSTAIR 68

Query: 178 EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL----YPTLSDYDVRYY 233
           EI +L+ L   PNIV L+D++  ++  T  L+FE +   D K +       L D  ++ Y
Sbjct: 69  EISLLKELHH-PNIVSLIDVIHSERCLT--LVFEFME-KDLKKVLDENKTGLQDSQIKIY 124

Query: 234 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASR 292
           +Y+LL+ + +CH   I+HRD+KP N++I+ +   L+L D+GLA  +  P + Y   V + 
Sbjct: 125 LYQLLRGVAHCHQHRILHRDLKPQNLLINSDGA-LKLADFGLARAFGIPVRSYTHEVVTL 183

Query: 293 YFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT-DEL 351
           +++ P++L+  + Y  S+D+WS+GC+FA MI  K P F G  + DQL KI  +LGT +  
Sbjct: 184 WYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK-PLFPGVTDDDQLPKIFSILGTPNPR 242

Query: 352 N----AYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQ 407
                  L  +                +KPWS  I          E +D L  +L +D  
Sbjct: 243 EWPQVQELPLWKQRTFQ-------VFEKKPWSSIIPG-----FCQEGIDLLSNMLCFDPN 290

Query: 408 ERPTAKEAMAHPYF 421
           +R +A++AM HPYF
Sbjct: 291 KRISARDAMNHPYF 304

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  198 bits (505), Expect = 7e-60
 Identities = 82/337 (24%), Positives = 152/337 (45%), Gaps = 37/337 (10%)

Query: 116 RPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKK-- 172
              E    + +      Q  Y V R +  G Y  V  GV  ++     IK +   V    
Sbjct: 4   AKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGR 62

Query: 173 -----------KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS---LIFEHVNNTDF 218
                      K++ REI++L +    PNI+ L DI    +        L+ E +  TD 
Sbjct: 63  TVNILSDSFLCKRVLREIRLLNHF-HHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDL 120

Query: 219 -KVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG 274
            +V++     +S   ++Y++Y +L  L   H  G++HRD+ P N+++  +   + + D+ 
Sbjct: 121 AQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLA-DNNDITICDFN 179

Query: 275 LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD 334
           LA            V  R+++ PEL++  + +   +D+WS GC+ A M  RK   F G  
Sbjct: 180 LAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK-ALFRGST 238

Query: 335 NYDQLVKIAKVLGT---DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAV 391
            Y+QL KI +V+GT   +++  + +    +   +L   +     + W+  +   +     
Sbjct: 239 FYNQLNKIVEVVGTPKIEDVVMFSSPSARD---YLRNSLSNVPARAWTAVVPTAD----- 290

Query: 392 PEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 428
           P A+D + K+L ++ Q R + ++A+ HPYF  + +  
Sbjct: 291 PVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPL 327

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  197 bits (503), Expect = 7e-60
 Identities = 84/318 (26%), Positives = 147/318 (46%), Gaps = 59/318 (18%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-------------REIK 180
           D Y  + K+G G Y EV++ +    NE         V  K+I+             RE+ 
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNET--------VAIKRIRLEHEEEGVPGTAIREVS 85

Query: 181 ILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYEL 237
           +L+ L    NI++L  ++         LIFE+    D K      P +S   ++ ++Y+L
Sbjct: 86  LLKELQH-RNIIELKSVIHHNHRLH--LIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQL 141

Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRK----LRLIDWGLAEFYH-PGKEYNVRVASR 292
           +  +++CHS+  +HRD+KP N+++          L++ D+GLA  +  P +++   + + 
Sbjct: 142 INGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITL 201

Query: 293 YFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---- 348
           +++ PE+L+  + Y  S+D+WS+ C++A M+  K P F G    DQL KI +VLG     
Sbjct: 202 WYRPPEILLGSRHYSTSVDIWSIACIWAEML-MKTPLFPGDSEIDQLFKIFEVLGLPDDT 260

Query: 349 -----DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLR 403
                  L  +   +             +   K   + +      L   E +D L  +L 
Sbjct: 261 TWPGVTALPDWKQSFP------------KFRGKTLKRVLG----ALLDDEGLDLLTAMLE 304

Query: 404 YDHQERPTAKEAMAHPYF 421
            D  +R +AK A+ HPYF
Sbjct: 305 MDPVKRISAKNALEHPYF 322

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  197 bits (502), Expect = 7e-60
 Identities = 91/319 (28%), Positives = 150/319 (47%), Gaps = 60/319 (18%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-------------REIK 180
             YE V ++G G Y +VF+     +  +        V  K+++             RE+ 
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRF-------VALKRVRVQTGEEGMPLSTIREVA 63

Query: 181 ILQNLCGG--PNIVKLLDIVRDQQSKTPS---LIFEHVNNTDFKVL-----YPTLSDYDV 230
           +L++L     PN+V+L D+    ++   +   L+FEHV+  D          P +    +
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETI 122

Query: 231 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVA 290
           +  +++LL+ LD+ HS  ++HRD+KP N+++    + ++L D+GLA  Y         V 
Sbjct: 123 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ-IKLADFGLARIYSFQMALTSVVV 181

Query: 291 SRYFKGPELLVDLQD-YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT- 348
           + +++ PE+L  LQ  Y   +DLWS+GC+FA M FR++P F G  + DQL KI  V+G  
Sbjct: 182 TLWYRAPEVL--LQSSYATPVDLWSVGCIFAEM-FRRKPLFRGSSDVDQLGKILDVIGLP 238

Query: 349 DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAV------PEAVDFLDKLL 402
            E          E  P   AL       P   F +   Q +            D L K L
Sbjct: 239 GE----------EDWPRDVAL-------PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCL 281

Query: 403 RYDHQERPTAKEAMAHPYF 421
            ++  +R +A  A++HPYF
Sbjct: 282 TFNPAKRISAYSALSHPYF 300

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  195 bits (497), Expect = 5e-59
 Identities = 85/310 (27%), Positives = 153/310 (49%), Gaps = 48/310 (15%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK------------REIKI 181
           + Y  + K+G G Y+ V++G     +          V  K+I+            RE+ +
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNL--------VALKEIRLEHEEGAPCTAIREVSL 53

Query: 182 LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL----YPTLSDYDVRYYIYEL 237
           L++L    NIV L DI+  ++S T  L+FE+++  D K         ++ ++V+ ++++L
Sbjct: 54  LKDLKH-ANIVTLHDIIHTEKSLT--LVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQL 109

Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKG 296
           L+ L YCH Q ++HRD+KP N++I+     L+L D+GLA     P K Y+  V + +++ 
Sbjct: 110 LRGLAYCHRQKVLHRDLKPQNLLINERGE-LKLADFGLARAKSIPTKTYDNEVVTLWYRP 168

Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT-DELN--- 352
           P++L+   DY   +D+W +GC+F  M   + P F G    +QL  I ++LGT  E     
Sbjct: 169 PDILLGSTDYSTQIDMWGVGCIFYEMATGR-PLFPGSTVEEQLHFIFRILGTPTEETWPG 227

Query: 353 -AYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT 411
                ++     P       ++  +                +  D L KLL+++ + R +
Sbjct: 228 ILSNEEFKTYNYP-------KYRAEALLSHAP-----RLDSDGADLLTKLLQFEGRNRIS 275

Query: 412 AKEAMAHPYF 421
           A++AM HP+F
Sbjct: 276 AEDAMKHPFF 285

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  195 bits (498), Expect = 9e-59
 Identities = 93/321 (28%), Positives = 166/321 (51%), Gaps = 31/321 (9%)

Query: 123 YESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKK----KKIKR 177
            E     W  +  Y  ++ VG G Y  V   V      K  IK + +P +     K+  R
Sbjct: 14  QEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR 73

Query: 178 EIKILQNLCGGPNIVKLLDIVRDQQSKTPS----LIFEHVNNTDF-KVLYP-TLSDYDVR 231
           E+++L+++    N++ LLD+    ++        L+   +  TD  K++    L +  ++
Sbjct: 74  ELRLLKHMRH-ENVIGLLDVFTPDETLDDFTDFYLVMPFMG-TDLGKLMKHEKLGEDRIQ 131

Query: 232 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNVRVA 290
           + +Y++LK L Y H+ GI+HRD+KP N+ ++ E  +L+++D+GLA         Y   V 
Sbjct: 132 FLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN-EDCELKILDFGLARQADSEMTGY---VV 187

Query: 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT-- 348
           +R+++ PE++++   Y  ++D+WS+GC+ A MI  K   F G D+ DQL +I KV GT  
Sbjct: 188 TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK-TLFKGSDHLDQLKEIMKVTGTPP 246

Query: 349 -DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQ 407
            + +    +        ++  L     +K ++  +T  +     P AV+ L+K+L  D +
Sbjct: 247 AEFVQRLQSDEAKN---YMKGL-PELEKKDFASILTNAS-----PLAVNLLEKMLVLDAE 297

Query: 408 ERPTAKEAMAHPYFFPIRNAE 428
           +R TA EA+AHPYF  + + E
Sbjct: 298 QRVTAGEALAHPYFESLHDTE 318

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  194 bits (496), Expect = 1e-58
 Identities = 90/325 (27%), Positives = 156/325 (48%), Gaps = 37/325 (11%)

Query: 128 VQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK----KKIKREIKILQ 183
           + +    D+++   +G G Y  V    H    E   IK ++P  K     +  REIKIL+
Sbjct: 5   IVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILK 64

Query: 184 NLCGGPNIVKLLDIVRDQQSKTPS---LIFEHVNNTDF-KVLYP-TLSDYDVRYYIYELL 238
           +     NI+ + +I R    +  +   +I E +  TD  +V+    LSD  ++Y+IY+ L
Sbjct: 65  HF-KHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQMLSDDHIQYFIYQTL 122

Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR---------- 288
           +A+   H   ++HRD+KP N++I+     L++ D+GLA         N            
Sbjct: 123 RAVKVLHGSNVIHRDLKPSNLLIN-SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181

Query: 289 -VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG 347
            VA+R+++ PE+++    Y  ++D+WS GC+ A +  R+ P F G D   QL+ I  ++G
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR-PIFPGRDYRHQLLLIFGIIG 240

Query: 348 T----DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLR 403
           T    ++L    +    E   ++ +L   +   P  K     N     P+ +D L ++L 
Sbjct: 241 TPHSDNDLRCIESPRARE---YIKSL-PMYPAAPLEKMFPRVN-----PKGIDLLQRMLV 291

Query: 404 YDHQERPTAKEAMAHPYFFPIRNAE 428
           +D  +R TAKEA+ HPY     +  
Sbjct: 292 FDPAKRITAKEALEHPYLQTYHDPN 316

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  194 bits (494), Expect = 4e-58
 Identities = 85/325 (26%), Positives = 162/325 (49%), Gaps = 31/325 (9%)

Query: 119 EYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL-----KPVKKK 173
            ++  E     W   + Y+ +  VG G Y  V          +  +K L       +  K
Sbjct: 14  TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 73

Query: 174 KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS----LIFEHVNNTDF-KVLYP-TLSD 227
           +  RE+++L+++    N++ LLD+    +S        L+   +   D   ++    L+D
Sbjct: 74  RTYRELRLLKHMKH-ENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTD 131

Query: 228 YDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYN 286
             V++ IY++L+ L Y HS  I+HRD+KP N+ ++ E  +L+++D+GLA         Y 
Sbjct: 132 DHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLARHTADEMTGY- 189

Query: 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL 346
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 190 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR-TLFPGTDHIDQLKLILRLV 246

Query: 347 GT---DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLR 403
           GT   + L    ++       ++ +L  +  +  ++      N     P AVD L+K+L 
Sbjct: 247 GTPGAELLKKISSESARN---YIQSL-TQMPKMNFANVFIGAN-----PLAVDLLEKMLV 297

Query: 404 YDHQERPTAKEAMAHPYFFPIRNAE 428
            D  +R TA +A+AH YF    + +
Sbjct: 298 LDSDKRITAAQALAHAYFAQYHDPD 322

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  192 bits (491), Expect = 6e-58
 Identities = 88/303 (29%), Positives = 151/303 (49%), Gaps = 30/303 (9%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK--------REIKILQNL 185
             YE +  +G G+++ V++      N+   IK +K   + + K        REIK+LQ L
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69

Query: 186 CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL----YPTLSDYDVRYYIYELLKAL 241
              PNI+ LLD    + + +  L+F+ +  TD +V+       L+   ++ Y+   L+ L
Sbjct: 70  SH-PNIIGLLDAFGHKSNIS--LVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGL 125

Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELL 300
           +Y H   I+HRD+KP+N+++D     L+L D+GLA  F  P + Y  +V +R+++ PELL
Sbjct: 126 EYLHQHWILHRDLKPNNLLLDENGV-LKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELL 184

Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT-DELNAYLNKYH 359
              + Y   +D+W++GC+ A ++ R  PF  G  + DQL +I + LGT  E         
Sbjct: 185 FGARMYGVGVDMWAVGCILAELLLRV-PFLPGDSDLDQLTRIFETLGTPTE--------- 234

Query: 360 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHP 419
            E  P + +L    + K +           A  + +D +  L  ++   R TA +A+   
Sbjct: 235 -EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293

Query: 420 YFF 422
           YF 
Sbjct: 294 YFS 296

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  192 bits (491), Expect = 2e-57
 Identities = 83/334 (24%), Positives = 158/334 (47%), Gaps = 42/334 (12%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKK----KKIKREIKILQNLCGG 188
             YE+V+K+G+G Y  V++ +     E   +K I    +     ++  REI IL  L G 
Sbjct: 9   RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGH 68

Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDF-KVLY-PTLSDYDVRYYIYELLKALDYCHS 246
            NIV LL+++R    +   L+F+++  TD   V+    L     +Y +Y+L+K + Y HS
Sbjct: 69  ENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRANILEPVHKQYVVYQLIKVIKYLHS 127

Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR------------------ 288
            G++HRD+KP N++++  +  +++ D+GL+  +   +                       
Sbjct: 128 GGLLHRDMKPSNILLN-AECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186

Query: 289 ----VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
               VA+R+++ PE+L+    Y   +D+WSLGC+   ++  K P F G    +QL +I  
Sbjct: 187 LTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK-PIFPGSSTMNQLERIIG 245

Query: 345 VLGT---DELNAYLNKYHIEL-------DPHLAALVGRHSRKPWSKFITVENQHLAVPEA 394
           V+     +++ +  + +   +            +       K  +  + +  +     EA
Sbjct: 246 VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEA 305

Query: 395 VDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 428
           +D LDKLL+++  +R +A +A+ HP+     N  
Sbjct: 306 LDLLDKLLQFNPNKRISANDALKHPFVSIFHNPN 339

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  192 bits (489), Expect = 2e-57
 Identities = 86/315 (27%), Positives = 160/315 (50%), Gaps = 29/315 (9%)

Query: 130 WGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK----KKIKREIKILQNL 185
           +     Y  +  +G G Y  V       +  +  IK + P +     ++  REIKIL   
Sbjct: 23  FDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 82

Query: 186 CGGPNIVKLLDIVRDQQSKTPS---LIFEHVNNTDF-KVLY-PTLSDYDVRYYIYELLKA 240
               NI+ + DI+R    +      ++ + +  TD  K+L    LS+  + Y++Y++L+ 
Sbjct: 83  -RHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSNDHICYFLYQILRG 140

Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKG 296
           L Y HS  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ 
Sbjct: 141 LKYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199

Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---DELNA 353
           PE++++ + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN 
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNC 258

Query: 354 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK 413
            +N        +L +L    ++ PW++     +      +A+D LDK+L ++  +R   +
Sbjct: 259 IINLKARN---YLLSL-PHKNKVPWNRLFPNAD-----SKALDLLDKMLTFNPHKRIEVE 309

Query: 414 EAMAHPYFFPIRNAE 428
           +A+AHPY     +  
Sbjct: 310 QALAHPYLEQYYDPS 324

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  189 bits (482), Expect = 2e-56
 Identities = 78/331 (23%), Positives = 146/331 (44%), Gaps = 26/331 (7%)

Query: 116 RPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKK-- 172
           R   ++  E     +     Y+ ++ +G G    V             IK + +P +   
Sbjct: 7   RDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT 66

Query: 173 --KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS----LIFEHVNNTDFKVLYPTLS 226
             K+  RE+ +++ +    NI+ LL++   Q+S        ++ E ++    +V+   L 
Sbjct: 67  HAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD 125

Query: 227 DYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN 286
              + Y +Y++L  + + HS GI+HRD+KP N+++      L+++D+GLA          
Sbjct: 126 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMT 184

Query: 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL 346
             V +RY++ PE+++    Y  ++D+WS+GC+   MI      F G D+ DQ  K+ + L
Sbjct: 185 PYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGG-VLFPGTDHIDQWNKVIEQL 242

Query: 347 GT--DELNAYLNKYHIELDPHLAALVGRHSRKPWSKF-------ITVENQHLAVPEAVDF 397
           GT   E    L         ++     +++   + K           E+  L   +A D 
Sbjct: 243 GTPCPEFMKKLQPTVRT---YVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDL 298

Query: 398 LDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 428
           L K+L  D  +R +  EA+ HPY     +  
Sbjct: 299 LSKMLVIDASKRISVDEALQHPYINVWYDPS 329

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  188 bits (479), Expect = 4e-56
 Identities = 87/325 (26%), Positives = 137/325 (42%), Gaps = 63/325 (19%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-------------REIK 180
             YE + K+G+G + EVF+  H    +K        V  KK+              REIK
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQK--------VALKKVLMENEKEGFPITALREIK 68

Query: 181 ILQNLCGGPNIVKLLDIVRDQQSKTPS------LIFEHVNNTDFKVL----YPTLSDYDV 230
           ILQ L    N+V L++I R + S          L+F+     D   L        +  ++
Sbjct: 69  ILQLL-KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEI 126

Query: 231 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-----PGKEY 285
           +  +  LL  L Y H   I+HRD+K  NV+I  +   L+L D+GLA  +          Y
Sbjct: 127 KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV-LKLADFGLARAFSLAKNSQPNRY 185

Query: 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV 345
             RV + +++ PELL+  +DY   +DLW  GC+ A M + + P   G+    QL  I+++
Sbjct: 186 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM-WTRSPIMQGNTEQHQLALISQL 244

Query: 346 LGT---------DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVD 396
            G+         D                   L     +    K       ++  P A+D
Sbjct: 245 CGSITPEVWPNVDNY------------ELYEKL--ELVKGQKRKVKDRLKAYVRDPYALD 290

Query: 397 FLDKLLRYDHQERPTAKEAMAHPYF 421
            +DKLL  D  +R  + +A+ H +F
Sbjct: 291 LIDKLLVLDPAQRIDSDDALNHDFF 315

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  185 bits (472), Expect = 5e-54
 Identities = 79/336 (23%), Positives = 150/336 (44%), Gaps = 38/336 (11%)

Query: 117 PREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKK--- 172
             +++  E     +     Y+ ++ +G G    V        +    IK + +P +    
Sbjct: 45  DNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH 104

Query: 173 -KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS----LIFEHVNNTDFKVLYPTLSD 227
            K+  RE+ +++ +    NI+ LL++   Q++        L+ E ++    +V+   L  
Sbjct: 105 AKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH 163

Query: 228 YDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK---E 284
             + Y +Y++L  + + HS GI+HRD+KP N+++      L+++D+GLA           
Sbjct: 164 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTP 222

Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
           Y   V +RY++ PE+++    Y  ++D+WS+GC+   M+  K   F G D  DQ  K+ +
Sbjct: 223 Y---VVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHK-ILFPGRDYIDQWNKVIE 277

Query: 345 VLGT--DELNAYLN---KYHIELDPHLAALVGRHSRKPWSKF-------ITVENQHLAVP 392
            LGT   E    L    + ++E  P        ++   + K           E+  L   
Sbjct: 278 QLGTPCPEFMKKLQPTVRNYVENRPK-------YAGLTFPKLFPDSLFPADSEHNKLKAS 330

Query: 393 EAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 428
           +A D L K+L  D  +R +  +A+ HPY     +  
Sbjct: 331 QARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPA 366

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  182 bits (464), Expect = 7e-53
 Identities = 92/411 (22%), Positives = 167/411 (40%), Gaps = 84/411 (20%)

Query: 90  AQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSE 149
           AQ+     + + + S+            +           W   D YE+   +G G Y  
Sbjct: 9   AQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGH 68

Query: 150 VFEGVHCTDNEKCIIK-ILKPVKK----KKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204
           V E     +     IK IL+  +     K+I REI IL  L    ++VK+LDIV  +  +
Sbjct: 69  VCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL-NHDHVVKVLDIVIPKDVE 127

Query: 205 TPS---LIFEHVNNTDF-KVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHN 258
                 ++ E  + +DF K+      L++  ++  +Y LL  + Y HS GI+HRD+KP N
Sbjct: 128 KFDELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPAN 186

Query: 259 VMIDHEQRKLRLIDWGLAEFYHPGKEYNVR----------------------------VA 290
            +++ +   +++ D+GLA      +  N +                            V 
Sbjct: 187 CLVN-QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVV 245

Query: 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI----------FRKEPFFYGHD------ 334
           +R+++ PEL++  ++Y  ++D+WS+GC+FA ++            + P F G        
Sbjct: 246 TRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSP 305

Query: 335 --------------NYDQLVKIAKVLGT---DELNAYLNKYHIELDPHLAALVGRHSRKP 377
                         N DQL  I  +LGT   +++ A   +              +     
Sbjct: 306 DQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIF----PKREGTD 361

Query: 378 WSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 428
            ++     +      +A+  L ++L ++  +R T  E +AHP+F  +R AE
Sbjct: 362 LAERFPASS-----ADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAE 407

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  177 bits (451), Expect = 2e-51
 Identities = 82/347 (23%), Positives = 152/347 (43%), Gaps = 60/347 (17%)

Query: 121 WDYESLTVQWGE--QDDYEVVR-KVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK- 176
           +D++       E  +D +E    KVGRG Y  V++       +     +      K+I+ 
Sbjct: 5   YDFKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYAL------KQIEG 58

Query: 177 --------REIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL------- 221
                   REI +L+ L   PN++ L  +      +   L+F++    D   +       
Sbjct: 59  TGISMSACREIALLRELKH-PNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRAS 116

Query: 222 -----YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRK---LRLIDW 273
                   L    V+  +Y++L  + Y H+  ++HRD+KP N+++  E  +   +++ D 
Sbjct: 117 KANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM 176

Query: 274 GLA-EFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
           G A  F  P K     +  V + +++ PELL+  + Y  ++D+W++GC+FA ++   EP 
Sbjct: 177 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL-TSEPI 235

Query: 330 FYGHD---------NYDQLVKIAKVLGT--DELNAYLNKYHIELDPHLAALVGRHSRKPW 378
           F+            ++DQL +I  V+G   D+    + K      P  + L+    R  +
Sbjct: 236 FHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKM-----PEHSTLMKDFRRNTY 290

Query: 379 SKFITVENQHLAVP----EAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
           +    ++           +A   L KLL  D  +R T+++AM  PYF
Sbjct: 291 TNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 337

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  174 bits (444), Expect = 3e-50
 Identities = 78/359 (21%), Positives = 150/359 (41%), Gaps = 76/359 (21%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKK----KKIKREIKILQNLCGG 188
           D+Y +   +GRG Y  V+        +   IK + +  +     K+I REI IL  L   
Sbjct: 26  DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL-KS 84

Query: 189 PNIVKLLDIVRDQQSKTPS---LIFEHVNNTDF-KVLYP--TLSDYDVRYYIYELLKALD 242
             I++L D++            ++ E  + +D  K+      L++  ++  +Y LL   +
Sbjct: 85  DYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGEN 143

Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR-------------- 288
           + H  GI+HRD+KP N +++ +   +++ D+GLA   +  K+ N+               
Sbjct: 144 FIHESGIIHRDLKPANCLLN-QDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNK 202

Query: 289 ---------VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI----------FRKEPF 329
                    V +R+++ PEL++  ++Y  S+D+WS GC+FA ++            + P 
Sbjct: 203 NLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL 262

Query: 330 FYG-----------------HDNYDQLVKIAKVLGT---DELNAYLNKYHIELDPHLAAL 369
           F G                   N DQL  I  ++GT   D+L        I+   ++   
Sbjct: 263 FPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIK---YIKLF 319

Query: 370 VGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 428
                     +            + ++ L+ +L+++  +R T  +A+ HPY   +R  +
Sbjct: 320 -PHRKPINLKQKY-----PSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKK 372

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  169 bits (431), Expect = 2e-49
 Identities = 66/308 (21%), Positives = 113/308 (36%), Gaps = 61/308 (19%)

Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLCGG- 188
            Y +++++G G  S+VF+ ++    +   IK               + EI  L  L    
Sbjct: 29  IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87

Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPTLSDYDVRYYIYELLKALDYCHS 246
             I++L D       +   ++ E  N      L    ++  ++ + Y   +L+A+   H 
Sbjct: 88  DKIIRLYDYEIT--DQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145

Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELLVDL 303
            GI+H D+KP N +I      L+LID+G+A    P     V+   V +  +  PE + D+
Sbjct: 146 HGIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203

Query: 304 ----------QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 353
                            D+WSLGC+   M + K PF    +   +L  I           
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID--------- 254

Query: 354 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK 413
               + IE                               +  D L   L+ D ++R +  
Sbjct: 255 --PNHEIEFPDIPE------------------------KDLQDVLKCCLKRDPKQRISIP 288

Query: 414 EAMAHPYF 421
           E +AHPY 
Sbjct: 289 ELLAHPYV 296

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  169 bits (429), Expect = 6e-49
 Identities = 67/308 (21%), Positives = 112/308 (36%), Gaps = 61/308 (19%)

Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLCGG- 188
            Y +++++G G  S+VF+ ++    +   IK               + EI  L  L    
Sbjct: 10  IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68

Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPTLSDYDVRYYIYELLKALDYCHS 246
             I++L D     Q     ++ E  N      L    ++  ++ + Y   +L+A+   H 
Sbjct: 69  DKIIRLYDYEITDQ--YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126

Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELLVD- 302
            GI+H D+KP N +I      L+LID+G+A    P     V+   V +  +  PE + D 
Sbjct: 127 HGIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184

Query: 303 ---------LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 353
                            D+WSLGC+   M + K PF    +   +L  I           
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID--------- 235

Query: 354 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK 413
               + IE                               +  D L   L+ D ++R +  
Sbjct: 236 --PNHEIEFPDIPE------------------------KDLQDVLKCCLKRDPKQRISIP 269

Query: 414 EAMAHPYF 421
           E +AHPY 
Sbjct: 270 ELLAHPYV 277

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  169 bits (431), Expect = 1e-48
 Identities = 73/369 (19%), Positives = 128/369 (34%), Gaps = 66/369 (17%)

Query: 74  HQHQRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQ 133
           H H        P  +  ++   +           + +D +          E ++V+    
Sbjct: 1   HHHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSS--ANECISVKGR-- 56

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLCG- 187
             Y +++++G G  S+VF+ ++    +   IK               + EI  L  L   
Sbjct: 57  -IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 114

Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPTLSDYDVRYYIYELLKALDYCH 245
              I++L D     Q     ++ E  N      L    ++  ++ + Y   +L+A+   H
Sbjct: 115 SDKIIRLYDYEITDQ--YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 172

Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELLVD 302
             GI+H D+KP N +I      L+LID+G+A    P     V+   V +  +  PE + D
Sbjct: 173 QHGIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230

Query: 303 ----------LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELN 352
                             D+WSLGC+   M + K PF    +   +L  I          
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID-------- 282

Query: 353 AYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA 412
                + IE                               +  D L   L+ D ++R + 
Sbjct: 283 ---PNHEIEFPDIPE------------------------KDLQDVLKCCLKRDPKQRISI 315

Query: 413 KEAMAHPYF 421
            E +AHPY 
Sbjct: 316 PELLAHPYV 324

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  165 bits (420), Expect = 3e-46
 Identities = 69/299 (23%), Positives = 132/299 (44%), Gaps = 49/299 (16%)

Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLCG 187
            + Y+ V+K+G G Y EV        + +  IKI     +      K+  E+ +L+ L  
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL-D 94

Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYC 244
            PNI+KL D   D+++    L+ E        D  +     ++ D    I ++L  + Y 
Sbjct: 95  HPNIMKLYDFFEDKRNY--YLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYL 152

Query: 245 HSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
           H   I+HRD+KP N++++   +   ++++D+GL+  +   K+   R+ + Y+  PE+L  
Sbjct: 153 HKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL-- 210

Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 362
            + YD   D+WS+G +   ++    PF        ++++  KV           K     
Sbjct: 211 RKKYDEKCDVWSIGVILFILLAGYPPFG--GQTDQEILR--KVE----------KGKYTF 256

Query: 363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
           D              W   ++          A D + ++L++D Q R +A++A+ HP+ 
Sbjct: 257 D-----------SPEWKN-VS--------EGAKDLIKQMLQFDSQRRISAQQALEHPWI 295

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  163 bits (414), Expect = 2e-45
 Identities = 71/300 (23%), Positives = 129/300 (43%), Gaps = 50/300 (16%)

Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK------PVKKKKIKREIKILQNLC 186
            D Y+  R +G+G + EV         ++C +K++          K+ + RE+++L+ L 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL- 83

Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDY 243
             PNI+KL +   D+      L+ E        D  +     S+ D    I ++L  + Y
Sbjct: 84  DHPNIMKLYEFFEDKGYF--YLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITY 141

Query: 244 CHSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 301
            H   I+HRD+KP N++++   +   +R+ID+GL+  +   K+   ++ + Y+  PE+L 
Sbjct: 142 MHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL- 200

Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 361
               YD   D+WS G +   ++    P F G + YD L K+              K    
Sbjct: 201 -HGTYDEKCDVWSTGVILYILLSGCPP-FNGANEYDILKKV-------------EKGKYT 245

Query: 362 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            +              W K ++          A D + K+L Y    R +A++A+ H + 
Sbjct: 246 FE-----------LPQWKK-VS--------ESAKDLIRKMLTYVPSMRISARDALDHEWI 285

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  157 bits (399), Expect = 5e-45
 Identities = 68/329 (20%), Positives = 127/329 (38%), Gaps = 71/329 (21%)

Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVKKKKIKREIKILQNLCGGPN 190
             D+E +  +G+G + +V +  +  D+    IK ++    K   I  E+ +L +L     
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-NHQY 63

Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-Y---PTLSDY-----------DVRYYIY 235
           +V+      ++++    +      +T F  + Y    TL D            +      
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123

Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 295
           ++L+AL Y HSQGI+HRD+KP N+ ID E R +++ D+GLA+  H   +     +     
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182

Query: 296 G---------------PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
                            E+L     Y+  +D++SLG +F  MI+   PF  G +  + L 
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILK 239

Query: 341 KIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDK 400
           K+                 IE  P                 +               +  
Sbjct: 240 KL-------------RSVSIEFPPDF-----------DDNKM---------KVEKKIIRL 266

Query: 401 LLRYDHQERPTAKEAMAHPYFFPIRNAES 429
           L+ +D  +RP A+  +    + P+++ + 
Sbjct: 267 LIDHDPNKRPGARTLLNSG-WLPVKHQDE 294

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  162 bits (411), Expect = 5e-45
 Identities = 70/306 (22%), Positives = 128/306 (41%), Gaps = 63/306 (20%)

Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLCG 187
            + Y +V  +G+G + EV +       ++  +K+      K      I RE+++L+ L  
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-D 79

Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKAL 241
            PNI+KL +I+ D  S    ++ E     +   L+         S++D    I ++   +
Sbjct: 80  HPNIMKLFEILEDSSSF--YIVGELYTGGE---LFDEIIKRKRFSEHDAARIIKQVFSGI 134

Query: 242 DYCHSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 299
            Y H   I+HRD+KP N++++   +   +++ID+GL+  +    +   R+ + Y+  PE+
Sbjct: 135 TYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV 194

Query: 300 LVDLQDYDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 355
           L     YD   D+WS G     + +G      P FYG + YD L ++             
Sbjct: 195 L--RGTYDEKCDVWSAGVILYILLSG-----TPPFYGKNEYDILKRV------------- 234

Query: 356 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEA 415
                  D              W   I+         +A D + K+L +    R TA + 
Sbjct: 235 ETGKYAFD-----------LPQWRT-IS--------DDAKDLIRKMLTFHPSLRITATQC 274

Query: 416 MAHPYF 421
           + HP+ 
Sbjct: 275 LEHPWI 280

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  157 bits (399), Expect = 6e-45
 Identities = 58/310 (18%), Positives = 109/310 (35%), Gaps = 34/310 (10%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK----IKREIKILQNLCGGP 189
             + +   +G+G  + VF G H    +   IK+   +   +      RE ++L+ L    
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH-K 67

Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVL-----YPTLSDYDVRYYIYELLKALDY 243
           NIVKL  I  +  ++   LI E       + VL        L + +    + +++  +++
Sbjct: 68  NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 244 CHSQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 300
               GI+HR++KP N+M    +  Q   +L D+G A      +++     +  +  P++ 
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187

Query: 301 -------VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 353
                     + Y  ++DLWS+G  F        PF            + K++      A
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247

Query: 354 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQ--HLAVPEAVDFLDKLLRYDHQERPT 411
                  E  P             WS  + V               L  +L  D ++   
Sbjct: 248 ISGVQKAENGP-----------IDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG 296

Query: 412 AKEAMAHPYF 421
             +  A    
Sbjct: 297 FDQFFAETSD 306

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  160 bits (407), Expect = 7e-45
 Identities = 60/304 (19%), Positives = 119/304 (39%), Gaps = 52/304 (17%)

Query: 132 EQDDYEVVRKVGRGKYSE-VFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPN 190
            +  +     +G G     V+ G+   DN    +K + P       RE+++L+     PN
Sbjct: 22  GKISFCPKDVLGHGAEGTIVYRGMF--DNRDVAVKRILPECFSFADREVQLLRESDEHPN 79

Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCHSQ 247
           +++     +D+Q +   +  E    T  + +          +    + +    L + HS 
Sbjct: 80  VIRYFCTEKDRQFQ--YIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL 137

Query: 248 GIMHRDVKPHNVMIDHE----QRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKGPEL 299
            I+HRD+KPHN++I       + K  + D+GL +    G+    R      +  +  PE+
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197

Query: 300 LVDL--QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 357
           L +   ++  Y++D++S GC+F  +I      F    +  +           + N  L  
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG--KSLQR-----------QANILLGA 244

Query: 358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 417
             ++               P                A + ++K++  D Q+RP+AK  + 
Sbjct: 245 CSLD------------CLHPEKHED---------VIARELIEKMIAMDPQKRPSAKHVLK 283

Query: 418 HPYF 421
           HP+F
Sbjct: 284 HPFF 287

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  156 bits (397), Expect = 7e-45
 Identities = 64/306 (20%), Positives = 121/306 (39%), Gaps = 61/306 (19%)

Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGG 188
            D +   RK+G G + +V      +   + +IK +      V  ++I+ EI++L++L   
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL-DH 79

Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNN-------TDFKVLYPTLSDYDVRYYIYELLKAL 241
           PNI+K+ ++  D  +    ++ E              +     LS+  V   + +++ AL
Sbjct: 80  PNIIKIFEVFEDYHNM--YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNAL 137

Query: 242 DYCHSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 299
            Y HSQ ++H+D+KP N++         +++ID+GLAE +   +       +  +  PE+
Sbjct: 138 AYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEV 197

Query: 300 LVDLQDYDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 355
               +D  +  D+WS G     +  G        F G    +   K              
Sbjct: 198 F--KRDVTFKCDIWSAGVVMYFLLTGC-----LPFTGTSLEEVQQKATYK---------- 240

Query: 356 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEA 415
                                     +T        P+AVD L ++L  D + RP+A + 
Sbjct: 241 ---EPNYAVE-----------CRP--LT--------PQAVDLLKQMLTKDPERRPSAAQV 276

Query: 416 MAHPYF 421
           + H +F
Sbjct: 277 LHHEWF 282

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  159 bits (405), Expect = 5e-44
 Identities = 71/309 (22%), Positives = 133/309 (43%), Gaps = 60/309 (19%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK----------------PVKKKKIKR 177
           + Y  VRK+G G Y EV        + +  IK++K                    ++I  
Sbjct: 36  ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95

Query: 178 EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FK--VLYPTLSDYDVRYYI 234
           EI +L++L   PNI+KL D+  D++     L+ E     + F+  +      + D    +
Sbjct: 96  EISLLKSL-DHPNIIKLFDVFEDKKYF--YLVTEFYEGGELFEQIINRHKFDECDAANIM 152

Query: 235 YELLKALDYCHSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKEYNVRVASR 292
            ++L  + Y H   I+HRD+KP N++++  +    ++++D+GL+ F+    +   R+ + 
Sbjct: 153 KQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTA 212

Query: 293 YFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELN 352
           Y+  PE+L   + Y+   D+WS G +   ++    P F G ++ D + K+          
Sbjct: 213 YYIAPEVL--KKKYNEKCDVWSCGVIMYILLCGYPP-FGGQNDQDIIKKV---------- 259

Query: 353 AYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA 412
               K     D              W   I+         EA + +  +L YD+ +R TA
Sbjct: 260 ---EKGKYYFD-----------FNDWKN-IS--------DEAKELIKLMLTYDYNKRCTA 296

Query: 413 KEAMAHPYF 421
           +EA+   + 
Sbjct: 297 EEALNSRWI 305

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  154 bits (392), Expect = 7e-44
 Identities = 70/359 (19%), Positives = 115/359 (32%), Gaps = 60/359 (16%)

Query: 71  HARHQHQRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQW 130
           H  H H     L T             +        RV          +   Y+    + 
Sbjct: 2   HHHHHHSSGVDLGTE--------NLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPES 53

Query: 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNL 185
             Q  ++ + ++G G Y EVF+     D     +K        P  + +   E+   + +
Sbjct: 54  FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKV 113

Query: 186 CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALD 242
              P  V+L      ++     L  E    +  +       +L +  V  Y+ + L AL 
Sbjct: 114 GQHPCCVRLEQ--AWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALA 171

Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
           + HSQG++H DVKP N+ +    R  +L D+GL           V+     +  PELL  
Sbjct: 172 HLHSQGLVHLDVKPANIFLGPRGR-CKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG 230

Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 362
              Y  + D++SLG     +    E    G + + QL +                   E 
Sbjct: 231 --SYGTAADVFSLGLTILEVACNMELPHGG-EGWQQLRQ--------------GYLPPEF 273

Query: 363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
                           S             E    L  +L  D + R TA+  +A P  
Sbjct: 274 TAG------------LS------------SELRSVLVMMLEPDPKLRATAEALLALPVL 308

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  154 bits (391), Expect = 2e-43
 Identities = 68/301 (22%), Positives = 120/301 (39%), Gaps = 52/301 (17%)

Query: 133 QDDYEVVRKV-GRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNI 191
            DDY++ ++V G G   +V E  H    +KC +K+L      K ++E+       GGP+I
Sbjct: 27  TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY--DSPKARQEVDHHWQASGGPHI 84

Query: 192 VKLLDIVRDQQSKTPS--LIFEHVNNTD-----FKVLYPTLSDYDVRYYIYELLKALDYC 244
           V +LD+  +         +I E +   +      +      ++ +    + ++  A+ + 
Sbjct: 85  VCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFL 144

Query: 245 HSQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
           HS  I HRDVKP N++   +++   L+L D+G A+             + Y+  PE+L  
Sbjct: 145 HSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYVAPEVL-G 202

Query: 303 LQDYDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 358
            + YD S D+WSLG     +  G      P FY +        + + +            
Sbjct: 203 PEKYDKSCDMWSLGVIMYILLCGF-----PPFYSNTGQAISPGMKRRIR---------LG 248

Query: 359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
                              WS+ ++         +A   +  LL+ D  ER T  + M H
Sbjct: 249 QYGFP-----------NPEWSE-VS--------EDAKQLIRLLLKTDPTERLTITQFMNH 288

Query: 419 P 419
           P
Sbjct: 289 P 289

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  156 bits (396), Expect = 3e-43
 Identities = 53/321 (16%), Positives = 111/321 (34%), Gaps = 67/321 (20%)

Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIV 192
           ++     + +G G    V             +K +          EIK+L      PN++
Sbjct: 14  KNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVI 72

Query: 193 KLLDIVRDQQSKTPSLIFEH---------VNNTDFKVLYPTLSDYDVRYYIYELLKALDY 243
           +        +     +  E           +            +Y+    + ++   + +
Sbjct: 73  RYYCSETTDRFL--YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130

Query: 244 CHSQGIMHRDVKPHNVMID------------HEQRKLRLIDWGLAEFYHPGKEY-----N 286
            HS  I+HRD+KP N+++              E  ++ + D+GL +    G+       N
Sbjct: 131 LHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190

Query: 287 VRVASRYFKGPELLVDLQD------YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
               +  ++ PELL +  +         S+D++S+GC+F  ++ + +  F   D Y +  
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG--DKYSRES 248

Query: 341 KIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDK 400
            I +             + ++                    I          EA D + +
Sbjct: 249 NIIR-----------GIFSLDEMK----------CLHDRSLI---------AEATDLISQ 278

Query: 401 LLRYDHQERPTAKEAMAHPYF 421
           ++ +D  +RPTA + + HP F
Sbjct: 279 MIDHDPLKRPTAMKVLRHPLF 299

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  153 bits (389), Expect = 3e-43
 Identities = 64/303 (21%), Positives = 123/303 (40%), Gaps = 63/303 (20%)

Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL--KPVKKKKIKREIKILQNLCGGPN 190
            + Y +   +GRG++  V   V  +  +  + K +  K   +  +K+EI IL       N
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRN 62

Query: 191 IVKLLDIVRDQQSKTPSLI---------FEHVNNTDFKVLYPTLSDYDVRYYIYELLKAL 241
           I+ L +     +     +I         FE +N + F+     L++ ++  Y++++ +AL
Sbjct: 63  ILHLHESFESMEELV--MIFEFISGLDIFERINTSAFE-----LNEREIVSYVHQVCEAL 115

Query: 242 DYCHSQGIMHRDVKPHNVM-IDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 300
            + HS  I H D++P N++        +++I++G A    PG  + +   +  +  PE+ 
Sbjct: 116 QFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVH 175

Query: 301 VDLQDYDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 356
                   + D+WSLG     + +G+       F    N   +  I              
Sbjct: 176 -QHDVVSTATDMWSLGTLVYVLLSGI-----NPFLAETNQQIIENIMNA----------- 218

Query: 357 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAM 416
                 D            + + + I+         EA+DF+D+LL  + + R TA EA+
Sbjct: 219 --EYTFD-----------EEAFKE-IS--------IEAMDFVDRLLVKERKSRMTASEAL 256

Query: 417 AHP 419
            HP
Sbjct: 257 QHP 259

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  155 bits (393), Expect = 3e-43
 Identities = 69/353 (19%), Positives = 129/353 (36%), Gaps = 68/353 (19%)

Query: 90  AQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGE-QDDYEVVRKV-GRGKY 147
           A            P            +  ++     L ++     DDY+V  +V G G  
Sbjct: 16  APAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGIN 75

Query: 148 SEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207
            +V +  +    EK  +K+L+     K +RE+++       P+IV+++D+  +  +    
Sbjct: 76  GKVLQIFNKRTQEKFALKMLQ--DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133

Query: 208 --LIFEHVN------------NTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRD 253
             ++ E ++            +  F       ++ +    +  + +A+ Y HS  I HRD
Sbjct: 134 LLIVMECLDGGELFSRIQDRGDQAF-------TEREASEIMKSIGEAIQYLHSINIAHRD 186

Query: 254 VKPHNVMIDHEQR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD 311
           VKP N++   ++    L+L D+G A+             + Y+  PE+L   + YD S D
Sbjct: 187 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL-GPEKYDKSCD 245

Query: 312 LWSLGC----MFAGMIFRKEPFFYGHDNYDQLVKI-AKVLGTDELNAYLNKYHIELDPHL 366
           +WSLG     +  G      P FY +        +  ++               E     
Sbjct: 246 MWSLGVIMYILLCGY-----PPFYSNHGLAISPGMKTRIR----------MGQYEFP--- 287

Query: 367 AALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHP 419
                      WS+ ++         E    +  LL+ +  +R T  E M HP
Sbjct: 288 --------NPEWSE-VS--------EEVKMLIRNLLKTEPTQRMTITEFMNHP 323

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  151 bits (384), Expect = 5e-43
 Identities = 68/301 (22%), Positives = 117/301 (38%), Gaps = 55/301 (18%)

Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL---KPVKKKKIKREIKILQNLCGGP 189
              Y +   +GRG + EV   V      +   K +         + K+EI+I+++L   P
Sbjct: 8   NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL-DHP 66

Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCHS 246
           NI++L +   D       L+ E        +  V      + D    + ++L A+ YCH 
Sbjct: 67  NIIRLYETFEDNTDI--YLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHK 124

Query: 247 QGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
             + HRD+KP N +         L+LID+GLA  + PGK    +V + Y+  P++L    
Sbjct: 125 LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL--EG 182

Query: 305 DYDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 360
            Y    D WS G     +  G      P F    + + ++KI +                
Sbjct: 183 LYGPECDEWSAGVMMYVLLCGY-----PPFSAPTDSEVMLKIREG-------------TF 224

Query: 361 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 420
                          K W   ++        P+A   + +LL    ++R T+ +A+ H +
Sbjct: 225 TFP-----------EKDWLN-VS--------PQAESLIRRLLTKSPKQRITSLQALEHEW 264

Query: 421 F 421
           F
Sbjct: 265 F 265

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  157 bits (399), Expect = 7e-43
 Identities = 71/358 (19%), Positives = 130/358 (36%), Gaps = 69/358 (19%)

Query: 84  TPPDTLAQKIGKSVRRSGAPSKAR----VYSDINVVRPREYWDYESLTVQWGE-QDDYEV 138
            P D   ++ G  V   G   + +       D  V    + +  + + ++     D Y++
Sbjct: 102 IPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDI 161

Query: 139 VRKVGRGKYSEVFEGVHCTDNEKC---IIKILKPVKKKKIKREIKILQNLCGGPNIVKLL 195
             ++G G +  V                +       K+ +++EI+ +  L   P +V L 
Sbjct: 162 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVNLH 220

Query: 196 DIVRDQQSKTPSLI---------FEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHS 246
           D   D       +I         FE V +   K     +S+ +   Y+ ++ K L + H 
Sbjct: 221 DAFEDDNEMV--MIYEFMSGGELFEKVADEHNK-----MSEDEAVEYMRQVCKGLCHMHE 273

Query: 247 QGIMHRDVKPHNVMI-DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
              +H D+KP N+M       +L+LID+GL     P +   V   +  F  PE+  + + 
Sbjct: 274 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA-EGKP 332

Query: 306 YDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 361
             Y  D+WS+G     + +G+       F G ++ + L  +                   
Sbjct: 333 VGYYTDMWSVGVLSYILLSGL-----SPFGGENDDETLRNVKSC-------------DWN 374

Query: 362 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHP 419
           +D              +S  I+         +  DF+ KLL  D   R T  +A+ HP
Sbjct: 375 MD-----------DSAFSG-IS--------EDGKDFIRKLLLADPNTRMTIHQALEHP 412

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  153 bits (388), Expect = 2e-42
 Identities = 70/304 (23%), Positives = 127/304 (41%), Gaps = 64/304 (21%)

Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKC---IIKILKPVKKKKIKREIKILQNLCGGP 189
            D Y+++ ++G G +  V   V            I    P+ K  +K EI I+  L   P
Sbjct: 50  YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH-P 108

Query: 190 NIVKLLDIVRDQQSKTPSLI---------FEHVNNTDFKVLYPTLSDYDVRYYIYELLKA 240
            ++ L D   D+      LI         F+ +   D+K     +S+ +V  Y+ +  + 
Sbjct: 109 KLINLHDAFEDKYEMV--LILEFLSGGELFDRIAAEDYK-----MSEAEVINYMRQACEG 161

Query: 241 LDYCHSQGIMHRDVKPHNVMI-DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 299
           L + H   I+H D+KP N+M    +   +++ID+GLA   +P +   V  A+  F  PE+
Sbjct: 162 LKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEI 221

Query: 300 LVDLQDYDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 355
           + D +   +  D+W++G     + +G+       F G D+ + L  + +           
Sbjct: 222 V-DREPVGFYTDMWAIGVLGYVLLSGL-----SPFAGEDDLETLQNVKRC---------- 265

Query: 356 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEA 415
                E D              +S  ++        PEA DF+  LL+ + ++R T  +A
Sbjct: 266 ---DWEFDE-----------DAFSS-VS--------PEAKDFIKNLLQKEPRKRLTVHDA 302

Query: 416 MAHP 419
           + HP
Sbjct: 303 LEHP 306

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  149 bits (378), Expect = 3e-42
 Identities = 55/319 (17%), Positives = 108/319 (33%), Gaps = 67/319 (21%)

Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIV 192
             D++ +  +G G + +VF+  H  D +  +IK +K    +K +RE+K L  L    NIV
Sbjct: 10  GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK-YNNEKAEREVKALAKLDH-VNIV 67

Query: 193 KLLDIVRDQQSKTPSLIFEHVNNTDFKVLY--------------------PTLSDYDVRY 232
                         +       +   K L+                      L       
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKT-KCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126

Query: 233 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASR 292
              ++ K +DY HS+ +++RD+KP N+ +   + ++++ D+GL        +      + 
Sbjct: 127 LFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK-QVKIGDFGLVTSLKNDGKRTRSKGTL 185

Query: 293 YFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELN 352
            +  PE +   QDY   +DL++LG + A ++   +  F     +  L             
Sbjct: 186 RYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRD----------- 233

Query: 353 AYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA 412
                    +               +              +    L KLL    ++RP  
Sbjct: 234 -------GIISDI------------FD------------KKEKTLLQKLLSKKPEDRPNT 262

Query: 413 KEAMAHPYFFPIRNAESSR 431
            E +     +     ++ R
Sbjct: 263 SEILRTLTVWKKSPEKNER 281

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  150 bits (381), Expect = 4e-42
 Identities = 70/306 (22%), Positives = 133/306 (43%), Gaps = 61/306 (19%)

Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK---------PVKKKKIKREIKILQ 183
           +D Y++  ++G G+++ V +    +   +   K +K          V +++I+RE+ IL+
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKA 240
            +    N++ L D+  ++      LI E V+     DF     +LS+ +   +I ++L  
Sbjct: 71  QV-LHHNVITLHDVYENRTDVV--LILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127

Query: 241 LDYCHSQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 297
           ++Y H++ I H D+KP N+M+   +     ++LID+GLA     G E+     +  F  P
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187

Query: 298 ELLVDLQDYDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 353
           E++ + +      D+WS+G     + +G        F G    + L  I  V        
Sbjct: 188 EIV-NYEPLGLEADMWSIGVITYILLSGA-----SPFLGDTKQETLANITSV-------- 233

Query: 354 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK 413
                  + D            + +S   +          A DF+ KLL  + ++R T +
Sbjct: 234 -----SYDFDE-----------EFFSH-TS--------ELAKDFIRKLLVKETRKRLTIQ 268

Query: 414 EAMAHP 419
           EA+ HP
Sbjct: 269 EALRHP 274

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  148 bits (377), Expect = 7e-42
 Identities = 70/301 (23%), Positives = 126/301 (41%), Gaps = 57/301 (18%)

Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLCG 187
            + Y +V  +G+G + EV +       ++  +K+      K      I RE+++L+ L  
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-D 79

Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYC 244
            PNI+KL +I+ D  S    ++ E        D  +     S++D    I ++   + Y 
Sbjct: 80  HPNIMKLFEILEDSSSF--YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYM 137

Query: 245 HSQGIMHRDVKPHNVMIDH--EQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
           H   I+HRD+KP N++++   +   +++ID+GL+  +    +   R+ + Y+  PE+L  
Sbjct: 138 HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-- 195

Query: 303 LQDYDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 358
              YD   D+WS G     + +G      P FYG + YD L ++                
Sbjct: 196 RGTYDEKCDVWSAGVILYILLSGT-----PPFYGKNEYDILKRVETG------------- 237

Query: 359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
               D              W   I+         +A D + K+L +    R TA + + H
Sbjct: 238 KYAFDL-----------PQWRT-IS--------DDAKDLIRKMLTFHPSLRITATQCLEH 277

Query: 419 P 419
           P
Sbjct: 278 P 278

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  149 bits (379), Expect = 9e-42
 Identities = 58/304 (19%), Positives = 125/304 (41%), Gaps = 58/304 (19%)

Query: 133 QDDYEVVRKV-GRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLC 186
            + Y +  K  GRGK++ V + +  +  ++   K           + +I  EI +L+   
Sbjct: 27  NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAK 86

Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-F----KVLYPTLSDYDVRYYIYELLKAL 241
             P ++ L ++  +       LI E+    + F      L   +S+ DV   I ++L+ +
Sbjct: 87  SCPRVINLHEVYENTSEII--LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGV 144

Query: 242 DYCHSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 299
            Y H   I+H D+KP N+++   +    ++++D+G++       E    + +  +  PE+
Sbjct: 145 YYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEI 204

Query: 300 LVDLQDYDYSLDLWSLG----CMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 355
           L +      + D+W++G     +           F G DN +  + I++V          
Sbjct: 205 L-NYDPITTATDMWNIGIIAYMLLTHT-----SPFVGEDNQETYLNISQV---------- 248

Query: 356 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEA 415
              +++              + +S  ++          A DF+  LL  + ++RPTA+  
Sbjct: 249 ---NVDYS-----------EETFSS-VS--------QLATDFIQSLLVKNPEKRPTAEIC 285

Query: 416 MAHP 419
           ++H 
Sbjct: 286 LSHS 289

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  152 bits (385), Expect = 1e-41
 Identities = 77/345 (22%), Positives = 149/345 (43%), Gaps = 61/345 (17%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--KKIKREIKILQNLC-----GG 188
           YEV++ +G+G + +V +      ++   +K+++  K+  ++   EI+IL++L        
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158

Query: 189 PNIVKLLD---------IVRDQQSKTPSL---IFEHVNNTDFKVLYPTLSDYDVRYYIYE 236
            N++ +L+         +          L   ++E +    F+     L    VR + + 
Sbjct: 159 MNVIHMLENFTFRNHICMT------FELLSMNLYELIKKNKFQGFSLPL----VRKFAHS 208

Query: 237 LLKALDYCHSQGIMHRDVKPHNVMIDHEQR-KLRLIDWGLAEFYHPGKEYNVRVASRYFK 295
           +L+ LD  H   I+H D+KP N+++  + R  +++ID+G + + H  + Y   + SR+++
Sbjct: 209 ILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH-QRVYTY-IQSRFYR 266

Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-------- 347
            PE+++    Y   +D+WSLGC+ A +     P   G D  DQL  + ++LG        
Sbjct: 267 APEVILGA-RYGMPIDMWSLGCILAEL-LTGYPLLPGEDEGDQLACMIELLGMPSQKLLD 324

Query: 348 ---------TDELNAYLNKYHIELDPHLAALVGRHSRK-----PWSKFITVENQHLAVPE 393
                    + +            D  +    GR  R      P S+      +    P 
Sbjct: 325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPL 384

Query: 394 AVDFLDKLLRYDHQERPTAKEAMAHPYF-----FPIRNAESSRSR 433
            +DFL + L +D   R T  +A+ HP+       P    ++S  R
Sbjct: 385 FLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPKPPTGEKTSVKR 429

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  149 bits (379), Expect = 2e-41
 Identities = 77/332 (23%), Positives = 140/332 (42%), Gaps = 60/332 (18%)

Query: 102 APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEK 161
            P  A +     + R  E+    S        D+Y+V  ++G+G +S V   VH T   +
Sbjct: 1   GPHMASMTGGQQMGRGSEFMMNASTKFS----DNYDVKEELGKGAFSVVRRCVHKTTGLE 56

Query: 162 CIIKI-----LKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT 216
              KI     L     +K++RE +I + L   PNIV+L D ++++      L+F+ V   
Sbjct: 57  FAAKIINTKKLSARDFQKLEREARICRKLQH-PNIVRLHDSIQEESFH--YLVFDLVTGG 113

Query: 217 ---DFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID--HEQRKLRLI 271
              +  V     S+ D  + I ++L+++ YCHS GI+HR++KP N+++    +   ++L 
Sbjct: 114 ELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLA 173

Query: 272 DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMF----AGMIFRKE 327
           D+GLA   +  + ++    +  +  PE+L     Y   +D+W+ G +      G      
Sbjct: 174 DFGLAIEVNDSEAWHGFAGTPGYLSPEVL-KKDPYSKPVDIWACGVILYILLVGY----- 227

Query: 328 PFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQ 387
           P F+  D +    +I                  +                W   +T    
Sbjct: 228 PPFWDEDQHRLYAQIKAG-------------AYDYP-----------SPEWDT-VT---- 258

Query: 388 HLAVPEAVDFLDKLLRYDHQERPTAKEAMAHP 419
               PEA   +D +L  + ++R TA +A+  P
Sbjct: 259 ----PEAKSLIDSMLTVNPKKRITADQALKVP 286

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  148 bits (375), Expect = 2e-41
 Identities = 68/313 (21%), Positives = 123/313 (39%), Gaps = 65/313 (20%)

Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK------------PVKKKKIKREIK 180
            ++YE    +GRG  S V   +H    ++  +KI+                ++   +E+ 
Sbjct: 16  YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75

Query: 181 ILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYEL 237
           IL+ + G PNI++L D           L+F+ +      D+     TLS+ + R  +  L
Sbjct: 76  ILRKVSGHPNIIQLKDTYETNTFF--FLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 133

Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 297
           L+ +   H   I+HRD+KP N+++D +   ++L D+G +    PG++      +  +  P
Sbjct: 134 LEVICALHKLNIVHRDLKPENILLD-DDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAP 192

Query: 298 ELL-----VDLQDYDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
           E++      +   Y   +D+WS G     + AG      P F+       L  I      
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS-----PPFWHRKQMLMLRMIMSG--- 244

Query: 349 DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQE 408
                     + +                W    +            D + + L    Q+
Sbjct: 245 ----------NYQFGS-----------PEWDD-YS--------DTVKDLVSRFLVVQPQK 274

Query: 409 RPTAKEAMAHPYF 421
           R TA+EA+AHP+F
Sbjct: 275 RYTAEEALAHPFF 287

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  149 bits (379), Expect = 3e-41
 Identities = 58/307 (18%), Positives = 107/307 (34%), Gaps = 34/307 (11%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGP 189
             + +   +G+G  + VF G H    +   IK+   +          RE ++L+ L    
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH-K 67

Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVL-----YPTLSDYDVRYYIYELLKALDY 243
           NIVKL  I  +  ++   LI E       + VL        L + +    + +++  +++
Sbjct: 68  NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 244 CHSQGIMHRDVKPHNVMIDH---EQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 300
               GI+HR++KP N+M       Q   +L D+G A      +++     +  +  P++ 
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187

Query: 301 -------VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 353
                     + Y  ++DLWS+G  F        PF            + K++      A
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247

Query: 354 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQ--HLAVPEAVDFLDKLLRYDHQERPT 411
                  E  P             WS  + V               L  +L  D ++   
Sbjct: 248 ISGVQKAENGP-----------IDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG 296

Query: 412 AKEAMAH 418
             +  A 
Sbjct: 297 FDQFFAE 303

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  147 bits (373), Expect = 8e-41
 Identities = 73/338 (21%), Positives = 144/338 (42%), Gaps = 65/338 (19%)

Query: 136 YEVVRKVGRGKYSEVFEGV-HCTDNEKCIIKILKPVKK--KKIKREIKILQNLC-----G 187
           YE+V  +G G + +V E + H        +KI+K V +  +  + EI++L++L       
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75

Query: 188 GPNIVKLLD---------IVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELL 238
               V++L+         IV +      S  ++ +    F           +R   Y++ 
Sbjct: 76  TFRCVQMLEWFEHHGHICIVFELLG--LST-YDFIKENGFL----PFRLDHIRKMAYQIC 128

Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQR------------------KLRLIDWGLAEFYH 280
           K++++ HS  + H D+KP N++                         ++++D+G A +  
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDD 188

Query: 281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNY 336
                 + V++R+++ PE+++ L  +    D+WS+GC     + G        F  HD+ 
Sbjct: 189 E-HHSTL-VSTRHYRAPEVILALG-WSQPCDVWSIGCILIEYYLG-----FTVFPTHDSK 240

Query: 337 DQLVKIAKVLGT--DEL--NAYLNKYHIE--LDPHLAALVGRHSR---KPWSKFITVENQ 387
           + L  + ++LG     +       KY     LD    +  GR+     KP  +F+  ++ 
Sbjct: 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDV 300

Query: 388 HLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR 425
                   D + K+L YD  +R T +EA+ HP+F  ++
Sbjct: 301 EH--ERLFDLIQKMLEYDPAKRITLREALKHPFFDLLK 336

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  147 bits (373), Expect = 8e-41
 Identities = 82/358 (22%), Positives = 139/358 (38%), Gaps = 65/358 (18%)

Query: 74  HQHQRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQ 133
           H H     +    + L  +   SV  S AP  A +  D  +    +  + ++L+      
Sbjct: 3   HHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWI----DGSNRDALS------ 52

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKKKKIKREIKILQNLCGGPNIV 192
           D +EV  ++GRG  S V+        +   +K + K V KK ++ EI +L  L   PNI+
Sbjct: 53  DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSH-PNII 111

Query: 193 KLLDIVRDQQSKTPSLIFEHVNNT-----DFKVLYPTLSDYDVRYYIYELLKALDYCHSQ 247
           KL +I         SL+ E V  T     D  V     S+ D    + ++L+A+ Y H  
Sbjct: 112 KLKEIFETPTEI--SLVLELV--TGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN 167

Query: 248 GIMHRDVKPHNVMIDH--EQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
           GI+HRD+KP N++         L++ D+GL++             +  +  PE+L     
Sbjct: 168 GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRG-CA 226

Query: 306 YDYSLDLWSLGCMF----AGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 361
           Y   +D+WS+G +      G        FY       +    ++L               
Sbjct: 227 YGPEVDMWSVGIITYILLCGF-----EPFYDERGDQFM--FRRIL----------NCEYY 269

Query: 362 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHP 419
                           W + ++          A D + KL+  D ++R T  +A+ HP
Sbjct: 270 FIS-----------PWWDE-VS--------LNAKDLVRKLIVLDPKKRLTTFQALQHP 307

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  147 bits (372), Expect = 1e-40
 Identities = 66/345 (19%), Positives = 122/345 (35%), Gaps = 91/345 (26%)

Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--------PVKKKKIKREIKILQN 184
           Q  Y +   +G+G Y  V   +         IKI+         P   ++IK E+++++ 
Sbjct: 25  QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84

Query: 185 LCGGPNIVKLLDIVRDQQS----------------------------------------- 203
           L   PNI +L ++  D+Q                                          
Sbjct: 85  LHH-PNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143

Query: 204 KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH 263
           +          +   + L     +  +   + ++  AL Y H+QGI HRD+KP N +   
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFST 203

Query: 264 -EQRKLRLIDWGLAEFYHPGKE-----YNVRVASRYFKGPELL-VDLQDYDYSLDLWSLG 316
            +  +++L+D+GL++ ++            +  + YF  PE+L    + Y    D WS G
Sbjct: 204 NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263

Query: 317 CMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRK 376
            +   ++    P F G ++ D + ++              K   E               
Sbjct: 264 VLLHLLLMGAVP-FPGVNDADTISQVLN-----------KKLCFE-------------NP 298

Query: 377 PWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            ++  ++        P A D L  LL  +  ER  A  A+ HP+ 
Sbjct: 299 NYNV-LS--------PLARDLLSNLLNRNVDERFDAMRALQHPWI 334

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  145 bits (368), Expect = 1e-40
 Identities = 69/308 (22%), Positives = 133/308 (43%), Gaps = 65/308 (21%)

Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK---------PVKKKKIKREIKILQ 183
           +D YE+  ++G G+++ V +       ++   K +K          V +++I+RE+ IL+
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT-----DFKVLYPTLSDYDVRYYIYELL 238
            +   PNI+ L DI  ++      LI E V  +     DF     +L++ +   ++ ++L
Sbjct: 64  EI-RHPNIITLHDIFENKTDVV--LILELV--SGGELFDFLAEKESLTEDEATQFLKQIL 118

Query: 239 KALDYCHSQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 295
             + Y HS+ I H D+KP N+M+   +    +++LID+G+A     G E+     +  F 
Sbjct: 119 DGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFV 178

Query: 296 GPELLVDLQDYDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL 351
            PE++ + +      D+WS+G     + +G        F G    + L  I+ V      
Sbjct: 179 APEIV-NYEPLGLEADMWSIGVITYILLSGA-----SPFLGETKQETLTNISAV------ 226

Query: 352 NAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT 411
                  + + D            + +S   +          A DF+ +LL  D + R T
Sbjct: 227 -------NYDFD-----------EEYFSN-TS--------ELAKDFIRRLLVKDPKRRMT 259

Query: 412 AKEAMAHP 419
             +++ H 
Sbjct: 260 IAQSLEHS 267

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  147 bits (372), Expect = 1e-40
 Identities = 72/306 (23%), Positives = 135/306 (44%), Gaps = 61/306 (19%)

Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK---------PVKKKKIKREIKILQ 183
           +D Y++  ++G G+++ V +    +   +   K +K          V +++I+RE+ IL+
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKA 240
            +   PNI+ L D+  ++      LI E V+     DF     +LS+ +   +I ++L  
Sbjct: 71  QV-LHPNIITLHDVYENRTDVV--LILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127

Query: 241 LDYCHSQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 297
           ++Y H++ I H D+KP N+M+   +     ++LID+GLA     G E+     +  F  P
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187

Query: 298 ELLVDLQDYDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 353
           E++ + +      D+WS+G     + +G        F G    + L  I  V        
Sbjct: 188 EIV-NYEPLGLEADMWSIGVITYILLSGA-----SPFLGDTKQETLANITAV-------- 233

Query: 354 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK 413
                  + D            + +S+  +          A DF+ KLL  + ++R T +
Sbjct: 234 -----SYDFDE-----------EFFSQ-TS--------ELAKDFIRKLLVKETRKRLTIQ 268

Query: 414 EAMAHP 419
           EA+ HP
Sbjct: 269 EALRHP 274

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  145 bits (369), Expect = 2e-40
 Identities = 71/303 (23%), Positives = 124/303 (40%), Gaps = 53/303 (17%)

Query: 133 QDDYEV---VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGP 189
              Y++    + +G G +S   + VH   N+   +KI+    +   ++EI  L+   G P
Sbjct: 7   YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHP 66

Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTD-F-----KVLYPTLSDYDVRYYIYELLKALDY 243
           NIVKL ++  DQ      L+ E +N  + F     K  +   S+ +  Y + +L+ A+ +
Sbjct: 67  NIVKLHEVFHDQLHT--FLVMELLNGGELFERIKKKKHF---SETEASYIMRKLVSAVSH 121

Query: 244 CHSQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAEFYHP-GKEYNVRVASRYFKGPELL 300
            H  G++HRD+KP N++   E    ++++ID+G A    P  +       + ++  PELL
Sbjct: 122 MHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELL 181

Query: 301 VDLQDYDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 356
            +   YD S DLWSLG     M +G        F  HD         +++        + 
Sbjct: 182 -NQNGYDESCDLWSLGVILYTMLSGQ-----VPFQSHDRSLTCTSAVEIM------KKIK 229

Query: 357 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAM 416
           K     +            + W   ++         EA D +  LL  D  +R       
Sbjct: 230 KGDFSFEG-----------EAWKN-VS--------QEAKDLIQGLLTVDPNKRLKMSGLR 269

Query: 417 AHP 419
            + 
Sbjct: 270 YNE 272

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  145 bits (367), Expect = 2e-40
 Identities = 63/342 (18%), Positives = 120/342 (35%), Gaps = 89/342 (26%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGGP 189
            D+E ++ +GRG +  VFE  +  D+    IK ++     + ++K+ RE+K L  L   P
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEH-P 63

Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY--------PTLSDY------------- 228
            IV+  +   ++ +       +   ++    LY          L D+             
Sbjct: 64  GIVRYFNAWLEKNTTE-----KLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERS 118

Query: 229 DVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-------EFYHP 281
              +   ++ +A+++ HS+G+MHRD+KP N+    +   +++ D+GL        E    
Sbjct: 119 VCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD-VVKVGDFGLVTAMDQDEEEQTV 177

Query: 282 GKEYNVRVASRYFKG------PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN 335
                         G      PE +     Y + +D++SLG +   +++   PF    + 
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFSTQMER 233

Query: 336 YDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAV 395
              L  +                             +       K+          P   
Sbjct: 234 VRTLTDVRN--------------------------LKFPPLFTQKY----------PCEY 257

Query: 396 DFLDKLLRYDHQERPTAKEAMAHPYF----FPIRNAESSRSR 433
             +  +L     ERP A   + +  F    FP +     RSR
Sbjct: 258 VMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSR 299

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  146 bits (370), Expect = 3e-40
 Identities = 80/347 (23%), Positives = 152/347 (43%), Gaps = 61/347 (17%)

Query: 136 YEVVRKVGRGKYSEVFEGV-HCTDNEKCIIKILKPVKK--KKIKREIKILQNLC-----G 187
           YE+V  +G G + +V E + H     +  +KI++ V K  +  + EI +L+ +       
Sbjct: 21  YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKEN 80

Query: 188 GPNIVKLLD---------IVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELL 238
               V + D         I  +      +  FE +   +F+          VR+  Y+L 
Sbjct: 81  KFLCVLMSDWFNFHGHMCIAFELLG--KNT-FEFLKENNFQ----PYPLPHVRHMAYQLC 133

Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRK------------------LRLIDWGLAEFYH 280
            AL + H   + H D+KP N++  + + +                  +R+ D+G A F H
Sbjct: 134 HALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDH 193

Query: 281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
                 + VA+R+++ PE++++L  +    D+WS+GC+     +R    F  H+N + LV
Sbjct: 194 E-HHTTI-VATRHYRPPEVILELG-WAQPCDVWSIGCILFEY-YRGFTLFQTHENREHLV 249

Query: 341 KIAKVLGT--DEL--NAYLNKYHIE--LDPHLAALVGRHSR---KPWSKFITVENQHLAV 391
            + K+LG     +       KY  +  L     +  GR+ +   KP   ++  ++     
Sbjct: 250 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEH-- 307

Query: 392 PEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI----RNAESSRSRS 434
            +  D + ++L +D  +R T  EA+ HP+F  +    R+  +SR+ S
Sbjct: 308 VQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRNPS 354

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  145 bits (368), Expect = 3e-40
 Identities = 65/308 (21%), Positives = 132/308 (42%), Gaps = 65/308 (21%)

Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK---------PVKKKKIKREIKILQ 183
            D Y+   ++G G+++ V +    +   +   K +K          V ++ I+RE+ IL+
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69

Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT-----DFKVLYPTLSDYDVRYYIYELL 238
            +   PN++ L ++  ++      LI E V        DF     +L++ +   ++ ++L
Sbjct: 70  EI-QHPNVITLHEVYENKTDVI--LILELV--AGGELFDFLAEKESLTEEEATEFLKQIL 124

Query: 239 KALDYCHSQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 295
             + Y HS  I H D+KP N+M+   +  + ++++ID+GLA     G E+     +  F 
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 184

Query: 296 GPELLVDLQDYDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL 351
            PE++ + +      D+WS+G     + +G        F G    + L  ++ V      
Sbjct: 185 APEIV-NYEPLGLEADMWSIGVITYILLSGA-----SPFLGDTKQETLANVSAV------ 232

Query: 352 NAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT 411
                  + E +            + +S   +          A DF+ +LL  D ++R T
Sbjct: 233 -------NYEFE-----------DEYFSN-TS--------ALAKDFIRRLLVKDPKKRMT 265

Query: 412 AKEAMAHP 419
            ++++ HP
Sbjct: 266 IQDSLQHP 273

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  143 bits (364), Expect = 4e-40
 Identities = 72/301 (23%), Positives = 132/301 (43%), Gaps = 56/301 (18%)

Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLCG 187
            D+Y+V  ++G+G +S V   VH T   +   KI     L     +K++RE +I + L  
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64

Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYC 244
            PNIV+L D ++++      L+F+ V      +  V     S+ D  + I ++L+++ YC
Sbjct: 65  -PNIVRLHDSIQEESFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 121

Query: 245 HSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
           HS GI+HR++KP N+++    +   ++L D+GLA   +  + ++    +  +  PE+L  
Sbjct: 122 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL-K 180

Query: 303 LQDYDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 358
              Y   +D+W+ G     +  G      P F+  D +    +I                
Sbjct: 181 KDPYSKPVDIWACGVILYILLVGY-----PPFWDEDQHRLYAQIKAG------------- 222

Query: 359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
             +                W   +T        PEA   +D +L  + ++R TA +A+  
Sbjct: 223 AYDYPS-----------PEWDT-VT--------PEAKSLIDSMLTVNPKKRITADQALKV 262

Query: 419 P 419
           P
Sbjct: 263 P 263

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  145 bits (367), Expect = 9e-40
 Identities = 76/333 (22%), Positives = 132/333 (39%), Gaps = 63/333 (18%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--KKIKREIKILQNLC------- 186
           Y +VRK+G G +S V+      +N    +KI++  K   +  + EIK+LQ +        
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80

Query: 187 ---GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD------FKVLYPTLSDY--------- 228
              G  +I+KLLD             F H           F+VL   L            
Sbjct: 81  DSMGANHILKLLDH------------FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGI 128

Query: 229 ---DVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQR-----KLRLIDWGLAEFY 279
               V+    +LL  LDY H + GI+H D+KP NV+++         ++++ D G A +Y
Sbjct: 129 PLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 188

Query: 280 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD----- 334
              + Y   + +R ++ PE+L+    +    D+WS  C+   +I      F   +     
Sbjct: 189 D--EHYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGD-FLFEPDEGHSYT 244

Query: 335 -NYDQLVKIAKVLG--TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAV 391
            + D + +I ++LG     L           +           +    + +  E    + 
Sbjct: 245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSK 304

Query: 392 PEA---VDFLDKLLRYDHQERPTAKEAMAHPYF 421
            EA    DFL  +L+ D ++R  A   + HP+ 
Sbjct: 305 DEAKEISDFLSPMLQLDPRKRADAGGLVNHPWL 337

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  144 bits (365), Expect = 1e-39
 Identities = 72/309 (23%), Positives = 127/309 (41%), Gaps = 65/309 (21%)

Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--------PVKKKKIKREIKILQN 184
           +D YE+   +G+G +S V   ++    ++  +KI+          +  + +KRE  I   
Sbjct: 23  EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82

Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN-------TDFKVLYPTLSDYDVRYYIYEL 237
           L   P+IV+LL+           ++FE ++                  S+    +Y+ ++
Sbjct: 83  L-KHPHIVELLETYSSDGML--YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI 139

Query: 238 LKALDYCHSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYF 294
           L+AL YCH   I+HRDVKPH V++        ++L  +G+A +    G     RV + +F
Sbjct: 140 LEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHF 199

Query: 295 KGPELLVDLQDYDYSLDLWSLG----CMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE 350
             PE++   + Y   +D+W  G     + +G        FYG                + 
Sbjct: 200 MAPEVV-KREPYGKPVDVWGCGVILFILLSGC-----LPFYGTK--------------ER 239

Query: 351 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP 410
           L   + K   +++P           + WS  I+          A D + ++L  D  ER 
Sbjct: 240 LFEGIIKGKYKMNP-----------RQWSH-IS--------ESAKDLVRRMLMLDPAERI 279

Query: 411 TAKEAMAHP 419
           T  EA+ HP
Sbjct: 280 TVYEALNHP 288

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  144 bits (364), Expect = 2e-39
 Identities = 73/384 (19%), Positives = 140/384 (36%), Gaps = 64/384 (16%)

Query: 61  RGLASSASLSHARHQHQRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREY 120
           R       L +   + +R    +   D        +  +    ++ +   ++        
Sbjct: 21  RARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPE 80

Query: 121 WDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK------- 173
            +             Y+    +GRG  S V   VH     +  +KI++   ++       
Sbjct: 81  DELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLE 140

Query: 174 ----KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLS 226
                 +RE  IL+ + G P+I+ L+D           L+F+ +      D+      LS
Sbjct: 141 EVREATRRETHILRQVAGHPHIITLIDSYESSSFM--FLVFDLMRKGELFDYLTEKVALS 198

Query: 227 DYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN 286
           + + R  +  LL+A+ + H+  I+HRD+KP N+++D +  ++RL D+G +    PG++  
Sbjct: 199 EKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLD-DNMQIRLSDFGFSCHLEPGEKLR 257

Query: 287 VRVASRYFKGPELL-----VDLQDYDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYD 337
               +  +  PE+L          Y   +DLW+ G     + AG      P F+      
Sbjct: 258 ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGS-----PPFWHRRQIL 312

Query: 338 QLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDF 397
            L  I +                +                W    +            D 
Sbjct: 313 MLRMIMEG-------------QYQFS-----------SPEWDD-RS--------STVKDL 339

Query: 398 LDKLLRYDHQERPTAKEAMAHPYF 421
           + +LL+ D + R TA++A+ HP+F
Sbjct: 340 ISRLLQVDPEARLTAEQALQHPFF 363

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  144 bits (363), Expect = 3e-39
 Identities = 49/344 (14%), Positives = 89/344 (25%), Gaps = 73/344 (21%)

Query: 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL------KPVKKKKIKREIKILQN 184
             +   ++V  +  G  S VF        E   +K+          + +++         
Sbjct: 59  QGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAAR 118

Query: 185 L-----------------------CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT----- 216
           L                          P   +L     D       L+    +       
Sbjct: 119 LLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLF 178

Query: 217 ----DFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLID 272
                  V         +     +L++      S+G++H    P N+ I  + R L L D
Sbjct: 179 STLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGR-LMLGD 237

Query: 273 WGLAEFYHPGKEYNVRVASRYFKGPELL-VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFY 331
                 +  G           +   E L      + ++L+ W LG     +     PF  
Sbjct: 238 VSAL--WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295

Query: 332 GHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAV 391
                    K   +                          R        F +       +
Sbjct: 296 VTPGIKGSWKRPSL--------------------------RVPGTDSLAFGSCTP----L 325

Query: 392 PEAV-DFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAESSRSRS 434
           P+ V   + + L +D + R    EAM  P F  ++N  SS   +
Sbjct: 326 PDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEISSSLST 369

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  142 bits (361), Expect = 4e-39
 Identities = 69/297 (23%), Positives = 116/297 (39%), Gaps = 50/297 (16%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVK 193
           D YEV   +G G YS     +H   N +  +KI+    K+    EI+IL      PNI+ 
Sbjct: 22  DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID-KSKRDPTEEIEILLRYGQHPNIIT 80

Query: 194 LLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIM 250
           L D+  D +     ++ E +      D  +     S+ +    ++ + K ++Y H+QG++
Sbjct: 81  LKDVYDDGKYV--YVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVV 138

Query: 251 HRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQDY 306
           HRD+KP N++          +R+ D+G A+              +  F  PE+L + Q Y
Sbjct: 139 HRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVL-ERQGY 197

Query: 307 DYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 362
           D + D+WSLG     M  G        F    +      +A++                L
Sbjct: 198 DAACDIWSLGVLLYTMLTGY-----TPFANGPDDTPEEILARIG----------SGKFSL 242

Query: 363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHP 419
                          W+  ++          A D + K+L  D  +R TA   + HP
Sbjct: 243 S-----------GGYWNS-VS--------DTAKDLVSKMLHVDPHQRLTAALVLRHP 279

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  143 bits (363), Expect = 4e-39
 Identities = 73/332 (21%), Positives = 141/332 (42%), Gaps = 57/332 (17%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--KKIKREIKILQNLC-----GG 188
           YE+   +G+G + +V +     + E   IKI+K  K    + + E+++L+ +        
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115

Query: 189 PNIVKLLD---------IVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLK 239
             IV L           +V +  S   +L ++ + NT+F+     +S    R +  ++  
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLS--YNL-YDLLRNTNFR----GVSLNLTRKFAQQMCT 168

Query: 240 ALDYCHSQ--GIMHRDVKPHNVMIDHEQR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKG 296
           AL +  +    I+H D+KP N+++ + +R  ++++D+G +      +     + SR+++ 
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG--QRIYQYIQSRFYRS 226

Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--TDEL--N 352
           PE+L+ +  YD ++D+WSLGC+   M    EP F G +  DQ+ KI +VLG     +   
Sbjct: 227 PEVLLGM-PYDLAIDMWSLGCILVEM-HTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQ 284

Query: 353 AYLNKYHIELDPHLAALV-------GRHSRKPWSKFITVENQHLAVPEA----------- 394
           A   +   E  P     +         +      K   +       P             
Sbjct: 285 APKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVA 344

Query: 395 -----VDFLDKLLRYDHQERPTAKEAMAHPYF 421
                 D + ++L YD + R     A+ H +F
Sbjct: 345 DYLKFKDLILRMLDYDPKTRIQPYYALQHSFF 376

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  143 bits (363), Expect = 5e-39
 Identities = 69/350 (19%), Positives = 143/350 (40%), Gaps = 67/350 (19%)

Query: 90  AQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGE-QDDYEVVRK--VGRGK 146
                    R    SK      +++  P   +D+  +T + G     Y V +   +G G+
Sbjct: 42  VWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGR 101

Query: 147 YSEVFEGVHCTDNEKC---IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203
           + +V +        K    IIK      K+++K EI ++  L    N+++L D    +  
Sbjct: 102 FGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL-DHANLIQLYDAFESKND 160

Query: 204 KTPSLI---------FEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDV 254
               L+         F+ + +  +      L++ D   ++ ++ + + + H   I+H D+
Sbjct: 161 IV--LVMEYVDGGELFDRIIDESYN-----LTELDTILFMKQICEGIRHMHQMYILHLDL 213

Query: 255 KPHNVM-IDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLW 313
           KP N++ ++ + +++++ID+GLA  Y P ++  V   +  F  PE++ +     +  D+W
Sbjct: 214 KPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVV-NYDFVSFPTDMW 272

Query: 314 SLG----CMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAAL 369
           S+G     + +G+       F G ++ + L  I                  +L+      
Sbjct: 273 SVGVIAYMLLSGL-----SPFLGDNDAETLNNILAC-------------RWDLED----- 309

Query: 370 VGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHP 419
                 + +   I+         EA +F+ KLL  +   R +A EA+ HP
Sbjct: 310 ------EEFQD-IS--------EEAKEFISKLLIKEKSWRISASEALKHP 344

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  144 bits (365), Expect = 5e-39
 Identities = 67/311 (21%), Positives = 124/311 (39%), Gaps = 63/311 (20%)

Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL-----------KPVKKKKIKREIKI 181
           +D+Y + + +G G   EV         +K  I+I+           +      ++ EI+I
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193

Query: 182 LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN---TDFKVLYPTLSDYDVRYYIYELL 238
           L+ L   P I+K+ +      ++   ++ E +      D  V    L +   + Y Y++L
Sbjct: 194 LKKL-NHPCIIKIKNFF---DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 249

Query: 239 KALDYCHSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 296
            A+ Y H  GI+HRD+KP NV++    E   +++ D+G ++             +  +  
Sbjct: 250 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 309

Query: 297 PELLVDLQD--YDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE 350
           PE+LV +    Y+ ++D WSLG       +G      PF           +I        
Sbjct: 310 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGY----PPFSEHRTQVSLKDQITSG----- 360

Query: 351 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP 410
                        P           + W++ ++         +A+D + KLL  D + R 
Sbjct: 361 --------KYNFIP-----------EVWAE-VS--------EKALDLVKKLLVVDPKARF 392

Query: 411 TAKEAMAHPYF 421
           T +EA+ HP+ 
Sbjct: 393 TTEEALRHPWL 403

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  147 bits (372), Expect = 9e-39
 Identities = 66/304 (21%), Positives = 119/304 (39%), Gaps = 32/304 (10%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVKKKKIKREIKILQNLCGGP 189
             +E+  ++G G +  V   +H    E    K   + L P  +++   EI+I++ L   P
Sbjct: 14  GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL-NHP 72

Query: 190 NIVKLLDIVRDQQSKTPS----LIFEHVNNTD-FKVL-----YPTLSDYDVRYYIYELLK 239
           N+V   ++    Q   P+    L  E+    D  K L        L +  +R  + ++  
Sbjct: 73  NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132

Query: 240 ALDYCHSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 297
           AL Y H   I+HRD+KP N+++    ++   ++ID G A+    G+     V +  +  P
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAP 192

Query: 298 ELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 357
           ELL + + Y  ++D WS G +    I    P F  +    Q     +    +        
Sbjct: 193 ELL-EQKKYTVTVDYWSFGTLAFECITGFRP-FLPNWQPVQWHGKVREKSNE-------- 242

Query: 358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 417
            HI +   L   V   S  P    ++             +L  +L +  ++R T  +   
Sbjct: 243 -HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLER----WLQCMLMWHQRQRGTDPQNPN 297

Query: 418 HPYF 421
              F
Sbjct: 298 VGCF 301

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  141 bits (358), Expect = 1e-38
 Identities = 73/336 (21%), Positives = 142/336 (42%), Gaps = 63/336 (18%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--KKIKREIKILQNL----CGGP 189
           + V+RK+G G +  V    H  + +   +K+++ +KK  +  K E  IL+ +        
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNN 96

Query: 190 NIVKLLD---------IVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKA 240
           NIVK            ++ +     PSL +E +   ++   +       ++ Y  E+LKA
Sbjct: 97  NIVKYHGKFMYYDHMCLIFEPLG--PSL-YEIITRNNYNGFHIED----IKLYCIEILKA 149

Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRK------------------------LRLIDWGLA 276
           L+Y     + H D+KP N+++D    +                        ++LID+G A
Sbjct: 150 LNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA 209

Query: 277 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNY 336
            F       ++ + +R ++ PE++++L  +D S D+WS GC+ A + +     F  H++ 
Sbjct: 210 TFKSD-YHGSI-INTRQYRAPEVILNLG-WDVSSDMWSFGCVLAEL-YTGSLLFRTHEHM 265

Query: 337 DQLVKIAKVLGT-----------DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVE 385
           + L  +  ++                + Y+NK  ++L     A    +S K   K + + 
Sbjct: 266 EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENA-SSINSIKHVKKCLPLY 324

Query: 386 NQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
              +      DFL  +L+ D   RP+  E + H + 
Sbjct: 325 KI-IKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  140 bits (354), Expect = 1e-38
 Identities = 63/308 (20%), Positives = 113/308 (36%), Gaps = 88/308 (28%)

Query: 134 DDYEVVRKV-GRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIV 192
           DDY+V  +V G G   +V +  +    EK  +K+L+     K +RE+++       P+IV
Sbjct: 17  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--DCPKARREVELHWRASQCPHIV 74

Query: 193 KLLDIVRDQQSKTPS--LIFEHV------------NNTDFKVLYPTLSDYDVRYYIYELL 238
           +++D+  +  +      ++ E +             +  F       ++ +    +  + 
Sbjct: 75  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF-------TEREASEIMKSIG 127

Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKG 296
           +A+ Y HS  I HRDVKP N++   ++    L+L D+G A                    
Sbjct: 128 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA-------------------- 167

Query: 297 PELLVDLQDYDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVKI-AKVLGTDEL 351
            E     + YD S D+WSLG     +  G      P FY +        +  ++      
Sbjct: 168 KETT--GEKYDKSCDMWSLGVIMYILLCGY-----PPFYSNHGLAISPGMKTRIR----- 215

Query: 352 NAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT 411
                    E                WS+ ++         E    +  LL+ +  +R T
Sbjct: 216 -----MGQYEFP-----------NPEWSE-VS--------EEVKMLIRNLLKTEPTQRMT 250

Query: 412 AKEAMAHP 419
             E M HP
Sbjct: 251 ITEFMNHP 258

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  140 bits (355), Expect = 2e-38
 Identities = 62/317 (19%), Positives = 130/317 (41%), Gaps = 60/317 (18%)

Query: 133 QDDYEVVRKV-GRGKYSEVFEGVHCTDNEKCIIKIL---KPVKKKKIKREIKILQNLCGG 188
           +D Y++   V G G ++ V   ++   +++  +KI+       + ++ RE+++L    G 
Sbjct: 11  EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH 70

Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTD-F-----KVLYPTLSDYDVRYYIYELLKALD 242
            N+++L++   ++      L+FE +           +  +   ++ +    + ++  ALD
Sbjct: 71  RNVLELIEFFEEEDRF--YLVFEKMRGGSILSHIHKRRHF---NELEASVVVQDVASALD 125

Query: 243 YCHSQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAEFYHPGKEYNV--------RVASR 292
           + H++GI HRD+KP N++ +H  +   +++ D+ L        + +            S 
Sbjct: 126 FLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185

Query: 293 YFKGPELL----VDLQDYDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVKIAK 344
            +  PE++     +   YD   DLWSLG     + +G      P F G    D      +
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGY-----PPFVGRCGSDCGWDRGE 240

Query: 345 VLGTDELNAYLN--KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLL 402
                +   + +  +   E              K W+  I+          A D + KLL
Sbjct: 241 ACPACQNMLFESIQEGKYEFP-----------DKDWAH-IS--------CAAKDLISKLL 280

Query: 403 RYDHQERPTAKEAMAHP 419
             D ++R +A + + HP
Sbjct: 281 VRDAKQRLSAAQVLQHP 297

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  140 bits (354), Expect = 2e-38
 Identities = 68/301 (22%), Positives = 118/301 (39%), Gaps = 59/301 (19%)

Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL---KPVKKKKIKREIKILQNLCGGP 189
           +  +  +  +G G +SEVF        +   +K +      +   ++ EI +L+ +    
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKH-E 66

Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNT-----DFKVLYPTLSDYDVRYYIYELLKALDYC 244
           NIV L DI          L+ + V  +     D  +     ++ D    I ++L A+ Y 
Sbjct: 67  NIVTLEDIYESTTHY--YLVMQLV--SGGELFDRILERGVYTEKDASLVIQQVLSAVKYL 122

Query: 245 HSQGIMHRDVKPHNVMIDH--EQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
           H  GI+HRD+KP N++     E  K+ + D+GL++    G   +    +  +  PE+L  
Sbjct: 123 HENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI-MSTACGTPGYVAPEVLAQ 181

Query: 303 LQDYDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 358
            + Y  ++D WS+G     +  G      P FY         KI +              
Sbjct: 182 -KPYSKAVDCWSIGVITYILLCGY-----PPFYEETESKLFEKIKEG------------- 222

Query: 359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
           + E +              W   I+          A DF+  LL  D  ER T ++A++H
Sbjct: 223 YYEFES-----------PFWDD-IS--------ESAKDFICHLLEKDPNERYTCEKALSH 262

Query: 419 P 419
           P
Sbjct: 263 P 263

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  140 bits (354), Expect = 3e-38
 Identities = 70/311 (22%), Positives = 125/311 (40%), Gaps = 63/311 (20%)

Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------KKKIKREIKI 181
           +D+Y + + +G G   EV         +K  IKI+   K              ++ EI+I
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 182 LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELL 238
           L+ L   P I+K+ +      ++   ++ E +      D  V    L +   + Y Y++L
Sbjct: 69  LKKL-NHPCIIKIKNFF---DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124

Query: 239 KALDYCHSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 296
            A+ Y H  GI+HRD+KP NV++    E   +++ D+G ++             +  +  
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 184

Query: 297 PELLVDLQD--YDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE 350
           PE+LV +    Y+ ++D WSLG       +G      PF           +I    G   
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGY----PPFSEHRTQVSLKDQITS--G--- 235

Query: 351 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP 410
                        P           + W++ ++         +A+D + KLL  D + R 
Sbjct: 236 --------KYNFIP-----------EVWAE-VS--------EKALDLVKKLLVVDPKARF 267

Query: 411 TAKEAMAHPYF 421
           T +EA+ HP+ 
Sbjct: 268 TTEEALRHPWL 278

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  137 bits (348), Expect = 7e-38
 Identities = 63/306 (20%), Positives = 118/306 (38%), Gaps = 58/306 (18%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLCGG 188
           +DYEV+  +G G Y    +    +D +  + K      +   +K+ +  E+ +L+ L   
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-H 64

Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTD-------FKVLYPTLSDYDVRYYIYELLKAL 241
           PNIV+  D + D+ + T  ++ E+    D              L +  V   + +L  AL
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124

Query: 242 DYCHSQG-----IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFK 295
             CH +      ++HRD+KP NV +D +Q  ++L D+GLA   +    +    V + Y+ 
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDFGLARILNHDTSFAKTFVGTPYYM 183

Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 355
            PE +     Y+   D+WSLGC+   +     PF     +  +L                
Sbjct: 184 SPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFT--AFSQKELAG-------------- 226

Query: 356 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEA 415
                         +     +      +         E  + + ++L      RP+ +E 
Sbjct: 227 -------------KIREGKFRRIPYRYS--------DELNEIITRMLNLKDYHRPSVEEI 265

Query: 416 MAHPYF 421
           + +P  
Sbjct: 266 LENPLI 271

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  137 bits (347), Expect = 1e-37
 Identities = 53/324 (16%), Positives = 101/324 (31%), Gaps = 75/324 (23%)

Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNLCG 187
             ++  + K+G G++  VF+ V   D     IK  K      V ++   RE+     L  
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 188 GPNIVKLLDIVRDQQSKTPSLIF-EHVNN-------TDFKVLYPTLSDYDVRYYIYELLK 239
             ++V+      +       LI  E+ N        ++   +     + +++  + ++ +
Sbjct: 70  HSHVVRYFSAWAEDDH---MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126

Query: 240 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-------------- 285
            L Y HS  ++H D+KP N+ I          + G  + +   K                
Sbjct: 127 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186

Query: 286 -NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
             V      F   E+L +   +    D+++L          +        N DQ  +I +
Sbjct: 187 PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR----NGDQWHEIRQ 242

Query: 345 VLGTDELNAYLNKYHIELDPHLAALVGRHSRKP--WSKFITVENQHLAVPEAVDFLDKLL 402
                                     GR  R P   S             E  + L  ++
Sbjct: 243 --------------------------GRLPRIPQVLS------------QEFTELLKVMI 264

Query: 403 RYDHQERPTAKEAMAHPYFFPIRN 426
             D + RP+A   + H        
Sbjct: 265 HPDPERRPSAMALVKHSVLLSASR 288

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  140 bits (356), Expect = 1e-37
 Identities = 70/301 (23%), Positives = 128/301 (42%), Gaps = 57/301 (18%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLCGG 188
           ++Y++  ++G+G +S V   V     ++    I     L     +K++RE +I + L   
Sbjct: 11  EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL-KH 69

Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCH 245
           PNIV+L D + ++      LIF+ V      +  V     S+ D  + I ++L+A+ +CH
Sbjct: 70  PNIVRLHDSISEEGHH--YLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCH 127

Query: 246 SQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVD 302
             G++HR++KP N+++    +   ++L D+GLA       + +     +  +  PE+L  
Sbjct: 128 QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVL-R 186

Query: 303 LQDYDYSLDLWSLGCMF----AGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 358
              Y   +DLW+ G +      G      P F+  D +    +I                
Sbjct: 187 KDPYGKPVDLWACGVILYILLVGY-----PPFWDEDQHRLYQQIKAG------------- 228

Query: 359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
             +                W   +T        PEA D ++K+L  +  +R TA EA+ H
Sbjct: 229 AYDFP-----------SPEWDT-VT--------PEAKDLINKMLTINPSKRITAAEALKH 268

Query: 419 P 419
           P
Sbjct: 269 P 269

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  135 bits (342), Expect = 1e-36
 Identities = 57/328 (17%), Positives = 118/328 (35%), Gaps = 64/328 (19%)

Query: 117 PREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL---KPVKKK 173
            RE   ++   V    +  Y  ++K+G G +S V       D     +K +   +   ++
Sbjct: 13  GRENLYFQGHMVIIDNKH-YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDRE 71

Query: 174 KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS--LIFEHVNNTD-------FKVLYPT 224
           + +RE  + +     PNI++L+     ++       L+                K     
Sbjct: 72  EAQREADMHRLF-NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNF 130

Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
           L++  + + +  + + L+  H++G  HRD+KP N+++  ++ +  L+D G         E
Sbjct: 131 LTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLG-DEGQPVLMDLGSMNQACIHVE 189

Query: 285 YNVRVASR----------YFKGPELLVDLQDY---DYSLDLWSLGCMFAGMIFRKEPFFY 331
            + +  +            ++ PE L  +Q +   D   D+WSLGC+   M+F + P+  
Sbjct: 190 GSRQALTLQDWAAQRCTISYRAPE-LFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248

Query: 332 GHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAV 391
                D +    +           N+  I   P        HS                 
Sbjct: 249 VFQKGDSVALAVQ-----------NQLSIPQSPR-------HS----------------- 273

Query: 392 PEAVDFLDKLLRYDHQERPTAKEAMAHP 419
                 L+ ++  D  +RP     ++  
Sbjct: 274 SALWQLLNSMMTVDPHQRPHIPLLLSQL 301

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  131 bits (333), Expect = 9e-36
 Identities = 66/307 (21%), Positives = 126/307 (41%), Gaps = 73/307 (23%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK--------KIKREIKILQNL 185
           +D+E+ R +G+GK+  V+            +K+L   K +        +++RE++I  +L
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLF--KAQLEKAGVEHQLRREVEIQSHL 66

Query: 186 CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYPT--LSDYDVRYYIYELLKALD 242
              PNI++L     D  +    LI E+      ++ L       +     YI EL  AL 
Sbjct: 67  RH-PNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 123

Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--------EYNVRVASRYF 294
           YCHS+ ++HRD+KP N+++     +L++ D+G +      +        +Y   +     
Sbjct: 124 YCHSKRVIHRDIKPENLLLGS-AGELKIADFGWSVHAPSSRRTDLCGTLDY---LP---- 175

Query: 295 KGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAY 354
             PE++   + +D  +DLWSLG +    +  K P F  +   +   +I++V         
Sbjct: 176 --PEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPP-FEANTYQETYKRISRV--------- 222

Query: 355 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKE 414
                      +                           A D + +LL+++  +RP  +E
Sbjct: 223 ----EFTFPDFVT------------------------EGARDLISRLLKHNPSQRPMLRE 254

Query: 415 AMAHPYF 421
            + HP+ 
Sbjct: 255 VLEHPWI 261

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  132 bits (335), Expect = 2e-35
 Identities = 69/363 (19%), Positives = 117/363 (32%), Gaps = 58/363 (15%)

Query: 80  RQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVV 139
             LA+   T +    K  R                ++P +Y +Y         Q      
Sbjct: 11  HSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDY-EYREEVHWMTHQP----- 64

Query: 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVR 199
            +VGRG + EV          +C +K ++   +     E+     L   P IV L   VR
Sbjct: 65  -RVGRGSFGEVHRMKDKQTGFQCAVKKVR--LEVFRVEELVACAGLSS-PRIVPLYGAVR 120

Query: 200 DQQSKTPSLIFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKP 256
           +      ++  E +              L +    YY+ + L+ L+Y H++ I+H DVK 
Sbjct: 121 EGP--WVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKA 178

Query: 257 HNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------PELLVDLQDYDYSL 310
            NV++  +  +  L D+G A    P       +   Y  G      PE +V  +  D  +
Sbjct: 179 DNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE-VVMGKPCDAKV 237

Query: 311 DLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALV 370
           D+WS  CM   M+    P+      Y +      +              I  +P      
Sbjct: 238 DIWSSCCMMLHMLNGCHPWT----QYFRG----PLC-----------LKIASEPP----- 273

Query: 371 GRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAESS 430
                         E      P     + + LR +   R +A E         ++     
Sbjct: 274 -----------PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKV-GKALQEVGGL 321

Query: 431 RSR 433
           +S 
Sbjct: 322 KSP 324

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  131 bits (332), Expect = 3e-35
 Identities = 63/306 (20%), Positives = 115/306 (37%), Gaps = 69/306 (22%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL---------KPVKKKKIKREIKILQN 184
             Y+V   +G G +  V+ G+  +DN    IK +         +     ++  E+ +L+ 
Sbjct: 43  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 102

Query: 185 LC-GGPNIVKLLDIVRDQQSKTPS---LIFEHVNNT----DFKVLYPTLSDYDVRYYIYE 236
           +  G   +++LLD       + P    LI E         DF      L +   R + ++
Sbjct: 103 VSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 157

Query: 237 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 296
           +L+A+ +CH+ G++HRD+K  N++ID  + +L+LID+G          Y     +R +  
Sbjct: 158 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSP 216

Query: 297 PELLVDLQDYD-YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 355
           PE +     Y   S  +WSLG +   M+    PF       +   +I +           
Sbjct: 217 PEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPF-------EHDEEIIR----------- 257

Query: 356 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEA 415
            +        ++                         E    +   L     +RPT +E 
Sbjct: 258 GQVFFR--QRVS------------------------SECQHLIRWCLALRPSDRPTFEEI 291

Query: 416 MAHPYF 421
             HP+ 
Sbjct: 292 QNHPWM 297

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  132 bits (333), Expect = 4e-35
 Identities = 53/311 (17%), Positives = 123/311 (39%), Gaps = 53/311 (17%)

Query: 122 DYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIK 176
           D  +  + +   + Y  ++K+G G + +        D  + +IK      +   ++++ +
Sbjct: 12  DLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESR 71

Query: 177 REIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVL----YPTLSDYDVR 231
           RE+ +L N+   PNIV+  +   +  S    ++ ++    D FK +         +  + 
Sbjct: 72  REVAVLANMKH-PNIVQYRESFEENGSL--YIVMDYCEGGDLFKRINAQKGVLFQEDQIL 128

Query: 232 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVA 290
            +  ++  AL + H + I+HRD+K  N+ +  +   ++L D+G+A   +   E     + 
Sbjct: 129 DWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG-TVQLGDFGIARVLNSTVELARACIG 187

Query: 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE 350
           + Y+  PE+  + + Y+   D+W+LGC+   +   K   F      + ++KI        
Sbjct: 188 TPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHA-FEAGSMKNLVLKIIS------ 239

Query: 351 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP 410
                               G     P S   +         +    + +L + + ++RP
Sbjct: 240 --------------------GSF--PPVSLHYS--------YDLRSLVSQLFKRNPRDRP 269

Query: 411 TAKEAMAHPYF 421
           +    +   + 
Sbjct: 270 SVNSILEKGFI 280

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  129 bits (327), Expect = 9e-35
 Identities = 68/319 (21%), Positives = 132/319 (41%), Gaps = 75/319 (23%)

Query: 125 SLTVQWGEQ-DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL------KPVKKKKIKR 177
           SL    GE+ +D++V   +G+G ++ V+         +  IK++      K    ++++ 
Sbjct: 1   SLATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQN 60

Query: 178 EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYP---TLSDYDVRYY 233
           E+KI   L   P+I++L +   D  S    L+ E  +N +  + L       S+ + R++
Sbjct: 61  EVKIHCQLKH-PSILELYNYFED--SNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHF 117

Query: 234 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE--------- 284
           +++++  + Y HS GI+HRD+   N+++      +++ D+GLA       E         
Sbjct: 118 MHQIITGMLYLHSHGILHRDLTLSNLLLT-RNMNIKIADFGLATQLKMPHEKHYTLCGTP 176

Query: 285 -YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV-KI 342
            Y   ++      PE+      +    D+WSLGCMF  ++  + PF    D     + K+
Sbjct: 177 NY---IS------PEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFD--TDTVKNTLNKV 224

Query: 343 AKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLL 402
                          Y +   P                F++         EA D + +LL
Sbjct: 225 VL-----------ADYEM---P---------------SFLS--------IEAKDLIHQLL 247

Query: 403 RYDHQERPTAKEAMAHPYF 421
           R +  +R +    + HP+ 
Sbjct: 248 RRNPADRLSLSSVLDHPFM 266

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  129 bits (326), Expect = 2e-34
 Identities = 65/308 (21%), Positives = 122/308 (39%), Gaps = 73/308 (23%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL------KPVKKKKIKREIKILQNLCG 187
             Y   R +G+G +++ FE       E    KI+      KP +++K+  EI I ++L  
Sbjct: 15  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74

Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKALDYC 244
             ++V       D  +    ++ E        +       L++ + RYY+ +++    Y 
Sbjct: 75  -QHVVGFHGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYL 131

Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE----------YNVRVASRYF 294
           H   ++HRD+K  N+ ++ E  ++++ D+GLA       E          Y   +A    
Sbjct: 132 HRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPNY---IA---- 183

Query: 295 KGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQL-VKIAKVLGTDELNA 353
             PE+L   + + + +D+WS+GC+   ++  K PF        +  ++I K         
Sbjct: 184 --PEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFE--TSCLKETYLRIKK--------- 229

Query: 354 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK 413
             N+Y I    H+                         P A   + K+L+ D   RPT  
Sbjct: 230 --NEYSI--PKHIN------------------------PVAASLIQKMLQTDPTARPTIN 261

Query: 414 EAMAHPYF 421
           E +   +F
Sbjct: 262 ELLNDEFF 269

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  129 bits (326), Expect = 3e-34
 Identities = 65/308 (21%), Positives = 122/308 (39%), Gaps = 73/308 (23%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL------KPVKKKKIKREIKILQNLCG 187
             Y   R +G+G +++ FE       E    KI+      KP +++K+  EI I ++L  
Sbjct: 41  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100

Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKALDYC 244
             ++V       D  +    ++ E        +       L++ + RYY+ +++    Y 
Sbjct: 101 -QHVVGFHGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYL 157

Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE----------YNVRVASRYF 294
           H   ++HRD+K  N+ ++ E  ++++ D+GLA       E          Y   +A    
Sbjct: 158 HRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPNY---IA---- 209

Query: 295 KGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQL-VKIAKVLGTDELNA 353
             PE+L   + + + +D+WS+GC+   ++  K PF        +  ++I K         
Sbjct: 210 --PEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFE--TSCLKETYLRIKK--------- 255

Query: 354 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK 413
             N+Y I    H+                         P A   + K+L+ D   RPT  
Sbjct: 256 --NEYSI--PKHIN------------------------PVAASLIQKMLQTDPTARPTIN 287

Query: 414 EAMAHPYF 421
           E +   +F
Sbjct: 288 ELLNDEFF 295

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  128 bits (323), Expect = 5e-34
 Identities = 64/302 (21%), Positives = 116/302 (38%), Gaps = 55/302 (18%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK------ILKPVKKKKIKREIKILQNLCG 187
            ++ + +K+GRG++SEV+      D     +K      ++    +    +EI +L+ L  
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-------FKVLYPTLSDYDVRYYIYELLKA 240
            PN++K      +      +++ E  +  D       FK     + +  V  Y  +L  A
Sbjct: 92  -PNVIKYYASFIEDN--ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148

Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPEL 299
           L++ HS+ +MHRD+KP NV I      ++L D GL  F+       +  V + Y+  PE 
Sbjct: 149 LEHMHSRRVMHRDIKPANVFITATG-VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 207

Query: 300 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV-KIAKVLGTDELNAYLNKY 358
           + +   Y++  D+WSLGC+   M   + PF+    N   L  KI +              
Sbjct: 208 IHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ-------------- 252

Query: 359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
                         +   P   +           E    ++  +  D ++RP        
Sbjct: 253 ------------CDYPPLPSDHY---------SEELRQLVNMCINPDPEKRPDVTYVYDV 291

Query: 419 PY 420
             
Sbjct: 292 AK 293

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  126 bits (319), Expect = 2e-33
 Identities = 63/312 (20%), Positives = 115/312 (36%), Gaps = 79/312 (25%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL---------KPVKKKKIKREIKILQN 184
            +Y +   +G+G +  VF G   TD  +  IK++                   E+ +L  
Sbjct: 31  AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90

Query: 185 LCGG---PNIVKLLDIVRDQQSKTPS---LIFEHVNNT----DFKVLYPTLSDYDVRYYI 234
           +  G   P +++LLD       +T     L+ E         D+      L +   R + 
Sbjct: 91  VGAGGGHPGVIRLLDWF-----ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFF 145

Query: 235 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYF 294
            +++ A+ +CHS+G++HRD+K  N++ID  +   +LID+G     H    Y     +R +
Sbjct: 146 GQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP-YTDFDGTRVY 204

Query: 295 KGPELLVDLQDYD-YSLDLWSLG----CMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTD 349
             PE +     Y      +WSLG     M  G I    PF    +   ++++        
Sbjct: 205 SPPEWISR-HQYHALPATVWSLGILLYDMVCGDI----PF----ERDQEILE-------- 247

Query: 350 ELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQER 409
                  + H    P                       H++ P+    + + L      R
Sbjct: 248 ------AELHF---PA----------------------HVS-PDCCALIRRCLAPKPSSR 275

Query: 410 PTAKEAMAHPYF 421
           P+ +E +  P+ 
Sbjct: 276 PSLEEILLDPWM 287

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  125 bits (317), Expect = 2e-33
 Identities = 66/308 (21%), Positives = 125/308 (40%), Gaps = 75/308 (24%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK--------KIKREIKILQNL 185
           DD+++ R +G+GK+  V+      +     +K+L   K +        +++REI+I  +L
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLF--KSQLEKEGVEHQLRREIEIQSHL 71

Query: 186 CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVL--YPTLSDYDVRYYIYELLKALD 242
              PNI+++ +   D   K   L+ E     + +K L  +    +     ++ EL  AL 
Sbjct: 72  RH-PNILRMYNYFHD--RKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALH 128

Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK---------EYNVRVASRY 293
           YCH + ++HRD+KP N+++ + + +L++ D+G +  + P           +Y   +    
Sbjct: 129 YCHERKVIHRDIKPENLLMGY-KGELKIADFGWS-VHAPSLRRRTMCGTLDY---LP--- 180

Query: 294 FKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 353
              PE++   + +D  +DLW  G +    +    P F    + +   +I  V        
Sbjct: 181 ---PEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPP-FDSPSHTETHRRIVNV-------- 227

Query: 354 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK 413
                     P L+                          + D + KLLRY   +R   K
Sbjct: 228 ---DLKF--PPFLS------------------------DGSKDLISKLLRYHPPQRLPLK 258

Query: 414 EAMAHPYF 421
             M HP+ 
Sbjct: 259 GVMEHPWV 266

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  125 bits (316), Expect = 7e-33
 Identities = 64/306 (20%), Positives = 118/306 (38%), Gaps = 71/306 (23%)

Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----------PVKKKKIKREIKILQ 183
            Y  +  +G G +  V+  V    N++ ++K +K             K  K+  EI IL 
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84

Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIF----EHVNNT---DFKVLYPTLSDYDVRYYIYE 236
            +    NI+K+LDI      +          +H +      F   +P L +    Y   +
Sbjct: 85  RVEH-ANIIKVLDIF-----ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ 138

Query: 237 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 296
           L+ A+ Y   + I+HRD+K  N++I  E   ++LID+G A +   GK +     +  +  
Sbjct: 139 LVSAVGYLRLKDIIHRDIKDENIVIA-EDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCA 197

Query: 297 PELLVDLQDYD-YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 355
           PE+L+    Y    L++WSLG     ++F + PF       ++ V+              
Sbjct: 198 PEVLMG-NPYRGPELEMWSLGVTLYTLVFEENPF----CELEETVE-------------- 238

Query: 356 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEA 415
              H    P+                       ++  E +  +  LL+   + R T ++ 
Sbjct: 239 AAIHP---PY----------------------LVS-KELMSLVSGLLQPVPERRTTLEKL 272

Query: 416 MAHPYF 421
           +  P+ 
Sbjct: 273 VTDPWV 278

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  124 bits (313), Expect = 8e-33
 Identities = 57/294 (19%), Positives = 112/294 (38%), Gaps = 51/294 (17%)

Query: 141 KVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK-----IKREIKILQNLCGGPNIVKLL 195
           ++GRG +  V++G+      +     L+  K  K      K E ++L+ L   PNIV+  
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH-PNIVRFY 91

Query: 196 DIVRDQQSKTPSLIF--EHVNN---TDFKVLYPTLSDYDVRYYIYELLKALDYCHSQG-- 248
           D           ++   E + +     +   +  +    +R +  ++LK L + H++   
Sbjct: 92  DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPP 151

Query: 249 IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 308
           I+HRD+K  N+ I      +++ D GLA          V + +  F  PE+    + YD 
Sbjct: 152 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV-IGTPEFMAPEMY--EEKYDE 208

Query: 309 SLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAA 368
           S+D+++ G     M   + P +    N  Q+ +                           
Sbjct: 209 SVDVYAFGMCMLEMATSEYP-YSECQNAAQIYRRVT------------------------ 243

Query: 369 LVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFF 422
                     S         +A+PE  + ++  +R +  ER + K+ + H +F 
Sbjct: 244 ----------SGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 287

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  125 bits (316), Expect = 1e-32
 Identities = 63/323 (19%), Positives = 123/323 (38%), Gaps = 62/323 (19%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--------------------PVKKK 173
           +DY ++R + +GK++++       DN+   +K  +                      K  
Sbjct: 31  NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88

Query: 174 KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVL----------Y 222
             K E++I+ ++      +    I+ +       +I+E++ N    K             
Sbjct: 89  DFKNELQIITDIKN-EYCLTCEGIITN--YDEVYIIYEYMENDSILKFDEYFFVLDKNYT 145

Query: 223 PTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281
             +    ++  I  +L +  Y H++  I HRDVKP N+++D +  +++L D+G +E Y  
Sbjct: 146 CFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD-KNGRVKLSDFGESE-YMV 203

Query: 282 GKEYNVRVASRYFKGPELLVDLQDYD-YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
            K+      +  F  PE   +   Y+   +D+WSLG     M +   PF     +  +L 
Sbjct: 204 DKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF-SLKISLVELF 262

Query: 341 -KIAKVLGTDELNAYLNKYHI-ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFL 398
             I                       H    +        + F++         E +DFL
Sbjct: 263 NNIRTK-----------NIEYPLDRNHFLYPLTNKKSTCSNNFLS--------NEDIDFL 303

Query: 399 DKLLRYDHQERPTAKEAMAHPYF 421
              LR +  ER T+++A+ H + 
Sbjct: 304 KLFLRKNPAERITSEDALKHEWL 326

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  124 bits (312), Expect = 3e-32
 Identities = 68/330 (20%), Positives = 120/330 (36%), Gaps = 75/330 (22%)

Query: 122 DYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL---KPVKKKKIKRE 178
           D+   TV+ GE     V R +  G ++ V+E        +  +K L   +  K + I +E
Sbjct: 17  DFVGQTVELGELR-LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQE 75

Query: 179 IKILQNLCGGPNIVKLLD--IVRDQQSKTPSLIF----EHVNNTDFKVLYPT-----LSD 227
           +  ++ L G PNIV+      +  ++S T    F    E       + L        LS 
Sbjct: 76  VCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSC 135

Query: 228 YDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285
             V    Y+  +A+ + H Q   I+HRD+K  N+++   Q  ++L D+G A       +Y
Sbjct: 136 DTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS-NQGTIKLCDFGSATTISHYPDY 194

Query: 286 NVRVASR-------------YFKGPELLVDL---QDYDYSLDLWSLGCMFAGMIFRKEPF 329
           +     R              ++ PE ++DL          D+W+LGC+   + FR+ PF
Sbjct: 195 SWSAQRRALVEEEITRNTTPMYRTPE-IIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF 253

Query: 330 FYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHL 389
                                          E    L  + G++S  P            
Sbjct: 254 -------------------------------EDGAKLRIVNGKYSIPPHDTQ-------- 274

Query: 390 AVPEAVDFLDKLLRYDHQERPTAKEAMAHP 419
                   +  +L+ + +ER +  E +   
Sbjct: 275 -YTVFHSLIRAMLQVNPEERLSIAEVVHQL 303

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  123 bits (310), Expect = 7e-32
 Identities = 38/239 (15%), Positives = 84/239 (35%), Gaps = 31/239 (12%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDN-----EKCIIKILKPVKKKKIKREIKILQNLCGG 188
               V   +G G +++V+E      N     +K ++K+ KP    +     ++++ L   
Sbjct: 65  KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPS 124

Query: 189 --PNIVKLLDIVRDQQSKTPSLIFEHVN--------NTDFKVLYPTLSDYDVRYYIYELL 238
                +K       Q      L+ E  +        N         +    V  +   +L
Sbjct: 125 MQHMFMKFYSAHLFQNGS--VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182

Query: 239 KALDYCHSQGIMHRDVKPHNVMIDH----------EQRKLRLIDWGLA---EFYHPGKEY 285
             ++  H   I+H D+KP N ++ +              L LID G +   + +  G  +
Sbjct: 183 YMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIF 242

Query: 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
             +  +  F+  E+L + + ++Y +D + +      M+F             +   + +
Sbjct: 243 TAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFR 300

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  122 bits (309), Expect = 8e-32
 Identities = 67/299 (22%), Positives = 134/299 (44%), Gaps = 58/299 (19%)

Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLCGGP 189
           +Y +++ +G+G +++V    H     +  IKI     L P   +K+ RE++I++ L   P
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNH-P 74

Query: 190 NIVKLLDIVRDQQSKTPS---LIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDY 243
           NIVKL +++     +T     LI E+ +     D+ V +  + + + R    +++ A+ Y
Sbjct: 75  NIVKLFEVI-----ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQY 129

Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 303
           CH + I+HRD+K  N+++D     +++ D+G +  +  G + +    +  +  PEL    
Sbjct: 130 CHQKRIVHRDLKAENLLLD-ADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQG- 187

Query: 304 QDYD-YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 362
           + YD   +D+WSLG +   ++    PF     N  +L +  +VL          KY I  
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVSGSLPF--DGQNLKELRE--RVLR--------GKYRI-- 233

Query: 363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            P                       +++  +  + L + L  +  +R T ++ M   + 
Sbjct: 234 -PF----------------------YMS-TDCENLLKRFLVLNPIKRGTLEQIMKDRWI 268

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  122 bits (308), Expect = 2e-31
 Identities = 54/423 (12%), Positives = 116/423 (27%), Gaps = 109/423 (25%)

Query: 71  HARHQHQRLRQ---LATPPDTLAQKIGKSVRRSGAPSKA-RVYSDINVVRPREYWDYES- 125
           H  H H   R+      P D + +++   + ++   + +  + S  + +     W+    
Sbjct: 2   HHHHHHSSGRENLYFQGPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQP 61

Query: 126 ---LTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK------KKIK 176
               +              +G+       E       E   + +    ++      K++K
Sbjct: 62  FRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMK 121

Query: 177 REIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDV------ 230
            E+  L+ L G  N  +    +R      P  + +         +     D  V      
Sbjct: 122 EEVLRLRLLRGIKNQKQAKVHLRFI---FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFL 178

Query: 231 ------------------------------RYYIYELLKALDYCHSQGIMHRDVKPHNVM 260
                                              ++++ L   H  G++H  ++P +++
Sbjct: 179 YPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIV 238

Query: 261 IDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD----------YDYSL 310
           +D     + L  +             V   SR F+ PEL                  +S 
Sbjct: 239 LDQRGG-VFLTGFEHL---VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSF 294

Query: 311 DLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALV 370
           D W+LG +   +     P                   T +     +++      ++    
Sbjct: 295 DAWALGLVIYWIWCADLPI------------------TKDAALGGSEWIFRSCKNI---- 332

Query: 371 GRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAESS 430
                 P                    L+  LRY  ++R    +AM  P +  +R   S+
Sbjct: 333 ------P--------------QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSA 372

Query: 431 RSR 433
              
Sbjct: 373 ALP 375

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  120 bits (304), Expect = 2e-31
 Identities = 61/312 (19%), Positives = 115/312 (36%), Gaps = 67/312 (21%)

Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKK---KKIKREIKILQNLCGGPNIVKLLDIV 198
           +G+G Y  V+ G   ++  +  IK +        + +  EI + ++L    NIV+ L   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKH-KNIVQYLGSF 88

Query: 199 RDQQSKTPSLIFEHVNN----TDFKVLYPTLSDYD--VRYYIYELLKALDYCHSQGIMHR 252
            +       +  E V         +  +  L D +  + +Y  ++L+ L Y H   I+HR
Sbjct: 89  SENG--FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHR 146

Query: 253 DVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------PE-LLVDLQD 305
           D+K  NV+I+     L++ D+G +      +   +   +  F G      PE +    + 
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTS-----KRLAGINPCTETFTGTLQYMAPEIIDKGPRG 201

Query: 306 YDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 361
           Y  + D+WSLGC    M  G    K PF+   +    + K+              K H E
Sbjct: 202 YGKAADIWSLGCTIIEMATG----KPPFYELGEPQAAMFKVGM-----------FKVHPE 246

Query: 362 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
           +   ++                         EA  F+ K    D  +R  A + +   + 
Sbjct: 247 IPESMS------------------------AEAKAFILKCFEPDPDKRACANDLLVDEFL 282

Query: 422 FPIRNAESSRSR 433
                 + ++ +
Sbjct: 283 KVSSKKKKTQPK 294

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  117 bits (296), Expect = 3e-30
 Identities = 66/301 (21%), Positives = 121/301 (40%), Gaps = 55/301 (18%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-------PVKKKKIKREIKILQNLCGG 188
           Y +   +G G Y +V E +      +  +KILK       P  +  +K+EI++L+ L   
Sbjct: 7   YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH- 65

Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDF----KVLYPTLSDYDVRYYIYELLKALDYC 244
            N+++L+D++ +++ +   ++ E+           V            Y  +L+  L+Y 
Sbjct: 66  KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYL 125

Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV---RVASRYFKGPELLV 301
           HSQGI+H+D+KP N+++      L++   G+AE  HP    +       S  F+ PE+  
Sbjct: 126 HSQGIVHKDIKPGNLLLT-TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIAN 184

Query: 302 DLQDYD-YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 360
            L  +  + +D+WS G     +     PF    DN  +L +   +            Y I
Sbjct: 185 GLDTFSGFKVDIWSAGVTLYNITTGLYPFE--GDNIYKLFE--NIGKGS--------YAI 232

Query: 361 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 420
              P                           P   D L  +L Y+  +R + ++   H +
Sbjct: 233 ---P---------------GDCG--------PPLSDLLKGMLEYEPAKRFSIRQIRQHSW 266

Query: 421 F 421
           F
Sbjct: 267 F 267

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  114 bits (288), Expect = 2e-29
 Identities = 62/306 (20%), Positives = 119/306 (38%), Gaps = 65/306 (21%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK----KKIKREIKILQNLCGGP 189
           +D+++V+ +G G Y EV   V+    E   +KI+   +     + IK+EI I + L    
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH-E 65

Query: 190 NIVKLLDIVRDQQSKTPSLIF---EHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDY 243
           N+VK          +  ++ +   E+ +     D       + + D + + ++L+  + Y
Sbjct: 66  NVVKFYGHR-----REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120

Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV---RVASRYFKGPELL 300
            H  GI HRD+KP N+++D E+  L++ D+GLA  +       +      +  +  PELL
Sbjct: 121 LHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179

Query: 301 VDLQDYD-YSLDLWSLG----CMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 355
              +++    +D+WS G     M AG +    P+    D+  +     +           
Sbjct: 180 KR-REFHAEPVDVWSCGIVLTAMLAGEL----PWDQPSDSCQEYSDWKE----------- 223

Query: 356 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEA 415
                           +    PW K              +  L K+L  +   R T  + 
Sbjct: 224 ---------------KKTYLNPWKKI---------DSAPLALLHKILVENPSARITIPDI 259

Query: 416 MAHPYF 421
               ++
Sbjct: 260 KKDRWY 265

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  114 bits (286), Expect = 9e-29
 Identities = 58/367 (15%), Positives = 119/367 (32%), Gaps = 120/367 (32%)

Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL----KPVKKKKIKREIKILQNLCGG 188
             D+E ++ +GRG +  VFE  +  D+    IK +    + + ++K+ RE+K L  L   
Sbjct: 5   LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EH 63

Query: 189 PNIVKLLD----------------------------------------IVRDQQSKTPSL 208
           P IV+  +                                        I R     T + 
Sbjct: 64  PGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNT 123

Query: 209 IFEHVNNTDFKVLY--------PTLSDY-------------DVRYYIYELLKALDYCHSQ 247
           + +   ++    LY          L D+                +   ++ +A+++ HS+
Sbjct: 124 VGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK 183

Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG----------- 296
           G+MHRD+KP N+    +   +++ D+GL       +E    +                  
Sbjct: 184 GLMHRDLKPSNIFFTMDD-VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242

Query: 297 --PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAY 354
             PE +    +Y + +D++SLG +   +++    F    +    +  +            
Sbjct: 243 MSPEQIHG-NNYSHKVDIFSLGLILFELLY---SFSTQMERVRIITDVRN---------- 288

Query: 355 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKE 414
                            +       K+          P+    +  +L     ERP A +
Sbjct: 289 ----------------LKFPLLFTQKY----------PQEHMMVQDMLSPSPTERPEATD 322

Query: 415 AMAHPYF 421
            + +  F
Sbjct: 323 IIENAIF 329

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  112 bits (283), Expect = 2e-28
 Identities = 67/322 (20%), Positives = 129/322 (40%), Gaps = 76/322 (23%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL---KPVKKK------------------- 173
           Y +  ++G+G Y  V    +  DN    +K+L   K +++                    
Sbjct: 15  YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74

Query: 174 -------KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYPT- 224
                  ++ +EI IL+     PN+VKL++++ D       ++FE VN     +V     
Sbjct: 75  QPRGPIEQVYQEIAILK-KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP 133

Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
           LS+   R+Y  +L+K ++Y H Q I+HRD+KP N+++  E   +++ D+G++  +     
Sbjct: 134 LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG-EDGHIKIADFGVSNEFKGSDA 192

Query: 285 Y-NVRVASRYFKGPELLVDL-QDYD-YSLDLWSLGC-MFAGMIFRKEPFFYGHDNYDQL- 339
             +  V +  F  PE L +  + +   +LD+W++G  ++   +F + PF    +    L 
Sbjct: 193 LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYC-FVFGQCPFM--DERIMCLH 249

Query: 340 VKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLD 399
            KI                     P +A                         +  D + 
Sbjct: 250 SKIKS-----------QALEFPDQPDIA------------------------EDLKDLIT 274

Query: 400 KLLRYDHQERPTAKEAMAHPYF 421
           ++L  + + R    E   HP+ 
Sbjct: 275 RMLDKNPESRIVVPEIKLHPWV 296

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  113 bits (286), Expect = 2e-28
 Identities = 64/298 (21%), Positives = 116/298 (38%), Gaps = 49/298 (16%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL--KPVKKKKIKREIKILQNLCGGPNI 191
           D Y+ V+ +G G +            E   +K +       + ++REI   ++L   PNI
Sbjct: 20  DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRH-PNI 78

Query: 192 VKLLDIVRDQQSKTPSLIF---EHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCH 245
           V+  +++      TP+ +    E+ +     +        S+ + R++  +LL  + YCH
Sbjct: 79  VRFKEVI-----LTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCH 133

Query: 246 SQGIMHRDVKPHNVMIDHEQR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           S  I HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+  Q
Sbjct: 134 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR-Q 192

Query: 305 DYD-YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363
           +YD    D+WS G     M+    PF    +  D    I ++L           Y I   
Sbjct: 193 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVK--------YSI--- 241

Query: 364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
                        P    I+        PE    + ++   D   R +  E   H +F
Sbjct: 242 -------------PDDIRIS--------PECCHLISRIFVADPATRISIPEIKTHSWF 278

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  112 bits (282), Expect = 3e-28
 Identities = 73/326 (22%), Positives = 128/326 (39%), Gaps = 76/326 (23%)

Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI--LKPVKKKKIKREIKILQNLCGGPN 190
              +E+V  VG G Y +V++G H    +   IK+  +   ++++IK+EI +L+      N
Sbjct: 23  AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN 82

Query: 191 IVKLLDIVRDQQSKTPS----LIFEH---------VNNTDFKVLYPTLSDYDVRYYIYEL 237
           I         +          L+ E          + NT       TL +  + Y   E+
Sbjct: 83  IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN----TLKEEWIAYICREI 138

Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKG 296
           L+ L + H   ++HRD+K  NV++  E  +++L+D+G+ A+        N  + + Y+  
Sbjct: 139 LRGLSHLHQHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMA 197

Query: 297 PELLVDLQD----YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELN 352
           PE++   ++    YD+  DLWSLG     M     P    H          + L      
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH--------PMRAL------ 243

Query: 353 AYLNKYHI------ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDH 406
                + I       L             K WSK            +   F++  L  +H
Sbjct: 244 -----FLIPRNPAPRLKS-----------KKWSK------------KFQSFIESCLVKNH 275

Query: 407 QERPTAKEAMAHPYFFPIRNAESSRS 432
            +RP  ++ M HP+   IR+  + R 
Sbjct: 276 SQRPATEQLMKHPF---IRDQPNERQ 298

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  112 bits (282), Expect = 4e-28
 Identities = 62/306 (20%), Positives = 119/306 (38%), Gaps = 65/306 (21%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK----KKIKREIKILQNLCGGP 189
           +D+++V+ +G G Y EV   V+    E   +KI+   +     + IK+EI I + L    
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH-E 65

Query: 190 NIVKLLDIVRDQQSKTPSLIF---EHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDY 243
           N+VK          +  ++ +   E+ +     D       + + D + + ++L+  + Y
Sbjct: 66  NVVKFYGHR-----REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120

Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV---RVASRYFKGPELL 300
            H  GI HRD+KP N+++D E+  L++ D+GLA  +       +      +  +  PELL
Sbjct: 121 LHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179

Query: 301 VDLQDYD-YSLDLWSLG----CMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 355
              +++    +D+WS G     M AG +    P+    D+  +     +           
Sbjct: 180 KR-REFHAEPVDVWSCGIVLTAMLAGEL----PWDQPSDSCQEYSDWKE----------- 223

Query: 356 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEA 415
                           +    PW K              +  L K+L  +   R T  + 
Sbjct: 224 ---------------KKTYLNPWKKI---------DSAPLALLHKILVENPSARITIPDI 259

Query: 416 MAHPYF 421
               ++
Sbjct: 260 KKDRWY 265

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  110 bits (277), Expect = 7e-28
 Identities = 71/301 (23%), Positives = 127/301 (42%), Gaps = 63/301 (20%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK--------KIKREIKILQNLCG 187
           Y +   +G G + +V  G H     K  +KIL   ++K        KIKREI+ L+    
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILN--RQKIRSLDVVGKIKREIQNLKLFRH 70

Query: 188 GPNIVKLLDIVRDQQSKTPSLIF---EHVNNT---DFKVLYPTLSDYDVRYYIYELLKAL 241
            P+I+KL  ++      TP+  F   E+V+     D+   +  + + + R    ++L A+
Sbjct: 71  -PHIIKLYQVI-----STPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAV 124

Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 301
           DYCH   ++HRD+KP NV++D      ++ D+GL+     G+       S  +  PE++ 
Sbjct: 125 DYCHRHMVVHRDLKPENVLLD-AHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVIS 183

Query: 302 DLQDYD-YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 360
             + Y    +D+WS G +   ++    PF    ++   L K  K+ G          ++I
Sbjct: 184 G-RLYAGPEVDIWSCGVILYALLCGTLPF--DDEHVPTLFK--KIRGGV--------FYI 230

Query: 361 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 420
              P               +++               L  +L+ D  +R T K+   H +
Sbjct: 231 ---P---------------EYLN--------RSVATLLMHMLQVDPLKRATIKDIREHEW 264

Query: 421 F 421
           F
Sbjct: 265 F 265

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  109 bits (275), Expect = 4e-27
 Identities = 49/193 (25%), Positives = 94/193 (48%), Gaps = 20/193 (10%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL------KPVKKKKIKREIKILQNLCGGP 189
           Y +   +G G + +V    H    +K  +K +      K     +++REI  L+ L   P
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRH-P 69

Query: 190 NIVKLLDIVRDQQSKTPSLIF---EHVNNT--DFKVLYPTLSDYDVRYYIYELLKALDYC 244
           +I+KL D++      TP+ I    E+      D+ V    +++ + R +  +++ A++YC
Sbjct: 70  HIIKLYDVI-----TTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYC 124

Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           H   I+HRD+KP N+++D +   +++ D+GL+     G        S  +  PE++   +
Sbjct: 125 HRHKIVHRDLKPENLLLD-DNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVING-K 182

Query: 305 DYD-YSLDLWSLG 316
            Y    +D+WS G
Sbjct: 183 LYAGPEVDVWSCG 195

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  108 bits (271), Expect = 8e-27
 Identities = 69/335 (20%), Positives = 122/335 (36%), Gaps = 84/335 (25%)

Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGG 188
           +DDYE+   +G G  + V         EK  IK +          ++ +EI+ +   C  
Sbjct: 14  RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMS-QCHH 72

Query: 189 PNIVK----------------------LLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLS 226
           PNIV                       +LDI++   +K                    L 
Sbjct: 73  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHK-------------SGVLD 119

Query: 227 DYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN 286
           +  +   + E+L+ L+Y H  G +HRDVK  N+++  E   +++ D+G++ F   G +  
Sbjct: 120 ESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDIT 178

Query: 287 VRVASRYFKG------PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
                + F G      PE++  ++ YD+  D+WS G     +     P+      Y  + 
Sbjct: 179 RNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYH----KYPPM- 233

Query: 341 KIAKVLGTDELNAYLNKYHI--ELDPHL-AALVGRHSRKPWSKFITVENQHLAVPEAVDF 397
              KVL                   P L   +  +   K + K                 
Sbjct: 234 ---KVL-----------MLTLQNDPPSLETGVQDKEMLKKYGK------------SFRKM 267

Query: 398 LDKLLRYDHQERPTAKEAMAHPYFFPIRNAESSRS 432
           +   L+ D ++RPTA E + H +F   + A++   
Sbjct: 268 ISLCLQKDPEKRPTAAELLRHKFF---QKAKNKEF 299

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  108 bits (271), Expect = 1e-26
 Identities = 63/311 (20%), Positives = 130/311 (41%), Gaps = 59/311 (18%)

Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK-KKIKREIKILQNLCGGPNI 191
           ++ ++V+ K+G G Y  V++ +H    +   IK +      ++I +EI I+Q  C  P++
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQ-CDSPHV 86

Query: 192 VKLLD-IVRDQQSKTPSL--IFEHVNN---TD-FKVLYPTLSDYDVRYYIYELLKALDYC 244
           VK      ++       L  + E+      +D  ++   TL++ ++   +   LK L+Y 
Sbjct: 87  VKYYGSYFKNTD-----LWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYL 141

Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDL 303
           H    +HRD+K  N++++  +   +L D+G+  +      + N  + + ++  PE++ + 
Sbjct: 142 HFMRKIHRDIKAGNILLN-TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE- 199

Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363
             Y+   D+WSLG     M   K P+   H          + +           + I  +
Sbjct: 200 IGYNCVADIWSLGITAIEMAEGKPPYADIH--------PMRAI-----------FMIPTN 240

Query: 364 --PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
             P           + WS                DF+ + L    ++R TA + + HP+ 
Sbjct: 241 PPPTF------RKPELWS------------DNFTDFVKQCLVKSPEQRATATQLLQHPF- 281

Query: 422 FPIRNAESSRS 432
             +R+A+    
Sbjct: 282 --VRSAKGVSI 290

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  109 bits (273), Expect = 2e-26
 Identities = 50/428 (11%), Positives = 111/428 (25%), Gaps = 113/428 (26%)

Query: 71  HARHQH---------QRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYW 121
           H  H H         Q  R        + +   +  + +   +   + S  + +     W
Sbjct: 2   HHHHHHSSGRENLYFQGFRGTDPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLW 61

Query: 122 ----DYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK----- 172
                +   +              +G+       E       E   + +    ++     
Sbjct: 62  NTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNA 121

Query: 173 -KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDV- 230
            K++K E+  L+ L G  N  +    +R      P  + +         +     D  V 
Sbjct: 122 IKQMKEEVLRLRLLRGIKNQKQAKVHLRFI---FPFDLVKDPQKKKMIRVRLDERDMWVL 178

Query: 231 -----------------------------------RYYIYELLKALDYCHSQGIMHRDVK 255
                                                   ++++ L   H  G++H  ++
Sbjct: 179 SRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLR 238

Query: 256 PHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY----FKGPELLVDLQD----YD 307
           P ++++D     + L  +        G      +   +         +L   Q       
Sbjct: 239 PVDIVLDQRGG-VFLTGFEHLV--RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMT 295

Query: 308 YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLA 367
           ++ D W+LG     +     P                   TD+     +++      +  
Sbjct: 296 FAFDTWTLGLAIYWIWCADLPN------------------TDDAALGGSEWIFRSCKN-- 335

Query: 368 ALVGRHSRKPWSKFITVENQHLAVPEAV-DFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 426
                                  +P+ V   L+  LRY  ++R    +AM  P +  +R 
Sbjct: 336 -----------------------IPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT 372

Query: 427 AESSRSRS 434
             S+    
Sbjct: 373 ELSAALPL 380

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  107 bits (269), Expect = 3e-26
 Identities = 76/381 (19%), Positives = 140/381 (36%), Gaps = 81/381 (21%)

Query: 69  LSHARHQHQRLRQLATPPDTLAQKIGKSV---RRSGAPSKARVYSDINVVRPREYWDYES 125
           +S+  H H     + T  +   Q     +    R+G+     V        P +      
Sbjct: 1   MSYYHHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEK------ 54

Query: 126 LTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK------IKREI 179
                     +  +R++G G +  V+      ++E   IK +    K+       I +E+
Sbjct: 55  ---------LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEV 105

Query: 180 KILQNLCGGPNIVKLLD-IVRDQQSKTPSLIFEHVN---NTDFKVLYPTLSDYDVRYYIY 235
           + LQ     PN ++     +R+       L+ E+     +   +V    L + ++    +
Sbjct: 106 RFLQK-LRHPNTIQYRGCYLREHT---AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTH 161

Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 295
             L+ L Y HS  ++HRDVK  N+++  E   ++L D+G A    P   +   V + Y+ 
Sbjct: 162 GALQGLAYLHSHNMIHRDVKAGNILLS-EPGLVKLGDFGSASIMAPANSF---VGTPYWM 217

Query: 296 GPELLVDLQD--YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 353
            PE+++ + +  YD  +D+WSLG     +  RK P F  +            L       
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSAL------- 262

Query: 354 YLNKYHIELD--PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT 411
               YHI  +  P L           WS                +F+D  L+   Q+RPT
Sbjct: 263 ----YHIAQNESPAL-------QSGHWS------------EYFRNFVDSCLQKIPQDRPT 299

Query: 412 AKEAMAHPYFFPIRNAESSRS 432
           ++  + H +   +        
Sbjct: 300 SEVLLKHRF---VLRERPPTV 317

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  109 bits (273), Expect = 4e-26
 Identities = 73/301 (24%), Positives = 125/301 (41%), Gaps = 63/301 (20%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK--------KIKREIKILQNLCG 187
           Y +   +G G + +V  G H     K  +KIL   ++K        KI+REI+ L+    
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVKILN--RQKIRSLDVVGKIRREIQNLKLFRH 75

Query: 188 GPNIVKLLDIVRDQQSKTPSLIF---EHVNNT---DFKVLYPTLSDYDVRYYIYELLKAL 241
            P+I+KL  ++      TPS IF   E+V+     D+      L + + R    ++L  +
Sbjct: 76  -PHIIKLYQVI-----STPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGV 129

Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 301
           DYCH   ++HRD+KP NV++D      ++ D+GL+     G+       S  +  PE++ 
Sbjct: 130 DYCHRHMVVHRDLKPENVLLD-AHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVIS 188

Query: 302 DLQDYD-YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 360
             + Y    +D+WS G +   ++    PF    D+   L K  K+            ++ 
Sbjct: 189 G-RLYAGPEVDIWSSGVILYALLCGTLPF--DDDHVPTLFK--KICD--------GIFYT 235

Query: 361 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 420
              P                       +L  P  +  L  +L+ D  +R T K+   H +
Sbjct: 236 ---PQ----------------------YLN-PSVISLLKHMLQVDPMKRATIKDIREHEW 269

Query: 421 F 421
           F
Sbjct: 270 F 270

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  106 bits (267), Expect = 1e-25
 Identities = 60/339 (17%), Positives = 113/339 (33%), Gaps = 55/339 (16%)

Query: 132 EQDDYEVVRKVGRG--KYSEVFEGVHCTDNEKCIIKILKPVKKKK-----IKREIKILQN 184
           E   YE++  +G+G      V    +    E   ++ +            ++ E+ + + 
Sbjct: 23  EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSK- 81

Query: 185 LCGGPNIVKLLD-IVRDQQ-----------SKTPSLIFEHVNNTDFKVLYPTLSDYDVRY 232
           L   PNIV      + D +           S    LI  H  +         +++  + Y
Sbjct: 82  LFNHPNIVPYRATFIADNELWVVTSFMAYGSAK-DLICTHFMDG--------MNELAIAY 132

Query: 233 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE--FYHPGKEYNVRVA 290
            +  +LKALDY H  G +HR VK  +++I     K+ L           H  ++  V   
Sbjct: 133 ILQGVLKALDYIHHMGYVHRSVKASHILIS-VDGKVYLSGLRSNLSMISHGQRQRVVHDF 191

Query: 291 SRYFKG------PELLV-DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYD---QLV 340
            +Y         PE+L  +LQ YD   D++S+G     +     PF     +      L+
Sbjct: 192 PKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK----DMPATQMLL 247

Query: 341 KIAK----VLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAV- 395
           +        L                     + +         +    ++          
Sbjct: 248 EKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFS 307

Query: 396 ----DFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAESS 430
                F+++ L+ +   RP+A   + H +F  I+   S 
Sbjct: 308 PHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASE 346

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  104 bits (262), Expect = 1e-25
 Identities = 71/311 (22%), Positives = 131/311 (42%), Gaps = 59/311 (18%)

Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL---KPVKKKKIKREIKILQNLCGGP 189
           +  Y    K+G+G    V+  +     ++  I+ +   +  KK+ I  EI +++     P
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE-NKNP 77

Query: 190 NIVKLLD--IVRDQQSKTPSL--IFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKALD 242
           NIV  LD  +V D+      L  + E++     TD  V    + +  +     E L+AL+
Sbjct: 78  NIVNYLDSYLVGDE------LWVVMEYLAGGSLTDV-VTETCMDEGQIAAVCRECLQALE 130

Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLV 301
           + HS  ++HRD+K  N+++      ++L D+G  A+      + +  V + Y+  PE +V
Sbjct: 131 FLHSNQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE-VV 188

Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 361
             + Y   +D+WSLG M   MI  + P+   +          + L           Y I 
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP--------LRAL-----------YLIA 229

Query: 362 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            +             P      ++N         DFL++ L  D ++R +AKE + H + 
Sbjct: 230 TNG-----------TP-----ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQF- 272

Query: 422 FPIRNAESSRS 432
             ++ A+   S
Sbjct: 273 --LKIAKPLSS 281

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  104 bits (262), Expect = 2e-25
 Identities = 70/317 (22%), Positives = 132/317 (41%), Gaps = 64/317 (20%)

Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGP 189
            + +E+V ++G G + +V++  +         K+++     + +    EI+IL   C  P
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILAT-CDHP 76

Query: 190 NIVKLLD-IVRDQQSKTPSL--IFEHVNN---TD-FKVLYPTLSDYDVRYYIYELLKALD 242
            IVKLL     D +     L  + E             L   L++  ++    ++L+AL+
Sbjct: 77  YIVKLLGAYYHDGK-----LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALN 131

Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLV 301
           + HS+ I+HRD+K  NV++   +  +RL D+G+ A+     ++ +  + + Y+  PE+++
Sbjct: 132 FLHSKRIIHRDLKAGNVLMT-LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVM 190

Query: 302 DLQ----DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 357
                   YDY  D+WSLG     M   + P    +          +VL           
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN--------PMRVL----------- 231

Query: 358 YHIELD--PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEA 415
             I     P L       +   WS             E  DFL   L  + + RP+A + 
Sbjct: 232 LKIAKSDPPTLL------TPSKWS------------VEFRDFLKIALDKNPETRPSAAQL 273

Query: 416 MAHPYFFPIRNAESSRS 432
           + HP+   + +  S+++
Sbjct: 274 LEHPF---VSSITSNKA 287

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  104 bits (261), Expect = 2e-25
 Identities = 73/311 (23%), Positives = 133/311 (42%), Gaps = 59/311 (18%)

Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGG 188
           ++ +  + K+G+G + EVF+G+     +   IKI+       + + I++EI +L   C  
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQ-CDS 79

Query: 189 PNIVKLLD-IVRDQQSKTPSLIFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKALDYC 244
           P + K     ++D +     +I E++      D  +    L +  +   + E+LK LDY 
Sbjct: 80  PYVTKYYGSYLKDTKL---WIIMEYLGGGSALDL-LEPGPLDETQIATILREILKGLDYL 135

Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDL 303
           HS+  +HRD+K  NV++  E  +++L D+G+  +      + N  V + ++  PE++   
Sbjct: 136 HSEKKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ- 193

Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363
             YD   D+WSLG     +   + P          +    KVL           + I  +
Sbjct: 194 SAYDSKADIWSLGITAIELARGEPPHS----ELHPM----KVL-----------FLIPKN 234

Query: 364 --PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
             P L           +SK               +F++  L  +   RPTAKE + H   
Sbjct: 235 NPPTL--------EGNYSK------------PLKEFVEACLNKEPSFRPTAKELLKHK-- 272

Query: 422 FPIRNAESSRS 432
           F +RNA+ +  
Sbjct: 273 FILRNAKKTSY 283

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  104 bits (261), Expect = 2e-25
 Identities = 64/311 (20%), Positives = 127/311 (40%), Gaps = 59/311 (18%)

Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL---KPVKKKKIKREIKILQNLCGGP 189
           +   +   K+G G    V          +  +K++   K  +++ +  E+ I+++     
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRD-YQHF 102

Query: 190 NIVKLLD--IVRDQQSKTPSL--IFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKALD 242
           N+V++    +V ++      L  + E +     TD  V    L++  +      +L+AL 
Sbjct: 103 NVVEMYKSYLVGEE------LWVLMEFLQGGALTDI-VSQVRLNEEQIATVCEAVLQALA 155

Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLV 301
           Y H+QG++HRD+K  ++++     +++L D+G  A+      +    V + Y+  PE++ 
Sbjct: 156 YLHAQGVIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVIS 214

Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 361
               Y   +D+WSLG M   M+  + P+F             + +             + 
Sbjct: 215 R-SLYATEVDIWSLGIMVIEMVDGEPPYFSDS--------PVQAM-----------KRLR 254

Query: 362 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
             P            P      ++N H   P   DFL+++L  D QER TA+E + HP+ 
Sbjct: 255 DSP-----------PP-----KLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPF- 297

Query: 422 FPIRNAESSRS 432
             +        
Sbjct: 298 --LLQTGLPEC 306

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  104 bits (261), Expect = 3e-25
 Identities = 56/328 (17%), Positives = 113/328 (34%), Gaps = 88/328 (26%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL----KPVKKKKIKREIKILQNLCGGP 189
           +D E + ++G G   +V++           +K +       + K+I  ++ ++      P
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84

Query: 190 NIVK---------------------LLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY 228
            IV+                        + +    +    I E +               
Sbjct: 85  YIVQCFGTFITNTDVFIAMELMGTCAEKLKK----RMQGPIPERI--------------- 125

Query: 229 DVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV 287
            +      ++KAL Y   + G++HRDVKP N+++D  + +++L D+G++      K  + 
Sbjct: 126 -LGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDE-RGQIKLCDFGISGRLVDDKAKDR 183

Query: 288 RVASRYFKGPE----LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA 343
                 +  PE          DYD   D+WSLG     +   + P+     +++ L K+ 
Sbjct: 184 SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVL 243

Query: 344 KVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLR 403
           +                E  P L           +S             +   F+   L 
Sbjct: 244 Q----------------EEPPLLP------GHMGFS------------GDFQSFVKDCLT 269

Query: 404 YDHQERPTAKEAMAHPYFFPIRNAESSR 431
            DH++RP   + + H +   I+  E+  
Sbjct: 270 KDHRKRPKYNKLLEHSF---IKRYETLE 294

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  105 bits (263), Expect = 4e-25
 Identities = 81/403 (20%), Positives = 142/403 (35%), Gaps = 107/403 (26%)

Query: 109 YSDINVVRPREYWDYESLTVQWGE--QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI 166
             D     P +Y       V+ G+     Y V+RK+G G +S V+        +   +K+
Sbjct: 10  SDDDEQEDPNDYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKV 69

Query: 167 LKPVKK--KKIKREIKILQNLC-------GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD 217
           +K  +   +    EI++L+++            +V+LLD             F+      
Sbjct: 70  VKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDD------------FKISGVNG 117

Query: 218 ------FKVLYPTLSDY------------DVRYYIYELLKALDYCHSQ-GIMHRDVKPHN 258
                 F+VL   L  +             V+  I ++L+ LDY H++  I+H D+KP N
Sbjct: 118 THICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPEN 177

Query: 259 VMI------------------------------------------------DHEQRKLRL 270
           +++                                                + E+ K+++
Sbjct: 178 ILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKI 237

Query: 271 IDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
            D G A      K +   + +R ++  E+L+    Y+   D+WS  CM    +   +  F
Sbjct: 238 ADLGNA--CWVHKHFTEDIQTRQYRSLEVLIGS-GYNTPADIWSTACMAFE-LATGDYLF 293

Query: 331 YGHDNY------DQLVKIAKVLGT--DELNAYLNKYHIELDPHLAALVGRHSRKPWSKF- 381
             H         D +  I ++LG    +L                 L      KPW  F 
Sbjct: 294 EPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKK-GDLKHITKLKPWGLFE 352

Query: 382 ITVENQHLAVPEA---VDFLDKLLRYDHQERPTAKEAMAHPYF 421
           + VE    +  EA    DFL  +L    ++R TA E + HP+ 
Sbjct: 353 VLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWL 395

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  104 bits (260), Expect = 5e-25
 Identities = 66/326 (20%), Positives = 115/326 (35%), Gaps = 68/326 (20%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI----LKPVKKKKIKREIKILQNLCGGP 189
           DD+E + ++G G    VF+  H         K+    +KP  + +I RE+++L   C  P
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE-CNSP 91

Query: 190 NIVK----------------------LLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSD 227
            IV                       L  ++     K    I E +              
Sbjct: 92  YIVGFYGAFYSDGEISICMEHMDGGSLDQVL-----KKAGRIPEQI-------------- 132

Query: 228 YDVRYYIYELLKALDYCHSQG-IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--- 283
             +      ++K L Y   +  IMHRDVKP N++++  + +++L D+G++     G+   
Sbjct: 133 --LGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS-RGEIKLCDFGVS-----GQLID 184

Query: 284 -EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKI 342
              N  V +R +  PE L     Y    D+WS+G     M   + P     D  +  +  
Sbjct: 185 SMANSFVGTRSYMSPERL-QGTHYSVQSDIWSMGLSLVEMAVGRYPIP-PPDAKELELMF 242

Query: 343 AKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAV-------PEAV 395
              +  D               +   +  R     +     + N+            E  
Sbjct: 243 GCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQ 302

Query: 396 DFLDKLLRYDHQERPTAKEAMAHPYF 421
           DF++K L  +  ER   K+ M H + 
Sbjct: 303 DFVNKCLIKNPAERADLKQLMVHAFI 328

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  101 bits (254), Expect = 3e-24
 Identities = 63/333 (18%), Positives = 118/333 (35%), Gaps = 93/333 (27%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL----KPVKKKKIKREIKILQNLCGGP 189
           +D + + ++GRG Y  V + VH    +   +K +       ++K++  ++ ++      P
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81

Query: 190 NIVK---------------------LLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY 228
            IV+                          +   S    +I E +               
Sbjct: 82  YIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEI--------------- 126

Query: 229 DVRYYIYELLKALDYCHSQG-IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV 287
            +       +KAL++      I+HRD+KP N+++D     ++L D+G++       +   
Sbjct: 127 -LGKITLATVKALNHLKENLKIIHRDIKPSNILLDR-SGNIKLCDFGIS------GQLVD 178

Query: 288 RVASRYFKG------PELL---VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQ 338
            +A     G      PE +      Q YD   D+WSLG     +   + P+   +  +DQ
Sbjct: 179 SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ 238

Query: 339 LVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFL 398
           L ++ K                   P L+    R     +S            P  ++F+
Sbjct: 239 LTQVVK----------------GDPPQLSNSEERE----FS------------PSFINFV 266

Query: 399 DKLLRYDHQERPTAKEAMAHPYFFPIRNAESSR 431
           +  L  D  +RP  KE + HP+   I   E   
Sbjct: 267 NLCLTKDESKRPKYKELLKHPF---ILMYEERA 296

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 98.8 bits (247), Expect = 2e-23
 Identities = 75/316 (23%), Positives = 129/316 (40%), Gaps = 75/316 (23%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKI---KREIKILQNLCG 187
           +D++  + +G G +S V        + +  IKIL+    +K+ K+    RE  ++  L  
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-D 88

Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYP--TLSDYDVRYYIYELLKALDYC 244
            P  VKL    +D +         +  N +  K +    +  +   R+Y  E++ AL+Y 
Sbjct: 89  HPFFVKLYFTFQDDEKLY--FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 146

Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------PE 298
           H +GI+HRD+KP N++++ +   +++ D+G A+     +    R  S  F G      PE
Sbjct: 147 HGKGIIHRDLKPENILLNEDMH-IQITDFGTAK-VLSPESKQARANS--FVGTAQYVSPE 202

Query: 299 LLVDLQDYDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAY 354
           LL + +    S DLW+LGC    + AG+     P F   + Y    KI K          
Sbjct: 203 LLTE-KSACKSSDLWALGCIIYQLVAGL-----PPFRAGNEYLIFQKIIK---------- 246

Query: 355 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT--- 411
             +Y                   + +           P+A D ++KLL  D  +R     
Sbjct: 247 -LEYD------------------FPEKFF--------PKARDLVEKLLVLDATKRLGCEE 279

Query: 412 ---AKEAMAHPYFFPI 424
                   AHP+F  +
Sbjct: 280 MEGYGPLKAHPFFESV 295

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  100 bits (251), Expect = 4e-23
 Identities = 68/332 (20%), Positives = 123/332 (37%), Gaps = 74/332 (22%)

Query: 122 DYESLTVQWGEQ-------DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK 174
            Y +  +QW          + +   R +G+G + EV         +    K L+   KK+
Sbjct: 165 IYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLE---KKR 221

Query: 175 IKR---------EIKILQNLCGGPNIVKLLDIVRDQQSKTPS---LIFEHVNNTD----- 217
           IK+         E +IL+       +V L         +T     L+   +N  D     
Sbjct: 222 IKKRKGEAMALNEKQILE-KVNSRFVVSLA-----YAYETKDALCLVLTLMNGGDLKFHI 275

Query: 218 FKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277
           + +      +    +Y  E+   L+  H + I++RD+KP N+++D     +R+ D GLA 
Sbjct: 276 YHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGH-IRISDLGLAV 334

Query: 278 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYD 337
               G+    RV +  +  PE++ + + Y +S D W+LGC+   MI  + P F       
Sbjct: 335 HVPEGQTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSP-FQQRKKKI 392

Query: 338 QLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDF 397
           +  ++ +++          +Y                                 P+A   
Sbjct: 393 KREEVERLVKEVPE-----EYSERFS----------------------------PQARSL 419

Query: 398 LDKLLRYDHQER-----PTAKEAMAHPYFFPI 424
             +LL  D  ER      +A+E   HP F  +
Sbjct: 420 CSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 99.2 bits (247), Expect = 2e-22
 Identities = 90/403 (22%), Positives = 147/403 (36%), Gaps = 71/403 (17%)

Query: 46  PLSQSSRIFTPFGTLRGLASSASLS--HARHQHQRLRQLATPPDTLAQKIGKSVRRSGAP 103
            L  S  IF  +     LA S   S     H    L +   PPD L Q   + + ++   
Sbjct: 101 RLVCSREIFDTYIMKELLACSHPFSKSAIEHVQGHLVKKQVPPD-LFQPYIEEICQNLRG 159

Query: 104 SKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI 163
              + + + +       W    L +     +D+ V R +GRG + EV+        +   
Sbjct: 160 DVFQKFIESDKFTRFCQWKNVELNIHLTM-NDFSVHRIIGRGGFGEVYGCRKADTGKMYA 218

Query: 164 IKILKPVKKKKIKR---------EIKILQ--NLCGGPNIVKLLDIVRDQQSKTPS---LI 209
           +K L    KK+IK          E  +L   +    P IV +          TP     I
Sbjct: 219 MKCLD---KKRIKMKQGETLALNERIMLSLVSTGDCPFIVCM-----SYAFHTPDKLSFI 270

Query: 210 FEHVNNTD-FKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR 266
            + +N  D    L      S+ D+R+Y  E++  L++ H++ +++RD+KP N+++D    
Sbjct: 271 LDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH 330

Query: 267 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRK 326
            +R+ D GLA      K+ +  V +  +  PE+L     YD S D +SLGCM   ++   
Sbjct: 331 -VRISDLGLAC-DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

Query: 327 EPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVEN 386
            P F  H   D+       L                                    +   
Sbjct: 389 SP-FRQHKTKDKHEIDRMTL--------------------------TMAVELPDSFS--- 418

Query: 387 QHLAVPEAVDFLDKLLRYDHQER-----PTAKEAMAHPYFFPI 424
                PE    L+ LL+ D   R       A+E    P+F  +
Sbjct: 419 -----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 96.4 bits (240), Expect = 1e-21
 Identities = 74/340 (21%), Positives = 124/340 (36%), Gaps = 87/340 (25%)

Query: 122 DYESLTVQWGEQ-------DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK 174
            Y    +QW          D +   R +GRG + EVF        +    K L    KK+
Sbjct: 166 LYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLN---KKR 222

Query: 175 IKR---------EIKILQNLCGGPNIVKL-------------LDIVR--DQQSKTPSLIF 210
           +K+         E KIL        IV L             + I+   D        I 
Sbjct: 223 LKKRKGYQGAMVEKKILA-KVHSRFIVSLAYAFETKTDLCLVMTIMNGGD--------IR 273

Query: 211 EHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRL 270
            H+ N D     P   +    +Y  +++  L++ H + I++RD+KP NV++D +   +R+
Sbjct: 274 YHIYNVDED--NPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGN-VRI 330

Query: 271 IDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
            D GLA E      +      +  F  PELL+  ++YD+S+D ++LG     MI  + P 
Sbjct: 331 SDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGP- 388

Query: 330 FYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHL 389
           F       +  ++ + +    +      Y  +                            
Sbjct: 389 FRARGEKVENKELKQRVLEQAV-----TYPDKFS-------------------------- 417

Query: 390 AVPEAVDFLDKLLRYDHQER-----PTAKEAMAHPYFFPI 424
             P + DF + LL+ D ++R      +      HP F  I
Sbjct: 418 --PASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 92.3 bits (230), Expect = 3e-21
 Identities = 66/326 (20%), Positives = 118/326 (36%), Gaps = 83/326 (25%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVKKKKIKREIKILQNLCGGP 189
           DD E + ++GRG Y  V +  H    +    K I   +   ++K++  ++ I       P
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66

Query: 190 NIVKL--------------------LDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD 229
             V                      LD    Q       I E +                
Sbjct: 67  FTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDI---------------- 110

Query: 230 VRYYIYELLKALDYCHSQG-IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR 288
           +      ++KAL++ HS+  ++HRDVKP NV+I+    ++++ D+G++ +       ++ 
Sbjct: 111 LGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINA-LGQVKMCDFGISGYLVDDVAKDID 169

Query: 289 VASRYFKGPE---LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV 345
              + +  PE     ++ + Y    D+WSLG     +   + P+      + QL ++ + 
Sbjct: 170 AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE- 228

Query: 346 LGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYD 405
                          E  P L           +S             E VDF  + L+ +
Sbjct: 229 ---------------EPSPQL-------PADKFS------------AEFVDFTSQCLKKN 254

Query: 406 HQERPTAKEAMAHPYFFPIRNAESSR 431
            +ERPT  E M HP+       ES  
Sbjct: 255 SKERPTYPELMQHPF---FTLHESKG 277

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 91.5 bits (227), Expect = 6e-20
 Identities = 43/203 (21%), Positives = 80/203 (39%), Gaps = 17/203 (8%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCT-DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPN 190
           YEV   +  G    ++  +    +    ++K L        +     E + L  +   P+
Sbjct: 82  YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEV-VHPS 140

Query: 191 IVKLLDIVRDQQSKTPSLIF---EHVNNTDFK-VLYPTLSDYDVRYYIYELLKALDYCHS 246
           IV++ + V         + +   E+V     K      L   +   Y+ E+L AL Y HS
Sbjct: 141 IVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHS 200

Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 306
            G+++ D+KP N+M+  EQ K  LID G          +     +  F+ PE++      
Sbjct: 201 IGLVYNDLKPENIMLTEEQLK--LIDLGAV---SRINSFGYLYGTPGFQAPEIVRTGPT- 254

Query: 307 DYSLDLWSLGCMFAGMIFRKEPF 329
             + D++++G   A +       
Sbjct: 255 VAT-DIYTVGRTLAALTLDLPTR 276

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 87.4 bits (217), Expect = 4e-19
 Identities = 57/313 (18%), Positives = 111/313 (35%), Gaps = 71/313 (22%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVKKKK----IKREIKILQNLCG 187
           D +E++R +G+G + +V         +   +K +      ++     + +E++I+Q L  
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-E 73

Query: 188 GPNIVKLLDIVRDQQS-KTPS---LIFEHVNNTD-FKVLY--PTLSDYDVRYYIYELLKA 240
            P +V L        S +      ++ + +   D    L       +  V+ +I EL+ A
Sbjct: 74  HPFLVNL------WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMA 127

Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG---- 296
           LDY  +Q I+HRD+KP N+++D E   + + D+ +A                   G    
Sbjct: 128 LDYLQNQRIIHRDMKPDNILLD-EHGHVHITDFNIA------AMLPRETQITTMAGTKPY 180

Query: 297 --PELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELN 352
             PE+        Y +++D WSLG     ++  + P ++   +      +          
Sbjct: 181 MAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP-YHIRSSTSSKEIVHTFE------ 233

Query: 353 AYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQER-PT 411
                                +   +    +         E V  L KLL  +  +R   
Sbjct: 234 --------------------TTVVTYPSAWS--------QEMVSLLKKLLEPNPDQRFSQ 265

Query: 412 AKEAMAHPYFFPI 424
             +    PY   I
Sbjct: 266 LSDVQNFPYMNDI 278

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 85.1 bits (211), Expect = 3e-18
 Identities = 70/325 (21%), Positives = 121/325 (37%), Gaps = 85/325 (26%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR--------EIKILQNL 185
           DD+E+++ +GRG +SEV         +   +KI+   K   +KR        E  +L N 
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMN--KWDMLKRGEVSCFREERDVLVN- 117

Query: 186 CGGPNIVKLLDIVRDQQS-KTPS---LIFEHVNNTD-FKVLY---PTLSDYDVRYYIYEL 237
                I +L        + +  +   L+ E+    D   +L      +     R+Y+ E+
Sbjct: 118 GDRRWITQL------HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEI 171

Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV--RVASRYFK 295
           + A+D  H  G +HRD+KP N+++D     +RL D+G         +      V S    
Sbjct: 172 VMAIDSVHRLGYVHRDIKPDNILLDRCG-HIRLADFGSC------LKLRADGTVRSLVAV 224

Query: 296 G------PELL------VDLQDYDYSLDLWSLG-CMFAGMIFRKEPFFYGHDNYDQLVKI 342
           G      PE+L           Y    D W+LG   +  M + + PF+   D+  +    
Sbjct: 225 GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYE-MFYGQTPFY--ADSTAET--Y 279

Query: 343 AKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLL 402
            K++   + +  L      +                              EA DF+ +LL
Sbjct: 280 GKIV-HYKEHLSLPLVDEGVP----------------------------EEARDFIQRLL 310

Query: 403 RYDHQER---PTAKEAMAHPYFFPI 424
               + R     A +   HP+FF +
Sbjct: 311 C-PPETRLGRGGAGDFRTHPFFFGL 334

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 83.9 bits (208), Expect = 5e-18
 Identities = 66/314 (21%), Positives = 119/314 (37%), Gaps = 77/314 (24%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVKKKK----IKREIKILQNLCG 187
           D ++ ++ +G G +  V    H        +KIL    V K K       E +ILQ    
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 99

Query: 188 GPNIVKLLDIVRDQQSKTPS---LIFEHVNNTD-FKVLY--PTLSDYDVRYYIYELLKAL 241
            P +VKL     +   K  S   ++ E+V   + F  L      S+   R+Y  +++   
Sbjct: 100 FPFLVKL-----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154

Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG----- 296
           +Y HS  +++RD+KP N++ID +   +++ D+G A      K    R  +    G     
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFA------KRVKGRTWT--LCGTPEAL 205

Query: 297 -PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 355
            PE+++  + Y+ ++D W+LG +   M     PFF   D   Q+ +  K++         
Sbjct: 206 APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF--ADQPIQIYE--KIV--------- 251

Query: 356 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQER-----P 410
                              +  +    +         +  D L  LL+ D  +R      
Sbjct: 252 -----------------SGKVRFPSHFS--------SDLKDLLRNLLQVDLTKRFGNLKN 286

Query: 411 TAKEAMAHPYFFPI 424
              +   H +F   
Sbjct: 287 GVNDIKNHKWFATT 300

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 83.8 bits (208), Expect = 6e-18
 Identities = 74/321 (23%), Positives = 126/321 (39%), Gaps = 88/321 (27%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR--------EIKILQNL 185
            D+  ++ +G+G + +V    H  +     +K+L+  KK  +K+        E  +L   
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQ--KKAILKKKEEKHIMSERNVLLKN 95

Query: 186 CGGPNIVKLLDIVRDQQS-KTPS---LIFEHVNNTD-FKVLY--PTLSDYDVRYYIYELL 238
              P +V L        S +T      + +++N  + F  L       +   R+Y  E+ 
Sbjct: 96  VKHPFLVGL------HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIA 149

Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGK---------EYNVR 288
            AL Y HS  I++RD+KP N+++D +   + L D+GL  E               EY   
Sbjct: 150 SALGYLHSLNIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNSTTSTFCGTPEY--- 205

Query: 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
           +A      PE+L   Q YD ++D W LG +   M++   P FY  +             T
Sbjct: 206 LA------PEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPP-FYSRN-------------T 244

Query: 349 DEL-NAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQ 407
            E+ +  LNK  ++L P++                           A   L+ LL+ D  
Sbjct: 245 AEMYDNILNK-PLQLKPNIT------------------------NSARHLLEGLLQKDRT 279

Query: 408 ER----PTAKEAMAHPYFFPI 424
           +R        E  +H +F  I
Sbjct: 280 KRLGAKDDFMEIKSHVFFSLI 300

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 83.4 bits (207), Expect = 6e-18
 Identities = 71/323 (21%), Positives = 125/323 (38%), Gaps = 81/323 (25%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVKKKK----IKREIKILQNLCG 187
            D++++R +GRG Y++V        +    +K++K   V   +    ++ E  + +    
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68

Query: 188 GPNIVKLLDIVRDQQSK----TPS---LIFEHVNNTD-FKVLY--PTLSDYDVRYYIYEL 237
            P +V L              T S    + E+VN  D    +     L +   R+Y  E+
Sbjct: 69  HPFLVGL---------HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEI 119

Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGK---------EYNV 287
             AL+Y H +GI++RD+K  NV++D E   ++L D+G+  E   PG           Y  
Sbjct: 120 SLALNYLHERGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNY-- 176

Query: 288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG 347
            +A      PE+L   +DY +S+D W+LG +   M+  + PF     + +          
Sbjct: 177 -IA------PEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN-----T 223

Query: 348 TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQ 407
            D L   + +  I +   L+                         +A   L   L  D +
Sbjct: 224 EDYLFQVILEKQIRIPRSLS------------------------VKAASVLKSFLNKDPK 259

Query: 408 ER------PTAKEAMAHPYFFPI 424
           ER          +   HP+F  +
Sbjct: 260 ERLGCHPQTGFADIQGHPFFRNV 282

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 84.0 bits (208), Expect = 9e-18
 Identities = 64/322 (19%), Positives = 122/322 (37%), Gaps = 81/322 (25%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR--------EIKILQNL 185
           +D+E+++ +GRG + EV        ++   +KIL   K + +KR        E  +L N 
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILN--KWEMLKRAETACFREERDVLVN- 130

Query: 186 CGGPNIVKLLDIVRDQQS-KTPS---LIFEHVNNTD-FKVLY---PTLSDYDVRYYIYEL 237
                I  L        + +  +   L+ ++    D   +L      L +   R+Y+ E+
Sbjct: 131 GDSKWITTL------HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEM 184

Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE--YNVRVASRYFK 295
           + A+D  H    +HRD+KP N+++D     +RL D+G         +   +  V S    
Sbjct: 185 VIAIDSVHQLHYVHRDIKPDNILMDMNG-HIRLADFGSC------LKLMEDGTVQSSVAV 237

Query: 296 G------PELLVDLQD----YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV 345
           G      PE+L  ++     Y    D WSLG     M++ + PF+   ++  +     K+
Sbjct: 238 GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFY--AESLVET--YGKI 293

Query: 346 LGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYD 405
           +         +K   +    +  +                        A D + +L+   
Sbjct: 294 MN--------HKERFQFPTQVTDV---------------------SENAKDLIRRLIC-S 323

Query: 406 HQER---PTAKEAMAHPYFFPI 424
            + R      ++   HP+F  I
Sbjct: 324 REHRLGQNGIEDFKKHPFFSGI 345

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 82.3 bits (204), Expect = 2e-17
 Identities = 74/319 (23%), Positives = 129/319 (40%), Gaps = 84/319 (26%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR--------EIKILQNL 185
           +D++ ++ +G+G + +V             +KIL+  K+  I +        E ++LQN 
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILR--KEVIIAKDEVAHTVTESRVLQN- 61

Query: 186 CGGPNIVKLLDIVRDQQSKTPS---LIFEHVNNTD-FKVLY--PTLSDYDVRYYIYELLK 239
              P +  L         +T      + E+ N  + F  L      ++   R+Y  E++ 
Sbjct: 62  TRHPFLTALK-----YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVS 116

Query: 240 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKG 296
           AL+Y HS+ +++RD+K  N+M+D +   +++ D+GL       KE       + +  F G
Sbjct: 117 ALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLC------KEGISDGATMKT--FCG 167

Query: 297 ------PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE 350
                 PE+L D  DY  ++D W LG +   M+  + P FY  D+      I      +E
Sbjct: 168 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLP-FYNQDHERLFELILM----EE 221

Query: 351 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQER- 409
           +     ++   L                             PEA   L  LL+ D ++R 
Sbjct: 222 I-----RFPRTLS----------------------------PEAKSLLAGLLKKDPKQRL 248

Query: 410 ----PTAKEAMAHPYFFPI 424
                 AKE M H +F  I
Sbjct: 249 GGGPSDAKEVMEHRFFLSI 267

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 82.1 bits (203), Expect = 3e-17
 Identities = 72/320 (22%), Positives = 119/320 (37%), Gaps = 81/320 (25%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKIKR---EIKILQNLCG 187
           +DYEVV+ +GRG + EV    H +  +   +K+L     +K+        E  I+     
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF-AN 127

Query: 188 GPNIVKLLDIVRDQQS-KTPS---LIFEHVNNTDFKVLYPTLSDYD-----VRYYIYELL 238
            P +V+L        + +      ++ E++   D   L   +S+YD      R+Y  E++
Sbjct: 128 SPWVVQL------FYAFQDDRYLYMVMEYMPGGD---LVNLMSNYDVPEKWARFYTAEVV 178

Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV--RVASRYFKG 296
            ALD  HS G +HRDVKP N+++D     L+L D+G         + N    V      G
Sbjct: 179 LALDAIHSMGFIHRDVKPDNMLLDK-SGHLKLADFGTC------MKMNKEGMVRCDTAVG 231

Query: 297 ------PELLVD---LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG 347
                 PE+L        Y    D WS+G     M+    PF+   D+       +K++ 
Sbjct: 232 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY--ADSLVGT--YSKIM- 286

Query: 348 TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQ 407
                 + N      D  ++                         EA + +   L  D +
Sbjct: 287 -----NHKNSLTFPDDNDIS------------------------KEAKNLICAFLT-DRE 316

Query: 408 ER---PTAKEAMAHPYFFPI 424
            R      +E   H +F   
Sbjct: 317 VRLGRNGVEEIKRHLFFKND 336

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 81.2 bits (201), Expect = 5e-17
 Identities = 70/323 (21%), Positives = 125/323 (38%), Gaps = 81/323 (25%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVKKKK----IKREIKILQNLCG 187
            D++++R +GRG Y++V        +    ++++K   V   +    ++ E  + +    
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111

Query: 188 GPNIVKLLDIVRDQQSK----TPS---LIFEHVNNTD-FKVLY--PTLSDYDVRYYIYEL 237
            P +V L              T S    + E+VN  D    +     L +   R+Y  E+
Sbjct: 112 HPFLVGL---------HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEI 162

Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGK---------EYNV 287
             AL+Y H +GI++RD+K  NV++D E   ++L D+G+  E   PG           Y  
Sbjct: 163 SLALNYLHERGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNY-- 219

Query: 288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG 347
            +A      PE+L   +DY +S+D W+LG +   M+  + PF     + +          
Sbjct: 220 -IA------PEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN-----T 266

Query: 348 TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQ 407
            D L   + +  I +   L+                         +A   L   L  D +
Sbjct: 267 EDYLFQVILEKQIRIPRSLS------------------------VKAASVLKSFLNKDPK 302

Query: 408 ER------PTAKEAMAHPYFFPI 424
           ER          +   HP+F  +
Sbjct: 303 ERLGCHPQTGFADIQGHPFFRNV 325

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 80.5 bits (199), Expect = 5e-17
 Identities = 39/156 (25%), Positives = 71/156 (45%), Gaps = 18/156 (11%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-PVKKKKIKREIKILQNLCGGPNIVKL 194
           + V +K+G G + E+  G +   NE   IK+     +  ++  E +  + L  G  I ++
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQV 70

Query: 195 LDIVRDQQSKT-------PSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ 247
                  +          PSL  E +    F +   T S   V     +L+  ++Y HS+
Sbjct: 71  YYFGPCGKYNAMVLELLGPSL--EDL----FDLCDRTFSLKTVLMIAIQLISRMEYVHSK 124

Query: 248 GIMHRDVKPHNVMI----DHEQRKLRLIDWGLAEFY 279
            +++RDVKP N +I    +  Q+ + +ID+ LA+ Y
Sbjct: 125 NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 80.7 bits (200), Expect = 5e-17
 Identities = 65/325 (20%), Positives = 113/325 (34%), Gaps = 95/325 (29%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKI---------KREIKILQN 184
            D+  +  +G+G + +V        +E   +KILK   K  +           E ++L  
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILK---KDVVIQDDDVECTMVEKRVLAL 76

Query: 185 LCGGPNIVKLLDIVRDQQSKTPS---LIFEHVNNTD-FKVLYPT--LSDYDVRYYIYELL 238
               P + +L         +T      + E+VN  D    +       +    +Y  E+ 
Sbjct: 77  PGKPPFLTQLH-----SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIA 131

Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGK---------EYNVR 288
             L +  S+GI++RD+K  NVM+D E   +++ D+G+  E    G          +Y   
Sbjct: 132 IGLFFLQSKGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDY--- 187

Query: 289 VASRYFKGPELLVDLQDYDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVKIAK 344
           +A      PE++   Q Y  S+D W+ G     M AG     +  F G D  +    I +
Sbjct: 188 IA------PEIIAY-QPYGKSVDWWAFGVLLYEMLAG-----QAPFEGEDEDELFQSIME 235

Query: 345 VLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRY 404
                 +                         P  K ++         EAV     L+  
Sbjct: 236 ----HNV-----------------------AYP--KSMS--------KEAVAICKGLMTK 258

Query: 405 DHQER----PT-AKEAMAHPYFFPI 424
              +R    P   ++   H +F  I
Sbjct: 259 HPGKRLGCGPEGERDIKEHAFFRYI 283

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 80.7 bits (200), Expect = 6e-17
 Identities = 68/326 (20%), Positives = 115/326 (35%), Gaps = 96/326 (29%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKI---------KREIKILQN 184
           D++E +R +G+G + +V         +   +K+LK   K  I           E +IL  
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLK---KDVILQDDDVECTMTEKRILSL 79

Query: 185 LCGGPNIVKLLDIVRDQQSK----TPS---LIFEHVNNTD-FKVLYPT--LSDYDVRYYI 234
               P + +L              TP     + E VN  D    +  +    +   R+Y 
Sbjct: 80  ARNHPFLTQL---------FCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYA 130

Query: 235 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGK---------E 284
            E++ AL + H +GI++RD+K  NV++DHE    +L D+G+  E    G          +
Sbjct: 131 AEIISALMFLHDKGIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGICNGVTTATFCGTPD 189

Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
           Y   +A      PE+L +   Y  ++D W++G +   M+    P F   +  D    I  
Sbjct: 190 Y---IA------PEILQE-MLYGPAVDWWAMGVLLYEMLCGHAP-FEAENEDDLFEAILN 238

Query: 345 VLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRY 404
               DE+      Y   L                              +A   L   +  
Sbjct: 239 ----DEV-----VYPTWLH----------------------------EDATGILKSFMTK 261

Query: 405 DHQER------PTAKEAMAHPYFFPI 424
           +   R            + HP+F  I
Sbjct: 262 NPTMRLGSLTQGGEHAILRHPFFKEI 287

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 80.3 bits (199), Expect = 6e-17
 Identities = 59/314 (18%), Positives = 120/314 (38%), Gaps = 77/314 (24%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVKKKK----IKREIKILQNLCG 187
            D++++R +G G +  V       +     +K+LK   V + K       E  +L  +  
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-T 64

Query: 188 GPNIVKLLDIVRDQQSKTPS---LIFEHVNNTD-FKVLY--PTLSDYDVRYYIYELLKAL 241
            P I+++         +      +I +++   + F +L       +   ++Y  E+  AL
Sbjct: 65  HPFIIRMWG-----TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLAL 119

Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG----- 296
           +Y HS+ I++RD+KP N+++D     +++ D+G A      K       +    G     
Sbjct: 120 EYLHSKDIIYRDLKPENILLDKNGH-IKITDFGFA------KYVPDVTYT--LCGTPDYI 170

Query: 297 -PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 355
            PE++   + Y+ S+D WS G +   M+    PF+    N  +  +  K+L         
Sbjct: 171 APEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFY--DSNTMKTYE--KIL--------- 216

Query: 356 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQER-----P 410
                            ++   +  F           +  D L +L+  D  +R      
Sbjct: 217 -----------------NAELRFPPFFN--------EDVKDLLSRLITRDLSQRLGNLQN 251

Query: 411 TAKEAMAHPYFFPI 424
             ++   HP+F  +
Sbjct: 252 GTEDVKNHPWFKEV 265

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 79.7 bits (197), Expect = 7e-17
 Identities = 39/154 (25%), Positives = 69/154 (44%), Gaps = 16/154 (10%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIVKL 194
           Y + RK+G G + +++ G      E+  IK+     K  ++  E KI + + GG  I  +
Sbjct: 11  YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 70

Query: 195 LDIVRDQQSKT-------PSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ 247
                +            PSL  E +    F       S   V     +++  ++Y HS+
Sbjct: 71  RWCGAEGDYNVMVMELLGPSL--EDL----FNFCSRKFSLKTVLLLADQMISRIEYIHSK 124

Query: 248 GIMHRDVKPHNVMIDHEQR--KLRLIDWGLAEFY 279
             +HRDVKP N ++   ++   + +ID+GLA+ Y
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 80.4 bits (199), Expect = 7e-17
 Identities = 71/328 (21%), Positives = 137/328 (41%), Gaps = 90/328 (27%)

Query: 134 DDYEVVRKVGRGKYSEVF--EGVHCTDNEK-CIIKILKP---VKKKK----IKREIKILQ 183
           +++E+++ +G G Y +VF    +   D  K   +K+LK    V+K K     + E ++L+
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113

Query: 184 NLCGGPNIVKLLDIVRDQQS-KTPS---LIFEHVNNTD-FKVLY--PTLSDYDVRYYIYE 236
           ++   P +V L        + +T +   LI +++N  + F  L      ++++V+ Y+ E
Sbjct: 114 HIRQSPFLVTL------HYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGE 167

Query: 237 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE----YNVRVASR 292
           ++ AL++ H  GI++RD+K  N+++D     + L D+GL+      KE       R    
Sbjct: 168 IVLALEHLHKLGIIYRDIKLENILLDSNGH-VVLTDFGLS------KEFVADETERAYD- 219

Query: 293 YFKG------PELLVDL-QDYDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVK 341
            F G      P+++      +D ++D WSLG     +  G        F      +   +
Sbjct: 220 -FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA-----SPFTVDGEKNSQAE 273

Query: 342 IAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKL 401
           I++ +   E                          P+ + ++          A D + +L
Sbjct: 274 ISRRILKSEP-------------------------PYPQEMS--------ALAKDLIQRL 300

Query: 402 LRYDHQER----PT-AKEAMAHPYFFPI 424
           L  D ++R    P  A E   H +F  I
Sbjct: 301 LMKDPKKRLGCGPRDADEIKEHLFFQKI 328

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 81.6 bits (201), Expect = 8e-17
 Identities = 65/319 (20%), Positives = 114/319 (35%), Gaps = 83/319 (26%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR--------EIKILQNL 185
            D+  +  +G+G + +V        +E   +KILK  K   I+         E ++L   
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILK--KDVVIQDDDVECTMVEKRVLALP 398

Query: 186 CGGPNIVKLLDIVRDQQSKTPS---LIFEHVNNTD-FKVLYPT--LSDYDVRYYIYELLK 239
              P + +L         +T      + E+VN  D    +       +    +Y  E+  
Sbjct: 399 GKPPFLTQLH-----SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAI 453

Query: 240 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKG 296
            L +  S+GI++RD+K  NVM+D E   +++ D+G+       KE     V   +  F G
Sbjct: 454 GLFFLQSKGIIYRDLKLDNVMLDSEGH-IKIADFGMC------KENIWDGVTTKT--FCG 504

Query: 297 ------PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE 350
                 PE++   Q Y  S+D W+ G +   M+  + P F G D  +    I +      
Sbjct: 505 TPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAP-FEGEDEDELFQSIME----HN 558

Query: 351 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQER- 409
           +                         P  K ++         EAV     L+     +R 
Sbjct: 559 V-----------------------AYP--KSMS--------KEAVAICKGLMTKHPGKRL 585

Query: 410 ----PTAKEAMAHPYFFPI 424
                  ++   H +F  I
Sbjct: 586 GCGPEGERDIKEHAFFRYI 604

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 79.3 bits (196), Expect = 1e-16
 Identities = 33/156 (21%), Positives = 67/156 (42%), Gaps = 18/156 (11%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIVKL 194
           Y+V R++G G +  +FEG +  +N++  IK         +++ E +  + L G   I  +
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71

Query: 195 LDIVRDQQSKT-------PSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ 247
               ++            PSL  E +      +     S   V     ++L  +   H +
Sbjct: 72  YYFGQEGLHNVLVIDLLGPSL--EDL----LDLCGRKFSVKTVAMAAKQMLARVQSIHEK 125

Query: 248 GIMHRDVKPHNVMI----DHEQRKLRLIDWGLAEFY 279
            +++RD+KP N +I          + ++D+G+ +FY
Sbjct: 126 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 78.8 bits (195), Expect = 1e-16
 Identities = 38/150 (25%), Positives = 68/150 (45%), Gaps = 13/150 (8%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK------PVKKKKIKREIKILQNLCGGP 189
           Y++V K+G G  S V+       N K  IK +           K+ +RE+     L    
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL-SHQ 71

Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCHS 246
           NIV ++D+  +       L+ E++           +  LS      +  ++L  + + H 
Sbjct: 72  NIVSMIDVDEEDD--CYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD 129

Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
             I+HRD+KP N++ID  +  L++ D+G+A
Sbjct: 130 MRIVHRDIKPQNILIDSNKT-LKIFDFGIA 158

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score = 78.9 bits (195), Expect = 2e-16
 Identities = 48/218 (22%), Positives = 80/218 (36%), Gaps = 44/218 (20%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-KKKIKREIKILQNLCGGPNIV 192
            + EV   VGRG +  V +       +   IK ++    +K    E++ L  +   PNIV
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERKAFIVELRQLSRVNH-PNIV 64

Query: 193 KLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLK---ALD------Y 243
           KL             L+ E+        LY  L   +   Y          L       Y
Sbjct: 65  KLYGACL----NPVCLVMEYAEGGS---LYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117

Query: 244 CHS---QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG---- 296
            HS   + ++HRD+KP N+++      L++ D+G A                +       
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA-----------CDIQTHMTNNKGS 166

Query: 297 -----PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
                PE+     +Y    D++S G +   +I R++PF
Sbjct: 167 AAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPF 203

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 78.8 bits (195), Expect = 2e-16
 Identities = 63/314 (20%), Positives = 118/314 (37%), Gaps = 77/314 (24%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVKKKK----IKREIKILQNLCG 187
           +D+ + + +G+G + +VF       N+   IK LK   V           E ++L     
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76

Query: 188 GPNIVKLLDIVRDQQSKTPS---LIFEHVNNTD-FKVLYP--TLSDYDVRYYIYELLKAL 241
            P +  +         +T      + E++N  D    +            +Y  E++  L
Sbjct: 77  HPFLTHMF-----CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGL 131

Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGK---------EYNVRVAS 291
            + HS+GI++RD+K  N+++D +   +++ D+G+  E               +Y   +A 
Sbjct: 132 QFLHSKGIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNTFCGTPDY---IA- 186

Query: 292 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL 351
                PE+L+  Q Y++S+D WS G +   M+  + P F+G D  +    I      D  
Sbjct: 187 -----PEILLG-QKYNHSVDWWSFGVLLYEMLIGQSP-FHGQDEEELFHSIRM----DNP 235

Query: 352 NAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT 411
                                     + +++          EA D L KL   + ++R  
Sbjct: 236 -------------------------FYPRWLE--------KEAKDLLVKLFVREPEKRLG 262

Query: 412 AKEA-MAHPYFFPI 424
            +     HP F  I
Sbjct: 263 VRGDIRQHPLFREI 276

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score = 78.1 bits (193), Expect = 3e-16
 Identities = 46/223 (20%), Positives = 90/223 (40%), Gaps = 33/223 (14%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPN 190
            D      +G+G + +  +  H    E  ++K L       ++   +E+K+++ L   PN
Sbjct: 10  SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEH-PN 68

Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLK-ALD------Y 243
           ++K + ++   + K  + I E++       L   +   D +Y   + +  A D      Y
Sbjct: 69  VLKFIGVLY--KDKRLNFITEYIKGGT---LRGIIKSMDSQYPWSQRVSFAKDIASGMAY 123

Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF---------YHPGKEYNVRVASRYF 294
            HS  I+HRD+  HN ++  E + + + D+GLA                +   R      
Sbjct: 124 LHSMNIIHRDLNSHNCLVR-ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTV 182

Query: 295 KG------PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFY 331
            G      PE++   + YD  +D++S G +   +I R      
Sbjct: 183 VGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPD 224

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 79.0 bits (195), Expect = 3e-16
 Identities = 74/312 (23%), Positives = 125/312 (40%), Gaps = 69/312 (22%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR--------EIKILQNL 185
           +++E ++ +G+G + +V             +KILK  K+  + +        E ++LQN 
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILK--KEVIVAKDEVAHTLTENRVLQN- 204

Query: 186 CGGPNIVKLLDIVRDQQSKTPS---LIFEHVNNTD-FKVLY--PTLSDYDVRYYIYELLK 239
              P +  L         +T      + E+ N  + F  L      S+   R+Y  E++ 
Sbjct: 205 SRHPFLTALK-----YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS 259

Query: 240 ALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGP 297
           ALDY HS+  +++RD+K  N+M+D +   +++ D+GL  E    G        +  +  P
Sbjct: 260 ALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAP 318

Query: 298 ELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 357
           E+L D  DY  ++D W LG +   M+  + P FY  D              ++L   +  
Sbjct: 319 EVLED-NDYGRAVDWWGLGVVMYEMMCGRLP-FYNQD-------------HEKLFELILM 363

Query: 358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQER-----PTA 412
             I     L                         PEA   L  LL+ D ++R       A
Sbjct: 364 EEIRFPRTLG------------------------PEAKSLLSGLLKKDPKQRLGGGSEDA 399

Query: 413 KEAMAHPYFFPI 424
           KE M H +F  I
Sbjct: 400 KEIMQHRFFAGI 411

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 77.6 bits (192), Expect = 5e-16
 Identities = 79/327 (24%), Positives = 129/327 (39%), Gaps = 98/327 (29%)

Query: 134 DDYEVVRKVGRGKYSEVF--EGVHCTDNEK-CIIKILKPVKKKKIKR--------EIKIL 182
             +E+++ +G+G + +VF  + +  +D  +   +K+LK   K  +K         E  IL
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK---KATLKVRDRVRTKMERDIL 80

Query: 183 QNLCGGPNIVKLLDIVRDQQSK----TPS---LIFEHVNNTD-FKVLY--PTLSDYDVRY 232
                 P IVKL              T     LI + +   D F  L      ++ DV++
Sbjct: 81  VE-VNHPFIVKL---------HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF 130

Query: 233 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGK-------- 283
           Y+ EL  ALD+ HS GI++RD+KP N+++D E   ++L D+GL+ E     K        
Sbjct: 131 YLAELALALDHLHSLGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGT 189

Query: 284 -EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKI 342
            EY   +A      PE++   + +  S D WS G +   M+    P F G D  + +  I
Sbjct: 190 VEY---MA------PEVVNR-RGHTQSADWWSFGVLMFEMLTGTLP-FQGKDRKETMTMI 238

Query: 343 AKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLL 402
            K     +L                            +F++        PEA   L  L 
Sbjct: 239 LK----AKL-------------------------GMPQFLS--------PEAQSLLRMLF 261

Query: 403 RYDHQER-----PTAKEAMAHPYFFPI 424
           + +   R        +E   H +F  I
Sbjct: 262 KRNPANRLGAGPDGVEEIKRHSFFSTI 288

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 77.8 bits (192), Expect = 5e-16
 Identities = 29/169 (17%), Positives = 60/169 (35%), Gaps = 21/169 (12%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVKKKKIKREIKILQNLCGGPNIVK 193
           + + +K+G G +  ++        EK    ++K    +   +  E+K  Q +     I K
Sbjct: 39  WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKK 98

Query: 194 LLDIVRDQQSKTPSLIF---EHVNNTDFKV-----LYPTLSDY----------DVRYYIY 235
            ++  +      P              ++      L   L              V     
Sbjct: 99  WIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGI 158

Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHE-QRKLRLIDWGLAEFYHPGK 283
            +L  L+Y H    +H D+K  N+++ ++   ++ L D+GL+  Y P  
Sbjct: 159 RMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNG 207

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score = 76.2 bits (188), Expect = 9e-16
 Identities = 50/229 (21%), Positives = 89/229 (38%), Gaps = 52/229 (22%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----------KKKKIKREIKILQ 183
           ++ E  +++G+G +  V +G    D     IK L             K ++ +RE+ I+ 
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78

Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLK-ALD 242
           NL   PNIVKL  ++ +     P ++ E V   D   LY  L D          L+  LD
Sbjct: 79  NLN-HPNIVKLYGLMHNP----PRMVMEFVPCGD---LYHRLLDKAHPIKWSVKLRLMLD 130

Query: 243 ------YCHSQG--IMHRDVKPHNVMIDHEQRK----LRLIDWGLAEFYHPGKEYNVRVA 290
                 Y  +Q   I+HRD++  N+ +           ++ D+GL+           + +
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS-----------QQS 179

Query: 291 SRYFKG---------PELLVDLQD-YDYSLDLWSLGCMFAGMIFRKEPF 329
                G         PE +   ++ Y    D +S   +   ++  + PF
Sbjct: 180 VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 76.8 bits (190), Expect = 1e-15
 Identities = 84/330 (25%), Positives = 130/330 (39%), Gaps = 102/330 (30%)

Query: 134 DDYEVVRKVGRGKYSEVF---EGVHCTDNEKCIIKILKP---VKKKK----IKREIKILQ 183
           + +E++R +G+G Y +VF   +       +   +K+LK    V+  K     K E  IL+
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76

Query: 184 NLCGGPNIVKLLDIVRDQQSK----TPS---LIFEHVNNTD-FKVLY--PTLSDYDVRYY 233
                P IV L              T     LI E+++  + F  L       +    +Y
Sbjct: 77  E-VKHPFIVDL---------IYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFY 126

Query: 234 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGK--------- 283
           + E+  AL + H +GI++RD+KP N+M++H+   ++L D+GL  E  H G          
Sbjct: 127 LAEISMALGHLHQKGIIYRDLKPENIMLNHQGH-VKLTDFGLCKESIHDGTVTHTFCGTI 185

Query: 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQL 339
           EY   +A      PE+L+    ++ ++D WSLG     M  G      P F G +    +
Sbjct: 186 EY---MA------PEILMR-SGHNRAVDWWSLGALMYDMLTG-----APPFTGENRKKTI 230

Query: 340 VKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLD 399
            KI K     +L          L                              EA D L 
Sbjct: 231 DKILK----CKL-----NLPPYLT----------------------------QEARDLLK 253

Query: 400 KLLRYDHQER----PT-AKEAMAHPYFFPI 424
           KLL+ +   R    P  A E  AHP+F  I
Sbjct: 254 KLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 76.5 bits (189), Expect = 1e-15
 Identities = 47/208 (22%), Positives = 87/208 (41%), Gaps = 22/208 (10%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK------PVKKKKIKREIKI---LQNLC 186
           Y + R VGRG   +V+E           +K++       PV + +++RE +    LQ   
Sbjct: 36  YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQE-- 93

Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDY 243
             P++V + D    +      +    +N  D   +      L+       + ++  ALD 
Sbjct: 94  --PHVVPIHD--FGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDA 149

Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--EYNVRVASRYFKGPELLV 301
            H+ G  HRDVKP N+++  +     L+D+G+A      K  +    V + Y+  PE   
Sbjct: 150 AHAAGATHRDVKPENILVSADDF-AYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFS 208

Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
           +     Y  D+++L C+    +    P+
Sbjct: 209 E-SHATYRADIYALTCVLYECLTGSPPY 235

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 75.7 bits (185), Expect = 3e-15
 Identities = 50/345 (14%), Positives = 96/345 (27%), Gaps = 75/345 (21%)

Query: 129 QWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL-----------KPVKKKKIKR 177
                +  +   K+G G + EVF+ +   D+    IKI+                ++I  
Sbjct: 15  HCLPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILP 72

Query: 178 EIKILQNLCG--------GPNIVKLLDIVRDQQSKTPSLI-------------------- 209
           EI I + L              + L  +   Q S  P L+                    
Sbjct: 73  EIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFF 132

Query: 210 ----------FEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHN 258
                     FE       ++     S    +  +++L  +L    +     HRD+   N
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGN 192

Query: 259 VMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCM 318
           V++               +       Y +   S       L V + DY  S        +
Sbjct: 193 VLLK--------------KTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVV 238

Query: 319 FAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGR-HSRKP 377
           F  +    E  F G    D    I +++  +  N +   +       L  L  +   +  
Sbjct: 239 FCDV-SMDEDLFTGD--GDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMT 295

Query: 378 WSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFF 422
           +              +  +F   +L +      +A + +     F
Sbjct: 296 FKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLF 335

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 73.8 bits (182), Expect = 8e-15
 Identities = 39/152 (25%), Positives = 69/152 (45%), Gaps = 13/152 (8%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK------PVKKKKIKREIKILQNLCGGP 189
           YE+   +G G  SEV       D+    +K+L+      P    + +RE +    L   P
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHP 72

Query: 190 NIVKLLDI--VRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYC 244
            IV + D           P ++ E+V+    + +      ++       I +  +AL++ 
Sbjct: 73  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132

Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
           H  GI+HRDVKP N+MI      ++++D+G+A
Sbjct: 133 HQNGIIHRDVKPANIMISATNA-VKVMDFGIA 163

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 75.0 bits (184), Expect = 8e-15
 Identities = 40/154 (25%), Positives = 71/154 (46%), Gaps = 16/154 (10%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIVKL 194
           + + RK+G G + E++ G +   NE+  IK+     K  ++  E KI + L GG  I  +
Sbjct: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNV 68

Query: 195 LDIVRDQQSKT-------PSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ 247
                +            PSL  E +    F      LS   V     +++  +++ HS+
Sbjct: 69  RWFGVEGDYNVLVMDLLGPSL--EDL----FNFCSRKLSLKTVLMLADQMINRVEFVHSK 122

Query: 248 GIMHRDVKPHNVMI--DHEQRKLRLIDWGLAEFY 279
             +HRD+KP N ++       ++ +ID+GLA+ Y
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 69.6 bits (171), Expect = 1e-13
 Identities = 42/211 (19%), Positives = 75/211 (35%), Gaps = 33/211 (15%)

Query: 126 LTVQWG-EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREI 179
           +    G +      + K+      E+++G         ++K+LK       K +    E 
Sbjct: 1   MNKHSGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEEC 58

Query: 180 KILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN-TDFKVLYPTLSDYDVRYYIYELL 238
             L+     PN++ +L   +   +  P+LI   +   + + VL       +      + +
Sbjct: 59  PRLRIFSH-PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVL---HEGTNFVVDQSQAV 114

Query: 239 K-ALD------YCHSQG--IMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVR 288
           K ALD      + H+    I    +   +VMID E    R+    +   F  PG+ Y   
Sbjct: 115 KFALDMARGMAFLHTLEPLIPRHALNSRSVMID-EDMTARISMADVKFSFQSPGRMYAPA 173

Query: 289 -VASRYFKGPELLVDLQDYDYSL--DLWSLG 316
            VA      PE L    +       D+WS  
Sbjct: 174 WVA------PEALQKKPEDTNRRSADMWSFA 198

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 70.6 bits (173), Expect = 2e-13
 Identities = 30/173 (17%), Positives = 65/173 (37%), Gaps = 26/173 (15%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVKKKKIKREIKILQNLCGGPN 190
           ++V   +G+G +  ++     +      +  C++K+ +P     +  E+K  Q       
Sbjct: 37  WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKV-EPSDNGPLFTELKFYQRAAKPEQ 95

Query: 191 IVKLLDIVRDQQSKTPSLIF---EHVNNTDFKVLY-----PTLSDY-----------DVR 231
           I K +   + +    P          N   ++ +        L               V 
Sbjct: 96  IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVL 155

Query: 232 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-QRKLRLIDWGLAEFYHPGK 283
                +L  L+Y H    +H D+K  N++++++   ++ L+D+GLA  Y P  
Sbjct: 156 QLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 69.0 bits (169), Expect = 2e-13
 Identities = 22/190 (11%), Positives = 53/190 (27%), Gaps = 38/190 (20%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------VKKKKIKREIKILQNLCGGP 189
           Y ++   G     + ++ +    + +  +  + P         ++       L  +   P
Sbjct: 33  YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKP 91

Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFK-VLYPTLSDYDVRYYIYELLKALDYCHSQG 248
            + ++LD+V  +      ++ E +     + V   + S       +  L  A D  H  G
Sbjct: 92  GVARVLDVVHTRA--GGLVVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAG 149

Query: 249 IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 308
           +      P  V +  +                      V +A                + 
Sbjct: 150 VALSIDHPSRVRVSIDGD--------------------VVLAYPATMPDA--------NP 181

Query: 309 SLDLWSLGCM 318
             D+  +G  
Sbjct: 182 QDDIRGIGAS 191

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score = 68.5 bits (168), Expect = 4e-13
 Identities = 49/241 (20%), Positives = 94/241 (39%), Gaps = 40/241 (16%)

Query: 98  RRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCT 157
                P           +  +   D + + + W    D  +  K+G G +  V       
Sbjct: 4   HHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPW---CDLNIKEKIGAGSFGTVHRAEWH- 59

Query: 158 DNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212
                 +KIL           +  RE+ I++ L   PNIV  +  V        S++ E+
Sbjct: 60  -GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH-PNIVLFMGAVTQPP--NLSIVTEY 115

Query: 213 VNNTDFKVLYPTLSDYDVRYYI--YELLK-ALD------YCHSQG--IMHRDVKPHNVMI 261
           ++      LY  L     R  +     L  A D      Y H++   I+HR++K  N+++
Sbjct: 116 LSRGS---LYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV 172

Query: 262 DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------PELLVDLQDYDYSLDLWSL 315
           D ++  +++ D+GL+       + +  ++S+   G      PE+L D +  +   D++S 
Sbjct: 173 D-KKYTVKVCDFGLSRL-----KASTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDVYSF 225

Query: 316 G 316
           G
Sbjct: 226 G 226

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 66.3 bits (162), Expect = 3e-12
 Identities = 39/213 (18%), Positives = 84/213 (39%), Gaps = 28/213 (13%)

Query: 128 VQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQ-NLC 186
           VQ        +   +G+G++ EV+ G      E+  +KI    +++   RE +I Q  + 
Sbjct: 36  VQRTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFREAEIYQTVML 93

Query: 187 GGPNIVKLLDIVRDQQSKTP--SLIFE-HVNNTDFKVLYPTLSDYDVRYYI-YELLKALD 242
              NI+  +              L+ + H + + F  L       +    +       L 
Sbjct: 94  RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLA 153

Query: 243 YCHSQ--------GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYF 294
           + H +         I HRD+K  N+++  +     + D GLA  +    +  + +A  + 
Sbjct: 154 HLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDT-IDIAPNHR 211

Query: 295 KG------PELL---VDLQDYDYSL--DLWSLG 316
            G      PE+L   ++++ ++     D++++G
Sbjct: 212 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMG 244

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 66.3 bits (162), Expect = 3e-12
 Identities = 48/216 (22%), Positives = 86/216 (39%), Gaps = 28/216 (12%)

Query: 125 SLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQ- 183
            L VQ       ++V+++G+G+Y EV+ G      EK  +K+    ++    RE +I Q 
Sbjct: 28  PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQT 85

Query: 184 NLCGGPNIVKLLDIVRDQQSKTP--SLIFE-HVNNTDFKVLYPTLSDYDVRYYI-YELLK 239
            L    NI+  +              LI + H N + +  L  T  D      + Y  + 
Sbjct: 86  VLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVS 145

Query: 240 ALDYCHSQ--------GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS 291
            L + H++         I HRD+K  N+++  +     + D GLA  +       V +  
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVKFISDTN-EVDIPP 203

Query: 292 RYFKG------PELL---VDLQDYDYSL--DLWSLG 316
               G      PE+L   ++   +   +  D++S G
Sbjct: 204 NTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFG 239

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 65.8 bits (161), Expect = 5e-12
 Identities = 44/224 (19%), Positives = 87/224 (38%), Gaps = 41/224 (18%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNLCGG 188
           +  E+   +G+G++ +V+ G    +     I+++        + K  KRE+   +     
Sbjct: 33  EQLEIGELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRH- 88

Query: 189 PNIVKLLDIVRDQQSKTPSL--IFEHVNNTDFKVLYPTLSDYDVRYYIYELLK-ALD--- 242
            N+V  +          P L  I           LY  + D  +   + +  + A +   
Sbjct: 89  ENVVLFMGAC----MSPPHLAIITSLCKGRT---LYSVVRDAKIVLDVNKTRQIAQEIVK 141

Query: 243 ---YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG--- 296
              Y H++GI+H+D+K  NV  D+   K+ + D+GL       +        R   G   
Sbjct: 142 GMGYLHAKGILHKDLKSKNVFYDN--GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLC 199

Query: 297 ---PELL--------VDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
              PE++         D   +    D+++LG ++  +  R+ PF
Sbjct: 200 HLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF 243

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score = 64.6 bits (158), Expect = 8e-12
 Identities = 44/227 (19%), Positives = 95/227 (41%), Gaps = 35/227 (15%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNLCGG 188
               V +++G G +  V++G    D     +K+L      P + +  K E+ +L+     
Sbjct: 24  GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH- 79

Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLK-ALD----- 242
            NI+  +      Q    +++ +    +    LY  L   + ++ + +L+  A       
Sbjct: 80  VNILLFMGYSTAPQ---LAIVTQWCEGSS---LYHHLHASETKFEMKKLIDIARQTARGM 133

Query: 243 -YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG----- 296
            Y H++ I+HRD+K +N+ +  E   +++ D+GLA         +         G     
Sbjct: 134 DYLHAKSIIHRDLKSNNIFLH-EDNTVKIGDFGLATEKSRWSGSHQFEQL---SGSILWM 189

Query: 297 -PELLVDLQDYDYSL--DLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
            PE++       YS   D+++ G +   ++  + P+    +N DQ++
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQII 235

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 63.5 bits (155), Expect = 2e-11
 Identities = 47/204 (23%), Positives = 79/204 (38%), Gaps = 28/204 (13%)

Query: 137 EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQ-NLCGGPNIVKLL 195
            ++  VG+G+Y EV+ G      E   +KI     +K   RE ++    +    NI+  +
Sbjct: 11  TLLECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFI 68

Query: 196 --DIVRDQQSKTPSLIFE-HVNNTDFKVLYPTLSDYDVRYYI-YELLKALDYCHSQ---- 247
             D+     S    LI   H   + +  L  T  D      I   +   L + H +    
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGT 128

Query: 248 ----GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------P 297
                I HRD+K  N+++  +  +  + D GLA  +       + V +    G      P
Sbjct: 129 QGKPAIAHRDLKSKNILVK-KNGQCCIADLGLAVMHSQSTNQ-LDVGNNPRVGTKRYMAP 186

Query: 298 ELL-----VDLQDYDYSLDLWSLG 316
           E+L     VD  D    +D+W+ G
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFG 210

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 63.3 bits (154), Expect = 3e-11
 Identities = 40/229 (17%), Positives = 83/229 (36%), Gaps = 44/229 (19%)

Query: 122 DYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKI 181
                ++     D+ +++  +GRG+Y  V++G    D     +K+     ++    E  I
Sbjct: 4   AASEPSLDL---DNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNI 58

Query: 182 -----LQNLCGGPNIVKLL--DIVRDQQSKTP-SLIFE-HVNNTDFKVLYPTLSDYDVRY 232
                +++     NI + +  D       +    L+ E + N +  K L    SD+    
Sbjct: 59  YRVPLMEH----DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSC 114

Query: 233 YI-YELLKALDYCHSQ---------GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282
            + + + + L Y H++          I HRD+   NV++        + D+GL+      
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK-NDGTCVISDFGLSMRLTGN 173

Query: 283 KEYNVRVASRYFKG---------PELL------VDLQDYDYSLDLWSLG 316
           +                      PE+L       D +     +D+++LG
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALG 222

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 60.7 bits (148), Expect = 1e-10
 Identities = 40/221 (18%), Positives = 86/221 (38%), Gaps = 38/221 (17%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-------KKKIKREIKILQNLC 186
            +  +   +G G + +V+        ++  +K  +           + +++E K+   L 
Sbjct: 7   AELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK 64

Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYPTLSDYDVRYYI-YELLKALDYC 244
             PNI+ L  +   +      L+ E        +VL       D+      ++ + ++Y 
Sbjct: 65  H-PNIIALRGVCLKEP--NLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYL 121

Query: 245 HSQG---IMHRDVKPHNVMIDHEQRK-------LRLIDWGLAEFYHPGKEYNVRVASRYF 294
           H +    I+HRD+K  N++I  +          L++ D+GLA  +H   + +        
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMS-------A 174

Query: 295 KG------PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
            G      PE++     +    D+WS G +   ++  + PF
Sbjct: 175 AGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPF 214

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 29/175 (16%), Positives = 57/175 (32%), Gaps = 28/175 (16%)

Query: 136 YEVVRKVGRGKYSEVFEGVH--------CTDNEKCIIKILKPVKKKKIKREIKILQNLCG 187
           +++     R     ++E               +K  +K+    K  ++  E    Q    
Sbjct: 44  WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDA--KDGRLFNEQNFFQRAAK 101

Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKV-----LYPTLSDY------------DV 230
              + K   +        P+ +   V+   ++      L  +L                V
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSV 161

Query: 231 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-QRKLRLIDWGLAEFYHPGKE 284
                 LL AL++ H    +H +V   N+ +D E Q ++ L  +G A  Y P  +
Sbjct: 162 LQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGK 216

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 58.6 bits (142), Expect = 1e-09
 Identities = 47/240 (19%), Positives = 87/240 (36%), Gaps = 32/240 (13%)

Query: 121 WDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK--KIKRE 178
              E+L  Q       +++    RG++  V++      NE   +KI     K+  + + E
Sbjct: 14  LGTENLYFQS---MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYE 68

Query: 179 IKILQNLCGGPNIVKLL--DIVRDQQSKTPSLIFE-HVNNTDFKVLYPTLSDYDVRYYI- 234
           +  L  +    NI++ +  +           LI   H   +    L   +  ++   +I 
Sbjct: 69  VYSLPGMKH-ENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIA 127

Query: 235 YELLKALDYCHSQ----------GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
             + + L Y H             I HRD+K  NV++        + D+GLA  +  GK 
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK-NNLTACIADFGLALKFEAGKS 186

Query: 285 YNVRVAS----RYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNY 336
                      RY   PE+L       +D    +D++++G +   +  R        D Y
Sbjct: 187 AGDTHGQVGTRRYM-APEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 57.3 bits (139), Expect = 4e-09
 Identities = 52/199 (26%), Positives = 85/199 (42%), Gaps = 26/199 (13%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP----VKKKKIKREIKILQNLCGGP 189
           +D  +  ++GRG + EVF G    DN    +K  +       K K  +E +IL+     P
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYS-HP 172

Query: 190 NIVKLLDIVRDQQSKTPSLI-FEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDY 243
           NIV+L+ +   +Q   P  I  E V   DF   +       L    +   + +    ++Y
Sbjct: 173 NIVRLIGVCTQKQ---PIYIVMELVQGGDFLT-FLRTEGARLRVKTLLQMVGDAAAGMEY 228

Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYF--K--GPEL 299
             S+  +HRD+   N ++  E+  L++ D+G++     G  Y      R    K   PE 
Sbjct: 229 LESKCCIHRDLAARNCLVT-EKNVLKISDFGMSREEADG-VYAASGGLRQVPVKWTAPEA 286

Query: 300 LVDLQDYDYSL--DLWSLG 316
           L   +   YS   D+WS G
Sbjct: 287 LNYGR---YSSESDVWSFG 302

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 54.2 bits (131), Expect = 2e-08
 Identities = 42/167 (25%), Positives = 77/167 (46%), Gaps = 16/167 (9%)

Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI----IKILKP----VKKKKIKREIKILQ 183
           E+   + +R +G G + +V    +  + +       +K LKP         +K+EI+IL+
Sbjct: 19  EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILR 78

Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELL 238
           NL    NIVK   I  +       LI E + +   K  Y       ++      Y  ++ 
Sbjct: 79  NLYH-ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKE-YLPKNKNKINLKQQLKYAVQIC 136

Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285
           K +DY  S+  +HRD+   NV+++  + ++++ D+GL +     KEY
Sbjct: 137 KGMDYLGSRQYVHRDLAARNVLVE-SEHQVKIGDFGLTKAIETDKEY 182

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 54.0 bits (130), Expect = 3e-08
 Identities = 54/313 (17%), Positives = 114/313 (36%), Gaps = 47/313 (15%)

Query: 63  LASSASLSHARHQHQRLRQLA----TPPDTLAQKIGKSVRRSGAPSKARVYSDINVV--- 115
           ++    + H  H H R R         P       G       + S  +     N+    
Sbjct: 1   MSPIDPMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQG 60

Query: 116 RPREYWDYESLTVQWGEQ-DDYEV---------VRKVGRGKYSEVFEGVHCTDNEKCI-- 163
               + D  +L  +  +      +            +GRG +  V+ G    ++ K I  
Sbjct: 61  ANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHC 120

Query: 164 -IKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF 218
            +K L  +    +  +   E  I+++    PN++ LL I    +   P ++  ++ + D 
Sbjct: 121 AVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGS-PLVVLPYMKHGDL 178

Query: 219 KVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDW 273
           +  +        +  D+  +  ++ K + +  S+  +HRD+   N M+D E+  +++ D+
Sbjct: 179 RN-FIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD-EKFTVKVADF 236

Query: 274 GLAEFYHPGKEYNVRVASRYFKG--------PELLVDLQDYDYSLDLWSLG-CMFAGMIF 324
           GLA   +  +  +V   +              E L   Q +    D+WS G  ++  M  
Sbjct: 237 GLARDMYDKEFDSVHNKT---GAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTR 292

Query: 325 RKEPFFYGHDNYD 337
              P +   + +D
Sbjct: 293 GAPP-YPDVNTFD 304

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 53.5 bits (129), Expect = 5e-08
 Identities = 46/192 (23%), Positives = 86/192 (44%), Gaps = 17/192 (8%)

Query: 139 VRKVGRGKYSEVFEGV--HCTDNEKCI--IKILK----PVKKKKIKREIKILQNLCGGPN 190
           +R +G G + +V         D    +  +K LK    P  +   K+EI IL+ L    +
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYH-EH 94

Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYCHSQG 248
           I+K      D  + +  L+ E+V     +  +   ++    +  +  ++ + + Y H+Q 
Sbjct: 95  IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQH 154

Query: 249 IMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRY-FK--GPELLVDLQ 304
            +HRD+   NV++D   R +++ D+GLA       + Y VR           PE L + +
Sbjct: 155 YIHRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK 213

Query: 305 DYDYSLDLWSLG 316
            + Y+ D+WS G
Sbjct: 214 -FYYASDVWSFG 224

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 53.6 bits (129), Expect = 7e-08
 Identities = 46/223 (20%), Positives = 97/223 (43%), Gaps = 20/223 (8%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNI 191
            D  +  K+G G+Y EV+EGV    +    +K LK   ++ ++  +E  +++ +   PN+
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNL 278

Query: 192 VKLLDIVRDQQSKTPSLI-FEHVNN---TDF--KVLYPTLSDYDVRYYIYELLKALDYCH 245
           V+LL +   +    P  I  E +      D+  +     +S   + Y   ++  A++Y  
Sbjct: 279 VQLLGVCTREP---PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 335

Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGPELLVD 302
            +  +HR++   N ++  E   +++ D+GL+     G  Y     +++   +  PE L  
Sbjct: 336 KKNFIHRNLAARNCLVG-ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY 393

Query: 303 LQDYDYSLDLWSLG-CMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
              +    D+W+ G  ++    +   P + G D       + K
Sbjct: 394 -NKFSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELLEK 434

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 52.6 bits (127), Expect = 7e-08
 Identities = 39/164 (23%), Positives = 74/164 (45%), Gaps = 25/164 (15%)

Query: 132 EQDDYEV-------VRKVGRGKYSEVFEGVHCTDNEKCI---IKILKP----VKKKKIKR 177
              DYE+        R +G G++ +V +G++ +     +   IK  K       ++K  +
Sbjct: 6   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 65

Query: 178 EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI-FEHVNNTDF----KVLYPTLSDYDVRY 232
           E   ++     P+IVKL+ ++    ++ P  I  E     +     +V   +L    +  
Sbjct: 66  EALTMRQFD-HPHIVKLIGVI----TENPVWIIMELCTLGELRSFLQVRKYSLDLASLIL 120

Query: 233 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
           Y Y+L  AL Y  S+  +HRD+   NV++      ++L D+GL+
Sbjct: 121 YAYQLSTALAYLESKRFVHRDIAARNVLVS-SNDCVKLGDFGLS 163

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 53.3 bits (128), Expect = 1e-07
 Identities = 41/221 (18%), Positives = 89/221 (40%), Gaps = 32/221 (14%)

Query: 76  HQRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDD 135
            +  ++      ++ +      +   + + +   +D       E   Y   +       D
Sbjct: 330 IRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPS-----TRD 384

Query: 136 YEV-------VRKVGRGKYSEVFEGVHCTDNEKCI---IKILKP----VKKKKIKREIKI 181
           YE+        R +G G++ +V +G++ +     +   IK  K       ++K  +E   
Sbjct: 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALT 444

Query: 182 LQNLCGGPNIVKLLDIVRDQQSKTPSLI-FEHVNNTDFKVLY-----PTLSDYDVRYYIY 235
           ++     P+IVKL+ ++    ++ P  I  E     + +  +      +L    +  Y Y
Sbjct: 445 MRQFDH-PHIVKLIGVI----TENPVWIIMELCTLGELRS-FLQVRKFSLDLASLILYAY 498

Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
           +L  AL Y  S+  +HRD+   NV++      ++L D+GL+
Sbjct: 499 QLSTALAYLESKRFVHRDIAARNVLVS-SNDCVKLGDFGLS 538

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 48/227 (21%), Positives = 100/227 (44%), Gaps = 24/227 (10%)

Query: 139 VRKVGRGKYSEVFEGVHCTDNEKCI----IKILK---PVKKKKIKREIKILQNLCGGPNI 191
           + ++G+G +  V    +    +       +K L+   P +++  +REI+IL+ L     I
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSDFI 86

Query: 192 VKLLDIVRDQQSKTPSLIFEHVNN---TDF-KVLYPTLSDYDVRYYIYELLKALDYCHSQ 247
           VK   +      ++  L+ E++ +    DF +     L    +  Y  ++ K ++Y  S+
Sbjct: 87  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR 146

Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-YNVRVASRY-FK--GPELLVDL 303
             +HRD+   N++++  +  +++ D+GLA+     K+ Y VR   +       PE L D 
Sbjct: 147 RCVHRDLAARNILVE-SEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 205

Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE 350
             +    D+WS G      +   E F Y   +     +  +++G + 
Sbjct: 206 I-FSRQSDVWSFG------VVLYELFTYCDKSCSPSAEFLRMMGCER 245

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 47/248 (18%), Positives = 105/248 (42%), Gaps = 27/248 (10%)

Query: 109 YSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI---IK 165
           + D++ + P      + + +             +GRG +  V+ G    ++ K I   +K
Sbjct: 1   HIDLSALNPELVQAVQHVVIG-PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK 59

Query: 166 ILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL 221
            L  +    +  +   E  I+++    PN++ LL I    +  +P ++  ++ + D +  
Sbjct: 60  SLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEG-SPLVVLPYMKHGDLRN- 116

Query: 222 Y-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
           +        +  D+  +  ++ K + Y  S+  +HRD+   N M+D E+  +++ D+GLA
Sbjct: 117 FIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD-EKFTVKVADFGLA 175

Query: 277 ------EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLG-CMFAGMIFRKEPF 329
                 E+Y    +   ++  ++    E L   Q +    D+WS G  ++  M     P 
Sbjct: 176 RDMYDKEYYSVHNKTGAKLPVKWM-ALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPP- 232

Query: 330 FYGHDNYD 337
           +   + +D
Sbjct: 233 YPDVNTFD 240

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 52.0 bits (125), Expect = 1e-07
 Identities = 44/262 (16%), Positives = 111/262 (42%), Gaps = 33/262 (12%)

Query: 109 YSDINVVRPREYWDYESLTVQWGEQDDYEV-------VRKVGRGKYSEVFEGVHCTDNEK 161
           + D ++      +   ++   + ++D  +        ++++G+G +  V    +    + 
Sbjct: 9   HHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDN 68

Query: 162 CI----IKILKPVKKKKIK---REIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVN 214
                 +K L+   ++ ++   REI+IL++L    NIVK   +      +   LI E++ 
Sbjct: 69  TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH-DNIVKYKGVCYSAGRRNLKLIMEYLP 127

Query: 215 N---TDF-KVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRL 270
                D+ +     +    +  Y  ++ K ++Y  ++  +HRD+   N++++  + ++++
Sbjct: 128 YGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE-NENRVKI 186

Query: 271 IDWGLA-EFYHPGKEYNVRVASRY-FK--GPELLVDLQDYDYSLDLWSLG-CMFAGMIFR 325
            D+GL        + Y V+           PE L + + +  + D+WS G  ++      
Sbjct: 187 GDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLY------ 239

Query: 326 KEPFFYGHDNYDQLVKIAKVLG 347
            E F Y   +     +  +++G
Sbjct: 240 -ELFTYIEKSKSPPAEFMRMIG 260

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 51.8 bits (125), Expect = 1e-07
 Identities = 41/164 (25%), Positives = 72/164 (43%), Gaps = 25/164 (15%)

Query: 132 EQDDYEV-------VRKVGRGKYSEVFEGVHCTDNEKCI---IKILKP----VKKKKIKR 177
               Y +        R +G G + EV+EGV+     + I   +K  K       K+K   
Sbjct: 3   GGPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMS 62

Query: 178 EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI-FEHVNNTDF----KVLYPTLSDYDVRY 232
           E  I++NL   P+IVKL+ I+     + P+ I  E     +     +    +L    +  
Sbjct: 63  EAVIMKNLD-HPHIVKLIGII----EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVL 117

Query: 233 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
           Y  ++ KA+ Y  S   +HRD+   N+++      ++L D+GL+
Sbjct: 118 YSLQICKAMAYLESINCVHRDIAVRNILVA-SPECVKLGDFGLS 160

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 51.7 bits (124), Expect = 3e-07
 Identities = 44/223 (19%), Positives = 92/223 (41%), Gaps = 22/223 (9%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNI 191
           +   +  K+G+G + EV+ G       +  IK LKP  +  +   +E ++++ L     +
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR-HEKL 241

Query: 192 VKLLDIVRDQQSKTPSLI-FEHVNNTDF-----KVLYPTLSDYDVRYYIYELLKALDYCH 245
           V+L  +V    S+ P  I  E+++               L    +     ++   + Y  
Sbjct: 242 VQLYAVV----SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 297

Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGPELLVD 302
               +HRD++  N+++  E    ++ D+GLA       EY  R  +++   +  PE  + 
Sbjct: 298 RMNYVHRDLRAANILVG-ENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALY 355

Query: 303 LQDYDYSLDLWSLG-CMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
              +    D+WS G  +       + P + G  N + L ++ +
Sbjct: 356 -GRFTIKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVER 396

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 51.8 bits (123), Expect = 3e-07
 Identities = 41/310 (13%), Positives = 83/310 (26%), Gaps = 94/310 (30%)

Query: 120 YWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREI 179
           + D+E+   Q+  +D   V        + + F+     D  K I+           K EI
Sbjct: 6   HMDFETGEHQYQYKDILSVFED----AFVDNFDCKDVQDMPKSILS----------KEEI 51

Query: 180 KILQNLCGGPNIV----KLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLS----DYDVR 231
               ++    + V    +L   +  +Q +      E V   ++K L   +        + 
Sbjct: 52  D---HIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMM 108

Query: 232 YYIYELLKALDYCHSQGIMHRDV---KPHNVMIDHEQRKLR-----------LIDWGLAE 277
             +Y           +  ++ D      +NV       KLR           ++  G+  
Sbjct: 109 TRMYI------EQRDR--LYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLG 160

Query: 278 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYD 337
               GK                 V    Y        + C     IF             
Sbjct: 161 S---GK--TWVALD---------V-CLSYK-------VQCKMDFKIF------------- 185

Query: 338 QLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGR--------HSRKPWSKFITVENQHL 389
             + +      + +   L K   ++DP+  +            HS +   + +     + 
Sbjct: 186 -WLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPY- 243

Query: 390 AVPEAVDFLD 399
                +  L 
Sbjct: 244 --ENCLLVLL 251

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 50.6 bits (120), Expect = 7e-07
 Identities = 61/428 (14%), Positives = 123/428 (28%), Gaps = 120/428 (28%)

Query: 36  TTSVSKILFSP--LSQSSRIFTPFGTLRGLASSASLSHARHQHQRLRQLATPPDT--LAQ 91
              +  I+ S   +S + R+F              LS      Q+  +     +   L  
Sbjct: 48  KEEIDHIIMSKDAVSGTLRLFWTL-----------LSKQEEMVQKFVEEVLRINYKFLMS 96

Query: 92  KIGKSVRRSGAPSKA------------RVYSDINVVRPREYWDYESLTVQWGEQDDYEVV 139
            I    R+    ++             +V++  NV R + Y       ++     +  + 
Sbjct: 97  PIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLID 156

Query: 140 RKVGRGKYSEVFEGVHCTDNE-KCII--KI--LKPVKKKKIKREIKILQNLCGGPNIVKL 194
             +G GK     +   C   + +C +  KI  L        +  +++LQ L         
Sbjct: 157 GVLGSGKTWVALDV--CLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLL------YQ 208

Query: 195 LDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDV 254
           +D     +S   S I   ++               ++  +  LLK+  Y +   ++  +V
Sbjct: 209 IDPNWTSRSDHSSNIKLRIH--------------SIQAELRRLLKSKPYENCLLVL-LNV 253

Query: 255 KPHNV--MIDHEQRKL---RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYS 309
           +        +   + L   R     + +F       ++ +        +        D  
Sbjct: 254 QNAKAWNAFNLSCKILLTTR--FKQVTDFLSAATTTHISL--------DHHSMTLTPDEV 303

Query: 310 LDLWS--LGC------------------MFAGMIFRKEPF---FYGHDNYDQLVKIAK-- 344
             L    L C                  + A  I R        + H N D+L  I +  
Sbjct: 304 KSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESI-RDGLATWDNWKHVNCDKLTTIIESS 362

Query: 345 --VLGTDELNAYLNKYHI-ELDPH-----LAALVGRHSRKPWSKFITVENQHLAVPEAVD 396
             VL   E     ++  +     H     L+ +        W   I  +           
Sbjct: 363 LNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLI--------WFDVIKSDVM--------V 406

Query: 397 FLDKLLRY 404
            ++KL +Y
Sbjct: 407 VVNKLHKY 414

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 50.2 bits (119), Expect = 1e-06
 Identities = 61/376 (16%), Positives = 109/376 (28%), Gaps = 115/376 (30%)

Query: 25  FAISSNT-SSSRTTSVSKILFS------PLSQSSRIFTPFGTLRGLASSASLSHARHQHQ 77
           F +S     ++R   V+  L +       L   S   TP      L             Q
Sbjct: 262 FNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRP-----Q 316

Query: 78  RLRQLA--TPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDD 135
            L +    T P  L+  I +S+R       A              WD       W     
Sbjct: 317 DLPREVLTTNPRRLSI-IAESIR----DGLAT-------------WDN------W----- 347

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNI-VKL 194
               + V   K + + E          +  +L+P + +K+   + +        +I   L
Sbjct: 348 ----KHVNCDKLTTIIE--------SSL-NVLEPAEYRKMFDRLSVFPP---SAHIPTIL 391

Query: 195 LDI---------VRD--QQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDY 243
           L +         V     +    SL+ +    +                 I  +   L+ 
Sbjct: 392 LSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKES--------------TISIPSIY--LEL 435

Query: 244 CHSQGIMHRDVKP--HNVMIDHEQRKLRLIDWGLAE------FY-HPGKEY---NVRVAS 291
                 +  + +   H  ++DH           L        FY H G  +   N+    
Sbjct: 436 K-----VKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIG--HHLKNIEHPE 488

Query: 292 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI------FRK-EPFFYGHDN-YDQLVK-I 342
           R      + +D +  +  +   S     +G I       +  +P+   +D  Y++LV  I
Sbjct: 489 RMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAI 548

Query: 343 AKVLGTDELNAYLNKY 358
              L   E N   +KY
Sbjct: 549 LDFLPKIEENLICSKY 564

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 50.3 bits (121), Expect = 4e-07
 Identities = 41/204 (20%), Positives = 84/204 (41%), Gaps = 26/204 (12%)

Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI---IKILKPV----KKKKIKREIKILQN 184
           E+      R +G+G +  V+ G +    +  I   IK L  +    + +   RE  +++ 
Sbjct: 19  ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRG 78

Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK----VLYPTLSDYDVRYYIYELLKA 240
           L   PN++ L+ I+   +   P ++  ++ + D            +  D+  +  ++ + 
Sbjct: 79  LN-HPNVLALIGIMLPPEG-LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARG 136

Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG---- 296
           ++Y   Q  +HRD+   N M+D E   +++ D+GLA      + Y+V+            
Sbjct: 137 MEYLAEQKFVHRDLAARNCMLD-ESFTVKVADFGLARDILDREYYSVQQHR---HARLPV 192

Query: 297 ----PELLVDLQDYDYSLDLWSLG 316
                E L     +    D+WS G
Sbjct: 193 KWTALESLQT-YRFTTKSDVWSFG 215

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 51.0 bits (122), Expect = 5e-07
 Identities = 45/223 (20%), Positives = 92/223 (41%), Gaps = 22/223 (9%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNI 191
           +   +  K+G+G + EV+ G       +  IK LKP  +  +   +E ++++ L     +
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR-HEKL 324

Query: 192 VKLLDIVRDQQSKTPSLI-FEHVNNTDF-----KVLYPTLSDYDVRYYIYELLKALDYCH 245
           V+L  +V    S+ P  I  E+++               L    +     ++   + Y  
Sbjct: 325 VQLYAVV----SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 380

Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK--GPELLVD 302
               +HRD++  N+++  E    ++ D+GLA       EY  R  +++  K   PE  + 
Sbjct: 381 RMNYVHRDLRAANILVG-ENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALY 438

Query: 303 LQDYDYSLDLWSLG-CMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
              +    D+WS G  +       + P + G  N + L ++ +
Sbjct: 439 -GRFTIKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVER 479

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 50.0 bits (120), Expect = 6e-07
 Identities = 46/240 (19%), Positives = 97/240 (40%), Gaps = 40/240 (16%)

Query: 132 EQDDYEV-------VRKVGRGKYSEVFEGVHCTDNEKCI---IKILKP-----VKKKKIK 176
           + +D  +        R +G+G++  V E     ++   +   +K+LK         ++  
Sbjct: 14  KLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFL 73

Query: 177 REIKILQNLCGGPNIVKLLDIVRDQQSKTPS----LIFEHVNNTDFK---------VLYP 223
           RE   ++     P++ KL+ +    ++K       +I   + + D               
Sbjct: 74  REAACMKEFD-HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPF 132

Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
            L    +  ++ ++   ++Y  S+  +HRD+   N M+  E   + + D+GL+   + G 
Sbjct: 133 NLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA-EDMTVCVADFGLSRKIYSGD 191

Query: 284 EYNVRVASRY-FK--GPELLVDLQDYDYSL--DLWSLG-CMFAGMIFRKEPFFYGHDNYD 337
            Y    AS+   K    E    L D  Y++  D+W+ G  M+  M   + P + G +N +
Sbjct: 192 YYRQGCASKLPVKWLALE---SLADNLYTVHSDVWAFGVTMWEIMTRGQTP-YAGIENAE 247

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 49.9 bits (120), Expect = 6e-07
 Identities = 38/177 (21%), Positives = 78/177 (44%), Gaps = 23/177 (12%)

Query: 132 EQDDYEV-------VRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKIL 182
             D +E+         K+G G+Y EV+EGV    +    +K LK   ++ ++  +E  ++
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 63

Query: 183 QNLCGGPNIVKLLDIVRDQQSKTPSLI-FEHVNNTDFKVLY------PTLSDYDVRYYIY 235
           + +   PN+V+LL +   +    P  I  E +   +    Y        +S   + Y   
Sbjct: 64  KEIK-HPNLVQLLGVCTREP---PFYIITEFMTYGNLLD-YLRECNRQEVSAVVLLYMAT 118

Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASR 292
           ++  A++Y   +  +HRD+   N ++  E   +++ D+GL+     G  Y     ++
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVG-ENHLVKVADFGLSRLMT-GDTYTAHAGAK 173

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 49.2 bits (118), Expect = 1e-06
 Identities = 43/225 (19%), Positives = 100/225 (44%), Gaps = 26/225 (11%)

Query: 139 VRKVGRGKYSEVFEGV--HCTDNEKCI--IKILKPVKKKKIK---REIKILQNLCGGPNI 191
           ++++G+G +  V         DN   +  +K L+   ++ ++   REI+IL++L    NI
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH-DNI 73

Query: 192 VKLLDIVRDQQSKTPSLIFEHVNN---TDF-KVLYPTLSDYDVRYYIYELLKALDYCHSQ 247
           VK   +      +   LI E++      D+ +     +    +  Y  ++ K ++Y  ++
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 133

Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRY-FK--GPELLVDL 303
             +HRD+   N++++  + ++++ D+GL        + + V+           PE L + 
Sbjct: 134 RYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTES 192

Query: 304 QDYDYSLDLWSLG-CMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG 347
           + +  + D+WS G  ++       E F Y   +     +  +++G
Sbjct: 193 K-FSVASDVWSFGVVLY-------ELFTYIEKSKSPPAEFMRMIG 229

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540

 Score = 49.6 bits (119), Expect = 1e-06
 Identities = 30/185 (16%), Positives = 68/185 (36%), Gaps = 34/185 (18%)

Query: 111 DINVVRPREYWDYESLTVQWGEQDDYEVVR----KVGRGKYSEVFEGVHCTDNEKCIIKI 166
           D   + P   +  + + V W ++   +  +     +G+G  +++    +   +   IIK 
Sbjct: 311 DETKIIPN--YRTDMVEVNWIKEIKGKKRKIPEHLIGKGAEADIKRDSY--LDFDVIIKE 366

Query: 167 LKP-----------VKKKKIKREIKILQNL--CGGPNIVKLLDIVRDQQSKTPSLIFEHV 213
                         ++K +  RE + L  +   G P        + D       ++  ++
Sbjct: 367 RVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPA-----PYIFDVDLDNKRIMMSYI 421

Query: 214 NNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDW 273
           N    K +     D       Y++ + +   H   ++H D+   N + D   + L +ID+
Sbjct: 422 NGKLAKDVIEDNLDI-----AYKIGEIVGKLHKNDVIHNDLTTSNFIFD---KDLYIIDF 473

Query: 274 GLAEF 278
           GL + 
Sbjct: 474 GLGKI 478

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 48.8 bits (117), Expect = 1e-06
 Identities = 36/213 (16%), Positives = 86/213 (40%), Gaps = 33/213 (15%)

Query: 134 DDYEV-------VRKVGRGKYSEVFEGVHCTDNEKCI---IKILKP-----VKKKKIKRE 178
           +D  +        + +G G++  V EG    ++   +   +K +K       + ++   E
Sbjct: 27  EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSE 86

Query: 179 IKILQNLCGGPNIVKLLDIVRDQQSK---TPSLIFEHVNNTDFK---------VLYPTLS 226
              +++    PN+++LL +  +  S+    P +I   +   D                + 
Sbjct: 87  AACMKDFS-HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIP 145

Query: 227 DYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN 286
              +  ++ ++   ++Y  ++  +HRD+   N M+  +   + + D+GL++  + G  Y 
Sbjct: 146 LQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR-DDMTVCVADFGLSKKIYSGDYYR 204

Query: 287 VRVASRY-FK--GPELLVDLQDYDYSLDLWSLG 316
               ++   K    E L D + Y    D+W+ G
Sbjct: 205 QGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFG 236

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 48.8 bits (117), Expect = 2e-06
 Identities = 33/172 (19%), Positives = 68/172 (39%), Gaps = 33/172 (19%)

Query: 134 DDYEV-------VRKVGRGKYSEVFEGV-----HCTDNEKCIIKILKP----VKKKKIKR 177
           D++EV        R++G+G +  V+EGV           +  IK +       ++ +   
Sbjct: 18  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 77

Query: 178 EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK-------------VLYPT 224
           E  +++      ++V+LL +V   Q     +I E +   D K              +   
Sbjct: 78  EASVMKEF-NCHHVVRLLGVVSQGQP--TLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 134

Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
            S   +     E+   + Y ++   +HRD+   N M+  E   +++ D+G+ 
Sbjct: 135 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA-EDFTVKIGDFGMT 185

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 48.4 bits (116), Expect = 2e-06
 Identities = 32/236 (13%), Positives = 80/236 (33%), Gaps = 39/236 (16%)

Query: 134 DDYEVVRKVGRGKYSEVFEGV-------HCTDNEKCIIKILKPV---KKKKIKREIKILQ 183
           +D      +G+G ++++F+GV             + ++K+L        +       ++ 
Sbjct: 8   EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67

Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLI-FEHVNNTDFKVLY-----PTLSDYDVRYYIYEL 237
            L    ++V    +         +++  E V        Y       ++         +L
Sbjct: 68  KLS-HKHLVLNYGVCVCGD---ENILVQEFVKFGSLD-TYLKKNKNCINILWKLEVAKQL 122

Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLI-------DWGLAEFYHPGKEYNVRV- 289
             A+ +     ++H +V   N+++  E+ +           D G++    P      R+ 
Sbjct: 123 AAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP 182

Query: 290 --ASRYFKGPELLVDLQDYDYSLDLWSLG-CMFAGMIFRKEPFFYGHDNYDQLVKI 342
                    PE + + ++ + + D WS G  ++       +P     D+  +L   
Sbjct: 183 WVP------PECIENPKNLNLATDKWSFGTTLWEICSGGDKP-LSALDSQRKLQFY 231

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 48.8 bits (117), Expect = 2e-06
 Identities = 35/217 (16%), Positives = 75/217 (34%), Gaps = 36/217 (16%)

Query: 74  HQHQRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYW--DYESLTVQWG 131
           H H      ++  + L  +      +  A      Y +            +   + +   
Sbjct: 4   HHHH-----SSGRENLYFQGKLPEPQFYAEPH--TYEEPGRAGRSFTREIEASRIHI--- 53

Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI---IKILKP----VKKKKIKREIKILQN 184
                   + +G G   EV  G      ++ +   IK LK      +++    E  I+  
Sbjct: 54  -------EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQ 106

Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLI-FEHVNNTDF----KVLYPTLSDYDVRYYIYELLK 239
               PNI++L  +V   +    ++I  E++ N       +      +   +   +  +  
Sbjct: 107 FD-HPNIIRLEGVVTRGR---LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGA 162

Query: 240 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
            + Y    G +HRD+   NV++D      ++ D+GL+
Sbjct: 163 GMRYLSDLGYVHRDLAARNVLVD-SNLVCKVSDFGLS 198

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 48.0 bits (115), Expect = 3e-06
 Identities = 43/227 (18%), Positives = 99/227 (43%), Gaps = 23/227 (10%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCI----IKILK----PVKKKKIKREIKILQNL 185
            +++ ++ +G G +  V++G+   + EK      IK L+    P   K+I  E  ++ ++
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74

Query: 186 CGGPNIVKLLDIVRDQQSKTPSLIFEHVNN---TDF-KVLYPTLSDYDVRYYIYELLKAL 241
              P++ +LL I          LI + +      D+ +     +    +  +  ++ K +
Sbjct: 75  D-NPHVCRLLGICLTST---VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130

Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK--GPE 298
           +Y   + ++HRD+   NV++    + +++ D+GLA+     ++       +   K    E
Sbjct: 131 NYLEDRRLVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189

Query: 299 LLVDLQDYDYSLDLWSLG-CMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
            ++    Y +  D+WS G  ++  M F  +P+  G    +    + K
Sbjct: 190 SILHRI-YTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEK 234

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 47.6 bits (114), Expect = 3e-06
 Identities = 26/151 (17%), Positives = 65/151 (43%), Gaps = 15/151 (9%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNI 191
           ++  +++++G G++  V  G          +K++K   + + +  +E + +  L   P +
Sbjct: 8   EEITLLKELGSGQFGVVKLGK-WKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLS-HPKL 65

Query: 192 VKLLDIVRDQQSKTPSLI-FEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCH 245
           VK   +   +    P  I  E+++N      Y       L    +    Y++ + + +  
Sbjct: 66  VKFYGVCSKEY---PIYIVTEYISNGCLLN-YLRSHGKGLEPSQLLEMCYDVCEGMAFLE 121

Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
           S   +HRD+   N ++D     +++ D+G+ 
Sbjct: 122 SHQFIHRDLAARNCLVD-RDLCVKVSDFGMT 151

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 46.8 bits (112), Expect = 5e-06
 Identities = 30/159 (18%), Positives = 71/159 (44%), Gaps = 20/159 (12%)

Query: 132 EQDDYEV-------VRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKIL 182
               +E+       ++++G G++  V  G          IK++K   + + +   E K++
Sbjct: 15  GYGSWEIDPKDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVM 73

Query: 183 QNLCGGPNIVKLLDIVRDQQSKTPSLI-FEHVNNTDF----KVLYPTLSDYDVRYYIYEL 237
            NL     +V+L  +   Q+   P  I  E++ N       + +        +     ++
Sbjct: 74  MNLS-HEKLVQLYGVCTKQR---PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDV 129

Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
            +A++Y  S+  +HRD+   N +++ +Q  +++ D+GL+
Sbjct: 130 CEAMEYLESKQFLHRDLAARNCLVN-DQGVVKVSDFGLS 167

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 47.3 bits (113), Expect = 5e-06
 Identities = 43/223 (19%), Positives = 88/223 (39%), Gaps = 41/223 (18%)

Query: 132 EQDDYEV-------VRKVGRGKYSEVFEG-----VHCTDNEKCIIKILKP----VKKKKI 175
           +   +E         + +GRG + +V E                +K+LK      + + +
Sbjct: 18  DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL 77

Query: 176 KREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK---------------- 219
             E+KIL ++    N+V LL     +      +I E     +                  
Sbjct: 78  MSELKILIHIGHHLNVVNLLGAC-TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136

Query: 220 ---VLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
              +    L+   +  Y +++ K +++  S+  +HRD+   N+++  E+  +++ D+GLA
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLA 195

Query: 277 EFYHPGKEYNVRVASRY-FK--GPELLVDLQDYDYSLDLWSLG 316
              +   +Y  +  +R   K   PE + D + Y    D+WS G
Sbjct: 196 RDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFG 237

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 47.0 bits (112), Expect = 6e-06
 Identities = 33/155 (21%), Positives = 65/155 (41%), Gaps = 17/155 (10%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCI---IKILKP----VKKKKIKREIKILQNLC 186
            +  + + VG G++ EV  G     ++K I   IK LK      +++    E  I+    
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104

Query: 187 GGPNIVKLLDIVRDQQSKTPSLI-FEHVNNTDF----KVLYPTLSDYDVRYYIYELLKAL 241
             PNI++L  +V   +   P +I  E++ N       +      +   +   +  +   +
Sbjct: 105 -HPNIIRLEGVVTKSK---PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160

Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
            Y    G +HRD+   N++I+      ++ D+GL 
Sbjct: 161 KYLSDMGYVHRDLAARNILIN-SNLVCKVSDFGLG 194

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 46.4 bits (111), Expect = 7e-06
 Identities = 31/161 (19%), Positives = 71/161 (44%), Gaps = 24/161 (14%)

Query: 132 EQDDYEV-------VRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKIL 182
            +D++EV       V ++G G++ EV+ G     + K  +K LK   +       E  ++
Sbjct: 4   WEDEWEVPRETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLM 62

Query: 183 QNLCGGPNIVKLLDIVRDQQSKTPSLI-FEHVNNTDFKVLY------PTLSDYDVRYYIY 235
           + L     +V+L  +V    ++ P  I  E++ N      +        L+   +     
Sbjct: 63  KQLQ-HQRLVRLYAVV----TQEPIYIITEYMENGSLVD-FLKTPSGIKLTINKLLDMAA 116

Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
           ++ + + +   +  +HRD++  N+++  +    ++ D+GLA
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVS-DTLSCKIADFGLA 156

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 46.6 bits (111), Expect = 7e-06
 Identities = 29/156 (18%), Positives = 64/156 (41%), Gaps = 18/156 (11%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCI----IKILKP----VKKKKIKREIKILQNL 185
                 + +G G++ EV++G+  T + K      IK LK      ++     E  I+   
Sbjct: 44  SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103

Query: 186 CGGPNIVKLLDIVRDQQSKTPSLI-FEHVNNTDF----KVLYPTLSDYDVRYYIYELLKA 240
               NI++L  ++   +   P +I  E++ N       +      S   +   +  +   
Sbjct: 104 S-HHNIIRLEGVISKYK---PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG 159

Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
           + Y  +   +HRD+   N++++      ++ D+GL+
Sbjct: 160 MKYLANMNYVHRDLAARNILVN-SNLVCKVSDFGLS 194

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 45.7 bits (109), Expect = 1e-05
 Identities = 46/223 (20%), Positives = 83/223 (37%), Gaps = 40/223 (17%)

Query: 132 EQDDYEV-------VRKVGRGKYSEVFEG-----VHCTDNEKCIIKILKP----VKKKKI 175
               +E         + +G G + +V E      +         +K+LKP     +++ +
Sbjct: 14  YDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREAL 73

Query: 176 KREIKILQNLCGGPNIVKLLDIVRDQQ-------------------SKTPSLIFEHVNNT 216
             E+K+L  L    NIV LL                           K  S I    +  
Sbjct: 74  MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPA 133

Query: 217 DFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
             +     L   D+  + Y++ K + +  S+  +HRD+   N+++    R  ++ D+GLA
Sbjct: 134 IMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT-HGRITKICDFGLA 192

Query: 277 EFYHPGKEYNVRVASRY-FK--GPELLVDLQDYDYSLDLWSLG 316
                   Y V+  +R   K   PE + +   Y +  D+WS G
Sbjct: 193 RDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYG 234

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 45.8 bits (109), Expect = 1e-05
 Identities = 32/164 (19%), Positives = 78/164 (47%), Gaps = 17/164 (10%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCI----IKILK----PVKKKKIKREIKILQNL 185
            +++ ++ +G G +  V++G+   + EK      IK L+    P   K+I  E  ++ ++
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74

Query: 186 CGGPNIVKLLDIVRDQQSKTPSLIFEHVNN---TDF-KVLYPTLSDYDVRYYIYELLKAL 241
              P++ +LL I     + T  LI + +      D+ +     +    +  +  ++ K +
Sbjct: 75  D-NPHVCRLLGIC---LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130

Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285
           +Y   + ++HRD+   NV++    + +++ D+GLA+     ++ 
Sbjct: 131 NYLEDRRLVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKE 173

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 45.3 bits (108), Expect = 1e-05
 Identities = 24/150 (16%), Positives = 65/150 (43%), Gaps = 13/150 (8%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNI 191
            +   V+++G G++  V  G    + +K  IK ++   + ++    E +++  L   P +
Sbjct: 8   SELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLS-HPKL 65

Query: 192 VKLLDIVRDQQSKTPSLI-FEHVNNTDF----KVLYPTLSDYDVRYYIYELLKALDYCHS 246
           V+L  +  +Q    P  +  E + +       +      +   +     ++ + + Y   
Sbjct: 66  VQLYGVCLEQA---PICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 122

Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
             ++HRD+   N ++  E + +++ D+G+ 
Sbjct: 123 ACVIHRDLAARNCLVG-ENQVIKVSDFGMT 151

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 45.7 bits (108), Expect = 2e-05
 Identities = 35/231 (15%), Positives = 85/231 (36%), Gaps = 15/231 (6%)

Query: 56  PFGTLRGLASSASLSHARHQHQRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVV 115
                 G A+    +H        R++ T            +     P    + + +   
Sbjct: 258 SASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFES 317

Query: 116 RPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI--IKILK----P 169
              +  + +   +     +      ++G G +  V +GV+    ++    IK+LK     
Sbjct: 318 PFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK 377

Query: 170 VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF----KVLYPTL 225
              +++ RE +I+  L   P IV+L+ +    Q++   L+ E                 +
Sbjct: 378 ADTEEMMREAQIMHQLD-NPYIVRLIGVC---QAEALMLVMEMAGGGPLHKFLVGKREEI 433

Query: 226 SDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
              +V   ++++   + Y   +  +HR++   NV++   +   ++ D+GL+
Sbjct: 434 PVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLV-NRHYAKISDFGLS 483

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 45.0 bits (107), Expect = 2e-05
 Identities = 40/224 (17%), Positives = 92/224 (41%), Gaps = 27/224 (12%)

Query: 139 VRKVGRGKYSEVFEGVHCTDNEKCI----IKILK----PVKKKKIKREIKILQNLCGGPN 190
           ++ +G G +  V +GV   + E       IK+++        + +   +  + +L    +
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD-HAH 76

Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNN---TDF-KVLYPTLSDYDVRYYIYELLKALDYCHS 246
           IV+LL +          L+ +++      D  +     L    +  +  ++ K + Y   
Sbjct: 77  IVRLLGLCPGSS---LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE 133

Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK--GPELLVDL 303
            G++HR++   NV++     ++++ D+G+A+   P  +  +   ++   K    E    +
Sbjct: 134 HGMVHRNLAARNVLLK-SPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE---SI 189

Query: 304 QDYDYSL--DLWSLG-CMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
               Y+   D+WS G  ++  M F  EP+  G    +    + K
Sbjct: 190 HFGKYTHQSDVWSYGVTVWELMTFGAEPYA-GLRLAEVPDLLEK 232

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 45.1 bits (107), Expect = 3e-05
 Identities = 32/167 (19%), Positives = 71/167 (42%), Gaps = 16/167 (9%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNI 191
           +  ++ +K+G G++ EV+       + K  +K +KP  +  +    E  +++ L     +
Sbjct: 188 ESLKLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQ-HDKL 245

Query: 192 VKLLDIVRDQQSKTPSLI-FEHVNN---TDF--KVLYPTLSDYDVRYYIYELLKALDYCH 245
           VKL  +V    +K P  I  E +      DF             +  +  ++ + + +  
Sbjct: 246 VKLHAVV----TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 301

Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASR 292
            +  +HRD++  N+++       ++ D+GLA       EY  R  ++
Sbjct: 302 QRNYIHRDLRAANILVS-ASLVCKIADFGLARVIE-DNEYTAREGAK 346

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 44.6 bits (106), Expect = 3e-05
 Identities = 34/198 (17%), Positives = 71/198 (35%), Gaps = 40/198 (20%)

Query: 132 EQDDYEV-------VRKVGRGKYSEVFEGV-------HCTDNEKCIIKILKP----VKKK 173
           E   +E         + +G G + +V              +     +K+LK         
Sbjct: 26  EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 85

Query: 174 KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK-------------- 219
            +  E+++++ +    NI+ LL            +I E+ +  + +              
Sbjct: 86  DLVSEMEMMKMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLRARRPPGMEYS 143

Query: 220 -----VLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG 274
                V    ++  D+    Y+L + ++Y  SQ  +HRD+   NV++  E   +++ D+G
Sbjct: 144 YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFG 202

Query: 275 LAEFYHPGKEYNVRVASR 292
           LA   +    Y      R
Sbjct: 203 LARDINNIDYYKKTTNGR 220

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 44.5 bits (106), Expect = 3e-05
 Identities = 28/152 (18%), Positives = 68/152 (44%), Gaps = 17/152 (11%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIV 192
            + ++++ +G+G++ +V  G +     K  +K +K     +    E  ++  L    N+V
Sbjct: 21  KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLR-HSNLV 77

Query: 193 KLLDIVRDQQSKTPSL--IFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALDYC 244
           +LL ++ +++     L  + E++        Y        L    +  +  ++ +A++Y 
Sbjct: 78  QLLGVIVEEK---GGLYIVTEYMAKGSLVD-YLRSRGRSVLGGDCLLKFSLDVCEAMEYL 133

Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
                +HRD+   NV++  E    ++ D+GL 
Sbjct: 134 EGNNFVHRDLAARNVLVS-EDNVAKVSDFGLT 164

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 44.3 bits (105), Expect = 4e-05
 Identities = 39/251 (15%), Positives = 83/251 (33%), Gaps = 49/251 (19%)

Query: 72  ARHQHQRLRQLATPPDTLAQKIG----KSVRRSGAPSKARVYSDINVVRPREYWDYESLT 127
           + H H    Q       L ++I      +V    + S       + +           + 
Sbjct: 3   SSHHHHHHSQDPPAVHKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPML 62

Query: 128 VQWGEQ-----DDYEV-------VRKVGRGKYSEVFEGV-------HCTDNEKCIIKILK 168
               E        +E         + +G G + +V              +     +K+LK
Sbjct: 63  AGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK 122

Query: 169 P----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK----- 219
                     +  E+++++ +    NI+ LL            +I E+ +  + +     
Sbjct: 123 DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLRA 180

Query: 220 --------------VLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ 265
                         V    ++  D+    Y+L + ++Y  SQ  +HRD+   NV++  E 
Sbjct: 181 RRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT-EN 239

Query: 266 RKLRLIDWGLA 276
             +++ D+GLA
Sbjct: 240 NVMKIADFGLA 250

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 43.8 bits (104), Expect = 5e-05
 Identities = 47/234 (20%), Positives = 89/234 (38%), Gaps = 35/234 (14%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCI---IKILKP------VKKKKIKREIKILQN 184
            D  ++ K+G G +  V  G     + K +   +K LKP             RE+  + +
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77

Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELL------ 238
           L    N+++L  +V     K   ++ E         L   L  +   + +  L       
Sbjct: 78  LD-HRNLIRLYGVVLTPPMK---MVTELAPLGS---LLDRLRKHQGHFLLGTLSRYAVQV 130

Query: 239 -KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRY-FK 295
            + + Y  S+  +HRD+   N+++   +  +++ D+GL          Y ++   +  F 
Sbjct: 131 AEGMGYLESKRFIHRDLAARNLLLA-TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 189

Query: 296 --GPELLVDLQDYDYSL--DLWSLG-CMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
              PE L       +S   D W  G  ++    + +EP + G +    L KI K
Sbjct: 190 WCAPESLKTRT---FSHASDTWMFGVTLWEMFTYGQEP-WIGLNGSQILHKIDK 239

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 43.4 bits (103), Expect = 8e-05
 Identities = 34/187 (18%), Positives = 64/187 (34%), Gaps = 40/187 (21%)

Query: 117 PREYW--DYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI--IKILKP--- 169
           P  Y   D+  +  Q            +G G + +V +     D  +    IK +K    
Sbjct: 16  PTIYPVLDWNDIKFQ----------DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS 65

Query: 170 -VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK--------- 219
               +    E+++L  L   PNI+ LL     +      L  E+  + +           
Sbjct: 66  KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY--LYLAIEYAPHGNLLDFLRKSRVL 123

Query: 220 ---VLYPTLSDYDVRYYIYELLK-ALD------YCHSQGIMHRDVKPHNVMIDHEQRKLR 269
                +   +         +LL  A D      Y   +  +HRD+   N+++  E    +
Sbjct: 124 ETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG-ENYVAK 182

Query: 270 LIDWGLA 276
           + D+GL+
Sbjct: 183 IADFGLS 189

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 43.0 bits (102), Expect = 9e-05
 Identities = 32/164 (19%), Positives = 66/164 (40%), Gaps = 29/164 (17%)

Query: 134 DDYEVVR--------KVGRGKYSEVFEGVHCTDNEKCI--IKILKP----VKKKKIKREI 179
               + R        ++G G +  V +GV+    ++    IK+LK        +++ RE 
Sbjct: 2   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 61

Query: 180 KILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELL- 238
           +I+  L   P IV+L+ +    Q++   L+ E         L+  L        +  +  
Sbjct: 62  QIMHQLD-NPYIVRLIGVC---QAEALMLVMEMAGGGP---LHKFLVGKREEIPVSNVAE 114

Query: 239 ------KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
                   + Y   +  +HRD+   NV++   +   ++ D+GL+
Sbjct: 115 LLHQVSMGMKYLEEKNFVHRDLAARNVLLV-NRHYAKISDFGLS 157

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 42.2 bits (100), Expect = 2e-04
 Identities = 31/156 (19%), Positives = 69/156 (44%), Gaps = 15/156 (9%)

Query: 140 RKVGRGKYSEVFEGVHCTDNE--KCIIKILK-----PVKKKKIKREIKILQNLCGGPNIV 192
           +++G G +  V +G +          +KILK     P  K ++  E  ++Q L   P IV
Sbjct: 23  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIV 81

Query: 193 KLLDIVRDQQSKTPSLIFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGI 249
           +++ I    ++++  L+ E         +      + D ++   ++++   + Y      
Sbjct: 82  RMIGIC---EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 138

Query: 250 MHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285
           +HRD+   NV++   Q   ++ D+GL++     + Y
Sbjct: 139 VHRDLAARNVLLV-TQHYAKISDFGLSKALRADENY 173

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282

 Score = 42.2 bits (99), Expect = 2e-04
 Identities = 30/168 (17%), Positives = 66/168 (39%), Gaps = 36/168 (21%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-------VKKKKI------------- 175
             + + +G GK S VF         +C++K  K        VK+K+              
Sbjct: 92  DAIGKLMGEGKESAVFNCY-SEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 150

Query: 176 -KREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYI 234
            + E + LQ L G   + K+     +      +++ E ++  +       +   +    +
Sbjct: 151 ARNEFRALQKLQGLA-VPKVYAWEGN------AVLMELIDAKEL----YRVRVENPDEVL 199

Query: 235 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHP 281
             +L+ +   + +GI+H D+  +NV++  E   + +ID+  + E    
Sbjct: 200 DMILEEVAKFYHRGIVHGDLSQYNVLVSEEG--IWIIDFPQSVEVGEE 245

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 49/213 (23%), Positives = 85/213 (39%), Gaps = 35/213 (16%)

Query: 134 DDYEVVRKVGRGKYSEVFEG-----VHCTDNEKCIIKILKP----VKKKKIKREIKILQN 184
           ++ +  + +G G + +V E             K  +K+LK      +K+ +  E+KI+ +
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105

Query: 185 LCGGPNIVKLLDIVRDQQSKTPSL-IFEHVNNTDFK-----------------VLYPTLS 226
           L    NIV LL          P L I E+    D                   +   T S
Sbjct: 106 LGQHENIVNLLGACTHGG---PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162

Query: 227 DYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN 286
             D+ ++  ++ + + +  S+  +HRDV   NV++       ++ D+GLA        Y 
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYI 221

Query: 287 VRVASRY-FK--GPELLVDLQDYDYSLDLWSLG 316
           V+  +R   K   PE + D   Y    D+WS G
Sbjct: 222 VKGNARLPVKWMAPESIFD-CVYTVQSDVWSYG 253

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 28/161 (17%), Positives = 71/161 (44%), Gaps = 17/161 (10%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIV 192
            + ++++ +G+G++ +V  G +     K  +K +K     +    E  ++  L    N+V
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLR-HSNLV 249

Query: 193 KLLDIVRDQQSKTPSL--IFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALDYC 244
           +LL ++ +++     L  + E++        Y        L    +  +  ++ +A++Y 
Sbjct: 250 QLLGVIVEEK---GGLYIVTEYMAKGSLVD-YLRSRGRSVLGGDCLLKFSLDVCEAMEYL 305

Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285
                +HRD+   NV++  E    ++ D+GL +     ++ 
Sbjct: 306 EGNNFVHRDLAARNVLVS-EDNVAKVSDFGLTKEASSTQDT 345

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 42.4 bits (100), Expect = 2e-04
 Identities = 32/182 (17%), Positives = 68/182 (37%), Gaps = 40/182 (21%)

Query: 132 EQDDYEV-------VRKVGRGKYSEVFEGV-------HCTDNEKCIIKILKP----VKKK 173
           E   +E+        + +G G + +V                 K  +K+LK         
Sbjct: 60  EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS 119

Query: 174 KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK-------------- 219
            +  E+++++ +    NI+ LL            +I E+ +  + +              
Sbjct: 120 DLISEMEMMKMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLQARRPPGLEYS 177

Query: 220 -----VLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG 274
                     LS  D+    Y++ + ++Y  S+  +HRD+   NV++  E   +++ D+G
Sbjct: 178 YNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT-EDNVMKIADFG 236

Query: 275 LA 276
           LA
Sbjct: 237 LA 238

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 41.6 bits (98), Expect = 3e-04
 Identities = 40/236 (16%), Positives = 81/236 (34%), Gaps = 33/236 (13%)

Query: 69  LSHARHQHQRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTV 128
           +S+  H H     + T  +   Q    S  +S     +++ +  + +      +Y     
Sbjct: 1   MSYYHHHHHHDYDIPTTENLYFQGAMGSELQSPEYKLSKLRT--STIMTDYNPNYCFAGK 58

Query: 129 QWGEQDDYEV-------VRKVGRGKYSEVFEG-----VHCTDNEKCIIKILKPV----KK 172
                D  EV       +R +G G + EV+EG      +     +  +K L  V     +
Sbjct: 59  TSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE 118

Query: 173 KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK----------VLY 222
                E  I+       NIV+ + +          ++ E +   D K             
Sbjct: 119 LDFLMEALIISKFN-HQNIVRCIGVSLQSLP--RFILLELMAGGDLKSFLRETRPRPSQP 175

Query: 223 PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--EQRKLRLIDWGLA 276
            +L+  D+ +   ++     Y      +HRD+   N ++      R  ++ D+G+A
Sbjct: 176 SSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 41.5 bits (98), Expect = 3e-04
 Identities = 28/207 (13%), Positives = 70/207 (33%), Gaps = 38/207 (18%)

Query: 96  SVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEG-- 153
                G+  +  +  +            +        + D  +  ++G G + +VF    
Sbjct: 11  PTEGKGSGLQGHIIENPQYFSDACVHHIK--------RRDIVLKWELGEGAFGKVFLAEC 62

Query: 154 ---VHCTDNEKCIIKILKPVKKKKIK---REIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207
              +   D     +K LK   +   +   RE ++L  L    +IV+   +    + +   
Sbjct: 63  HNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQ-HQHIVRFFGVCT--EGRPLL 119

Query: 208 LIFEHVNNTDFK------------------VLYPTLSDYDVRYYIYELLKALDYCHSQGI 249
           ++FE++ + D                    V    L    +     ++   + Y      
Sbjct: 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHF 179

Query: 250 MHRDVKPHNVMIDHEQRKLRLIDWGLA 276
           +HRD+   N ++  +   +++ D+G++
Sbjct: 180 VHRDLATRNCLVG-QGLVVKIGDFGMS 205

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 41.1 bits (97), Expect = 4e-04
 Identities = 33/183 (18%), Positives = 63/183 (34%), Gaps = 31/183 (16%)

Query: 122 DYESLTVQWGEQDDYEV-------VRKVGRGKYSEVFEGV-----HCTDNEKCIIKILKP 169
           +Y          D  EV       +R +G G + EV+EG      +     +  +K L  
Sbjct: 11  NYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE 70

Query: 170 V----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK------ 219
           V     +     E  I+       NIV+ + +          ++ E +   D K      
Sbjct: 71  VCSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQSLP--RFILMELMAGGDLKSFLRET 127

Query: 220 ----VLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--EQRKLRLIDW 273
                   +L+  D+ +   ++     Y      +HRD+   N ++      R  ++ D+
Sbjct: 128 RPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDF 187

Query: 274 GLA 276
           G+A
Sbjct: 188 GMA 190

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	434
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.98
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.87
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.75
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.46
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.36
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.28
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.19
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.95
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.81
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.76
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.61
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.54
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.53
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.34
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.08
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.91
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.85
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.81
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.81
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.77
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.76
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.71
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.59
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.54
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.41
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.38
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	97.04
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.84
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.65
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.63
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.47
1cja_A	342	Protein (actin-fragmin kinase); transferase; HET:	81.1
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	80.66

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=7.5e-62  Score=470.62  Aligned_cols=252  Identities=22%  Similarity=0.403  Sum_probs=214.6

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecc---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF  210 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  210 (434)
                      +.|+++++||+|+||+||+|+++.+|+.||||+++.   ...+.+.+|+.+|+.+ +|||||++++++.+.  ..+||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~--~~~~ivm  150 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLVG--DELWVVM  150 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHC-CCTTBCCEEEEEEET--TEEEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEEC--CEEEEEE
Confidence            569999999999999999999999999999999963   3346688999999999 999999999999764  5788999


Q ss_pred             eecCCCchhhhc--CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC-Cccce
Q 013897          211 EHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYNV  287 (434)
Q Consensus       211 e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~-~~~~~  287 (434)
                      |||.+|+|..++  ..+++.+++.++.||+.||+|||++|||||||||+||||+.++ .+||+|||+|+.+... .....
T Consensus       151 Ey~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g-~vKl~DFGla~~~~~~~~~~~~  229 (346)
T 4fih_A          151 EFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEVPRRKS  229 (346)
T ss_dssp             CCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSSSCCBCC
T ss_pred             eCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCC-CEEEecCcCceecCCCCCcccc
Confidence            999999998775  4699999999999999999999999999999999999999777 8999999999877544 34567


Q ss_pred             eccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHH
Q 013897          288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLA  367 (434)
Q Consensus       288 ~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~  367 (434)
                      .+||+.|||||++.+ ..|+.++|||||||++|||++|+.||. +.+..+.+..+.....                    
T Consensus       230 ~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~-~~~~~~~~~~i~~~~~--------------------  287 (346)
T 4fih_A          230 LVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYF-NEPPLKAMKMIRDNLP--------------------  287 (346)
T ss_dssp             CCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHHHSSC--------------------
T ss_pred             cccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCC-CcCHHHHHHHHHcCCC--------------------
Confidence            799999999999876 789999999999999999999999984 3343444433322100                    


Q ss_pred             HHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccc
Q 013897          368 ALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                                    ........+++++.|||.+||+.||++|||++|+|+||||++..
T Consensus       288 --------------~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~  331 (346)
T 4fih_A          288 --------------PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  331 (346)
T ss_dssp             --------------CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             --------------CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence                          00112234788999999999999999999999999999999754

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=7.3e-62  Score=463.97  Aligned_cols=254  Identities=27%  Similarity=0.470  Sum_probs=216.5

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      ++|++++.||+|+||+||+|+++.+++.||||+++..      ..+.+.+|+++|+.+ +|||||++++++.+.  ..++
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~--~~~y  108 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDD--EKLY  108 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECS--SEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeC--CEEE
Confidence            6799999999999999999999999999999999642      346789999999999 999999999999754  5788


Q ss_pred             EEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC-
Q 013897          208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-  283 (434)
Q Consensus       208 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~-  283 (434)
                      ||||||.+|+|..++   ..+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.+.... 
T Consensus       109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g-~vKl~DFGla~~~~~~~~  187 (311)
T 4aw0_A          109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM-HIQITDFGTAKVLSPESK  187 (311)
T ss_dssp             EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCEECCTTTT
T ss_pred             EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCC-CEEEEEcCCceecCCCCC
Confidence            999999999997765   4699999999999999999999999999999999999999777 89999999999875432 


Q ss_pred             --ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcccc
Q 013897          284 --EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE  361 (434)
Q Consensus       284 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  361 (434)
                        ...+.+||+.|||||++.+ ..|+.++|||||||++|||++|+.||. +.+..+.+.+|...  .             
T Consensus       188 ~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~-~~~~~~~~~~i~~~--~-------------  250 (311)
T 4aw0_A          188 QARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFR-AGNEGLIFAKIIKL--E-------------  250 (311)
T ss_dssp             CCCBCCCCSCGGGCCHHHHHH-SCBCHHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHT--C-------------
T ss_pred             cccccCcccCcccCCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHcC--C-------------
Confidence              3456799999999999987 789999999999999999999999983 44433444333220  0             


Q ss_pred             CChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHH------HhcCCCcccccccccc
Q 013897          362 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKE------AMAHPYFFPIRNAESS  430 (434)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~e------lL~Hp~~~~~~~~~~~  430 (434)
                                            ...+..+++++.|||.+||+.||++|||++|      +++||||+++++....
T Consensus       251 ----------------------~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~  303 (311)
T 4aw0_A          251 ----------------------YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLH  303 (311)
T ss_dssp             ----------------------CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGG
T ss_pred             ----------------------CCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhc
Confidence                                  0112246789999999999999999999987      6899999999876543

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.6e-60  Score=472.38  Aligned_cols=253  Identities=22%  Similarity=0.403  Sum_probs=215.6

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecc---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      .+.|+++++||+|+||+||+|+++.+|+.||||+++.   ...+.+.+|+.+|+.+ +|||||+++++|.+.  ..+|||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~--~~~~iV  226 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLVG--DELWVV  226 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHC-CCTTBCCEEEEEEET--TEEEEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhC-CCCCCCceEEEEEEC--CEEEEE
Confidence            4679999999999999999999999999999999963   3356789999999999 999999999999764  578899


Q ss_pred             EeecCCCchhhhc--CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC-Cccc
Q 013897          210 FEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYN  286 (434)
Q Consensus       210 ~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~-~~~~  286 (434)
                      ||||.+|+|..++  ..+++.+++.++.||+.||+|||++|||||||||+||||+.++ .+||+|||+|+.+... ....
T Consensus       227 mEy~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g-~vKl~DFGla~~~~~~~~~~~  305 (423)
T 4fie_A          227 MEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEVPRRK  305 (423)
T ss_dssp             EECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTC-CEEECCCTTCEECCSSCCCBC
T ss_pred             EeCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC-CEEEecCccceECCCCCcccc
Confidence            9999999998775  4699999999999999999999999999999999999999777 8999999999877544 3456


Q ss_pred             eeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhH
Q 013897          287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL  366 (434)
Q Consensus       287 ~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~  366 (434)
                      ..+||++|||||++.+ ..|+.++|||||||++|||++|+.||. +.+..+.+..|.....                   
T Consensus       306 ~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~-~~~~~~~~~~i~~~~~-------------------  364 (423)
T 4fie_A          306 SLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYF-NEPPLKAMKMIRDNLP-------------------  364 (423)
T ss_dssp             CCEECTTTCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHHHSCC-------------------
T ss_pred             ccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCC-CcCHHHHHHHHHcCCC-------------------
Confidence            7799999999999877 789999999999999999999999984 3344444433322100                   


Q ss_pred             HHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccc
Q 013897          367 AALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                                     ........+++++.+||.+||+.||++|||++|+|+||||++..
T Consensus       365 ---------------~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~  408 (423)
T 4fie_A          365 ---------------PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  408 (423)
T ss_dssp             ---------------CCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             ---------------CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence                           00112234788999999999999999999999999999999754

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.2e-60  Score=468.29  Aligned_cols=291  Identities=28%  Similarity=0.450  Sum_probs=231.4

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEc---CCCeEEEEEEeccc-cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHC---TDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~---~~~~~vaiK~~~~~-~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      .+.|++.++||+|+||+||+|+++   .+++.||||.+... ...++.+|+++|+.+.+|||||++++++.+.  ..+++
T Consensus        20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~--~~~~l   97 (361)
T 4f9c_A           20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKN--DHVVI   97 (361)
T ss_dssp             GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEET--TEEEE
T ss_pred             cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEEC--CEEEE
Confidence            367999999999999999999875   45789999988643 4567889999999997899999999999754  67889


Q ss_pred             EEeecCCCchhhhcCCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC-----
Q 013897          209 IFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-----  283 (434)
Q Consensus       209 v~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~-----  283 (434)
                      ||||+++++|..++..+++.+++.++.||+.||+|||++||+||||||+|||++.+.+.+||+|||+|+......     
T Consensus        98 vmE~~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~  177 (361)
T 4f9c_A           98 AMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLK  177 (361)
T ss_dssp             EEECCCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGG
T ss_pred             EEeCCCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccc
Confidence            999999999999999999999999999999999999999999999999999999775599999999997654321     


Q ss_pred             ------------------------ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHH
Q 013897          284 ------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQL  339 (434)
Q Consensus       284 ------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~  339 (434)
                                              .....+||+.|+|||++.+...|+.++||||+||++|||++|+.||+.+.++.+++
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l  257 (361)
T 4f9c_A          178 FVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTAL  257 (361)
T ss_dssp             GC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHH
T ss_pred             cccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHH
Confidence                                    12345899999999999876679999999999999999999999999999999999


Q ss_pred             HHHHHHhCChhHHHHHhhccccC-------ChhHHHHhcccCC----------CCCccccccccccCCchHHHHHHHHcc
Q 013897          340 VKIAKVLGTDELNAYLNKYHIEL-------DPHLAALVGRHSR----------KPWSKFITVENQHLAVPEAVDFLDKLL  402 (434)
Q Consensus       340 ~~i~~~~g~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~dll~~cL  402 (434)
                      ..|.+.+|......+........       .............          ..............+++++.|||.+||
T Consensus       258 ~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL  337 (361)
T 4f9c_A          258 AQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLL  337 (361)
T ss_dssp             HHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHT
T ss_pred             HHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHC
Confidence            99999999766554443221111       0111111110000          000001112223457899999999999


Q ss_pred             ccCCCCCccHHHHhcCCCccccc
Q 013897          403 RYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       403 ~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                      ++||++|||++|+|+||||++++
T Consensus       338 ~~dP~~R~ta~eaL~Hp~f~~i~  360 (361)
T 4f9c_A          338 DLNPASRITAEEALLHPFFKDMS  360 (361)
T ss_dssp             CSCTTTSCCHHHHHTSGGGTTC-
T ss_pred             cCChhHCcCHHHHhcCcccCCCC
Confidence            99999999999999999999875

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=5.2e-61  Score=465.42  Aligned_cols=251  Identities=18%  Similarity=0.374  Sum_probs=206.0

Q ss_pred             CCCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCc
Q 013897          131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT  205 (434)
Q Consensus       131 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  205 (434)
                      ...++|++++.||+|+||+||+|+++.+|+.||||+++..     ..+.+.+|+.+|++| +|||||++++++.+.  ..
T Consensus        21 ~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~--~~   97 (350)
T 4b9d_A           21 QSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM-KHPNIVQYRESFEEN--GS   97 (350)
T ss_dssp             SCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEET--TE
T ss_pred             CcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHC-CCCCCCcEEEEEEEC--CE
Confidence            3458999999999999999999999999999999999643     245689999999999 999999999999754  57


Q ss_pred             cEEEEeecCCCchhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecC
Q 013897          206 PSLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH  280 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~  280 (434)
                      ++||||||.+|+|..++.     .+++.+++.++.||+.||+|||++|||||||||+||||+.++ .+||+|||+|+...
T Consensus        98 ~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g-~vKl~DFGla~~~~  176 (350)
T 4b9d_A           98 LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG-TVQLGDFGIARVLN  176 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTC-CEEECSTTEESCCC
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC-CEEEcccccceeec
Confidence            889999999999977652     368889999999999999999999999999999999999777 89999999998765


Q ss_pred             CCC-ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcc
Q 013897          281 PGK-EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH  359 (434)
Q Consensus       281 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  359 (434)
                      ... .....+||+.|||||++.+ ..|+.++|||||||+||||++|+.||. +.+..+.+.++....             
T Consensus       177 ~~~~~~~~~~GT~~YmAPE~l~~-~~y~~~~DiwSlGvilyemltG~~PF~-~~~~~~~~~~i~~~~-------------  241 (350)
T 4b9d_A          177 STVELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFE-AGSMKNLVLKIISGS-------------  241 (350)
T ss_dssp             HHHHHHHHHHSCCTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCC-CSSHHHHHHHHHHTC-------------
T ss_pred             CCcccccccCCCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCC-CcCHHHHHHHHHcCC-------------
Confidence            332 2345689999999999987 789999999999999999999999983 444444443332200             


Q ss_pred             ccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccc
Q 013897          360 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP  423 (434)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~  423 (434)
                                   .          ......+++++.+||.+||+.||++|||++|+|+||||++
T Consensus       242 -------------~----------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  282 (350)
T 4b9d_A          242 -------------F----------PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK  282 (350)
T ss_dssp             -------------C----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred             -------------C----------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence                         0          0011236789999999999999999999999999999975

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.8e-60  Score=448.13  Aligned_cols=247  Identities=24%  Similarity=0.474  Sum_probs=192.3

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      ++|++++.||+|+||+||+|+++.+++.||||+++..      ....+.+|+.+|+.+ +|||||++++++.+.  ..++
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~--~~~~   89 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL-RHPHIIKLYDVIKSK--DEII   89 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHC-CCTTBCCEEEEEECS--SEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEEC--CEEE
Confidence            6799999999999999999999999999999998642      245689999999999 999999999999654  5788


Q ss_pred             EEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc
Q 013897          208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE  284 (434)
Q Consensus       208 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~  284 (434)
                      +||||++ |+|...+   ..+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.......
T Consensus        90 ivmEy~~-g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~-~vkl~DFGla~~~~~~~~  167 (275)
T 3hyh_A           90 MVIEYAG-NELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHL-NVKIADFGLSNIMTDGNF  167 (275)
T ss_dssp             EEEECCC-EEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTC-CEEECCSSCC--------
T ss_pred             EEEeCCC-CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCC-CEEEeecCCCeecCCCCc
Confidence            9999995 5554443   4699999999999999999999999999999999999999776 899999999987766666


Q ss_pred             cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCCh
Q 013897          285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP  364 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  364 (434)
                      ....+||+.|||||++.+...++.++|||||||++|||++|+.||. +.+....+..+...  .                
T Consensus       168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~-~~~~~~~~~~i~~~--~----------------  228 (275)
T 3hyh_A          168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD-DESIPVLFKNISNG--V----------------  228 (275)
T ss_dssp             -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHT--C----------------
T ss_pred             cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHcC--C----------------
Confidence            6778999999999999874445789999999999999999999983 33322222222110  0                


Q ss_pred             hHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccc
Q 013897          365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP  423 (434)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~  423 (434)
                                         ...+..+++++.+||.+||+.||++|||++|+|+||||+.
T Consensus       229 -------------------~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          229 -------------------YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             -------------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             -------------------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence                               0011236889999999999999999999999999999973

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=6.3e-60  Score=448.09  Aligned_cols=249  Identities=22%  Similarity=0.401  Sum_probs=204.4

Q ss_pred             eEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEcc--CCCccEE
Q 013897          136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ--QSKTPSL  208 (434)
Q Consensus       136 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~~~~~l  208 (434)
                      |++.++||+|+||+||+|.+..++..||+|++...     ..+.+.+|+.+|++| +|||||+++++|.+.  ....++|
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~~~~l  106 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEEETTEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEeeccCCCcEEEE
Confidence            37788899999999999999999999999998642     245689999999999 999999999998653  2356889


Q ss_pred             EEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCC--ceeecCCCCceEecCCCCeEEEEecccceecCCCC
Q 013897          209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       209 v~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~  283 (434)
                      |||||.+|+|..++   ..+++..++.++.||+.||+|||+++  ||||||||+|||++..++.+||+|||+|+... ..
T Consensus       107 vmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~-~~  185 (290)
T 3fpq_A          107 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-AS  185 (290)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC-TT
T ss_pred             EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC-CC
Confidence            99999999998776   46899999999999999999999998  99999999999998544489999999998543 34


Q ss_pred             ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                      .....+||+.|||||++.+  .|+.++|||||||++|||+||+.||... .+...+.....   ..              
T Consensus       186 ~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~-~~~~~~~~~i~---~~--------------  245 (290)
T 3fpq_A          186 FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSEC-QNAAQIYRRVT---SG--------------  245 (290)
T ss_dssp             SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTC-SSHHHHHHHHT---TT--------------
T ss_pred             ccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCC-CcHHHHHHHHH---cC--------------
Confidence            4566799999999999864  6999999999999999999999998433 33333222110   00              


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP  423 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~  423 (434)
                               .        ........+++++.+||.+||+.||++|||++|+|+||||++
T Consensus       246 ---------~--------~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          246 ---------V--------KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             ---------C--------CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             ---------C--------CCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence                     0        000112236788999999999999999999999999999985

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.9e-59  Score=461.23  Aligned_cols=284  Identities=29%  Similarity=0.550  Sum_probs=225.6

Q ss_pred             CCCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEcc----
Q 013897          131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ----  201 (434)
Q Consensus       131 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~----  201 (434)
                      ...++|++++.||+|+||+||+|+++.+|+.||||+++..     ..+.+.+|+.+|+.| +|||||++++++...    
T Consensus        51 ~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~  129 (398)
T 4b99_A           51 DVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHF-KHDNIIAIKDILRPTVPYG  129 (398)
T ss_dssp             CCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSSCTT
T ss_pred             CCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhc-CCCCcceEeeeeecccccc
Confidence            3457899999999999999999999999999999999643     235678999999999 999999999998643    


Q ss_pred             CCCccEEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEeccccee
Q 013897          202 QSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF  278 (434)
Q Consensus       202 ~~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~  278 (434)
                      ....+|||||||++ +|..++   ..+++.+++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+.
T Consensus       130 ~~~~~~ivmE~~~g-~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~-~~Ki~DFGla~~  207 (398)
T 4b99_A          130 EFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENC-ELKIGDFGMARG  207 (398)
T ss_dssp             TCCCEEEEEECCSE-EHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTC-CEEECCCTTCBC
T ss_pred             cCCEEEEEEeCCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCC-CEEEeecceeee
Confidence            23578999999975 454443   3599999999999999999999999999999999999999777 899999999986


Q ss_pred             cCCC-----CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHH
Q 013897          279 YHPG-----KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA  353 (434)
Q Consensus       279 ~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~  353 (434)
                      +...     ......+||+.|||||++.+...|+.++||||+||++|||++|+.|| .+.+..+++..|.+..|.+....
T Consensus       208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF-~g~~~~~~l~~I~~~~g~p~~~~  286 (398)
T 4b99_A          208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLF-PGKNYVHQLQLIMMVLGTPSPAV  286 (398)
T ss_dssp             C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSS-CCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCC-CCCCHHHHHHHHHHhcCCCChHH
Confidence            5332     23456799999999999988667899999999999999999999887 67788899999999888765433


Q ss_pred             HHhhccccCChhHHHHhccc---CCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccccc
Q 013897          354 YLNKYHIELDPHLAALVGRH---SRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA  427 (434)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~  427 (434)
                      +....    ...........   ...+|..     ....+++++.|||.+||++||++|||++|+|+||||++...+
T Consensus       287 ~~~~~----~~~~~~~~~~~~~~~~~~~~~-----~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p  354 (398)
T 4b99_A          287 IQAVG----AERVRAYIQSLPPRQPVPWET-----VYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDP  354 (398)
T ss_dssp             TC---------CHHHHHHSSCCCCCCCHHH-----HSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCG
T ss_pred             hhhhh----hhhhhhhhhcCCCcCCCCHHH-----hCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCC
Confidence            21110    00111111111   1111111     112467899999999999999999999999999999987543

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3.3e-60  Score=452.32  Aligned_cols=252  Identities=27%  Similarity=0.441  Sum_probs=205.9

Q ss_pred             CCeEEEeeeeecCceEEEEEEEc---CCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCc
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHC---TDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT  205 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~---~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  205 (434)
                      ++|++++.||+|+||+||+|++.   .+++.||||+++..     ....+.+|+.+|+++ +|||||++++++.+.  ..
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~--~~  100 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV-NHPFIVKLHYAFQTE--GK  100 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCC-CCTTEECEEEEEEET--TE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEEC--CE
Confidence            67999999999999999999874   35789999998643     234688999999999 999999999999764  57


Q ss_pred             cEEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC
Q 013897          206 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG  282 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~  282 (434)
                      ++||||||.+|+|..++   ..+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.....
T Consensus       101 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g-~vKl~DFGla~~~~~~  179 (304)
T 3ubd_A          101 LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG-HIKLTDFGLSKESIDH  179 (304)
T ss_dssp             EEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTS-CEEEESSEEEEC----
T ss_pred             EEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCC-CEEecccccceeccCC
Confidence            88999999999997765   4699999999999999999999999999999999999999777 8999999999865433


Q ss_pred             -CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcccc
Q 013897          283 -KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE  361 (434)
Q Consensus       283 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  361 (434)
                       ......+||+.|||||++.+ ..|+.++|||||||++|||+||+.|| .+.+..+.+..|.+.  .             
T Consensus       180 ~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~PF-~~~~~~~~~~~i~~~--~-------------  242 (304)
T 3ubd_A          180 EKKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPF-QGKDRKETMTMILKA--K-------------  242 (304)
T ss_dssp             -CCCCSCCCCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHC--C-------------
T ss_pred             CccccccccCcccCCHHHhcc-CCCCCCCcccchHHHHHHHHhCCCCC-CCcCHHHHHHHHHcC--C-------------
Confidence             34456789999999999987 78999999999999999999999998 344444444443220  0             


Q ss_pred             CChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCcc-----HHHHhcCCCcccccccc
Q 013897          362 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT-----AKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt-----~~elL~Hp~~~~~~~~~  428 (434)
                                            ...+..+++++.+||.+||+.||++|||     ++|+|+||||+++++..
T Consensus       243 ----------------------~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~  292 (304)
T 3ubd_A          243 ----------------------LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNK  292 (304)
T ss_dssp             ----------------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHH
T ss_pred             ----------------------CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHH
Confidence                                  0112247889999999999999999998     58999999999987654

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=3.1e-59  Score=450.99  Aligned_cols=255  Identities=23%  Similarity=0.317  Sum_probs=209.6

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEee
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH  212 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  212 (434)
                      .+.|++.++||+|+||+||+|+++.+|+.||||+++...  ...+|+.+|+.+ +|||||++++++.+.  ..++|||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~--~~~~E~~il~~l-~HpnIV~l~~~~~~~--~~~~ivmEy  131 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV--FRVEELVACAGL-SSPRIVPLYGAVREG--PWVNIFMEL  131 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCTHHHHTTTTC-CCTTBCCEEEEEEET--TEEEEEECC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH--hHHHHHHHHHhC-CCCCCCcEEEEEEEC--CEEEEEEec
Confidence            357999999999999999999999999999999997542  235799999999 999999999999754  578899999


Q ss_pred             cCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc-----
Q 013897          213 VNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-----  284 (434)
Q Consensus       213 ~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~-----  284 (434)
                      |.+|+|..++   ..+++.+++.++.||+.||+|||++|||||||||+||||+.++..+||+|||+|+.+.....     
T Consensus       132 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~  211 (336)
T 4g3f_A          132 LEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLL  211 (336)
T ss_dssp             CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----------
T ss_pred             cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccccee
Confidence            9999998776   46999999999999999999999999999999999999997775699999999987754322     


Q ss_pred             -cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          285 -YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       285 -~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                       ....+||+.|||||++.+ ..|+.++|||||||++|||++|+.||.. .+..+.+..|...  ...             
T Consensus       212 ~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~Pf~~-~~~~~~~~~i~~~--~~~-------------  274 (336)
T 4g3f_A          212 TGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQ-YFRGPLCLKIASE--PPP-------------  274 (336)
T ss_dssp             --CCCCCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSTT-TCCSCCHHHHHHS--CCG-------------
T ss_pred             cCCccccCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCcCCCCC-CCHHHHHHHHHcC--CCC-------------
Confidence             123579999999999987 7899999999999999999999999843 3332333332210  000             


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHH-------------hcCCCcccccccc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEA-------------MAHPYFFPIRNAE  428 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~el-------------L~Hp~~~~~~~~~  428 (434)
                                         ....+..+++++.+||.+||+.||++|||+.|+             |+|||+....++.
T Consensus       275 -------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~Pr  333 (336)
T 4g3f_A          275 -------------------IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPR  333 (336)
T ss_dssp             -------------------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCCC
T ss_pred             -------------------chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCCC
Confidence                               001123478899999999999999999999997             6799999887654

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.9e-57  Score=440.97  Aligned_cols=324  Identities=76%  Similarity=1.317  Sum_probs=295.6

Q ss_pred             CCCCcccccCccCCCCCcccccccccccCCCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHH
Q 013897          103 PSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKIL  182 (434)
Q Consensus       103 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~E~~~l  182 (434)
                      |+.++...+.+...+.++|++....+.++..++|++++.||+|+||.||+|.+..+++.||||+++....+.+.+|+.++
T Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l   84 (330)
T 3nsz_A            5 PSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKIL   84 (330)
T ss_dssp             CCCCSSSTTTTTTSCHHHHCGGGCCCCCEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHH
T ss_pred             CCceeEeccccccCchhHHHhhhhhhcccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHH
Confidence            34455567777778888999888888888899999999999999999999999999999999999988889999999999


Q ss_pred             HHhcCCCCeeeEeeEEEccCCCccEEEEeecCCCchhhhcCCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEec
Q 013897          183 QNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID  262 (434)
Q Consensus       183 ~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~  262 (434)
                      +.+.+||||+++++++.+......++||||+.+++|..+...+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus        85 ~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~  164 (330)
T 3nsz_A           85 ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID  164 (330)
T ss_dssp             HHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE
T ss_pred             HHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEc
Confidence            99966999999999998766778899999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCeEEEEecccceecCCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHH
Q 013897          263 HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKI  342 (434)
Q Consensus       263 ~~~~~vkl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i  342 (434)
                      .++..+||+|||+++...........+++..|+|||++.+...++.++|||||||++|+|++|+.||+.+....+++..+
T Consensus       165 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~  244 (330)
T 3nsz_A          165 HEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI  244 (330)
T ss_dssp             TTTTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHH
T ss_pred             CCCCEEEEEeCCCceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHH
Confidence            77768999999999887766666777899999999999876679999999999999999999999999999999999999


Q ss_pred             HHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcc
Q 013897          343 AKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFF  422 (434)
Q Consensus       343 ~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~  422 (434)
                      .+.++......+........++.+...........|..+........+++++.+||.+||+.||++|||++|+|+||||+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~  324 (330)
T 3nsz_A          245 AKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY  324 (330)
T ss_dssp             HHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGT
T ss_pred             HHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHh
Confidence            99999988888888888999999999888888888888777777777899999999999999999999999999999999


Q ss_pred             cccc
Q 013897          423 PIRN  426 (434)
Q Consensus       423 ~~~~  426 (434)
                      .+..
T Consensus       325 ~~~~  328 (330)
T 3nsz_A          325 TVVK  328 (330)
T ss_dssp             TCC-
T ss_pred             hhcc
Confidence            8864

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.7e-58  Score=440.16  Aligned_cols=253  Identities=22%  Similarity=0.410  Sum_probs=192.2

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC------
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS------  203 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~------  203 (434)
                      ++|++++.||+|+||+||+|+++.+++.||||+++..    ..+.+.+|+.+|++| +|||||++++++.+.+.      
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEEC-------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEecCccccccc
Confidence            4699999999999999999999999999999998632    235688999999999 99999999999875432      


Q ss_pred             ----CccEEEEeecCCCchhhhcCC------CChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEec
Q 013897          204 ----KTPSLIFEHVNNTDFKVLYPT------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDW  273 (434)
Q Consensus       204 ----~~~~lv~e~~~~~~l~~~~~~------l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DF  273 (434)
                          .++++|||||.+++|..++..      ..+..++.++.||+.||+|||++||+||||||+|||++.++ .+||+||
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~-~vKl~DF  162 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD-VVKVGDF  162 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECCC
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCC-cEEEccC
Confidence                247899999999999877532      34456889999999999999999999999999999999777 8999999


Q ss_pred             ccceecCCCCc-------------cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHH
Q 013897          274 GLAEFYHPGKE-------------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV  340 (434)
Q Consensus       274 Gla~~~~~~~~-------------~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~  340 (434)
                      |+|+.......             .+..+||+.|||||++.+ ..|+.++|||||||++|||++   ||..   ..+...
T Consensus       163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyell~---Pf~~---~~~~~~  235 (299)
T 4g31_A          163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFST---QMERVR  235 (299)
T ss_dssp             CCC--------------------------CCCTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHS---CCSS---HHHHHH
T ss_pred             ccceecCCCccccccccccccccccCCcccCccccCHHHHcC-CCCCCHHHHHHHHHHHHHHcc---CCCC---ccHHHH
Confidence            99987653321             234589999999999987 789999999999999999996   7732   122222


Q ss_pred             HHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCC
Q 013897          341 KIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY  420 (434)
Q Consensus       341 ~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~  420 (434)
                      .+......            ..++...                     ..++.+.+||.+||+.||++|||+.|+|+|||
T Consensus       236 ~~~~~~~~------------~~p~~~~---------------------~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~  282 (299)
T 4g31_A          236 TLTDVRNL------------KFPPLFT---------------------QKYPCEYVMVQDMLSPSPMERPEAINIIENAV  282 (299)
T ss_dssp             HHHHHHTT------------CCCHHHH---------------------HHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred             HHHHHhcC------------CCCCCCc---------------------ccCHHHHHHHHHHcCCChhHCcCHHHHhcCHh
Confidence            22211110            1111111                     13467889999999999999999999999999


Q ss_pred             cccccccc
Q 013897          421 FFPIRNAE  428 (434)
Q Consensus       421 ~~~~~~~~  428 (434)
                      |++++.+.
T Consensus       283 ~~~~~~p~  290 (299)
T 4g31_A          283 FEDLDFPG  290 (299)
T ss_dssp             GCCC----
T ss_pred             hCCCCCCC
Confidence            99987643

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=4.2e-55  Score=453.62  Aligned_cols=258  Identities=23%  Similarity=0.412  Sum_probs=218.5

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      .++|++++.||+|+||+||+|.++.+|+.||+|+++...   .+.+.+|+.+|+.| +|||||+++++|.+.  ..++||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~--~~~~iv  232 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVNLHDAFEDD--NEMVMI  232 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHT-CCTTBCCEEEEEECS--SEEEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhC-CCCCCCeEEEEEEEC--CEEEEE
Confidence            378999999999999999999999999999999986533   45688999999999 999999999999654  678899


Q ss_pred             EeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC-CCeEEEEecccceecCCCCc
Q 013897          210 FEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-QRKLRLIDWGLAEFYHPGKE  284 (434)
Q Consensus       210 ~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~-~~~vkl~DFGla~~~~~~~~  284 (434)
                      ||||.+|+|..++    ..+++.+++.++.||+.||+|||++||+||||||+|||++.+ .+.+||+|||+|+.+.+...
T Consensus       233 ~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~  312 (573)
T 3uto_A          233 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS  312 (573)
T ss_dssp             EECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE
T ss_pred             EeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc
Confidence            9999999987655    358899999999999999999999999999999999999854 24899999999999887777


Q ss_pred             cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCCh
Q 013897          285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP  364 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  364 (434)
                      ....+||+.|||||++.+ ..|+.++|||||||++|||++|+.|| .+.+..+.+..|.....             .+  
T Consensus       313 ~~~~~GT~~y~APEv~~~-~~y~~~~DiWSlGvilyeml~G~~Pf-~~~~~~~~~~~i~~~~~-------------~~--  375 (573)
T 3uto_A          313 VKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPF-GGENDDETLRNVKSCDW-------------NM--  375 (573)
T ss_dssp             EEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSS-CCSSHHHHHHHHHTTCC-------------CC--
T ss_pred             eeeeEECccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCC-CCcCHHHHHHHHHhCCC-------------CC--
Confidence            788899999999999987 78999999999999999999999998 44444444444322100             00  


Q ss_pred             hHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccccc
Q 013897          365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~  428 (434)
                                        .......+++++.|||.+||+.||++|||+.|+|+||||+..+...
T Consensus       376 ------------------~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~  421 (573)
T 3uto_A          376 ------------------DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG  421 (573)
T ss_dssp             ------------------CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTT
T ss_pred             ------------------CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCC
Confidence                              0111224788999999999999999999999999999999776543

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=9.1e-55  Score=420.79  Aligned_cols=243  Identities=18%  Similarity=0.315  Sum_probs=193.4

Q ss_pred             CCeEEEeeeeecCceEEEEEEEc-----CCCeEEEEEEecccc---HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCc
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT  205 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vaiK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  205 (434)
                      ++|.+.++||+|+||+||+|++.     .+++.||||+++...   .++|.+|+.+|+++ +|||||+++|+|.+.  ..
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~~--~~  117 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML-QHQHIVRFFGVCTEG--RP  117 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSS--SS
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEEC--CE
Confidence            67889999999999999999875     357899999997543   46789999999999 999999999999654  56


Q ss_pred             cEEEEeecCCCchhhhc------------------CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCe
Q 013897          206 PSLIFEHVNNTDFKVLY------------------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRK  267 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~------------------~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~  267 (434)
                      ++||||||++|+|..++                  .++++.++..++.||+.||+|||+++||||||||+||||+.++ .
T Consensus       118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~-~  196 (329)
T 4aoj_A          118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL-V  196 (329)
T ss_dssp             EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT-E
T ss_pred             EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCC-c
Confidence            78999999999998764                  2488999999999999999999999999999999999999776 8


Q ss_pred             EEEEecccceecCCCCc---cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHH
Q 013897          268 LRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIA  343 (434)
Q Consensus       268 vkl~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~  343 (434)
                      +||+|||+|+.......   ....+||+.|||||++.+ ..|+.++|||||||+||||+| |+.||. +.+..+.+..+.
T Consensus       197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~-~~~~~~~~~~i~  274 (329)
T 4aoj_A          197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPWY-QLSNTEAIDCIT  274 (329)
T ss_dssp             EEECCCC----------------CCCCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTC-SSCHHHHHHHHH
T ss_pred             EEEcccccceeccCCCcceecCcccccccccChhhhcC-CCCCccccccchHHHHHHHHcCCCCCCC-CCCHHHHHHHHH
Confidence            99999999987644322   234578999999999887 789999999999999999999 899984 333333332222


Q ss_pred             HHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          344 KVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       344 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                      +.                            .+        ...+..+++++.+|+.+||+.||++|||++|++++
T Consensus       275 ~g----------------------------~~--------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          275 QG----------------------------RE--------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HT----------------------------CC--------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             cC----------------------------CC--------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            10                            00        11223478899999999999999999999999864

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-55  Score=422.03  Aligned_cols=249  Identities=16%  Similarity=0.320  Sum_probs=194.8

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      .+++.+.++||+|+||+||+|++.   ..||||+++..     ..+.|.+|+.+|+++ +|||||++++++.+   ..++
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~~---~~~~  107 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKT-RHVNILLFMGYMTK---DNLA  107 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS---SSCE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEC---CeEE
Confidence            367889999999999999999863   35899998642     246789999999999 99999999999854   3478


Q ss_pred             EEEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC-
Q 013897          208 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-  282 (434)
Q Consensus       208 lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~-  282 (434)
                      ||||||++|+|..++    ..+++.++..++.||+.||+|||+++||||||||+||||+.++ .+||+|||+|+..... 
T Consensus       108 iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~-~~Ki~DFGla~~~~~~~  186 (307)
T 3omv_A          108 IVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGL-TVKIGDFGLATVKSRWS  186 (307)
T ss_dssp             EEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTE-EEEECCCSSCBC-----
T ss_pred             EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCC-cEEEeeccCceecccCC
Confidence            999999999998765    3589999999999999999999999999999999999999776 8999999999865432 


Q ss_pred             --CccceeccCCcccccccccC--CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhc
Q 013897          283 --KEYNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY  358 (434)
Q Consensus       283 --~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  358 (434)
                        ......+||+.|||||++.+  ...|+.++|||||||+||||+||+.||. +.++...+..+... +           
T Consensus       187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~-~~~~~~~~~~~~~~-~-----------  253 (307)
T 3omv_A          187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYS-HINNRDQIIFMVGR-G-----------  253 (307)
T ss_dssp             -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTT-TCCCHHHHHHHHHT-T-----------
T ss_pred             cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCC-CCChHHHHHHHHhc-C-----------
Confidence              22355689999999999864  2469999999999999999999999984 33343333322110 0           


Q ss_pred             cccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHH------hcCCCc
Q 013897          359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEA------MAHPYF  421 (434)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~el------L~Hp~~  421 (434)
                                    ......     ......+++++.+|+.+||+.||++|||+.|+      |+|++-
T Consensus       254 --------------~~~p~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp  303 (307)
T 3omv_A          254 --------------YASPDL-----SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP  303 (307)
T ss_dssp             --------------CCCCCS-----TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred             --------------CCCCCc-----ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence                          000000     01123478899999999999999999999876      567664

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3.5e-55  Score=453.15  Aligned_cols=256  Identities=25%  Similarity=0.402  Sum_probs=208.8

Q ss_pred             CCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHH---HHHHHHhcCCCCeeeEeeEEEccC
Q 013897          132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKRE---IKILQNLCGGPNIVKLLDIVRDQQ  202 (434)
Q Consensus       132 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~E---~~~l~~l~~h~niv~l~~~~~~~~  202 (434)
                      ..++|++++.||+|+||+||+|+++.+|+.||||++++..      ...+.+|   +.+++.+ +|||||+++++|.+. 
T Consensus       187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~-~HP~IV~l~~~f~~~-  264 (689)
T 3v5w_A          187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTP-  264 (689)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEECS-
T ss_pred             chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhC-CCCCEeEEEEEEEEC-
Confidence            3588999999999999999999999999999999996422      2334444   4444455 899999999999654 


Q ss_pred             CCccEEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceec
Q 013897          203 SKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY  279 (434)
Q Consensus       203 ~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~  279 (434)
                       ..+|||||||.||+|..++   ..+++..++.|+.||+.||+|||++|||||||||+||||+.++ .+||+|||+|+.+
T Consensus       265 -~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G-~vKL~DFGlA~~~  342 (689)
T 3v5w_A          265 -DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDF  342 (689)
T ss_dssp             -SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred             -CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCC-CEEecccceeeec
Confidence             6788999999999997775   4699999999999999999999999999999999999999777 8999999999877


Q ss_pred             CCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCC-CHHHHHHHHHHhCChhHHHHHhhc
Q 013897          280 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD-NYDQLVKIAKVLGTDELNAYLNKY  358 (434)
Q Consensus       280 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~-~~~~~~~i~~~~g~~~~~~~~~~~  358 (434)
                      ... ...+.+||+.|||||++.....|+.++|||||||++|||++|+.||..... +...+.....  .           
T Consensus       343 ~~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~--~-----------  408 (689)
T 3v5w_A          343 SKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--T-----------  408 (689)
T ss_dssp             SSC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHH--H-----------
T ss_pred             CCC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc--C-----------
Confidence            544 345679999999999997546899999999999999999999999953221 1111111000  0           


Q ss_pred             cccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCcc-----HHHHhcCCCcccccccc
Q 013897          359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT-----AKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt-----~~elL~Hp~~~~~~~~~  428 (434)
                                   .          ....+..+++++.+||.+||+.||++|++     ++|+++||||+++++..
T Consensus       409 -------------~----------~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~  460 (689)
T 3v5w_A          409 -------------M----------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQM  460 (689)
T ss_dssp             -------------C----------CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHH
T ss_pred             -------------C----------CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHH
Confidence                         0          01112347889999999999999999998     79999999999998654

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=4.8e-55  Score=417.22  Aligned_cols=249  Identities=19%  Similarity=0.337  Sum_probs=201.6

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEc-----CCCeEEEEEEecccc---HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK  204 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vaiK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  204 (434)
                      .++|.+.++||+|+||+||+|++.     .++..||||+++...   .++|.+|+++|+++ +|||||+++|+|.+.  .
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~~--~   88 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHEHIVKFYGVCVEG--D   88 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSS--S
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhC-CCCCCccEEEEEeeC--C
Confidence            468999999999999999999875     357899999997543   46789999999999 999999999999654  5


Q ss_pred             ccEEEEeecCCCchhhhc----------------CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeE
Q 013897          205 TPSLIFEHVNNTDFKVLY----------------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKL  268 (434)
Q Consensus       205 ~~~lv~e~~~~~~l~~~~----------------~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~v  268 (434)
                      .++||||||++|+|..++                ..+++.++..++.||+.||+|||+++||||||||+|||++.++ .+
T Consensus        89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~-~~  167 (299)
T 4asz_A           89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL-LV  167 (299)
T ss_dssp             SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CE
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC-cE
Confidence            678999999999998775                2489999999999999999999999999999999999999776 89


Q ss_pred             EEEecccceecCCCCcc---ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHH
Q 013897          269 RLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAK  344 (434)
Q Consensus       269 kl~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~  344 (434)
                      ||+|||+|+........   ...+||+.|||||++.+ ..|+.++|||||||+||||+| |+.||. +.+..+.+..+.+
T Consensus       168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~-~~~~~~~~~~i~~  245 (299)
T 4asz_A          168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWY-QLSNNEVIECITQ  245 (299)
T ss_dssp             EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTT-TSCHHHHHHHHHH
T ss_pred             EECCcccceecCCCCceeecCceecChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHcCCCCCCC-CCCHHHHHHHHHc
Confidence            99999999866443322   23468999999999987 789999999999999999998 899984 3333333332221


Q ss_pred             HhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccc
Q 013897          345 VLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI  424 (434)
Q Consensus       345 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~  424 (434)
                      .                            .+        ...+..+++++.+|+.+||+.||++|||++|+  |+|++++
T Consensus       246 ~----------------------------~~--------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~  287 (299)
T 4asz_A          246 G----------------------------RV--------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNL  287 (299)
T ss_dssp             T----------------------------CC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHH
T ss_pred             C----------------------------CC--------CCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHH
Confidence            0                            00        11123478899999999999999999999999  4577655


Q ss_pred             c
Q 013897          425 R  425 (434)
Q Consensus       425 ~  425 (434)
                      .
T Consensus       288 ~  288 (299)
T 4asz_A          288 A  288 (299)
T ss_dssp             H
T ss_pred             H
Confidence            3

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.3e-54  Score=415.99  Aligned_cols=243  Identities=18%  Similarity=0.318  Sum_probs=198.9

Q ss_pred             CCeEEEeeeeecCceEEEEEEEc-----CCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCC
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK  204 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  204 (434)
                      +++++.++||+|+||+||+|.+.     .+++.||||+++..    ..++|.+|+.+|+++ +|||||+++|+|.+.  .
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~~~--~  102 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARL-QHPNVVCLLGVVTKD--Q  102 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHC-CCTTBCCEEEEECSS--S
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhC-CCCCCCCcceEEEEC--C
Confidence            56889999999999999999864     35689999999643    346799999999999 999999999999654  5


Q ss_pred             ccEEEEeecCCCchhhhc-------------------CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCC
Q 013897          205 TPSLIFEHVNNTDFKVLY-------------------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ  265 (434)
Q Consensus       205 ~~~lv~e~~~~~~l~~~~-------------------~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~  265 (434)
                      .++||||||++|+|..++                   ..+++.++..++.||+.||+|||+++||||||||+||||+.++
T Consensus       103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred             EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCC
Confidence            678999999999998765                   2478899999999999999999999999999999999999776


Q ss_pred             CeEEEEecccceecCCCC---ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHH
Q 013897          266 RKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVK  341 (434)
Q Consensus       266 ~~vkl~DFGla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~  341 (434)
                       .+||+|||+|+......   .....+||+.|||||++.+ ..|+.++|||||||+||||+| |+.|| .+.+..+.+..
T Consensus       183 -~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~~s~ksDVwSfGvvl~El~t~g~~Pf-~~~~~~~~~~~  259 (308)
T 4gt4_A          183 -NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPY-CGYSNQDVVEM  259 (308)
T ss_dssp             -CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTT-TTCCHHHHHHH
T ss_pred             -CEEECCcccceeccCCCceeEecccccCCcccCHHHHhC-CCCCccchhhhHHHHHHHHHhCCCCCC-CCCCHHHHHHH
Confidence             89999999998664332   2344578999999999987 789999999999999999998 88887 34333333222


Q ss_pred             HHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          342 IAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       342 i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                      +..                            ..+        .+.+..+++++.+|+.+||+.||++|||+.|++++
T Consensus       260 i~~----------------------------~~~--------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          260 IRN----------------------------RQV--------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHT----------------------------TCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHc----------------------------CCC--------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            211                            000        01123478899999999999999999999999875

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=4.8e-54  Score=419.16  Aligned_cols=247  Identities=20%  Similarity=0.354  Sum_probs=202.0

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCC-----eEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDN-----EKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS  203 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~-----~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  203 (434)
                      .++|++.+.||+|+||+||+|.+...+     +.||||.++...    .+.+.+|+.+|.++.+|||||+++|+|.+. .
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~-~  141 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-G  141 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-T
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec-C
Confidence            478999999999999999999986543     689999997532    356889999999997779999999999654 3


Q ss_pred             CccEEEEeecCCCchhhhcC-------------------CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC
Q 013897          204 KTPSLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE  264 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~~-------------------~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~  264 (434)
                      ..++||||||.+|+|..++.                   .+++.++..++.||++||+|||+++||||||||+|||++.+
T Consensus       142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~  221 (353)
T 4ase_A          142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK  221 (353)
T ss_dssp             SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred             CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCC
Confidence            45789999999999987652                   37889999999999999999999999999999999999977


Q ss_pred             CCeEEEEecccceecCCCCcc---ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHH
Q 013897          265 QRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLV  340 (434)
Q Consensus       265 ~~~vkl~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~  340 (434)
                      + .+||+|||+|+........   ...+||+.|||||++.+ ..|+.++|||||||+||||+| |+.||...... +.+.
T Consensus       222 ~-~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~-~~~~  298 (353)
T 4ase_A          222 N-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-EEFC  298 (353)
T ss_dssp             G-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS-HHHH
T ss_pred             C-CEEECcchhhhhcccCCCceeeccccccccccCHHHHhc-CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH-HHHH
Confidence            7 8999999999876544332   34578999999999987 789999999999999999998 89998433333 2222


Q ss_pred             HHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          341 KIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       341 ~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                      .+...                           ..+        ...+..+++++.+||.+||+.||++|||+.|+++|
T Consensus       299 ~~i~~---------------------------g~~--------~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          299 RRLKE---------------------------GTR--------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHHH---------------------------TCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHc---------------------------CCC--------CCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            21110                           000        11123477899999999999999999999999998

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.4e-51  Score=418.07  Aligned_cols=286  Identities=27%  Similarity=0.469  Sum_probs=224.3

Q ss_pred             CCCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccC---
Q 013897          131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ---  202 (434)
Q Consensus       131 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---  202 (434)
                      ...++|++++.||+|+||+||+|.+..+++.||||++...     ..+.+.+|+.+|+.+ +||||+++++++....   
T Consensus        59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~  137 (464)
T 3ttj_A           59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLE  137 (464)
T ss_dssp             EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTT
T ss_pred             eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhC-CCCCCCcEEEEEccCCccc
Confidence            3358899999999999999999999999999999999642     245678999999999 9999999999996542   


Q ss_pred             -CCccEEEEeecCCCchhhhcCCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC
Q 013897          203 -SKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP  281 (434)
Q Consensus       203 -~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~  281 (434)
                       ...+++||||+.++.+..+...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+....
T Consensus       138 ~~~~~~lv~E~~~~~l~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~  216 (464)
T 3ttj_A          138 EFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGT  216 (464)
T ss_dssp             TCCEEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCCCC-----
T ss_pred             cCCeEEEEEeCCCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCC-CEEEEEEEeeeecCC
Confidence             245789999999987777777899999999999999999999999999999999999999777 899999999987766


Q ss_pred             CCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcccc
Q 013897          282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE  361 (434)
Q Consensus       282 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  361 (434)
                      .......+||+.|+|||++.+ ..|+.++|||||||++|||++|+.|| .+.+..+++..+.+.+|.+....+. .    
T Consensus       217 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pF-~g~~~~~~~~~i~~~lg~p~~~~~~-~----  289 (464)
T 3ttj_A          217 SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILF-PGRDYIDQWNKVIEQLGTPCPEFMK-K----  289 (464)
T ss_dssp             CCCC----CCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCSCCHHHHT-T----
T ss_pred             CcccCCCcccccccCHHHHcC-CCCCHHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCCCHHHHH-H----
Confidence            556677899999999999987 68999999999999999999999887 7778888999999999876543221 1    


Q ss_pred             CChhHHHHhcccCCCCC---ccccc-------cccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccc
Q 013897          362 LDPHLAALVGRHSRKPW---SKFIT-------VENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       362 ~~~~~~~~~~~~~~~~~---~~~~~-------~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                      +.+..............   .....       .......++++.+||.+||+.||++|||++|+|+||||+.+.
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~  363 (464)
T 3ttj_A          290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY  363 (464)
T ss_dssp             SCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             cchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhcc
Confidence            11222222222111110   00000       000111256799999999999999999999999999999654

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.8e-51  Score=404.74  Aligned_cols=291  Identities=27%  Similarity=0.535  Sum_probs=217.0

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      .++|++++.||+|+||.||+|.+..+++.||||++...     ....+.+|+.+++.+.+||||+++++++...+...++
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~   87 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY   87 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence            36899999999999999999999999999999998532     2356789999999996699999999999876666789


Q ss_pred             EEEeecCCCchhhhc--CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC----
Q 013897          208 LIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP----  281 (434)
Q Consensus       208 lv~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~----  281 (434)
                      +||||+.+ +|..++  ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+....    
T Consensus        88 lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~~  165 (388)
T 3oz6_A           88 LVFDYMET-DLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAEC-HVKVADFGLSRSFVNIRRV  165 (388)
T ss_dssp             EEEECCSE-EHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEESSSCCCC
T ss_pred             EEecccCc-CHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCC-CEEecCCcccccccccccc
Confidence            99999995 555443  4588999999999999999999999999999999999999777 899999999986532    


Q ss_pred             ------------------CCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 013897          282 ------------------GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA  343 (434)
Q Consensus       282 ------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~  343 (434)
                                        .......+||+.|+|||++.+...|+.++|||||||++|||++|+.|| .+.+..+++..+.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf-~~~~~~~~~~~i~  244 (388)
T 3oz6_A          166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF-PGSSTMNQLERII  244 (388)
T ss_dssp             CCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHH
T ss_pred             cccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHH
Confidence                              112344689999999999987668999999999999999999999887 6777888888888


Q ss_pred             HHhCChhHHHHHhhccccCChhHHHHhcccC---CCCCcccc--------ccccccCCchHHHHHHHHccccCCCCCccH
Q 013897          344 KVLGTDELNAYLNKYHIELDPHLAALVGRHS---RKPWSKFI--------TVENQHLAVPEAVDFLDKLLRYDHQERPTA  412 (434)
Q Consensus       344 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~--------~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~  412 (434)
                      ..++.+....+.. .................   ...+....        .......+++++.+||.+||+.||++|||+
T Consensus       245 ~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~  323 (388)
T 3oz6_A          245 GVIDFPSNEDVES-IQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA  323 (388)
T ss_dssp             HHHCCCCHHHHHT-SCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred             HhcCCCCHHHHHh-ccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH
Confidence            8888765443321 11111111111000000   00000000        011122568899999999999999999999


Q ss_pred             HHHhcCCCccccccc
Q 013897          413 KEAMAHPYFFPIRNA  427 (434)
Q Consensus       413 ~elL~Hp~~~~~~~~  427 (434)
                      +|+|+||||+.....
T Consensus       324 ~e~l~Hp~~~~~~~~  338 (388)
T 3oz6_A          324 NDALKHPFVSIFHNP  338 (388)
T ss_dssp             HHHTTSTTTTTTCCG
T ss_pred             HHHhCCHHHHHhcCC
Confidence            999999999876543

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.1e-51  Score=395.84  Aligned_cols=261  Identities=18%  Similarity=0.198  Sum_probs=189.6

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHH--HHHHhcCCCCeeeEeeEEEccCC--CccEEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIK--ILQNLCGGPNIVKLLDIVRDQQS--KTPSLI  209 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~E~~--~l~~l~~h~niv~l~~~~~~~~~--~~~~lv  209 (434)
                      .+|.+.++||+|+||+||+|++  +|+.||||+++......+.+|.+  .+.++ +|||||++++++.+.+.  ..++||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l-~HpNIv~l~g~~~~~~~~~~~~~lV   79 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVML-RHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcC-CCCCCCcEEEEEEecCCCceEEEEE
Confidence            3588999999999999999987  58999999998766655555544  44566 89999999999986543  257899


Q ss_pred             EeecCCCchhhhc--CCCChHHHHHHHHHHHHHHHHHHHC--------CceeecCCCCceEecCCCCeEEEEecccceec
Q 013897          210 FEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQ--------GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY  279 (434)
Q Consensus       210 ~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~--------~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~  279 (434)
                      ||||++|+|..++  ..+++..+..++.|++.||+|||++        +||||||||+|||++.++ .+||+|||+|+..
T Consensus        80 ~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~-~~Ki~DFGla~~~  158 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVRH  158 (303)
T ss_dssp             EECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTS-CEEECCCTTCEEE
T ss_pred             ecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCC-CEEEEeCCCCccc
Confidence            9999999998776  4689999999999999999999987        999999999999999777 8999999999876


Q ss_pred             CCCCc-----cceeccCCcccccccccCCC-----CCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCh
Q 013897          280 HPGKE-----YNVRVASRYFKGPELLVDLQ-----DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTD  349 (434)
Q Consensus       280 ~~~~~-----~~~~~~t~~y~aPE~~~~~~-----~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~  349 (434)
                      .....     ....+||+.|||||++.+..     .|+.++|||||||+||||+||..||............        
T Consensus       159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~--------  230 (303)
T 3hmm_A          159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD--------  230 (303)
T ss_dssp             ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT--------
T ss_pred             cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchh--------
Confidence            54332     12458999999999987521     3678999999999999999998776322111000000        


Q ss_pred             hHHHHHhhccccCChhHHHH----hcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          350 ELNAYLNKYHIELDPHLAAL----VGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                               ....++....+    .....+.....   ......+++.+.+|+.+||+.||++|||+.|+++.
T Consensus       231 ---------~~~~~~~~~~~~~~~~~~~~rp~~p~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          231 ---------LVPSDPSVEEMRKVVCEQKLRPNIPN---RWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             ---------TSCSSCCHHHHHHHHTTSCCCCCCCG---GGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             ---------cccccchHHHHHHHHhcccCCCCCCc---cccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                     00000000000    00111110000   00111234578899999999999999999999864

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=6e-51  Score=388.70  Aligned_cols=279  Identities=30%  Similarity=0.531  Sum_probs=224.4

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      ++|++++.||+|+||+||+|.+..+++.||+|+++...     ...+.+|+.+++++ +||||+++++++.+.  ...++
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~l   78 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHSD--KKLTL   78 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEEET--TEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcC-CCCCEeeEEeEEEeC--CEEEE
Confidence            57999999999999999999999999999999986432     36678999999999 899999999999754  56789


Q ss_pred             EEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC-Cc
Q 013897          209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KE  284 (434)
Q Consensus       209 v~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~-~~  284 (434)
                      ||||+.++.+..+.   ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..... ..
T Consensus        79 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~  157 (292)
T 3o0g_A           79 VFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG-ELKLANFGLARAFGIPVRC  157 (292)
T ss_dssp             EEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECCSCCSC
T ss_pred             EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEeecccceecCCcccc
Confidence            99999987665443   4689999999999999999999999999999999999999777 8999999999876433 33


Q ss_pred             cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCCh
Q 013897          285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP  364 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  364 (434)
                      ....+||+.|+|||++.+...++.++|||||||++|+|++|+.||+.+.+..+.+..+.+.++.+....+......... 
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-  236 (292)
T 3o0g_A          158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY-  236 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC-
T ss_pred             ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc-
Confidence            4556889999999999875568999999999999999999999998888888888888888776544333221110000 


Q ss_pred             hHHHHhcccCCCCCcc-ccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccc
Q 013897          365 HLAALVGRHSRKPWSK-FITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       365 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                              ........ .........+++++.+||.+||+.||++|||++|+|+||||+++.
T Consensus       237 --------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          237 --------KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             --------CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             --------cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence                    00000000 001112234778999999999999999999999999999999764

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.2e-50  Score=388.66  Aligned_cols=281  Identities=32%  Similarity=0.580  Sum_probs=217.7

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      .++|++++.||+|+||+||+|.+ .+++.||+|+++...     ...+.+|+.+++.+ +||||+++++++.+  ....+
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~~   95 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKEL-HHPNIVSLIDVIHS--ERCLT   95 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEE-TTSCEEEEEEEC------CHHHHHHHHHHHHHHC-CCTTBCCEEEEECC--SSCEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEE-CCCCEEEEEEEecccccchhhHHHHHHHHHHHHc-CCCCEeeeeeEEcc--CCEEE
Confidence            57899999999999999999998 468999999986432     35688999999999 99999999999964  45778


Q ss_pred             EEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC-C
Q 013897          208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-K  283 (434)
Q Consensus       208 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~-~  283 (434)
                      +||||+.++.+..+.   ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..... .
T Consensus        96 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~~~~~  174 (311)
T 3niz_A           96 LVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDG-ALKLADFGLARAFGIPVR  174 (311)
T ss_dssp             EEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEETTSCCC
T ss_pred             EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCC-CEEEccCcCceecCCCcc
Confidence            999999975444433   2489999999999999999999999999999999999999777 8999999999876433 3


Q ss_pred             ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                      .....++|+.|+|||++.+...++.++|||||||++|+|++|+.|| .+....+.+..+...++.+....+.....    
T Consensus       175 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~----  249 (311)
T 3niz_A          175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLF-PGVTDDDQLPKIFSILGTPNPREWPQVQE----  249 (311)
T ss_dssp             ---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSTTTHHHHHHHHHCCCCTTTSGGGTT----
T ss_pred             cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHHCCCChHHhhhhhc----
Confidence            3455688999999999877567999999999999999999999887 56666677778877777654433321110    


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN  426 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~  426 (434)
                        ....... ................+++++.+||.+||+.||++|||++|+|+||||++++.
T Consensus       250 --~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  309 (311)
T 3niz_A          250 --LPLWKQR-TFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP  309 (311)
T ss_dssp             --SHHHHSC-CCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred             --cchhhhc-ccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence              0000000 00000000001112346789999999999999999999999999999999864

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.5e-50  Score=397.69  Aligned_cols=256  Identities=27%  Similarity=0.479  Sum_probs=214.5

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc---------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS  203 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~---------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  203 (434)
                      .+.|++.+.||+|+||.||+|.++.+++.||+|+++..         ..+.+.+|+.+|+.+ +||||+++++++.+.  
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~--   87 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV-LHPNIITLHDVYENR--   87 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTC-CCTTBCCEEEEEECS--
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhC-CCcCCCcEEEEEEeC--
Confidence            47799999999999999999999999999999998643         246789999999999 899999999999654  


Q ss_pred             CccEEEEeecCCCchhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCC---eEEEEecccce
Q 013897          204 KTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR---KLRLIDWGLAE  277 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~---~vkl~DFGla~  277 (434)
                      ...++||||+.+++|..++.   .+++..+..++.||+.||.|||++||+||||||+|||++.++.   .+||+|||+++
T Consensus        88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~  167 (361)
T 2yab_A           88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (361)
T ss_dssp             SEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence            56789999999999987753   5899999999999999999999999999999999999986653   69999999998


Q ss_pred             ecCCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhh
Q 013897          278 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK  357 (434)
Q Consensus       278 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  357 (434)
                      ...........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+.+..+....           
T Consensus       168 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~Pf~-~~~~~~~~~~i~~~~-----------  234 (361)
T 2yab_A          168 EIEDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANITAVS-----------  234 (361)
T ss_dssp             ECCTTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSC-CSSHHHHHHHHHTTC-----------
T ss_pred             EcCCCCccccCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhcC-----------
Confidence            8776666677789999999999876 689999999999999999999999984 333333333332110           


Q ss_pred             ccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccc
Q 013897          358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN  426 (434)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~  426 (434)
                        ..+++.                    ....+++++.+||.+||..||++|||+.|+|+||||+.++.
T Consensus       235 --~~~~~~--------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~  281 (361)
T 2yab_A          235 --YDFDEE--------------------FFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDT  281 (361)
T ss_dssp             --CCCCHH--------------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSSH
T ss_pred             --CCCCch--------------------hccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCch
Confidence              001110                    11236788999999999999999999999999999997753

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2e-50  Score=391.80  Aligned_cols=251  Identities=22%  Similarity=0.442  Sum_probs=210.8

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      .++|++++.||+|+||.||+|.+..+++.||||++...     ..+.+.+|+.+|+.+ +||||+++++++...  ...+
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~--~~~~   90 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKIL-NHPNIVKLFEVIETE--KTLY   90 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECS--SEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEEC--CEEE
Confidence            36899999999999999999999999999999998643     235678999999999 899999999999653  5678


Q ss_pred             EEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc
Q 013897          208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE  284 (434)
Q Consensus       208 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~  284 (434)
                      +||||+.+++|..++   ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++........
T Consensus        91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~  169 (328)
T 3fe3_A           91 LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADM-NIKIADFGFSNEFTVGGK  169 (328)
T ss_dssp             EEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECSTTCCGGGSSSCG
T ss_pred             EEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCC-CEEEeeccCceecCCCCc
Confidence            999999999987665   5699999999999999999999999999999999999999777 899999999987766666


Q ss_pred             cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCCh
Q 013897          285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP  364 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  364 (434)
                      ....+||+.|+|||++.+....+.++|||||||++|+|++|+.||. +.+..+....+..                    
T Consensus       170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~-~~~~~~~~~~i~~--------------------  228 (328)
T 3fe3_A          170 LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-GQNLKELRERVLR--------------------  228 (328)
T ss_dssp             GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHH--------------------
T ss_pred             cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCC-CCCHHHHHHHHHh--------------------
Confidence            6778899999999999874444589999999999999999999983 3322222222211                    


Q ss_pred             hHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccc
Q 013897          365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                             ..          ...+..+++++.+||.+||+.||.+|||++|+|+||||+...
T Consensus       229 -------~~----------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  272 (328)
T 3fe3_A          229 -------GK----------YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH  272 (328)
T ss_dssp             -------CC----------CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred             -------CC----------CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence                   00          001123678999999999999999999999999999998654

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=6.5e-50  Score=405.80  Aligned_cols=287  Identities=30%  Similarity=0.556  Sum_probs=208.5

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccC---CC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ---SK  204 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---~~  204 (434)
                      .++|++++.||+|+||+||+|.+..+++.||||++...     ..+.+.+|+.+|+.+ +||||+++++++....   ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~  130 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL-NHDHVVKVLDIVIPKDVEKFD  130 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCTTTCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhC-CCCCCCceEEEEecCCcccCc
Confidence            47899999999999999999999999999999998642     235688999999999 9999999999985432   25


Q ss_pred             ccEEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC
Q 013897          205 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP  281 (434)
Q Consensus       205 ~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~  281 (434)
                      .+++||||+.+ +|..++   ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+....
T Consensus       131 ~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~-~~kl~DFGla~~~~~  208 (458)
T 3rp9_A          131 ELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDC-SVKVCDFGLARTVDY  208 (458)
T ss_dssp             CEEEEECCCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTC-CEEECCCTTCBCTTS
T ss_pred             eEEEEEecccc-chhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCC-CEeecccccchhccC
Confidence            68999999865 554443   3489999999999999999999999999999999999999777 899999999986542


Q ss_pred             CC----------------------------ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhC--------
Q 013897          282 GK----------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFR--------  325 (434)
Q Consensus       282 ~~----------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg--------  325 (434)
                      ..                            ..+..+||+.|+|||++.....|+.++|||||||++|||++|        
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~  288 (458)
T 3rp9_A          209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH  288 (458)
T ss_dssp             CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSG
T ss_pred             ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccc
Confidence            21                            234557899999999876557899999999999999999984        


Q ss_pred             --CCCCCCCCC--------------------CHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccc
Q 013897          326 --KEPFFYGHD--------------------NYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFIT  383 (434)
Q Consensus       326 --~~pf~~~~~--------------------~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (434)
                        ..|+|.+.+                    ..+++..|.+.+|.+....+..    ....................+  
T Consensus       289 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~--  362 (458)
T 3rp9_A          289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEA----LEKEDAKRYIRIFPKREGTDL--  362 (458)
T ss_dssp             GGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHT----SSCHHHHHHHTTSCCCCCCCG--
T ss_pred             ccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhh----cCCHHHHHHHHhcCCCCCCCH--
Confidence              334445543                    2567778888888765443321    111122222221111111111  


Q ss_pred             cccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccccc
Q 013897          384 VENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       384 ~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~  428 (434)
                      ......+++++.+||.+||+.||++|||++|+|+||||++++..+
T Consensus       363 ~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~  407 (458)
T 3rp9_A          363 AERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAE  407 (458)
T ss_dssp             GGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGG
T ss_pred             HHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCc
Confidence            112234688999999999999999999999999999999987654

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.4e-50  Score=396.77  Aligned_cols=254  Identities=23%  Similarity=0.387  Sum_probs=208.4

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      .++|++++.||+|+||+||+|+++.+++.||||+++..      ....+.+|..+++.+.+||||+++++++.+.  ..+
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~--~~~   99 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP--DRL   99 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC--CEE
Confidence            37899999999999999999999999999999999643      2355788999999987899999999999654  568


Q ss_pred             EEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC-C
Q 013897          207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-G  282 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~-~  282 (434)
                      ++||||+.+++|..++   ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.... .
T Consensus       100 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g-~ikL~DFG~a~~~~~~~  178 (353)
T 3txo_A          100 FFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEG-HCKLADFGMCKEGICNG  178 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCSCC--
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCC-CEEEccccceeecccCC
Confidence            8999999999987665   4699999999999999999999999999999999999999777 899999999986432 2


Q ss_pred             CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                      ......+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||. +.+..+.+..+...                 
T Consensus       179 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~-~~~~~~~~~~i~~~-----------------  239 (353)
T 3txo_A          179 VTTATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFE-AENEDDLFEAILND-----------------  239 (353)
T ss_dssp             -------CCGGGCCHHHHHH-HHCTTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHC-----------------
T ss_pred             ccccccCCCcCeEChhhcCC-CCcCCccCCCcchHHHHHHHhCCCCCC-CCCHHHHHHHHHcC-----------------
Confidence            34456689999999999876 679999999999999999999999983 33333333333210                 


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccH------HHHhcCCCcccccccc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA------KEAMAHPYFFPIRNAE  428 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~------~elL~Hp~~~~~~~~~  428 (434)
                                          ....+..+++++.+||.+||+.||++||++      +|+++||||+++++..
T Consensus       240 --------------------~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~  291 (353)
T 3txo_A          240 --------------------EVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQ  291 (353)
T ss_dssp             --------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHH
T ss_pred             --------------------CCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHH
Confidence                                001122367899999999999999999998      9999999999987543

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=9.3e-50  Score=388.45  Aligned_cols=253  Identities=25%  Similarity=0.445  Sum_probs=211.5

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      .++|++++.||+|+||+||+|+++.+++.||+|+++..      ....+.+|+.+++.+ +||||+++++++.+.  ..+
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~--~~~   80 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTH--DRL   80 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEECS--SEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhC-CCCcCcceEEEEEeC--CEE
Confidence            36899999999999999999999999999999999642      345688999999998 899999999999654  578


Q ss_pred             EEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecC-CC
Q 013897          207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PG  282 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~-~~  282 (434)
                      ++||||+.+++|..++   ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++... ..
T Consensus        81 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~vkL~DFG~a~~~~~~~  159 (337)
T 1o6l_A           81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCSCCTT
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCC-CEEEeeccchhhcccCC
Confidence            8999999999987665   4689999999999999999999999999999999999999777 89999999998643 23


Q ss_pred             CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                      ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.. .+.......+..  +               
T Consensus       160 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~--~---------------  220 (337)
T 1o6l_A          160 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILM--E---------------  220 (337)
T ss_dssp             CCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHH--C---------------
T ss_pred             CcccccccChhhCChhhhcC-CCCCchhhcccchhHHHHHhcCCCCCCC-CCHHHHHHHHHc--C---------------
Confidence            34566789999999999877 6899999999999999999999999843 222222222211  0               


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCc-----cHHHHhcCCCcccccccc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-----TAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rp-----t~~elL~Hp~~~~~~~~~  428 (434)
                                .          ...+..+++++.+||.+||+.||++||     +++|+++||||+++++..
T Consensus       221 ----------~----------~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~  271 (337)
T 1o6l_A          221 ----------E----------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQD  271 (337)
T ss_dssp             ----------C----------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHH
T ss_pred             ----------C----------CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHH
Confidence                      0          001123678999999999999999999     999999999999887543

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.9e-49  Score=399.42  Aligned_cols=287  Identities=27%  Similarity=0.539  Sum_probs=223.1

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC---C
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS---K  204 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~---~  204 (434)
                      .++|++++.||+|+||.||+|.+..+++.||||+++..     ..+.+.+|+.+|+.+ +||||+++++++.....   .
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~  103 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL-KSDYIIRLYDLIIPDDLLKFD  103 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCTTTCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHc-CCCCcceEEEEEecCCCCcCC
Confidence            57899999999999999999999999999999999642     235688999999999 89999999999865432   5


Q ss_pred             ccEEEEeecCCCchhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC
Q 013897          205 TPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP  281 (434)
Q Consensus       205 ~~~lv~e~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~  281 (434)
                      .+++||||+++ +|..++.   .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+....
T Consensus       104 ~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~-~~kL~DFGla~~~~~  181 (432)
T 3n9x_A          104 ELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDC-SVKVCDFGLARTINS  181 (432)
T ss_dssp             CEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEEC--
T ss_pred             eEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCC-CEEEccCCCcccccc
Confidence            68999999885 6655542   489999999999999999999999999999999999999776 899999999987643


Q ss_pred             CC-----------------------ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhC----------CCC
Q 013897          282 GK-----------------------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFR----------KEP  328 (434)
Q Consensus       282 ~~-----------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg----------~~p  328 (434)
                      ..                       ..+..+||+.|+|||++.....|+.++|||||||++|||++|          +.|
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p  261 (432)
T 3n9x_A          182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP  261 (432)
T ss_dssp             -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCC
T ss_pred             cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccc
Confidence            32                       235678999999999976657899999999999999999974          556


Q ss_pred             CCCCCC-----------------CHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCc
Q 013897          329 FFYGHD-----------------NYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAV  391 (434)
Q Consensus       329 f~~~~~-----------------~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  391 (434)
                      ++.+.+                 ..+++..+.+.+|.+....+..    ...+................+  ......++
T Consensus       262 ~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~--~~~~~~~s  335 (432)
T 3n9x_A          262 LFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKN----INKPEVIKYIKLFPHRKPINL--KQKYPSIS  335 (432)
T ss_dssp             SCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHT----CCCHHHHHHHHTSCCCCCCCH--HHHSTTSC
T ss_pred             cCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHh----ccCHHHHHHHHhCCCCCCCCH--HHHCCCCC
Confidence            556554                 3577888888888776544322    112222222222111111100  01113478


Q ss_pred             hHHHHHHHHccccCCCCCccHHHHhcCCCcccccccc
Q 013897          392 PEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       392 ~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~  428 (434)
                      +++.+||.+||+.||++|||++|+|+||||++++...
T Consensus       336 ~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~  372 (432)
T 3n9x_A          336 DDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKK  372 (432)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTT
T ss_pred             HHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcc
Confidence            8999999999999999999999999999999987654

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=7.3e-50  Score=396.73  Aligned_cols=263  Identities=24%  Similarity=0.437  Sum_probs=210.9

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      .++|++++.||+|+||+||+|+++.+++.||+|+++...      ...+.+|..++.++.+||||+++++++.+.  ..+
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~--~~~  128 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--SRL  128 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECS--SEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC--CEE
Confidence            478999999999999999999999999999999997432      244788999999887999999999999653  578


Q ss_pred             EEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceec-CCC
Q 013897          207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY-HPG  282 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~-~~~  282 (434)
                      ++||||+.+++|..++   ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.. ...
T Consensus       129 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g-~ikL~DFGla~~~~~~~  207 (396)
T 4dc2_A          129 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRPG  207 (396)
T ss_dssp             EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCCCCTT
T ss_pred             EEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCC-CEEEeecceeeecccCC
Confidence            8999999999987665   4699999999999999999999999999999999999999777 8999999999863 334


Q ss_pred             CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                      ......+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||............      .   ....       
T Consensus       208 ~~~~~~~gt~~Y~aPE~l~~-~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~------~---~~~~-------  270 (396)
T 4dc2_A          208 DTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN------T---EDYL-------  270 (396)
T ss_dssp             CCBCCCCBCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------C------C---HHHH-------
T ss_pred             CccccccCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchh------h---HHHH-------
Confidence            45567789999999999987 78999999999999999999999999432111100000      0   0000       


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccH------HHHhcCCCcccccccc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA------KEAMAHPYFFPIRNAE  428 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~------~elL~Hp~~~~~~~~~  428 (434)
                         ...+...          ....+..+++++.+||.+||+.||++||++      +|+++||||+++++..
T Consensus       271 ---~~~i~~~----------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~  329 (396)
T 4dc2_A          271 ---FQVILEK----------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDM  329 (396)
T ss_dssp             ---HHHHHHC----------CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHH
T ss_pred             ---HHHHhcc----------ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHH
Confidence               0000000          011122467899999999999999999984      8999999999987543

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.7e-50  Score=405.48  Aligned_cols=284  Identities=32%  Similarity=0.536  Sum_probs=224.5

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeEeeEEEcc----CCCccEEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ----QSKTPSLI  209 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~----~~~~~~lv  209 (434)
                      .+|++.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+|+.+ +|||||++++++...    ...++++|
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~E~~il~~l-~hpniv~l~~~~~~~~~~~~~~~~~lv  131 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-RFKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLV  131 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-TSCCHHHHHHHTC-CCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-hhHHHHHHHHHHc-CCCCccceeeEEeccCCCCcceeEEee
Confidence            46999999999999999999999899999999986432 3345899999999 999999999988542    22357799


Q ss_pred             EeecCCCchhhh------cCCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC
Q 013897          210 FEHVNNTDFKVL------YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       210 ~e~~~~~~l~~~------~~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~  283 (434)
                      |||+.++.+..+      ...+++..++.++.||+.||+|||++||+||||||+|||++.++..+||+|||+++......
T Consensus       132 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~  211 (420)
T 1j1b_A          132 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE  211 (420)
T ss_dssp             EECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred             hhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcccCC
Confidence            999998644322      24689999999999999999999999999999999999999766589999999998876655


Q ss_pred             ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                      .....++|+.|+|||++.+...|+.++|||||||++|||++|+.|| .+.+..+++.++.+.+|.+....+.........
T Consensus       212 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf-~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~  290 (420)
T 1j1b_A          212 PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF-PGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE  290 (420)
T ss_dssp             CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCC
T ss_pred             CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhh
Confidence            5566789999999999877567999999999999999999999887 566777888899998887655444321100000


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccccc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~  428 (434)
                      ..    .......+|..    .....+++++.+||.+||+.||++|||+.|+|+||||+.+....
T Consensus       291 ~~----~p~~~~~~~~~----~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  347 (420)
T 1j1b_A          291 FK----FPQIKAHPWTK----VFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN  347 (420)
T ss_dssp             CC----CCCCCCCCHHH----HSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTT
T ss_pred             hc----cCccCCCCHHH----hcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccccc
Confidence            00    00000111111    01234678999999999999999999999999999999876543

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-49  Score=385.36  Aligned_cols=255  Identities=25%  Similarity=0.437  Sum_probs=212.9

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc--HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF  210 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  210 (434)
                      .++|++.+.||+|+||.||+|.+..+++.||+|+++...  ...+.+|+.+++.+ +||||+++++++.+.  ...++||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~--~~~~lv~   80 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNILHLHESFESM--EELVMIF   80 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHS-CCTTBCCEEEEEEET--TEEEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhC-CCCCCCeEeEEEecC--CEEEEEE
Confidence            478999999999999999999999999999999987543  45678999999999 999999999999654  5678999


Q ss_pred             eecCCCchhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC-CCeEEEEecccceecCCCCcc
Q 013897          211 EHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-QRKLRLIDWGLAEFYHPGKEY  285 (434)
Q Consensus       211 e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~-~~~vkl~DFGla~~~~~~~~~  285 (434)
                      ||+.+++|...+.    .+++.++..++.||+.||.|||++||+||||||+|||++.+ +..+||+|||++.........
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~  160 (321)
T 1tki_A           81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF  160 (321)
T ss_dssp             CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred             EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcc
Confidence            9999999877653    48999999999999999999999999999999999999862 348999999999988766666


Q ss_pred             ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChh
Q 013897          286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH  365 (434)
Q Consensus       286 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~  365 (434)
                      ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +....+.+..+......             .+  
T Consensus       161 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~i~~~~~~-------------~~--  223 (321)
T 1tki_A          161 RLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFL-AETNQQIIENIMNAEYT-------------FD--  223 (321)
T ss_dssp             EEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHHTCCC-------------CC--
T ss_pred             ccccCChhhcCcHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCc-CCCHHHHHHHHHcCCCC-------------CC--
Confidence            77789999999999876 578999999999999999999999984 33333333333221100             00  


Q ss_pred             HHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccc
Q 013897          366 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                                        ......+++++.+||.+||..||++|||+.|+|+||||++..
T Consensus       224 ------------------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  265 (321)
T 1tki_A          224 ------------------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI  265 (321)
T ss_dssp             ------------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred             ------------------hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence                              001123678999999999999999999999999999998653

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.6e-49  Score=380.11  Aligned_cols=255  Identities=24%  Similarity=0.417  Sum_probs=211.8

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecc---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      .++|++.+.||+|+||+||+|.+..+++.||||++..   ...+.+.+|+.+++.+ +||||+++++++.+.  ...++|
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~--~~~~lv   95 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLVG--DELWVV   95 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEET--TEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcC-CCCCCCeEeEEEEEC--CEEEEE
Confidence            4679999999999999999999999999999999853   3356788999999998 999999999999754  567899


Q ss_pred             EeecCCCchhhhc--CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC-ccc
Q 013897          210 FEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYN  286 (434)
Q Consensus       210 ~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~-~~~  286 (434)
                      |||+.+++|..++  ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++....... ...
T Consensus        96 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~  174 (297)
T 3fxz_A           96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRS  174 (297)
T ss_dssp             EECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSTTCCBC
T ss_pred             EECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCC-CEEEeeCCCceecCCcccccC
Confidence            9999999998775  3589999999999999999999999999999999999999777 89999999998765433 334


Q ss_pred             eeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhH
Q 013897          287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL  366 (434)
Q Consensus       287 ~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~  366 (434)
                      ..+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.. .+.......+.....                   
T Consensus       175 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~-~~~~~~~~~~~~~~~-------------------  233 (297)
T 3fxz_A          175 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGT-------------------  233 (297)
T ss_dssp             CCCSCGGGCCHHHHHC-SCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHHCS-------------------
T ss_pred             CccCCcCccChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC-------------------
Confidence            5689999999999987 6899999999999999999999999843 232222222211100                   


Q ss_pred             HHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccccc
Q 013897          367 AALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA  427 (434)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~  427 (434)
                                     ........+++.+.+||.+||+.||++|||++|+|+||||+.....
T Consensus       234 ---------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  279 (297)
T 3fxz_A          234 ---------------PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPL  279 (297)
T ss_dssp             ---------------CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred             ---------------CCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccCcc
Confidence                           0011223467889999999999999999999999999999976543

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=6.1e-50  Score=386.58  Aligned_cols=285  Identities=28%  Similarity=0.555  Sum_probs=207.3

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      .++|++++.||+|+||.||+|.+..+++.||+|+++..    ....+.+|+.+++.+ +||||+++++++.+  ....++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~~l   80 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL-KHENIVRLYDVIHT--ENKLTL   80 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTC-CBTTBCCEEEEECC--TTEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhc-CCCCcceEEEEEEE--CCeEEE
Confidence            36799999999999999999999899999999998643    236788999999999 99999999999964  357789


Q ss_pred             EEeecCCCchhhhc---------CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceec
Q 013897          209 IFEHVNNTDFKVLY---------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY  279 (434)
Q Consensus       209 v~e~~~~~~l~~~~---------~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~  279 (434)
                      ||||+.+ +|..++         ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus        81 v~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~~  158 (317)
T 2pmi_A           81 VFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRG-QLKLGDFGLARAF  158 (317)
T ss_dssp             EEECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCSSCEET
T ss_pred             EEEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCC-CEEECcCccceec
Confidence            9999996 554443         2488999999999999999999999999999999999999777 8999999999876


Q ss_pred             CCC-CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhc
Q 013897          280 HPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY  358 (434)
Q Consensus       280 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  358 (434)
                      ... ......++|+.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+.+.++......+....
T Consensus       159 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          159 GIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLF-PGTNDEEQLKLIFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             TSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred             CCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence            432 33455688999999999977567899999999999999999999987 5566667777777777754332222111


Q ss_pred             ccc-CChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccccc
Q 013897          359 HIE-LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA  427 (434)
Q Consensus       359 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~  427 (434)
                      ... ..+.    ....................+++++.+||.+||+.||++|||++|+|+||||++....
T Consensus       238 ~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~  303 (317)
T 2pmi_A          238 KLPKYNPN----IQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH  303 (317)
T ss_dssp             GCTTCCTT----CCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred             hhhhcccc----cccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence            000 0000    0000001111111112233577899999999999999999999999999999977643

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-49  Score=390.13  Aligned_cols=286  Identities=31%  Similarity=0.543  Sum_probs=219.6

Q ss_pred             CCCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC--
Q 013897          131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS--  203 (434)
Q Consensus       131 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~--  203 (434)
                      ...++|++++.||+|+||.||+|.+..+|+.||||++...     ..+.+.+|+.+++.+ +||||+++++++.....  
T Consensus        22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~  100 (367)
T 1cm8_A           22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETLD  100 (367)
T ss_dssp             CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSSTT
T ss_pred             eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-CCcCCCCceeeEecCCccc
Confidence            3457899999999999999999999999999999998532     235678999999999 89999999999975432  


Q ss_pred             --CccEEEEeecCCCchhhhc--CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceec
Q 013897          204 --KTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY  279 (434)
Q Consensus       204 --~~~~lv~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~  279 (434)
                        ...++||||+ +++|..++  ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus       101 ~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~  178 (367)
T 1cm8_A          101 DFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLARQA  178 (367)
T ss_dssp             TCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEEC
T ss_pred             cCceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCC-CEEEEeeeccccc
Confidence              3468999999 67776665  4689999999999999999999999999999999999999776 8999999999875


Q ss_pred             CCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcc
Q 013897          280 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH  359 (434)
Q Consensus       280 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  359 (434)
                      ..  .....++|+.|+|||++.+...++.++|||||||++|||++|+.|| .+.+..+++..+.+..|.+....+. .. 
T Consensus       179 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~l~~i~~~~g~~~~~~~~-~~-  253 (367)
T 1cm8_A          179 DS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF-KGSDHLDQLKEIMKVTGTPPAEFVQ-RL-  253 (367)
T ss_dssp             CS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCHHHHH-TC-
T ss_pred             cc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCCCHHHHH-Hh-
Confidence            42  3455688999999999987668999999999999999999999887 6677778888888888875432221 11 


Q ss_pred             ccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccccc
Q 013897          360 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~  428 (434)
                        ...................+.  .....+++++.+||.+||+.||++|||++|+|+||||+.+...+
T Consensus       254 --~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~  318 (367)
T 1cm8_A          254 --QSDEAKNYMKGLPELEKKDFA--SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE  318 (367)
T ss_dssp             --SCHHHHHHHHHSCCCCCCCGG--GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC---
T ss_pred             --hhHHHHHHHHhCCCCCCCCHH--HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCc
Confidence              111111111111111111111  11224678999999999999999999999999999999876543

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-49  Score=382.40  Aligned_cols=280  Identities=25%  Similarity=0.486  Sum_probs=216.1

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc--------HHHHHHHHHHHHHhc--CCCCeeeEeeEEEccC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--------KKKIKREIKILQNLC--GGPNIVKLLDIVRDQQ  202 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~--------~~~~~~E~~~l~~l~--~h~niv~l~~~~~~~~  202 (434)
                      .++|++++.||+|+||+||+|.+..+++.||||+++...        ...+.+|+.+++.+.  +||||+++++++....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~   87 (308)
T 3g33_A            8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR   87 (308)
T ss_dssp             --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence            478999999999999999999998999999999986322        346778888888773  5999999999997643


Q ss_pred             CC---ccEEEEeecCCCchhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecc
Q 013897          203 SK---TPSLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG  274 (434)
Q Consensus       203 ~~---~~~lv~e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFG  274 (434)
                      ..   ..++||||+.+ +|..++.     .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||
T Consensus        88 ~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg  165 (308)
T 3g33_A           88 TDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG-TVKLADFG  165 (308)
T ss_dssp             SSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTS-CEEECSCS
T ss_pred             CCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC-CEEEeeCc
Confidence            22   57899999986 6555432     289999999999999999999999999999999999999776 89999999


Q ss_pred             cceecCCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHH
Q 013897          275 LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAY  354 (434)
Q Consensus       275 la~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~  354 (434)
                      +++...........+||+.|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.+..+.+..+.+..+......|
T Consensus       166 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~  243 (308)
T 3g33_A          166 LARIYSYQMALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLF-CGNSEADQLGKIFDLIGLPPEDDW  243 (308)
T ss_dssp             CTTTSTTCCCSGGGGCCCSSCCHHHHHT-SCCCSTHHHHHHHHHHHHTTTSSCSC-CCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             cccccCCCcccCCccccccccCchHHcC-CCCCchHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCChhhc
Confidence            9987765556667789999999999987 67999999999999999999999887 566667777777777765543333


Q ss_pred             HhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccc
Q 013897          355 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN  426 (434)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~  426 (434)
                      .......  ..   ........     ........+++++.+||.+||+.||++|||+.|+|+||||++.+.
T Consensus       244 ~~~~~~~--~~---~~~~~~~~-----~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~~  305 (308)
T 3g33_A          244 PRDVSLP--RG---AFPPRGPR-----PVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG  305 (308)
T ss_dssp             CSSCSSC--GG---GSCCCCCC-----CHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC-----
T ss_pred             cchhhcc--cc---ccCCCCCC-----cHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCCC
Confidence            2111100  00   00000000     001112347789999999999999999999999999999997643

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.6e-49  Score=387.96  Aligned_cols=254  Identities=23%  Similarity=0.396  Sum_probs=212.7

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      .++|++.+.||+|+||.||+|+++.+++.||||+++..      ....+..|..++..+.+||||+++++++.+.  ..+
T Consensus        16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~--~~~   93 (345)
T 1xjd_A           16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK--ENL   93 (345)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS--SEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC--CEE
Confidence            47899999999999999999999999999999999643      3456788999999877999999999999654  568


Q ss_pred             EEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC-C
Q 013897          207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-G  282 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~-~  282 (434)
                      ++||||+.+++|..++   ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.... .
T Consensus        94 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~vkL~DFG~a~~~~~~~  172 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG-HIKIADFGMCKENMLGD  172 (345)
T ss_dssp             EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCCCCTT
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCC-CEEEeEChhhhhcccCC
Confidence            8999999999997765   4689999999999999999999999999999999999999777 899999999976432 2


Q ss_pred             CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                      ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||. +.+..+.+..+..  +.              
T Consensus       173 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~-~~~~~~~~~~i~~--~~--------------  234 (345)
T 1xjd_A          173 AKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFH-GQDEEELFHSIRM--DN--------------  234 (345)
T ss_dssp             CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHH--CC--------------
T ss_pred             CcccCCCCCcccCChhhhcC-CCCCChhhhHHHHHHHHHHhcCCCCCC-CCCHHHHHHHHHh--CC--------------
Confidence            34456789999999999987 689999999999999999999999984 3333333322211  00              


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHH-HHhcCCCcccccccc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK-EAMAHPYFFPIRNAE  428 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~-elL~Hp~~~~~~~~~  428 (434)
                                           ...+..+++++.+||.+||+.||++||++. |+++||||+++++..
T Consensus       235 ---------------------~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~~  280 (345)
T 1xjd_A          235 ---------------------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEE  280 (345)
T ss_dssp             ---------------------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHH
T ss_pred             ---------------------CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCHHH
Confidence                                 001123678999999999999999999998 999999999987544

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.8e-49  Score=382.58  Aligned_cols=255  Identities=25%  Similarity=0.457  Sum_probs=212.5

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc---------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCC
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK  204 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~---------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  204 (434)
                      +.|++.+.||+|+||.||+|.+..+++.||+|+++..         ..+.+.+|+.+|+.+ +||||+++++++.+.  .
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~--~   87 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYENK--T   87 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECS--S
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEeC--C
Confidence            6799999999999999999999999999999998642         246789999999999 899999999999654  5


Q ss_pred             ccEEEEeecCCCchhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCC---eEEEEeccccee
Q 013897          205 TPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR---KLRLIDWGLAEF  278 (434)
Q Consensus       205 ~~~lv~e~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~---~vkl~DFGla~~  278 (434)
                      ..++||||+.+++|..++.   .+++..++.++.||+.||.|||++||+||||||+|||++.++.   .+||+|||+++.
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~  167 (326)
T 2y0a_A           88 DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK  167 (326)
T ss_dssp             EEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             EEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence            6789999999999987763   4899999999999999999999999999999999999986542   699999999988


Q ss_pred             cCCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhc
Q 013897          279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY  358 (434)
Q Consensus       279 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  358 (434)
                      ..........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +....+.+..+.....           
T Consensus       168 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~~~~~~~-----------  234 (326)
T 2y0a_A          168 IDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAVNY-----------  234 (326)
T ss_dssp             CCTTSCCCCCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSC-CSSHHHHHHHHHHTCC-----------
T ss_pred             CCCCCccccccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCCCC-CCCHHHHHHHHHhcCC-----------
Confidence            765555666789999999999876 689999999999999999999999984 3333333333221100           


Q ss_pred             cccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccc
Q 013897          359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN  426 (434)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~  426 (434)
                        ....                    .....+++.+.+||.+||+.||++|||+.|+|+||||++.+.
T Consensus       235 --~~~~--------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  280 (326)
T 2y0a_A          235 --EFED--------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT  280 (326)
T ss_dssp             --CCCH--------------------HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCSH
T ss_pred             --CcCc--------------------cccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCcc
Confidence              0000                    011236788999999999999999999999999999997653

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.2e-49  Score=377.81  Aligned_cols=253  Identities=25%  Similarity=0.477  Sum_probs=204.7

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc-----------------------------HHHHHHHHHHHH
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------------------------KKKIKREIKILQ  183 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----------------------------~~~~~~E~~~l~  183 (434)
                      .++|++.+.||+|+||.||+|.+..+++.||||++....                             .+.+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            378999999999999999999999999999999986432                             245789999999


Q ss_pred             HhcCCCCeeeEeeEEEccCCCccEEEEeecCCCchhhhcC--CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEe
Q 013897          184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI  261 (434)
Q Consensus       184 ~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll  261 (434)
                      .+ +||||+++++++.+......++||||+.+++|..+..  .+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus        92 ~l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~  170 (298)
T 2zv2_A           92 KL-DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV  170 (298)
T ss_dssp             TC-CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred             hC-CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence            99 9999999999998766678899999999999876643  58999999999999999999999999999999999999


Q ss_pred             cCCCCeEEEEecccceecCCCC-ccceeccCCcccccccccCCCC--CCccccHHHHHHHHHHHHhCCCCCCCCCCCHHH
Q 013897          262 DHEQRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQD--YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQ  338 (434)
Q Consensus       262 ~~~~~~vkl~DFGla~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~--~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~  338 (434)
                      +.++ .+||+|||+++...... ......||+.|+|||++.+...  ++.++|||||||++|+|++|+.||... .....
T Consensus       171 ~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~-~~~~~  248 (298)
T 2zv2_A          171 GEDG-HIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE-RIMCL  248 (298)
T ss_dssp             CTTS-CEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS-SHHHH
T ss_pred             CCCC-CEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc-cHHHH
Confidence            9777 89999999998765432 2345679999999999876332  478899999999999999999998432 11111


Q ss_pred             HHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          339 LVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       339 ~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                      ...+..                           ..        ........+++++.+||.+||+.||++|||+.|+|+|
T Consensus       249 ~~~~~~---------------------------~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          249 HSKIKS---------------------------QA--------LEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             HHHHHH---------------------------CC--------CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             HHHHhc---------------------------cc--------CCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence            111100                           00        0011123467899999999999999999999999999


Q ss_pred             CCccc
Q 013897          419 PYFFP  423 (434)
Q Consensus       419 p~~~~  423 (434)
                      |||+.
T Consensus       294 p~~~~  298 (298)
T 2zv2_A          294 PWVTR  298 (298)
T ss_dssp             HHHHC
T ss_pred             ccccC
Confidence            99963

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=3.7e-49  Score=375.69  Aligned_cols=275  Identities=32%  Similarity=0.628  Sum_probs=211.5

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      ++|++++.||+|+||.||+|.+ .+++.||+|+++...     ...+.+|+.+++.+ +||||+++++++.+.  ...++
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~l   77 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVIHTK--KRLVL   77 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEECS--SCEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhc-CCCCEeeeeeEEccC--CeEEE
Confidence            5799999999999999999998 678999999986432     35688999999999 899999999999654  56789


Q ss_pred             EEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC-C
Q 013897          209 IFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-K  283 (434)
Q Consensus       209 v~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~-~  283 (434)
                      ||||+.+ ++..++    ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..... .
T Consensus        78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~  155 (288)
T 1ob3_A           78 VFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG-ELKIADFGLARAFGIPVR  155 (288)
T ss_dssp             EEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECCTTHHHHHCC---
T ss_pred             EEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-CEEEeECccccccCcccc
Confidence            9999997 554433    4588999999999999999999999999999999999999777 8999999999765432 2


Q ss_pred             ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcccc-C
Q 013897          284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE-L  362 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~-~  362 (434)
                      ......+|+.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+.+.++......+....... .
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T 1ob3_A          156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF-PGVSEADQLMRIFRILGTPNSKNWPNVTELPKY  234 (288)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHHCCCChhhchhhhccccc
Confidence            3345678999999999877567999999999999999999999887 4556667777777776654433322111000 0


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI  424 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~  424 (434)
                      ++.+    ......++.     .....+++++.+||.+||+.||++|||++|+|+||||++.
T Consensus       235 ~~~~----~~~~~~~~~-----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          235 DPNF----TVYEPLPWE-----SFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             CTTC----CCCCCCCGG-----GTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             cccc----ccccCccHH-----HHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence            0000    000001111     1123478899999999999999999999999999999875

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.8e-49  Score=386.48  Aligned_cols=254  Identities=22%  Similarity=0.348  Sum_probs=212.1

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      .++|++++.||+|+||+||+|+++.+++.||||+++..      ..+.+..|..++..+.+||||+++++++.+.  ..+
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~--~~~   96 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM--DRL   96 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS--SEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC--CEE
Confidence            47899999999999999999999989999999999643      3356788999998877899999999999654  578


Q ss_pred             EEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecC-CC
Q 013897          207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PG  282 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~-~~  282 (434)
                      ++||||+.+++|..++   ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++... ..
T Consensus        97 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g-~vkL~DFG~a~~~~~~~  175 (353)
T 2i0e_A           97 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKENIWDG  175 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCCCCTT
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCC-cEEEEeCCcccccccCC
Confidence            8999999999987665   4699999999999999999999999999999999999999777 89999999997643 23


Q ss_pred             CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                      ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||. +.+..+....+...             .   
T Consensus       176 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~-~~~~~~~~~~i~~~-------------~---  237 (353)
T 2i0e_A          176 VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFE-GEDEDELFQSIMEH-------------N---  237 (353)
T ss_dssp             CCBCCCCSCGGGCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHC-------------C---
T ss_pred             cccccccCCccccChhhhcC-CCcCCcccccchHHHHHHHHcCCCCCC-CCCHHHHHHHHHhC-------------C---
Confidence            34456789999999999877 689999999999999999999999984 33333333332210             0   


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCc-----cHHHHhcCCCcccccccc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-----TAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rp-----t~~elL~Hp~~~~~~~~~  428 (434)
                                           ...+..+++++.+||.+||+.||++||     +++|+++||||+.+++..
T Consensus       238 ---------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~  287 (353)
T 2i0e_A          238 ---------------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK  287 (353)
T ss_dssp             ---------------------CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHH
T ss_pred             ---------------------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHH
Confidence                                 001123678999999999999999999     579999999999887544

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.4e-50  Score=397.14  Aligned_cols=281  Identities=31%  Similarity=0.567  Sum_probs=223.1

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeEeeEEEcc-----------
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ-----------  201 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~-----------  201 (434)
                      .++|++++.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.+ +||||+++++++...           
T Consensus         6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~   83 (383)
T 3eb0_A            6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-RYKNRELDIMKVL-DHVNIIKLVDYFYTTGDEEPKPPQPP   83 (383)
T ss_dssp             CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT-TSCCHHHHHHTTC-CCTTBCCEEEEEEEC-----------
T ss_pred             cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc-chHHHHHHHHHHc-CCCCccchhheeeecCcccccccccc
Confidence            478999999999999999999999999999999986432 3345899999999 999999999998542           


Q ss_pred             -------------------------CCCccEEEEeecCCCchhhhc-------CCCChHHHHHHHHHHHHHHHHHHHCCc
Q 013897          202 -------------------------QSKTPSLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGI  249 (434)
Q Consensus       202 -------------------------~~~~~~lv~e~~~~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~~i  249 (434)
                                               ...++++||||+++ +|...+       ..+++..++.++.||+.||+|||++||
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi  162 (383)
T 3eb0_A           84 DDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGI  162 (383)
T ss_dssp             --------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTE
T ss_pred             cccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcC
Confidence                                     23457899999996 433221       468999999999999999999999999


Q ss_pred             eeecCCCCceEecCCCCeEEEEecccceecCCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCC
Q 013897          250 MHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF  329 (434)
Q Consensus       250 vHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf  329 (434)
                      +||||||+|||++.+++.+||+|||+|+............+|+.|+|||++.+...++.++|||||||++|||++|+.||
T Consensus       163 ~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf  242 (383)
T 3eb0_A          163 CHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLF  242 (383)
T ss_dssp             ECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             ccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCC
Confidence            99999999999985444899999999998776666677789999999999887567999999999999999999999887


Q ss_pred             CCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHH-hcccCCCCCccccccccccCCchHHHHHHHHccccCCCC
Q 013897          330 FYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAAL-VGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQE  408 (434)
Q Consensus       330 ~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~  408 (434)
                       .+.+..+++..+.+.+|.+....+....     +.+... ........|.    ......+++++.+||.+||+.||++
T Consensus       243 -~~~~~~~~~~~i~~~~g~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~L~~dP~~  312 (383)
T 3eb0_A          243 -SGETSIDQLVRIIQIMGTPTKEQMIRMN-----PHYTEVRFPTLKAKDWR----KILPEGTPSLAIDLLEQILRYEPDL  312 (383)
T ss_dssp             -CCSSHHHHHHHHHHHHCCCCHHHHHHHC-----TTC--CCCCCCCCCCHH----HHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred             -CCCChHHHHHHHHHHhCCCCHHHHHHhC-----cccccccCCccCcccHH----hhCCCCCCHHHHHHHHHHccCChhh
Confidence             6677788899999998877654443211     000000 0000000010    1122346788999999999999999


Q ss_pred             CccHHHHhcCCCcccccc
Q 013897          409 RPTAKEAMAHPYFFPIRN  426 (434)
Q Consensus       409 Rpt~~elL~Hp~~~~~~~  426 (434)
                      |||+.|+|+||||+.++.
T Consensus       313 R~t~~e~l~hp~f~~~~~  330 (383)
T 3eb0_A          313 RINPYEAMAHPFFDHLRN  330 (383)
T ss_dssp             SCCHHHHHTSGGGHHHHH
T ss_pred             CCCHHHHhcCHHHHHHHh
Confidence            999999999999997754

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=9.1e-49  Score=382.82  Aligned_cols=262  Identities=24%  Similarity=0.436  Sum_probs=209.3

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      .++|++++.||+|+||.||+|+++.+++.||+|+++...      ...+.+|+.+++++.+||||+++++++.+.  ..+
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~--~~~   85 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--SRL   85 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC--CEE
Confidence            368999999999999999999999999999999996432      345788999999887899999999999654  578


Q ss_pred             EEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecC-CC
Q 013897          207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PG  282 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~-~~  282 (434)
                      ++||||+.+++|..++   ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++... ..
T Consensus        86 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~~kL~DFG~a~~~~~~~  164 (345)
T 3a8x_A           86 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRPG  164 (345)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCGGGCBCSCCTT
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCC-CEEEEeccccccccCCC
Confidence            8999999999987665   4699999999999999999999999999999999999999777 89999999998643 33


Q ss_pred             CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                      ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.............         ....       
T Consensus       165 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~---------~~~~-------  227 (345)
T 3a8x_A          165 DTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT---------EDYL-------  227 (345)
T ss_dssp             CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------C---------HHHH-------
T ss_pred             CcccccCCCccccCccccCC-CCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccccc---------HHHH-------
Confidence            34556789999999999987 689999999999999999999999995321111000000         0000       


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccH------HHHhcCCCccccccc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA------KEAMAHPYFFPIRNA  427 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~------~elL~Hp~~~~~~~~  427 (434)
                         ...+....          ...+..+++++.+||.+||+.||++||++      +|+++||||+++++.
T Consensus       228 ---~~~i~~~~----------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~  285 (345)
T 3a8x_A          228 ---FQVILEKQ----------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD  285 (345)
T ss_dssp             ---HHHHHHCC----------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHH
T ss_pred             ---HHHHHcCC----------CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHH
Confidence               00000000          01122467899999999999999999995      899999999988753

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=6.5e-49  Score=379.58  Aligned_cols=251  Identities=21%  Similarity=0.423  Sum_probs=210.7

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      .++|++++.||+|+||+||+|+++.+++.||+|+++..      ..+.+.+|+.+++.+ +||||+++++++.+.  ..+
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~--~~~   81 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQDA--QQI   81 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEECS--SEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhC-CCCCCceEeEEEEeC--CEE
Confidence            36899999999999999999999999999999999643      345678899999998 999999999999654  578


Q ss_pred             EEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC
Q 013897          207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~  283 (434)
                      ++||||+.+++|..++   ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++....  
T Consensus        82 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~~kL~Dfg~a~~~~~--  158 (318)
T 1fot_A           82 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG-HIKITDFGFAKYVPD--  158 (318)
T ss_dssp             EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS-CEEECCCSSCEECSS--
T ss_pred             EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCC-CEEEeecCcceecCC--
Confidence            8999999999987765   4589999999999999999999999999999999999999777 899999999987543  


Q ss_pred             ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                      .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.. .+.......+...                  
T Consensus       159 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~------------------  218 (318)
T 1fot_A          159 VTYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNA------------------  218 (318)
T ss_dssp             CBCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHC------------------
T ss_pred             ccccccCCccccCHhHhcC-CCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhC------------------
Confidence            3345689999999999877 6899999999999999999999999843 2322333222210                  


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCc-----cHHHHhcCCCcccccccc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-----TAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rp-----t~~elL~Hp~~~~~~~~~  428 (434)
                               .          ...+..+++++.+||.+||+.||++||     +++|+++||||+++++..
T Consensus       219 ---------~----------~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~  269 (318)
T 1fot_A          219 ---------E----------LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEK  269 (318)
T ss_dssp             ---------C----------CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHH
T ss_pred             ---------C----------CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHHH
Confidence                     0          001123678999999999999999999     999999999999887543

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2e-49  Score=395.58  Aligned_cols=257  Identities=26%  Similarity=0.399  Sum_probs=211.7

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      .++|++++.||+|+||+||+|+++.+++.||+|+++..      ....+.+|+.+++.+ +|||||++++++.+  ...+
T Consensus        68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~--~~~~  144 (410)
T 3v8s_A           68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQD--DRYL  144 (410)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEE
T ss_pred             ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEE--CCEE
Confidence            57899999999999999999999999999999998642      224478999999998 99999999999965  4678


Q ss_pred             EEEEeecCCCchhhhc--CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc
Q 013897          207 SLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE  284 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~  284 (434)
                      ++||||+.+++|..++  ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.......
T Consensus       145 ~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g-~ikL~DFG~a~~~~~~~~  223 (410)
T 3v8s_A          145 YMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG-HLKLADFGTCMKMNKEGM  223 (410)
T ss_dssp             EEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECCTTSE
T ss_pred             EEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCC-CEEEeccceeEeeccCCc
Confidence            8999999999997765  3589999999999999999999999999999999999999777 899999999987654432


Q ss_pred             --cceeccCCcccccccccCCCC---CCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcc
Q 013897          285 --YNVRVASRYFKGPELLVDLQD---YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH  359 (434)
Q Consensus       285 --~~~~~~t~~y~aPE~~~~~~~---~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  359 (434)
                        ....+||+.|+|||++.+...   |+.++|||||||++|||++|+.||. +.+..+....|....         ..  
T Consensus       224 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~-~~~~~~~~~~i~~~~---------~~--  291 (410)
T 3v8s_A          224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY-ADSLVGTYSKIMNHK---------NS--  291 (410)
T ss_dssp             EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHTHH---------HH--
T ss_pred             ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCC-CCChhhHHHHHHhcc---------cc--
Confidence              346689999999999976321   7899999999999999999999984 333333333332100         00  


Q ss_pred             ccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCC--CccHHHHhcCCCccccccc
Q 013897          360 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQE--RPTAKEAMAHPYFFPIRNA  427 (434)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~--Rpt~~elL~Hp~~~~~~~~  427 (434)
                                            ........+++++.+||.+||+.+|.+  |++++|+++||||+++++.
T Consensus       292 ----------------------~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~  339 (410)
T 3v8s_A          292 ----------------------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWA  339 (410)
T ss_dssp             ----------------------CCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCC
T ss_pred             ----------------------ccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHH
Confidence                                  001112246789999999999999988  9999999999999988653

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=6.8e-49  Score=380.38  Aligned_cols=255  Identities=23%  Similarity=0.370  Sum_probs=207.4

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      .++|++++.||+|+||+||+|.+..+++.||||++....    .+.+.+|+.+++.+ +||||+++++++.+.  ...++
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~--~~~~l   82 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRREG--NIQYL   82 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHC-CCTTBCCEEEEEECS--SEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhC-CCCCCCeEEEEEecC--CeEEE
Confidence            478999999999999999999999999999999986432    35688999999999 999999999999654  56789


Q ss_pred             EEeecCCCchhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC--
Q 013897          209 IFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--  283 (434)
Q Consensus       209 v~e~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~--  283 (434)
                      ||||+.+++|..++.   .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.+....  
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~  161 (323)
T 3tki_A           83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRE  161 (323)
T ss_dssp             EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEECEETTEE
T ss_pred             EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCC-CEEEEEeeccceeccCCcc
Confidence            999999999987764   489999999999999999999999999999999999999776 89999999997654222  


Q ss_pred             -ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          284 -EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       284 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                       .....+||+.|+|||++.+...++.++|||||||++|+|++|+.||................                 
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~-----------------  224 (323)
T 3tki_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK-----------------  224 (323)
T ss_dssp             CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTT-----------------
T ss_pred             cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcc-----------------
Confidence             23456899999999999874445789999999999999999999995433322222111100                 


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN  426 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~  426 (434)
                                ..        .......+++++.+||.+||+.||++|||++|+|+||||++...
T Consensus       225 ----------~~--------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~  270 (323)
T 3tki_A          225 ----------KT--------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK  270 (323)
T ss_dssp             ----------CT--------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             ----------cc--------cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccccc
Confidence                      00        00011236788999999999999999999999999999986543

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.6e-49  Score=384.76  Aligned_cols=281  Identities=28%  Similarity=0.569  Sum_probs=213.8

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccccHH----HHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK----KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      ++|.+++.||+|+||.||+|.+..+++.||+|+++.....    .+.+|+.+++.+ +||||+++++++.+.  ...++|
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv   78 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIIHTE--KSLTLV   78 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCC-CCTTBCCEEEEEECS--SCEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhc-CCCCCCeeeeEEeeC--CEEEEE
Confidence            6799999999999999999999989999999999754322    345799999999 899999999999654  567899


Q ss_pred             EeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC-Cc
Q 013897          210 FEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KE  284 (434)
Q Consensus       210 ~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~-~~  284 (434)
                      |||+.+ ++..++    ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...... ..
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~~~~~~  156 (324)
T 3mtl_A           79 FEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERG-ELKLADFGLARAKSIPTKT  156 (324)
T ss_dssp             EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTC-CEEECSSSEEECC------
T ss_pred             eccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCC-CEEEccCcccccccCCccc
Confidence            999996 444332    3488999999999999999999999999999999999999777 8999999999765432 23


Q ss_pred             cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCCh
Q 013897          285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP  364 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  364 (434)
                      ....++|+.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+++..+.+.++.+....+.....   ..
T Consensus       157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~---~~  232 (324)
T 3mtl_A          157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLF-PGSTVEEQLHFIFRILGTPTEETWPGILS---NE  232 (324)
T ss_dssp             ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCTTTSTTGGG---CH
T ss_pred             cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCChHhchhhhc---ch
Confidence            345678999999999887667999999999999999999999887 56667778888888877654433322110   00


Q ss_pred             hHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccccc
Q 013897          365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA  427 (434)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~  427 (434)
                      .....    ....+...........+++++.+||.+||+.||++|||++|+|+||||.++.+.
T Consensus       233 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  291 (324)
T 3mtl_A          233 EFKTY----NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER  291 (324)
T ss_dssp             HHHHT----CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred             hhccc----ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence            01000    000000001112223578899999999999999999999999999999988653

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=8.7e-49  Score=387.63  Aligned_cols=256  Identities=22%  Similarity=0.427  Sum_probs=214.1

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      .++|++++.||+|+||.||+|.+..+++.||+|++...      ....+.+|+.+|+.+ +|||||++++++.+.  ..+
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~--~~~   90 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-EHPFLVNLWYSFQDE--EDM   90 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECS--SEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeC--CEE
Confidence            37899999999999999999999999999999998642      235688999999999 999999999999654  567


Q ss_pred             EEEEeecCCCchhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC
Q 013897          207 SLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~  283 (434)
                      ++||||+.+++|..++.   .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g-~vkL~DFG~a~~~~~~~  169 (384)
T 4fr4_A           91 FMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHG-HVHITDFNIAAMLPRET  169 (384)
T ss_dssp             EEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECCTTC
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCC-CEEEeccceeeeccCCC
Confidence            89999999999977653   589999999999999999999999999999999999999777 89999999999877666


Q ss_pred             ccceeccCCcccccccccC--CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCC-HHHHHHHHHHhCChhHHHHHhhccc
Q 013897          284 EYNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN-YDQLVKIAKVLGTDELNAYLNKYHI  360 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~~--~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~-~~~~~~i~~~~g~~~~~~~~~~~~~  360 (434)
                      .....+||+.|+|||++.+  ...|+.++|||||||++|||++|+.||...... ...+.......              
T Consensus       170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~--------------  235 (384)
T 4fr4_A          170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT--------------  235 (384)
T ss_dssp             CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC--------------
T ss_pred             ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc--------------
Confidence            6677899999999999864  246899999999999999999999999543222 11111110000              


Q ss_pred             cCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCcc-HHHHhcCCCcccccccc
Q 013897          361 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT-AKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt-~~elL~Hp~~~~~~~~~  428 (434)
                                            ....+..+++++.+||.+||+.||++||+ ++++++||||+++++..
T Consensus       236 ----------------------~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~~  282 (384)
T 4fr4_A          236 ----------------------VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDA  282 (384)
T ss_dssp             ----------------------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHHH
T ss_pred             ----------------------ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHHH
Confidence                                  01112236789999999999999999998 89999999999887543

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=6.9e-49  Score=390.65  Aligned_cols=283  Identities=31%  Similarity=0.541  Sum_probs=222.3

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccC----CCccEEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ----SKTPSLI  209 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----~~~~~lv  209 (434)
                      .+|.+.+.||+|+||.||+|.+..++. +|+|.+.... ....+|+.+++.+ +||||+++++++....    ..++++|
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~-~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~~lv  116 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDK-RFKNRELQIMRIV-KHPNVVDLKAFFYSNGDKKDEVFLNLV  116 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCT-TSCCHHHHHHHTC-CCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCc-chHHHHHHHHHhC-CCCCcceEEEEEEecCCCCCceEEEEE
Confidence            579999999999999999999876655 7777764322 2335799999999 9999999999986533    2347899


Q ss_pred             EeecCCCchhhh------cCCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC
Q 013897          210 FEHVNNTDFKVL------YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       210 ~e~~~~~~l~~~------~~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~  283 (434)
                      |||+.++.+..+      ...+++..++.++.||+.||+|||++||+||||||+|||++.+.+.+||+|||+|+......
T Consensus       117 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~  196 (394)
T 4e7w_A          117 LEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE  196 (394)
T ss_dssp             EECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred             eeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC
Confidence            999998765433      35689999999999999999999999999999999999999444489999999998876666


Q ss_pred             ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                      .....++|+.|+|||++.+...|+.++|||||||++|||++|+.|| .+.+..+++..+.+.+|.+....+.........
T Consensus       197 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf-~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~  275 (394)
T 4e7w_A          197 PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLF-PGESGIDQLVEIIKVLGTPSREQIKTMNPNYME  275 (394)
T ss_dssp             CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSS
T ss_pred             CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhh
Confidence            6667789999999999987567999999999999999999999887 667778889999999887665443321100000


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccccc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~  428 (434)
                      ..    .......++    .......+++++.+||.+||+.||++|||+.|+|+||||++++...
T Consensus       276 ~~----~~~~~~~~~----~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  332 (394)
T 4e7w_A          276 HK----FPQIRPHPF----SKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGE  332 (394)
T ss_dssp             SC----CCCCCCCCH----HHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSC
T ss_pred             hc----cccccCCcH----HHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcccc
Confidence            00    000000111    1112234778999999999999999999999999999999887654

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2e-48  Score=374.37  Aligned_cols=284  Identities=30%  Similarity=0.486  Sum_probs=214.0

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      ++|++++.||+|+||.||+|.+..+++.||+|++....     .+.+.+|+.+++.+ +||||+++++++.+.  ...++
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~--~~~~l   79 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQL-KHPNLVNLLEVFRRK--RRLHL   79 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEET--TEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhC-CCCCccchhheeecC--CeEEE
Confidence            67999999999999999999999999999999885432     35578999999999 899999999999754  56789


Q ss_pred             EEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC-Cc
Q 013897          209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KE  284 (434)
Q Consensus       209 v~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~-~~  284 (434)
                      ||||+.++++..+.   ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...... ..
T Consensus        80 v~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~  158 (311)
T 4agu_A           80 VFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHS-VIKLCDFGFARLLTGPSDY  158 (311)
T ss_dssp             EEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECC-----
T ss_pred             EEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCC-CEEEeeCCCchhccCcccc
Confidence            99999999887664   4589999999999999999999999999999999999999776 8999999999876533 23


Q ss_pred             cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCCh
Q 013897          285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP  364 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  364 (434)
                      ....+++..|+|||++.+...++.++|||||||++|+|++|+.|| .+....+....+.+.++.............   .
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~  234 (311)
T 4agu_A          159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLW-PGKSDVDQLYLIRKTLGDLIPRHQQVFSTN---Q  234 (311)
T ss_dssp             -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCSCCHHHHHHHHTC---G
T ss_pred             cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhcccccccccccccc---c
Confidence            355688999999999987567899999999999999999999887 555666666666666664322111100000   0


Q ss_pred             hHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccccc
Q 013897          365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~  428 (434)
                      ...   ......+............+++++.+||.+||+.||++|||++|+|+||||+++++.+
T Consensus       235 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  295 (311)
T 4agu_A          235 YFS---GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE  295 (311)
T ss_dssp             GGT---TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC---
T ss_pred             ccc---cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHH
Confidence            000   0000000000000011134778899999999999999999999999999999987654

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.8e-49  Score=398.85  Aligned_cols=260  Identities=23%  Similarity=0.385  Sum_probs=212.8

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      .++|+++++||+|+||+||+|+++.+++.||+|+++...      ...+.+|+.++..+ +||||+++++++.+.  ..+
T Consensus        73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~~--~~~  149 (437)
T 4aw2_A           73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DSKWITTLHYAFQDD--NNL  149 (437)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHS-CTTTBCCEEEEEECS--SEE
T ss_pred             hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeeC--CEE
Confidence            578999999999999999999999999999999996422      23388999999998 999999999999654  568


Q ss_pred             EEEEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC
Q 013897          207 SLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG  282 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~  282 (434)
                      ++||||+.+++|..++    ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.....
T Consensus       150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g-~vkL~DFGla~~~~~~  228 (437)
T 4aw2_A          150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG-HIRLADFGSCLKLMED  228 (437)
T ss_dssp             EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECCTT
T ss_pred             EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCC-CEEEcchhhhhhcccC
Confidence            8999999999997765    3589999999999999999999999999999999999999777 8999999999876544


Q ss_pred             Ccc--ceeccCCccccccccc----CCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHh
Q 013897          283 KEY--NVRVASRYFKGPELLV----DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN  356 (434)
Q Consensus       283 ~~~--~~~~~t~~y~aPE~~~----~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~  356 (434)
                      ...  ...+||+.|+|||++.    +...|+.++|||||||++|||++|+.||. +.+..+....+....         .
T Consensus       229 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~-~~~~~~~~~~i~~~~---------~  298 (437)
T 4aw2_A          229 GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKIMNHK---------E  298 (437)
T ss_dssp             SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHTHH---------H
T ss_pred             CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCC-CCChhHHHHhhhhcc---------c
Confidence            332  3468999999999986    23568999999999999999999999984 334344444332100         0


Q ss_pred             hccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCC--CccHHHHhcCCCccccccccc
Q 013897          357 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQE--RPTAKEAMAHPYFFPIRNAES  429 (434)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~--Rpt~~elL~Hp~~~~~~~~~~  429 (434)
                      .  ..+                     ......+++++.+||++||+.+|++  |++++|+++||||+++++...
T Consensus       299 ~--~~~---------------------p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l  350 (437)
T 4aw2_A          299 R--FQF---------------------PTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNI  350 (437)
T ss_dssp             H--CCC---------------------CSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTG
T ss_pred             c--ccC---------------------CcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHH
Confidence            0  000                     0011236789999999999999988  999999999999999876543

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=5.1e-49  Score=387.16  Aligned_cols=253  Identities=26%  Similarity=0.470  Sum_probs=209.1

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      ++|++.+.||+|+||.||+|.++.+++.||+|+++..     ..+.+.+|+.+++.+ +||||+++++++.+.  ...++
T Consensus        29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~--~~~~l  105 (362)
T 2bdw_A           29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEE--SFHYL  105 (362)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECS--SEEEE
T ss_pred             cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeC--CEEEE
Confidence            6799999999999999999999999999999999643     235688999999999 999999999999654  56789


Q ss_pred             EEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCC--CeEEEEecccceecCCCC
Q 013897          209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ--RKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       209 v~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~--~~vkl~DFGla~~~~~~~  283 (434)
                      ||||+.+++|...+   ..+++..+..++.||+.||.|||++||+||||||+|||++.++  ..+||+|||++.......
T Consensus       106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~  185 (362)
T 2bdw_A          106 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE  185 (362)
T ss_dssp             EECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC
T ss_pred             EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc
Confidence            99999999986654   3489999999999999999999999999999999999998543  369999999998776555


Q ss_pred             ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                      .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.. .+..+....+.....             .. 
T Consensus       186 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~-~~~~~~~~~i~~~~~-------------~~-  249 (362)
T 2bdw_A          186 AWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYAQIKAGAY-------------DY-  249 (362)
T ss_dssp             SCCCSCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCC-------------CC-
T ss_pred             ccccCCCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCC-------------CC-
Confidence            5566789999999999876 6899999999999999999999999843 232222222211000             00 


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI  424 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~  424 (434)
                                         .......+++++.+||.+||+.||++|||+.|+|+||||+..
T Consensus       250 -------------------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  291 (362)
T 2bdw_A          250 -------------------PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR  291 (362)
T ss_dssp             -------------------CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred             -------------------CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence                               001112367899999999999999999999999999999854

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=9.7e-49  Score=388.14  Aligned_cols=256  Identities=25%  Similarity=0.470  Sum_probs=212.5

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      .++|++++.||+|+||.||+|.+..+++.||+|++...   ....+.+|+.+|+.+ +||||+++++++.+.  ...++|
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~--~~~~lv  126 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLHDAFEDK--YEMVLI  126 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CSTTBCCEEEEEECS--SEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhC-CCcCCCeEEEEEEeC--CEEEEE
Confidence            36899999999999999999999999999999998754   345688999999999 999999999999654  567899


Q ss_pred             EeecCCCchhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC-CCeEEEEecccceecCCCCc
Q 013897          210 FEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-QRKLRLIDWGLAEFYHPGKE  284 (434)
Q Consensus       210 ~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~-~~~vkl~DFGla~~~~~~~~  284 (434)
                      |||+.+++|..++.    .+++..+..++.||+.||+|||++||+||||||+|||++.+ ...+||+|||+++.......
T Consensus       127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~  206 (387)
T 1kob_A          127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI  206 (387)
T ss_dssp             EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred             EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence            99999999977663    48899999999999999999999999999999999999743 34799999999988766655


Q ss_pred             cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCCh
Q 013897          285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP  364 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  364 (434)
                      ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+.+..+...             ....  
T Consensus       207 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~-~~~~~~~~~~i~~~-------------~~~~--  269 (387)
T 1kob_A          207 VKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFA-GEDDLETLQNVKRC-------------DWEF--  269 (387)
T ss_dssp             EEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSC-CSSHHHHHHHHHHC-------------CCCC--
T ss_pred             eeeeccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhCCCCCC-CCCHHHHHHHHHhC-------------CCCC--
Confidence            667789999999999876 689999999999999999999999984 33333333322110             0000  


Q ss_pred             hHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccc
Q 013897          365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN  426 (434)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~  426 (434)
                                        .......+++++.+||.+||+.||++|||+.|+|+||||++...
T Consensus       270 ------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  313 (387)
T 1kob_A          270 ------------------DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS  313 (387)
T ss_dssp             ------------------CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred             ------------------CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCcc
Confidence                              00111246789999999999999999999999999999986543

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=7.1e-49  Score=384.62  Aligned_cols=253  Identities=26%  Similarity=0.442  Sum_probs=206.9

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc--------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCc
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT  205 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~--------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  205 (434)
                      +.|++.+.||+|+||.||+|.++.+++.||||+++..        ..+.+.+|+.+++.+ +||||+++++++.+.  ..
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~--~~  100 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML-KHPHIVELLETYSSD--GM  100 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHC-CCTTBCCEEEEEEET--TE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhC-CCCCCCcEEEEEEeC--CE
Confidence            6799999999999999999999999999999998532        356789999999999 999999999999754  56


Q ss_pred             cEEEEeecCCCchhhhc-------CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCC--CeEEEEecccc
Q 013897          206 PSLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ--RKLRLIDWGLA  276 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~--~~vkl~DFGla  276 (434)
                      +++||||+.+++|...+       ..+++..++.++.||+.||+|||++||+||||||+|||++.++  ..+||+|||++
T Consensus       101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a  180 (351)
T 3c0i_A          101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA  180 (351)
T ss_dssp             EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred             EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence            78999999999986443       1388999999999999999999999999999999999998554  24999999999


Q ss_pred             eecCCCCc-cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHH
Q 013897          277 EFYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL  355 (434)
Q Consensus       277 ~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~  355 (434)
                      ........ ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...  ....+..+...          
T Consensus       181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~~i~~~----------  247 (351)
T 3c0i_A          181 IQLGESGLVAGGRVGTPHFMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGT--KERLFEGIIKG----------  247 (351)
T ss_dssp             EECCTTSCBCCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCSS--HHHHHHHHHHT----------
T ss_pred             eEecCCCeeecCCcCCcCccCHHHHcC-CCCCchHhhHHHHHHHHHHHHCCCCCCCc--HHHHHHHHHcC----------
Confidence            87654432 345689999999999877 67999999999999999999999999532  11222221110          


Q ss_pred             hhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccc
Q 013897          356 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                         .....+                    .....+++++.+||.+||+.||++|||+.|+|+||||+..+
T Consensus       248 ---~~~~~~--------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~  294 (351)
T 3c0i_A          248 ---KYKMNP--------------------RQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERD  294 (351)
T ss_dssp             ---CCCCCH--------------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHH
T ss_pred             ---CCCCCc--------------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCc
Confidence               000000                    01123678999999999999999999999999999998754

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.1e-48  Score=383.48  Aligned_cols=284  Identities=29%  Similarity=0.535  Sum_probs=209.9

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEcc----CC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ----QS  203 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~----~~  203 (434)
                      .++|++++.||+|+||.||+|.+..+++.||||++...     ..+.+.+|+.+++.+ +||||+++++++...    ..
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~  106 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEEF  106 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSGGGC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEecCCccccC
Confidence            47899999999999999999999999999999998642     245678999999999 899999999998643    22


Q ss_pred             CccEEEEeecCCCchhhhc--CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC
Q 013897          204 KTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP  281 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~  281 (434)
                      ...++|+|++ +++|..++  ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus       107 ~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~-~~kL~DFG~a~~~~~  184 (367)
T 2fst_X          107 NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTAD  184 (367)
T ss_dssp             CCCEEEEECC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECC---------
T ss_pred             CeEEEEeccc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCC-CEEEeeccccccccc
Confidence            5578999999 56776554  3589999999999999999999999999999999999999776 899999999976532


Q ss_pred             CCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcccc
Q 013897          282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE  361 (434)
Q Consensus       282 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  361 (434)
                        .....+||+.|+|||++.+...++.++|||||||++|||++|+.|| .+.+..+++..+.+.+|.+....+..    .
T Consensus       185 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~l~~i~~~~g~p~~~~~~~----~  257 (367)
T 2fst_X          185 --EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAELLKK----I  257 (367)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCSCCHHHHTT----C
T ss_pred             --cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHHH----h
Confidence              3455689999999999887568999999999999999999999887 66777888889998888764332211    1


Q ss_pred             CChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccccc
Q 013897          362 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~  428 (434)
                      ...............+...+.  .....+++++.+||.+||+.||++|||++|+|+||||+....++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~  322 (367)
T 2fst_X          258 SSESARNYIQSLTQMPKMNFA--NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD  322 (367)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHH--HHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGG
T ss_pred             hhHHHHHHHhccCCCCCCCHH--HHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCC
Confidence            111122222211111111110  01123678999999999999999999999999999999876543

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.2e-48  Score=385.76  Aligned_cols=284  Identities=27%  Similarity=0.473  Sum_probs=210.4

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC----
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS----  203 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~----  203 (434)
                      .++|++++.||+|+||.||+|.+..+++.||||++...     ..+.+.+|+.+++.+ +||||+++++++.....    
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~  102 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEF  102 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSCCSTTTC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhc-CCCCccceEEeeccccccccc
Confidence            47899999999999999999999999999999998642     235678999999999 99999999999975432    


Q ss_pred             CccEEEEeecCCCchhhhcCCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC
Q 013897          204 KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~  283 (434)
                      ...++||||+.++.+..+...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus       103 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~a~~~~~~~  181 (371)
T 2xrw_A          103 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSF  181 (371)
T ss_dssp             CEEEEEEECCSEEHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECCCCC--------
T ss_pred             cceEEEEEcCCCCHHHHHhhccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC-CEEEEEeeccccccccc
Confidence            36789999999866565666799999999999999999999999999999999999999776 89999999998765544


Q ss_pred             ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                      .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.+..+++..+.+.++.+....+.     .+.
T Consensus       182 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~-----~~~  254 (371)
T 2xrw_A          182 MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLF-PGTDHIDQWNKVIEQLGTPCPEFMK-----KLQ  254 (371)
T ss_dssp             --------CTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHC-CCCCCHHHHT-----TSC
T ss_pred             ccCCceecCCccCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHH-----Hhh
Confidence            4556789999999999987 68999999999999999999999997 5566667777777766654322111     111


Q ss_pred             hhHHHHhcccCCCCCccc---c-------ccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccc
Q 013897          364 PHLAALVGRHSRKPWSKF---I-------TVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~---~-------~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                      +................+   .       ........++++.+||.+||+.||++|||++|+|+||||+...
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  326 (371)
T 2xrw_A          255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY  326 (371)
T ss_dssp             HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred             hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhc
Confidence            222222211111100000   0       0000112356899999999999999999999999999998654

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1e-48  Score=384.87  Aligned_cols=256  Identities=23%  Similarity=0.417  Sum_probs=196.8

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF  210 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  210 (434)
                      .++|++++.||+|+||.||+|.+..+++.||||++...  ..+.+.+|+.+++.+ +||||+++++++.+.  ...++||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~--~~~~lv~   95 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSL-RHPNIVRFKEVILTP--THLAIIM   95 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHC-CCTTBCCEEEEEECS--SEEEEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhC-CCCCCCcEEEEEeeC--CEEEEEE
Confidence            47899999999999999999999999999999999743  346788999999999 899999999999754  5678999


Q ss_pred             eecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCC-eEEEEecccceecCCCCccc
Q 013897          211 EHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR-KLRLIDWGLAEFYHPGKEYN  286 (434)
Q Consensus       211 e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~-~vkl~DFGla~~~~~~~~~~  286 (434)
                      ||+.+++|..++   ..+++..++.++.||+.||+|||++||+||||||+|||++.++. .+||+|||+++.........
T Consensus        96 e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~  175 (361)
T 3uc3_A           96 EYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK  175 (361)
T ss_dssp             ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC----------
T ss_pred             EeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCC
Confidence            999999987664   56999999999999999999999999999999999999986542 49999999997654444556


Q ss_pred             eeccCCcccccccccCCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChh
Q 013897          287 VRVASRYFKGPELLVDLQDYD-YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH  365 (434)
Q Consensus       287 ~~~~t~~y~aPE~~~~~~~~~-~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~  365 (434)
                      ..+||+.|+|||++.+ ..++ .++|||||||++|+|++|+.||............+.......                
T Consensus       176 ~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~----------------  238 (361)
T 3uc3_A          176 STVGTPAYIAPEVLLR-QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVK----------------  238 (361)
T ss_dssp             -----CTTSCHHHHHC-SSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTC----------------
T ss_pred             CCcCCCCcCChhhhcC-CCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCC----------------
Confidence            6789999999999987 4554 459999999999999999999854332221111111111100                


Q ss_pred             HHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccc
Q 013897          366 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI  424 (434)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~  424 (434)
                                      ........+++++.+||.+||+.||++|||+.|+|+||||.+.
T Consensus       239 ----------------~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  281 (361)
T 3uc3_A          239 ----------------YSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN  281 (361)
T ss_dssp             ----------------CCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred             ----------------CCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence                            0011122367899999999999999999999999999999654

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.4e-48  Score=393.45  Aligned_cols=254  Identities=26%  Similarity=0.446  Sum_probs=206.7

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      .++|++.+.||+|+||.||+|.+..+++.+|+|++....     .+.+.+|+.+++.+ +||||+++++++.+.  ...+
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~--~~~~   86 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL-KHPNIVRLHDSISEE--GHHY   86 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHC-CBTTBCCEEEEEECS--SEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCcCCCeEEEEEEEC--CEEE
Confidence            367999999999999999999999999999999986432     35688999999999 999999999999654  5778


Q ss_pred             EEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC--CCeEEEEecccceecCCC
Q 013897          208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--QRKLRLIDWGLAEFYHPG  282 (434)
Q Consensus       208 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~--~~~vkl~DFGla~~~~~~  282 (434)
                      +||||+.+++|...+   ..+++..+..++.||+.||.|||++||+||||||+|||++.+  +..+||+|||++......
T Consensus        87 lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~  166 (444)
T 3soa_A           87 LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE  166 (444)
T ss_dssp             EEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred             EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence            999999999986554   468999999999999999999999999999999999999842  347999999999776543


Q ss_pred             C-ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcccc
Q 013897          283 K-EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE  361 (434)
Q Consensus       283 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  361 (434)
                      . .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||. +.+..+.+..+.....             .
T Consensus       167 ~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyell~G~~Pf~-~~~~~~~~~~i~~~~~-------------~  231 (444)
T 3soa_A          167 QQAWFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFW-DEDQHRLYQQIKAGAY-------------D  231 (444)
T ss_dssp             CCBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSCC-CSSHHHHHHHHHHTCC-------------C
T ss_pred             CceeecccCCcccCCHHHhcC-CCCCCccccHHHHHHHHHHHhCCCCCC-CccHHHHHHHHHhCCC-------------C
Confidence            2 3355689999999999876 689999999999999999999999984 3333333333221000             0


Q ss_pred             CChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccc
Q 013897          362 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI  424 (434)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~  424 (434)
                      .                    .......+++++.+||.+||+.||++|||+.|+|+||||+..
T Consensus       232 ~--------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          232 F--------------------PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             C--------------------CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             C--------------------CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence            0                    001112467899999999999999999999999999999854

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.1e-48  Score=380.97  Aligned_cols=251  Identities=23%  Similarity=0.375  Sum_probs=211.1

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      .++|++++.||+|+||.||+|++..+++.||+|+++..      ..+.+.+|+.+++.+ +||||+++++++.+.  ..+
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~--~~~  116 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDN--SNL  116 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECS--SEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcC--CEE
Confidence            37899999999999999999999999999999998643      235678999999999 999999999999654  578


Q ss_pred             EEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC
Q 013897          207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~  283 (434)
                      ++||||+.+++|..++   ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..... 
T Consensus       117 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~~kL~DFg~a~~~~~~-  194 (350)
T 1rdq_E          117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG-YIQVTDFGFAKRVKGR-  194 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECSSC-
T ss_pred             EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCC-CEEEcccccceeccCC-
Confidence            8999999999987665   4689999999999999999999999999999999999999777 8999999999876432 


Q ss_pred             ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                       ....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.. .+..+....+...                  
T Consensus       195 -~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~------------------  253 (350)
T 1rdq_E          195 -TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSG------------------  253 (350)
T ss_dssp             -BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHC------------------
T ss_pred             -cccccCCccccCHHHhcC-CCCCCcCCEecccHhHhHHhhCCCCCCC-CCHHHHHHHHHcC------------------
Confidence             345689999999999887 6899999999999999999999999843 2322222222210                  


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCcc-----HHHHhcCCCcccccccc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT-----AKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt-----~~elL~Hp~~~~~~~~~  428 (434)
                               .          ...+..+++++.+||.+||+.||++||+     ++|+++||||+.+++..
T Consensus       254 ---------~----------~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~  304 (350)
T 1rdq_E          254 ---------K----------VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA  304 (350)
T ss_dssp             ---------C----------CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHH
T ss_pred             ---------C----------CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHHH
Confidence                     0          0011236789999999999999999998     99999999999887543

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=7.6e-49  Score=380.90  Aligned_cols=282  Identities=28%  Similarity=0.542  Sum_probs=211.8

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      .++|++++.||+|+||.||+|.+..+++.||||+++...     ...+.+|+.+++.+ +||||+++++++.+.  ...+
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~  109 (329)
T 3gbz_A           33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKEL-QHRNIIELKSVIHHN--HRLH  109 (329)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGC-CCTTBCCEEEEEEET--TEEE
T ss_pred             hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHc-CCCCcceEEEEEecC--CEEE
Confidence            368999999999999999999999999999999996433     24567999999999 999999999999754  5678


Q ss_pred             EEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC----CCeEEEEecccceecC
Q 013897          208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE----QRKLRLIDWGLAEFYH  280 (434)
Q Consensus       208 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~----~~~vkl~DFGla~~~~  280 (434)
                      +||||+.+ +|..++   ..+++..++.++.||+.||.|||++||+||||||+|||++.+    ...+||+|||+++...
T Consensus       110 lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~  188 (329)
T 3gbz_A          110 LIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG  188 (329)
T ss_dssp             EEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred             EEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence            99999996 555443   458999999999999999999999999999999999999532    2369999999997654


Q ss_pred             CC-CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcc
Q 013897          281 PG-KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH  359 (434)
Q Consensus       281 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  359 (434)
                      .. ......++|..|+|||++.+...++.++|||||||++|+|++|+.|| .+....+.+..+.+.++.+....+.....
T Consensus       189 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (329)
T 3gbz_A          189 IPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLF-PGDSEIDQLFKIFEVLGLPDDTTWPGVTA  267 (329)
T ss_dssp             -----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             CcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCc-CCCCHHHHHHHHHHHhCCCchhhhhhhhh
Confidence            32 33455678999999999987566899999999999999999999887 55666677777777766544332221100


Q ss_pred             ccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccc
Q 013897          360 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN  426 (434)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~  426 (434)
                      ..   .+..   ..... ............+++++.+||.+||+.||++|||++|+|+||||++++.
T Consensus       268 ~~---~~~~---~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  327 (329)
T 3gbz_A          268 LP---DWKQ---SFPKF-RGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF  327 (329)
T ss_dssp             ST---TCCT---TCCCC-CCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred             hh---hhhh---hhhhh-ccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence            00   0000   00000 0000001112236789999999999999999999999999999998865

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=7.7e-48  Score=380.06  Aligned_cols=289  Identities=31%  Similarity=0.570  Sum_probs=221.1

Q ss_pred             ccCCCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC
Q 013897          129 QWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS  203 (434)
Q Consensus       129 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  203 (434)
                      .+...++|.+.+.||+|+||.||+|.+..+++.||||++....     .+.+.+|+.+++.+ +||||+++++++.....
T Consensus        37 ~~~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  115 (371)
T 4exu_A           37 AWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASS  115 (371)
T ss_dssp             EEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSS
T ss_pred             eecccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhc-CCCCchhhhhheeccCC
Confidence            3344588999999999999999999999999999999996421     35678999999999 89999999999975433


Q ss_pred             C----ccEEEEeecCCCchhhhcCCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceec
Q 013897          204 K----TPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY  279 (434)
Q Consensus       204 ~----~~~lv~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~  279 (434)
                      .    ..++||||+.+.....+...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus       116 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~-~~kL~Dfg~a~~~  194 (371)
T 4exu_A          116 LRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC-ELKILDFGLARHA  194 (371)
T ss_dssp             STTCCCCEEEEECCCEEHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECSTTCC---
T ss_pred             cccceeEEEEEccccccHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCC-CEEEEecCccccc
Confidence            2    2389999999644344445699999999999999999999999999999999999999776 8999999999765


Q ss_pred             CCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcc
Q 013897          280 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH  359 (434)
Q Consensus       280 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  359 (434)
                      .  ......+||+.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+.+..+.+..... ....
T Consensus       195 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~-~~~~  270 (371)
T 4exu_A          195 D--AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF-KGKDYLDQLTQILKVTGVPGTEFV-QKLN  270 (371)
T ss_dssp             -------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCHHHH-TTCS
T ss_pred             c--cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCcHHHH-HHhh
Confidence            3  23345678999999999887568999999999999999999999997 566667777788777776543221 1111


Q ss_pred             ccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccccc
Q 013897          360 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~  428 (434)
                         +.................+.  .....+++++.+||.+||+.||++|||++|+|+||||+++...+
T Consensus       271 ---~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  334 (371)
T 4exu_A          271 ---DKAAKSYIQSLPQTPRKDFT--QLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPE  334 (371)
T ss_dssp             ---CHHHHHHHHHSCCCCCCCHH--HHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGG
T ss_pred             ---hhhhhhhhhccCCCcchhHH--HhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCcc
Confidence               11111111111111111111  11234678999999999999999999999999999999876554

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.1e-48  Score=382.85  Aligned_cols=257  Identities=26%  Similarity=0.386  Sum_probs=195.0

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEe
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE  211 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  211 (434)
                      .+.|++.+.||+|+||.||+|.+..+++.||||+++.. ..+.+.+|+.+++++ +||||+++++++.+.  ...++|||
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~~~~lv~e  128 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRL-SHPNIIKLKEIFETP--TEISLVLE  128 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHC-CCTTBCCEEEEEECS--SEEEEEEC
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhC-CCCCCcceeeeEecC--CeEEEEEE
Confidence            46799999999999999999999989999999999754 345688999999999 899999999999654  56789999


Q ss_pred             ecCCCchhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecC--CCCeEEEEecccceecCCCCccc
Q 013897          212 HVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--EQRKLRLIDWGLAEFYHPGKEYN  286 (434)
Q Consensus       212 ~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~--~~~~vkl~DFGla~~~~~~~~~~  286 (434)
                      |+.+++|..++.   .+++.+++.++.||+.||.|||++||+||||||+|||++.  ++..+||+|||+++.........
T Consensus       129 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~  208 (349)
T 2w4o_A          129 LVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK  208 (349)
T ss_dssp             CCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC------------
T ss_pred             eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccccc
Confidence            999999876653   4889999999999999999999999999999999999974  23489999999998765544455


Q ss_pred             eeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhH
Q 013897          287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL  366 (434)
Q Consensus       287 ~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~  366 (434)
                      ..+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........+..+.....             .     
T Consensus       209 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~-------------~-----  269 (349)
T 2w4o_A          209 TVCGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEY-------------Y-----  269 (349)
T ss_dssp             ----CGGGSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCC-------------C-----
T ss_pred             cccCCCCccCHHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCC-------------c-----
Confidence            6789999999999887 67999999999999999999999999654443323322211000             0     


Q ss_pred             HHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccc
Q 013897          367 AALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN  426 (434)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~  426 (434)
                                     ........+++++.+||.+||+.||++|||+.|+|+||||++...
T Consensus       270 ---------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  314 (349)
T 2w4o_A          270 ---------------FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAA  314 (349)
T ss_dssp             ---------------CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTC
T ss_pred             ---------------cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCcc
Confidence                           000011236789999999999999999999999999999997654

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.4e-48  Score=379.80  Aligned_cols=248  Identities=22%  Similarity=0.420  Sum_probs=204.9

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      .++|.+.+.||+|+||.||+|.+..+++.||||++...      ....+.+|+.+++.+ +||||+++++++.+.  ...
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~--~~~   84 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-RHPHIIKLYDVITTP--TDI   84 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTC-CCTTBCCEEEEEECS--SEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeC--CEE
Confidence            36899999999999999999999999999999998642      235688999999999 899999999999754  567


Q ss_pred             EEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC
Q 013897          207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~  283 (434)
                      ++||||++ +++...+   ..+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus        85 ~lv~E~~~-g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~-~~kl~DFG~s~~~~~~~  162 (336)
T 3h4j_B           85 VMVIEYAG-GELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNL-NVKIADFGLSNIMTDGN  162 (336)
T ss_dssp             EEEECCCC-EEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTC-CEEECCSSCTBTTTTSB
T ss_pred             EEEEECCC-CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCC-CEEEEEeccceeccCCc
Confidence            89999995 5554433   5699999999999999999999999999999999999999776 89999999998776666


Q ss_pred             ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                      .....+||+.|+|||++.+....+.++|||||||++|+|++|+.||...... .                          
T Consensus       163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-~--------------------------  215 (336)
T 3h4j_B          163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP-N--------------------------  215 (336)
T ss_dssp             TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST-T--------------------------
T ss_pred             ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH-H--------------------------
Confidence            6677889999999999987433478999999999999999999998321110 0                          


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP  423 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~  423 (434)
                           +......      .....+..+++++.+||.+||+.||.+|||++|+++||||+.
T Consensus       216 -----~~~~i~~------~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  264 (336)
T 3h4j_B          216 -----LFKKVNS------CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV  264 (336)
T ss_dssp             -----CBCCCCS------SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred             -----HHHHHHc------CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence                 0000000      001122347889999999999999999999999999999985

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=4.1e-48  Score=378.85  Aligned_cols=288  Identities=29%  Similarity=0.467  Sum_probs=218.5

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccC-----
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ-----  202 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~-----  202 (434)
                      .++|++++.||+|+||.||+|.+..+++.||||++....     ...+.+|+.+++.+ +||||+++++++....     
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~   94 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKASPYNR   94 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEEC------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhc-cCCCcccHhheeecccccccc
Confidence            478999999999999999999999999999999985432     35678999999999 8999999999997643     


Q ss_pred             -CCccEEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEeccccee
Q 013897          203 -SKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF  278 (434)
Q Consensus       203 -~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~  278 (434)
                       ...+++||||+.++.+..+.   ..+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus        95 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~a~~  173 (351)
T 3mi9_A           95 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG-VLKLADFGLARA  173 (351)
T ss_dssp             --CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEE
T ss_pred             CCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC-CEEEccchhccc
Confidence             34678999999975544443   4589999999999999999999999999999999999999777 899999999987


Q ss_pred             cCCC-----CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHH
Q 013897          279 YHPG-----KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA  353 (434)
Q Consensus       279 ~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~  353 (434)
                      ....     ......+||+.|+|||++.+...++.++|||||||++|+|++|+.|| .+....+.+..+.+..+......
T Consensus       174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~  252 (351)
T 3mi9_A          174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM-QGNTEQHQLALISQLCGSITPEV  252 (351)
T ss_dssp             CCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             ccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCChhh
Confidence            6422     22345678999999999887567899999999999999999999887 56666677777777766543322


Q ss_pred             HHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccccc
Q 013897          354 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~  428 (434)
                      +...........    ... .................++++.+||.+||+.||++|||++|+|+||||+....+.
T Consensus       253 ~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  322 (351)
T 3mi9_A          253 WPNVDNYELYEK----LEL-VKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS  322 (351)
T ss_dssp             STTGGGCGGGTS----SCC-CSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCC
T ss_pred             ccccccchhhcc----ccc-ccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCcc
Confidence            211100000000    000 0000000000000112367899999999999999999999999999998765443

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.8e-49  Score=391.11  Aligned_cols=259  Identities=26%  Similarity=0.404  Sum_probs=211.2

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      .++|++++.||+|+||+||+|+++.+++.||||+++...      ...+.+|+.++..+ +||||+++++++.+.  ..+
T Consensus        60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~~--~~~  136 (412)
T 2vd5_A           60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG-DRRWITQLHFAFQDE--NYL  136 (412)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHS-CTTTBCCEEEEEECS--SEE
T ss_pred             hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeeC--CEE
Confidence            578999999999999999999999999999999996422      23478999999998 999999999999654  578


Q ss_pred             EEEEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC
Q 013897          207 SLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG  282 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~  282 (434)
                      ++||||+.+++|..++    ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus       137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g-~vkL~DFGla~~~~~~  215 (412)
T 2vd5_A          137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCG-HIRLADFGSCLKLRAD  215 (412)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECCTT
T ss_pred             EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCC-CEEEeechhheeccCC
Confidence            8999999999987765    3689999999999999999999999999999999999999777 8999999999877544


Q ss_pred             Cc--cceeccCCcccccccccC------CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHH
Q 013897          283 KE--YNVRVASRYFKGPELLVD------LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAY  354 (434)
Q Consensus       283 ~~--~~~~~~t~~y~aPE~~~~------~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~  354 (434)
                      ..  ....+||+.|+|||++..      ...|+.++|||||||++|||++|+.||. +.+..+....+....        
T Consensus       216 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~-~~~~~~~~~~i~~~~--------  286 (412)
T 2vd5_A          216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFY-ADSTAETYGKIVHYK--------  286 (412)
T ss_dssp             SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHTHH--------
T ss_pred             CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCC-CCCHHHHHHHHHhcc--------
Confidence            33  234589999999999862      2468999999999999999999999984 333333333332100        


Q ss_pred             HhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCC---ccHHHHhcCCCccccccccc
Q 013897          355 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQER---PTAKEAMAHPYFFPIRNAES  429 (434)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~R---pt~~elL~Hp~~~~~~~~~~  429 (434)
                       ...  ..                     ......+++++.+||.+||. +|.+|   ++++|+++||||+++++...
T Consensus       287 -~~~--~~---------------------p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l  339 (412)
T 2vd5_A          287 -EHL--SL---------------------PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGL  339 (412)
T ss_dssp             -HHC--CC---------------------C----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTS
T ss_pred             -cCc--CC---------------------CccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence             000  00                     00012367899999999999 99998   59999999999999887654

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.4e-48  Score=389.00  Aligned_cols=257  Identities=25%  Similarity=0.411  Sum_probs=200.4

Q ss_pred             CCCeEEE-eeeeecCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeEeeEEEc--cCCCccEEE
Q 013897          133 QDDYEVV-RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRD--QQSKTPSLI  209 (434)
Q Consensus       133 ~~~y~~~-~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--~~~~~~~lv  209 (434)
                      .++|.+. +.||+|+||+||+|.+..+++.||||+++.  ...+.+|+.++.++.+||||+++++++..  ....++++|
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~--~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv  137 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV  137 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc--chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEE
Confidence            3678887 789999999999999999999999999964  35678999998777799999999998864  224568899


Q ss_pred             EeecCCCchhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC--CCeEEEEecccceecCCC
Q 013897          210 FEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--QRKLRLIDWGLAEFYHPG  282 (434)
Q Consensus       210 ~e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~--~~~vkl~DFGla~~~~~~  282 (434)
                      |||+.+++|..++.     .+++..++.++.||+.||+|||++||+||||||+|||++.+  +..+||+|||+++.....
T Consensus       138 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~  217 (400)
T 1nxk_A          138 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH  217 (400)
T ss_dssp             EECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--
T ss_pred             EEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCC
Confidence            99999999877653     38999999999999999999999999999999999999862  348999999999877655


Q ss_pred             CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCH---HHHHHHHHHhCChhHHHHHhhcc
Q 013897          283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNY---DQLVKIAKVLGTDELNAYLNKYH  359 (434)
Q Consensus       283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~---~~~~~i~~~~g~~~~~~~~~~~~  359 (434)
                      ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.......   .....+..  +         .  
T Consensus       218 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~--~---------~--  283 (400)
T 1nxk_A          218 NSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM--G---------Q--  283 (400)
T ss_dssp             ---------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH--T---------C--
T ss_pred             CccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc--C---------c--
Confidence            55667789999999999876 789999999999999999999999995433211   01111100  0         0  


Q ss_pred             ccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccc
Q 013897          360 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                                    ...      .......+++++.+||.+||+.||++|||+.|+|+||||.+..
T Consensus       284 --------------~~~------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  329 (400)
T 1nxk_A          284 --------------YEF------PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  329 (400)
T ss_dssp             --------------CCC------CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred             --------------ccC------CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence                          000      0011124678999999999999999999999999999998543

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=4.6e-48  Score=373.94  Aligned_cols=257  Identities=26%  Similarity=0.472  Sum_probs=213.1

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc---------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS  203 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~---------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  203 (434)
                      .++|++.+.||+|+||.||+|.+..+++.||+|+++..         ..+.+.+|+.+++.+ +||||+++++++.+.  
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--   87 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV-LHHNVITLHDVYENR--   87 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECS--
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhC-CCCCcceEEEEEecC--
Confidence            36799999999999999999999999999999998642         246789999999999 899999999999654  


Q ss_pred             CccEEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCC---eEEEEecccce
Q 013897          204 KTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR---KLRLIDWGLAE  277 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~---~vkl~DFGla~  277 (434)
                      ...++||||+.+++|..++   ..+++..+..++.||+.||+|||++||+||||||+|||++.++.   .+||+|||++.
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~  167 (321)
T 2a2a_A           88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (321)
T ss_dssp             SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence            5678999999999997765   34789999999999999999999999999999999999986653   69999999998


Q ss_pred             ecCCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhh
Q 013897          278 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK  357 (434)
Q Consensus       278 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  357 (434)
                      ............|++.|+|||++.+ ..++.++|||||||++|+|++|+.||. +....+.+..+....           
T Consensus       168 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~-~~~~~~~~~~i~~~~-----------  234 (321)
T 2a2a_A          168 EIEDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANITSVS-----------  234 (321)
T ss_dssp             ECCTTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSC-CSSHHHHHHHHHTTC-----------
T ss_pred             ecCccccccccCCCCCccCcccccC-CCCCCccccHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHhcc-----------
Confidence            8766555566789999999999876 689999999999999999999999984 333333333222110           


Q ss_pred             ccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccccc
Q 013897          358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA  427 (434)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~  427 (434)
                        ...++.                    ....+++.+.+||.+||..||++|||+.|+|+||||++++..
T Consensus       235 --~~~~~~--------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~~  282 (321)
T 2a2a_A          235 --YDFDEE--------------------FFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQ  282 (321)
T ss_dssp             --CCCCHH--------------------HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSHH
T ss_pred             --cccChh--------------------hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCcc
Confidence              000100                    112367789999999999999999999999999999987643

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=3.9e-48  Score=384.45  Aligned_cols=290  Identities=19%  Similarity=0.240  Sum_probs=206.5

Q ss_pred             CCCCeEEEeeeeec--CceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCC
Q 013897          132 EQDDYEVVRKVGRG--KYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK  204 (434)
Q Consensus       132 ~~~~y~~~~~lG~G--~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  204 (434)
                      ..++|++++.||+|  +||.||+|++..+++.||||+++...     .+.+.+|+.+++.+ +|||||++++++.+.  .
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~   99 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF-NHPNIVPYRATFIAD--N   99 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEET--T
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCCCcEeEEEEEC--C
Confidence            35789999999999  99999999999999999999996432     35678899999999 899999999999754  5


Q ss_pred             ccEEEEeecCCCchhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceec
Q 013897          205 TPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY  279 (434)
Q Consensus       205 ~~~lv~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~  279 (434)
                      .+++||||+.+++|..++     ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||.+...
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~-~~kl~dfg~~~~~  178 (389)
T 3gni_B          100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG-KVYLSGLRSNLSM  178 (389)
T ss_dssp             EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCGGGCEEC
T ss_pred             EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEcccccceee
Confidence            678999999999987765     4589999999999999999999999999999999999999777 8999999998654


Q ss_pred             CCCC--------ccceeccCCcccccccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHH-hC--
Q 013897          280 HPGK--------EYNVRVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV-LG--  347 (434)
Q Consensus       280 ~~~~--------~~~~~~~t~~y~aPE~~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~-~g--  347 (434)
                      ....        .....+||..|+|||++.+. ..++.++|||||||++|||++|+.||... +....+..+... ..  
T Consensus       179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~-~~~~~~~~~~~~~~~~~  257 (389)
T 3gni_B          179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM-PATQMLLEKLNGTVPCL  257 (389)
T ss_dssp             EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTC-CSTTHHHHC--------
T ss_pred             ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHhcCCCCcc
Confidence            2211        12334788999999998763 47899999999999999999999998543 333333221110 00  


Q ss_pred             --ChhHHH--HH-hhccccCChhHHHHh-cccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          348 --TDELNA--YL-NKYHIELDPHLAALV-GRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       348 --~~~~~~--~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                        ......  .. ............... ....+..............+++++.+||.+||+.||++|||++|+|+||||
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f  337 (389)
T 3gni_B          258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF  337 (389)
T ss_dssp             ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGG
T ss_pred             ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHH
Confidence              000000  00 000000000000000 000000000111112234578899999999999999999999999999999


Q ss_pred             ccccc
Q 013897          422 FPIRN  426 (434)
Q Consensus       422 ~~~~~  426 (434)
                      +.+..
T Consensus       338 ~~~~~  342 (389)
T 3gni_B          338 KQIKR  342 (389)
T ss_dssp             GGC--
T ss_pred             HHHhh
Confidence            98764

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.1e-48  Score=390.58  Aligned_cols=288  Identities=25%  Similarity=0.496  Sum_probs=206.9

Q ss_pred             CCeEE-EeeeeecCceEEEEEEEc--CCCeEEEEEEecccc-HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          134 DDYEV-VRKVGRGKYSEVFEGVHC--TDNEKCIIKILKPVK-KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       134 ~~y~~-~~~lG~G~fg~Vy~~~~~--~~~~~vaiK~~~~~~-~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      +.|++ .++||+|+||.||+|.++  .+++.||||+++... ...+.+|+.+|+.+ +||||+++++++.......+++|
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~lv   98 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLREL-KHPNVISLQKVFLSHADRKVWLL   98 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHC-CCTTBCCCCEEEEETTTTEEEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhc-CCCCeeeEeeEEecCCCCeEEEE
Confidence            45776 457999999999999976  468899999997543 45788999999999 89999999999987667788999


Q ss_pred             EeecCCCchhhhc-----------CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEe----cCCCCeEEEEecc
Q 013897          210 FEHVNNTDFKVLY-----------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI----DHEQRKLRLIDWG  274 (434)
Q Consensus       210 ~e~~~~~~l~~~~-----------~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll----~~~~~~vkl~DFG  274 (434)
                      |||+.++.+..+.           ..+++..++.++.||+.||+|||++||+||||||+|||+    +.++ .+||+|||
T Consensus        99 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~-~~kl~Dfg  177 (405)
T 3rgf_A           99 FDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERG-RVKIADMG  177 (405)
T ss_dssp             EECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTT-CEEECCTT
T ss_pred             EeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCC-cEEEEECC
Confidence            9999875443322           138999999999999999999999999999999999999    4344 89999999


Q ss_pred             cceecCCC----CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCC--------CHHHHHHH
Q 013897          275 LAEFYHPG----KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD--------NYDQLVKI  342 (434)
Q Consensus       275 la~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~--------~~~~~~~i  342 (434)
                      +|+.....    ......+||+.|+|||++.+...++.++|||||||++|+|++|+.||.....        ..+++..+
T Consensus       178 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i  257 (405)
T 3rgf_A          178 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI  257 (405)
T ss_dssp             CCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHH
T ss_pred             CceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHH
Confidence            99866432    2234568899999999998756699999999999999999999999854332        25778888


Q ss_pred             HHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccc--cc--cccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          343 AKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKF--IT--VENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       343 ~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~--~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                      ...+|.+....|.......   ..........+..+...  ..  .......++.+.+||.+||+.||++|||++|+|+|
T Consensus       258 ~~~~g~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h  334 (405)
T 3rgf_A          258 FNVMGFPADKDWEDIKKMP---EHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD  334 (405)
T ss_dssp             HHHHCCCCTTTCGGGGGST---THHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHhhCCCChhhcchhhcCc---chhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            8888876544433221111   11111111111100000  00  00112246789999999999999999999999999


Q ss_pred             CCcccccc
Q 013897          419 PYFFPIRN  426 (434)
Q Consensus       419 p~~~~~~~  426 (434)
                      |||+....
T Consensus       335 p~f~~~~~  342 (405)
T 3rgf_A          335 PYFLEDPL  342 (405)
T ss_dssp             GGGTSSSC
T ss_pred             hhhccCCC
Confidence            99997653

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3.9e-48  Score=375.56  Aligned_cols=257  Identities=23%  Similarity=0.399  Sum_probs=207.2

Q ss_pred             CCeEEE-eeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          134 DDYEVV-RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       134 ~~y~~~-~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      +.|.+. +.||+|+||.||+|.+..+++.||+|+++..     ....+.+|+.+++.+.+||||+++++++.+.  ...+
T Consensus        28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~--~~~~  105 (327)
T 3lm5_A           28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT--SEII  105 (327)
T ss_dssp             HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEEE
T ss_pred             hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC--CeEE
Confidence            568887 8999999999999999999999999998643     2467899999999997889999999999654  5678


Q ss_pred             EEEeecCCCchhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecC--CCCeEEEEecccceecC
Q 013897          208 LIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--EQRKLRLIDWGLAEFYH  280 (434)
Q Consensus       208 lv~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~--~~~~vkl~DFGla~~~~  280 (434)
                      +||||+.+++|..++     ..+++..++.++.||+.||+|||++||+||||||+|||++.  +.+.+||+|||+++...
T Consensus       106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~  185 (327)
T 3lm5_A          106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG  185 (327)
T ss_dssp             EEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-
T ss_pred             EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccC
Confidence            999999999987775     35899999999999999999999999999999999999986  13389999999998876


Q ss_pred             CCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccc
Q 013897          281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI  360 (434)
Q Consensus       281 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  360 (434)
                      ........+|++.|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+....+.......           
T Consensus       186 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~i~~~~~~~-----------  252 (327)
T 3lm5_A          186 HACELREIMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTSPFV-GEDNQETYLNISQVNVDY-----------  252 (327)
T ss_dssp             --------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHTCCCC-----------
T ss_pred             CccccccccCCcCccCCeeecC-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCchHHHHHHHhccccc-----------
Confidence            5555566789999999999876 689999999999999999999999983 333333333322211000           


Q ss_pred             cCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccccc
Q 013897          361 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA  427 (434)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~  427 (434)
                                            .......+++.+.+||.+||+.||++|||++|+|+||||++++..
T Consensus       253 ----------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~  297 (327)
T 3lm5_A          253 ----------------------SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFE  297 (327)
T ss_dssp             ----------------------CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTT
T ss_pred             ----------------------CchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccc
Confidence                                  011112467889999999999999999999999999999987654

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.7e-48  Score=377.81  Aligned_cols=261  Identities=27%  Similarity=0.432  Sum_probs=190.2

Q ss_pred             CCeEEE---eeeeecCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEE
Q 013897          134 DDYEVV---RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF  210 (434)
Q Consensus       134 ~~y~~~---~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  210 (434)
                      ++|++.   +.||+|+||.||+|.+..+++.||||++.......+.+|+.+++.+.+||||+++++++.+.  ...++||
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~--~~~~lv~   85 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQ--LHTFLVM   85 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEEEEEE
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcC--CEEEEEE
Confidence            456664   78999999999999999999999999998877788999999999996699999999999654  5678999


Q ss_pred             eecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCC--eEEEEecccceecCCC-Cc
Q 013897          211 EHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAEFYHPG-KE  284 (434)
Q Consensus       211 e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~--~vkl~DFGla~~~~~~-~~  284 (434)
                      ||+.+++|..++   ..+++.+++.++.||+.||+|||++||+||||||+|||++.++.  .+||+|||+++..... ..
T Consensus        86 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~  165 (325)
T 3kn6_A           86 ELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP  165 (325)
T ss_dssp             CCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred             EccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc
Confidence            999999987665   45899999999999999999999999999999999999975442  7999999999866443 23


Q ss_pred             cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHH--HHHHHHHHhCChhHHHHHhhccccC
Q 013897          285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYD--QLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~--~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                      ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........  ....+.+...         ......
T Consensus       166 ~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~---------~~~~~~  235 (325)
T 3kn6_A          166 LKTPCFTLHYAAPELLNQ-NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIK---------KGDFSF  235 (325)
T ss_dssp             -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHT---------TTCCCC
T ss_pred             ccccCCCcCccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHH---------cCCCCC
Confidence            456678999999999876 6899999999999999999999999843221100  0000000000         000000


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN  426 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~  426 (434)
                                          .......+++++.+||.+||+.||++|||++|+|+||||+....
T Consensus       236 --------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~  279 (325)
T 3kn6_A          236 --------------------EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ  279 (325)
T ss_dssp             --------------------CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred             --------------------CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCcc
Confidence                                00111236789999999999999999999999999999997643

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=3.1e-48  Score=375.71  Aligned_cols=249  Identities=21%  Similarity=0.386  Sum_probs=198.4

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecc----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC------
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS------  203 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~------  203 (434)
                      ++|++++.||+|+||.||+|++..+++.||||+++.    ...+.+.+|+.+|+++ +||||+++++++.+...      
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSC-CCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhC-CCCCEeeEEEEEEEeccchhhhh
Confidence            579999999999999999999998999999999863    2346789999999999 89999999999865432      


Q ss_pred             -------------------------------------------------CccEEEEeecCCCchhhhcCC------CChH
Q 013897          204 -------------------------------------------------KTPSLIFEHVNNTDFKVLYPT------LSDY  228 (434)
Q Consensus       204 -------------------------------------------------~~~~lv~e~~~~~~l~~~~~~------l~~~  228 (434)
                                                                       .+.++||||+.+++|..++..      ..+.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                             237899999999999877632      4555


Q ss_pred             HHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC-------------ccceeccCCccc
Q 013897          229 DVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-------------EYNVRVASRYFK  295 (434)
Q Consensus       229 ~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~-------------~~~~~~~t~~y~  295 (434)
                      .+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++......             .....+||+.|+
T Consensus       165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~  243 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD-VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM  243 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred             HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCC-CEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence            6889999999999999999999999999999999776 89999999998765432             223457999999


Q ss_pred             ccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCC
Q 013897          296 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSR  375 (434)
Q Consensus       296 aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  375 (434)
                      |||++.+ ..++.++|||||||++|||++|..|+      ......+......            ..+..          
T Consensus       244 aPE~~~~-~~~~~~~Di~slG~il~el~~~~~~~------~~~~~~~~~~~~~------------~~~~~----------  294 (332)
T 3qd2_B          244 SPEQIHG-NNYSHKVDIFSLGLILFELLYSFSTQ------MERVRIITDVRNL------------KFPLL----------  294 (332)
T ss_dssp             CHHHHHC-CCCCTHHHHHHHHHHHHHHHSCCCCH------HHHHHHHHHHHTT------------CCCHH----------
T ss_pred             ChHHhcC-CCCcchhhHHHHHHHHHHHHHcCCCh------hHHHHHHHHhhcc------------CCCcc----------
Confidence            9999987 68999999999999999999987664      1111111110000            00000          


Q ss_pred             CCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccc
Q 013897          376 KPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI  424 (434)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~  424 (434)
                                 ....++++.+||.+||+.||++|||++|+|+||||+++
T Consensus       295 -----------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~  332 (332)
T 3qd2_B          295 -----------FTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL  332 (332)
T ss_dssp             -----------HHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred             -----------cccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence                       01134678999999999999999999999999999875

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=7.9e-49  Score=382.83  Aligned_cols=259  Identities=28%  Similarity=0.461  Sum_probs=208.4

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEee
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH  212 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  212 (434)
                      .++|++.+.||+|+||.||+|.++.+++.||||+++... ....+|++++.++.+||||+++++++.+  ...+++||||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~E~   97 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-RDPTEEIEILLRYGQHPNIITLKDVYDD--GKYVYVVTEL   97 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT-CCCHHHHHHHHHHTTSTTBCCEEEEEEC--SSEEEEEECC
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc-CChHHHHHHHHHhcCCCCcCeEEEEEEc--CCEEEEEEeC
Confidence            367999999999999999999999999999999996543 3456799999998789999999999965  4678899999


Q ss_pred             cCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCC---eEEEEecccceecCCC-Ccc
Q 013897          213 VNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR---KLRLIDWGLAEFYHPG-KEY  285 (434)
Q Consensus       213 ~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~---~vkl~DFGla~~~~~~-~~~  285 (434)
                      +.+++|...+   ..+++.+++.++.||+.||+|||++||+||||||+|||+..+++   .+||+|||+++..... ...
T Consensus        98 ~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~  177 (342)
T 2qr7_A           98 MKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL  177 (342)
T ss_dssp             CCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCB
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCce
Confidence            9999986654   35899999999999999999999999999999999999854432   4999999999876543 334


Q ss_pred             ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCC-CHH-HHHHHHHHhCChhHHHHHhhccccCC
Q 013897          286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD-NYD-QLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       286 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~-~~~-~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                      ...+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||..... ... .+..+..  +           .... 
T Consensus       178 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~--~-----------~~~~-  242 (342)
T 2qr7_A          178 MTPCYTANFVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGS--G-----------KFSL-  242 (342)
T ss_dssp             CCSSCCSSCCCHHHHHH-HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHH--C-----------CCCC-
T ss_pred             eccCCCccccCHHHhcC-CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHcc--C-----------Cccc-
Confidence            56688999999999876 5688999999999999999999999964322 111 1212111  0           0000 


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccccc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~  428 (434)
                                         .......+++++.+||.+||..||++|||+.|+|+||||..++...
T Consensus       243 -------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~~~  288 (342)
T 2qr7_A          243 -------------------SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLP  288 (342)
T ss_dssp             -------------------CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGGGSC
T ss_pred             -------------------CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCccccc
Confidence                               0011124678999999999999999999999999999998765443

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=6.1e-48  Score=374.29  Aligned_cols=252  Identities=27%  Similarity=0.452  Sum_probs=200.3

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEc---CCCeEEEEEEeccc-------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHC---TDNEKCIIKILKPV-------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ  202 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~---~~~~~vaiK~~~~~-------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  202 (434)
                      .++|++.+.||+|+||.||+|++.   .+++.||+|+++..       ....+.+|+.+|+.+ +||||+++++++.+. 
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~-   93 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV-KHPFIVDLIYAFQTG-   93 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHC-CCTTBCCEEEEEECS-
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhC-CCCCccceeEEEEcC-
Confidence            368999999999999999999985   57899999998753       234577899999999 899999999999654 


Q ss_pred             CCccEEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceec
Q 013897          203 SKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY  279 (434)
Q Consensus       203 ~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~  279 (434)
                       ..+++||||+.+++|..++   ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus        94 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~~~~~  171 (327)
T 3a62_A           94 -GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQG-HVKLTDFGLCKES  171 (327)
T ss_dssp             -SCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTS-CEEECCCSCC---
T ss_pred             -CEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCC-cEEEEeCCccccc
Confidence             5678999999999987665   4588999999999999999999999999999999999999776 8999999999754


Q ss_pred             CCC-CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhc
Q 013897          280 HPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY  358 (434)
Q Consensus       280 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  358 (434)
                      ... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+....+..+...             
T Consensus       172 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~-~~~~~~~~~~i~~~-------------  236 (327)
T 3a62_A          172 IHDGTVTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFT-GENRKKTIDKILKC-------------  236 (327)
T ss_dssp             -------CTTSSCCTTSCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCC-CSSHHHHHHHHHHT-------------
T ss_pred             ccCCccccccCCCcCccCHhhCcC-CCCCCcccchhHHHHHHHHHHCCCCCC-CCCHHHHHHHHHhC-------------
Confidence            322 23345679999999999877 678999999999999999999999984 33333333222210             


Q ss_pred             cccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCc-----cHHHHhcCCCccccccc
Q 013897          359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-----TAKEAMAHPYFFPIRNA  427 (434)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rp-----t~~elL~Hp~~~~~~~~  427 (434)
                      .                        ...+..+++++.+||.+||+.||++||     +++|+|+||||+.+++.
T Consensus       237 ~------------------------~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~  286 (327)
T 3a62_A          237 K------------------------LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWE  286 (327)
T ss_dssp             C------------------------CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHH
T ss_pred             C------------------------CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHH
Confidence            0                        001123678999999999999999999     89999999999988643

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.1e-47  Score=375.94  Aligned_cols=284  Identities=28%  Similarity=0.517  Sum_probs=223.1

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccC---CCc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ---SKT  205 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---~~~  205 (434)
                      .++|++++.||+|+||.||+|.+..+++.||||++....    ...+.+|+.+++.+ +||||+++++++....   ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTTCCC
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhc-CCCCCccceeEEecCCccccce
Confidence            478999999999999999999999999999999997432    35678999999999 8999999999996542   246


Q ss_pred             cEEEEeecCCCchhhhc--CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC
Q 013897          206 PSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~  283 (434)
                      .++||||+.+ +|..++  ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus       105 ~~iv~e~~~~-~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~~~~  182 (364)
T 3qyz_A          105 VYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDH  182 (364)
T ss_dssp             EEEEEECCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECCGGG
T ss_pred             EEEEEcccCc-CHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCC-CEEEEeCcceEecCCCC
Confidence            7899999996 554443  4689999999999999999999999999999999999999776 89999999998764332


Q ss_pred             c----cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcc
Q 013897          284 E----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH  359 (434)
Q Consensus       284 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  359 (434)
                      .    ....+||+.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+...++.+....+...  
T Consensus       183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~--  259 (364)
T 3qyz_A          183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF-PGKHYLDQLNHILGILGSPSQEDLNCI--  259 (364)
T ss_dssp             CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSS-CCSSGGGHHHHHHHHHCSCCHHHHHTC--
T ss_pred             CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCC-CCCChHHHHHHHHHHhCCCCHHHHHHh--
Confidence            2    244589999999999876567999999999999999999999887 666777888888888887654433211  


Q ss_pred             ccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccc
Q 013897          360 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN  426 (434)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~  426 (434)
                        ...................+  ......+++++.+||.+||+.||++|||++|+|+||||++...
T Consensus       260 --~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~  322 (364)
T 3qyz_A          260 --INLKARNYLLSLPHKNKVPW--NRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD  322 (364)
T ss_dssp             --CCHHHHHHHHTSCCCCCCCH--HHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred             --hhhhHHHHHHhcCCccCCCH--HHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccC
Confidence              11111111111111000000  1112346789999999999999999999999999999997643

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=3.1e-48  Score=381.24  Aligned_cols=286  Identities=27%  Similarity=0.471  Sum_probs=213.8

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc--------------HHHHHHHHHHHHHhcCCCCeeeEeeEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--------------KKKIKREIKILQNLCGGPNIVKLLDIV  198 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~--------------~~~~~~E~~~l~~l~~h~niv~l~~~~  198 (434)
                      .++|.+.+.||+|+||.||+|.+. ++..||||++....              .+.+.+|+.+++.+ +||||+++++++
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~   98 (362)
T 3pg1_A           21 QSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF-HHPNILGLRDIF   98 (362)
T ss_dssp             TCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEE
T ss_pred             ccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhC-CCcCccceeeeE
Confidence            578999999999999999999874 58999999985321              26789999999999 899999999998


Q ss_pred             Ecc---CCCccEEEEeecCCCchhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEe
Q 013897          199 RDQ---QSKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLID  272 (434)
Q Consensus       199 ~~~---~~~~~~lv~e~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~D  272 (434)
                      ...   .....++||||+.++.+..+..   .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus        99 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~-~~kl~D  177 (362)
T 3pg1_A           99 VHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNN-DITICD  177 (362)
T ss_dssp             EECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECC
T ss_pred             EeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCC-CEEEEe
Confidence            653   3346789999999655444432   489999999999999999999999999999999999999776 899999


Q ss_pred             cccceecCCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHH
Q 013897          273 WGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELN  352 (434)
Q Consensus       273 FGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~  352 (434)
                      ||++.............+++.|+|||++.+...++.++|||||||++|+|++|+.|| .+....+.+..+.+..+.+...
T Consensus       178 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~  256 (362)
T 3pg1_A          178 FNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF-RGSTFYNQLNKIVEVVGTPKIE  256 (362)
T ss_dssp             TTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCHH
T ss_pred             cCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHcCCCChH
Confidence            999986655555566789999999999887567999999999999999999999997 5566677788888888776554


Q ss_pred             HHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccccc
Q 013897          353 AYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA  427 (434)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~  427 (434)
                      .....    ..+.............. ..........+++.+.+||.+||+.||++|||+.|+|+||||+.+...
T Consensus       257 ~~~~~----~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  326 (362)
T 3pg1_A          257 DVVMF----SSPSARDYLRNSLSNVP-ARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDP  326 (362)
T ss_dssp             HHHHT----SCHHHHHHTTTCCCCCC-CCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred             Hhhhc----cchhhhHHHHhhcccCC-hhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCc
Confidence            43321    11112221111111000 000011223467889999999999999999999999999999987544

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=3.5e-48  Score=399.28  Aligned_cols=255  Identities=24%  Similarity=0.403  Sum_probs=213.5

Q ss_pred             CCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCc
Q 013897          132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT  205 (434)
Q Consensus       132 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  205 (434)
                      ..++|++.+.||+|+||.||+|.++.+++.||+|++...      ....+.+|+.+|+.+ +||||+++++++.+.  ..
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~--~~  258 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYETK--DA  258 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEECS--SE
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHc-CCCCEeeEEEEEeeC--CE
Confidence            457899999999999999999999999999999998642      235578999999999 999999999999654  57


Q ss_pred             cEEEEeecCCCchhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecC
Q 013897          206 PSLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH  280 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~  280 (434)
                      +++||||+.+++|..++.     .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+...
T Consensus       259 l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g-~vKL~DFGla~~~~  337 (576)
T 2acx_A          259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHG-HIRISDLGLAVHVP  337 (576)
T ss_dssp             EEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCTTCEECC
T ss_pred             EEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCC-CeEEEecccceecc
Confidence            889999999999976642     389999999999999999999999999999999999999777 89999999998876


Q ss_pred             CCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCC--CHHHHHHHHHHhCChhHHHHHhhc
Q 013897          281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD--NYDQLVKIAKVLGTDELNAYLNKY  358 (434)
Q Consensus       281 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~--~~~~~~~i~~~~g~~~~~~~~~~~  358 (434)
                      ........+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.....  ....+.......            
T Consensus       338 ~~~~~~~~~GT~~Y~APEvl~~-~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~------------  404 (576)
T 2acx_A          338 EGQTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV------------  404 (576)
T ss_dssp             TTCCEECCCSCGGGCCHHHHTT-CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC------------
T ss_pred             cCccccccCCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc------------
Confidence            6655566799999999999887 6799999999999999999999999954322  112221111000            


Q ss_pred             cccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCc-----cHHHHhcCCCccccccc
Q 013897          359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-----TAKEAMAHPYFFPIRNA  427 (434)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rp-----t~~elL~Hp~~~~~~~~  427 (434)
                                      .        ......+++++.+||.+||+.||.+||     +++|+++||||+++++.
T Consensus       405 ----------------~--------~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~  454 (576)
T 2acx_A          405 ----------------P--------EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFK  454 (576)
T ss_dssp             ----------------C--------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHH
T ss_pred             ----------------c--------ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHH
Confidence                            0        001124678999999999999999999     89999999999987643

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.2e-47  Score=364.00  Aligned_cols=259  Identities=27%  Similarity=0.460  Sum_probs=212.2

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....     .+.+.+|+.+++++ +||||+++++++.+.  ...+
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~   81 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEE--SFHY   81 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECS--SEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEcC--CEEE
Confidence            478999999999999999999999999999999986432     35678999999999 899999999999654  5678


Q ss_pred             EEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCC--CeEEEEecccceecCCC
Q 013897          208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ--RKLRLIDWGLAEFYHPG  282 (434)
Q Consensus       208 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~--~~vkl~DFGla~~~~~~  282 (434)
                      +||||+.++++...+   ..+++..+..++.||+.||.|||++||+||||||+|||++.++  ..+||+|||++......
T Consensus        82 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  161 (284)
T 3kk8_A           82 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS  161 (284)
T ss_dssp             EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence            999999999885553   4589999999999999999999999999999999999997554  24999999999877665


Q ss_pred             CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                      .......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.. .........+.....               
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~~~~~~~~~~~---------------  224 (284)
T 3kk8_A          162 EAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYAQIKAGAY---------------  224 (284)
T ss_dssp             CBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCC---------------
T ss_pred             ccccCCCCCcCCcCchhhcC-CCCCcccchHHHHHHHHHHHHCCCCCCC-CchhHHHHHHHhccc---------------
Confidence            55566789999999999877 6789999999999999999999999843 222222222211000               


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccccccc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAES  429 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~~  429 (434)
                                  ..      .......+++++.+||.+||+.||++|||++|+|+||||++.+....
T Consensus       225 ------------~~------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~  273 (284)
T 3kk8_A          225 ------------DY------PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVAS  273 (284)
T ss_dssp             ------------CC------CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGGG
T ss_pred             ------------cC------CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHHh
Confidence                        00      00111246789999999999999999999999999999998765543

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=3.8e-48  Score=388.33  Aligned_cols=257  Identities=25%  Similarity=0.437  Sum_probs=199.6

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc-----------HHHHHHHHHHHHHhcCCCCeeeEeeEEEcc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------KKKIKREIKILQNLCGGPNIVKLLDIVRDQ  201 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  201 (434)
                      .++|.+.+.||+|+||.||+|.+..+++.||||++....           ...+.+|+.+|+++ +||||+++++++.. 
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~-  211 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFDA-  211 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHC-CCTTBCCCCEEEES-
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhC-CCCCEeeEEEEEec-
Confidence            478999999999999999999999999999999986432           12478999999999 99999999999854 


Q ss_pred             CCCccEEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCC--CeEEEEecccc
Q 013897          202 QSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ--RKLRLIDWGLA  276 (434)
Q Consensus       202 ~~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~--~~vkl~DFGla  276 (434)
                        ...++||||+.+++|...+   ..+++..++.++.||+.||+|||++||+||||||+|||++.++  ..+||+|||+|
T Consensus       212 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a  289 (419)
T 3i6u_A          212 --EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS  289 (419)
T ss_dssp             --SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred             --CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence              3468999999999987665   3589999999999999999999999999999999999997543  25999999999


Q ss_pred             eecCCCCccceeccCCcccccccccC--CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHH
Q 013897          277 EFYHPGKEYNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAY  354 (434)
Q Consensus       277 ~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~  354 (434)
                      +...........+||+.|+|||++.+  ...++.++|||||||++|+|++|+.||............+..  +       
T Consensus       290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~--~-------  360 (419)
T 3i6u_A          290 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS--G-------  360 (419)
T ss_dssp             TSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHT--T-------
T ss_pred             eecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhc--C-------
Confidence            87765555566789999999999853  356889999999999999999999998543322222211111  0       


Q ss_pred             HhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccc
Q 013897          355 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN  426 (434)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~  426 (434)
                          .....+                    .....+++.+.+||.+||+.||++|||++|+|+||||+..+.
T Consensus       361 ----~~~~~~--------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~  408 (419)
T 3i6u_A          361 ----KYNFIP--------------------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDM  408 (419)
T ss_dssp             ----CCCCCH--------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHHH
T ss_pred             ----CCCCCc--------------------hhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChhH
Confidence                000000                    011236789999999999999999999999999999987643

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=9.1e-48  Score=365.63  Aligned_cols=250  Identities=24%  Similarity=0.445  Sum_probs=199.1

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      ++|.+.+.||+|+||.||+|.+..++..+|+|++...    ..+.+.+|+.+++.+ +||||+++++++.+.  ...++|
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~--~~~~lv   98 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL-DHPNIIKIFEVFEDY--HNMYIV   98 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECS--SEEEEE
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhC-CCchHHhHHHheecC--CeEEEE
Confidence            6799999999999999999999999999999998643    347789999999999 999999999999653  567899


Q ss_pred             EeecCCCchhhhc-------CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC--CCeEEEEecccceecC
Q 013897          210 FEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--QRKLRLIDWGLAEFYH  280 (434)
Q Consensus       210 ~e~~~~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~--~~~vkl~DFGla~~~~  280 (434)
                      |||+.+++|...+       ..+++..+..++.||+.||+|||++||+||||||+|||++.+  ...+||+|||++....
T Consensus        99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A           99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            9999999886654       568999999999999999999999999999999999999532  2379999999998766


Q ss_pred             CCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccc
Q 013897          281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI  360 (434)
Q Consensus       281 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  360 (434)
                      .........|++.|+|||++.  ..++.++|||||||++|+|++|+.||.. ....+....+.. ..             
T Consensus       179 ~~~~~~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~il~~ll~g~~pf~~-~~~~~~~~~~~~-~~-------------  241 (285)
T 3is5_A          179 SDEHSTNAAGTALYMAPEVFK--RDVTFKCDIWSAGVVMYFLLTGCLPFTG-TSLEEVQQKATY-KE-------------  241 (285)
T ss_dssp             --------CTTGGGCCHHHHT--TCCCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHH-CC-------------
T ss_pred             CcccCcCcccccCcCChHHhc--cCCCcccCeehHHHHHHHHHhCCCCCCC-CCHHHHHhhhcc-CC-------------
Confidence            555556678999999999975  4689999999999999999999999842 221111111100 00             


Q ss_pred             cCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccc
Q 013897          361 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP  423 (434)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~  423 (434)
                                   ..       .......+++++.+||.+||+.||++|||+.|+|+||||++
T Consensus       242 -------------~~-------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          242 -------------PN-------YAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             -------------CC-------CCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             -------------cc-------cccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence                         00       00011235788999999999999999999999999999986

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.8e-47  Score=384.53  Aligned_cols=281  Identities=25%  Similarity=0.443  Sum_probs=215.5

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc--HHHHHHHHHHHHHhc-----CCCCeeeEeeEEEccCCCc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLC-----GGPNIVKLLDIVRDQQSKT  205 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~E~~~l~~l~-----~h~niv~l~~~~~~~~~~~  205 (434)
                      .++|++++.||+|+||.||+|.+..+++.||||+++...  ...+.+|+.+++.+.     +|+||+++++++...  ..
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~--~~  173 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR--NH  173 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET--TE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC--Ce
Confidence            467999999999999999999999999999999997654  356788999998873     567999999999654  57


Q ss_pred             cEEEEeecCCCchhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCC-eEEEEecccceec
Q 013897          206 PSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR-KLRLIDWGLAEFY  279 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~-~vkl~DFGla~~~  279 (434)
                      +++||||+.+ +|..++     ..+++..++.++.||+.||+|||++||+||||||+|||++.++. .+||+|||+|...
T Consensus       174 ~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~  252 (429)
T 3kvw_A          174 ICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE  252 (429)
T ss_dssp             EEEEECCCCC-BHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred             EEEEEeccCC-CHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceec
Confidence            7899999986 444332     24899999999999999999999999999999999999997762 2999999999765


Q ss_pred             CCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcc
Q 013897          280 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH  359 (434)
Q Consensus       280 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  359 (434)
                      .  ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.|| .+.+..+++..+.+.++.+...-+...  
T Consensus       253 ~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf-~~~~~~~~l~~i~~~~~~p~~~~~~~~--  326 (429)
T 3kvw_A          253 H--QRVYTYIQSRFYRAPEVILG-ARYGMPIDMWSLGCILAELLTGYPLL-PGEDEGDQLACMIELLGMPSQKLLDAS--  326 (429)
T ss_dssp             T--CCCCSSCSCGGGCCHHHHHT-BCCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCHHHHHTB--
T ss_pred             C--CcccccCCCCCccChHHHhC-CCCCchHHHHhHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHcCCCCHHHHHhh--
Confidence            3  23345689999999999987 67999999999999999999999886 677778888888888886544322110  


Q ss_pred             ccCChhHHHHhcccCCC----------------------------CCccccccccccCCchHHHHHHHHccccCCCCCcc
Q 013897          360 IELDPHLAALVGRHSRK----------------------------PWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT  411 (434)
Q Consensus       360 ~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt  411 (434)
                          .............                            +.............++++.+||.+||++||++|||
T Consensus       327 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpt  402 (429)
T 3kvw_A          327 ----KRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMT  402 (429)
T ss_dssp             ----TTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCC
T ss_pred             ----hhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCC
Confidence                0000000000000                            00000000011234678999999999999999999


Q ss_pred             HHHHhcCCCcccccc
Q 013897          412 AKEAMAHPYFFPIRN  426 (434)
Q Consensus       412 ~~elL~Hp~~~~~~~  426 (434)
                      ++|+|+||||++...
T Consensus       403 a~e~L~Hpw~~~~~~  417 (429)
T 3kvw_A          403 PGQALRHPWLRRRLP  417 (429)
T ss_dssp             HHHHHTSTTTC----
T ss_pred             HHHHhCChhhccCCC
Confidence            999999999997643

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=3.2e-48  Score=382.61  Aligned_cols=253  Identities=24%  Similarity=0.415  Sum_probs=202.5

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHH-HHhcCCCCeeeEeeEEEccCCCc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKIL-QNLCGGPNIVKLLDIVRDQQSKT  205 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~E~~~l-~~l~~h~niv~l~~~~~~~~~~~  205 (434)
                      .++|++++.||+|+||+||+|+++.+++.||||+++...      ...+.+|..++ +.+ +||||+++++++.+.  ..
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~-~hp~Iv~l~~~~~~~--~~  113 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQTA--DK  113 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCC-CCTTBCCEEEEEECS--SE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEeC--CE
Confidence            368999999999999999999999999999999996432      23456676664 445 999999999999654  57


Q ss_pred             cEEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecC-C
Q 013897          206 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-P  281 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~-~  281 (434)
                      +++||||+.+++|..++   ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++... .
T Consensus       114 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g-~ikL~DFG~a~~~~~~  192 (373)
T 2r5t_A          114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG-HIVLTDFGLCKENIEH  192 (373)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCCBCGGGBCC
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCC-CEEEeeCccccccccC
Confidence            88999999999987665   4589999999999999999999999999999999999999777 89999999997643 3


Q ss_pred             CCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcccc
Q 013897          282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE  361 (434)
Q Consensus       282 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  361 (434)
                      .......+||+.|+|||++.+ ..++.++|||||||++|||++|..||.. .+..+....+...                
T Consensus       193 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~----------------  254 (373)
T 2r5t_A          193 NSTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILNK----------------  254 (373)
T ss_dssp             CCCCCSBSCCCCCCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCC-SBHHHHHHHHHHS----------------
T ss_pred             CCccccccCCccccCHHHhCC-CCCCchhhhHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHhc----------------
Confidence            334556789999999999887 6899999999999999999999999843 3333333332210                


Q ss_pred             CChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccH----HHHhcCCCcccccccc
Q 013897          362 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA----KEAMAHPYFFPIRNAE  428 (434)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~----~elL~Hp~~~~~~~~~  428 (434)
                                           .......+++++.+||.+||+.||.+||++    .|+++||||+.+++..
T Consensus       255 ---------------------~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~  304 (373)
T 2r5t_A          255 ---------------------PLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDD  304 (373)
T ss_dssp             ---------------------CCCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHH
T ss_pred             ---------------------ccCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHH
Confidence                                 001122367899999999999999999996    6999999999887544

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2.5e-48  Score=392.88  Aligned_cols=252  Identities=26%  Similarity=0.429  Sum_probs=201.6

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      .++|++++.||+|+||.||+|.+..+++.||||+++..      ....+.+|+.+++.+ +||||+++++++.+.  ..+
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~--~~~  223 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQTH--DRL  223 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCC-SCTTSCCEEEEEEET--TEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhC-CCCeEeeEEEEEeeC--CEE
Confidence            47899999999999999999999999999999998643      224567899999998 899999999999754  567


Q ss_pred             EEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHH-CCceeecCCCCceEecCCCCeEEEEecccceecCC-
Q 013897          207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-  281 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~-  281 (434)
                      ++||||+.+++|..++   ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+.... 
T Consensus       224 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~  302 (446)
T 4ejn_A          224 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-HIKITDFGLCKEGIKD  302 (446)
T ss_dssp             EEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSS-CEEECCCCCCCTTCC-
T ss_pred             EEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCC-CEEEccCCCceeccCC
Confidence            8999999999987665   468999999999999999999998 9999999999999999777 899999999976432 


Q ss_pred             CCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcccc
Q 013897          282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE  361 (434)
Q Consensus       282 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  361 (434)
                      .......+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.. .+.......+..                 
T Consensus       303 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~-----------------  363 (446)
T 4ejn_A          303 GATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILM-----------------  363 (446)
T ss_dssp             ----CCSSSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHH-----------------
T ss_pred             CcccccccCCccccCHhhcCC-CCCCCccchhhhHHHHHHHhhCCCCCCC-CCHHHHHHHHHh-----------------
Confidence            333456789999999999877 7899999999999999999999999843 222222222211                 


Q ss_pred             CChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCc-----cHHHHhcCCCccccccc
Q 013897          362 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-----TAKEAMAHPYFFPIRNA  427 (434)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rp-----t~~elL~Hp~~~~~~~~  427 (434)
                                ..          ...+..+++++.+||.+||+.||++||     +++|+|+||||+++++.
T Consensus       364 ----------~~----------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~  414 (446)
T 4ejn_A          364 ----------EE----------IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQ  414 (446)
T ss_dssp             ----------CC----------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             ----------CC----------CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHH
Confidence                      00          001123678999999999999999999     99999999999988643

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.3e-47  Score=376.34  Aligned_cols=289  Identities=28%  Similarity=0.473  Sum_probs=212.5

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccC-----CCc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ-----SKT  205 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~-----~~~  205 (434)
                      .++|++.+.||+|+||.||+|.+..+++.||||++...  ......+|+..+..+ +||||+++++++....     ..+
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~  100 (360)
T 3e3p_A           22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL-HHPNIVQLQSYFYTLGERDRRDIY  100 (360)
T ss_dssp             HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHH-CCTTBCCEEEEEEEECSSCTTCEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhc-CCCCcccHHHhhhcccccccccee
Confidence            37899999999999999999999999999999988543  234567788888888 9999999999986532     223


Q ss_pred             cEEEEeecCCCchhhh------cCCCChHHHHHHHHHHHHHHHHHH--HCCceeecCCCCceEecCCCCeEEEEecccce
Q 013897          206 PSLIFEHVNNTDFKVL------YPTLSDYDVRYYIYELLKALDYCH--SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE  277 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~------~~~l~~~~~~~~~~qi~~~L~~LH--~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~  277 (434)
                      +++||||+.++.+..+      ...+++..++.++.||+.||.|||  ++||+||||||+|||++..++.+||+|||+++
T Consensus       101 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~  180 (360)
T 3e3p_A          101 LNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK  180 (360)
T ss_dssp             EEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCB
T ss_pred             EEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCce
Confidence            7899999998754332      235788899999999999999999  99999999999999999634499999999998


Q ss_pred             ecCCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhh
Q 013897          278 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK  357 (434)
Q Consensus       278 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  357 (434)
                      ............||+.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+....+..+.+.++.+....+...
T Consensus       181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (360)
T 3e3p_A          181 KLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIF-RGDNSAGQLHEIVRVLGCPSREVLRKL  259 (360)
T ss_dssp             CCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred             ecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCc-CCCChHHHHHHHHHHcCCCCHHHHHhc
Confidence            7766666666788999999999877566999999999999999999999887 556666777778777776544333221


Q ss_pred             ccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccccc
Q 013897          358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~  428 (434)
                      .........    ......+|.... .......++++.+||.+||+.||++|||+.|+|+||||+++....
T Consensus       260 ~~~~~~~~~----~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~  325 (360)
T 3e3p_A          260 NPSHTDVDL----YNSKGIPWSNVF-SDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPA  325 (360)
T ss_dssp             CTTCCCGGG----GCCCCCCHHHHT-TTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTT
T ss_pred             ccchhhccc----cccccCCccccc-chhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCcc
Confidence            110000000    000011111110 011223567899999999999999999999999999999887554

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-47  Score=369.80  Aligned_cols=245  Identities=24%  Similarity=0.289  Sum_probs=195.7

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      ++|+++++||+|+||+||+|.+..+++.||||++...     .......|+..+..+.+||||+++++++.+.  ..+++
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~--~~~~l  134 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG--GILYL  134 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC--CEEEE
Confidence            6799999999999999999999989999999998542     2234566777777777999999999999653  56789


Q ss_pred             EEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc
Q 013897          209 IFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE  284 (434)
Q Consensus       209 v~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~  284 (434)
                      ||||+.+ ++..++    ..+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+||+|||++........
T Consensus       135 v~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~-~~kl~DFG~a~~~~~~~~  212 (311)
T 3p1a_A          135 QTELCGP-SLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRG-RCKLGDFGLLVELGTAGA  212 (311)
T ss_dssp             EEECCCC-BHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGG-CEEECCCTTCEECC----
T ss_pred             EEeccCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC-CEEEccceeeeecccCCC
Confidence            9999965 444332    3599999999999999999999999999999999999999777 899999999987765555


Q ss_pred             cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCCh
Q 013897          285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP  364 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  364 (434)
                      .....||+.|+|||++.+  .++.++|||||||++|||++|..|++..    .....+..               ....+
T Consensus       213 ~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~----~~~~~~~~---------------~~~~~  271 (311)
T 3p1a_A          213 GEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGG----EGWQQLRQ---------------GYLPP  271 (311)
T ss_dssp             --CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSH----HHHHHHTT---------------TCCCH
T ss_pred             CcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCc----cHHHHHhc---------------cCCCc
Confidence            566779999999999875  6899999999999999999998776321    11111100               00000


Q ss_pred             hHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccc
Q 013897          365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP  423 (434)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~  423 (434)
                                          .....+++++.+||.+||+.||++|||++|+|+||||++
T Consensus       272 --------------------~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          272 --------------------EFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             --------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             --------------------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence                                111236789999999999999999999999999999985

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.8e-47  Score=375.54  Aligned_cols=280  Identities=24%  Similarity=0.427  Sum_probs=213.0

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc--HHHHHHHHHHHHHhc----CCCCeeeEeeEEEccCCCcc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLC----GGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~E~~~l~~l~----~h~niv~l~~~~~~~~~~~~  206 (434)
                      .++|.++++||+|+||.||+|.+..+++.||||+++...  ...+..|+.+++.+.    .||||+++++++...  ...
T Consensus        34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~--~~~  111 (360)
T 3llt_A           34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY--DHM  111 (360)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET--TEE
T ss_pred             cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC--Cee
Confidence            478999999999999999999999999999999997433  456788999999984    499999999999764  567


Q ss_pred             EEEEeecCCCchhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecC------------------
Q 013897          207 SLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH------------------  263 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~------------------  263 (434)
                      ++||||+ +++|..++     ..+++..++.++.||+.||+|||++||+||||||+|||++.                  
T Consensus       112 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~  190 (360)
T 3llt_A          112 CLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKK  190 (360)
T ss_dssp             EEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCE
T ss_pred             EEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccccc
Confidence            8999999 77776554     24889999999999999999999999999999999999974                  


Q ss_pred             ------CCCeEEEEecccceecCCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHH
Q 013897          264 ------EQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYD  337 (434)
Q Consensus       264 ------~~~~vkl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~  337 (434)
                            ....+||+|||+|.....  .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.+..+
T Consensus       191 ~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~  266 (360)
T 3llt_A          191 IQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILN-LGWDVSSDMWSFGCVLAELYTGSLLF-RTHEHME  266 (360)
T ss_dssp             EEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSC-CCSSHHH
T ss_pred             ccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcC-CCCCCccchHHHHHHHHHHHHCCCCC-CCCcHHH
Confidence                  134899999999986432  3345678999999999987 68999999999999999999999998 4555666


Q ss_pred             HHHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCcccc------------ccccccCCchHHHHHHHHccccC
Q 013897          338 QLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFI------------TVENQHLAVPEAVDFLDKLLRYD  405 (434)
Q Consensus       338 ~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~dll~~cL~~d  405 (434)
                      .+..+....+...................   ........|....            ........++.+.+||.+||+.|
T Consensus       267 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~---~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d  343 (360)
T 3llt_A          267 HLAMMESIIQPIPKNMLYEATKTNGSKYV---NKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQID  343 (360)
T ss_dssp             HHHHHHHHTCCCCHHHHHHHTTSGGGGGE---ETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSS
T ss_pred             HHHHHHHhcCCCCHHHHhhhhhccCcccc---CcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCC
Confidence            77777776665433222211100000000   0000000000000            00001123467889999999999


Q ss_pred             CCCCccHHHHhcCCCcc
Q 013897          406 HQERPTAKEAMAHPYFF  422 (434)
Q Consensus       406 P~~Rpt~~elL~Hp~~~  422 (434)
                      |++|||++|+|+||||+
T Consensus       344 P~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          344 PTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             GGGSCCHHHHTTSGGGC
T ss_pred             hhhCCCHHHHhcCcccC
Confidence            99999999999999996

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.3e-47  Score=369.23  Aligned_cols=254  Identities=22%  Similarity=0.414  Sum_probs=209.4

Q ss_pred             CeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEe
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE  211 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  211 (434)
                      .|+..+.||+|+||.||+|.+..+|+.||||+++..   ..+.+.+|+.+++.+ +||||+++++++...  ...++|||
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~~~~lv~e  122 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-QHFNVVEMYKSYLVG--EELWVLME  122 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTC-CCTTBCCEEEEEEET--TEEEEEEC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEEC--CEEEEEEe
Confidence            477888999999999999999889999999998643   346788999999999 999999999999754  56789999


Q ss_pred             ecCCCchhhhcC--CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC-cccee
Q 013897          212 HVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNVR  288 (434)
Q Consensus       212 ~~~~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~-~~~~~  288 (434)
                      |+.+++|..++.  .+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++....... .....
T Consensus       123 ~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~~~~~~~~  201 (321)
T 2c30_A          123 FLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPKRKSL  201 (321)
T ss_dssp             CCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSSSCCBCCC
T ss_pred             cCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-cEEEeeeeeeeecccCccccccc
Confidence            999999987764  589999999999999999999999999999999999999776 89999999998765432 33456


Q ss_pred             ccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHH
Q 013897          289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAA  368 (434)
Q Consensus       289 ~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~  368 (434)
                      +||+.|+|||++.+ ..++.++|||||||++|+|++|+.||... .....+..+...                       
T Consensus       202 ~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~~~-~~~~~~~~~~~~-----------------------  256 (321)
T 2c30_A          202 VGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSD-SPVQAMKRLRDS-----------------------  256 (321)
T ss_dssp             CSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHS-----------------------
T ss_pred             cCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcC-----------------------
Confidence            89999999999876 67999999999999999999999998432 222222221110                       


Q ss_pred             HhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccccc
Q 013897          369 LVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~  428 (434)
                           ...      .......+++.+.+||.+||+.||++|||+.|+|+||||++...++
T Consensus       257 -----~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~~  305 (321)
T 2c30_A          257 -----PPP------KLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPE  305 (321)
T ss_dssp             -----SCC------CCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCCCGG
T ss_pred             -----CCC------CcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCCCcc
Confidence                 000      0111223678899999999999999999999999999999776444

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2e-48  Score=384.43  Aligned_cols=252  Identities=24%  Similarity=0.426  Sum_probs=203.4

Q ss_pred             EEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeec
Q 013897          137 EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV  213 (434)
Q Consensus       137 ~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  213 (434)
                      ...+.||+|+||.||+|.+..+++.||+|+++..   ..+.+.+|+.+++++ +||||+++++++.+.  ...++||||+
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~--~~~~lv~E~~  168 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL-DHANLIQLYDAFESK--NDIVLVMEYV  168 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEECS--SEEEEEEECC
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhC-CCCCCCeEEEEEEEC--CEEEEEEeCC
Confidence            3467899999999999999999999999999763   346789999999999 999999999999754  5678999999


Q ss_pred             CCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecC-CCCeEEEEecccceecCCCCcccee
Q 013897          214 NNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH-EQRKLRLIDWGLAEFYHPGKEYNVR  288 (434)
Q Consensus       214 ~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~-~~~~vkl~DFGla~~~~~~~~~~~~  288 (434)
                      .+++|...+    ..+++..+..++.||+.||+|||++||+||||||+|||++. +...+||+|||+++...........
T Consensus       169 ~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~  248 (373)
T 2x4f_A          169 DGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN  248 (373)
T ss_dssp             TTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCC
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccc
Confidence            999886554    24889999999999999999999999999999999999942 3348999999999987766666677


Q ss_pred             ccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHH
Q 013897          289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAA  368 (434)
Q Consensus       289 ~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~  368 (434)
                      +||+.|+|||++.+ ..++.++|||||||++|||++|+.||. +.+..+.+..+......             .      
T Consensus       249 ~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~-~~~~~~~~~~i~~~~~~-------------~------  307 (373)
T 2x4f_A          249 FGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFL-GDNDAETLNNILACRWD-------------L------  307 (373)
T ss_dssp             CSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHHTCCC-------------S------
T ss_pred             cCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhccCC-------------C------
Confidence            89999999999876 679999999999999999999999984 33333343333221000             0      


Q ss_pred             HhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccc
Q 013897          369 LVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN  426 (434)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~  426 (434)
                                    .......+++++.+||.+||+.||++|||+.|+|+||||+..+.
T Consensus       308 --------------~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~~  351 (373)
T 2x4f_A          308 --------------EDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKL  351 (373)
T ss_dssp             --------------CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHHH
T ss_pred             --------------ChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCch
Confidence                          00111246789999999999999999999999999999997753

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-47  Score=373.78  Aligned_cols=280  Identities=29%  Similarity=0.531  Sum_probs=213.5

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc--------HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK  204 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~--------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  204 (434)
                      .++|++++.||+|+||.||+|.+..+++.||||+++...        ...+.+|+.+++.+ +||||+++++++.+  ..
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~   85 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGH--KS   85 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECC--TT
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhC-CCCCCCeEEEEEee--CC
Confidence            467999999999999999999998899999999986422        23578999999999 89999999999964  35


Q ss_pred             ccEEEEeecCCCchhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecC
Q 013897          205 TPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH  280 (434)
Q Consensus       205 ~~~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~  280 (434)
                      ..++||||+.+ ++...+.    .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus        86 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~~~~  163 (346)
T 1ua2_A           86 NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG-VLKLADFGLAKSFG  163 (346)
T ss_dssp             CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECCCGGGSTTT
T ss_pred             ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCC-CEEEEecccceecc
Confidence            67899999997 4544432    488899999999999999999999999999999999999776 89999999998664


Q ss_pred             CC-CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcc
Q 013897          281 PG-KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH  359 (434)
Q Consensus       281 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  359 (434)
                      .. ......++|+.|+|||++.+...++.++|||||||++|+|++|..|| .+.+..+.+..+.+..+.+....|.....
T Consensus       164 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  242 (346)
T 1ua2_A          164 SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFL-PGDSDLDQLTRIFETLGTPTEEQWPDMCS  242 (346)
T ss_dssp             SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred             CCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCC-CCCCHHHHHHHHHHHcCCCChhhhhhhcc
Confidence            32 33455688999999999876567899999999999999999998665 66677777778777766544333221110


Q ss_pred             ccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccccc
Q 013897          360 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA  427 (434)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~  427 (434)
                      ..   ..   .   ................+++++.+||.+||+.||++|||++|+|+||||++...+
T Consensus       243 ~~---~~---~---~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~  301 (346)
T 1ua2_A          243 LP---DY---V---TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP  301 (346)
T ss_dssp             ST---TC---C---CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred             Cc---cc---c---cccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCC
Confidence            00   00   0   000000000000113467899999999999999999999999999999976533

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=9e-48  Score=390.37  Aligned_cols=250  Identities=24%  Similarity=0.419  Sum_probs=210.9

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      .++|.+.+.||+|+||.||+|.+..+|+.||||+++..      ....+.+|+.+++.+ +||||+++++++...  ..+
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~--~~~   91 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF-RHPHIIKLYQVISTP--SDI   91 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTC-CCTTBCCEEEEEECS--SEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEEC--CEE
Confidence            36899999999999999999999999999999999643      235688999999998 999999999999654  567


Q ss_pred             EEEEeecCCCchhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC
Q 013897          207 SLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~  283 (434)
                      ++||||+.+++|..++.   .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus        92 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~-~vkL~DFG~a~~~~~~~  170 (476)
T 2y94_A           92 FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHM-NAKIADFGLSNMMSDGE  170 (476)
T ss_dssp             EEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTC-CEEECCCSSCEECCTTC
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCC-CeEEEeccchhhccccc
Confidence            89999999999987763   589999999999999999999999999999999999999776 89999999998876666


Q ss_pred             ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                      .....+||+.|+|||++.+...++.++|||||||++|+|++|+.||. +.+.......+...                  
T Consensus       171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~-~~~~~~~~~~i~~~------------------  231 (476)
T 2y94_A          171 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFD-DDHVPTLFKKICDG------------------  231 (476)
T ss_dssp             CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSC-CSSSHHHHHHHHTT------------------
T ss_pred             cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCC-CCCHHHHHHHHhcC------------------
Confidence            66677899999999999874345789999999999999999999984 33333333222110                  


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI  424 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~  424 (434)
                               .          ...+..+++++.+||.+||+.||++|||++|+++||||++.
T Consensus       232 ---------~----------~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          232 ---------I----------FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             ---------C----------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             ---------C----------cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence                     0          01122367899999999999999999999999999999853

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.5e-47  Score=362.02  Aligned_cols=254  Identities=26%  Similarity=0.450  Sum_probs=210.2

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecc---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF  210 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  210 (434)
                      ++|.+.+.||+|+||.||+|.+..++..+|+|++..   ...+.+.+|+.+++.+ +||||+++++++.+.  ...++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~   85 (277)
T 3f3z_A            9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL-DHPNIIRLYETFEDN--TDIYLVM   85 (277)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECS--SEEEEEE
T ss_pred             hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhC-CCCCEeeEEEEEecC--CeEEEEE
Confidence            679999999999999999999999999999999864   3457789999999999 999999999999654  5678999


Q ss_pred             eecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEe---cCCCCeEEEEecccceecCCCCc
Q 013897          211 EHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGKE  284 (434)
Q Consensus       211 e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll---~~~~~~vkl~DFGla~~~~~~~~  284 (434)
                      ||+.+++|...+   ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++ .+||+|||++........
T Consensus        86 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~-~~~l~Dfg~~~~~~~~~~  164 (277)
T 3f3z_A           86 ELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDS-PLKLIDFGLAARFKPGKM  164 (277)
T ss_dssp             ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTC-CEEECCCTTCEECCTTSC
T ss_pred             eccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCC-cEEEEecccceeccCccc
Confidence            999999986654   458999999999999999999999999999999999999   5444 899999999988776666


Q ss_pred             cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCCh
Q 013897          285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP  364 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  364 (434)
                      .....||+.|+|||++.+  .++.++|||||||++|+|++|+.||.. ....+....+......             .+ 
T Consensus       165 ~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~-------------~~-  227 (277)
T 3f3z_A          165 MRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSA-PTDSEVMLKIREGTFT-------------FP-  227 (277)
T ss_dssp             BCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC-------------CC-
T ss_pred             hhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCCC-------------CC-
Confidence            677789999999999865  489999999999999999999999843 3333332222211000             00 


Q ss_pred             hHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccccc
Q 013897          365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA  427 (434)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~  427 (434)
                                         ......+++++.+||.+||+.||++|||+.|+|+||||++....
T Consensus       228 -------------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~  271 (277)
T 3f3z_A          228 -------------------EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSS  271 (277)
T ss_dssp             -------------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHCC
T ss_pred             -------------------chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccccc
Confidence                               00011367899999999999999999999999999999865443

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=4.7e-47  Score=371.71  Aligned_cols=284  Identities=31%  Similarity=0.590  Sum_probs=217.4

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC----
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS----  203 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~----  203 (434)
                      .++|.+.+.||+|+||.||+|.+..+|+.||||++....     .+.+.+|+.+++.+ +||||+++++++.....    
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~  101 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASSLRNF  101 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSGGGC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCCcccHhheEecccccccc
Confidence            478999999999999999999999999999999986422     35678999999999 89999999999975432    


Q ss_pred             CccEEEEeecCCCchhhhc-CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC
Q 013897          204 KTPSLIFEHVNNTDFKVLY-PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG  282 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~  282 (434)
                      ...++||||+.+ +|..+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..... 
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~-  178 (353)
T 3coi_A          102 YDFYLVMPFMQT-DLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC-ELKILDFGLARHADA-  178 (353)
T ss_dssp             CCCEEEEECCSE-EGGGTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTC-CEEECSTTCTTC----
T ss_pred             eeEEEEeccccC-CHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCC-cEEEeecccccCCCC-
Confidence            235899999995 555444 4689999999999999999999999999999999999999776 899999999976432 


Q ss_pred             CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                       .....++++.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+.+..|.+... +....   .
T Consensus       179 -~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~-~~~~~---~  252 (353)
T 3coi_A          179 -EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF-KGKDYLDQLTQILKVTGVPGTE-FVQKL---N  252 (353)
T ss_dssp             ------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSS-BSSCHHHHHHHHHHHHCBCCHH-HHTTC---S
T ss_pred             -CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHH-HHHHH---h
Confidence             2345678999999999877567999999999999999999999998 4555667777777777654322 11111   1


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccccc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~  428 (434)
                      +.............+...+  ......+++++.+||.+||..||++|||++|+|+||||+.+..++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~  316 (353)
T 3coi_A          253 DKAAKSYIQSLPQTPRKDF--TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPE  316 (353)
T ss_dssp             CHHHHHHHHTSCBCSSCCT--TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGG
T ss_pred             hHHHHHHHHhCcCCCCccH--HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCcc
Confidence            1111111111111111111  011224678999999999999999999999999999999887554

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.4e-47  Score=393.21  Aligned_cols=255  Identities=27%  Similarity=0.480  Sum_probs=210.4

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc----------------cHHHHHHHHHHHHHhcCCCCeeeEee
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----------------KKKKIKREIKILQNLCGGPNIVKLLD  196 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~----------------~~~~~~~E~~~l~~l~~h~niv~l~~  196 (434)
                      .++|.++++||+|+||+||+|.++.+++.||+|+++..                ..+.+.+|+.+|+.+ +||||+++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~  113 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-DHPNIIKLFD  113 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTC-CCTTBCCEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhC-CCCCCCeEEE
Confidence            47899999999999999999999999999999998642                235688999999999 8999999999


Q ss_pred             EEEccCCCccEEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCC--eEEEE
Q 013897          197 IVRDQQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR--KLRLI  271 (434)
Q Consensus       197 ~~~~~~~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~--~vkl~  271 (434)
                      ++.+  ....++||||+.+++|...+   ..+++..++.++.||+.||+|||++||+||||||+|||++.++.  .+||+
T Consensus       114 ~~~~--~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~  191 (504)
T 3q5i_A          114 VFED--KKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIV  191 (504)
T ss_dssp             EEEC--SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred             EEEc--CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEE
Confidence            9965  45778999999999986554   56999999999999999999999999999999999999986653  59999


Q ss_pred             ecccceecCCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhH
Q 013897          272 DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL  351 (434)
Q Consensus       272 DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~  351 (434)
                      |||++............+||+.|+|||++.+  .++.++|||||||++|+|++|..||. +.+..+.+..+.......  
T Consensus       192 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~i~~~~~~~--  266 (504)
T 3q5i_A          192 DFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFG-GQNDQDIIKKVEKGKYYF--  266 (504)
T ss_dssp             CCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHCCCCC--
T ss_pred             ECCCCEEcCCCCccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHcCCCCC--
Confidence            9999988776666677789999999999864  69999999999999999999999983 333333333332210000  


Q ss_pred             HHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccc
Q 013897          352 NAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN  426 (434)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~  426 (434)
                                                     .......+++++.+||.+||+.||.+|||++|+|+||||++...
T Consensus       267 -------------------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~  310 (504)
T 3q5i_A          267 -------------------------------DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN  310 (504)
T ss_dssp             -------------------------------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred             -------------------------------CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence                                           00111236789999999999999999999999999999987643

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.3e-47  Score=391.77  Aligned_cols=254  Identities=24%  Similarity=0.514  Sum_probs=208.9

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecc-----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      ++|++++.||+|+||+||+|.+..+++.||||++..     .....+.+|+.+++++ +||||+++++++.+.  ...++
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~--~~~~l   98 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEILEDS--SSFYI   98 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECS--SEEEE
T ss_pred             cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhC-CCCCcCeEEEEEEcC--CEEEE
Confidence            679999999999999999999999999999999853     3356789999999999 999999999999654  56789


Q ss_pred             EEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC--CCeEEEEecccceecCCCC
Q 013897          209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--QRKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       209 v~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~--~~~vkl~DFGla~~~~~~~  283 (434)
                      ||||+.+++|...+   ..+++..++.++.||+.||.|||++||+||||||+|||++..  ...+||+|||+++......
T Consensus        99 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~  178 (486)
T 3mwu_A           99 VGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT  178 (486)
T ss_dssp             EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred             EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC
Confidence            99999999986554   568999999999999999999999999999999999999632  2379999999998776666


Q ss_pred             ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                      .....+||+.|+|||++.+  .|+.++|||||||++|+|++|+.||. +.+..+.+..+......               
T Consensus       179 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~i~~~~~~---------------  240 (486)
T 3mwu_A          179 KMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFY-GKNEYDILKRVETGKYA---------------  240 (486)
T ss_dssp             ---CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHTCCC---------------
T ss_pred             ccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhCCCC---------------
Confidence            6667789999999999875  59999999999999999999999984 33333333333211000               


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN  426 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~  426 (434)
                                        ........+++++.+||.+||+.||++|||+.|+|+||||++...
T Consensus       241 ------------------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~  285 (486)
T 3mwu_A          241 ------------------FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (486)
T ss_dssp             ------------------SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred             ------------------CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence                              001112246789999999999999999999999999999997654

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.3e-47  Score=405.28  Aligned_cols=254  Identities=22%  Similarity=0.348  Sum_probs=214.0

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      .++|++++.||+|+||+||+|.++.+++.||||+++..      ..+.+..|..++..+.+||||+++++++.+  ...+
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~--~~~~  417 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDRL  417 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC--SSEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe--CCEE
Confidence            47899999999999999999999999999999998642      235678899999988789999999999854  4678


Q ss_pred             EEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecC-CC
Q 013897          207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PG  282 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~-~~  282 (434)
                      +|||||+.+++|..++   ..+++..++.++.||+.||+|||++||+||||||+||||+.++ .+||+|||+|+... ..
T Consensus       418 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g-~ikL~DFGla~~~~~~~  496 (674)
T 3pfq_A          418 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKENIWDG  496 (674)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSS-CEEECCCTTCEECCCTT
T ss_pred             EEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCC-cEEEeecceeeccccCC
Confidence            8999999999997765   4699999999999999999999999999999999999999777 89999999998643 33


Q ss_pred             CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                      ......+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||. +.+..+.+..|...                 
T Consensus       497 ~~~~~~~GT~~Y~APE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~-~~~~~~~~~~i~~~-----------------  557 (674)
T 3pfq_A          497 VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFE-GEDEDELFQSIMEH-----------------  557 (674)
T ss_dssp             CCBCCCCSCSSSCCHHHHTC-CCBSTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHSS-----------------
T ss_pred             cccccccCCCcccCHhhhcC-CCCCccceEechHHHHHHHHcCCCCCC-CCCHHHHHHHHHhC-----------------
Confidence            44566789999999999876 789999999999999999999999984 33333333333210                 


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccH-----HHHhcCCCcccccccc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA-----KEAMAHPYFFPIRNAE  428 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~-----~elL~Hp~~~~~~~~~  428 (434)
                                          ....+..+++++.+||.+||+.||++||++     +|+++||||+.+++..
T Consensus       558 --------------------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~  608 (674)
T 3pfq_A          558 --------------------NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK  608 (674)
T ss_dssp             --------------------CCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHH
T ss_pred             --------------------CCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHH
Confidence                                001122477899999999999999999997     9999999999987554

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-47  Score=374.63  Aligned_cols=259  Identities=25%  Similarity=0.445  Sum_probs=205.6

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc--------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK  204 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~--------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  204 (434)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++...        ..+.+.+|+.+++.+ +||||+++++++.+.  .
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~--~  101 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL-HHPNIARLYEVYEDE--Q  101 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHC-CCTTBCCEEEEEECS--S
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhC-CCCCcceeehhhccC--C
Confidence            36799999999999999999999999999999998532        236788999999999 899999999999653  5


Q ss_pred             ccEEEEeecCCCchhhhcC-------------------------------------------CCChHHHHHHHHHHHHHH
Q 013897          205 TPSLIFEHVNNTDFKVLYP-------------------------------------------TLSDYDVRYYIYELLKAL  241 (434)
Q Consensus       205 ~~~lv~e~~~~~~l~~~~~-------------------------------------------~l~~~~~~~~~~qi~~~L  241 (434)
                      ..++||||+.+++|..++.                                           .+++..++.++.||+.||
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l  181 (345)
T 3hko_A          102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL  181 (345)
T ss_dssp             EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence            6789999999999987663                                           124667888999999999


Q ss_pred             HHHHHCCceeecCCCCceEecCCCC-eEEEEecccceecCCCC-----ccceeccCCcccccccccCC-CCCCccccHHH
Q 013897          242 DYCHSQGIMHRDVKPHNVMIDHEQR-KLRLIDWGLAEFYHPGK-----EYNVRVASRYFKGPELLVDL-QDYDYSLDLWS  314 (434)
Q Consensus       242 ~~LH~~~ivHrDlKp~NIll~~~~~-~vkl~DFGla~~~~~~~-----~~~~~~~t~~y~aPE~~~~~-~~~~~~~DvwS  314 (434)
                      +|||++||+||||||+|||++.++. .+||+|||++..+....     ......||+.|+|||++.+. ..++.++||||
T Consensus       182 ~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws  261 (345)
T 3hko_A          182 HYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS  261 (345)
T ss_dssp             HHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred             HHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence            9999999999999999999985542 79999999998653221     13456789999999998642 57899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHH
Q 013897          315 LGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEA  394 (434)
Q Consensus       315 lGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (434)
                      |||++|||++|+.||. +....+....+....                           ...      .......+++++
T Consensus       262 lG~il~el~~g~~pf~-~~~~~~~~~~~~~~~---------------------------~~~------~~~~~~~~~~~~  307 (345)
T 3hko_A          262 AGVLLHLLLMGAVPFP-GVNDADTISQVLNKK---------------------------LCF------ENPNYNVLSPLA  307 (345)
T ss_dssp             HHHHHHHHHHSSCSSC-CSSHHHHHHHHHHCC---------------------------CCT------TSGGGGGSCHHH
T ss_pred             HHHHHHHHHHCCCCCC-CCChHHHHHHHHhcc---------------------------ccc------CCcccccCCHHH
Confidence            9999999999999983 333333333222100                           000      011112367899


Q ss_pred             HHHHHHccccCCCCCccHHHHhcCCCcccccccc
Q 013897          395 VDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       395 ~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~  428 (434)
                      .+||.+||+.||++|||+.|+|+||||+++.+.-
T Consensus       308 ~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~~~  341 (345)
T 3hko_A          308 RDLLSNLLNRNVDERFDAMRALQHPWISQFSDKI  341 (345)
T ss_dssp             HHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSSCS
T ss_pred             HHHHHHHcCCChhHCCCHHHHhcChhhccChHhh
Confidence            9999999999999999999999999999886543

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=3.9e-47  Score=374.23  Aligned_cols=253  Identities=26%  Similarity=0.467  Sum_probs=208.8

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc-----------HHHHHHHHHHHHHhcCCCCeeeEeeEEEccC
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ  202 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  202 (434)
                      ++|++.+.||+|+||.||+|.+..+|+.||||+++...           .+.+.+|+.+++.+.+||||+++++++..  
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--  171 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES--  171 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB--
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee--
Confidence            57999999999999999999998899999999986432           34678999999999789999999999965  


Q ss_pred             CCccEEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceec
Q 013897          203 SKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY  279 (434)
Q Consensus       203 ~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~  279 (434)
                      ....++||||+.+++|..++   ..+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||++...
T Consensus       172 ~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~-~ikl~DfG~~~~~  250 (365)
T 2y7j_A          172 SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNM-QIRLSDFGFSCHL  250 (365)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEEC
T ss_pred             CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEEEecCccccc
Confidence            35678999999999987765   4689999999999999999999999999999999999999776 8999999999887


Q ss_pred             CCCCccceeccCCcccccccccC-----CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHH
Q 013897          280 HPGKEYNVRVASRYFKGPELLVD-----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAY  354 (434)
Q Consensus       280 ~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~  354 (434)
                      .........+||+.|+|||++.+     ...++.++|||||||++|+|++|+.||.. ......+..+.....       
T Consensus       251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~-------  322 (365)
T 2y7j_A          251 EPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH-RRQILMLRMIMEGQY-------  322 (365)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCC-------
T ss_pred             CCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCC-------
Confidence            76666667789999999999853     23588999999999999999999999843 222222222211000       


Q ss_pred             HhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccc
Q 013897          355 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP  423 (434)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~  423 (434)
                            ...                    ......+++.+.+||.+||+.||++|||++|+|+||||+.
T Consensus       323 ------~~~--------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          323 ------QFS--------------------SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             ------CCC--------------------HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             ------CCC--------------------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence                  000                    0011235778999999999999999999999999999974

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=5.9e-47  Score=361.70  Aligned_cols=260  Identities=25%  Similarity=0.414  Sum_probs=211.5

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc------------HHHHHHHHHHHHHhcCCCCeeeEeeEEEc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------------KKKIKREIKILQNLCGGPNIVKLLDIVRD  200 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------------~~~~~~E~~~l~~l~~h~niv~l~~~~~~  200 (434)
                      .++|++.+.||+|+||.||+|.+..+++.||||+++...            .+.+.+|+.+++++.+||||+++++++.+
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            478999999999999999999999999999999986432            35578999999999669999999999965


Q ss_pred             cCCCccEEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccce
Q 013897          201 QQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE  277 (434)
Q Consensus       201 ~~~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~  277 (434)
                        ....++||||+.+++|..++   ..+++..+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||++.
T Consensus        96 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~  172 (298)
T 1phk_A           96 --NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM-NIKLTDFGFSC  172 (298)
T ss_dssp             --SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCE
T ss_pred             --CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCC-cEEEecccchh
Confidence              36778999999999987765   3689999999999999999999999999999999999999776 89999999998


Q ss_pred             ecCCCCccceeccCCccccccccc-----CCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHH
Q 013897          278 FYHPGKEYNVRVASRYFKGPELLV-----DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELN  352 (434)
Q Consensus       278 ~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~  352 (434)
                      ............++..|+|||++.     ....++.++|||||||++|+|++|..||.. .........+....      
T Consensus       173 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~------  245 (298)
T 1phk_A          173 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGN------  245 (298)
T ss_dssp             ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTC------
T ss_pred             hcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcC-ccHHHHHHHHhcCC------
Confidence            876665566678999999999985     235688999999999999999999999843 22222222221100      


Q ss_pred             HHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccccccc
Q 013897          353 AYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAES  429 (434)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~~  429 (434)
                                           ...      .......+++++.+||.+||..||++|||+.|+|+||||++....+.
T Consensus       246 ---------------------~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~  295 (298)
T 1phk_A          246 ---------------------YQF------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV  295 (298)
T ss_dssp             ---------------------CCC------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC----
T ss_pred             ---------------------ccc------CcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccchhh
Confidence                                 000      00111236788999999999999999999999999999998876553

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=8.9e-48  Score=373.54  Aligned_cols=285  Identities=28%  Similarity=0.457  Sum_probs=216.5

Q ss_pred             CCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       132 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      ..++|++++.||+|+||.||+|.+..+++.||||++....     .+.+.+|+.+++.+ +||||+++++++.+.  ...
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~   99 (331)
T 4aaa_A           23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL-RHENLVNLLEVCKKK--KRW   99 (331)
T ss_dssp             CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEET--TEE
T ss_pred             hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhC-CCCCEeeEEEEeecC--CEE
Confidence            3578999999999999999999999999999999985432     34577999999999 899999999999754  567


Q ss_pred             EEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC-
Q 013897          207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-  282 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~-  282 (434)
                      ++||||+.++++..+.   ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...... 
T Consensus       100 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~  178 (331)
T 4aaa_A          100 YLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSG-VVKLCDFGFARTLAAPG  178 (331)
T ss_dssp             EEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCTTC-------
T ss_pred             EEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCC-cEEEEeCCCceeecCCc
Confidence            8999999999887663   4689999999999999999999999999999999999999777 8999999999765432 


Q ss_pred             CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                      .......++..|+|||++.+...++.++|||||||++|+|++|+.|| .+....+.+..+....+............   
T Consensus       179 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  254 (331)
T 4aaa_A          179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLF-PGDSDIDQLYHIMMCLGNLIPRHQELFNK---  254 (331)
T ss_dssp             -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCSCCHHHHHHHHH---
T ss_pred             cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCC-CCCCcHHHHHHHHHHhCCCChhhhhHhhh---
Confidence            33455678999999999987557899999999999999999999887 55566667777766666432221110000   


Q ss_pred             ChhHHHHhcccCCCCCccc-cccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccccc
Q 013897          363 DPHLAALVGRHSRKPWSKF-ITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~  428 (434)
                      .+..    ........... ........+++.+.+||.+||+.||++|||++|+|+||||+....++
T Consensus       255 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  317 (331)
T 4aaa_A          255 NPVF----AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAE  317 (331)
T ss_dssp             CGGG----TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGGHHH
T ss_pred             cccc----ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCChhh
Confidence            0000    00000000000 00111234688999999999999999999999999999999776544

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.3e-47  Score=392.04  Aligned_cols=254  Identities=26%  Similarity=0.400  Sum_probs=210.7

Q ss_pred             CCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCc
Q 013897          132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT  205 (434)
Q Consensus       132 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  205 (434)
                      ..++|++.+.||+|+||.||+|+++.+++.||+|+++..      ....+.+|+.+++.+ +||||+++++++.+.  ..
T Consensus       183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~--~~  259 (543)
T 3c4z_A          183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSLAYAFETK--TD  259 (543)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEECS--SE
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhc-CCCCEeeEEEEEeeC--CE
Confidence            357899999999999999999999999999999999643      235678999999999 999999999999654  56


Q ss_pred             cEEEEeecCCCchhhhc-------CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEeccccee
Q 013897          206 PSLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF  278 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~  278 (434)
                      +++||||+.+++|..++       ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus       260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g-~vkL~DFGla~~  338 (543)
T 3c4z_A          260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDG-NVRISDLGLAVE  338 (543)
T ss_dssp             EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCTTCEE
T ss_pred             EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCC-CEEEeecceeee
Confidence            88999999999987654       2488999999999999999999999999999999999999777 899999999987


Q ss_pred             cCCCCc-cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCC--HHHHH-HHHHHhCChhHHHH
Q 013897          279 YHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN--YDQLV-KIAKVLGTDELNAY  354 (434)
Q Consensus       279 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~--~~~~~-~i~~~~g~~~~~~~  354 (434)
                      ...... ....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||......  ...+. .+..          
T Consensus       339 ~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~----------  407 (543)
T 3c4z_A          339 LKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE----------  407 (543)
T ss_dssp             CCTTCCCBCCCCSCTTTSCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH----------
T ss_pred             ccCCCcccccccCCccccChhhhcC-CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhh----------
Confidence            755443 334589999999999987 78999999999999999999999999543221  11111 1110          


Q ss_pred             HhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCcc-----HHHHhcCCCccccccc
Q 013897          355 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT-----AKEAMAHPYFFPIRNA  427 (434)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt-----~~elL~Hp~~~~~~~~  427 (434)
                                       ..          ...+..+++++.+||.+||+.||++||+     ++++++||||+++++.
T Consensus       408 -----------------~~----------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~  458 (543)
T 3c4z_A          408 -----------------QA----------VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWR  458 (543)
T ss_dssp             -----------------CC----------CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHH
T ss_pred             -----------------cc----------cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHH
Confidence                             00          0111246789999999999999999995     5899999999988754

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.3e-46  Score=368.06  Aligned_cols=288  Identities=28%  Similarity=0.520  Sum_probs=219.5

Q ss_pred             CCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccC---CC
Q 013897          132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ---SK  204 (434)
Q Consensus       132 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---~~  204 (434)
                      ..++|.+.+.||+|+||.||+|.+..+++.||||+++...    ...+.+|+.+++.+ +||||+++++++....   ..
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~   87 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHF-KHENIITIFNIQRPDSFENFN   87 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCSTTCC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhC-cCCCcCCeeeeecccccCccc
Confidence            3578999999999999999999999899999999996432    34577999999999 8999999999886432   35


Q ss_pred             ccEEEEeecCCCchhhhc--CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC
Q 013897          205 TPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG  282 (434)
Q Consensus       205 ~~~lv~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~  282 (434)
                      ..++||||+.+ +|..++  ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++......
T Consensus        88 ~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~~  165 (353)
T 2b9h_A           88 EVYIIQELMQT-DLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNC-DLKVCDFGLARIIDES  165 (353)
T ss_dssp             CEEEEECCCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCCTTCEECC--
T ss_pred             eEEEEEeccCc-cHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCC-cEEEEecccccccccc
Confidence            67899999985 565543  4689999999999999999999999999999999999999776 8999999999876432


Q ss_pred             Cc-----------cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhH
Q 013897          283 KE-----------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL  351 (434)
Q Consensus       283 ~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~  351 (434)
                      ..           ....+||+.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+++..+....+.+..
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~  244 (353)
T 2b9h_A          166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF-PGRDYRHQLLLIFGIIGTPHS  244 (353)
T ss_dssp             --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCS
T ss_pred             cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCC-CCCCcHHHHHHHHHHhCCCch
Confidence            11           123478999999999876568999999999999999999999887 555666667777776665432


Q ss_pred             HHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccccc
Q 013897          352 NAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~  428 (434)
                      ...   ......+............+....  ......+++++.+||.+||+.||++|||++|+|+||||+.+....
T Consensus       245 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~  316 (353)
T 2b9h_A          245 DND---LRCIESPRAREYIKSLPMYPAAPL--EKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPN  316 (353)
T ss_dssp             TTT---TTTCCCHHHHHHHHTSCCCCCCCH--HHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTT
T ss_pred             hcc---ccccccchhhHHhhcccCCCCcch--hhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcc
Confidence            111   011111112222111111110000  011134788999999999999999999999999999999876543

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=7.6e-48  Score=374.90  Aligned_cols=243  Identities=26%  Similarity=0.455  Sum_probs=205.5

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccC
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ  202 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  202 (434)
                      ++|++.+.||+|+||.||+|.+..+++.||||+++..           ....+.+|+.+++.+ +||||+++++++.+. 
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~-  101 (335)
T 3dls_A           24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV-EHANIIKVLDIFENQ-  101 (335)
T ss_dssp             HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTC-CCTTBCCEEEEEECS-
T ss_pred             cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEeeC-
Confidence            6799999999999999999999999999999998653           224577899999999 999999999999654 


Q ss_pred             CCccEEEEeecCCC-chhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEeccccee
Q 013897          203 SKTPSLIFEHVNNT-DFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF  278 (434)
Q Consensus       203 ~~~~~lv~e~~~~~-~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~  278 (434)
                       ...++||||+.++ +|..++   ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus       102 -~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~a~~  179 (335)
T 3dls_A          102 -GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDF-TIKLIDFGSAAY  179 (335)
T ss_dssp             -SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCEE
T ss_pred             -CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCC-cEEEeecccceE
Confidence             5678999999776 776654   3589999999999999999999999999999999999999776 899999999988


Q ss_pred             cCCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhc
Q 013897          279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY  358 (434)
Q Consensus       279 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  358 (434)
                      ..........+||+.|+|||++.+...++.++|||||||++|+|++|+.||.....                   .    
T Consensus       180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------------------~----  236 (335)
T 3dls_A          180 LERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-------------------T----  236 (335)
T ss_dssp             CCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-------------------G----
T ss_pred             CCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-------------------H----
Confidence            77666666778999999999998743448899999999999999999999932000                   0    


Q ss_pred             cccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccc
Q 013897          359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI  424 (434)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~  424 (434)
                                 ...          ....+..+++++.+||.+||+.||++|||++|+|+||||++.
T Consensus       237 -----------~~~----------~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          237 -----------VEA----------AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             -----------TTT----------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             -----------Hhh----------ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence                       000          011122367899999999999999999999999999999864

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.8e-47  Score=360.81  Aligned_cols=252  Identities=25%  Similarity=0.460  Sum_probs=205.5

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      .++|++.+.||+|+||.||+|.+..++..||+|++...      ....+.+|+.+++.+ +||||+++++++.+.  ...
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~   84 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHDA--TRV   84 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECS--SEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcC-CCCCCcchhheEecC--CEE
Confidence            47899999999999999999999999999999998542      245688999999999 899999999999654  567


Q ss_pred             EEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC
Q 013897          207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~  283 (434)
                      ++||||+.++++...+   ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..... .
T Consensus        85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~-~~~l~Dfg~~~~~~~-~  162 (279)
T 3fdn_A           85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPS-S  162 (279)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTS-CEEECSCCEESCC----
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCC-CEEEEeccccccCCc-c
Confidence            8999999999987664   4689999999999999999999999999999999999999776 899999999865432 2


Q ss_pred             ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                      ......|++.|+|||.+.+ ..++.++|||||||++|+|++|..||. +.+..+....+...                  
T Consensus       163 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~-~~~~~~~~~~~~~~------------------  222 (279)
T 3fdn_A          163 RRTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRV------------------  222 (279)
T ss_dssp             -----CCCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHHT------------------
T ss_pred             cccccCCCCCccCHhHhcc-CCCCccchhHhHHHHHHHHHHCCCCCC-CCcHHHHHHHHHhC------------------
Confidence            3345678999999999877 688999999999999999999999983 22222222222110                  


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccccc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~  428 (434)
                                         ....+..+++++.+||.+||+.||++|||++|+|+||||+...+..
T Consensus       223 -------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~  268 (279)
T 3fdn_A          223 -------------------EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP  268 (279)
T ss_dssp             -------------------CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCSSC
T ss_pred             -------------------CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCccCc
Confidence                               0011223678899999999999999999999999999999766544

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.4e-47  Score=361.69  Aligned_cols=258  Identities=26%  Similarity=0.473  Sum_probs=208.0

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc---------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCC
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK  204 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~---------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  204 (434)
                      ++|++.+.||+|+||.||+|.+..+++.||+|+++..         ..+.+.+|+.+++.+ +||||+++++++.+.  .
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~--~   81 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI-RHPNIITLHDIFENK--T   81 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECS--S
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhC-CCCCeeehhheecCC--C
Confidence            5799999999999999999999989999999998643         256789999999999 899999999999654  5


Q ss_pred             ccEEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCC---eEEEEeccccee
Q 013897          205 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR---KLRLIDWGLAEF  278 (434)
Q Consensus       205 ~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~---~vkl~DFGla~~  278 (434)
                      ..++||||+.+++|..++   ..+++..+..++.||+.||.|||++||+||||||+||+++.++.   .+||+|||++..
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~  161 (283)
T 3bhy_A           82 DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK  161 (283)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             eEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence            678999999999987765   46899999999999999999999999999999999999986542   699999999987


Q ss_pred             cCCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhc
Q 013897          279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY  358 (434)
Q Consensus       279 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  358 (434)
                      ...........+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.. ....+.+..+...             
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~-------------  226 (283)
T 3bhy_A          162 IEAGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLG-ETKQETLTNISAV-------------  226 (283)
T ss_dssp             CC--------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTT-------------
T ss_pred             ccCCCcccccCCCcCccCcceecC-CCCCcchhhhhHHHHHHHHHHCCCCCCC-cchHHHHHHhHhc-------------
Confidence            765555566679999999999876 6799999999999999999999999843 3322222222110             


Q ss_pred             cccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccccccc
Q 013897          359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAES  429 (434)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~~  429 (434)
                      ....++                    .....+++.+.+||.+||..||++|||+.|+|+||||+.++....
T Consensus       227 ~~~~~~--------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~  277 (283)
T 3bhy_A          227 NYDFDE--------------------EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNV  277 (283)
T ss_dssp             CCCCCH--------------------HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCCC
T ss_pred             ccCCcc--------------------hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHhh
Confidence            000000                    011235778999999999999999999999999999998865543

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=7.7e-47  Score=365.52  Aligned_cols=282  Identities=29%  Similarity=0.545  Sum_probs=219.1

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEc-CCCeEEEEEEecccc-----HHHHHHHHHHHHHhc--CCCCeeeEeeEEEc---c
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHC-TDNEKCIIKILKPVK-----KKKIKREIKILQNLC--GGPNIVKLLDIVRD---Q  201 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~~vaiK~~~~~~-----~~~~~~E~~~l~~l~--~h~niv~l~~~~~~---~  201 (434)
                      .++|++++.||+|+||.||+|.+. .+++.||+|+++...     ...+.+|+.+++.+.  +||||+++++++..   .
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~   89 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   89 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence            478999999999999999999985 678999999986432     235778888888774  79999999999862   1


Q ss_pred             CCCccEEEEeecCCCchhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccc
Q 013897          202 QSKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA  276 (434)
Q Consensus       202 ~~~~~~lv~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla  276 (434)
                      .....++||||+.+ +|..++     ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus        90 ~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~-~~kl~Dfg~~  167 (326)
T 1blx_A           90 RETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-QIKLADFGLA  167 (326)
T ss_dssp             SEEEEEEEEECCSC-BHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECSCCSC
T ss_pred             CCceEEEEEecCCC-CHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCC-CEEEecCccc
Confidence            34567899999995 665543     2388999999999999999999999999999999999999776 8999999999


Q ss_pred             eecCCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHh
Q 013897          277 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN  356 (434)
Q Consensus       277 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~  356 (434)
                      .............++..|+|||++.+ ..++.++|||||||++|+|++|+.|| .+....+.+..+.+.++.+....|..
T Consensus       168 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~  245 (326)
T 1blx_A          168 RIYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLF-RGSSDVDQLGKILDVIGLPGEEDWPR  245 (326)
T ss_dssp             CCCCGGGGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred             ccccCCCCccccccccceeCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHHHHcCCCCcccCcc
Confidence            87654444556688999999999877 67999999999999999999999887 45556667777777666544333322


Q ss_pred             hccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccccc
Q 013897          357 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~  428 (434)
                      ......     .........+     .......+++.+.+||.+||..||++|||+.|+|+||||+.++...
T Consensus       246 ~~~~~~-----~~~~~~~~~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~  307 (326)
T 1blx_A          246 DVALPR-----QAFHSKSAQP-----IEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK  307 (326)
T ss_dssp             TCSSCG-----GGSCCCCCCC-----GGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred             ccccch-----hhhcccCcch-----hhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhh
Confidence            111000     0000000000     0112234788999999999999999999999999999999887654

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.7e-47  Score=391.63  Aligned_cols=252  Identities=27%  Similarity=0.510  Sum_probs=206.5

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      ++|++++.||+|+||+||+|.+..++..||+|+++..     ....+.+|+.+++.+ +||||+++++++.+.  ...++
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~--~~~~l  113 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL-DHPNIMKLYDFFEDK--RNYYL  113 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTC-CCTTBCCEEEEEECS--SEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeC--CEEEE
Confidence            5799999999999999999999999999999998643     346788999999999 999999999999654  56789


Q ss_pred             EEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCC--CeEEEEecccceecCCCC
Q 013897          209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ--RKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       209 v~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~--~~vkl~DFGla~~~~~~~  283 (434)
                      ||||+.+++|...+   ..+++..++.++.||+.||.|||++||+||||||+|||++..+  ..+||+|||++.......
T Consensus       114 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~  193 (494)
T 3lij_A          114 VMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK  193 (494)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB
T ss_pred             EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc
Confidence            99999999986554   4689999999999999999999999999999999999997533  359999999998877666


Q ss_pred             ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                      .....+||+.|+|||++.  ..|+.++|||||||++|+|++|..||. +....+.+..+......             . 
T Consensus       194 ~~~~~~gt~~y~aPE~l~--~~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~i~~~~~~-------------~-  256 (494)
T 3lij_A          194 KMKERLGTAYYIAPEVLR--KKYDEKCDVWSIGVILFILLAGYPPFG-GQTDQEILRKVEKGKYT-------------F-  256 (494)
T ss_dssp             CBCCCCSCTTTCCHHHHT--TCBCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHTCCC-------------C-
T ss_pred             cccccCCCcCeeCHHHHc--ccCCCchhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhCCCC-------------C-
Confidence            667778999999999976  469999999999999999999999983 33333333333211000             0 


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI  424 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~  424 (434)
                                         .......+++++.+||.+||+.||++|||+.|+|+||||+..
T Consensus       257 -------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          257 -------------------DSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             -------------------CSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             -------------------CchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence                               001112467899999999999999999999999999999875

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.9e-47  Score=366.34  Aligned_cols=271  Identities=20%  Similarity=0.306  Sum_probs=209.2

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      .++|.+.+.||+|+||.||+|.+..+++.||||+++..    ..+.+.+|+.+++.+ +||||+++++++.+......++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~l   86 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTTRHKVL   86 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCCcceEEEEeecCCCceEEE
Confidence            47899999999999999999999999999999999743    346678999999999 8999999999998776678899


Q ss_pred             EEeecCCCchhhhcCC------CChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEe----cCCCCeEEEEeccccee
Q 013897          209 IFEHVNNTDFKVLYPT------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI----DHEQRKLRLIDWGLAEF  278 (434)
Q Consensus       209 v~e~~~~~~l~~~~~~------l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll----~~~~~~vkl~DFGla~~  278 (434)
                      ||||+.+++|..++..      +++..++.++.||+.||+|||++||+||||||+|||+    +.++ .+||+|||+++.
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~-~~kL~Dfg~a~~  165 (319)
T 4euu_A           87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS-VYKLTDFGAARE  165 (319)
T ss_dssp             EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCE-EEEECCCTTCEE
T ss_pred             EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCc-eEEEccCCCcee
Confidence            9999999999777632      8999999999999999999999999999999999998    5444 799999999988


Q ss_pred             cCCCCccceeccCCcccccccccC-------CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCH---HHHHHHHHHhCC
Q 013897          279 YHPGKEYNVRVASRYFKGPELLVD-------LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNY---DQLVKIAKVLGT  348 (434)
Q Consensus       279 ~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~---~~~~~i~~~~g~  348 (434)
                      ...........||+.|+|||++..       ...++.++|||||||++|||++|+.||.......   +.+..+......
T Consensus       166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~  245 (319)
T 4euu_A          166 LEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS  245 (319)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCT
T ss_pred             cCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCc
Confidence            776666667789999999999852       2578999999999999999999999985433322   222222221110


Q ss_pred             hhHHHHHhhccccCChhHHHHhcccCCCCCcccc--ccccccCCchHHHHHHHHccccCCCCCccHHHHhcCC
Q 013897          349 DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFI--TVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHP  419 (434)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp  419 (434)
                      ...    .......          .....|....  .......+++.+.+||.+||+.||++|||++|+|+||
T Consensus       246 ~~~----~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~  304 (319)
T 4euu_A          246 GAI----SGVQKAE----------NGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET  304 (319)
T ss_dssp             TCC----EEEECST----------TCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred             ccc----hhhhccc----------CCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence            000    0000000          0000000000  0011123456789999999999999999999999997

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=8.9e-48  Score=392.76  Aligned_cols=254  Identities=27%  Similarity=0.502  Sum_probs=211.3

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecc------ccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      ++|++.+.||+|+||.||+|.+..+++.||||++..      .....+.+|+.+++++ +||||+++++++.+  ....+
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--~~~~~  102 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL-DHPNIMKLYEFFED--KGYFY  102 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSEEE
T ss_pred             CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhC-CCCCCCcEEEEEEe--CCEEE
Confidence            679999999999999999999999999999999853      2356789999999999 99999999999965  35778


Q ss_pred             EEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecC--CCCeEEEEecccceecCCC
Q 013897          208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--EQRKLRLIDWGLAEFYHPG  282 (434)
Q Consensus       208 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~--~~~~vkl~DFGla~~~~~~  282 (434)
                      +||||+.+++|...+   ..+++..++.++.||+.||.|||++||+||||||+|||++.  .+..+||+|||+++.....
T Consensus       103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  182 (484)
T 3nyv_A          103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS  182 (484)
T ss_dssp             EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence            999999999986654   46899999999999999999999999999999999999952  2348999999999877666


Q ss_pred             CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                      ......+||+.|+|||++.+  .|+.++|||||||++|+|++|+.||. +.+..+.+..+......              
T Consensus       183 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~i~~~~~~--------------  245 (484)
T 3nyv_A          183 KKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFN-GANEYDILKKVEKGKYT--------------  245 (484)
T ss_dssp             CSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHCCCC--------------
T ss_pred             cccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHcCCCC--------------
Confidence            66667789999999999875  69999999999999999999999983 33433333333211000              


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN  426 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~  426 (434)
                                         ........+++++.+||.+||+.||++|||+.|+|+||||+....
T Consensus       246 -------------------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~  290 (484)
T 3nyv_A          246 -------------------FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK  290 (484)
T ss_dssp             -------------------CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred             -------------------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence                               001112246789999999999999999999999999999986543

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=5.6e-47  Score=366.37  Aligned_cols=255  Identities=25%  Similarity=0.428  Sum_probs=205.0

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc-----------HHHHHHHHHHHHHhcCCCCeeeEeeEEEccC
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ  202 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  202 (434)
                      ++|.+.+.||+|+||.||+|.+..+++.||||++....           ...+.+|+.+++.+ +||||+++++++... 
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~-   87 (322)
T 2ycf_A           10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFDAE-   87 (322)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHC-CCTTBCCEEEEEESS-
T ss_pred             hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhC-CCCCCceEeeEEcCC-
Confidence            67999999999999999999999999999999986432           23478999999999 999999999998643 


Q ss_pred             CCccEEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCC--eEEEEecccce
Q 013897          203 SKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAE  277 (434)
Q Consensus       203 ~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~--~vkl~DFGla~  277 (434)
                        ..++||||+.+++|...+   ..+++..++.++.||+.||.|||++||+||||||+|||++.++.  .+||+|||++.
T Consensus        88 --~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~  165 (322)
T 2ycf_A           88 --DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK  165 (322)
T ss_dssp             --SEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred             --ceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence              368999999999987665   35889999999999999999999999999999999999986542  49999999998


Q ss_pred             ecCCCCccceeccCCccccccccc--CCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHH
Q 013897          278 FYHPGKEYNVRVASRYFKGPELLV--DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL  355 (434)
Q Consensus       278 ~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~  355 (434)
                      ............|++.|+|||++.  +...++.++|||||||++|+|++|..||............+...          
T Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~----------  235 (322)
T 2ycf_A          166 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG----------  235 (322)
T ss_dssp             ECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHT----------
T ss_pred             ecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhC----------
Confidence            775444445567999999999974  23578999999999999999999999985433322222221110          


Q ss_pred             hhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccc
Q 013897          356 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                         .....+.                    ....+++++.+||.+||..||++|||++|+|+||||+..+
T Consensus       236 ---~~~~~~~--------------------~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~  282 (322)
T 2ycf_A          236 ---KYNFIPE--------------------VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED  282 (322)
T ss_dssp             ---CCCCCHH--------------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHH
T ss_pred             ---ccccCch--------------------hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHH
Confidence               0000000                    1123678899999999999999999999999999998654

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=5.3e-47  Score=365.22  Aligned_cols=273  Identities=20%  Similarity=0.356  Sum_probs=199.4

Q ss_pred             CCCeEEE-eeeeecCceEEEEEEEcCCCeEEEEEEeccc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          133 QDDYEVV-RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       133 ~~~y~~~-~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      .+.|.+. +.||+|+||.||+|.+..+++.||||+++..   ....+.+|+.++.++.+||||+++++++.+.  ...++
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~--~~~~l   88 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE--DRFYL   88 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC--CEEEE
Confidence            4678885 7899999999999999889999999999643   3567899999999976899999999999754  57789


Q ss_pred             EEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCC--eEEEEecccceecCCCC
Q 013897          209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       209 v~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~--~vkl~DFGla~~~~~~~  283 (434)
                      ||||+.+++|..++   ..+++..++.++.||+.||+|||++||+||||||+|||++.++.  .+||+|||++.......
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~  168 (316)
T 2ac3_A           89 VFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG  168 (316)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC------
T ss_pred             EEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCC
Confidence            99999999987665   46899999999999999999999999999999999999986652  39999999987653221


Q ss_pred             --------ccceeccCCcccccccccCC----CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhH
Q 013897          284 --------EYNVRVASRYFKGPELLVDL----QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL  351 (434)
Q Consensus       284 --------~~~~~~~t~~y~aPE~~~~~----~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~  351 (434)
                              .....+||+.|+|||++.+.    ..++.++|||||||++|+|++|+.||.........+... .  .....
T Consensus       169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~-~--~~~~~  245 (316)
T 2ac3_A          169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRG-E--ACPAC  245 (316)
T ss_dssp             -------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC-------CCHHH
T ss_pred             ccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccc-c--cchhH
Confidence                    12344689999999998641    347889999999999999999999985432211000000 0  00000


Q ss_pred             HHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccc
Q 013897          352 NAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN  426 (434)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~  426 (434)
                      ...          ....+......  +    .......+++++.+||.+||+.||++|||++|+|+||||++...
T Consensus       246 ~~~----------~~~~i~~~~~~--~----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~  304 (316)
T 2ac3_A          246 QNM----------LFESIQEGKYE--F----PDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP  304 (316)
T ss_dssp             HHH----------HHHHHHHCCCC--C----CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC----
T ss_pred             HHH----------HHHHHhccCcc--c----CchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCC
Confidence            000          00000000000  0    00011236789999999999999999999999999999997653

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.6e-46  Score=354.56  Aligned_cols=255  Identities=23%  Similarity=0.364  Sum_probs=207.7

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      ++|++.+.||+|+||.||+|.+..+++.||+|+++..    ..+.+.+|+.+++.+ +||||+++++++.+.  ...++|
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv   83 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRREG--NIQYLF   83 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTC-CCTTBCCEEEEEEET--TEEEEE
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhc-CCCCceeeeeEEEcC--CEEEEE
Confidence            6799999999999999999999889999999998643    246788999999999 999999999999654  567899


Q ss_pred             EeecCCCchhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC---
Q 013897          210 FEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK---  283 (434)
Q Consensus       210 ~e~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~---  283 (434)
                      |||+.+++|..++.   .+++..+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||++.......   
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~  162 (276)
T 2yex_A           84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRER  162 (276)
T ss_dssp             EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEECEETTEEC
T ss_pred             EEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCC-CEEEeeCCCccccCCCcchh
Confidence            99999999887764   488999999999999999999999999999999999999776 89999999997653222   


Q ss_pred             ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                      ......|+..|+|||++.+...++.++|||||||++|+|++|+.||.........+..+...                  
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------------  224 (276)
T 2yex_A          163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK------------------  224 (276)
T ss_dssp             CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTT------------------
T ss_pred             cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhc------------------
Confidence            23455789999999998764445789999999999999999999995443332222221100                  


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccccc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA  427 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~  427 (434)
                               ..        .......+++.+.+||.+||..||++|||++|+++||||++....
T Consensus       225 ---------~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  271 (276)
T 2yex_A          225 ---------KT--------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKK  271 (276)
T ss_dssp             ---------CT--------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC-
T ss_pred             ---------cc--------ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChhhc
Confidence                     00        000112367889999999999999999999999999999976443

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=9.5e-47  Score=374.47  Aligned_cols=288  Identities=25%  Similarity=0.415  Sum_probs=215.2

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc--HHHHHHHHHHHHHhcC-------CCCeeeEeeEEEcc--
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCG-------GPNIVKLLDIVRDQ--  201 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~E~~~l~~l~~-------h~niv~l~~~~~~~--  201 (434)
                      .++|++++.||+|+||.||+|.+..+++.||||+++...  .+.+.+|+.+++.+.+       |+||+++++++...  
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~  115 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV  115 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence            478999999999999999999999999999999997543  4668899999999842       78899999998632  


Q ss_pred             CCCccEEEEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHC-CceeecCCCCceEecCCC-----------
Q 013897          202 QSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQ-----------  265 (434)
Q Consensus       202 ~~~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlKp~NIll~~~~-----------  265 (434)
                      .....++||||+.++.+..+.    ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++           
T Consensus       116 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~  195 (397)
T 1wak_A          116 NGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEAT  195 (397)
T ss_dssp             TEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC
T ss_pred             CCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhH
Confidence            345788999999777666554    3489999999999999999999998 999999999999998654           


Q ss_pred             -------------------------------------CeEEEEecccceecCCCCccceeccCCcccccccccCCCCCCc
Q 013897          266 -------------------------------------RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY  308 (434)
Q Consensus       266 -------------------------------------~~vkl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~  308 (434)
                                                           ..+||+|||++.....  .....+||+.|+|||++.+ ..++.
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~  272 (397)
T 1wak_A          196 EWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRSLEVLIG-SGYNT  272 (397)
T ss_dssp             ---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSCGGGCCHHHHHT-SCCCT
T ss_pred             HHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCCCcccCChhhcC-CCCCc
Confidence                                                 2699999999987643  3455689999999999987 67999


Q ss_pred             cccHHHHHHHHHHHHhCCCCCCCCCC-----CHHHHHHHHHHhCChhHHHHHhh-ccccCChhHHHHhcccCCCCCccc-
Q 013897          309 SLDLWSLGCMFAGMIFRKEPFFYGHD-----NYDQLVKIAKVLGTDELNAYLNK-YHIELDPHLAALVGRHSRKPWSKF-  381 (434)
Q Consensus       309 ~~DvwSlGvil~elltg~~pf~~~~~-----~~~~~~~i~~~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~-  381 (434)
                      ++|||||||++|||++|+.||.....     ..+.+..+.+.+|......+... +..........+.......++... 
T Consensus       273 ~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (397)
T 1wak_A          273 PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFE  352 (397)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHH
T ss_pred             HHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhH
Confidence            99999999999999999999854332     34556677777776433222110 000000000000000000000000 


Q ss_pred             ---cccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccc
Q 013897          382 ---ITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP  423 (434)
Q Consensus       382 ---~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~  423 (434)
                         .........++++.+||.+||+.||++|||++|+|+||||++
T Consensus       353 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          353 VLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             HHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             hhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence               000112234567899999999999999999999999999974

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.9e-46  Score=371.52  Aligned_cols=280  Identities=24%  Similarity=0.414  Sum_probs=212.8

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc--HHHHHHHHHHHHHhcCCCC-----eeeEeeEEEccCCCc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPN-----IVKLLDIVRDQQSKT  205 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~E~~~l~~l~~h~n-----iv~l~~~~~~~~~~~  205 (434)
                      .++|++.+.||+|+||+||+|.+..+++.||||+++...  ...+.+|+.+++.+.+|++     |+++++++...  ..
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~--~~  130 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR--NH  130 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET--TE
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC--Cc
Confidence            478999999999999999999999999999999997543  3567889999998865664     99999998654  57


Q ss_pred             cEEEEeecCCCchhhhc-----CCCChHHHHHHHHHHHHHHHHHH--HCCceeecCCCCceEecC-CCCeEEEEecccce
Q 013897          206 PSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCH--SQGIMHRDVKPHNVMIDH-EQRKLRLIDWGLAE  277 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH--~~~ivHrDlKp~NIll~~-~~~~vkl~DFGla~  277 (434)
                      .++||||+.+ +|..++     ..+++..++.++.||+.||.|||  +.||+||||||+|||++. +...+||+|||+++
T Consensus       131 ~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~  209 (382)
T 2vx3_A          131 LCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC  209 (382)
T ss_dssp             EEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             eEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCce
Confidence            7899999986 554443     34889999999999999999999  579999999999999953 23379999999998


Q ss_pred             ecCCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhh
Q 013897          278 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK  357 (434)
Q Consensus       278 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  357 (434)
                      ....  .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.|| .+.+..+.+..+.+.++.+....+.. 
T Consensus       210 ~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~-  284 (382)
T 2vx3_A          210 QLGQ--RIYQYIQSRFYRSPEVLLG-MPYDLAIDMWSLGCILVEMHTGEPLF-SGANEVDQMNKIVEVLGIPPAHILDQ-  284 (382)
T ss_dssp             ETTC--CCCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCSCCHHHHTT-
T ss_pred             eccc--ccccccCCccccChHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHHh-
Confidence            7643  3345688999999999987 67999999999999999999999887 56666777888888777654322110 


Q ss_pred             ccccCChhHHHHhcccCCCCCcccc--------------------cc----------c---cccCCchHHHHHHHHcccc
Q 013897          358 YHIELDPHLAALVGRHSRKPWSKFI--------------------TV----------E---NQHLAVPEAVDFLDKLLRY  404 (434)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~----------~---~~~~~~~~~~dll~~cL~~  404 (434)
                           .+.............|....                    ..          .   ......+++.+||.+||+.
T Consensus       285 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~  359 (382)
T 2vx3_A          285 -----APKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDY  359 (382)
T ss_dssp             -----CTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCS
T ss_pred             -----hHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCC
Confidence                 11111111111111110000                    00          0   0000114789999999999


Q ss_pred             CCCCCccHHHHhcCCCccccc
Q 013897          405 DHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       405 dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                      ||++|||++|+|+||||++..
T Consensus       360 dP~~Rpta~e~L~hp~f~~~~  380 (382)
T 2vx3_A          360 DPKTRIQPYYALQHSFFKKTA  380 (382)
T ss_dssp             CTTTSCCHHHHTTSGGGCC--
T ss_pred             ChhhCCCHHHHhcCcccccCC
Confidence            999999999999999999764

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.6e-46  Score=361.85  Aligned_cols=286  Identities=27%  Similarity=0.477  Sum_probs=210.7

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHHHhcCCCCeeeEeeEEEcc--------
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQ--------  201 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--------  201 (434)
                      .++|.+++.||+|+||.||+|.+..+++.||+|++....   .+.+.+|+.+++.+ +||||+++++++...        
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~   88 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRL-DHDNIVKVFEILGPSGSQLTDDV   88 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECTTSCBCCC--
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhc-CCCCeeEEEEecccccccccccc
Confidence            478999999999999999999999899999999986443   35678999999999 999999999988532        


Q ss_pred             ----CCCccEEEEeecCCCchhhhcC--CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEeccc
Q 013897          202 ----QSKTPSLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL  275 (434)
Q Consensus       202 ----~~~~~~lv~e~~~~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGl  275 (434)
                          .....++||||+.+ +|..++.  .+++..++.++.||+.||+|||++||+||||||+|||++.++..+||+|||+
T Consensus        89 ~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~  167 (320)
T 2i6l_A           89 GSLTELNSVYIVQEYMET-DLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGL  167 (320)
T ss_dssp             --CCSCSEEEEEEECCSE-EHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTT
T ss_pred             ccccccCceeEEeeccCC-CHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCcc
Confidence                23567899999984 7766653  4889999999999999999999999999999999999986555899999999


Q ss_pred             ceecCCC----CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhH
Q 013897          276 AEFYHPG----KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL  351 (434)
Q Consensus       276 a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~  351 (434)
                      ++.....    .......++..|+|||.+.+...++.++|||||||++|||++|+.|| .+....+.+..+....+....
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf-~~~~~~~~~~~~~~~~~~~~~  246 (320)
T 2i6l_A          168 ARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLF-AGAHELEQMQLILESIPVVHE  246 (320)
T ss_dssp             CBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHSCCCCH
T ss_pred             ccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCCch
Confidence            9865432    12234567889999999876568999999999999999999999998 444555556666555443322


Q ss_pred             HHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccccc
Q 013897          352 NAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~  428 (434)
                      ..... ....+......... ....++     ......+++++.+||.+||+.||++|||++|+|+||||+....+.
T Consensus       247 ~~~~~-~~~~~~~~~~~~~~-~~~~~~-----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~  316 (320)
T 2i6l_A          247 EDRQE-LLSVIPVYIRNDMT-EPHKPL-----TQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPM  316 (320)
T ss_dssp             HHHHH-HHTTSCHHHHHHTT-SCCCCH-----HHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC--
T ss_pred             hhhhh-hhhcCccccccccc-CCCCCh-----hHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCcc
Confidence            22111 11111111111000 000000     011224678999999999999999999999999999999876554

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.7e-46  Score=355.96  Aligned_cols=253  Identities=21%  Similarity=0.379  Sum_probs=204.1

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEcc--CCCc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ--QSKT  205 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~~~  205 (434)
                      ...|.+.+.||+|+||.||+|.+..++..||+|++...     ..+.+.+|+.+++.+ +||||+++++++.+.  ....
T Consensus        25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~  103 (290)
T 1t4h_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKC  103 (290)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCEE
T ss_pred             ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeeccccCCCce
Confidence            35589999999999999999999999999999998643     235688999999999 999999999998653  3456


Q ss_pred             cEEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCC--ceeecCCCCceEecCCCCeEEEEecccceecC
Q 013897          206 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH  280 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~  280 (434)
                      +++||||+.+++|..++   ..+++..++.++.||+.||.|||+++  |+||||||+|||++.+++.+||+|||++....
T Consensus       104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~  183 (290)
T 1t4h_A          104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence            88999999999998776   46899999999999999999999999  99999999999998444489999999997543


Q ss_pred             CCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccc
Q 013897          281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI  360 (434)
Q Consensus       281 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  360 (434)
                       ........|++.|+|||++.+  .++.++|||||||++|+|++|+.||............+....              
T Consensus       184 -~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~--------------  246 (290)
T 1t4h_A          184 -ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV--------------  246 (290)
T ss_dssp             -TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC--------------
T ss_pred             -ccccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccC--------------
Confidence             233455679999999998764  589999999999999999999999843332222211111000              


Q ss_pred             cCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccc
Q 013897          361 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI  424 (434)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~  424 (434)
                                           .........++++.+||.+||+.||++|||++|+|+||||++.
T Consensus       247 ---------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~  289 (290)
T 1t4h_A          247 ---------------------KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             ---------------------CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             ---------------------CccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence                                 0011122356789999999999999999999999999999863

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.6e-46  Score=355.24  Aligned_cols=253  Identities=23%  Similarity=0.453  Sum_probs=184.6

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....      .+.+.+|+.+++.+ +||||+++++++.+.  ...
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~   86 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-KHPSILELYNYFEDS--NYV   86 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTB-CCTTBCCEEEEEECS--SEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhC-CCCCeEeEEEEEccC--CeE
Confidence            367999999999999999999998899999999986432      35688999999999 899999999999654  567


Q ss_pred             EEEEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC
Q 013897          207 SLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG  282 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~  282 (434)
                      ++||||+.+++|..++    ..+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++......
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~-~~kl~dfg~~~~~~~~  165 (278)
T 3cok_A           87 YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNM-NIKIADFGLATQLKMP  165 (278)
T ss_dssp             EEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTC-CEEECCCTTCEECC--
T ss_pred             EEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-CEEEEeecceeeccCC
Confidence            8999999999987665    3589999999999999999999999999999999999999776 8999999999876432


Q ss_pred             -CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcccc
Q 013897          283 -KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE  361 (434)
Q Consensus       283 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  361 (434)
                       .......|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...... ..+..+                   
T Consensus       166 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~-------------------  224 (278)
T 3cok_A          166 HEKHYTLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK-NTLNKV-------------------  224 (278)
T ss_dssp             ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------C-------------------
T ss_pred             CCcceeccCCCCcCCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCChhHH-HHHHHH-------------------
Confidence             22344678999999999876 67899999999999999999999998432211 111000                   


Q ss_pred             CChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccccc
Q 013897          362 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~  428 (434)
                              .    .      .....+..+++++.+||.+||+.||++|||++++|+||||.......
T Consensus       225 --------~----~------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~  273 (278)
T 3cok_A          225 --------V----L------ADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSSTK  273 (278)
T ss_dssp             --------C----S------SCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC------
T ss_pred             --------h----h------cccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCCCcc
Confidence                    0    0      00111234678999999999999999999999999999999766544

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.6e-47  Score=371.19  Aligned_cols=258  Identities=22%  Similarity=0.387  Sum_probs=205.8

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEc---CCCeEEEEEEeccc-------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHC---TDNEKCIIKILKPV-------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ  202 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~---~~~~~vaiK~~~~~-------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  202 (434)
                      .++|++++.||+|+||.||+|++.   .+++.||||+++..       ..+.+.+|+.+++.+.+||||+++++++.+. 
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-  131 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE-  131 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC-
Confidence            368999999999999999999984   47899999998642       2356788999999997899999999999654 


Q ss_pred             CCccEEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceec
Q 013897          203 SKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY  279 (434)
Q Consensus       203 ~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~  279 (434)
                       ...++||||+.+++|..++   ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus       132 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~a~~~  209 (355)
T 1vzo_A          132 -TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG-HVVLTDFGLSKEF  209 (355)
T ss_dssp             -TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEESCSSEEEEC
T ss_pred             -ceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-cEEEeeCCCCeec
Confidence             5678999999999987765   4689999999999999999999999999999999999999776 8999999999865


Q ss_pred             CCCC--ccceeccCCcccccccccC-CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHh
Q 013897          280 HPGK--EYNVRVASRYFKGPELLVD-LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN  356 (434)
Q Consensus       280 ~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~  356 (434)
                      ....  .....+||+.|+|||++.+ ...++.++|||||||++|||++|+.||......... ..+.+.           
T Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~-----------  277 (355)
T 1vzo_A          210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ-AEISRR-----------  277 (355)
T ss_dssp             CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH-HHHHHH-----------
T ss_pred             ccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH-HHHHHH-----------
Confidence            4322  2234579999999999875 235789999999999999999999998543222111 111100           


Q ss_pred             hccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCc-----cHHHHhcCCCccccccc
Q 013897          357 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-----TAKEAMAHPYFFPIRNA  427 (434)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rp-----t~~elL~Hp~~~~~~~~  427 (434)
                                  .....          ......+++.+.+||.+||..||++||     +++|+++||||+++++.
T Consensus       278 ------------~~~~~----------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~  331 (355)
T 1vzo_A          278 ------------ILKSE----------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWD  331 (355)
T ss_dssp             ------------HHHCC----------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHH
T ss_pred             ------------HhccC----------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChh
Confidence                        00000          011123678899999999999999999     99999999999987643

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.5e-46  Score=373.14  Aligned_cols=252  Identities=25%  Similarity=0.446  Sum_probs=196.9

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcC-CCCeeeEeeEEEccCCCcc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCG-GPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~-h~niv~l~~~~~~~~~~~~  206 (434)
                      .++|++++.||+|+||.||+|.+. +++.||||++...     ..+.+.+|+.+|+.+.+ ||||+++++++...  ..+
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~--~~~  131 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD--QYI  131 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcC-CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC--CEE
Confidence            356999999999999999999875 4899999998643     23568899999999954 69999999998754  468


Q ss_pred             EEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC
Q 013897          207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~  283 (434)
                      ++||| +.+++|..++   ..+++.+++.++.||+.||+|||++||+||||||+|||++ ++ .+||+|||+++......
T Consensus       132 ~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~-~~kl~DFG~a~~~~~~~  208 (390)
T 2zmd_A          132 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DG-MLKLIDFGIANQMQPDT  208 (390)
T ss_dssp             EEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SS-CEEECCCSSSCCC----
T ss_pred             EEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CC-eEEEEecCccccccCCC
Confidence            89999 5667776654   4588889999999999999999999999999999999996 44 79999999998765432


Q ss_pred             c---cceeccCCcccccccccCC----------CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChh
Q 013897          284 E---YNVRVASRYFKGPELLVDL----------QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE  350 (434)
Q Consensus       284 ~---~~~~~~t~~y~aPE~~~~~----------~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~  350 (434)
                      .   ....+||+.|+|||++.+.          ..++.++|||||||++|||++|+.||.........+..+   +..  
T Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~---~~~--  283 (390)
T 2zmd_A          209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI---IDP--  283 (390)
T ss_dssp             -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH---HCT--
T ss_pred             ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHH---hCc--
Confidence            2   2456799999999998641          368999999999999999999999994332222222111   110  


Q ss_pred             HHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccc
Q 013897          351 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                                            ...        ...+...++++.+||.+||+.||++|||+.|+|+||||+...
T Consensus       284 ----------------------~~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  328 (390)
T 2zmd_A          284 ----------------------NHE--------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  328 (390)
T ss_dssp             ----------------------TSC--------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             ----------------------ccc--------CCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence                                  000        111223467899999999999999999999999999998543

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.2e-46  Score=358.06  Aligned_cols=253  Identities=23%  Similarity=0.411  Sum_probs=188.2

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHH-HHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKI-LQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~E~~~-l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      .++|++++.||+|+||.||+|.+..+++.||+|+++...    ..+...|... ++.+ +||||+++++++.+.  ...+
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~iv~~~~~~~~~--~~~~   82 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTV-DCPFTVTFYGALFRE--GDVW   82 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEECS--SSEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhC-CCCeEEEEeeeeecc--CCEE
Confidence            478999999999999999999999999999999996532    1223334444 5555 999999999999754  5678


Q ss_pred             EEEeecCCCchhhhc-------CCCChHHHHHHHHHHHHHHHHHHHC-CceeecCCCCceEecCCCCeEEEEecccceec
Q 013897          208 LIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY  279 (434)
Q Consensus       208 lv~e~~~~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~  279 (434)
                      +||||+.+ ++..++       ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++...
T Consensus        83 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~  160 (290)
T 3fme_A           83 ICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALG-QVKMCDFGISGYL  160 (290)
T ss_dssp             EEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTC-CEEBCCC------
T ss_pred             EEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC-CEEEeecCCcccc
Confidence            99999986 443332       4689999999999999999999998 999999999999999766 8999999999877


Q ss_pred             CCCCccceeccCCccccccccc---CCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHh
Q 013897          280 HPGKEYNVRVASRYFKGPELLV---DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN  356 (434)
Q Consensus       280 ~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~  356 (434)
                      ..........|++.|+|||++.   ....++.++|||||||++|+|++|+.||.........+........         
T Consensus       161 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------  231 (290)
T 3fme_A          161 VDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS---------  231 (290)
T ss_dssp             ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCC---------
T ss_pred             cccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCC---------
Confidence            6555555668999999999972   3357899999999999999999999999543333333322211000         


Q ss_pred             hccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccc
Q 013897          357 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                                       .         ......+++++.+||.+||+.||++|||+.|+|+||||+...
T Consensus       232 -----------------~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~  274 (290)
T 3fme_A          232 -----------------P---------QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE  274 (290)
T ss_dssp             -----------------C---------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             -----------------C---------CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence                             0         001123678899999999999999999999999999998654

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=4.1e-46  Score=362.53  Aligned_cols=252  Identities=23%  Similarity=0.411  Sum_probs=209.1

Q ss_pred             CCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCc
Q 013897          132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT  205 (434)
Q Consensus       132 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  205 (434)
                      ..++|.+.+.||+|+||.||++.+..+++.||+|++...      ..+.+.+|+.+++.+ +||||+++++++.+.  ..
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~  115 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDN--DF  115 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECS--SE
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecC--Ce
Confidence            357899999999999999999999999999999998643      246688999999999 999999999999754  56


Q ss_pred             cEEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC
Q 013897          206 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG  282 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~  282 (434)
                      .++||||+.+++|..++   ..+++.++..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++......
T Consensus       116 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~  194 (335)
T 2owb_A          116 VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYD  194 (335)
T ss_dssp             EEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCCTTCEECCST
T ss_pred             EEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCC-CEEEeeccCceecccC
Confidence            78999999999987765   4689999999999999999999999999999999999999776 8999999999876432


Q ss_pred             -CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcccc
Q 013897          283 -KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE  361 (434)
Q Consensus       283 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  361 (434)
                       .......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.. ....+....+...             .  
T Consensus       195 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~~~~~-------------~--  257 (335)
T 2owb_A          195 GERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFET-SCLKETYLRIKKN-------------E--  257 (335)
T ss_dssp             TCCBCCCCSCCSSCCHHHHHT-SCBCTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHT-------------C--
T ss_pred             cccccccCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHHHCcCCCCC-CCHHHHHHHHhcC-------------C--
Confidence             33455678999999999877 6789999999999999999999999842 2222222211100             0  


Q ss_pred             CChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccc
Q 013897          362 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN  426 (434)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~  426 (434)
                                            ......+++.+.+||.+||+.||++|||++|+|+||||+....
T Consensus       258 ----------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~  300 (335)
T 2owb_A          258 ----------------------YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI  300 (335)
T ss_dssp             ----------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred             ----------------------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCc
Confidence                                  0011236788999999999999999999999999999986543

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=5e-46  Score=352.66  Aligned_cols=247  Identities=18%  Similarity=0.247  Sum_probs=199.8

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      .++|++.+.||+|+||.||+|.+..+++.||+|+++..     ....+.+|+.++..+.+||||+++++++.+.  ...+
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~--~~~~   87 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED--DHML   87 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET--TEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC--CeEE
Confidence            36799999999999999999999889999999998742     3456788999999987999999999999654  5778


Q ss_pred             EEEeecCCCchhhhc-------CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCC---------------
Q 013897          208 LIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ---------------  265 (434)
Q Consensus       208 lv~e~~~~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~---------------  265 (434)
                      +||||+.+++|..++       ..+++..++.++.||+.||.|||++||+||||||+|||++.++               
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~  167 (289)
T 1x8b_A           88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA  167 (289)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------------
T ss_pred             EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence            999999999987765       4589999999999999999999999999999999999998432               


Q ss_pred             ---CeEEEEecccceecCCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHH
Q 013897          266 ---RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKI  342 (434)
Q Consensus       266 ---~~vkl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i  342 (434)
                         ..+||+|||++......   ....|++.|+|||++.+...++.++|||||||++|+|++|..|+...    .....+
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~~~~~~  240 (289)
T 1x8b_A          168 SNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----DQWHEI  240 (289)
T ss_dssp             --CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS----HHHHHH
T ss_pred             CCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch----hHHHHH
Confidence               26999999999876433   33468999999999987456778999999999999999998665221    111111


Q ss_pred             HHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcc
Q 013897          343 AKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFF  422 (434)
Q Consensus       343 ~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~  422 (434)
                      .+                           ...         ......+++++.+||.+||..||++|||+.|+|+||||+
T Consensus       241 ~~---------------------------~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~  284 (289)
T 1x8b_A          241 RQ---------------------------GRL---------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL  284 (289)
T ss_dssp             HT---------------------------TCC---------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC-
T ss_pred             Hc---------------------------CCC---------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhh
Confidence            10                           000         011124678999999999999999999999999999998


Q ss_pred             cc
Q 013897          423 PI  424 (434)
Q Consensus       423 ~~  424 (434)
                      +.
T Consensus       285 ~~  286 (289)
T 1x8b_A          285 SA  286 (289)
T ss_dssp             --
T ss_pred             hh
Confidence            75

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=4.3e-46  Score=351.73  Aligned_cols=250  Identities=24%  Similarity=0.394  Sum_probs=197.4

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      .++|.+.+.||+|+||.||+|.+..+++.||||++...      ..+.+.+|+.+++.+ +||||+++++++.+.  ...
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~   86 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF-RHPHIIKLYQVISTP--TDF   86 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECS--SEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcC-CCCCEeEEEEEEecC--CeE
Confidence            36899999999999999999999889999999998643      235688999999999 899999999999654  567


Q ss_pred             EEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC
Q 013897          207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~  283 (434)
                      ++||||+.+++|..++   ..+++..+..++.||+.||.|||++||+|+||||+|||++.++ .+||+|||++.......
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~~l~dfg~~~~~~~~~  165 (276)
T 2h6d_A           87 FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHM-NAKIADFGLSNMMSDGE  165 (276)
T ss_dssp             EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTS-CEEECCCCGGGCCCC--
T ss_pred             EEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCC-CEEEeecccccccCCCc
Confidence            8999999999987665   4689999999999999999999999999999999999999776 89999999998766554


Q ss_pred             ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                      ......+++.|+|||.+.+....+.++|||||||++|+|++|+.||.. .........+..                   
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~-------------------  225 (276)
T 2h6d_A          166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD-EHVPTLFKKIRG-------------------  225 (276)
T ss_dssp             -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHH-------------------
T ss_pred             ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCC-CcHHHHHHHhhc-------------------
Confidence            455668899999999988733346899999999999999999999842 221111111110                   


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI  424 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~  424 (434)
                              ..          ...+..+++++.+||.+||+.||++|||++|+|+||||++.
T Consensus       226 --------~~----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          226 --------GV----------FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             --------CC----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             --------Cc----------ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence                    00          00112356789999999999999999999999999999864

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=5.3e-46  Score=355.73  Aligned_cols=259  Identities=25%  Similarity=0.414  Sum_probs=205.3

Q ss_pred             CCCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       131 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      ...+.|++++.||+|+||.||+|.+..+++.||+|++...   ..+.+.+|+.+++.+ +||||+++++++.+.  ...+
T Consensus        16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~   92 (302)
T 2j7t_A           16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATC-DHPYIVKLLGAYYHD--GKLW   92 (302)
T ss_dssp             CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHC-CCTTBCCEEEEEECC---CEE
T ss_pred             CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcC-CCCCEeeeeeeeeeC--CeEE
Confidence            3457899999999999999999999989999999998643   346788999999999 999999999999754  5678


Q ss_pred             EEEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC-
Q 013897          208 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-  282 (434)
Q Consensus       208 lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~-  282 (434)
                      +||||+.+++|..++    ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...... 
T Consensus        93 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~  171 (302)
T 2j7t_A           93 IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEG-DIRLADFGVSAKNLKTL  171 (302)
T ss_dssp             EEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTS-CEEECCCHHHHHHHHHH
T ss_pred             EEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCC-CEEEEECCCCccccccc
Confidence            999999999987654    4689999999999999999999999999999999999999776 8999999997533211 


Q ss_pred             CccceeccCCccccccccc----CCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhc
Q 013897          283 KEYNVRVASRYFKGPELLV----DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY  358 (434)
Q Consensus       283 ~~~~~~~~t~~y~aPE~~~----~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  358 (434)
                      .......|+..|+|||++.    ....++.++|||||||++|+|++|+.||.. .+.......+....            
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~------------  238 (302)
T 2j7t_A          172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE-LNPMRVLLKIAKSD------------  238 (302)
T ss_dssp             HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSC------------
T ss_pred             cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCcc-CCHHHHHHHHhccC------------
Confidence            1223457899999999984    236789999999999999999999999842 22222222211100            


Q ss_pred             cccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccccc
Q 013897          359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~  428 (434)
                                     .       ........++.++.+||.+||..||++|||+.|+|+||||+.+...+
T Consensus       239 ---------------~-------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  286 (302)
T 2j7t_A          239 ---------------P-------PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNK  286 (302)
T ss_dssp             ---------------C-------CCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCCCH
T ss_pred             ---------------C-------cccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhccch
Confidence                           0       00111233678899999999999999999999999999999887543

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=3.7e-46  Score=357.59  Aligned_cols=252  Identities=25%  Similarity=0.401  Sum_probs=205.0

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF  210 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  210 (434)
                      ++|.+.+.||+|+||.||+|.+..+++.||+|+++..   ..+.+.+|+.+++.+ +||||+++++++.+.  ...++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~   85 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKI-KHENIVTLEDIYEST--THYYLVM   85 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHC-CCTTBCCEEEEEECS--SEEEEEE
T ss_pred             ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhC-CCCCeeehhhhcccC--CEEEEEE
Confidence            6799999999999999999999989999999999753   335688999999999 999999999999654  5678999


Q ss_pred             eecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEe---cCCCCeEEEEecccceecCCCCc
Q 013897          211 EHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGKE  284 (434)
Q Consensus       211 e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll---~~~~~~vkl~DFGla~~~~~~~~  284 (434)
                      ||+.+++|...+   ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++ .+||+|||++..... ..
T Consensus        86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~-~~kl~Dfg~~~~~~~-~~  163 (304)
T 2jam_A           86 QLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENS-KIMITDFGLSKMEQN-GI  163 (304)
T ss_dssp             CCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTC-CEEBCSCSTTCCCCC-BT
T ss_pred             EcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCC-CEEEccCCcceecCC-Cc
Confidence            999999986654   468999999999999999999999999999999999999   5444 899999999975432 23


Q ss_pred             cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCCh
Q 013897          285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP  364 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  364 (434)
                      .....|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.. .........+.+...             ..  
T Consensus       164 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~-------------~~--  226 (304)
T 2jam_A          164 MSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYE-ETESKLFEKIKEGYY-------------EF--  226 (304)
T ss_dssp             THHHHSCCCBCCTTTBSS-CSCCHHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHCCC-------------CC--
T ss_pred             cccccCCCCccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCC-------------CC--
Confidence            345678999999999876 6899999999999999999999999843 222222222211000             00  


Q ss_pred             hHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccc
Q 013897          365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                                        .......+++++.+||.+||..||++|||++|+|+||||++..
T Consensus       227 ------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (304)
T 2jam_A          227 ------------------ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT  269 (304)
T ss_dssp             ------------------CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred             ------------------CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence                              0011123678999999999999999999999999999998754

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=6e-46  Score=363.35  Aligned_cols=249  Identities=26%  Similarity=0.410  Sum_probs=202.5

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      +.|.+++.||+|+||.||+|.+..+++.||||++...      ..+.+.+|+.+++++ +||||+++++++.+.  ...+
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~--~~~~  130 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLRE--HTAW  130 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEET--TEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEEC--CeEE
Confidence            5699999999999999999999999999999998642      125688999999999 999999999999754  5678


Q ss_pred             EEEeecCCCchhhh---cCCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc
Q 013897          208 LIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE  284 (434)
Q Consensus       208 lv~e~~~~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~  284 (434)
                      +||||+.++.+..+   ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.....   
T Consensus       131 lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~---  206 (348)
T 1u5q_A          131 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG-LVKLGDFGSASIMAP---  206 (348)
T ss_dssp             EEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT-EEEECCCTTCBSSSS---
T ss_pred             EEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC-CEEEeeccCceecCC---
Confidence            99999986443332   25689999999999999999999999999999999999999776 899999999976543   


Q ss_pred             cceeccCCcccccccccC--CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          285 YNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~--~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                      ....+||+.|+|||++.+  ...++.++|||||||++|||++|+.||... +....+..+...                 
T Consensus       207 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~-~~~~~~~~~~~~-----------------  268 (348)
T 1u5q_A          207 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQN-----------------  268 (348)
T ss_dssp             BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHS-----------------
T ss_pred             CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHhc-----------------
Confidence            244679999999999852  357899999999999999999999998432 222222222110                 


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                                ...        ......+++.+.+||.+||+.||++|||++++|+||||....
T Consensus       269 ----------~~~--------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~  313 (348)
T 1u5q_A          269 ----------ESP--------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  313 (348)
T ss_dssp             ----------CCC--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             ----------CCC--------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccC
Confidence                      000        001123678899999999999999999999999999998654

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.2e-46  Score=358.46  Aligned_cols=258  Identities=24%  Similarity=0.419  Sum_probs=203.3

Q ss_pred             CCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecc--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccC----CCc
Q 013897          132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ----SKT  205 (434)
Q Consensus       132 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~--~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----~~~  205 (434)
                      ..++|++++.||+|+||.||+|.+..+++.||||++..  .....+.+|+.+++++.+||||+++++++....    ...
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~  101 (326)
T 2x7f_A           22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ  101 (326)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccce
Confidence            35789999999999999999999988999999999864  345778999999999978999999999997643    457


Q ss_pred             cEEEEeecCCCchhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecC
Q 013897          206 PSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH  280 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~  280 (434)
                      .++||||+.+++|..++     ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~~~~  180 (326)
T 2x7f_A          102 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLD  180 (326)
T ss_dssp             EEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC-CEEECCCTTTC---
T ss_pred             EEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCC-CEEEeeCcCceecC
Confidence            89999999999987765     3588999999999999999999999999999999999999776 89999999997654


Q ss_pred             CC-CccceeccCCcccccccccC----CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHH
Q 013897          281 PG-KEYNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL  355 (434)
Q Consensus       281 ~~-~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~  355 (434)
                      .. .......|+..|+|||++.+    ...++.++|||||||++|+|++|+.||.. .........+..           
T Consensus       181 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~-----------  248 (326)
T 2x7f_A          181 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD-MHPMRALFLIPR-----------  248 (326)
T ss_dssp             ----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHH-----------
T ss_pred             cCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCC-CcHHHHHHHhhc-----------
Confidence            32 22345578999999999862    25688999999999999999999999832 222222111110           


Q ss_pred             hhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccc
Q 013897          356 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN  426 (434)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~  426 (434)
                                      . ..       .......+++.+.+||.+||..||++|||++|+|+||||+....
T Consensus       249 ----------------~-~~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~  295 (326)
T 2x7f_A          249 ----------------N-PA-------PRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPN  295 (326)
T ss_dssp             ----------------S-CC-------CCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTT
T ss_pred             ----------------C-cc-------ccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCcc
Confidence                            0 00       00012236789999999999999999999999999999997654

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=5.6e-46  Score=352.76  Aligned_cols=249  Identities=23%  Similarity=0.437  Sum_probs=206.7

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++...      ....+.+|+.+++.+ +||||+++++++.+.  ...
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~   89 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-RHPNILRMYNYFHDR--KRI   89 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECS--SEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcC-CCCCEeeEEEEEEcC--CEE
Confidence            37899999999999999999999999999999998542      245688999999999 899999999999654  567


Q ss_pred             EEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC
Q 013897          207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~  283 (434)
                      ++||||+.+++|..++   ..+++..+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||++..... .
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~Dfg~~~~~~~-~  167 (284)
T 2vgo_A           90 YLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKG-ELKIADFGWSVHAPS-L  167 (284)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTC-CEEECCCTTCEECSS-S
T ss_pred             EEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCC-CEEEecccccccCcc-c
Confidence            8999999999887665   4589999999999999999999999999999999999999776 899999999976543 2


Q ss_pred             ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                      ......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.. ....+....+..                   
T Consensus       168 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~~~~-------------------  226 (284)
T 2vgo_A          168 RRRTMCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDS-PSHTETHRRIVN-------------------  226 (284)
T ss_dssp             CBCCCCSCGGGCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHT-------------------
T ss_pred             ccccccCCCCcCCHHHhcc-CCCCcccchhhHHHHHHHHHHCCCCCCC-CCHhHHHHHHhc-------------------
Confidence            3345678999999999887 6789999999999999999999999842 222222111110                   


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                              .          ....+..+++++.+||.+||..||++|||++|+|+||||+...
T Consensus       227 --------~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~  270 (284)
T 2vgo_A          227 --------V----------DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS  270 (284)
T ss_dssp             --------T----------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred             --------c----------ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence                    0          0011123678899999999999999999999999999998654

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=5.9e-46  Score=354.35  Aligned_cols=252  Identities=23%  Similarity=0.414  Sum_probs=208.5

Q ss_pred             CCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCc
Q 013897          132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT  205 (434)
Q Consensus       132 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  205 (434)
                      ..++|.+.+.||+|+||.||+|.+..+++.+|+|++...      ..+.+.+|+.+++.+ +||||+++++++.+.  ..
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~   89 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDN--DF   89 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECS--SE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhC-CCCCEeeeeeeeccC--CE
Confidence            357899999999999999999999999999999998543      245688999999999 999999999999654  56


Q ss_pred             cEEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC
Q 013897          206 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG  282 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~  282 (434)
                      .++||||+.+++|..+.   ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++......
T Consensus        90 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~  168 (294)
T 2rku_A           90 VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYD  168 (294)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECCST
T ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCC-CEEEEeccCceecccC
Confidence            78999999999987765   4689999999999999999999999999999999999999776 8999999999876432


Q ss_pred             -CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcccc
Q 013897          283 -KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE  361 (434)
Q Consensus       283 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  361 (434)
                       .......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.. ....+....+..                 
T Consensus       169 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~-----------------  229 (294)
T 2rku_A          169 GERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFET-SCLKETYLRIKK-----------------  229 (294)
T ss_dssp             TCCBCCCCSCCSSCCHHHHTT-SCBCTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHT-----------------
T ss_pred             ccccccccCCCCcCCcchhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhh-----------------
Confidence             23345678999999999876 6789999999999999999999999832 222221111100                 


Q ss_pred             CChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccc
Q 013897          362 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN  426 (434)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~  426 (434)
                                .          .......+++.+.+||.+||+.||++|||++|+|+||||+....
T Consensus       230 ----------~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~  274 (294)
T 2rku_A          230 ----------N----------EYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI  274 (294)
T ss_dssp             ----------T----------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred             ----------c----------cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCc
Confidence                      0          00111236788999999999999999999999999999986643

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.6e-46  Score=365.18  Aligned_cols=251  Identities=25%  Similarity=0.443  Sum_probs=194.4

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCC-CCeeeEeeEEEccCCCcc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGG-PNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h-~niv~l~~~~~~~~~~~~  206 (434)
                      .+.|++++.||+|+||.||+|.+ .+++.||||+++..     ..+.+.+|+.+|+.+.+| |||+++++++.+.  ...
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~--~~~   84 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD--QYI   84 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC--CEE
Confidence            46799999999999999999987 56899999998642     235688999999999433 9999999999654  577


Q ss_pred             EEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC
Q 013897          207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~  283 (434)
                      ++||| +.+++|..++   ..+++.+++.++.||+.||+|||++||+||||||+|||++ ++ .+||+|||+++......
T Consensus        85 ~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~-~~kl~DFG~a~~~~~~~  161 (343)
T 3dbq_A           85 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DG-MLKLIDFGIANQMQPDT  161 (343)
T ss_dssp             EEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TT-EEEECCCSSSCCC----
T ss_pred             EEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CC-cEEEeecccccccCccc
Confidence            89999 5566776554   4689999999999999999999999999999999999998 45 79999999998765433


Q ss_pred             c---cceeccCCcccccccccC----------CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChh
Q 013897          284 E---YNVRVASRYFKGPELLVD----------LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE  350 (434)
Q Consensus       284 ~---~~~~~~t~~y~aPE~~~~----------~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~  350 (434)
                      .   ....+||+.|+|||++.+          ...++.++|||||||++|||++|+.||.........+..+   ...  
T Consensus       162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~---~~~--  236 (343)
T 3dbq_A          162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI---IDP--  236 (343)
T ss_dssp             --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH---HCT--
T ss_pred             ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHH---hcC--
Confidence            2   235679999999999853          2468899999999999999999999984332222211111   100  


Q ss_pred             HHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccc
Q 013897          351 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI  424 (434)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~  424 (434)
                                            ..        ....+...++++.+||.+||+.||++|||+.|+|+||||+..
T Consensus       237 ----------------------~~--------~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  280 (343)
T 3dbq_A          237 ----------------------NH--------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  280 (343)
T ss_dssp             ----------------------TS--------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             ----------------------Cc--------ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence                                  00        011122356789999999999999999999999999999843

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=6.5e-47  Score=373.38  Aligned_cols=262  Identities=17%  Similarity=0.191  Sum_probs=189.6

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhc-CCCCeeeEe-------eEEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLC-GGPNIVKLL-------DIVR  199 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~E~~~l~~l~-~h~niv~l~-------~~~~  199 (434)
                      .+|.+.+.||+|+||.||+|.+..+++.||||+++...      .+.+.+|+.+++.+. +||||++++       +++.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            45999999999999999999999999999999997632      355778877777774 599988755       4554


Q ss_pred             ccCC---------------CccEEEEeecCCCchhhhcC----CCChHHH------HHHHHHHHHHHHHHHHCCceeecC
Q 013897          200 DQQS---------------KTPSLIFEHVNNTDFKVLYP----TLSDYDV------RYYIYELLKALDYCHSQGIMHRDV  254 (434)
Q Consensus       200 ~~~~---------------~~~~lv~e~~~~~~l~~~~~----~l~~~~~------~~~~~qi~~~L~~LH~~~ivHrDl  254 (434)
                      ....               ..+++||||+. ++|..++.    .+.+..+      ..++.||+.||+|||++||+||||
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi  220 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF  220 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence            3322               33789999999 78876653    2444444      567799999999999999999999


Q ss_pred             CCCceEecCCCCeEEEEecccceecCCCCccceeccCCcccccccccC-CCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 013897          255 KPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD-LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH  333 (434)
Q Consensus       255 Kp~NIll~~~~~~vkl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DvwSlGvil~elltg~~pf~~~~  333 (434)
                      ||+|||++.++ .+||+|||+|+....  ......+|+.|+|||++.+ ...++.++|||||||++|||++|+.||....
T Consensus       221 kp~NIll~~~~-~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~  297 (371)
T 3q60_A          221 TPDNLFIMPDG-RLMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT  297 (371)
T ss_dssp             SGGGEEECTTS-CEEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCC
T ss_pred             CHHHEEECCCC-CEEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcC
Confidence            99999999777 899999999986532  2224566799999999864 2468999999999999999999999984332


Q ss_pred             CCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHH
Q 013897          334 DNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK  413 (434)
Q Consensus       334 ~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~  413 (434)
                      .....                  .+...           .................+++.+.+||.+||+.||++|||+.
T Consensus       298 ~~~~~------------------~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  348 (371)
T 3q60_A          298 PGIKG------------------SWKRP-----------SLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPL  348 (371)
T ss_dssp             TTCTT------------------CCCBC-----------CTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHH
T ss_pred             ccccc------------------chhhh-----------hhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHH
Confidence            11000                  00000           00000000011122235788999999999999999999999


Q ss_pred             HHhcCCCcccccccc
Q 013897          414 EAMAHPYFFPIRNAE  428 (434)
Q Consensus       414 elL~Hp~~~~~~~~~  428 (434)
                      |+|+||||+++.+..
T Consensus       349 e~l~hp~f~~~~~~~  363 (371)
T 3q60_A          349 EAMETPEFLQLQNEI  363 (371)
T ss_dssp             HHTTSHHHHHHHHHH
T ss_pred             HHhcCHHHHHHHHHH
Confidence            999999999886543

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.5e-45  Score=357.62  Aligned_cols=283  Identities=23%  Similarity=0.465  Sum_probs=211.5

Q ss_pred             CCCeEEEeeeeecCceEEEEEEE-cCCCeEEEEEEecccc--HHHHHHHHHHHHHhcCC------CCeeeEeeEEEccCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVH-CTDNEKCIIKILKPVK--KKKIKREIKILQNLCGG------PNIVKLLDIVRDQQS  203 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~~vaiK~~~~~~--~~~~~~E~~~l~~l~~h------~niv~l~~~~~~~~~  203 (434)
                      .++|++++.||+|+||.||+|.+ ..+++.||||+++...  .+.+.+|+.+++.+ +|      ++++++++++.+.  
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~i~~~~~~~~~~--   89 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHL-NTTDPNSTFRCVQMLEWFEHH--   89 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHH-HHHCTTCTTCBCCEEEEEEET--
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHh-hhcCCCCceeeEeeecccccC--
Confidence            47899999999999999999998 5678999999997543  36688999999988 44      4599999999654  


Q ss_pred             CccEEEEeecCCCchhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC--------------
Q 013897          204 KTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--------------  264 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~--------------  264 (434)
                      ...++||||+ ++++..++     ..+++..++.++.||+.||+|||++||+||||||+|||++.+              
T Consensus        90 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~  168 (339)
T 1z57_A           90 GHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDE  168 (339)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred             CcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccccc
Confidence            5778999999 55655443     247899999999999999999999999999999999999863              


Q ss_pred             ----CCeEEEEecccceecCCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHH
Q 013897          265 ----QRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV  340 (434)
Q Consensus       265 ----~~~vkl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~  340 (434)
                          ...+||+|||++.....  .....+||+.|+|||++.+ ..++.++|||||||++|||++|..|| .+.+..+.+.
T Consensus       169 ~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf-~~~~~~~~~~  244 (339)
T 1z57_A          169 RTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVF-PTHDSKEHLA  244 (339)
T ss_dssp             EEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSC-CCSCHHHHHH
T ss_pred             ccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhC-CCCCcchhhHHHHHHHHHHHhCCCCC-CCCChHHHHH
Confidence                23699999999986532  3345678999999999887 68999999999999999999999998 4555566666


Q ss_pred             HHHHHhCChhHHHHHhhcc----------ccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCc
Q 013897          341 KIAKVLGTDELNAYLNKYH----------IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP  410 (434)
Q Consensus       341 ~i~~~~g~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rp  410 (434)
                      .+....+......+.....          ............... .+....  .......++++.+||.+||+.||++||
T Consensus       245 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~l~~li~~~L~~dP~~Rp  321 (339)
T 1z57_A          245 MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRAC-KPLKEF--MLSQDVEHERLFDLIQKMLEYDPAKRI  321 (339)
T ss_dssp             HHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHC-CCGGGG--CSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcC-cchhhh--cccchhhHHHHHHHHHHHhCcCccccc
Confidence            6666666433222111000          000000000000000 000000  011123457899999999999999999


Q ss_pred             cHHHHhcCCCcccccc
Q 013897          411 TAKEAMAHPYFFPIRN  426 (434)
Q Consensus       411 t~~elL~Hp~~~~~~~  426 (434)
                      |++|+|+||||+.++.
T Consensus       322 t~~ell~hp~f~~~~~  337 (339)
T 1z57_A          322 TLREALKHPFFDLLKK  337 (339)
T ss_dssp             CHHHHTTSGGGGGGGC
T ss_pred             CHHHHhcCHHHHHHhc
Confidence            9999999999998754

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=9.3e-47  Score=370.51  Aligned_cols=284  Identities=23%  Similarity=0.343  Sum_probs=208.0

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      .++|++++.||+|+||.||+|.+..++..||+|+++..    ..+.+.+|+.+++.+ +||||+++++++.+.  ...++
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~l  108 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSD--GEISI  108 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEET--TEEEE
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHC-CCCCEEEEeEEEEEC--CEEEE
Confidence            47899999999999999999999999999999998643    235688999999999 999999999999754  56789


Q ss_pred             EEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHC-CceeecCCCCceEecCCCCeEEEEecccceecCCCCc
Q 013897          209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE  284 (434)
Q Consensus       209 v~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~  284 (434)
                      ||||+.+++|..++   ..+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++...... .
T Consensus       109 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~-~  186 (360)
T 3eqc_A          109 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDS-M  186 (360)
T ss_dssp             EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-CEEECCCCCCHHHHHH-C
T ss_pred             EEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCC-CEEEEECCCCcccccc-c
Confidence            99999999997775   3689999999999999999999996 999999999999999777 8999999999654322 2


Q ss_pred             cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH--HHhCChhHHHHHh------
Q 013897          285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA--KVLGTDELNAYLN------  356 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~--~~~g~~~~~~~~~------  356 (434)
                      .....|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.....  ..+..+.  ...+.........      
T Consensus       187 ~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (360)
T 3eqc_A          187 ANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDA--KELELMFGCQVEGDAAETPPRPRTPGRP  263 (360)
T ss_dssp             ----CCCCTTCCHHHHTT-CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCH--HHHHHHHC--------------------
T ss_pred             ccCCCCCCCeECHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHhcccccccCCCCCCCcccCCCc
Confidence            344678999999999887 6899999999999999999999999854322  2222111  1111000000000      


Q ss_pred             --hccccC--ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccccc
Q 013897          357 --KYHIEL--DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       357 --~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~  428 (434)
                        ......  ...............    ........+++++.+||.+||+.||++|||++|+|+||||+.....+
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~  335 (360)
T 3eqc_A          264 LNKFGMDSRPPMAIFELLDYIVNEP----PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEE  335 (360)
T ss_dssp             ----------CCCHHHHHHHHHHSC----CCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHSC
T ss_pred             ccccccCCCCcccchhhhhHHhccC----CCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHhh
Confidence              000000  000000000000000    00011223678999999999999999999999999999999776443

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=8.4e-46  Score=361.91  Aligned_cols=285  Identities=25%  Similarity=0.458  Sum_probs=213.2

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCC-eEEEEEEeccc--cHHHHHHHHHHHHHhcCCCC------eeeEeeEEEccCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDN-EKCIIKILKPV--KKKKIKREIKILQNLCGGPN------IVKLLDIVRDQQS  203 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~-~~vaiK~~~~~--~~~~~~~E~~~l~~l~~h~n------iv~l~~~~~~~~~  203 (434)
                      .++|++++.||+|+||.||+|.+..++ ..||+|+++..  ..+.+.+|+.+++.+ .|++      ++.+++++...  
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~~~~~~--   94 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKI-KEKDKENKFLCVLMSDWFNFH--   94 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHH-HHHCTTSCSCBCCEEEEEEET--
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHH-hhcCCCCceeEEEeeeeeeeC--
Confidence            478999999999999999999997766 79999999753  346688899999998 5544      89999988654  


Q ss_pred             CccEEEEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEe------------------
Q 013897          204 KTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI------------------  261 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll------------------  261 (434)
                      ...++||||+.++.+..+.    ..+++..++.++.||+.||+|||++||+||||||+|||+                  
T Consensus        95 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~  174 (355)
T 2eu9_A           95 GHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEK  174 (355)
T ss_dssp             TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEE
T ss_pred             CeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccccc
Confidence            5778999999776665443    358999999999999999999999999999999999999                  


Q ss_pred             -cCCCCeEEEEecccceecCCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHH
Q 013897          262 -DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV  340 (434)
Q Consensus       262 -~~~~~~vkl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~  340 (434)
                       +.++ .+||+|||+++....  .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.|| .+.+..+.+.
T Consensus       175 ~~~~~-~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf-~~~~~~~~~~  249 (355)
T 2eu9_A          175 SVKNT-SIRVADFGSATFDHE--HHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLF-QTHENREHLV  249 (355)
T ss_dssp             EESCC-CEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHH
T ss_pred             ccCCC-cEEEeecCccccccc--cccCCcCCCcccCCeeeec-CCCCCccchHHHHHHHHHHHhCCCCC-CCCCHHHHHH
Confidence             3344 899999999986432  3345689999999999987 68999999999999999999999998 4555566666


Q ss_pred             HHHHHhCChhHHHHHhhcc--------ccCCh--hHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCc
Q 013897          341 KIAKVLGTDELNAYLNKYH--------IELDP--HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP  410 (434)
Q Consensus       341 ~i~~~~g~~~~~~~~~~~~--------~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rp  410 (434)
                      .+.+.++............        ...+.  .......... .+...  ........++++.+||.+||+.||++||
T Consensus       250 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~l~~li~~~L~~dP~~Rp  326 (355)
T 2eu9_A          250 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENC-KPLKS--YMLQDSLEHVQLFDLMRRMLEFDPAQRI  326 (355)
T ss_dssp             HHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHC-CCGGG--GCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccC-Ccccc--cccccchhHHHHHHHHHHHhcCChhhCc
Confidence            7777766543221111000        00000  0000000000 00000  0011122356899999999999999999


Q ss_pred             cHHHHhcCCCcccccccc
Q 013897          411 TAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       411 t~~elL~Hp~~~~~~~~~  428 (434)
                      |+.|+|+||||++++..+
T Consensus       327 t~~e~l~hp~f~~~~~~~  344 (355)
T 2eu9_A          327 TLAEALLHPFFAGLTPEE  344 (355)
T ss_dssp             CHHHHTTSGGGGGCCHHH
T ss_pred             CHHHHhcChhhcCCChhh
Confidence            999999999999987654

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.5e-46  Score=361.67  Aligned_cols=256  Identities=21%  Similarity=0.335  Sum_probs=200.7

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCC--
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK--  204 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~--  204 (434)
                      .++|++.+.||+|+||.||+|.+..+++.||||+++...      ...+.+|+.+++.+ +||||+++++++......  
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~~   89 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETPAGP   89 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCC-CCTTBCCEEEEEEEEETTEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcC-CCCCcceEEEeeeccCCCCc
Confidence            478999999999999999999999999999999996532      24678999999998 999999999998754333  


Q ss_pred             ccEEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC
Q 013897          205 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP  281 (434)
Q Consensus       205 ~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~  281 (434)
                      ..++||||+.+++|..++   ..+++.++..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~  168 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN-AVKVMDFGIARAIAD  168 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTS-CEEECCCSCC-----
T ss_pred             ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCC-CEEEeeccCcccccc
Confidence            458999999999998775   4689999999999999999999999999999999999999776 899999999976543


Q ss_pred             CC----ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhh
Q 013897          282 GK----EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK  357 (434)
Q Consensus       282 ~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  357 (434)
                      ..    .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||. +.........+.....          
T Consensus       169 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~-~~~~~~~~~~~~~~~~----------  236 (311)
T 3ork_A          169 SGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFT-GDSPVSVAYQHVREDP----------  236 (311)
T ss_dssp             -------------CCTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSCC-CSSHHHHHHHHHHCCC----------
T ss_pred             cccccccccccCcCcccCCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHhcCCC----------
Confidence            32    1234568999999999987 689999999999999999999999983 3222222222111000          


Q ss_pred             ccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccc
Q 013897          358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                          ..+                   ......+++++.+||.+||+.||++||++.++|.|+|++...
T Consensus       237 ----~~~-------------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  281 (311)
T 3ork_A          237 ----IPP-------------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  281 (311)
T ss_dssp             ----CCH-------------------HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred             ----CCc-------------------ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence                000                   001123678899999999999999999999999999998543

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.4e-47  Score=379.04  Aligned_cols=250  Identities=17%  Similarity=0.227  Sum_probs=195.4

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhc--CCCCeeeEe-------eE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLC--GGPNIVKLL-------DI  197 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~--~h~niv~l~-------~~  197 (434)
                      .++|.+.+.||+|+||.||+|.+..+++.||||+++..      ..+.+.+|+.+++.+.  +|||||+++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            47899999999999999999999889999999998632      2467889996555543  799999998       66


Q ss_pred             EEccCC----------C-----ccEEEEeecCCCchhhhcC---CCCh-------HHHHHHHHHHHHHHHHHHHCCceee
Q 013897          198 VRDQQS----------K-----TPSLIFEHVNNTDFKVLYP---TLSD-------YDVRYYIYELLKALDYCHSQGIMHR  252 (434)
Q Consensus       198 ~~~~~~----------~-----~~~lv~e~~~~~~l~~~~~---~l~~-------~~~~~~~~qi~~~L~~LH~~~ivHr  252 (434)
                      +.+.+.          .     ..++||||+ +|+|..++.   .+++       ..+..++.||+.||+|||++||+||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr  230 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  230 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            654321          0     378999999 468776653   2444       6777899999999999999999999


Q ss_pred             cCCCCceEecCCCCeEEEEecccceecCCCCccceeccCCcccccccccCC----------CCCCccccHHHHHHHHHHH
Q 013897          253 DVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL----------QDYDYSLDLWSLGCMFAGM  322 (434)
Q Consensus       253 DlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~----------~~~~~~~DvwSlGvil~el  322 (434)
                      ||||+|||++.++ .+||+|||+|+...  ......+| +.|+|||++.+.          ..++.++|||||||++|||
T Consensus       231 Dikp~NIll~~~~-~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el  306 (377)
T 3byv_A          231 YLRPVDIVLDQRG-GVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI  306 (377)
T ss_dssp             CCCGGGEEECTTC-CEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred             CCCHHHEEEcCCC-CEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence            9999999999776 89999999998632  33455577 999999999862          1799999999999999999


Q ss_pred             HhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHcc
Q 013897          323 IFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLL  402 (434)
Q Consensus       323 ltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL  402 (434)
                      ++|+.||..... .....                                       ..  ......+++++.+||.+||
T Consensus       307 ltg~~Pf~~~~~-~~~~~---------------------------------------~~--~~~~~~~~~~~~~li~~~L  344 (377)
T 3byv_A          307 WCADLPITKDAA-LGGSE---------------------------------------WI--FRSCKNIPQPVRALLEGFL  344 (377)
T ss_dssp             HHSSCCC-------CCSG---------------------------------------GG--GSSCCCCCHHHHHHHHHHT
T ss_pred             HHCCCCCccccc-ccchh---------------------------------------hh--hhhccCCCHHHHHHHHHHc
Confidence            999999832110 00000                                       00  0011246789999999999


Q ss_pred             ccCCCCCccHHHHhcCCCccccccccc
Q 013897          403 RYDHQERPTAKEAMAHPYFFPIRNAES  429 (434)
Q Consensus       403 ~~dP~~Rpt~~elL~Hp~~~~~~~~~~  429 (434)
                      +.||++|||+.|+|+||||+++....+
T Consensus       345 ~~dp~~Rpt~~e~l~hp~f~~~~~~~~  371 (377)
T 3byv_A          345 RYPKEDRLLPLQAMETPEYEQLRTELS  371 (377)
T ss_dssp             CSSGGGCCCHHHHHTSHHHHHHHHHHH
T ss_pred             CCCchhCCCHHHHhhChHHHHHHHHHH
Confidence            999999999999999999998875543

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=3.9e-46  Score=354.49  Aligned_cols=255  Identities=24%  Similarity=0.506  Sum_probs=208.9

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      ++|++++.||+|+||.||+|.+..+++.||+|++...     ....+.+|+.+++++ +||||+++++++.+.  ...++
T Consensus        22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~l   98 (287)
T 2wei_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEILEDS--SSFYI   98 (287)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECS--SEEEE
T ss_pred             hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-cCCCccEEEEEEeCC--CeEEE
Confidence            6799999999999999999999889999999998532     356788999999999 999999999999654  56789


Q ss_pred             EEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCC--CeEEEEecccceecCCCC
Q 013897          209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ--RKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       209 v~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~--~~vkl~DFGla~~~~~~~  283 (434)
                      |+||+.+++|...+   ..+++..+..++.||+.||.|||++||+||||||+||+++.++  ..+||+|||++.......
T Consensus        99 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~  178 (287)
T 2wei_A           99 VGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT  178 (287)
T ss_dssp             EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS
T ss_pred             EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC
Confidence            99999999886554   4689999999999999999999999999999999999997543  269999999998766555


Q ss_pred             ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                      ......+++.|+|||.+.+  .++.++|||||||++|+|++|+.||.. .+..+....+...                  
T Consensus       179 ~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~------------------  237 (287)
T 2wei_A          179 KMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYG-KNEYDILKRVETG------------------  237 (287)
T ss_dssp             SCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHC------------------
T ss_pred             ccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcC------------------
Confidence            5556678999999999875  589999999999999999999999843 2222222222110                  


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccccc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA  427 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~  427 (434)
                               ...      ........+++++.+||.+||..||++|||+.|+|+||||++..+.
T Consensus       238 ---------~~~------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~  286 (287)
T 2wei_A          238 ---------KYA------FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSE  286 (287)
T ss_dssp             ---------CCC------CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCCC
T ss_pred             ---------CCC------CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhccccC
Confidence                     000      0011112467899999999999999999999999999999987654

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.1e-46  Score=360.26  Aligned_cols=264  Identities=22%  Similarity=0.367  Sum_probs=185.6

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      .++|++.+.||+|+||.||+|.+..+++.||||++...    ..+.+.+|+.+++.+ +||||+++++++...  ...++
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~l   90 (303)
T 2vwi_A           14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC-HHPNIVSYYTSFVVK--DELWL   90 (303)
T ss_dssp             CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCC-CCTTBCCEEEEEESS--SCEEE
T ss_pred             hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhc-CCCCEeeEEEEEeec--CCcEE
Confidence            47899999999999999999998888999999998643    245678899999998 899999999999754  45789


Q ss_pred             EEeecCCCchhhhcC-----------CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccce
Q 013897          209 IFEHVNNTDFKVLYP-----------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE  277 (434)
Q Consensus       209 v~e~~~~~~l~~~~~-----------~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~  277 (434)
                      ||||+.+++|..++.           .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus        91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~  169 (303)
T 2vwi_A           91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDG-SVQIADFGVSA  169 (303)
T ss_dssp             EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC-CEEECCCHHHH
T ss_pred             EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCC-CEEEEeccchh
Confidence            999999999876642           388999999999999999999999999999999999999776 89999999997


Q ss_pred             ecCCCC------ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhH
Q 013897          278 FYHPGK------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL  351 (434)
Q Consensus       278 ~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~  351 (434)
                      ......      ......|++.|+|||++.+...++.++|||||||++|+|++|+.||.... ..........  +    
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-~~~~~~~~~~--~----  242 (303)
T 2vwi_A          170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYP-PMKVLMLTLQ--N----  242 (303)
T ss_dssp             HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSC-GGGHHHHHHT--S----
T ss_pred             eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCc-hhhHHHHHhc--c----
Confidence            654322      12345789999999998654568999999999999999999999984332 2222111100  0    


Q ss_pred             HHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccccc
Q 013897          352 NAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~  428 (434)
                                           .................+++++.+||.+||+.||.+|||+.|+|+||||++....+
T Consensus       243 ---------------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  298 (303)
T 2vwi_A          243 ---------------------DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKE  298 (303)
T ss_dssp             ---------------------SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-------
T ss_pred             ---------------------CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCCc
Confidence                                 00000000001112234678999999999999999999999999999999887655

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=6.9e-46  Score=362.25  Aligned_cols=271  Identities=22%  Similarity=0.391  Sum_probs=210.1

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccccH--------------------HHHHHHHHHHHHhcCCCCee
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--------------------KKIKREIKILQNLCGGPNIV  192 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~--------------------~~~~~E~~~l~~l~~h~niv  192 (434)
                      .++|++.+.||+|+||.||+|.+  +++.||||++.....                    +.+.+|+.+++.+ +||||+
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~  106 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI-KNEYCL  106 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC-CCTTBC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC-CCCCcc
Confidence            37899999999999999999998  899999999864221                    7789999999999 899999


Q ss_pred             eEeeEEEccCCCccEEEEeecCCCchhhh------c-----CCCChHHHHHHHHHHHHHHHHHHH-CCceeecCCCCceE
Q 013897          193 KLLDIVRDQQSKTPSLIFEHVNNTDFKVL------Y-----PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVM  260 (434)
Q Consensus       193 ~l~~~~~~~~~~~~~lv~e~~~~~~l~~~------~-----~~l~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlKp~NIl  260 (434)
                      ++++++.+.  ...++||||+.+++|..+      +     ..+++..++.++.||+.||.|||+ +||+||||||+|||
T Consensus       107 ~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil  184 (348)
T 2pml_X          107 TCEGIITNY--DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL  184 (348)
T ss_dssp             CCSEEEESS--SEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEE
T ss_pred             eEEEEEeeC--CeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEE
Confidence            999999764  577899999999998776      3     358899999999999999999999 99999999999999


Q ss_pred             ecCCCCeEEEEecccceecCCCCccceeccCCcccccccccCCCCCCc-cccHHHHHHHHHHHHhCCCCCCCCCCCHHHH
Q 013897          261 IDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY-SLDLWSLGCMFAGMIFRKEPFFYGHDNYDQL  339 (434)
Q Consensus       261 l~~~~~~vkl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~DvwSlGvil~elltg~~pf~~~~~~~~~~  339 (434)
                      ++.++ .+||+|||++...... ......++..|+|||++.+...++. ++|||||||++|+|++|+.||.......+..
T Consensus       185 ~~~~~-~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  262 (348)
T 2pml_X          185 MDKNG-RVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF  262 (348)
T ss_dssp             ECTTS-CEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH
T ss_pred             EcCCC-cEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence            99777 8999999999876433 3455678999999999987436666 9999999999999999999985444433333


Q ss_pred             HHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCC
Q 013897          340 VKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHP  419 (434)
Q Consensus       340 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp  419 (434)
                      ..+...  .           ...+.......     ..............+++++.+||.+||+.||.+|||++|+|+||
T Consensus       263 ~~i~~~--~-----------~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp  324 (348)
T 2pml_X          263 NNIRTK--N-----------IEYPLDRNHFL-----YPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHE  324 (348)
T ss_dssp             HHHTSC--C-----------CCCCCSSSSST-----TTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred             HHHhcc--C-----------cCCccchhhhh-----ccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence            332110  0           00000000000     00000000111235788999999999999999999999999999


Q ss_pred             Ccccccccc
Q 013897          420 YFFPIRNAE  428 (434)
Q Consensus       420 ~~~~~~~~~  428 (434)
                      ||++.+..+
T Consensus       325 ~f~~~~~~~  333 (348)
T 2pml_X          325 WLADTNIED  333 (348)
T ss_dssp             GGTTCCHHH
T ss_pred             cccCCCHHH
Confidence            999887543

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.9e-45  Score=354.07  Aligned_cols=254  Identities=23%  Similarity=0.407  Sum_probs=204.1

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEe
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE  211 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  211 (434)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++.+ +||||+++++++.+.  ...++|||
T Consensus        28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~e  104 (314)
T 3com_A           28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQC-DSPHVVKYYGSYFKN--TDLWIVME  104 (314)
T ss_dssp             --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTC-CCTTBCCEEEEEEET--TEEEEEEE
T ss_pred             hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhC-CCCCCccEEEEEEeC--CEEEEEee
Confidence            47899999999999999999999889999999998753 346789999999999 999999999999754  56789999


Q ss_pred             ecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC-ccc
Q 013897          212 HVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYN  286 (434)
Q Consensus       212 ~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~-~~~  286 (434)
                      |+.+++|..++    ..+++..+..++.||+.||.|||++||+|+||||+||+++.++ .+||+|||++....... ...
T Consensus       105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~  183 (314)
T 3com_A          105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEG-HAKLADFGVAGQLTDTMAKRN  183 (314)
T ss_dssp             CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECBTTBSCBC
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCC-CEEEeecccchhhhhhccccC
Confidence            99999987765    3689999999999999999999999999999999999999776 89999999997765432 234


Q ss_pred             eeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhH
Q 013897          287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL  366 (434)
Q Consensus       287 ~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~  366 (434)
                      ...|+..|+|||++.+ ..++.++|||||||++|+|++|+.||... ........+..                      
T Consensus       184 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~----------------------  239 (314)
T 3com_A          184 TVIGTPFWMAPEVIQE-IGYNCVADIWSLGITAIEMAEGKPPYADI-HPMRAIFMIPT----------------------  239 (314)
T ss_dssp             CCCSCGGGCCHHHHSS-SCBCTTHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHH----------------------
T ss_pred             ccCCCCCccChhhcCC-CCCCccccHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHhc----------------------
Confidence            5578999999999877 67899999999999999999999998432 21111111100                      


Q ss_pred             HHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccc
Q 013897          367 AALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN  426 (434)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~  426 (434)
                            ....      .......+++.+.+||.+||..||++|||+.++|+||||+....
T Consensus       240 ------~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~  287 (314)
T 3com_A          240 ------NPPP------TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKG  287 (314)
T ss_dssp             ------SCCC------CCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCC
T ss_pred             ------CCCc------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCc
Confidence                  0000      01112236788999999999999999999999999999997753

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.6e-45  Score=353.01  Aligned_cols=253  Identities=25%  Similarity=0.409  Sum_probs=202.8

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      ++|.+.+.||+|+||.||+|.+..+++.||+|+++..       ....+.+|+.+++.+ +||||+++++++.+......
T Consensus         5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-RHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECC---CE
T ss_pred             cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCCCeE
Confidence            6799999999999999999999899999999999643       235688999999999 89999999999876666778


Q ss_pred             EEEEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC
Q 013897          207 SLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG  282 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~  282 (434)
                      ++||||+.++....+.    ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++......
T Consensus        84 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~-~~kl~dfg~~~~~~~~  162 (305)
T 2wtk_C           84 YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGG-TLKISALGVAEALHPF  162 (305)
T ss_dssp             EEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEECCTT
T ss_pred             EEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCC-cEEeeccccccccCcc
Confidence            9999999988433221    3588999999999999999999999999999999999999776 8999999999876432


Q ss_pred             ---CccceeccCCcccccccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhc
Q 013897          283 ---KEYNVRVASRYFKGPELLVDLQ-DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY  358 (434)
Q Consensus       283 ---~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  358 (434)
                         .......|+..|+|||++.+.. .++.++|||||||++|+|++|+.||.. .+.......+..              
T Consensus       163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~i~~--------------  227 (305)
T 2wtk_C          163 AADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG-DNIYKLFENIGK--------------  227 (305)
T ss_dssp             CSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHH--------------
T ss_pred             ccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCC-chHHHHHHHHhc--------------
Confidence               2224457899999999987522 347899999999999999999999842 222222222111              


Q ss_pred             cccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccc
Q 013897          359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN  426 (434)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~  426 (434)
                                   .          .......+++.+.+||.+||..||++|||++|+++||||++...
T Consensus       228 -------------~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  272 (305)
T 2wtk_C          228 -------------G----------SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP  272 (305)
T ss_dssp             -------------C----------CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred             -------------C----------CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence                         0          00111236788999999999999999999999999999987654

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=9.8e-46  Score=349.86  Aligned_cols=253  Identities=26%  Similarity=0.420  Sum_probs=205.6

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      .++|++++.||+|+||.||+|.+..+++.||+|++...     ..+.+.+|+.+++++ +||||+++++++.+......+
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~   83 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLY   83 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEEGGGTEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhc-CCCCCCeEEEEEecCCCceEE
Confidence            36899999999999999999999999999999998642     245688999999999 899999999998766667789


Q ss_pred             EEEeecCCCchhhhcC-------CCChHHHHHHHHHHHHHHHHHHHCC-----ceeecCCCCceEecCCCCeEEEEeccc
Q 013897          208 LIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQG-----IMHRDVKPHNVMIDHEQRKLRLIDWGL  275 (434)
Q Consensus       208 lv~e~~~~~~l~~~~~-------~l~~~~~~~~~~qi~~~L~~LH~~~-----ivHrDlKp~NIll~~~~~~vkl~DFGl  275 (434)
                      +||||+.+++|..++.       .+++..+..++.||+.||+|||+++     |+||||||+|||++.++ .+||+|||+
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~-~~kl~dfg~  162 (279)
T 2w5a_A           84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDFGL  162 (279)
T ss_dssp             EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSS-CEEECCCCH
T ss_pred             EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCC-CEEEecCch
Confidence            9999999999877653       3899999999999999999999999     99999999999999776 899999999


Q ss_pred             ceecCCCCc-cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHH
Q 013897          276 AEFYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAY  354 (434)
Q Consensus       276 a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~  354 (434)
                      +........ .....|+..|+|||++.+ ..++.++|||||||++|+|++|+.||... +..+....+...         
T Consensus       163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~i~~~---------  231 (279)
T 2w5a_A          163 ARILNHDTSFAKTFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAF-SQKELAGKIREG---------  231 (279)
T ss_dssp             HHHC---CHHHHHHHSCCTTCCHHHHHC-C-CCHHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHT---------
T ss_pred             heeeccccccccccCCCccccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCccc-CHHHHHHHHhhc---------
Confidence            976543322 234578999999999887 67899999999999999999999998432 222222111110         


Q ss_pred             HhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccc
Q 013897          355 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                                         ..        ......+++++.+||.+||..||++|||+.|+|+|+|+.+-.
T Consensus       232 -------------------~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  275 (279)
T 2w5a_A          232 -------------------KF--------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH  275 (279)
T ss_dssp             -------------------CC--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred             -------------------cc--------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence                               00        001123678999999999999999999999999999998754

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=3.9e-45  Score=350.23  Aligned_cols=251  Identities=25%  Similarity=0.412  Sum_probs=207.8

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      .+.|++++.||+|+||.||+|.+..+++.||||+++..    ..+.+.+|+.+++.+ +||||+++++++.+.  ...++
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~l   97 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKD--TKLWI   97 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHC-CCTTBCCEEEEEEET--TEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecC--CeEEE
Confidence            46799999999999999999999899999999998643    346789999999999 999999999999754  56789


Q ss_pred             EEeecCCCchhhhcC--CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC-cc
Q 013897          209 IFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EY  285 (434)
Q Consensus       209 v~e~~~~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~-~~  285 (434)
                      ||||+.+++|..++.  .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....... ..
T Consensus        98 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~  176 (303)
T 3a7i_A           98 IMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKR  176 (303)
T ss_dssp             EEECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECBTTBCCB
T ss_pred             EEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCC-CEEEeecccceecCcccccc
Confidence            999999999987764  588999999999999999999999999999999999999776 89999999998765432 23


Q ss_pred             ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChh
Q 013897          286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH  365 (434)
Q Consensus       286 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~  365 (434)
                      ....|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.. .........+.+                     
T Consensus       177 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~---------------------  233 (303)
T 3a7i_A          177 NTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELARGEPPHSE-LHPMKVLFLIPK---------------------  233 (303)
T ss_dssp             CCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHH---------------------
T ss_pred             CccCCCcCccCHHHHhc-CCCCchhhhHHHHHHHHHHccCCCCCCC-cCHHHHHHHhhc---------------------
Confidence            45678999999999876 6789999999999999999999999832 222111111110                     


Q ss_pred             HHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccc
Q 013897          366 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                             ...        ......+++.+.+||.+||..||++|||+.|+|+||||....
T Consensus       234 -------~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  278 (303)
T 3a7i_A          234 -------NNP--------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNA  278 (303)
T ss_dssp             -------SCC--------CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred             -------CCC--------CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCC
Confidence                   000        001123678899999999999999999999999999997553

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.9e-45  Score=361.05  Aligned_cols=292  Identities=26%  Similarity=0.422  Sum_probs=212.5

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc--HHHHHHHHHHHHHhc----------CCCCeeeEeeEEEc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLC----------GGPNIVKLLDIVRD  200 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~E~~~l~~l~----------~h~niv~l~~~~~~  200 (434)
                      .++|.+.+.||+|+||.||+|.+..+++.||||++....  .+.+.+|+.+++++.          .||||+++++++..
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~   97 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   97 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence            468999999999999999999999999999999997543  466889999999883          28999999999875


Q ss_pred             cC--CCccEEEEeecCCCchhhhc-----CCCChHHHHHHHHHHHHHHHHHHHC-CceeecCCCCceEecCC-----CCe
Q 013897          201 QQ--SKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHE-----QRK  267 (434)
Q Consensus       201 ~~--~~~~~lv~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlKp~NIll~~~-----~~~  267 (434)
                      ..  ....++||||+ +++|..++     ..+++..++.++.||+.||+|||++ ||+||||||+|||++.+     ...
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~  176 (373)
T 1q8y_A           98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ  176 (373)
T ss_dssp             EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred             cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcce
Confidence            42  33678999999 66766554     3488999999999999999999998 99999999999999532     227


Q ss_pred             EEEEecccceecCCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-----CCHHHHHHH
Q 013897          268 LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH-----DNYDQLVKI  342 (434)
Q Consensus       268 vkl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~-----~~~~~~~~i  342 (434)
                      +||+|||++.....  .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||....     ...+.+..+
T Consensus       177 ~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  253 (373)
T 1q8y_A          177 IKIADLGNACWYDE--HYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI  253 (373)
T ss_dssp             EEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred             EEEcccccccccCC--CCCCCCCCccccCcHHHhC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHH
Confidence            99999999987643  3345688999999999987 679999999999999999999999985432     134556666


Q ss_pred             HHHhCChhHHHHHhhccccCChhHHHHhcccCCCC-Cc--cc--cccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          343 AKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKP-WS--KF--ITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       343 ~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~--~~--~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                      .+.+|......+....................... +.  ..  ........+++++.+||.+||+.||++|||++|+|+
T Consensus       254 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  333 (373)
T 1q8y_A          254 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN  333 (373)
T ss_dssp             HHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred             HHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhh
Confidence            66666543221111000000000000000000000 00  00  000111235678999999999999999999999999


Q ss_pred             CCCcccccccc
Q 013897          418 HPYFFPIRNAE  428 (434)
Q Consensus       418 Hp~~~~~~~~~  428 (434)
                      ||||++....+
T Consensus       334 hp~f~~~~~~~  344 (373)
T 1q8y_A          334 HPWLKDTLGME  344 (373)
T ss_dssp             CGGGTTCTTCT
T ss_pred             ChhhhcccCcc
Confidence            99999865433

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=9e-46  Score=353.54  Aligned_cols=257  Identities=25%  Similarity=0.415  Sum_probs=198.2

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccC---------
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ---------  202 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---------  202 (434)
                      ++|++++.||+|+||.||+|.+..+++.||||+++..  ..+.+.+|+.+++.+ +||||+++++++.+..         
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~   84 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-NHQYVVRYYAAWLERRNFVKPMTAV   84 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEECCCCCC-----
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhc-CchHHHHHHHHHHhhcchhhhhccc
Confidence            5799999999999999999999889999999998643  235688999999999 8999999999886532         


Q ss_pred             --CCccEEEEeecCCCchhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccc
Q 013897          203 --SKTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA  276 (434)
Q Consensus       203 --~~~~~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla  276 (434)
                        ....++||||+.+++|..++.    .+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~  163 (303)
T 1zy4_A           85 KKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESR-NVKIGDFGLA  163 (303)
T ss_dssp             -CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECCCCCC
T ss_pred             ccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCC-CEEEeeCcch
Confidence              346789999999999987763    367788999999999999999999999999999999999776 8999999999


Q ss_pred             eecCCC---------------CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHH
Q 013897          277 EFYHPG---------------KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK  341 (434)
Q Consensus       277 ~~~~~~---------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~  341 (434)
                      ......               .......|+..|+|||++.+...++.++|||||||++|+|++   ||..+.+.......
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~  240 (303)
T 1zy4_A          164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKK  240 (303)
T ss_dssp             SCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHH
T ss_pred             hhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHh
Confidence            765421               122445789999999999875579999999999999999998   65322111111111


Q ss_pred             HHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          342 IAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       342 i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                      +..             .....+                    .......++.+.+||.+||+.||++|||+.|+|+||||
T Consensus       241 ~~~-------------~~~~~~--------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  287 (303)
T 1zy4_A          241 LRS-------------VSIEFP--------------------PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL  287 (303)
T ss_dssp             HHS-------------TTCCCC--------------------TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCS
T ss_pred             ccc-------------cccccC--------------------ccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCc
Confidence            100             000000                    01112356789999999999999999999999999999


Q ss_pred             ccccccc
Q 013897          422 FPIRNAE  428 (434)
Q Consensus       422 ~~~~~~~  428 (434)
                      +.....+
T Consensus       288 ~~~~~~~  294 (303)
T 1zy4_A          288 PVKHQDE  294 (303)
T ss_dssp             CCCCHHH
T ss_pred             CCCChHH
Confidence            8765433

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=5.3e-45  Score=350.85  Aligned_cols=250  Identities=19%  Similarity=0.331  Sum_probs=192.1

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      .++|++.+.||+|+||.||+|.+  +++.||||++....     .+.+.+|+.+++++ +||||+++++++.+.  ...+
T Consensus        36 ~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~--~~~~  110 (309)
T 3p86_A           36 WCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRL-RHPNIVLFMGAVTQP--PNLS  110 (309)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECST--TCCE
T ss_pred             hhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEEC--CceE
Confidence            47899999999999999999986  68899999986432     35688999999999 899999999999654  5578


Q ss_pred             EEEeecCCCchhhhcCC------CChHHHHHHHHHHHHHHHHHHHCC--ceeecCCCCceEecCCCCeEEEEecccceec
Q 013897          208 LIFEHVNNTDFKVLYPT------LSDYDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY  279 (434)
Q Consensus       208 lv~e~~~~~~l~~~~~~------l~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlKp~NIll~~~~~~vkl~DFGla~~~  279 (434)
                      +||||+.+++|..++..      +++..+..++.||+.||+|||++|  |+||||||+|||++.++ .+||+|||+++..
T Consensus       111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~-~~kL~Dfg~a~~~  189 (309)
T 3p86_A          111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKY-TVKVCDFGLSRLK  189 (309)
T ss_dssp             EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTC-CEEECCCC-----
T ss_pred             EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCC-cEEECCCCCCccc
Confidence            99999999999877632      888899999999999999999999  99999999999999776 8999999999755


Q ss_pred             CCCC-ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhc
Q 013897          280 HPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY  358 (434)
Q Consensus       280 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  358 (434)
                      .... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.. .+..+....+... .           
T Consensus       190 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~-~~~~~~~~~~~~~-~-----------  255 (309)
T 3p86_A          190 ASTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDVYSFGVILWELATLQQPWGN-LNPAQVVAAVGFK-C-----------  255 (309)
T ss_dssp             ------------CCTTSCHHHHTT-CCCCTTHHHHHHHHHHHHHHHCCCTTTT-SCHHHHHHHHHHS-C-----------
T ss_pred             cccccccccCCCCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhc-C-----------
Confidence            4332 2345679999999999887 6789999999999999999999999832 2222221111100 0           


Q ss_pred             cccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc--CCCccccc
Q 013897          359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA--HPYFFPIR  425 (434)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~--Hp~~~~~~  425 (434)
                                     .        .......+++++.+||.+||+.||++|||+.|+++  +++++...
T Consensus       256 ---------------~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~  301 (309)
T 3p86_A          256 ---------------K--------RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV  301 (309)
T ss_dssp             ---------------C--------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred             ---------------C--------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence                           0        01112346789999999999999999999999997  67766543

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=5e-45  Score=357.70  Aligned_cols=247  Identities=19%  Similarity=0.329  Sum_probs=199.1

Q ss_pred             CCCeEEEeeeeecCceEEEEEEE-----cCCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVH-----CTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS  203 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~-----~~~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  203 (434)
                      .++|++.+.||+|+||.||+|.+     ..+++.||||+++...    .+.+.+|+.++.++.+||||+++++++.+. .
T Consensus        21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~-~   99 (359)
T 3vhe_A           21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-G   99 (359)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-T
T ss_pred             ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC-C
Confidence            57899999999999999999984     4566899999997532    346889999999998899999999999754 3


Q ss_pred             CccEEEEeecCCCchhhhcCC-----------------------------------------------------------
Q 013897          204 KTPSLIFEHVNNTDFKVLYPT-----------------------------------------------------------  224 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~~~-----------------------------------------------------------  224 (434)
                      ...++||||+.+++|..++..                                                           
T Consensus       100 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  179 (359)
T 3vhe_A          100 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  179 (359)
T ss_dssp             SCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------------
T ss_pred             CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhc
Confidence            457899999999998766521                                                           


Q ss_pred             ----------CChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc---cceeccC
Q 013897          225 ----------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YNVRVAS  291 (434)
Q Consensus       225 ----------l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~---~~~~~~t  291 (434)
                                +++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.......   .....+|
T Consensus       180 ~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~t  258 (359)
T 3vhe_A          180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKGDARLP  258 (359)
T ss_dssp             ----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCGGGSCTTSCTTCEEC--CEEC
T ss_pred             ccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC-cEEEEeccceeeecccccchhccccCCC
Confidence                      78888999999999999999999999999999999999776 899999999986643322   2345678


Q ss_pred             CcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHh
Q 013897          292 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALV  370 (434)
Q Consensus       292 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~  370 (434)
                      ..|+|||++.+ ..++.++|||||||++|||++ |..||............+.. .                        
T Consensus       259 ~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~------------------------  312 (359)
T 3vhe_A          259 LKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE-G------------------------  312 (359)
T ss_dssp             GGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHH-T------------------------
T ss_pred             ceeEChhhhcC-CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHc-C------------------------
Confidence            89999999876 689999999999999999998 99998443333222222111 0                        


Q ss_pred             cccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          371 GRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                         .        .......+++++.++|.+||+.||++|||+.|+++|
T Consensus       313 ---~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          313 ---T--------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             ---C--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---C--------CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence               0        011122367899999999999999999999999986

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=4.3e-45  Score=348.90  Aligned_cols=255  Identities=21%  Similarity=0.336  Sum_probs=198.3

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      .++|++++.||+|+||.||+|.+..++..||+|++...      ..+.+.+|+.+++.+ +||||+++++++.+.  ...
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~--~~~   86 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL-SHQNIVSMIDVDEED--DCY   86 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CBTTBCCEEEEEECS--SEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcC-CCCCCceEEEeeeeC--CeE
Confidence            47899999999999999999999999999999998432      235688999999999 999999999999643  567


Q ss_pred             EEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC
Q 013897          207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~  283 (434)
                      ++||||+.+++|..++   ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus        87 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~  165 (294)
T 4eqm_A           87 YLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNK-TLKIFDFGIAKALSETS  165 (294)
T ss_dssp             EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCSSSTTC----
T ss_pred             EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEEeCCCcccccccc
Confidence            8999999999998775   4589999999999999999999999999999999999999776 89999999997654332


Q ss_pred             --ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcccc
Q 013897          284 --EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE  361 (434)
Q Consensus       284 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  361 (434)
                        .....+||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.. ............  +             .
T Consensus       166 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~-~~~~~~~~~~~~--~-------------~  228 (294)
T 4eqm_A          166 LTQTNHVLGTVQYFSPEQAKG-EATDECTDIYSIGIVLYEMLVGEPPFNG-ETAVSIAIKHIQ--D-------------S  228 (294)
T ss_dssp             ---------CCSSCCHHHHHT-CCCCTTHHHHHHHHHHHHHHHSSCSSCS-SCHHHHHHHHHS--S-------------C
T ss_pred             ccccCccccCccccCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHhh--c-------------c
Confidence              2234578999999999987 6789999999999999999999999832 222221111110  0             0


Q ss_pred             CChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccc
Q 013897          362 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                      . +.                ........+++.+.++|.+||..||++||+..+.+.+.|..-..
T Consensus       229 ~-~~----------------~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          229 V-PN----------------VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             C-CC----------------HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             C-CC----------------cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence            0 00                00111234678999999999999999999766666666655443

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=5.7e-45  Score=359.39  Aligned_cols=245  Identities=18%  Similarity=0.304  Sum_probs=197.4

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEc-------CCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEcc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHC-------TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQ  201 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~-------~~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  201 (434)
                      .++|++.+.||+|+||.||+|.+.       .++..||||+++...    .+.+.+|+.+++.+.+||||+++++++.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            478999999999999999999874       345689999997532    356889999999997899999999999653


Q ss_pred             CCCccEEEEeecCCCchhhhcC-------------------CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEec
Q 013897          202 QSKTPSLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID  262 (434)
Q Consensus       202 ~~~~~~lv~e~~~~~~l~~~~~-------------------~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~  262 (434)
                        ..+++||||+.+++|..++.                   .+++.++..++.||+.||+|||++||+||||||+|||++
T Consensus       160 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~  237 (370)
T 2psq_A          160 --GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT  237 (370)
T ss_dssp             --SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred             --CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEEC
Confidence              56789999999999977652                   368889999999999999999999999999999999999


Q ss_pred             CCCCeEEEEecccceecCCCCc---cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHH
Q 013897          263 HEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQ  338 (434)
Q Consensus       263 ~~~~~vkl~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~  338 (434)
                      .++ .+||+|||+++.......   .....+++.|+|||++.+ ..++.++|||||||++|||++ |+.||. +....+.
T Consensus       238 ~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~p~~-~~~~~~~  314 (370)
T 2psq_A          238 ENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYP-GIPVEEL  314 (370)
T ss_dssp             TTC-CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHTTSCCSST-TCCGGGH
T ss_pred             CCC-CEEEccccCCcccCcccceecccCCCcccceECHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCCC-CCCHHHH
Confidence            776 899999999987654322   233456778999999987 689999999999999999999 888873 3332222


Q ss_pred             HHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          339 LVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       339 ~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                      ...+..                            ..        .......+++++.+||.+||+.||++|||+.|++++
T Consensus       315 ~~~~~~----------------------------~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          315 FKLLKE----------------------------GH--------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             HHHHHT----------------------------TC--------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhc----------------------------CC--------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            221110                            00        011122467899999999999999999999999874

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=4.8e-45  Score=352.73  Aligned_cols=247  Identities=25%  Similarity=0.437  Sum_probs=203.4

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc---------HHHHHHHHHHHHHhc-CCCCeeeEeeEEEccC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---------KKKIKREIKILQNLC-GGPNIVKLLDIVRDQQ  202 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---------~~~~~~E~~~l~~l~-~h~niv~l~~~~~~~~  202 (434)
                      .++|++.+.||+|+||.||+|.+..+++.||||+++...         ...+.+|+.+++.+. .|+||+++++++.+. 
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~-  120 (320)
T 3a99_A           42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP-  120 (320)
T ss_dssp             TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS-
T ss_pred             cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC-
Confidence            478999999999999999999999999999999986432         245678999999995 379999999999654 


Q ss_pred             CCccEEEEeecCC-Cchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEeccccee
Q 013897          203 SKTPSLIFEHVNN-TDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF  278 (434)
Q Consensus       203 ~~~~~lv~e~~~~-~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~  278 (434)
                       ...++|+|++.+ ++|..++   ..+++..++.++.||+.||+|||++||+||||||+|||++.+++.+||+|||++..
T Consensus       121 -~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~  199 (320)
T 3a99_A          121 -DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL  199 (320)
T ss_dssp             -SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             -CcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccccc
Confidence             567899999986 7776654   46899999999999999999999999999999999999984444899999999987


Q ss_pred             cCCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhc
Q 013897          279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY  358 (434)
Q Consensus       279 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  358 (434)
                      ... .......||+.|+|||++.+...++.++|||||||++|||++|+.||..    ...   +.            .  
T Consensus       200 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~----~~~---~~------------~--  257 (320)
T 3a99_A          200 LKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEE---II------------R--  257 (320)
T ss_dssp             CCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS----HHH---HH------------H--
T ss_pred             ccc-ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCC----hhh---hh------------c--
Confidence            653 3344567899999999987644457899999999999999999999831    110   00            0  


Q ss_pred             cccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccc
Q 013897          359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN  426 (434)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~  426 (434)
                                   .          .......+++++.+||.+||..||++|||++|+++||||+.+..
T Consensus       258 -------------~----------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~  302 (320)
T 3a99_A          258 -------------G----------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL  302 (320)
T ss_dssp             -------------C----------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred             -------------c----------cccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccC
Confidence                         0          00011236789999999999999999999999999999998754

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.2e-44  Score=348.17  Aligned_cols=250  Identities=18%  Similarity=0.309  Sum_probs=201.0

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|++...   ..+.+.+|+.+++.+ +||||+++++++.+.  ...++|
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~--~~~~lv   85 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL-EHPNVLKFIGVLYKD--KRLNFI   85 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEET--TEEEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCcCcccEEEEEecC--CeeEEE
Confidence            47899999999999999999999999999999988543   346688999999999 899999999999754  567899


Q ss_pred             EeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCcc
Q 013897          210 FEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY  285 (434)
Q Consensus       210 ~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~  285 (434)
                      |||+.+++|..++    ..+++.++..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++........
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~  164 (310)
T 3s95_A           86 TEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENK-NVVVADFGLARLMVDEKTQ  164 (310)
T ss_dssp             EECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTS-CEEECCCTTCEECC-----
T ss_pred             EEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCC-CEEEeecccceeccccccc
Confidence            9999999997765    4588999999999999999999999999999999999999776 8999999999876433221


Q ss_pred             ---------------ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChh
Q 013897          286 ---------------NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE  350 (434)
Q Consensus       286 ---------------~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~  350 (434)
                                     ...+||+.|+|||++.+ ..++.++|||||||++|||++|..||...........          
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~----------  233 (310)
T 3s95_A          165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG----------  233 (310)
T ss_dssp             ---------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS----------
T ss_pred             ccccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh----------
Confidence                           14578999999999887 7899999999999999999999988743222110000          


Q ss_pred             HHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccc
Q 013897          351 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI  424 (434)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~  424 (434)
                                   .......            .......+++.+.+|+.+||+.||++|||+.|+++  |+..+
T Consensus       234 -------------~~~~~~~------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l  280 (310)
T 3s95_A          234 -------------LNVRGFL------------DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETL  280 (310)
T ss_dssp             -------------BCHHHHH------------HHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred             -------------hhhhccc------------cccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHH
Confidence                         0000000            00112346778999999999999999999999987  45443

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=8.2e-45  Score=346.15  Aligned_cols=254  Identities=22%  Similarity=0.354  Sum_probs=198.1

Q ss_pred             eEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEee
Q 013897          136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH  212 (434)
Q Consensus       136 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  212 (434)
                      |.....||+|+||.||+|.+..++..||||.++...   .+.+.+|+.+++.+ +||||+++++++.+.  ...++||||
T Consensus        24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv~e~  100 (295)
T 2clq_A           24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHL-KHKNIVQYLGSFSEN--GFIKIFMEQ  100 (295)
T ss_dssp             TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTC-CCTTBCCEEEEEEET--TEEEEEEEC
T ss_pred             CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhC-CCCCEeeEeeEEEeC--CcEEEEEEe
Confidence            344558999999999999999999999999986432   46688999999999 999999999999654  567899999


Q ss_pred             cCCCchhhhcC------CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC-cc
Q 013897          213 VNNTDFKVLYP------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EY  285 (434)
Q Consensus       213 ~~~~~l~~~~~------~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~-~~  285 (434)
                      +.+++|..++.      .+++..+..++.||+.||.|||++||+||||||+|||++..++.+||+|||++....... ..
T Consensus       101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~  180 (295)
T 2clq_A          101 VPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCT  180 (295)
T ss_dssp             CSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----
T ss_pred             CCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCcc
Confidence            99999877652      356788889999999999999999999999999999998734489999999998764332 23


Q ss_pred             ceeccCCcccccccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCCh
Q 013897          286 NVRVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP  364 (434)
Q Consensus       286 ~~~~~t~~y~aPE~~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  364 (434)
                      ....|+..|+|||++.+. ..++.++|||||||++|+|++|+.||...............                    
T Consensus       181 ~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--------------------  240 (295)
T 2clq_A          181 ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGM--------------------  240 (295)
T ss_dssp             CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHH--------------------
T ss_pred             cccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcc--------------------
Confidence            455789999999998652 24889999999999999999999998432221111111000                    


Q ss_pred             hHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccccc
Q 013897          365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA  427 (434)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~  427 (434)
                           ...          .......+++++.+||.+||..||++|||++|+|+||||+.....
T Consensus       241 -----~~~----------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~  288 (295)
T 2clq_A          241 -----FKV----------HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKK  288 (295)
T ss_dssp             -----HCC----------CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC----
T ss_pred             -----ccc----------cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcccc
Confidence                 000          001122467899999999999999999999999999999976543

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=8.6e-45  Score=349.75  Aligned_cols=254  Identities=20%  Similarity=0.345  Sum_probs=184.4

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccccH----HHHHHHH-HHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK----KKIKREI-KILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~E~-~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      .++|++++.||+|+||.||+|.+..+++.||||++.....    .+...|+ .+++.+ +||||+++++++.+.  ...+
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~--~~~~  100 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSH-DCPYIVQCFGTFITN--TDVF  100 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTT-TCTTBCCEEEEEECS--SEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCceeeEEEEEecC--CcEE
Confidence            4789999999999999999999988999999999965321    2233344 455555 999999999999754  5678


Q ss_pred             EEEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHC-CceeecCCCCceEecCCCCeEEEEecccceecCCC
Q 013897          208 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG  282 (434)
Q Consensus       208 lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~  282 (434)
                      +||||++ +.+..+.    ..+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++......
T Consensus       101 lv~e~~~-~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~~~~  178 (318)
T 2dyl_A          101 IAMELMG-TCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-QIKLCDFGISGRLVDD  178 (318)
T ss_dssp             EEECCCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTS-CEEECCCTTC------
T ss_pred             EEEeccC-CcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCC-CEEEEECCCchhccCC
Confidence            9999994 4443332    4689999999999999999999995 999999999999999776 8999999999776555


Q ss_pred             CccceeccCCcccccccccC----CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhc
Q 013897          283 KEYNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY  358 (434)
Q Consensus       283 ~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  358 (434)
                      .......+++.|+|||++.+    ...++.++|||||||++|+|++|+.||.......+.+..+.....           
T Consensus       179 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-----------  247 (318)
T 2dyl_A          179 KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEP-----------  247 (318)
T ss_dssp             --------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCC-----------
T ss_pred             ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCC-----------
Confidence            55556689999999999852    356889999999999999999999998544443333333221000           


Q ss_pred             cccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccc
Q 013897          359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                                             ........+++++.+||.+||..||.+|||++|+|+||||+..+
T Consensus       248 -----------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (318)
T 2dyl_A          248 -----------------------PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE  291 (318)
T ss_dssp             -----------------------CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred             -----------------------CCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence                                   00111123678999999999999999999999999999998764

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=6.3e-45  Score=351.93  Aligned_cols=256  Identities=18%  Similarity=0.364  Sum_probs=184.5

Q ss_pred             CCCCeEEEeeeeecCceEEEEEEEcCCCe---EEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC
Q 013897          132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNE---KCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS  203 (434)
Q Consensus       132 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~---~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  203 (434)
                      ..++|++.+.||+|+||.||+|.+..++.   .||||+++..     ..+.+.+|+.+++.+ +||||+++++++.+...
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~   99 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF-DHPHVAKLVGVSLRSRA   99 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTC-CCTTBCCCCEEEECC--
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHC-CCCceehhhceeecccc
Confidence            35789999999999999999999876665   8999998643     346788999999999 99999999999975433


Q ss_pred             C----ccEEEEeecCCCchhhhcC---------CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEE
Q 013897          204 K----TPSLIFEHVNNTDFKVLYP---------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRL  270 (434)
Q Consensus       204 ~----~~~lv~e~~~~~~l~~~~~---------~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl  270 (434)
                      .    ..++||||+.+++|..++.         .+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||
T Consensus       100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~-~~kl  178 (323)
T 3qup_A          100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM-TVCV  178 (323)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS-CEEE
T ss_pred             ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC-CEEE
Confidence            2    2489999999999876652         488999999999999999999999999999999999999776 8999


Q ss_pred             EecccceecCCCCcc---ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHh
Q 013897          271 IDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL  346 (434)
Q Consensus       271 ~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~  346 (434)
                      +|||+++........   ....+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||. +....+....+... 
T Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~-~~~~~~~~~~~~~~-  255 (323)
T 3qup_A          179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD-NLYTVHSDVWAFGVTMWEIMTRGQTPYA-GIENAEIYNYLIGG-  255 (323)
T ss_dssp             CCCCC-----------------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTT-TCCGGGHHHHHHTT-
T ss_pred             eeccccccccccccccccccccCcccccCchhhcC-CCCCCccchhhHHHHHHHHHhCCCCCcc-ccChHHHHHHHhcC-
Confidence            999999766443322   23356678999999877 679999999999999999999 888873 33333322222110 


Q ss_pred             CChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCcc-------HHHHhcCC
Q 013897          347 GTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT-------AKEAMAHP  419 (434)
Q Consensus       347 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt-------~~elL~Hp  419 (434)
                                                .         .......+++++.+||.+||+.||++|||       ++++++||
T Consensus       256 --------------------------~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~  300 (323)
T 3qup_A          256 --------------------------N---------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL  300 (323)
T ss_dssp             --------------------------C---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             --------------------------C---------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence                                      0         01112246789999999999999999999       88899999


Q ss_pred             Cccccccc
Q 013897          420 YFFPIRNA  427 (434)
Q Consensus       420 ~~~~~~~~  427 (434)
                      |+....+.
T Consensus       301 ~~~~~~~~  308 (323)
T 3qup_A          301 SVLSTSQD  308 (323)
T ss_dssp             --------
T ss_pred             hhcCCCCC
Confidence            99976543

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=4.3e-45  Score=355.58  Aligned_cols=259  Identities=24%  Similarity=0.414  Sum_probs=181.4

Q ss_pred             CCCeEEEe-eeeecCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeEeeEEEcc--CCCccEEE
Q 013897          133 QDDYEVVR-KVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ--QSKTPSLI  209 (434)
Q Consensus       133 ~~~y~~~~-~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~~~~~lv  209 (434)
                      .++|.+.+ .||+|+||.||+|.+..+++.||||++...  ....+|+..+.++.+||||+++++++...  ....+++|
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv  104 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS--PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLII  104 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS--HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc--HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEE
Confidence            47899965 699999999999999999999999999653  33455555555555999999999998652  23457899


Q ss_pred             EeecCCCchhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCC--CeEEEEecccceecCCC
Q 013897          210 FEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ--RKLRLIDWGLAEFYHPG  282 (434)
Q Consensus       210 ~e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~--~~vkl~DFGla~~~~~~  282 (434)
                      |||+.+++|..++.     .+++.+++.++.||+.||.|||++||+||||||+|||++.++  ..+||+|||++..... 
T Consensus       105 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~-  183 (336)
T 3fhr_A          105 MECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ-  183 (336)
T ss_dssp             EECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC---
T ss_pred             EeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceeccc-
Confidence            99999999877652     489999999999999999999999999999999999997532  3599999999986543 


Q ss_pred             CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                      ......++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ ...+....                
T Consensus       184 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~----------------  245 (336)
T 3fhr_A          184 NALQTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI-SPGMKRRI----------------  245 (336)
T ss_dssp             ---------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------------------
T ss_pred             cccccCCCCcCccChhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhh-hhhHHHhh----------------
Confidence            23355678999999999866 6788999999999999999999999843322110 00000000                


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                             ......      ........+++++.+||.+||+.||++|||++|+|+||||++..
T Consensus       246 -------~~~~~~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  295 (336)
T 3fhr_A          246 -------RLGQYG------FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM  295 (336)
T ss_dssp             ------------C------CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred             -------hccccc------cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence                   000000      00111124678999999999999999999999999999998654

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.2e-45  Score=362.41  Aligned_cols=269  Identities=20%  Similarity=0.316  Sum_probs=205.5

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      .++|.+.+.||+|+||.||+|.+..+++.||||+++..    ..+.+.+|+.+++.+ +||||+++++++.+......++
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~l   86 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTTRHKVL   86 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCCCCeEEEeeccCCCCeeEE
Confidence            47899999999999999999999999999999999743    346678999999999 8999999999998776668899


Q ss_pred             EEeecCCCchhhhcCC------CChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEe----cCCCCeEEEEeccccee
Q 013897          209 IFEHVNNTDFKVLYPT------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI----DHEQRKLRLIDWGLAEF  278 (434)
Q Consensus       209 v~e~~~~~~l~~~~~~------l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll----~~~~~~vkl~DFGla~~  278 (434)
                      ||||+.+++|..++..      +++..++.++.||+.||+|||++||+||||||+|||+    +.++ .+||+|||+++.
T Consensus        87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~-~~kL~DFG~a~~  165 (396)
T 4eut_A           87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS-VYKLTDFGAARE  165 (396)
T ss_dssp             EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCE-EEEECCGGGCEE
T ss_pred             EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCce-eEEEecCCCceE
Confidence            9999999999887643      8999999999999999999999999999999999998    5444 799999999988


Q ss_pred             cCCCCccceeccCCcccccccccCC-------CCCCccccHHHHHHHHHHHHhCCCCCCCCCCC---HHHHHHHHHHhCC
Q 013897          279 YHPGKEYNVRVASRYFKGPELLVDL-------QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN---YDQLVKIAKVLGT  348 (434)
Q Consensus       279 ~~~~~~~~~~~~t~~y~aPE~~~~~-------~~~~~~~DvwSlGvil~elltg~~pf~~~~~~---~~~~~~i~~~~g~  348 (434)
                      ...........||+.|+|||++.+.       ..++.++|||||||++|||++|+.||......   .+.+..+..  +.
T Consensus       166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~--~~  243 (396)
T 4eut_A          166 LEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT--GK  243 (396)
T ss_dssp             CCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH--SC
T ss_pred             ccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc--CC
Confidence            7666556667899999999998531       35778999999999999999999998543322   222222221  11


Q ss_pred             hhHHHHHhhccccCChhHHHHhcccCCCCCccccc--cccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          349 DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFIT--VENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                      + ...+ .......          .....|.....  ......+++.+.+||.+||+.||++||++.|+++
T Consensus       244 p-~~~~-~~~~~~~----------~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~  302 (396)
T 4eut_A          244 P-SGAI-SGVQKAE----------NGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA  302 (396)
T ss_dssp             C-TTCC-EEEECST----------TCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             C-cccc-hhheecc----------CCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence            0 0000 0000000          00000000000  0111234567899999999999999999999864

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.6e-44  Score=344.66  Aligned_cols=261  Identities=19%  Similarity=0.352  Sum_probs=197.4

Q ss_pred             CCCeEEEeeeeecCceEEEEEE----EcCCCeEEEEEEecccc---HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGV----HCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT  205 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~----~~~~~~~vaiK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  205 (434)
                      .++|++++.||+|+||.||+|+    +..+++.||||+++...   .+.+.+|+.+++.+ +||||+++++++.......
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~   87 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRRN   87 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECHHHHTS
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCCCc
Confidence            4789999999999999999998    45688999999997544   35688999999999 8999999999997665567


Q ss_pred             cEEEEeecCCCchhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC
Q 013897          206 PSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP  281 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~  281 (434)
                      .++||||+.+++|..++.    .+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus        88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~-~~kl~Dfg~~~~~~~  166 (295)
T 3ugc_A           88 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN-RVKIGDFGLTKVLPQ  166 (295)
T ss_dssp             CEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCCCSCC----
T ss_pred             eEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCC-eEEEccCcccccccC
Confidence            889999999999987653    388999999999999999999999999999999999999776 899999999987644


Q ss_pred             CCc----cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhh
Q 013897          282 GKE----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK  357 (434)
Q Consensus       282 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  357 (434)
                      ...    .....++..|+|||.+.+ ..++.++|||||||++|+|++|..|+...   ...   .....+......... 
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~---~~~---~~~~~~~~~~~~~~~-  238 (295)
T 3ugc_A          167 DKEFFKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSP---PAE---FMRMIGNDKQGQMIV-  238 (295)
T ss_dssp             ---------CTTCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTTCTTCSH---HHH---HHHHHCTTCCTHHHH-
T ss_pred             CcceeeeccCCCCccceeCcHHhcC-CCCChHHHHHHHHHHHHHHHhcccccCCC---hHH---HHhhhcCccccchhH-
Confidence            322    123356777999999887 67999999999999999999999887321   111   111111110000000 


Q ss_pred             ccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                            ...........+        ......+++++.+||.+||+.||++|||+.|+++
T Consensus       239 ------~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          239 ------FHLIELLKNNGR--------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             ------HHHHHHHHTTCC--------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ------HHHHHHHhccCc--------CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                  000111111111        1122347789999999999999999999999985

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.2e-44  Score=345.88  Aligned_cols=256  Identities=21%  Similarity=0.304  Sum_probs=197.7

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHh-cCCCCeeeEeeEEEcc--CCCccEEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNL-CGGPNIVKLLDIVRDQ--QSKTPSLI  209 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~E~~~l~~l-~~h~niv~l~~~~~~~--~~~~~~lv  209 (434)
                      .++|++.+.||+|+||.||+|.+  +++.||||++.......+.+|.+++... .+||||+++++++.+.  .....++|
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv   84 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLI   84 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEe
Confidence            47899999999999999999987  6899999999887777888888888873 2899999999987643  23457899


Q ss_pred             EeecCCCchhhhcC--CCChHHHHHHHHHHHHHHHHHH--------HCCceeecCCCCceEecCCCCeEEEEecccceec
Q 013897          210 FEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCH--------SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY  279 (434)
Q Consensus       210 ~e~~~~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~LH--------~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~  279 (434)
                      |||+.+++|..++.  .+++..+..++.||+.||+|||        +++|+||||||+|||++.++ .+||+|||+++..
T Consensus        85 ~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~a~~~  163 (301)
T 3q4u_A           85 THYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG-QCCIADLGLAVMH  163 (301)
T ss_dssp             ECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTS-CEEECCCTTCEEE
T ss_pred             hhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCC-CEEEeeCCCeeec
Confidence            99999999988764  5889999999999999999999        99999999999999999776 8999999999766


Q ss_pred             CCCCc-----cceeccCCcccccccccCCC-----CCCccccHHHHHHHHHHHHhC----------CCCCCCCCCCHHHH
Q 013897          280 HPGKE-----YNVRVASRYFKGPELLVDLQ-----DYDYSLDLWSLGCMFAGMIFR----------KEPFFYGHDNYDQL  339 (434)
Q Consensus       280 ~~~~~-----~~~~~~t~~y~aPE~~~~~~-----~~~~~~DvwSlGvil~elltg----------~~pf~~~~~~~~~~  339 (434)
                      .....     ....+||+.|+|||++.+..     .++.++|||||||++|||++|          +.||..........
T Consensus       164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~  243 (301)
T 3q4u_A          164 SQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF  243 (301)
T ss_dssp             ETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             ccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcch
Confidence            44322     22347999999999987632     344799999999999999999          88875433322222


Q ss_pred             HHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          340 VKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       340 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                      ..+.+.....                       ..+....   .......+++++.+||.+||+.||++|||+.|+++
T Consensus       244 ~~~~~~~~~~-----------------------~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          244 EDMRKVVCVD-----------------------QQRPNIP---NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             HHHHHHHTTS-----------------------CCCCCCC---GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             hhhhHHHhcc-----------------------CCCCCCC---hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            2211111100                       0000000   00011124568999999999999999999999985

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1e-44  Score=351.14  Aligned_cols=258  Identities=21%  Similarity=0.377  Sum_probs=180.3

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      .++|++++.||+|+||.||+|.+..+++.||||+++...    ...+..|+..+.+..+||||+++++++.+.  ...++
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~--~~~~l   98 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE--GDCWI   98 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS--SEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC--CceEE
Confidence            478999999999999999999999999999999996532    234566766444444999999999999754  56789


Q ss_pred             EEeecCCCchhhh--------cCCCChHHHHHHHHHHHHHHHHHHHC-CceeecCCCCceEecCCCCeEEEEecccceec
Q 013897          209 IFEHVNNTDFKVL--------YPTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY  279 (434)
Q Consensus       209 v~e~~~~~~l~~~--------~~~l~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~  279 (434)
                      ||||+.++ +..+        ...+++..+..++.|++.||.|||+. ||+||||||+|||++.++ .+||+|||+++..
T Consensus        99 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~~~~~  176 (327)
T 3aln_A           99 CMELMSTS-FDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSG-NIKLCDFGISGQL  176 (327)
T ss_dssp             EECCCSEE-HHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTT-EEEECCCSSSCC-
T ss_pred             EEeecCCC-hHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCC-CEEEccCCCceec
Confidence            99999974 3322        24588999999999999999999999 999999999999999776 8999999999876


Q ss_pred             CCCCccceeccCCccccccccc---CCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHh
Q 013897          280 HPGKEYNVRVASRYFKGPELLV---DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN  356 (434)
Q Consensus       280 ~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~  356 (434)
                      ..........|++.|+|||++.   ....++.++|||||||++|+|++|+.||.......+.+..+              
T Consensus       177 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--------------  242 (327)
T 3aln_A          177 VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV--------------  242 (327)
T ss_dssp             -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCC--------------
T ss_pred             ccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHH--------------
Confidence            5554445557999999999983   22568999999999999999999999984322111110000              


Q ss_pred             hccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccc
Q 013897          357 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN  426 (434)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~  426 (434)
                                       ...... .........+++++.+||.+||..||++|||+.|+|+||||....+
T Consensus       243 -----------------~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~  294 (327)
T 3aln_A          243 -----------------VKGDPP-QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEE  294 (327)
T ss_dssp             -----------------CCSCCC-CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred             -----------------hcCCCC-CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHh
Confidence                             000000 0011112346789999999999999999999999999999987653

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.6e-44  Score=350.02  Aligned_cols=243  Identities=17%  Similarity=0.298  Sum_probs=194.4

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCC---eEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDN---EKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT  205 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~---~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  205 (434)
                      .++|++.+.||+|+||.||+|.+..++   ..||||+++..    ..+.+.+|+.+++.+ +||||+++++++.+.  ..
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~  124 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF-DHPNIIRLEGVVTRG--RL  124 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECGG--GC
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeC--Cc
Confidence            478999999999999999999987544   46999999753    245688999999999 899999999999654  46


Q ss_pred             cEEEEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC
Q 013897          206 PSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP  281 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~  281 (434)
                      .++||||+.+++|..++    ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus       125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~  203 (325)
T 3kul_A          125 AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNL-VCKVSDFGLSRVLED  203 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCSSCEECC-
T ss_pred             cEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCC-CEEECCCCccccccc
Confidence            78999999999998776    3589999999999999999999999999999999999999776 899999999987654


Q ss_pred             CCcc----ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHh
Q 013897          282 GKEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN  356 (434)
Q Consensus       282 ~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~  356 (434)
                      ....    ....+|..|+|||++.+ ..++.++|||||||++|+|++ |..||.. ....+....+...           
T Consensus       204 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~-~~~~~~~~~~~~~-----------  270 (325)
T 3kul_A          204 DPDAAYTTTGGKIPIRWTAPEAIAF-RTFSSASDVWSFGVVMWEVLAYGERPYWN-MTNRDVISSVEEG-----------  270 (325)
T ss_dssp             ---CCEECC---CCGGGSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTT-SCHHHHHHHHHTT-----------
T ss_pred             CccceeeccCCCCcccccCHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCccc-CCHHHHHHHHHcC-----------
Confidence            3221    22345678999999876 678999999999999999999 9989832 2222222221110           


Q ss_pred             hccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          357 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                       .        .......+++++.+||.+||..||++|||+.|+++
T Consensus       271 -----------------~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          271 -----------------Y--------RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             -----------------C--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------------C--------CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                             0        01112246789999999999999999999999986

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=6.2e-45  Score=358.76  Aligned_cols=249  Identities=16%  Similarity=0.281  Sum_probs=198.0

Q ss_pred             CCCeEEEeeeeecCceEEEEEEE-----cCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVH-----CTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS  203 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~-----~~~~~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  203 (434)
                      .++|++++.||+|+||.||+|.+     ..++..||||+++..    ....+.+|+.+++.+ +||||+++++++.+.  
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~--  146 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQS--  146 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSS--
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhC-CCCCCCeEEEEEecC--
Confidence            47899999999999999999994     456789999998643    234688999999999 999999999999653  


Q ss_pred             CccEEEEeecCCCchhhhcC----------CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCC--CeEEEE
Q 013897          204 KTPSLIFEHVNNTDFKVLYP----------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ--RKLRLI  271 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~~----------~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~--~~vkl~  271 (434)
                      ...++||||+.+++|..++.          .+++.++..++.||+.||+|||++||+||||||+|||++.++  ..+||+
T Consensus       147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEEC
Confidence            55689999999999877652          388899999999999999999999999999999999998443  259999


Q ss_pred             ecccceecCCC---CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC
Q 013897          272 DWGLAEFYHPG---KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG  347 (434)
Q Consensus       272 DFGla~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g  347 (434)
                      |||+++.....   .......+|+.|+|||++.+ ..++.++|||||||++|||++ |..||. +....+....+...  
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~pf~-~~~~~~~~~~i~~~--  302 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYP-SKSNQEVLEFVTSG--  302 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSST-TCCHHHHHHHHHTT--
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHcC--
Confidence            99999754221   22334567889999999877 689999999999999999998 888873 33322222221110  


Q ss_pred             ChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcc
Q 013897          348 TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFF  422 (434)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~  422 (434)
                                                .        .......+++.+.+||.+||+.||++|||+.|+++|.++.
T Consensus       303 --------------------------~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          303 --------------------------G--------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             --------------------------C--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --------------------------C--------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                                      0        0111224678899999999999999999999999987654

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.5e-44  Score=342.34  Aligned_cols=246  Identities=22%  Similarity=0.352  Sum_probs=204.6

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeEeeEEEcc------------
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ------------  201 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~------------  201 (434)
                      ++|++++.||+|+||.||+|.+..+++.||+|+++... +.+.+|+.+++.+ +||||+++++++...            
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~~   88 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-EKAEREVKALAKL-DHVNIVHYNGCWDGFDYDPETSSKNSS   88 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-GGGHHHHHHHHHC-CCTTBCCEEEEEEEEEEC---------
T ss_pred             cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-HHHHHHHHHHHhC-CCCCEEEEeeeEeccccCccccccccc
Confidence            57999999999999999999998899999999997543 5678999999999 999999999988541            


Q ss_pred             --CCCccEEEEeecCCCchhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecc
Q 013897          202 --QSKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG  274 (434)
Q Consensus       202 --~~~~~~lv~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFG  274 (434)
                        .....++||||+.+++|..++     ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg  167 (284)
T 2a19_B           89 RSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK-QVKIGDFG  167 (284)
T ss_dssp             CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCCT
T ss_pred             ccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCC-CEEECcch
Confidence              134578999999999997765     3588999999999999999999999999999999999999776 89999999


Q ss_pred             cceecCCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHH
Q 013897          275 LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAY  354 (434)
Q Consensus       275 la~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~  354 (434)
                      ++.............+++.|+|||++.+ ..++.++|||||||++|+|++|..|+...       .....        . 
T Consensus       168 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~-------~~~~~--------~-  230 (284)
T 2a19_B          168 LVTSLKNDGKRTRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFET-------SKFFT--------D-  230 (284)
T ss_dssp             TCEESSCCSCCCCCCSCCTTSCHHHHHC-SCCCTHHHHHHHHHHHHHHHSCCSSHHHH-------HHHHH--------H-
T ss_pred             hheeccccccccccCCcccccChhhhcc-CCCcchhhhHHHHHHHHHHHhcCCcchhH-------HHHHH--------H-
Confidence            9988766555566789999999999887 67899999999999999999999887210       00000        0 


Q ss_pred             HhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccc
Q 013897          355 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                                    +...            .....+++.+.+||.+||..||++|||+.|+++|.+.-.-.
T Consensus       231 --------------~~~~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~  275 (284)
T 2a19_B          231 --------------LRDG------------IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS  275 (284)
T ss_dssp             --------------HHTT------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred             --------------hhcc------------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence                          0000            00123677899999999999999999999999998776543

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=6e-44  Score=340.64  Aligned_cols=249  Identities=17%  Similarity=0.258  Sum_probs=200.0

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEe
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE  211 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  211 (434)
                      .++|++.+.||+|+||.||+|.+..+++.||||++... ..+.+.+|+.+++.+.+|+|++++++++.+  ....++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCC--CceeEEEEE
Confidence            47899999999999999999999999999999998643 345689999999999889999999999864  356789999


Q ss_pred             ecCCCchhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCC----eEEEEecccceecCCCC
Q 013897          212 HVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR----KLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       212 ~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~----~vkl~DFGla~~~~~~~  283 (434)
                      |+ +++|..++.    .+++..+..++.||+.||+|||++||+||||||+|||++.++.    .+||+|||+++......
T Consensus        87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~  165 (298)
T 1csn_A           87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV  165 (298)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred             ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccc
Confidence            99 888876653    5899999999999999999999999999999999999986551    39999999998765432


Q ss_pred             c--------cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCC--CHHHHHHHHHHhCChhHHH
Q 013897          284 E--------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD--NYDQLVKIAKVLGTDELNA  353 (434)
Q Consensus       284 ~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~--~~~~~~~i~~~~g~~~~~~  353 (434)
                      .        .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....  ....+..+........   
T Consensus       166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---  241 (298)
T 1csn_A          166 TKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP---  241 (298)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC---
T ss_pred             ccccccccCccCCCCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc---
Confidence            2        244578999999999877 6799999999999999999999999854322  1222222211100000   


Q ss_pred             HHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          354 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                  .                 ......+++++.+|+.+||..||++|||++++++
T Consensus       242 ------------~-----------------~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          242 ------------L-----------------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             ------------H-----------------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             ------------H-----------------HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence                        0                 0001136789999999999999999999999875

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.3e-44  Score=337.83  Aligned_cols=243  Identities=17%  Similarity=0.350  Sum_probs=197.4

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF  210 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  210 (434)
                      .++|++++.||+|+||.||+|.+. +++.||+|++...  ..+.+.+|+.+++++ +||||+++++++.+.  ...++||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~   84 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQ--APICLVF   84 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTC-CCTTBCCEEEEECSS--SSEEEEE
T ss_pred             hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhC-CCCCEeeEEEEEecC--CceEEEE
Confidence            478999999999999999999985 6788999999753  457799999999999 899999999999653  5678999


Q ss_pred             eecCCCchhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC--c
Q 013897          211 EHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--E  284 (434)
Q Consensus       211 e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~--~  284 (434)
                      ||+.+++|..++.    .+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||++.......  .
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~  163 (269)
T 4hcu_A           85 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLDDQYTS  163 (269)
T ss_dssp             ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGG-CEEECCTTGGGGBCCHHHHS
T ss_pred             EeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCC-CEEecccccccccccccccc
Confidence            9999999887652    388999999999999999999999999999999999998776 89999999997654321  1


Q ss_pred             cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                      .....++..|+|||.+.+ ..++.++|||||||++|+|++ |+.||. +....+....+...                  
T Consensus       164 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~~g~~p~~-~~~~~~~~~~~~~~------------------  223 (269)
T 4hcu_A          164 STGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYE-NRSNSEVVEDISTG------------------  223 (269)
T ss_dssp             TTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTT-TCCHHHHHHHHHTT------------------
T ss_pred             ccCcccccccCCHHHhcC-CCCCchhhhHHHHHHHHHHhcCCCCCCC-CCCHHHHHHHHhcC------------------
Confidence            223355678999999876 679999999999999999999 888873 33322222221110                  


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                                        .....+..+++++.+|+.+||+.||++|||+.|+++|
T Consensus       224 ------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          224 ------------------FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             ------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------ccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence                              0011122357889999999999999999999999976

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=4.2e-44  Score=347.53  Aligned_cols=247  Identities=21%  Similarity=0.276  Sum_probs=197.5

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEe
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE  211 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  211 (434)
                      .++|++.+.||+|+||.||+|.+..+++.||||++... ..+.+.+|+.+++.+.+||||+++++++.+.  ...++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCG--KYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEET--TEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecC--CccEEEEE
Confidence            37899999999999999999999999999999998643 3456899999999998999999999999764  56789999


Q ss_pred             ecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCe-----EEEEecccceecCCC
Q 013897          212 HVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRK-----LRLIDWGLAEFYHPG  282 (434)
Q Consensus       212 ~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~-----vkl~DFGla~~~~~~  282 (434)
                      |+ +++|..++    ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .     +||+|||+++.....
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~-~~~~~~~kl~DFg~a~~~~~~  163 (330)
T 2izr_A           86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPG-NKTQQVIHIIDFALAKEYIDP  163 (330)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGG-GTCTTSEEECCCTTCEESBCT
T ss_pred             eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCC-CCCCceEEEEEcccceeeecC
Confidence            99 78877664    4689999999999999999999999999999999999998665 4     999999999876443


Q ss_pred             Cc--------cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCC-H-HHHHHHHHHhCChhHH
Q 013897          283 KE--------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN-Y-DQLVKIAKVLGTDELN  352 (434)
Q Consensus       283 ~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~-~-~~~~~i~~~~g~~~~~  352 (434)
                      ..        ....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... . +.+..+.....     
T Consensus       164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~-----  237 (330)
T 2izr_A          164 ETKKHIPYREHKSLTGTARYMSINTHLG-KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR-----  237 (330)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH-----
T ss_pred             CCCccccccccCCcCCCccccChHHHcC-CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc-----
Confidence            22        245689999999999887 78999999999999999999999998543221 1 11222211000     


Q ss_pred             HHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          353 AYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                              .....                   .....++ ++.+|+.+||..||.+||+++++++
T Consensus       238 --------~~~~~-------------------~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          238 --------ATPIE-------------------VLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             --------HSCHH-------------------HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             --------cCCHH-------------------HHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence                    00000                   0001133 8999999999999999999988876

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=4.9e-44  Score=351.85  Aligned_cols=254  Identities=16%  Similarity=0.238  Sum_probs=192.0

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCC-----CeEEEEEEeccccHHHHHHHHHHHHHhc--------------CCCCeee
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTD-----NEKCIIKILKPVKKKKIKREIKILQNLC--------------GGPNIVK  193 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~-----~~~vaiK~~~~~~~~~~~~E~~~l~~l~--------------~h~niv~  193 (434)
                      .++|.+.+.||+|+||.||+|.+..+     ++.||||++.... ..+.+|+.+++.+.              +||||++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN-GPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTC-HHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccc-hhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            46899999999999999999998664     5789999986543 23444444444432              5999999


Q ss_pred             EeeEEEccCC--CccEEEEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEec--CCC
Q 013897          194 LLDIVRDQQS--KTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID--HEQ  265 (434)
Q Consensus       194 l~~~~~~~~~--~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~--~~~  265 (434)
                      +++++.....  .+.++||||+ +++|..++    ..+++..+..++.||+.||+|||++||+||||||+|||++  .++
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~  191 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD  191 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence            9999875432  4678999999 88887765    4689999999999999999999999999999999999998  555


Q ss_pred             CeEEEEecccceecCCCCc--------cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHH
Q 013897          266 RKLRLIDWGLAEFYHPGKE--------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYD  337 (434)
Q Consensus       266 ~~vkl~DFGla~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~  337 (434)
                       .+||+|||+++.+.....        ....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....+..
T Consensus       192 -~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~  269 (364)
T 3op5_A          192 -QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG-VAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK  269 (364)
T ss_dssp             -CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred             -eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence             899999999977643221        133459999999999887 6799999999999999999999999954333333


Q ss_pred             HHHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          338 QLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       338 ~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                      .......... ........               .           ......+++++.+|+..||..||++||++.++++
T Consensus       270 ~~~~~~~~~~-~~~~~~~~---------------~-----------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          270 YVRDSKIRYR-ENIASLMD---------------K-----------CFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHHHH-HCHHHHHH---------------H-----------HSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHHhh-hhHHHHHH---------------H-----------hcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            2222111100 00111100               0           0011236789999999999999999999998875

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.3e-43  Score=336.88  Aligned_cols=244  Identities=19%  Similarity=0.297  Sum_probs=196.1

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc----------HHHHHHHHHHHHHhcCCCCeeeEeeEEEccC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ  202 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  202 (434)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....          .+.+.+|+.+++++ +||||+++++++.+. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~-   95 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-NHPNIVKLYGLMHNP-   95 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTC-CCTTBCCEEEEETTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhC-CCCCchhhheeecCC-
Confidence            478999999999999999999999999999999985322          16788999999999 899999999998543 


Q ss_pred             CCccEEEEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCC--ceeecCCCCceEecCCCC----eEEEEe
Q 013897          203 SKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHEQR----KLRLID  272 (434)
Q Consensus       203 ~~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlKp~NIll~~~~~----~vkl~D  272 (434)
                         .++||||+.+++|...+    ..+++..+..++.||+.||+|||++|  |+||||||+|||++.++.    .+||+|
T Consensus        96 ---~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           96 ---PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             ---TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             ---CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence               26999999999886544    35899999999999999999999999  999999999999986552    299999


Q ss_pred             cccceecCCCCccceeccCCcccccccccC-CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhH
Q 013897          273 WGLAEFYHPGKEYNVRVASRYFKGPELLVD-LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL  351 (434)
Q Consensus       273 FGla~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~  351 (434)
                      ||+++...  .......|++.|+|||++.+ ...++.++|||||||++|+|++|+.||.................+.   
T Consensus       173 fg~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---  247 (287)
T 4f0f_A          173 FGLSQQSV--HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL---  247 (287)
T ss_dssp             CTTCBCCS--SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC---
T ss_pred             CCcccccc--ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC---
Confidence            99997543  23455678999999999843 2457899999999999999999999985443332222211111000   


Q ss_pred             HHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          352 NAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                                     .......+++++.+||.+||+.||++|||++|+++
T Consensus       248 -------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          248 -------------------------------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             -------------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------------------------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                                           01112246789999999999999999999999985

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-44  Score=346.03  Aligned_cols=247  Identities=24%  Similarity=0.438  Sum_probs=195.7

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc---------HHHHHHHHHHHHHhc---CCCCeeeEeeEEEc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---------KKKIKREIKILQNLC---GGPNIVKLLDIVRD  200 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---------~~~~~~E~~~l~~l~---~h~niv~l~~~~~~  200 (434)
                      .++|++.+.||+|+||.||+|.+..+++.||||+++...         ...+.+|+.++.++.   +||||+++++++.+
T Consensus        30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~  109 (312)
T 2iwi_A           30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET  109 (312)
T ss_dssp             ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred             hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence            467999999999999999999998899999999996432         233567999999885   79999999999865


Q ss_pred             cCCCccEEEEee-cCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccc
Q 013897          201 QQSKTPSLIFEH-VNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA  276 (434)
Q Consensus       201 ~~~~~~~lv~e~-~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla  276 (434)
                      .  ...++|+|| +.+++|..++   ..+++..+..++.||+.||.|||++||+||||||+|||++.+++.+||+|||++
T Consensus       110 ~--~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~  187 (312)
T 2iwi_A          110 Q--EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG  187 (312)
T ss_dssp             -----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred             C--CeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchh
Confidence            4  456799999 7888887665   358999999999999999999999999999999999999844448999999999


Q ss_pred             eecCCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHh
Q 013897          277 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN  356 (434)
Q Consensus       277 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~  356 (434)
                      ...... ......|+..|+|||++.+...++.++|||||||++|+|++|+.||..    ...   +..            
T Consensus       188 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~----~~~---~~~------------  247 (312)
T 2iwi_A          188 ALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER----DQE---ILE------------  247 (312)
T ss_dssp             EECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS----HHH---HHH------------
T ss_pred             hhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC----hHH---Hhh------------
Confidence            876533 345567899999999987634445689999999999999999999831    110   000            


Q ss_pred             hccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccc
Q 013897          357 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN  426 (434)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~  426 (434)
                                     .          .......+++++.+||.+||..||++|||++|+|+||||+...+
T Consensus       248 ---------------~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~  292 (312)
T 2iwi_A          248 ---------------A----------ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE  292 (312)
T ss_dssp             ---------------T----------CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred             ---------------h----------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence                           0          00011236788999999999999999999999999999997653

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=5e-44  Score=344.22  Aligned_cols=255  Identities=25%  Similarity=0.443  Sum_probs=194.5

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcC-CCCeeeEeeEEEccCCCcc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCG-GPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~-h~niv~l~~~~~~~~~~~~  206 (434)
                      .++|++++.||+|+||.||+|.+ .+++.||||++...     ..+.+.+|+.+++++.+ ||||+++++++.+.  ...
T Consensus        27 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~--~~~  103 (313)
T 3cek_A           27 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD--QYI  103 (313)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEC-TTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS--SEE
T ss_pred             cceEEEEEEecCCCCEEEEEEEc-CCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC--CEE
Confidence            46799999999999999999987 45889999998542     23668899999999954 69999999999654  567


Q ss_pred             EEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC
Q 013897          207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~  283 (434)
                      ++||| +.+++|..++   ..+++..++.++.||+.||.|||++||+||||||+|||++ ++ .+||+|||++.......
T Consensus       104 ~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~-~~kL~Dfg~~~~~~~~~  180 (313)
T 3cek_A          104 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DG-MLKLIDFGIANQMQPDT  180 (313)
T ss_dssp             EEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TT-EEEECCCSSSCC-----
T ss_pred             EEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CC-eEEEeeccccccccCcc
Confidence            89999 5667776554   4588999999999999999999999999999999999997 44 89999999997664332


Q ss_pred             c---cceeccCCcccccccccCC----------CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChh
Q 013897          284 E---YNVRVASRYFKGPELLVDL----------QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE  350 (434)
Q Consensus       284 ~---~~~~~~t~~y~aPE~~~~~----------~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~  350 (434)
                      .   .....|++.|+|||++.+.          ..++.++|||||||++|+|++|+.||.........+..+   ..   
T Consensus       181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~---~~---  254 (313)
T 3cek_A          181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI---ID---  254 (313)
T ss_dssp             ---------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH---HC---
T ss_pred             ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHH---Hh---
Confidence            2   2345789999999998641          368889999999999999999999985433222221111   00   


Q ss_pred             HHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccccc
Q 013897          351 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~  428 (434)
                                           ....        .......++++.+||.+||..||++||++.|+|+||||+....+.
T Consensus       255 ---------------------~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~  303 (313)
T 3cek_A          255 ---------------------PNHE--------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV  303 (313)
T ss_dssp             ---------------------TTSC--------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC----
T ss_pred             ---------------------cccc--------cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCch
Confidence                                 0000        111123567899999999999999999999999999999765443

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=8.6e-45  Score=351.30  Aligned_cols=265  Identities=19%  Similarity=0.244  Sum_probs=196.5

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccccH--HHHHHHHHHHHHhcCCCCeeeEeeEEEccC--CCccEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--KKIKREIKILQNLCGGPNIVKLLDIVRDQQ--SKTPSL  208 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~E~~~l~~l~~h~niv~l~~~~~~~~--~~~~~l  208 (434)
                      .++|++.+.||+|+||+||+|.+.  ++.||||+++....  ....+|+.+++++ +||||+++++++.+..  ...+++
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~l   99 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGM-KHENILQFIGAEKRGTSVDVDLWL   99 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcC-CCCCchhhcceeccCCCCCceEEE
Confidence            478999999999999999999874  79999999975543  3456688889898 8999999999997654  234689


Q ss_pred             EEeecCCCchhhhc--CCCChHHHHHHHHHHHHHHHHHHHC----------CceeecCCCCceEecCCCCeEEEEecccc
Q 013897          209 IFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQ----------GIMHRDVKPHNVMIDHEQRKLRLIDWGLA  276 (434)
Q Consensus       209 v~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~----------~ivHrDlKp~NIll~~~~~~vkl~DFGla  276 (434)
                      ||||+.+++|..++  ..+++..+..++.||+.||.|||+.          +|+||||||+|||++.++ .+||+|||++
T Consensus       100 v~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~-~~kL~DFg~a  178 (322)
T 3soc_A          100 ITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL-TACIADFGLA  178 (322)
T ss_dssp             EEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC-CEEECCCTTC
T ss_pred             EEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC-eEEEccCCcc
Confidence            99999999998776  4589999999999999999999999          999999999999999776 8999999999


Q ss_pred             eecCCCCc---cceeccCCcccccccccCC----CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCh
Q 013897          277 EFYHPGKE---YNVRVASRYFKGPELLVDL----QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTD  349 (434)
Q Consensus       277 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~----~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~  349 (434)
                      +.......   ....+||+.|+|||++.+.    ..++.++|||||||++|||++|+.||........ ........+..
T Consensus       179 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-~~~~~~~~~~~  257 (322)
T 3soc_A          179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM-LPFEEEIGQHP  257 (322)
T ss_dssp             EEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCC-CTTHHHHCSSC
T ss_pred             cccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhc-cchhhhhccCC
Confidence            87654332   2345789999999998762    2456788999999999999999999854322111 00000011111


Q ss_pred             hHHHHHhhccccCChhHHHHh-cccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          350 ELNAYLNKYHIELDPHLAALV-GRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                      .....            .... ....+.....   .......++++.+||.+||+.||++|||+.|+++
T Consensus       258 ~~~~~------------~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          258 SLEDM------------QEVVVHKKKRPVLRD---YWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             CHHHH------------HHHHTTSCCCCCCCG---GGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             chhhh------------hhhhhcccCCCCccc---cccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            11111            1111 1111111110   0111123456999999999999999999999986

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=6.9e-44  Score=335.31  Aligned_cols=243  Identities=16%  Similarity=0.301  Sum_probs=197.0

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF  210 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  210 (434)
                      .++|++++.||+|+||.||+|.+. ++..||+|+++..  ..+.+.+|+.+++.+ +||||+++++++.+  ....++||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~   82 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKL-SHPKLVKFYGVCSK--EYPIYIVT   82 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHC-CCTTBCCEEEEECS--SSSEEEEE
T ss_pred             hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhC-CCCCEeeEEEEEcc--CCceEEEE
Confidence            478999999999999999999874 6778999999753  457789999999999 89999999999954  45678999


Q ss_pred             eecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCcc-
Q 013897          211 EHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-  285 (434)
Q Consensus       211 e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~-  285 (434)
                      ||+.+++|..++    ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++......... 
T Consensus        83 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~~~~~~~~~~  161 (268)
T 3sxs_A           83 EYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDL-CVKVSDFGMTRYVLDDQYVS  161 (268)
T ss_dssp             ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTC-CEEECCTTCEEECCTTCEEE
T ss_pred             EccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCC-CEEEccCccceecchhhhhc
Confidence            999999987765    2489999999999999999999999999999999999999776 8999999999876543321 


Q ss_pred             -ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          286 -NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       286 -~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                       ....++..|+|||.+.+ ..++.++|||||||++|+|++ |+.||. .....+....+...                  
T Consensus       162 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~-~~~~~~~~~~~~~~------------------  221 (268)
T 3sxs_A          162 SVGTKFPVKWSAPEVFHY-FKYSSKSDVWAFGILMWEVFSLGKMPYD-LYTNSEVVLKVSQG------------------  221 (268)
T ss_dssp             CCSCCCCGGGCCHHHHHH-SEEETTHHHHHHHHHHHHHHTTTCCTTT-TSCHHHHHHHHHTT------------------
T ss_pred             ccCCCcCcccCCHHHHhc-cCCchhhhhHHHHHHHHHHHcCCCCCcc-ccChHHHHHHHHcC------------------
Confidence             22345567999999876 678999999999999999999 998883 22222222221100                  


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                                .        ....+..+++.+.+||.+||+.||++|||+.|+++|
T Consensus       222 ----------~--------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          222 ----------H--------RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             ----------C--------CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ----------C--------CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                      0        011122357889999999999999999999999986

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-43  Score=350.17  Aligned_cols=245  Identities=19%  Similarity=0.320  Sum_probs=198.0

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcC-------CCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEcc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCT-------DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQ  201 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~-------~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  201 (434)
                      .++|.+.+.||+|+||.||+|.+..       .+..||||+++...    ...+.+|+.+++.+.+||||+++++++.+.
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            4789999999999999999999753       33689999997532    356889999999998899999999999654


Q ss_pred             CCCccEEEEeecCCCchhhhcC-------------------CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEec
Q 013897          202 QSKTPSLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID  262 (434)
Q Consensus       202 ~~~~~~lv~e~~~~~~l~~~~~-------------------~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~  262 (434)
                        ...++||||+.+++|..++.                   .+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus       148 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~  225 (382)
T 3tt0_A          148 --GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT  225 (382)
T ss_dssp             --SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred             --CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEc
Confidence              56789999999999977652                   388999999999999999999999999999999999999


Q ss_pred             CCCCeEEEEecccceecCCCC---ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHH
Q 013897          263 HEQRKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQ  338 (434)
Q Consensus       263 ~~~~~vkl~DFGla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~  338 (434)
                      .++ .+||+|||+++......   ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||. +....+.
T Consensus       226 ~~~-~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~ellt~g~~p~~-~~~~~~~  302 (382)
T 3tt0_A          226 EDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYP-GVPVEEL  302 (382)
T ss_dssp             TTC-CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCSST-TCCHHHH
T ss_pred             CCC-cEEEcccCcccccccccccccccCCCCCcceeCHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCC-CCCHHHH
Confidence            776 89999999998664332   2233456788999999987 789999999999999999999 888873 2222222


Q ss_pred             HHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          339 LVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       339 ~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                      ...+..                            ..        .......+++++.+||.+||+.||++|||+.|++++
T Consensus       303 ~~~~~~----------------------------~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          303 FKLLKE----------------------------GH--------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             HHHHHT----------------------------TC--------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHc----------------------------CC--------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            111110                            00        011123467899999999999999999999999975

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=3.7e-44  Score=340.73  Aligned_cols=241  Identities=15%  Similarity=0.257  Sum_probs=196.4

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCC-------eEEEEEEeccc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDN-------EKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ  202 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~-------~~vaiK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  202 (434)
                      .++|.+.+.||+|+||.||+|.+..++       ..||+|++...   ..+.+.+|+.+++.+ +||||+++++++.+. 
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~-   84 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL-SHKHLVLNYGVCVCG-   84 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTS-CCTTBCCEEEEECCT-
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEEeC-
Confidence            478999999999999999999987766       57999998643   346788999999999 899999999999654 


Q ss_pred             CCccEEEEeecCCCchhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCe--------EEE
Q 013897          203 SKTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRK--------LRL  270 (434)
Q Consensus       203 ~~~~~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~--------vkl  270 (434)
                       ...++||||+.+++|..++.    .+++..+..++.||+.||.|||++||+||||||+|||++.++ .        +||
T Consensus        85 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~~~~~~~~~kl  162 (289)
T 4fvq_A           85 -DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREE-DRKTGNPPFIKL  162 (289)
T ss_dssp             -TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECC-BGGGTBCCEEEE
T ss_pred             -CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCC-cccccccceeee
Confidence             45679999999999977753    288999999999999999999999999999999999998766 4        999


Q ss_pred             EecccceecCCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChh
Q 013897          271 IDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE  350 (434)
Q Consensus       271 ~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~  350 (434)
                      +|||++.....   .....++..|+|||++.+...++.++|||||||++|||++|..|++...+..........      
T Consensus       163 ~Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~------  233 (289)
T 4fvq_A          163 SDPGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED------  233 (289)
T ss_dssp             CCCCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT------
T ss_pred             ccCcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhc------
Confidence            99999865432   234568889999999986567999999999999999999977776555443222211100      


Q ss_pred             HHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          351 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                                            .          .......++++.+||.+||+.||++|||+.|+++|
T Consensus       234 ----------------------~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          234 ----------------------R----------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             ----------------------T----------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             ----------------------c----------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                                  0          00111245679999999999999999999999986

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.6e-43  Score=340.10  Aligned_cols=246  Identities=22%  Similarity=0.330  Sum_probs=198.8

Q ss_pred             CCCeEEEeeeeecCceEEEEEEE-----cCCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVH-----CTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS  203 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~-----~~~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  203 (434)
                      .++|++.+.||+|+||.||+|.+     ..+++.||+|+++...    .+.+.+|+.+++++.+||||+++++++.+.  
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--   99 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG--   99 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC--
Confidence            47899999999999999999985     3467899999997532    466889999999998899999999999654  


Q ss_pred             CccEEEEeecCCCchhhhcC---------------------CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEec
Q 013897          204 KTPSLIFEHVNNTDFKVLYP---------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID  262 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~~---------------------~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~  262 (434)
                      ...++||||+.+++|..++.                     .+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~  179 (313)
T 1t46_A          100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT  179 (313)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEc
Confidence            56789999999999876652                     378999999999999999999999999999999999999


Q ss_pred             CCCCeEEEEecccceecCCCCcc---ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHH
Q 013897          263 HEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQ  338 (434)
Q Consensus       263 ~~~~~vkl~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~  338 (434)
                      .++ .+||+|||++.........   ....++..|+|||++.+ ..++.++|||||||++|+|++ |..||...... ..
T Consensus       180 ~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~  256 (313)
T 1t46_A          180 HGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-SK  256 (313)
T ss_dssp             TTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-HH
T ss_pred             CCC-CEEEccccccccccccccceeccCCCCcceeeChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCCcccch-hH
Confidence            776 8999999999876544322   23456778999999876 689999999999999999999 88888433322 22


Q ss_pred             HHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          339 LVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       339 ~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                      +..+....                           .        .......+++++.+||.+||..||.+|||+.|++++
T Consensus       257 ~~~~~~~~---------------------------~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          257 FYKMIKEG---------------------------F--------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             HHHHHHHT---------------------------C--------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhccC---------------------------C--------CCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            22211100                           0        001122367899999999999999999999999975

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-43  Score=346.14  Aligned_cols=247  Identities=20%  Similarity=0.341  Sum_probs=198.3

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEc-----CCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS  203 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  203 (434)
                      .++|++.+.||+|+||.||+|.+.     .++..||||+++..    ..+.+.+|+.+++++.+||||+++++++.+.  
T Consensus        44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--  121 (344)
T 1rjb_A           44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS--  121 (344)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred             HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC--
Confidence            478999999999999999999973     45678999999643    2466889999999998899999999999654  


Q ss_pred             CccEEEEeecCCCchhhhcC--------------------------CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCC
Q 013897          204 KTPSLIFEHVNNTDFKVLYP--------------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPH  257 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~~--------------------------~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~  257 (434)
                      ...++||||+.+++|..++.                          .+++..+..++.||+.||+|||++||+||||||+
T Consensus       122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~  201 (344)
T 1rjb_A          122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR  201 (344)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred             CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChh
Confidence            56789999999999877652                          2688889999999999999999999999999999


Q ss_pred             ceEecCCCCeEEEEecccceecCCCCcc---ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCC
Q 013897          258 NVMIDHEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGH  333 (434)
Q Consensus       258 NIll~~~~~~vkl~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~  333 (434)
                      |||++.++ .+||+|||++.........   ....+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||....
T Consensus       202 NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          202 NVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             GEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hEEEcCCC-cEEeCCCccCcccccCccceeccCccCccCccCHHHhcc-CCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            99999776 8999999999766433322   23456788999999876 679999999999999999998 998984433


Q ss_pred             CCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHH
Q 013897          334 DNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK  413 (434)
Q Consensus       334 ~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~  413 (434)
                      .. ..+..+..                           ...        .......+++++.+||.+||..||.+|||+.
T Consensus       280 ~~-~~~~~~~~---------------------------~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  323 (344)
T 1rjb_A          280 VD-ANFYKLIQ---------------------------NGF--------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFP  323 (344)
T ss_dssp             CS-HHHHHHHH---------------------------TTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             cH-HHHHHHHh---------------------------cCC--------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHH
Confidence            22 22221111                           000        0111223678999999999999999999999


Q ss_pred             HHhcCC
Q 013897          414 EAMAHP  419 (434)
Q Consensus       414 elL~Hp  419 (434)
                      |+++|-
T Consensus       324 ~l~~~l  329 (344)
T 1rjb_A          324 NLTSFL  329 (344)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999863

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=3.3e-44  Score=354.82  Aligned_cols=243  Identities=22%  Similarity=0.385  Sum_probs=195.7

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      .++|.+.+.||+|+||.||+|.+..+++.||||+++...    ...+.+|+.+|+.+ +||||+++++++.+.  ...++
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~--~~~~l  189 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQK--QPIYI  189 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTC-CCTTBCCEEEEECSS--SSCEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEecC--CCcEE
Confidence            478999999999999999999998899999999987532    34578999999999 999999999999643  56789


Q ss_pred             EEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc
Q 013897          209 IFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE  284 (434)
Q Consensus       209 v~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~  284 (434)
                      ||||+.+++|..++    ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.......
T Consensus       190 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~-~~kl~DfG~s~~~~~~~~  268 (377)
T 3cbl_A          190 VMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKN-VLKISDFGMSREEADGVY  268 (377)
T ss_dssp             EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCGGGCEECTTSEE
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCC-cEEECcCCCceecCCCce
Confidence            99999999987765    2488999999999999999999999999999999999999776 899999999986543211


Q ss_pred             c---ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccc
Q 013897          285 Y---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI  360 (434)
Q Consensus       285 ~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  360 (434)
                      .   ....++..|+|||++.+ ..++.++|||||||++|||++ |..||. +....+....+..                
T Consensus       269 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~t~g~~p~~-~~~~~~~~~~~~~----------------  330 (377)
T 3cbl_A          269 AASGGLRQVPVKWTAPEALNY-GRYSSESDVWSFGILLWETFSLGASPYP-NLSNQQTREFVEK----------------  330 (377)
T ss_dssp             ECCSSCCEEEGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCSST-TSCHHHHHHHHHT----------------
T ss_pred             eecCCCCCCCcCcCCHhHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHc----------------
Confidence            1   12234667999999876 678999999999999999998 888873 3222221111100                


Q ss_pred             cCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          361 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                  ..+        ...+..+++++.+||.+||+.||++|||++++++
T Consensus       331 ------------~~~--------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          331 ------------GGR--------LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             ------------TCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------CCC--------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                        000        1112236789999999999999999999999975

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.4e-44  Score=360.72  Aligned_cols=254  Identities=22%  Similarity=0.359  Sum_probs=190.3

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEee
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH  212 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  212 (434)
                      ..+|.+.+.||+|+||+||... ..+++.||||++.......+.+|+.+|+.+.+|||||++++++.+.  ...++||||
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~-~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~--~~~~lv~E~   99 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRG-MFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDR--QFQYIAIEL   99 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEE-ESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEET--TEEEEEEEC
T ss_pred             cEEEecCCeeecCcCEEEEEEE-EeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecC--CEEEEEEEC
Confidence            3569999999999999976433 3678999999997766666789999999987899999999998654  567899999


Q ss_pred             cCCCchhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC----CCeEEEEecccceecCCCC-
Q 013897          213 VNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE----QRKLRLIDWGLAEFYHPGK-  283 (434)
Q Consensus       213 ~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~----~~~vkl~DFGla~~~~~~~-  283 (434)
                      +.+ +|..++.    .+.+..+..++.||+.||+|||++||+||||||+|||++.+    ...+||+|||+|+...... 
T Consensus       100 ~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~  178 (432)
T 3p23_A          100 CAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH  178 (432)
T ss_dssp             CSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-----
T ss_pred             CCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCc
Confidence            985 6655442    24556778999999999999999999999999999999532    2258899999998765432 


Q ss_pred             ---ccceeccCCcccccccccC--CCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhh
Q 013897          284 ---EYNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK  357 (434)
Q Consensus       284 ---~~~~~~~t~~y~aPE~~~~--~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  357 (434)
                         .....+||+.|+|||++.+  ...++.++|||||||++|||++ |..||...  .......+   .+..        
T Consensus       179 ~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~--~~~~~~~~---~~~~--------  245 (432)
T 3p23_A          179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS--LQRQANIL---LGAC--------  245 (432)
T ss_dssp             -------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBST--TTHHHHHH---TTCC--------
T ss_pred             ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchh--hHHHHHHH---hccC--------
Confidence               2344679999999999874  2567889999999999999999 88887321  11111111   0000        


Q ss_pred             ccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccc
Q 013897          358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                                      ...      ........+..+.+||.+||+.||++|||++|+|+||||..+.
T Consensus       246 ----------------~~~------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~  291 (432)
T 3p23_A          246 ----------------SLD------CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE  291 (432)
T ss_dssp             ----------------CCT------TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHH
T ss_pred             ----------------Ccc------ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChH
Confidence                            000      0000112345689999999999999999999999999998764

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=8.1e-44  Score=337.54  Aligned_cols=243  Identities=19%  Similarity=0.320  Sum_probs=194.5

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF  210 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  210 (434)
                      .++|++++.||+|+||.||+|.+. ++..||+|+++..  ..+.+.+|+.+++.+ +||||+++++++.+  ....++||
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~   98 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-SHEKLVQLYGVCTK--QRPIFIIT   98 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTC-CCTTBCCEEEEECS--SSSEEEEE
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcC-CCCCEeeEEEEEec--CCCeEEEE
Confidence            478999999999999999999874 6788999999754  457789999999999 89999999999954  45678999


Q ss_pred             eecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc--
Q 013897          211 EHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE--  284 (434)
Q Consensus       211 e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~--  284 (434)
                      ||+.+++|..++    ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++........  
T Consensus        99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~  177 (283)
T 3gen_A           99 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDEYTS  177 (283)
T ss_dssp             CCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTS-CEEECSTTGGGGBCCHHHHS
T ss_pred             eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCC-CEEEcccccccccccccccc
Confidence            999999987765    3589999999999999999999999999999999999999776 899999999976543211  


Q ss_pred             cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                      .....++..|+|||++.+ ..++.++|||||||++|+|++ |+.||. .....+....+.+..                 
T Consensus       178 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~t~g~~p~~-~~~~~~~~~~~~~~~-----------------  238 (283)
T 3gen_A          178 SVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYE-RFTNSETAEHIAQGL-----------------  238 (283)
T ss_dssp             TTSTTSCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTTCCTTT-TSCHHHHHHHHHTTC-----------------
T ss_pred             ccCCccCcccCCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCcc-ccChhHHHHHHhccc-----------------
Confidence            122345677999999886 679999999999999999998 998883 222222222221100                 


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                                         .......+++.+.+||.+||+.||++|||+.|+++|
T Consensus       239 -------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          239 -------------------RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             -------------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             -------------------CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence                               011122356889999999999999999999999976

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.8e-44  Score=350.58  Aligned_cols=281  Identities=19%  Similarity=0.285  Sum_probs=200.5

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHH--HhcCCCCeeeEeeEEEc---cCCCccE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQ--NLCGGPNIVKLLDIVRD---QQSKTPS  207 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~E~~~l~--~l~~h~niv~l~~~~~~---~~~~~~~  207 (434)
                      .++|++++.||+|+||.||+|.+  +++.||||+++......+..|.+++.  .+ +||||+++++.+..   ......+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~-~h~~i~~~~~~~~~~~~~~~~~~~   88 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLM-EHDNIARFIVGDERVTADGRMEYL   88 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECTTSCEEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhc-cCcchhhheecccccccCCCceEE
Confidence            47899999999999999999976  68999999998777666666666654  35 99999999986543   2333568


Q ss_pred             EEEeecCCCchhhhc--CCCChHHHHHHHHHHHHHHHHHHHC---------CceeecCCCCceEecCCCCeEEEEecccc
Q 013897          208 LIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQ---------GIMHRDVKPHNVMIDHEQRKLRLIDWGLA  276 (434)
Q Consensus       208 lv~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~---------~ivHrDlKp~NIll~~~~~~vkl~DFGla  276 (434)
                      +||||+.+++|..++  ...++..+..++.||+.||.|||++         ||+||||||+|||++.++ .+||+|||++
T Consensus        89 lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~-~~kL~DFG~a  167 (336)
T 3g2f_A           89 LVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG-TCVISDFGLS  167 (336)
T ss_dssp             EEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS-CEEECCCTTC
T ss_pred             EEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC-cEEEeeccce
Confidence            999999999998776  3568888999999999999999999         999999999999999776 8999999999


Q ss_pred             eecCCCC---------ccceeccCCcccccccccCC------CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHH
Q 013897          277 EFYHPGK---------EYNVRVASRYFKGPELLVDL------QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK  341 (434)
Q Consensus       277 ~~~~~~~---------~~~~~~~t~~y~aPE~~~~~------~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~  341 (434)
                      +......         .....+||+.|+|||++.+.      ..++.++|||||||++|||++|..||+.+....+....
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~  247 (336)
T 3g2f_A          168 MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMA  247 (336)
T ss_dssp             EECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCT
T ss_pred             eecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHh
Confidence            8764321         12344799999999998752      24567899999999999999999998776553322111


Q ss_pred             HHHHhCChhHHHHHhhccccCChhHHHHhcc-cCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHH-----
Q 013897          342 IAKVLGTDELNAYLNKYHIELDPHLAALVGR-HSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEA-----  415 (434)
Q Consensus       342 i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~el-----  415 (434)
                      +....+.....           ......... ..+....  ..+.....+++++.+||.+||+.||++|||+.|+     
T Consensus       248 ~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~  314 (336)
T 3g2f_A          248 FQTEVGNHPTF-----------EDMQVLVSREKQRPKFP--EAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMA  314 (336)
T ss_dssp             THHHHCSSCCH-----------HHHHHHHTTSCCCCCCC--TTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             hhcccCCCchH-----------HHHHhhhcccccCCCCC--cccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHH
Confidence            11111111000           001111111 0111111  1111222355689999999999999999999999     


Q ss_pred             -hcCCCcccccccccc
Q 013897          416 -MAHPYFFPIRNAESS  430 (434)
Q Consensus       416 -L~Hp~~~~~~~~~~~  430 (434)
                       +.++|-++...+..+
T Consensus       315 ~ll~~~~~~~~~~~~~  330 (336)
T 3g2f_A          315 ELMMIWERNKSVSPTA  330 (336)
T ss_dssp             HHHHCCCC--------
T ss_pred             HHHHHHHhcccCCCcc
Confidence             558998877655544

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.1e-43  Score=357.62  Aligned_cols=255  Identities=22%  Similarity=0.376  Sum_probs=190.6

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEee
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH  212 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  212 (434)
                      .+.|.+.+.||+|+||+||.+. ..+|+.||||++.....+.+.+|+.+++.+.+||||+++++++.+  ...+++||||
T Consensus        14 ~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~~~~~lv~E~   90 (434)
T 2rio_A           14 KNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETT--DRFLYIALEL   90 (434)
T ss_dssp             SSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEEC--SSEEEEEECC
T ss_pred             hheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEec--CCeEEEEEec
Confidence            3567778999999999998764 467999999999877777889999999987789999999999864  3678899999


Q ss_pred             cCCCchhhhcCC----------CChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC------------CCeEEE
Q 013897          213 VNNTDFKVLYPT----------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE------------QRKLRL  270 (434)
Q Consensus       213 ~~~~~l~~~~~~----------l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~------------~~~vkl  270 (434)
                      +. ++|..++..          ..+..+..++.||+.||+|||++||+||||||+|||++.+            ...+||
T Consensus        91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL  169 (434)
T 2rio_A           91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI  169 (434)
T ss_dssp             CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred             CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence            97 477666532          1233457799999999999999999999999999999743            237999


Q ss_pred             EecccceecCCCCc-----cceeccCCcccccccccC------CCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHH
Q 013897          271 IDWGLAEFYHPGKE-----YNVRVASRYFKGPELLVD------LQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQ  338 (434)
Q Consensus       271 ~DFGla~~~~~~~~-----~~~~~~t~~y~aPE~~~~------~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~  338 (434)
                      +|||+++.......     ....+||+.|+|||++.+      ...++.++|||||||++|||++ |+.||...... . 
T Consensus       170 ~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~-~-  247 (434)
T 2rio_A          170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR-E-  247 (434)
T ss_dssp             CCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH-H-
T ss_pred             cccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh-H-
Confidence            99999987654322     234579999999999865      2468999999999999999999 89888432211 1 


Q ss_pred             HHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          339 LVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       339 ~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                       ..+..  +.         .  ..                ... .......+++++.+||.+||+.||++|||+.|+|+|
T Consensus       248 -~~i~~--~~---------~--~~----------------~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  296 (434)
T 2rio_A          248 -SNIIR--GI---------F--SL----------------DEM-KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH  296 (434)
T ss_dssp             -HHHHH--TC---------C--CC----------------CCC-TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -HHHhc--CC---------C--Cc----------------ccc-cccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence             11111  00         0  00                000 000111245789999999999999999999999999


Q ss_pred             CCcccc
Q 013897          419 PYFFPI  424 (434)
Q Consensus       419 p~~~~~  424 (434)
                      |||...
T Consensus       297 p~f~~~  302 (434)
T 2rio_A          297 PLFWPK  302 (434)
T ss_dssp             GGGSCH
T ss_pred             CccCCc
Confidence            999754

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=7.8e-44  Score=345.30  Aligned_cols=243  Identities=19%  Similarity=0.349  Sum_probs=190.7

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeE----EEEEEecc----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEK----CIIKILKP----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK  204 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~----vaiK~~~~----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  204 (434)
                      .++|++++.||+|+||.||+|.+..+++.    ||+|.++.    ...+.+.+|+.+++++ +||||+++++++.+.   
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~---   89 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS---   89 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHC-CBTTBCCEEEEEESS---
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecC---
Confidence            47899999999999999999998777764    57887753    2346789999999999 999999999999753   


Q ss_pred             ccEEEEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecC
Q 013897          205 TPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH  280 (434)
Q Consensus       205 ~~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~  280 (434)
                      ..++|+||+.+++|..++    ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+...
T Consensus        90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           90 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLG  168 (327)
T ss_dssp             SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT-EEEECCTTHHHHHT
T ss_pred             CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCC-CEEEccCcceeEcc
Confidence            367999999999987664    3588999999999999999999999999999999999999776 89999999998764


Q ss_pred             CCCcc---ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHh
Q 013897          281 PGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN  356 (434)
Q Consensus       281 ~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~  356 (434)
                      .....   ....+|..|+|||++.+ ..++.++|||||||++|||++ |+.||. +.........+..            
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~-~~~~~~~~~~~~~------------  234 (327)
T 3poz_A          169 AEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEK------------  234 (327)
T ss_dssp             TTCC-------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTT-TCCGGGHHHHHHT------------
T ss_pred             CCcccccccCCCccccccChHHhcc-CCCCchhhhhhhHHHHHHHHhcCCCCcc-CCCHHHHHHHHHc------------
Confidence            43322   23355778999999887 789999999999999999999 998883 2222221111110            


Q ss_pred             hccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          357 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                                      ...        ......++.++.+|+.+||+.||++|||+.|+++|
T Consensus       235 ----------------~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          235 ----------------GER--------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             ----------------TCC--------CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             ----------------CCC--------CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                            000        11122367789999999999999999999999975

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=7.4e-44  Score=347.01  Aligned_cols=244  Identities=18%  Similarity=0.316  Sum_probs=196.0

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcC-----CCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS  203 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~-----~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  203 (434)
                      .++|++++.||+|+||.||+|.+..     +++.||||+++...    .+.+.+|+.+++.+ +||||+++++++.+  .
T Consensus        46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~  122 (343)
T 1luf_A           46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPNIVKLLGVCAV--G  122 (343)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS--S
T ss_pred             HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEcc--C
Confidence            4789999999999999999999863     45899999997542    35688999999999 99999999999965  3


Q ss_pred             CccEEEEeecCCCchhhhc---------------------------CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCC
Q 013897          204 KTPSLIFEHVNNTDFKVLY---------------------------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKP  256 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~---------------------------~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp  256 (434)
                      ...++||||+.+++|..++                           ..+++.++..++.||+.||+|||++||+||||||
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp  202 (343)
T 1luf_A          123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT  202 (343)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCc
Confidence            5678999999999987764                           3588899999999999999999999999999999


Q ss_pred             CceEecCCCCeEEEEecccceecCCCC---ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCC
Q 013897          257 HNVMIDHEQRKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYG  332 (434)
Q Consensus       257 ~NIll~~~~~~vkl~DFGla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~  332 (434)
                      +|||++.++ .+||+|||+++......   ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.. 
T Consensus       203 ~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~-  279 (343)
T 1luf_A          203 RNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYG-  279 (343)
T ss_dssp             GGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTT-
T ss_pred             ceEEECCCC-eEEEeecCCCcccccCccccccCCCcccceecChhhhcc-CCcCcccccHHHHHHHHHHHhcCCCcCCC-
Confidence            999999776 89999999997653322   2234467888999999876 679999999999999999999 9989842 


Q ss_pred             CCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccH
Q 013897          333 HDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA  412 (434)
Q Consensus       333 ~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~  412 (434)
                      ....+....+.+                           . ..        ......+++++.+||.+||..||++|||+
T Consensus       280 ~~~~~~~~~~~~---------------------------~-~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~  323 (343)
T 1luf_A          280 MAHEEVIYYVRD---------------------------G-NI--------LACPENCPLELYNLMRLCWSKLPADRPSF  323 (343)
T ss_dssp             SCHHHHHHHHHT---------------------------T-CC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CChHHHHHHHhC---------------------------C-Cc--------CCCCCCCCHHHHHHHHHHcccCcccCCCH
Confidence            222222111110                           0 00        00112467899999999999999999999


Q ss_pred             HHHhcC
Q 013897          413 KEAMAH  418 (434)
Q Consensus       413 ~elL~H  418 (434)
                      .+++++
T Consensus       324 ~~~~~~  329 (343)
T 1luf_A          324 CSIHRI  329 (343)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999864

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=7.6e-44  Score=340.78  Aligned_cols=260  Identities=22%  Similarity=0.346  Sum_probs=199.3

Q ss_pred             CCCeEEEeeeeecCceEEEEEE----EcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGV----HCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK  204 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~----~~~~~~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  204 (434)
                      ...|++++.||+|+||.||+|.    +..+++.||+|+++..    ....+.+|+.+++.+ +||||+++++++.+....
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~   98 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGGN   98 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC---C
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhC-CCCCeeeeeeEEecCCCc
Confidence            3569999999999999999998    4568899999999743    346789999999999 899999999999877667


Q ss_pred             ccEEEEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecC
Q 013897          205 TPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH  280 (434)
Q Consensus       205 ~~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~  280 (434)
                      ..++||||+.+++|..++    ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++....
T Consensus        99 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~~  177 (302)
T 4e5w_A           99 GIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH-QVKIGDFGLTKAIE  177 (302)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCCTTCEECC
T ss_pred             eEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCC-CEEECccccccccc
Confidence            789999999999998775    4589999999999999999999999999999999999999776 89999999998765


Q ss_pred             CCCc----cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHh
Q 013897          281 PGKE----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN  356 (434)
Q Consensus       281 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~  356 (434)
                      ....    .....+|..|+|||++.+ ..++.++|||||||++|+|++|..|+..      .........+........ 
T Consensus       178 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~------~~~~~~~~~~~~~~~~~~-  249 (302)
T 4e5w_A          178 TDKEYYTVKDDRDSPVFWYAPECLMQ-SKFYIASDVWSFGVTLHELLTYCDSDSS------PMALFLKMIGPTHGQMTV-  249 (302)
T ss_dssp             TTCCEEECCCCTTCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGS------HHHHHHHHHCSCCGGGHH-
T ss_pred             CCCcceeccCCCCCCccccCCeeecC-CCCCcchhHHHHHHHHHHHHHccCCCcc------hhhHHhhccCCcccccCH-
Confidence            4432    233467788999999876 6788999999999999999999988621      111111111111100000 


Q ss_pred             hccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          357 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                             ..+.........        ......+++++.+||.+||+.||++|||+.|+++
T Consensus       250 -------~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          250 -------TRLVNTLKEGKR--------LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             -------HHHHHHHHTTCC--------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             -------HHHHHHHhccCC--------CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence                   000001111011        1122346789999999999999999999999985

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=7.5e-44  Score=342.53  Aligned_cols=244  Identities=16%  Similarity=0.323  Sum_probs=196.5

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEc-----CCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS  203 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  203 (434)
                      .++|.+.+.||+|+||.||+|.+.     .++..||||+++...    .+.+.+|+.+++.+ +||||+++++++.+.  
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~--   98 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV-NHPHVIKLYGACSQD--   98 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSS--
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-CCCceeeEEEEEecC--
Confidence            478999999999999999999873     455899999997532    35688999999999 999999999999654  


Q ss_pred             CccEEEEeecCCCchhhhcC---------------------------CCChHHHHHHHHHHHHHHHHHHHCCceeecCCC
Q 013897          204 KTPSLIFEHVNNTDFKVLYP---------------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKP  256 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~~---------------------------~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp  256 (434)
                      ...++||||+.+++|..++.                           .+++.++..++.||+.||+|||++||+||||||
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp  178 (314)
T 2ivs_A           99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAA  178 (314)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred             CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccch
Confidence            56789999999999877652                           278889999999999999999999999999999


Q ss_pred             CceEecCCCCeEEEEecccceecCCCCcc---ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCC
Q 013897          257 HNVMIDHEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYG  332 (434)
Q Consensus       257 ~NIll~~~~~~vkl~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~  332 (434)
                      +|||++.++ .+||+|||++.........   ....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||. +
T Consensus       179 ~NIli~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~-~  255 (314)
T 2ivs_A          179 RNILVAEGR-KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYP-G  255 (314)
T ss_dssp             GGEEEETTT-EEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSST-T
T ss_pred             heEEEcCCC-CEEEccccccccccccccceeccCCCCcccccChhhhcC-CCcCchhhHHHHHHHHHHHHhCCCCCCC-C
Confidence            999999766 8999999999876443321   23356778999999876 678999999999999999999 998883 2


Q ss_pred             CCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccH
Q 013897          333 HDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA  412 (434)
Q Consensus       333 ~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~  412 (434)
                      .........+..                            ..        .......+++++.+||.+||+.||++|||+
T Consensus       256 ~~~~~~~~~~~~----------------------------~~--------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~  299 (314)
T 2ivs_A          256 IPPERLFNLLKT----------------------------GH--------RMERPDNCSEEMYRLMLQCWKQEPDKRPVF  299 (314)
T ss_dssp             CCGGGHHHHHHT----------------------------TC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCHHHHHHHhhc----------------------------CC--------cCCCCccCCHHHHHHHHHHccCChhhCcCH
Confidence            222222211110                            00        011122467899999999999999999999


Q ss_pred             HHHhcC
Q 013897          413 KEAMAH  418 (434)
Q Consensus       413 ~elL~H  418 (434)
                      .|++++
T Consensus       300 ~~l~~~  305 (314)
T 2ivs_A          300 ADISKD  305 (314)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999875

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.6e-43  Score=340.52  Aligned_cols=247  Identities=20%  Similarity=0.350  Sum_probs=199.3

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEc-----CCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS  203 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  203 (434)
                      .++|++.+.||+|+||.||+|.+.     .+++.||||+++...    ...+.+|+.+++++.+||||+++++++... .
T Consensus        26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-~  104 (316)
T 2xir_A           26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-G  104 (316)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-T
T ss_pred             hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC-C
Confidence            578999999999999999999853     467899999997532    346889999999997899999999998654 3


Q ss_pred             CccEEEEeecCCCchhhhcCC-------------------CChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC
Q 013897          204 KTPSLIFEHVNNTDFKVLYPT-------------------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE  264 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~~~-------------------l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~  264 (434)
                      ...++||||+.+++|..++..                   +++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~  184 (316)
T 2xir_A          105 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK  184 (316)
T ss_dssp             SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred             CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCC
Confidence            457899999999999777532                   6788899999999999999999999999999999999976


Q ss_pred             CCeEEEEecccceecCCCCcc---ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHH
Q 013897          265 QRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLV  340 (434)
Q Consensus       265 ~~~vkl~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~  340 (434)
                      + .+||+|||+++........   ....++..|+|||++.+ ..++.++|||||||++|+|++ |..||...........
T Consensus       185 ~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~  262 (316)
T 2xir_A          185 N-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR  262 (316)
T ss_dssp             G-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred             C-CEEECCCccccccccCccceeccCCCcceeecCchhhcc-ccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHH
Confidence            6 8999999999866443322   33467888999999876 679999999999999999998 9988844333322222


Q ss_pred             HHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          341 KIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       341 ~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                      .+...                            ..        ......+++++.++|.+||+.||.+|||+.|+++|
T Consensus       263 ~~~~~----------------------------~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          263 RLKEG----------------------------TR--------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHT----------------------------CC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HhccC----------------------------cc--------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            21110                            00        01112367889999999999999999999999986

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=4.4e-43  Score=330.22  Aligned_cols=243  Identities=17%  Similarity=0.333  Sum_probs=187.5

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT  205 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  205 (434)
                      .++|++.+.||+|+||.||+|.+  +++.||||+++..       ..+.+.+|+.+++.+ +||||+++++++.+.  ..
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~   80 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAML-KHPNIIALRGVCLKE--PN   80 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHC-CCTTBCCEEEEECCC----
T ss_pred             hhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhc-CCCCEeeEEEEEecC--Cc
Confidence            47899999999999999999997  4899999998642       235688999999999 899999999999654  56


Q ss_pred             cEEEEeecCCCchhhhc--CCCChHHHHHHHHHHHHHHHHHHHCC---ceeecCCCCceEecCC-------CCeEEEEec
Q 013897          206 PSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQG---IMHRDVKPHNVMIDHE-------QRKLRLIDW  273 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlKp~NIll~~~-------~~~vkl~DF  273 (434)
                      .++||||+.+++|..++  ..+++..+..++.||+.||.|||++|   |+||||||+|||++.+       ...+||+||
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           81 LCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             CEEEEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             eEEEEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            78999999999998776  46899999999999999999999999   9999999999999852       347999999


Q ss_pred             ccceecCCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHH
Q 013897          274 GLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA  353 (434)
Q Consensus       274 Gla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~  353 (434)
                      |++....... .....|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.. .+.......+..         
T Consensus       161 g~~~~~~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~---------  228 (271)
T 3dtc_A          161 GLAREWHRTT-KMSAAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPFRG-IDGLAVAYGVAM---------  228 (271)
T ss_dssp             CC--------------CCGGGSCHHHHHH-CCCSHHHHHHHHHHHHHHHHHCCCTTTT-SCHHHHHHHHHT---------
T ss_pred             Cccccccccc-ccCCCCccceeCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHhhhc---------
Confidence            9997654332 235578999999999876 6799999999999999999999999842 222111111100         


Q ss_pred             HHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          354 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                                        ...        .......+++.+.+|+.+||+.||++|||+.|+++|
T Consensus       229 ------------------~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          229 ------------------NKL--------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             ------------------SCC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------CCC--------CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence                              000        011123467889999999999999999999999875

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=9.1e-44  Score=344.50  Aligned_cols=243  Identities=18%  Similarity=0.293  Sum_probs=192.6

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeE----EEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEK----CIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK  204 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~----vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  204 (434)
                      .++|++++.||+|+||.||+|.+..+++.    ||+|.+...    ....+.+|+.+++.+ +||||+++++++.+   .
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~---~   87 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL-DHAHIVRLLGLCPG---S   87 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTC-CCTTBCCEEEEECB---S
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEcC---C
Confidence            47899999999999999999999877765    777777432    234577899999999 99999999999853   4


Q ss_pred             ccEEEEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecC
Q 013897          205 TPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH  280 (434)
Q Consensus       205 ~~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~  280 (434)
                      ..++||||+.+++|..++    ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus        88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~-~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPS-QVQVADFGVADLLP  166 (325)
T ss_dssp             SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSS-CEEECSCSGGGGSC
T ss_pred             ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCC-eEEECCCCcccccC
Confidence            578999999999987664    3588899999999999999999999999999999999999776 89999999998764


Q ss_pred             CCCc---cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHh
Q 013897          281 PGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN  356 (434)
Q Consensus       281 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~  356 (434)
                      ....   .....++..|+|||++.+ ..++.++|||||||++|+|++ |+.||... ...+....+..            
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~------------  232 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHF-GKYTHQSDVWSYGVTVWELMTFGAEPYAGL-RLAEVPDLLEK------------  232 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTS-CTTHHHHHHHT------------
T ss_pred             cccccccccCCCCcccccChHHhcc-CCCChhhHhHHhHHHHHHHHhCCCCCcccc-CHHHHHHHHHc------------
Confidence            4322   244567788999999976 679999999999999999999 99998432 22221111110            


Q ss_pred             hccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          357 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                                      ..        .......+++++.+||.+||..||++|||+.|+++|
T Consensus       233 ----------------~~--------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          233 ----------------GE--------RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             ----------------TC--------BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             ----------------CC--------CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                            00        011122356788999999999999999999999876

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=8.5e-44  Score=337.33  Aligned_cols=243  Identities=23%  Similarity=0.416  Sum_probs=185.9

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCC---CeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTD---NEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT  205 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~---~~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  205 (434)
                      .++|++.+.||+|+||.||+|.+..+   +..||+|+++..    ..+.+.+|+.+++.+ +||||+++++++.+   ..
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~---~~   89 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVITE---NP   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS---SS
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCccceEEEEEcc---Cc
Confidence            47899999999999999999998643   467999998653    245688999999999 99999999999843   45


Q ss_pred             cEEEEeecCCCchhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC
Q 013897          206 PSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP  281 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~  281 (434)
                      .++||||+.+++|..++.    .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~  168 (281)
T 1mp8_A           90 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYMED  168 (281)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECC---------
T ss_pred             cEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCC-CEEECccccccccCc
Confidence            689999999999877653    588999999999999999999999999999999999999776 899999999987644


Q ss_pred             CCcc--ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhc
Q 013897          282 GKEY--NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY  358 (434)
Q Consensus       282 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  358 (434)
                      ....  ....+++.|+|||++.+ ..++.++|||||||++|||++ |..||. +....+....+...             
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~pf~-~~~~~~~~~~i~~~-------------  233 (281)
T 1mp8_A          169 STYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQ-GVKNNDVIGRIENG-------------  233 (281)
T ss_dssp             ----------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTT-TCCGGGHHHHHHTT-------------
T ss_pred             ccccccccCCCcccccChhhccc-CCCCCccCchHHHHHHHHHHhcCCCCCC-cCCHHHHHHHHHcC-------------
Confidence            3222  23356678999999876 679999999999999999997 888873 33333322222110             


Q ss_pred             cccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                                     ..        ......+++++.+||.+||..||++|||+.|++++
T Consensus       234 ---------------~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          234 ---------------ER--------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             ---------------CC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------CC--------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                           00        01122467899999999999999999999999864

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=5.5e-44  Score=346.14  Aligned_cols=261  Identities=18%  Similarity=0.306  Sum_probs=201.8

Q ss_pred             CCCeEEEeeeeecCceEEEEEEE----cCCCeEEEEEEecccc---HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVH----CTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT  205 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~----~~~~~~vaiK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  205 (434)
                      .++|++++.||+|+||.||+|.+    ..+++.||||++....   .+.+.+|+.+++.+ +||||+++++++.......
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~  100 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSDFIVKYRGVSYGPGRQS  100 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSSCE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCCCce
Confidence            47899999999999999999984    5678999999997543   35588999999999 9999999999998766778


Q ss_pred             cEEEEeecCCCchhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC
Q 013897          206 PSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP  281 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~  281 (434)
                      .++||||+.+++|..++.    .+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~~~~~~~  179 (327)
T 3lxl_A          101 LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEA-HVKIADFGLAKLLPL  179 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCGGGCEECCT
T ss_pred             EEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCC-CEEEcccccceeccc
Confidence            899999999999877653    489999999999999999999999999999999999999776 899999999987654


Q ss_pred             CCc----cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhh
Q 013897          282 GKE----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK  357 (434)
Q Consensus       282 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  357 (434)
                      ...    .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||.....   .   .............   
T Consensus       180 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~---~---~~~~~~~~~~~~~---  249 (327)
T 3lxl_A          180 DKDYYVVREPGQSPIFWYAPESLSD-NIFSRQSDVWSFGVVLYELFTYCDKSCSPSA---E---FLRMMGCERDVPA---  249 (327)
T ss_dssp             TCSEEECSSCCCSCGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH---H---HHHHCC----CCH---
T ss_pred             CCccceeeccCCccccccCHHHhcc-CCCChHHhHHHHHHHHHHHHhCCCCCccccc---h---hhhhccccccccc---
Confidence            332    233457788999999876 6789999999999999999999999842111   0   0000000000000   


Q ss_pred             ccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                           .............        ......+++++.+||.+||+.||++|||+.|+++|
T Consensus       250 -----~~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          250 -----LSRLLELLEEGQR--------LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             -----HHHHHHHHHTTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----HHHHHHHhhcccC--------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                 0000111111111        11223478899999999999999999999999654

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.8e-43  Score=345.23  Aligned_cols=255  Identities=16%  Similarity=0.183  Sum_probs=192.8

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcC---CCeEEEEEEecccc--------------HHHHHHHHHHHHHhcCCCCeeeEe
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCT---DNEKCIIKILKPVK--------------KKKIKREIKILQNLCGGPNIVKLL  195 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~---~~~~vaiK~~~~~~--------------~~~~~~E~~~l~~l~~h~niv~l~  195 (434)
                      .++|.+.+.||+|+||.||+|.+..   ++..+|||++....              ...+.+|+.+++.+ +||||++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~h~ni~~~~  114 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQL-DYLGIPLFY  114 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTC-SCCCCCCEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccc-cccCcceee
Confidence            4789999999999999999999976   78899999986432              12355777888887 999999999


Q ss_pred             eEEEcc--CCCccEEEEeecCCCchhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCC-CeEE
Q 013897          196 DIVRDQ--QSKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ-RKLR  269 (434)
Q Consensus       196 ~~~~~~--~~~~~~lv~e~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~-~~vk  269 (434)
                      +++.+.  .....++||||+ +++|..++.   .+++.++..++.||+.||+|||++||+||||||+|||++.++ ..+|
T Consensus       115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~k  193 (345)
T 2v62_A          115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY  193 (345)
T ss_dssp             EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEE
T ss_pred             cccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEE
Confidence            998762  246789999999 889887764   589999999999999999999999999999999999998553 2799


Q ss_pred             EEecccceecCCCC--------ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHH
Q 013897          270 LIDWGLAEFYHPGK--------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK  341 (434)
Q Consensus       270 l~DFGla~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~  341 (434)
                      |+|||+++.+....        ......||..|+|||++.+ ..++.++|||||||++|||++|+.||............
T Consensus       194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~  272 (345)
T 2v62_A          194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG-VALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT  272 (345)
T ss_dssp             ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH
T ss_pred             EEeCCCceecccccccccchhccccccCCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHH
Confidence            99999997764321        1144578999999999887 67999999999999999999999999543333333322


Q ss_pred             HHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          342 IAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       342 i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                      ......            ..++..+..               ......+++++.+||.+||..||++|||++++++
T Consensus       273 ~~~~~~------------~~~~~~~~~---------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          273 AKTNLL------------DELPQSVLK---------------WAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             HHHHHH------------HTTTHHHHH---------------HSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHhhc------------ccccHHHHh---------------hccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            211100            001111110               0011136789999999999999999999998876

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=3.4e-43  Score=341.66  Aligned_cols=245  Identities=19%  Similarity=0.311  Sum_probs=195.7

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEc-------CCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEcc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHC-------TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQ  201 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~-------~~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  201 (434)
                      .++|.+.+.||+|+||.||+|.+.       .++..||||+++...    ...+.+|+.+++.+.+||||+++++++.+.
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            478999999999999999999975       356789999997532    356889999999998899999999999654


Q ss_pred             CCCccEEEEeecCCCchhhhcC-------------------CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEec
Q 013897          202 QSKTPSLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID  262 (434)
Q Consensus       202 ~~~~~~lv~e~~~~~~l~~~~~-------------------~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~  262 (434)
                        ...++||||+.+++|..++.                   .+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus       114 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~  191 (334)
T 2pvf_A          114 --GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT  191 (334)
T ss_dssp             --SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred             --CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEc
Confidence              56789999999999877652                   278889999999999999999999999999999999999


Q ss_pred             CCCCeEEEEecccceecCCCCc---cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHH
Q 013897          263 HEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQ  338 (434)
Q Consensus       263 ~~~~~vkl~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~  338 (434)
                      .++ .+||+|||++........   .....+++.|+|||++.+ ..++.++|||||||++|+|++ |+.||. +....+.
T Consensus       192 ~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~-~~~~~~~  268 (334)
T 2pvf_A          192 ENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYP-GIPVEEL  268 (334)
T ss_dssp             TTC-CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSST-TCCHHHH
T ss_pred             CCC-CEEEccccccccccccccccccCCCCcccceeChHHhcC-CCcChHHHHHHHHHHHHHHHhCCCCCcC-cCCHHHH
Confidence            776 899999999987654322   223356778999999876 678999999999999999999 888873 3222222


Q ss_pred             HHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          339 LVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       339 ~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                      ...+...                            ..        ......+++++.+||.+||..||.+|||+.|++++
T Consensus       269 ~~~~~~~----------------------------~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          269 FKLLKEG----------------------------HR--------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             HHHHHHT----------------------------CC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhcC----------------------------CC--------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            2111110                            00        01122367899999999999999999999999875

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=8.3e-43  Score=332.43  Aligned_cols=248  Identities=18%  Similarity=0.266  Sum_probs=194.5

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEe
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE  211 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  211 (434)
                      .++|++.+.||+|+||.||+|.+..+++.||||++... ....+.+|+.+++.+ .|++++..+..+.. .....++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l-~~~~~i~~~~~~~~-~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMM-QGGVGIPTIRWCGA-EGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHH-TTSTTCCCEEEEEE-ETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHh-hcCCCCCccccccC-CCCceEEEEE
Confidence            47899999999999999999999999999999998643 346789999999999 66665555555543 3456789999


Q ss_pred             ecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEec---CCCCeEEEEecccceecCCCCc
Q 013897          212 HVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID---HEQRKLRLIDWGLAEFYHPGKE  284 (434)
Q Consensus       212 ~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~---~~~~~vkl~DFGla~~~~~~~~  284 (434)
                      |+ +++|..++    ..+++..+..++.||+.||+|||++||+||||||+|||++   .++ .+||+|||++........
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~-~~kl~Dfg~~~~~~~~~~  163 (296)
T 3uzp_A           86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAKKYRDART  163 (296)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTT-CEEECCCTTCEECBCTTT
T ss_pred             ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCC-eEEEeeCCCccccccccc
Confidence            99 77876654    3589999999999999999999999999999999999994   444 899999999987654322


Q ss_pred             --------cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCC--CHHHHHHHHHHhCChhHHHH
Q 013897          285 --------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD--NYDQLVKIAKVLGTDELNAY  354 (434)
Q Consensus       285 --------~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~--~~~~~~~i~~~~g~~~~~~~  354 (434)
                              .....|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.....  ....+..+.......     
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----  237 (296)
T 3uzp_A          164 HQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-----  237 (296)
T ss_dssp             CCBCCCCCSCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS-----
T ss_pred             ccccccccccccccccccCChhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC-----
Confidence                    245578999999999887 6799999999999999999999999854221  112222221100000     


Q ss_pred             HhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          355 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                              .  .                 ......+++++.+|+.+||+.||++|||++++++
T Consensus       238 --------~--~-----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          238 --------P--I-----------------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             --------C--H-----------------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             --------c--h-----------------HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence                    0  0                 0001236788999999999999999999999876

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.3e-43  Score=342.67  Aligned_cols=258  Identities=18%  Similarity=0.292  Sum_probs=198.2

Q ss_pred             CCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       132 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      ..++|++.+.||+|+||.||+|.+ .+++.||||++...   ..+.+.+|+.+++.+ +||||+++++++.+  ....++
T Consensus        37 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~l  112 (321)
T 2qkw_B           37 ATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFC-RHPHLVSLIGFCDE--RNEMIL  112 (321)
T ss_dssp             CCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSC-CCTTBCCEEEECCC--TTCCEE
T ss_pred             HHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcC--CCeEEE
Confidence            357899999999999999999996 57899999998643   346788999999999 89999999999864  356789


Q ss_pred             EEeecCCCchhhhcC-------CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC
Q 013897          209 IFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP  281 (434)
Q Consensus       209 v~e~~~~~~l~~~~~-------~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~  281 (434)
                      ||||+.+++|..++.       .+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~  191 (321)
T 2qkw_B          113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENF-VPKITDFGISKKGTE  191 (321)
T ss_dssp             EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTC-CEEECCCTTCEECSS
T ss_pred             EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCC-CEEEeeccccccccc
Confidence            999999999987763       378899999999999999999999999999999999999776 899999999976532


Q ss_pred             CC---ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHH-HHHH-HHHHhCChhHHHHHh
Q 013897          282 GK---EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYD-QLVK-IAKVLGTDELNAYLN  356 (434)
Q Consensus       282 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~-~~~~-i~~~~g~~~~~~~~~  356 (434)
                      ..   ......|++.|+|||++.+ ..++.++|||||||++|||++|+.||........ .... .......       .
T Consensus       192 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~-------~  263 (321)
T 2qkw_B          192 LDQTHLSTVVKGTLGYIDPEYFIK-GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN-------G  263 (321)
T ss_dssp             SSCCCCBCCCEEETTTCCHHHHHH-CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTT-------T
T ss_pred             ccccccccccCCCccccCHHHhcC-CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccc-------c
Confidence            21   2234568999999999876 6799999999999999999999999854322110 0000 0000000       0


Q ss_pred             hccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          357 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                      .....+++.                ........++..+.+++.+||+.||++|||+.|+++|
T Consensus       264 ~~~~~~~~~----------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  309 (321)
T 2qkw_B          264 QLEQIVDPN----------------LADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK  309 (321)
T ss_dssp             CCCSSSSSS----------------CTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cHHHhcChh----------------hccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            000000000                0001112345679999999999999999999999976

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=4.8e-43  Score=340.18  Aligned_cols=245  Identities=21%  Similarity=0.309  Sum_probs=197.3

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCe-----EEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNE-----KCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS  203 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~-----~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  203 (434)
                      .++|.+.+.||+|+||.||+|.+..++.     .||+|+++..    ..+.+.+|+.+++.+.+||||+++++++.+.  
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--  122 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG--  122 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred             HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC--
Confidence            5789999999999999999999876654     8999999754    3456889999999997899999999999654  


Q ss_pred             CccEEEEeecCCCchhhhcC-----------------CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCC
Q 013897          204 KTPSLIFEHVNNTDFKVLYP-----------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR  266 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~~-----------------~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~  266 (434)
                      ...++||||+.+++|..++.                 .+++..+..++.||+.||+|||++||+||||||+|||++.++ 
T Consensus       123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~-  201 (333)
T 2i1m_A          123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH-  201 (333)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGG-
T ss_pred             CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCC-
Confidence            56789999999999876642                 468889999999999999999999999999999999999766 


Q ss_pred             eEEEEecccceecCCCCcc---ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHH
Q 013897          267 KLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKI  342 (434)
Q Consensus       267 ~vkl~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i  342 (434)
                      .+||+|||++.........   ....++..|+|||++.+ ..++.++|||||||++|+|++ |..||...... ..+..+
T Consensus       202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-~~~~~~  279 (333)
T 2i1m_A          202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN-SKFYKL  279 (333)
T ss_dssp             EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS-HHHHHH
T ss_pred             eEEECccccccccccccceeecCCCCCCccccCHHHhcc-CCCChHHHHHHHHHHHHHHHcCCCCCCcccchh-HHHHHH
Confidence            8999999999765433221   23456778999999876 679999999999999999998 88887433222 222221


Q ss_pred             HHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          343 AKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       343 ~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                      ....                           .        .......+++.+.+||.+||+.||.+|||+.|+++
T Consensus       280 ~~~~---------------------------~--------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  319 (333)
T 2i1m_A          280 VKDG---------------------------Y--------QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS  319 (333)
T ss_dssp             HHHT---------------------------C--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HhcC---------------------------C--------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            1100                           0        00112235788999999999999999999999987

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.3e-43  Score=357.17  Aligned_cols=247  Identities=16%  Similarity=0.310  Sum_probs=199.3

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF  210 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  210 (434)
                      .++|++.+.||+|+||.||+|.+. ++..||||+++..  ..+.+.+|+.+|+.+ +||||+++++++.   ...+++||
T Consensus       187 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~---~~~~~lv~  261 (454)
T 1qcf_A          187 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHDKLVKLHAVVT---KEPIYIIT  261 (454)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTC-CCTTBCCEEEEEC---SSSCEEEE
T ss_pred             hHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhC-CCCCEeeEEEEEe---CCccEEEE
Confidence            578999999999999999999984 5788999999753  467899999999999 9999999999985   34578999


Q ss_pred             eecCCCchhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc-
Q 013897          211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-  284 (434)
Q Consensus       211 e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~-  284 (434)
                      ||+.+++|..++.     .+++..+..++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+++....... 
T Consensus       262 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-~~kl~DFG~a~~~~~~~~~  340 (454)
T 1qcf_A          262 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL-VCKIADFGLARVIEDNEYT  340 (454)
T ss_dssp             CCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTC-CEEECSTTGGGGBCCHHHH
T ss_pred             eecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCC-cEEEeeCCCceEcCCCcee
Confidence            9999999987764     588889999999999999999999999999999999999776 899999999986543211 


Q ss_pred             -cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          285 -YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       285 -~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                       .....++..|+|||++.. ..++.++|||||||++|||++ |+.||. +.+..+....+....                
T Consensus       341 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~t~g~~P~~-~~~~~~~~~~i~~~~----------------  402 (454)
T 1qcf_A          341 AREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYP-GMSNPEVIRALERGY----------------  402 (454)
T ss_dssp             TTCSSSSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSST-TCCHHHHHHHHHHTC----------------
T ss_pred             ccCCCcccccccCHHHhcc-CCCCcHHHHHhHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHcCC----------------
Confidence             122345678999999876 679999999999999999999 998883 333333322221100                


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc--CCCccc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA--HPYFFP  423 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~--Hp~~~~  423 (434)
                                          ....+..+++++.+||.+||..||++|||++++++  ..++..
T Consensus       403 --------------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~  445 (454)
T 1qcf_A          403 --------------------RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA  445 (454)
T ss_dssp             --------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred             --------------------CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence                                01112346789999999999999999999999875  344443

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=6.4e-43  Score=335.89  Aligned_cols=246  Identities=24%  Similarity=0.453  Sum_probs=187.9

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      .++|++.+.||+|+||.||+|.+..+++.||||+++..      ....+.+|+.+++.+ +||||+++++++.+.  ...
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~--~~~  107 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIED--NEL  107 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEET--TEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcC--CcE
Confidence            46799999999999999999999889999999998642      235688999999999 999999999999754  567


Q ss_pred             EEEEeecCCCchhhhc-------CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceec
Q 013897          207 SLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY  279 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~  279 (434)
                      ++||||+.+++|..++       ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~-~~kl~Dfg~~~~~  186 (310)
T 2wqm_A          108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG-VVKLGDLGLGRFF  186 (310)
T ss_dssp             EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCC------
T ss_pred             EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCC-CEEEEeccceeee
Confidence            8999999999987665       3488999999999999999999999999999999999999776 8999999999765


Q ss_pred             CCCC-ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhc
Q 013897          280 HPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY  358 (434)
Q Consensus       280 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  358 (434)
                      .... ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||.........+........           
T Consensus       187 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----------  254 (310)
T 2wqm_A          187 SSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD-----------  254 (310)
T ss_dssp             ------------CCSSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTC-----------
T ss_pred             cCCCccccccCCCeeEeChHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhccc-----------
Confidence            4332 2234578999999999876 68999999999999999999999998644333222221110000           


Q ss_pred             cccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                    ..         ......+++++.+||.+||..||++|||+.++++
T Consensus       255 --------------~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~  290 (310)
T 2wqm_A          255 --------------YP---------PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD  290 (310)
T ss_dssp             --------------SC---------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------CC---------CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                          00         0011236788999999999999999999999986

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.9e-43  Score=360.17  Aligned_cols=243  Identities=19%  Similarity=0.348  Sum_probs=198.7

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF  210 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  210 (434)
                      .++|++.+.||+|+||.||+|.+..++..||||+++..  ..+.+.+|+.+|+++ +||||+++++++.+.  ...++||
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~--~~~~lv~  295 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTRE--PPFYIIT  295 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECSS--SSCEEEE
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhc-CCCCEeeEEEEEecC--CcEEEEE
Confidence            46899999999999999999999888999999999753  457899999999999 999999999999654  5678999


Q ss_pred             eecCCCchhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc-
Q 013897          211 EHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-  284 (434)
Q Consensus       211 e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~-  284 (434)
                      ||+.+++|..++     ..+++..+..++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+++....... 
T Consensus       296 E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~~  374 (495)
T 1opk_A          296 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENH-LVKVADFGLSRLMTGDTYT  374 (495)
T ss_dssp             ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG-CEEECCTTCEECCTTCCEE
T ss_pred             EccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCC-cEEEeecccceeccCCcee
Confidence            999999987775     2488889999999999999999999999999999999999776 899999999987643321 


Q ss_pred             -cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          285 -YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       285 -~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                       .....++..|+|||++.+ ..++.++|||||||++|||++ |..||. +.+..+....+..                  
T Consensus       375 ~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlG~~l~el~t~g~~p~~-~~~~~~~~~~~~~------------------  434 (495)
T 1opk_A          375 AHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYP-GIDLSQVYELLEK------------------  434 (495)
T ss_dssp             CCTTCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSST-TCCGGGHHHHHHT------------------
T ss_pred             ecCCCcCCcceeCHhHHhc-CCCCcHHhHHhHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHc------------------
Confidence             122245668999999876 679999999999999999999 888873 3332222221110                  


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                ..        .......+++++.+||.+||+.||++|||+.++++
T Consensus       435 ----------~~--------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          435 ----------DY--------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             ----------TC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------CC--------CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence                      00        01122346789999999999999999999999986

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1e-42  Score=334.46  Aligned_cols=240  Identities=21%  Similarity=0.310  Sum_probs=188.8

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEe
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE  211 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  211 (434)
                      .++|++.+.||+|+||.||+|.+  .++.||||++... ..+.+.+|+.+++++ +||||+++++++.+    ..++|||
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~----~~~lv~e   79 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRV-NHPNIVKLYGACLN----PVCLVME   79 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTTHHHHHHHHHHHHHHC-CCTTBCCEEEBCTT----TTEEEEE
T ss_pred             HhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChhHHHHHHHHHHHHhcC-CCCCcCeEEEEEcC----CcEEEEE
Confidence            46899999999999999999987  4789999999754 356789999999999 99999999998842    3689999


Q ss_pred             ecCCCchhhhcC------CCChHHHHHHHHHHHHHHHHHHH---CCceeecCCCCceEecCCCCeEEEEecccceecCCC
Q 013897          212 HVNNTDFKVLYP------TLSDYDVRYYIYELLKALDYCHS---QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG  282 (434)
Q Consensus       212 ~~~~~~l~~~~~------~l~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~  282 (434)
                      |+.+++|..++.      .++...+..++.||+.||+|||+   +||+||||||+|||++.++..+||+|||++..... 
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~-  158 (307)
T 2eva_A           80 YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT-  158 (307)
T ss_dssp             CCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred             cCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc-
Confidence            999999977753      36788899999999999999999   89999999999999987775689999999975532 


Q ss_pred             CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                       ......|+..|+|||++.+ ..++.++|||||||++|||++|+.||............... .+               
T Consensus       159 -~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~~---------------  220 (307)
T 2eva_A          159 -HMTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVH-NG---------------  220 (307)
T ss_dssp             -------CCTTSSCHHHHTC-CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHH-TT---------------
T ss_pred             -ccccCCCCCceEChhhhCC-CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHh-cC---------------
Confidence             2334578999999999876 68999999999999999999999998543332211111000 00               


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                 ..        ......+++.+.+||.+||+.||++|||++|+++
T Consensus       221 -----------~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  256 (307)
T 2eva_A          221 -----------TR--------PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK  256 (307)
T ss_dssp             -----------CC--------CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------CC--------CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                       00        0111236788999999999999999999999987

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=8.4e-43  Score=352.66  Aligned_cols=240  Identities=17%  Similarity=0.331  Sum_probs=194.8

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEe
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE  211 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  211 (434)
                      .++|++.+.||+|+||.||+|.+  .++.||||+++.. ..+.+.+|+.+|+++ +||||+++++++.+. ...+++|||
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-~~~~~iv~e  267 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEE-KGGLYIVTE  267 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCTTSHHHHHHHHHHHTC-CCTTBCCEEEEEECT-TSCEEEEEE
T ss_pred             hHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCchHHHHHHHHHHHHHhc-cCCCEEEEEEEEEcC-CCceEEEEE
Confidence            47899999999999999999987  4789999999754 356789999999999 999999999998654 246789999


Q ss_pred             ecCCCchhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCccc
Q 013897          212 HVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN  286 (434)
Q Consensus       212 ~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~~  286 (434)
                      |+.+++|..++.     .+++..+..++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+++.....  ..
T Consensus       268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~--~~  344 (450)
T 1k9a_A          268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASST--QD  344 (450)
T ss_dssp             CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTS-CEEECCCTTCEECC------
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCC-CEEEeeCCCccccccc--cc
Confidence            999999877653     268889999999999999999999999999999999999776 8999999999854322  22


Q ss_pred             eeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChh
Q 013897          287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH  365 (434)
Q Consensus       287 ~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~  365 (434)
                      ...++..|+|||++.+ ..++.++|||||||++|||++ |+.||. +....+....+.+                     
T Consensus       345 ~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~-~~~~~~~~~~i~~---------------------  401 (450)
T 1k9a_A          345 TGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYP-RIPLKDVVPRVEK---------------------  401 (450)
T ss_dssp             --CCCTTTSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTTCCSST-TSCTTTHHHHHHT---------------------
T ss_pred             CCCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHc---------------------
Confidence            3466788999999987 689999999999999999998 999984 2222222222110                     


Q ss_pred             HHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          366 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                            . .        ....+..+++++.+||.+||..||++|||+.++++
T Consensus       402 ------~-~--------~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          402 ------G-Y--------KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             ------T-C--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------C-C--------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                  0 0        01122347789999999999999999999999875

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=9.7e-43  Score=329.90  Aligned_cols=243  Identities=24%  Similarity=0.414  Sum_probs=193.3

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCC---CeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTD---NEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT  205 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~---~~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  205 (434)
                      .++|.+.+.||+|+||.||+|.+..+   +..||+|+++..    ..+.+.+|+.+++.+ +||||+++++++.+   ..
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~---~~   86 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL-DHPHIVKLIGIIEE---EP   86 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHH-CCTTBCCEEEEECS---SS
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhC-CCCCcceEEEEEcC---CC
Confidence            47899999999999999999987543   356999998753    346788999999999 99999999999854   34


Q ss_pred             cEEEEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC
Q 013897          206 PSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP  281 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~  281 (434)
                      .++||||+.+++|..++    ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus        87 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~  165 (281)
T 3cc6_A           87 TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPE-CVKLGDFGLSRYIED  165 (281)
T ss_dssp             CEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETT-EEEECCCCGGGCC--
T ss_pred             CEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCC-cEEeCccCCCccccc
Confidence            57999999999987765    3489999999999999999999999999999999999999776 899999999976543


Q ss_pred             CCc--cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhc
Q 013897          282 GKE--YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY  358 (434)
Q Consensus       282 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  358 (434)
                      ...  .....++..|+|||++.+ ..++.++|||||||++|+|++ |+.||.... ..+....+...             
T Consensus       166 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~llt~g~~p~~~~~-~~~~~~~~~~~-------------  230 (281)
T 3cc6_A          166 EDYYKASVTRLPIKWMSPESINF-RRFTTASDVWMFAVCMWEILSFGKQPFFWLE-NKDVIGVLEKG-------------  230 (281)
T ss_dssp             -------CCCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-GGGHHHHHHHT-------------
T ss_pred             ccccccccCCCCcceeCchhhcc-CCCCchhccHHHHHHHHHHHhCCCCCcccCC-hHHHHHHHhcC-------------
Confidence            322  233456778999999876 679999999999999999998 999984322 22222211110             


Q ss_pred             cccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                                     ..        ......+++.+.+||.+||..||++|||+.|++++
T Consensus       231 ---------------~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          231 ---------------DR--------LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             ---------------CC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------CC--------CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence                           00        01122367889999999999999999999999875

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2.6e-43  Score=334.74  Aligned_cols=243  Identities=19%  Similarity=0.351  Sum_probs=198.9

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF  210 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  210 (434)
                      .++|++.+.||+|+||.||+|.+..++..||+|+++..  ..+.+.+|+.+++.+ +||||+++++++.+  ....++||
T Consensus        12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~~v~   88 (288)
T 3kfa_A           12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTR--EPPFYIIT   88 (288)
T ss_dssp             GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHC-CCTTBCCEEEEECS--SSSEEEEE
T ss_pred             ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcc--CCCEEEEE
Confidence            57899999999999999999999999999999999754  346788999999999 89999999999964  35678999


Q ss_pred             eecCCCchhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc-
Q 013897          211 EHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-  284 (434)
Q Consensus       211 e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~-  284 (434)
                      ||+.+++|..++     ..+++..+..++.||+.||+|||++||+||||||+||+++.++ .+||+|||++........ 
T Consensus        89 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~~~~~~~~~  167 (288)
T 3kfa_A           89 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTYT  167 (288)
T ss_dssp             ECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGG-CEEECCCCGGGTSCSSSSE
T ss_pred             EcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCC-CEEEccCccceeccCCccc
Confidence            999999987765     2388999999999999999999999999999999999999776 899999999976643322 


Q ss_pred             -cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          285 -YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       285 -~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                       .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||. +.+.......+..                  
T Consensus       168 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~~g~~p~~-~~~~~~~~~~~~~------------------  227 (288)
T 3kfa_A          168 AHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYP-GIDLSQVYELLEK------------------  227 (288)
T ss_dssp             EETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSST-TCCGGGHHHHHHT------------------
T ss_pred             cccCCccccCcCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHhc------------------
Confidence             223456778999999876 679999999999999999999 888873 3222222211110                  


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                .        ........+++.+.+||.+||..||++|||+.|+++
T Consensus       228 ----------~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          228 ----------D--------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             ----------T--------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------c--------CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence                      0        001122346789999999999999999999999976

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.8e-42  Score=327.57  Aligned_cols=241  Identities=17%  Similarity=0.319  Sum_probs=196.2

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF  210 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  210 (434)
                      .++|++++.||+|+||.||+|.+ .++..||+|+++..  ..+.+.+|+.+++.+ +||||+++++++.+   ...++||
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~---~~~~~v~   86 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAVVTQ---EPIYIIT   86 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS---SSCEEEE
T ss_pred             HHhhhheeeecCCCCeEEEEEEE-cCCcEEEEEEecCCcccHHHHHHHHHHHHhC-CCcCcceEEEEEcC---CCcEEEE
Confidence            47899999999999999999997 46788999998753  457789999999999 99999999999853   3478999


Q ss_pred             eecCCCchhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc-
Q 013897          211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-  284 (434)
Q Consensus       211 e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~-  284 (434)
                      ||+.+++|..++.     .+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++........ 
T Consensus        87 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~  165 (279)
T 1qpc_A           87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL-SCKIADFGLARLIEDNEYT  165 (279)
T ss_dssp             ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCEECSSSCEE
T ss_pred             ecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCC-CEEECCCcccccccCcccc
Confidence            9999999988875     588999999999999999999999999999999999999766 899999999987653321 


Q ss_pred             -cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          285 -YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       285 -~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                       .....++..|+|||++.+ ..++.++|||||||++|+|++ |+.||. +....+....+...                 
T Consensus       166 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~-~~~~~~~~~~~~~~-----------------  226 (279)
T 1qpc_A          166 AREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYP-GMTNPEVIQNLERG-----------------  226 (279)
T ss_dssp             CCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSST-TCCHHHHHHHHHTT-----------------
T ss_pred             cccCCCCccCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCc-ccCHHHHHHHHhcc-----------------
Confidence             122345678999999876 678999999999999999999 888873 33322222221100                 


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                 .        .......+++++.+|+.+||..||++|||+.++++
T Consensus       227 -----------~--------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          227 -----------Y--------RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             -----------C--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------c--------CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence                       0        00112246789999999999999999999999986

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.1e-43  Score=341.99  Aligned_cols=244  Identities=19%  Similarity=0.312  Sum_probs=194.8

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEE--EEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKC--IIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~v--aiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      ++|++.+.||+|+||.||+|.+..++..+  |+|.++..    ....+.+|+.+++++.+||||+++++++.+.  ...+
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~~~~  102 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYLY  102 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET--TEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeC--CceE
Confidence            67999999999999999999998888765  99988642    3356889999999998899999999999654  5678


Q ss_pred             EEEeecCCCchhhhcC-------------------CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeE
Q 013897          208 LIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKL  268 (434)
Q Consensus       208 lv~e~~~~~~l~~~~~-------------------~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~v  268 (434)
                      +||||+.+++|..++.                   .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~-~~  181 (327)
T 1fvr_A          103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY-VA  181 (327)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG-CE
T ss_pred             EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC-eE
Confidence            9999999999877652                   478999999999999999999999999999999999999776 89


Q ss_pred             EEEecccceecCCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC
Q 013897          269 RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG  347 (434)
Q Consensus       269 kl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g  347 (434)
                      ||+|||+++............++..|+|||++.+ ..++.++|||||||++|+|++ |+.||. +....+....+..   
T Consensus       182 kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~-~~~~~~~~~~~~~---  256 (327)
T 1fvr_A          182 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYC-GMTCAELYEKLPQ---  256 (327)
T ss_dssp             EECCTTCEESSCEECCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTT-TCCHHHHHHHGGG---
T ss_pred             EEcccCcCccccccccccCCCCCccccChhhhcc-ccCCchhcchHHHHHHHHHHcCCCCCCC-CCcHHHHHHHhhc---
Confidence            9999999975433333344567788999999876 678999999999999999998 999983 2222111111100   


Q ss_pred             ChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          348 TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                                              .         ........+++++.+||.+||..||++|||++|+++|
T Consensus       257 ------------------------~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          257 ------------------------G---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             ------------------------T---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------------C---------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                    0         0011122467899999999999999999999999975

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.6e-43  Score=339.30  Aligned_cols=255  Identities=19%  Similarity=0.277  Sum_probs=192.2

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHh-cCCCCeeeEeeEEEccCC--CccEEEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNL-CGGPNIVKLLDIVRDQQS--KTPSLIF  210 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~E~~~l~~l-~~h~niv~l~~~~~~~~~--~~~~lv~  210 (434)
                      ++|++.+.||+|+||.||+|.+  +++.||||++.........+|.+++..+ .+||||+++++++.+...  ...++||
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~  114 (337)
T 3mdy_A           37 KQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLIT  114 (337)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEE
T ss_pred             cceEEEeEeecCCCeEEEEEEE--CCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEE
Confidence            6799999999999999999987  4899999999877666777777776654 389999999999876533  5678999


Q ss_pred             eecCCCchhhhc--CCCChHHHHHHHHHHHHHHHHHHHC--------CceeecCCCCceEecCCCCeEEEEecccceecC
Q 013897          211 EHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQ--------GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH  280 (434)
Q Consensus       211 e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~--------~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~  280 (434)
                      ||+.+++|..++  ..+++..+..++.|++.||+|||++        ||+||||||+|||++.++ .+||+|||++....
T Consensus       115 e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~-~~kl~Dfg~a~~~~  193 (337)
T 3mdy_A          115 DYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVKFI  193 (337)
T ss_dssp             CCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS-CEEECCCTTCEECC
T ss_pred             eccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC-CEEEEeCCCceeec
Confidence            999999998776  3588999999999999999999998        999999999999999776 89999999997664


Q ss_pred             CCCcc-----ceeccCCcccccccccCCCCCCcc------ccHHHHHHHHHHHHhC----------CCCCCCCCCCHHHH
Q 013897          281 PGKEY-----NVRVASRYFKGPELLVDLQDYDYS------LDLWSLGCMFAGMIFR----------KEPFFYGHDNYDQL  339 (434)
Q Consensus       281 ~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~------~DvwSlGvil~elltg----------~~pf~~~~~~~~~~  339 (434)
                      .....     ...+||+.|+|||++.+ ..+..+      +|||||||++|||++|          +.||..........
T Consensus       194 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~  272 (337)
T 3mdy_A          194 SDTNEVDIPPNTRVGTKRYMPPEVLDE-SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY  272 (337)
T ss_dssp             ---------CCSSCSCGGGCCHHHHTT-CCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             cccccccCCCCCCccCcceeChhhccc-ccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCch
Confidence            33221     24579999999999876 344443      9999999999999999          66663322111111


Q ss_pred             HHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          340 VKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       340 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                      ..+.....                       ....+....   .......+++++.+||.+||+.||++|||+.|+++|
T Consensus       273 ~~~~~~~~-----------------------~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          273 EDMREIVC-----------------------IKKLRPSFP---NRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             HHHHHHHT-----------------------TSCCCCCCC---GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             hhhHHHHh-----------------------hhccCcccc---ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            11111000                       000000000   000112356789999999999999999999999975

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=5e-43  Score=333.47  Aligned_cols=245  Identities=16%  Similarity=0.328  Sum_probs=184.9

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      .++|++.++||+|+||.||+|.+.   ..+|+|+++..     ..+.+.+|+.+++.+ +||||+++++++.   ....+
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~---~~~~~   95 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGYST---APQLA   95 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEC---SSSCE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCcEEEEEeecc---CCccE
Confidence            478999999999999999999853   35999998643     235688999999999 8999999999763   24568


Q ss_pred             EEEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC--
Q 013897          208 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP--  281 (434)
Q Consensus       208 lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~--  281 (434)
                      +||||+.+++|..++    ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.....  
T Consensus        96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~  174 (289)
T 3og7_A           96 IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDN-TVKIGDFGLATEKSRWS  174 (289)
T ss_dssp             EEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT-EEEECCCC---------
T ss_pred             EEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCC-CEEEccceecccccccc
Confidence            999999999987765    3488899999999999999999999999999999999999776 899999999975532  


Q ss_pred             -CCccceeccCCcccccccccC--CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhc
Q 013897          282 -GKEYNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY  358 (434)
Q Consensus       282 -~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  358 (434)
                       ........|++.|+|||++..  ...++.++|||||||++|+|++|+.||... ...+.+..+......          
T Consensus       175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~-~~~~~~~~~~~~~~~----------  243 (289)
T 3og7_A          175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI-NNRDQIIEMVGRGSL----------  243 (289)
T ss_dssp             ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSC-CCHHHHHHHHHHTSC----------
T ss_pred             ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCcccc-chHHHHHHHhccccc----------
Confidence             122344578999999999862  256889999999999999999999998433 333333322211000          


Q ss_pred             cccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                      ....     ......+++++.+||.+||..||++|||+.|+++
T Consensus       244 ----------------~~~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          244 ----------------SPDL-----SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             ----------------CCCT-----TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------Ccch-----hhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                            0000     0011246789999999999999999999999985

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=9.9e-43  Score=331.73  Aligned_cols=248  Identities=18%  Similarity=0.265  Sum_probs=191.0

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEe
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE  211 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  211 (434)
                      .++|++.+.||+|+||.||+|.+..+++.||||++... ....+.+|+.+++.+ .|++++..+..+... ....++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l-~~~~~i~~~~~~~~~-~~~~~lv~e   85 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMM-QGGVGIPTIRWCGAE-GDYNVMVME   85 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHH-TTSTTCCCEEEEEEE-TTEEEEEEE
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHh-cCCCCCCeeeeecCC-CCceEEEEE
Confidence            47899999999999999999999999999999987543 345688999999999 666666655555432 456789999


Q ss_pred             ecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEe---cCCCCeEEEEecccceecCCCCc
Q 013897          212 HVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGKE  284 (434)
Q Consensus       212 ~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll---~~~~~~vkl~DFGla~~~~~~~~  284 (434)
                      |+ +++|..++    ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++ .+||+|||+++.......
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~-~~kL~Dfg~a~~~~~~~~  163 (296)
T 4hgt_A           86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAKKYRDART  163 (296)
T ss_dssp             CC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTT-CEEECCCTTCEECBCTTT
T ss_pred             cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCC-eEEEecCccceeccCccc
Confidence            99 77876664    468999999999999999999999999999999999999   5555 899999999987654322


Q ss_pred             --------cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCC--HHHHHHHHHHhCChhHHHH
Q 013897          285 --------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN--YDQLVKIAKVLGTDELNAY  354 (434)
Q Consensus       285 --------~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~--~~~~~~i~~~~g~~~~~~~  354 (434)
                              .....||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||......  ...+..+.......     
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----  237 (296)
T 4hgt_A          164 HQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-----  237 (296)
T ss_dssp             CCBCCCCCSCCCCSCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS-----
T ss_pred             CccCCCCcccccCCCccccchHHhcC-CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc-----
Confidence                    234578999999999887 67999999999999999999999998532221  11222211100000     


Q ss_pred             HhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          355 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                              +  .                 ......+++++.+||.+||+.||++|||++++++
T Consensus       238 --------~--~-----------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          238 --------P--I-----------------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             --------C--H-----------------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             --------h--h-----------------hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence                    0  0                 0011235788999999999999999999999886

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=5.4e-43  Score=336.87  Aligned_cols=247  Identities=17%  Similarity=0.320  Sum_probs=188.4

Q ss_pred             CCCCeEEEeeeeecCceEEEEEEEcC---CCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC
Q 013897          132 EQDDYEVVRKVGRGKYSEVFEGVHCT---DNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS  203 (434)
Q Consensus       132 ~~~~y~~~~~lG~G~fg~Vy~~~~~~---~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  203 (434)
                      ..++|.+.+.||+|+||.||+|.+..   ++..||+|+++..     ..+.+.+|+.+++.+ +||||+++++++.+...
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~  110 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF-SHPNVIRLLGVCIEMSS  110 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEC---
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcC-CCCCeeeeeEEEeeccc
Confidence            35789999999999999999998765   4568999998643     235688999999999 89999999999976543


Q ss_pred             C---ccEEEEeecCCCchhhhc---------CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEE
Q 013897          204 K---TPSLIFEHVNNTDFKVLY---------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLI  271 (434)
Q Consensus       204 ~---~~~lv~e~~~~~~l~~~~---------~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~  271 (434)
                      .   ..++||||+.+++|..++         ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+
T Consensus       111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~-~~kl~  189 (313)
T 3brb_A          111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM-TVCVA  189 (313)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTS-CEEEC
T ss_pred             cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC-cEEEe
Confidence            2   458999999999987765         3589999999999999999999999999999999999999776 89999


Q ss_pred             ecccceecCCCCc---cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC
Q 013897          272 DWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG  347 (434)
Q Consensus       272 DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g  347 (434)
                      |||++........   .....+++.|+|||.+.+ ..++.++|||||||++|+|++ |..|| .+.........+..   
T Consensus       190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~-~~~~~~~~~~~~~~---  264 (313)
T 3brb_A          190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGMTPY-PGVQNHEMYDYLLH---  264 (313)
T ss_dssp             SCSCC----------------CCGGGSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTSCCSS-TTCCGGGHHHHHHT---
T ss_pred             ecCcceecccccccCcccccCCCccccCchhhcC-CCccchhhhHHHHHHHHHHHhcCCCCC-ccCCHHHHHHHHHc---
Confidence            9999976643321   233456778999999887 789999999999999999999 77776 33333222222110   


Q ss_pred             ChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          348 TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                                              . .        .......+++++.+||.+||..||++|||+.++++|
T Consensus       265 ------------------------~-~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          265 ------------------------G-H--------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             ------------------------T-C--------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ------------------------C-C--------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                    0 0        001122467889999999999999999999999875

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2.8e-43  Score=346.55  Aligned_cols=239  Identities=16%  Similarity=0.239  Sum_probs=192.8

Q ss_pred             CCCeEEEeeeeecCceEEEEEE-----EcCCCeEEEEEEeccccHHHHHHHHHHHHHhcC--CCCeeeEeeEEEccCCCc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGV-----HCTDNEKCIIKILKPVKKKKIKREIKILQNLCG--GPNIVKLLDIVRDQQSKT  205 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~-----~~~~~~~vaiK~~~~~~~~~~~~E~~~l~~l~~--h~niv~l~~~~~~~~~~~  205 (434)
                      .++|.+.+.||+|+||.||+|.     +..+++.||||+++.....++.+|+.+++.+..  |+||+++++++...  ..
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~--~~  141 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ--NG  141 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS--SC
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC--CC
Confidence            5789999999999999999994     567889999999998888899999999999832  89999999999654  45


Q ss_pred             cEEEEeecCCCchhhhc--------CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecC-----------CCC
Q 013897          206 PSLIFEHVNNTDFKVLY--------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH-----------EQR  266 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~--------~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~-----------~~~  266 (434)
                      .++||||+.+++|..++        ..+++..++.++.||+.||+|||++||+||||||+|||++.           ++ 
T Consensus       142 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~-  220 (365)
T 3e7e_A          142 SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSA-  220 (365)
T ss_dssp             EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CT-
T ss_pred             cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccC-
Confidence            67999999999997765        24899999999999999999999999999999999999986           44 


Q ss_pred             eEEEEecccceecC---CCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 013897          267 KLRLIDWGLAEFYH---PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA  343 (434)
Q Consensus       267 ~vkl~DFGla~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~  343 (434)
                      .+||+|||+|+.+.   ........+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.........     
T Consensus       221 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-----  294 (365)
T 3e7e_A          221 GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK-----  294 (365)
T ss_dssp             TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE-----
T ss_pred             CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC-CCCCccccHHHHHHHHHHHHhCCCccccCCCCcee-----
Confidence            89999999997543   2333455689999999999987 67999999999999999999999998432211000     


Q ss_pred             HHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          344 KVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       344 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                        ..                   ........++.+.+++.+||..+|.+|++..+.|.
T Consensus       295 ------------------~~-------------------~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~  331 (365)
T 3e7e_A          295 ------------------PE-------------------GLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLR  331 (365)
T ss_dssp             ------------------EC-------------------SCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred             ------------------ec-------------------hhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence                              00                   00001123567889999999999999966544444

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=6.7e-43  Score=328.43  Aligned_cols=241  Identities=16%  Similarity=0.269  Sum_probs=194.2

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      .++|++.+.||+|+||.||+|.+  +++.||+|+++...     .+.+.+|+.+++.+ +||||+++++++.+......+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~   85 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF-SHPNVLPVLGACQSPPAPHPT   85 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCC-SCTTEECEEEEECTTTSSSCE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCchhheEEEEccCCCCCeE
Confidence            36799999999999999999998  48899999987432     35688999999999 899999999999876567789


Q ss_pred             EEEeecCCCchhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCC--ceeecCCCCceEecCCCCeEEEEecccceecC
Q 013897          208 LIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH  280 (434)
Q Consensus       208 lv~e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~  280 (434)
                      +||||+.+++|..++.     .+++..+..++.||+.||.|||+++  |+||||||+|||++.++ .++|+|||++....
T Consensus        86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~-~~~l~~~~~~~~~~  164 (271)
T 3kmu_A           86 LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDM-TARISMADVKFSFQ  164 (271)
T ss_dssp             EEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTS-CEEEEGGGSCCTTS
T ss_pred             eeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCc-ceeEEeccceeeec
Confidence            9999999999987763     3789999999999999999999999  99999999999999776 79999999875432


Q ss_pred             CCCccceeccCCcccccccccCCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhc
Q 013897          281 PGKEYNVRVASRYFKGPELLVDLQ--DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY  358 (434)
Q Consensus       281 ~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  358 (434)
                          .....+|+.|+|||.+.+..  .++.++|||||||++|||++|+.||.. ....+....+..              
T Consensus       165 ----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~-~~~~~~~~~~~~--------------  225 (271)
T 3kmu_A          165 ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD-LSNMEIGMKVAL--------------  225 (271)
T ss_dssp             ----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTT-SCHHHHHHHHHH--------------
T ss_pred             ----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccc-cChHHHHHHHHh--------------
Confidence                23457889999999987621  233489999999999999999999842 222222221110              


Q ss_pred             cccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                   ...        .......+++++.+||.+||+.||++|||++|+++
T Consensus       226 -------------~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          226 -------------EGL--------RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             -------------SCC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------cCC--------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                         000        00112246789999999999999999999999985

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=4.5e-43  Score=340.12  Aligned_cols=244  Identities=21%  Similarity=0.356  Sum_probs=179.5

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHHHhcCCCCeeeEeeEEEc------cCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRD------QQS  203 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~------~~~  203 (434)
                      ..+|++.+.||+|+||.||+|.+..+++.||||++....   ...+.+|+.+++++.+||||+++++++..      ...
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            357999999999999999999999999999999885433   45678999999999669999999999853      223


Q ss_pred             CccEEEEeecCCCchhhhc------CCCChHHHHHHHHHHHHHHHHHHHCC--ceeecCCCCceEecCCCCeEEEEeccc
Q 013897          204 KTPSLIFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHEQRKLRLIDWGL  275 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~------~~l~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlKp~NIll~~~~~~vkl~DFGl  275 (434)
                      ...++||||+.+ +|..++      ..+++..+..++.||+.||.|||++|  |+||||||+|||++.++ .+||+|||+
T Consensus       107 ~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~  184 (337)
T 3ll6_A          107 AEFLLLTELCKG-QLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQG-TIKLCDFGS  184 (337)
T ss_dssp             EEEEEEEECCSE-EHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTS-CEEBCCCTT
T ss_pred             ceEEEEEEecCC-CHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCC-CEEEecCcc
Confidence            457899999975 554332      34899999999999999999999999  99999999999999776 899999999


Q ss_pred             ceecCCCCcc-------------ceeccCCccccccccc--CCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHH
Q 013897          276 AEFYHPGKEY-------------NVRVASRYFKGPELLV--DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV  340 (434)
Q Consensus       276 a~~~~~~~~~-------------~~~~~t~~y~aPE~~~--~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~  340 (434)
                      ++........             ....+++.|+|||++.  ....++.++|||||||++|+|++|+.||..... ...  
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-~~~--  261 (337)
T 3ll6_A          185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK-LRI--  261 (337)
T ss_dssp             CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred             ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH-HHh--
Confidence            9876433221             1456899999999983  225788999999999999999999999832111 000  


Q ss_pred             HHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          341 KIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       341 ~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                       +.                            ..        .........++.+.+||.+||+.||++|||+.|+++|
T Consensus       262 -~~----------------------------~~--------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  302 (337)
T 3ll6_A          262 -VN----------------------------GK--------YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ  302 (337)
T ss_dssp             -----------------------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             -hc----------------------------Cc--------ccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHH
Confidence             00                            00        0011122355679999999999999999999999987

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=4.6e-44  Score=346.33  Aligned_cols=261  Identities=19%  Similarity=0.251  Sum_probs=197.3

Q ss_pred             CCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccccH----HHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK----KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       132 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      ..++|++.+.||+|+||.||+|.+ .+++.||||+++....    ..+.+|+.+++.+ +||||+++++++.+.  ...+
T Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~~  103 (326)
T 3uim_A           28 ASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTP--TERL  103 (326)
T ss_dssp             TTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTC-CCTTBCCCCEEECCS--SCCE
T ss_pred             HhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhc-cCCCccceEEEEecC--CceE
Confidence            457899999999999999999985 5689999999875432    3688999999998 899999999999654  4567


Q ss_pred             EEEeecCCCchhhhcC-------CCChHHHHHHHHHHHHHHHHHHHC---CceeecCCCCceEecCCCCeEEEEecccce
Q 013897          208 LIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQ---GIMHRDVKPHNVMIDHEQRKLRLIDWGLAE  277 (434)
Q Consensus       208 lv~e~~~~~~l~~~~~-------~l~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlKp~NIll~~~~~~vkl~DFGla~  277 (434)
                      +||||+.+++|..++.       .+++..+..++.||+.||+|||++   ||+||||||+|||++.++ .+||+|||++.
T Consensus       104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~~~  182 (326)
T 3uim_A          104 LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAK  182 (326)
T ss_dssp             EEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC-CEEECCCSSCE
T ss_pred             EEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC-CEEeccCcccc
Confidence            9999999999877652       388899999999999999999999   999999999999999776 89999999998


Q ss_pred             ecCCCCc--cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCC----CCCCHHHHHHHHHHhCChhH
Q 013897          278 FYHPGKE--YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFY----GHDNYDQLVKIAKVLGTDEL  351 (434)
Q Consensus       278 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~----~~~~~~~~~~i~~~~g~~~~  351 (434)
                      .......  .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..    ......             .
T Consensus       183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-------------~  248 (326)
T 3uim_A          183 LMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM-------------L  248 (326)
T ss_dssp             ECCSSSSCEECCCCSCGGGCCHHHHHH-SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSB-------------H
T ss_pred             ccCcccccccccccCCcCccCHHHhcc-CCCCccccchhHHHHHHHHHhCCCcccccccccccchh-------------H
Confidence            7643322  234468999999999876 6789999999999999999999999831    000000             0


Q ss_pred             HHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          352 NAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                      ..+.....  ........        .............++.+.+|+.+||+.||++|||+.|+++|-.-
T Consensus       249 ~~~~~~~~--~~~~~~~~--------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          249 LDWVKGLL--KEKKLEAL--------VDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             HHHHTTTT--SSCCSTTS--------SCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             HHHHHHHh--hchhhhhh--------cChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence            00000000  00000000        00000011112244679999999999999999999999998543

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=6.6e-43  Score=337.44  Aligned_cols=251  Identities=18%  Similarity=0.333  Sum_probs=200.2

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEc-----CCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS  203 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  203 (434)
                      .++|++.+.||+|+||.||+|.+.     .+++.||||++....    ...+.+|+.+++.+ +||||+++++++.+.  
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~--  100 (322)
T 1p4o_A           24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQG--  100 (322)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-CCTTBCCEEEEECSS--
T ss_pred             hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCEeeeEEEEccC--
Confidence            478999999999999999999876     357899999996432    34588999999999 999999999999653  


Q ss_pred             CccEEEEeecCCCchhhhc-------------CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEE
Q 013897          204 KTPSLIFEHVNNTDFKVLY-------------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRL  270 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~-------------~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl  270 (434)
                      ...++||||+.+++|..++             ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||
T Consensus       101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~-~~kl  179 (322)
T 1p4o_A          101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF-TVKI  179 (322)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC-CEEE
T ss_pred             CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC-eEEE
Confidence            5678999999999987765             2468889999999999999999999999999999999999776 8999


Q ss_pred             EecccceecCCCCc---cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHh
Q 013897          271 IDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL  346 (434)
Q Consensus       271 ~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~  346 (434)
                      +|||++........   .....+++.|+|||++.+ ..++.++|||||||++|+|++ |..||. +.........+..  
T Consensus       180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~-~~~~~~~~~~~~~--  255 (322)
T 1p4o_A          180 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQ-GLSNEQVLRFVME--  255 (322)
T ss_dssp             CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTT-TSCHHHHHHHHHT--
T ss_pred             CcCccccccccccccccccCCCCCCCccChhhhcc-CCCCchhhHHHHHHHHHHHHhcCCCccc-cCCHHHHHHHHHc--
Confidence            99999976543221   123456788999999876 679999999999999999999 777773 3322222211110  


Q ss_pred             CChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC------CC
Q 013897          347 GTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH------PY  420 (434)
Q Consensus       347 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H------p~  420 (434)
                                               . ..        ......+++.+.+||.+||..||++|||+.|+++|      |+
T Consensus       256 -------------------------~-~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~  301 (322)
T 1p4o_A          256 -------------------------G-GL--------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG  301 (322)
T ss_dssp             -------------------------T-CC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred             -------------------------C-Cc--------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccC
Confidence                                     0 00        01122467889999999999999999999999987      77


Q ss_pred             ccccc
Q 013897          421 FFPIR  425 (434)
Q Consensus       421 ~~~~~  425 (434)
                      |+.++
T Consensus       302 ~~~~~  306 (322)
T 1p4o_A          302 FREVS  306 (322)
T ss_dssp             HHHHC
T ss_pred             Ccccc
Confidence            76554

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.9e-42  Score=332.86  Aligned_cols=245  Identities=19%  Similarity=0.309  Sum_probs=187.9

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      .++|++.+.||+|+||.||+|.+..+++.||+|+++...      .+.+.+|+.+++.+ +||||+++++++.+.  ...
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~--~~~  109 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL-QEPHVVPIHDFGEID--GQL  109 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEET--TEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhc-CCCCeeEEEEEEeeC--CeE
Confidence            378999999999999999999998899999999986432      35688999999999 999999999999764  567


Q ss_pred             EEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC
Q 013897          207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~  283 (434)
                      ++||||+.+++|..++   ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus       110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~  188 (309)
T 2h34_A          110 YVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADD-FAYLVDFGIASATTDEK  188 (309)
T ss_dssp             EEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECSCCC--------
T ss_pred             EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCC-CEEEecCccCccccccc
Confidence            8999999999988775   4589999999999999999999999999999999999999776 89999999997654332


Q ss_pred             --ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcccc
Q 013897          284 --EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE  361 (434)
Q Consensus       284 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  361 (434)
                        ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||... . ...+.....  ..             
T Consensus       189 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~-~-~~~~~~~~~--~~-------------  250 (309)
T 2h34_A          189 LTQLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQGD-Q-LSVMGAHIN--QA-------------  250 (309)
T ss_dssp             --------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSC-H-HHHHHHHHH--SC-------------
T ss_pred             cccccccCCCcCccCHHHHcC-CCCCchHhHHHHHHHHHHHHHCCCCCCCc-h-HHHHHHHhc--cC-------------
Confidence              2235578999999999876 68899999999999999999999998421 1 111111100  00             


Q ss_pred             CChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCc-cHHHHhc
Q 013897          362 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-TAKEAMA  417 (434)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rp-t~~elL~  417 (434)
                                  ..      ........+++++.+||.+||..||++|| +++++++
T Consensus       251 ------------~~------~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          251 ------------IP------RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             ------------CC------CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             ------------CC------CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence                        00      00011234678899999999999999999 7777764

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.9e-43  Score=348.83  Aligned_cols=243  Identities=18%  Similarity=0.322  Sum_probs=184.4

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEc---CCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHC---TDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT  205 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~---~~~~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  205 (434)
                      .++|++.+.||+|+||.||+|++.   .++..||||+++..    ..+.+.+|+.+++++ +||||+++++++.+.  ..
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~~  120 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNIIRLEGVVTKS--KP  120 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSS--SS
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeC--Cc
Confidence            367889999999999999999876   45778999998743    245688999999999 999999999999653  56


Q ss_pred             cEEEEeecCCCchhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC
Q 013897          206 PSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP  281 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~  281 (434)
                      .++||||+.+++|..++.    .+++.++..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus       121 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~  199 (373)
T 2qol_A          121 VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNL-VCKVSDFGLGRVLED  199 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCC--------
T ss_pred             eEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCC-CEEECcCcccccccc
Confidence            789999999999987752    588999999999999999999999999999999999999776 899999999987643


Q ss_pred             CCcc----ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHh
Q 013897          282 GKEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN  356 (434)
Q Consensus       282 ~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~  356 (434)
                      ....    ....++..|+|||++.+ ..++.++|||||||++|||++ |+.||... ...+....+..            
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~SlG~il~ellt~g~~P~~~~-~~~~~~~~i~~------------  265 (373)
T 2qol_A          200 DPEAAYTTRGGKIPIRWTSPEAIAY-RKFTSASDVWSYGIVLWEVMSYGERPYWEM-SNQDVIKAVDE------------  265 (373)
T ss_dssp             --------------CTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTC-CTTTTC-CHHHHHHHHHT------------
T ss_pred             CCccceeccCCCcCCCccChhhhcc-CCcCchhcHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHc------------
Confidence            3211    12234668999999876 689999999999999999998 99998432 22222111110            


Q ss_pred             hccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          357 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                      .                        ........++.++.+|+.+||+.||++||++.|+++
T Consensus       266 ~------------------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          266 G------------------------YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             T------------------------EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             C------------------------CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence            0                        001112236788999999999999999999999876

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.3e-42  Score=326.00  Aligned_cols=243  Identities=17%  Similarity=0.331  Sum_probs=196.4

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF  210 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  210 (434)
                      .++|++.+.||+|+||.||+|.+. +++.||+|+++..  ..+.+.+|+.+++.+ +||||+++++++.+.  ...++||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~   82 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQ--APICLVT   82 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTC-CCTTBCCEEEEECSS--SSCEEEE
T ss_pred             hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEccC--CCeEEEE
Confidence            468999999999999999999985 6789999999754  457789999999999 899999999999654  5678999


Q ss_pred             eecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC--c
Q 013897          211 EHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--E  284 (434)
Q Consensus       211 e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~--~  284 (434)
                      ||+.+++|..++    ..+++..+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||++.......  .
T Consensus        83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~-~~kl~dfg~~~~~~~~~~~~  161 (267)
T 3t9t_A           83 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLDDQYTS  161 (267)
T ss_dssp             CCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGG-CEEECCTTGGGGBCCHHHHS
T ss_pred             eCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCC-CEEEcccccccccccccccc
Confidence            999999987765    3488999999999999999999999999999999999998776 89999999997653321  1


Q ss_pred             cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                      .....++..|+|||++.+ ..++.++|||||||++|+|++ |+.||. +....+....+...                  
T Consensus       162 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~-~~~~~~~~~~i~~~------------------  221 (267)
T 3t9t_A          162 STGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYE-NRSNSEVVEDISTG------------------  221 (267)
T ss_dssp             TTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTT-TCCHHHHHHHHHTT------------------
T ss_pred             cccccccccccChhhhcC-CCccchhchhhhHHHHHHHhccCCCCCC-CCCHHHHHHHHhcC------------------
Confidence            123356678999999876 678999999999999999999 888873 22222222221100                  


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                                .        .......+++.+.+|+.+||..||++|||+.|++++
T Consensus       222 ----------~--------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          222 ----------F--------RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             ----------C--------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------C--------cCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                      0        001122357889999999999999999999999874

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.3e-42  Score=351.59  Aligned_cols=251  Identities=19%  Similarity=0.322  Sum_probs=198.0

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF  210 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  210 (434)
                      .++|++.+.||+|+||.||+|.+. ++..||||+++..  ..+.+.+|+.+|+++ +||||+++++++.+   ...++||
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~---~~~~iv~  257 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE---EPIYIVT  257 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS---SSCEEEE
T ss_pred             hhHceeeeeecCCCCeEEEEEEEC-CCceEEEEEeccCCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEcC---CceEEEe
Confidence            478999999999999999999985 4577999999753  457799999999999 99999999999854   4578999


Q ss_pred             eecCCCchhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc-
Q 013897          211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-  284 (434)
Q Consensus       211 e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~-  284 (434)
                      ||+.+++|..++.     .+++..+..++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+++....... 
T Consensus       258 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~~  336 (452)
T 1fmk_A          258 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYT  336 (452)
T ss_dssp             CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCCTTC--------
T ss_pred             hhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCC-CEEECCCccceecCCCcee
Confidence            9999999987764     488999999999999999999999999999999999999766 899999999986643221 


Q ss_pred             -cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          285 -YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       285 -~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                       .....++..|+|||++.+ ..++.++|||||||++|||++ |+.|| .+....+.+..+...                 
T Consensus       337 ~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~-~~~~~~~~~~~i~~~-----------------  397 (452)
T 1fmk_A          337 ARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVLDQVERG-----------------  397 (452)
T ss_dssp             ------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSS-TTCCHHHHHHHHHTT-----------------
T ss_pred             cccCCcccccccCHhHHhc-CCCCccccHHhHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcC-----------------
Confidence             122345678999999876 689999999999999999999 88887 333332222221100                 


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc--CCCccccccc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA--HPYFFPIRNA  427 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~--Hp~~~~~~~~  427 (434)
                                 .+        ...+..+++.+.+||.+||+.||++|||++++++  ..++......
T Consensus       398 -----------~~--------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~  445 (452)
T 1fmk_A          398 -----------YR--------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ  445 (452)
T ss_dssp             -----------CC--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCC
T ss_pred             -----------CC--------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCcc
Confidence                       00        1112246788999999999999999999999987  4777655433

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.3e-42  Score=331.83  Aligned_cols=244  Identities=19%  Similarity=0.315  Sum_probs=193.7

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCC---CeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTD---NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~---~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      ..|++.+.||+|+||.||+|.+..+   ...+|+|.++...    .+.+.+|+.+++++ +||||+++++++.+. ....
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~-~~~~  102 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRS-EGSP  102 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCS-SSCC
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhC-CCCCEeeeeeEEEcC-CCce
Confidence            4689999999999999999987543   3468999986532    35688999999999 899999999997543 3567


Q ss_pred             EEEEeecCCCchhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC
Q 013897          207 SLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG  282 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~  282 (434)
                      ++||||+.+++|..++.    .+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus       103 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~a~~~~~~  181 (298)
T 3f66_A          103 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDK  181 (298)
T ss_dssp             EEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC-CEEECSCGGGCCCSCG
T ss_pred             EEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCC-CEEECccccccccccc
Confidence            89999999999987753    478899999999999999999999999999999999999776 8999999999765433


Q ss_pred             Cc-----cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhh
Q 013897          283 KE-----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK  357 (434)
Q Consensus       283 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  357 (434)
                      ..     .....+++.|+|||.+.+ ..++.++|||||||++|+|++|..|++.+....+....+....           
T Consensus       182 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~-----------  249 (298)
T 3f66_A          182 EYYSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-----------  249 (298)
T ss_dssp             GGCBC-----CCBCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTC-----------
T ss_pred             chhccccccCCCCCccccChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCC-----------
Confidence            21     233456778999999876 6799999999999999999997666656555444333321100           


Q ss_pred             ccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                       .        ......+++.+.+++.+||..||++|||+.|+++
T Consensus       250 -----------------~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          250 -----------------R--------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             -----------------C--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------------C--------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                             0        0112236788999999999999999999999986

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.9e-44  Score=374.02  Aligned_cols=276  Identities=21%  Similarity=0.356  Sum_probs=205.6

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEc----cCCCc
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRD----QQSKT  205 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~----~~~~~  205 (434)
                      ++|++.+.||+|+||.||+|.+..+++.||||+++..    ..+.+.+|+.+++.+ +||||+++++++..    .....
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL-NHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHC-CBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCCCCceeeeecccccccCCCe
Confidence            6799999999999999999999889999999998643    245688999999999 99999999998754    12456


Q ss_pred             cEEEEeecCCCchhhhcC------CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCC--eEEEEecccce
Q 013897          206 PSLIFEHVNNTDFKVLYP------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAE  277 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~~------~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~--~vkl~DFGla~  277 (434)
                      .++||||+.+++|..++.      .+++..++.++.||+.||+|||++||+||||||+|||++.++.  .+||+|||++.
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~  172 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK  172 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence            789999999999977753      4888999999999999999999999999999999999986552  48999999998


Q ss_pred             ecCCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhh
Q 013897          278 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK  357 (434)
Q Consensus       278 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  357 (434)
                      ............|+..|+|||++.+ ..++.++|||||||++|+|++|..||...... ..+.               ..
T Consensus       173 ~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-~~~~---------------~~  235 (676)
T 3qa8_A          173 ELDQGELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-VQWH---------------GK  235 (676)
T ss_dssp             BTTSCCCCCCCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-HHSS---------------TT
T ss_pred             ccccccccccccCCcccCChHHhcc-CCCCchhHHHHHHHHHHHHHHCCCCCCcccch-hhhh---------------hh
Confidence            8766655666789999999999876 78999999999999999999999999543211 1000               00


Q ss_pred             ccccCChhHHHHhcccCCCCCccccc--cccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccccc
Q 013897          358 YHIELDPHLAALVGRHSRKPWSKFIT--VENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA  427 (434)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~  427 (434)
                      ....................+.....  ......+++.+.+||.+||..||++|||+.|+|+||||+.++..
T Consensus       236 i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~i  307 (676)
T 3qa8_A          236 VREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSI  307 (676)
T ss_dssp             CC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHH
T ss_pred             hhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHH
Confidence            00000000000000000000110000  11122367889999999999999999999999999999987644

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-42  Score=329.32  Aligned_cols=243  Identities=19%  Similarity=0.322  Sum_probs=195.9

Q ss_pred             CeEEEeeeeecCceEEEEEEEcCCCe---EEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCTDNE---KCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~~~~---~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      .|.+.+.||+|+||.||+|.+..++.   .+|+|+++...    .+.+.+|+.+++.+ +||||+++++++.+.. ...+
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~-~~~~   99 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL-NHPNVLALIGIMLPPE-GLPH   99 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCSS-SCCE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEecCC-CCcE
Confidence            47788999999999999999755544   79999987532    35678999999999 9999999999996543 3447


Q ss_pred             EEEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC
Q 013897          208 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       208 lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~  283 (434)
                      +||||+.+++|..++    ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus       100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~-~~kl~Dfg~~~~~~~~~  178 (298)
T 3pls_A          100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESF-TVKVADFGLARDILDRE  178 (298)
T ss_dssp             EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC-CEEECCTTSSCTTTTGG
T ss_pred             EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC-cEEeCcCCCcccccCCc
Confidence            999999999987765    3478889999999999999999999999999999999999776 89999999997553321


Q ss_pred             -----ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhc
Q 013897          284 -----EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY  358 (434)
Q Consensus       284 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  358 (434)
                           ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.|++...+..+....+....            
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~------------  245 (298)
T 3pls_A          179 YYSVQQHRHARLPVKWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR------------  245 (298)
T ss_dssp             GGCSCCSSCTTCGGGGSCHHHHTT-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTC------------
T ss_pred             ccccccCcCCCCCccccChhhhcc-CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCC------------
Confidence                 2234467788999999876 6899999999999999999998888766655444333221100            


Q ss_pred             cccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                              .......+++.+.+|+.+||..||.+|||+.++++
T Consensus       246 ------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          246 ------------------------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             ------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                                    01112236788999999999999999999999986

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-42  Score=328.49  Aligned_cols=244  Identities=19%  Similarity=0.344  Sum_probs=196.3

Q ss_pred             CCCeEEEe-eeeecCceEEEEEEEc--CCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCc
Q 013897          133 QDDYEVVR-KVGRGKYSEVFEGVHC--TDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT  205 (434)
Q Consensus       133 ~~~y~~~~-~lG~G~fg~Vy~~~~~--~~~~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  205 (434)
                      .++|.+.+ .||+|+||.||+|.+.  .++..||||+++..    ..+.+.+|+.+++.+ +||||+++++++..   ..
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~---~~   83 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA---EA   83 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEES---SS
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhC-CCCCEeEEEEEecC---CC
Confidence            46777877 9999999999999864  46789999999753    245688999999999 99999999999943   35


Q ss_pred             cEEEEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC
Q 013897          206 PSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP  281 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~  281 (434)
                      .++||||+.+++|..++    ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           84 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH-YAKISDFGLSKALGA  162 (287)
T ss_dssp             EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT-EEEECCCTTCEECTT
T ss_pred             cEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCC-CEEECcccceeeecc
Confidence            78999999999998775    3489999999999999999999999999999999999999776 899999999987654


Q ss_pred             CCcc----ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHh
Q 013897          282 GKEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN  356 (434)
Q Consensus       282 ~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~  356 (434)
                      ....    ....++..|+|||++.+ ..++.++|||||||++|+|++ |+.||.. ....+....+...           
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~~~~i~~~-----------  229 (287)
T 1u59_A          163 DDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKK-MKGPEVMAFIEQG-----------  229 (287)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTT-CCTHHHHHHHHTT-----------
T ss_pred             CcceeeccccccccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCccc-CCHHHHHHHHhcC-----------
Confidence            3321    22345788999999876 678999999999999999998 9999843 3332222221110           


Q ss_pred             hccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCC
Q 013897          357 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHP  419 (434)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp  419 (434)
                                       .+        ......+++++.+||.+||..||++||++.|+++|.
T Consensus       230 -----------------~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l  267 (287)
T 1u59_A          230 -----------------KR--------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM  267 (287)
T ss_dssp             -----------------CC--------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             -----------------Cc--------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence                             00        011224678999999999999999999999999873

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-42  Score=337.28  Aligned_cols=242  Identities=19%  Similarity=0.348  Sum_probs=188.9

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeE----EEEEEecc----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEK----CIIKILKP----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK  204 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~----vaiK~~~~----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  204 (434)
                      .++|++++.||+|+||.||+|.+..+++.    ||+|.+..    ...+.+.+|+.+++.+ +||||+++++++...   
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~---   89 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS---   89 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTC-CBTTBCCCCEEEESS---
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEecC---
Confidence            47899999999999999999999877765    46776643    3457789999999999 899999999999753   


Q ss_pred             ccEEEEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecC
Q 013897          205 TPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH  280 (434)
Q Consensus       205 ~~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~  280 (434)
                      ..++|+||+.+++|..++    ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus        90 ~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~kL~DfG~a~~~~  168 (327)
T 3lzb_A           90 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLG  168 (327)
T ss_dssp             SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT-EEEECCTTC-----
T ss_pred             CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCC-CEEEccCcceeEcc
Confidence            367999999999987664    3588999999999999999999999999999999999999776 89999999998664


Q ss_pred             CCCc---cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHh
Q 013897          281 PGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN  356 (434)
Q Consensus       281 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~  356 (434)
                      ....   .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||. +....+....+..            
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~-~~~~~~~~~~~~~------------  234 (327)
T 3lzb_A          169 AEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEK------------  234 (327)
T ss_dssp             -----------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTT-TCCGGGHHHHHHT------------
T ss_pred             CccccccccCCCccccccCHHHHcC-CCCChHHHHHHHHHHHHHHHHCCCCCCC-CCCHHHHHHHHHc------------
Confidence            3322   123345778999999987 689999999999999999999 998883 3222222111110            


Q ss_pred             hccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          357 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                      ..        .......+++++.+||.+||..||++|||+.|+++
T Consensus       235 ----------------~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          235 ----------------GE--------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             ----------------TC--------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------CC--------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                            00        01112236788999999999999999999999986

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.7e-42  Score=331.58  Aligned_cols=240  Identities=24%  Similarity=0.395  Sum_probs=186.7

Q ss_pred             CCCeEEE-eeeeecCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeEeeEEEc--cCCCccEEE
Q 013897          133 QDDYEVV-RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRD--QQSKTPSLI  209 (434)
Q Consensus       133 ~~~y~~~-~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--~~~~~~~lv  209 (434)
                      .++|.+. +.||+|+||.||+|.+..+++.||+|+++.  ...+.+|+.++.++.+||||+++++++..  ......++|
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv   93 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV   93 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc--cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEE
Confidence            3678887 789999999999999999999999999964  35678999998777799999999999865  224567899


Q ss_pred             EeecCCCchhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC--CCeEEEEecccceecCCC
Q 013897          210 FEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--QRKLRLIDWGLAEFYHPG  282 (434)
Q Consensus       210 ~e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~--~~~vkl~DFGla~~~~~~  282 (434)
                      |||+.+++|..++.     .+++..++.++.||+.||+|||++||+||||||+|||++.+  +..+||+|||++....  
T Consensus        94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~--  171 (299)
T 3m2w_A           94 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT--  171 (299)
T ss_dssp             ECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT--
T ss_pred             EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc--
Confidence            99999999876652     48999999999999999999999999999999999999962  3379999999986432  


Q ss_pred             CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                                         + ..++.++|||||||++|+|++|+.||...... .....                ..   
T Consensus       172 -------------------~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~-~~~~~----------------~~---  211 (299)
T 3m2w_A          172 -------------------G-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-AISPG----------------MK---  211 (299)
T ss_dssp             -------------------T-CGGGGHHHHHHHHHHHHHHHHSSCSCCC--------CC----------------SC---
T ss_pred             -------------------c-ccCCchhhHHHHHHHHHHHHHCCCCCCCCcch-hhhHH----------------HH---
Confidence                               1 35677999999999999999999998432111 00000                00   


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN  426 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~  426 (434)
                              ........  .........+++++.+||.+||+.||++|||+.|+|+||||++...
T Consensus       212 --------~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~  265 (299)
T 3m2w_A          212 --------TRIRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK  265 (299)
T ss_dssp             --------CSSCTTCC--SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGG
T ss_pred             --------HHHhhccc--cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccccc
Confidence                    00000000  0000111347889999999999999999999999999999987653

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=3e-43  Score=339.12  Aligned_cols=249  Identities=20%  Similarity=0.357  Sum_probs=194.1

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEEcc--CCCccE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ--QSKTPS  207 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~~~~~  207 (434)
                      .++|++.+.||+|+||.||+|.+..+++.||||++...   ..+.+.+|+.+++.+ +||||+++++++...  .....+
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~  106 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF-NHPNILRLVAYCLRERGAKHEAW  106 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEEEETTEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhc-CCCCeeeEEEEEEeccCCCceeE
Confidence            47899999999999999999999999999999988543   345688999999999 999999999998632  234678


Q ss_pred             EEEeecCCCchhhhc-------CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecC
Q 013897          208 LIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH  280 (434)
Q Consensus       208 lv~e~~~~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~  280 (434)
                      +||||+.+++|..++       ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~-~~kl~dfg~~~~~~  185 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEG-QPVLMDLGSMNQAC  185 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCSSCEESC
T ss_pred             EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCC-CEEEEecCcchhcc
Confidence            999999999986654       3489999999999999999999999999999999999999776 89999999987643


Q ss_pred             CCCc----------cceeccCCcccccccccCCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCC
Q 013897          281 PGKE----------YNVRVASRYFKGPELLVDLQ--DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT  348 (434)
Q Consensus       281 ~~~~----------~~~~~~t~~y~aPE~~~~~~--~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~  348 (434)
                      ....          .....|++.|+|||++.+..  .++.++|||||||++|+|++|+.||......           +.
T Consensus       186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----------~~  254 (317)
T 2buj_A          186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK-----------GD  254 (317)
T ss_dssp             EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT-----------TS
T ss_pred             cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc-----------cc
Confidence            2111          12335789999999986522  3788999999999999999999998210000           00


Q ss_pred             hhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          349 DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                      .                ........        ........+++++.+||.+||+.||.+|||+.|+++|
T Consensus       255 ~----------------~~~~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          255 S----------------VALAVQNQ--------LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             C----------------HHHHHHCC----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             h----------------hhHHhhcc--------CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            0                00000000        0011123467899999999999999999999999986

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=8.1e-43  Score=336.77  Aligned_cols=258  Identities=21%  Similarity=0.343  Sum_probs=197.6

Q ss_pred             CeEEEeeeeecCceEEEEEEE----cCCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          135 DYEVVRKVGRGKYSEVFEGVH----CTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~----~~~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      .|++++.||+|+||.||++.+    ..+++.||||+++...    ...+.+|+.+++.+ +||||+++++++.+.....+
T Consensus        32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~  110 (318)
T 3lxp_A           32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL-YHEHIIKYKGCCEDAGAASL  110 (318)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTTTEE
T ss_pred             HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhC-CCcchhhEEEEEecCCCceE
Confidence            359999999999999988864    3478999999997543    45688999999999 89999999999987766788


Q ss_pred             EEEEeecCCCchhhhcC--CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc
Q 013897          207 SLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE  284 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~  284 (434)
                      ++||||+.+++|..++.  .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++........
T Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~-~~kl~Dfg~a~~~~~~~~  189 (318)
T 3lxp_A          111 QLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDR-LVKIGDFGLAKAVPEGHE  189 (318)
T ss_dssp             EEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCGGGCEECCTTCS
T ss_pred             EEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCC-CEEECCcccccccccccc
Confidence            99999999999988764  489999999999999999999999999999999999999776 899999999987754432


Q ss_pred             ----cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccc
Q 013897          285 ----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI  360 (434)
Q Consensus       285 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  360 (434)
                          .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||.....   ..   ....+........     
T Consensus       190 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~---~~---~~~~~~~~~~~~~-----  257 (318)
T 3lxp_A          190 YYRVREDGDSPVFWYAPECLKE-YKFYYASDVWSFGVTLYELLTHCDSSQSPPT---KF---LELIGIAQGQMTV-----  257 (318)
T ss_dssp             EEEC---CCCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH---HH---HHHHCSCCHHHHH-----
T ss_pred             ccccccCCCCCceeeChHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCcccccch---hh---hhhhcccccchhH-----
Confidence                233457788999999876 6788999999999999999999999832110   00   0111100000000     


Q ss_pred             cCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          361 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                         ..+.........        ......+++++.+||.+||+.||++|||+.|+++
T Consensus       258 ---~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          258 ---LRLTELLERGER--------LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             ---HHHHHHHHTTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---HHHHHHHhcccC--------CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence               001111111111        1122347789999999999999999999999984

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.2e-42  Score=340.40  Aligned_cols=252  Identities=17%  Similarity=0.216  Sum_probs=195.5

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcC--------CCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeee-----------
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCT--------DNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVK-----------  193 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~--------~~~~vaiK~~~~~~~~~~~~E~~~l~~l~~h~niv~-----------  193 (434)
                      .++|.+.+.||+|+||.||+|.+..        .++.||||++...  +.+.+|+.+++.+ +||||++           
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  117 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--GRLFNEQNFFQRA-AKPLQVNKWKKLYSTPLL  117 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--STHHHHHHHHHHH-CCHHHHHHHHHHTTCTTC
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--chHHHHHHHHHHh-cccchhhhhhhhccCCcc
Confidence            4789999999999999999999976        4889999998754  5788999999999 8999887           


Q ss_pred             ----EeeEEEccCCCccEEEEeecCCCchhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC
Q 013897          194 ----LLDIVRDQQSKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE  264 (434)
Q Consensus       194 ----l~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~  264 (434)
                          +++++.. .....++||||+ +++|..++     ..+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus       118 ~i~~~~~~~~~-~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~  195 (352)
T 2jii_A          118 AIPTCMGFGVH-QDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPE  195 (352)
T ss_dssp             SCCCCCEEEEE-TTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETT
T ss_pred             Cccchhhcccc-CCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCC
Confidence                5666654 246778999999 88887765     458999999999999999999999999999999999999965


Q ss_pred             C-CeEEEEecccceecCCCCc--------cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCC
Q 013897          265 Q-RKLRLIDWGLAEFYHPGKE--------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN  335 (434)
Q Consensus       265 ~-~~vkl~DFGla~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~  335 (434)
                      + ..+||+|||+++.......        .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......
T Consensus       196 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  274 (352)
T 2jii_A          196 DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG-CGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPN  274 (352)
T ss_dssp             EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCcccCCcC
Confidence            4 2799999999976543221        133478999999999887 68999999999999999999999999554434


Q ss_pred             HHHHHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHH
Q 013897          336 YDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEA  415 (434)
Q Consensus       336 ~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~el  415 (434)
                      ...+.......        ...                . .  ...........+++++.+||.+||..||++|||++++
T Consensus       275 ~~~~~~~~~~~--------~~~----------------~-~--~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  327 (352)
T 2jii_A          275 TEDIMKQKQKF--------VDK----------------P-G--PFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAML  327 (352)
T ss_dssp             HHHHHHHHHHH--------HHS----------------C-C--CEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHH
T ss_pred             HHHHHHHHHhc--------cCC----------------h-h--hhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHH
Confidence            33333221110        000                0 0  0000011112467899999999999999999999999


Q ss_pred             hc
Q 013897          416 MA  417 (434)
Q Consensus       416 L~  417 (434)
                      ++
T Consensus       328 ~~  329 (352)
T 2jii_A          328 RN  329 (352)
T ss_dssp             HH
T ss_pred             HH
Confidence            75

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-42  Score=335.25  Aligned_cols=244  Identities=17%  Similarity=0.298  Sum_probs=189.1

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCC----eEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDN----EKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK  204 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~----~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  204 (434)
                      .++|.+.+.||+|+||.||+|.+..++    ..||||+++..    ....+.+|+.+++.+ +||||+++++++.+  ..
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~  119 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISK--YK  119 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS--SS
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEec--CC
Confidence            478999999999999999999886543    46999999753    234688999999999 99999999999954  45


Q ss_pred             ccEEEEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecC
Q 013897          205 TPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH  280 (434)
Q Consensus       205 ~~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~  280 (434)
                      ..++||||+.+++|..++    ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus       120 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~~~~~~  198 (333)
T 1mqb_A          120 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL-VCKVSDFGLSRVLE  198 (333)
T ss_dssp             SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCCCC-----
T ss_pred             CcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCC-cEEECCCCcchhhc
Confidence            678999999999987765    3589999999999999999999999999999999999999776 89999999997664


Q ss_pred             CCCc----cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHH
Q 013897          281 PGKE----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYL  355 (434)
Q Consensus       281 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~  355 (434)
                      ....    .....++..|+|||++.+ ..++.++|||||||++|||++ |+.||.. ....+....+..           
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~-~~~~~~~~~~~~-----------  265 (333)
T 1mqb_A          199 DDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWE-LSNHEVMKAIND-----------  265 (333)
T ss_dssp             ------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHT-----------
T ss_pred             cccccccccCCCCccccccCchhccc-CCCCchhhhHHHHHHHHHHHcCCCCCccc-CCHHHHHHHHHC-----------
Confidence            3321    122345678999999876 689999999999999999999 9999843 222222221110           


Q ss_pred             hhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          356 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                                       ..+        ......+++.+.++|.+||+.||++||++.+++++
T Consensus       266 -----------------~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          266 -----------------GFR--------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             -----------------TCC--------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             -----------------CCc--------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                             000        01122367889999999999999999999999874

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=4.6e-43  Score=339.68  Aligned_cols=249  Identities=16%  Similarity=0.291  Sum_probs=193.3

Q ss_pred             CCCeEEEeeeeecCceEEEEEE-----EcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGV-----HCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS  203 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~-----~~~~~~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  203 (434)
                      .++|++++.||+|+||.||+|.     ...++..||||++...    ....+.+|+.+++.+ +||||+++++++.+.  
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--  105 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQS--  105 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSS--
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhC-CCCCCCeEEEEEcCC--
Confidence            4689999999999999999998     4567789999998643    235688999999999 999999999999654  


Q ss_pred             CccEEEEeecCCCchhhhcC----------CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC--CCeEEEE
Q 013897          204 KTPSLIFEHVNNTDFKVLYP----------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--QRKLRLI  271 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~~----------~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~--~~~vkl~  271 (434)
                      ...++||||+.+++|..++.          .+++..+..++.||+.||.|||++||+||||||+|||++.+  +..+||+
T Consensus       106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEEC
Confidence            45689999999999877652          37888999999999999999999999999999999999843  2369999


Q ss_pred             ecccceecCCCC---ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC
Q 013897          272 DWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG  347 (434)
Q Consensus       272 DFGla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g  347 (434)
                      |||++.......   ......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||. +....+....+..   
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~-~~~~~~~~~~~~~---  260 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYP-SKSNQEVLEFVTS---  260 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSST-TCCHHHHHHHHHT---
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCC-CcCHHHHHHHHhc---
Confidence            999997543222   1233467889999999876 679999999999999999998 888873 2222222211110   


Q ss_pred             ChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcc
Q 013897          348 TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFF  422 (434)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~  422 (434)
                                               ...        ......+++.+.+||.+||..||.+|||+.|+++|.|+.
T Consensus       261 -------------------------~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          261 -------------------------GGR--------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             -------------------------TCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------------------------CCC--------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence                                     000        011223678899999999999999999999999998765

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=3.6e-42  Score=327.75  Aligned_cols=242  Identities=18%  Similarity=0.310  Sum_probs=192.6

Q ss_pred             CCCeEEEe-eeeecCceEEEEEEE--cCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCC
Q 013897          133 QDDYEVVR-KVGRGKYSEVFEGVH--CTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK  204 (434)
Q Consensus       133 ~~~y~~~~-~lG~G~fg~Vy~~~~--~~~~~~vaiK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  204 (434)
                      .++|.+.+ .||+|+||.||+|.+  ..+++.||||+++...     .+.+.+|+.+++.+ +||||+++++++.   ..
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~---~~   90 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICE---AE   90 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEEEEE---SS
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEC---CC
Confidence            46799988 999999999999954  4567899999997432     46788999999999 8999999999993   24


Q ss_pred             ccEEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC
Q 013897          205 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP  281 (434)
Q Consensus       205 ~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~  281 (434)
                      ..++||||+.+++|..++   ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus        91 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~  169 (291)
T 1xbb_A           91 SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH-YAKISDFGLSKALRA  169 (291)
T ss_dssp             SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCCTTCEECCT
T ss_pred             CcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCC-cEEEccCCcceeecc
Confidence            578999999999987765   3589999999999999999999999999999999999999776 899999999987654


Q ss_pred             CCcc----ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHh
Q 013897          282 GKEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN  356 (434)
Q Consensus       282 ~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~  356 (434)
                      ....    ....++..|+|||.+.+ ..++.++|||||||++|+|++ |+.||.. ....+....+..            
T Consensus       170 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~------------  235 (291)
T 1xbb_A          170 DENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEK------------  235 (291)
T ss_dssp             TCSEEEC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHT------------
T ss_pred             CCCcccccccCCCCceeeChHHhcc-CCCChhhhHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHc------------
Confidence            4322    22345678999999876 578899999999999999999 9999832 222221111110            


Q ss_pred             hccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          357 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                      ..+        ......+++++.++|.+||..||++||++.++++
T Consensus       236 ----------------~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          236 ----------------GER--------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             ----------------TCC--------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ----------------CCC--------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                            000        0112246789999999999999999999999985

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-42  Score=342.57  Aligned_cols=245  Identities=19%  Similarity=0.329  Sum_probs=185.4

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCC---eEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDN---EKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~---~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      ..|.+.+.||+|+||.||+|.+..++   ..||+|.++..    ..+.+.+|+.+++++ +||||+++++++.+. ....
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~-~~~~  166 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRS-EGSP  166 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTC-CCTTBCCCCEEECCC-SSCC
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcC-CCCe
Confidence            45889999999999999999875432   46899998642    346788999999999 899999999987543 3456


Q ss_pred             EEEEeecCCCchhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC
Q 013897          207 SLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG  282 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~  282 (434)
                      ++||||+.+++|..++.    .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus       167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-~~kL~DFG~a~~~~~~  245 (373)
T 3c1x_A          167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDK  245 (373)
T ss_dssp             EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCC---------
T ss_pred             EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCC-CEEEeecccccccccc
Confidence            89999999999987763    478888999999999999999999999999999999999776 8999999999765432


Q ss_pred             Cc-----cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhh
Q 013897          283 KE-----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK  357 (434)
Q Consensus       283 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  357 (434)
                      ..     .....++..|+|||++.+ ..++.++|||||||++|||++|..|++.+.+..+....+.+  +          
T Consensus       246 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~--~----------  312 (373)
T 3c1x_A          246 EFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--G----------  312 (373)
T ss_dssp             ------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHT--T----------
T ss_pred             ccccccccCCCCCcccccChHHhcC-CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHc--C----------
Confidence            21     123356778999999876 68999999999999999999954454444443332222111  0          


Q ss_pred             ccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                                      .+        ...+..+++.+.++|.+||..||++|||+.|++++
T Consensus       313 ----------------~~--------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          313 ----------------RR--------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             ----------------CC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------------CC--------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                            00        01122467889999999999999999999999874

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.2e-42  Score=332.18  Aligned_cols=261  Identities=19%  Similarity=0.356  Sum_probs=198.1

Q ss_pred             CCCeEEEeeeeecCceEEEEEEE----cCCCeEEEEEEecccc---HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVH----CTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT  205 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~----~~~~~~vaiK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  205 (434)
                      .++|++++.||+|+||.||+|.+    ..+++.||||++....   .+.+.+|+.+++.+ +||||+++++++.......
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~  118 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRRN  118 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTC-CCTTBCCEEEEECC----C
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEecCCCc
Confidence            46799999999999999999984    5678999999997543   35688999999999 8999999999987665567


Q ss_pred             cEEEEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC
Q 013897          206 PSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP  281 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~  281 (434)
                      .++||||+.+++|..++    ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus       119 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~-~~kL~Dfg~~~~~~~  197 (326)
T 2w1i_A          119 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN-RVKIGDFGLTKVLPQ  197 (326)
T ss_dssp             CEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT-EEEECCCTTCEECCS
T ss_pred             eEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCC-cEEEecCcchhhccc
Confidence            88999999999987765    3488999999999999999999999999999999999999776 899999999987654


Q ss_pred             CCcc----ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhh
Q 013897          282 GKEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK  357 (434)
Q Consensus       282 ~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  357 (434)
                      ....    ....++..|+|||.+.+ ..++.++|||||||++|+|++|..||...      .....+..+......... 
T Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~~~~~~------~~~~~~~~~~~~~~~~~~-  269 (326)
T 2w1i_A          198 DKEYYKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSP------PAEFMRMIGNDKQGQMIV-  269 (326)
T ss_dssp             SCSEEECSSCCSCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHHTTCGGGSH------HHHHHHHHCTTCCTHHHH-
T ss_pred             cccccccccCCCCceeEECchhhcC-CCCCchhhHHHHHHHHHHHHhcCCCCCCC------HHHHHHhhccccchhhhH-
Confidence            4321    23356678999999876 57889999999999999999999887311      111111111111000000 


Q ss_pred             ccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                            ..+...+....+.        .....+++++.+||.+||..||++|||+.|+++
T Consensus       270 ------~~~~~~~~~~~~~--------~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          270 ------FHLIELLKNNGRL--------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             ------HHHHHHHHTTCCC--------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ------HHHHHHhhcCCCC--------CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                  0011111111111        112347789999999999999999999999985

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=4.7e-42  Score=348.98  Aligned_cols=257  Identities=19%  Similarity=0.280  Sum_probs=200.0

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEe
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE  211 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  211 (434)
                      .++|+++++||+|+||.||+|.+..+++.||||+++.. ....+.+|+++++.+.++++++.+..++.+  ....+||||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~--~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVE--GDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEE--TTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEee--CCEEEEEEE
Confidence            47899999999999999999999999999999998643 345689999999999656777776666543  456789999


Q ss_pred             ecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEe---cCCCCeEEEEecccceecCCCCc
Q 013897          212 HVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGKE  284 (434)
Q Consensus       212 ~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll---~~~~~~vkl~DFGla~~~~~~~~  284 (434)
                      |+ +++|..++    ..+++..++.++.||+.||+|||++||+||||||+||||   +.++ .+||+|||+++.......
T Consensus        84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~-~vkL~DFGla~~~~~~~~  161 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKKYRDTST  161 (483)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTT-CEEECCCTTCEECBCTTT
T ss_pred             CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCC-eEEEEeCCcceeccCCcc
Confidence            99 77776664    368999999999999999999999999999999999999   4444 899999999987654332


Q ss_pred             --------cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCC--HHHHHHHHHHhCChhHHHH
Q 013897          285 --------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN--YDQLVKIAKVLGTDELNAY  354 (434)
Q Consensus       285 --------~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~--~~~~~~i~~~~g~~~~~~~  354 (434)
                              ....+||..|+|||++.+ ..++.++|||||||+||||++|+.||......  ...+..+....-.      
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~------  234 (483)
T 3sv0_A          162 HQHIPYRENKNLTGTARYASVNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA------  234 (483)
T ss_dssp             CCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH------
T ss_pred             ccccccccccccCCCccccCHHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc------
Confidence                    125679999999999887 68999999999999999999999998543221  1122222110000      


Q ss_pred             HhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc----------CCCcccc
Q 013897          355 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA----------HPYFFPI  424 (434)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~----------Hp~~~~~  424 (434)
                               .....                 ....+++++.+||.+||..||++||++.+|++          ++|+..+
T Consensus       235 ---------~~~~~-----------------l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~  288 (483)
T 3sv0_A          235 ---------TSIEA-----------------LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVF  288 (483)
T ss_dssp             ---------SCHHH-----------------HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCC
T ss_pred             ---------ccHHH-----------------HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCc
Confidence                     00000                 01236789999999999999999999987765          6776555


Q ss_pred             cc
Q 013897          425 RN  426 (434)
Q Consensus       425 ~~  426 (434)
                      ++
T Consensus       289 dW  290 (483)
T 3sv0_A          289 DW  290 (483)
T ss_dssp             HH
T ss_pred             Cc
Confidence            53

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.2e-42  Score=336.47  Aligned_cols=256  Identities=18%  Similarity=0.239  Sum_probs=197.5

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHh-cCCCCeeeEeeEEEccCC--CccEEEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNL-CGGPNIVKLLDIVRDQQS--KTPSLIF  210 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~E~~~l~~l-~~h~niv~l~~~~~~~~~--~~~~lv~  210 (434)
                      ++|.+.+.||+|+||.||+|.+  +++.||||+++......+.+|++++..+ .+||||+++++++.....  ...++||
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~  119 (342)
T 1b6c_B           42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS  119 (342)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEE
T ss_pred             ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEE
Confidence            6799999999999999999987  5899999999887778889999999883 389999999999976542  3678999


Q ss_pred             eecCCCchhhhc--CCCChHHHHHHHHHHHHHHHHHH--------HCCceeecCCCCceEecCCCCeEEEEecccceecC
Q 013897          211 EHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCH--------SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH  280 (434)
Q Consensus       211 e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH--------~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~  280 (434)
                      ||+.+++|..++  ..+++..+..++.||+.||.|||        +++|+||||||+|||++.++ .+||+|||++....
T Consensus       120 e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~~  198 (342)
T 1b6c_B          120 DYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVRHD  198 (342)
T ss_dssp             CCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTS-CEEECCCTTCEEEE
T ss_pred             eecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCC-CEEEEECCCceecc
Confidence            999999998776  35889999999999999999999        89999999999999999776 89999999997765


Q ss_pred             CCCc-----cceeccCCcccccccccCCCC-----CCccccHHHHHHHHHHHHhC----------CCCCCCCCCCHHHHH
Q 013897          281 PGKE-----YNVRVASRYFKGPELLVDLQD-----YDYSLDLWSLGCMFAGMIFR----------KEPFFYGHDNYDQLV  340 (434)
Q Consensus       281 ~~~~-----~~~~~~t~~y~aPE~~~~~~~-----~~~~~DvwSlGvil~elltg----------~~pf~~~~~~~~~~~  340 (434)
                      ....     .....|++.|+|||++.+...     ++.++|||||||++|||++|          ..||...........
T Consensus       199 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~  278 (342)
T 1b6c_B          199 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE  278 (342)
T ss_dssp             TTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred             ccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHH
Confidence            4432     244578999999999876322     23689999999999999999          778754322211111


Q ss_pred             HHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          341 KIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       341 ~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                      .+.+...                       ....+.....   ......+++.+.+||.+||+.||++|||+.|+++|
T Consensus       279 ~~~~~~~-----------------------~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          279 EMRKVVC-----------------------EQKLRPNIPN---RWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             HHHHHHT-----------------------TSCCCCCCCG---GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHH-----------------------HHHhCCCCcc---cccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            1111100                       0000000000   00011234679999999999999999999999976

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=4.5e-42  Score=324.83  Aligned_cols=240  Identities=16%  Similarity=0.325  Sum_probs=187.8

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEe
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE  211 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  211 (434)
                      .++|++.+.||+|+||.||+|.+  +++.||+|+++.. ..+.+.+|+.+++.+ +||||+++++++.+. ....++|||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~-~~~~~lv~e   95 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEE-KGGLYIVTE   95 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTC-CCTTBCCEEEEECCC---CCEEEEC
T ss_pred             hhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchhHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcC-CCceEEEEe
Confidence            47899999999999999999987  4889999999754 456789999999999 899999999987543 346789999


Q ss_pred             ecCCCchhhhcCC-----CChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCccc
Q 013897          212 HVNNTDFKVLYPT-----LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN  286 (434)
Q Consensus       212 ~~~~~~l~~~~~~-----l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~~  286 (434)
                      |+.+++|..++..     +++..+..++.||+.||+|||++||+||||||+||+++.++ .+||+|||++......  ..
T Consensus        96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~~~~~~--~~  172 (278)
T 1byg_A           96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASST--QD  172 (278)
T ss_dssp             CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS-CEEECCCCC-----------
T ss_pred             cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCC-cEEEeecccccccccc--cc
Confidence            9999998777642     78889999999999999999999999999999999999776 8999999999754322  23


Q ss_pred             eeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChh
Q 013897          287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH  365 (434)
Q Consensus       287 ~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~  365 (434)
                      ...++..|+|||++.+ ..++.++|||||||++|+|++ |+.||.. ....+....+..                     
T Consensus       173 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~-~~~~~~~~~~~~---------------------  229 (278)
T 1byg_A          173 TGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEK---------------------  229 (278)
T ss_dssp             ---CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTT-SCGGGHHHHHTT---------------------
T ss_pred             CCCccccccCHHHhCC-CCCCchhcHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhc---------------------
Confidence            3467888999999876 679999999999999999998 9988832 222221111100                     


Q ss_pred             HHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          366 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                            . .        .......+++.+.++|.+||..||++|||+.|+++
T Consensus       230 ------~-~--------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          230 ------G-Y--------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             ------T-C--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------C-C--------CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence                  0 0        01112346789999999999999999999999985

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3.3e-42  Score=355.49  Aligned_cols=249  Identities=18%  Similarity=0.322  Sum_probs=200.4

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF  210 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  210 (434)
                      .++|++.++||+|+||.||+|.+. .+..||||+++..  ..+.+.+|+.+|+++ +||||+++++++.+   ..++|||
T Consensus       266 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~---~~~~lv~  340 (535)
T 2h8h_A          266 RESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE---EPIYIVT  340 (535)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS---SSCEEEE
T ss_pred             hhhhhhheecccCCCeEEEEEEEC-CCceEEEEEeCCCCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEee---ccceEee
Confidence            467999999999999999999985 4577999999753  457899999999999 99999999999854   4578999


Q ss_pred             eecCCCchhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC--
Q 013897          211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--  283 (434)
Q Consensus       211 e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~--  283 (434)
                      ||+.+++|..++.     .+++.++..++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+++......  
T Consensus       341 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~~  419 (535)
T 2h8h_A          341 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYT  419 (535)
T ss_dssp             CCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCTTSTTTCCCHHHH
T ss_pred             ehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCC-cEEEcccccceecCCCcee
Confidence            9999999987764     388999999999999999999999999999999999999766 89999999997654221  


Q ss_pred             ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                      ......++..|+|||++.+ ..++.++|||||||+||||++ |+.|| .+....+.+..+...                 
T Consensus       420 ~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~t~g~~P~-~~~~~~~~~~~i~~~-----------------  480 (535)
T 2h8h_A          420 ARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVLDQVERG-----------------  480 (535)
T ss_dssp             TTCSTTSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTTCCSS-TTCCHHHHHHHHHTT-----------------
T ss_pred             cccCCcCcccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcC-----------------
Confidence            1122345678999999876 679999999999999999999 88887 333332222221100                 


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC--CCccccc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH--PYFFPIR  425 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H--p~~~~~~  425 (434)
                                 .        .......+++++.+||.+||+.||++|||++++++.  .++....
T Consensus       481 -----------~--------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~  526 (535)
T 2h8h_A          481 -----------Y--------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  526 (535)
T ss_dssp             -----------C--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred             -----------C--------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence                       0        011122467889999999999999999999999874  6766554

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1e-41  Score=356.99  Aligned_cols=242  Identities=18%  Similarity=0.339  Sum_probs=191.7

Q ss_pred             CCCeEEEe-eeeecCceEEEEEEEc--CCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCc
Q 013897          133 QDDYEVVR-KVGRGKYSEVFEGVHC--TDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT  205 (434)
Q Consensus       133 ~~~y~~~~-~lG~G~fg~Vy~~~~~--~~~~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  205 (434)
                      .+++.+.+ .||+|+||.||+|.+.  .++..||||+++..    ..+.+.+|+.+|+.+ +|||||++++++.+   ..
T Consensus       334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~---~~  409 (613)
T 2ozo_A          334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA---EA  409 (613)
T ss_dssp             TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTC-CCTTBCCEEEEEES---SS
T ss_pred             ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhC-CCCCEeeEEEEecc---CC
Confidence            45666666 8999999999999875  35578999999753    357799999999999 99999999999964   34


Q ss_pred             cEEEEeecCCCchhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC
Q 013897          206 PSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP  281 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~  281 (434)
                      +++||||+.+++|..++.    .+++..+..++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+++....
T Consensus       410 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~-~vkL~DFGla~~~~~  488 (613)
T 2ozo_A          410 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH-YAKISDFGLSKALGA  488 (613)
T ss_dssp             EEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCCSTTTTCC-
T ss_pred             eEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCC-cEEEeeccCcccccC
Confidence            789999999999987652    488999999999999999999999999999999999999776 899999999986643


Q ss_pred             CCcc----ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHh
Q 013897          282 GKEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN  356 (434)
Q Consensus       282 ~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~  356 (434)
                      ....    ....++..|+|||++.+ ..++.++|||||||++|||++ |+.||. +.+..+....+...           
T Consensus       489 ~~~~~~~~~~~~~~~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~-~~~~~~~~~~i~~~-----------  555 (613)
T 2ozo_A          489 DDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYK-KMKGPEVMAFIEQG-----------  555 (613)
T ss_dssp             -------------CCTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTT-TCCSHHHHHHHHTT-----------
T ss_pred             CCceeeeccCCCCccceeCHhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCC-CCCHHHHHHHHHcC-----------
Confidence            3221    12245578999999876 689999999999999999998 999983 33433333222110           


Q ss_pred             hccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          357 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                       .        .......+++++.+||.+||..||++||++.++++
T Consensus       556 -----------------~--------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          556 -----------------K--------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             -----------------C--------CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             -----------------C--------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                             0        01112247789999999999999999999998853

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=6.6e-43  Score=349.62  Aligned_cols=245  Identities=16%  Similarity=0.213  Sum_probs=182.6

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCC-CCee-------------
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGG-PNIV-------------  192 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h-~niv-------------  192 (434)
                      ...|...+.||+|+||.||+|.+..+++.||||+++..      ..+.+.+|+.+++.+ .| +|..             
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l-~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL-RGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGS-TTCCSHHHHHHHTCBCCCCE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhh-ccCCCHHHHHHhcccccchh
Confidence            35588999999999999999999999999999998732      246688999999988 44 3221             


Q ss_pred             --------eEeeEEEccC---CCccEEEEeecCCCchhhhcC----------CCChHHHHHHHHHHHHHHHHHHHCCcee
Q 013897          193 --------KLLDIVRDQQ---SKTPSLIFEHVNNTDFKVLYP----------TLSDYDVRYYIYELLKALDYCHSQGIMH  251 (434)
Q Consensus       193 --------~l~~~~~~~~---~~~~~lv~e~~~~~~l~~~~~----------~l~~~~~~~~~~qi~~~L~~LH~~~ivH  251 (434)
                              .+..++....   ....+++|+++ +++|..++.          .+++..+..++.||+.||+|||++||+|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH  234 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH  234 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence                    1111111111   23345666654 466655541          2566778888999999999999999999


Q ss_pred             ecCCCCceEecCCCCeEEEEecccceecCCCCccceeccCCccccccccc---------CCCCCCccccHHHHHHHHHHH
Q 013897          252 RDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV---------DLQDYDYSLDLWSLGCMFAGM  322 (434)
Q Consensus       252 rDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~---------~~~~~~~~~DvwSlGvil~el  322 (434)
                      |||||+|||++.++ .+||+|||+++....  .....+| +.|+|||++.         ....++.++|||||||++|||
T Consensus       235 rDiKp~NILl~~~~-~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el  310 (413)
T 3dzo_A          235 TYLRPVDIVLDQRG-GVFLTGFEHLVRDGA--SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI  310 (413)
T ss_dssp             SCCCGGGEEECTTC-CEEECCGGGCEETTE--EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred             CCcccceEEEecCC-eEEEEeccceeecCC--ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence            99999999999777 799999999976532  2455677 9999999983         325688899999999999999


Q ss_pred             HhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHcc
Q 013897          323 IFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLL  402 (434)
Q Consensus       323 ltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL  402 (434)
                      ++|+.||..... .+.                       ..                .  .......+++++.+||.+||
T Consensus       311 ltg~~Pf~~~~~-~~~-----------------------~~----------------~--~~~~~~~~~~~~~~li~~~l  348 (413)
T 3dzo_A          311 WCADLPNTDDAA-LGG-----------------------SE----------------W--IFRSCKNIPQPVRALLEGFL  348 (413)
T ss_dssp             HHSSCCCCTTGG-GSC-----------------------SG----------------G--GGSSCCCCCHHHHHHHHHHT
T ss_pred             HHCCCCCCCcch-hhh-----------------------HH----------------H--HHhhcccCCHHHHHHHHHHc
Confidence            999999832210 000                       00                0  00111246789999999999


Q ss_pred             ccCCCCCccHHHHhcCCCccccc
Q 013897          403 RYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       403 ~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                      +.||++|||+.|+|+||||+.+.
T Consensus       349 ~~dP~~Rpt~~~~l~~~~~~~~~  371 (413)
T 3dzo_A          349 RYPKEDRLLPLQAMETPEYEQLR  371 (413)
T ss_dssp             CSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             cCChhhCcCHHHHHhCHHHHHHH
Confidence            99999999999999999999775

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.9e-41  Score=356.00  Aligned_cols=240  Identities=18%  Similarity=0.310  Sum_probs=189.2

Q ss_pred             CeEE-EeeeeecCceEEEEEEEc--CCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          135 DYEV-VRKVGRGKYSEVFEGVHC--TDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       135 ~y~~-~~~lG~G~fg~Vy~~~~~--~~~~~vaiK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      .+.+ .+.||+|+||.||+|.+.  .+++.||||+++...     .+++.+|+.+|+++ +|||||++++++.+   ...
T Consensus       369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~---~~~  444 (635)
T 4fl3_A          369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICEA---ESW  444 (635)
T ss_dssp             GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHC-CCTTBCCEEEEEES---SSE
T ss_pred             hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEec---CCE
Confidence            3444 358999999999999653  456899999997532     46789999999999 89999999999954   346


Q ss_pred             EEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC
Q 013897          207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~  283 (434)
                      ++||||+.+++|..++   ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+......
T Consensus       445 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~-~~kL~DFGla~~~~~~~  523 (635)
T 4fl3_A          445 MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH-YAKISDFGLSKALRADE  523 (635)
T ss_dssp             EEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCTTHHHHTTC--
T ss_pred             EEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCC-CEEEEEcCCccccccCc
Confidence            8999999999997775   3589999999999999999999999999999999999999776 89999999998765433


Q ss_pred             c----cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhc
Q 013897          284 E----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY  358 (434)
Q Consensus       284 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  358 (434)
                      .    .....++..|+|||++.+ ..++.++|||||||++|||++ |+.||. +....+....+...             
T Consensus       524 ~~~~~~~~~~~t~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~-~~~~~~~~~~i~~~-------------  588 (635)
T 4fl3_A          524 NYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYR-GMKGSEVTAMLEKG-------------  588 (635)
T ss_dssp             -----------CGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSST-TCCHHHHHHHHHTT-------------
T ss_pred             cccccccCCCCceeeeChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHcC-------------
Confidence            2    123346678999999976 689999999999999999998 999983 33332222222110             


Q ss_pred             cccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                     .+        ......+++++.+||.+||..||++|||++++++
T Consensus       589 ---------------~~--------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          589 ---------------ER--------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             ---------------CC--------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ---------------CC--------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence                           00        1112246789999999999999999999999975

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=5.2e-42  Score=326.12  Aligned_cols=243  Identities=19%  Similarity=0.304  Sum_probs=186.1

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcC-CC--eEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCT-DN--EKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS  203 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~-~~--~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  203 (434)
                      .++|++.+.||+|+||.||+|.+.. ++  ..||||+++..      ..+.+.+|+.+++.+ +||||+++++++.+.  
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--   93 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLTP--   93 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSS--
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEEEccC--
Confidence            4789999999999999999998643 33  36899998643      246688999999999 899999999999653  


Q ss_pred             CccEEEEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceec
Q 013897          204 KTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY  279 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~  279 (434)
                       ..++|+||+.+++|..++    ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus        94 -~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~-~~kl~Dfg~~~~~  171 (291)
T 1u46_A           94 -PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD-LVKIGDFGLMRAL  171 (291)
T ss_dssp             -SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT-EEEECCCTTCEEC
T ss_pred             -CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCC-CEEEccccccccc
Confidence             367999999999987665    3588999999999999999999999999999999999999776 8999999999876


Q ss_pred             CCCCcc----ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHH
Q 013897          280 HPGKEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAY  354 (434)
Q Consensus       280 ~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~  354 (434)
                      ......    ....++..|+|||++.+ ..++.++|||||||++|+|++ |+.||. +.+..+....+..          
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~-~~~~~~~~~~~~~----------  239 (291)
T 1u46_A          172 PQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWI-GLNGSQILHKIDK----------  239 (291)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTT-TCCHHHHHHHHHT----------
T ss_pred             cccccchhhhccCCCCceeeCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcc-cCCHHHHHHHHHc----------
Confidence            543321    23456778999999876 678899999999999999999 998983 2222222221110          


Q ss_pred             HhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          355 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                       ...        .......+++++.++|.+||..||++|||+.++++
T Consensus       240 -----------------~~~--------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  277 (291)
T 1u46_A          240 -----------------EGE--------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  277 (291)
T ss_dssp             -----------------SCC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------------cCC--------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                             000        01112246789999999999999999999999997

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.6e-41  Score=325.55  Aligned_cols=252  Identities=19%  Similarity=0.289  Sum_probs=191.5

Q ss_pred             eEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       136 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      |...+.||+|+||.||+|.+  +++.||+|++...       ..+.+.+|+.+++.+ +||||+++++++.+.  ...++
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~--~~~~l  107 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC-QHENLVELLGFSSDG--DDLCL  107 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHC-CCTTBCCEEEEECSS--SSCEE
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhc-CCCCeEEEEEEEecC--CceEE
Confidence            44558899999999999985  6889999998642       246788999999999 999999999999654  56789


Q ss_pred             EEeecCCCchhhhc------CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC
Q 013897          209 IFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG  282 (434)
Q Consensus       209 v~e~~~~~~l~~~~------~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~  282 (434)
                      ||||+.+++|..++      ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++......
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~kl~Dfg~~~~~~~~  186 (307)
T 2nru_A          108 VYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAF-TAKISDFGLARASEKF  186 (307)
T ss_dssp             EEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCCTTCEECCSC
T ss_pred             EEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCC-cEEEeecccccccccc
Confidence            99999999987664      2488999999999999999999999999999999999999766 8999999999866433


Q ss_pred             Cc---cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcc
Q 013897          283 KE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH  359 (434)
Q Consensus       283 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  359 (434)
                      ..   .....|++.|+|||.+.+  .++.++|||||||++|+|++|..||...... ..+..+.+.....          
T Consensus       187 ~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~----------  253 (307)
T 2nru_A          187 AQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREP-QLLLDIKEEIEDE----------  253 (307)
T ss_dssp             SSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS-SBTTHHHHHHHTT----------
T ss_pred             cccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcch-HHHHHHHHHhhhh----------
Confidence            22   233478999999999865  5889999999999999999999998543222 1111111110000          


Q ss_pred             ccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          360 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                         ...+...+....         .......++.+.+++.+||..||++|||+.+++++
T Consensus       254 ---~~~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          254 ---EKTIEDYIDKKM---------NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             ---SCCHHHHSCSSC---------SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ---hhhhhhhccccc---------cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence               001111111000         00111245679999999999999999999999864

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=4.9e-42  Score=333.79  Aligned_cols=246  Identities=19%  Similarity=0.245  Sum_probs=185.7

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc-----------HHHHHHHHHHHHHhc--------CCCCeeeE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------KKKIKREIKILQNLC--------GGPNIVKL  194 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----------~~~~~~E~~~l~~l~--------~h~niv~l  194 (434)
                      ++|++++.||+|+||+||+|++  +++.||||+++...           .+.+.+|+.+++.+.        .||||+++
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             ccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            6688999999999999999997  68999999996432           267899999999985        48888888


Q ss_pred             eeEEEcc----------------------------CCCccEEEEeecCCCc-hhhhc-CCCChHHHHHHHHHHHHHHHHH
Q 013897          195 LDIVRDQ----------------------------QSKTPSLIFEHVNNTD-FKVLY-PTLSDYDVRYYIYELLKALDYC  244 (434)
Q Consensus       195 ~~~~~~~----------------------------~~~~~~lv~e~~~~~~-l~~~~-~~l~~~~~~~~~~qi~~~L~~L  244 (434)
                      .+++...                            ....+++||||+.+|+ +..+. ..+++..++.++.||+.||+||
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~l  177 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVA  177 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHHH
Confidence            7765311                            1467899999999885 44443 3578999999999999999999


Q ss_pred             H-HCCceeecCCCCceEecCCC-------------------CeEEEEecccceecCCCCccceeccCCcccccccccCCC
Q 013897          245 H-SQGIMHRDVKPHNVMIDHEQ-------------------RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ  304 (434)
Q Consensus       245 H-~~~ivHrDlKp~NIll~~~~-------------------~~vkl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~  304 (434)
                      | ++||+||||||+|||++.++                   ..+||+|||+|+....    ...+||+.|+|||++.+. 
T Consensus       178 H~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~----~~~~gt~~y~aPE~~~g~-  252 (336)
T 2vuw_A          178 EASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD----GIVVFCDVSMDEDLFTGD-  252 (336)
T ss_dssp             HHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET----TEEECCCCTTCSGGGCCC-
T ss_pred             HHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC----CcEEEeecccChhhhcCC-
Confidence            9 99999999999999998664                   2799999999987653    245899999999999863 


Q ss_pred             CCCccccHHHHHHH-HHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccc
Q 013897          305 DYDYSLDLWSLGCM-FAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFIT  383 (434)
Q Consensus       305 ~~~~~~DvwSlGvi-l~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (434)
                      . +.++||||||++ .+++++|..||.    .......+.+        ........             ...     ..
T Consensus       253 ~-~~~~Diwsl~~~~~~~~~~g~~p~~----~~~~~~~~~~--------~~~~~~~~-------------~~~-----~~  301 (336)
T 2vuw_A          253 G-DYQFDIYRLMKKENNNRWGEYHPYS----NVLWLHYLTD--------KMLKQMTF-------------KTK-----CN  301 (336)
T ss_dssp             S-SHHHHHHHHHHHHHTTCTTSCCTHH----HHHHHHHHHH--------HHHHTCCC-------------SSC-----CC
T ss_pred             C-ccceehhhhhCCCCcccccccCCCc----chhhhhHHHH--------hhhhhhcc-------------Ccc-----cc
Confidence            3 889999998776 777888998871    1000000000        00000000             000     00


Q ss_pred             cccccCCchHHHHHHHHccccCCCCCccHHHHh-cCCCcc
Q 013897          384 VENQHLAVPEAVDFLDKLLRYDHQERPTAKEAM-AHPYFF  422 (434)
Q Consensus       384 ~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL-~Hp~~~  422 (434)
                      ......+++++.+||.+||+.|     |++|+| +||||+
T Consensus       302 ~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          302 TPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             SHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred             hhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence            0011235788999999999987     999999 999995

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.3e-40  Score=348.90  Aligned_cols=242  Identities=23%  Similarity=0.421  Sum_probs=193.1

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCC---CeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTD---NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT  205 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~---~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  205 (434)
                      .++|++.+.||+|+||.||+|.+..+   +..||||.++...    .+.+.+|+.+++.+ +||||+++++++.+   ..
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~---~~  464 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVITE---NP  464 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS---SS
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEec---Cc
Confidence            47899999999999999999998643   4689999986432    36688999999999 99999999999843   35


Q ss_pred             cEEEEeecCCCchhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC
Q 013897          206 PSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP  281 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~  281 (434)
                      .++||||+.+++|..++.    .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus       465 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~-~vkL~DFG~a~~~~~  543 (656)
T 2j0j_A          465 VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYMED  543 (656)
T ss_dssp             CEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCCCCCCSCCC
T ss_pred             eEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCC-CEEEEecCCCeecCC
Confidence            789999999999987653    488899999999999999999999999999999999999776 899999999987644


Q ss_pred             CCcc--ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhc
Q 013897          282 GKEY--NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY  358 (434)
Q Consensus       282 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  358 (434)
                      ....  ....+++.|+|||++.+ ..++.++|||||||++|||++ |..|| .+....+.+..+...             
T Consensus       544 ~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ellt~g~~Pf-~~~~~~~~~~~i~~~-------------  608 (656)
T 2j0j_A          544 STYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPF-QGVKNNDVIGRIENG-------------  608 (656)
T ss_dssp             ----------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTT-TTCCHHHHHHHHHHT-------------
T ss_pred             CcceeccCCCCCcceeCHHHhcC-CCCCchhhHHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHHcC-------------
Confidence            3322  23456678999999876 689999999999999999997 88887 333333333222110             


Q ss_pred             cccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                     .+        ......+++.+.+||.+||..||++|||+.|+++
T Consensus       609 ---------------~~--------~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          609 ---------------ER--------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             ---------------CC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------CC--------CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                           00        0112246789999999999999999999999986

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=5.4e-41  Score=323.47  Aligned_cols=241  Identities=20%  Similarity=0.321  Sum_probs=188.5

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      .++|++.+.||+|+||.||+|.+..   .+|+|+++..     ..+.+.+|+.+++.+ +||||+++++++.+.  ...+
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~~  105 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQT-RHENVVLFMGACMSP--PHLA  105 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTC-CCTTBCCCCEEEECS--SCEE
T ss_pred             HHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcC-CCCCEeEEEEEEecC--CceE
Confidence            4789999999999999999999743   4999998642     235578899999999 999999999999754  4578


Q ss_pred             EEEeecCCCchhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC--
Q 013897          208 LIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP--  281 (434)
Q Consensus       208 lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~--  281 (434)
                      +||||+.+++|..++.    .+++..+..++.||+.||+|||++||+||||||+|||++ ++ .+||+|||++.....  
T Consensus       106 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~-~~~l~Dfg~~~~~~~~~  183 (319)
T 2y4i_B          106 IITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NG-KVVITDFGLFSISGVLQ  183 (319)
T ss_dssp             EECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC----CCEECCCSCCC------
T ss_pred             EEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CC-CEEEeecCCcccccccc
Confidence            9999999999988764    488999999999999999999999999999999999998 45 799999999865421  


Q ss_pred             ----CCccceeccCCcccccccccC--------CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCh
Q 013897          282 ----GKEYNVRVASRYFKGPELLVD--------LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTD  349 (434)
Q Consensus       282 ----~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~  349 (434)
                          ........|+..|+|||++.+        ...++.++|||||||++|+|++|+.||.. .........+..     
T Consensus       184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~-~~~~~~~~~~~~-----  257 (319)
T 2y4i_B          184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT-QPAEAIIWQMGT-----  257 (319)
T ss_dssp             ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSS-CCHHHHHHHHHT-----
T ss_pred             ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHhcc-----
Confidence                122334568899999999864        23578999999999999999999999842 222111111100     


Q ss_pred             hHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          350 ELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                            . ...       ......+++++.+||.+||..||++|||+.++++
T Consensus       258 ----------------------~-~~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  295 (319)
T 2y4i_B          258 ----------------------G-MKP-------NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD  295 (319)
T ss_dssp             ----------------------T-CCC-------CCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred             ----------------------C-CCC-------CCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                                  0 000       0011135678999999999999999999999987

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.6e-40  Score=352.69  Aligned_cols=239  Identities=21%  Similarity=0.278  Sum_probs=194.3

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcC-CCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCC---
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCT-DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK---  204 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~-~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~---  204 (434)
                      .++|++.+.||+|+||.||+|.+.. +++.||||++....    ...+.+|+.+++.+ +||||+++++++.+....   
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~~~  157 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEV-VHPSIVQIFNFVEHTDRHGDP  157 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEEECTTSCE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhc-CCCCcCeEeeeEeecCCCCCc
Confidence            3789999999999999999999975 78999999986432    34678999999999 899999999999765431   


Q ss_pred             ccEEEEeecCCCchhhhc-CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC
Q 013897          205 TPSLIFEHVNNTDFKVLY-PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       205 ~~~lv~e~~~~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~  283 (434)
                      ..+|||||+.+++|.... ..+++.++..++.||+.||.|||++||+||||||+|||++.+  .+||+|||+++..... 
T Consensus       158 ~~~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~--~~kl~DFG~a~~~~~~-  234 (681)
T 2pzi_A          158 VGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE--QLKLIDLGAVSRINSF-  234 (681)
T ss_dssp             EEEEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS--CEEECCCTTCEETTCC-
T ss_pred             eeEEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC--cEEEEecccchhcccC-
Confidence            258999999999997665 368999999999999999999999999999999999999854  7999999999876533 


Q ss_pred             ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                        ...+||+.|+|||++.+  .++.++|||||||++|+|++|..||......                         .+.
T Consensus       235 --~~~~gt~~y~aPE~~~~--~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~-------------------------~~~  285 (681)
T 2pzi_A          235 --GYLYGTPGFQAPEIVRT--GPTVATDIYTVGRTLAALTLDLPTRNGRYVD-------------------------GLP  285 (681)
T ss_dssp             --SCCCCCTTTSCTTHHHH--CSCHHHHHHHHHHHHHHHHSCCCEETTEECS-------------------------SCC
T ss_pred             --CccCCCccccCHHHHcC--CCCCceehhhhHHHHHHHHhCCCCCcccccc-------------------------ccc
Confidence              45679999999999875  4589999999999999999998877311000                         000


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP  423 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~  423 (434)
                      .                   .......++.+.+||.+||+.||++||+..+.|.|+|+.-
T Consensus       286 ~-------------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          286 E-------------------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             T-------------------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             c-------------------cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence            0                   0000013467899999999999999999999999988764

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=7.2e-39  Score=304.64  Aligned_cols=221  Identities=13%  Similarity=0.120  Sum_probs=174.4

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      ++|++.+.||+|+||.||+|.+..+++.||||+++...      ...+.+|+.++..+ +||||+++++++.+.  ...+
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~--~~~~  107 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKPGVARVLDVVHTR--AGGL  107 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEET--TEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcC-CCCCcceeeEEEEEC--CcEE
Confidence            67999999999999999999998889999999997532      26688999999998 999999999999764  5678


Q ss_pred             EEEeecCCCchhhhcCC-CChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCccc
Q 013897          208 LIFEHVNNTDFKVLYPT-LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN  286 (434)
Q Consensus       208 lv~e~~~~~~l~~~~~~-l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~~  286 (434)
                      +||||+.+++|..++.. ....++..++.||+.||+|||++||+||||||+|||++.++ .+||+++|            
T Consensus       108 lv~e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g-~~kl~~~~------------  174 (286)
T 3uqc_A          108 VVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDG-DVVLAYPA------------  174 (286)
T ss_dssp             EEEECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTS-CEEECSCC------------
T ss_pred             EEEEecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCC-CEEEEecc------------
Confidence            99999999999877643 56677889999999999999999999999999999999776 78987543            


Q ss_pred             eeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhH
Q 013897          287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL  366 (434)
Q Consensus       287 ~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~  366 (434)
                             |++        .++.++|||||||++|||++|+.||...... ..+..            ..           
T Consensus       175 -------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~-~~~~~------------~~-----------  215 (286)
T 3uqc_A          175 -------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVR-SGLAP------------AE-----------  215 (286)
T ss_dssp             -------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBC-CCSEE------------CC-----------
T ss_pred             -------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcc-hhhHH------------HH-----------
Confidence                   222        3678999999999999999999998432211 00000            00           


Q ss_pred             HHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          367 AALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                           ........  ........+++++.+||.+||+.||++| |+.|+++
T Consensus       216 -----~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~  258 (286)
T 3uqc_A          216 -----RDTAGQPI--EPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN  258 (286)
T ss_dssp             -----BCTTSCBC--CHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred             -----HHhccCCC--ChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence                 00000000  0001123477899999999999999999 9999987

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.98  E-value=1.2e-34  Score=300.21  Aligned_cols=185  Identities=20%  Similarity=0.155  Sum_probs=129.9

Q ss_pred             eeeeecCceEEEEEEEcCCCeEEEEEEeccc-------------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-------------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       140 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-------------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      ..++.|++|.+..++....|+.+|+|++...             ..+++.+|+++|+++..|+||+++++++++.  ..+
T Consensus       240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~--~~~  317 (569)
T 4azs_A          240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENA--QSG  317 (569)
T ss_dssp             CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECS--SEE
T ss_pred             hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEEC--CEE
Confidence            3467788888877776678999999998532             2356899999999998899999999999754  567


Q ss_pred             EEEEeecCCCchhhhcCCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC-Ccc
Q 013897          207 SLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEY  285 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~-~~~  285 (434)
                      ||||||++|++|.+++..........|+.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+..... ...
T Consensus       318 yLVMEyv~G~~L~d~i~~~~~l~~~~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg-~vKL~DFGlAr~~~~~~~~~  396 (569)
T 4azs_A          318 WLVMEKLPGRLLSDMLAAGEEIDREKILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQ-HARLIDFGSIVTTPQDCSWP  396 (569)
T ss_dssp             EEEEECCCSEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTS-CEEECCCTTEESCC---CCS
T ss_pred             EEEEecCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHCCceeccCchHhEEECCCC-CEEEeecccCeeCCCCCccc
Confidence            89999999999988875433333456899999999999999999999999999999777 8999999999876543 334


Q ss_pred             ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCC
Q 013897          286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF  329 (434)
Q Consensus       286 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf  329 (434)
                      ...+||+.|+|||++.+  .+..++|+||+|+++++|.++..++
T Consensus       397 ~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          397 TNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             HHHHHHHHHHHHHHC-------------------CCCCTTHHHH
T ss_pred             cCceechhhccHHHhCC--CCCCcccccccccchhhhccccchh
Confidence            56789999999999875  5677899999999988876665443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=2.9e-28  Score=251.00  Aligned_cols=180  Identities=17%  Similarity=0.214  Sum_probs=139.5

Q ss_pred             EEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc-----------HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCc
Q 013897          137 EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT  205 (434)
Q Consensus       137 ~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  205 (434)
                      ...+.||+|+||.||+|.  ..+..+++|......           .+.+.+|+.+++++ +||||+++..++...  ..
T Consensus       339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~--~~  413 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALV-KDFGIPAPYIFDVDL--DN  413 (540)
T ss_dssp             ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHG-GGGTCCCCCEEEEET--TT
T ss_pred             CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhc-CCCCcCceEEEEEeC--Cc
Confidence            345789999999999995  457888888764321           24478999999999 999999555544433  34


Q ss_pred             cEEEEeecCCCchhhhcCCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc-
Q 013897          206 PSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-  284 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~-  284 (434)
                      .++||||+++++|..++..     +..++.||+.||+|||++||+||||||+|||++.   .+||+|||+|+....... 
T Consensus       414 ~~lVmE~~~ggsL~~~l~~-----~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~---~~kL~DFGla~~~~~~~~~  485 (540)
T 3en9_A          414 KRIMMSYINGKLAKDVIED-----NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK---DLYIIDFGLGKISNLDEDK  485 (540)
T ss_dssp             TEEEEECCCSEEHHHHSTT-----CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS---SEEECCCTTCEECCCHHHH
T ss_pred             cEEEEECCCCCCHHHHHHH-----HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC---eEEEEECccCEECCCcccc
Confidence            5899999999999888766     6689999999999999999999999999999996   799999999988754322 


Q ss_pred             -------cceeccCCcccccccccC-CCCCCccccHHHHHHHHHHHHhCCCCC
Q 013897          285 -------YNVRVASRYFKGPELLVD-LQDYDYSLDLWSLGCMFAGMIFRKEPF  329 (434)
Q Consensus       285 -------~~~~~~t~~y~aPE~~~~-~~~~~~~~DvwSlGvil~elltg~~pf  329 (434)
                             ....+||++|+|||++.. ...|+..+|+|+..+-..+.+.++.+|
T Consensus       486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence                   135689999999999864 135788899999999888888777666

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=3.1e-25  Score=209.98  Aligned_cols=143  Identities=18%  Similarity=0.246  Sum_probs=116.8

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc---------------------cHHHHHHHHHHHHHhcCCCCe
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---------------------KKKKIKREIKILQNLCGGPNI  191 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~---------------------~~~~~~~E~~~l~~l~~h~ni  191 (434)
                      ...|.+.+.||+|+||.||+|.+ .+++.||||+++..                     ....+.+|+.+++.+ +  | 
T Consensus        89 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l-~--~-  163 (282)
T 1zar_A           89 GKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-Q--G-  163 (282)
T ss_dssp             TSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-T--T-
T ss_pred             CeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc-c--C-
Confidence            34567789999999999999999 88999999999632                     234588999999999 4  4 


Q ss_pred             eeEeeEEEccCCCccEEEEeecCCCchhhhcCCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEE
Q 013897          192 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLI  271 (434)
Q Consensus       192 v~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~  271 (434)
                      +++.+++..   ...++||||+++++|..+    .......++.||+.||.|||++||+||||||+|||++ ++ .+||+
T Consensus       164 ~~v~~~~~~---~~~~lvmE~~~g~~L~~l----~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~-~vkl~  234 (282)
T 1zar_A          164 LAVPKVYAW---EGNAVLMELIDAKELYRV----RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EE-GIWII  234 (282)
T ss_dssp             SSSCCEEEE---ETTEEEEECCCCEEGGGC----CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TT-EEEEC
T ss_pred             CCcCeEEec---cceEEEEEecCCCcHHHc----chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CC-cEEEE
Confidence            566665533   345899999999999873    2245667999999999999999999999999999999 66 89999


Q ss_pred             ecccceecCCCCccceeccCCccccccccc
Q 013897          272 DWGLAEFYHPGKEYNVRVASRYFKGPELLV  301 (434)
Q Consensus       272 DFGla~~~~~~~~~~~~~~t~~y~aPE~~~  301 (434)
                      |||+|+..            ..++|||++.
T Consensus       235 DFG~a~~~------------~~~~a~e~l~  252 (282)
T 1zar_A          235 DFPQSVEV------------GEEGWREILE  252 (282)
T ss_dssp             CCTTCEET------------TSTTHHHHHH
T ss_pred             ECCCCeEC------------CCCCHHHHHH
Confidence            99999643            3467888874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.87  E-value=3.7e-22  Score=186.41  Aligned_cols=135  Identities=18%  Similarity=0.199  Sum_probs=107.4

Q ss_pred             CeEEEeeeeecCceEEEEEEEcCCCeE--EEEEEecccc---------------------------HHHHHHHHHHHHHh
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCTDNEK--CIIKILKPVK---------------------------KKKIKREIKILQNL  185 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~--vaiK~~~~~~---------------------------~~~~~~E~~~l~~l  185 (434)
                      -|++.+.||+|+||.||+|.+..+|+.  ||||+++...                           ...+.+|+.+|..+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            478999999999999999998778888  9999875321                           12578999999999


Q ss_pred             cCCCCe--eeEeeEEEccCCCccEEEEeecCC-C----chhhhcCCCChHHHHHHHHHHHHHHHHHH-HCCceeecCCCC
Q 013897          186 CGGPNI--VKLLDIVRDQQSKTPSLIFEHVNN-T----DFKVLYPTLSDYDVRYYIYELLKALDYCH-SQGIMHRDVKPH  257 (434)
Q Consensus       186 ~~h~ni--v~l~~~~~~~~~~~~~lv~e~~~~-~----~l~~~~~~l~~~~~~~~~~qi~~~L~~LH-~~~ivHrDlKp~  257 (434)
                       .|+++  +.+++.      ...+|||||+++ |    .|.......++..+..++.||+.||.||| ++||+||||||+
T Consensus       128 -~~~~i~~p~~~~~------~~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~  200 (258)
T 1zth_A          128 -KEAGVSVPQPYTY------MKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEAELVHADLSEY  200 (258)
T ss_dssp             -HHTTCCCCCEEEE------ETTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTT
T ss_pred             -HhCCCCCCeEEEc------CCCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH
Confidence             66643  444442      245799999953 3    55555434445678899999999999999 999999999999


Q ss_pred             ceEecCCCCeEEEEecccceec
Q 013897          258 NVMIDHEQRKLRLIDWGLAEFY  279 (434)
Q Consensus       258 NIll~~~~~~vkl~DFGla~~~  279 (434)
                      |||++.   .++|+|||+|...
T Consensus       201 NILl~~---~~~liDFG~a~~~  219 (258)
T 1zth_A          201 NIMYID---KVYFIDMGQAVTL  219 (258)
T ss_dssp             SEEESS---SEEECCCTTCEET
T ss_pred             HEEEcC---cEEEEECcccccC
Confidence            999985   6999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.75  E-value=3.2e-18  Score=166.83  Aligned_cols=135  Identities=16%  Similarity=0.232  Sum_probs=101.0

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc-----------------HH--------HHHHHHHHHHHhcCC
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------------KK--------KIKREIKILQNLCGG  188 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----------------~~--------~~~~E~~~l~~l~~h  188 (434)
                      .-|.+.+.||+|+||.||+|.+ .+|+.||||+++...                 ..        ...+|...|.++ .+
T Consensus        95 ~iY~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL-~~  172 (397)
T 4gyi_A           95 DVYSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL-YE  172 (397)
T ss_dssp             SCSEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH-HH
T ss_pred             CEEEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH-Hh
Confidence            3489999999999999999987 578999999975310                 00        124577777777 33


Q ss_pred             CCe--eeEeeEEEccCCCccEEEEeecCCCchhhhcCCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCC
Q 013897          189 PNI--VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR  266 (434)
Q Consensus       189 ~ni--v~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~  266 (434)
                      .++  ...++..      ..+|||||+.+..+..+..   ......++.||+.+|.+||++|||||||||.|||++.++.
T Consensus       173 ~gv~vp~p~~~~------~~~LVME~i~G~~L~~l~~---~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd  243 (397)
T 4gyi_A          173 EGFPVPEPIAQS------RHTIVMSLVDALPMRQVSS---VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKD  243 (397)
T ss_dssp             TTCSCCCEEEEE------TTEEEEECCSCEEGGGCCC---CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEEC
T ss_pred             cCCCCCeeeecc------CceEEEEecCCccHhhhcc---cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCC
Confidence            333  2333321      2369999999988866542   2355678899999999999999999999999999986541


Q ss_pred             ---------eEEEEecccceec
Q 013897          267 ---------KLRLIDWGLAEFY  279 (434)
Q Consensus       267 ---------~vkl~DFGla~~~  279 (434)
                               .+.|+||+-+...
T Consensus       244 ~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          244 AEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             SSCTTSEEEEEEECCCTTCEET
T ss_pred             cccccccccceEEEEeCCcccC
Confidence                     3899999987543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.46  E-value=3.9e-13  Score=125.06  Aligned_cols=138  Identities=18%  Similarity=0.241  Sum_probs=111.2

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecc---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF  210 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  210 (434)
                      +.|.+...+|.|+.+.||++..  .+..+++|+...   .....+.+|+.+++.+..+..++++++++.+.  ...++||
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~~lv~   89 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHD--GWSNLLM   89 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEEEE
T ss_pred             ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecC--CceEEEE
Confidence            4588889999999999999974  468999999865   34457899999999996678889999988653  5678999


Q ss_pred             eecCCCchhhhcCCCChHHHHHHHHHHHHHHHHHHH--------------------------------------------
Q 013897          211 EHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHS--------------------------------------------  246 (434)
Q Consensus       211 e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~--------------------------------------------  246 (434)
                      ||++|.++......  ......++.+++.+|..||+                                            
T Consensus        90 e~i~G~~l~~~~~~--~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (263)
T 3tm0_A           90 SEADGVLCSEEYED--EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP  167 (263)
T ss_dssp             ECCSSEEHHHHCCT--TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSH
T ss_pred             EecCCeehhhccCC--cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCH
Confidence            99999998765322  23445788899999999998                                            


Q ss_pred             ---------------CCceeecCCCCceEecCCCCeEEEEeccccee
Q 013897          247 ---------------QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF  278 (434)
Q Consensus       247 ---------------~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~  278 (434)
                                     ..++|+|++|.|||++. +..+.|+||+.+..
T Consensus       168 ~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~-~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKD-GKVSGFIDLGRSGR  213 (263)
T ss_dssp             HHHHHHHHHCCCCCCEEEECSSCCTTSEEEET-TEEEEECCCTTCEE
T ss_pred             HHHHHHHHhcCCCCCceEECCCCCcCcEEEEC-CcEEEEEEchhccc
Confidence                           34899999999999984 43567999998753

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.36  E-value=2.6e-12  Score=118.88  Aligned_cols=136  Identities=17%  Similarity=0.159  Sum_probs=100.3

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCC-CeeeEeeEEEccCCCccEEEEee
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGP-NIVKLLDIVRDQQSKTPSLIFEH  212 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~E~~~l~~l~~h~-niv~l~~~~~~~~~~~~~lv~e~  212 (434)
                      ..|.+....+.|..+.||++.. .+|..+++|+........+.+|+.+++.+..+. .+++++++..+.  ...++||||
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~--~~~~~v~e~   96 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEA--GRDWLLLGE   96 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECS--SCEEEEEEC
T ss_pred             CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccCC--CCCEEEEEe
Confidence            3455544444666699999964 567789999987654567889999999995552 266788877543  456899999


Q ss_pred             cCCCchhhhcCCCChHHHHHHHHHHHHHHHHHHHCC--------------------------------------------
Q 013897          213 VNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQG--------------------------------------------  248 (434)
Q Consensus       213 ~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~--------------------------------------------  248 (434)
                      ++|..+.  .....   ...++.+++..|..||+..                                            
T Consensus        97 i~G~~l~--~~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (264)
T 1nd4_A           97 VPGQDLL--SSHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF  171 (264)
T ss_dssp             CSSEETT--TSCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred             cCCcccC--cCcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHH
Confidence            9999884  22222   2356777888888888643                                            


Q ss_pred             --------------ceeecCCCCceEecCCCCeEEEEeccccee
Q 013897          249 --------------IMHRDVKPHNVMIDHEQRKLRLIDWGLAEF  278 (434)
Q Consensus       249 --------------ivHrDlKp~NIll~~~~~~vkl~DFGla~~  278 (434)
                                    ++|+|++|.|||++.++ .+.|+|||.+..
T Consensus       172 ~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~~liD~~~a~~  214 (264)
T 1nd4_A          172 ARLKARMPDGEDLVVTHGDACLPNIMVENGR-FSGFIDCGRLGV  214 (264)
T ss_dssp             HHHHHTCCSSCCEEEECSSCCGGGEEEETTE-EEEECCCTTCEE
T ss_pred             HHHHHhcCCCCCeEEECCCCCCCcEEEECCc-EEEEEcchhccc
Confidence                          99999999999998543 567999999854

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.28  E-value=2.4e-11  Score=118.32  Aligned_cols=141  Identities=21%  Similarity=0.352  Sum_probs=108.4

Q ss_pred             EEeeeeecCceEEEEEEEcCCCeEEEEEEec--ccc----HHHHHHHHHHHHHhcC-CCCeeeEeeEEEccCC-CccEEE
Q 013897          138 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVK----KKKIKREIKILQNLCG-GPNIVKLLDIVRDQQS-KTPSLI  209 (434)
Q Consensus       138 ~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~--~~~----~~~~~~E~~~l~~l~~-h~niv~l~~~~~~~~~-~~~~lv  209 (434)
                      .++.|+.|.++.||+...  .+..+++|+..  ...    ...+.+|+.+++.|.. +..+++++.++.+... ...++|
T Consensus        42 ~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v  119 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI  119 (359)
T ss_dssp             EEEECCC-CCSCEEEEEC--SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred             eEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence            467799999999999875  34678899876  322    3568899999999943 4568899998865421 346899


Q ss_pred             EeecCCCchh-hhcCCCChHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 013897          210 FEHVNNTDFK-VLYPTLSDYDVRYYIYELLKALDYCHS------------------------------------------  246 (434)
Q Consensus       210 ~e~~~~~~l~-~~~~~l~~~~~~~~~~qi~~~L~~LH~------------------------------------------  246 (434)
                      |||++|..+. .....++..+...++.+++..|..||+                                          
T Consensus       120 me~v~G~~l~~~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  199 (359)
T 3dxp_A          120 MEFVSGRVLWDQSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDS  199 (359)
T ss_dssp             EECCCCBCCCCTTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHH
T ss_pred             EEecCCeecCCCccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHH
Confidence            9999998874 344567888888999999999999997                                          


Q ss_pred             ----------------CCceeecCCCCceEecCCCC-eEEEEecccceecC
Q 013897          247 ----------------QGIMHRDVKPHNVMIDHEQR-KLRLIDWGLAEFYH  280 (434)
Q Consensus       247 ----------------~~ivHrDlKp~NIll~~~~~-~vkl~DFGla~~~~  280 (434)
                                      ..++|+|+++.|||++.++. .+.|+||+.+....
T Consensus       200 ~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g~  250 (359)
T 3dxp_A          200 LMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLGH  250 (359)
T ss_dssp             HHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEEC
T ss_pred             HHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccCC
Confidence                            35899999999999986652 46999999997543

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.19  E-value=2.1e-11  Score=116.04  Aligned_cols=186  Identities=17%  Similarity=0.253  Sum_probs=123.4

Q ss_pred             EeeeeecCceEEEEEEEcCCCeEEEEEEeccc-cHHHHHHHHHHHHHhcCCCC--eeeEeeEEEccCC-CccEEEEeecC
Q 013897          139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPN--IVKLLDIVRDQQS-KTPSLIFEHVN  214 (434)
Q Consensus       139 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~E~~~l~~l~~h~n--iv~l~~~~~~~~~-~~~~lv~e~~~  214 (434)
                      ++.++.|....||++.     ..+++|+.... ....+.+|..+|+.+..+..  +++++........ ...++||++++
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~   99 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK   99 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence            3458999999999863     45888986543 34678999999999844433  4455554332221 24578999999


Q ss_pred             CCchhh-hcCCCChHHHHHHHHHHHHHHHHHHH-----------------------------------------------
Q 013897          215 NTDFKV-LYPTLSDYDVRYYIYELLKALDYCHS-----------------------------------------------  246 (434)
Q Consensus       215 ~~~l~~-~~~~l~~~~~~~~~~qi~~~L~~LH~-----------------------------------------------  246 (434)
                      |..+.. ....++..+...++.+++..|..||+                                               
T Consensus       100 G~~l~~~~~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  179 (304)
T 3sg8_A          100 GVPLTPLLLNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRD  179 (304)
T ss_dssp             CEECCHHHHHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHH
T ss_pred             CeECCccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHH
Confidence            988753 34567778888888888888888886                                               


Q ss_pred             -----------CCceeecCCCCceEecCC-CCeEEEEecccceecCCCCccceeccCCcccccccc----cCCC------
Q 013897          247 -----------QGIMHRDVKPHNVMIDHE-QRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL----VDLQ------  304 (434)
Q Consensus       247 -----------~~ivHrDlKp~NIll~~~-~~~vkl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~----~~~~------  304 (434)
                                 ..++|+|++|.||+++.+ +..+.|+||+.+....+............-..|+..    ..+.      
T Consensus       180 ~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~  259 (304)
T 3sg8_A          180 ILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPT  259 (304)
T ss_dssp             HHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHH
T ss_pred             HHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHH
Confidence                       136999999999999964 446889999998765432111100000000112111    0000      


Q ss_pred             ---CCCccccHHHHHHHHHHHHhCCCCC
Q 013897          305 ---DYDYSLDLWSLGCMFAGMIFRKEPF  329 (434)
Q Consensus       305 ---~~~~~~DvwSlGvil~elltg~~pf  329 (434)
                         ......+.|++|.+++.+.+|..+|
T Consensus       260 ~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          260 VLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence               1122368999999999999998776

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.81  E-value=6.6e-08  Score=91.82  Aligned_cols=136  Identities=18%  Similarity=0.258  Sum_probs=96.5

Q ss_pred             EeeeeecCceEEEEEEEcCCCeEEEEEEeccc-cHHHHHHHHHHHHHhcCCC--CeeeEeeEEEccCCCccEEEEeecCC
Q 013897          139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGP--NIVKLLDIVRDQQSKTPSLIFEHVNN  215 (434)
Q Consensus       139 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~E~~~l~~l~~h~--niv~l~~~~~~~~~~~~~lv~e~~~~  215 (434)
                      ++.++.|....||+.     +..+++|+-... ....+.+|..+|+.|..+-  .+.+.+.+... .....++||||++|
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~-~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR-SDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC-TTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc-CCCceEEEEeccCC
Confidence            455889999999987     466888885432 3467889999999995442  35677776642 23456799999999


Q ss_pred             Cchhh-hcCCCChHHHHHHHHHHHHHHHHHHHC-----------------------------------------------
Q 013897          216 TDFKV-LYPTLSDYDVRYYIYELLKALDYCHSQ-----------------------------------------------  247 (434)
Q Consensus       216 ~~l~~-~~~~l~~~~~~~~~~qi~~~L~~LH~~-----------------------------------------------  247 (434)
                      ..+.. ....++..+...++.++...|..||+.                                               
T Consensus        98 ~~l~~~~~~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~  177 (306)
T 3tdw_A           98 QILGEDGMAVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQ  177 (306)
T ss_dssp             EECHHHHHTTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHH
T ss_pred             eECchhhhhhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHH
Confidence            88764 234455555566666666666666642                                               


Q ss_pred             -------------CceeecCCCCceEecC---CCCeEEEEecccceecC
Q 013897          248 -------------GIMHRDVKPHNVMIDH---EQRKLRLIDWGLAEFYH  280 (434)
Q Consensus       248 -------------~ivHrDlKp~NIll~~---~~~~vkl~DFGla~~~~  280 (434)
                                   .++|+|+++.|||++.   ++..+.|+||+.+....
T Consensus       178 ~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd  226 (306)
T 3tdw_A          178 SYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD  226 (306)
T ss_dssp             HHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred             HHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence                         3599999999999986   35345899999987543

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.76  E-value=5.6e-08  Score=90.29  Aligned_cols=134  Identities=14%  Similarity=0.112  Sum_probs=96.9

Q ss_pred             eeeecCce-EEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeecCCCchh
Q 013897          141 KVGRGKYS-EVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK  219 (434)
Q Consensus       141 ~lG~G~fg-~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~  219 (434)
                      .+..|..| .||+.....++..+++|+-.......+.+|..+|+.|..+--+.++++++.+.  ...++|||++++..+.
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~--~~~~lvme~l~G~~~~  108 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTP--DDAWLLTTAIPGKTAF  108 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEEEEECCCSEEHH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEEC--CeEEEEEEeeCCcccc
Confidence            45556665 69998776677889999987776778899999999996665678888888765  4567999999998765


Q ss_pred             hhcCCCChHHHHHHHHHHHHHHHHHHHC----------------------------------------------------
Q 013897          220 VLYPTLSDYDVRYYIYELLKALDYCHSQ----------------------------------------------------  247 (434)
Q Consensus       220 ~~~~~l~~~~~~~~~~qi~~~L~~LH~~----------------------------------------------------  247 (434)
                      ...... ......+..++...|.-||..                                                    
T Consensus       109 ~~~~~~-~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  187 (272)
T 4gkh_A          109 QVLEEY-PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLL  187 (272)
T ss_dssp             HHHHHC-GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTC
T ss_pred             ccccCC-HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcc
Confidence            443221 222334445555555555531                                                    


Q ss_pred             ------CceeecCCCCceEecCCCCeEEEEeccccee
Q 013897          248 ------GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF  278 (434)
Q Consensus       248 ------~ivHrDlKp~NIll~~~~~~vkl~DFGla~~  278 (434)
                            .++|+|+.+.|||++.++ .+-|+||+.+..
T Consensus       188 ~~~~~~~l~HGDl~~~Nil~~~~~-~~~viDwe~a~~  223 (272)
T 4gkh_A          188 PFSPDSVVTHGDFSLDNLIFDEGK-LIGCIDVGRVGI  223 (272)
T ss_dssp             CCCCCEEEECSCCCTTSEEEETTE-EEEECCCTTCEE
T ss_pred             cccCCcEEEcCCCCCCeEEEECCe-EEEEEECccccc
Confidence                  168999999999998543 567999999864

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.53  E-value=3.4e-07  Score=88.60  Aligned_cols=83  Identities=12%  Similarity=0.108  Sum_probs=59.0

Q ss_pred             EEEeee-eecCceEEEEEEEc--C----CCeEEEEEEecccc------HHHHHHHHHHHHHhcCC--CCeeeEeeEEEcc
Q 013897          137 EVVRKV-GRGKYSEVFEGVHC--T----DNEKCIIKILKPVK------KKKIKREIKILQNLCGG--PNIVKLLDIVRDQ  201 (434)
Q Consensus       137 ~~~~~l-G~G~fg~Vy~~~~~--~----~~~~vaiK~~~~~~------~~~~~~E~~~l~~l~~h--~niv~l~~~~~~~  201 (434)
                      ...+.| +.|....+|+....  .    ++..+++|+.....      ...+.+|+.+++.|..+  -.+.+++.++.+.
T Consensus        23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~  102 (357)
T 3ats_A           23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG  102 (357)
T ss_dssp             EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred             EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence            345778 88999999988652  0    26789999875432      25688999999998654  4578888887543


Q ss_pred             CC-CccEEEEeecCCCchh
Q 013897          202 QS-KTPSLIFEHVNNTDFK  219 (434)
Q Consensus       202 ~~-~~~~lv~e~~~~~~l~  219 (434)
                      .. ...++||||++|..+.
T Consensus       103 ~~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          103 DVLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TTTSSCEEEEECCCCBCCC
T ss_pred             CccCCceEEEEecCCCChh
Confidence            21 2457999999987653

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.34  E-value=2.5e-06  Score=83.85  Aligned_cols=75  Identities=16%  Similarity=0.215  Sum_probs=50.4

Q ss_pred             EEeeeeecCceEEEEEEEcCCCeEEEEEEeccc----------cHHHHHHHHHHHHHhcCC-C-CeeeEeeEEEccCCCc
Q 013897          138 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----------KKKKIKREIKILQNLCGG-P-NIVKLLDIVRDQQSKT  205 (434)
Q Consensus       138 ~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~----------~~~~~~~E~~~l~~l~~h-~-niv~l~~~~~~~~~~~  205 (434)
                      ..+.||.|.++.||++....++..++||...+.          ....+..|.++|+.+..+ + .+++++.+.  .  ..
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~--~~  109 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--T--EM  109 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--T--TT
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--C--Cc
Confidence            356799999999999976556788999986432          124567899999988443 3 345666543  2  23


Q ss_pred             cEEEEeecCCC
Q 013897          206 PSLIFEHVNNT  216 (434)
Q Consensus       206 ~~lv~e~~~~~  216 (434)
                      .++|||++.+.
T Consensus       110 ~~lvmE~l~g~  120 (397)
T 2olc_A          110 AVTVMEDLSHL  120 (397)
T ss_dssp             TEEEECCCTTS
T ss_pred             cEEEEEeCCCc
Confidence            47999999763

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.08  E-value=1.6e-05  Score=76.02  Aligned_cols=135  Identities=13%  Similarity=0.175  Sum_probs=78.5

Q ss_pred             EeeeeecCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCC-CCeeeEeeE-----EEccCCCccEEEEee
Q 013897          139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGG-PNIVKLLDI-----VRDQQSKTPSLIFEH  212 (434)
Q Consensus       139 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~E~~~l~~l~~h-~niv~l~~~-----~~~~~~~~~~lv~e~  212 (434)
                      ++.|+.|..+.||++.. . +..+++|+... ....+..|..+++.|..+ -.+++++..     +.. .....++||+|
T Consensus        37 ~~~l~gG~~n~~~~v~~-~-~~~~vlk~~~~-~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~-~~~~~~~l~~~  112 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHT-D-SGAVCLKRIHR-PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSK-HGSFLFVVYDW  112 (346)
T ss_dssp             EEECC----CEEEEEEE-T-TEEEEEEEECS-CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEE-ETTEEEEEEEC
T ss_pred             eeeccccccCcEEEEEe-C-CCCEEEEecCC-CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEE-ECCEEEEEEEe
Confidence            45577778899999875 3 44589999875 334556677777766321 234444431     111 12346799999


Q ss_pred             cCCCchh---------------hhc---CCC--C-----------hHH-------------------------------H
Q 013897          213 VNNTDFK---------------VLY---PTL--S-----------DYD-------------------------------V  230 (434)
Q Consensus       213 ~~~~~l~---------------~~~---~~l--~-----------~~~-------------------------------~  230 (434)
                      ++|..+.               .+.   ..+  +           +..                               +
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9986431               111   111  1           100                               0


Q ss_pred             HHHHHHHHHHHHHHHH-------------CCceeecCCCCceEecCCCCeEEEEeccccee
Q 013897          231 RYYIYELLKALDYCHS-------------QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF  278 (434)
Q Consensus       231 ~~~~~qi~~~L~~LH~-------------~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~  278 (434)
                      ..+..++..++.+|++             ..++|+|+++.|||++.++ .+.|+||+.+..
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~-~~~lIDfe~a~~  252 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENE-QIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGG-CEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCC-cEEEEehhhccc
Confidence            1111223345666652             5799999999999997555 799999998854

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.91  E-value=7.9e-05  Score=70.58  Aligned_cols=76  Identities=18%  Similarity=0.207  Sum_probs=60.1

Q ss_pred             EEeeeeecCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCC--CCeeeEeeEEEccCCCccEEEEeecCC
Q 013897          138 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGG--PNIVKLLDIVRDQQSKTPSLIFEHVNN  215 (434)
Q Consensus       138 ~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~E~~~l~~l~~h--~niv~l~~~~~~~~~~~~~lv~e~~~~  215 (434)
                      -.+.|+.|....||+...  ++..+++|+........+..|...|+.|..+  ..+++++.+....  ...++||||+++
T Consensus        40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~--g~~~lvme~l~G  115 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ--GHSFLLLEALNK  115 (312)
T ss_dssp             EEEEECCSSSSEEEEEES--SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS--SEEEEEEECCCC
T ss_pred             eeEEeCCccceeeeEEEE--CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC--CceEEEEEeccC
Confidence            457799999999999874  5678889988766667789999999998543  5678888887543  456899999998


Q ss_pred             Cc
Q 013897          216 TD  217 (434)
Q Consensus       216 ~~  217 (434)
                      ..
T Consensus       116 ~~  117 (312)
T 3jr1_A          116 SK  117 (312)
T ss_dssp             CC
T ss_pred             CC
Confidence            64

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.85  E-value=6.6e-05  Score=70.65  Aligned_cols=70  Identities=9%  Similarity=0.022  Sum_probs=45.8

Q ss_pred             EeeeeecCceEEEEEEEcCCCeEEEEEEeccccH--HHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeec-CC
Q 013897          139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV-NN  215 (434)
Q Consensus       139 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~-~~  215 (434)
                      ++.|+.|....+|++      ..+++|+......  -...+|+.+++.+..+.-..+++++.  ...  -++|+||+ ++
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~--~~~v~e~i~~g   92 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--PAT--GVMVTRYIAGA   92 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTT--CCEEEECCTTC
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--CCC--CEEEEeecCCC
Confidence            567899999999998      5588898754321  12367888888875443335666654  222  24899999 66


Q ss_pred             Cch
Q 013897          216 TDF  218 (434)
Q Consensus       216 ~~l  218 (434)
                      ..+
T Consensus        93 ~~l   95 (301)
T 3dxq_A           93 QTM   95 (301)
T ss_dssp             EEC
T ss_pred             ccC
Confidence            544

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.81  E-value=8.5e-05  Score=73.71  Aligned_cols=74  Identities=14%  Similarity=0.127  Sum_probs=53.5

Q ss_pred             EEeeeeecCceEEEEEEEcC-------CCeEEEEEEeccccH-HHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          138 VVRKVGRGKYSEVFEGVHCT-------DNEKCIIKILKPVKK-KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       138 ~~~~lG~G~fg~Vy~~~~~~-------~~~~vaiK~~~~~~~-~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      .++.|+.|....||++....       ++..+++|+...... ..+.+|..+++.|..+.-.+++++.+.+      .+|
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~------g~v  150 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG------GRL  150 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT------EEE
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC------CEE
Confidence            35678889999999998642       257899999854222 5667899999998655445778876632      289


Q ss_pred             EeecCCCc
Q 013897          210 FEHVNNTD  217 (434)
Q Consensus       210 ~e~~~~~~  217 (434)
                      +||++|..
T Consensus       151 ~e~l~G~~  158 (429)
T 1nw1_A          151 EEYIPSRP  158 (429)
T ss_dssp             ECCCCEEE
T ss_pred             EEEeCCcc
Confidence            99998744

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.81  E-value=5.2e-05  Score=74.99  Aligned_cols=78  Identities=13%  Similarity=0.131  Sum_probs=46.5

Q ss_pred             HCCceeecCCCCceEecCCCCeEEEEecccceecCCCCccceecc--CCcccccccccCCC--CCCccccHHHHHHHHHH
Q 013897          246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVA--SRYFKGPELLVDLQ--DYDYSLDLWSLGCMFAG  321 (434)
Q Consensus       246 ~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~~~~~~--t~~y~aPE~~~~~~--~~~~~~DvwSlGvil~e  321 (434)
                      ...++|+|+++.|||++.++  ++|+||+.+....+.........  ...|.+|+......  .-....++..+...+++
T Consensus       231 ~~~liHGDl~~~Nil~~~~~--~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS--TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC--EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC--CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            45799999999999998554  89999999976543222111111  12355555442100  11123445577777777


Q ss_pred             HHhC
Q 013897          322 MIFR  325 (434)
Q Consensus       322 lltg  325 (434)
                      .+.+
T Consensus       309 ~y~~  312 (420)
T 2pyw_A          309 LFNK  312 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            7654

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.77  E-value=0.0003  Score=65.66  Aligned_cols=76  Identities=14%  Similarity=0.130  Sum_probs=55.6

Q ss_pred             CeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHHHhcCC--CCeeeEeeEEEccCCCccEEE
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGG--PNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~E~~~l~~l~~h--~niv~l~~~~~~~~~~~~~lv  209 (434)
                      ...-++.+|.|..+.||+... .+|+.|++|+-....   ...+..|...|+.|...  --+++++++.  .    -++|
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~----~~lv   88 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D----RTLA   88 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T----TEEE
T ss_pred             CeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc--C----ceEE
Confidence            355678899999999999986 678899999865332   34688999999998543  2345666543  1    2589


Q ss_pred             EeecCCCc
Q 013897          210 FEHVNNTD  217 (434)
Q Consensus       210 ~e~~~~~~  217 (434)
                      |||+.++.
T Consensus        89 ~e~l~~~~   96 (288)
T 3f7w_A           89 MEWVDERP   96 (288)
T ss_dssp             EECCCCCC
T ss_pred             EEeecccC
Confidence            99987653

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.76  E-value=5.7e-05  Score=72.15  Aligned_cols=137  Identities=14%  Similarity=0.125  Sum_probs=73.7

Q ss_pred             EeeeeecCceE-EEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCC-CCeeeEeeEEEccCCCccEEEEeecCCC
Q 013897          139 VRKVGRGKYSE-VFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGG-PNIVKLLDIVRDQQSKTPSLIFEHVNNT  216 (434)
Q Consensus       139 ~~~lG~G~fg~-Vy~~~~~~~~~~vaiK~~~~~~~~~~~~E~~~l~~l~~h-~niv~l~~~~~~~~~~~~~lv~e~~~~~  216 (434)
                      ++.|+.|.... +|+... .++..+++|...+.....+..|+.+++.+..+ -.+++++.+.  ....  ++|||++++.
T Consensus        23 ~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~~~~~~~e~~~l~~L~~~g~~vP~v~~~d--~~~g--~ll~e~l~~~   97 (333)
T 3csv_A           23 RTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEEGGDTQPFVDLAQYLRNLDISAPEIYAEE--HARG--LLLIEDLGDA   97 (333)
T ss_dssp             ECC--------CCEEEEC-TTCCEEEEEECCTTTTCCSHHHHHHHHHHHHTTCBCCCEEEEE--TTTT--EEEECCCCSC
T ss_pred             eeECCCCCCCceEEEEEc-CCCCeEEEEECCCCCCccccHHHHHHHHHHhCCCCCCceeeec--CCCC--EEEEeeCCCc
Confidence            34566665554 666653 33667788876544335567788888888543 2356677663  2222  5899998765


Q ss_pred             chhhhc----------------------C----CCC---hHHHH-------H-HH------------HHHHHHHHHHH--
Q 013897          217 DFKVLY----------------------P----TLS---DYDVR-------Y-YI------------YELLKALDYCH--  245 (434)
Q Consensus       217 ~l~~~~----------------------~----~l~---~~~~~-------~-~~------------~qi~~~L~~LH--  245 (434)
                      .+...+                      .    .++   .....       . +.            ..+...++.|.  
T Consensus        98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~  177 (333)
T 3csv_A           98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA  177 (333)
T ss_dssp             BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred             chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence            442110                      0    111   11000       0 00            01112223331  


Q ss_pred             ----HCCceeecCCCCceEecCC---CCeEEEEecccceecC
Q 013897          246 ----SQGIMHRDVKPHNVMIDHE---QRKLRLIDWGLAEFYH  280 (434)
Q Consensus       246 ----~~~ivHrDlKp~NIll~~~---~~~vkl~DFGla~~~~  280 (434)
                          ...++|+|+.+.|||++.+   ...+.|+||+.+....
T Consensus       178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~  219 (333)
T 3csv_A          178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH  219 (333)
T ss_dssp             HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred             cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence                2369999999999999854   1378999999987543

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.71  E-value=8.3e-05  Score=70.50  Aligned_cols=139  Identities=17%  Similarity=0.185  Sum_probs=79.9

Q ss_pred             EEEeeeeecCceEEEEEEEcCCCeEEEEEEecc-ccHHHHHHHHHHHHHhcCCC-CeeeEeeEEEc----cCCCccEEEE
Q 013897          137 EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-VKKKKIKREIKILQNLCGGP-NIVKLLDIVRD----QQSKTPSLIF  210 (434)
Q Consensus       137 ~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~-~~~~~~~~E~~~l~~l~~h~-niv~l~~~~~~----~~~~~~~lv~  210 (434)
                      .-++.|+.|....||+... .++ .+++|+... .....+..|+.+++.|..+. .+++++.....    ......++|+
T Consensus        25 ~~~~~i~~G~~n~~~~v~~-~~g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~  102 (322)
T 2ppq_A           25 TSYKGIAEGVENSNFLLHT-TKD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI  102 (322)
T ss_dssp             EEEEEECC---EEEEEEEE-SSC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred             eEeeccCCCcccceEEEEe-CCc-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEE
Confidence            3456788899999999975 333 688999876 34466788999988885431 13444421100    0013357899


Q ss_pred             eecCCCchhh---------------hc---CCCC-----------hHHH-HH-----------HHHHHHHHHHHHHH---
Q 013897          211 EHVNNTDFKV---------------LY---PTLS-----------DYDV-RY-----------YIYELLKALDYCHS---  246 (434)
Q Consensus       211 e~~~~~~l~~---------------~~---~~l~-----------~~~~-~~-----------~~~qi~~~L~~LH~---  246 (434)
                      +|++|..+..               +.   ..+.           +... ..           +...+...++.+..   
T Consensus       103 ~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~  182 (322)
T 2ppq_A          103 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP  182 (322)
T ss_dssp             ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred             EeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCc
Confidence            9998854311               10   1110           0000 00           00113445555553   


Q ss_pred             ----CCceeecCCCCceEecCCCCeEEEEeccccee
Q 013897          247 ----QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF  278 (434)
Q Consensus       247 ----~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~  278 (434)
                          .+++|+|+.+.|||++.++ .+.|+||+.+..
T Consensus       183 ~~~~~~liHgDl~~~Nil~~~~~-~~~lIDf~~a~~  217 (322)
T 2ppq_A          183 KDLPAGVIHADLFQDNVFFLGDE-LSGLIDFYFACN  217 (322)
T ss_dssp             CSSCEEEECSCCCGGGEEEETTE-EEEECCCTTCEE
T ss_pred             ccCCcccCCCCCCccCEEEeCCc-eEEEecchhccC
Confidence                3699999999999998543 457999998854

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.59  E-value=0.00019  Score=69.79  Aligned_cols=134  Identities=13%  Similarity=0.184  Sum_probs=82.8

Q ss_pred             EeeeeecCceEEEEEEEcC-------CCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          139 VRKVGRGKYSEVFEGVHCT-------DNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       139 ~~~lG~G~fg~Vy~~~~~~-------~~~~vaiK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      ++.|..|-...+|++....       ++..+++|+.-..  ......+|..+++.|..+.-..++++.+.+      .+|
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~------g~v  128 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE------GRL  128 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT------EEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC------ccE
Confidence            3567778888999987632       3578999986432  345567999999988665555778877632      289


Q ss_pred             EeecCCCchhhh------------------cC---C----CC--hHHHHHHHHHHH-------------------HHHHH
Q 013897          210 FEHVNNTDFKVL------------------YP---T----LS--DYDVRYYIYELL-------------------KALDY  243 (434)
Q Consensus       210 ~e~~~~~~l~~~------------------~~---~----l~--~~~~~~~~~qi~-------------------~~L~~  243 (434)
                      |||++|..+..-                  ..   .    ..  +.++..+..++.                   ..+..
T Consensus       129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  208 (379)
T 3feg_A          129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN  208 (379)
T ss_dssp             EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred             EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence            999998654210                  00   0    11  234444444332                   12333


Q ss_pred             HH----HC----CceeecCCCCceEecCC---CCeEEEEeccccee
Q 013897          244 CH----SQ----GIMHRDVKPHNVMIDHE---QRKLRLIDWGLAEF  278 (434)
Q Consensus       244 LH----~~----~ivHrDlKp~NIll~~~---~~~vkl~DFGla~~  278 (434)
                      |.    ..    .++|+|+.+.|||++.+   ...+.|+||..|..
T Consensus       209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            33    22    48999999999999865   23789999999864

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.54  E-value=0.00042  Score=69.22  Aligned_cols=75  Identities=16%  Similarity=0.164  Sum_probs=50.9

Q ss_pred             EEeeeeecCceEEEEEEEcCCCeEEEEEEeccccHH--HHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEeecCC
Q 013897          138 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK--KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN  215 (434)
Q Consensus       138 ~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~  215 (434)
                      -++.|+.|-...+|++.....+..+++|+.......  .-.+|..+++.|..+.-.+++++.+.  +    .+|+||+++
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~----G~v~e~I~G  185 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N----GRIEEFMDG  185 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T----EEEEECCCS
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C----eEEEEeeCC
Confidence            356788899999999987443588999987543211  12689999999965544577888772  1    269999987


Q ss_pred             Cch
Q 013897          216 TDF  218 (434)
Q Consensus       216 ~~l  218 (434)
                      ..+
T Consensus       186 ~~l  188 (458)
T 2qg7_A          186 YAL  188 (458)
T ss_dssp             EEC
T ss_pred             ccC
Confidence            543

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.41  E-value=0.00046  Score=65.45  Aligned_cols=73  Identities=14%  Similarity=0.216  Sum_probs=48.5

Q ss_pred             eeeecCceEEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCC-CCeeeEeeEEEccC-----CCccEEEEee
Q 013897          141 KVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGG-PNIVKLLDIVRDQQ-----SKTPSLIFEH  212 (434)
Q Consensus       141 ~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~E~~~l~~l~~h-~niv~l~~~~~~~~-----~~~~~lv~e~  212 (434)
                      .|+ |....||+... .+|+.+++|+..+.  ....+..|..+++.|..+ -.+++++..  +..     ....++||++
T Consensus        33 ~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~~l~~~  108 (328)
T 1zyl_A           33 PLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYFAVFPS  108 (328)
T ss_dssp             EEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEEEEEEC
T ss_pred             eec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEEEEEEe
Confidence            456 78889998764 45668999998743  456788899999888433 124555543  111     2344689999


Q ss_pred             cCCCc
Q 013897          213 VNNTD  217 (434)
Q Consensus       213 ~~~~~  217 (434)
                      ++|..
T Consensus       109 i~G~~  113 (328)
T 1zyl_A          109 VGGRQ  113 (328)
T ss_dssp             CCCEE
T ss_pred             cCCCC
Confidence            98854

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.38  E-value=0.00067  Score=65.63  Aligned_cols=73  Identities=14%  Similarity=0.140  Sum_probs=46.3

Q ss_pred             EeeeeecCceEEEEEEEcC--------CCeEEEEEEeccccHH--HHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          139 VRKVGRGKYSEVFEGVHCT--------DNEKCIIKILKPVKKK--KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       139 ~~~lG~G~fg~Vy~~~~~~--------~~~~vaiK~~~~~~~~--~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      ++.|+.|....||++....        .+..+++|+.......  ....|..+++.|..+.-++++++..  .    -.+
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~----~~~  111 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N----GGR  111 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T----TEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C----CcE
Confidence            4668888889999997632        1268899987543221  2468888998885543355777654  2    258


Q ss_pred             EEeecCCCc
Q 013897          209 IFEHVNNTD  217 (434)
Q Consensus       209 v~e~~~~~~  217 (434)
                      ||||++|..
T Consensus       112 v~e~i~G~~  120 (369)
T 3c5i_A          112 IEEWLYGDP  120 (369)
T ss_dssp             EEECCCSEE
T ss_pred             EEEEecCCc
Confidence            999998754

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.84  E-value=0.013  Score=51.78  Aligned_cols=88  Identities=10%  Similarity=0.012  Sum_probs=55.6

Q ss_pred             cCCCChHHHHHHHHHHHHHHHHHHH-CCceeecCCCCceEecCCCCeEEEEecccceecCCCCccceeccCCcccccccc
Q 013897          222 YPTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL  300 (434)
Q Consensus       222 ~~~l~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~  300 (434)
                      -.++++++++.++.|.+.+|.-+-. +.-..+=+.|..|++..+| .|.+.+ +.+.           .....+.|||..
T Consensus        43 ~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG-~V~f~~-~~s~-----------~~~~~~~~pe~~  109 (229)
T 2yle_A           43 NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDG-AVTLAP-AADD-----------AGEPPPVAGKLG  109 (229)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTS-CEEECC-C-----------------------CCS
T ss_pred             CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCC-ceeccc-cccc-----------ccccCCCChhhc
Confidence            4689999999999999999877622 2222334456888888777 665543 1110           112235688875


Q ss_pred             cCCCCCCccccHHHHHHHHHHHHh
Q 013897          301 VDLQDYDYSLDLWSLGCMFAGMIF  324 (434)
Q Consensus       301 ~~~~~~~~~~DvwSlGvil~ellt  324 (434)
                      .  ...+.+.-|||||+++|..+-
T Consensus       110 ~--~~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A          110 Y--SQCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             S--SSSCHHHHHHHHHHHHHHHHT
T ss_pred             c--ccchHHHHHHHHHHHHHHHhh
Confidence            3  356678999999999999874

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.65  E-value=0.0066  Score=57.92  Aligned_cols=71  Identities=10%  Similarity=0.144  Sum_probs=43.9

Q ss_pred             eecCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCC--CCeeeEeeEEEc----cCCCccEEEEeecCCC
Q 013897          143 GRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGG--PNIVKLLDIVRD----QQSKTPSLIFEHVNNT  216 (434)
Q Consensus       143 G~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~E~~~l~~l~~h--~niv~l~~~~~~----~~~~~~~lv~e~~~~~  216 (434)
                      |.|....||+... .++ .+++|+.....   ...|+.+++.|..+  |++++.+.....    ......++||+|++|.
T Consensus        32 G~g~~N~vy~v~~-~~g-~~vLK~~~~~~---~~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~  106 (339)
T 3i1a_A           32 GADTNAFAYQADS-ESK-SYFIKLKYGYH---DEINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAP  106 (339)
T ss_dssp             TSCSSCEEEEEEC-SSC-EEEEEEEECSS---CCHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCC
T ss_pred             cCccccceEEEEe-CCC-CEEEEEecCcc---chHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCC
Confidence            4444689999974 345 89999876544   25677777777432  335555542100    1124567999999886


Q ss_pred             ch
Q 013897          217 DF  218 (434)
Q Consensus       217 ~l  218 (434)
                      .+
T Consensus       107 ~~  108 (339)
T 3i1a_A          107 NG  108 (339)
T ss_dssp             BT
T ss_pred             cC
Confidence            54

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.63  E-value=0.0038  Score=61.48  Aligned_cols=75  Identities=12%  Similarity=0.146  Sum_probs=51.6

Q ss_pred             EEeeeeecCceEEEEEEEcCC-------CeEEEEEEeccccH--HHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          138 VVRKVGRGKYSEVFEGVHCTD-------NEKCIIKILKPVKK--KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       138 ~~~~lG~G~fg~Vy~~~~~~~-------~~~vaiK~~~~~~~--~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      -++.|..|-...+|+......       +..+++|+......  -...+|..+++.|..+.-.+++++.+  .    -++
T Consensus        74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~----~~~  147 (424)
T 3mes_A           74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--P----EGR  147 (424)
T ss_dssp             EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T----TEE
T ss_pred             EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--C----CCE
Confidence            356677888899999986421       57899998754321  12368999998886555566777654  2    158


Q ss_pred             EEeecCCCch
Q 013897          209 IFEHVNNTDF  218 (434)
Q Consensus       209 v~e~~~~~~l  218 (434)
                      |+||++|..+
T Consensus       148 I~efI~G~~l  157 (424)
T 3mes_A          148 IEEFIDGEPL  157 (424)
T ss_dssp             EEECCCSEEC
T ss_pred             EEEEeCCccC
Confidence            9999998653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=96.47  E-value=0.012  Score=57.46  Aligned_cols=30  Identities=30%  Similarity=0.596  Sum_probs=24.5

Q ss_pred             ceeecCCCCceEecC-----CCCeEEEEeccccee
Q 013897          249 IMHRDVKPHNVMIDH-----EQRKLRLIDWGLAEF  278 (434)
Q Consensus       249 ivHrDlKp~NIll~~-----~~~~vkl~DFGla~~  278 (434)
                      ++|+|+.+.|||+..     +...+.++||..|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            679999999999932     334799999999854

>1cja_A Protein (actin-fragmin kinase); transferase; HET: AMP; 2.90A {Physarum polycephalum} SCOP: d.144.1.3

Probab=81.10  E-value=17  Score=33.94  Aligned_cols=140  Identities=14%  Similarity=0.201  Sum_probs=72.3

Q ss_pred             CeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeEee------------------
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLD------------------  196 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~------------------  196 (434)
                      ++..++..-.|..| ||.+..  ++..++||-......+-+-.++...-.+ .-|+..-+.-                  
T Consensus        70 ~v~~I~~s~~Gstg-vff~~t--d~~~~VVK~s~~l~~E~l~s~LA~~LGl-piP~~Riv~~~~~E~~e~~~~L~~~~~~  145 (342)
T 1cja_A           70 QFKGIERSEKGTEG-LFFVET--ESGVFIVKRSTNIESETFCSLLCMRLGL-HAPKVRVVSSNSEEGTNMLECLAAIDKS  145 (342)
T ss_dssp             GEEEEEECCSTTSC-EEEEEE--SSCEEEEECCTTHHHHHHHHHHHHHHTC-CCCCEEEEESSSHHHHHHHHHHHHHCSS
T ss_pred             CeeEEEeccCCCCC-eEEEEe--CCCEEEEeCcHHHHHHHHHHHHHHHhCC-CCCCeeEEeeCcHHHHHHHHHHHHhhhh
Confidence            46677777777655 555543  5778999965322222222222222222 2233211110                  


Q ss_pred             --EEEccCCCccEEEEeecCCCchhhhcCCC-ChHHHHHHHHHH--HHHHHHHHHCC-----ceeecCCCCceEecCCCC
Q 013897          197 --IVRDQQSKTPSLIFEHVNNTDFKVLYPTL-SDYDVRYYIYEL--LKALDYCHSQG-----IMHRDVKPHNVMIDHEQR  266 (434)
Q Consensus       197 --~~~~~~~~~~~lv~e~~~~~~l~~~~~~l-~~~~~~~~~~qi--~~~L~~LH~~~-----ivHrDlKp~NIll~~~~~  266 (434)
                        ...........++|+|..|..|....... ..........++  +-+++.+..+.     +-+.--.++|||++.++.
T Consensus       146 ~~~l~~l~~~~~~l~meyv~G~~L~e~~~~~~~~~f~~~~~k~LG~Ii~FDi~InN~DR~Pl~W~n~GN~~NIL~~~~n~  225 (342)
T 1cja_A          146 FRVITTLANQANILLMELVRGITLNKLTTTSAPEVLTKSTMQQLGSLMALDVIVNNSDRLPIAWTNEGNLDNIMLSERGA  225 (342)
T ss_dssp             SCHHHHHTTCSEEEEEECCCEEESTTCCSSSHHHHSCHHHHHHHHHHHHHHHHHTCCSSSCSSSCSCCCGGGEEEESBTT
T ss_pred             hHHHHHhhcccceehhhhcCCCccccchhhhhhhhcCHHHHHhhchhheehhhhcCCccCcccccCCCChhheEEeCCCC
Confidence              00011122445899999977665443221 000011223332  34566666552     122235899999987776


Q ss_pred             eEEEEeccccee
Q 013897          267 KLRLIDWGLAEF  278 (434)
Q Consensus       267 ~vkl~DFGla~~  278 (434)
                      .+.++|-+++..
T Consensus       226 ~~~~IDhn~af~  237 (342)
T 1cja_A          226 TVVPIDSKIIPL  237 (342)
T ss_dssp             CEEECSCCCCCC
T ss_pred             eEEEEcCCcccc
Confidence            789999999854

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=80.66  E-value=0.15  Score=50.74  Aligned_cols=59  Identities=12%  Similarity=0.147  Sum_probs=18.4

Q ss_pred             EEeeeeecCceEEEEEEEcCCCeEEEE------EEecc-----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEEc
Q 013897          138 VVRKVGRGKYSEVFEGVHCTDNEKCII------KILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRD  200 (434)
Q Consensus       138 ~~~~lG~G~fg~Vy~~~~~~~~~~vai------K~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  200 (434)
                      +.++||   ||.||+|.+......||+      |..+.     .....+.+|..+++.+ +|||+++.+++...
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~-~H~niv~~h~f~~~  215 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENE-QIPKYEKIHNFKVH  215 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC------------------------------------CBCCCEEEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccc-cccccCCCcceEEe
Confidence            445676   999999998665567888      65543     1224567788888887 89999999887653

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	434
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-112
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-61
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-58
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-56
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	6e-56
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-55
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	9e-55
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-54
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-54
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	6e-54
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	7e-54
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	8e-54
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-52
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	5e-52
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	5e-52
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	8e-52
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-51
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	4e-51
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-50
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-50
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	5e-50
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	5e-49
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-48
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-47
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-47
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-45
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	7e-45
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-44
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-44
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-42
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	8e-42
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-40
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-39
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	7e-39
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	6e-38
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	6e-38
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	7e-38
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-37
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	7e-37
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-36
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	4e-36
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	7e-36
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-35
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-35
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	3e-35
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-35
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-34
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-34
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	7e-34
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-33
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	4e-33
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	9e-33
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-32
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-32
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-32
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	6e-31
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	4e-30
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-28
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-28
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-27
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-27
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-27
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-20

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  331 bits (848), Expect = e-112
 Identities = 245/323 (75%), Positives = 285/323 (88%)

Query: 103 PSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKC 162
           PS+ARVY+D+N  RPREYWDYES  V+WG QDDY++VRK+GRGKYSEVFE ++ T+NEK 
Sbjct: 4   PSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKV 63

Query: 163 IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY 222
           ++KILKPVKKKKIKREIKIL+NL GGPNI+ L DIV+D  S+TP+L+FEHVNNTDFK LY
Sbjct: 64  VVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY 123

Query: 223 PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282
            TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPG
Sbjct: 124 QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183

Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKI 342
           +EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFRKEPFF+GHDNYDQLV+I
Sbjct: 184 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI 243

Query: 343 AKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLL 402
           AKVLGT++L  Y++KY+IELDP    ++GRHSRK W +F+  ENQHL  PEA+DFLDKLL
Sbjct: 244 AKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLL 303

Query: 403 RYDHQERPTAKEAMAHPYFFPIR 425
           RYDHQ R TA+EAM HPYF+ + 
Sbjct: 304 RYDHQSRLTAREAMEHPYFYTVV 326

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (512), Expect = 1e-61
 Identities = 92/305 (30%), Positives = 145/305 (47%), Gaps = 21/305 (6%)

Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNI 191
           ++  Y   + +G G +  V++   C   E   IK +    K+   RE++I++ L    NI
Sbjct: 18  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKNRELQIMRKL-DHCNI 75

Query: 192 VKLLDIVRDQQSKTPS----LIFEHVNNTDFKVL------YPTLSDYDVRYYIYELLKAL 241
           V+L         K       L+ ++V  T ++V         TL    V+ Y+Y+L ++L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135

Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 301
            Y HS GI HRD+KP N+++D +   L+L D+G A+    G+     + SRY++ PEL+ 
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF 195

Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 361
              DY  S+D+WS GC+ A ++  + P F G    DQLV+I KVLGT             
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254

Query: 362 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
            +        +    PW+K      +    PEA+    +LL Y    R T  EA AH +F
Sbjct: 255 TEFKFP----QIKAHPWTKVF----RPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306

Query: 422 FPIRN 426
             +R+
Sbjct: 307 DELRD 311

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 2e-58
 Identities = 62/302 (20%), Positives = 111/302 (36%), Gaps = 20/302 (6%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGGP 189
           DD+E + ++G G    VF+  H         K++     P  + +I RE+++L      P
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS-P 64

Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCHS 246
            IV              S+  EH++      +      + +  +      ++K L Y   
Sbjct: 65  YIVGFYGAFYSDGE--ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122

Query: 247 Q-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
           +  IMHRDVKP N++++     ++L D+G++         N  V +R +  PE L     
Sbjct: 123 KHKIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQG-TH 179

Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT------DELNAYLNKYH 359
           Y    D+WS+G     M   + P         +L+   +V G                  
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239

Query: 360 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHP 419
             +D      +        ++        +   E  DF++K L  +  ER   K+ M H 
Sbjct: 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 299

Query: 420 YF 421
           + 
Sbjct: 300 FI 301

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 2e-56
 Identities = 88/319 (27%), Positives = 163/319 (51%), Gaps = 21/319 (6%)

Query: 120 YWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKK 174
           ++  E     W  +  Y  ++ VG G Y  V   V      K  IK L       +  K+
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 175 IKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS----LIFEHVNNTDFKVL-YPTLSDYD 229
             RE+++L+++    N++ LLD+    ++        L+   +     K++ +  L +  
Sbjct: 64  AYRELRLLKHMRH-ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDR 122

Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRV 289
           +++ +Y++LK L Y H+ GI+HRD+KP N+ ++ +    +++D+GLA       E    V
Sbjct: 123 IQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCEL-KILDFGLA--RQADSEMTGYV 179

Query: 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTD 349
            +R+++ PE++++   Y  ++D+WS+GC+ A MI  K  F  G D+ DQL +I KV GT 
Sbjct: 180 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF-KGSDHLDQLKEIMKVTGTP 238

Query: 350 ELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQER 409
               ++ +   +   +    +    +K ++  +T  +     P AV+ L+K+L  D ++R
Sbjct: 239 PAE-FVQRLQSDEAKNYMKGLPELEKKDFASILTNAS-----PLAVNLLEKMLVLDAEQR 292

Query: 410 PTAKEAMAHPYFFPIRNAE 428
            TA EA+AHPYF  + + E
Sbjct: 293 VTAGEALAHPYFESLHDTE 311

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 6e-56
 Identities = 83/300 (27%), Positives = 155/300 (51%), Gaps = 21/300 (7%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK----KKIKREIKILQNLCGGP 189
             Y  +  +G G Y  V       +  +  IK + P +     ++  REIKIL       
Sbjct: 8   PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH-E 66

Query: 190 NIVKLLDIVRD---QQSKTPSLIFEHVNNTDFKVL-YPTLSDYDVRYYIYELLKALDYCH 245
           NI+ + DI+R    +Q K   L+   +    +K+L    LS+  + Y++Y++L+ L Y H
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126

Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV----RVASRYFKGPELLV 301
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 127 SANVLHRDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185

Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 361
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+          +++
Sbjct: 186 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244

Query: 362 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
              +L + +   ++ PW++     +      +A+D LDK+L ++  +R   ++A+AHPY 
Sbjct: 245 ARNYLLS-LPHKNKVPWNRLFPNAD-----SKALDLLDKMLTFNPHKRIEVEQALAHPYL 298

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (469), Expect = 1e-55
 Identities = 89/307 (28%), Positives = 145/307 (47%), Gaps = 27/307 (8%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK-----IKREIKILQNLCGG 188
             YE + K+G+G + EVF+  H    +K  +K +    +K+       REIKILQ L   
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KH 68

Query: 189 PNIVKLLDIVRDQQSK------TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLK 239
            N+V L++I R + S       +  L+F+   +    +L       +  +++  +  LL 
Sbjct: 69  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 128

Query: 240 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-----YNVRVASRYF 294
            L Y H   I+HRD+K  NV+I  +   L+L D+GLA  +   K      Y  RV + ++
Sbjct: 129 GLYYIHRNKILHRDMKAANVLITRDGV-LKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187

Query: 295 KGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAY 354
           + PELL+  +DY   +DLW  GC+ A M  R  P   G+    QL  I+++ G+     +
Sbjct: 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRS-PIMQGNTEQHQLALISQLCGSITPEVW 246

Query: 355 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKE 414
            N  + EL   L        +    K       ++  P A+D +DKLL  D  +R  + +
Sbjct: 247 PNVDNYELYEKL-----ELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 301

Query: 415 AMAHPYF 421
           A+ H +F
Sbjct: 302 ALNHDFF 308

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  181 bits (460), Expect = 9e-55
 Identities = 87/297 (29%), Positives = 153/297 (51%), Gaps = 23/297 (7%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGG 188
           + Y  + K+G G Y  V++  +    E   +K ++  K          REI IL+ L   
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKH- 59

Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCH 245
            NIVKL D++  ++     L+FEH++    K+L      L     + ++ +LL  + YCH
Sbjct: 60  SNIVKLYDVIHTKKRLV--LVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117

Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQ 304
            + ++HRD+KP N++I+ E   L++ D+GLA  +  P ++Y   + + +++ P++L+  +
Sbjct: 118 DRRVLHRDLKPQNLLINREGE-LKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176

Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y  ++D+WS+GC+FA M+    P F G    DQL++I ++LGT     + N   +   P
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGT-PLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL---P 232

Query: 365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
                   +   PW  F+   +        +D L K+L+ D  +R TAK+A+ H YF
Sbjct: 233 KYDPNFTVYEPLPWESFLKGLD-----ESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 2e-54
 Identities = 86/296 (29%), Positives = 155/296 (52%), Gaps = 19/296 (6%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK-----IKREIKILQNLCGG 188
           ++++ V K+G G Y  V++  +    E   +K ++   + +       REI +L+ L   
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH- 60

Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDF--KVLYPTLSDYDVRYYIYELLKALDYCHS 246
           PNIVKLLD++  +        F H +   F        +    ++ Y+++LL+ L +CHS
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120

Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQD 305
             ++HRD+KP N++I+ E   ++L D+GLA  +  P + Y   V + +++ PE+L+  + 
Sbjct: 121 HRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179

Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH 365
           Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   P 
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRAL-FPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM---PD 235

Query: 366 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
                 + +R+ +SK +   +      +    L ++L YD  +R +AK A+AHP+F
Sbjct: 236 YKPSFPKWARQDFSKVVPPLD-----EDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 3e-54
 Identities = 83/297 (27%), Positives = 144/297 (48%), Gaps = 21/297 (7%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK-----IKREIKILQNLCGG 188
             YE + K+G G Y  VF+  +   +E   +K ++     +       REI +L+ L   
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH- 60

Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCH 245
            NIV+L D++   +    +L+FE  +      F      L    V+ ++++LLK L +CH
Sbjct: 61  KNIVRLHDVLHSDK--KLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118

Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           S+ ++HRD+KP N++I+      +L ++GLA  F  P + Y+  V + +++ P++L   +
Sbjct: 119 SRNVLHRDLKPQNLLINRNGEL-KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177

Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y  S+D+WS GC+FA +     P F G+D  DQL +I ++LGT     + +   +    
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237

Query: 365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
                    S       +             D L  LL+ +  +R +A+EA+ HPYF
Sbjct: 238 PYPMYPATTSLVNVVPKLN--------ATGRDLLQNLLKCNPVQRISAEEALQHPYF 286

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (456), Expect = 6e-54
 Identities = 85/310 (27%), Positives = 147/310 (47%), Gaps = 28/310 (9%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHC-TDNEKCIIKILKPVKKKK-----IKREIKILQNLCG 187
             YE V ++G G Y +VF+            +K ++    ++       RE+ +L++L  
Sbjct: 7   QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66

Query: 188 G--PNIVKLLDIVRDQQSKTPS---LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELL 238
              PN+V+L D+    ++   +   L+FEHV+      L     P +    ++  +++LL
Sbjct: 67  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126

Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
           + LD+ HS  ++HRD+KP N+++    +  +L D+GLA  Y         V + +++ PE
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQI-KLADFGLARIYSFQMALTSVVVTLWYRAPE 185

Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 358
           +L+    Y   +DLWS+GC+FA M  RK P F G  + DQL KI  V+G      +    
Sbjct: 186 VLLQ-SSYATPVDLWSVGCIFAEMFRRK-PLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243

Query: 359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
            +             S +P  KF+T  +         D L K L ++  +R +A  A++H
Sbjct: 244 ALPRQ-----AFHSKSAQPIEKFVTDID-----ELGKDLLLKCLTFNPAKRISAYSALSH 293

Query: 419 PYFFPIRNAE 428
           PYF  +   +
Sbjct: 294 PYFQDLERCK 303

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 7e-54
 Identities = 82/297 (27%), Positives = 144/297 (48%), Gaps = 26/297 (8%)

Query: 137 EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--------KKIKREIKILQNLCGG 188
           E +  +G G+++ V++      N+   IK +K   +        +   REIK+LQ L   
Sbjct: 1   EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH- 59

Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCH 245
           PNI+ LLD    +     SL+F+ +      ++      L+   ++ Y+   L+ L+Y H
Sbjct: 60  PNIIGLLDAFGHK--SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 117

Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQ 304
              I+HRD+KP+N+++D E   L+L D+GLA  F  P + Y  +V +R+++ PELL   +
Sbjct: 118 QHWILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGAR 176

Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            Y   +D+W++GC+ A ++ R  PF  G  + DQL +I + LGT     + +   +    
Sbjct: 177 MYGVGVDMWAVGCILAELLLRV-PFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235

Query: 365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
              +  G      +S          A  + +D +  L  ++   R TA +A+   YF
Sbjct: 236 TFKSFPGIPLHHIFSA---------AGDDLLDLIQGLFLFNPCARITATQALKMKYF 283

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (459), Expect = 8e-54
 Identities = 87/323 (26%), Positives = 159/323 (49%), Gaps = 22/323 (6%)

Query: 116 RPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PV 170
           RP  ++  E     W   + Y+ +  VG G Y  V          +  +K L       +
Sbjct: 1   RP-TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 59

Query: 171 KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS---KTPSLIFEHVNNTDFKVLY--PTL 225
             K+  RE+++L+++    N++ LLD+    +S        +  H+   D   +     L
Sbjct: 60  HAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 118

Query: 226 SDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285
           +D  V++ IY++L+ L Y HS  I+HRD+KP N+ ++ +    +++D+GLA   H   E 
Sbjct: 119 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLA--RHTDDEM 175

Query: 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV 345
              VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I ++
Sbjct: 176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL-FPGTDHIDQLKLILRL 234

Query: 346 LGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYD 405
           +GT      L K   E   +    + +  +  ++      N     P AVD L+K+L  D
Sbjct: 235 VGTPGAE-LLKKISSESARNYIQSLTQMPKMNFANVFIGAN-----PLAVDLLEKMLVLD 288

Query: 406 HQERPTAKEAMAHPYFFPIRNAE 428
             +R TA +A+AH YF    + +
Sbjct: 289 SDKRITAAQALAHAYFAQYHDPD 311

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  177 bits (451), Expect = 1e-52
 Identities = 65/296 (21%), Positives = 128/296 (43%), Gaps = 46/296 (15%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK---PVKKKKIKREIKILQNLCGGPN 190
           D Y+++ ++G G +  V   V        + K +    P+ K  +K EI I+  L   P 
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPK 87

Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHS 246
           ++ L D   D+      LI E ++  +           +S+ +V  Y+ +  + L + H 
Sbjct: 88  LINLHDAFEDKYE--MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 145

Query: 247 QGIMHRDVKPHNVMIDHEQR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
             I+H D+KP N+M + ++   +++ID+GLA   +P +   V  A+  F  PE++ D + 
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV-DREP 204

Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH 365
             +  D+W++G +   ++    P F G D+ + L  + +             +  +    
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGLSP-FAGEDDLETLQNVKRCDWE---------FDEDAFSS 254

Query: 366 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
           ++                        PEA DF+  LL+ + ++R T  +A+ HP+ 
Sbjct: 255 VS------------------------PEAKDFIKNLLQKEPRKRLTVHDALEHPWL 286

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (442), Expect = 5e-52
 Identities = 64/311 (20%), Positives = 126/311 (40%), Gaps = 51/311 (16%)

Query: 123 YESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK---REI 179
           YE +T     +D +E++ ++G G + +V++  +   +     K++    +++++    EI
Sbjct: 1   YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60

Query: 180 KILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIY 235
            IL +    PNIVKLLD    + +    ++ E         +       L++  ++    
Sbjct: 61  DILASCDH-PNIVKLLDAFYYENN--LWILIEFCAGGAVDAVMLELERPLTESQIQVVCK 117

Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYF 294
           + L AL+Y H   I+HRD+K  N++   +   ++L D+G++ +     +  +  + + Y+
Sbjct: 118 QTLDALNYLHDNKIIHRDLKAGNILFTLDGD-IKLADFGVSAKNTRTIQRRDSFIGTPYW 176

Query: 295 KGPELLV----DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE 350
             PE+++      + YDY  D+WSLG     M   + P  +  +    L+KIAK      
Sbjct: 177 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP-HHELNPMRVLLKIAK------ 229

Query: 351 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP 410
                                           +            DFL K L  +   R 
Sbjct: 230 --------------------SEPPTLAQPSRWS--------SNFKDFLKKCLEKNVDARW 261

Query: 411 TAKEAMAHPYF 421
           T  + + HP+ 
Sbjct: 262 TTSQLLQHPFV 272

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  174 bits (441), Expect = 5e-52
 Identities = 68/309 (22%), Positives = 125/309 (40%), Gaps = 57/309 (18%)

Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------------KKKIKREIK 180
            ++YE    +GRG  S V   +H    ++  +KI+                ++   +E+ 
Sbjct: 2   YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 61

Query: 181 ILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLY--PTLSDYDVRYYIYEL 237
           IL+ + G PNI++L D           L+F+ +   + F  L    TLS+ + R  +  L
Sbjct: 62  ILRKVSGHPNIIQLKDTYETNTF--FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 119

Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 297
           L+ +   H   I+HRD+KP N+++D +   ++L D+G +    PG++      +  +  P
Sbjct: 120 LEVICALHKLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVCGTPSYLAP 178

Query: 298 ELL-----VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELN 352
           E++      +   Y   +D+WS G +   ++    P F+       L  I          
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP-FWHRKQMLMLRMI---------- 227

Query: 353 AYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA 412
                                      +F + E    +     D + + L    Q+R TA
Sbjct: 228 ----------------------MSGNYQFGSPEWDDYS-DTVKDLVSRFLVVQPQKRYTA 264

Query: 413 KEAMAHPYF 421
           +EA+AHP+F
Sbjct: 265 EEALAHPFF 273

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 8e-52
 Identities = 66/297 (22%), Positives = 124/297 (41%), Gaps = 53/297 (17%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCG 187
           +D+E+ R +G+GK+  V+            +K+L   +      + +++RE++I  +L  
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYC 244
            PNI++L     D       LI E+                 +     YI EL  AL YC
Sbjct: 66  -PNILRLYGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 122

Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS+ ++HRD+KP N+++      L++ D+G +  + P         +  +  PE++   +
Sbjct: 123 HSKRVIHRDIKPENLLLGSAGE-LKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEG-R 179

Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            +D  +DLWSLG +    +  K P F  +   +   +I++V                   
Sbjct: 180 MHDEKVDLWSLGVLCYEFLVGKPP-FEANTYQETYKRISRV------------------- 219

Query: 365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
                        +  F+T          A D + +LL+++  +RP  +E + HP+ 
Sbjct: 220 ----------EFTFPDFVT--------EGARDLISRLLKHNPSQRPMLREVLEHPWI 258

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 2e-51
 Identities = 64/295 (21%), Positives = 124/295 (42%), Gaps = 45/295 (15%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNI 191
           + Y +   +GRG++  V   V  +  +  + K +K     +  +K+EI IL       NI
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNI 63

Query: 192 VKLLDIVRDQQSKTPSLIFEHVNNTD-FKVL---YPTLSDYDVRYYIYELLKALDYCHSQ 247
           + L +     +     +IFE ++  D F+ +      L++ ++  Y++++ +AL + HS 
Sbjct: 64  LHLHESFESMEE--LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121

Query: 248 GIMHRDVKPHNVMID-HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 306
            I H D++P N++        +++I++G A    PG  + +   +  +  PE+       
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH-DVV 180

Query: 307 DYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL 366
             + D+WSLG +   ++    P F    N   +  I     T         +  E    +
Sbjct: 181 STATDMWSLGTLVYVLLSGINP-FLAETNQQIIENIMNAEYT---------FDEEAFKEI 230

Query: 367 AALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
           +                         EA+DF+D+LL  + + R TA EA+ HP+ 
Sbjct: 231 S------------------------IEAMDFVDRLLVKERKSRMTASEALQHPWL 261

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  174 bits (441), Expect = 4e-51
 Identities = 60/300 (20%), Positives = 114/300 (38%), Gaps = 46/300 (15%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPN 190
           D Y++  ++G G +  V              K +       K+ +++EI+ +  L   P 
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH-PT 84

Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL----YPTLSDYDVRYYIYELLKALDYCHS 246
           +V L D   D       +I+E ++  +        +  +S+ +   Y+ ++ K L + H 
Sbjct: 85  LVNLHDAFEDDNE--MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 142

Query: 247 QGIMHRDVKPHNVMIDHEQR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
              +H D+KP N+M   ++  +L+LID+GL     P +   V   +  F  PE+    + 
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG-KP 201

Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH 365
             Y  D+WS+G +   ++    P F G ++ + L  +                       
Sbjct: 202 VGYYTDMWSVGVLSYILLSGLSP-FGGENDDETLRNVKSCDWN---------MDDSAFSG 251

Query: 366 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR 425
           ++                         +  DF+ KLL  D   R T  +A+ HP+  P  
Sbjct: 252 IS------------------------EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 287

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 2e-50
 Identities = 66/298 (22%), Positives = 122/298 (40%), Gaps = 43/298 (14%)

Query: 134 DDYEVVRKV-GRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIV 192
           DDY+V  +V G G   +V +  +    EK  +K+L+     K +RE+++       P+IV
Sbjct: 11  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--DCPKARREVELHWRASQCPHIV 68

Query: 193 KLLDIVRDQQS--KTPSLIFEHVNNTD-FKVLY----PTLSDYDVRYYIYELLKALDYCH 245
           +++D+  +  +  K   ++ E ++  + F  +        ++ +    +  + +A+ Y H
Sbjct: 69  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 128

Query: 246 SQGIMHRDVKPHNVMIDH--EQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 303
           S  I HRDVKP N++         L+L D+G A+             + Y+  PE+L   
Sbjct: 129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP- 187

Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363
           + YD S D+WSLG +   ++    PF Y +        +   +                 
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPPF-YSNHGLAISPGMKTRI----------------- 229

Query: 364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
                      R    +F   E   ++  E    +  LL+ +  +R T  E M HP+ 
Sbjct: 230 -----------RMGQYEFPNPEWSEVS-EEVKMLIRNLLKTEPTQRMTITEFMNHPWI 275

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (435), Expect = 3e-50
 Identities = 76/317 (23%), Positives = 143/317 (45%), Gaps = 18/317 (5%)

Query: 119 EYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKK 173
           +++  E     +     Y+ ++ +G G    V        +    IK L          K
Sbjct: 2   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK 61

Query: 174 KIKREIKILQNLCGGPNIVKLLDIVRDQQS----KTPSLIFEHVNNTDFKVLYPTLSDYD 229
           +  RE+ +++ +    NI+ LL++   Q++    +   L+ E ++    +V+   L    
Sbjct: 62  RAYRELVLMKCVNH-KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER 120

Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRV 289
           + Y +Y++L  + + HS GI+HRD+KP N+++  +    +++D+GLA            V
Sbjct: 121 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL-KILDFGLARTAGTSFMMTPYV 179

Query: 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTD 349
            +RY++ PE+++    Y  ++D+WS+GC+   M+  K   F G D  DQ  K+ + LGT 
Sbjct: 180 VTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHK-ILFPGRDYIDQWNKVIEQLGTP 237

Query: 350 -----ELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRY 404
                +      + ++E  P  A L               E+  L   +A D L K+L  
Sbjct: 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 297

Query: 405 DHQERPTAKEAMAHPYF 421
           D  +R +  +A+ HPY 
Sbjct: 298 DPAKRISVDDALQHPYI 314

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (427), Expect = 5e-50
 Identities = 63/298 (21%), Positives = 116/298 (38%), Gaps = 49/298 (16%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGP 189
           +D+++V+ +G G Y EV   V+    E   +KI+   +     + IK+EI I + L    
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHE 63

Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYP--TLSDYDVRYYIYELLKALDYCHS 246
           N+VK     R  +     L  E+ +  + F  + P   + + D + + ++L+  + Y H 
Sbjct: 64  NVVKFYGHRR--EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121

Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDL 303
            GI HRD+KP N+++D     L++ D+GLA  +         N    +  +  PELL   
Sbjct: 122 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180

Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363
           + +   +D+WS G +   M+  +   +    +  Q     K                   
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGE-LPWDQPSDSCQEYSDWK------------------- 220

Query: 364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
                   +    PW K              +  L K+L  +   R T  +     ++
Sbjct: 221 ------EKKTYLNPWKKID---------SAPLALLHKILVENPSARITIPDIKKDRWY 263

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 5e-49
 Identities = 60/295 (20%), Positives = 117/295 (39%), Gaps = 46/295 (15%)

Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKIKREIKILQNLCGGP 189
           +  Y    K+G+G    V+  +     ++  I+ +      KK+ I  EI +++     P
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNP 77

Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQ 247
           NIV  LD           ++ E++       +     + +  +     E L+AL++ HS 
Sbjct: 78  NIVNYLDSYLVGDE--LWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN 135

Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDY 306
            ++HRD+K  N+++  +   ++L D+G   +      + +  V + Y+  PE++   + Y
Sbjct: 136 QVIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAY 193

Query: 307 DYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL 366
              +D+WSLG M   MI  + P +   +    L  IA                ++    L
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPP-YLNENPLRALYLIAT----------NGTPELQNPEKL 242

Query: 367 AALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
           +                            DFL++ L  D ++R +AKE + H + 
Sbjct: 243 S------------------------AIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  165 bits (418), Expect = 3e-48
 Identities = 64/299 (21%), Positives = 120/299 (40%), Gaps = 54/299 (18%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK------KKIKREIKILQNLCG 187
             +  +R++G G +  V+      ++E   IK +    K      + I +E++ LQ L  
Sbjct: 15  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74

Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYC 244
            PN ++       +   T  L+ E+   +     +V    L + ++    +  L+ L Y 
Sbjct: 75  -PNTIQYRGCYLRE--HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 131

Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
           HS  ++HRDVK  N+++      ++L D+G A    P   +   V + Y+  PE+++ + 
Sbjct: 132 HSHNMIHRDVKAGNILLSEPGL-VKLGDFGSASIMAPANSF---VGTPYWMAPEVILAMD 187

Query: 305 D--YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 362
           +  YD  +D+WSLG     +  RK P F   +    L  IA+           N+     
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLF-NMNAMSALYHIAQ-----------NESPALQ 235

Query: 363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
             H +                            +F+D  L+   Q+RPT++  + H + 
Sbjct: 236 SGHWS------------------------EYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 1e-47
 Identities = 66/305 (21%), Positives = 119/305 (39%), Gaps = 58/305 (19%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNLCGG 188
           +DYEV+  +G G Y    +    +D +  + K L        +K+ +  E+ +L+ L   
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-H 62

Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLY------PTLSDYDVRYYIYELLKAL 241
           PNIV+  D + D+ + T  ++ E+    D   V+         L +  V   + +L  AL
Sbjct: 63  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122

Query: 242 DYCHSQG-----IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFK 295
             CH +      ++HRD+KP NV +D +Q  ++L D+GLA   +    +    V + Y+ 
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQN-VKLGDFGLARILNHDTSFAKAFVGTPYYM 181

Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 355
            PE +     Y+   D+WSLGC+   +     P F      +   KI             
Sbjct: 182 SPEQMNR-MSYNEKSDIWSLGCLLYELCALMPP-FTAFSQKELAGKI------------R 227

Query: 356 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEA 415
                 +    +                         E  + + ++L      RP+ +E 
Sbjct: 228 EGKFRRIPYRYS------------------------DELNEIITRMLNLKDYHRPSVEEI 263

Query: 416 MAHPY 420
           + +P 
Sbjct: 264 LENPL 268

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  162 bits (412), Expect = 2e-47
 Identities = 68/298 (22%), Positives = 124/298 (41%), Gaps = 47/298 (15%)

Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP----VKKKKIKREIKILQNLCGG 188
           +D Y+    +G G +SEV         +   IK +       K+  ++ EI +L  +   
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-KH 66

Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLY--PTLSDYDVRYYIYELLKALDYCH 245
           PNIV L DI          LI + V+  + F  +      ++ D    I+++L A+ Y H
Sbjct: 67  PNIVALDDIYESGGH--LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLH 124

Query: 246 SQGIMHRDVKPHNVMIDH--EQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 303
             GI+HRD+KP N++     E  K+ + D+GL++   PG   +    +  +  PE+L   
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ- 183

Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363
           + Y  ++D WS+G +   ++    PF Y  ++     +I K            ++     
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGYPPF-YDENDAKLFEQILKAEY---------EFDSPYW 233

Query: 364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
             ++                          A DF+  L+  D ++R T ++A+ HP+ 
Sbjct: 234 DDIS------------------------DSAKDFIRHLMEKDPEKRFTCEQALQHPWI 267

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 2e-45
 Identities = 58/301 (19%), Positives = 115/301 (38%), Gaps = 57/301 (18%)

Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---------KKKIKREIKILQ 183
           +  Y+V   +G G +  V+ G+  +DN    IK ++  +           ++  E+ +L+
Sbjct: 3   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62

Query: 184 NLCGG-PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPTLSDYDVRYYIYELLKA 240
            +  G   +++LLD      S    L         F  +     L +   R + +++L+A
Sbjct: 63  KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEA 122

Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 300
           + +CH+ G++HRD+K  N++ID  + +L+LID+G          Y     +R +  PE +
Sbjct: 123 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-TVYTDFDGTRVYSPPEWI 181

Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 360
              + +  S  +WSLG +   M+    PF +  +                    + +  +
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------------------IIRGQV 221

Query: 361 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 420
                ++                         E    +   L     +RPT +E   HP+
Sbjct: 222 FFRQRVS------------------------SECQHLIRWCLALRPSDRPTFEEIQNHPW 257

Query: 421 F 421
            
Sbjct: 258 M 258

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 7e-45
 Identities = 70/306 (22%), Positives = 124/306 (40%), Gaps = 61/306 (19%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCG 187
           +D++  + +G G +S V        + +  IKIL+        K   + RE  ++  L  
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTD---FKVLYPTLSDYDVRYYIYELLKALDYC 244
            P  VKL    +D +         +  N +   +     +  +   R+Y  E++ AL+Y 
Sbjct: 68  -PFFVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 124

Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLV 301
           H +GI+HRD+KP N++++ +   +++ D+G A+   P  +    N  V +  +  PELL 
Sbjct: 125 HGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183

Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 361
           + +    S DLW+LGC+   ++    P F   + Y    KI K+               +
Sbjct: 184 E-KSACKSSDLWALGCIIYQLVAGLPP-FRAGNEYLIFQKIIKL-------------EYD 228

Query: 362 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEA------ 415
                                         P+A D ++KLL  D  +R   +E       
Sbjct: 229 FPEKFF------------------------PKARDLVEKLLVLDATKRLGCEEMEGYGPL 264

Query: 416 MAHPYF 421
            AHP+F
Sbjct: 265 KAHPFF 270

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 1e-44
 Identities = 64/306 (20%), Positives = 132/306 (43%), Gaps = 53/306 (17%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---------KKKIKREIKILQN 184
           D Y+   ++G G+++ V +    +   +   K +K  +         ++ I+RE+ IL+ 
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKAL 241
           +   PN++ L ++  ++      LI E V      DF     +L++ +   ++ ++L  +
Sbjct: 70  IQH-PNVITLHEVYENKTD--VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 126

Query: 242 DYCHSQGIMHRDVKPHNVMIDHE---QRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
            Y HS  I H D+KP N+M+      + ++++ID+GLA     G E+     +  F  PE
Sbjct: 127 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186

Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 358
           ++ + +      D+WS+G +   ++    PF  G    + L  ++ V           ++
Sbjct: 187 IV-NYEPLGLEADMWSIGVITYILLSGASPF-LGDTKQETLANVSAVNY---------EF 235

Query: 359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
             E   + +                          A DF+ +LL  D ++R T ++++ H
Sbjct: 236 EDEYFSNTS------------------------ALAKDFIRRLLVKDPKKRMTIQDSLQH 271

Query: 419 PYFFPI 424
           P+  P 
Sbjct: 272 PWIKPK 277

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 2e-44
 Identities = 56/298 (18%), Positives = 114/298 (38%), Gaps = 51/298 (17%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPN 190
            +   ++GRG +  V++G+      +     L+  K     +++ K E ++L+ L   PN
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH-PN 69

Query: 191 IVKLLDIVRD--QQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCH 245
           IV+  D      +  K   L+ E + +   K     +  +    +R +  ++LK L + H
Sbjct: 70  IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129

Query: 246 SQG--IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 303
           ++   I+HRD+K  N+ I      +++ D GLA          V + +  F  PE+    
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV-IGTPEFMAPEMY--E 186

Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363
           + YD S+D+++ G     M   + P+    +      ++                    D
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-----------GVKPASFD 235

Query: 364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 421
                                      +PE  + ++  +R +  ER + K+ + H +F
Sbjct: 236 KVA------------------------IPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 3e-42
 Identities = 59/299 (19%), Positives = 118/299 (39%), Gaps = 53/299 (17%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCG 187
           +D+ + + +G+G + +VF       N+   IK LK          +    E ++L     
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYC 244
            P +  +    + +++     + E++N  D                 +Y  E++  L + 
Sbjct: 62  HPFLTHMFCTFQTKEN--LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFL 119

Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDL 303
           HS+GI++RD+K  N+++D +    ++ D+G+  E      + N    +  +  PE+L+  
Sbjct: 120 HSKGIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG- 177

Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363
           Q Y++S+D WS G +   M+  + P F+G D  +    I                     
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQSP-FHGQDEEELFHSI--------------------- 215

Query: 364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK-EAMAHPYF 421
                   R     + +++          EA D L KL   + ++R   + +   HP F
Sbjct: 216 --------RMDNPFYPRWLE--------KEAKDLLVKLFVREPEKRLGVRGDIRQHPLF 258

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  149 bits (377), Expect = 8e-42
 Identities = 70/307 (22%), Positives = 121/307 (39%), Gaps = 55/307 (17%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCG 187
           +D+ V R +GRG + EV+        +   +K L   +      +     E  +L  +  
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 188 G--PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALD 242
           G  P IV +            S I + +N  D       +   S+ D+R+Y  E++  L+
Sbjct: 64  GDCPFIVCMSYAFHTPDK--LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 121

Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
           + H++ +++RD+KP N+++D E   +R+ D GLA  +   K +     +  +  PE+L  
Sbjct: 122 HMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQK 179

Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 362
              YD S D +SLGCM   ++    P F  H   D+           E++       +EL
Sbjct: 180 GVAYDSSADWFSLGCMLFKLLRGHSP-FRQHKTKDKH----------EIDRMTLTMAVEL 228

Query: 363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT-----AKEAMA 417
               +                        PE    L+ LL+ D   R       A+E   
Sbjct: 229 PDSFS------------------------PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264

Query: 418 HPYFFPI 424
            P+F  +
Sbjct: 265 SPFFRSL 271

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  145 bits (365), Expect = 4e-40
 Identities = 73/328 (22%), Positives = 128/328 (39%), Gaps = 33/328 (10%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVKKKKIKREIKILQNL-------- 185
           Y +VRK+G G +S V+      +N    +KI++   V  +  + EIK+LQ +        
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74

Query: 186 --CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF------KVLYPTLSDYDVRYYIYEL 237
              G  +I+KLLD    +      ++       +       K  +  +    V+    +L
Sbjct: 75  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134

Query: 238 LKALDYCH-SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS---RY 293
           L  LDY H   GI+H D+KP NV+++       LI   +A+  +          S   R 
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194

Query: 294 FKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF-----FYGHDNYDQLVKIAKVLGT 348
           ++ PE+L+    +    D+WS  C+   +I     F          + D + +I ++LG 
Sbjct: 195 YRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGE 253

Query: 349 DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAV-----PEAVDFLDKLLR 403
                  N  +     +   L+   S+  +     V  +          E  DFL  +L+
Sbjct: 254 LPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQ 313

Query: 404 YDHQERPTAKEAMAHPYFFPIRNAESSR 431
            D ++R  A   + HP+       E  R
Sbjct: 314 LDPRKRADAGGLVNHPWLKDTLGMEEIR 341

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 4e-39
 Identities = 46/299 (15%), Positives = 109/299 (36%), Gaps = 54/299 (18%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNLCGG 188
               V +++G G +  V++G     +    +K+L      P + +  K E+ +L+     
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH- 63

Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLY---PTLSDYDVRYYIYELLKALDYC 244
            NI+  +      Q    +++ +    +  +  L+          +     +  + +DY 
Sbjct: 64  VNILLFMGYSTAPQ---LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 120

Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELLV 301
           H++ I+HRD+K +N+ +  +   +++ D+GLA         +       S  +  PE++ 
Sbjct: 121 HAKSIIHRDLKSNNIFLHEDLT-VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179

Query: 302 DLQD--YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 359
                 Y +  D+++ G +   ++  + P +   +N DQ++ +                 
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQIIFMVG--------------R 224

Query: 360 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
             L P L+ +                            + + L+    ERP   + +A 
Sbjct: 225 GYLSPDLSKVRSNCP-----------------KAMKRLMAECLKKKRDERPLFPQILAS 266

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  139 bits (351), Expect = 7e-39
 Identities = 54/301 (17%), Positives = 99/301 (32%), Gaps = 50/301 (16%)

Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK------PVKKKKIKREIKILQNLC 186
            D YE+   +G G  SEV        +    +K+L+      P    + +RE +    L 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL- 64

Query: 187 GGPNIVKLLDIVRDQ--QSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKAL 241
             P IV + D    +      P ++ E+V+    + +      ++       I +  +AL
Sbjct: 65  NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 124

Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQR---KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
           ++ H  GI+HRDVKP N+MI            I   +A+  +   +    + +  +  PE
Sbjct: 125 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184

Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 358
                   D   D++SLGC+   ++  + P F G        +  +              
Sbjct: 185 QARG-DSVDARSDVYSLGCVLYEVLTGEPP-FTGDSPVSVAYQHVREDPIPPS------- 235

Query: 359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
                  L+                         +    + K L  + + R      M  
Sbjct: 236 --ARHEGLS------------------------ADLDAVVLKALAKNPENRYQTAAEMRA 269

Query: 419 P 419
            
Sbjct: 270 D 270

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 6e-38
 Identities = 40/291 (13%), Positives = 102/291 (35%), Gaps = 50/291 (17%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-PVKKKKIKREIKILQNLCGGPNIV 192
            + ++++ +G+G++ +V  G +     K  +K +K     +    E  ++  L    N+V
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRH-SNLV 63

Query: 193 KLLDIVRDQQSKTPSLIFEHVNNTD-FKVLY----PTLSDYDVRYYIYELLKALDYCHSQ 247
           +LL ++ +++     ++ E++        L       L    +  +  ++ +A++Y    
Sbjct: 64  QLLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 122

Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 307
             +HRD+   NV++  +    ++ D+GL +     +  +       +  PE L + + + 
Sbjct: 123 NFVHRDLAARNVLVSEDNV-AKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALRE-KKFS 178

Query: 308 YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLA 367
              D+WS G +   +       +      D + ++ K             Y ++      
Sbjct: 179 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------------GYKMDAPDGCP 226

Query: 368 ALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
                                   P   + +      D   RP+  +    
Sbjct: 227 ------------------------PAVYEVMKNCWHLDAAMRPSFLQLREQ 253

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 6e-38
 Identities = 54/323 (16%), Positives = 109/323 (33%), Gaps = 77/323 (23%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNE-----KCIIKILK----PVKKKKIKREIKILQN 184
           ++ E  + +G G + +V        ++     +  +K+LK      +++ +  E+K++  
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLY--------------------- 222
           L    NIV LL       S    LIFE+    D    L                      
Sbjct: 97  LGSHENIVNLLGACTL--SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154

Query: 223 ----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278
                 L+  D+  + Y++ K +++   +  +HRD+   NV++ H +  +++ D+GLA  
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV-VKICDFGLARD 213

Query: 279 YHPGKEYNVR---VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN 335
                 Y VR        +  PE L +   Y    D+WS G +   +       + G   
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272

Query: 336 YDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAV 395
                K+ +           N + ++   +                           E  
Sbjct: 273 DANFYKLIQ-----------NGFKMDQPFYAT------------------------EEIY 297

Query: 396 DFLDKLLRYDHQERPTAKEAMAH 418
             +     +D ++RP+     + 
Sbjct: 298 IIMQSCWAFDSRKRPSFPNLTSF 320

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (347), Expect = 7e-38
 Identities = 55/307 (17%), Positives = 124/307 (40%), Gaps = 54/307 (17%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTD---NEKCIIKILKPVK-------KKKIKREIKILQ 183
           +++E+++ +G G Y +VF     +     +   +K+LK           +  + E ++L+
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-YPTLSDYDVRYYIYELLKALD 242
           ++   P +V L    + +      L + +       +      ++++V+ Y+ E++ AL+
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143

Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPEL 299
           + H  GI++RD+K  N+++D     + L D+GL++ +   +    Y+      Y     +
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202

Query: 300 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 359
                 +D ++D WSLG +   ++    P F      +   +I++ +   E         
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGASP-FTVDGEKNSQAEISRRILKSEP-------- 253

Query: 360 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-----TAKE 414
                            P+ + ++          A D + +LL  D ++R       A E
Sbjct: 254 -----------------PYPQEMS--------ALAKDLIQRLLMKDPKKRLGCGPRDADE 288

Query: 415 AMAHPYF 421
              H +F
Sbjct: 289 IKEHLFF 295

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 3e-37
 Identities = 58/300 (19%), Positives = 106/300 (35%), Gaps = 52/300 (17%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCG 187
           +D++ ++ +G+G + +V             +KIL+               E ++LQN   
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 188 GPNIVKLLDIVRDQQSK-TPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHS 246
            P +  L    +                           ++   R+Y  E++ AL+Y HS
Sbjct: 65  -PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123

Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 306
           + +++RD+K  N+M+D +   +++ D+GL +                      +++  DY
Sbjct: 124 RDVVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182

Query: 307 DYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL 366
             ++D W LG +   M+  + P FY  D+      I                 I     L
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLP-FYNQDHERLFELI-------------LMEEIRFPRTL 228

Query: 367 AALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-----TAKEAMAHPYF 421
           +                        PEA   L  LL+ D ++R       AKE M H +F
Sbjct: 229 S------------------------PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  135 bits (340), Expect = 7e-37
 Identities = 55/300 (18%), Positives = 111/300 (37%), Gaps = 55/300 (18%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK------PVKKKKIKREIKILQNLCG 187
            D++++R +G G +  V       +     +K+LK        + +    E  +L  +  
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-T 62

Query: 188 GPNIVKLLDIVRDQQSKTPSLIF-EHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHS 246
            P I+++    +D Q     + + E               +   ++Y  E+  AL+Y HS
Sbjct: 63  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122

Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 306
           + I++RD+KP N+++D +   +++ D+G A++            +  +  PE++   + Y
Sbjct: 123 KDIIYRDLKPENILLD-KNGHIKITDFGFAKYVP--DVTYTLCGTPDYIAPEVVST-KPY 178

Query: 307 DYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL 366
           + S+D WS G +   M+    P FY  +      KI                 +   P  
Sbjct: 179 NKSIDWWSFGILIYEMLAGYTP-FYDSNTMKTYEKILNA-------------ELRFPPFF 224

Query: 367 AALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQER-----PTAKEAMAHPYF 421
                                     +  D L +L+  D  +R        ++   HP+F
Sbjct: 225 N------------------------EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 260

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (334), Expect = 2e-36
 Identities = 42/299 (14%), Positives = 92/299 (30%), Gaps = 56/299 (18%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCI---IKILKPVK------KKKIKREIKILQN 184
            D  ++ K+G G +  V  G     + K +   +K LKP             RE+  + +
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKA 240
           L    N+++L  +V     K   ++ E                      +  Y  ++ + 
Sbjct: 68  LDH-RNLIRLYGVVLTPPMK---MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123

Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGP 297
           + Y  S+  +HRD+   N+++      +++ D+GL        ++ V        +    
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDL-VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182

Query: 298 ELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 357
              +  + + ++ D W  G     M    +  + G +    L KI K             
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK-----------EG 231

Query: 358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAM 416
             +                                +  + + +   +  ++RPT     
Sbjct: 232 ERLPRPEDCP------------------------QDIYNVMVQCWAHKPEDRPTFVALR 266

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 4e-36
 Identities = 48/299 (16%), Positives = 103/299 (34%), Gaps = 54/299 (18%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNI 191
           +   +  K+G+G + EV+ G       +  IK LKP  +  +   +E ++++ L     +
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRH-EKL 74

Query: 192 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHS 246
           V+L  +V ++      ++ E+++               L    +     ++   + Y   
Sbjct: 75  VQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131

Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY--NVRVASRYFKGPELLVDLQ 304
              +HRD++  N+++  E    ++ D+GLA      +            +  PE  +   
Sbjct: 132 MNYVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-G 189

Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
            +    D+WS G +   +  +    + G  N + L ++               Y +   P
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV------------ERGYRMPCPP 237

Query: 365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKE--AMAHPYF 421
                                          D + +  R + +ERPT +   A    YF
Sbjct: 238 ECP------------------------ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 7e-36
 Identities = 41/298 (13%), Positives = 103/298 (34%), Gaps = 52/298 (17%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNI 191
           +  ++V ++G G++ EV+ G +   + K  +K LK   +       E  +++ L     +
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQH-QRL 70

Query: 192 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHS 246
           V+L  +V  +      +I E++ N              L+   +     ++ + + +   
Sbjct: 71  VRLYAVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127

Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG-PELLVDLQD 305
           +  +HRD++  N+++  +    ++ D+GLA      +      A    K      ++   
Sbjct: 128 RNYIHRDLRAANILV-SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186

Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH 365
           +    D+WS G +   ++      + G  N + +  + +             Y +    +
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER------------GYRMVRPDN 234

Query: 366 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKE--AMAHPYF 421
                                      E    +    +   ++RPT     ++   +F
Sbjct: 235 CP------------------------EELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 1e-35
 Identities = 42/293 (14%), Positives = 100/293 (34%), Gaps = 50/293 (17%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNI 191
            +   V+++G G++  V  G    + +K  IK ++   + ++    E +++  L   P +
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSH-PKL 62

Query: 192 VKLLDIVRDQQSKTPSLIFEHVNNTD----FKVLYPTLSDYDVRYYIYELLKALDYCHSQ 247
           V+L  +  +Q      L+FE + +       +      +   +     ++ + + Y    
Sbjct: 63  VQLYGVCLEQAP--ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120

Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR--VASRYFKGPELLVDLQD 305
            ++HRD+   N ++   Q  +++ D+G+  F    +  +         +  PE+      
Sbjct: 121 CVIHRDLAARNCLVGENQV-IKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SR 178

Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH 365
           Y    D+WS G +   +    +  +    N + +  I+                      
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST--------------------- 217

Query: 366 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
                G    KP           LA       ++   +   ++RP     +  
Sbjct: 218 -----GFRLYKP----------RLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  132 bits (332), Expect = 2e-35
 Identities = 58/303 (19%), Positives = 112/303 (36%), Gaps = 55/303 (18%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK------REIKILQNLCG 187
           D ++ ++ +G G +  V    H        +KIL   K  K+K       E +ILQ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99

Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-YPTLSDYDVRYYIYELLKALDYCHS 246
            P +VKL    +D  +    + +         +      S+   R+Y  +++   +Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159

Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 306
             +++RD+KP N++ID +   +++ D+G A+             +     PE+++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKG--RTWTLCGTPEALAPEIILS-KGY 215

Query: 307 DYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL 366
           + ++D W+LG +   M     PFF   D   Q+ +             +    +    H 
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFF--ADQPIQIYE------------KIVSGKVRFPSHF 261

Query: 367 AALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQER-----PTAKEAMAHPYF 421
           +                         +  D L  LL+ D  +R         +   H +F
Sbjct: 262 S------------------------SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

Query: 422 FPI 424
              
Sbjct: 298 ATT 300

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 3e-35
 Identities = 47/293 (16%), Positives = 106/293 (36%), Gaps = 50/293 (17%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNI 191
            D   ++++G G++  V  G          IK++K   + + +   E K++ NL     +
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSH-EKL 61

Query: 192 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQ 247
           V+L  +   Q  +   +I E++ N                  +     ++ +A++Y  S+
Sbjct: 62  VQLYGVCTKQ--RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 119

Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV--RVASRYFKGPELLVDLQD 305
             +HRD+   N +++ +   +++ D+GL+ +    +  +         +  PE+L+    
Sbjct: 120 QFLHRDLAARNCLVNDQGV-VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SK 177

Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH 365
           +    D+W+ G +   +    +  +    N +    IA+                     
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ--------------------- 216

Query: 366 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
                G    +P          HLA  +    +         ERPT K  +++
Sbjct: 217 -----GLRLYRP----------HLASEKVYTIMYSCWHEKADERPTFKILLSN 254

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 4e-35
 Identities = 53/297 (17%), Positives = 105/297 (35%), Gaps = 53/297 (17%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK-------KKIKREIKILQNLC 186
           +  E+ R +G G++ +V +G++ +     +   +K  K        +K  +E   ++   
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF- 65

Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALD 242
             P+IVKL+ ++ +       +I E     + +        +L    +  Y Y+L  AL 
Sbjct: 66  DHPHIVKLIGVITENP---VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 122

Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV-RVASRYFKGPELLV 301
           Y  S+  +HRD+   NV++      ++L D+GL+ +      Y   +            +
Sbjct: 123 YLESKRFVHRDIAARNVLVS-SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 181

Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 361
           + + +  + D+W  G     ++      F G  N D + +I             N   + 
Sbjct: 182 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI------------ENGERLP 229

Query: 362 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
           + P+                          P     + K   YD   RP   E  A 
Sbjct: 230 MPPNCP------------------------PTLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  128 bits (323), Expect = 1e-34
 Identities = 47/305 (15%), Positives = 101/305 (33%), Gaps = 50/305 (16%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIV 192
           + Y + RK+G G + +++ G      E+  IK+     K  ++  E KI + + GG  I 
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIP 66

Query: 193 KLLDIVRDQQSKTPSLIFEHVNNTD---FKVLYPTLSDYDVRYYIYELLKALDYCHSQGI 249
            +     +       ++ E +  +    F       S   V     +++  ++Y HS+  
Sbjct: 67  TIRWCGAEGDY--NVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNF 124

Query: 250 MHRDVKPHNVMIDHEQRKLRL--IDWGLAEFYHPGKEYNVR--------VASRYFKGPEL 299
           +HRDVKP N ++   ++   +  ID+GLA+ Y   + +             +  +     
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184

Query: 300 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 359
            +   +     DL SLG +         P+                    +   Y     
Sbjct: 185 HLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA-------------TKRQKYERISE 230

Query: 360 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA---KEAM 416
            ++   +  L   +                   E   +L+        ++P     ++  
Sbjct: 231 KKMSTPIEVLCKGYP-----------------SEFATYLNFCRSLRFDDKPDYSYLRQLF 273

Query: 417 AHPYF 421
            + + 
Sbjct: 274 RNLFH 278

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 2e-34
 Identities = 46/310 (14%), Positives = 98/310 (31%), Gaps = 65/310 (20%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK------PVKKKKIKREIKILQNLCG 187
           +D +    +G G + +V +     D  +    I +          +    E+++L  L  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-------------------FKVLYPTLSDY 228
            PNI+ LL     +      L  E+  + +                         TLS  
Sbjct: 70  HPNIINLLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127

Query: 229 DVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR 288
            + ++  ++ + +DY   +  +HRD+   N+++  E    ++ D+GL+       +  + 
Sbjct: 128 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVG-ENYVAKIADFGLSRGQEVYVKKTMG 186

Query: 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
                +   E L     Y  + D+WS G +   ++      + G    +   K+      
Sbjct: 187 RLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL------ 239

Query: 349 DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQE 408
                    Y +E   +                           E  D + +  R    E
Sbjct: 240 ------PQGYRLEKPLNCD------------------------DEVYDLMRQCWREKPYE 269

Query: 409 RPTAKEAMAH 418
           RP+  + +  
Sbjct: 270 RPSFAQILVS 279

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  126 bits (317), Expect = 7e-34
 Identities = 43/295 (14%), Positives = 97/295 (32%), Gaps = 49/295 (16%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL-KPVKKKKIKREIKILQNLCGGPNIVKL 194
           Y+V R++G G +  +FEG +  +N++  IK   +     +++ E +  + L G   I  +
Sbjct: 7   YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 66

Query: 195 LDIVRDQQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMH 251
               ++       L+ + +  +   +L       S   V     ++L  +   H + +++
Sbjct: 67  YYFGQEG--LHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVY 124

Query: 252 RDVKPHNVMID----HEQRKLRLIDWGLAEFYHPG--------KEYNVRVASRYFKGPEL 299
           RD+KP N +I          + ++D+G+ +FY           +E      +  +     
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184

Query: 300 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 359
            +  ++     DL +LG +F   +      + G        K  ++    +     +   
Sbjct: 185 HLG-REQSRRDDLEALGHVFMYFLRGS-LPWQGLKAATNKQKYERIGEKKQ-----STPL 237

Query: 360 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKE 414
            EL                              E   ++           P    
Sbjct: 238 RELCAGFP------------------------EEFYKYMHYARNLAFDATPDYDY 268

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 2e-33
 Identities = 53/315 (16%), Positives = 100/315 (31%), Gaps = 70/315 (22%)

Query: 134 DDYEVVRKVGRGKYSEVFEG-----VHCTDNEKCIIKILKPVK----KKKIKREIKILQN 184
           +     + +G G + +V E      +         +K+LKP      ++ +  E+K+L  
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD---------------------FKVLYP 223
           L    NIV LL            +I E+    D                      +    
Sbjct: 83  LGNHMNIVNLLGACTIG--GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140

Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
            L   D+  + Y++ K + +  S+  +HRD+   N+++ H +   ++ D+GLA       
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT-KICDFGLARDIKNDS 199

Query: 284 EYNVRVASRYFKG--PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 341
            Y V+  +R          +    Y +  D+WS G     +       + G     +  K
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259

Query: 342 IAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKL 401
           + K             + +    H                           E  D +   
Sbjct: 260 MIK-----------EGFRMLSPEHAP------------------------AEMYDIMKTC 284

Query: 402 LRYDHQERPTAKEAM 416
              D  +RPT K+ +
Sbjct: 285 WDADPLKRPTFKQIV 299

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  124 bits (311), Expect = 4e-33
 Identities = 44/290 (15%), Positives = 100/290 (34%), Gaps = 46/290 (15%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVKKKKIKREIKILQNLCGGPNI 191
            D  +  K+G G+Y EV+EGV    +    +K LK   ++ ++  +E  +++ +   PN+
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH-PNL 75

Query: 192 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQ 247
           V+LL +   +        F          L       +S   + Y   ++  A++Y   +
Sbjct: 76  VQLLGVCTREPPFYIITEF-MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 134

Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLVDLQDY 306
             +HRD+   N ++  E   +++ D+GL+          +              +    +
Sbjct: 135 NFIHRDLAARNCLVG-ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 193

Query: 307 DYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL 366
               D+W+ G +   +       + G D   Q+ ++ +             Y +E     
Sbjct: 194 SIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLE-----------KDYRMERPEGC 241

Query: 367 AALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAM 416
                                     +  + +    +++  +RP+  E  
Sbjct: 242 P------------------------EKVYELMRACWQWNPSDRPSFAEIH 267

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 9e-33
 Identities = 44/301 (14%), Positives = 102/301 (33%), Gaps = 57/301 (18%)

Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVKKKK----IKREIKILQN 184
           + +++ ++ +G G +  V++G+   + E       IK L+     K    I  E  ++ +
Sbjct: 8   ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 67

Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKA 240
           +   P++ +LL I       T  LI + +               +    +  +  ++ K 
Sbjct: 68  VDN-PHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 123

Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGP 297
           ++Y   + ++HRD+   NV++   Q  +++ D+GLA+     ++            +   
Sbjct: 124 MNYLEDRRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182

Query: 298 ELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 357
           E ++  + Y +  D+WS G     ++      + G    +    + K             
Sbjct: 183 ESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK------------G 229

Query: 358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 417
             +   P                            +    + K    D   RP  +E + 
Sbjct: 230 ERLPQPPICT------------------------IDVYMIMVKCWMIDADSRPKFRELII 265

Query: 418 H 418
            
Sbjct: 266 E 266

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 1e-32
 Identities = 47/303 (15%), Positives = 101/303 (33%), Gaps = 58/303 (19%)

Query: 140 RKVGRGKYSEVFEGVHC--TDNEKCIIKILK-----PVKKKKIKREIKILQNLCGGPNIV 192
           +++G G +  V +G +      +   +KILK     P  K ++  E  ++Q L   P IV
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN-PYIV 71

Query: 193 KLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGI 249
           +++ I    ++++  L+ E                + D ++   ++++   + Y      
Sbjct: 72  RMIGIC---EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 128

Query: 250 MHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKGPELLVDLQD 305
           +HRD+   NV++   Q   ++ D+GL++     + Y            +  PE +     
Sbjct: 129 VHRDLAARNVLLV-TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-YK 186

Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH 365
           +    D+WS G +        +  + G    +    + K               +     
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK------------GERMGCPAG 234

Query: 366 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKE--AMAHPYFFP 423
                                      E  D ++    YD + RP           Y++ 
Sbjct: 235 CP------------------------REMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270

Query: 424 IRN 426
           + N
Sbjct: 271 VVN 273

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 2e-32
 Identities = 50/308 (16%), Positives = 105/308 (34%), Gaps = 60/308 (19%)

Query: 132 EQDDYEVV-RKVGRGKYSEVFEGVHCTDNEKCI--IKILKPVKKKK----IKREIKILQN 184
           ++D+  +   ++G G +  V +GV+    ++    IK+LK   +K     + RE +I+  
Sbjct: 6   KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65

Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLY---PTLSDYDVRYYIYELLKA 240
           L   P IV+L+ + + +      L+ E        K L      +   +V   ++++   
Sbjct: 66  L-DNPYIVRLIGVCQAEA---LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMG 121

Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKG 296
           + Y   +  +HRD+   NV++   +   ++ D+GL++       Y            +  
Sbjct: 122 MKYLEEKNFVHRDLAARNVLLV-NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 180

Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 356
           PE +   + +    D+WS G      +   +  +      + +  I              
Sbjct: 181 PECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI------------EQ 227

Query: 357 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKE-- 414
              +E  P                           PE    +     Y  ++RP      
Sbjct: 228 GKRMECPPECP------------------------PELYALMSDCWIYKWEDRPDFLTVE 263

Query: 415 -AMAHPYF 421
             M   Y+
Sbjct: 264 QRMRACYY 271

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  122 bits (307), Expect = 2e-32
 Identities = 41/301 (13%), Positives = 90/301 (29%), Gaps = 56/301 (18%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK-------KKIKREIKILQNLC 186
              ++ + +G G++ EV  G      ++ I   +K +K        +    E  I+    
Sbjct: 26  SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 85

Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALD 242
             PN++ L  +V    S    +I E + N              +   +   +  +   + 
Sbjct: 86  H-PNVIHLEGVVTK--STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMK 142

Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
           Y      +HRD+   N++++      ++ D+GL+ F           ++   K P     
Sbjct: 143 YLADMNYVHRDLAARNILVNSNLV-CKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTA 201

Query: 303 -----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 357
                 + +  + D+WS G +   ++   E  ++   N D +  I               
Sbjct: 202 PEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI------------EQD 249

Query: 358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 417
           Y +                                     +    + D   RP   + + 
Sbjct: 250 YRLPPPMDCP------------------------SALHQLMLDCWQKDRNHRPKFGQIVN 285

Query: 418 H 418
            
Sbjct: 286 T 286

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  118 bits (296), Expect = 6e-31
 Identities = 47/320 (14%), Positives = 96/320 (30%), Gaps = 78/320 (24%)

Query: 133 QDDYEVVRKVGRGKYSEVFEGVH-----CTDNEKCIIKILKPVK----KKKIKREIKILQ 183
           +++ E VR +G G +  VF+                +K+LK       +   +RE  ++ 
Sbjct: 12  RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMA 71

Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK------------------------ 219
                PNIVKLL +    +     L+FE++   D                          
Sbjct: 72  EFDN-PNIVKLLGVCAVGKP--MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 128

Query: 220 ---VLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
                 P LS  +      ++   + Y   +  +HRD+   N ++  E   +++ D+GL+
Sbjct: 129 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG-ENMVVKIADFGLS 187

Query: 277 EFYHPGKEYNV--RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD 334
              +    Y      A      P   +    Y    D+W+ G +   +       +YG  
Sbjct: 188 RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247

Query: 335 NYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEA 394
           + + +  +             +   +    +                           E 
Sbjct: 248 HEEVIYYV------------RDGNILACPENC------------------------PLEL 271

Query: 395 VDFLDKLLRYDHQERPTAKE 414
            + +         +RP+   
Sbjct: 272 YNLMRLCWSKLPADRPSFCS 291

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (291), Expect = 4e-30
 Identities = 48/295 (16%), Positives = 106/295 (35%), Gaps = 56/295 (18%)

Query: 140 RKVGRGKYSEVFEGVHCTDNEKCI---IKILKPVKK----KKIKREIKILQNLCGGPNIV 192
             +GRG +  V+ G    ++ K I   +K L  +       +   E  I+++    PN++
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH-PNVL 91

Query: 193 KLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQG 248
            LL I    +   P ++  ++ + D +          +  D+  +  ++ K + +  S+ 
Sbjct: 92  SLLGICLRSEGS-PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 150

Query: 249 IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY-----FKGPELLVDL 303
            +HRD+   N M+D +   +++ D+GLA   +  +  +V   +       +   E L   
Sbjct: 151 FVHRDLAARNCMLDEKFT-VKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT- 208

Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363
           Q +    D+WS G +   ++ R  P +   + +D  V +            L    +   
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL------------LQGRRLLQP 256

Query: 364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 418
            +                              + + K      + RP+  E ++ 
Sbjct: 257 EYCP------------------------DPLYEVMLKCWHPKAEMRPSFSELVSR 287

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (279), Expect = 1e-28
 Identities = 41/300 (13%), Positives = 98/300 (32%), Gaps = 57/300 (19%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEK----CIIKILKPV----KKKKIKREIKILQNL 185
                 + +G G++ EV++G+  T + K      IK LK      ++     E  I+   
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 186 CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKAL 241
               NI++L  ++   +     +I E++ N              S   +   +  +   +
Sbjct: 67  SH-HNIIRLEGVISKYKPMM--IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM 123

Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGP 297
            Y  +   +HRD+   N++++      ++ D+GL+       E     +       +  P
Sbjct: 124 KYLANMNYVHRDLAARNILVN-SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182

Query: 298 ELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 357
           E +   +    S D+WS G +   ++   E  ++   N++ +  I             + 
Sbjct: 183 EAISYRKFTSAS-DVWSFGIVMWEVMTYGERPYWELSNHEVMKAI------------NDG 229

Query: 358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 417
           + +                                     + +  + +   RP   + ++
Sbjct: 230 FRLPTPMDC------------------------PSAIYQLMMQCWQQERARRPKFADIVS 265

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 2e-28
 Identities = 48/306 (15%), Positives = 100/306 (32%), Gaps = 42/306 (13%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQ-NLCGGPNIV 192
               +   +G+G++ EV+ G      E+  +KI    +++   RE +I Q  +    NI+
Sbjct: 3   RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENIL 60

Query: 193 KLLDIVRDQQSKTPS--LIFEHVNNTD-FKVLY-PTLSDYDVRYYIYELLKALDYCHSQ- 247
             +              L+ ++  +   F  L   T++   +          L + H + 
Sbjct: 61  GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 120

Query: 248 -------GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-----NVRVASRYFK 295
                   I HRD+K  N+++        + D GLA  +    +      N RV ++ + 
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGT-CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179

Query: 296 GPELL-----VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE 350
            PE+L     +   +     D++++G +F  +  R        D       +     + E
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239

Query: 351 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP 410
                          +  +V     +P            A+      + +    +   R 
Sbjct: 240 --------------EMRKVVCEQKLRP--NIPNRWQSCEALRVMAKIMRECWYANGAARL 283

Query: 411 TAKEAM 416
           TA    
Sbjct: 284 TALRIK 289

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (272), Expect = 1e-27
 Identities = 51/318 (16%), Positives = 107/318 (33%), Gaps = 73/318 (22%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNE-------KCIIKILKPVKKKK----IKREIKIL 182
           D   + + +G G + +V        ++       K  +K+LK    +K    +  E++++
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 183 QNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-------------------YP 223
           + +    NI+ LL            +I E+ +  + +                       
Sbjct: 73  KMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130

Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
            LS  D+    Y++ + ++Y  S+  +HRD+   NV++  +    ++ D+GLA   H   
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVM-KIADFGLARDIHHID 189

Query: 284 EY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
            Y           +  PE L D + Y +  D+WS G +   +       + G    ++L 
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-EELF 247

Query: 341 KIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDK 400
           K+ K             + ++   +                           E    +  
Sbjct: 248 KLLK-----------EGHRMDKPSNCT------------------------NELYMMMRD 272

Query: 401 LLRYDHQERPTAKEAMAH 418
                  +RPT K+ +  
Sbjct: 273 CWHAVPSQRPTFKQLVED 290

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (271), Expect = 2e-27
 Identities = 48/317 (15%), Positives = 106/317 (33%), Gaps = 71/317 (22%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKP----VKKKKIKREIKILQN 184
           D  ++ + +GRG + +V E                +K+LK      + + +  E+KIL +
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK-------------------VLYPTL 225
           +    N+V LL            +I E     +                     +    L
Sbjct: 73  IGHHLNVVNLLGACTKPGGP-LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131

Query: 226 SDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285
           +   +  Y +++ K +++  S+  +HRD+   N+++  E+  +++ D+GLA   +   +Y
Sbjct: 132 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDY 190

Query: 286 ----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 341
               + R+  ++     +    + Y    D+WS G +   +       + G    ++  +
Sbjct: 191 VRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248

Query: 342 IAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKL 401
             K               +    +                          PE    +   
Sbjct: 249 RLK-----------EGTRMRAPDYTT------------------------PEMYQTMLDC 273

Query: 402 LRYDHQERPTAKEAMAH 418
              +  +RPT  E + H
Sbjct: 274 WHGEPSQRPTFSELVEH 290

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (270), Expect = 3e-27
 Identities = 48/319 (15%), Positives = 104/319 (32%), Gaps = 72/319 (22%)

Query: 134 DDYEVVRKVGRGKYSEVFEGVH-----CTDNEKCIIKILKPVK----KKKIKREIKILQN 184
           +   + R++G+G +  V+EGV           +  IK +        + +   E  +++ 
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-------------YPTLSDYDVR 231
                ++V+LL +V   Q +   +I E +   D K                   S   + 
Sbjct: 80  F-NCHHVVRLLGVV--SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136

Query: 232 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY---NVR 288
               E+   + Y ++   +HRD+   N M+  +   +++ D+G+    +    Y      
Sbjct: 137 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT-VKIGDFGMTRDIYETDYYRKGGKG 195

Query: 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
           +    +  PE L D   +    D+WS G +   +    E  + G  N   L  +      
Sbjct: 196 LLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV------ 248

Query: 349 DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQE 408
                 +    ++   +                              + +    +Y+ + 
Sbjct: 249 ------MEGGLLDKPDNCP------------------------DMLFELMRMCWQYNPKM 278

Query: 409 RPTAKEAMA------HPYF 421
           RP+  E ++       P F
Sbjct: 279 RPSFLEIISSIKEEMEPGF 297

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 86.4 bits (213), Expect = 2e-20
 Identities = 32/203 (15%), Positives = 68/203 (33%), Gaps = 34/203 (16%)

Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------------VKKKKIKREIKILQ 183
             + + +G GK S VF         +C++K  K                      + I  
Sbjct: 2   DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60

Query: 184 NLCGGPNIVKLLD--IVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKAL 241
                  + KL    + +    +  +++ E ++  +   +       +    +  +L+ +
Sbjct: 61  ARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRV----ENPDEVLDMILEEV 116

Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEY----NVRVASRYFKG 296
              + +GI+H D+  +NV++  E     +ID+  + E    G       +VR    YF  
Sbjct: 117 AKFYHRGIVHGDLSQYNVLVSEEGIW--IIDFPQSVEVGEEGWREILERDVRNIITYFS- 173

Query: 297 PELLVDLQDYDYSLDLWSLGCMF 319
                  + Y    D+ S     
Sbjct: 174 -------RTYRTEKDINSAIDRI 189

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	434
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.93
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.51
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.2
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.05
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.6
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.47
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.91
d1cjaa_	342	Actin-fragmin kinase, catalytic domain {Physarum p	81.87

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=4.9e-64  Score=485.46  Aligned_cols=325  Identities=75%  Similarity=1.313  Sum_probs=294.2

Q ss_pred             CCCCCcccccCccCCCCCcccccccccccCCCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHH
Q 013897          102 APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKI  181 (434)
Q Consensus       102 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~E~~~  181 (434)
                      .|++++++.+.+...+.++|++....+.++..++|+++++||+|+||+||+|+++.+++.||||+++....+.+.+|+.+
T Consensus         3 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~i   82 (328)
T d3bqca1           3 VPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKI   82 (328)
T ss_dssp             CCCCCSSSTTTTTTSCHHHHCGGGCCCCCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHH
T ss_pred             CCCcceeeccccccCCCccchhhhcccCCCCCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHH
Confidence            57788889999999999999999888888889999999999999999999999999999999999998888899999999


Q ss_pred             HHHhcCCCCeeeEeeEEEccCCCccEEEEeecCCCchhhhcCCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEe
Q 013897          182 LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI  261 (434)
Q Consensus       182 l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll  261 (434)
                      |+.+.+||||+++++++.......+++||||+.+++|..+.+.+++.+++.++.||+.||+|||++||+||||||+|||+
T Consensus        83 l~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi  162 (328)
T d3bqca1          83 LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI  162 (328)
T ss_dssp             HHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred             HHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEE
Confidence            99997799999999999877777899999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCCeEEEEecccceecCCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHH
Q 013897          262 DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK  341 (434)
Q Consensus       262 ~~~~~~vkl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~  341 (434)
                      +.++..+||+|||+|+...........++|+.|+|||.+.+...++.++|||||||++|||++|+.||..+.+..++...
T Consensus       163 ~~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~  242 (328)
T d3bqca1         163 DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR  242 (328)
T ss_dssp             ETTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHH
T ss_pred             cCCCCeeeecccccceeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHH
Confidence            97776899999999998877777778899999999999987667899999999999999999999999888888888999


Q ss_pred             HHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          342 IAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       342 i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                      +.+.+|.+....+.........+.+........+..+...........+++++.|||++||+.||++|||++|+|+||||
T Consensus       243 i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F  322 (328)
T d3bqca1         243 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF  322 (328)
T ss_dssp             HHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             HHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence            99999988887887777777777766666666666666665555666789999999999999999999999999999999


Q ss_pred             ccccc
Q 013897          422 FPIRN  426 (434)
Q Consensus       422 ~~~~~  426 (434)
                      +.+.+
T Consensus       323 ~~v~~  327 (328)
T d3bqca1         323 YTVVK  327 (328)
T ss_dssp             TTSCC
T ss_pred             CCCCC
Confidence            98864

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-59  Score=440.34  Aligned_cols=252  Identities=23%  Similarity=0.377  Sum_probs=207.6

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      .++|++++.||+|+||+||+|+++.+++.||||+++...    .+.+.+|+.+|+++ +|||||++++++.+.  ..+++
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~~~~~~~--~~~~i   80 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRREG--NIQYL   80 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTC-CCTTBCCEEEEEEET--TEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhC-CCCCEeeEeeeeccC--ceeEE
Confidence            478999999999999999999999999999999986432    35688999999999 999999999999764  57789


Q ss_pred             EEeecCCCchhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC--
Q 013897          209 IFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--  283 (434)
Q Consensus       209 v~e~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~--  283 (434)
                      ||||+.+|+|..++.   .+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+......  
T Consensus        81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~-~~KL~DFG~a~~~~~~~~~  159 (271)
T d1nvra_          81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRE  159 (271)
T ss_dssp             EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCCTTCEECEETTEE
T ss_pred             EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCC-CEEEccchhheeeccCCcc
Confidence            999999999987763   489999999999999999999999999999999999999776 89999999998764332  


Q ss_pred             -ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          284 -EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       284 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                       .....+||+.|+|||++.+...++.++|||||||++|||++|+.||............+... .               
T Consensus       160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~-~---------------  223 (271)
T d1nvra_         160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK-K---------------  223 (271)
T ss_dssp             CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTT-C---------------
T ss_pred             ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-C---------------
Confidence             23556899999999999874345788999999999999999999995443332222221100 0               


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP  423 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~  423 (434)
                                 .        .......+++++.+||.+||+.||++|||++|+|+||||++
T Consensus       224 -----------~--------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~  265 (271)
T d1nvra_         224 -----------T--------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK  265 (271)
T ss_dssp             -----------T--------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             -----------C--------CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence                       0        00111236789999999999999999999999999999984

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-59  Score=435.35  Aligned_cols=248  Identities=25%  Similarity=0.473  Sum_probs=210.3

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      .++|++++.||+|+||+||+|+++.+++.||+|++...      ..+.+.+|+.+++.+ +|||||++++++.+.  ..+
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~--~~~   81 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHDA--TRV   81 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECS--SEE
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhc-CCCCCCeEEEEEEEC--CEE
Confidence            36899999999999999999999999999999998632      346688999999999 999999999999754  568


Q ss_pred             EEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC
Q 013897          207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~  283 (434)
                      ++||||+.+|+|..++   ..+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.... .
T Consensus        82 ~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~-~~kl~DFG~a~~~~~-~  159 (263)
T d2j4za1          82 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPS-S  159 (263)
T ss_dssp             EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCCSCSCCCC-C
T ss_pred             EEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCC-CEeecccceeeecCC-C
Confidence            8999999999997664   4699999999999999999999999999999999999999777 899999999986643 3


Q ss_pred             ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                      .....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.|| .+.+..+.+..+.+.                  
T Consensus       160 ~~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf-~~~~~~~~~~~i~~~------------------  219 (263)
T d2j4za1         160 RRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRV------------------  219 (263)
T ss_dssp             CCEETTEEGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTT-CCSSHHHHHHHHHTT------------------
T ss_pred             cccccCCCCcccCHHHHcC-CCCCchhhhhhHhHHHHHHhcCCCCC-CCCCHHHHHHHHHcC------------------
Confidence            4456789999999999987 78999999999999999999999998 333333333322110                  


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI  424 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~  424 (434)
                                         ....+..+++++.+||.+||+.||++|||++|+|+||||++-
T Consensus       220 -------------------~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~~  261 (263)
T d2j4za1         220 -------------------EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN  261 (263)
T ss_dssp             -------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHHH
T ss_pred             -------------------CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCCc
Confidence                               001122467899999999999999999999999999999853

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-58  Score=439.19  Aligned_cols=252  Identities=24%  Similarity=0.420  Sum_probs=212.8

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecc---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      .++|+++++||+|+||+||+|.++.+|+.||||+++.   ...+.+.+|+.+|+.+ +|||||++++++.+.  ..+++|
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~--~~~~iv   95 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLVG--DELWVV   95 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEET--TEEEEE
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhC-CCCCEeeEeEEEEEC--CEEEEE
Confidence            3579999999999999999999999999999999864   2356789999999999 999999999999764  567899


Q ss_pred             EeecCCCchhhhc--CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC-Cccc
Q 013897          210 FEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYN  286 (434)
Q Consensus       210 ~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~-~~~~  286 (434)
                      |||+.+++|..+.  ..+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+..... ....
T Consensus        96 mEy~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~-~vkl~DFG~a~~~~~~~~~~~  174 (293)
T d1yhwa1          96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRS  174 (293)
T ss_dssp             EECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSTTCCBC
T ss_pred             EEecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCC-cEeeccchhheeecccccccc
Confidence            9999999997765  4699999999999999999999999999999999999999776 8999999999877544 3445


Q ss_pred             eeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChhH
Q 013897          287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL  366 (434)
Q Consensus       287 ~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~  366 (434)
                      ..+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||. +.+..+.+..+.....                   
T Consensus       175 ~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~-~~~~~~~~~~~~~~~~-------------------  233 (293)
T d1yhwa1         175 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYL-NENPLRALYLIATNGT-------------------  233 (293)
T ss_dssp             CCCSCGGGCCHHHHSS-SCBCTHHHHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHHHHCS-------------------
T ss_pred             ccccCCCccChhhhcC-CCCCchhceehHhHHHHHHhhCCCCCC-CCCHHHHHHHHHhCCC-------------------
Confidence            6689999999999987 789999999999999999999999984 3333333333221100                   


Q ss_pred             HHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccc
Q 013897          367 AALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI  424 (434)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~  424 (434)
                                     ........+++++.+||.+||+.||++|||++|+|+||||+..
T Consensus       234 ---------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~  276 (293)
T d1yhwa1         234 ---------------PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA  276 (293)
T ss_dssp             ---------------CCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             ---------------CCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence                           0011223478899999999999999999999999999999854

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-58  Score=435.99  Aligned_cols=254  Identities=24%  Similarity=0.397  Sum_probs=210.6

Q ss_pred             CCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       132 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      ..|.|++++.||+|+||+||+|+++.+++.||||+++..   ..+.+.+|+++|+++ +|||||++++++.+.  ..+++
T Consensus        10 p~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~--~~~~l   86 (288)
T d2jfla1          10 PEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASC-DHPNIVKLLDAFYYE--NNLWI   86 (288)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHC-CCTTBCCEEEEEEET--TEEEE
T ss_pred             cccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeC--CeEEE
Confidence            346799999999999999999999999999999998643   346788999999999 999999999999764  56789


Q ss_pred             EEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC-C
Q 013897          209 IFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-K  283 (434)
Q Consensus       209 v~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~-~  283 (434)
                      ||||+.+|+|..++    ..+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+..... .
T Consensus        87 vmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~-~~Kl~DFG~a~~~~~~~~  165 (288)
T d2jfla1          87 LIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQ  165 (288)
T ss_dssp             EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECHHHHH
T ss_pred             EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCC-CEEEEechhhhccCCCcc
Confidence            99999999987663    3599999999999999999999999999999999999999777 8999999999765322 2


Q ss_pred             ccceeccCCcccccccccC----CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcc
Q 013897          284 EYNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH  359 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~~----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  359 (434)
                      .....+||+.|+|||++.+    ...|+.++|||||||++|||++|+.||. +.+..+.+..+....             
T Consensus       166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~-~~~~~~~~~~i~~~~-------------  231 (288)
T d2jfla1         166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHH-ELNPMRVLLKIAKSE-------------  231 (288)
T ss_dssp             HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTT-TSCGGGHHHHHHHSC-------------
T ss_pred             cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCC-CCCHHHHHHHHHcCC-------------
Confidence            2345689999999999842    2568999999999999999999999984 334444443332200             


Q ss_pred             ccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccc
Q 013897          360 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI  424 (434)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~  424 (434)
                                           .........+++++.+||.+||+.||++|||++|+|+||||+.-
T Consensus       232 ---------------------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~  275 (288)
T d2jfla1         232 ---------------------PPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD  275 (288)
T ss_dssp             ---------------------CCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred             ---------------------CCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence                                 00111223478899999999999999999999999999999853

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-59  Score=448.06  Aligned_cols=285  Identities=22%  Similarity=0.320  Sum_probs=214.2

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      .|+|+++++||+|+||+||+|+++.+|+.||+|+++..    ....+.+|+.+|+.+ +|||||+++++|.+.  ..+++
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~--~~~~i   81 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSD--GEISI   81 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGC-CCTTBCCEEEEEECS--SEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEEC--CEEEE
Confidence            47899999999999999999999999999999998642    246788999999999 999999999999754  56789


Q ss_pred             EEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHH-CCceeecCCCCceEecCCCCeEEEEecccceecCCCCc
Q 013897          209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE  284 (434)
Q Consensus       209 v~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~  284 (434)
                      ||||+.+++|..++   ..+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+|+...+. .
T Consensus        82 VmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~-~vkl~DFGla~~~~~~-~  159 (322)
T d1s9ja_          82 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDS-M  159 (322)
T ss_dssp             EEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-CEEECCCCCCHHHHHH-T
T ss_pred             EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCC-CEEEeeCCCccccCCC-c
Confidence            99999999998775   469999999999999999999997 4999999999999999777 8999999999866432 3


Q ss_pred             cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhh-------
Q 013897          285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK-------  357 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~-------  357 (434)
                      ....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||........+...+....+..........       
T Consensus       160 ~~~~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (322)
T d1s9ja_         160 ANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS  238 (322)
T ss_dssp             C---CCSSCCCCHHHHHC-SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------------
T ss_pred             cccccCCccccCchHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccc
Confidence            356799999999999988 789999999999999999999999997766555554444433332211100000       


Q ss_pred             -cc--ccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccccc
Q 013897          358 -YH--IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA  427 (434)
Q Consensus       358 -~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~  427 (434)
                       ..  ........+...........    ......+++++.|||.+||+.||++|||++|+|+||||++.+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~~  307 (322)
T d1s9ja_         239 SYGMDSRPPMAIFELLDYIVNEPPP----KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE  307 (322)
T ss_dssp             -------CCCCHHHHHHHHHTSCCC----CCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHHS
T ss_pred             ccccccccchhHHHHHhhhhccCCc----cCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCcc
Confidence             00  00000000000000000000    01112367899999999999999999999999999999976544

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-58  Score=431.06  Aligned_cols=248  Identities=26%  Similarity=0.436  Sum_probs=196.3

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      |+|++++.||+|+||+||+|+++.+|+.||||+++...     .+.+.+|+.+|+++ +|||||++++++.+.....+++
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSC-CCTTBCCEEEEEEC----CEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEeCCCCEEEE
Confidence            78999999999999999999999999999999986432     35588999999999 9999999999998766677899


Q ss_pred             EEeecCCCchhhhc-------CCCChHHHHHHHHHHHHHHHHHHHCC-----ceeecCCCCceEecCCCCeEEEEecccc
Q 013897          209 IFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQG-----IMHRDVKPHNVMIDHEQRKLRLIDWGLA  276 (434)
Q Consensus       209 v~e~~~~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~~-----ivHrDlKp~NIll~~~~~~vkl~DFGla  276 (434)
                      ||||+.+|+|..++       ..+++..++.++.||+.||+|||+++     |+||||||+|||++.++ .+||+|||+|
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~-~vkl~DFG~a  161 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDFGLA  161 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTS-CEEECCHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCC-cEEEeeccce
Confidence            99999999997765       35899999999999999999999976     99999999999999776 8999999999


Q ss_pred             eecCCCC-ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHH
Q 013897          277 EFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL  355 (434)
Q Consensus       277 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~  355 (434)
                      +...... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||. +.+..+....+...          
T Consensus       162 ~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyel~tg~~Pf~-~~~~~~~~~~i~~~----------  229 (269)
T d2java1         162 RILNHDTSFAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFT-AFSQKELAGKIREG----------  229 (269)
T ss_dssp             HHC-----------CCCSCCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCC-CSSHHHHHHHHHHT----------
T ss_pred             eecccCCCccccCCCCcccCCHHHHcC-CCCChHHHHHhhCHHHHHHhhCCCCCC-CCCHHHHHHHHHcC----------
Confidence            8765443 3355789999999999876 689999999999999999999999983 33333322222110          


Q ss_pred             hhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCc
Q 013897          356 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF  421 (434)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~  421 (434)
                                      . .         ...+..+++++.+||.+||+.||++|||++|+|+|||+
T Consensus       230 ----------------~-~---------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         230 ----------------K-F---------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             ----------------C-C---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             ----------------C-C---------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence                            0 0         00112367899999999999999999999999999996

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-58  Score=434.08  Aligned_cols=252  Identities=28%  Similarity=0.491  Sum_probs=209.7

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecc------ccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      ++|++++.||+|+||+||+|.++.+++.||||+++.      ...+.+.+|+.+|+++ +|||||++++++.+.  ..++
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~--~~~~   84 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDD--EKLY   84 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CSTTBCCEEEEEECS--SEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHc-CCCCeeEEEEEEEEC--CEEE
Confidence            679999999999999999999999999999999863      2345689999999999 999999999999654  6678


Q ss_pred             EEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC-
Q 013897          208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-  283 (434)
Q Consensus       208 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~-  283 (434)
                      +||||+.+|+|..++   ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.+.... 
T Consensus        85 ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~-~vkl~DFG~a~~~~~~~~  163 (288)
T d1uu3a_          85 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM-HIQITDFGTAKVLSPESK  163 (288)
T ss_dssp             EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCEECC----
T ss_pred             EEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCc-eEEecccccceecccCCc
Confidence            999999999987664   4699999999999999999999999999999999999999777 89999999998775332 


Q ss_pred             --ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcccc
Q 013897          284 --EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE  361 (434)
Q Consensus       284 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  361 (434)
                        .....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||. +.+..+.+..+...             .  
T Consensus       164 ~~~~~~~~GT~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~-~~~~~~~~~~i~~~-------------~--  226 (288)
T d1uu3a_         164 QARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFR-AGNEYLIFQKIIKL-------------E--  226 (288)
T ss_dssp             ------CCCCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHTT-------------C--
T ss_pred             ccccccccCCccccCceeecc-CCCCcccceehhhHHHHHHhhCCCCCC-CcCHHHHHHHHHcC-------------C--
Confidence              2345689999999999987 689999999999999999999999984 33333333332110             0  


Q ss_pred             CChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHH------HhcCCCcccccccc
Q 013897          362 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKE------AMAHPYFFPIRNAE  428 (434)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~e------lL~Hp~~~~~~~~~  428 (434)
                                            ...+..+++++.+||.+||+.||++|||++|      +++||||+++++..
T Consensus       227 ----------------------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~  277 (288)
T d1uu3a_         227 ----------------------YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN  277 (288)
T ss_dssp             ----------------------CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTT
T ss_pred             ----------------------CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHH
Confidence                                  0111246789999999999999999999987      68999999987554

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-57  Score=426.65  Aligned_cols=247  Identities=23%  Similarity=0.414  Sum_probs=203.1

Q ss_pred             eEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEcc--CCCccEE
Q 013897          136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ--QSKTPSL  208 (434)
Q Consensus       136 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~~~~~l  208 (434)
                      |++.++||+|+||+||+|.+..+++.||+|.+...     ..+.+.+|+++|+++ +|||||++++++.+.  ....+++
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~~~~i   89 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKCIVL   89 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeccccCCEEEE
Confidence            46778999999999999999999999999998643     235688999999999 899999999998653  3456789


Q ss_pred             EEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCC--ceeecCCCCceEecCCCCeEEEEecccceecCCCC
Q 013897          209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       209 v~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~  283 (434)
                      ||||+++++|..++   ..+++..++.++.||+.||+|||+++  |+||||||+|||++.+++.+||+|||+|+... ..
T Consensus        90 vmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~-~~  168 (270)
T d1t4ha_          90 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-AS  168 (270)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC-TT
T ss_pred             EEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc-CC
Confidence            99999999997765   46899999999999999999999998  99999999999997544489999999998543 33


Q ss_pred             ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHH-HHHHHhCChhHHHHHhhccccC
Q 013897          284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV-KIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~-~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                      .....+||+.|+|||++.+  .|+.++|||||||++|||++|+.||.... +...+. .+.....               
T Consensus       169 ~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~-~~~~~~~~i~~~~~---------------  230 (270)
T d1t4ha_         169 FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQ-NAAQIYRRVTSGVK---------------  230 (270)
T ss_dssp             SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-SHHHHHHHHTTTCC---------------
T ss_pred             ccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcc-cHHHHHHHHHcCCC---------------
Confidence            4456789999999999864  69999999999999999999999984333 333222 2111000               


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFF  422 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~  422 (434)
                                          .......+++++.+||.+||+.||++|||++|+|+||||+
T Consensus       231 --------------------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         231 --------------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             --------------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             --------------------CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence                                0011223678899999999999999999999999999996

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-57  Score=431.96  Aligned_cols=258  Identities=24%  Similarity=0.451  Sum_probs=214.1

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc---------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS  203 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~---------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  203 (434)
                      .+.|++++.||+|+||+||+|+++.+|+.||||+++..         ..+.+.+|+.+|+++ +|||||++++++.+.  
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~--   85 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYENK--   85 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECS--
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEEC--
Confidence            36799999999999999999999999999999998532         246789999999999 999999999999654  


Q ss_pred             CccEEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCC---eEEEEecccce
Q 013897          204 KTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR---KLRLIDWGLAE  277 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~---~vkl~DFGla~  277 (434)
                      ..++|||||+.+|+|..++   ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.   .+||+|||+|+
T Consensus        86 ~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~  165 (293)
T d1jksa_          86 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  165 (293)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             CEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhh
Confidence            6778999999999997765   46999999999999999999999999999999999999986653   59999999999


Q ss_pred             ecCCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhh
Q 013897          278 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK  357 (434)
Q Consensus       278 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  357 (434)
                      ............||+.|+|||++.+ ..++.++|||||||++|||++|+.||. +.+..+.+..+.....          
T Consensus       166 ~~~~~~~~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~-~~~~~~~~~~i~~~~~----------  233 (293)
T d1jksa_         166 KIDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAVNY----------  233 (293)
T ss_dssp             ECTTSCBCSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHTTCC----------
T ss_pred             hcCCCccccccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCCCCC-CCCHHHHHHHHHhcCC----------
Confidence            8876666677889999999999987 689999999999999999999999984 3343333333321100          


Q ss_pred             ccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccccc
Q 013897          358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~  428 (434)
                         ...                    ......+++++.+||.+||+.||++|||++|+|+||||++.+..+
T Consensus       234 ---~~~--------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~  281 (293)
T d1jksa_         234 ---EFE--------------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ  281 (293)
T ss_dssp             ---CCC--------------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-----
T ss_pred             ---CCC--------------------chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCChhH
Confidence               000                    011124678999999999999999999999999999999876544

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.2e-57  Score=441.00  Aligned_cols=256  Identities=23%  Similarity=0.415  Sum_probs=216.5

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      .++|++++.||+|+||+||+|+++.+|+.||||++....   .+.+.+|+.+|+++ +|||||++++++.+.  ..+++|
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~--~~~~iv  101 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVNLHDAFEDD--NEMVMI  101 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHT-CCTTBCCEEEEEEET--TEEEEE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEEC--CEEEEE
Confidence            368999999999999999999999999999999986533   35688999999999 899999999999764  578899


Q ss_pred             EeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC-CCeEEEEecccceecCCCCc
Q 013897          210 FEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-QRKLRLIDWGLAEFYHPGKE  284 (434)
Q Consensus       210 ~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~-~~~vkl~DFGla~~~~~~~~  284 (434)
                      |||+.+|+|..++    ..+++.+++.++.||+.||+|||++||+||||||+|||++.+ ++.+||+|||+|+.......
T Consensus       102 mE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~  181 (350)
T d1koaa2         102 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS  181 (350)
T ss_dssp             ECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred             EEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence            9999999986655    248999999999999999999999999999999999999643 34899999999998877777


Q ss_pred             cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCCh
Q 013897          285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP  364 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  364 (434)
                      ....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.|| .+.+..+.+..+......             .  
T Consensus       182 ~~~~~gT~~Y~aPEv~~~-~~~~~~~DiwSlGvilyell~G~~Pf-~~~~~~~~~~~i~~~~~~-------------~--  244 (350)
T d1koaa2         182 VKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPF-GGENDDETLRNVKSCDWN-------------M--  244 (350)
T ss_dssp             EEEECSCTTTCCHHHHHT-CCBCHHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHTCCC-------------S--
T ss_pred             cceecCcccccCHHHHcC-CCCChhHhhhhhhHHHHHHHhCCCCC-CCCCHHHHHHHHHhCCCC-------------C--
Confidence            778899999999999987 78999999999999999999999998 344444444444321100             0  


Q ss_pred             hHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccc
Q 013897          365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN  426 (434)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~  426 (434)
                                        .......+++++.+||.+||+.||++|||++|+|+||||+..+.
T Consensus       245 ------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~  288 (350)
T d1koaa2         245 ------------------DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA  288 (350)
T ss_dssp             ------------------CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred             ------------------CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence                              00111236789999999999999999999999999999997654

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.8e-58  Score=436.71  Aligned_cols=255  Identities=26%  Similarity=0.436  Sum_probs=195.1

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      .+.|++.+.||+|+||+||+|+++.+++.||||++....    ...+.+|+.+|+.+ +|||||++++++.+.  ..+++
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~--~~~~l   84 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-KHPNIVALDDIYESG--GHLYL   84 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTC-CCTTBCCEEEEEECS--SEEEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEEC--CEEEE
Confidence            467999999999999999999999999999999986432    34577999999999 999999999999654  57889


Q ss_pred             EEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecC--CCCeEEEEecccceecCCCC
Q 013897          209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--EQRKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       209 v~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~--~~~~vkl~DFGla~~~~~~~  283 (434)
                      ||||+.+++|..++   ..+++.+++.++.||+.||+|||++||+||||||+|||+..  +++.+||+|||+|+......
T Consensus        85 vmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~  164 (307)
T d1a06a_          85 IMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS  164 (307)
T ss_dssp             EECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred             EEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence            99999999997665   35999999999999999999999999999999999999953  33489999999998776666


Q ss_pred             ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                      .....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||. +....+....+.+.             ...  
T Consensus       165 ~~~~~~GT~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~-~~~~~~~~~~i~~~-------------~~~--  227 (307)
T d1a06a_         165 VLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFY-DENDAKLFEQILKA-------------EYE--  227 (307)
T ss_dssp             --------CTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCC-CSSHHHHHHHHHTT-------------CCC--
T ss_pred             eeeeeeeCccccCcHHHcC-CCCCcHHHhhhhhHHHHHHHhCCCCCC-CCCHHHHHHHHhcc-------------CCC--
Confidence            6667889999999999987 689999999999999999999999984 33333333222210             000  


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                                        ........+++++.+||.+||+.||++|||++|+|+||||++..
T Consensus       228 ------------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  271 (307)
T d1a06a_         228 ------------------FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDT  271 (307)
T ss_dssp             ------------------CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSSC
T ss_pred             ------------------CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence                              00112234788999999999999999999999999999998643

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.8e-57  Score=440.57  Aligned_cols=254  Identities=25%  Similarity=0.456  Sum_probs=214.5

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF  210 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  210 (434)
                      ++|++++.||+|+||+||+|+++.+|+.||||+++...   ...+.+|+.+|+++ +|||||++++++.+.  ..+++||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~--~~~~ivm  105 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLHDAFEDK--YEMVLIL  105 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CSTTBCCEEEEEECS--SEEEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEEC--CEEEEEE
Confidence            67999999999999999999999999999999986533   35678999999999 999999999999754  6778999


Q ss_pred             eecCCCchhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecC-CCCeEEEEecccceecCCCCcc
Q 013897          211 EHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH-EQRKLRLIDWGLAEFYHPGKEY  285 (434)
Q Consensus       211 e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~-~~~~vkl~DFGla~~~~~~~~~  285 (434)
                      |||.+++|...+.    .+++.+++.++.||+.||+|||++||+||||||+|||++. +.+.+||+|||+|+........
T Consensus       106 E~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~  185 (352)
T d1koba_         106 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV  185 (352)
T ss_dssp             ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred             EcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCce
Confidence            9999999966542    4899999999999999999999999999999999999973 2348999999999988777777


Q ss_pred             ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChh
Q 013897          286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH  365 (434)
Q Consensus       286 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~  365 (434)
                      ....||+.|+|||++.+ ..|+.++|||||||++|||++|+.|| .+.+..+.+..+......                 
T Consensus       186 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf-~~~~~~~~~~~i~~~~~~-----------------  246 (352)
T d1koba_         186 KVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPF-AGEDDLETLQNVKRCDWE-----------------  246 (352)
T ss_dssp             EEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSS-CCSSHHHHHHHHHHCCCC-----------------
T ss_pred             eeccCcccccCHHHHcC-CCCCCccchHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhCCCC-----------------
Confidence            78899999999999887 78999999999999999999999998 444444444443221000                 


Q ss_pred             HHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccc
Q 013897          366 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                                      ........+++++.+||.+||+.||++|||++|+|+||||++..
T Consensus       247 ----------------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~  290 (352)
T d1koba_         247 ----------------FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  290 (352)
T ss_dssp             ----------------CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             ----------------CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence                            00111224788999999999999999999999999999998643

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-57  Score=434.61  Aligned_cols=251  Identities=25%  Similarity=0.447  Sum_probs=212.5

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCcc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  206 (434)
                      .++|++++.||+|+||+||+|+++.+++.||||+++..      ..+.+.+|+.+|+.+ +|||||++++++.+.  ..+
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~--~~~   80 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTH--DRL   80 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEECS--SEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhC-CCCCEEEEEeeeccc--ccc
Confidence            37899999999999999999999999999999998642      346688999999999 899999999999654  678


Q ss_pred             EEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC-C
Q 013897          207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-G  282 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~-~  282 (434)
                      ++||||+.+|+|..++   ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.... .
T Consensus        81 ~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g-~vkl~DFG~a~~~~~~~  159 (337)
T d1o6la_          81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCSCCTT
T ss_pred             ccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCC-CEEEeecccccccccCC
Confidence            8999999999997665   4689999999999999999999999999999999999999777 899999999987643 3


Q ss_pred             CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                      ......+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||. +.+..+....+..  +               
T Consensus       160 ~~~~~~~GT~~Y~aPE~~~~-~~y~~~~DiwSlGvilyeml~G~~pf~-~~~~~~~~~~i~~--~---------------  220 (337)
T d1o6la_         160 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY-NQDHERLFELILM--E---------------  220 (337)
T ss_dssp             CCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHH--C---------------
T ss_pred             cccccceeCHHHhhhhhccC-CCCChhhcccchhhHHHHHHHCCCCCC-CcCHHHHHHHHhc--C---------------
Confidence            44566799999999999987 789999999999999999999999984 3332222222211  0               


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCcc-----HHHHhcCCCcccccc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT-----AKEAMAHPYFFPIRN  426 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt-----~~elL~Hp~~~~~~~  426 (434)
                                          ....+..+++++.+||.+||+.||++|++     ++|+++||||+++++
T Consensus       221 --------------------~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~  269 (337)
T d1o6la_         221 --------------------EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW  269 (337)
T ss_dssp             --------------------CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred             --------------------CCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCH
Confidence                                01112347889999999999999999994     999999999998764

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-57  Score=429.99  Aligned_cols=276  Identities=27%  Similarity=0.486  Sum_probs=219.1

Q ss_pred             EEeeeeecCceEEEEEEEcCCCeEEEEEEecccc--------HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEE
Q 013897          138 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI  209 (434)
Q Consensus       138 ~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~--------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  209 (434)
                      .+++||+|+||+||+|+++.+|+.||||+++...        .+.+.+|+.+|+++ +|||||++++++.+.  ..+++|
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~~~~~--~~~~iv   78 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGHK--SNISLV   78 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECCT--TCCEEE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhC-CCCCEeEEEeeeccC--Cceeeh
Confidence            4688999999999999999999999999986432        24578999999999 999999999999654  567899


Q ss_pred             EeecCCCchhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC-Ccc
Q 013897          210 FEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEY  285 (434)
Q Consensus       210 ~e~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~-~~~  285 (434)
                      |||+.++++..+..   .+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+..... ...
T Consensus        79 mE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~-~~KL~DFG~a~~~~~~~~~~  157 (299)
T d1ua2a_          79 FDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG-VLKLADFGLAKSFGSPNRAY  157 (299)
T ss_dssp             EECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECCCGGGSTTTSCCCCC
T ss_pred             hhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCC-ccccccCccccccCCCcccc
Confidence            99999998776653   489999999999999999999999999999999999999776 8999999999876443 334


Q ss_pred             ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChh
Q 013897          286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH  365 (434)
Q Consensus       286 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~  365 (434)
                      ...+||+.|+|||++.+...|+.++|||||||++|||++|..|| .+.++.+++..|.+.+|.+....+...........
T Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf-~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~  236 (299)
T d1ua2a_         158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFL-PGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT  236 (299)
T ss_dssp             CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred             cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCC-CCCCHHHHHHHHHHhcCCCChhhccchhccchhhh
Confidence            55689999999999877567899999999999999999998776 77788888899988888655433322111110000


Q ss_pred             HHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccccc
Q 013897          366 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA  427 (434)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~  427 (434)
                               ...............+++++.|||.+||+.||++||||+|+|+||||+....+
T Consensus       237 ---------~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p  289 (299)
T d1ua2a_         237 ---------FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP  289 (299)
T ss_dssp             ---------CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred             ---------hccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCC
Confidence                     00000000001122467899999999999999999999999999999976543

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-56  Score=426.02  Aligned_cols=283  Identities=29%  Similarity=0.530  Sum_probs=225.2

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCC-CeEEEEEEecccc-----HHHHHHHHHHHHHhc--CCCCeeeEeeEEEcc---
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTD-NEKCIIKILKPVK-----KKKIKREIKILQNLC--GGPNIVKLLDIVRDQ---  201 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~-~~~vaiK~~~~~~-----~~~~~~E~~~l~~l~--~h~niv~l~~~~~~~---  201 (434)
                      .++|+++++||+|+||+||+|++..+ ++.||||+++...     ...+.+|+.+|+.|.  +||||++++++|...   
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            47899999999999999999998654 6789999986422     335778988888763  799999999998642   


Q ss_pred             CCCccEEEEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccce
Q 013897          202 QSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE  277 (434)
Q Consensus       202 ~~~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~  277 (434)
                      ....++++|||+.++.+....    ..+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+++
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~-~~kl~dfg~~~  164 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-QIKLADFGLAR  164 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECSCCSCC
T ss_pred             cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCC-Ceeecchhhhh
Confidence            234678999999998765332    3588999999999999999999999999999999999999776 89999999998


Q ss_pred             ecCCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhh
Q 013897          278 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK  357 (434)
Q Consensus       278 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  357 (434)
                      ...........+||+.|+|||++.+ ..|+.++|||||||++|||++|+.|| .+.+..+++..+.+.++.+....+...
T Consensus       165 ~~~~~~~~~~~~gT~~Y~APE~~~~-~~y~~~~DiwSlG~il~ell~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~  242 (305)
T d1blxa_         165 IYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLF-RGSSDVDQLGKILDVIGLPGEEDWPRD  242 (305)
T ss_dssp             CCCGGGGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred             hhcccccCCCcccChhhcCcchhcC-CCCChhehhhchHHHHHHHHHCCCCC-CCCCHHHHHHHHHHhhCCCchhccccc
Confidence            7665666677899999999999987 78999999999999999999999998 566777888888888887654433221


Q ss_pred             ccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccccc
Q 013897          358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~  428 (434)
                      ......     ........+     .......+++.+.|||.+||+.||++|||++|+|+||||+.++.+.
T Consensus       243 ~~~~~~-----~~~~~~~~~-----~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~~k  303 (305)
T d1blxa_         243 VALPRQ-----AFHSKSAQP-----IEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK  303 (305)
T ss_dssp             CSSCGG-----GSCCCCCCC-----GGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred             ccchhh-----hhccccccc-----hhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchhhC
Confidence            111000     000000000     0112234778999999999999999999999999999999997654

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.5e-56  Score=427.98  Aligned_cols=248  Identities=25%  Similarity=0.397  Sum_probs=206.3

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      +.|++++.||+|+||+||+|++..+++.||||+++...      .+.+.+|+.+|+++ +|||||++++++.+.  ..++
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~--~~~~   91 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLRE--HTAW   91 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEET--TEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEEC--CEEE
Confidence            35999999999999999999999999999999986432      24588999999999 899999999999754  5678


Q ss_pred             EEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc
Q 013897          208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE  284 (434)
Q Consensus       208 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~  284 (434)
                      +|||||.++++..+.   ..+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+....   
T Consensus        92 iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~-~~Kl~DFG~a~~~~~---  167 (309)
T d1u5ra_          92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG-LVKLGDFGSASIMAP---  167 (309)
T ss_dssp             EEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT-EEEECCCTTCBSSSS---
T ss_pred             EEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCC-CEEEeecccccccCC---
Confidence            999999999886543   5699999999999999999999999999999999999999776 899999999986543   


Q ss_pred             cceeccCCcccccccccC--CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          285 YNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~--~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                      ....+||+.|+|||++.+  ...|+.++|||||||++|||++|+.||.. ....+.+..+....                
T Consensus       168 ~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~-~~~~~~~~~i~~~~----------------  230 (309)
T d1u5ra_         168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-MNAMSALYHIAQNE----------------  230 (309)
T ss_dssp             BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSC----------------
T ss_pred             CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCC----------------
Confidence            345689999999999864  24689999999999999999999999843 33333333322100                


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI  424 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~  424 (434)
                                 ..        ......+++++.+||.+||+.||++|||++|+|+||||++-
T Consensus       231 -----------~~--------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~  273 (309)
T d1u5ra_         231 -----------SP--------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (309)
T ss_dssp             -----------CC--------CCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             -----------CC--------CCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence                       00        00122467899999999999999999999999999999854

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.8e-56  Score=427.57  Aligned_cols=248  Identities=21%  Similarity=0.432  Sum_probs=210.2

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      ++|++++.||+|+||+||+|+++.+|+.||||+++..      ..+.+.+|+.+|+.+ +|||||++++++.+.  ..++
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~--~~~~   80 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQDA--QQIF   80 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEECS--SEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhc-cCcChhheeeeEeeC--Ceee
Confidence            6799999999999999999999999999999998632      346788999999999 999999999999654  6788


Q ss_pred             EEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc
Q 013897          208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE  284 (434)
Q Consensus       208 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~  284 (434)
                      +||||+.++++..+.   ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+....  .
T Consensus        81 ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g-~vkL~DFG~a~~~~~--~  157 (316)
T d1fota_          81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG-HIKITDFGFAKYVPD--V  157 (316)
T ss_dssp             EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS-CEEECCCSSCEECSS--C
T ss_pred             eEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCC-CEEEecCccceEecc--c
Confidence            999999999987665   4588899999999999999999999999999999999999777 899999999987643  3


Q ss_pred             cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCCh
Q 013897          285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP  364 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  364 (434)
                      ....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||. +.+..+....+...                   
T Consensus       158 ~~~~~Gt~~Y~APE~l~~-~~y~~~~DiwSlGvilyemltG~~Pf~-~~~~~~~~~~i~~~-------------------  216 (316)
T d1fota_         158 TYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFY-DSNTMKTYEKILNA-------------------  216 (316)
T ss_dssp             BCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHHC-------------------
T ss_pred             cccccCcccccCHHHHcC-CCCCchhhccccchhHHHHHhCCCCCC-CcCHHHHHHHHHcC-------------------
Confidence            345789999999999887 689999999999999999999999984 33333333332210                   


Q ss_pred             hHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCc-----cHHHHhcCCCcccccc
Q 013897          365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-----TAKEAMAHPYFFPIRN  426 (434)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rp-----t~~elL~Hp~~~~~~~  426 (434)
                                        ....+..+++++.++|.+||+.||.+|+     |++|+|+||||+++++
T Consensus       217 ------------------~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~  265 (316)
T d1fota_         217 ------------------ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW  265 (316)
T ss_dssp             ------------------CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred             ------------------CCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCH
Confidence                              0011223678999999999999999996     9999999999998864

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-56  Score=424.20  Aligned_cols=281  Identities=30%  Similarity=0.578  Sum_probs=222.8

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      |+|++++.||+|+||+||+|++..+++.||||+++..     ..+.+.+|+.+|+++ +|||||++++++.+.  ..+++
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~Hp~Iv~~~~~~~~~--~~~~i   78 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLDVIHTE--NKLYL   78 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTC-CCTTBCCEEEEEEET--TEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-CCCcEEEeccccccc--cceeE
Confidence            7899999999999999999999999999999998643     246788999999999 999999999999764  57789


Q ss_pred             EEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC-C
Q 013897          209 IFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-K  283 (434)
Q Consensus       209 v~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~-~  283 (434)
                      ||||+.++.+....    ..+++.+++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+..... .
T Consensus        79 v~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~-~~kl~DFG~a~~~~~~~~  157 (298)
T d1gz8a_          79 VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVR  157 (298)
T ss_dssp             EEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECSTTHHHHHCCCSB
T ss_pred             EEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccC-cceeccCCcceeccCCcc
Confidence            99999987654432    4589999999999999999999999999999999999999776 8999999999876543 3


Q ss_pred             ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                      .....+||+.|+|||++.....++.++|||||||++|+|++|+.|| .+.+..+++..+....+.+....+.......  
T Consensus       158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~--  234 (298)
T d1gz8a_         158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF-PGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP--  234 (298)
T ss_dssp             CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCTTTSTTGGGST--
T ss_pred             cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCC-CCCCHHHHHHHHHHhcCCCchhhcccccccc--
Confidence            4456689999999999887566789999999999999999999998 5666677777777776654332222110000  


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccccc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA  427 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~  427 (434)
                       ...   ...  ..+...........+++++.|||.+||+.||++|||++|+|+||||++++.+
T Consensus       235 -~~~---~~~--~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p  292 (298)
T d1gz8a_         235 -DYK---PSF--PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP  292 (298)
T ss_dssp             -TCC---TTS--CCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             -ccc---ccc--ccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence             000   000  0000000011223567899999999999999999999999999999988765

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-56  Score=435.41  Aligned_cols=282  Identities=32%  Similarity=0.537  Sum_probs=227.9

Q ss_pred             CeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeEeeEEEcc----CCCccEEEE
Q 013897          135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ----QSKTPSLIF  210 (434)
Q Consensus       135 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~----~~~~~~lv~  210 (434)
                      +|+.+++||+|+||+||+|++..+++.||||+++... ....+|+.+|+++ +||||++++++|...    +..++++||
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~Ei~il~~l-~h~niv~~~~~~~~~~~~~~~~~~~lv~   98 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-RFKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVL   98 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-SSCCHHHHHHHHC-CCTTBCCEEEEEEEC--CCSCCEEEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc-hHHHHHHHHHHhc-CCCCCCcEEEEEEecCccCCceEEEEEE
Confidence            5999999999999999999999999999999996543 3346899999999 999999999998542    345688999


Q ss_pred             eecCCCchhhhc------CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc
Q 013897          211 EHVNNTDFKVLY------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE  284 (434)
Q Consensus       211 e~~~~~~l~~~~------~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~  284 (434)
                      ||++++.+..+.      ..+++.+++.++.||+.||+|||++||+||||||+|||++.++..+||+|||+++.......
T Consensus        99 Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~  178 (350)
T d1q5ka_          99 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP  178 (350)
T ss_dssp             ECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSC
T ss_pred             eccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCCcc
Confidence            999987644332      35899999999999999999999999999999999999997766899999999998877766


Q ss_pred             cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCCh
Q 013897          285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP  364 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  364 (434)
                      ....+|++.|+|||++.+...|+.++|||||||++|||++|+.|| .+.+..+++..+.+.+|......+..........
T Consensus       179 ~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf-~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~  257 (350)
T d1q5ka_         179 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF-PGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF  257 (350)
T ss_dssp             CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSS-CCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CC
T ss_pred             cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCC-CCCCHHHHHHHHHHHhCCChHHhhhhhccchhhc
Confidence            777899999999999887678999999999999999999999887 5666778888898988886655443321111000


Q ss_pred             hHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccccc
Q 013897          365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA  427 (434)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~  427 (434)
                      .    .......++.    .......++++.|||.+||+.||++|||+.|+|+||||+.+.+.
T Consensus       258 ~----~~~~~~~~~~----~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~  312 (350)
T d1q5ka_         258 K----FPQIKAHPWT----KVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP  312 (350)
T ss_dssp             C----CCCCCCCCGG----GTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred             c----ccccccCchh----hhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCC
Confidence            0    0000111111    11223478899999999999999999999999999999987653

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=6.6e-56  Score=417.18  Aligned_cols=254  Identities=25%  Similarity=0.431  Sum_probs=212.3

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc------------HHHHHHHHHHHHHhcCCCCeeeEeeEEEc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------------KKKIKREIKILQNLCGGPNIVKLLDIVRD  200 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------------~~~~~~E~~~l~~l~~h~niv~l~~~~~~  200 (434)
                      .++|++.+.||+|+||+||+|++..+++.||||+++...            .+.+.+|+.+|+++..|||||++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            378999999999999999999999999999999986421            23578999999999669999999999965


Q ss_pred             cCCCccEEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccce
Q 013897          201 QQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE  277 (434)
Q Consensus       201 ~~~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~  277 (434)
                        ...++|||||+.+++|..++   ..+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+
T Consensus        82 --~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~-~~kl~DFG~a~  158 (277)
T d1phka_          82 --NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM-NIKLTDFGFSC  158 (277)
T ss_dssp             --SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCE
T ss_pred             --CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCC-CeEEccchhee
Confidence              46788999999999997665   4699999999999999999999999999999999999999776 89999999999


Q ss_pred             ecCCCCccceeccCCcccccccccC-----CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHH
Q 013897          278 FYHPGKEYNVRVASRYFKGPELLVD-----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELN  352 (434)
Q Consensus       278 ~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~  352 (434)
                      ...........+||+.|+|||.+.+     ...++.++||||+||++|||++|+.||. +.+..+....+...  .    
T Consensus       159 ~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~-~~~~~~~~~~i~~~--~----  231 (277)
T d1phka_         159 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW-HRKQMLMLRMIMSG--N----  231 (277)
T ss_dssp             ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHT--C----
T ss_pred             EccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCC-CCCHHHHHHHHHhC--C----
Confidence            8876666677889999999999853     2457889999999999999999999984 33333333332210  0    


Q ss_pred             HHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccc
Q 013897          353 AYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP  423 (434)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~  423 (434)
                                           ..      ........+++++.+||.+||+.||++|||++|+|+||||++
T Consensus       232 ---------------------~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         232 ---------------------YQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             ---------------------CC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             ---------------------CC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence                                 00      001112247889999999999999999999999999999985

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.7e-56  Score=430.73  Aligned_cols=249  Identities=23%  Similarity=0.385  Sum_probs=211.5

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      ++|++++.||+|+||+||+|+++.+|+.||||+++..      ..+.+.+|+.+|+.+ +|||||++++++.+.  ..++
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~--~~~~  117 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDN--SNLY  117 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECS--SEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHc-CCCcEeecccccccc--cccc
Confidence            6899999999999999999999999999999998632      235688999999999 999999999999654  5678


Q ss_pred             EEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc
Q 013897          208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE  284 (434)
Q Consensus       208 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~  284 (434)
                      +||||+.++++...+   ..+++..++.++.||+.||.|||++|||||||||+|||++.++ .+||+|||+|+....  .
T Consensus       118 ~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g-~ikL~DFG~a~~~~~--~  194 (350)
T d1rdqe_         118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG-YIQVTDFGFAKRVKG--R  194 (350)
T ss_dssp             EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECSS--C
T ss_pred             cccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCC-CEEeeeceeeeeccc--c
Confidence            999999999986664   4699999999999999999999999999999999999999777 899999999987653  3


Q ss_pred             cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCCh
Q 013897          285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP  364 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  364 (434)
                      ....+||+.|+|||++.+ ..|+.++|||||||++|||+||+.||. +.+....+..+...                   
T Consensus       195 ~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~-~~~~~~~~~~i~~~-------------------  253 (350)
T d1rdqe_         195 TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF-ADQPIQIYEKIVSG-------------------  253 (350)
T ss_dssp             BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHC-------------------
T ss_pred             cccccCccccCCHHHHcC-CCCCccccccchhHHHHHHHhCCCCCC-CcCHHHHHHHHhcC-------------------
Confidence            345789999999999987 789999999999999999999999984 33333333333210                   


Q ss_pred             hHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCc-----cHHHHhcCCCccccccc
Q 013897          365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-----TAKEAMAHPYFFPIRNA  427 (434)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rp-----t~~elL~Hp~~~~~~~~  427 (434)
                                        ....+..+++++.+||.+||+.||.+|+     |++|+|+||||+++++.
T Consensus       254 ------------------~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~  303 (350)
T d1rdqe_         254 ------------------KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI  303 (350)
T ss_dssp             ------------------CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred             ------------------CCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHH
Confidence                              0011224678999999999999999995     99999999999988754

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-56  Score=425.68  Aligned_cols=253  Identities=25%  Similarity=0.443  Sum_probs=213.0

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccccH--HHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF  210 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  210 (434)
                      .++|++++.||+|+||+||+|.++.+++.||||+++....  ..+.+|+.+|+.+ +|||||++++++.+.  ..+++||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~--~~~~lvm   80 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNILHLHESFESM--EELVMIF   80 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHS-CCTTBCCEEEEEEET--TEEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhC-CCCCCCeEEEEEEEC--CEEEEEE
Confidence            3789999999999999999999999999999999976543  4578999999999 999999999999764  5688999


Q ss_pred             eecCCCchhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCC-CeEEEEecccceecCCCCcc
Q 013897          211 EHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ-RKLRLIDWGLAEFYHPGKEY  285 (434)
Q Consensus       211 e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~-~~vkl~DFGla~~~~~~~~~  285 (434)
                      |||.+++|..++.    .+++.+++.++.||+.||+|||++||+||||||+|||++.++ ..+||+|||+++........
T Consensus        81 E~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~  160 (321)
T d1tkia_          81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF  160 (321)
T ss_dssp             CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred             ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCcc
Confidence            9999999877653    489999999999999999999999999999999999997543 37999999999988766666


Q ss_pred             ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChh
Q 013897          286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH  365 (434)
Q Consensus       286 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~  365 (434)
                      ...++++.|+|||.+.+ ..|+.++|||||||++|+|++|+.||. +.+..+.+..|.....             .++  
T Consensus       161 ~~~~~t~~y~ape~~~~-~~~~~~~DiWSlGvily~ll~G~~Pf~-~~~~~~~~~~i~~~~~-------------~~~--  223 (321)
T d1tkia_         161 RLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFL-AETNQQIIENIMNAEY-------------TFD--  223 (321)
T ss_dssp             EEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHHTCC-------------CCC--
T ss_pred             cccccccccccchhccC-CCCCchhhcccHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhCCC-------------CCC--
Confidence            77889999999999877 689999999999999999999999983 3343444444322100             000  


Q ss_pred             HHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccc
Q 013897          366 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP  423 (434)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~  423 (434)
                                        ......+++++.+||.+||+.||++|||++|+|+||||++
T Consensus       224 ------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  263 (321)
T d1tkia_         224 ------------------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             ------------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             ------------------hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence                              0111236789999999999999999999999999999974

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.8e-55  Score=430.01  Aligned_cols=254  Identities=26%  Similarity=0.414  Sum_probs=205.8

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHH---HHHHHHhcCCCCeeeEeeEEEccCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKRE---IKILQNLCGGPNIVKLLDIVRDQQS  203 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~E---~~~l~~l~~h~niv~l~~~~~~~~~  203 (434)
                      .++|++++.||+|+||+||+|+++.+|+.||||++....      ...+.+|   +.+++.+ +|||||++++++.+.  
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~-~hpnIv~l~~~~~~~--   79 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTP--   79 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEECS--
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcC-CCCcEEEEEEEEEEC--
Confidence            478999999999999999999999999999999986322      2334455   4445555 799999999999754  


Q ss_pred             CccEEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecC
Q 013897          204 KTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH  280 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~  280 (434)
                      ..+++||||+.+++|..++   ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+...
T Consensus        80 ~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g-~iKl~DFGla~~~~  158 (364)
T d1omwa3          80 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDFS  158 (364)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSS-CEEECCCTTCEECS
T ss_pred             CEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCC-cEEEeeeceeeecC
Confidence            5678999999999998765   4588999999999999999999999999999999999999777 89999999998765


Q ss_pred             CCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccc
Q 013897          281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI  360 (434)
Q Consensus       281 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  360 (434)
                      .. .....+||+.|+|||++.....|+.++|||||||++|||+||+.||...... +... +.+...             
T Consensus       159 ~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-~~~~-~~~~~~-------------  222 (364)
T d1omwa3         159 KK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-DKHE-IDRMTL-------------  222 (364)
T ss_dssp             SS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS-CHHH-HHHHSS-------------
T ss_pred             CC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH-HHHH-HHHhcc-------------
Confidence            43 3455689999999999976467999999999999999999999998543221 1111 111000             


Q ss_pred             cCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCcc-----HHHHhcCCCcccccc
Q 013897          361 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT-----AKEAMAHPYFFPIRN  426 (434)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt-----~~elL~Hp~~~~~~~  426 (434)
                                    .      .....+..+++++.+||.+||+.||++|||     |+|+|+||||+++++
T Consensus       223 --------------~------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~  273 (364)
T d1omwa3         223 --------------T------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW  273 (364)
T ss_dssp             --------------S------CCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCH
T ss_pred             --------------c------CCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCH
Confidence                          0      001122347889999999999999999999     899999999998864

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-55  Score=422.54  Aligned_cols=252  Identities=23%  Similarity=0.405  Sum_probs=210.4

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      |+|++++.||+|+||+||+|+++.+++.||||+++..      ..+.+..|+.++.+..+|||||++++++.+.  ..++
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~--~~~y   79 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK--ENLF   79 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS--SEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC--Ccee
Confidence            6899999999999999999999999999999999632      2345677887776544999999999999754  5688


Q ss_pred             EEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC-C
Q 013897          208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-K  283 (434)
Q Consensus       208 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~-~  283 (434)
                      +||||+.+|+|..++   ..+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+..... .
T Consensus        80 ivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~-~~kl~DFG~a~~~~~~~~  158 (320)
T d1xjda_          80 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG-HIKIADFGMCKENMLGDA  158 (320)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCCCCTTC
T ss_pred             EEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCC-ceeccccchhhhcccccc
Confidence            999999999998776   5699999999999999999999999999999999999999776 8999999999866433 3


Q ss_pred             ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                      .....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||. +.+..+.+..+..  +.               
T Consensus       159 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~PF~-~~~~~~~~~~i~~--~~---------------  219 (320)
T d1xjda_         159 KTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFH-GQDEEELFHSIRM--DN---------------  219 (320)
T ss_dssp             CBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHH--CC---------------
T ss_pred             cccccCCCCCcCCHHHHcC-CCCCchhhhhhhhHHHHHHHhCCCCCC-CCCHHHHHHHHHc--CC---------------
Confidence            3455689999999999987 789999999999999999999999983 4333333333211  00               


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHH-HHhcCCCccccccc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK-EAMAHPYFFPIRNA  427 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~-elL~Hp~~~~~~~~  427 (434)
                                          ...+..+++++.+||.+||+.||++|||+. |+++||||++++..
T Consensus       220 --------------------~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~~  264 (320)
T d1xjda_         220 --------------------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWE  264 (320)
T ss_dssp             --------------------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHH
T ss_pred             --------------------CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCCHH
Confidence                                011224688999999999999999999996 89999999987643

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-56  Score=428.46  Aligned_cols=259  Identities=23%  Similarity=0.396  Sum_probs=208.5

Q ss_pred             CCCeEEEe-eeeecCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeEeeEEEc--cCCCccEEE
Q 013897          133 QDDYEVVR-KVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRD--QQSKTPSLI  209 (434)
Q Consensus       133 ~~~y~~~~-~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--~~~~~~~lv  209 (434)
                      .++|.+++ .||+|+||+||+|++..+++.||||+++.  ...+.+|+.++.++.+|||||++++++.+  .....+++|
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~--~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~iv   87 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV   87 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC--cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEE
Confidence            36899886 59999999999999999999999999964  45678999998877699999999999865  234568999


Q ss_pred             EeecCCCchhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC--CCeEEEEecccceecCCC
Q 013897          210 FEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--QRKLRLIDWGLAEFYHPG  282 (434)
Q Consensus       210 ~e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~--~~~vkl~DFGla~~~~~~  282 (434)
                      ||||++|+|..++.     .+++.+++.++.||+.||+|||++||+||||||+|||++.+  ...+||+|||+|+.....
T Consensus        88 mEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~  167 (335)
T d2ozaa1          88 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH  167 (335)
T ss_dssp             EECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCC
T ss_pred             EECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCC
Confidence            99999999977652     48999999999999999999999999999999999999853  236999999999988777


Q ss_pred             CccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccC
Q 013897          283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL  362 (434)
Q Consensus       283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  362 (434)
                      ......+||+.|+|||++.+ ..|+.++|||||||++|+|+||+.||... +.......+....                
T Consensus       168 ~~~~~~~gt~~y~aPE~~~~-~~y~~~~DiwSlGvily~lltg~~Pf~~~-~~~~~~~~~~~~i----------------  229 (335)
T d2ozaa1         168 NSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSN-HGLAISPGMKTRI----------------  229 (335)
T ss_dssp             CCCCCCSCCCSSCCCCCCCG-GGGSHHHHHHHHHHHHHHHTTSSCSCEET-TCC--------CC----------------
T ss_pred             CccccccCCcccCCcHHHcC-CCCCHHHHHHhhchhHHHHhhCCCCCCCC-CHHHHHHHHHHHH----------------
Confidence            77777899999999999877 68999999999999999999999999432 2211111111000                


Q ss_pred             ChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccc
Q 013897          363 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI  424 (434)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~  424 (434)
                                 ....+.  ........+++++.+||.+||+.||++|||+.|+|+||||++.
T Consensus       230 -----------~~~~~~--~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  278 (335)
T d2ozaa1         230 -----------RMGQYE--FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  278 (335)
T ss_dssp             -----------CSCSSS--CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred             -----------hcCCCC--CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence                       000000  0001112478899999999999999999999999999999754

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-54  Score=421.25  Aligned_cols=287  Identities=31%  Similarity=0.560  Sum_probs=218.4

Q ss_pred             cCCCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccC--
Q 013897          130 WGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ--  202 (434)
Q Consensus       130 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~--  202 (434)
                      |...++|+++++||+|+||+||+|.++.+|+.||||+++...     .+.+.+|+.+|+.+ +|||||+++++|....  
T Consensus        14 ~~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpniv~l~~~~~~~~~~   92 (346)
T d1cm8a_          14 WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETL   92 (346)
T ss_dssp             ECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSST
T ss_pred             eecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhc-CCCCeeEEEEEeccCccc
Confidence            345689999999999999999999999999999999996422     35678999999999 9999999999997543  


Q ss_pred             --CCccEEEEeecCCCchhhhc--CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEeccccee
Q 013897          203 --SKTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF  278 (434)
Q Consensus       203 --~~~~~lv~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~  278 (434)
                        ...+++||||++ .++..+.  ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.
T Consensus        93 ~~~~~~~lv~e~~~-~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~-~~kl~Dfg~a~~  170 (346)
T d1cm8a_          93 DDFTDFYLVMPFMG-TDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLARQ  170 (346)
T ss_dssp             TTCCCCEEEEECCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred             cccceEEEEEeccc-ccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccccc-ccccccccceec
Confidence              235789999994 4554443  4799999999999999999999999999999999999999777 899999999987


Q ss_pred             cCCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhc
Q 013897          279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY  358 (434)
Q Consensus       279 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  358 (434)
                      ..  ...+..+||+.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+....+......+. ..
T Consensus       171 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~-~~  246 (346)
T d1cm8a_         171 AD--SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF-KGSDHLDQLKEIMKVTGTPPAEFVQ-RL  246 (346)
T ss_dssp             CC--SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCHHHHH-TC
T ss_pred             cC--CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCC-CCCChHHHHHHHHhccCCCcHHHHh-hh
Confidence            54  34466789999999999987667899999999999999999999887 5566677777777777765432221 11


Q ss_pred             cccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccccc
Q 013897          359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~  428 (434)
                      ...................+..     ....+++++.|||.+||+.||++|||++|+|+||||+.+...+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~-----~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~  311 (346)
T d1cm8a_         247 QSDEAKNYMKGLPELEKKDFAS-----ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE  311 (346)
T ss_dssp             SCHHHHHHHHHSCCCCCCCGGG-----TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC---
T ss_pred             cchhhhhhhccCCcccccchHH-----hccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCcc
Confidence            1111111111111111111111     1234678999999999999999999999999999999876443

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.7e-54  Score=410.37  Aligned_cols=276  Identities=30%  Similarity=0.565  Sum_probs=217.1

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      |+|+++++||+|+||+||+|++ .+++.||||+++...     .+.+.+|+.+|+++ +|||||++++++.+.  ...++
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~--~~~~i   77 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVIHTK--KRLVL   77 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEECS--SCEEE
T ss_pred             CCceeccEEecCCCcEEEEEEe-CCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-CCCcEEeeeeecccC--CceeE
Confidence            6899999999999999999998 478999999986432     36789999999999 899999999999754  56779


Q ss_pred             EEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCC-Cc
Q 013897          209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KE  284 (434)
Q Consensus       209 v~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~-~~  284 (434)
                      ++||+.++++..+.   ..+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+|...... ..
T Consensus        78 ~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~-~~kl~DfG~a~~~~~~~~~  156 (286)
T d1ob3a_          78 VFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG-ELKIADFGLARAFGIPVRK  156 (286)
T ss_dssp             EEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECCTTHHHHHCC----
T ss_pred             EEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCC-CEEecccccceecccCccc
Confidence            99999998876664   4589999999999999999999999999999999999999777 8999999999776433 23


Q ss_pred             cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCCh
Q 013897          285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP  364 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  364 (434)
                      ....++++.|+|||.+.+...++.++|||||||++|||++|+.|| .+.+..+++.++...++.+....+........  
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~--  233 (286)
T d1ob3a_         157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF-PGVSEADQLMRIFRILGTPNSKNWPNVTELPK--  233 (286)
T ss_dssp             -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT--
T ss_pred             cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCC-CCCCHHHHHHHHHHhhCCCChhhccchhhhhh--
Confidence            355578999999999987677899999999999999999999998 55666777888877777654433322111000  


Q ss_pred             hHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccc
Q 013897          365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP  423 (434)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~  423 (434)
                       ...........+     .......+++++.|||++||+.||++|||++|+|+||||++
T Consensus       234 -~~~~~~~~~~~~-----~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         234 -YDPNFTVYEPLP-----WESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             -CCTTCCCCCCCC-----GGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             -cccccccccCcc-----hhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence             000000001111     11123357789999999999999999999999999999984

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-55  Score=410.85  Aligned_cols=247  Identities=25%  Similarity=0.438  Sum_probs=204.0

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc---------HHHHHHHHHHHHHhc-CCCCeeeEeeEEEccC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---------KKKIKREIKILQNLC-GGPNIVKLLDIVRDQQ  202 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---------~~~~~~E~~~l~~l~-~h~niv~l~~~~~~~~  202 (434)
                      .++|++.+.||+|+||+||+|++..+++.||||+++...         ..++.+|+.+|+++. .|||||++++++.+. 
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~-   81 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP-   81 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS-
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC-
Confidence            367999999999999999999999999999999986422         234678999999984 389999999999654 


Q ss_pred             CCccEEEEeecCC-Cchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEeccccee
Q 013897          203 SKTPSLIFEHVNN-TDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF  278 (434)
Q Consensus       203 ~~~~~lv~e~~~~-~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~  278 (434)
                       ...++||||+.+ +++..++   ..+++.+++.++.||+.||+|||++||+||||||+|||++.+++.+||+|||+|+.
T Consensus        82 -~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~  160 (273)
T d1xwsa_          82 -DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL  160 (273)
T ss_dssp             -SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             -CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccccee
Confidence             567899999976 4554443   46999999999999999999999999999999999999986655899999999986


Q ss_pred             cCCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhc
Q 013897          279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY  358 (434)
Q Consensus       279 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  358 (434)
                      .. ....+..+||+.|+|||++.+...++.++|||||||++|||++|+.||..    ..   .+.+             .
T Consensus       161 ~~-~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~----~~---~i~~-------------~  219 (273)
T d1xwsa_         161 LK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DE---EIIR-------------G  219 (273)
T ss_dssp             CC-SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS----HH---HHHH-------------C
T ss_pred             cc-cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCC----ch---HHhh-------------c
Confidence            54 33446678999999999998744567889999999999999999999832    11   1100             0


Q ss_pred             cccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccc
Q 013897          359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN  426 (434)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~  426 (434)
                      .                        ...+..+++++.+||.+||+.||++|||++|+|+||||+++..
T Consensus       220 ~------------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~~  263 (273)
T d1xwsa_         220 Q------------------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL  263 (273)
T ss_dssp             C------------------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred             c------------------------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCCC
Confidence            0                        0112247889999999999999999999999999999998753

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-54  Score=407.53  Aligned_cols=280  Identities=30%  Similarity=0.519  Sum_probs=224.5

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL  208 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  208 (434)
                      ++|+++++||+|+||+||+|++..+++.||||+++..     ...++.+|+.+|+.+ +||||+++++++.+.  ...++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~--~~~~i   78 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHSD--KKLTL   78 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECS--SEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhc-CcCCEEeeccccccc--cceeE
Confidence            6899999999999999999999999999999998642     246788999999998 999999999999764  56779


Q ss_pred             EEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC-c
Q 013897          209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-E  284 (434)
Q Consensus       209 v~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~-~  284 (434)
                      |+|++.++++..+.   ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||.|+...... .
T Consensus        79 v~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~-~~kl~DFG~a~~~~~~~~~  157 (292)
T d1unla_          79 VFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG-ELKLANFGLARAFGIPVRC  157 (292)
T ss_dssp             EEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSCCSC
T ss_pred             EeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCC-ceeeeecchhhcccCCCcc
Confidence            99999999876553   4688999999999999999999999999999999999999776 89999999998775443 3


Q ss_pred             cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCCh
Q 013897          285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP  364 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  364 (434)
                      .....++++|+|||++.+...++.++|||||||++|||++|+.||+.+.+..+++..+....+......+..........
T Consensus       158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (292)
T d1unla_         158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK  237 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred             ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence            34556788899999988756689999999999999999999999998888888888887777764433222111100000


Q ss_pred             hHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccc
Q 013897          365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                             ........ .........+++++.|||.+||+.||++||||+|+|+||||++..
T Consensus       238 -------~~~~~~~~-~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~  290 (292)
T d1unla_         238 -------PYPMYPAT-TSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             -------CCCCCCTT-CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred             -------cccccccc-chhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence                   00000000 001112234678999999999999999999999999999998764

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-53  Score=411.00  Aligned_cols=284  Identities=30%  Similarity=0.473  Sum_probs=216.1

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccC-----
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ-----  202 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~-----  202 (434)
                      -++|+++++||+|+||+||+|++..+|+.||||++...     ....+.+|+.+|+++ +||||+++++++....     
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~nii~~~~~~~~~~~~~~~   87 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKASPYNR   87 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEC-------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHh-cCCCccceEeeeecccccccc
Confidence            37899999999999999999999999999999998532     235688999999999 8999999999986532     


Q ss_pred             -CCccEEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEeccccee
Q 013897          203 -SKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF  278 (434)
Q Consensus       203 -~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~  278 (434)
                       ...+++||||+.++++....   ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus        88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~-~~kl~dfg~~~~  166 (318)
T d3blha1          88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG-VLKLADFGLARA  166 (318)
T ss_dssp             ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCTTCEE
T ss_pred             cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCC-cEEeeecceeee
Confidence             34678999999988876554   3588999999999999999999999999999999999999777 899999999976


Q ss_pred             cCCCC-----ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHH
Q 013897          279 YHPGK-----EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA  353 (434)
Q Consensus       279 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~  353 (434)
                      .....     .....+||+.|+|||++.+...|+.++|||||||++|||++|+.|| .+.++.+.+..+.+..+......
T Consensus       167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~  245 (318)
T d3blha1         167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM-QGNTEQHQLALISQLCGSITPEV  245 (318)
T ss_dssp             CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCC-CCCCHHHHHHHHHHhcCCCChhh
Confidence            64322     2244579999999999987668999999999999999999999887 56667777777877777543322


Q ss_pred             HHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccc
Q 013897          354 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI  424 (434)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~  424 (434)
                      +...........+    .... ...............++++.|||.+||+.||++|||++|+|+||||+.-
T Consensus       246 ~~~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~  311 (318)
T d3blha1         246 WPNVDNYELYEKL----ELVK-GQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  311 (318)
T ss_dssp             STTCCCC-----------CCS-SCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred             ccccchhhhhhhh----cccc-cccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence            1111000000000    0000 0000000000112246789999999999999999999999999999853

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-53  Score=414.69  Aligned_cols=284  Identities=27%  Similarity=0.470  Sum_probs=216.0

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEcc----CC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ----QS  203 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~----~~  203 (434)
                      .++|+++++||+|+||+||+|+++.+|+.||||+++..     ...++.+|+.+|+++ +|||||+++++|...    ..
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~f~~~~~~~~~   94 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEF   94 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTTTC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEecccccccC
Confidence            36899999999999999999999999999999999642     234688999999999 999999999999654    23


Q ss_pred             CccEEEEeecCCCchhhhcCCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC
Q 013897          204 KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~  283 (434)
                      ..+++||||+.++++..+...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+|++|||+++......
T Consensus        95 ~~~~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~-~~kl~df~~~~~~~~~~  173 (355)
T d2b1pa1          95 QDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSF  173 (355)
T ss_dssp             CEEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCCCC--------
T ss_pred             ceeEEEEeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccccccc-ceeeechhhhhcccccc
Confidence            67899999999999988888999999999999999999999999999999999999999777 79999999998776666


Q ss_pred             ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                      .....++|+.|+|||++.+ ..++.++||||+||++|+|++|+.|| .+.+...+...+...++.+....+..     ..
T Consensus       174 ~~~~~~~t~~y~aPE~l~~-~~~~~~~DiwSlG~~l~ell~g~~pF-~~~~~~~~~~~i~~~~~~~~~~~~~~-----~~  246 (355)
T d2b1pa1         174 MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILF-PGRDYIDQWNKVIEQLGTPCPEFMKK-----LQ  246 (355)
T ss_dssp             -------CCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCHHHHTT-----SC
T ss_pred             ccccccccccccChhhhcC-CCCCCCcccccccchHHHHhhCCCCC-CCCCHHHHHHHHHHhccCCCHHHHHH-----hh
Confidence            6677789999999999987 68999999999999999999999887 66677777777777776643332211     11


Q ss_pred             hhHHHHhcccCCCCCccc----------cccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccc
Q 013897          364 PHLAALVGRHSRKPWSKF----------ITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR  425 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~  425 (434)
                      ..................          .........++++.|||++||+.||++||||+|+|+||||+...
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~  318 (355)
T d2b1pa1         247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY  318 (355)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence            222222221111110000          00111223567899999999999999999999999999999743

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-54  Score=401.95  Aligned_cols=248  Identities=16%  Similarity=0.313  Sum_probs=206.4

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecc--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF  210 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~--~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  210 (434)
                      .++|++.+.||+|+||+||+|.++ ++..||||+++.  ...+.+.+|+.+|+++ +|||||++++++.+   ..+++||
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~---~~~~iv~   86 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAVVTQ---EPIYIIT   86 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS---SSCEEEE
T ss_pred             HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhC-CCCCEeEEEeeecc---CCeEEEE
Confidence            378999999999999999999984 678999999974  3457799999999999 99999999998854   3468999


Q ss_pred             eecCCCchhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc-
Q 013897          211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-  284 (434)
Q Consensus       211 e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~-  284 (434)
                      ||+.+|+|..++.     .+++.++..++.||+.||.|||+++|+||||||+|||++.++ .+||+|||+|+....... 
T Consensus        87 Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~-~~Kl~DFGla~~~~~~~~~  165 (272)
T d1qpca_          87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL-SCKIADFGLARLIEDNEYT  165 (272)
T ss_dssp             ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCEECSSSCEE
T ss_pred             EeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeeccc-ceeeccccceEEccCCccc
Confidence            9999999977653     489999999999999999999999999999999999999776 899999999987754432 


Q ss_pred             -cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          285 -YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       285 -~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                       .....||+.|+|||++.+ ..++.++|||||||++|||+||+.|++......+.+..+....                 
T Consensus       166 ~~~~~~gt~~y~APE~~~~-~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~-----------------  227 (272)
T d1qpca_         166 AREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY-----------------  227 (272)
T ss_dssp             CCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-----------------
T ss_pred             cccccCCcccccChHHHhC-CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC-----------------
Confidence             234568889999999876 6799999999999999999998878766655544443322100                 


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc--CCCccc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA--HPYFFP  423 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~--Hp~~~~  423 (434)
                                         ....+..+++++.+|+.+||+.||++|||++|+++  |+||..
T Consensus       228 -------------------~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         228 -------------------RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             -------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -------------------CCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence                               01112347789999999999999999999999998  888864

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-52  Score=407.37  Aligned_cols=286  Identities=28%  Similarity=0.510  Sum_probs=216.2

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCC--cc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK--TP  206 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~--~~  206 (434)
                      .++|+++++||+|+||+||+|++..+|+.||||+++...    .+.+.+|+.+|+.+ +||||+++++++......  ..
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-~hp~iv~~~~~~~~~~~~~~~~   85 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQMKD   85 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTTCCC
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHc-CCCCCCcEEEEEeeccccccce
Confidence            467999999999999999999999999999999997433    34678999999999 999999999999654321  23


Q ss_pred             EEEEeecCCCchhhhc--CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC-
Q 013897          207 SLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-  283 (434)
Q Consensus       207 ~lv~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~-  283 (434)
                      +++++|+.+++|..++  ..+++..++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+...... 
T Consensus        86 ~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~-~~kl~DfG~a~~~~~~~~  164 (345)
T d1pmea_          86 VYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHD  164 (345)
T ss_dssp             EEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECCGGGC
T ss_pred             EEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCC-CEEEcccCceeeccCCCc
Confidence            4556677888887665  4799999999999999999999999999999999999999776 89999999998764332 


Q ss_pred             ---ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccc
Q 013897          284 ---EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI  360 (434)
Q Consensus       284 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  360 (434)
                         .....+||+.|+|||++.....++.++||||+||++|+|++|+.|| .+.+..++...+...++.+........   
T Consensus       165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~---  240 (345)
T d1pmea_         165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF-PGKHYLDQLNHILGILGSPSQEDLNCI---  240 (345)
T ss_dssp             BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCSCCHHHHHTC---
T ss_pred             cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCC-CCCCHHHHHHHHhhhccCCChhhhhhh---
Confidence               2355679999999999866567899999999999999999999997 555556666666666655433222111   


Q ss_pred             cCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCccccccc
Q 013897          361 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA  427 (434)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~  427 (434)
                       ...................+  ......+++++.+||.+||+.||++|||++|+|+||||+.....
T Consensus       241 -~~~~~~~~~~~~~~~~~~~~--~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~  304 (345)
T d1pmea_         241 -INLKARNYLLSLPHKNKVPW--NRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP  304 (345)
T ss_dssp             -CCHHHHHHHHTSCCCCCCCH--HHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred             -hhhhhhcccccCCccCCCCH--HHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence             01111111111111100000  01112467889999999999999999999999999999966544

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-53  Score=395.34  Aligned_cols=244  Identities=16%  Similarity=0.333  Sum_probs=193.6

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecc--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF  210 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~--~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  210 (434)
                      .++|++++.||+|+||+||+|.+. +++.||||+++.  ...+++.+|+.+++++ +|||||+++|++.+.  ...++||
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~--~~~~lv~   79 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQ--APICLVF   79 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECSS--SSCEEEE
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhc-CCCCcccccceeccC--CceEEEE
Confidence            367999999999999999999984 678899999974  3457799999999999 999999999999654  5678999


Q ss_pred             eecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc--
Q 013897          211 EHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE--  284 (434)
Q Consensus       211 e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~--  284 (434)
                      ||+.+|+|..++    ..+++..+..++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+|+.......  
T Consensus        80 E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~-~~Kl~DFGla~~~~~~~~~~  158 (263)
T d1sm2a_          80 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLDDQYTS  158 (263)
T ss_dssp             ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGG-CEEECSCC------------
T ss_pred             EecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCC-CeEecccchheeccCCCcee
Confidence            999999987764    3478889999999999999999999999999999999999777 899999999987654332  


Q ss_pred             cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCCh
Q 013897          285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP  364 (434)
Q Consensus       285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  364 (434)
                      .....||..|+|||++.+ ..|+.++|||||||++|||+|++.|++...+..+.+..+....                  
T Consensus       159 ~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~------------------  219 (263)
T d1sm2a_         159 STGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF------------------  219 (263)
T ss_dssp             ------CTTSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTC------------------
T ss_pred             ecceecCcccCChHHhcC-CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcC------------------
Confidence            234578999999999887 6899999999999999999997677766555444443332100                  


Q ss_pred             hHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                                        ....+..+++++.+|+.+||+.||++|||++|+|+|
T Consensus       220 ------------------~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         220 ------------------RLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             ------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------CCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                              011122467899999999999999999999999987

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.9e-53  Score=402.72  Aligned_cols=244  Identities=18%  Similarity=0.328  Sum_probs=203.1

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF  210 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  210 (434)
                      .++|++.+.||+|+||+||+|.++.+++.||||+++..  ..+++.+|+.+|+++ +|||||++++++.+.  ...++||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~--~~~~iv~   92 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTRE--PPFYIIT   92 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHC-CCTTBCCEEEEECSS--SSCEEEE
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhC-CCCCEecCCccEeeC--CeeEEEe
Confidence            36899999999999999999999999999999999643  457799999999999 999999999999654  5678999


Q ss_pred             eecCCCchhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCcc
Q 013897          211 EHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY  285 (434)
Q Consensus       211 e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~  285 (434)
                      ||+.+|++..++     ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+........
T Consensus        93 E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~-~~Kl~DFG~a~~~~~~~~~  171 (287)
T d1opja_          93 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTYT  171 (287)
T ss_dssp             ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCCCTTTCCSSSSE
T ss_pred             ecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCC-cEEEccccceeecCCCCce
Confidence            999999987664     3578999999999999999999999999999999999999776 8999999999876543322


Q ss_pred             --ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          286 --NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       286 --~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                        ....|+..|+|||++.+ ..|+.++|||||||++|||++|+.||+.+.+.......+...                  
T Consensus       172 ~~~~~~g~~~y~aPE~~~~-~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~------------------  232 (287)
T d1opja_         172 AHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD------------------  232 (287)
T ss_dssp             EETTEEECGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT------------------
T ss_pred             eeccccccccccChHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC------------------
Confidence              23357889999999887 689999999999999999999888886655543322222110                  


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                .        ....+..+++++.+||.+||+.||++|||++|+++
T Consensus       233 ----------~--------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         233 ----------Y--------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             ----------C--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------C--------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence                      0        01122347789999999999999999999999976

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-53  Score=399.74  Aligned_cols=246  Identities=17%  Similarity=0.323  Sum_probs=193.8

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecc-----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      .++|++.+.||+|+||+||+|+++   ..||||+++.     ...+.+.+|+.+|+++ +|||||++++++.+   ..++
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~---~~~~   79 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGYSTA---PQLA   79 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTC-CCTTBCCEEEEECS---SSCE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeeeeEEEec---cEEE
Confidence            467899999999999999999853   3599999863     2346788999999999 99999999998853   3568


Q ss_pred             EEEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC
Q 013897          208 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       208 lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~  283 (434)
                      +||||+++|+|..++    ..+++..+..++.||+.||+|||+++||||||||+|||++.++ .+||+|||+|+......
T Consensus        80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~-~~Kl~DFGla~~~~~~~  158 (276)
T d1uwha_          80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWS  158 (276)
T ss_dssp             EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTS-SEEECCCCCSCC-----
T ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCC-CEEEccccceeeccccC
Confidence            999999999997765    3489999999999999999999999999999999999999776 89999999997664322


Q ss_pred             ---ccceeccCCcccccccccCC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhc
Q 013897          284 ---EYNVRVASRYFKGPELLVDL--QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY  358 (434)
Q Consensus       284 ---~~~~~~~t~~y~aPE~~~~~--~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  358 (434)
                         ......||+.|+|||++.+.  ..|+.++|||||||++|||+||+.||. +.+....+..+......          
T Consensus       159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~-~~~~~~~~~~~~~~~~~----------  227 (276)
T d1uwha_         159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYL----------  227 (276)
T ss_dssp             -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTT-TCCCHHHHHHHHHHTSC----------
T ss_pred             CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCC-CCChHHHHHHHHhcCCC----------
Confidence               23456799999999998642  358999999999999999999999984 33444333332211000          


Q ss_pred             cccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                          .+.                 .......+++++.+||.+||..||++|||++|+++|
T Consensus       228 ----~p~-----------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         228 ----SPD-----------------LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             ----CCC-----------------GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----CCc-----------------chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                000                 001123467899999999999999999999999986

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-52  Score=403.62  Aligned_cols=246  Identities=21%  Similarity=0.353  Sum_probs=200.0

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCC-----eEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDN-----EKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS  203 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~-----~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  203 (434)
                      .++|++.+.||+|+||+||+|++..++     ..||+|.+...    ....+.+|+.+|.++.+|||||++++++.+.  
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~--  113 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS--  113 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC--
Confidence            478999999999999999999986554     37999998543    2356889999999987899999999999654  


Q ss_pred             CccEEEEeecCCCchhhhcC--------------------------CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCC
Q 013897          204 KTPSLIFEHVNNTDFKVLYP--------------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPH  257 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~~--------------------------~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~  257 (434)
                      ..+++||||+++|+|..++.                          .+++..++.++.||+.||+|||+++|+||||||+
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~  193 (325)
T d1rjba_         114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR  193 (325)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred             CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchh
Confidence            56789999999999977652                          3788899999999999999999999999999999


Q ss_pred             ceEecCCCCeEEEEecccceecCCCCcc---ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCC
Q 013897          258 NVMIDHEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGH  333 (434)
Q Consensus       258 NIll~~~~~~vkl~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~  333 (434)
                      |||++.++ .+||+|||+|+........   ....||+.|+|||++.+ ..|+.++|||||||++|||+| |+.||. +.
T Consensus       194 Nill~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwS~Gvil~emlt~g~~Pf~-~~  270 (325)
T d1rjba_         194 NVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYP-GI  270 (325)
T ss_dssp             GEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSST-TC
T ss_pred             ccccccCC-eEEEeeccccccccCCCceeeeccccCCCccCChHHHcC-CCCCcceeccchhHHHHHHHhCCCCCCC-CC
Confidence            99999776 8999999999876544332   34567999999999887 789999999999999999998 888873 43


Q ss_pred             CCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHH
Q 013897          334 DNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK  413 (434)
Q Consensus       334 ~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~  413 (434)
                      +....+.++.+.                           ..        ....+..+++++.+||.+||+.||++|||++
T Consensus       271 ~~~~~~~~~~~~---------------------------~~--------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~  315 (325)
T d1rjba_         271 PVDANFYKLIQN---------------------------GF--------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFP  315 (325)
T ss_dssp             CCSHHHHHHHHT---------------------------TC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CHHHHHHHHHhc---------------------------CC--------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHH
Confidence            333333332210                           00        0112234778999999999999999999999


Q ss_pred             HHhcC
Q 013897          414 EAMAH  418 (434)
Q Consensus       414 elL~H  418 (434)
                      |+++|
T Consensus       316 ei~~~  320 (325)
T d1rjba_         316 NLTSF  320 (325)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99976

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-52  Score=405.79  Aligned_cols=288  Identities=28%  Similarity=0.550  Sum_probs=220.0

Q ss_pred             cCCCCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccC--
Q 013897          130 WGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ--  202 (434)
Q Consensus       130 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~--  202 (434)
                      |...++|+++++||+|+||+||+|++..+|+.||||+++..     ..+.+.+|+.+|+.+ +|||+|++++++....  
T Consensus        14 ~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~h~~iv~~~~~~~~~~~~   92 (348)
T d2gfsa1          14 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSL   92 (348)
T ss_dssp             EEEETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSST
T ss_pred             ccCCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeecccc
Confidence            33458899999999999999999999999999999999643     235678999999999 9999999999986432  


Q ss_pred             -CCccEEEEeecCCCchhhhc--CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceec
Q 013897          203 -SKTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY  279 (434)
Q Consensus       203 -~~~~~lv~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~  279 (434)
                       ....+++++|+.+++|..++  +.+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+|++|||+|...
T Consensus        93 ~~~~~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~-~~kl~dfg~a~~~  171 (348)
T d2gfsa1          93 EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHT  171 (348)
T ss_dssp             TTCCCCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECCC----CC
T ss_pred             ccCceEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccc-cccccccchhccc
Confidence             22345677888899998775  4699999999999999999999999999999999999999777 8999999999654


Q ss_pred             CCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcc
Q 013897          280 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH  359 (434)
Q Consensus       280 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  359 (434)
                      .  .......|++.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+.......+.+..+.........   
T Consensus       172 ~--~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF-~~~~~~~~~~~i~~~~~~~~~~~~~~---  245 (348)
T d2gfsa1         172 D--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAELLKK---  245 (348)
T ss_dssp             T--GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCHHHHTT---
T ss_pred             C--cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCCChHHhhh---
Confidence            3  34456788999999999887667899999999999999999999887 56666777777777666543222111   


Q ss_pred             ccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcccccccc
Q 013897          360 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~~~~~~~  428 (434)
                       ................+...+  ......+++++.|||.+||+.||++|||++|+|+||||++.....
T Consensus       246 -~~~~~~~~~~~~~~~~~~~~~--~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~  311 (348)
T d2gfsa1         246 -ISSESARNYIQSLTQMPKMNF--ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD  311 (348)
T ss_dssp             -CCCHHHHHHHTTSCCCCCCCH--HHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTT
T ss_pred             -ccchhhhhhhhhcccCCCcch--hhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCc
Confidence             001111111111111111111  011234678999999999999999999999999999999876443

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-52  Score=391.75  Aligned_cols=251  Identities=18%  Similarity=0.307  Sum_probs=203.7

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEE
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF  210 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  210 (434)
                      .++|++.+.||+|+||+||+|+++ +++.||||+++..  ..+.+.+|+.+|+++ +|||||++++++.+   ...++||
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~g~~~~---~~~~lv~   90 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE---EPIYIVT   90 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS---SSCEEEE
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEEC-CCCEEEEEEECcccCCHHHHHHHHHHHHhc-ccCCEeEEEEEEec---CCeEEEE
Confidence            368999999999999999999985 4467999999753  357799999999999 99999999999853   3467999


Q ss_pred             eecCCCchhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCC--
Q 013897          211 EHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--  283 (434)
Q Consensus       211 e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~--  283 (434)
                      ||+.+|++..++     ..+++.++..++.||+.||+|||+++|+||||||+||||+.++ .+||+|||+|+......  
T Consensus        91 Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~-~~kl~DfGla~~~~~~~~~  169 (285)
T d1fmka3          91 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYT  169 (285)
T ss_dssp             CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCCTTC--------
T ss_pred             EecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCC-cEEEcccchhhhccCCCce
Confidence            999999876554     3589999999999999999999999999999999999999776 89999999998764333  


Q ss_pred             ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCC
Q 013897          284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD  363 (434)
Q Consensus       284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  363 (434)
                      ......||+.|+|||++.+ ..++.++|||||||++|||++|+.|++.+....+.+..+....                 
T Consensus       170 ~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~-----------------  231 (285)
T d1fmka3         170 ARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-----------------  231 (285)
T ss_dssp             ------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-----------------
T ss_pred             eeccccccccccChHHHhC-CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC-----------------
Confidence            2234578999999999987 7899999999999999999998888877666555544432100                 


Q ss_pred             hhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc--CCCcccccc
Q 013897          364 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA--HPYFFPIRN  426 (434)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~--Hp~~~~~~~  426 (434)
                                         ..+....+++++.+||.+||+.||++|||++++++  |+||.....
T Consensus       232 -------------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p  277 (285)
T d1fmka3         232 -------------------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP  277 (285)
T ss_dssp             -------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred             -------------------CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCC
Confidence                               01122347789999999999999999999999998  999987654

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.5e-52  Score=396.23  Aligned_cols=244  Identities=17%  Similarity=0.302  Sum_probs=186.5

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCe---EEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNE---KCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT  205 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~---~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  205 (434)
                      .++|++.+.||+|+||+||+|.++.+++   .||||.+...    ..+.+.+|+.+|+++ +|||||+++|++.+.  ..
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~--~~  101 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNVIHLEGVVTKS--TP  101 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSS--SS
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-CCCCCccEEEEEeeC--CE
Confidence            3679999999999999999999876654   6889988643    235689999999999 999999999999654  56


Q ss_pred             cEEEEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC
Q 013897          206 PSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP  281 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~  281 (434)
                      +++||||+.+|+|..++    ..+++.++..++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+|+....
T Consensus       102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~-~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLED  180 (299)
T ss_dssp             CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCC--------
T ss_pred             EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCC-cEEECCcccceEccC
Confidence            78999999999997654    3489999999999999999999999999999999999999776 899999999987654


Q ss_pred             CCcc------ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHH
Q 013897          282 GKEY------NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAY  354 (434)
Q Consensus       282 ~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~  354 (434)
                      ....      ....||+.|+|||++.+ ..|+.++|||||||++|||+| |+.||. +....+.+..+.+          
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~el~t~g~~Pf~-~~~~~~~~~~i~~----------  248 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYW-DMTNQDVINAIEQ----------  248 (299)
T ss_dssp             ---------------CGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTT-TCCHHHHHHHHHT----------
T ss_pred             CCCcceeeecccccCCccccCHHHHhc-CCCCcccccccchHHHHHHHhCCCCCCC-CCCHHHHHHHHHc----------
Confidence            3222      12357889999999887 789999999999999999998 788873 3333322222211          


Q ss_pred             HhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          355 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                                        ..+        ...+..+++++.+|+.+||+.||++|||+.|++++
T Consensus       249 ------------------~~~--------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         249 ------------------DYR--------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             ------------------TCC--------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ------------------CCC--------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                              000        11122467899999999999999999999998875

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-52  Score=392.56  Aligned_cols=250  Identities=20%  Similarity=0.359  Sum_probs=201.1

Q ss_pred             CCCeEEEee-eeecCceEEEEEEEcC--CCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCc
Q 013897          133 QDDYEVVRK-VGRGKYSEVFEGVHCT--DNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT  205 (434)
Q Consensus       133 ~~~y~~~~~-lG~G~fg~Vy~~~~~~--~~~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  205 (434)
                      .++|.+.+. ||+|+||+||+|.++.  ++..||||+++..    ..+++.+|+.+|+++ +|||||++++++.+   ..
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~---~~   82 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA---EA   82 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEES---SS
T ss_pred             ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhC-CCCCEeeEeeeecc---Ce
Confidence            467888884 9999999999998753  4558999999643    235689999999999 99999999999864   34


Q ss_pred             cEEEEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC
Q 013897          206 PSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP  281 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~  281 (434)
                      +++||||+++|+|..++    ..+++..+..++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+|+....
T Consensus        83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~-~~Kl~DFGla~~~~~  161 (285)
T d1u59a_          83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH-YAKISDFGLSKALGA  161 (285)
T ss_dssp             EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT-EEEECCCTTCEECTT
T ss_pred             EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCC-ceeeccchhhhcccc
Confidence            68999999999998764    3489999999999999999999999999999999999999776 899999999987754


Q ss_pred             CCcc----ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHh
Q 013897          282 GKEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN  356 (434)
Q Consensus       282 ~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~  356 (434)
                      ....    ....||+.|+|||++.+ ..++.++|||||||++|||+| |+.||. +....+....+.+  |         
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~-~~~~~~~~~~i~~--~---------  228 (285)
T d1u59a_         162 DDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYK-KMKGPEVMAFIEQ--G---------  228 (285)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTT-TCCTHHHHHHHHT--T---------
T ss_pred             cccccccccccccCccccChHHHhC-CCCCccchhhcchHHHHHHHhCCCCCCC-CCCHHHHHHHHHc--C---------
Confidence            4322    23467889999999876 689999999999999999998 899984 3333333332211  0         


Q ss_pred             hccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHH---hcCCCccccc
Q 013897          357 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEA---MAHPYFFPIR  425 (434)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~el---L~Hp~~~~~~  425 (434)
                                       .+        ...+..+++++.+||.+||+.||++|||+.++   |+|+|+.-..
T Consensus       229 -----------------~~--------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~  275 (285)
T d1u59a_         229 -----------------KR--------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS  275 (285)
T ss_dssp             -----------------CC--------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred             -----------------CC--------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhh
Confidence                             00        11123478899999999999999999999877   6788875433

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3.4e-52  Score=392.54  Aligned_cols=253  Identities=21%  Similarity=0.317  Sum_probs=196.7

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC--C
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS--K  204 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~--~  204 (434)
                      .++|++.+.||+|+||+||+|++..+++.||||+++...      ...+.+|+.+|+.+ +|||||++++++.....  .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~-~hpniv~~~~~~~~~~~~~~   84 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETPAGP   84 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEECSSSE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhc-CCCCCCcccceeeeccCCCc
Confidence            377999999999999999999999999999999996422      34688999999998 99999999999876543  3


Q ss_pred             ccEEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC
Q 013897          205 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP  281 (434)
Q Consensus       205 ~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~  281 (434)
                      .+++||||+.+++|....   ..+++.+++.++.||+.||+|||++||+||||||+|||++.++ .++|+|||.+.....
T Consensus        85 ~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~-~~~l~d~~~~~~~~~  163 (277)
T d1o6ya_          85 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN-AVKVMDFGIARAIAD  163 (277)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTS-CEEECCCTTCEECC-
T ss_pred             eEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccc-cceeehhhhhhhhcc
Confidence            478999999999987654   4699999999999999999999999999999999999999777 899999999876543


Q ss_pred             CC----ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhh
Q 013897          282 GK----EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK  357 (434)
Q Consensus       282 ~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  357 (434)
                      ..    .....+||+.|+|||++.+ ..|+.++|||||||++|||+||+.||. +.+..+.+..+.....          
T Consensus       164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~-~~~~~~~~~~~~~~~~----------  231 (277)
T d1o6ya_         164 SGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFT-GDSPVSVAYQHVREDP----------  231 (277)
T ss_dssp             ---------------TTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCC-CSSHHHHHHHHHHCCC----------
T ss_pred             ccccccccccccCcccccCHHHHcC-CCCCcceecccchHHHHHHHhCCCCCC-CcCHHHHHHHHHhcCC----------
Confidence            22    2345689999999999887 689999999999999999999999983 3333333332221000          


Q ss_pred             ccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcCCCcc
Q 013897          358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFF  422 (434)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp~~~  422 (434)
                                             .........+++++.+||.+||+.||++||+..+.|.|+|++
T Consensus       232 -----------------------~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         232 -----------------------IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             -----------------------CCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             -----------------------CCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence                                   000112234788999999999999999999544445566654

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-52  Score=386.63  Aligned_cols=242  Identities=19%  Similarity=0.328  Sum_probs=200.4

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecc--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEe
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE  211 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~--~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  211 (434)
                      ++|+++++||+|+||+||+|++ .++..||||+++.  ...+++.+|+.+++++ +|||||+++|++.+.  ..+++|||
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l-~HpnIv~~~g~~~~~--~~~~iv~E   79 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-SHEKLVQLYGVCTKQ--RPIFIITE   79 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSCHHHHHHHHHHHHTC-CCTTBCCEEEEECCS--SSEEEEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCCHHHHHHHHHHHHhc-CCCceeeEEEEEeeC--CceEEEEE
Confidence            6788999999999999999998 5788999999975  3457899999999999 999999999999654  56789999


Q ss_pred             ecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc--c
Q 013897          212 HVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE--Y  285 (434)
Q Consensus       212 ~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~--~  285 (434)
                      |+.+|++..+.    ..+++..+..++.||++||+|||++||+||||||+|||++.++ .+||+|||+|+.......  .
T Consensus        80 y~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~-~~kl~DfG~a~~~~~~~~~~~  158 (258)
T d1k2pa_          80 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDEYTSS  158 (258)
T ss_dssp             CCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTC-CEEECCCSSCCBCSSSSCCCC
T ss_pred             ccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCC-cEEECcchhheeccCCCceee
Confidence            99999986663    3588999999999999999999999999999999999999776 899999999986654332  2


Q ss_pred             ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCCh
Q 013897          286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP  364 (434)
Q Consensus       286 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  364 (434)
                      ....+|..|+|||++.+ ..++.++|||||||++|||+| |+.|| .+.+..+....+.+.                   
T Consensus       159 ~~~~~t~~y~aPE~~~~-~~~~~ksDiwS~G~~l~el~t~g~~Pf-~~~~~~~~~~~i~~~-------------------  217 (258)
T d1k2pa_         159 VGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPY-ERFTNSETAEHIAQG-------------------  217 (258)
T ss_dssp             CCSCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTT-TTSCHHHHHHHHHTT-------------------
T ss_pred             cccCCCCCcCCcHHhcC-CCCCcceeecccchhhHhHHhcCCCCC-CCCCHHHHHHHHHhC-------------------
Confidence            34578899999999987 689999999999999999998 78787 333333333222110                   


Q ss_pred             hHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                               .        ....+..+++++.+||.+||+.||++|||++|+|+|
T Consensus       218 ---------~--------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         218 ---------L--------RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             ---------C--------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ---------C--------CCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                     0        011123467899999999999999999999999987

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-52  Score=390.18  Aligned_cols=243  Identities=19%  Similarity=0.346  Sum_probs=192.8

Q ss_pred             eeeeecCceEEEEEEEcC--CCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEee
Q 013897          140 RKVGRGKYSEVFEGVHCT--DNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH  212 (434)
Q Consensus       140 ~~lG~G~fg~Vy~~~~~~--~~~~vaiK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  212 (434)
                      ++||+|+||+||+|.+..  +++.||||+++...     .+++.+|+.+|+++ +|||||+++++|.+   ...+|||||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~g~~~~---~~~~lvmE~   88 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICEA---ESWMLVMEM   88 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEEEEES---SSEEEEEEC
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhC-CCCCCceEEEEecc---CCEEEEEEc
Confidence            579999999999998754  45789999986422     35789999999999 99999999999854   245799999


Q ss_pred             cCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCcc----
Q 013897          213 VNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY----  285 (434)
Q Consensus       213 ~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~----  285 (434)
                      +++|+|..++   ..+++..+..++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+|+........    
T Consensus        89 ~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~-~~kl~DFGla~~~~~~~~~~~~~  167 (277)
T d1xbba_          89 AELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH-YAKISDFGLSKALRADENYYKAQ  167 (277)
T ss_dssp             CTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCCTTCEECCTTCSEEEC-
T ss_pred             CCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccC-cccccchhhhhhccccccccccc
Confidence            9999997765   4589999999999999999999999999999999999999777 8999999999876544322    


Q ss_pred             ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCCh
Q 013897          286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP  364 (434)
Q Consensus       286 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  364 (434)
                      ....||+.|+|||++.+ ..++.++|||||||++|||+| |+.||. +.+..+....+.+                    
T Consensus       168 ~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gv~l~ellt~g~~Pf~-~~~~~~~~~~i~~--------------------  225 (277)
T d1xbba_         168 THGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYR-GMKGSEVTAMLEK--------------------  225 (277)
T ss_dssp             ---CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSST-TCCHHHHHHHHHT--------------------
T ss_pred             cccCCCceecCchhhcC-CCCCchhhhccchhhhhHHhhCCCCCCC-CCCHHHHHHHHHc--------------------
Confidence            23468889999999876 679999999999999999998 898883 3332222222110                    


Q ss_pred             hHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHH---hcCCCccccc
Q 013897          365 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEA---MAHPYFFPIR  425 (434)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~el---L~Hp~~~~~~  425 (434)
                              ..+        ...+..+++++.+||.+||+.||++|||++++   |+|+|+.-++
T Consensus       226 --------~~~--------~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~~  273 (277)
T d1xbba_         226 --------GER--------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN  273 (277)
T ss_dssp             --------TCC--------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHH
T ss_pred             --------CCC--------CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhcCC
Confidence                    000        11123477899999999999999999999988   5677765443

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-51  Score=395.93  Aligned_cols=259  Identities=21%  Similarity=0.381  Sum_probs=207.3

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEc---CCCeEEEEEEeccc-------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHC---TDNEKCIIKILKPV-------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ  202 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~---~~~~~vaiK~~~~~-------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  202 (434)
                      .++|++++.||+|+||+||+|.+.   .+|+.||||+++..       ..+.+.+|+.+|+++.+||||+++++++.+. 
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~-  101 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE-  101 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC-
Confidence            378999999999999999999873   46899999998642       2356889999999996669999999999765 


Q ss_pred             CCccEEEEeecCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceec
Q 013897          203 SKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY  279 (434)
Q Consensus       203 ~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~  279 (434)
                       ...++||||+.+++|...+   ..+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+|+.+
T Consensus       102 -~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~-~vkL~DFG~a~~~  179 (322)
T d1vzoa_         102 -TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG-HVVLTDFGLSKEF  179 (322)
T ss_dssp             -TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEESCSSEEEEC
T ss_pred             -CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCC-CEEEeeccchhhh
Confidence             5678999999999987665   4688999999999999999999999999999999999999777 8999999999876


Q ss_pred             CCCC--ccceeccCCcccccccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHh
Q 013897          280 HPGK--EYNVRVASRYFKGPELLVDLQ-DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN  356 (434)
Q Consensus       280 ~~~~--~~~~~~~t~~y~aPE~~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~  356 (434)
                      ....  ......|++.|++||.+.+.. .++.++|||||||+||||++|+.||.... ..+....+.+..          
T Consensus       180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~-~~~~~~~i~~~~----------  248 (322)
T d1vzoa_         180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG-EKNSQAEISRRI----------  248 (322)
T ss_dssp             CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT-SCCCHHHHHHHH----------
T ss_pred             cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHhc----------
Confidence            4332  234567999999999987533 57889999999999999999999984432 222222221100          


Q ss_pred             hccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCc-----cHHHHhcCCCcccccccc
Q 013897          357 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-----TAKEAMAHPYFFPIRNAE  428 (434)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rp-----t~~elL~Hp~~~~~~~~~  428 (434)
                                   ...          ....+..+++++.+||.+||+.||++||     |++|+|+||||+++++..
T Consensus       249 -------------~~~----------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~  302 (322)
T d1vzoa_         249 -------------LKS----------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDD  302 (322)
T ss_dssp             -------------HHC----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHH
T ss_pred             -------------ccC----------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHH
Confidence                         000          0111224788999999999999999999     589999999999987443

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-51  Score=384.87  Aligned_cols=244  Identities=17%  Similarity=0.281  Sum_probs=191.9

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCC----eEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDN----EKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK  204 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~----~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  204 (434)
                      .+.|++.+.||+|+||+||+|.++.++    ..||||.++...    ..++.+|+.+|+++ +|||||+++|++.+.  .
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~~~g~~~~~--~   82 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISKY--K   82 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSS--S
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhc-CCCCEeeeeEEEecC--C
Confidence            356999999999999999999987654    479999986432    34688999999999 999999999999654  5


Q ss_pred             ccEEEEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecC
Q 013897          205 TPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH  280 (434)
Q Consensus       205 ~~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~  280 (434)
                      ..++||||+.++++....    ..+++.++..++.||+.||+|||+++|+||||||+||||+.++ .+||+|||+|+...
T Consensus        83 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~-~~Kl~DFGla~~~~  161 (283)
T d1mqba_          83 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL-VCKVSDFGLSRVLE  161 (283)
T ss_dssp             SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCCCC-----
T ss_pred             ceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCC-eEEEcccchhhccc
Confidence            678999999999876543    4689999999999999999999999999999999999999776 89999999998765


Q ss_pred             CCCc----cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHh
Q 013897          281 PGKE----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN  356 (434)
Q Consensus       281 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~  356 (434)
                      ....    .....||..|+|||++.+ ..++.++|||||||++|||++|+.|++.+....+.+..+...           
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~-----------  229 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-----------  229 (283)
T ss_dssp             ------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-----------
T ss_pred             CCCccceEeccCCCCccccCHHHHcc-CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhcc-----------
Confidence            4322    123467889999999887 789999999999999999999888876655544333322110           


Q ss_pred             hccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          357 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                       .+        ...+..+++++.+||.+||..||++|||+.|+++
T Consensus       230 -----------------~~--------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         230 -----------------FR--------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             -----------------CC--------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -----------------CC--------CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence                             00        1112246788999999999999999999999987

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-51  Score=388.92  Aligned_cols=248  Identities=20%  Similarity=0.326  Sum_probs=193.6

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCC-----CeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTD-----NEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS  203 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~-----~~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  203 (434)
                      .++|++.++||+|+||+||+|.+...     ++.||||+++..    ..+.+.+|+.++.++.+|+||+.+++++.+. .
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~-~   90 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-G   90 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-T
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC-C
Confidence            37899999999999999999997543     478999998643    2356778889999988899999999988654 3


Q ss_pred             CccEEEEeecCCCchhhhcC-------------------CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC
Q 013897          204 KTPSLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE  264 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~~-------------------~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~  264 (434)
                      ..+++||||+++|+|..++.                   .+++.++..++.||+.||+|||+++|+||||||+|||++.+
T Consensus        91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~  170 (299)
T d1ywna1          91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK  170 (299)
T ss_dssp             SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG
T ss_pred             CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCC
Confidence            56789999999999977641                   37889999999999999999999999999999999999977


Q ss_pred             CCeEEEEecccceecCCCCc---cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHH
Q 013897          265 QRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK  341 (434)
Q Consensus       265 ~~~vkl~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~  341 (434)
                      + .+||+|||+|+.......   ....+||+.|+|||++.+ ..++.++|||||||++|||++|..|++.+....+.+..
T Consensus       171 ~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~  248 (299)
T d1ywna1         171 N-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR  248 (299)
T ss_dssp             G-CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred             C-cEEEccCcchhhccccccccccCceeeCccccchhHhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            6 899999999986543322   244578999999999987 78999999999999999999986654455444444333


Q ss_pred             HHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          342 IAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       342 i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                      +....                           .+        ...+..+++++.+||.+||+.||++|||++|+++|
T Consensus       249 ~~~~~---------------------------~~--------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         249 RLKEG---------------------------TR--------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHHT---------------------------CC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhcC---------------------------CC--------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            22110                           00        11122467899999999999999999999999987

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-50  Score=387.69  Aligned_cols=243  Identities=19%  Similarity=0.349  Sum_probs=192.8

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCe----EEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK  204 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~----~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  204 (434)
                      .++|++++.||+|+||+||+|.+..+|+    +||+|.++..    ..+++.+|+.+|+++ +|||||+++++|.+.   
T Consensus         8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~---   83 (317)
T d1xkka_           8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS---   83 (317)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHC-CCTTBCCEEEEEESS---
T ss_pred             HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecC---
Confidence            4679999999999999999999987775    6888887542    346799999999999 999999999999753   


Q ss_pred             ccEEEEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecC
Q 013897          205 TPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH  280 (434)
Q Consensus       205 ~~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~  280 (434)
                      ..++++||+.++++...+    ..+++..+..++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+|+...
T Consensus        84 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~-~~kl~DFGla~~~~  162 (317)
T d1xkka_          84 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLG  162 (317)
T ss_dssp             SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT-EEEECCCSHHHHTT
T ss_pred             CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCC-CeEeeccccceecc
Confidence            456889999988875443    4589999999999999999999999999999999999999776 89999999998765


Q ss_pred             CCCcc---ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHh
Q 013897          281 PGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN  356 (434)
Q Consensus       281 ~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~  356 (434)
                      .....   ....||+.|+|||++.+ ..|+.++|||||||++|||+| |..|| .+.+..+....+.+            
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwS~Gvil~el~t~g~~p~-~~~~~~~~~~~i~~------------  228 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPY-DGIPASEISSILEK------------  228 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTT-TTSCGGGHHHHHHH------------
T ss_pred             cccccccccccccCccccChHHHhc-CCCChhhhhhhHHHHHHHHHHCCCCCC-CCCCHHHHHHHHHc------------
Confidence            43322   33468999999999887 689999999999999999999 56555 44443333222211            


Q ss_pred             hccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          357 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                                      ..+        ...+..+++++.+|+.+||..||++|||+.|+++|
T Consensus       229 ----------------~~~--------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         229 ----------------GER--------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             ----------------TCC--------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------------CCC--------CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence                            000        11123467899999999999999999999999987

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-50  Score=379.65  Aligned_cols=243  Identities=23%  Similarity=0.415  Sum_probs=187.6

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCC---eEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDN---EKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT  205 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~---~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  205 (434)
                      .++|++.+.||+|+||.||+|++..++   ..||||.++..    ..+.+.+|+.+|+++ +|||||++++++.+   ..
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~---~~   81 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVITE---NP   81 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS---SS
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEec---Ce
Confidence            378999999999999999999986543   57899988643    235688999999999 99999999999953   46


Q ss_pred             cEEEEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCC
Q 013897          206 PSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP  281 (434)
Q Consensus       206 ~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~  281 (434)
                      +++||||+.+|++..+.    ..+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+|+....
T Consensus        82 ~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~-~~Kl~DfG~a~~~~~  160 (273)
T d1mp8a_          82 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYMED  160 (273)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECC---------
T ss_pred             EEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCC-cEEEccchhheeccC
Confidence            78999999999987653    3589999999999999999999999999999999999999777 899999999987653


Q ss_pred             CCc--cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhc
Q 013897          282 GKE--YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY  358 (434)
Q Consensus       282 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  358 (434)
                      ...  .....||+.|+|||++.+ ..|+.++|||||||++|||++ |..|| .+....+....+..  +           
T Consensus       161 ~~~~~~~~~~gt~~y~apE~l~~-~~~~~~~DiwSlGvil~e~lt~g~~P~-~~~~~~~~~~~i~~--~-----------  225 (273)
T d1mp8a_         161 STYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPF-QGVKNNDVIGRIEN--G-----------  225 (273)
T ss_dssp             ----------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTT-TTCCGGGHHHHHHT--T-----------
T ss_pred             CcceeccceecCcccchhhHhcc-CCCCCccccccchHHHHHHHhcCCCCC-CCCCHHHHHHHHHc--C-----------
Confidence            322  244567889999999986 789999999999999999998 67666 44444433333211  0           


Q ss_pred             cccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                                     .+        ...+..+++++.+||.+||..||++|||+.|+++|
T Consensus       226 ---------------~~--------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         226 ---------------ER--------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             ---------------CC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------CC--------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                           00        11123478899999999999999999999999987

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-51  Score=389.34  Aligned_cols=245  Identities=19%  Similarity=0.301  Sum_probs=199.4

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeE--EEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEK--CIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS  207 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~--vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  207 (434)
                      ++|++.+.||+|+||+||+|.++.++..  ||||.++..    ..+.+.+|+++|.++.+|||||++++++.+.  ..++
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~--~~~~   87 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYLY   87 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET--TEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC--CeeE
Confidence            7899999999999999999999888764  677777532    3456899999999987799999999999754  5678


Q ss_pred             EEEeecCCCchhhhc-------------------CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeE
Q 013897          208 LIFEHVNNTDFKVLY-------------------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKL  268 (434)
Q Consensus       208 lv~e~~~~~~l~~~~-------------------~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~v  268 (434)
                      +||||+++|+|..++                   ..+++..+..++.||+.||.|||+++|+||||||+|||++.++ .+
T Consensus        88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~-~~  166 (309)
T d1fvra_          88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY-VA  166 (309)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG-CE
T ss_pred             EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC-ce
Confidence            999999999997765                   3588999999999999999999999999999999999999777 89


Q ss_pred             EEEecccceecCCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCC
Q 013897          269 RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT  348 (434)
Q Consensus       269 kl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~  348 (434)
                      ||+|||+|+............||..|+|||.+.+ ..|+.++|||||||++|||++|..|++.+.+..+....+.+    
T Consensus       167 kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~----  241 (309)
T d1fvra_         167 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ----  241 (309)
T ss_dssp             EECCTTCEESSCEECCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG----
T ss_pred             EEccccccccccccccccceecCCcccchHHhcc-CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHh----
Confidence            9999999986654444455678999999999987 68999999999999999999987766555544333322211    


Q ss_pred             hhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          349 DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                                              ..+        ......+++++.+||.+||..||++|||++|+++|
T Consensus       242 ------------------------~~~--------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         242 ------------------------GYR--------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             ------------------------TCC--------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------------cCC--------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                                    000        11122467899999999999999999999999987

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.7e-50  Score=383.91  Aligned_cols=245  Identities=18%  Similarity=0.297  Sum_probs=199.2

Q ss_pred             CCCCeEEEeeeeecCceEEEEEEEcC-----CCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccC
Q 013897          132 EQDDYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ  202 (434)
Q Consensus       132 ~~~~y~~~~~lG~G~fg~Vy~~~~~~-----~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  202 (434)
                      ..++|++++.||+|+||+||+|+++.     +++.||||+++...    .+++.+|+.+|+.+ +||||+++++++.+. 
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~-   88 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPNIVKLLGVCAVG-   88 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSS-
T ss_pred             CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhc-CCCCcccceeeeccC-
Confidence            35789999999999999999999753     45789999996432    45689999999999 999999999999653 


Q ss_pred             CCccEEEEeecCCCchhhhcC---------------------------CCChHHHHHHHHHHHHHHHHHHHCCceeecCC
Q 013897          203 SKTPSLIFEHVNNTDFKVLYP---------------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVK  255 (434)
Q Consensus       203 ~~~~~lv~e~~~~~~l~~~~~---------------------------~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlK  255 (434)
                       ...++||||+.+++|..++.                           .+++..+..++.||+.||+|||+++|||||||
T Consensus        89 -~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlK  167 (301)
T d1lufa_          89 -KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA  167 (301)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             -CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEc
Confidence             56789999999999877641                           37888999999999999999999999999999


Q ss_pred             CCceEecCCCCeEEEEecccceecCCCC---ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Q 013897          256 PHNVMIDHEQRKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYG  332 (434)
Q Consensus       256 p~NIll~~~~~~vkl~DFGla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~  332 (434)
                      |+|||++.++ .+||+|||+|+......   ......+++.|+|||.+.+ ..|+.++|||||||++|||++|..|++.+
T Consensus       168 p~NILld~~~-~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~t~ksDVwS~Gvvl~ell~~~~~p~~~  245 (301)
T d1lufa_         168 TRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYG  245 (301)
T ss_dssp             GGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             ccceEECCCC-cEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc-CCCChhhhhccchhhHHHHHccCCCCCCC
Confidence            9999999776 89999999997664332   2234578899999999987 78999999999999999999997665555


Q ss_pred             CCCHHHHHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccH
Q 013897          333 HDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA  412 (434)
Q Consensus       333 ~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~  412 (434)
                      .+..+....+.+.                            .+        ...+..+++++.+||.+||+.||++|||+
T Consensus       246 ~~~~e~~~~v~~~----------------------------~~--------~~~p~~~~~~~~~li~~cl~~~P~~RPt~  289 (301)
T d1lufa_         246 MAHEEVIYYVRDG----------------------------NI--------LACPENCPLELYNLMRLCWSKLPADRPSF  289 (301)
T ss_dssp             SCHHHHHHHHHTT----------------------------CC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCHHHHHHHHHcC----------------------------CC--------CCCCccchHHHHHHHHHHcCCChhHCcCH
Confidence            5554443332110                            00        01123467899999999999999999999


Q ss_pred             HHHhc
Q 013897          413 KEAMA  417 (434)
Q Consensus       413 ~elL~  417 (434)
                      .||++
T Consensus       290 ~ev~~  294 (301)
T d1lufa_         290 CSIHR  294 (301)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99964

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-49  Score=378.46  Aligned_cols=246  Identities=22%  Similarity=0.326  Sum_probs=202.9

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEc-----CCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS  203 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  203 (434)
                      .++|++.+.||+|+||.||+|++.     .+++.||||+++..    ....+.+|+.+++.+.+|||||++++++.+.  
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~--   99 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG--   99 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC--
Confidence            478999999999999999999863     45679999999753    2356889999999997899999999999654  


Q ss_pred             CccEEEEeecCCCchhhhcC---------------------CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEec
Q 013897          204 KTPSLIFEHVNNTDFKVLYP---------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID  262 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~~---------------------~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~  262 (434)
                      ..+++||||++++++..++.                     .+++..+..++.||+.||+|||+++|+||||||+|||++
T Consensus       100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~  179 (311)
T d1t46a_         100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT  179 (311)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccc
Confidence            56789999999999876642                     478899999999999999999999999999999999999


Q ss_pred             CCCCeEEEEecccceecCCCCcc---ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHH
Q 013897          263 HEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQL  339 (434)
Q Consensus       263 ~~~~~vkl~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~  339 (434)
                      .++ .+||+|||+++........   ...+||+.|+|||++.+ ..++.++|||||||++|||+|++.|++.+....+.+
T Consensus       180 ~~~-~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~  257 (311)
T d1t46a_         180 HGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF  257 (311)
T ss_dssp             TTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred             ccC-cccccccchheeccCCCcceEeeecccChHHcCHHHhcC-CCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            776 8999999999876543332   33578999999999986 789999999999999999999777776766665555


Q ss_pred             HHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          340 VKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       340 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                      .++.+.--                                   ....+..+++++.+||.+||+.||++|||++|+|+
T Consensus       258 ~~~i~~~~-----------------------------------~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         258 YKMIKEGF-----------------------------------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHHHHHTC-----------------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhcCC-----------------------------------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            44332100                                   01112236789999999999999999999999986

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-49  Score=370.30  Aligned_cols=241  Identities=16%  Similarity=0.328  Sum_probs=190.2

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc-HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEe
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE  211 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  211 (434)
                      .++|++.+.||+|+||.||+|.+  .|..||||+++... .+.+.+|+++++++ +||||++++|++.+.. ..+++|||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~-~~~~lv~e   81 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEEK-GGLYIVTE   81 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTC-CCTTBCCEEEEECCC---CCEEEEC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEecC-CcEEEEEe
Confidence            46799999999999999999998  47889999997543 46799999999999 9999999999986543 44689999


Q ss_pred             ecCCCchhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCccc
Q 013897          212 HVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN  286 (434)
Q Consensus       212 ~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~~~  286 (434)
                      |+.+|+|..++.     .+++..++.++.||+.||.|||+++|+||||||+|||++.++ .+||+|||+++....  ...
T Consensus        82 y~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~-~~kl~dfg~s~~~~~--~~~  158 (262)
T d1byga_          82 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASS--TQD  158 (262)
T ss_dssp             CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS-CEEECCCCC-----------
T ss_pred             ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCC-CEeecccccceecCC--CCc
Confidence            999999987752     389999999999999999999999999999999999999777 899999999986543  234


Q ss_pred             eeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhccccCChh
Q 013897          287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH  365 (434)
Q Consensus       287 ~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~  365 (434)
                      ...++..|+|||++.+ ..++.++|||||||++|||+| |+.|| ...+..+....+..                     
T Consensus       159 ~~~~~~~y~aPE~l~~-~~~t~~sDIwSfG~il~el~t~~~~p~-~~~~~~~~~~~i~~---------------------  215 (262)
T d1byga_         159 TGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPY-PRIPLKDVVPRVEK---------------------  215 (262)
T ss_dssp             ---CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSC-TTSCGGGHHHHHTT---------------------
T ss_pred             cccccccCCChHHHhC-CCCChHHHHHhHHHHHHHHHHCCCCCC-CCCCHHHHHHHHHc---------------------
Confidence            4577889999999987 689999999999999999998 56555 44333333222210                     


Q ss_pred             HHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          366 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                             ..        ..+....+++++.+||.+||..||++|||+.|++++
T Consensus       216 -------~~--------~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         216 -------GY--------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             -------TC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------CC--------CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                   00        011223467899999999999999999999999874

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-49  Score=373.60  Aligned_cols=243  Identities=19%  Similarity=0.292  Sum_probs=188.1

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCC-C--eEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTD-N--EKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS  203 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~-~--~~vaiK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  203 (434)
                      .++|++++.||+|+||.||+|++... +  ..||||+++..      ..+.+.+|+.+|+++ +|||||+++|++.+   
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~~~g~~~~---   82 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLT---   82 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS---
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEee---
Confidence            36799999999999999999987533 2  47899998642      235789999999999 99999999999964   


Q ss_pred             CccEEEEeecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceec
Q 013897          204 KTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY  279 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~  279 (434)
                      ...++||||+.++++....    ..+++..+..++.||+.||.|||+++|+||||||+|||++.++ .+||+|||+++..
T Consensus        83 ~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~-~vkl~DfGl~~~~  161 (273)
T d1u46a_          83 PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD-LVKIGDFGLMRAL  161 (273)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT-EEEECCCTTCEEC
T ss_pred             cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcccccc-ceeeccchhhhhc
Confidence            3567999999999876553    4599999999999999999999999999999999999999777 8999999999877


Q ss_pred             CCCCcc----ceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCChhHHHH
Q 013897          280 HPGKEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAY  354 (434)
Q Consensus       280 ~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~  354 (434)
                      ......    ....++..|+|||++.+ ..++.++|||||||++|||+| |+.|| .+.+..+.+..+.+.         
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~S~Gvil~emlt~G~~Pf-~~~~~~~~~~~i~~~---------  230 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPW-IGLNGSQILHKIDKE---------  230 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTT-TTCCHHHHHHHHHTS---------
T ss_pred             ccCCCcceecCccccCcccCCHHHHhC-CCCCcchhhhhhHHHHHHHHhCCCCCC-CCcCHHHHHHHHHhC---------
Confidence            544332    23357788999999987 789999999999999999998 88887 444444333332210         


Q ss_pred             HhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          355 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                        .        ...+....+++++.+||.+||..||++|||+.|+++
T Consensus       231 ------------------~--------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         231 ------------------G--------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             ------------------C--------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------C--------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                              0        001122346789999999999999999999999863

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-49  Score=376.40  Aligned_cols=252  Identities=18%  Similarity=0.314  Sum_probs=204.5

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcC-----CCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCC
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS  203 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~-----~~~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  203 (434)
                      .++|++.+.||+|+||+||+|.+..     ++..||||+++...    ...+.+|+.+++++ +|||||++++++...  
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~--   95 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQG--   95 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-CCTTBCCEEEEECSS--
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHc-CCCCEeeeeeEEecC--
Confidence            3789999999999999999998752     35789999997432    24578999999999 899999999999643  


Q ss_pred             CccEEEEeecCCCchhhhc-------------CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEE
Q 013897          204 KTPSLIFEHVNNTDFKVLY-------------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRL  270 (434)
Q Consensus       204 ~~~~lv~e~~~~~~l~~~~-------------~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl  270 (434)
                      ...++||||+.+|++..++             ..+++..+..++.|++.||.|||+++|+||||||+|||++.++ .+||
T Consensus        96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~-~~Kl  174 (308)
T d1p4oa_          96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF-TVKI  174 (308)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC-CEEE
T ss_pred             CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCc-eEEE
Confidence            5678999999999987664             2367888999999999999999999999999999999999776 8999


Q ss_pred             EecccceecCCCCc---cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC
Q 013897          271 IDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG  347 (434)
Q Consensus       271 ~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g  347 (434)
                      +|||+|+.......   .....+++.|+|||.+.+ ..++.++|||||||++|||+||..|++.+.+..+.+..+.+.  
T Consensus       175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~-~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~--  251 (308)
T d1p4oa_         175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG--  251 (308)
T ss_dssp             CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT--
T ss_pred             eecccceeccCCcceeeccceecccccCCHHHHcc-CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC--
Confidence            99999986643322   233468899999999887 789999999999999999999976655665554444433210  


Q ss_pred             ChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc------CCCc
Q 013897          348 TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA------HPYF  421 (434)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~------Hp~~  421 (434)
                                                .        ....+..+++.+.+||.+||+.||++|||++|+++      +|+|
T Consensus       252 --------------------------~--------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~  297 (308)
T d1p4oa_         252 --------------------------G--------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF  297 (308)
T ss_dssp             --------------------------C--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTH
T ss_pred             --------------------------C--------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence                                      0        01112246789999999999999999999999998      8888


Q ss_pred             cccc
Q 013897          422 FPIR  425 (434)
Q Consensus       422 ~~~~  425 (434)
                      ++++
T Consensus       298 ~~~~  301 (308)
T d1p4oa_         298 REVS  301 (308)
T ss_dssp             HHHC
T ss_pred             cCCC
Confidence            7653

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-49  Score=374.51  Aligned_cols=244  Identities=20%  Similarity=0.328  Sum_probs=192.7

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCC-------eEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeEeeEEEcc
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDN-------EKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQ  201 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~-------~~vaiK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  201 (434)
                      .++|++.+.||+|+||.||+|++..++       ..||||+++...    ..++.+|+..+.++.+|||||+++++|.+.
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            478999999999999999999876554       479999996533    356788999999988899999999999654


Q ss_pred             CCCccEEEEeecCCCchhhhc-------------------CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEec
Q 013897          202 QSKTPSLIFEHVNNTDFKVLY-------------------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID  262 (434)
Q Consensus       202 ~~~~~~lv~e~~~~~~l~~~~-------------------~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~  262 (434)
                        ..+++||||+.+|++..++                   ..+++..+..++.||+.||+|||+++||||||||+|||++
T Consensus        92 --~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~  169 (299)
T d1fgka_          92 --GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT  169 (299)
T ss_dssp             --SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred             --CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeec
Confidence              5678999999999997775                   2478999999999999999999999999999999999999


Q ss_pred             CCCCeEEEEecccceecCCCCc---cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHH
Q 013897          263 HEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQ  338 (434)
Q Consensus       263 ~~~~~vkl~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~  338 (434)
                      .++ .+||+|||+++.......   ....++++.|+|||.+.+ ..|+.++|||||||++|||++ |..|| .+.+....
T Consensus       170 ~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-~~y~~k~DiwS~Gvvl~ell~~g~~p~-~~~~~~~~  246 (299)
T d1fgka_         170 EDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPY-PGVPVEEL  246 (299)
T ss_dssp             TTC-CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSS-TTCCHHHH
T ss_pred             CCC-CeEeccchhhccccccccccccccCCCChhhhhhhHhcC-CCCCchhhhHHhHHHHHHhccCCCCCC-CCCCHHHH
Confidence            777 899999999987654332   234578889999999987 789999999999999999998 45555 44443222


Q ss_pred             HHHHHHHhCChhHHHHHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          339 LVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       339 ~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                      ...+..  +                          .        ....+..+++++.+||.+||+.||++|||+.|+|+
T Consensus       247 ~~~i~~--~--------------------------~--------~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         247 FKLLKE--G--------------------------H--------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHHHT--T--------------------------C--------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHc--C--------------------------C--------CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            221110  0                          0        01112346789999999999999999999999986

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-48  Score=370.88  Aligned_cols=241  Identities=20%  Similarity=0.346  Sum_probs=190.9

Q ss_pred             EEeeeeecCceEEEEEEEcCCC---eEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEE
Q 013897          138 VVRKVGRGKYSEVFEGVHCTDN---EKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF  210 (434)
Q Consensus       138 ~~~~lG~G~fg~Vy~~~~~~~~---~~vaiK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  210 (434)
                      ..++||+|+||+||+|.+..++   ..||||.++..    ..+++.+|+++|+++ +|||||+++|++.+. ....++||
T Consensus        31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~-~~~~~lv~  108 (311)
T d1r0pa_          31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRS-EGSPLVVL  108 (311)
T ss_dssp             EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEET-TTEEEEEE
T ss_pred             cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-CCCCEeEEeEEEEec-CCceEEEE
Confidence            3578999999999999986543   36899998642    236689999999999 899999999998654 34678999


Q ss_pred             eecCCCchhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecccceecCCCCc--
Q 013897          211 EHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE--  284 (434)
Q Consensus       211 e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~~~~~~--  284 (434)
                      ||+.++++..+..    .+++..+..++.|++.||.|||+++|+||||||+|||++.++ .+||+|||+++.......  
T Consensus       109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~-~~kL~DFG~~~~~~~~~~~~  187 (311)
T d1r0pa_         109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEFDS  187 (311)
T ss_dssp             ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC-CEEECSSGGGCCTTTTTCCC
T ss_pred             EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCC-CEEEecccchhhcccccccc
Confidence            9999999987653    366778899999999999999999999999999999999766 899999999987643322  


Q ss_pred             ---cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcccc
Q 013897          285 ---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE  361 (434)
Q Consensus       285 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  361 (434)
                         .....||..|+|||.+.+ ..++.++|||||||++|||+||+.||+...+..+....+..  |              
T Consensus       188 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~--g--------------  250 (311)
T d1r0pa_         188 VHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--G--------------  250 (311)
T ss_dssp             TTCTTCSSCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHT--T--------------
T ss_pred             ceecccccccccccChHHHhc-CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHc--C--------------
Confidence               223468889999999876 68999999999999999999998898655443322222110  0              


Q ss_pred             CChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          362 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                                  .+        ...+..+++++.+||.+||+.||++||++.|+++|
T Consensus       251 ------------~~--------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         251 ------------RR--------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             ------------CC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------CC--------CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                        00        11123467899999999999999999999999998

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2e-47  Score=373.42  Aligned_cols=289  Identities=25%  Similarity=0.391  Sum_probs=208.5

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc--HHHHHHHHHHHHHhc----------CCCCeeeEeeEEEcc
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLC----------GGPNIVKLLDIVRDQ  201 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~E~~~l~~l~----------~h~niv~l~~~~~~~  201 (434)
                      ++|+++++||+|+||+||+|++..+|+.||||+++...  .+.+.+|+.+++.+.          .|+||+++++++...
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            45999999999999999999999999999999997653  366788999998872          368899999998766


Q ss_pred             CCCccEEEEeecCCCchhhh------cCCCChHHHHHHHHHHHHHHHHHHH-CCceeecCCCCceEecCCCC-----eEE
Q 013897          202 QSKTPSLIFEHVNNTDFKVL------YPTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQR-----KLR  269 (434)
Q Consensus       202 ~~~~~~lv~e~~~~~~l~~~------~~~l~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlKp~NIll~~~~~-----~vk  269 (434)
                      .....+++++++........      ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++.     .++
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~k  172 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIK  172 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEE
T ss_pred             cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceee
Confidence            66666777777765542211      2458889999999999999999998 89999999999999986542     499


Q ss_pred             EEecccceecCCCCccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCC-----CHHHHHHHHH
Q 013897          270 LIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD-----NYDQLVKIAK  344 (434)
Q Consensus       270 l~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~-----~~~~~~~i~~  344 (434)
                      ++|||.|....  ......+||+.|+|||++.+ ..|+.++||||+||++++|++|+.||.....     ..+.+..+..
T Consensus       173 l~dfg~s~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~  249 (362)
T d1q8ya_         173 IADLGNACWYD--EHYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE  249 (362)
T ss_dssp             ECCCTTCEETT--BCCCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHH
T ss_pred             Eeecccccccc--cccccccccccccChhhccc-cCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHH
Confidence            99999997654  23356789999999999887 7899999999999999999999999853322     2345556666


Q ss_pred             HhCChhHHHHHhhccccCChhHHHHhcccCCC---CCcccc--ccccccCCchHHHHHHHHccccCCCCCccHHHHhcCC
Q 013897          345 VLGTDELNAYLNKYHIELDPHLAALVGRHSRK---PWSKFI--TVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHP  419 (434)
Q Consensus       345 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~--~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~Hp  419 (434)
                      .+|.............................   ++....  ........++++.|||.+||++||.+||||+|+|+||
T Consensus       250 ~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp  329 (362)
T d1q8ya_         250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHP  329 (362)
T ss_dssp             HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCG
T ss_pred             HhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence            77754322221100000000000000000000   000000  0111123467899999999999999999999999999


Q ss_pred             Cccccc
Q 013897          420 YFFPIR  425 (434)
Q Consensus       420 ~~~~~~  425 (434)
                      ||+.+.
T Consensus       330 ~f~~~~  335 (362)
T d1q8ya_         330 WLKDTL  335 (362)
T ss_dssp             GGTTCT
T ss_pred             ccCCCC
Confidence            999664

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-48  Score=367.60  Aligned_cols=264  Identities=17%  Similarity=0.193  Sum_probs=191.0

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHH--HHhcCCCCeeeEeeEEEccCC--CccEEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKIL--QNLCGGPNIVKLLDIVRDQQS--KTPSLI  209 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~E~~~l--~~l~~h~niv~l~~~~~~~~~--~~~~lv  209 (434)
                      .+|.+.+.||+|+||.||+|++  +|+.||||+++......+.+|.+++  ..+ +|||||++++++.+.+.  ..+++|
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~-~HpnIv~~~~~~~~~~~~~~~~~lv   79 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVML-RHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhC-CCCcCcceEEEEEeCCCcceEEEEE
Confidence            4688999999999999999986  6899999999877666666665554  455 89999999999986543  357899


Q ss_pred             EeecCCCchhhhcC--CCChHHHHHHHHHHHHHHHHHHH--------CCceeecCCCCceEecCCCCeEEEEecccceec
Q 013897          210 FEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHS--------QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY  279 (434)
Q Consensus       210 ~e~~~~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~LH~--------~~ivHrDlKp~NIll~~~~~~vkl~DFGla~~~  279 (434)
                      |||+.+|+|..++.  .+++..+..++.|++.||+|||+        +||+||||||+||||+.++ .+||+|||+++..
T Consensus        80 ~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~-~~Kl~DFGl~~~~  158 (303)
T d1vjya_          80 SDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVRH  158 (303)
T ss_dssp             EECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS-CEEECCCTTCEEE
T ss_pred             EecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC-CeEEEecCccccc
Confidence            99999999987764  68899999999999999999996        5999999999999999776 8999999999877


Q ss_pred             CCCCc-----cceeccCCcccccccccCCC-----CCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCh
Q 013897          280 HPGKE-----YNVRVASRYFKGPELLVDLQ-----DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTD  349 (434)
Q Consensus       280 ~~~~~-----~~~~~~t~~y~aPE~~~~~~-----~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~  349 (434)
                      .....     ....+||+.|+|||++.+..     .++.++|||||||+||||+||..||............+.  ....
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~--~~~~  236 (303)
T d1vjya_         159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV--PSDP  236 (303)
T ss_dssp             ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS--CSSC
T ss_pred             cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcc--cccc
Confidence            54332     23467999999999986522     257789999999999999999887643222110000000  0000


Q ss_pred             hHHHHHhhccccCChhHHHH-hcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhcC
Q 013897          350 ELNAYLNKYHIELDPHLAAL-VGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH  418 (434)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~H  418 (434)
                      ..            ...... .....+....   ...........+.+|+.+||+.||++|||+.|++++
T Consensus       237 ~~------------~~~~~~~~~~~~~p~~~---~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         237 SV------------EEMRKVVCEQKLRPNIP---NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             CH------------HHHHHHHTTSCCCCCCC---GGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             hH------------HHHHHHHhccccCCCCC---cccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            00            000000 0001110000   000111233568999999999999999999999873

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5e-47  Score=361.01  Aligned_cols=256  Identities=18%  Similarity=0.258  Sum_probs=192.9

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEee
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH  212 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  212 (434)
                      ++|++++.||+|+||+||+|++..+++.||||++... ..+++.+|+++++.+.+|++|+.+.+++.+  ....++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~--~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE--GDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEE--TTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEec--CCEEEEEEEE
Confidence            6799999999999999999999999999999998643 345688999999999444445555555543  3567899999


Q ss_pred             cCCCchhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecC--CCCeEEEEecccceecCCCCc---
Q 013897          213 VNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--EQRKLRLIDWGLAEFYHPGKE---  284 (434)
Q Consensus       213 ~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~--~~~~vkl~DFGla~~~~~~~~---  284 (434)
                      ++++.+..+.   ..+++..+..++.|++.||+|||++||+||||||+|||++.  .+..+||+|||+|+.......   
T Consensus        85 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~  164 (299)
T d1ckia_          85 LGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH  164 (299)
T ss_dssp             CCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCB
T ss_pred             cCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccc
Confidence            9776654432   46999999999999999999999999999999999999753  233699999999987754322   


Q ss_pred             -----cceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHhhcc
Q 013897          285 -----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH  359 (434)
Q Consensus       285 -----~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  359 (434)
                           ....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .....+.+...        ....
T Consensus       165 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~-~~~~~~~~~~~--------~~~~  234 (299)
T d1ckia_         165 IPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA-TKRQKYERISE--------KKMS  234 (299)
T ss_dssp             CCCCBCCSCCCCSSSCCHHHHTT-BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--------HHHHHH--------HHHH
T ss_pred             eeccccCCcCCCccccCHHHHhC-CCCCChhhEEecCHHHHHHHhCCCcccccchH-HHHHHHHHhhc--------ccCC
Confidence                 234579999999999887 68999999999999999999999998543222 11111111000        0000


Q ss_pred             ccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHH---HHhcCCCcc
Q 013897          360 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK---EAMAHPYFF  422 (434)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~---elL~Hp~~~  422 (434)
                        .  ..                 ......+++++.+||.+||+.||++||+++   ++|+|+|.+
T Consensus       235 --~--~~-----------------~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         235 --T--PI-----------------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  279 (299)
T ss_dssp             --S--CH-----------------HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             --C--Ch-----------------hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence              0  00                 001123678999999999999999999986   557887764

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.4e-45  Score=349.86  Aligned_cols=249  Identities=17%  Similarity=0.251  Sum_probs=194.3

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-cHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEEe
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE  211 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  211 (434)
                      .++|++++.||+|+||+||+|++..+|+.||||+++.. ....+.+|+++++.+.+|+|++.+++++.+.  ...++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~--~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEG--LHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEET--TEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecC--CccEEEEE
Confidence            36899999999999999999999999999999998543 3456889999999997779999999998654  56789999


Q ss_pred             ecCCCchhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC----CCeEEEEecccceecCCCC
Q 013897          212 HVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE----QRKLRLIDWGLAEFYHPGK  283 (434)
Q Consensus       212 ~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~----~~~vkl~DFGla~~~~~~~  283 (434)
                      |++ ++|..+.    ..++...+..++.|++.||+|||++||+||||||+|||++.+    .+.+||+|||+|+......
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~  160 (293)
T d1csna_          82 LLG-PSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV  160 (293)
T ss_dssp             CCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred             ecC-CCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence            995 4544333    458999999999999999999999999999999999999742    3379999999998764321


Q ss_pred             --------ccceeccCCcccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCC--HHHHHHHHHHhCChhHHH
Q 013897          284 --------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN--YDQLVKIAKVLGTDELNA  353 (434)
Q Consensus       284 --------~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~--~~~~~~i~~~~g~~~~~~  353 (434)
                              .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||......  ......+.......    
T Consensus       161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~----  235 (293)
T d1csna_         161 TKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST----  235 (293)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS----
T ss_pred             cccceeecccCceEEchhhcCHHHhcC-CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC----
Confidence                    2234579999999999987 78999999999999999999999998432222  11122221100000    


Q ss_pred             HHhhccccCChhHHHHhcccCCCCCccccccccccCCchHHHHHHHHccccCCCCCccHHHHhc
Q 013897          354 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA  417 (434)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~cL~~dP~~Rpt~~elL~  417 (434)
                                 ...+                 ....+++++.+++..|+..+|++||+++.+.+
T Consensus       236 -----------~~~~-----------------l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         236 -----------PLRE-----------------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             -----------CHHH-----------------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             -----------ChHH-----------------hcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence                       0000                 01236788999999999999999998776543

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.93  E-value=2e-26  Score=203.42  Aligned_cols=165  Identities=18%  Similarity=0.209  Sum_probs=121.3

Q ss_pred             eEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc---------------------HHHHHHHHHHHHHhcCCCCeeeE
Q 013897          136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---------------------KKKIKREIKILQNLCGGPNIVKL  194 (434)
Q Consensus       136 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---------------------~~~~~~E~~~l~~l~~h~niv~l  194 (434)
                      +.+.++||+|+||+||+|.+ .+|+.||||+++...                     .....+|...+.++ .|.+++..
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~v~~~   79 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-QGLAVPKV   79 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-TTSSSCCE
T ss_pred             chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHc-cCCCcceE
Confidence            35789999999999999998 578999999875311                     12345688899998 89999998


Q ss_pred             eeEEEccCCCccEEEEeecCCCchhhhcCCCChHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCeEEEEecc
Q 013897          195 LDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG  274 (434)
Q Consensus       195 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivHrDlKp~NIll~~~~~~vkl~DFG  274 (434)
                      +++..      .+++|||+++..+..    ++...+..++.|++.+|+|||++||+||||||+|||++.+  .++|+|||
T Consensus        80 ~~~~~------~~lvme~~~~~~~~~----l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~--~~~liDFG  147 (191)
T d1zara2          80 YAWEG------NAVLMELIDAKELYR----VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE--GIWIIDFP  147 (191)
T ss_dssp             EEEET------TEEEEECCCCEEGGG----CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT--EEEECCCT
T ss_pred             EEecC------CEEEEEeeccccccc----hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC--CEEEEECC
Confidence            87641      259999999877654    4556677899999999999999999999999999999954  58999999


Q ss_pred             cceecCCCCccceeccCCcccccccccCCCCCCccccHHHHHH
Q 013897          275 LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGC  317 (434)
Q Consensus       275 la~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv  317 (434)
                      +|.......... ........-.+.+.  +.|+.++|+||+.-
T Consensus       148 ~a~~~~~~~~~~-~l~rd~~~~~~~f~--r~y~~~~d~~s~~~  187 (191)
T d1zara2         148 QSVEVGEEGWRE-ILERDVRNIITYFS--RTYRTEKDINSAID  187 (191)
T ss_dssp             TCEETTSTTHHH-HHHHHHHHHHHHHH--HHHCCCCCHHHHHH
T ss_pred             CcccCCCCCcHH-HHHHHHHHHHHHHc--CCCCCcccHHHHHH
Confidence            997654222110 00000000012221  56888999999753

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.51  E-value=6.4e-07  Score=80.37  Aligned_cols=138  Identities=18%  Similarity=0.232  Sum_probs=91.6

Q ss_pred             CCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEE
Q 013897          134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF  210 (434)
Q Consensus       134 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  210 (434)
                      +.|..++..+.++.+.||+..  .+++.++||+.....   ...+.+|..++..+..+--+.+++.+..+.  ...++||
T Consensus        14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~--~~~~lv~   89 (263)
T d1j7la_          14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHD--GWSNLLM   89 (263)
T ss_dssp             TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEEEE
T ss_pred             hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecC--CceEEEE
Confidence            356666665555567999875  466778888875432   345789999999886665577888877544  4567999


Q ss_pred             eecCCCchhhhcCCCChHHHHHHHHHHHHHHHHHHH--------------------------------------------
Q 013897          211 EHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHS--------------------------------------------  246 (434)
Q Consensus       211 e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~--------------------------------------------  246 (434)
                      +++++..+.......  .....++.++...|..||+                                            
T Consensus        90 ~~l~G~~~~~~~~~~--~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (263)
T d1j7la_          90 SEADGVLCSEEYEDE--QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP  167 (263)
T ss_dssp             ECCSSEEHHHHTTTC--SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSH
T ss_pred             Eeccccccccccccc--ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHH
Confidence            999998775433211  1122233333333333432                                            


Q ss_pred             ---------C------CceeecCCCCceEecCCCCeEEEEeccccee
Q 013897          247 ---------Q------GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF  278 (434)
Q Consensus       247 ---------~------~ivHrDlKp~NIll~~~~~~vkl~DFGla~~  278 (434)
                               .      .++|+|+.|.|||++.++ .+-|+||+.+..
T Consensus       168 ~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~-~~~lIDwe~a~~  213 (263)
T d1j7la_         168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK-VSGFIDLGRSGR  213 (263)
T ss_dssp             HHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTE-EEEECCCTTCEE
T ss_pred             HHHHHHHHhcCCcCCcEEEEeeccCcceeecCCc-eEEEeechhccc
Confidence                     1      268999999999998543 556999998853

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.20  E-value=6.1e-06  Score=73.30  Aligned_cols=76  Identities=17%  Similarity=0.137  Sum_probs=55.2

Q ss_pred             eeeecCc-eEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCC-CCeeeEeeEEEccCCCccEEEEeecCCCch
Q 013897          141 KVGRGKY-SEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGG-PNIVKLLDIVRDQQSKTPSLIFEHVNNTDF  218 (434)
Q Consensus       141 ~lG~G~f-g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~E~~~l~~l~~h-~niv~l~~~~~~~~~~~~~lv~e~~~~~~l  218 (434)
                      .+..|.. +.||+... .++..+++|.........+..|...++.+..+ -.+.+++.+..+.  ...++||++++|..+
T Consensus        17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~--~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEA--GRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECS--SCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEe-CCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeecccc--cceEEEEEeeecccc
Confidence            4555554 68998875 56777899998777667788999999888443 2367778776544  456799999988665


Q ss_pred             h
Q 013897          219 K  219 (434)
Q Consensus       219 ~  219 (434)
                      .
T Consensus        94 ~   94 (255)
T d1nd4a_          94 L   94 (255)
T ss_dssp             T
T ss_pred             c
Confidence            3

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.05  E-value=1.3e-05  Score=76.32  Aligned_cols=75  Identities=15%  Similarity=0.179  Sum_probs=50.1

Q ss_pred             EeeeeecCceEEEEEEEcCCCeEEEEEEeccc----------cHHHHHHHHHHHHHhcCC--CCeeeEeeEEEccCCCcc
Q 013897          139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----------KKKKIKREIKILQNLCGG--PNIVKLLDIVRDQQSKTP  206 (434)
Q Consensus       139 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~----------~~~~~~~E~~~l~~l~~h--~niv~l~~~~~~~~~~~~  206 (434)
                      .+.||.|....||++....+++.++||.-.+.          ...+...|.++|+.+..+  ..+++++.+.  .  ...
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~--~~~  106 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--T--EMA  106 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--T--TTT
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--C--CCC
Confidence            45689999999999987667788999964321          224566788888877444  3466776654  2  234


Q ss_pred             EEEEeecCCCc
Q 013897          207 SLIFEHVNNTD  217 (434)
Q Consensus       207 ~lv~e~~~~~~  217 (434)
                      ++|||++.+..
T Consensus       107 ~lvmE~L~~~~  117 (392)
T d2pula1         107 VTVMEDLSHLK  117 (392)
T ss_dssp             EEEECCCTTSE
T ss_pred             EEEEeccCCcc
Confidence            68999998743

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.60  E-value=0.00015  Score=68.77  Aligned_cols=74  Identities=14%  Similarity=0.144  Sum_probs=53.5

Q ss_pred             EeeeeecCceEEEEEEEcC-------CCeEEEEEEecc-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEEccCCCccEEEE
Q 013897          139 VRKVGRGKYSEVFEGVHCT-------DNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF  210 (434)
Q Consensus       139 ~~~lG~G~fg~Vy~~~~~~-------~~~~vaiK~~~~-~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  210 (434)
                      ++.|+.|-.-.+|++....       ..+.|++++.-. ...-...+|..+++.+..+.-.+++++++.+      .+|+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~------g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG------GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT------EEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC------ceEE
Confidence            4678889999999998643       235788888642 2234456899999998666556788888732      4899


Q ss_pred             eecCCCch
Q 013897          211 EHVNNTDF  218 (434)
Q Consensus       211 e~~~~~~l  218 (434)
                      ||+.+..+
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99987543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.47  E-value=7.5e-05  Score=68.89  Aligned_cols=68  Identities=13%  Similarity=0.238  Sum_probs=44.3

Q ss_pred             ceEEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCC-CCeeeEee-----EEEccCCCccEEEEeecCCCc
Q 013897          147 YSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGG-PNIVKLLD-----IVRDQQSKTPSLIFEHVNNTD  217 (434)
Q Consensus       147 fg~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~E~~~l~~l~~h-~niv~l~~-----~~~~~~~~~~~lv~e~~~~~~  217 (434)
                      --.||++.. .+|+.|++|+.++.  ..+++..|...+..|..+ --++..+.     .+.  .....+.+++++.|..
T Consensus        35 EN~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~--~~~~~~~l~~~~~G~~  110 (325)
T d1zyla1          35 ENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLN--HQGFYFAVFPSVGGRQ  110 (325)
T ss_dssp             SSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEE--ETTEEEEEEECCCCEE
T ss_pred             cceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeee--eeeEEEEEEeecCCcC
Confidence            358999976 67889999999764  457788999999988433 11121111     111  1244567888887743

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.91  E-value=0.00072  Score=61.54  Aligned_cols=49  Identities=14%  Similarity=0.211  Sum_probs=32.5

Q ss_pred             eEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccc-cHHHHHHHHHHHHHhc
Q 013897          136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLC  186 (434)
Q Consensus       136 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~E~~~l~~l~  186 (434)
                      ..-.+.|..|---+.|+... . +..+++|+.... ..+++..|+.++..|.
T Consensus        20 ~~~~~~i~~G~~N~ny~v~t-~-~g~yVLri~~~~~~~~~l~~~~~~l~~L~   69 (316)
T d2ppqa1          20 LTSYKGIAEGVENSNFLLHT-T-KDPLILTLYEKRVEKNDLPFFLGLMQHLA   69 (316)
T ss_dssp             EEEEEEECC---EEEEEEEE-S-SCCEEEEEECC---CCHHHHHHHHHHHHH
T ss_pred             ceEeecCCCCcccCeEEEEE-C-CCcEEEEEcCCCCCHHHHHHHHHHHHhhh
Confidence            44456677888888999875 3 345899998653 4566788888888883

>d1cjaa_ d.144.1.3 (A:) Actin-fragmin kinase, catalytic domain {Physarum polycephalum [TaxId: 5791]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Actin-fragmin kinase, catalytic domain
domain: Actin-fragmin kinase, catalytic domain
species: Physarum polycephalum [TaxId: 5791]

Probab=81.87  E-value=4.8  Score=35.03  Aligned_cols=140  Identities=16%  Similarity=0.215  Sum_probs=77.5

Q ss_pred             CCCeEEEeeeeecCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeEee----------------
Q 013897          133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLD----------------  196 (434)
Q Consensus       133 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~----------------  196 (434)
                      .+.++.++.=-.|+-| |+-+.  .++..++||.-.....+.+-.|+...-.+ .-|...-+.-                
T Consensus        68 l~~~K~i~~s~~Gs~G-v~FV~--~e~gaiVlK~s~tta~E~y~~eLAr~LGv-pvPqmRvI~~~~~E~~~~~~~~l~~~  143 (342)
T d1cjaa_          68 LQQFKGIERSEKGTEG-LFFVE--TESGVFIVKRSTNIESETFCSLLCMRLGL-HAPKVRVVSSNSEEGTNMLECLAAID  143 (342)
T ss_dssp             GGGEEEEEECCSTTSC-EEEEE--ESSCEEEEECCTTHHHHHHHHHHHHHHTC-CCCCEEEEESSSHHHHHHHHHHHHHC
T ss_pred             HHhhhceEEeecCCce-EEEEE--cCCceEEEecCCchHHHHHHHHHHHHhCC-CCCceEEecCCCHHHHHHHHHHhcCC
Confidence            3556565544445555 44443  35678888986554445555565555555 5566554430                


Q ss_pred             ----EEEccCCCccEEEEeecCCCchhhhcCCC-ChHHHHHHHHHH--HHHHHH-HHHC---Cceeec-CCCCceEecCC
Q 013897          197 ----IVRDQQSKTPSLIFEHVNNTDFKVLYPTL-SDYDVRYYIYEL--LKALDY-CHSQ---GIMHRD-VKPHNVMIDHE  264 (434)
Q Consensus       197 ----~~~~~~~~~~~lv~e~~~~~~l~~~~~~l-~~~~~~~~~~qi--~~~L~~-LH~~---~ivHrD-lKp~NIll~~~  264 (434)
                          .....-.....++|||++|..+....... +.......+.++  +-+++- ++..   .+.+|+ =.++||+++.+
T Consensus       144 e~d~~I~sel~~A~~liMeYvpG~~l~e~~~~~a~~~fs~~~l~~LGkIiaFDifInN~DR~PL~Wrn~GN~~Niml~~n  223 (342)
T d1cjaa_         144 KSFRVITTLANQANILLMELVRGITLNKLTTTSAPEVLTKSTMQQLGSLMALDVIVNNSDRLPIAWTNEGNLDNIMLSER  223 (342)
T ss_dssp             SSSCHHHHHTTCSEEEEEECCCEEESTTCCSSSHHHHSCHHHHHHHHHHHHHHHHHTCCSSSCSSSCSCCCGGGEEEESB
T ss_pred             ChhHHHHHHHhcccceeeeccCCccccccccccchhhhcHHHHHHhhhHHHHHHHHcCCccccccccCCCCccceEEecC
Confidence                00011123456899999988775543321 111112233333  233333 4432   356662 28999999988


Q ss_pred             CCeEEEEecccc
Q 013897          265 QRKLRLIDWGLA  276 (434)
Q Consensus       265 ~~~vkl~DFGla  276 (434)
                      +..+..+|=|..
T Consensus       224 ~~~~~~IDs~i~  235 (342)
T d1cjaa_         224 GATVVPIDSKII  235 (342)
T ss_dssp             TTCEEECSCCCC
T ss_pred             CcEEEEecCCcc
Confidence            878888886655